PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Huang, F; Ramakrishnan, S; Pokhrel, S; Pflueger, C; Parnell, TJ; Kasten, MM; Currie, SL; Bhachech, N; Horikoshi, M; Graves, BJ; Cairns, BR; Bhaskara, S; Chandrasekharan, MB				Huang, Fu; Ramakrishnan, Saravanan; Pokhrel, Srijana; Pflueger, Christian; Parnell, Timothy J.; Kasten, Margaret M.; Currie, Simon L.; Bhachech, Niraja; Horikoshi, Masami; Graves, Barbara J.; Cairns, Bradley R.; Bhaskara, Srividya; Chandrasekharan, Mahesh B.			Interaction of the Jhd2 Histone H3 Lys-4 Demethylase with Chromatin Is Controlled by Histone H2A Surfaces and Restricted by H2B Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene transcription; histone; histone demethylase; histone methylation; histone modification; epigenetics; nucleosome; PHD finger; protein-protein interaction; transcription; H3K4 methylation	RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; PHD FINGER; LYSINE-4 METHYLATION; GENE REPRESSION; GENOME-WIDE; TRANSCRIPTION ELONGATION; DEACETYLASE COMPLEX; DI-METHYLATION; ACTIVE GENES	Histone H3 lysine 4 (H3K4) methylation is a dynamic modification. In budding yeast, H3K4 methylation is catalyzed by the Set1-COMPASS methyltransferase complex and is removed by Jhd2, a JMJC domain family demethylase. The catalytic JmjC and JmjN domains of Jhd2 have the ability to remove all three degrees (mono-, di-, and tri-) of H3K4 methylation. Jhd2 also contains a plant homeodomain (PHD) finger required for its chromatin association and H3K4 demethylase functions. The Jhd2 PHD finger associates with chromatin independent of H3K4 methylation and the H3 N-terminal tail. Therefore, how Jhd2 associates with chromatin to perform H3K4 demethylation has remained unknown. We report a novel interaction between the Jhd2 PHD finger and histone H2A. Two residues in H2A (Phe-26 and Glu-57) serve as a binding site for Jhd2 in vitro and mediate its chromatin association and H3K4 demethylase functions in vivo. Using RNA sequencing, we have identified the functional target genes for Jhd2 and the H2A Phe-26 and Glu-57 residues. We demonstrate that H2A Phe-26 and Glu-57 residues control chromatin association and H3K4 demethylase functions of Jhd2 during positive or negative regulation of transcription at target genes. Importantly, we show that H2B Lys-123 ubiquitination blocks Jhd2 from accessing its binding site on chromatin, and thereby, we have uncovered a second mechanism by which H2B ubiquitination contributes to the trans-histone regulation of H3K4 methylation. Overall, our study provides novel insights into the chromatin binding dynamics and H3K4 demethylase functions of Jhd2.	[Ramakrishnan, Saravanan; Pokhrel, Srijana; Bhaskara, Srividya; Chandrasekharan, Mahesh B.] Univ Utah, Dept Radiat Oncol, Salt Lake City, UT 84112 USA; [Pflueger, Christian; Kasten, Margaret M.; Currie, Simon L.; Bhachech, Niraja; Graves, Barbara J.; Cairns, Bradley R.; Bhaskara, Srividya] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Ramakrishnan, Saravanan; Pokhrel, Srijana; Pflueger, Christian; Parnell, Timothy J.; Kasten, Margaret M.; Currie, Simon L.; Bhachech, Niraja; Graves, Barbara J.; Cairns, Bradley R.; Bhaskara, Srividya; Chandrasekharan, Mahesh B.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Huang, Fu] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Horikoshi, Masami] Univ Tokyo, Inst Mol & Cellular Biosci, Dev Biol Lab, Bunkyo Ku, Tokyo 1130032, Japan	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Stowers Institute for Medical Research; University of Tokyo	Chandrasekharan, MB (corresponding author), Univ Utah, Sch Med, Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	mahesh.chandrasekharan@hci.utah.edu	Pflueger, Christian/AAD-9877-2020; Chandrasekharan, Mahesh/AAF-4793-2020	Huang, Fu/0000-0001-9549-8937; Parnell, Timothy/0000-0002-3632-3691; Pflueger, Christian/0000-0002-5039-2714; Chandrasekharan, Mahesh/0000-0002-9956-8354; Bhaskara, Srividya/0000-0002-2182-9585; Currie, Simon/0000-0001-5083-1484	Huntsman Cancer Institute; Department of Radiation Oncology; Cancer Center Support Grant (Nuclear Control of Cell Growth and Differentiation program); NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038663] Funding Source: NIH RePORTER	Huntsman Cancer Institute; Department of Radiation Oncology; Cancer Center Support Grant (Nuclear Control of Cell Growth and Differentiation program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds provided by the Huntsman Cancer Institute, the Department of Radiation Oncology, and the Cancer Center Support Grant (Nuclear Control of Cell Growth and Differentiation program) (to M. B. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Chandrasekharan MB, 2011, METHODS, V54, P304, DOI 10.1016/j.ymeth.2011.02.010; Chandrasekharan MB, 2010, MOL CELL BIOL, V30, P3216, DOI 10.1128/MCB.01008-09; Chandrasekharan MB, 2009, P NATL ACAD SCI USA, V106, P16686, DOI 10.1073/pnas.0907862106; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Cheng J, 2014, MOL CELL, V53, P979, DOI 10.1016/j.molcel.2014.02.032; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Daniel JA, 2012, BBA-GENE REGUL MECH, V1819, P733, DOI 10.1016/j.bbagrm.2012.01.019; Dehe PM, 2005, J MOL BIOL, V353, P477, DOI 10.1016/j.jmb.2005.08.059; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Eissenberg JC, 2010, DEV BIOL, V339, P240, DOI 10.1016/j.ydbio.2009.08.017; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Faucher D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001082; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Gadaleta MC, 2013, BIOTECHNIQUES, V55, P259, DOI 10.2144/000114100; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; HIRSCHHORN JN, 1995, MOL CELL BIOL, V15, P1999; Huang F, 2010, J BIOL CHEM, V285, P24548, DOI 10.1074/jbc.M110.117333; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kim J, 2013, MOL CELL, V49, P1121, DOI 10.1016/j.molcel.2013.01.034; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Lalonde ME, 2014, GENE DEV, V28, P1029, DOI 10.1101/gad.236331.113; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Maltby VE, 2012, P NATL ACAD SCI USA, V109, P18505, DOI 10.1073/pnas.1202070109; Margaritis T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002952; Matsubara K, 2007, GENES CELLS, V12, P13, DOI 10.1111/j.1365-2443.2007.01031.x; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Musselman CA, 2011, NUCLEIC ACIDS RES, V39, P9061, DOI 10.1093/nar/gkr613; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Parra MA, 2007, MOL CELL BIOL, V27, P7641, DOI 10.1128/MCB.00742-07; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Pinskaya M, 2009, EPIGENETICS-US, V4, P302, DOI 10.4161/epi.4.5.9369; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rizzardi LF, 2012, GENETICS, V192, P371, DOI 10.1534/genetics.112.142349; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schulze JM, 2011, GENE DEV, V25, P2242, DOI 10.1101/gad.177220.111; Secombe J, 2007, CELL CYCLE, V6, P1324, DOI 10.4161/cc.6.11.4269; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shilatifard A, 2008, CURR OPIN CELL BIOL, V20, P341, DOI 10.1016/j.ceb.2008.03.019; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Thornton JL, 2014, GENE DEV, V28, P115, DOI 10.1101/gad.232215.113; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Walter D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004095; Weiner A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001369; Wittmeyer J, 2004, METHOD ENZYMOL, V377, P322; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Xu MS, 2012, DEV CELL, V23, P1059, DOI 10.1016/j.devcel.2012.10.005; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1; Zheng ST, 2010, MOL CELL BIOL, V30, P3635, DOI 10.1128/MCB.00324-10	76	9	9	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28760	28777		10.1074/jbc.M115.693085	http://dx.doi.org/10.1074/jbc.M115.693085			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26451043	Green Published, hybrid			2022-12-28	WOS:000365762300019
J	Smardon, AM; Nasab, ND; Tarsio, M; Diakov, TT; Kane, PM				Smardon, Anne M.; Nasab, Negin Dehdar; Tarsio, Maureen; Diakov, Theodore T.; Kane, Patricia M.			Molecular Interactions and Cellular Itinerary of the Yeast RAVE (Regulator of the H+-ATPase of Vacuolar and Endosomal Membranes) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASE; SACCHAROMYCES-CEREVISIAE; SUBUNIT-C; CRYSTAL-STRUCTURE; IN-VIVO; PROTEIN; DOMAIN; RABCONNECTIN-3; PURIFICATION; PREDICTION	The RAVE complex (regulator of the H+-ATPase of vacuolar and endosomal membranes) is required for biosynthetic assembly and glucose-stimulated reassembly of the yeast vacuolar H+-ATPase (V-ATPase). Yeast RAVE contains three subunits: Rav1, Rav2, and Skp1. Rav1 is the largest subunit, and it binds Rav2 and Skp1 of RAVE; the E, G, and C subunits of the V-TPase peripheral V-1 sector; and Vph1 of the membrane Vo sector. We identified Rav1 regions required for interaction with its binding partners through deletion analysis, co-immunoprecipitation, two-hybrid assay, and pulldown assays with expressed proteins. We find that Skp1 binding requires sequences near the C terminus of Rav1, V-1 subunits E and C bind to a conserved region in the C-terminal half of Rav1, and the cytosolic domain of Vph1 binds near the junction of the Rav1 N- and C-terminal halves. In contrast, Rav2 binds to the N-terminal domain of Rav1, which can be modeled as a double beta-propeller. Only the V-1 C subunit binds to both Rav1 and Rav2. Using GFP-tagged RAVE subunits in vivo, we demonstrate glucose-dependent association of RAVE with the vacuolar membrane, consistent with its role in glucose-dependent V-ATPase assembly. It is known that V-1 subunit C localizes to the V-1-V-o interface in assembled V-ATPase complexes and is important in regulated disassembly of V-ATPases. We propose that RAVE cycles between cytosol and vacuolar membrane in a glucose-dependent manner, positioning V-1 and V-0 subcomplexes and orienting the V-1 C subunit to promote assembly.	[Smardon, Anne M.; Nasab, Negin Dehdar; Tarsio, Maureen; Diakov, Theodore T.; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, PM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	kanepm@upstate.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 GM50322, R01 GM63742]; American Heart Association postdoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063742, R01GM050322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM50322 and R01 GM63742 (to P. M. K.) and an American Heart Association postdoctoral fellowship (to A. M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bai C, 1997, METHOD ENZYMOL, V283, P141; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Brace EJ, 2006, EUKARYOT CELL, V5, P2104, DOI 10.1128/EC.00347-05; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Diepholz M, 2008, BIOCHEM SOC T, V36, P1027, DOI 10.1042/BST0361027; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; Einhorn Z, 2012, J NEUROSCI, V32, P11144, DOI 10.1523/JNEUROSCI.1705-12.2012; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; HO MN, 1993, J BIOL CHEM, V268, P221; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; James P, 1996, GENETICS, V144, P1425; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; KANE PM, 1995, J BIOL CHEM, V270, P17025; KANE PM, 1992, J BIOL CHEM, V267, P447; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Li KW, 2012, PROTEOMICS, V12, P2428, DOI 10.1002/pmic.201100675; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Oot RA, 2012, J BIOL CHEM, V287, P13396, DOI 10.1074/jbc.M112.343962; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Rawson S, 2015, STRUCTURE, V23, P461, DOI 10.1016/j.str.2014.12.016; Sakisaka T, 2005, METHOD ENZYMOL, V403, P401, DOI 10.1016/S0076-6879(05)03035-1; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Sethi N, 2010, J BIOL CHEM, V285, P34757, DOI 10.1074/jbc.M110.158634; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Smardon AM, 2014, MOL BIOL CELL, V25, P356, DOI 10.1091/mbc.E13-05-0231; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Tabke K, 2014, BIOCHEM J, V462, P185, DOI 10.1042/BJ20131293; Voegtli WC, 2003, J BIOL CHEM, V278, P34373, DOI 10.1074/jbc.M302773200; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; Yan Y, 2009, DEV CELL, V17, P387, DOI 10.1016/j.devcel.2009.07.001; ZHANG JM, 1992, J BIOL CHEM, V267, P9773; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365	49	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27511	27523		10.1074/jbc.M115.667634	http://dx.doi.org/10.1074/jbc.M115.667634			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26405040	Green Published, hybrid			2022-12-28	WOS:000365757500007
J	Nariai, Y; Mizuguchi, H; Ogasawara, T; Nagai, H; Sasaki, Y; Okamoto, Y; Yoshimura, Y; Kitamura, Y; Nemoto, H; Takeda, N; Fukui, H				Nariai, Yuki; Mizuguchi, Hiroyuki; Ogasawara, Takeyasu; Nagai, Hiroaki; Sasaki, Yohei; Okamoto, Yasunobu; Yoshimura, Yoshiyuki; Kitamura, Yoshiaki; Nemoto, Hisao; Takeda, Noriaki; Fukui, Hiroyuki			Disruption of Heat Shock Protein 90 (Hsp90)-Protein Kinase C delta (PKC delta) Interaction by (-)-Maackiain Suppresses Histamine H-1 Receptor Gene Transcription in HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESEASONAL PROPHYLACTIC TREATMENT; FLUORESCENCE POLARIZATION ASSAY; UP-REGULATION; ALLERGIC RHINITIS; MESSENGER-RNA; NASAL-MUCOSA; HISTIDINE-DECARBOXYLASE; MOLECULAR CHAPERONE; SIGNALING PATHWAY; HSP90	Background: The molecular mechanism of anti-allergic (-)-maackiain remains unknown. Results: (-)-Maackiain and Hsp90 inhibitors inhibited PKC delta activation and suppressed H1R gene expression. Conclusion: (-)-Maackiain is a novel Hsp90 pathway inhibitor, and its anti-allergic activity underlies the disruption of Hsp90-PKC delta interaction. Significance: Hsp90 is involved in H1R gene up-regulation, and its inhibition could be a novel therapeutic strategy for allergic rhinitis. The histamine H-1 receptor (H1R) gene is an allergic disease sensitive gene, and its expression level is strongly correlated with the severity of allergic symptoms. (-)-Maackiain was identified as a Kujin-derived anti-allergic compound that suppresses the up-regulation of the H1R gene. However, the underlying mechanism of H1R gene suppression remains unknown. Here, we sought to identify a target protein of (-)-maackiain and investigate its mechanism of action. A fluorescence quenching assay and immunoblot analysis identified heat shock protein 90 (Hsp90) as a target protein of (-)-maackiain. A pull-down assay revealed that (-)-maackiain disrupted the interaction of Hsp90 with PKC delta, resulting in the suppression of phorbol 12-myristate 13-acetate (PMA)-induced up-regulation of H1R gene expression in HeLa cells. Additional Hsp90 inhibitors, including 17-(allylamino)-17-demethoxygeldanamycin, celastrol, and novobiocin also suppressed PMA-induced H1R gene up-regulation. 17-(Allylamino)-17-demethoxygeldanamycin inhibited PKC delta translocation to the Golgi and phosphorylation of Tyr(311) on PKC delta. These data suggest that (-)-maackiain is a novel Hsp90 pathway inhibitor. The underlying mechanism of the suppression of PMA-induced up-regulation of H1R gene expression by (-)-maackiain and Hsp90 inhibitors is the inhibition of PKC delta activation through the disruption of Hsp90-PKC delta interaction. Involvement of Hsp90 in H1R gene up-regulation suggests that suppression of the Hsp90 pathway could be a novel therapeutic strategy for allergic rhinitis.	[Nariai, Yuki; Mizuguchi, Hiroyuki; Ogasawara, Takeyasu; Nagai, Hiroaki; Sasaki, Yohei; Okamoto, Yasunobu] Univ Tokushima, Grad Sch, Dept Mol Pharmacol, Inst Biomed Sci, Tokushima 7708505, Japan; [Yoshimura, Yoshiyuki] Univ Tokushima, Grad Sch, Dept Clin Pharm, Inst Biomed Sci, Tokushima 7708505, Japan; [Kitamura, Yoshiaki; Takeda, Noriaki] Univ Tokushima, Grad Sch, Dept Otolaryngol, Inst Biomed Sci, Tokushima 7708505, Japan; [Nemoto, Hisao] Univ Tokushima, Grad Sch, Dept Pharmaceut Chem, Inst Biomed Sci, Tokushima 7708505, Japan; [Fukui, Hiroyuki] Univ Tokushima, Grad Sch, Dept Mol Studies Incurable Dis, Inst Biomed Sci, Tokushima 7708505, Japan	Tokushima University; Tokushima University; Tokushima University; Tokushima University; Tokushima University	Mizuguchi, H (corresponding author), Univ Tokushima, Grad Sch, Dept Mol Pharmacol, Inst Biomed Sci, Tokushima 7708505, Japan.	guchi003@tokushima-u.ac.jp			Ministry of Health Labor and Welfare of Japan [10103185]; Japan Society for the Promotion of Science [26305004, 22580132, 15K07933]; Osaka Medical Research Foundation	Ministry of Health Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka Medical Research Foundation	This work was supported in part by Grant-in-Aid 10103185 for Research on Allergic Disease and Immunology from the Ministry of Health Labor and Welfare of Japan (to H. F.), Grants-in-Aid for Scientific Research (B) 26305004 (to H. F.) and Scientific Research (C) 22580132 (to H. M.) and 15K07933 (to H. M.) from the Japan Society for the Promotion of Science, and by a grant from the Osaka Medical Research Foundation for Incurable Diseases. The authors declare that they have no conflicts of interest with the contents of this article.	Bohl M, 2005, ANAL BIOCHEM, V346, P295, DOI 10.1016/j.ab.2005.08.037; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Chadli A, 2010, J BIOL CHEM, V285, P4224, DOI 10.1074/jbc.M109.081018; Church M. K., 2012, ALLERGY, P147; Das AK, 2007, J PHARMACOL SCI, V103, P374, DOI 10.1254/jphs.FP0061411; Dev S, 2009, J PHARMACOL SCI, V109, P606, DOI 10.1254/jphs.09003FP; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Gould CM, 2009, J BIOL CHEM, V284, P4921, DOI 10.1074/jbc.M808436200; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Gray PJ, 2008, NAT REV CANCER, V8, P491, DOI 10.1038/nrc2420; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Hattori M, 2013, INT IMMUNOPHARMACOL, V15, P232, DOI 10.1016/j.intimp.2012.12.030; HONDA G, 1982, PLANTA MED, V46, P122, DOI 10.1055/s-2007-970034; Howes R, 2006, ANAL BIOCHEM, V350, P202, DOI 10.1016/j.ab.2005.12.023; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kim J, 2004, J BIOMOL SCREEN, V9, P375, DOI 10.1177/1087057104265995; Kitamura Y, 2004, ACTA OTO-LARYNGOL, V124, P1053, DOI 10.1080/00016480410022525; Kitamura Y, 2012, ACTA OTO-LARYNGOL, V132, P434, DOI 10.3109/00016489.2011.644804; Langer T, 2003, CELL BIOL INT, V27, P47, DOI 10.1016/S1065-6995(02)00256-1; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Matsushita C., 2008, Journal of Traditional Medicines, V25, P133; Millson SH, 2007, FEBS J, V274, P4453, DOI 10.1111/j.1742-4658.2007.05974.x; Mizuguchi H, 2010, METHOD FIND EXP CLIN, V32, P745, DOI 10.1358/mf.2010.32.10.1533687; Mizuguchi H., PHARM RES PERSPECT, V3; Mizuguchi H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00916; Mizuguchi H, 2011, J BIOL CHEM, V286, P30542, DOI 10.1074/jbc.M111.253104; Mizuguchi H, 2008, J PHARMACOL SCI, V108, P480, DOI 10.1254/jphs.08222FP; Morimoto RI, 1998, NAT BIOTECHNOL, V16, P833, DOI 10.1038/nbt0998-833; Nathan RA, 1997, J ALLERGY CLIN IMMUN, V99, pS808, DOI 10.1016/S0091-6749(97)80040-1; Nurul IM, 2011, INT IMMUNOPHARMACOL, V11, P1766, DOI 10.1016/j.intimp.2011.07.003; Okubo K, 2014, ALLERGOL INT, V63, P357, DOI 10.2332/allergolint.14-RAI-0768; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Rowlands MG, 2004, ANAL BIOCHEM, V327, P176, DOI 10.1016/j.ab.2003.10.038; Shahriar M, 2009, J IMMUNOL, V183, P2133, DOI 10.4049/jimmunol.0901058; SHIBATA S, 1963, CHEM PHARM BULL, V11, P167; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Wang HB, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227991; Yoshimura Y, 2002, BIOCHEM BIOPH RES CO, V290, P948, DOI 10.1006/bbrc.2001.6320; Yun BG, 2004, BIOCHEMISTRY-US, V43, P8217, DOI 10.1021/bi0497998; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532	42	15	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27393	27402		10.1074/jbc.M115.657023	http://dx.doi.org/10.1074/jbc.M115.657023			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26391399	Green Published, hybrid			2022-12-28	WOS:000364794000045
J	Hu, F; Shi, XL; Li, BW; Huang, XC; Morelli, X; Shi, N				Hu, Fen; Shi, Xiaoli; Li, Bowen; Huang, Xiaochen; Morelli, Xavier; Shi, Ning			Structural Basis for the Interaction between the Golgi Reassembly-stacking Protein GRASP65 and the Golgi Matrix Protein GM130	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICLE-TETHERING PROTEIN; P115; COMPONENTS; CISTERNAE; TRANSPORT; RIBBON; ROLES; PHOSPHORYLATION; FEATURES; GIANTIN	GM130 and GRASP65 are Golgi peripheral membrane proteins that play a key role in Golgi stacking and vesicle tethering. However, the molecular details of their interaction and their structural role as a functional unit remain unclear. Here, we present the crystal structure of the PDZ domains of GRASP65 in complex with the GM130 C-terminal peptide at 1.96-angstrom resolution. In contrast to previous findings proposing that GM130 interacts with GRASP65 at the PDZ2 domain only, our crystal structure of the complex indicates that GM130 binds to GRASP65 at two distinct sites concurrently and that both the PDZ1 and PDZ2 domains of GRASP65 participate in this molecular interaction. Mutagenesis experiments support these structural observations and demonstrate that they are required for GRASP65-GM130 association.	[Hu, Fen; Shi, Xiaoli; Li, Bowen; Huang, Xiaochen; Shi, Ning] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China; [Morelli, Xavier] Aix Marseille Univ, INSERM, CNRS, Inst Paoli Calmettes,UMR7258,U1068,UM105, F-13009 Marseille, France	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Shi, N (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, 155 Yangqiao Rd West, Fuzhou 350002, Peoples R China.	shining@fjirsm.ac.cn	morelli, xavier/A-9218-2016	morelli, xavier/0000-0001-8101-7901	National Natural Science Foundation of China [31370738]; One Hundred Person Project of the Chinese Academy of Sciences; National Science Foundation of Fujian Province [2013J01150]; Campus France (PHC CAI YUANPEI) [26203WD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); One Hundred Person Project of the Chinese Academy of Sciences; National Science Foundation of Fujian Province; Campus France (PHC CAI YUANPEI)	This work was supported by the National Natural Science Foundation of China Grant 31370738, the One Hundred Person Project of the Chinese Academy of Sciences, the National Science Foundation of Fujian Province (2013J01150) and Campus France (PHC CAI YUANPEI 2013, Project 26203WD). The authors declare that they have no conflict of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; An Y, 2009, J MOL BIOL, V391, P26, DOI 10.1016/j.jmb.2009.04.062; Bachert C, 2010, J BIOL CHEM, V285, P16294, DOI 10.1074/jbc.M110.116129; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; CLUETT EB, 1992, J CELL SCI, V103, P773; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; Dirac-Svejstrup AB, 2000, J CELL BIOL, V150, P475, DOI 10.1083/jcb.150.3.475; Duran JM, 2008, MOL BIOL CELL, V19, P2579, DOI 10.1091/mbc.E07-10-0998; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FARQUHAR MG, 1981, J CELL BIOL, V91, pS77, DOI 10.1083/jcb.91.3.77s; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Feng YB, 2013, J BIOL CHEM, V288, P28418, DOI 10.1074/jbc.M113.478024; Jarvela T, 2014, MOL BIOL CELL, V25, P133, DOI 10.1091/mbc.E13-07-0395; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Klumperman J, 2011, COLD SPRING HARBOR P, V3, P1, DOI DOI 10.1101/CSHPERSPECTA005181; Kodani A, 2008, MOL BIOL CELL, V19, P745, DOI 10.1091/mbc.E07-08-0847; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Linstedt AD, 2000, J BIOL CHEM, V275, P10196, DOI 10.1074/jbc.275.14.10196; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nakamura N, 2010, J PHARMACOL SCI, V112, P255, DOI 10.1254/jphs.09R03CR; Orci L, 1998, P NATL ACAD SCI USA, V95, P2279, DOI 10.1073/pnas.95.5.2279; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Puthenveedu MA, 2001, J CELL BIOL, V155, P227, DOI 10.1083/jcb.200105005; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; RAMBOURG A, 1990, EUR J CELL BIOL, V51, P189; Ren JQ, 2015, BIOCHEM J, V468, P133, DOI 10.1042/BJ20141473; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Seemann J, 2000, MOL BIOL CELL, V11, P635, DOI 10.1091/mbc.11.2.635; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Striegl H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004656; Tang DM, 2012, BIOL OPEN, V1, P1204, DOI 10.1242/bio.20122659; Truschel ST, 2012, J BIOL CHEM, V287, P19870, DOI 10.1074/jbc.M111.326256; Truschel ST, 2011, J BIOL CHEM, V286, P20125, DOI 10.1074/jbc.C111.245324; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Xiang Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2669; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132; Zaccai NR, 2011, NAT CHEM BIOL, V7, P935, DOI [10.1038/nchembio.692, 10.1038/NCHEMBIO.692]	47	24	27	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26373	26382		10.1074/jbc.M115.657940	http://dx.doi.org/10.1074/jbc.M115.657940			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26363069	Green Published, hybrid			2022-12-28	WOS:000364793600003
J	Lussier, A; Bastet, L; Chauvier, A; Lafontaine, DA				Lussier, Antony; Bastet, Laurene; Chauvier, Adrien; Lafontaine, Daniel A.			A Kissing Loop Is Important for btuB Riboswitch Ligand Sensing and Regulatory Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; ESCHERICHIA-COLI; GENETIC-CONTROL; APTAMER DOMAIN; COENZYME B-12; NASCENT RNA; TRANSCRIPTION; BINDING; EXPRESSION; INSIGHTS	RNA-based genetic regulation is exemplified by metabolite-binding riboswitches that modulate gene expression through conformational changes. Crystal structures show that the Escherichia coli btuB riboswitch contains a kissing loop interaction that is in close proximity to the bound ligand. To analyze the role of the kissing loop interaction in the riboswitch regulatory mechanism, we used RNase H cleavage assays to probe the structure of nascent riboswitch transcripts produced by the E. coli RNA polymerase. By monitoring the folding of the aptamer, kissing loop, and riboswitch expression platform, we established the conformation of each structural component in the absence or presence of bound adenosylcobalamin. We found that the kissing loop interaction is not essential for ligand binding. However, we showed that kissing loop formation improves ligand binding efficiency and is required to couple ligand binding to the riboswitch conformational changes involved in regulating gene expression. These results support a mechanism by which the btuB riboswitch modulates the formation of a tertiary structure to perform metabolite sensing and regulate gene expression.	[Lussier, Antony; Bastet, Laurene; Chauvier, Adrien; Lafontaine, Daniel A.] Univ Sherbrooke, Dept Biol, RNA Grp, Fac Sci, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Lafontaine, DA (corresponding author), Univ Sherbrooke, Dept Biol, RNA Grp, Fac Sci, 2500 Blvd Univ, Sherbrooke, PQ J1K 2R1, Canada.	Daniel.Lafontaine@USherbrooke.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research. The authors declare that they have no conflicts of interest with the contents of this article.	Andersen AA, 2000, MOL CELL, V5, P469, DOI 10.1016/S1097-2765(00)80441-4; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Batey RT, 2012, Q REV BIOPHYS, V45, P345, DOI 10.1017/S0033583512000078; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Blouin S, 2007, RNA, V13, P1256, DOI 10.1261/rna.560307; Blouin S, 2011, NUCLEIC ACIDS RES, V39, P3373, DOI 10.1093/nar/gkq1247; BRADBEER C, 1978, J BIOL CHEM, V253, P1347; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Caron MP, 2012, P NATL ACAD SCI USA, V109, pE3444, DOI 10.1073/pnas.1214024109; Choudhary PK, 2014, RNA, V20, P36, DOI 10.1261/rna.039909.113; Dalgarno PA, 2013, NUCLEIC ACIDS RES, V41, P4253, DOI 10.1093/nar/gkt128; Gallo S, 2008, CHEMBIOCHEM, V9, P1408, DOI 10.1002/cbic.200800099; Garst AD, 2009, BBA-GENE REGUL MECH, V1789, P584, DOI 10.1016/j.bbagrm.2009.06.004; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Haller A, 2011, NAT CHEM BIOL, V7, P393, DOI [10.1038/NCHEMBIO.562, 10.1038/nchembio.562]; Heppell B, 2011, NAT CHEM BIOL, V7, P384, DOI [10.1038/NCHEMBIO.563, 10.1038/nchembio.563]; Hollands K, 2012, P NATL ACAD SCI USA, V109, P5376, DOI 10.1073/pnas.1112211109; Johnson JE, 2012, NATURE, V492, P133, DOI 10.1038/nature11607; Kalyani BS, 2011, J MOL BIOL, V413, P548, DOI 10.1016/j.jmb.2011.08.053; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Mandin P, 2009, MOL MICROBIOL, V72, P551, DOI 10.1111/j.1365-2958.2009.06665.x; Marsh ENG, 1999, ESSAYS BIOCHEM, V34, P139; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MONFORTE JA, 1990, BIOCHEMISTRY-US, V29, P7882, DOI 10.1021/bi00486a015; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Nechooshtan G, 2009, GENE DEV, V23, P2650, DOI 10.1101/gad.552209; Nou XW, 1998, J BACTERIOL, V180, P6719, DOI 10.1128/JB.180.24.6719-6728.1998; Nou XW, 2000, P NATL ACAD SCI USA, V97, P7190, DOI 10.1073/pnas.130013897; Nudler E, 2003, METHOD ENZYMOL, V371, P160; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Perdrizet GA, 2012, P NATL ACAD SCI USA, V109, P3323, DOI 10.1073/pnas.1113086109; Peselis A, 2014, BBA-GENE REGUL MECH, V1839, P908, DOI 10.1016/j.bbagrm.2014.02.012; Peselis A, 2012, NAT STRUCT MOL BIOL, V19, P1182, DOI 10.1038/nsmb.2405; Pleiss JA, 1998, RNA, V4, P1313, DOI 10.1017/S135583829800106X; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Souliere MF, 2013, ANGEW CHEM INT EDIT, V52, P1874, DOI 10.1002/anie.201208167; Treiber DK, 2000, METHOD ENZYMOL, V317, P330; Tremblay R, 2011, J BIOL CHEM, V286, P27406, DOI 10.1074/jbc.M111.229047; Vitreschak AG, 2003, RNA, V9, P1084, DOI 10.1261/rna.5710303; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wong TN, 2007, P NATL ACAD SCI USA, V104, P17995, DOI 10.1073/pnas.0705038104; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zarrinkar PP, 1996, RNA, V2, P564; ZARRINKAR PP, 1994, SCIENCE, V265, P918, DOI 10.1126/science.8052848	51	9	10	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26739	26751		10.1074/jbc.M115.684134	http://dx.doi.org/10.1074/jbc.M115.684134			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370077	hybrid, Green Published			2022-12-28	WOS:000364793600036
J	Okla, M; Wang, W; Kang, I; Pashaj, A; Carr, T; Chung, SY				Okla, Meshail; Wang, Wei; Kang, Inhae; Pashaj, Anjeza; Carr, Timothy; Chung, Soonkyu			Activation of Toll-like Receptor 4 (TLR4) Attenuates Adaptive Thermogenesis via Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; STEM-CELLS; CHRONIC INFLAMMATION; INSULIN-RESISTANCE; OBESITY; FAT; AUTOPHAGY; WHITE; BRITE; COLD	Adaptive thermogenesis is the cellular process transforming chemical energy into heat in response to cold. A decrease in adaptive thermogenesis is a contributing factor to obesity. However, the molecular mechanisms responsible for the compromised adaptive thermogenesis in obese subjects have not yet been elucidated. In this study we hypothesized that Toll-like receptor 4 (TLR4) activation and subsequent inflammatory responses are key regulators to suppress adaptive thermogenesis. To test this hypothesis, C57BL/6 mice were either fed a palmitate-enriched high fat diet or administered with chronic low-dose LPS before cold acclimation. TLR4 stimulation by a high fat diet or LPS were both associated with reduced core body temperature and heat release. Impairment of thermogenic activation was correlated with diminished expression of brown-specific markers and mitochondrial dysfunction in subcutaneous white adipose tissue (sWAT). Defective sWAT browning was concomitant with elevated levels of endoplasmic reticulum (ER) stress and autophagy. Consistently, TLR4 activation by LPS abolished cAMP-induced up-regulation of uncoupling protein 1 (UCP1) in primary human adipocytes, which was reversed by silencing of C/EBP homologous protein (CHOP). Moreover, the inactivation of ER stress by genetic deletion of CHOP or chemical chaperone conferred a resistance to the LPS-induced suppression of adaptive thermogenesis. Collectively, our data indicate the existence of a novel signaling network that links TLR4 activation, ER stress, and mitochondrial dysfunction, thereby antagonizing thermogenic activation of sWAT. Our results also suggest that TLR4/ER stress axis activation may be a responsible mechanism for obesity-mediated defective brown adipose tissue activation.	[Okla, Meshail; Wang, Wei; Kang, Inhae; Pashaj, Anjeza; Carr, Timothy; Chung, Soonkyu] Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Chung, SY (corresponding author), Univ Nebraska, Dept Nutr & Hlth Sci, 316G Ruth Leverton Hall,POB 830806, Lincoln, NE 68583 USA.	schung4@unl.edu	Regan, Clinton/E-6250-2012; Okla, Meshail S/E-9317-2017	Chung, Soonkyu/0000-0001-6279-7017	National Institutes of Health [1P20GM104320]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1P20GM104320 (Project 5; to S. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Arruda AP, 2011, ENDOCRINOLOGY, V152, P1314, DOI 10.1210/en.2010-0659; Bae JY, 2015, BIOCHEM CELL BIOL, V93, P251, DOI 10.1139/bcb-2014-0139; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Crane JD, 2014, MOL METAB, V3, P490, DOI 10.1016/j.molmet.2014.04.007; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Gawronska-Kozak B, 2014, METHOD ENZYMOL, V538, P1, DOI 10.1016/B978-0-12-800280-3.00001-3; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Heinonen S, 2015, DIABETES, V64, P3135, DOI 10.2337/db14-1937; Hotamisligil Gokhan S, 2007, Novartis Found Symp, V286, P86; Jansen HJ, 2012, ENDOCRINOLOGY, V153, P5866, DOI 10.1210/en.2012-1625; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kovsan J, 2011, J CLIN ENDOCR METAB, V96, pE268, DOI 10.1210/jc.2010-1681; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Lee YK, 2013, NAT CELL BIOL, V15, P568, DOI 10.1038/ncb2776; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu XM, 2015, ENDOCRINOLOGY, V156, P2461, DOI 10.1210/en.2014-1598; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maris M, 2012, DIABETOLOGIA, V55, P1167, DOI 10.1007/s00125-011-2427-7; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nunez CE, 2013, INT J OBESITY, V37, P1473, DOI 10.1038/ijo.2013.27; Okla M, 2015, LIPIDS, V50, P111, DOI 10.1007/s11745-014-3981-9; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pierre N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065061; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rosenwald M, 2014, ADIPOCYTE, V3, P4, DOI 10.4161/adip.26232; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sakamoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC729, DOI 10.1152/ajpcell.00312.2012; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Staszkiewicz J, 2010, STEM CELLS DEV, V19, P83, DOI 10.1089/scd.2009.0051; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Valdearcos M, 2015, ANNU REV PHYSIOL, V77, P131, DOI 10.1146/annurev-physiol-021014-071656; Vosselman MJ, 2012, DIABETES, V61, P3106, DOI 10.2337/db12-0288; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang Y, 2009, P NATL ACAD SCI USA, V106, P19860, DOI 10.1073/pnas.0906048106	49	68	70	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26476	26490		10.1074/jbc.M115.677724	http://dx.doi.org/10.1074/jbc.M115.677724			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370079	Green Published, hybrid			2022-12-28	WOS:000364793600017
J	Hogan, MF; Ravnskjaer, K; Matsumura, S; Huising, MO; Hull, RL; Kahn, SE; Montminy, M				Hogan, Meghan F.; Ravnskjaer, Kim; Matsumura, Shigenobu; Huising, Mark O.; Hull, Rebecca L.; Kahn, Steven E.; Montminy, Marc			Hepatic Insulin Resistance Following Chronic Activation of the CREB Coactivator CRTC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL PROLIFERATION; FREE FATTY-ACIDS; GLUCOSE-METABOLISM; GENE-EXPRESSION; LIVER; TORC2; GLUCONEOGENESIS; OBESITY; MICE; ISLET	Under fasting conditions, increases in circulating concentrations of glucagon maintain glucose homeostasis via the induction of hepatic gluconeogenesis. Triggering of the cAMP pathway in hepatocytes stimulates the gluconeogenic program via the PKA-mediated phosphorylation of CREB and dephosphorylation of the cAMP-regulated CREB coactivators CRTC2 and CRTC3. In parallel, decreases in circulating insulin also increase gluconeogenic gene expression via the de-phosphorylation and activation of the forkhead transcription factor FOXO1. Hepatic gluconeogenesis is increased in insulin resistance where it contributes to the attendant hyperglycemia. Whether selective activation of the hepatic CREB/CRTC pathway is sufficient to trigger metabolic changes in other tissues is unclear, however. Modest hepatic expression of a phosphorylation-defective and therefore constitutively active CRTC2S171,275A protein increased gluconeogenic gene expression under fasting as well as feeding conditions. Circulating glucose concentrations were constitutively elevated in CRTC2S(171,275)A-expressing mice, leading to compensatory increases in circulating insulin concentrations that enhance FOXO1 phosphorylation. Despite accompanying decreases in FOXO1 activity, hepatic gluconeogenic gene expression remained elevated in CRTC2S(171,275)A mice, demonstrating that chronic increases inCRTC2activity in the liver are indeed sufficient to promote hepatic insulin resistance and to disrupt glucose homeostasis.	[Hogan, Meghan F.; Ravnskjaer, Kim; Matsumura, Shigenobu; Huising, Mark O.; Montminy, Marc] Salk Inst Biol Studies, Peptide Biol Labs, La Jolla, CA 92037 USA; [Hogan, Meghan F.; Hull, Rebecca L.; Kahn, Steven E.] VA Puget Sound Hlth Care Syst, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98108 USA; [Hogan, Meghan F.; Hull, Rebecca L.; Kahn, Steven E.] Univ Washington, Seattle, WA 98108 USA; [Ravnskjaer, Kim] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Matsumura, Shigenobu] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Sakyo Ku, Kyoto 6068502, Japan; [Huising, Mark O.] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	Salk Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Southern Denmark; Kyoto University; University of California System; University of California Davis	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Hull-Meichle, Rebecca L./CAG-5879-2022; Matsumura, Shigenobu/Z-2088-2019; Regan, Clinton/E-6250-2012; Huising, Mark O./H-3885-2019; Hogan, Meghan/AAD-4425-2020; Ravnskjaer, Kim/GRJ-3065-2022	Huising, Mark O./0000-0002-6594-2205; Ravnskjaer, Kim/0000-0002-5322-3887; Hogan, Meghan/0000-0002-5767-1599; Hull, Rebecca/0000-0001-9690-4087; Kahn, Steven/0000-0001-7307-9002	National Institutes of Health [R37DK083834, 5T32GM007240, 5R01DK088082]; Clayton Foundation for Medical Research; Kieckhefer Foundation; Leona M. and Harry B. Helmsley Charitable Trust Grant [2012-PG-MED002]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088082, R37DK083834, P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Foundation for Medical Research; Kieckhefer Foundation; Leona M. and Harry B. Helmsley Charitable Trust Grant; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R37DK083834 (to M. M., M. F. H.); 5T32GM007240 (to M. F. H.); 5R01DK088082 (to R. L. H.); The Clayton Foundation for Medical Research (to M. M.), the Kieckhefer Foundation (to M. M.), the Leona M. and Harry B. Helmsley Charitable Trust Grant # 2012-PG-MED002 (to M. M., M. F. H.); and the Department of Veterans Affairs (S. E. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Garcia-Ocana A, 2000, J BIOL CHEM, V275, P1226, DOI 10.1074/jbc.275.2.1226; HAGIWARA M, 1993, MOL CELL BIOL, V13, P4852, DOI 10.1128/MCB.13.8.4852; Hardy OT, 2012, CURR OPIN ENDOCRINOL, V19, P81, DOI 10.1097/MED.0b013e3283514e13; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hull R, 2005, DIABETOLOGIA, V48, P1350, DOI 10.1007/s00125-005-1772-9; Hull RL, 2003, DIABETES, V52, P372, DOI 10.2337/diabetes.52.2.372; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Le Lay J, 2009, CELL METAB, V10, P55, DOI 10.1016/j.cmet.2009.06.006; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Luo Q, 2012, P NATL ACAD SCI USA, V109, P20865, DOI 10.1073/pnas.1219028109; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Nielsen JH, 1999, J MOL MED-JMM, V77, P62; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Ravnskjaer K, 2013, J CLIN INVEST, V123, P4318, DOI 10.1172/JCI69035; Ryysy L, 2000, DIABETES, V49, P749, DOI 10.2337/diabetes.49.5.749; Saberi M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1137, DOI 10.1152/ajpendo.00158.2009; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Song Y, 2010, NATURE, V468, P933, DOI 10.1038/nature09564; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Uebi T, 2010, AM J PHYSIOL-ENDOC M, V299, pE413, DOI 10.1152/ajpendo.00525.2009; van der Meulen T, 2015, NAT MED, V21, P769, DOI 10.1038/nm.3872; Wang XL, 2009, CELL METAB, V9, P428, DOI 10.1016/j.cmet.2009.04.001; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107	34	21	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25997	26006		10.1074/jbc.M115.679266	http://dx.doi.org/10.1074/jbc.M115.679266			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26342077	Green Published, hybrid			2022-12-28	WOS:000363527300021
J	Chan, AH; Yi, SW; Terwilliger, AL; Maresso, AW; Jung, ME; Clubb, RT				Chan, Albert H.; Yi, Sung Wook; Terwilliger, Austen L.; Maresso, Anthony W.; Jung, Michael E.; Clubb, Robert T.			Structure of the Bacillus anthracis Sortase A Enzyme Bound to Its Sorting Signal A FLEXIBLE AMINO-TERMINAL APPENDAGE MODULATES SUBSTRATE ACCESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE RELAXATION; NMR STRUCTURE DETERMINATION; MODEL-FREE APPROACH; STAPHYLOCOCCUS-AUREUS; SURFACE PROTEIN; ACTIVE-SITE; CELL-WALL; KINETIC MECHANISM; DIPOLAR COUPLINGS; MACROMOLECULES	The endospore forming bacterium Bacillus anthracis causes lethal anthrax disease in humans and animals. The ability of this pathogen to replicate within macrophages is dependent upon the display of bacterial surface proteins attached to the cell wall by the B. anthracis Sortase A ((Ba)SrtA) enzyme. Previously, we discovered that the class A (Ba)SrtA sortase contains a unique N-terminal appendage that wraps around the body of the protein to contact the active site of the enzyme. To gain insight into its function, we determined the NMR structure of (Ba)SrtA bound to a LPXTG sorting signal analog. The structure, combined with dynamics, kinetics, and whole cell protein display data suggest that the N terminus modulates substrate access to the enzyme. We propose that it may increase the efficiency of protein display by reducing the unproductive hydrolytic cleavage of enzyme-protein covalent intermediates that form during the cell wall anchoring reaction. Notably, a key active site loop (beta 7/beta 8 loop) undergoes a disordered to ordered transition upon binding the sorting signal, potentially facilitating recognition of lipid II.	[Chan, Albert H.; Yi, Sung Wook; Jung, Michael E.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Chan, Albert H.; Clubb, Robert T.] Univ Calif Los Angeles, DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Chan, Albert H.; Clubb, Robert T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Terwilliger, Austen L.; Maresso, Anthony W.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Baylor College of Medicine	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 602 Boyer Hall, Los Angeles, CA 90095 USA.	rclubb@mbi.ucla.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [AI52217, AI097167, AI109465, T32 GM008496]; Department of Energy [DE-FC-03-87ER60615]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI109465, R01AI052217, R01AI097167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008496] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016336] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants AI52217 (to R. T. C. and M. E. J.), AI097167 and AI109465 (to A. W. M.), and T32 GM008496 (to A. H. C.) and Department of Energy Grant DE-FC-03-87ER60615. The authors declare that they have no conflicts of interest with the contents of this article.	Aucher W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027411; Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8; Berjanskii MV, 2008, J BIOMOL NMR, V40, P31, DOI 10.1007/s10858-007-9208-0; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Brenke R, 2009, BIOINFORMATICS, V25, P621, DOI 10.1093/bioinformatics/btp036; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; Cascioferro S, 2014, MICROB PATHOGENESIS, V77, P105, DOI 10.1016/j.micpath.2014.10.007; Case DA, 2012, AMBER 12; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Clancy KW, 2010, BIOPOLYMERS, V94, P385, DOI 10.1002/bip.21472; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W., 2006, PYMOL MOL GRAPHICS S; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; GAGNE SM, 1994, PROTEIN SCI, V3, P1961, DOI 10.1002/pro.5560031108; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; Goddard T. D., 2006, SPARKY 3; Grishaev A, 2004, J AM CHEM SOC, V126, P7281, DOI 10.1021/ja0319994; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Holty JEC, 2006, ANN INTERN MED, V144, P270, DOI 10.7326/0003-4819-144-4-200602210-00009; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Iwahara J, 2001, J BIOMOL NMR, V19, P231, DOI 10.1023/A:1011296112710; Jacobitz AW, 2014, J BIOL CHEM, V289, P8891, DOI 10.1074/jbc.M113.509273; Jung ME, 2005, BIOORG MED CHEM LETT, V15, P5076, DOI 10.1016/j.bmcl.2005.07.073; Jung ME, 2012, TETRAHEDRON LETT, V53, P4216, DOI 10.1016/j.tetlet.2012.05.153; Keller R., 2004, COMPUTER AIDED RESON, V1; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; Liew CK, 2004, FEBS LETT, V571, P221, DOI 10.1016/j.febslet.2004.06.070; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Loria JP, 2008, ACCOUNTS CHEM RES, V41, P214, DOI 10.1021/ar700132n; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Marraffini LA, 2007, J BACTERIOL, V189, P6425, DOI 10.1128/JB.00702-07; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Ngan CH, 2012, BIOINFORMATICS, V28, P286, DOI 10.1093/bioinformatics/btr651; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POWERS R, 1993, BIOCHEMISTRY-US, V32, P6744, DOI 10.1021/bi00077a030; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Schneewind O, 2014, BBA-MOL CELL RES, V1843, P1687, DOI 10.1016/j.bbamcr.2013.11.009; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Suree N, 2007, MINI-REV MED CHEM, V7, P991, DOI 10.2174/138955707782110097; Suree N, 2009, BIOORGAN MED CHEM, V17, P7174, DOI 10.1016/j.bmc.2009.08.067; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Teng Q., 2005, STRUCTURAL BIOL PRAC; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Weiner EM, 2010, J BIOL CHEM, V285, P23431, DOI 10.1074/jbc.M110.135434; Zink SD, 2005, INFECT IMMUN, V73, P5222, DOI 10.1128/IAI.73.8.5222-5228.2005; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	72	15	16	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25461	25474		10.1074/jbc.M115.670984	http://dx.doi.org/10.1074/jbc.M115.670984			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26324714	Green Published, hybrid			2022-12-28	WOS:000362962800022
J	Henault, CM; Juranka, PF; Baenziger, JE				Henault, Camille M.; Juranka, Peter F.; Baenziger, John E.			The M4 Transmembrane alpha-Helix Contributes Differently to Both the Maturation and Function of Two Prokaryotic Pentameric Ligand-gated Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; TRYPTOPHAN SCANNING MUTAGENESIS; X-RAY STRUCTURES; TORPEDO-CALIFORNICA; ALLOSTERIC MODULATION; STRUCTURAL BASIS; GATING KINETICS; MOLECULAR-DYNAMICS; LIPID-COMPOSITION; DOMAIN INTERFACE	The role of the outermost transmembrane alpha-helix in both the maturation and function of the prokaryotic pentameric ligand-gated ion channels, GLIC and ELIC, was examined by Ala scanning mutagenesis, deletion mutations, and mutant cycle analyses. Ala mutations at the M4-M1/M3 interface lead to loss-of-function phenotypes in GLIC, with the largest negative effects occurring near the M4 C terminus. In particular, two aromatic residues at the M4 C terminus form a network of pi-pi and/or cation-pi interactions with residues on M3 and the beta 6-beta 7 loop that is essential for both maturation and function. M4-M1/M3 interactions appear to be optimized in GLIC with even subtle structural changes at this interface leading to detrimental effects. In contrast, mutations along the M4-M1/M3 interface of ELIC typically lead to gain-of-function phenotypes, suggesting that these interactions in ELIC are not optimized for channel function. In addition, no cluster of interacting residues involving the M4 C terminus, M3, and the beta 6-beta 7 loop was found, suggesting that the M4 C terminus plays little role in ELIC maturation or function. This study shows that M4 makes distinct contributions to the maturation and gating of these two closely related homologs, suggesting that GLIC and ELIC exhibit divergent features of channel function.	[Henault, Camille M.; Juranka, Peter F.; Baenziger, John E.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	Baenziger, JE (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	John.Baenziger@uottawa.ca		Baenziger, John/0000-0002-2888-5328	Canadian Institutes of Health Research [111243]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant 111243 (to J. E B.). The authors declare that they have no conflicts of interest with the contents of this article.	Antollini SS, 2005, MOL MEMBR BIOL, V22, P471, DOI 10.1080/09687860500367915; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Baenziger JE, 2015, BBA-BIOMEMBRANES, V1848, P1806, DOI 10.1016/j.bbamem.2015.03.010; Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Barrantes FJ, 2015, BBA-BIOMEMBRANES, V1848, P1796, DOI 10.1016/j.bbamem.2015.03.028; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2000, J GEN PHYSIOL, V115, P663, DOI 10.1085/jgp.115.5.663; Bouzat C, 1998, MOL PHARMACOL, V54, P146, DOI 10.1124/mol.54.1.146; Bouzat C, 2002, BIOPHYS J, V82, P1920, DOI 10.1016/S0006-3495(02)75541-0; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Butler AS, 2009, NEUROPHARMACOLOGY, V56, P292, DOI 10.1016/j.neuropharm.2008.08.017; Caballero-Rivera D, 2012, CHANNELS, V6, P111, DOI 10.4161/chan.19540; Carswell CL, 2015, STRUCTURE, V23, P1655, DOI 10.1016/j.str.2015.06.020; Carswell CL, 2015, J BIOL CHEM, V290, P2496, DOI 10.1074/jbc.M114.624395; CRIADO M, 1982, BIOCHEMISTRY-US, V21, P3622, DOI 10.1021/bi00258a015; CRIADO M, 1984, J BIOL CHEM, V259, P9188; daCosta CJB, 2002, J BIOL CHEM, V277, P201, DOI 10.1074/jbc.M108341200; Dacosta CJB, 2013, NAT CHEM BIOL, V9, P701, DOI [10.1038/NCHEMBIO.1338, 10.1038/nchembio.1338]; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; Dellisanti CD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001714; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Forman SA, 2015, NEUROPHARMACOLOGY, V96, P169, DOI 10.1016/j.neuropharm.2014.10.002; Gonzalez-Gutierrez G, 2015, J GEN PHYSIOL, V146, P15, DOI 10.1085/jgp.201411333; Gonzalez-Gutierrez G, 2012, P NATL ACAD SCI USA, V109, P6331, DOI 10.1073/pnas.1119268109; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; Henault CM, 2015, NEUROPHARMACOLOGY, V96, P157, DOI 10.1016/j.neuropharm.2014.11.011; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Kinde MN, 2015, STRUCTURE, V23, P995, DOI 10.1016/j.str.2015.03.017; Labriola JM, 2013, J BIOL CHEM, V288, P11294, DOI 10.1074/jbc.M113.458133; Lasalde JA, 1996, BIOCHEMISTRY-US, V35, P14139, DOI 10.1021/bi961583l; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; Leon RDD, 2008, CHANNELS, V2, P439, DOI 10.4161/chan.2.6.7130; LI L, 1990, BIOCHEMISTRY-US, V29, P5428, DOI 10.1021/bi00475a003; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Nury H, 2011, M S-MED SCI, V27, P1056, DOI 10.1051/medsci/20112712006; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Ortiz-Acevedo A, 2004, J BIOL CHEM, V279, P42250, DOI 10.1074/jbc.M405132200; OrtizMiranda SI, 1997, J MEMBRANE BIOL, V158, P17, DOI 10.1007/s002329900240; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; Pons S, 2004, EUR J NEUROSCI, V20, P2022, DOI 10.1111/j.1460-9568.2004.03673.x; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Rienzo M, 2014, CHEM BIOL, V21, P1700, DOI 10.1016/j.chembiol.2014.10.019; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Shen XM, 2006, ANN NEUROL, V60, P128, DOI 10.1002/ana.20861; Tamamizu S, 2000, BIOCHEMISTRY-US, V39, P4666, DOI 10.1021/bi992835w; Tamamizu S, 1999, J MEMBRANE BIOL, V170, P157, DOI 10.1007/s002329900545; Tillman TS, 2014, J BIOL CHEM, V289, P13851, DOI 10.1074/jbc.M113.524611; TOBIMATSU T, 1987, FEBS LETT, V222, P56, DOI 10.1016/0014-5793(87)80191-6; Velisetty P, 2014, J BIOL CHEM, V289, P3013, DOI 10.1074/jbc.M113.523050; Velisetty P, 2012, J BIOL CHEM, V287, P18467, DOI 10.1074/jbc.M112.348045; Wang HL, 2012, J BIOL CHEM, V287, P6482, DOI 10.1074/jbc.M111.305839; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918; Williamson PTF, 2005, MOL MEMBR BIOL, V22, P485, DOI 10.1080/09687860500370653; Xu YC, 2005, J AM CHEM SOC, V127, P1291, DOI 10.1021/ja044577i; Zimmermann I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001429; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	67	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25118	25128		10.1074/jbc.M115.676833	http://dx.doi.org/10.1074/jbc.M115.676833			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26318456	hybrid, Green Published			2022-12-28	WOS:000362598300039
J	Li, HC; Duann, P; Lin, PH; Zhao, L; Fan, ZB; Tan, T; Zhou, XY; Sun, MZ; Fu, MH; Orange, M; Sermersheim, M; Ma, H; He, DF; Steinberg, SM; Higgins, R; Zhu, H; John, E; Zeng, CY; Guan, JJ; Ma, JJ				Li, Haichang; Duann, Pu; Lin, Pei-Hui; Zhao, Li; Fan, Zhaobo; Tan, Tao; Zhou, Xinyu; Sun, Mingzhai; Fu, Minghuan; Orange, Matthew; Sermersheim, Matthew; Ma, Hanley; He, Duofen; Steinberg, Steven M.; Higgins, Robert; Zhu, Hua; John, Elizabeth; Zeng, Chunyu; Guan, Jianjun; Ma, Jianjie			Modulation of Wound Healing and Scar Formation by MG53 Protein-mediated Cell Membrane Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; THERMOSENSITIVE HYDROGELS; GRANULATION-TISSUE; TGF-BETA; MECHANISMS; FIBROSIS; DIFFERENTIATION; MYOFIBROBLAST; EXPRESSION; INJURY	Cell membrane repair is an important aspect of physiology, and disruption of this process can result in pathophysiology in a number of different tissues, including wound healing, chronic ulcer and scarring. We have previously identified a novel tripartite motif family protein, MG53, as an essential component of the cell membrane repair machinery. Here we report the functional role of MG53 in the modulation of wound healing and scarring. Although MG53 is absent from keratinocytes and fibroblasts, remarkable defects in skin architecture and collagen overproduction are observed in mg53(-/-) mice, and these animals display delayed wound healing and abnormal scarring. Recombinant human MG53 (rhMG53) protein, encapsulated in a hydrogel formulation, facilitates wound healing and prevents scarring in rodent models of dermal injuries. An in vitro study shows that rhMG53 protects against acute injury to keratinocytes and facilitates the migration of fibroblasts in response to scratch wounding. During fibrotic remodeling, rhMG53 interferes with TGF-beta-dependent activation of myofibroblast differentiation. The resulting down-regulation of alpha smooth muscle actin and extracellular matrix proteins contributes to reduced scarring. Overall, these studies establish a trifunctional role for MG53 as a facilitator of rapid injury repair, a mediator of cell migration, and a modulator of myofibroblast differentiation during wound healing. Targeting the functional interaction between MG53 and TGF-beta signaling may present a potentially effective means for promoting scarless wound healing.	[Li, Haichang; Duann, Pu; Lin, Pei-Hui; Zhao, Li; Tan, Tao; Zhou, Xinyu; Sun, Mingzhai; Sermersheim, Matthew; Ma, Hanley; Steinberg, Steven M.; Higgins, Robert; Zhu, Hua; Ma, Jianjie] Ohio State Univ, Davis Heart & Lung Res Inst, Dept Surg, Columbus, OH 43210 USA; [Fan, Zhaobo; Fu, Minghuan; Guan, Jianjun] Ohio State Univ, Dept Mat Sci & Engn, Columbus, OH 43210 USA; [Tan, Tao; John, Elizabeth; Ma, Jianjie] TRIM Edicine Inc, Div Prot Therapeut, Columbus, OH 43212 USA; [Orange, Matthew] Cent Connecticut State Univ, Dept Phys Educ & Human Performance, New Britain, CT 06050 USA; [Ma, Hanley] Olentangy Liberty High Sch, Powell, OH 43065 USA; [He, Duofen; Zeng, Chunyu] Third Mil Med Univ, Doping Hosp, Chongqing Inst Cardiol, Dept Cardiol, Chongqing 400042, Peoples R China	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Connecticut State University System; Central Connecticut State University; Army Medical University; Chinese Academy of Sciences	Li, HC (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Dept Surg, Columbus, OH 43210 USA.	Haichang.Li@osumc.edu; Jianjie.Ma@osumc.edu	Steinberg, Steven/E-4142-2011; Li, Haichang/AAL-6132-2020; Sun, Mingzhai/B-4945-2012; Regan, Clinton/E-6250-2012; Higgins, Robert/AGZ-7064-2022	Li, Haichang/0000-0001-9784-6480; Zhu, Hua/0000-0001-7136-7326	National Institutes of Health [R01-AR061385, R01-HL069000]; National Science Foundation [1006734, 1160122]; Ohio State University Lockwood Early Career Development Award; Division Of Materials Research [1006734] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061385] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Ohio State University Lockwood Early Career Development Award; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-AR061385 and R01-HL069000 (to J. M.). This work was also supported by National Science Foundation grants 1006734 and 1160122 (to J. G.) and the Ohio State University Lockwood Early Career Development Award (to P. L. and H. L.). J. M. and T. T. have an equity interest in TRIMedicine, which develops MG53 for the treatment of human disease. Patents on the use of MG53 are held by Rutgers University Robert Wood Johnson Medical School.	Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Duann P, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010755; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Frank S, 2003, METH MOLEC MED, V78, P3; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Gamelli RL, 2003, METH MOLEC MED, V78, P37; Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008; Grotendorst GR, 2004, FASEB J, V18, P469, DOI 10.1096/fj.03-0699com; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Howard AC, 2011, DIABETES, V60, P3034, DOI 10.2337/db11-0851; Jia YL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5387; KANE CJM, 1991, J CELL PHYSIOL, V148, P157, DOI 10.1002/jcp.1041480119; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Li ZQ, 2014, SCI CHINA CHEM, V57, P568, DOI 10.1007/s11426-014-5089-8; Li ZQ, 2011, EXPERT OPIN DRUG DEL, V8, P991, DOI 10.1517/17425247.2011.581656; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin PH, 2012, FASEB J, V26, P1875, DOI 10.1096/fj.11-188599; Liu JX, 2015, J MOL CELL CARDIOL, V80, P10, DOI 10.1016/j.yjmcc.2014.12.010; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Schmid P, 1998, AM J PATHOL, V152, P485; Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Wang XH, 2010, CIRC RES, V107, P76, DOI 10.1161/CIRCRESAHA.109.215822; Weisleder N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003921; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012; Zhang XT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3703	42	53	59	3	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24592	24603		10.1074/jbc.M115.680074	http://dx.doi.org/10.1074/jbc.M115.680074			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26306047	hybrid, Green Published			2022-12-28	WOS:000362218900042
J	Eckle, SBG; Corbett, AJ; Keller, AN; Chen, ZJ; Godfrey, DI; Liu, LG; Mak, JYW; Fairlie, DP; Rossjohn, J; McCluskey, J				Eckle, Sidonia B. G.; Corbett, Alexandra J.; Keller, Andrew N.; Chen, Zhenjun; Godfrey, Dale I.; Liu, Ligong; Mak, Jeffrey Y. W.; Fairlie, David P.; Rossjohn, Jamie; McCluskey, James			Recognition of Vitamin B Precursors and Byproducts by Mucosal Associated Invariant T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COMPLEX CLASS-I; MHC-RELATED PROTEIN-1; MAIT CELLS; RECEPTOR HETEROGENEITY; MOLECULAR-BASIS; MR1; GENE; IDENTIFICATION; METABOLITES; DERIVATIVES	Vitamin B2 (riboflavin) is essential for metabolic functions and is synthesized by many bacteria, yeast, and plants, but not by mammals and other animals, which must acquire it from the diet. In mammals, modified pyrimidine intermediates from the microbial biosynthesis of riboflavin are recognized as signature biomarkers of microbial infection. This recognition occurs by specialized lymphocytes known as mucosal associated invariant T (MAIT) cells. The major histocompatibility class I-like antigen-presenting molecule, MR1, captures these pyrimidine intermediates, but only after their condensation with small molecules derived from glycolysis and other metabolic pathways to form short-lived antigens. The resulting MR1-Ag complexes are recognized by MAIT cell antigen receptors (alpha beta T cell receptors (TCRs)), and the subsequent MAIT cell immune responses are thought to protect the host from pathogens at mucosal surfaces. Here, we review our understanding of how these novel antigens are generated and discuss their interactions with MR1 and MAIT TCRs.	[Eckle, Sidonia B. G.; Corbett, Alexandra J.; Chen, Zhenjun; Godfrey, Dale I.; McCluskey, James] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Godfrey, Dale I.] Univ Melbourne, Australian Res Council, Ctr Excellence Adv Mol Imaging, Parkville, Vic 3010, Australia; [Keller, Andrew N.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Keller, Andrew N.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Keller, Andrew N.; Rossjohn, Jamie] Monash Univ, Australian Res Council, Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Liu, Ligong; Mak, Jeffrey Y. W.; Fairlie, David P.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld 4072, Australia; [Liu, Ligong; Mak, Jeffrey Y. W.; Fairlie, David P.] Univ Queensland, Australian Res Council, Ctr Excellence Adv Mol Imaging, Brisbane, Qld 4072, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff CF14 4XN, S Glam, Wales	University of Melbourne; University of Melbourne; Monash University; Monash University; Monash University; University of Queensland; University of Queensland; Cardiff University	Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.	jamie.rossjohn@monash.edu; jamesm1@unimelb.edu.au	liu, ligong/B-1690-2010; Corbett, Alexandra/A-1225-2019; Mak, Jeffrey YW/E-8764-2011; McCluskey, James/A-1291-2007; Rossjohn, Jamie/F-9032-2013; Fairlie, David P/F-8865-2014; Eckle, Sidonia BG/O-8146-2014	liu, ligong/0000-0002-2693-1896; Corbett, Alexandra/0000-0003-1618-4337; Mak, Jeffrey YW/0000-0002-8011-4539; McCluskey, James/0000-0002-8597-815X; Rossjohn, Jamie/0000-0002-2020-7522; Fairlie, David P/0000-0002-7856-8566; Eckle, Sidonia BG/0000-0003-0766-171X; Godfrey, Dale/0000-0002-3009-5472	Australian Research Council [E140100011, LE110100106]; National Health and Medical Research Council (NHMRC) of Australia [1016629, 1013667, 1062889, 1063587]; University of Melbourne; Australia Fellowship [AF50]	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne); Australia Fellowship	This work was supported by Australian Research Council Grants E140100011 and LE110100106 and National Health and Medical Research Council (NHMRC) of Australia Grants 1016629, 1013667, 1062889, and 1063587. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Early Career Researcher award from The University of Melbourne.; Recipient of Australia Fellowship AF50. To whom correspondence may be addressed. E-mail: jamie.rossjohn@monash.edu.	Bacher A, 2000, ANNU REV NUTR, V20, P153, DOI 10.1146/annurev.nutr.20.1.153; Bhati M, 2014, PROTEIN SCI, V23, P260, DOI 10.1002/pro.2412; Birkinshaw RW, 2014, CURR OPIN IMMUNOL, V26, P7, DOI 10.1016/j.coi.2013.09.007; Burgess C, 2004, APPL ENVIRON MICROB, V70, P5769, DOI 10.1128/AEM.70.10.5769-5777.2004; Chua WJ, 2011, J IMMUNOL, V186, P4744, DOI 10.4049/jimmunol.1003254; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Cushman M, 2002, J ORG CHEM, V67, P5807, DOI 10.1021/jo0201631; Eckle SBG, 2014, J EXP MED, V211, P1585, DOI 10.1084/jem.20140484; Gold MC, 2014, J EXP MED, V211, P1601, DOI 10.1084/jem.20140507; Gold MC, 2013, NAT REV MICROBIOL, V11, P14, DOI 10.1038/nrmicro2918; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Goldfinch N, 2010, VET RES, V41, DOI 10.1051/vetres/2010034; Greenaway HY, 2013, IMMUNOBIOLOGY, V218, P213, DOI 10.1016/j.imbio.2012.04.003; Hansen TH, 2007, NAT IMMUNOL, V8, P563, DOI 10.1038/ni1475; Harriff MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097515; HASHIMOTO K, 1995, SCIENCE, V269, P693, DOI 10.1126/science.7624800; Huang SX, 2008, J EXP MED, V205, P1201, DOI 10.1084/jem.20072579; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Le Bourhis L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003681; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Lepore M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4866; Lopez-Sagaseta J, 2013, P NATL ACAD SCI USA, V110, pE1771, DOI 10.1073/pnas.1222678110; Miley MJ, 2003, J IMMUNOL, V170, P6090, DOI 10.4049/jimmunol.170.12.6090; Parra-Cuadrado JF, 2000, TISSUE ANTIGENS, V56, P170, DOI 10.1034/j.1399-0039.2000.560211.x; Patel O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3142; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Rahimpour A, 2015, J EXP MED, V212, P1095, DOI 10.1084/jem.20142110; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Riegert P, 1998, J IMMUNOL, V161, P4066; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Sakala IG, 2015, J IMMUNOL, V195, P587, DOI 10.4049/jimmunol.1402545; Scaviner D, 2000, EXP CLIN IMMUNOGENET, V17, P83, DOI 10.1159/000019128; Soudais C, 2015, J IMMUNOL, V194, P4641, DOI 10.4049/jimmunol.1403224; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Tynan FE, 2005, J BIOL CHEM, V280, P23900, DOI 10.1074/jbc.M503060200; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Van Rhijn I, 2013, NAT IMMUNOL, V14, P706, DOI 10.1038/ni.2630; Wang Y, 2012, CHEM SOC REV, V41, P4140, DOI 10.1039/c2cs35025d; Yamaguchi H, 1997, BIOCHEM BIOPH RES CO, V238, P697, DOI 10.1006/bbrc.1997.7379; Yamaguchi H, 2002, BIOCHEM BIOPH RES CO, V290, P722, DOI 10.1006/bbrc.2001.6277; Young MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053789	44	86	86	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30204	30211		10.1074/jbc.R115.685990	http://dx.doi.org/10.1074/jbc.R115.685990			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26468291	Green Published, hybrid			2022-12-28	WOS:000366738200001
J	Hirabayashi, K; Yuda, E; Tanaka, N; Katayama, S; Iwasaki, K; Matsumoto, T; Kurisu, G; Outten, FW; Fukuyama, K; Takahashi, Y; Wada, K				Hirabayashi, Kei; Yuda, Eiki; Tanaka, Naoyuki; Katayama, Sumie; Iwasaki, Kenji; Matsumoto, Takashi; Kurisu, Genji; Outten, F. Wayne; Fukuyama, Keiichi; Takahashi, Yasuhiro; Wada, Kei			Functional Dynamics Revealed by the Structure of the SufBCD Complex, a Novel ATP-binding Cassette (ABC) Protein That Serves as a Scaffold for Iron-Sulfur Cluster Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SMC PROTEINS; CRYSTAL-STRUCTURE; TRANSPORTER; SYSTEM; SUFC; BACTERIA; CONDENSATION; ARCHITECTURE; RESISTANCE	ATP-binding cassette (ABC)-type ATPases are chemomechanical engines involved in diverse biological pathways. Recent genomic information reveals that ABC ATPase domains/subunits act not only in ABC transporters and structural maintenance of chromosome proteins, but also in iron-sulfur (Fe-S) cluster biogenesis. A novel type of ABC protein, the SufBCD complex, functions in the biosynthesis of nascent Fe-S clusters in almost all Eubacteria and Archaea, as well as eukaryotic chloroplasts. In this study, we determined the first crystal structure of the Escherichia coli SufBCD complex, which exhibits the common architecture of ABC proteins: two ABC ATPase components (SufC) with function-specific components (SufB-SufD protomers). Biochemical and physiological analyses based on this structure provided critical insights into Fe-S cluster assembly and revealed a dynamic conformational change driven by ABC ATPase activity. We propose a molecular mechanism for the biogenesis of the Fe-S cluster in the SufBCD complex.	[Hirabayashi, Kei] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan; [Hirabayashi, Kei; Wada, Kei] Miyazaki Univ, Org Promot Tenure Track, Miyazaki 8891692, Japan; [Yuda, Eiki; Tanaka, Naoyuki; Takahashi, Yasuhiro] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Saitama 3388570, Japan; [Katayama, Sumie; Iwasaki, Kenji; Kurisu, Genji] Osaka Univ, Inst Prot Res, Osaka 5650871, Japan; [Matsumoto, Takashi] Rigaku Corp, Tokyo 1968666, Japan; [Outten, F. Wayne] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Fukuyama, Keiichi] Osaka Univ, Grad Sch Engn, Div Appl Chem, Osaka 5650871, Japan	Osaka University; University of Miyazaki; Saitama University; Osaka University; Rigaku Corporation; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Osaka University	Takahashi, Y (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Saitama 3388570, Japan.	ytaka@molbiol.saitama-u.ac.jp; keiwada@med.miyazaki-u.ac.jp	Regan, Clinton/E-6250-2012; KURISU, GENJI/AAD-7109-2022; KURISU, GENJI/ABA-5960-2020; Takahashi, Yasuhiro/F-1119-2011	KURISU, GENJI/0000-0002-5354-0807; KURISU, GENJI/0000-0002-5354-0807; Takahashi, Yasuhiro/0000-0002-0588-6045; Outten, Franklin/0000-0002-9095-0194; Wada, Kei/0000-0001-7631-4151	Platform for Drug Discovery, Informatics, and Structural Life Science - Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program to Disseminate Tenure Tracking from the Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Education, Culture, Sports, Science, and Technology [25840023, 21770112, 15H04472, 23370052]; Japan Society for the Promotion of Science [12J01292]; Japan Foundation for Applied Enzymology; National Institutes of Health [GM 81706, GM 112919]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081706, R01GM112919] Funding Source: NIH RePORTER	Platform for Drug Discovery, Informatics, and Structural Life Science - Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program to Disseminate Tenure Tracking from the Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Foundation for Applied Enzymology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Platform for Drug Discovery, Informatics, and Structural Life Science funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The synchrotron radiation experiments were performed on BL44XU and BL32XU at SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute under Proposals 2011B6535, 2012B6726, 2013AB6828, 2013B6863, 2014AB6963, 2015A6557, and PDIS1235. This work was also supported by the Program to Disseminate Tenure Tracking (to K. W.) from the Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Education, Culture, Sports, Science, and Technology Grants-in-Aid for Scientific Research 25840023 and 21770112 (to K. W.), 15H04472 (to Y. T.), and 23370052 (to K.F.); a Grant-in-Aid for the Japan Society for the Promotion of Science Fellows 12J01292 (to K. H.); a grant from the Japan Foundation for Applied Enzymology (to K. W.); and National Institutes of Health Grants GM 81706 and GM 112919 (to F. W. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreeva A, 2014, NUCLEIC ACIDS RES, V42, pD310, DOI 10.1093/nar/gkt1242; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Chahal HK, 2009, BIOCHEMISTRY-US, V48, P10644, DOI 10.1021/bi901518y; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gisselberg JE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003655; Graumann PL, 2001, BIOCHIMIE, V83, P53, DOI 10.1016/S0300-9084(00)01218-9; Gupta V, 2009, J AM CHEM SOC, V131, P6149, DOI 10.1021/ja807551e; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Hirano T, 2002, GENE DEV, V16, P399, DOI 10.1101/gad.955102; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kitaoka S, 2006, FEBS LETT, V580, P137, DOI 10.1016/j.febslet.2005.11.058; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Layer G, 2007, J BIOL CHEM, V282, P13342, DOI 10.1074/jbc.M608555200; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; NAMIHISA T, 1983, J IMMUNOL METHODS, V56, P125, DOI 10.1016/0022-1759(83)90055-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Outten FW, 2004, MOL MICROBIOL, V52, P861, DOI 10.1111/j.1365-2958.2004.04025.x; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petrovic A, 2008, PROTEIN SCI, V17, P1264, DOI 10.1110/ps.034652.108; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rangachari K, 2002, FEBS LETT, V514, P225, DOI 10.1016/S0014-5793(02)02369-4; Rees DC, 2003, SCIENCE, V300, P929, DOI 10.1126/science.1083075; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saini A, 2010, BIOCHEMISTRY-US, V49, P9402, DOI 10.1021/bi1011546; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Shimomura Y, 2008, J MOL BIOL, V383, P133, DOI 10.1016/j.jmb.2008.08.015; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tokumoto U, 2004, J BIOCHEM, V136, P199, DOI 10.1093/jb/mvh104; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wada K, 2009, J MOL BIOL, V387, P245, DOI 10.1016/j.jmb.2009.01.054; Wollers S, 2010, J BIOL CHEM, V285, P23329, DOI 10.1074/jbc.M110.127449; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	55	42	42	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29717	29731		10.1074/jbc.M115.680934	http://dx.doi.org/10.1074/jbc.M115.680934			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26472926	Green Published, hybrid			2022-12-28	WOS:000366614700005
J	Wu, Y; Shyng, SL; Chen, PC				Wu, Yi; Shyng, Show-Ling; Chen, Pei-Chun			Concerted Trafficking Regulation of Kv2.1 and K-ATP Channels by Leptin in Pancreatic beta-Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNELS; INSULIN-SECRETION; ELECTRICAL-ACTIVITY; PTEN INHIBITION; RAT CRI-G1; GLUCOSE; CALCIUM; ACTIVATION; EXPRESSION; AMPK	In pancreatic beta-cells, voltage-gated potassium 2.1 (Kv2.1) channels are the dominant delayed rectifier potassium channels responsible for action potential repolarization. Here, we report that leptin, a hormone secreted by adipocytes known to inhibit insulin secretion, causes a transient increase in surface expression of Kv2.1 channels in rodent and human beta-cells. The effect of leptin on Kv2.1 surface expression is mediated by the AMP-activated protein kinase (AMPK). Activation of AMPK mimics whereas inhibition of AMPK occludes the effect of leptin. Inhibition of Ca2+/calmodulin-dependent protein kinase kinase beta, a known upstream kinase of AMPK, also blocks the effect of leptin. In addition, the cAMP-dependent protein kinase (PKA) is involved in Kv2.1 channel trafficking regulation. Inhibition of PKA prevents leptin or AMPK activators from increasing Kv2.1 channel density, whereas stimulation of PKA is sufficient to promote Kv2.1 channel surface expression. The increased Kv2.1 surface expression by leptin is dependent on actin depolymerization, and pharmacologically induced actin depolymerization is sufficient to enhance Kv2.1 surface expression. The signaling and cellular mechanisms underlying Kv2.1 channel trafficking regulation by leptin mirror those reported recently for ATP-sensitive potassium (K-ATP) channels, which are critical for coupling glucose stimulation with membrane depolarization. We show that the leptin-induced increase in surface K-ATP channels results in more hyperpolarized membrane potentials than control cells at stimulating glucose concentrations, and the increase in Kv2.1 channels leads to a more rapid repolarization of membrane potential in cells firing action potentials. This study supports a model in which leptin exerts concerted trafficking regulation of K-ATP and Kv2.1 channels to coordinately inhibit insulin secretion.	[Wu, Yi; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Chen, Pei-Chun] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 701, Taiwan	Oregon Health & Science University; National Cheng Kung University	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	shyngs@ohsu.edu; pcchen@mail.ncku.edu.tw	Regan, Clinton/E-6250-2012	Chen, Pei-Chun/0000-0002-2550-6556	National Institutes of Health [R01DK057699, 3R01DK057699-14S1]; Ministry of Science and Technology Grant [MOST 1032320B006005MY2]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Technology Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK057699 and 3R01DK057699-14S1 (to S.-L. S) and by Ministry of Science and Technology Grant MOST 1032320B006005MY2 (to P.-C. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Ashcroft FM, 2006, BIOCHEM SOC T, V34, P243, DOI 10.1042/BST0340243; ASHCROFT FM, 1990, PFLUG ARCH EUR J PHY, V415, P504, DOI 10.1007/BF00373633; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; ASHCROFT FM, 1989, ANN NY ACAD SCI, V560, P410, DOI 10.1111/j.1749-6632.1989.tb24123.x; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; BOKVIST K, 1990, J PHYSIOL-LONDON, V423, P311, DOI 10.1113/jphysiol.1990.sp018024; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Cases JA, 2001, DIABETES, V50, P348, DOI 10.2337/diabetes.50.2.348; Chen PC, 2013, J BIOL CHEM, V288, P34098, DOI 10.1074/jbc.M113.516880; Dai XQ, 2012, DIABETOLOGIA, V55, P1709, DOI 10.1007/s00125-012-2512-6; Dhar M, 2014, J NEUROSCI, V34, P10022, DOI 10.1523/JNEUROSCI.2868-13.2014; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; Geng XH, 2003, DIABETES, V52, P767, DOI 10.2337/diabetes.52.3.767; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Harvey J, 1998, J PHYSIOL-LONDON, V510, P47, DOI 10.1111/j.1469-7793.1998.047bz.x; Harvey J, 1998, J PHYSIOL-LONDON, V511, P695, DOI 10.1111/j.1469-7793.1998.695bg.x; Harvey J, 2000, J PHYSIOL-LONDON, V527, P95, DOI 10.1111/j.1469-7793.2000.00095.x; Head WS, 2012, DIABETES, V61, P1700, DOI 10.2337/db11-1312; Herrington J, 2005, J PHYSIOL-LONDON, V567, P159, DOI 10.1113/jphysiol.2005.089375; Hohmeier HE, 1997, DIABETES, V46, P968, DOI 10.2337/diabetes.46.6.968; Holz GG, 2013, ISLETS, V5, P229, DOI 10.4161/isl.26958; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; Houamed KM, 2010, J PHYSIOL-LONDON, V588, P3511, DOI 10.1113/jphysiol.2009.184341; Jacobson DA, 2007, DIABETES OBES METAB, V9, P89, DOI 10.1111/j.1463-1326.2007.00784.x; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Jacobson DA, 2010, J PHYSIOL-LONDON, V588, P3525, DOI 10.1113/jphysiol.2010.190207; Jensen MV, 2013, J BIOL CHEM, V288, P23128, DOI 10.1074/jbc.M113.491654; Kalsbeek A, 2001, ENDOCRINOLOGY, V142, P2677, DOI 10.1210/en.142.6.2677; Kieffer TJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE1, DOI 10.1152/ajpendo.2000.278.1.E1; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; Kim SJ, 2012, CELL DEATH DIFFER, V19, P333, DOI 10.1038/cdd.2011.102; Komatsu M, 2013, J DIABETES INVEST, V4, P511, DOI 10.1111/jdi.12094; Li XY, 2013, J PHARMACOL EXP THER, V344, P407, DOI 10.1124/jpet.112.199083; Licinio J, 1997, NAT MED, V3, P575, DOI 10.1038/nm0597-575; Lim A, 2009, DIABETES, V58, P2813, DOI 10.2337/db09-0600; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Meda P, 2003, CELL COMMUN ADHES, V10, P431, DOI 10.1080/15419060390263263; Moult PR, 2010, J NEUROSCI, V30, P4088, DOI 10.1523/JNEUROSCI.3614-09.2010; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Ning K, 2006, EMBO J, V25, P2377, DOI 10.1038/sj.emboj.7601118; Pal SK, 2006, CELL DEATH DIFFER, V13, P661, DOI 10.1038/sj.cdd.4401792; Park SH, 2013, BIOCHEM BIOPH RES CO, V440, P539, DOI 10.1016/j.bbrc.2013.09.099; Park SH, 2013, P NATL ACAD SCI USA, V110, P12673, DOI 10.1073/pnas.1216351110; Rocheleau JV, 2006, PLOS BIOL, V4, P221, DOI 10.1371/journal.pbio.0040026; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; RORSMAN P, 1986, J PHYSIOL-LONDON, V374, P531, DOI 10.1113/jphysiol.1986.sp016096; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; SATIN LS, 1985, PFLUG ARCH EUR J PHY, V404, P385, DOI 10.1007/BF00585354; SATIN LS, 1988, PFLUG ARCH EUR J PHY, V411, P401, DOI 10.1007/BF00587719; Sher E, 2003, J BIOENERG BIOMEMBR, V35, P687, DOI 10.1023/B:JOBB.0000008032.49504.48; Silva JR, 2014, BIOPHYS J, V107, P2016, DOI 10.1016/j.bpj.2014.09.037; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; Szkudelski T, 2007, PHYSIOL RES, V56, P503, DOI 10.33549/physiolres.931038; Tamarina NA, 2005, AM J PHYSIOL-ENDOC M, V289, pE578, DOI 10.1152/ajpendo.00054.2005; Varadi A, 2006, DIABETOLOGIA, V49, P1567, DOI 10.1007/s00125-006-0257-9; Yan LZ, 2004, DIABETES, V53, P597, DOI 10.2337/diabetes.53.3.597; Yang SN, 2007, CELL METAB, V6, P217, DOI 10.1016/j.cmet.2007.08.002; Yang SN, 2014, CELL MOL LIFE SCI, V71, P4149, DOI 10.1007/s00018-014-1680-6	60	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29676	29690		10.1074/jbc.M115.670877	http://dx.doi.org/10.1074/jbc.M115.670877			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26453299	Green Published, hybrid			2022-12-28	WOS:000366614700001
J	Cho, SM; Jeoung, SC; Song, JY; Kupriyanova, EV; Pronina, NA; Lee, BW; Jo, SW; Park, BS; Choi, SB; Song, JJ; Park, YI				Cho, Sung Mi; Jeoung, Sae Chae; Song, Ji-Young; Kupriyanova, Elena V.; Pronina, Natalia A.; Lee, Bong-Woo; Jo, Seong-Whan; Park, Beom-Seok; Choi, Sang-Bong; Song, Ji-Joon; Park, Youn-Il			Genomic Survey and Biochemical Analysis of Recombinant Candidate Cyanobacteriochromes Reveals Enrichment for Near UV/Violet Sensors in the Halotolerant and Alkaliphilic Cyanobacterium Microcoleus IPPAS B353	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; GAF DOMAIN; LIGHT RECEPTOR; PHYTOCHROME; BLUE; PHOTOCONVERSION; CHROMOPHORE; PHOTOTAXIS; TEPIXJ; MULTICELLULARITY	Cyanobacteriochromes (CBCRs), which are exclusive to and widespread among cyanobacteria, are photoproteins that sense the entire range of near-UV and visible light. CBCRs are related to the red/far-red phytochromes that utilize linear tetrapyrrole (bilin) chromophores. Best characterized from the unicellular cyanobacterium Synechocystis sp. PCC 6803 and the multicellular heterocyst forming filamentous cyanobacteria Nostoc punctiforme ATCC 29133 and Anabaena sp. PCC 7120, CBCRs have been poorly investigated in mat-forming, nonheterocystous cyanobacteria. In this study, we sequenced the genome of one of such species, Microcoleus IPPAS B353 (Microcoleus B353), and identified two phytochromes and seven CBCRs with one or more bilin-binding cGMP-specific phosphodiesterase, adenylyl cyclase and FhlA (GAF) domains. Biochemical and spectroscopic measurements of 23 purified GAF proteins from phycocyanobilin (PCB) producing recombinant Escherichia coli indicated that 13 of these proteins formed near-UV and visible light-absorbing covalent adducts: 10 GAFs containedPCBchromophores, whereas three contained the PCB isomer, phycoviolobilin (PVB). Furthermore, the complement of Microcoleus B353 CBCRs is enriched in near-UV and violet sensors, but lacks red/green and green/red CBCRs that are widely distributed in other cyanobacteria. We hypothesize that enrichment in short wavelength-absorbing CBCRs is critical for acclimation to highlight environments where this organism is found.	[Cho, Sung Mi; Song, Ji-Young; Park, Youn-Il] Chungnam Natl Univ, Dept Biol Sci, Daejeon 305764, South Korea; [Jeoung, Sae Chae] Korea Res Inst Stand & Sci, Ctr Adv Measurement & Instrumentat, Daejeon 305340, South Korea; [Kupriyanova, Elena V.; Pronina, Natalia A.] Russian Acad Sci, Inst Plant Physiol, Moscow 127276, Russia; [Lee, Bong-Woo; Jo, Seong-Whan] Seeders Inc, Daejeon 305509, South Korea; [Park, Beom-Seok] Rural Dev Adm, Natl Acad Agr Sci, Agr Genome Ctr, Wonju 565851, South Korea; [Choi, Sang-Bong] Myongji Univ, Sch Biotechnol & Environm Engn, Yongin 449728, South Korea; [Song, Ji-Joon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 305701, South Korea	Chungnam National University; Korea Research Institute of Standards & Science (KRISS); Russian Academy of Sciences; Timiryazev Institute of Plant Physiology; Rural Development Administration (RDA); Myongji University; Korea Advanced Institute of Science & Technology (KAIST)	Park, YI (corresponding author), Chungnam Natl Univ, Dept Biol Sci, Daejeon 305764, South Korea.	yipark@cnu.ac.kr	Park, Youn-Il/S-2997-2019; Song, Ji-Joon/C-1721-2011	Park, Youn-Il/0000-0003-2912-2821; Song, Ji-Young/0000-0003-3964-1094; Jeoung, Sae Chae/0000-0001-5978-9286; Cho, Sung Mi/0000-0001-5414-7727	Next-Generation BioGreen 21 Program, Rural Development Administration [PJ011659]; Advanced Biomass R&D Center (ABC) of Korea - Ministry of Science, ICT, and Future Planning, Korea [NRF-2011-0031344]; Russian Science Foundation [14-24-00020] Funding Source: Russian Science Foundation	Next-Generation BioGreen 21 Program, Rural Development Administration; Advanced Biomass R&D Center (ABC) of Korea - Ministry of Science, ICT, and Future Planning, Korea; Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by grants from the Next-Generation BioGreen 21 Program, Rural Development Administration Grant PJ011659, and the Advanced Biomass R&D Center (ABC) of Korea Grant NRF-2011-0031344, funded by the Ministry of Science, ICT, and Future Planning, Korea (to Y-I. P.). The authors declare that they have no conflicts of interest related to the contents of this article.	Anders K, 2014, J BIOL CHEM, V289, P25590, DOI 10.1074/jbc.M114.562082; Auldridge ME, 2011, CRIT REV BIOCHEM MOL, V46, P67, DOI 10.3109/10409238.2010.546389; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bussell AN, 2013, P NATL ACAD SCI USA, V110, P12834, DOI 10.1073/pnas.1303371110; Campbell EL, 2015, J BACTERIOL, V197, P782, DOI 10.1128/JB.02374-14; Castenholz R. W., 1989, BERGEYS MANUAL SYSTE, V3, P1710; CHAMOVITZ D, 1993, J BIOL CHEM, V268, P17348; Chen Y, 2012, FEBS J, V279, P40, DOI 10.1111/j.1742-4658.2011.08397.x; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enomoto G, 2014, J BIOL CHEM, V289, P24801, DOI 10.1074/jbc.M114.583674; Enomoto G, 2012, BIOCHEMISTRY-US, V51, P3050, DOI 10.1021/bi300020u; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Gutu A, 2012, MOL PLANT, V5, P1, DOI 10.1093/mp/ssr054; Hirose Y, 2008, P NATL ACAD SCI USA, V105, P9528, DOI 10.1073/pnas.0801826105; Hirose Y, 2013, P NATL ACAD SCI USA, V110, P4974, DOI 10.1073/pnas.1302909110; Hirose Y, 2010, P NATL ACAD SCI USA, V107, P8854, DOI 10.1073/pnas.1000177107; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Ishizuka T, 2006, PLANT CELL PHYSIOL, V47, P1251, DOI 10.1093/pcp/pcj095; Ishizuka T, 2011, BIOCHEMISTRY-US, V50, P953, DOI 10.1021/bi101626t; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Kompantseva E I, 2005, Mikrobiologiia, V74, P410; Krauss U, 2009, J BACTERIOL, V191, P7234, DOI 10.1128/JB.00923-09; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lim S, 2014, PHOTOCH PHOTOBIO SCI, V13, P951, DOI 10.1039/c3pp50442e; Ma Q, 2012, FEBS J, V279, P4095, DOI 10.1111/febs.12003; Masuda S, 2004, BIOCHEMISTRY-US, V43, P5304, DOI 10.1021/bi049836v; Masuda S, 2013, PLANT CELL PHYSIOL, V54, P171, DOI 10.1093/pcp/pcs173; MYERS J, 1980, PLANT PHYSIOL, V66, P1144, DOI 10.1104/pp.66.6.1144; Myers JL, 2007, APPL ENVIRON MICROB, V73, P5173, DOI 10.1128/AEM.00900-07; Narikawa R, 2008, J MOL BIOL, V380, P844, DOI 10.1016/j.jmb.2008.05.035; Narikawa R, 2015, SCI REP-UK, V5, DOI 10.1038/srep07950; Narikawa R, 2013, P NATL ACAD SCI USA, V110, P918, DOI 10.1073/pnas.1212098110; Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159; Raffelberg S, 2013, BIOCHEM J, V455, P359, DOI 10.1042/BJ20130637; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Rockwell NC, 2015, BIOCHEMISTRY-US, V54, P3772, DOI 10.1021/acs.biochem.5b00438; Rockwell NC, 2015, PHOTOCH PHOTOBIO SCI, V14, P929, DOI 10.1039/c4pp00486h; Rockwell NC, 2015, BIOCHEMISTRY-US, V54, P2581, DOI 10.1021/bi501548t; Rockwell NC, 2015, PHOTOCH PHOTOBIO SCI, V14, P258, DOI 10.1039/c4pp00336e; Rockwell NC, 2014, BIOCHEMISTRY-US, V53, P3118, DOI 10.1021/bi500037a; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P9667, DOI 10.1021/bi3013565; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P3576, DOI 10.1021/bi300171s; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P1449, DOI 10.1021/bi201783j; Rockwell NC, 2011, P NATL ACAD SCI USA, V108, P11854, DOI 10.1073/pnas.1107844108; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Ryu JY, 2010, PLANT BIOTECHNOL REP, V4, P149, DOI 10.1007/s11816-010-0130-7; Ryu JY, 2004, J BIOL CHEM, V279, P25320, DOI 10.1074/jbc.M402541200; Savakis P, 2012, MOL MICROBIOL, V85, P239, DOI 10.1111/j.1365-2958.2012.08106.x; Schirrmeister BE, 2013, P NATL ACAD SCI USA, V110, P1791, DOI 10.1073/pnas.1209927110; Schirrmeister BE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-45; Sergeev V. N., 2002, Mikrobiologiya, V71, P725; Song JY, 2011, P NATL ACAD SCI USA, V108, P10780, DOI 10.1073/pnas.1104242108; Sun YF, 2014, PHOTOCH PHOTOBIO SCI, V13, P757, DOI 10.1039/c3pp50411e; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Xu XL, 2014, CHEMBIOCHEM, V15, P1190, DOI 10.1002/cbic.201400053; Yang EC, 2012, PROTIST, V163, P217, DOI 10.1016/j.protis.2011.08.001; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yoshihara S, 2004, PLANT CELL PHYSIOL, V45, P1729, DOI 10.1093/pcp/pch214; Yoshihara S, 2002, PLANT CELL PHYSIOL, V43, P513, DOI 10.1093/pcp/pcf061; Zavarzin GA, 2003, MICROBIOLOGY+, V72, P80, DOI 10.1023/A:1022234208175; Zhao KH, 2004, BIOCHEMISTRY-US, V43, P11576, DOI 10.1021/bi0491548	67	28	28	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28502	28514		10.1074/jbc.M115.669150	http://dx.doi.org/10.1074/jbc.M115.669150			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26405033	hybrid, Green Published			2022-12-28	WOS:000365761900043
J	Cui, JQ; Chen, W; Sun, JH; Guo, H; Madley, R; Xiong, Y; Pan, XY; Wang, HL; Tai, AW; Weiss, MA; Arvan, P; Liu, M				Cui, Jingqiu; Chen, Wei; Sun, Jinhong; Guo, Huan; Madley, Rachel; Xiong, Yi; Pan, Xingyi; Wang, Hongliang; Tai, Andrew W.; Weiss, Michael A.; Arvan, Peter; Liu, Ming			Competitive Inhibition of the Endoplasmic Reticulum Signal Peptidase by Non-cleavable Mutant Preprotein Cargos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; COLI LEADER PEPTIDASE; MEMBRANE TOPOLOGY; REM PROTEIN; SEQUENCE; GLYCOPROTEIN; TRANSLOCATION; MUTATIONS; MECHANISM; PRECURSOR	Upon translocation across the endoplasmic reticulum (ER) membrane, secretory proteins are proteolytically processed to remove their signal peptide by signal peptidase (SPase). This process is critical for subsequent folding, intracellular trafficking, and maturation of secretory proteins. Prokaryotic SPase has been shown to be a promising antibiotic target. In contrast, to date, no eukaryotic SPase inhibitors have been reported. Here we report that introducing a proline immediately following the natural signal peptide cleavage site not only blocks preprotein cleavage but also, in trans, impairs the processing and maturation of co-expressed preproteins in the ER. Specifically, we find that a variant preproinsulin, pPI-F25P, is translocated across the ER membrane, where it binds to the catalytic SPase subunit SEC11A, inhibiting SPase activity in a dose-dependent manner. Similar findings were obtained with an analogous variant of preproparathyroid hormone, demonstrating that inhibition of the SPase does not depend strictly on the sequence or structure of the downstream mature protein. We further show that inhibiting SPase in the ER impairs intracellular processing of viral polypeptides and their subsequent maturation. These observations suggest that eukaryotic SPases (including the human ortholog) are, in principle, suitable therapeutic targets for antiviral drug design.	[Cui, Jingqiu; Liu, Ming] Tianjin Med Univ, Gen Hosp, Dept Endocrinol & Metab, Tianjin 300052, Peoples R China; [Cui, Jingqiu; Chen, Wei; Sun, Jinhong; Guo, Huan; Madley, Rachel; Xiong, Yi; Pan, Xingyi; Arvan, Peter; Liu, Ming] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48105 USA; [Chen, Wei] Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China; [Wang, Hongliang; Tai, Andrew W.] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Tianjin Medical University; University of Michigan System; University of Michigan; Academy of Military Medical Sciences - China; University of Michigan System; University of Michigan; Case Western Reserve University	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu; parvan@umich.edu; mingli@umich.edu	Regan, Clinton/E-6250-2012; Wang, Hongliang/J-1941-2012; Tai, Andrew W./M-8380-2017	Wang, Hongliang/0000-0002-3304-2683; Tai, Andrew W./0000-0002-6877-450X; Liu, Ming/0000-0003-2665-4072	National Institutes of Health [P60-DK20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, R01DK040949, P60DK020572, R01DK069764, R01DK048280, R01DK088856, R01DK097374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Molecular Biology and DNA Sequencing Core of the University of Michigan Diabetes Research and Training Center funded by the National Institutes of Health (Grant P60-DK20572),	Auclair SM, 2012, PROTEIN SCI, V21, P13, DOI 10.1002/pro.757; BARKOCYGALLAGHER GA, 1992, J BIOL CHEM, V267, P1231; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Byun H, 2010, P NATL ACAD SCI USA, V107, P12287, DOI 10.1073/pnas.1004303107; Choo KH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S15; DALBEY RE, 1985, J BIOL CHEM, V260, P5925; Dalbey RE, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P3493, DOI 10.1016/B978-0-12-382219-2.00774-2; Datta R, 2007, P NATL ACAD SCI USA, V104, P19989, DOI 10.1073/pnas.0708725104; Dultz E, 2008, J BIOL CHEM, V283, P9966, DOI 10.1074/jbc.M705712200; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Guo H, 2014, J BIOL CHEM, V289, P16290, DOI 10.1074/jbc.M114.562355; ITO M, 1993, J CLIN INVEST, V91, P2565, DOI 10.1172/JCI116494; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; Kalies KU, 1996, J BIOL CHEM, V271, P3925; KOSHLAND D, 1982, CELL, V30, P903, DOI 10.1016/0092-8674(82)90295-1; KUO D, 1994, BIOCHEMISTRY-US, V33, P8347, DOI 10.1021/bi00193a023; KUO DW, 1993, ARCH BIOCHEM BIOPHYS, V303, P274, DOI 10.1006/abbi.1993.1283; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Lavie M, 2007, CURR ISSUES MOL BIOL, V9, P71; Law LMJ, 2001, J VIROL, V75, P1978, DOI 10.1128/JVI.75.4.1978-1983.2001; Li Y, 2000, VIROLOGY, V272, P417, DOI 10.1006/viro.2000.0357; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2012, DIABETES, V61, P828, DOI 10.2337/db11-0878; Liu M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013333; Meyer HA, 1997, J BIOL CHEM, V272, P13159, DOI 10.1074/jbc.272.20.13159; Mullins C, 1996, J BIOL CHEM, V271, P29094, DOI 10.1074/jbc.271.46.29094; NILSSON I, 1992, FEBS LETT, V299, P243, DOI 10.1016/0014-5793(92)80124-Y; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paetzel M, 2014, BBA-MOL CELL RES, V1843, P1497, DOI 10.1016/j.bbamcr.2013.12.003; Pekosz A, 1998, P NATL ACAD SCI USA, V95, P13233, DOI 10.1073/pnas.95.22.13233; Pene V, 2009, J VIRAL HEPATITIS, V16, P705, DOI 10.1111/j.1365-2893.2009.01118.x; RACCHI M, 1993, J BIOL CHEM, V268, P5735; Rao CVS, 2014, BBA-MOL CELL RES, V1843, P1762, DOI 10.1016/j.bbamcr.2014.02.004; RUSSEL M, 1981, P NATL ACAD SCI-BIOL, V78, P1717, DOI 10.1073/pnas.78.3.1717; SHELNESS GS, 1993, J BIOL CHEM, V268, P5201; SHEN LM, 1991, BIOCHEMISTRY-US, V30, P11775, DOI 10.1021/bi00115a006; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Sun JH, 2015, MOL ASPECTS MED, V42, P105, DOI 10.1016/j.mam.2015.01.001; Suzuki R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003589; VanValkenburgh C, 1999, J BIOL CHEM, V274, P11519, DOI 10.1074/jbc.274.17.11519; von Heijne G, 1998, NATURE, V396, P111, DOI 10.1038/24036; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; Walker SJ, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P3512, DOI 10.1016/B978-0-12-382219-2.00778-X; WALTER P, 1979, P NATL ACAD SCI USA, V76, P1795, DOI 10.1073/pnas.76.4.1795; Yanagi M, 1999, VIROLOGY, V262, P250, DOI 10.1006/viro.1999.9889; ZWIZINSKI C, 1981, J BIOL CHEM, V256, P3593	48	17	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28131	28140		10.1074/jbc.M115.692350	http://dx.doi.org/10.1074/jbc.M115.692350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26446786	Green Published, hybrid			2022-12-28	WOS:000365761900009
J	Jiang, H; Wang, WW; Zhang, Y; Yao, WW; Jiang, JY; Qin, B; Yao, WY; Liu, FS; Wu, HH; Ward, TL; Chen, CW; Liu, LF; Ding, X; Liu, X; Yao, XB				Jiang, Hao; Wang, Wenwen; Zhang, Yin; Yao, William W.; Jiang, Jiying; Qin, Bo; Yao, Wendy Y.; Liu, Fusheng; Wu, Huihui; Ward, Tarsha L.; Chen, Chun Wei; Liu, Lifang; Ding, Xia; Liu, Xing; Yao, Xuebiao			Cell Polarity Kinase MST4 Cooperates with cAMP-dependent Kinase to Orchestrate Histamine-stimulated Acid Secretion in Gastric Parietal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APICAL MEMBRANE; 80-KDA PHOSPHOPROTEIN; ERM PROTEINS; SYNTAXIN 3; EZRIN; PHOSPHORYLATION; ACTIVATION; LOCALIZATION; AURORA; CORTEX	The digestive function of the stomach depends on acidification of the gastric lumen. Acid secretion into the lumen is triggered by activation of the PKA cascade, which ultimately results in the insertion of gastric H,K-ATPases into the apical plasma membranes of parietal cells. A coupling protein is ezrin, whose phosphorylation at Ser-66 by PKA is required for parietal cell activation. However, little is known regarding the molecular mechanism(s) by which this signaling pathway operates in gastric acid secretion. Here we show that PKA cooperates with MST4 to orchestrate histamine-elicited acid secretion by phosphorylating ezrin at Ser-66 and Thr-567. Histamine stimulation activates PICA, which phosphorylates msT4 at Thr-178 and then promotes MST4 kinase activity. Interestingly, activated MST4 then phosphorylates ezrin prephosphorylated by PKA. Importantly, MST4 is important for acid secretion in parietal cells because either suppression of MST4 or overexpression of non-phosphorylatable MST4 prevents the apical membrane reorganization and proton pump translocation elicited by histamine stimulation. In addition, overexpressing MST4 phosphorylation-deficient ezrin results in an inhibition of gastric acid secretion. Taken together, these results define a novel molecular mechanism linking the PKA-MST4-ezrin signaling cascade to polarized epithelial secretion in gastric parietal cells.	[Jiang, Hao; Wang, Wenwen; Zhang, Yin; Jiang, Jiying; Qin, Bo; Liu, Fusheng; Wu, Huihui; Chen, Chun Wei; Ding, Xia; Liu, Xing; Yao, Xuebiao] Univ Sci & Technol China, BUCM USTC Joint Program Cellular Dynam, Hefei 230027, Peoples R China; [Jiang, Hao; Wang, Wenwen; Zhang, Yin; Jiang, Jiying; Qin, Bo; Liu, Fusheng; Wu, Huihui; Chen, Chun Wei; Ding, Xia; Liu, Xing; Yao, Xuebiao] Univ Sci & Technol China, Anhui Key Lab Cellular Dynam, Hefei 230027, Peoples R China; [Zhang, Yin; Liu, Fusheng; Ding, Xia] Beijing Univ Chinese Med, Beijing 100029, Peoples R China; [Wang, Wenwen; Yao, William W.; Qin, Bo; Yao, Wendy Y.; Wu, Huihui; Ward, Tarsha L.; Liu, Xing] Atlanta Clin & Translat Sci Inst, Mol Imaging Ctr, Atlanta, GA 30310 USA; [Liu, Fusheng; Liu, Lifang] Airforce Gen Hosp, Beijing 100036, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Beijing University of Chinese Medicine	Ding, X (corresponding author), Univ Sci & Technol China, BUCM USTC Joint Program Cellular Dynam, Hefei 230027, Peoples R China.	dingx@bucm.edu.cn; xing1017@ustc.edu.cn; xyao@msm.edu	Regan, Clinton/E-6250-2012; liu, li/HGC-0900-2022; Yao, Xuebiao/P-5771-2014; WANG, WENWEN/AAF-1080-2020	WANG, WENWEN/0000-0002-1545-4369	Chinese 973 Project [2013CB911203]; Ministry of Education [20113402130010]; Anhui Project Grant [08040102005]; Chinese Natural Science Foundation [31430054, 31271518, 31301105, 31501095, 90508002, 90913016]; National Institutes of Health [CA164133, DK56292]; China Postdoctoral Science Foundation [2014M560517]; Central University [WK2340000032, WK2340000021]; China Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER	Chinese 973 Project(National Basic Research Program of China); Ministry of Education; Anhui Project Grant; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Central University; China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Chinese 973 Project Grant 2013CB911203; Ministry of Education Grant 20113402130010; Anhui Project Grant 08040102005; Chinese Natural Science Foundation Grants 31430054, 31271518, 31301105, 31501095, 90508002, and 90913016; National Institutes of Health Grants CA164133 and DK56292; China Postdoctoral Science Foundation Grant 2014M560517; and Central University Grants WK2340000032 and WK2340000021. The authors declare that they have no conflicts of interest with the contents of this article.; Visiting scholar sponsored by the China Scholarship Council.	Ammar DA, 2002, AM J PHYSIOL-GASTR L, V282, pG23, DOI 10.1152/ajpgi.00277.2002; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cao XW, 2005, J BIOL CHEM, V280, P13584, DOI 10.1074/jbc.M411941200; Chen Y, 2011, CANCER RES, V71, P1721, DOI 10.1158/0008-5472.CAN-09-4683; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Ding X, 2010, J BIOL CHEM, V285, P18769, DOI 10.1074/jbc.M110.129007; Dransfield DT, 1997, EMBO J, V16, P35, DOI 10.1093/emboj/16.1.35; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; HANZEL DK, 1989, AM J PHYSIOL, V256, pG1082, DOI 10.1152/ajpgi.1989.256.6.G1082; Karvar S, 2002, J BIOL CHEM, V277, P50030, DOI 10.1074/jbc.M207694200; Karvar S, 2002, GASTROENTEROLOGY, V123, P281, DOI 10.1053/gast.2002.34217; Liu D, 2007, FEBS LETT, V581, P3563, DOI 10.1016/j.febslet.2007.06.071; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Peng XR, 1997, MOL BIOL CELL, V8, P399, DOI 10.1091/mbc.8.3.399; Rawat SJ, 2015, TRENDS BIOCHEM SCI, V40, P149, DOI 10.1016/j.tibs.2015.01.001; Tamura A, 2005, J CELL BIOL, V169, P21, DOI 10.1083/jcb.200410083; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; URUSHIDANI T, 1989, AM J PHYSIOL, V256, pG1070, DOI 10.1152/ajpgi.1989.256.6.G1070; Wang FS, 2008, J BIOL CHEM, V283, P26714, DOI 10.1074/jbc.M800527200; Xia P, 2014, MOL BIOL CELL, V25, P4166, DOI 10.1091/mbc.E14-06-1133; Xia P, 2014, J MOL CELL BIOL, V6, P240, DOI 10.1093/jmcb/mju016; Yao XB, 2003, ANNU REV PHYSIOL, V65, P103, DOI 10.1146/annurev.physiol.65.072302.114200; Yao XB, 1996, J BIOL CHEM, V271, P7224, DOI 10.1074/jbc.271.12.7224; YAO XB, 1995, MOL BIOL CELL, V6, P541, DOI 10.1091/mbc.6.5.541; Yu HJ, 2014, J BIOL CHEM, V289, P33333, DOI 10.1074/jbc.M114.581280; Zh LX, 2007, AM J PHYSIOL-CELL PH, V293, pC874, DOI 10.1152/ajpcell.00111.2007; Zhou RH, 2005, J CELL SCI, V118, P4381, DOI 10.1242/jcs.02559; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200	28	13	13	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28272	28285		10.1074/jbc.M115.668855	http://dx.doi.org/10.1074/jbc.M115.668855			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26405038	Green Published, hybrid			2022-12-28	WOS:000365761900020
J	Koyano-Nakagawa, N; Shi, XZ; Rasmussen, TL; Das, S; Walter, CA; Garry, DJ				Koyano-Nakagawa, Naoko; Shi, Xiaozhong; Rasmussen, Tara L.; Das, Satyabrata; Walter, Camille A.; Garry, Daniel J.			Feedback Mechanisms Regulate Ets Variant 2 (Etv2) Gene Expression and Hematoendothelial Lineages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; ACTIVATED T-CELLS; TRANSCRIPTION FACTOR; VASCULAR DEVELOPMENT; PRIMITIVE MESODERM; EMBRYONIC STEM; NUCLEAR FACTOR; NF-ATC; VEGF	Etv2 is an essential transcriptional regulator of hematoendothelial lineages during embryogenesis. Although Etv2 downstream targets have been identified, little is known regarding the upstream transcriptional regulation of Etv2 gene expression. In this study, we established a novel methodology that utilizes the differentiating ES cell and embryoid body system to define the modules and enhancers embedded within the Etv2 promoter. Using this system, we defined an autoactivating role for Etv2 that is mediated by two adjacent Ets motifs in the proximal promoter. In addition, we defined the role of VEGF/Flk1-Calcineurin-NFAT signaling cascade in the transcriptional regulation of Etv2. Furthermore, we defined an Etv2-Flt1-Flk1 cascade that serves as a negative feedback mechanism to regulate Etv2 gene expression. To complement and extend these studies, we demonstrated that the Flt1 null embryonic phenotype was partially rescued in the Etv2 conditional knockout background. In summary, these studies define upstream and downstream networks that serve as a transcriptional rheostat to regulate Etv2 gene expression.	[Koyano-Nakagawa, Naoko; Shi, Xiaozhong; Rasmussen, Tara L.; Das, Satyabrata; Walter, Camille A.; Garry, Daniel J.] Univ Minnesota, Sch Med, Lillehei Heart Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Garry, DJ (corresponding author), Univ Minnesota, Lillehei Heart Inst, 2231 6th St,SE,4-146 CCRB, Minneapolis, MN 55455 USA.	garry@umn.edu	Regan, Clinton/E-6250-2012; Das, Satyabrata/J-2629-2019		National Institutes of Health [U01 HL100407, 1R01 HL122576]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100407, R01HL122576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants U01 HL100407 and 1R01 HL122576 to D. J. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Armand AS, 2008, J BIOL CHEM, V283, P29004, DOI 10.1074/jbc.M801297200; Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; BORIES JC, 1995, NATURE, V377, P635, DOI 10.1038/377635a0; Bosc LVG, 2005, J BIOL CHEM, V280, P26113, DOI 10.1074/jbc.M411972200; Bowlin KM, 2013, DIFFERENTIATION, V86, P184, DOI 10.1016/j.diff.2013.08.002; Caprioli A, 2011, CIRCULATION, V123, P1633, DOI 10.1161/CIRCULATIONAHA.110.008185; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Donaldson LW, 1996, EMBO J, V15, P125, DOI 10.1002/j.1460-2075.1996.tb00340.x; Ferdous A, 2009, P NATL ACAD SCI USA, V106, P814, DOI 10.1073/pnas.0807583106; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Hayashi M, 2012, EXP HEMATOL, V40, P738, DOI 10.1016/j.exphem.2012.05.012; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Iacovino M, 2011, STEM CELLS, V29, P1580, DOI 10.1002/stem.715; Jin EJ, 2009, BLOOD, V114, P5557, DOI 10.1182/blood-2009-05-220434; Kanatous SB, 2010, J EXP BIOL, V213, P2741, DOI 10.1242/jeb.041442; Kataoka H, 2013, EXP HEMATOL, V41, P567, DOI 10.1016/j.exphem.2013.02.009; Kataoka H, 2011, BLOOD, V118, P6975, DOI 10.1182/blood-2011-05-352658; Kim JY, 2014, BLOOD, V124, P2948, DOI 10.1182/blood-2014-03-556332; Knebel J, 2006, J CELL BIOCHEM, V99, P319, DOI 10.1002/jcb.20945; Koyano-Nakagawa N, 2012, STEM CELLS, V30, P1611, DOI 10.1002/stem.1131; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Mayo LD, 2001, J BIOL CHEM, V276, P25184, DOI 10.1074/jbc.M102932200; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; MORISHITA K, 1995, J BIOL CHEM, V270, P27948, DOI 10.1074/jbc.270.46.27948; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Neuhaus H, 2010, DEV DYNAM, V239, P3436, DOI 10.1002/dvdy.22487; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rasmussen TL, 2013, GENESIS, V51, P471, DOI 10.1002/dvg.22396; Rasmussen TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050103; Rasmussen TL, 2011, DEVELOPMENT, V138, P4801, DOI 10.1242/dev.070912; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; Sato Y, 2000, ANN NY ACAD SCI, V902, P201; Schupp MO, 2014, DEV BIOL, V393, P71, DOI 10.1016/j.ydbio.2014.06.019; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shi XZ, 2015, J BIOL CHEM, V290, P9614, DOI 10.1074/jbc.M114.614628; Shi XZ, 2014, DEV BIOL, V389, P208, DOI 10.1016/j.ydbio.2014.02.018; Sumanas S, 2006, PLOS BIOL, V4, P60, DOI 10.1371/journal.pbio.0040010; van Bueren KL, 2012, CURR OPIN HEMATOL, V19, P199, DOI 10.1097/MOH.0b013e3283523e07; Veldman MB, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001590; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Yamamizu K, 2012, STEM CELLS, V30, P687, DOI 10.1002/stem.1041; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yao YG, 2004, BIOCHEM BIOPH RES CO, V321, P648, DOI 10.1016/j.bbrc.2004.06.176	60	25	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28107	28119		10.1074/jbc.M115.662197	http://dx.doi.org/10.1074/jbc.M115.662197			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26396195	Green Published, hybrid			2022-12-28	WOS:000365761900007
J	Meng, HZ; Zhang, WL; Liu, F; Yang, MW				Meng, Hong-Zheng; Zhang, Wei-Lin; Liu, Fei; Yang, Mao-Wei			Advanced Glycation End Products Affect Osteoblast Proliferation and Function by Modulating Autophagy Via the Receptor of Advanced Glycation End Products/Raf Protein/Mitogen-activated Protein Kinase/Extracellular Signalregulated Kinase Kinase/Extracellular Signal-regulated Kinase (RAGE/Raf/MEK/ERK) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MINERAL DENSITY; SMOOTH-MUSCLE-CELLS; FRACTURE RISK; APOPTOSIS; ENDPRODUCTS; DEATH; STRESS; RAGE; COMPLICATIONS; OSTEOPOROSIS	The interaction between advanced glycation end products (AGEs) and receptor of AGEs (RAGE) is associated with the development and progression of diabetes-associated osteoporosis, but the mechanisms involved are still poorly understood. In this study, we found that AGE-modified bovine serum albumin (AGE-BSA) induced a biphasic effect on the viability of hFOB1.19 cells; cell proliferation was stimulated after exposure to low dose AGE-BSA, but cell apoptosis was stimulated after exposure to high dose AGE-BSA. The low dose AGE-BSA facilitates proliferation of hEOB1.19 cells by concomitantly promoting autophagy, RAGE production, and the Raf/MEK/ERK signaling pathway activation. Furthermore, we investigated the effects of AGE-BSA on the function of hFOBL19 cells, Interestingly, the results suggest that the short term effects of low dose AGE-BSA increase osteogenic function and decrease osteoclastogenic function, which are likely mediated by autophagy and the RAGE/Raf/MEK/ERK signal pathway. In contrast, with increased treatment time, the opposite effects were observed. Collectively, AGE-BSA had a biphasic effect on the viability of hEOB1.19 cells in vitro, which was determined by the concentration of AGE-BSA and treatment time. A low concentration of AGE-BSA activated the Raf/MEK/ERK signal pathway through the interaction with RAGE, induced autophagy, and regulated the proliferation and function of hFOB1.19 cells.	[Meng, Hong-Zheng; Zhang, Wei-Lin; Liu, Fei; Yang, Mao-Wei] China Med Univ, Affiliated Hosp 1, Dept Orthopaed, Shenyang 110001, Peoples R China	China Medical University	Yang, MW (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Orthopaed, Shenyang 110001, Peoples R China.	maoweiyang@hotmail.com		Yang, Maowei/0000-0003-4304-7661	National Natural Science Foundation of China [81471094, 81170808]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 81471094 and 81170808. The authors declare that they have no conflicts of interest with the contents of this article.	Alikhani M, 2007, BONE, V40, P345, DOI 10.1016/j.bone.2006.09.011; Alva AS, 2004, CELL DEATH DIFFER, V11, P1046, DOI 10.1038/sj.cdd.4401445; Barbezier N, 2014, ANN BIOL CLIN-PARIS, V72, P669, DOI 10.1684/abc.2014.1010; Bartolome A, 2013, BIOCHEM J, V455, P329, DOI 10.1042/BJ20130562; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; de Liefde II, 2005, OSTEOPOROSIS INT, V16, P1713, DOI 10.1007/s00198-005-1909-1; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Deretic V, 2012, TRENDS CELL BIOL, V22, P397, DOI 10.1016/j.tcb.2012.04.008; Franke S, 2011, CLIN EXP RHEUMATOL, V29, P650; Franke Sybille, 2007, Archives of Physiology and Biochemistry, V113, P154, DOI 10.1080/13813450701602523; Galluzzi L, 2008, CURR MOL MED, V8, P78; Ge JB, 2005, ARTERIOSCL THROM VAS, V25, P2157, DOI 10.1161/01.ATV.0000181744.58265.63; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; HARRIS SA, 1995, J BONE MINER RES, V10, P178; Hein GE, 2006, CLIN CHIM ACTA, V371, P32, DOI 10.1016/j.cca.2006.03.017; Hofbauer LC, 2001, J MOL MED, V79, P243, DOI 10.1007/s001090100226; Hu PF, 2012, INT J MOL MED, V29, P613, DOI 10.3892/ijmm.2012.891; Kang R, 2010, CELL DEATH DIFFER, V17, P666, DOI 10.1038/cdd.2009.149; Kang R, 2011, AUTOPHAGY, V7, P442, DOI 10.4161/auto.7.4.14681; Kim JH, 2014, EXP CELL RES, V327, P340, DOI 10.1016/j.yexcr.2014.08.001; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lai EHH, 2012, J ENDODONT, V38, P757, DOI 10.1016/j.joen.2012.02.023; Lander HM, 1997, J BIOL CHEM, V272, P17810, DOI 10.1074/jbc.272.28.17810; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li LF, 2015, ACTA BIOCH BIOPH SIN, V47, P362, DOI 10.1093/abbs/gmv014; McCarthy AD, 1997, MOL CELL BIOCHEM, V170, P43, DOI 10.1023/A:1006816223292; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Mercer N, 2007, MOL CELL BIOCHEM, V306, P87, DOI 10.1007/s11010-007-9557-8; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Nollet M, 2014, AUTOPHAGY, V10, P1965, DOI 10.4161/auto.36182; Odetti P, 2005, ANN NY ACAD SCI, V1043, P710, DOI 10.1196/annals.1333.082; Oei L, 2015, CURR OSTEOPOROS REP, V13, P106, DOI 10.1007/s11914-015-0260-5; Pietschmann P, 2010, HORM METAB RES, V42, P763, DOI 10.1055/s-0030-1262825; Platini F, 2010, CURR PHARM DESIGN, V16, P101, DOI 10.2174/138161210789941810; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Saito M, 2014, CURR OSTEOPOROS REP, V12, P181, DOI 10.1007/s11914-014-0202-7; Satoh H, 1997, BIOCHEM BIOPH RES CO, V239, P111, DOI 10.1006/bbrc.1997.7424; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Xie JL, 2013, CELL SIGNAL, V25, P2185, DOI 10.1016/j.cellsig.2013.06.013; Xie Y, 2011, MOL MED REP, V4, P459, DOI 10.3892/mmr.2011.460; Yamagishi S, 2005, MED HYPOTHESES, V65, P1013, DOI 10.1016/j.mehy.2005.07.017; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005	45	48	60	5	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28189	28199		10.1074/jbc.M115.669499	http://dx.doi.org/10.1074/jbc.M115.669499			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26472922	Green Published, hybrid			2022-12-28	WOS:000365761900014
J	Ozer, HK; Dlouhy, AC; Thornton, JD; Hu, JJ; Liu, YL; Barycki, JJ; Balk, J; Outten, CE				Ozer, Hatice K.; Dlouhy, Adrienne C.; Thornton, Jeremy D.; Hu, Jingjing; Liu, Yilin; Barycki, Joseph J.; Balk, Janneke; Outten, Caryn E.			Cytosolic Fe-S Cluster Protein Maturation and Iron Regulation Are Independent of the Mitochondrial Erv1/Mia40 Import System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE RELAY SYSTEM; INTERMEMBRANE SPACE PROTEINS; SULFHYDRYL OXIDASE ERV1; SACCHAROMYCES-CEREVISIAE; SULFUR PROTEINS; TRANSCRIPTION FACTORS; RESPIRATORY-CHAIN; ELECTRON-TRANSFER; FUNCTIONAL-LINK; GENE-EXPRESSION	The sulfhydryl oxidase Erv1 partners with the oxidoreductase Mia40 to import cysteine-rich proteins in the mitochondrial intermembrane space. In Saccharomyces cerevisiae, Erv1 has also been implicated in cytosolic Fe-S protein maturation and iron regulation. To investigate the connection between Erv1/Mia40-dependent mitochondrial protein import and cytosolic Fe-S cluster assembly, we measured Mia40 oxidation and Fe-S enzyme activities in several erv1 and mia40 mutants. Although all the erv1 and mia40 mutants exhibited defects in Mia40 oxidation, only one erv1 mutant strain (erv1-1) had significantly decreased activities of cytosolic Fe-S enzymes. Further analysis of erv1-1 revealed that it had strongly decreased glutathione (GSH) levels, caused by an additional mutation in the gene encoding the glutathione biosynthesis enzyme glutamate cysteine ligase (GSH1). To address whether Erv1 or Mia40 plays a role in iron regulation, we measured iron-dependent expression of Aft1/2-regulated genes and mitochondrial iron accumulation in erv1 and mia40 strains. The only strain to exhibit iron mis-regulation is the GSH-deficient erv1-1 strain, which is rescued with addition of GSH. Together, these results confirm that GSH is critical for cytosolic Fe-S protein biogenesis and iron regulation, whereas ruling out significant roles for Erv1 or Mia40 in these pathways.	[Ozer, Hatice K.; Dlouhy, Adrienne C.; Hu, Jingjing; Outten, Caryn E.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Thornton, Jeremy D.; Balk, Janneke] John Innes Ctr, Norwich NR4 7UH, Norfolk, England; [Thornton, Jeremy D.; Balk, Janneke] Univ E Anglia, Norwich NR4 7UH, Norfolk, England; [Liu, Yilin; Barycki, Joseph J.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Liu, Yilin; Barycki, Joseph J.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Outten, CE (corresponding author), Univ S Carolina, 631 Sumter St, Columbia, SC 29208 USA.	outten@mailbox.sc.edu	Outten, Caryn E./I-9433-2019; Regan, Clinton/E-6250-2012	Outten, Caryn E./0000-0003-0335-6531; 	National Institutes of Health [GM086619, GM077289]; Biotechnology and Biological Sciences Research Council (Institute Strategic Programmes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077289, R01GM086619] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/K008838/1, BBS/E/J/000C0657] Funding Source: researchfish; BBSRC [BB/K008838/1, BBS/E/J/000C0657] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council (Institute Strategic Programmes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grants GM086619 (to C. E. O.) and GM077289 (to J. J. B.) and the Biotechnology and Biological Sciences Research Council (Institute Strategic Programmes) (to J. B.).	Allen S, 2005, J MOL BIOL, V353, P937, DOI 10.1016/j.jmb.2005.08.049; Aloria K, 2004, EMBO REP, V5, P1096, DOI 10.1038/sj.embor.7400272; Amutha B, 2008, J BIOL CHEM, V283, P1362, DOI 10.1074/jbc.M706808200; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Bedekovics T, 2011, J BIOL CHEM, V286, P40878, DOI 10.1074/jbc.M111.270082; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Biterova EI, 2009, J BIOL CHEM, V284, P32700, DOI 10.1074/jbc.M109.025114; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Daithankar VN, 2009, BIOCHEMISTRY-US, V48, P4828, DOI 10.1021/bi900347v; DAUM G, 1982, J BIOL CHEM, V257, P3028; Ferecatu I, 2014, J BIOL CHEM, V289, P28070, DOI 10.1074/jbc.M114.548438; Fischer Manuel, 2013, Int J Cell Biol, V2013, P742923, DOI 10.1155/2013/742923; Guo PC, 2012, J BIOL CHEM, V287, P34961, DOI 10.1074/jbc.M112.394759; Hausmann A, 2005, P NATL ACAD SCI USA, V102, P3266, DOI 10.1073/pnas.0406447102; Herrmann JM, 2012, J BIOL CHEM, V287, P4426, DOI 10.1074/jbc.R111.270678; Hofhaus G, 2003, EUR J BIOCHEM, V270, P1528, DOI 10.1046/j.1432-1033.2003.03519.x; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JY, 2014, SCIENCE, V343, P1133, DOI 10.1126/science.1246489; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; LISOWSKY T, 1994, CURR GENET, V26, P15, DOI 10.1007/BF00326299; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Miao R, 2008, BIOCHEMISTRY-US, V47, P9888, DOI 10.1021/bi801047q; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Muller JM, 2008, MOL BIOL CELL, V19, P226, DOI 10.1091/mbc.E07-08-0814; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Outten CE, 2013, CURR OPIN MICROBIOL, V16, P662, DOI 10.1016/j.mib.2013.07.020; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; Philpott CC, 2002, BIOCHEM SOC T, V30, P698, DOI 10.1042/bst0300698; Poor CB, 2014, P NATL ACAD SCI USA, V111, P4043, DOI 10.1073/pnas.1318869111; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Roy A, 2003, EMBO J, V22, P4826, DOI 10.1093/emboj/cdg455; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Schaedler TA, 2014, J BIOL CHEM, V289, P23264, DOI 10.1074/jbc.M114.553438; Sideris DP, 2010, ANTIOXID REDOX SIGN, V13, P1189, DOI 10.1089/ars.2010.3157; SIKORSKI RS, 1989, GENETICS, V122, P19; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Spiller MP, 2013, BIOCHEM J, V455, P27, DOI 10.1042/BJ20130442; Srinivasan V, 2014, SCIENCE, V343, P1137, DOI 10.1126/science.1246729; Terziyska N, 2007, FEBS LETT, V581, P1098, DOI 10.1016/j.febslet.2007.02.014; THORVALDSEN JL, 1993, J BIOL CHEM, V268, P12512; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Ueta R, 2012, MOL CELL BIOL, V32, P4998, DOI 10.1128/MCB.00726-12; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	57	16	16	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27829	27840		10.1074/jbc.M115.682179	http://dx.doi.org/10.1074/jbc.M115.682179			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26396185	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000365757500033
J	Wei, J; Graziane, NM; Gu, ZL; Yan, Z				Wei, Jing; Graziane, Nicholas M.; Gu, Zhenglin; Yan, Zhen			DISC1 Protein Regulates gamma-Aminobutyric Acid, Type A (GABA(A)) Receptor Trafficking and Inhibitory Synaptic Transmission in Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGENITOR PROLIFERATION; PREFRONTAL CORTEX; MUTANT HUNTINGTIN; PYRAMIDAL NEURONS; MENTAL-ILLNESS; NMDA RECEPTOR; SCHIZOPHRENIA; TRANSPORT; KINESIN; RISK	Association studies have suggested that Disrupted-in-Schizophrenia 1 (DISC1) confers a genetic risk at the level of endophenotypes that underlies many major mental disorders. Despite the progress in understanding the significance of DISC1 at neural development, the mechanisms underlying DISC1 regulation of synaptic functions remain elusive. Because alterations in the cortical GABA system have been strongly linked to the pathophysiology of schizophrenia, one potential target of DISC1 that is critically involved in the regulation of cognition and emotion is the GABA(A) receptor (GABA(A)R). We found that cellular knockdown of DISC1 significantly reduced GABA(A)R-mediated synaptic and whole-cell current, whereas overexpression of wild-type DISC1, but not the C-terminal-truncated DISC1 (a schizophrenia-related mutant), significantly increased GABA(A)R currents in pyramidal neurons of the prefrontal cortex. These effects were accompanied by DISC1-induced changes in surface GABA(A)R expression. Moreover, the regulation of GABA(A)Rs by DISC1 knockdown or overexpression depends on the microtubule motor protein kinesin 1 (KIF5). Our results suggest that DISC1 exerts an important effect on GABAergic inhibitory transmission by regulating KIF5/microtubule-based GABA(A)R trafficking in the cortex. The knowledge gained from this study would shed light on how DISC1 and the GABA system are linked mechanistically and how their interactions are critical for maintaining a normal mental state.	[Wei, Jing; Graziane, Nicholas M.; Gu, Zhenglin; Yan, Zhen] SUNY Buffalo, Sch Med & Biomed Sci, Dept Physiol & Biophys, Buffalo, NY 14214 USA; [Wei, Jing; Yan, Zhen] Vet Affairs Western New York Healthcare Syst, Buffalo, NY 14215 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yan, Z (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 124 Sherman Hall, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu	Regan, Clinton/E-6250-2012	Graziane, Nicholas/0000-0002-7055-7029	National Institutes of Health [MH101690]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH101690, R01MH108842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grant MH101690 (to Z. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; Carless MA, 2011, MOL PSYCHIATR, V16, P1096, DOI 10.1038/mp.2011.37; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Dumoulin A, 1999, J CELL SCI, V112, P811; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5; Guillaud L, 2003, J NEUROSCI, V23, P131; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Ishizuka K, 2011, NATURE, V473, P92, DOI 10.1038/nature09859; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037; Kirkpatrick B, 2006, J COMP NEUROL, V497, P436, DOI 10.1002/cne.21007; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Luscher B, 2011, MOL PSYCHIATR, V16, P383, DOI 10.1038/mp.2010.120; Mandal M, 2011, J BIOL CHEM, V286, P33719, DOI 10.1074/jbc.M111.236521; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; McCann CM, 2006, P NATL ACAD SCI USA, V103, P5149, DOI 10.1073/pnas.0600847103; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Prata DP, 2008, MOL PSYCHIATR, V13, P915, DOI 10.1038/mp.2008.76; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Sawamura N, 2008, MOL PSYCHIATR, V13, P1138, DOI 10.1038/mp.2008.101; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Thomas P, 2005, NAT NEUROSCI, V8, P889, DOI 10.1038/nn1483; Twelvetrees AE, 2010, NEURON, V65, P53, DOI 10.1016/j.neuron.2009.12.007; Volk DW, 2002, CEREB CORTEX, V12, P1063, DOI 10.1093/cercor/12.10.1063; Wang Q, 2011, MOL PSYCHIATR, V16, P1006, DOI 10.1038/mp.2010.87; Wang X, 2003, J NEUROSCI, V23, P9852; Wang X, 2002, J NEUROSCI, V22, P9185; Wei J, 2014, BIOL PSYCHIAT, V75, P414, DOI 10.1016/j.biopsych.2013.06.009; Yuen EY, 2012, NEUROBIOL DIS, V46, P497, DOI 10.1016/j.nbd.2012.02.015; Yuen EY, 2005, J NEUROSCI, V25, P5488, DOI 10.1523/JNEUROSCI.1187-05.2005; Yuen EY, 2005, J BIOL CHEM, V280, P29420, DOI 10.1074/jbc.M504499200	46	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27680	27687		10.1074/jbc.M115.656173	http://dx.doi.org/10.1074/jbc.M115.656173			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26424793	Green Published, hybrid			2022-12-28	WOS:000365757500021
J	Ji, C; Zhang, YD; Xu, PY; Xu, T; Lou, XL				Ji, Chen; Zhang, Yongdeng; Xu, Pingyong; Xu, Tao; Lou, Xuelin			Nanoscale Landscape of Phosphoinositides Revealed by Specific Pleckstrin Homology (PH) Domains Using Single-molecule Superresolution Imaging in the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; SECRETORY GRANULES; INSULIN-SECRETION; SYNTAXIN CLUSTERS; LIVE CELLS; LOCALIZATION MICROSCOPY; FLUORESCENCE MICROSCOPY; ACTIN DYNAMICS; MULTIPLE POOLS	Background: Phosphatidylinositides in the plasma membrane (PM) are pivotal for cellular functions. Results: Superresolution imaging reveals homogeneous distribution of PI(4,5)P-2, PI4P, and PI(3,4,5)P-3 in the major area of the PM. Conclusion: Phosphatidylinositides detected by PH domains are uniformly distributed in the major regions of the PM, with limited concentration gradients. Significance: This result may imply a new working model of phosphatidylinositides at nanometer scale. Both phosphatidylinositol 4-phosphate (PI4P) and phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) are independent plasma membrane (PM) determinant lipids that are essential for multiple cellular functions. However, their nanoscale spatial organization in the PM remains elusive. Using single-molecule superresolution microscopy and new photoactivatable fluorescence probes on the basis of pleckstrin homology domains that specifically recognize phosphatidylinositides in insulin-secreting INS-1 cells, we report that the PI(4,5)P-2 probes exhibited a remarkably uniform distribution in the major regions of the PM, with some sparse PI(4,5)P-2-enriched membrane patches/domains of diverse sizes (383 +/- 14 nm on average). Quantitative analysis revealed a modest concentration gradient that was much less steep than previously thought, and no densely packed PI(4,5)P-2 nanodomains were observed. Live-cell superresolution imaging further demonstrated the dynamic structural changes of those domains in the flat PM and membrane protrusions. PI4P and phosphatidylinositol (3,4,5)-trisphosphate (PI(3,4,5)P-3) showed similar spatial distributions as PI(4,5)P-2. These data reveal the nanoscale landscape of key inositol phospholipids in the native PM and imply a framework for local cellular signaling and lipid-protein interactions at a nanometer scale.	[Ji, Chen; Lou, Xuelin] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA; [Zhang, Yongdeng; Xu, Pingyong; Xu, Tao] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	University of Wisconsin System; University of Wisconsin Madison; Chinese Academy of Sciences; Institute of Biophysics, CAS	Lou, XL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI 53705 USA.	xlou3@wisc.edu	Regan, Clinton/E-6250-2012; Zhang, Yongdeng/L-6333-2016	Ji, Chen/0000-0002-9016-6623; Zhang, Yongdeng/0000-0002-4569-8137	National Institutes of Health [R01DK093953, P30NS069271, BRFSG-2014-07]; American Heart Association Predoctoral Fellowship [14PRE20380168]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01DK093953, P30NS069271, and BRFSG-2014-07 (to X.L.) and American Heart Association Predoctoral Fellowship 14PRE20380168 (to C.J.). The authors declare that they have no conflicts of interest with the contents of this article.	Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Arendt KL, 2010, NAT NEUROSCI, V13, P36, DOI 10.1038/nn.2462; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bar-On D, 2012, J BIOL CHEM, V287, P27158, DOI 10.1074/jbc.M112.353250; Barg S, 2010, P NATL ACAD SCI USA, V107, P20804, DOI 10.1073/pnas.1014823107; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Butler M, 2002, DIABETES, V51, P1028, DOI 10.2337/diabetes.51.4.1028; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Chang H, 2012, P NATL ACAD SCI USA, V109, P4455, DOI 10.1073/pnas.1113770109; Cheng KKY, 2012, P NATL ACAD SCI USA, V109, P8919, DOI 10.1073/pnas.1202435109; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/nmeth.1768, 10.1038/NMETH.1768]; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Durisic N, 2014, NAT METHODS, V11, P156, DOI [10.1038/NMETH.2784, 10.1038/nmeth.2784]; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Ester M, 1996, KDD; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Garcia P, 1995, BIOCHEMISTRY-US, V34, P16228, DOI 10.1021/bi00049a039; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; Golebiewska U, 2011, MOL BIOL CELL, V22, P3498, DOI 10.1091/mbc.E11-02-0114; Hagren OI, 2006, J BIOL CHEM, V281, P39121, DOI 10.1074/jbc.M607445200; Hammond GRV, 2015, BBA-MOL CELL BIOL L, V1851, P746, DOI 10.1016/j.bbalip.2015.02.013; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Huang F, 2013, NAT METHODS, V10, P653, DOI [10.1038/NMETH.2488, 10.1038/nmeth.2488]; Huang P, 2011, DIABETES, V60, P454, DOI 10.2337/db10-0614; Huang SH, 2004, MOL CELL BIOL, V24, P9102, DOI 10.1128/MCB.24.20.9102-9123.2004; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Kabachinski G, 2014, MOL BIOL CELL, V25, P508, DOI 10.1091/mbc.E12-11-0829; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Knowles MK, 2010, P NATL ACAD SCI USA, V107, P20810, DOI 10.1073/pnas.1014840107; Kolic J, 2014, J BIOL CHEM, V289, P32109, DOI 10.1074/jbc.M114.577510; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Murray D, 1999, BIOPHYS J, V77, P3176, DOI 10.1016/S0006-3495(99)77148-1; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Nan XL, 2013, P NATL ACAD SCI USA, V110, P18519, DOI 10.1073/pnas.1318188110; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Olsen HL, 2003, P NATL ACAD SCI USA, V100, P5187, DOI 10.1073/pnas.0931282100; Osborne SL, 2001, J CELL SCI, V114, P2501; Pertsinidis A, 2013, P NATL ACAD SCI USA, V110, pE2812, DOI 10.1073/pnas.1310654110; PETERS KR, 1985, J CELL BIOL, V101, P2233, DOI 10.1083/jcb.101.6.2233; Rickman C, 2010, J BIOL CHEM, V285, P13535, DOI 10.1074/jbc.M109.091058; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; SANAN DA, 1991, J HISTOCHEM CYTOCHEM, V39, P1017, DOI 10.1177/39.8.1906908; Sato K, 2009, P NATL ACAD SCI USA, V106, P1139, DOI 10.1073/pnas.0809541106; Sengupta P, 2012, DEV CELL, V23, P1092, DOI 10.1016/j.devcel.2012.09.022; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; Khuong TM, 2013, NEURON, V77, P1097, DOI 10.1016/j.neuron.2013.01.025; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; van Rheenen J, 2002, MOL BIOL CELL, V13, P3257, DOI 10.1091/mbc.E02-04-0231; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Wang J, 2012, BIOL OPEN, V1, P857, DOI 10.1242/bio.20122071; Wombacher R, 2010, NAT METHODS, V7, P717, DOI [10.1038/NMETH.1489, 10.1038/nmeth.1489]; Wuttke A, 2010, J CELL SCI, V123, P1492, DOI 10.1242/jcs.060525; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yaradanakul A, 2008, J MEMBRANE BIOL, V221, P175, DOI 10.1007/s00232-008-9095-7; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]; Zhang YD, 2010, PROG BIOCHEM BIOPHYS, V37, P1144, DOI 10.3724/SP.J.1206.2010.00202	90	40	40	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26978	26993		10.1074/jbc.M115.663013	http://dx.doi.org/10.1074/jbc.M115.663013			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26396197	Green Published, hybrid			2022-12-28	WOS:000364794000009
J	Chen, Q; Yue, F; Li, WJ; Zou, J; Xu, T; Huang, C; Zhang, Y; Song, K; Huang, GQ; Xu, GB; Huang, H; Li, J; Liu, LY				Chen, Qi; Yue, Fei; Li, Wenjiao; Zou, Jing; Xu, Tao; Huang, Cheng; Zhang, Ye; Song, Kun; Huang, Guanqun; Xu, Guibin; Huang, Hai; Li, Jun; Liu, Leyuan			Potassium Bisperoxo(1,10-phenanthroline)oxovanadate (bpV(phen)) Induces Apoptosis and Pyroptosis and Disrupts the P62-HDAC6 Protein Interaction to Suppress the Acetylated Microtubule-dependent Degradation of Autophagosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; PEROXOVANADIUM COMPOUNDS; CONJUGATION SYSTEM; P62/SQSTM1; DISEASE; INFLAMMASOMES; MICE; MITOCHONDRIA; PATHOGENESIS; ACTIVATION	Autophagy is a cellular process that controls and executes the turnover of dysfunctional organelles and misfolded or abnormally aggregated proteins. Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) activates the initiation of autophagy. Autophagosomes migrate along acetylated microtubules to fuse with lysosomes to execute the degradation of the engulfed substrates that usually bind with sequestosome 1 (SQSTM1, p62). Microtubule-associated protein 1 light chain 3 (LC3) traces the autophagy process by converting from the LC3-I to the LC3-II isoform and serves as a major marker of autophagy flux. Potassium bisperoxo(1,10-phenanthroline) oxovanadate (bpV(phen)) is an insulin mimic and a PTEN inhibitor and has the potential to treat different diseases. Here we show that bpV(phen) enhances the ubiquitination of p62, reduces the stability of p62, disrupts the interaction between p62 and histone deacetylase 6 (HDAC6), activates the deacetylase activity of HDAC6 on alpha-tubulin, and impairs stable acetylated microtubules. Microtubular destabilization leads to the blockade of autophagosome-lysosome fusion and accumulation of autophagosomes. Autophagy defects lead to oxidative stress and lysosomal rupture, which trigger different types of cell death, including apoptosis and pyroptosis. The consistent results from multiple systems, including mouse and different types of mammalian cells, are different from the predicted function of bpV(phen) as a PTEN inhibitor to activate autophagy flux. In addition, levels of p62 are reduced but not elevated when autophagosomal degradation is blocked, revealing a novel function of p62 in autophagy regulation. Therefore, it is necessary to pay attention to the roles of bpV(phen) in autophagy, apoptosis, and pyroptosis when it is developed as a drug.	[Chen, Qi; Xu, Tao; Huang, Cheng; Li, Jun] Anhui Med Univ, Sch Pharm, Hefei 230032, Anhui, Peoples R China; [Chen, Qi; Zhang, Ye] Anhui Med Univ, Hosp 2, Dept Anesthesiol, Hefei 230601, Anhui, Peoples R China; [Chen, Qi; Yue, Fei; Li, Wenjiao; Zou, Jing; Song, Kun; Huang, Guanqun; Xu, Guibin; Huang, Hai; Liu, Leyuan] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX 77030 USA; [Liu, Leyuan] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA	Anhui Medical University; Anhui Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Li, J (corresponding author), Anhui Med Univ, Inst Liver Dis, Sch Pharm, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.	lj@ahmu.edu.cn; lliu@ibt.tamhsc.edu	Yue, Fei/N-1891-2018; Li, Wenjiao/J-2198-2019	Li, Wenjiao/0000-0003-1308-8489	NCI/National Institutes of Health [CA142862]; Department of Defense New Investigator Award [W81XWH]; NATIONAL CANCER INSTITUTE [R01CA142862] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense New Investigator Award(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI/National Institutes of Health Grant CA142862 (to L. L.). This work was also supported by Department of Defense New Investigator Award W81XWH (to L. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lee J, 2012, J BIOL CHEM, V287, P4033, DOI 10.1074/jbc.M111.280065; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu LY, 2012, AUTOPHAGY, V8, P278, DOI 10.4161/auto.8.2.18939; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; POSNER BI, 1994, J BIOL CHEM, V269, P4596; Pouliot P, 2009, J IMMUNOL, V182, P1334, DOI 10.4049/jimmunol.182.3.1334; Ryter Stefan W, 2014, Int J Cell Biol, V2014, P502676, DOI 10.1155/2014/502676; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Xie R, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-89; YALE JF, 1995, DIABETES, V44, P1274, DOI 10.2337/diabetes.44.11.1274; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076016; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094903; Zou J, 2013, BIOCHEM J, V454, P447, DOI 10.1042/BJ20130306; Zu LY, 2011, EUR J PHARMACOL, V650, P298, DOI 10.1016/j.ejphar.2010.09.069	40	20	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26051	26058		10.1074/jbc.M115.653568	http://dx.doi.org/10.1074/jbc.M115.653568			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26363065	hybrid, Green Published			2022-12-28	WOS:000363527300026
J	Bu, YF; Wang, N; Wang, SL; Sheng, T; Tian, T; Chen, LL; Pan, WW; Zhu, MS; Luo, JH; Lu, W				Bu, Yunfei; Wang, Ning; Wang, Shaoli; Sheng, Tao; Tian, Tian; Chen, Linlin; Pan, Weiwei; Zhu, Minsheng; Luo, Jianhong; Lu, Wei			Myosin IIb-dependent Regulation of Actin Dynamics Is Required for N-Methyl-D-aspartate Receptor Trafficking during Synaptic Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; LIGHT-CHAIN KINASE; SMOOTH-MUSCLE CONTRACTION; DENDRITIC SPINES; NERVOUS-SYSTEM; IN-VITRO; AREA CA1; F-ACTIN; NMDA; LTP	N-Methyl-D-aspartate receptor (NMDAR) synaptic incorporation changes the number of NMDARs at synapses and is thus critical to various NMDAR-dependent brain functions. To date, the molecules involved in NMDAR trafficking and the underlying mechanisms are poorly understood. Here, we report that myosin IIb is an essential molecule in NMDAR synaptic incorporation during PKC- or theta burst stimulation-induced synaptic plasticity. Moreover, we demonstrate that myosin light chain kinase (MLCK)-dependent actin reorganization contributes to NMDAR trafficking. The findings from additional mutual occlusion experiments demonstrate that PKC and MLCK share a common signaling pathway in NMDAR-mediated synaptic regulation. Because myosin IIb is the primary substrate of MLCK and can regulate actin dynamics during synaptic plasticity, we propose that the MLCK-and myosin IIb-dependent regulation of actin dynamics is required for NMDAR trafficking during synaptic plasticity. This study provides important insights into a mechanical framework for understanding NMDAR trafficking associated with synaptic plasticity.	[Bu, Yunfei; Wang, Ning; Wang, Shaoli; Sheng, Tao; Tian, Tian; Chen, Linlin; Pan, Weiwei; Lu, Wei] Nanjing Med Univ, Dept Neurobiol, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Ning; Wang, Shaoli; Sheng, Tao; Lu, Wei] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Minist Educ China, Nanjing 210096, Jiangsu, Peoples R China; [Lu, Wei] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China; [Zhu, Minsheng] Nanjing Univ, Model Anim Res Ctr, Minist Educ China, Key Lab Model Anim Dis Study, Nanjing 210063, Jiangsu, Peoples R China; [Luo, Jianhong] Zhejiang Univ, Sch Med, Dept Neurobiol, Key Lab Med Neurobiol,Minist Hlth China,Zhejiang, Hangzhou 310058, Zhejiang, Peoples R China	Nanjing Medical University; Ministry of Education, China; Southeast University - China; Nantong University; Ministry of Education, China; Nanjing University; Zhejiang University	Lu, W (corresponding author), Nanjing Med Univ, Dept Neurobiol, Nanjing 210029, Jiangsu, Peoples R China.	luwei@seu.edu.cn	Wang, Shaoli/AAJ-5287-2020; Luo, jian/HGE-7331-2022	Sheng, Tao/0000-0001-5570-0424	National Natural Science Foundation of China [31471032]; Major State Basic Research Program of China [2013CB733801]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Program of China(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China Grant 31471032, Major State Basic Research Program of China Grant 2013CB733801, and a grant from the Priority Academic Program Development of Jiangsu Higher Education Institutions (to W. L.). The authors declare that they have no conflicts of interest with the contents of this article.	ALLEN BG, 1994, TRENDS BIOCHEM SCI, V19, P362, DOI 10.1016/0968-0004(94)90112-0; ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Burger C, 2004, MOL THER, V10, P302, DOI 10.1016/j.ymthe.2004.05.024; Caputi A, 1999, EUR J NEUROSCI, V11, P141, DOI 10.1046/j.1460-9568.1999.00414.x; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Cichon J, 2012, J BIOL CHEM, V287, P3919, DOI 10.1074/jbc.M111.301911; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Fan XL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00160; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gardoni F, 2001, J BIOL CHEM, V276, P7609, DOI 10.1074/jbc.M009922200; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Guillaud L, 2008, NAT CELL BIOL, V10, P19, DOI 10.1038/ncb1665; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Hodges JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024149; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; HUANG YY, 1993, J NEUROSCI, V13, P568; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kelly MT, 2007, NEUROPHARMACOLOGY, V52, P41, DOI 10.1016/j.neuropharm.2006.07.002; Kneussel M, 2013, NAT REV NEUROSCI, V14, P233, DOI 10.1038/nrn3445; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; Ledeboer R C, 1971, Ned Tijdschr Geneeskd, V115, P259; Lei SB, 2001, J NEUROSCI, V21, P8464, DOI 10.1523/JNEUROSCI.21-21-08464.2001; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Lin B, 2005, J NEUROSCI, V25, P2062, DOI 10.1523/JNEUROSCI.4283-04.2005; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALINOW R, 1988, NATURE, V335, P820, DOI 10.1038/335820a0; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mizui T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085367; NISHIKAWA M, 1984, J BIOL CHEM, V259, P8808; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; POTIER MC, 1995, GENOMICS, V29, P562, DOI 10.1006/geno.1995.9965; Ramachandran B, 2009, J NEUROSCI, V29, P12167, DOI 10.1523/JNEUROSCI.2045-09.2009; Rex CS, 2010, NEURON, V67, P603, DOI 10.1016/j.neuron.2010.07.016; Ryan TA, 1999, J NEUROSCI, V19, P1317; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Sanhueza M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-10; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Sheng M, 2000, NAT NEUROSCI, V3, P633, DOI 10.1038/76576; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Wylie SR, 2001, NAT CELL BIOL, V3, P88, DOI 10.1038/35050613; Yagi H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06353; Yan JZ, 2011, J BIOL CHEM, V286, P25187, DOI 10.1074/jbc.M110.192708; Zheng X, 1999, P NATL ACAD SCI USA, V96, P15262, DOI 10.1073/pnas.96.26.15262; Zoghbi HY, 2000, CURR OPIN NEUROBIOL, V10, P655, DOI 10.1016/S0959-4388(00)00135-5	56	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25395	25410		10.1074/jbc.M115.644229	http://dx.doi.org/10.1074/jbc.M115.644229			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26330558	hybrid, Green Published			2022-12-28	WOS:000362962800017
J	Moulick, R; Das, R; Udgaonkar, JB				Moulick, Roumita; Das, Ranabir; Udgaonkar, Jayant B.			Partially Unfolded Forms of the Prion Protein Populated under Misfolding-promoting Conditions CHARACTERIZATION BY HYDROGEN EXCHANGE MASS SPECTROMETRY AND NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLTEN GLOBULE; AMYLOID FORMATION; RIBONUCLEASE-H; INTERMEDIATE; STABILITY; STATE; PH; EQUILIBRIUM; PATHWAYS; KINETICS	The susceptibility of the cellular prion protein (PrPC) to convert to an alternative misfolded conformation (PrPSc), which is the key event in the pathogenesis of prion diseases, is indicative of a conformationally flexible native (N) state. In the present study, hydrogen-deuterium exchange (HDX) in conjunction with mass spectrometry and nuclear magnetic resonance spectroscopy were used for the structural and energetic characterization of the N state of the full-length mouse prion protein, moPrP(23-231), under conditions that favor misfolding. The kinetics of HDX of 34 backbone amide hydrogens in the N state were determined at pH 4. In contrast to the results of previous HDXstudies on the human and Syrian hamster prion proteins at a higher pH, various segments of moPrP were found to undergo different extents of subglobal unfolding events at pH 4, a pH at which the protein is known to be primed to misfold to a beta-rich conformation. No residual structure around the disulfide bond was observed for the unfolded state at pH 4. The N state of the prion protein was observed to be at equilibrium with at least two partially unfolded forms (PUFs). These PUFs, which are accessed by stochastic fluctuations of the N state, have altered surface area exposure relative to the N state. One of these PUFs resembles a conformation previously implicated to be an initial intermediate in the conversion of monomeric protein into misfolded oligomer at pH 4.	[Moulick, Roumita; Das, Ranabir; Udgaonkar, Jayant B.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Udgaonkar, JB (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, India.	jayant@ncbs.res.in	Moulick, Roumita/GNW-3933-2022		Tata Institute of Fundamental Research; Department of Science and Technology, Government of India; Department of Biotechnology, Government of India; Department of Biotechnology-Ramalingaswamy fellowship from the Government of India; J. C. Bose national fellowship from the Government of India	Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR)); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology-Ramalingaswamy fellowship from the Government of India; J. C. Bose national fellowship from the Government of India	This work was supported in part by the Tata Institute of Fundamental Research, the Department of Science and Technology, and the Department of Biotechnology, Government of India. The authors declare that they have no conflict of interest with the contents of this article.; Recipient of a Department of Biotechnology-Ramalingaswamy fellowship from the Government of India.; Recipient of a J. C. Bose national fellowship from the Government of India.	Apetri AC, 2002, J BIOL CHEM, V277, P44589, DOI 10.1074/jbc.C200507200; Apetri AC, 2006, J AM CHEM SOC, V128, P11673, DOI 10.1021/ja063880b; ARNOLD JE, 1995, J PATHOL, V176, P403, DOI 10.1002/path.1711760412; Bae SH, 2009, BIOCHEMISTRY-US, V48, P8120, DOI 10.1021/bi900923b; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Baskakov IV, 2001, J BIOL CHEM, V276, P19687, DOI 10.1074/jbc.C100180200; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Bjorndahl TC, 2011, BIOCHEMISTRY-US, V50, P1162, DOI 10.1021/bi101435c; Bollen YJM, 2006, P NATL ACAD SCI USA, V103, P4095, DOI 10.1073/pnas.0509133103; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Calzolai L, 2003, J BIOL CHEM, V278, P35592, DOI 10.1074/jbc.M303005200; Chen KC, 2011, BIOPHYS J, V101, P1221, DOI 10.1016/j.bpj.2011.07.024; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Clarke J, 1996, FOLD DES, V1, P243, DOI 10.1016/S1359-0278(96)00038-7; Clarke J, 1998, CURR OPIN STRUC BIOL, V8, P112, DOI 10.1016/S0959-440X(98)80018-3; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; DABORA JM, 1994, PROTEIN SCI, V3, P1401, DOI 10.1002/pro.5560030906; Dalby PA, 1998, J MOL BIOL, V276, P647, DOI 10.1006/jmbi.1997.1547; De Simone A, 2007, BIOPHYS J, V93, P1284, DOI 10.1529/biophysj.107.108613; Dhulesia A, 2010, J AM CHEM SOC, V132, P15580, DOI 10.1021/ja103524m; Dima RI, 2004, P NATL ACAD SCI USA, V101, P15335, DOI 10.1073/pnas.0404235101; Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213; Englander SW, 1998, TRENDS BIOCHEM SCI, V23, P378, DOI 10.1016/S0968-0004(98)01281-X; GAJDUSEK DC, 1977, SCIENCE, V197, P943, DOI 10.1126/science.142303; Gerber R, 2008, PROTEIN SCI, V17, P537, DOI 10.1110/ps.073163308; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Hart T, 2009, P NATL ACAD SCI USA, V106, P5651, DOI 10.1073/pnas.0811457106; Honda RP, 2015, STRUCTURE, V23, P1735, DOI 10.1016/j.str.2015.07.001; Honda RP, 2014, J BIOL CHEM, V289, P30355, DOI 10.1074/jbc.M114.559450; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Hosszu LLP, 1999, NAT STRUCT BIOL, V6, P740, DOI 10.1038/11507; HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Jain S, 2008, J MOL BIOL, V382, P1228, DOI 10.1016/j.jmb.2008.07.052; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; Juneja J, 2002, BIOCHEMISTRY-US, V41, P2641, DOI 10.1021/bi011480p; Kachel N, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-16; Khan MQ, 2010, P NATL ACAD SCI USA, V107, P19808, DOI 10.1073/pnas.1005267107; Kuwata K, 2002, BIOCHEMISTRY-US, V41, P12277, DOI 10.1021/bi026129y; Langella E, 2004, BIOPHYS J, V87, P3623, DOI [10.1529/biophysj.104.043448, 10.1529/biophysj.104.043449]; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; MOLDAY RS, 1972, BIOCHEMISTRY-US, V11, P150, DOI 10.1021/bi00752a003; Morrissey MP, 1999, P NATL ACAD SCI USA, V96, P11293, DOI 10.1073/pnas.96.20.11293; Moulick R, 2014, BIOPHYS J, V106, P410, DOI 10.1016/j.bpj.2013.11.4491; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Raschke TM, 1997, NAT STRUCT BIOL, V4, P298, DOI 10.1038/nsb0497-298; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Singh J, 2015, ANGEW CHEM INT EDIT, V54, P7529, DOI 10.1002/anie.201501011; Singh J, 2014, J AM CHEM SOC, V136, P16704, DOI 10.1021/ja510964t; Singh J, 2012, J MOL BIOL, V423, P217, DOI 10.1016/j.jmb.2012.06.040; Skinner JJ, 2012, PROTEIN SCI, V21, P987, DOI 10.1002/pro.2082; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Swietnicki W, 1997, J BIOL CHEM, V272, P27517, DOI 10.1074/jbc.272.44.27517; Vendrely C, 2005, BBA-GEN SUBJECTS, V1724, P355, DOI 10.1016/j.bbagen.2005.05.017; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Wildegger G, 1999, NAT STRUCT BIOL, V6, P550, DOI 10.1038/9323; Wooll JO, 2000, J MOL BIOL, V301, P247, DOI 10.1006/jmbi.2000.3889; Zhang H, 1997, BIOCHEMISTRY-US, V36, P3543, DOI 10.1021/bi961965r	66	32	32	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25227	25240		10.1074/jbc.M115.677575	http://dx.doi.org/10.1074/jbc.M115.677575			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26306043	Green Published, hybrid			2022-12-28	WOS:000362962800003
J	Bondos, SE; Swint-Kruse, L; Matthews, KS				Bondos, Sarah E.; Swint-Kruse, Liskin; Matthews, Kathleen S.			Flexibility and Disorder in Gene Regulation: LacI/GalR and Hox Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							LACTOSE REPRESSOR PROTEIN; TRANSCRIPTION FACTOR ULTRABITHORAX; DNA COGNATE SITES; LAC-REPRESSOR; ESCHERICHIA-COLI; DROSOPHILA-MELANOGASTER; CRYSTAL-STRUCTURE; INTERSEGMENT TRANSFER; INTRINSIC DISORDER; STRUCTURAL BASIS	To modulate transcription, a variety of input signals must be sensed by genetic regulatory proteins. In these proteins, flexibility and disorder are emerging as common themes. Prokaryotic regulators generally have short, flexible segments, whereas eukaryotic regulators have extended regions that lack predicted secondary structure (intrinsic disorder). Two examples illustrate the impact of flexibility and disorder on gene regulation: the prokaryotic LacI/GalR family, with detailed information from studies on LacI, and the eukaryotic family of Hox proteins, with specific insights from investigations of Ultrabithorax (Ubx). The widespread importance of structural disorder in gene regulatory proteins may derive from the need for flexibility in signal response and, particularly in eukaryotes, in protein partner selection.	[Bondos, Sarah E.] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Swint-Kruse, Liskin] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; [Matthews, Kathleen S.] Rice Univ, Dept Biosci, Houston, TX 77251 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Kansas; University of Kansas Medical Center; Rice University	Matthews, KS (corresponding author), Rice Univ, Dept Biosci, MS-140, Houston, TX 77251 USA.	ksm@rice.edu		Swint-Kruse, Liskin/0000-0002-5925-9741; Bondos, Sarah/0000-0002-9673-4169	National Science Foundation (NSF); Ted Nash Long Life Foundation; University of Kansas Medical Research Institute Health Clinical and Translational Science Award (National Institutes of Health) [UL1TR000001]; National Institutes of Health [GM22441]; Robert A. Welch Foundation [C-0576]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000001] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM022441] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Ted Nash Long Life Foundation; University of Kansas Medical Research Institute Health Clinical and Translational Science Award (National Institutes of Health); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Science Foundation (NSF) and the Ted Nash Long Life Foundation (to S. E B.); a Lied Basic Science Grant (to L. S. K.) from the University of Kansas Medical Research Institute Health Clinical and Translational Science Award (National Institutes of Health Grant UL1TR000001, formerly UL1RR033179); and grants from National Institutes of Health (GM22441) and The Robert A. Welch Foundation (C-0576) (to K. S. M.). This minireview is derived in part from the William C. Rose Award Lecture at the American Society for Biochemistry and Molecular Biology 2015 Annual Meeting at Boston, MA, March 30, 2015. The authors declare that they have no conflicts of interest with the contents of this article.	Atchison ML, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00045; Baeza M, 2015, ELIFE, V4, DOI 10.7554/eLife.06034; Batabyal Subrata, 2014, Biomol Concepts, V5, P21, DOI 10.1515/bmc-2013-0037; BEACHY PA, 1993, MOL CELL BIOL, V13, P6941, DOI 10.1128/MCB.13.11.6941; Becker NA, 2015, P NATL ACAD SCI USA, V112, P7177, DOI 10.1073/pnas.1500412112; Becker NA, 2014, NUCLEIC ACIDS RES, V42, P5495, DOI 10.1093/nar/gku180; Bell CE, 2001, J MOL BIOL, V313, P99, DOI 10.1006/jmbi.2001.5041; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berry M, 2000, EMBO J, V19, P2946, DOI 10.1093/emboj/19.12.2946; Bondos SE, 2006, MOL CELL PROTEOMICS, V5, P824, DOI 10.1074/mcp.M500256-MCP200; Bondos SE, 2004, J BIOL CHEM, V279, P26433, DOI 10.1074/jbc.M312842200; Boube M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004303; Chang CC, 2015, NUCLEIC ACIDS RES, V43, P7612, DOI 10.1093/nar/gkv681; CLARKE ND, 1994, PROTEIN SCI, V3, P1779, DOI 10.1002/pro.5560031018; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuculis L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8277; Daber R, 2007, J MOL BIOL, V370, P609, DOI 10.1016/j.jmb.2007.04.028; Doucleff M, 2008, P NATL ACAD SCI USA, V105, P13871, DOI 10.1073/pnas.0805050105; Dover LG, 2004, J MOL BIOL, V340, P1095, DOI 10.1016/j.jmb.2004.06.003; DuBay KH, 2015, ACCOUNTS CHEM RES, V48, P1098, DOI 10.1021/ar500351b; Eginton C, 2015, J MOL BIOL, V427, P1695, DOI 10.1016/j.jmb.2015.02.021; EKKER SC, 1991, EMBO J, V10, P1179, DOI 10.1002/j.1460-2075.1991.tb08058.x; Elrod-Erickson M, 1998, STRUCTURE, V6, P451, DOI 10.1016/S0969-2126(98)00047-1; Erokhin M, 2015, CELL MOL LIFE SCI, V72, P2361, DOI 10.1007/s00018-015-1871-9; Falcon CM, 2001, BIOCHEMISTRY-US, V40, P15650, DOI 10.1021/bi0114067; Falcon CM, 2000, BIOCHEMISTRY-US, V39, P11074, DOI 10.1021/bi000924z; Flynn TC, 2003, PROTEIN SCI, V12, P2523, DOI 10.1110/ps.03188303; Francke C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-145; Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; GAVIS ER, 1991, DEVELOPMENT, V112, P1077; Givaty O, 2009, J MOL BIOL, V385, P1087, DOI 10.1016/j.jmb.2008.11.016; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Greer AM, 2009, BIOMACROMOLECULES, V10, P829, DOI 10.1021/bm801315v; Guo X., 2012, PAC S BIOCOMPUT, P104, DOI [10.1142/9789814366496_0011, DOI 10.1142/9789814366496_0011]; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Howell DW, 2015, ADV FUNCT MATER, V25, P5988, DOI 10.1002/adfm.201502852; Hsiao HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108217; Huang Z, 2010, BIOMACROMOLECULES, V11, P3644, DOI 10.1021/bm1010992; Iwahara J, 2006, J AM CHEM SOC, V128, P404, DOI 10.1021/ja056786o; Iwahara J, 2006, P NATL ACAD SCI USA, V103, P15062, DOI 10.1073/pnas.0605868103; JOHNSON FB, 1995, P NATL ACAD SCI USA, V92, P739, DOI 10.1073/pnas.92.3.739; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Kallipolitis BH, 2004, J MOL BIOL, V342, P1, DOI 10.1016/j.jmb.2004.05.067; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Liu Y, 2008, J BIOL CHEM, V283, P20874, DOI 10.1074/jbc.M800375200; Liu Y, 2009, J MOL BIOL, V390, P760, DOI 10.1016/j.jmb.2009.05.059; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Mahmutovic A, 2015, NUCLEIC ACIDS RES, V43, P3454, DOI 10.1093/nar/gkv207; MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; Meinhardt S, 2012, NUCLEIC ACIDS RES, V40, P11139, DOI 10.1093/nar/gks806; Merabet S, 2014, DEV DYNAM, V243, P16, DOI 10.1002/dvdy.24002; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; Niklas KJ, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00008; Pancsa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034687; Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reed HC, 2010, GENETICS, V184, P745, DOI 10.1534/genetics.109.112086; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Rutkauskas D, 2009, P NATL ACAD SCI USA, V106, P16627, DOI 10.1073/pnas.0904617106; Schumacher MA, 2004, CELL, V118, P731, DOI 10.1016/j.cell.2004.08.027; SCHUMACHER MA, 1995, CELL, V83, P147, DOI 10.1016/0092-8674(95)90243-0; Semsey S, 2006, J MOL BIOL, V358, P355, DOI 10.1016/j.jmb.2006.02.022; Slattery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014686; Stadler CR, 2014, LEUKEMIA, V28, P1838, DOI 10.1038/leu.2014.74; Swint-Kruse L, 2005, BIOCHEMISTRY-US, V44, P11201, DOI 10.1021/bi050404+; Swint-Kruse L, 2004, BIOCHEMISTRY-US, V43, P10886, DOI 10.1021/bi049450k; Swint-Kruse L, 2003, BIOCHEMISTRY-US, V42, P14004, DOI 10.1021/bi035116x; Swint-Kruse L, 2002, PROTEIN SCI, V11, P778, DOI 10.1110/ps.4050102; Swint-Kruse L, 2009, CURR OPIN MICROBIOL, V12, P129, DOI 10.1016/j.mib.2009.01.009; Taghli-Lamallem O, 2008, DEV GENES EVOL, V218, P321, DOI 10.1007/s00427-008-0224-1; Tan XX, 2002, BIOCHEMISTRY-US, V41, P2774, DOI 10.1021/bi011967y; Taraban M, 2008, J MOL BIOL, V376, P466, DOI 10.1016/j.jmb.2007.11.067; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Toth-Petroczy A, 2009, J AM CHEM SOC, V131, P15084, DOI 10.1021/ja9052784; Tretyachenko-Ladokhina V, 2006, J MOL BIOL, V362, P271, DOI 10.1016/j.jmb.2006.06.085; Tsai SP, 2015, ADV FUNCT MATER, V25, P1442, DOI 10.1002/adfm.201402997; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vanzi F, 2006, NUCLEIC ACIDS RES, V34, P3409, DOI 10.1093/nar/gkl393; Vigano MA, 1998, MOL CELL BIOL, V18, P6201, DOI 10.1128/MCB.18.11.6201; Vuzman D, 2010, J MOL BIOL, V396, P674, DOI 10.1016/j.jmb.2009.11.056; WADEJARDETZKY N, 1979, J MOL BIOL, V128, P259, DOI 10.1016/0022-2836(79)90129-3; Wang H, 2015, J IMMUNOL, V194, P5375, DOI 10.4049/jimmunol.1401909; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; WHITSON PA, 1987, J BIOL CHEM, V262, P14592; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Xu J, 2011, BIOCHEMISTRY-US, V50, P9002, DOI 10.1021/bi200896t; Xu J, 2009, BIOCHEMISTRY-US, V48, P4988, DOI 10.1021/bi9002343; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Zhan HL, 2006, BIOCHEMISTRY-US, V45, P5896, DOI 10.1021/bi052619p	98	17	18	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24669	24677		10.1074/jbc.R115.685032	http://dx.doi.org/10.1074/jbc.R115.685032			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26342073	hybrid, Green Published			2022-12-28	WOS:000362598300004
J	Minges, JT; Grossman, G; Zhang, P; Kafri, T; Wilson, EM				Minges, John T.; Grossman, Gail; Zhang, Ping; Kafri, Tal; Wilson, Elizabeth M.			Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ANDROGEN RECEPTOR; PROSTATE-CANCER CELLS; HUMAN PROGESTERONE-RECEPTOR; TRANSCRIPTIONAL ACTIVITY; NUCLEOLAR LOCALIZATION; COREGULATOR MAGE-11; DNA METHYLATION; GENE-EXPRESSION; STABILIZES P53; CYCLE ARREST	X-linked primate-specific melanoma antigen-All (MAGE-A11) is a human androgen receptor (AR) coactivator and protooncogene expressed at low levels in normal human reproductive tract tissues and at higher levels in castration-resistant prostate cancer where it is required for androgen-dependent cell growth. In this report, we show that MACE-All is targeted for degradation by human p14-ARF, a tumor suppressor expressed from an alternative reading frame of the p16 cyclin-dependent kinase inhibitor INK4a/ARF gene. MACE-All degradation by the proteasome was mediated by an interaction with p14-ARE and was independent of lysine ubiquitination. A dose-dependent inverse relationship between MACE-All and p14-ARF correlated with p14-ARE inhibition of the MACE-All-induced increase in androgen-dependent AR transcriptional activity and constitutive activity of a splice variant-like AR. Reciprocal stabilization between MACE-A11 and AR did not protect against degradation promoted by p14-ARE. p14-ARE prevented MACE-All interaction with the E2F1 oncoprotein and inhibited the MACE-All-induced increase in E2E1 transcriptional activity. Post-translational down-regulation of MACE-All promoted by p14-ARF was independent of HDM2, the human homologue of mouse double minute 2, an E3 ubiquitin ligase inhibited by p14-ARF. However, MACE-All had a stabilizing effect on HDM2 in the absence or presence of p14-ARE and cooperated with HDM2 to increase E2E1 transcriptional activity in the absence of p14-ARF. We conclude that degradation of MACE-All promoted by the human p14-ARE tumor suppressor contributes to low levels of MACE-All in nontransformed cells and that higher levels of MAGE-All associated with low p14-ARE increase AR and E2F1 transcriptional activity and promote the development of castration-resistant prostate cancer.	[Minges, John T.; Grossman, Gail; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Dept Pediat, Chapel Hill, NC 27599 USA; [Zhang, Ping; Kafri, Tal] Univ N Carolina, Lentivirus Core Facil, Chapel Hill, NC 27599 USA; [Kafri, Tal; Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Kafri, Tal] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Kafri, Tal] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu			United States Public Health Service NCI from the National Institutes of Health [P01-CA77739]; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	United States Public Health Service NCI from the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by United States Public Health Service NCI Grant P01-CA77739 from the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Amir S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061064; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Askew EB, 2010, J BIOL CHEM, V285, P21824, DOI 10.1074/jbc.M110.120600; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Bai S, 2008, MOL HUM REPROD, V14, P107, DOI 10.1093/molehr/gam080; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bonvini P, 2007, LEUKEMIA, V21, P838, DOI 10.1038/sj.leu.2404528; Burchardt T, 1999, J UROLOGY, V162, P1800, DOI 10.1016/S0022-5347(05)68241-9; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Chomez P, 2001, CANCER RES, V61, P5544; Clark PA, 2002, ONCOGENE, V21, P4498, DOI 10.1038/sj.onc.1205558; Datta A, 2002, MOL CELL BIOL, V22, P8398, DOI 10.1128/MCB.22.24.8398-8408.2002; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Delbridge Margaret L, 2007, Soc Reprod Fertil Suppl, V65, P1; Deng XY, 2002, BIOCHEM BIOPH RES CO, V296, P792, DOI 10.1016/S0006-291X(02)00948-8; DEPLAEN E, 1994, IMMUNOGENETICS, V40, P360, DOI 10.1007/BF01246677; Eymin B, 2001, ONCOGENE, V20, P1033, DOI 10.1038/sj.onc.1204220; Fan C, 2008, BBA-MOL BASIS DIS, V1782, P642, DOI 10.1016/j.bbadis.2008.08.009; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P6591, DOI 10.1073/pnas.0811023106; Gregory CW, 2001, CANCER RES, V61, P2892; Haber DA, 1997, CELL, V91, P555, DOI 10.1016/S0092-8674(00)80441-9; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; Henderson DJP, 2014, BRIT J CANCER, V110, P1278, DOI 10.1038/bjc.2014.22; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; James SR, 2013, EPIGENETICS-US, V8, P849, DOI 10.4161/epi.25500; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Kobayashi T, 2013, MOL CANCER RES, V11, P828, DOI 10.1158/1541-7786.MCR-13-0207; Komori H, 2005, EMBO J, V24, P3724, DOI 10.1038/sj.emboj.7600836; Konishi N, 2002, JPN J CANCER RES, V93, P767, DOI 10.1111/j.1349-7006.2002.tb01318.x; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; Li YX, 2006, BBA-MOL CELL RES, V1763, P787, DOI 10.1016/j.bbamcr.2006.04.011; Lin HK, 2002, J BIOL CHEM, V277, P36570, DOI 10.1074/jbc.M204751200; Liu Q, 2011, J BIOL CHEM, V286, P29951, DOI 10.1074/jbc.M111.244715; Liu X, 2007, GENE DEV, V21, P2711, DOI 10.1101/gad.1590607; Loughran O, 2000, MOL CELL BIOL, V20, P2186, DOI 10.1128/MCB.20.6.2186-2197.2000; Lu WF, 2013, MOL ENDOCRINOL, V27, P635, DOI 10.1210/me.2012-1294; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Martelli F, 2001, P NATL ACAD SCI USA, V98, P4455, DOI 10.1073/pnas.081061398; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; Merkle D, 2011, CELL SIGNAL, V23, P507, DOI 10.1016/j.cellsig.2010.08.017; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Minges JT, 2013, J BIOL CHEM, V288, P1939, DOI 10.1074/jbc.M112.428409; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P1399, DOI 10.1210/mend-4-9-1399; QUELLE DE, 1995, CELL, V83, P993; Rizos H, 2000, ONCOGENE, V19, P2978, DOI 10.1038/sj.onc.1203629; Rizos H, 2007, CELL CYCLE, V6, P1741, DOI 10.4161/cc.6.14.4428; Robertson KD, 1998, MOL CELL BIOL, V18, P6457, DOI 10.1128/MCB.18.11.6457; ROGNER UC, 1995, GENOMICS, V29, P725, DOI 10.1006/geno.1995.9945; Saha A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002573; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Shen M, 2013, EXPERT OPIN THER TAR, V17, P1091, DOI 10.1517/14728222.2013.815728; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Su SF, 2013, J BIOL CHEM, V288, P24809, DOI 10.1074/jbc.M113.468579; Su SF, 2012, J BIOL CHEM, V287, P34809, DOI 10.1074/jbc.M112.372797; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tago K, 2005, P NATL ACAD SCI USA, V102, P7689, DOI 10.1073/pnas.0502978102; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Vonlanthen S, 1998, ONCOGENE, V17, P2779, DOI 10.1038/sj.onc.1202501; Wagner BL, 1998, MOL CELL BIOL, V18, P1369, DOI 10.1128/MCB.18.3.1369; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wilson EM, 2010, THER ADV UROL, V2, P105, DOI 10.1177/1756287210372380; Xu KL, 2001, MOL THER, V3, P97, DOI 10.1006/mthe.2000.0238; Yegnasubramanian S, 2004, CANCER RES, V64, P1975, DOI 10.1158/0008-5472.CAN-03-3972; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2; Zhang Z, 2005, ONCOGENE, V24, P7238, DOI 10.1038/sj.onc.1208814; Zhang ZH, 2006, MODERN PATHOL, V19, P1339, DOI 10.1038/modpathol.3800655	85	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25174	25187		10.1074/jbc.M115.663641	http://dx.doi.org/10.1074/jbc.M115.663641			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26330556	Green Published, hybrid			2022-12-28	WOS:000362598300044
J	Singh, BK; Sinha, RA; Zhou, J; Tripathi, M; Ohba, K; Wang, ME; Astapova, I; Ghosh, S; Hollenberg, AN; Gauthier, K; Yen, PM				Singh, Brijesh K.; Sinha, Rohit A.; Zhou, Jin; Tripathi, Madhulika; Ohba, Kenji; Wang, Mu-En; Astapova, Inna; Ghosh, Sujoy; Hollenberg, Anthony N.; Gauthier, Karine; Yen, Paul M.			Hepatic FOXO1 Target Genes Are Co-regulated by Thyroid Hormone via RICTOR Protein Deacetylation and MTORC2-AKT Protein Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; gene regulation; gluconeogenesis; thyroid hormone; transcription coregulator; AKT; MTORC2; RICTOR; insulin signaling	RAPAMYCIN COMPLEX 2; TRANSCRIPTION FACTORS; MAMMALIAN TARGET; TR-BETA; EXPRESSION PROFILES; NEGATIVE REGULATION; MOLECULAR-BASIS; SIRTUIN 1; METABOLISM; RECEPTOR	Background: Thyroid hormone (TH) and FOXO1 share similar transcriptional networks. However, TH regulation of FOXO1 activity is not well understood. Results: TH decreased RICTOR acetylation and MTORC2/AKT activity by SIRT1 activation and reduced FOXO1 phosphorylation. Conclusion: TH co-regulated transcription of FOXO1 target genes via RICTOR deacetylation. Significance: Downstream metabolic effects by TH can post-translationally activate other transcription factors. MTORC2-AKT is a key regulator of carbohydrate metabolism and insulin signaling due to its effects on FOXO1 phosphorylation. Interestingly, both FOXO1 and thyroid hormone (TH) have similar effects on carbohydrate and energy metabolism as well as overlapping transcriptional regulation of many target genes. Currently, little is known about the regulation of MTORC2-AKT or FOXO1 by TH. Accordingly, we performed hepatic transcriptome profiling in mice after FOXO1 knockdown in the absence or presence of TH, and we compared these results with hepatic FOXO1 and THRB1 (TR1) ChIP-Seq data. We identified a subset of TH-stimulated FOXO1 target genes that required co-regulation by FOXO1 and TH. TH activation of FOXO1 was directly linked to an increase in SIRT1-MTORC2 interaction and RICTOR deacetylation. This, in turn, led to decreased AKT and FOXO1 phosphorylation. Moreover, TH increased FOXO1 nuclear localization, DNA binding, and target gene transcription by reducing AKT-dependent FOXO1 phosphorylation in a THRB1-dependent manner. These events were associated with TH-mediated oxidative phosphorylation and NAD(+) production and suggested that downstream metabolic effects by TH can post-translationally activate other transcription factors. Our results showed that RICTOR/MTORC2-AKT can integrate convergent hormonal and metabolic signals to provide coordinated and sensitive regulation of hepatic FOXO1-target gene expression.	[Singh, Brijesh K.; Sinha, Rohit A.; Zhou, Jin; Tripathi, Madhulika; Ohba, Kenji; Wang, Mu-En; Ghosh, Sujoy; Yen, Paul M.] Duke Natl Univ Singapore, Grad Sch Med, Cardiovasc & Metab Disorders Program, Lab Hormonal Regulat, Singapore 169857, Singapore; [Ghosh, Sujoy] Duke Natl Univ Singapore, Grad Sch Med, Ctr Computat Biol, Singapore 169857, Singapore; [Tripathi, Madhulika] Natl Inst Neurosci, Stroke Trial Unit, Singapore 308433, Singapore; [Wang, Mu-En] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10617, Taiwan; [Astapova, Inna; Hollenberg, Anthony N.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02115 USA; [Astapova, Inna; Hollenberg, Anthony N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gauthier, Karine] Univ Lyon 1, Inst Genom Fonct Lyon, CNRS, Ecole Normale Super Lyon, F-69364 Lyon 07, France	National University of Singapore; National University of Singapore; National Neuroscience Institute (NNI); National Taiwan University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Yen, PM (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Cardiovasc & Metab Disorders Program, Lab Hormonal Regulat, 8 Coll Rd, Singapore 169857, Singapore.	paul.yen@duke-nus.edu.sg	Sinha, Rohit/GXV-2427-2022; Ohba, Kenji/AAU-5180-2021; Ghosh, Sujoy/I-3729-2017; Yen, Paul M/V-9857-2019; Singh, Brijesh K/C-1093-2009	Ohba, Kenji/0000-0001-8538-8742; Ghosh, Sujoy/0000-0002-7601-165X; Singh, Brijesh K/0000-0003-4615-3988; Yen, Paul/0000-0002-3790-8114; Wang, Mu-En/0000-0002-5953-3499	Duke-NUS Graduate Medical School Faculty Funds; National Medical Research Council/Early Development Grant [1044/2011]; National Medical Research Council/Clinical Investigator Research Grant [1340/2012]; National Medical Research Council/Clinician Scientist Award [MH95:03/1-8]; Ministry of Health; Ministry of Education; Ministry of Trade, Singapore; A*StaR; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056123, T32DK007516] Funding Source: NIH RePORTER	Duke-NUS Graduate Medical School Faculty Funds; National Medical Research Council/Early Development Grant; National Medical Research Council/Clinical Investigator Research Grant; National Medical Research Council/Clinician Scientist Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Health; Ministry of Education; Ministry of Trade, Singapore; A*StaR(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Duke-NUS Graduate Medical School Faculty Funds (to P. M. Y.), National Medical Research Council/Early Development Grant 1044/2011, National Medical Research Council/Clinical Investigator Research Grant 1340/2012, and National Medical Research Council/Clinician Scientist Award Grant MH95:03/1-8, Ministry of Health, Ministry of Education, and Ministry of Trade, Singapore, and A*StaR. The authors declare that they have no conflicts of interest with the contents of this article.	Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Billon C, 2014, ENDOCRINOLOGY, V155, P2735, DOI 10.1210/en.2014-1098; Boulbes D, 2010, MOL CANCER RES, V8, P896, DOI 10.1158/1541-7786.MCR-09-0409; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Cao X, 2005, MOL ENDOCRINOL, V19, P102, DOI 10.1210/me.2004-0093; Chan IH, 2009, MOL ENDOCRINOL, V23, P1758, DOI 10.1210/me.2009-0025; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Contreras-Jurado C, 2011, J BIOL CHEM, V286, P24079, DOI 10.1074/jbc.M111.218487; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Farah BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098155; Gauthier K, 1999, EMBO J, V18, P623, DOI 10.1093/emboj/18.3.623; Gauthier K, 2010, J BIOL CHEM, V285, P28156, DOI 10.1074/jbc.M110.146241; Glidden EJ, 2012, J BIOL CHEM, V287, P581, DOI 10.1074/jbc.M111.304337; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Gross DN, 2009, CURR DIABETES REP, V9, P208, DOI 10.1007/s11892-009-0034-5; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hiroi Y, 2006, P NATL ACAD SCI USA, V103, P14104, DOI 10.1073/pnas.0601600103; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; JAVITT NB, 1990, FASEB J, V4, P161, DOI 10.1096/fasebj.4.2.2153592; Kakkar P, 2007, MOL CELL BIOCHEM, V305, P235, DOI 10.1007/s11010-007-9520-8; Kalyanaraman H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004911; Kocalis HE, 2014, MOL METAB, V3, P394, DOI 10.1016/j.molmet.2014.01.014; Liberzon A, 2014, METHODS MOL BIOL, V1150, P153, DOI 10.1007/978-1-4939-0512-6_9; Liu YY, 2010, TRENDS ENDOCRIN MET, V21, P166, DOI 10.1016/j.tem.2009.11.004; Masui K, 2014, TRENDS ENDOCRIN MET, V25, P364, DOI 10.1016/j.tem.2014.04.002; McAninch EA, 2014, ANN NY ACAD SCI, V1311, P77, DOI 10.1111/nyas.12374; MOURADIAN M, 1983, DIABETES CARE, V6, P512, DOI 10.2337/diacare.6.5.512; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; OPPENHEIMER JH, 1985, ANN INTERN MED, V102, P374, DOI 10.7326/0003-4819-102-3-374; Ortiga-Carvalho TM, 2014, NAT REV ENDOCRINOL, V10, P582, DOI 10.1038/nrendo.2014.143; Ramadoss P, 2014, J BIOL CHEM, V289, P1313, DOI 10.1074/jbc.M113.521450; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Rehan L, 2014, LIFE SCI, V105, P1, DOI 10.1016/j.lfs.2014.03.015; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Selmi-Ruby S, 2014, ENDOCRINOLOGY, V155, P635, DOI 10.1210/en.2013-1435; Shin DJ, 2012, NUCLEIC ACIDS RES, V40, P11499, DOI 10.1093/nar/gks932; Singh BK, 2013, J BIOL CHEM, V288, P30365, DOI 10.1074/jbc.M113.504845; Sinha RA, 2014, TRENDS ENDOCRIN MET, V25, P538, DOI 10.1016/j.tem.2014.07.001; Sinha RA, 2012, J CLIN INVEST, V122, P2428, DOI 10.1172/JCI60580; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suh JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070097; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Thakran S, 2013, J BIOL CHEM, V288, P807, DOI 10.1074/jbc.M112.437970; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yen PM, 2003, TRENDS ENDOCRIN MET, V14, P327, DOI 10.1016/S1043-2760(03)00114-0; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200; Zhu XG, 2010, ONCOGENE, V29, P1909, DOI 10.1038/onc.2009.476	57	29	28	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					198	214		10.1074/jbc.M115.668673	http://dx.doi.org/10.1074/jbc.M115.668673			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26453307	hybrid, Green Published			2022-12-28	WOS:000367589500016
J	Gottlieb, CD; Zhang, S; Linder, ME				Gottlieb, Colin D.; Zhang, Sheng; Linder, Maurine E.			The Cysteine-rich Domain of the DHHC3 Palmitoyltransferase Is Palmitoylated and Contains Tightly Bound Zinc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PALMITOYLATION; S-PALMITOYLATION; MEDIATED PALMITOYLATION; SUBSTRATE-SPECIFICITY; GABA(A) RECEPTORS; PROTEOMICS; ACYLATION; REVEALS; BINDING; SIRT6	DHHC palmitoyltransferases catalyze the addition of the fatty acid palmitate to proteins on the cytoplasmic leaflet of cell membranes. There are 23 members of the highly diverse mammalian DHHC protein family, all of which contain a conserved catalytic domain called the cysteine-rich domain (CRD). DHHC proteins transfer palmitate via a two-step catalytic mechanism in which the enzyme first modifies itself with palmitate in a process termed autoacylation. The enzyme then transfers palmitate from itself onto substrate proteins. The number and location of palmitoylated cysteines in the autoacylated intermediate is unknown. In this study, we present evidence using mass spectrometry that DHHC3 is palmitoylated at the cysteine in the DHHC motif. Mutation of highly conserved CRD cysteines outside the DHHC motif resulted in activity deficits and a structural perturbation revealed by limited proteolysis. Treatment of DHHC3 with chelating agents in vitro replicated both the specific structural perturbations and activity deficits observed in conserved cysteine mutants, suggesting metal ion-binding in the CRD. Using the fluorescent indicator mag-fura-2, the metal released from DHHC3 was identified as zinc. The stoichiometry of zinc binding was measured as 2 mol of zinc/mol of DHHC3 protein. Taken together, our data demonstrate that coordination of zinc ions by cysteine residues within the CRD is required for the structural integrity of DHHC proteins.	[Gottlieb, Colin D.; Linder, Maurine E.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Zhang, Sheng] Cornell Univ, Core Prote & Mass Spectrometry Facil, Ithaca, NY 14853 USA	Cornell University; Cornell University	Linder, ME (corresponding author), Cornell Univ, CVM Box 41, Ithaca, NY 14853 USA.	mel237@cornell.edu	Linder, Maurine/AAU-9999-2021	Linder, Maurine/0000-0003-2202-9712	NCRR NIH HHS [S10 RR025449] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Bohm S, 1997, NUCLEIC ACIDS RES, V25, P2464, DOI 10.1093/nar/25.12.2464; CORNELL NW, 1972, ANAL BIOCHEM, V47, P203, DOI 10.1016/0003-2697(72)90293-X; Davda D, 2013, ACS CHEM BIOL, V8, P1912, DOI 10.1021/cb400380s; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Gonzalez Montoro A, 2013, BIOCHEM J, V454, P427, DOI 10.1042/BJ20121693; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; HALLAK H, 1994, J BIOL CHEM, V269, P4713; Hemsley PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028799; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Ji YH, 2013, ANAL CHEM, V85, P11952, DOI 10.1021/ac402850s; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Krezel A, 2003, INORG CHEM, V42, P1994, DOI 10.1021/ic025969y; Lai JB, 2013, J BIOL CHEM, V288, P22862, DOI 10.1074/jbc.M113.458794; Liu Z, 2015, ANGEW CHEM INT EDIT, V54, P1149, DOI 10.1002/anie.201408763; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mesilaty-Gross S, 1999, GENE, V231, P173, DOI 10.1016/S0378-1119(99)00053-0; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; OBRIEN PJ, 1987, J BIOL CHEM, V262, P5210; Ohno Y, 2012, MOL BIOL CELL, V23, P4543, DOI 10.1091/mbc.E12-05-0336; Pace NJ, 2014, BIOMOLECULES, V4, P419, DOI 10.3390/biom4020419; Putilina T, 1999, MOL CELL BIOCHEM, V195, P219, DOI 10.1023/A:1006932522197; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Sanders SS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004405; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; SIMONS TJB, 1993, J BIOCHEM BIOPH METH, V27, P25, DOI 10.1016/0165-022X(93)90065-V; Wilson JP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001198; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Yang Y, 2007, ELECTROPHORESIS, V28, P2080, DOI 10.1002/elps.200600524; Yeste-Velasco M, 2015, BBA-REV CANCER, V1856, P107, DOI 10.1016/j.bbcan.2015.06.004; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002	41	36	36	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29259	29269		10.1074/jbc.M115.691147	http://dx.doi.org/10.1074/jbc.M115.691147			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26487721	Green Published, hybrid			2022-12-28	WOS:000366613400014
J	Guo, HF; Vander Kooi, CW				Guo, Hou-Fu; Vander Kooi, Craig W.			Neuropilin Functions as an Essential Cell Surface Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ENDOTHELIAL GROWTH-FACTOR; CYTOPLASMIC DOMAIN; VEGF-C; SOLUBLE NEUROPILIN-1; SECRETED SEMAPHORINS; VESSEL DEVELOPMENT; STRUCTURAL BASIS; TUMOR-GROWTH; MYOSIN-VI; FACTOR-A	The Neuropilins (Nrps) are a family of essential cell surface receptors involved in multiple fundamental cellular signaling cascades. Nrp family members have key functions in VEGF-dependent angiogenesis and semaphorin-dependent axon guidance, controlling signaling and cross-talk between these fundamental physiological processes. More recently, Nrp function has been found in diverse signaling and adhesive functions, emphasizing their role as pleiotropic co-receptors. Pathological Nrp function has been shown to be important in aberrant activation of both canonical and alternative pathways. Here we review key recent insights into Nrp function in human health and disease.	[Vander Kooi, Craig W.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Vander Kooi, CW (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, 741 S Limestone Ave, Lexington, KY 40536 USA.	craig.vanderkooi@uky.edu		Guo, Hou-Fu/0000-0002-3659-9399	National Institutes of Health [R01GM094155]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM094155 (to C.W.V.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams RH, 1997, EMBO J, V16, P6077, DOI 10.1093/emboj/16.20.6077; Aspalter IM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8264; Bachelder RE, 2003, CANCER RES, V63, P5230; Banerjee S, 2006, MOL CARCINOGEN, V45, P871, DOI 10.1002/mc.20248; Bates DO, 2002, CANCER RES, V62, P4123; Bender RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061788; Berger P, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13318; Cai HB, 1999, J NEUROSCI, V19, P6519; Cao Y, 2008, CANCER RES, V68, P8667, DOI 10.1158/0008-5472.CAN-08-2614; Cao Y, 2013, CANCER RES, V73, P4579, DOI 10.1158/0008-5472.CAN-13-0529; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Dijkstra MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06238; Ellison TS, 2015, DIS MODEL MECH, V8, P1105, DOI 10.1242/dmm.019927; Evans IM, 2011, MOL CELL BIOL, V31, P1174, DOI 10.1128/MCB.00903-10; Fantin A, 2013, BLOOD, V121, P2352, DOI 10.1182/blood-2012-05-424713; Fantin A, 2011, DEVELOPMENT, V138, P4185, DOI 10.1242/dev.070037; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fuh G, 2000, J BIOL CHEM, V275, P26690; Fukasawa M, 2007, CANCER BIOL THER, V6, P1173; Gagnon ML, 2000, P NATL ACAD SCI USA, V97, P2573, DOI 10.1073/pnas.040337597; Gelfand MV, 2014, ELIFE, V3, DOI 10.7554/eLife.03720; Gephart MGH, 2013, J NEURO-ONCOL, V115, P161, DOI 10.1007/s11060-013-1216-1; Ghez D, 2006, J VIROL, V80, P6844, DOI 10.1128/JVI.02719-05; Glinka Y, 2008, J LEUKOCYTE BIOL, V84, P302, DOI 10.1189/jlb.0208090; Goel HL, 2014, CELL REP, V7, P747, DOI 10.1016/j.celrep.2014.03.059; Goel HL, 2013, EMBO MOL MED, V5, P488, DOI 10.1002/emmm.201202078; Goel HL, 2012, J CELL SCI, V125, P497, DOI 10.1242/jcs.094433; Gu CH, 2002, J BIOL CHEM, V277, P18069, DOI 10.1074/jbc.M201681200; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Guo HF, 2013, BIOCHEMISTRY-US, V52, P7551, DOI 10.1021/bi401034q; Hagberg CE, 2012, NATURE, V490, P426, DOI 10.1038/nature11464; Hanchate NK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002896; Hillman RT, 2011, GENE DEV, V25, P2333, DOI 10.1101/gad.173054.111; Hochman E, 2006, J BIOL CHEM, V281, P33860, DOI 10.1074/jbc.M605905200; Hota PK, 2012, CELL MOL LIFE SCI, V69, P3765, DOI 10.1007/s00018-012-1019-0; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Jia HY, 2006, J BIOL CHEM, V281, P13493, DOI 10.1074/jbc.M512121200; Jones EAV, 2008, DEVELOPMENT, V135, P2479, DOI 10.1242/dev.014902; Karpanen T, 2006, FASEB J, V20, P1462, DOI 10.1096/fj.05-5646com; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Kitsukawa T, 1995, DEVELOPMENT, V121, P4309; Koch S, 2014, DEV CELL, V28, P633, DOI 10.1016/j.devcel.2014.02.010; Krilleke D, 2007, J BIOL CHEM, V282, P28045, DOI 10.1074/jbc.M700319200; Lambert S, 2009, BLOOD, V113, P5176, DOI 10.1182/blood-2008-04-150342; Lanahan A, 2013, DEV CELL, V25, P156, DOI 10.1016/j.devcel.2013.03.019; Li Xiaobo, 2014, Biomol Concepts, V5, P157; Maric G, 2015, ONCOGENE, V34, P5494, DOI 10.1038/onc.2015.8; Merte J, 2010, J NEUROSCI, V30, P5767, DOI 10.1523/JNEUROSCI.5061-09.2010; Miao HQ, 2000, FASEB J, V14, P2532, DOI 10.1096/fj.00-0250com; Mumblat Y, 2015, CANCER RES, V75, P2177, DOI 10.1158/0008-5472.CAN-14-2464; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Nakayama H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11789; Ou JJ, 2015, CANCER LETT, V358, P200, DOI 10.1016/j.canlet.2014.12.046; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Pang HB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5904; Parker MW, 2015, STRUCTURE, V23, P677, DOI 10.1016/j.str.2015.01.018; Parker MW, 2013, J MOL BIOL, V425, P4405, DOI 10.1016/j.jmb.2013.07.017; Parker MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049177; Parker MW, 2012, BIOCHEMISTRY-US, V51, P9437, DOI 10.1021/bi3012143; Parker MW, 2012, J BIOL CHEM, V287, P11082, DOI 10.1074/jbc.M111.331140; Parker MW, 2010, BIOCHEMISTRY-US, V49, P4068, DOI 10.1021/bi100327r; Prahst C, 2008, J BIOL CHEM, V283, P25110, DOI 10.1074/jbc.C800137200; Raimondi C, 2014, J EXP MED, V211, P1167, DOI 10.1084/jem.20132330; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Robinson SD, 2009, J BIOL CHEM, V284, P33966, DOI 10.1074/jbc.M109.030700; Rossignol M, 2000, GENOMICS, V70, P211, DOI 10.1006/geno.2000.6381; Schuch G, 2002, BLOOD, V100, P4622, DOI 10.1182/blood.V100.13.4622; Seerapu HR, 2013, FEBS LETT, V587, P3392, DOI 10.1016/j.febslet.2013.08.040; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shintani Y, 2006, EMBO J, V25, P3045, DOI 10.1038/sj.emboj.7601188; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Starzec A, 2006, LIFE SCI, V79, P2370, DOI 10.1016/j.lfs.2006.08.005; Staton CA, 2013, HISTOPATHOLOGY, V62, P908, DOI 10.1111/his.12098; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Tamagnone L, 2011, DEV CELL, V21, P189, DOI 10.1016/j.devcel.2011.07.017; Teesalu T, 2012, METHOD ENZYMOL, V503, P35, DOI 10.1016/B978-0-12-396962-0.00002-1; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Teran M, 2015, J BIOL CHEM, V290, P16451, DOI 10.1074/jbc.M114.627372; Uniewicz KA, 2014, PEERJ, V2, DOI 10.7717/peerj.461; Uniewicz KA, 2011, J BIOL CHEM, V286, P12, DOI 10.1074/jbc.M110.190801; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Vander Kooi CW, 2007, P NATL ACAD SCI USA, V104, P6152, DOI 10.1073/pnas.0700043104; von Wronski MA, 2006, J BIOL CHEM, V281, P5702, DOI 10.1074/jbc.M511941200; Wang HB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7240; Wang L, 2003, J BIOL CHEM, V278, P48848, DOI 10.1074/jbc.M310047200; Wang L, 2006, FASEB J, V20, P1513, DOI 10.1096/fj.05-5504fje; West DC, 2005, J BIOL CHEM, V280, P13457, DOI 10.1074/jbc.M410924200; Xu YL, 2010, J CELL BIOL, V188, P115, DOI 10.1083/jcb.200903137; Yamada Y, 2003, BLOOD, V101, P1801, DOI 10.1182/blood-2002-01-0119; Yamada Y, 2001, BLOOD, V97, P1671, DOI 10.1182/blood.V97.6.1671; Yang SH, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/506428; Yang WJ, 2015, EMBO MOL MED, V7, P1267, DOI 10.15252/emmm.201404922; Yao XL, 2015, STRUCTURE, V23, P610, DOI 10.1016/j.str.2015.03.003; Yaqoob U, 2012, CANCER RES, V72, P4047, DOI 10.1158/0008-5472.CAN-11-3907; Yuan L, 2002, DEVELOPMENT, V129, P4797	100	121	127	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29120	29126		10.1074/jbc.R115.687327	http://dx.doi.org/10.1074/jbc.R115.687327			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26451046	Green Published, hybrid			2022-12-28	WOS:000366613400001
J	Li, YH; Kong, J; Peng, X; Hou, W; Qin, XH; Yu, XF				Li, Yanhong; Kong, Jia; Peng, Xin; Hou, Wen; Qin, Xiaohong; Yu, Xiao-Fang			Structural Insights into the High-efficiency Catalytic Mechanism of the Sterile alpha-Motif/Histidine-Aspartate Domain-containing Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTION FACTOR SAMHD1; AICARDI-GOUTIERES SYNDROME; IMMUNODEFICIENCY-VIRUS TYPE-1; ALLOSTERIC ACTIVATION; HIV-1 INFECTION; TRIPHOSPHOHYDROLASE; GTP; PHOSPHORYLATION; MACROPHAGES; INHIBITION	Sterile alpha-motif/histidine-aspartate domain-containing protein (SAMHD1), a homo-tetrameric GTP/dGTP-dependent dNTP triphosphohydrolase, catalyzes the conversion of dNTP into deoxynucleoside and triphosphate. As the only characterized dNTP triphosphohydrolase in human cells, SAMHD1 plays an important role in human innate immunity, autoimmunity, and cell cycle control. Previous biochemical studies and crystal structures have revealed that SAMHD1 interconverts between an inactive monomeric or dimeric form and a dGTP/GTP-induced active tetrameric form. Here, we describe a novel state of SAMHD1(109-626 amino acids, SAMHD1C) that is characterized by a rapid initial hydrolysis rate. Interestingly, the crystal structure showed that this novel SAMHD1 tetramer contains only GTP and has structural features distinct from the GTP/dNTP-bound SAMHD1 tetramer. Our work thus reveals structural features of SAMHD1 that may represent one of its biological assembly states in cells. The biochemical and structural information generated by the present study not only provides an ordered pathway for the assembly and activation of SAMHD1 but also provides insights into the potential mechanisms of the high-efficiency catalytic activity of this enzyme family in vivo.	[Li, Yanhong; Kong, Jia; Peng, Xin; Hou, Wen; Qin, Xiaohong; Yu, Xiao-Fang] Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China; [Yu, Xiao-Fang] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun 130061, Jilin Province, Peoples R China	Tianjin University; Jilin University	Qin, XH (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.	nkqinxiaohong@126.com; yuxiaofang@jlu.edu.cn		Peng, Xin/0000-0003-1654-2130	Chinese Ministry of Science and Technology [2012CB911100, 2013ZX0001-005]; National Natural Science Foundation of China [31400645]; Natural Science Foundation of Tianjin [15JCQNJC09800, 15JCQNJC06200]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported in part by funding from the Chinese Ministry of Science and Technology (Grants 2012CB911100 and 2013ZX0001-005), the National Natural Science Foundation of China (Grant 31400645), and the Natural Science Foundation of Tianjin (Grants 15JCQNJC09800 and 15JCQNJC06200). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Amie SM, 2013, J BIOL CHEM, V288, P25001, DOI 10.1074/jbc.C113.493619; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; BEBENEK K, 1992, J BIOL CHEM, V267, P3589; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Buckstein MH, 2008, J BACTERIOL, V190, P718, DOI 10.1128/JB.01020-07; Clifford R, 2014, BLOOD, V123, P1021, DOI 10.1182/blood-2013-04-490847; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Crow YJ, 2013, HAND CLINIC, V113, P1629, DOI 10.1016/B978-0-444-59565-2.00031-9; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGSTROM Y, 1985, J BIOL CHEM, V260, P9114; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Hansen EC, 2014, P NATL ACAD SCI USA, V111, pE1843, DOI 10.1073/pnas.1401706111; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ji XY, 2014, P NATL ACAD SCI USA, V111, pE4305, DOI 10.1073/pnas.1412289111; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Kim ET, 2013, J VIROL, V87, P12949, DOI 10.1128/JVI.02291-13; Koharudin LMI, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.591958; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NAKAI H, 1990, J BIOL CHEM, V265, P4411; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Ramantani G, 2011, J CHILD NEUROL, V26, P1425, DOI 10.1177/0883073811408310; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhao K, 2013, CELL REP, V4, P1108, DOI 10.1016/j.celrep.2013.08.019; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	43	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29428	29437		10.1074/jbc.M115.663658	http://dx.doi.org/10.1074/jbc.M115.663658			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26438820	hybrid, Green Published			2022-12-28	WOS:000366613400027
J	Ma, JF; Liu, T; Wei, AC; Banerjee, P; O'Rourke, B; Hart, GW				Ma, Junfeng; Liu, Ting; Wei, An-Chi; Banerjee, Partha; O'Rourke, Brian; Hart, Gerald W.			O-GlcNAcomic Profiling Identifies Widespread O-Linked beta-N-Acetylglucosamine Modification (O-GlcNAcylation) in Oxidative Phosphorylation System Regulating Cardiac Mitochondrial Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS; LINKAGE; CARDIOPROTECTION; LOCALIZATION; TRANSFERASE; EXPRESSION; GLCNACASE; TAU	Dynamic cycling of O-linked beta-N-acetylglucosamine (O-GlcNAc) on nucleocytoplasmic proteins serves as a nutrient sensor to regulate numerous biological processes. However, mitochondrial protein O-GlcNAcylation and its effects on function are largely unexplored. In this study, we performed a comparative analysis of the proteome and O-GlcNAcome of cardiac mitochondria from rats acutely (12 h) treated without or with thiamet-G (TMG), a potent and specific inhibitor of O-GlcNAcase. We then determined the functional consequences in mitochondria isolated from the two groups. O-GlcNAcomic profiling finds that over 88 mitochondrial proteins are O-GlcNAcylated, with the oxidative phosphorylation system as a major target. Moreover, in comparison with controls, cardiac mitochondria from TMG-treated rats did not exhibit altered protein abundance but showed overall elevated O-GlcNAcylation of many proteins. However, O-GlcNAc was unexpectedly down-regulated at certain sites of specific proteins. Concomitantly, TMG treatment resulted in significantly increased mitochondrial oxygen consumption rates, ATP production rates, and enhanced threshold for permeability transition pore opening by Ca2+. Our data reveal widespread and dynamic mitochondrial protein O-GlcNAcylation, serving as a regulator to their function.	[Ma, Junfeng; Banerjee, Partha; Hart, Gerald W.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Liu, Ting; Wei, An-Chi; O'Rourke, Brian] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Hart, GW (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, 725 North Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu	Regan, Clinton/E-6250-2012	Liu, Ting/0000-0002-8304-5751; Hart, Gerald/0000-0001-7812-4351; Banerjee, Partha/0000-0002-2602-1681; Wei, An-Chi/0000-0001-7927-1636; O'Rourke, Brian/0000-0002-5548-4853	National Institutes of Health [N01-HV-00240, P01HL107153, R01DK61671]; NCRR [S10RR26474]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026474] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK061671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants N01-HV-00240, P01HL107153, and R01DK61671 and Award S10RR26474 from the NCRR (for sharing the Seahorse instrument). Dr. Hart receives a share of royalty received by the university on sales of the CTD 110.6 antibody, which are managed by the Johns Hopkins University.	Andres-Bergos J, 2012, J BIOL CHEM, V287, P33615, DOI 10.1074/jbc.M112.354241; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P71, DOI 10.1016/j.bbabio.2009.08.002; Aon MA, 2012, J GEN PHYSIOL, V139, P479, DOI 10.1085/jgp.201210772; Banerjee PS, 2015, P NATL ACAD SCI USA, V112, P6050, DOI 10.1073/pnas.1424017112; Baycin-Hizal D, 2012, J PROTEOME RES, V11, P5265, DOI 10.1021/pr300476w; Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239; Cao WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076399; Clark RJ, 2003, J BIOL CHEM, V278, P44230, DOI 10.1074/jbc.M303810200; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Duncan JG, 2011, BBA-MOL CELL RES, V1813, P1351, DOI 10.1016/j.bbamcr.2011.01.014; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Foster DB, 2008, BIOCHEM BIOPH RES CO, V366, P649, DOI 10.1016/j.bbrc.2007.11.154; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Heath JM, 2014, CIRC RES, V114, P1094, DOI 10.1161/CIRCRESAHA.114.302968; HOLT GD, 1986, J BIOL CHEM, V261, P8049; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Johnsen VL, 2013, PHYSIOL GENOMICS, V45, P17, DOI 10.1152/physiolgenomics.00111.2012; Jones SP, 2008, CIRCULATION, V117, P1172, DOI 10.1161/CIRCULATIONAHA.107.730515; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Laczy B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018417; Liu J, 2006, J MOL CELL CARDIOL, V40, P303, DOI 10.1016/j.yjmcc.2005.11.003; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Marsh SA, 2014, J BIOL CHEM, V289, P34449, DOI 10.1074/jbc.R114.585984; Nicholls DG, 2013, BIOENERGETICS 4, P89; Ramirez-Corream G. A., 2015, DIABETES, DOI [10.2337/db14-1107, DOI 10.2337/DB14-1107]; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shin SH, 2011, AMINO ACIDS, V40, P885, DOI 10.1007/s00726-010-0719-8; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; SUMEGI B, 1984, J BIOL CHEM, V259, P5040; Tan EP, 2014, J BIOL CHEM, V289, P14719, DOI 10.1074/jbc.M113.525790; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vaidyanathan K, 2014, J BIOL CHEM, V289, P34466, DOI 10.1074/jbc.R114.591560; Vosseller K, 2005, PROTEOMICS, V5, P388, DOI 10.1002/pmic.200401066; Wang SB, 2011, CIRC RES, V109, P750, DOI 10.1161/CIRCRESAHA.111.246124; Wang Z, 2008, P NATL ACAD SCI USA, V105, P13793, DOI 10.1073/pnas.0806216105; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wang Z, 2009, DIABETES, V58, P309, DOI 10.2337/db08-0994; Wei AC, 2011, BBA-MOL CELL RES, V1813, P1373, DOI 10.1016/j.bbamcr.2011.02.012; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wu TJ, 2009, EUR J PHARMACOL, V613, P93, DOI 10.1016/j.ejphar.2009.04.012; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2014, CHEM SOC REV, V43, P6839, DOI 10.1039/c4cs00038b; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/nchembio.797, 10.1038/NCHEMBIO.797]	51	64	67	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29141	29153		10.1074/jbc.M115.691741	http://dx.doi.org/10.1074/jbc.M115.691741			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26446791	Green Published, hybrid			2022-12-28	WOS:000366613400003
J	Liu, WS; Liu, YD; Liu, HO; Zhang, WJ; Fu, Q; Xu, JJ; Gu, JX				Liu, Weisi; Liu, Yidong; Liu, Haiou; Zhang, Weijuan; Fu, Qiang; Xu, Jiejie; Gu, Jianxin			Tumor Suppressive Function of p21-activated Kinase 6 in Hepatocellular Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CELL CARCINOMA; ZESTE HOMOLOG 2; PROSTATE-CANCER; ANDROGEN RECEPTOR; HEPATOMA-CELLS; PAK6; GROWTH; IDENTIFICATION; EXPRESSION; ANOIKIS	Our previous studies identified the oncogenic role of p21-activated kinase 1 (PAK1) in hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC). Contrarily, PAK6 was found to predict a favorable prognosis in RCC patients. Nevertheless, the ambiguous tumor suppressive function of PAK6 in hepatocarcinogenesis remains obscure. Herein, decreased PAK6 expression was found to be associated with tumor node metastasis stage progression and unfavorable overall survival inHCCpatients. Additionally, overexpression and silence of PAK6 experiments showed that PAK6 inhibited xenografted tumor growth in vivo, and restricted cell proliferation, colony formation, migration, and invasion and promoted cell apoptosis and anoikis in vitro. Moreover, overexpression of kinase dead and nuclear localization signal deletion mutants of PAK6 experiments indicated the tumor suppressive function of PAK6 was partially dependent on its kinase activity and nuclear translocation. Furthermore, gain or loss of function in polycomb repressive complex 2 (PRC2) components, including EZH2, SUZ12, and EED, elucidated epigenetic control of H3K27me3-arbitrated PAK6 down-regulation in hepatoma cells. More importantly, negative correlation between PAK6 and EZH2 expression was observed in hepatoma tissues from HCC patients. These data identified the tumor suppressive role and potential underlying mechanism of PAK6 in hepatocarcinogenesis.	[Liu, Weisi; Liu, Yidong; Fu, Qiang; Xu, Jiejie; Gu, Jianxin] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China; [Zhang, Weijuan] Fudan Univ, Sch Basic Med Sci, Dept Immunol, Shanghai 200032, Peoples R China; [Liu, Haiou] Fudan Univ, Hosp Obstet & Gynecol, Shanghai Key Lab Female Reprod Endocrine Related, Shanghai 200011, Peoples R China	Fudan University; Fudan University; Fudan University	Xu, JJ (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200032, Peoples R China.	jjxufdu@fudan.edu.cn; jxgu@shmu.edu.cn	Liu, Haiou/AFS-2886-2022; Zhang, Weijuan/Q-1645-2019	Liu, Haiou/0000-0003-0200-8981; Zhang, Weijuan/0000-0003-3494-3114; liu, weisi/0000-0002-4730-5448	National Basic Research Program of China [2012CB822104]; National Key Projects for Infectious Diseases of China [2012ZX10002-012]; National Natural Science Foundation of China [31100629, 31270863, 31300671, 81372755, 31470794, 81401988, 81402082, 81402085, 81471621, 81472227, 81472376, 31570803, 81572352]; Program for New Century Excellent Talents in University [NCET-13-0146]; Shanghai Rising-Star Program [13QA1400300]	National Basic Research Program of China(National Basic Research Program of China); National Key Projects for Infectious Diseases of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Shanghai Rising-Star Program	This work was supported by National Basic Research Program of China Grant 2012CB822104, National Key Projects for Infectious Diseases of China Grant 2012ZX10002-012, National Natural Science Foundation of China Grants 31100629, 31270863, 31300671, 81372755, 31470794, 81401988, 81402082, 81402085, 81471621, 81472227, 81472376, 31570803, and 81572352, Program for New Century Excellent Talents in University Grant NCET-13-0146, and Shanghai Rising-Star Program Grant 13QA1400300. All study sponsors have no roles in the study design, collection, analysis, and interpretation of data.	Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Au SLK, 2012, HEPATOLOGY, V56, P622, DOI 10.1002/hep.25679; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Cai SW, 2015, ONCOTARGET, V6, P3904, DOI 10.18632/oncotarget.2880; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chen HW, 2014, J SURG RES, V189, P81, DOI 10.1016/j.jss.2014.01.049; Chen J, 2015, ONCOTARGET, V6, P355, DOI 10.18632/oncotarget.2803; Cheng CC, 2015, IN VIVO, V29, P237; Cotteret S, 2006, MOL CELL BIOL, V26, P3215, DOI 10.1128/MCB.26.8.3215-3230.2006; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Eswaran J, 2012, CLIN CANCER RES, V18, P3743, DOI 10.1158/1078-0432.CCR-11-1952; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Hayashi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091330; Henrici A, 2015, MOL CARCINOGEN, V54, P585, DOI 10.1002/mc.22122; Hodgson MC, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0061-y; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Kamarajan P, 2012, CANCER-AM CANCER SOC, V118, P5800, DOI 10.1002/cncr.27655; Kaur R, 2008, PROSTATE, V68, P1510, DOI 10.1002/pros.20787; Lee EJ, 2010, ONCOL RES, V18, P401; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Liu T, 2013, J BIOL CHEM, V288, P3359, DOI 10.1074/jbc.M112.384289; Liu WS, 2014, ANN SURG ONCOL, V21, pS575, DOI 10.1245/s10434-014-3680-z; Lu GD, 2015, HEPATOLOGY, V61, P965, DOI 10.1002/hep.27593; Ma CL, 2008, GASTROENTEROLOGY, V135, P947, DOI 10.1053/j.gastro.2008.05.046; Ma WL, 2008, GASTROENTEROLOGY, V135, P1805; Mann DA, 2014, HEPATOLOGY, V60, P1418, DOI 10.1002/hep.27131; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schrantz N, 2004, J BIOL CHEM, V279, P1922, DOI 10.1074/jbc.M311145200; Tian XC, 2010, J VIROL, V84, P3373, DOI 10.1128/JVI.02555-09; Trivedi AK, 2007, ONCOGENE, V26, P1789, DOI 10.1038/sj.onc.1209964; van de Wijngaart DJ, 2006, J BIOL CHEM, V281, P19407, DOI 10.1074/jbc.M602567200; Villanueva A, 2013, NAT REV GASTRO HEPAT, V10, P34, DOI 10.1038/nrgastro.2012.199; Wang RA, 2002, EMBO J, V21, P5437, DOI 10.1093/emboj/cdf543; Wang SS, 2013, CANCER SCI, V104, P750, DOI 10.1111/cas.12132; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; Wells CM, 2010, BIOCHEM J, V425, P465, DOI 10.1042/BJ20091173; Wu J, 2013, DIGEST DIS SCI, V58, P3545, DOI 10.1007/s10620-013-2867-7; Xiao QY, 2013, GUT, V62, P440, DOI 10.1136/gutjnl-2011-300781; Xu JJ, 2012, GASTROENTEROLOGY, V143, P199, DOI 10.1053/j.gastro.2012.03.053; Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613; Yang F, 2001, J BIOL CHEM, V276, P15345, DOI 10.1074/jbc.M010311200; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875; Zhu Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.2; Zhu Y, 2013, CANCER SCI, V104, P1052, DOI 10.1111/cas.12176	49	16	18	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28489	28501		10.1074/jbc.M115.658237	http://dx.doi.org/10.1074/jbc.M115.658237			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26442588	hybrid, Green Published			2022-12-28	WOS:000365761900042
J	Roth, R; Swanson, R; Izaguirre, G; Bock, SC; Gettins, PGW; Olson, ST				Roth, Ryan; Swanson, Richard; Izaguirre, Gonzalo; Bock, Susan C.; Gettins, Peter G. W.; Olson, Steven T.			Saturation Mutagenesis of the Antithrombin Reactive Center Loop P14 Residue Supports a Three-step Mechanism of Heparin Allosteric Activation Involving Intermediate and Fully Activated States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR IXA; FACTOR-XA; CONFORMATIONAL ACTIVATION; PROTEINASE REACTIONS; RAPID INHIBITION; BETA-SHEET; HELIX-D; BINDING; SERPIN; EXOSITE	Past studies have suggested that a key feature of the mechanism of heparin allosteric activation of the anticoagulant serpin, antithrombin, is the release of the reactive center loop P14 residue from a native state stabilizing interaction with the hydrophobic core. However, more recent studies have indicated that this structural change plays a secondary role in the activation mechanism. To clarify this role, we expressed and characterized 15 antithrombin P14 variants. The variants exhibited basal reactivities with factors Xa and IXa, heparin affinities and thermal stabilities that were dramatically altered from wild type, consistent with the P14 mutations perturbing native state stability and shifting an allosteric equilibrium between native and activated states. Rapid kinetic studies confirmed that limiting rate constants for heparin allosteric activation of the mutants were altered in conjunction with the observed shifts of the allosteric equilibrium. However, correlations of the P14 mutations' effects on parameters reflecting the allosteric activation state of the serpin were inconsistent with a two-state model of allosteric activation and suggested multiple activated states. Together, these findings support a minimal three-state model of allosteric activation in which the P14 mutations perturb equilibria involving distinct native, intermediate, and fully activated states wherein the P14 residue retains an interaction with the hydrophobic core in the intermediate state but is released from the core in the fully activated state, and the bulk of allosteric activation has occurred in the intermediate.	Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Roth, Ryan; Swanson, Richard; Izaguirre, Gonzalo; Olson, Steven T.] Univ Illinois, Dept Periodont, Chicago, IL 60612 USA; [Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60612 USA; [Bock, Susan C.] Univ Utah, Dept Med, Salt Lake City, UT 84132 USA; [Bock, Susan C.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84132 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Olson, ST (corresponding author), 801 S Paulina St,MC 860, Chicago, IL 60612 USA.	stolson@uic.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R37 HL39888]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in wholeor in part, by National Institutes of Health Grant R37 HL39888 (to S. T. O.). The authors declare that they have no conflicts of interest with the contents of this article.	BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; Bedsted T, 2003, BIOCHEMISTRY-US, V42, P8143, DOI 10.1021/bi034363y; Dementiev A, 2013, J BIOL CHEM, V288, P33611, DOI 10.1074/jbc.M113.510727; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; ERSDALBADJU E, 1995, BIOCHEM J, V310, P323, DOI 10.1042/bj3100323; Futamura A, 2000, J BIOL CHEM, V275, P4092, DOI 10.1074/jbc.275.6.4092; Gettins PGW, 2009, FEBS LETT, V583, P3397, DOI 10.1016/j.febslet.2009.10.005; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hopfner KP, 1997, EMBO J, V16, P6626, DOI 10.1093/emboj/16.22.6626; Huntington JA, 2000, J BIOL CHEM, V275, P15377, DOI 10.1074/jbc.275.20.15377; Huntington JA, 1998, BIOCHEMISTRY-US, V37, P3272, DOI 10.1021/bi972182o; Huntington JA, 1996, BIOCHEMISTRY-US, V35, P8495, DOI 10.1021/bi9604643; Ishiguro K, 2000, J CLIN INVEST, V106, P873, DOI 10.1172/JCI10489; Izaguirre G, 2006, J BIOL CHEM, V281, P13424, DOI 10.1074/jbc.M600415200; Izaguirre G, 2003, J BIOL CHEM, V278, P51433, DOI 10.1074/jbc.M309266200; Izaguirre G, 2014, J BIOL CHEM, V289, P34049, DOI 10.1074/jbc.M114.611707; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; Johnson DJD, 2003, BIOCHEMISTRY-US, V42, P8712, DOI 10.1021/bi034524y; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langdown J, 2009, J MOL BIOL, V386, P1278, DOI 10.1016/j.jmb.2009.01.028; Lawrence DA, 2000, J BIOL CHEM, V275, P5839, DOI 10.1074/jbc.275.8.5839; LAWRENCE DA, 1994, BIOCHEMISTRY-US, V33, P3643, DOI 10.1021/bi00178a022; Liu Y, 2014, BLOOD, V124, P142, DOI 10.1182/blood-2014-03-561027; MASCOTTI DP, 1995, BIOCHEMISTRY-US, V34, P2908, DOI 10.1021/bi00009a022; Meagher JL, 2000, J BIOL CHEM, V275, P2698, DOI 10.1074/jbc.275.4.2698; NORDENMAN B, 1977, EUR J BIOCHEM, V78, P195, DOI 10.1111/j.1432-1033.1977.tb11730.x; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Olson ST, 2010, BIOCHIMIE, V92, P1587, DOI 10.1016/j.biochi.2010.05.011; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; Richard B, 2008, J BIOL CHEM, V283, P14417, DOI 10.1074/jbc.M710327200; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schedin-Weiss S, 2010, ARCH BIOCHEM BIOPHYS, V504, P169, DOI 10.1016/j.abb.2010.08.021; Sturzebecher J, 1997, FEBS LETT, V412, P295, DOI 10.1016/S0014-5793(97)00811-9; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; vanBoven HH, 1997, SEMIN HEMATOL, V34, P188	41	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28020	28036		10.1074/jbc.M115.678839	http://dx.doi.org/10.1074/jbc.M115.678839			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26359493	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000365761900001
J	Bamford, NC; Snarr, BD; Gravelat, FN; Little, DJ; Lee, MJ; Zacharias, CA; Chabot, JC; Geller, AM; Baptista, SD; Baker, P; Robinson, H; Howell, PL; Sheppard, DC				Bamford, Natalie C.; Snarr, Brendan D.; Gravelat, Fabrice N.; Little, Dustin J.; Lee, Mark J.; Zacharias, Caitlin A.; Chabot, Josee C.; Geller, Alexander M.; Baptista, Stefanie D.; Baker, Perrin; Robinson, Howard; Howell, P. Lynne; Sheppard, Donald C.			Sph3 Is a Glycoside Hydrolase Required for the Biosynthesis of Galactosaminogalactan in Aspergillus fumigatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EVOLUTIONARY CONSERVATION; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; BIOFILM FORMATION; ALGINATE LYASE; POLYSACCHARIDE; SEQUENCE; CONSURF; CLASSIFICATION; IDENTIFICATION	Aspergillus fumigatus is the most virulent species within the Aspergillus genus and causes invasive infections with high mortality rates. The exopolysaccharide galactosaminogalactan (GAG) contributes to the virulence of A. fumigatus. A co-regulated five-gene cluster has been identified and proposed to encode the proteins required for GAG biosynthesis. One of these genes, sph3, is predicted to encode a protein belonging to the spherulin 4 family, a protein family with no known function. Construction of an sph3-deficient mutant demonstrated that the gene is necessary for GAG production. To determine the role of Sph3 in GAG biosynthesis, we determined the structure of Aspergillus clavatus Sph3 to 1.25 angstrom. The structure revealed a (beta/alpha)(8) fold, with similarities to glycoside hydrolase families 18, 27, and 84. Recombinant Sph3 displayed hydrolytic activity against both purified and cell wall-associated GAG. Structural and sequence alignments identified three conserved acidic residues, Asp-166, Glu-167, and Glu-222, that are located within the putative active site groove. In vitro and in vivo mutagenesis analysis demonstrated that all three residues are important for activity. Variants of Asp-166 yielded the greatest decrease in activity suggesting a role in catalysis. This work shows that Sph3 is a glycoside hydrolase essential for GAG production and defines a new glycoside hydrolase family, GH135.	[Bamford, Natalie C.; Little, Dustin J.; Baker, Perrin; Howell, P. Lynne] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 0A4, Canada; [Bamford, Natalie C.; Little, Dustin J.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Snarr, Brendan D.; Gravelat, Fabrice N.; Lee, Mark J.; Zacharias, Caitlin A.; Chabot, Josee C.; Geller, Alexander M.; Baptista, Stefanie D.; Sheppard, Donald C.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H4A 3J1, Canada; [Snarr, Brendan D.; Gravelat, Fabrice N.; Lee, Mark J.; Zacharias, Caitlin A.; Chabot, Josee C.; Geller, Alexander M.; Baptista, Stefanie D.; Sheppard, Donald C.] McGill Univ, Dept Med, Montreal, PQ H4A 3J1, Canada; [Robinson, Howard] Brookhaven Natl Lab, Photon Sci Div, Upton, NY 11973 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University; McGill University; United States Department of Energy (DOE); Brookhaven National Laboratory	Howell, PL (corresponding author), Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 0A4, Canada.	howell@sickkids.ca; don.sheppard@mcgill.ca	Sheppard, Donald/B-4637-2008	Sheppard, Donald/0000-0001-8877-880X; Bamford, Natalie/0000-0003-1959-856X; Gravelat, Fabrice/0000-0003-2416-9380	United States Department of Energy Office; National Institutes of Health from NCRR [P41RR012408]; National Institutes of Health from NIGMS [P41GM103473]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103473] Funding Source: NIH RePORTER	United States Department of Energy Office(United States Department of Energy (DOE)); National Institutes of Health from NCRR; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Magee (University of Minnesota, St. Paul) for the Af293 strain, J. P. Latge (Institut Pasteur, Paris, France) for the anti-GAG antibody, and P. Yip (The Hospital for Sick Children, Toronto, Canada) for technical assistance. Beamline X29 at the National Synchrotron Light Source is supported by the United States Department of Energy Office and National Institutes of Health Grant P41RR012408 from NCRR and Grant P41GM103473 from NIGMS. Beamline 08B1-1 at the Canadian Light Source is supported by Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research, the National Research Council Canada, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anthon GE, 2001, J AGR FOOD CHEM, V49, P32, DOI 10.1021/jf000871s; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bakkevig K, 2005, J BACTERIOL, V187, P8375, DOI 10.1128/JB.187.24.8375-8384.2005; Bourne Y, 2004, J BIOL CHEM, V279, P527, DOI 10.1074/jbc.M308218200; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colvin KM, 2013, J BACTERIOL, V195, P2329, DOI 10.1128/JB.02150-12; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontaine T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002372; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Geiser DM, 2007, STUD MYCOL, P1, DOI 10.3114/sim.2007.59.01; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gravelat FN, 2008, INFECT IMMUN, V76, P3632, DOI 10.1128/IAI.01483-07; Gravelat FN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003575; Gravelat Fabrice N, 2012, Methods Mol Biol, V845, P119, DOI 10.1007/978-1-61779-539-8_8; Gravelat FN, 2010, CELL MICROBIOL, V12, P473, DOI 10.1111/j.1462-5822.2009.01408.x; Gresnigt MS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003936; Guce AI, 2010, J BIOL CHEM, V285, P3625, DOI 10.1074/jbc.M109.060145; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Jain S, 2005, INFECT IMMUN, V73, P6429, DOI 10.1128/IAI.73.10.6429-6436.2005; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kaur S, 2014, MED MYCOL, V52, P2, DOI 10.3109/13693786.2013.819592; Kawano S, 2002, J BIOSCI BIOENG, V94, P275, DOI 10.1263/jbb.94.275; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Koseoglu VK, 2015, MOL MICROBIOL, V96, P728, DOI 10.1111/mmi.12966; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Lee M. J., 2015, MBIO; Lee MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005187; Lee MJ, 2014, J BIOL CHEM, V289, P1243, DOI 10.1074/jbc.M113.522516; Lewis RE, 2013, MYCOSES, V56, P638, DOI 10.1111/myc.12081; Little DJ, 2015, J BIOL CHEM, V290, P22827, DOI 10.1074/jbc.M115.672469; Little DJ, 2014, P NATL ACAD SCI USA, V111, P11013, DOI 10.1073/pnas.1406388111; Little DJ, 2012, J BIOL CHEM, V287, P31126, DOI 10.1074/jbc.M112.390005; Loussert C, 2010, CELL MICROBIOL, V12, P405, DOI 10.1111/j.1462-5822.2009.01409.x; Mazur O, 2011, J BIOL CHEM, V286, P17601, DOI 10.1074/jbc.M111.227660; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nakai T, 2013, J BACTERIOL, V195, P958, DOI 10.1128/JB.01473-12; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Payne CM, 2012, J BIOL CHEM, V287, P36322, DOI 10.1074/jbc.M112.402149; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Roberts SM, 2012, METHOD ENZYMOL, V510, P141, DOI 10.1016/B978-0-12-415931-0.00008-2; Robinet P, 2014, J IMMUNOL, V192, P5332, DOI 10.4049/jimmunol.1303180; Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005; SAVARD L, 1989, BIOCHIM BIOPHYS ACTA, V1007, P264, DOI 10.1016/0167-4781(89)90146-2; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; Steiner S, 2013, EMBO J, V32, P354, DOI 10.1038/emboj.2012.315; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001	67	49	53	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27438	27450		10.1074/jbc.M115.679050	http://dx.doi.org/10.1074/jbc.M115.679050			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26342082	Green Published, hybrid			2022-12-28	WOS:000365757500001
J	Cheng, YH; Rao, V; Tu, AY; Lindert, S; Wang, D; Oxenford, L; McCulloch, AD; McCammon, JA; Regnier, M				Cheng, Yuanhua; Rao, Vijay; Tu, An-yue; Lindert, Steffen; Wang, Dan; Oxenford, Lucas; McCulloch, Andrew D.; McCammon, J. Andrew; Regnier, Michael			Troponin I Mutations R146G and R21C Alter Cardiac Troponin Function, Contractile Properties, and Modulation by Protein Kinase A (PKA)-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; RABBIT SKELETAL-MUSCLE; MOLECULAR-DYNAMICS; RELAXATION KINETICS; STRIATED-MUSCLE; CONFORMATIONAL TRANSITION; PKA PHOSPHORYLATION; CALCIUM SENSITIVITY; SINGLE MYOFIBRILS; REGULATORY DOMAIN	Two hypertrophic cardiomyopathy-associated cardiac troponin I (cTnI) mutations, R146G and R21C, are located in different regions of cTnI, the inhibitory peptide and the cardiac-specific N terminus. We recently reported that these regions may interact when Ser-23/Ser-24 are phosphorylated, weakening the interaction of cTnI with cardiac TnC. Little is known about how these mutations influence the affinity of cardiac TnC for cTnI (KC-I) or contractile kinetics during beta-adrenergic stimulation. Here, we tested how cTnI(R146G) or cTnI(R21C) influences contractile activation and relaxation and their response to protein kinase A (PKA). Both mutations significantly increased Ca2+ binding affinity to cTn (K-Ca) and KC-I. PKA phosphorylation resulted in a similar reduction of K-Ca for all complexes, but KC-I was reduced only with cTnI(WT). cTnI(WT), cTnI(R146G), and cTnI(R21C) were complexed into cardiac troponin and exchanged into rat ventricular myofibrils, and contraction/relaxation kinetics were measured +/- PKA phosphorylation. Maximal tension (T-max) was maintained for cTnI(R146G)- and cTnI(R21C)-exchanged myofibrils, and Ca2+ sensitivity of tension (pCa(50)) was increased. PKA phosphorylation decreased pCa(50) for cTnI(WT)-exchanged myofibrils but not for either mutation. PKA phosphorylation accelerated the early slow phase relaxation for cTnI(WT) myofibrils, especially at Ca2+ levels that the heart operates in vivo. Importantly, this effect was blunted for cTnI(R146G)- and cTnI(R21C)-exchanged myofibrils. Molecular dynamics simulations suggest both mutations inhibit formation of intra-subunit contacts between the N terminus and the inhibitory peptide of cTnI that is normally seen with WT-cTn upon PKA phosphorylation. Together, our results suggest that cTnI(R146G) and cTnI(R21C) blunt PKA modulation of activation and relaxation kinetics by prohibiting cardiac-specific N-terminal interaction with the cTnI inhibitory peptide.	[Cheng, Yuanhua; Rao, Vijay; Tu, An-yue; Wang, Dan; Oxenford, Lucas; Regnier, Michael] Univ Washington, Dept Bioengn, Seattle, WA 98105 USA; [Cheng, Yuanhua; McCulloch, Andrew D.; McCammon, J. Andrew] Univ Calif San Diego, Natl Biomed Computat Resource, La Jolla, CA 92093 USA; [McCulloch, Andrew D.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Lindert, Steffen; McCammon, J. Andrew] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Regnier, Michael] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Washington; University of Washington Seattle	Regnier, M (corresponding author), Univ Washington, Dept Bioengn, Box 358056,850 Republican St, Seattle, WA 98195 USA.	mregnier@uw.edu	McCammon, J. Andrew/AAG-1832-2021; Regan, Clinton/E-6250-2012	McCammon, J. Andrew/0000-0003-3065-1456	National Institutes of Health [R01 HL-111197, P41 GM103426]; American Heart Association [15POST25080292, 11POST7400069, 12POST11570005]; National Science Foundation; Howard Hughes Medical Institution; National Science Foundation Supercomputer Centers; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111197, U01HL122199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103426, R01GM031749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institution(Howard Hughes Medical Institute); National Science Foundation Supercomputer Centers(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01 HL-111197 (to M. R.) and P41 GM103426 (to NBCR), by American Heart Association Grants 15POST25080292 (to Y. C.), 11POST7400069 (to V. R.), and 12POST11570005 (to S. L.), and by grants from National Science Foundation, National Institutes of Health, Howard Hughes Medical Institution, and the National Science Foundation Supercomputer Centers (to the J. A. M. group). The authors declare that they have no conflicts of interest with the contents of this article.	Adhikari BB, 2004, BIOPHYS J, V87, P1784, DOI 10.1529/biophysj.103.039131; Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Brunet NM, 2014, ARCH BIOCHEM BIOPHYS, V552, P11, DOI 10.1016/j.abb.2013.12.021; Chandra M, 1997, BIOCHEMISTRY-US, V36, P13305, DOI 10.1021/bi9710129; Cheng YH, 2014, BIOPHYS J, V107, P1675, DOI 10.1016/j.bpj.2014.08.008; Colomo F, 1997, J PHYSIOL-LONDON, V500, P535, DOI 10.1113/jphysiol.1997.sp022039; Colson BA, 2008, CIRC RES, V103, P244, DOI 10.1161/CIRCRESAHA.108.178996; Deng Y, 2001, BIOCHEMISTRY-US, V40, P14593, DOI 10.1021/bi0115232; Dohet C, 1995, FEBS LETT, V377, P131, DOI 10.1016/0014-5793(95)01319-9; Dong WJ, 2000, PROTEINS, V41, P438, DOI 10.1002/1097-0134(20001201)41:4<438::AID-PROT20>3.0.CO;2-E; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6754, DOI 10.1021/bi9622276; Dong WJ, 2003, J BIOL CHEM, V278, P8686, DOI 10.1074/jbc.M212886200; Dweck D, 2014, J BIOL CHEM, V289, P23097, DOI 10.1074/jbc.M114.561472; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Finley N, 1999, FEBS LETT, V453, P107, DOI 10.1016/S0014-5793(99)00693-6; George SE, 1996, BIOCHEMISTRY-US, V35, P8307, DOI 10.1021/bi960495y; Gomes AV, 2005, J MOL CELL CARDIOL, V39, P754, DOI 10.1016/j.yjmcc.2005.05.013; Gordon AM, 1997, J MUSCLE RES CELL M, V18, P643, DOI 10.1023/A:1018631806182; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Heller WT, 2003, BIOCHEMISTRY-US, V42, P7790, DOI 10.1021/bi0341509; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUXLEY AF, 1970, J PHYSIOL-LONDON, V210, pP32; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kentish JC, 2001, CIRC RES, V88, P1059, DOI 10.1161/hh1001.091640; Kimura A, 1997, NAT GENET, V16, P379, DOI 10.1038/ng0897-379; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Kohler J, 2003, PHYSIOL GENOMICS, V14, P117, DOI 10.1152/physiolgenomics.00101.2002; KRESS M, 1986, J MOL BIOL, V188, P325, DOI 10.1016/0022-2836(86)90158-0; Kreutziger KL, 2008, J PHYSIOL-LONDON, V586, P3683, DOI 10.1113/jphysiol.2008.152181; Kreutziger KL, 2011, J MOL CELL CARDIOL, V50, P165, DOI 10.1016/j.yjmcc.2010.10.025; Kruger M, 2005, J PHYSIOL-LONDON, V564, P347, DOI 10.1113/jphysiol.2004.079095; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; Liang JS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/742536; Lindert S, 2015, BIOPHYS J, V108, P395, DOI 10.1016/j.bpj.2014.11.3461; Lindhout DA, 2002, BIOCHEMISTRY-US, V41, P7267, DOI 10.1021/bi020100c; Luo Y, 2003, ADV EXP MED BIOL, V538, P573; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Martyn DA, 2001, BIOPHYS J, V80, P360, DOI 10.1016/S0006-3495(01)76020-1; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poggesi C, 2005, PFLUG ARCH EUR J PHY, V449, P505, DOI 10.1007/s00424-004-1363-5; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; Rao V, 2014, BIOPHYS J, V107, P1196, DOI 10.1016/j.bpj.2014.07.027; Rao VS, 2013, J PHYSIOL-LONDON, V591, P475, DOI 10.1113/jphysiol.2012.241604; Regnier M, 2000, CIRC RES, V86, P1211, DOI 10.1161/01.RES.86.12.1211; Reiffert SU, 1998, BIOCHEMISTRY-US, V37, P13516, DOI 10.1021/bi980280j; Reis S, 2008, PFLUG ARCH EUR J PHY, V457, P17, DOI 10.1007/s00424-008-0487-4; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sadayappan S, 2008, FASEB J, V22, P1246, DOI 10.1096/fj.07-9458com; Sakthivel S, 2005, J BIOL CHEM, V280, P703, DOI 10.1074/jbc.M409513200; Seidman CE, 2011, CIRC RES, V108, P743, DOI 10.1161/CIRCRESAHA.110.223834; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Takahashi-Yanaga F, 2001, J MOL CELL CARDIOL, V33, P2095, DOI 10.1006/jmcc.2001.1473; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Takimoto E, 2004, CIRC RES, V94, P496, DOI 10.1161/01.RES.0000117307.57798.F5; Tesi C, 2002, BIOPHYS J, V83, P2142, DOI 10.1016/S0006-3495(02)73974-X; Tesi C, 2000, BIOPHYS J, V78, P3081, DOI 10.1016/S0006-3495(00)76845-7; Wang D, 2013, ARCH BIOCHEM BIOPHYS, V535, P68, DOI 10.1016/j.abb.2013.02.006; Wang D, 2012, BIOCHEMISTRY-US, V51, P4473, DOI 10.1021/bi3003007; Wang YC, 2012, J BIOL CHEM, V287, P2156, DOI 10.1074/jbc.M111.294306; Warren CM, 2009, J BIOL CHEM, V284, P14258, DOI 10.1074/jbc.M807621200; Wen YH, 2008, J BIOL CHEM, V283, P20484, DOI 10.1074/jbc.M801661200; Westfall MV, 2002, CIRC RES, V91, P525, DOI 10.1161/01.RES.0000034710.46739.C0; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028; Zhou ZQ, 2013, ARCH BIOCHEM BIOPHYS, V535, P56, DOI 10.1016/j.abb.2012.12.007	72	28	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27749	27766		10.1074/jbc.M115.683045	http://dx.doi.org/10.1074/jbc.M115.683045			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26391394	Green Published, hybrid			2022-12-28	WOS:000365757500027
J	Lu, M; Boschetti, C; Tunnacliffe, A				Lu, Meng; Boschetti, Chiara; Tunnacliffe, Alan			Long Term Aggresome Accumulation Leads to DNA Damage, p53-dependent Cell Cycle Arrest, and Steric Interference in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; DOUBLE-STRAND BREAKS; DISEASE; P53; DYSFUNCTION; AGGREGATION; APOPTOSIS; MOUSE; ATM; ABNORMALITIES	Juxtanuclear aggresomes form in cells when levels of aggregation-prone proteins exceed the capacity of the proteasome to degrade them. It is widely believed that aggresomes have a protective function, sequestering potentially damaging aggregates until these can be removed by autophagy. However, most in-cell studies have been carried out over a few days at most, and there is little information on the long term effects of aggresomes. To examine these long term effects, we created inducible, single-copy cell lines that expressed aggregation-prone polyglutamine proteins over several months. We present evidence that, as perinuclear aggresomes accumulate, they are associated with abnormal nuclear morphology and DNA double-strand breaks, resulting in cell cycle arrest via the phosphorylated p53 (Ser-15)-dependent pathway. Further analysis reveals that aggresomes can have a detrimental effect on mitosis by steric interference with chromosome alignment, centrosome positioning, and spindle formation. The incidence of apoptosis also increased in aggresome-containing cells. These severe defects developed gradually after juxtanuclear aggresome formation and were not associated with small cytoplasmic aggregates alone. Thus, our findings demonstrate that, in dividing cells, aggresomes are detrimental over the long term, rather than protective. This suggests a novel mechanism for polyglutamine-associated developmental and cell biological abnormalities, particularly those with early onset and non-neuronal pathologies.	[Lu, Meng; Boschetti, Chiara; Tunnacliffe, Alan] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England	University of Cambridge	Tunnacliffe, A (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England.	at10004@cam.ac.uk		Boschetti, Chiara/0000-0003-4552-3975	European Research Council [AdG233232]; Cambridge Overseas Trust; Chinese Scholarship Council	European Research Council(European Research Council (ERC)European Commission); Cambridge Overseas Trust; Chinese Scholarship Council(China Scholarship Council)	This work was supported by an Advanced Investigator Award (AdG233232) from the European Research Council (to A. T.) and by scholarships from the Cambridge Overseas Trust and the Chinese Scholarship Council (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Adamec E, 1999, BRAIN RES, V849, P67, DOI 10.1016/S0006-8993(99)02004-1; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Bertoni A, 2011, J BIOL CHEM, V286, P4727, DOI 10.1074/jbc.M110.156521; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Bjorkqvist M, 2005, HUM MOL GENET, V14, P565, DOI 10.1093/hmg/ddi053; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bouwman P, 2012, NAT REV CANCER, V12, P587, DOI 10.1038/nrc3342; Bufalino MR, 2014, CELL CYCLE, V13, P1201, DOI 10.4161/cc.28106; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Burnett BG, 2005, P NATL ACAD SCI USA, V102, P4330, DOI 10.1073/pnas.0407252102; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chapple JP, 2008, NEUROSCI LETT, V447, P172, DOI 10.1016/j.neulet.2008.09.075; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Dobbin MM, 2013, NAT NEUROSCI, V16, P1008, DOI 10.1038/nn.3460; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Enokido Y, 2010, J CELL BIOL, V189, P425, DOI 10.1083/jcb.200905138; Giuliano P, 2003, HUM MOL GENET, V12, P2301, DOI 10.1093/hmg/ddg242; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Illuzzi J, 2009, J NEUROSCI RES, V87, P733, DOI 10.1002/jnr.21881; Imreh G, 2011, J CELL SCI, V124, P2951, DOI 10.1242/jcs.081612; Jacobsen E, 2004, MOL BRAIN RES, V128, P1, DOI 10.1016/j.molbrainres.2004.05.023; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaina B, 2003, BIOCHEM PHARMACOL, V66, P1547, DOI 10.1016/S0006-2952(03)00510-0; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kazantsev A, 2002, NAT GENET, V30, P367, DOI 10.1038/ng864; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu KY, 2015, HUM MOL GENET, V24, P1602, DOI 10.1093/hmg/ddu574; Lu M, 2015, BIOTECHNOL BIOENG, V112, P1883, DOI 10.1002/bit.25606; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Molero AE, 2009, P NATL ACAD SCI USA, V106, P21900, DOI 10.1073/pnas.0912171106; MULLAART E, 1990, NEUROBIOL AGING, V11, P169, DOI 10.1016/0197-4580(90)90542-8; Nanduri P, 2015, J BIOL CHEM, V290, P9455, DOI 10.1074/jbc.M114.627950; Nopoulos PC, 2011, BRAIN, V134, P137, DOI 10.1093/brain/awq280; Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172; Ortega Z, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmol.2014.00077, 10.3389/fnmo1.2014.00077]; Park R, 2011, J BIOL CHEM, V286, P9748, DOI 10.1074/jbc.M110.198325; Pattison JS, 2008, CIRCULATION, V117, P2743, DOI 10.1161/CIRCULATIONAHA.107.750232; Paulson HL, 2000, P NATL ACAD SCI USA, V97, P12957, DOI 10.1073/pnas.210395797; Pelegri C, 2008, INT J DEV NEUROSCI, V26, P665, DOI 10.1016/j.ijdevneu.2008.07.016; Phan J, 2009, HUM MOL GENET, V18, P1006, DOI 10.1093/hmg/ddn428; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; Qi ML, 2007, NAT CELL BIOL, V9, P402, DOI 10.1038/ncb1553; Ribchester RR, 2004, EUR J NEUROSCI, V20, P3092, DOI 10.1111/j.1460-9568.2004.03783.x; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Fernandez-Fernandez MR, 2011, NEUROBIOL DIS, V41, P23, DOI 10.1016/j.nbd.2010.08.014; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Shackelford DA, 2006, NEUROBIOL AGING, V27, P596, DOI 10.1016/j.neurobiolaging.2005.03.009; Shrestha RL, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130108; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614	61	21	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27986	28000		10.1074/jbc.M115.676437	http://dx.doi.org/10.1074/jbc.M115.676437			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26408200	hybrid, Green Published			2022-12-28	WOS:000365757500045
J	Veya, L; Piguet, J; Vogel, H				Veya, Luc; Piguet, Joachim; Vogel, Horst			Single Molecule Imaging Deciphers the Relation between Mobility and Signaling of a Prototypical G Protein-coupled Receptor in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-COATED-PIT; NEUROKININ 1 RECEPTOR; FLUID-MOSAIC MODEL; TACHYKININ NK1 RECEPTOR; PLASMA-MEMBRANE; SUBSTANCE-P; PARTICLE TRACKING; BIOLOGICAL-MEMBRANES; EPITHELIAL-CELLS; SURFACE PROTEINS	Lateral diffusion enables efficient interactions between membrane proteins, leading to signal transmission across the plasma membrane. An open question is how the spatiotemporal distribution of cell surface receptors influences the transmembrane signaling network. Here we addressed this issue by studying the mobility of a prototypical G protein-coupled receptor, the neurokinin-1 receptor, during its different phases of cellular signaling. Attaching a single quantum dot to individual neurokinin-1 receptors enabled us to follow with high spatial and temporal resolution over long time regimes the fate of individual receptors at the plasma membrane. Single receptor trajectories revealed a very heterogeneous mobility distribution pattern with diffusion constants ranging from 0.0005 to 0.1 mu m(2)/s comprising receptors freely diffusing and others confined in 100-600-nm-sized membrane domains as well as immobile receptors. A two-dimensional representation of mobility and confinement resolved two major, broadly distributed receptor populations, one showing high mobility and low lateral restriction and the other showing low mobility and high restriction. We found that about 40% of the receptors in the basal state are already confined in membrane domains and are associated with clathrin. After stimulation with an agonist, an additional 30% of receptors became further confined. Using inhibitors of clathrin-mediated endocytosis, we found that the fraction of confined receptors at the basal state depends on the quantity of membrane-associated clathrin and is correlated to a significant decrease of the canonical pathway activity of the receptors. This shows that the high plasticity of receptor mobility is of central importance for receptor homeostasis and fine regulation of receptor activity.	[Veya, Luc; Piguet, Joachim; Vogel, Horst] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Piguet, J (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland.	joachim.jpiguet@kth.se; horst.vogel@epfl.ch	Piguet, Joachim/E-2329-2011; Vogel, Horst/AAJ-5490-2021	Piguet, Joachim/0000-0002-4762-4887; 	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation; National Centre of Competence in Research Chemical Biology; European Community (Project SynSignal) [FP7-KBBE-2013-613879]	Ecole Polytechnique Federale de Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research Chemical Biology; European Community (Project SynSignal)	This work was supported by grants of the Ecole Polytechnique Federale de Lausanne, the Swiss National Science Foundation, the National Centre of Competence in Research Chemical Biology, and the European Community (Project SynSignal, Grant FP7-KBBE-2013-613879). The authors declare that they have no conflicts of interest with the contents of this article.	Adam G., 1968, STRUCTURAL CHEM MOL, P198; ALBRECHTBUEHLER G, 1980, P NATL ACAD SCI-BIOL, V77, P6639, DOI 10.1073/pnas.77.11.6639; Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Baker A, 2007, EUR BIOPHYS J BIOPHY, V36, P849, DOI 10.1007/s00249-007-0214-7; Bauer B, 2009, ANGEW CHEM INT EDIT, V48, P1656, DOI 10.1002/anie.200803898; Bellve KD, 2006, J BIOL CHEM, V281, P16139, DOI 10.1074/jbc.M511370200; Bouzigues C, 2007, P NATL ACAD SCI USA, V104, P11251, DOI 10.1073/pnas.0702536104; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Cezanne L, 2004, J BIOL CHEM, V279, P45057, DOI 10.1074/jbc.M404811200; Chen PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045322; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; de Keijzer S, 2011, BBA-BIOMEMBRANES, V1808, P1701, DOI 10.1016/j.bbamem.2011.02.009; den Otter WK, 2011, TRAFFIC, V12, P1407, DOI 10.1111/j.1600-0854.2011.01241.x; Destainville N, 2006, BIOPHYS J, V90, pL17, DOI 10.1529/biophysj.105.075176; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Ewers H, 2005, P NATL ACAD SCI USA, V102, P15110, DOI 10.1073/pnas.0504407102; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ganguly S, 2011, BBA-BIOMEMBRANES, V1808, P1921, DOI 10.1016/j.bbamem.2011.04.001; GARLAND AM, 1994, BIOCHEM J, V303, P177, DOI 10.1042/bj3030177; George N, 2004, J AM CHEM SOC, V126, P8896, DOI 10.1021/ja048396s; GRADY EF, 1995, MOL BIOL CELL, V6, P509, DOI 10.1091/mbc.6.5.509; Grasso L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070929; Grecco HE, 2011, CELL, V144, P897, DOI 10.1016/j.cell.2011.01.029; Grove J, 2014, MOL BIOL CELL, V25, P3581, DOI 10.1091/mbc.E14-06-1154; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; Helmuth JA, 2007, J STRUCT BIOL, V159, P347, DOI 10.1016/j.jsb.2007.04.003; Heng BC, 2013, BIOTECHNOL ADV, V31, P1676, DOI 10.1016/j.biotechadv.2013.08.017; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Jacquier V, 2006, P NATL ACAD SCI USA, V103, P14325, DOI 10.1073/pnas.0603942103; Jaqaman K, 2012, TRENDS CELL BIOL, V22, P515, DOI 10.1016/j.tcb.2012.07.006; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Khawaja AM, 1996, INT J BIOCHEM CELL B, V28, P721, DOI 10.1016/1357-2725(96)00017-9; Kubale V, 2007, CELL TISSUE RES, V330, P231, DOI 10.1007/s00441-007-0462-y; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Kusumi A, 2014, NAT CHEM BIOL, V10, P524, DOI [10.1038/NCHEMBIO.1558, 10.1038/nchembio.1558]; Kusumi A, 2012, ANNU REV CELL DEV BI, V28, P215, DOI 10.1146/annurev-cellbio-100809-151736; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; Lill Y, 2005, CHEMPHYSCHEM, V6, P1633, DOI 10.1002/cphc.200500111; LIN HC, 1991, J CELL BIOL, V114, P881, DOI 10.1083/jcb.114.5.881; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lommerse PHM, 2004, BIOPHYS J, V86, P609, DOI 10.1016/S0006-3495(04)74139-9; Luttrell LM, 2002, J CELL SCI, V115, P455; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McConalogue K, 1999, J BIOL CHEM, V274, P16257, DOI 10.1074/jbc.274.23.16257; Meshki J, 2009, J BIOL CHEM, V284, P9280, DOI 10.1074/jbc.M808825200; Meyer BH, 2006, FEBS LETT, V580, P1654, DOI 10.1016/j.febslet.2006.02.007; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; MILLER K, 1991, CELL, V65, P621, DOI 10.1016/0092-8674(91)90094-F; Murphy JE, 2011, AM J PHYSIOL-CELL PH, V301, pC780, DOI 10.1152/ajpcell.00096.2011; Nicolau DV, 2007, BIOPHYS J, V92, P1975, DOI 10.1529/biophysj.105.076869; Nicolson GL, 2014, BBA-BIOMEMBRANES, V1838, P1451, DOI 10.1016/j.bbamem.2013.10.019; Pelayo JC, 2011, J PHYSIOL-LONDON, V589, P5213, DOI 10.1113/jphysiol.2011.214452; Pick H, 2005, J AM CHEM SOC, V127, P2908, DOI 10.1021/ja044605x; Piguet J, 2011, J BIOL CHEM, V286, P363, DOI 10.1074/jbc.M110.139782; Prummer M, 2006, CHEMBIOCHEM, V7, P908, DOI 10.1002/cbic.200500477; Quartara L, 1998, NEUROPEPTIDES, V32, P1, DOI 10.1016/S0143-4179(98)90015-4; Quartara L, 1997, NEUROPEPTIDES, V31, P537, DOI 10.1016/S0143-4179(97)90001-9; Reiter E, 2012, ANNU REV PHARMACOL, V52, P179, DOI 10.1146/annurev.pharmtox.010909.105800; Roosterman D, 2004, J BIOL CHEM, V279, P30670, DOI 10.1074/jbc.M402479200; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013; Subtil A, 1997, J CELL SCI, V110, P2441; TAKAHASHI K, 1992, EUR J BIOCHEM, V204, P1025, DOI 10.1111/j.1432-1033.1992.tb16724.x; TANK DW, 1982, J CELL BIOL, V92, P207, DOI 10.1083/jcb.92.1.207; Thurner P, 2014, J BIOL CHEM, V289, P9263, DOI 10.1074/jbc.M113.505685; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Valant C, 2012, ANNU REV PHARMACOL, V52, P153, DOI 10.1146/annurev-pharmtox-010611-134514; VAZ WLC, 1982, BIOCHEMISTRY-US, V21, P5608, DOI 10.1021/bi00265a034; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wang XR, 2002, BRAIN RES, V944, P239, DOI 10.1016/S0006-8993(02)02918-9; Weigel AV, 2013, P NATL ACAD SCI USA, V110, pE4591, DOI 10.1073/pnas.1315202110; Zhou HX, 2009, J PHYS CHEM B, V113, P7995, DOI 10.1021/jp8107446	83	21	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27723	27735		10.1074/jbc.M115.666677	http://dx.doi.org/10.1074/jbc.M115.666677			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26363070	Green Published, hybrid			2022-12-28	WOS:000365757500025
J	Won, JH; Park, S; Hong, S; Son, S; Yu, JW				Won, Ji-Hee; Park, Sangjun; Hong, Sujeong; Son, Seunghwan; Yu, Je-Wook			Rotenone-induced Impairment of Mitochondrial Electron Transport Chain Confers a Selective Priming Signal for NLRP3 Inflammasome Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; APOPTOSIS; DISEASES; DNA; DEUBIQUITINATION; DAMAGE; LEADS	Mitochondrial dysfunction is considered crucial for NLRP3 inflammasome activation partly through its release of mitochondrial toxic products, such as mitochondrial reactive oxygen species (mROS)(2) and mitochondrial DNA (mtDNA). Although previous studies have shown that classical NLRP3-activating stimulations lead to mROS generation and mtDNA release, it remains poorly understood whether and how mitochondrial damage-derived factors may contribute to NLRP3 inflammasome activation. Here, we demonstrate that impairment of the mitochondrial electron transport chain by rotenone primes NLRP3 inflammasome activation only upon costimulation with ATP and not with nigericin or alum. Rotenone-induced priming of NLRP3 in the presence of ATP triggered the formation of specklike NLRP3 or ASC aggregates and the association of NLRP3 with ASC, resulting in NLRP3-dependent caspase-1 activation. Mechanistically, rotenone confers a priming signal for NLRP3 inflammasome activation only in the context of aberrant high-grade, but not low-grade, mROS production and mitochondrial hyperpolarization. By contrast, rotenone/ATP-mediated mtDNA release and mitochondrial depolarization are likely to be merely an indication of mitochondrial damage rather than triggering factors for NLRP3 inflammasome activation. Our results provide a molecular insight into the selective contribution made by mitochondrial dysfunction to the NLRP3 inflammasome pathway.	[Won, Ji-Hee; Park, Sangjun; Hong, Sujeong; Son, Seunghwan; Yu, Je-Wook] Yonsei Univ, Coll Med, Dept Microbiol, Inst Immunol & Immunol Dis,Brain Korea PLUS Proje, Seoul 120752, South Korea	Yonsei University; Yonsei University Health System	Yu, JW (corresponding author), Yonsei Univ, Coll Med, Dept Microbiol, Inst Immunol & Immunol Dis,Brain Korea PLUS Proje, 50-1 Yonsei Ro, Seoul 120752, South Korea.	Jewookyu@yuhs.ac		Yu, Je-Wook/0000-0001-5943-4071; Son, Seunghwan/0000-0003-2408-2613	National Research Foundation of Korea - Korean Government [2012R1A1A2041532, 2013R1A2A2A01067985, 2014R1A4A1008625]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by National Research Foundation of Korea Grants 2012R1A1A2041532, 2013R1A2A2A01067985, and 2014R1A4A1008625, funded by the Korean Government. The authors declare that they have no conflicts of interest with the contents of this article.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Chan Katie, 2005, Expert Opin Drug Metab Toxicol, V1, P655, DOI 10.1517/17425255.1.4.655; Choi WS, 2011, J CELL BIOL, V192, P873, DOI 10.1083/jcb.201009132; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ghonime MG, 2014, J IMMUNOL, V192, P3881, DOI 10.4049/jimmunol.1301974; Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008; Haines BA, 2010, J CEREBR BLOOD F MET, V30, P1825, DOI 10.1038/jcbfm.2010.52; Henao-Mejia J, 2014, ANNU REV PHYSIOL, V76, P57, DOI 10.1146/annurev-physiol-021113-170324; Hwang I, 2015, IMMUNOL CELL BIOL, V93, P591, DOI 10.1038/icb.2014.125; Ichinohe T, 2013, P NATL ACAD SCI USA, V110, P17963, DOI 10.1073/pnas.1312571110; Iijima T, 2003, BRAIN RES, V993, P140, DOI 10.1016/j.brainres.2003.09.041; Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Park S, 2013, J IMMUNOL, V191, P4358, DOI 10.4049/jimmunol.1301170; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6; Schon EA, 2012, NAT REV GENET, V13, P878, DOI 10.1038/nrg3275; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; THOR H, 1982, J BIOL CHEM, V257, P2419; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Wen HT, 2013, IMMUNITY, V39, P432, DOI 10.1016/j.immuni.2013.08.037; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Yu AK, 2015, HUM MOL GENET, V24, P2848, DOI 10.1093/hmg/ddv045; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	34	71	72	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27425	27437		10.1074/jbc.M115.667063	http://dx.doi.org/10.1074/jbc.M115.667063			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26416893	hybrid, Green Published			2022-12-28	WOS:000364794000048
J	Ebrahimi, KH; Hagedoorn, PL; Hagen, WR				Ebrahimi, Kourosh Honarmand; Hagedoorn, Peter-Leon; Hagen, Wilfred R.			Self-assembly Is Prerequisite for Catalysis of Fe(II) Oxidation by Catalytically Active Subunits of Ferritin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN H-CHAIN; 4-ALPHA-HELIX BUNDLE PROTEIN; IRON-CORE FORMATION; FERROXIDASE CENTER; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; BINDING SITES; ION CHANNELS; MECHANISM; BACTERIOFERRITIN	Fe(III) storage by ferritin is an essential process of the iron homeostasis machinery. It begins by translocation of Fe(II) from outside the hollow spherical shape structure of the protein, which is formed as the result of self-assembly of 24 subunits, to a di-iron binding site, the ferroxidase center, buried in the middle of each active subunit. The pathway of Fe(II) to the ferroxidase center has remained elusive, and the importance of self-assembly for the functioning of the ferroxidase center has not been investigated. Here we report spectroscopic and metal ion binding studies with a mutant of ferritin from Pyrococcus furiosus (PfFtn) in which self-assembly was abolished by a single amino acid substitution. Weshow that in this mutant metal ion binding to the ferroxidase center and Fe(II) oxidation at this site was obliterated. However, metal ion binding to a conserved third site (site C), which is located in the inner surface of each subunit in the vicinity of the ferroxidase center and is believed to be the path for Fe(II) to the ferroxidase center, was not disrupted. These results are the basis of a new model for Fe(II) translocation to the ferroxidase center: self-assembly creates channels that guide the Fe(II) ions toward the ferroxidase center directly through the protein shell and not via the internal cavity and site C. The results may be of significance for understanding the molecular basis of ferritin-related disorders such as neuroferritinopathy in which the 24-meric structure with 432 symmetry is distorted.	[Ebrahimi, Kourosh Honarmand; Hagedoorn, Peter-Leon; Hagen, Wilfred R.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands	Delft University of Technology	Ebrahimi, KH (corresponding author), Delft Univ Technol, Dept Biotechnol, Julianalaan 67, NL-2628 BC Delft, Netherlands.	k.h.ebrahimi@tudelft.nl; w.r.hagen@tudelft.nl	Ebrahimi, Kourosh Honarmand/X-4579-2019; Hagedoorn, Peter-Leon/C-8535-2014; Hagen, Wilfred R./H-8918-2017	Ebrahimi, Kourosh Honarmand/0000-0001-6628-944X; Hagedoorn, Peter-Leon/0000-0001-6342-2022; Hagen, Wilfred R./0000-0002-1609-6671				AROSIO P, 1978, J BIOL CHEM, V253, P4451; Arosio P, 2002, FREE RADICAL BIO MED, V33, P457, DOI 10.1016/S0891-5849(02)00842-0; Behera RK, 2015, J BIOL INORG CHEM, V20, P957, DOI 10.1007/s00775-015-1279-x; Behera RK, 2014, P NATL ACAD SCI USA, V111, P7925, DOI 10.1073/pnas.1318417111; Bou-Abdallah F, 2014, BIOCHEMISTRY-US, V53, P483, DOI 10.1021/bi401517f; Bou-Abdallah F, 2003, J BIOL INORG CHEM, V8, P489, DOI 10.1007/s00775-003-0455-6; Bou-Abdallah F, 2002, BIOCHEMISTRY-US, V41, P11184, DOI 10.1021/bi020215g; Bou-Abdallah F, 2008, J AM CHEM SOC, V130, P17801, DOI 10.1021/ja8054035; BOYD D, 1985, J BIOL CHEM, V260, P1755; Brask J, 2001, BIOORG MED CHEM LETT, V11, P697, DOI 10.1016/S0960-894X(01)00035-X; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Cohen B, 2005, NEOPLASIA, V7, P109, DOI 10.1593/neo.04436; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; DICKEY LF, 1987, J BIOL CHEM, V262, P7901; Douglas T, 1998, PROTEIN SCI, V7, P1083, DOI 10.1002/pro.5560070502; DOUGLAS T, 1995, SCIENCE, V269, P54, DOI 10.1126/science.269.5220.54; Ebrahimi KH, 2015, CHEM REV, V115, P295, DOI 10.1021/cr5004908; Ebrahimi KH, 2013, CHEMBIOCHEM, V14, P1123, DOI 10.1002/cbic.201300149; Ebrahimi KH, 2012, NAT CHEM BIOL, V8, P941, DOI [10.1038/NCHEMBIO.1071, 10.1038/nchembio.1071]; Ebrahimi KH, 2012, J BIOL INORG CHEM, V17, P975, DOI 10.1007/s00775-012-0913-0; Ebrahimi KH, 2010, J BIOL INORG CHEM, V15, P1243, DOI 10.1007/s00775-010-0682-6; Ebrahimi KH, 2009, J BIOL INORG CHEM, V14, P1265, DOI 10.1007/s00775-009-0571-z; Giorgi A, 2008, ARCH BIOCHEM BIOPHYS, V478, P69, DOI 10.1016/j.abb.2008.06.022; GRANICK S, 1946, CHEM REV, V38, P379, DOI 10.1021/cr60121a001; Ha Y, 1999, J BIOL INORG CHEM, V4, P243, DOI 10.1007/s007750050310; Hem LH, 2003, BIOTECHNOL PROGR, V19, P544, DOI 10.1021/bp0256059; Hosein HA, 2004, LANGMUIR, V20, P10283, DOI 10.1021/la0491100; Jutz G, 2015, CHEM REV, V115, P1653, DOI 10.1021/cr400011b; Kanbak-Aksu S, 2012, CHEM COMMUN, V48, P5745, DOI 10.1039/c2cc31401k; Keyes JD, 2011, J NANOPART RES, V13, P2563, DOI 10.1007/s11051-010-0149-2; Laghaei R, 2013, PROTEINS, V81, P1042, DOI 10.1002/prot.24251; Lee HY, 2006, J AM CHEM SOC, V128, P337, DOI 10.1021/ja0563410; Lee KH, 2004, BIOCHEMISTRY-US, V43, P16277, DOI 10.1021/bi049086p; LEVI S, 1993, FEBS LETT, V336, P309, DOI 10.1016/0014-5793(93)80826-G; LEVI S, 1988, J BIOL CHEM, V263, P18086; Liu HL, 2004, FEBS LETT, V573, P93, DOI 10.1016/j.febslet.2004.07.054; Luscieti S, 2010, J BIOL CHEM, V285, P11948, DOI 10.1074/jbc.M109.096404; OSTERHOUT JJ, 1992, J AM CHEM SOC, V114, P331, DOI 10.1021/ja00027a043; Pfaffen S, 2013, J BIOL CHEM, V288, P14917, DOI 10.1074/jbc.M113.454496; Pozzi C, 2015, ACTA CRYSTALLOGR D, V71, P941, DOI 10.1107/S1399004715002333; Rouault TA, 2001, NAT GENET, V28, P299, DOI 10.1038/91036; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; STEIF C, 1993, BIOCHEMISTRY-US, V32, P3867, DOI 10.1021/bi00066a005; Tatur J, 2007, J BIOL INORG CHEM, V12, P615, DOI 10.1007/s00775-007-0212-3; Treffry A, 1998, J BIOL INORG CHEM, V3, P682, DOI 10.1007/s007750050282; Treffry A, 1998, FEBS LETT, V432, P213, DOI 10.1016/S0014-5793(98)00867-9; TREFFRY A, 1995, BIOCHEMISTRY-US, V34, P15204, DOI 10.1021/bi00046a028; Uchida M, 2010, BBA-GEN SUBJECTS, V1800, P834, DOI 10.1016/j.bbagen.2009.12.005; Ueno T, 2004, ANGEW CHEM INT EDIT, V43, P2527, DOI 10.1002/anie.200353436; Watt RK, 2013, CHEMBIOCHEM, V14, P415, DOI 10.1002/cbic.201200783; Watt RK, 2011, BIOMETALS, V24, P489, DOI 10.1007/s10534-011-9415-8; Weeratunga SK, 2010, BIOCHEMISTRY-US, V49, P1160, DOI 10.1021/bi9015204; Wong SG, 2015, J BIOL CHEM, V290, P3732, DOI 10.1074/jbc.M114.623082; Yao HL, 2015, BIOCHEMISTRY-US, V54, P1611, DOI 10.1021/bi501255r; Yevenes AE, 2011, BIOCHIMIE, V93, P352, DOI 10.1016/j.biochi.2010.10.008	55	10	10	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26801	26810		10.1074/jbc.M115.678375	http://dx.doi.org/10.1074/jbc.M115.678375			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370076	Green Published, hybrid			2022-12-28	WOS:000364793600042
J	Mahanic, CS; Budhavarapu, V; Graves, JD; Li, G; Lin, WC				Mahanic, Christina S.; Budhavarapu, Varija; Graves, Joshua D.; Li, Gang; Lin, Weei-Chin			Regulation of E2 Promoter Binding Factor 1 (E2F1) Transcriptional Activity through a Deubiquitinating Enzyme, UCH37	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL HYDROLASE 37; FAMILY-MEMBERS; CANCER-THERAPY; DNA-DAMAGE; PROTEASOME; P53; APOPTOSIS; ROLES; DISTINCT; TOPBP1	E2F1 is tightly controlled by multiple mechanisms, but whether ubiquitination regulates its transcriptional activity remains unknown. Here we identify UCH37 as the first, to our knowledge, deubiquitinating enzyme for E2F1. UCH37 does not deubiquitinate UbK48 chains or affect E2F1 protein stability. Instead, UCH37, but not a catalytically dead mutant, decreases the Lys-63-linked ubiquitination of E2F1 and activates its transcriptional activity. UCH37 depletion reduces the gene expression of both proliferative and pro-apoptotic E2F1 target genes. UCH37 depletion also decreases both cell proliferation and apoptosis induction in functional assays. Interestingly, UCH37 expression is induced by E2F1, and its level rises in G(1)/S transition and S phase, suggesting a positive feedback loop between UCH37 and E2F1. UCH37 protein and mRNA levels are also induced after DNA damage. UCH37 localizes to the promoters of E2F1 pro-apoptotic target genes such as caspase 3, caspase 7, PARP1, and Apaf-1 and activates their expression after DNA damage. Moreover, the expression of E2F1 proliferative and pro-apoptotic genes is correlated with the levels of UCH37 in many primary tumors. These results uncover a novel mechanism for E2F1 transcriptional activation through removal of its Lys-63-linked ubiquitination by UCH37.	[Mahanic, Christina S.; Budhavarapu, Varija; Graves, Joshua D.; Li, Gang; Lin, Weei-Chin] Baylor Coll Med, Dept Med, Hematol Oncol Sect, Houston, TX 77030 USA; [Mahanic, Christina S.; Budhavarapu, Varija; Graves, Joshua D.; Li, Gang; Lin, Weei-Chin] Baylor Coll Med, Dept Mol & Cellular Biol, Hematol Oncol Sect, Houston, TX 77030 USA; [Mahanic, Christina S.; Graves, Joshua D.; Lin, Weei-Chin] Baylor Coll Med, Dept Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Mahanic, Christina S.; Graves, Joshua D.; Lin, Weei-Chin] Baylor Coll Med, Dept Mol & Cellular Biol, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lin, WC (corresponding author), 1 Baylor Pl,MS BCM187, Houston, TX 77030 USA.	weeichil@bcm.edu	Li, Gang/H-5714-2015; Regan, Clinton/E-6250-2012		National Institutes of Health [AI036211, CA125123, RR024574]; NATIONAL CANCER INSTITUTE [P30CA125123, R01CA138641, R01CA100857] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Joan Conaway, Chittaranjan Das, Dong-Er Zhang, and Ze'ev Ronai for plasmids and members of the W. C. L. and Fang-Tsyr (Fannie) Lin laboratories for discussions. We also thank the Cytometry and Cell Sorting Core at Baylor College of Medicine (with funding from the National Institutes of Health (AI036211, CA125123, and RR024574) and Joel M. Sederstrom for assistance.	Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Budhavarapu VN, 2012, CELL CYCLE, V11, P2030, DOI 10.4161/cc.20643; Cao AR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217158; Chen ZW, 2011, CELL BIOCHEM FUNCT, V29, P142, DOI 10.1002/cbf.1734; Chowdhury P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6476; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; DeGregori J, 2006, CURR MOL MED, V6, P739; Fang Y, 2013, BBA-MOL CELL RES, V1833, P559, DOI 10.1016/j.bbamcr.2012.11.020; Fang Y, 2010, BBA-REV CANCER, V1806, P1, DOI 10.1016/j.bbcan.2010.03.001; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Laine A, 2006, MOL CELL BIOL, V26, P8901, DOI 10.1128/MCB.01156-06; Lin WC, 2001, GENE DEV, V15, P1833; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Moroni MC, 2001, NAT CELL BIOL, V3, P552, DOI 10.1038/35078527; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nishi R, 2014, NAT CELL BIOL, V16, P1016, DOI 10.1038/ncb3028; Paik JC, 2010, J BIOL CHEM, V285, P6348, DOI 10.1074/jbc.M109.072074; Peart MJ, 2010, CELL CYCLE, V9, P3956, DOI 10.4161/cc.9.19.13162; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Roworth AP, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970480; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Wicks SJ, 2005, ONCOGENE, V24, P8080, DOI 10.1038/sj.onc.1208944; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460	33	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26508	26522		10.1074/jbc.M115.659425	http://dx.doi.org/10.1074/jbc.M115.659425			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26396186	Green Published, hybrid			2022-12-28	WOS:000364793600019
J	Nguyen, Y; Harvey, H; Sugiman-Marangos, S; Bell, SD; Buensuceso, RNC; Junop, MS; Burrows, LL				Nguyen, Ylan; Harvey, Hanjeong; Sugiman-Marangos, Seiji; Bell, Stephanie D.; Buensuceso, Ryan N. C.; Junop, Murray S.; Burrows, Lori L.			Structural and Functional Studies of the Pseudomonas aeruginosa Mninor Pilin, PilE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN-COREGULATED PILUS; IV PILI; NEISSERIA-MENINGITIDIS; II SECRETION; MINOR PILINS; AMINO-ACID; PROTEIN-SECRETION; GONORRHOEAE; PREPILIN; REVEALS	Many bacterial pathogens, including Pseudomonas aeruginosa, use type IVa pili (T4aP) for attachment and twitching motility. T4aP are composed primarily of major pilin subunits, which are repeatedly assembled and disassembled to mediate function. A group of pilin-like proteins, the minor pilins FimU and PilVWXE, prime pilus assembly and are incorporated into the pilus. We showed previously that minor pilin PilE depends on the putative priming subcomplex PilVWX and the non-pilin protein PilY1 for incorporation into pili, and that with FimU, PilE may couple the priming subcomplex to the major pilin PilA, allowing for efficient pilus assembly. Here we provide further support for this model, showing interaction of PilE with other minor pilins and the major pilin. A 1.25 angstrom crystal structure of PilE(Delta 1-28) shows a typical type IV pilin fold, demonstrating how it may be incorporated into the pilus. Despite limited sequence identity, PilE is structurally similar to Neisseria meningitidis minor pilins PilX(Nm) and PilV(Nm), recently suggested via characterization of mCherry fusions to modulate pilus assembly from within the periplasm. A P. aeruginosa PilE-mCherry fusion failed to complement twitching motility or piliation of a pilE mutant. However, in a retraction-deficient strain where surface piliation depends solely on PilE, the fusion construct restored some surface piliation. PilE-mCherry was present in sheared surface fractions, suggesting that it was incorporated into pili. Together, these data provide evidence that PilE, the sole P. aeruginosa equivalent of PilX(Nm) and PilV(Nm), likely connects a priming subcomplex to the major pilin, promoting efficient assembly of T4aP.	[Nguyen, Ylan; Harvey, Hanjeong; Sugiman-Marangos, Seiji; Bell, Stephanie D.; Buensuceso, Ryan N. C.; Burrows, Lori L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4K1, Canada; [Nguyen, Ylan; Harvey, Hanjeong; Sugiman-Marangos, Seiji; Bell, Stephanie D.; Buensuceso, Ryan N. C.; Burrows, Lori L.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4K1, Canada; [Junop, Murray S.] Western Univ, Dept Biochem, London, ON N6A 3K7, Canada	McMaster University; McMaster University; Western University (University of Western Ontario)	Burrows, LL (corresponding author), 4H18 Hlth Sci Ctr, 1200 Main St West, Hamilton, ON L8N 3Z5, Canada.	burrowl@mcmaster.ca	Junop, Murray S/E-4160-2015	Junop, Murray S/0000-0001-6676-5717; Sugiman-Marangos, Seiji/0000-0002-8475-5456	Canadian Institutes of Health Research (CIHR) [MOP 86639, MOP 89903]; Cystic Fibrosis Canada; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grants MOP 86639 (to L. L. B.) and MOP 89903 (to M. S. J.). This work was also supported by a Graduate Studentship from Cystic Fibrosis Canada and a Banting Scholarship from the CIHR (to Y. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albers SV, 2009, EXTREMOPHILES, V13, P403, DOI 10.1007/s00792-009-0241-7; Asikyan ML, 2008, J BACTERIOL, V190, P7022, DOI 10.1128/JB.00938-08; Ayers M, 2010, FUTURE MICROBIOL, V5, P1203, DOI 10.2217/FMB.10.76; Belete B, 2008, J BACTERIOL, V190, P2023, DOI 10.1128/JB.01623-07; Brown DR, 2010, INFECT IMMUN, V78, P3053, DOI 10.1128/IAI.00099-10; Cehovin A, 2013, P NATL ACAD SCI USA, V110, P3065, DOI 10.1073/pnas.1218832110; Cisneros DA, 2012, MOL MICROBIOL, V86, P805, DOI 10.1111/mmi.12033; Cisneros DA, 2012, EMBO J, V31, P1041, DOI 10.1038/emboj.2011.454; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Giltner CL, 2011, ENVIRON MICROBIOL, V13, P250, DOI 10.1111/j.1462-2920.2010.02327.x; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; Hartung S, 2011, J BIOL CHEM, V286, P44254, DOI 10.1074/jbc.M111.297242; Harvey H, 2009, J BACTERIOL, V191, P6513, DOI 10.1128/JB.00943-09; Helaine S, 2005, MOL MICROBIOL, V55, P65, DOI 10.1111/j.1365-2958.2004.04372.x; Helaine S, 2007, P NATL ACAD SCI USA, V104, P15888, DOI 10.1073/pnas.0707581104; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Imhaus AF, 2014, EMBO J, V33, P1767, DOI 10.15252/embj.201488031; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; JONSSON AB, 1992, P NATL ACAD SCI USA, V89, P3204, DOI 10.1073/pnas.89.8.3204; Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Li J, 2008, STRUCTURE, V16, P137, DOI 10.1016/j.str.2007.10.027; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morand PC, 2001, MOL MICROBIOL, V40, P846, DOI 10.1046/j.1365-2958.2001.02452.x; Otwinowski Z, 1997, METHODS ENZYMOL, V276, P307; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; RUSSELL MA, 1994, MOL MICROBIOL, V13, P973, DOI 10.1111/j.1365-2958.1994.tb00489.x; SASTRY PA, 1985, J BACTERIOL, V164, P571, DOI 10.1128/JB.164.2.571-577.1985; Siryaporn A, 2014, P NATL ACAD SCI USA, V111, P16860, DOI 10.1073/pnas.1415712111; STROM MS, 1991, J BIOL CHEM, V266, P1656; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06; Takahashi H, 2012, INFECT IMMUN, V80, P4154, DOI 10.1128/IAI.00423-12; Winther-Larsen HC, 2005, MOL MICROBIOL, V56, P903, DOI 10.1111/j.1365-2958.2005.04591.x; Winther-Larsen HC, 2001, P NATL ACAD SCI USA, V98, P15276, DOI 10.1073/pnas.261574998; Wolfgang M, 1999, MOL MICROBIOL, V31, P1345, DOI 10.1046/j.1365-2958.1999.01269.x	48	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26856	26865		10.1074/jbc.M115.683334	http://dx.doi.org/10.1074/jbc.M115.683334			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26359492	Green Published, hybrid			2022-12-28	WOS:000364793600047
J	Cahill, TJ; Leo, V; Kelly, M; Stockenhuber, A; Kennedy, NW; Bao, LY; Cereghetti, G; Harper, AR; Czibik, G; Lao, CY; Bellahcene, M; Steeples, V; Ghaffari, S; Yavari, A; Mayer, A; Poulton, J; Ferguson, DJP; Scorrano, L; Hettiarachchi, NT; Peers, C; Boyle, J; Hill, RB; Simmons, A; Watkins, H; Dear, TN; Ashrafian, H				Cahill, Thomas J.; Leo, Vincenzo; Kelly, Matthew; Stockenhuber, Alexander; Kennedy, Nolan W.; Bao, Leyuan; Cereghetti, Grazia; Harper, Andrew R.; Czibik, Gabor; Lao, Chunyan; Bellahcene, Mohamed; Steeples, Violetta; Ghaffari, Safar; Yavari, Arash; Mayer, Alice; Poulton, Joanna; Ferguson, David J. P.; Scorrano, Luca; Hettiarachchi, Nishani T.; Peers, Chris; Boyle, John; Hill, R. Blake; Simmons, Alison; Watkins, Hugh; Dear, T. Neil; Ashrafian, Houman			Resistance of Dynamin-related Protein 1 Oligomers to Disassembly Impairs Mitophagy, Resulting in Myocardial Inflammation and Heart Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL FISSION; AUTOPHAGY; DRP1; FUSION; PROTECTS; STRESS; CELLS; ELIMINATION; DEGRADATION; ACTIVATION	We have reported previously that a missense mutation in the mitochondrial fission gene Dynamin-related protein 1 (Drp1) underlies the Python mouse model of monogenic dilated cardiomyopathy. The aim of this study was to investigate the consequences of the C452F mutation on Drp1 protein function and to define the cellular sequelae leading to heart failure in the Python monogenic dilated cardiomyopathy model. We found that the C452F mutation increased Drp1 GTPase activity. The mutation also conferred resistance to oligomer disassembly by guanine nucleotides and high ionic strength solutions. In a mouse embryonic fibroblast model, Drp1 C452F cells exhibited abnormal mitochondrial morphology and defective mitophagy. Mitochondria in C452F mouse embryonic fibroblasts were depolarized and had reduced calcium uptake with impaired ATP production by oxidative phosphorylation. In the Python heart, we found a corresponding progressive decline in oxidative phosphorylation with age and activation of sterile inflammation. As a corollary, enhancing autophagy by exposure to a prolonged low-protein diet improved cardiac function in Python mice. In conclusion, failure of Drp1 disassembly impairs mitophagy, leading to a downstream cascade of mitochondrial depolarization, aberrant calcium handling, impaired ATP synthesis, and activation of sterile myocardial inflammation, resulting in heart failure.	[Cahill, Thomas J.; Kelly, Matthew; Stockenhuber, Alexander; Harper, Andrew R.; Czibik, Gabor; Bellahcene, Mohamed; Steeples, Violetta; Ghaffari, Safar; Yavari, Arash; Watkins, Hugh] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, Oxford OX3 9DU, England; [Ferguson, David J. P.] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford OX3 9DU, England; [Ashrafian, Houman] Univ Oxford, Radcliffe Dept Med, Expt Therapeut, Oxford OX3 9DU, England; [Bao, Leyuan; Mayer, Alice; Simmons, Alison] Univ Oxford, Nuffield Dept Med, Weatherall Inst Mol Med, Oxford OX3 9DU, England; [Lao, Chunyan; Poulton, Joanna] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England; [Leo, Vincenzo; Dear, T. Neil] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Kennedy, Nolan W.; Hill, R. Blake] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Cereghetti, Grazia; Scorrano, Luca] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Hettiarachchi, Nishani T.; Peers, Chris; Boyle, John] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Div Cardiovasc & Diabet Res, Leeds LS2 9JT, W Yorkshire, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford; Saint James's University Hospital; University of Leeds; Medical College of Wisconsin; University of Geneva; University of Leeds	Ashrafian, H (corresponding author), Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Expt Therapeut, Oxford OX3 9DU, England.	houman.ashrafian@cardiov.ox.ac.uk	Harper, Andrew/B-7044-2017; Regan, Clinton/E-6250-2012; Czibik, Gabor/U-9295-2018; Poulton, Joanna/I-3913-2016; Poulton, Joanna/AAB-4828-2021; Scorrano, Luca/A-6652-2008	Harper, Andrew/0000-0001-5327-0328; Czibik, Gabor/0000-0002-4914-6794; Scorrano, Luca/0000-0002-8515-8928; Kennedy, Nolan/0000-0002-2944-5439; Ashrafian, Houman/0000-0003-3988-378X; Cahill, Thomas/0000-0003-4318-5618; Peers, Chris/0000-0002-8354-346X; Mayer, Alice/0000-0002-6859-0612; Stockenhuber, Alexander/0000-0002-5523-6673; Hill, Blake/0000-0001-6228-3905; Poulton, Joanna/0000-0002-2460-5587	National Institutes for Health Research Academic Clinical Fellowship; Medical Research Council [MR/J010448/1]; Wellcome Trust [0948685/Z/10/Z]; National Institutes of Health [R01-GM067180]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067180] Funding Source: NIH RePORTER; British Heart Foundation [RG/12/16/29939] Funding Source: researchfish; Medical Research Council [MC_UU_12010/7] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-R3-12-026] Funding Source: researchfish; MRC [MC_UU_12010/7, MR/J010448/1] Funding Source: UKRI	National Institutes for Health Research Academic Clinical Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a National Institutes for Health Research Academic Clinical Fellowship.; Supported by Medical Research Council Project Grant MR/J010448/1 and Wellcome Trust Project Grant 0948685/Z/10/Z.; Supported by National Institutes of Health Grant R01-GM067180.	Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Ashrafian H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001000; Beraud N, 2009, J BIOENERG BIOMEMBR, V41, P195, DOI 10.1007/s10863-009-9214-x; Cahill TJ, 2013, CIRC RES, V113, P660, DOI 10.1161/CIRCRESAHA.113.300282; Carley AN, 2014, CIRC RES, V114, P717, DOI 10.1161/CIRCRESAHA.114.301863; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Cloonan SM, 2013, CURR OPIN MICROBIOL, V16, P327, DOI 10.1016/j.mib.2013.05.005; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Disatnik MH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000461; Dorn GW, 2015, CIRC RES, V116, P225, DOI 10.1161/CIRCRESAHA.114.305672; Dorn GW, 2013, BBA-MOL CELL RES, V1833, P233, DOI 10.1016/j.bbamcr.2012.03.008; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Hom J, 2010, BBA-BIOENERGETICS, V1797, P913, DOI 10.1016/j.bbabio.2010.03.018; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; James NG, 2014, BBA-GEN SUBJECTS, V1840, P315, DOI 10.1016/j.bbagen.2013.09.001; Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658; Kanamori H, 2009, AM J PATHOL, V174, P1705, DOI 10.2353/ajpath.2009.080875; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Murgia M, 2009, J MOL CELL CARDIOL, V46, P781, DOI 10.1016/j.yjmcc.2009.03.003; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Redpath CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069165; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Shintani Y, 2014, EMBO REP, V15, P438, DOI 10.1002/embr.201337945; Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wang L, 2010, J BIOL CHEM, V285, P22751, DOI 10.1074/jbc.C110.130013; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zanna C, 2008, BRAIN, V131, P352, DOI 10.1093/brain/awm335; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	42	39	42	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25907	25919		10.1074/jbc.M115.665695	http://dx.doi.org/10.1074/jbc.M115.665695			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26370078	Green Published, hybrid			2022-12-28	WOS:000363527300014
J	Basta, LAB; Ghosh, A; Pan, Y; Jakoncic, J; Lloyd, EP; Townsend, CA; Lamichhane, G; Bianchet, MA				Basta, Leighanne A. Brammer; Ghosh, Anita; Pan, Ying; Jakoncic, Jean; Lloyd, Evan P.; Townsend, Craig A.; Lamichhane, Gyanu; Bianchet, Mario A.			Loss of a Functionally and Structurally Distinct LD-Transpeptidase, Ldt(Mt5), Compromises Cell Wall Integrity in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN CROSS-LINKING; CRYSTAL-STRUCTURE; BETA-LACTAMASES; L,D-TRANSPEPTIDASE; PROTEIN; MEROPENEM; RESISTANCE; IDENTIFICATION; MUTAGENESIS; INHIBITION	The final step of peptidoglycan (PG) biosynthesis in bacteria involves cross-linking of peptide side chains. This step in Mycobacterium tuberculosis is catalyzed by LD- and DD-transpeptidases that generate 3 -> 3 and 4 -> 3 transpeptide linkages, respectively. M. tuberculosis PG is predominantly 3 -> 3 cross-linked, and Ldt(Mt2) is the dominant LD-transpeptidase. There are four additional sequence paralogs of Ldt(Mt2) encoded by the genome of this pathogen, and the reason for this apparent redundancy is unknown. Here, we studied one of the paralogs, Ldt(Mt5), and found it to be structurally and functionally distinct. The structures of apo-Ldt(Mt5) and its meropenem adduct presented here demonstrate that, despite overall architectural similarity to Ldt(Mt2), the Ldt(Mt5) active site has marked differences. The presence of a structurally divergent catalytic site and a proline-rich C-terminal subdomain suggest that this protein may have a distinct role in PG metabolism, perhaps involving other cell wall-anchored proteins. Furthermore, M. tuberculosis lacking a functional copy of Ldt(Mt5) displayed aberrant growth and was more susceptible to killing by crystal violet, osmotic shock, and select carbapenem antibiotics. Therefore, we conclude that Ldt(Mt5) is not a functionally redundant LD-transpeptidase, but rather it serves a unique and important role in maintaining the integrity of the M. tuberculosis cell wall.	[Basta, Leighanne A. Brammer; Lamichhane, Gyanu] Johns Hopkins Univ, Sch Med, Taskforce Study Resistance Emergence & Antimicrob, Baltimore, MD 21231 USA; [Basta, Leighanne A. Brammer; Lamichhane, Gyanu] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21231 USA; [Ghosh, Anita; Pan, Ying; Bianchet, Mario A.] Johns Hopkins Univ, Sch Med, Struct Enzymol & Thermodynam Grp, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Bianchet, Mario A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Jakoncic, Jean] Brookhaven Natl Lab, Natl Synchrotron Light Source 2, Upton, NY 11973 USA; [Lloyd, Evan P.; Townsend, Craig A.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; United States Department of Energy (DOE); Brookhaven National Laboratory; Johns Hopkins University	Lamichhane, G (corresponding author), Johns Hopkins Univ, Sch Med, 1503 E Jefferson St, Baltimore, MD 21231 USA.	lamichhane@jhu.edu; bianchet@jhmi.edu	Ghosh, Anita/AAR-8845-2020; Bianchet, Mario a/K-2131-2015	Bianchet, Mario a/0000-0001-9032-7549; Lloyd, Evan/0000-0001-6984-7400; Lamichhane, Gyanu/0000-0002-2214-0114; Basta, Leighanne/0000-0002-4121-5505	National Institute of General Medical Sciences, National Institute of Health [GM-0080]; United States Department of Energy [DE-AC02-98CH10886]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008459] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy(United States Department of Energy (DOE)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We kindly thank Amit Kaushik for assistance with genetic experiments and Maia Schoonmaker Arnold and Mike Delanoy for assistance with electron microscopy. Research was carried out at X6A beamline funded by the National Institute of General Medical Sciences, National Institute of Health under Agreement GM-0080. The National Synchrotron Light Source, Brookhaven National Laboratory is supported by the United States Department of Energy under Contract DE-AC02-98CH10886.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Biarrotte-Sorin S, 2006, J MOL BIOL, V359, P533, DOI 10.1016/j.jmb.2006.03.014; Bielnicki J, 2006, PROTEINS, V62, P144, DOI 10.1002/prot.20702; Both D, 2013, ACTA CRYSTALLOGR D, V69, P432, DOI 10.1107/S0907444912049268; Cava F, 2011, EMBO J, V30, P3442, DOI 10.1038/emboj.2011.246; Cho H, 2014, CELL, V159, P1300, DOI 10.1016/j.cell.2014.11.017; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cordillot M, 2013, ANTIMICROB AGENTS CH, V57, P5940, DOI 10.1128/AAC.01663-13; COREY DR, 1992, J AM CHEM SOC, V114, P1784, DOI 10.1021/ja00031a037; Correale S, 2013, ACTA CRYSTALLOGR D, V69, P1697, DOI 10.1107/S0907444913013085; Cynamon MH, 1998, ANTIMICROB AGENTS CH, V42, P462; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erdemli SB, 2012, STRUCTURE, V20, P2103, DOI 10.1016/j.str.2012.09.016; Flores AR, 2005, MICROBIOL-SGM, V151, P521, DOI 10.1099/mic.0.27629-0; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; Hugonnet JE, 2007, BIOCHEMISTRY-US, V46, P11998, DOI 10.1021/bi701506h; Hugonnet JE, 2014, ANTIMICROB AGENTS CH, V58, P1749, DOI 10.1128/AAC.02329-13; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Kim HS, 2013, ACTA CRYSTALLOGR D, V69, P420, DOI 10.1107/S0907444912048998; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar P, 2012, MOL MICROBIOL, V86, P367, DOI 10.1111/j.1365-2958.2012.08199.x; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lamichhane G, 2011, MBIO, V2, DOI 10.1128/mBio.00301-10; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Lavollay M, 2011, J BACTERIOL, V193, P778, DOI 10.1128/JB.00606-10; Li WJ, 2013, CELL RES, V23, P728, DOI 10.1038/cr.2013.53; Magnet S, 2008, J BACTERIOL, V190, P4782, DOI 10.1128/JB.00025-08; Magnet S, 2007, J BACTERIOL, V189, P3927, DOI 10.1128/JB.00084-07; Magnet S, 2007, J BIOL CHEM, V282, P13151, DOI 10.1074/jbc.M610911200; Mainard JL, 2002, J BIOL CHEM, V277, P35801, DOI 10.1074/jbc.M204319200; Mainardi JL, 2005, J BIOL CHEM, V280, P38146, DOI 10.1074/jbc.M507384200; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Patru MM, 2010, J BACTERIOL, V192, P3043, DOI 10.1128/JB.00025-10; Peltier J, 2011, J BIOL CHEM, V286, P29053, DOI 10.1074/jbc.M111.259150; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PISABARRO AG, 1985, J BACTERIOL, V161, P238, DOI 10.1128/JB.161.1.238-242.1985; Sanders AN, 2014, MICROBIOL-SGM, V160, P1795, DOI 10.1099/mic.0.078980-0; Sanders AN, 2013, MICROBIOL-SGM, V159, P1842, DOI 10.1099/mic.0.069211-0; Schillinger C, 2009, BIOINFORMATICS, V25, P1632, DOI 10.1093/bioinformatics/btp264; Schoonmaker MK, 2014, J BACTERIOL, V196, P1394, DOI 10.1128/JB.01396-13; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; Walsh C., 2003, ANTIBIOTICS ACTIONS; WIETZERBIN J, 1974, BIOCHEMISTRY-US, V13, P3471, DOI 10.1021/bi00714a008; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	48	25	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25670	25685		10.1074/jbc.M115.660753	http://dx.doi.org/10.1074/jbc.M115.660753			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26304120	Green Published, hybrid			2022-12-28	WOS:000362962800039
J	Kenealey, J; Subramanian, P; Comitato, A; Bullock, J; Keehan, L; Polato, F; Hoover, D; Marigo, V; Becerra, SP				Kenealey, Jason; Subramanian, Preeti; Comitato, Antonella; Bullock, Jeanee; Keehan, Laura; Polato, Federica; Hoover, David; Marigo, Valeria; Becerra, S. Patricia			Small Retinoprotective Peptides Reveal a Receptor-binding Region on Pigment Epithelium-derived Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; PROTEIN-PROTEIN DOCKING; INDUCED CELL-DEATH; RETINAL DEGENERATION; FACTOR PEDF; CHOROIDAL NEOVASCULARIZATION; INTERPHOTORECEPTOR MATRIX; NEUROTROPHIC ACTIVITY; ROYAL-COLLEGE; SURGEONS RATS	The cytoprotective effects of pigment epithelium-derived factor (PEDF) require interactions between an as of a yet undefined region with a distinct ectodomain on the PEDF receptor (PEDFR). Here we characterized the area in PEDF that interacts with PEDF-R to promote photoreceptor survival. Molecular docking studies suggested that the ligand binding site of PEDF-R interacts with the neurotrophic region of PEDF (44-mer, positions 78-121). Binding assays demonstrated that PEDF-R bound the 44-mer peptide. Moreover, peptide P1 from the PEDF-R ectodomain had affinity for the 44-mer and a shorter fragment within it, 17-mer (positions 98-114). Single residue substitutions to alanine along the 17-mer sequence were designed and tested for binding and biological activity. Altered 17-mer[R99A] did not bind to the P1 peptide, whereas 17-mer[H105A] had higher affinity than the unmodified 17-mer. Peptides 17-mer, 17-mer[H105A], and 44-mer exhibited cytoprotective effects in cultured retina R28 cells. Intravitreal injections of these peptides and PEDF in the rd1 mouse model of retinal degeneration decreased the numbers of dying photoreceptors, 17-mer[H105A] being most effective. The blocking peptide P1 hindered their protective effects both in retina cells and in vivo. Thus, in addition to demonstrating that the region composed of positions 98-114 of PEDF contains critical residues for PEDF-R interaction that mediates survival effects, the findings reveal distinct small PEDF fragments with neurotrophic effects on photoreceptors.	[Kenealey, Jason; Subramanian, Preeti; Bullock, Jeanee; Keehan, Laura; Polato, Federica; Becerra, S. Patricia] NEI, NIH, Bethesda, MD 20892 USA; [Hoover, David] NIH, Ctr Informat Technol, Bethesda, MD 20892 USA; [Comitato, Antonella; Marigo, Valeria] Univ Modena & Reggio Emilia, Dept Life Sci, I-41125 Modena, Italy; [Bullock, Jeanee] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); Universita di Modena e Reggio Emilia; Georgetown University	Becerra, SP (corresponding author), NEI, NIH, Bethesda, MD 20892 USA.	becerrap@nei.nih.gov	Polato, Federica/Q-1803-2018; Marigo, Valeria/B-7947-2015	Marigo, Valeria/0000-0002-4428-2084; , Preeti/0000-0002-6062-6158	National Eye Institute, National Institutes of Health Intramural Research Program; Fondazione Telethon Grant [GGP06096]; E-RARE (RHORCOD); Italian Ministry Grant [20094CZ3M2]; NATIONAL EYE INSTITUTE [ZIAEY000438, ZIAEY000306] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health Intramural Research Program; Fondazione Telethon Grant(Fondazione Telethon); E-RARE (RHORCOD); Italian Ministry Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Eye Institute, National Institutes of Health Intramural Research Program (to S.P.B.). This work was also supported by Fondazione Telethon Grant GGP06096, by E-RARE 2009 (RHORCOD), and by Italian Ministry Grant 20094CZ3M2 (to V.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama G, 2012, MOL VIS, V18, P3079; Alberdi E, 1999, J BIOL CHEM, V274, P31605, DOI 10.1074/jbc.274.44.31605; Amaral J, 2010, INVEST OPHTH VIS SCI, V51, P1318, DOI 10.1167/iovs.09-4455; Aymerich MS, 2001, INVEST OPHTH VIS SCI, V42, P3287; Becerra SP, 2013, NAT REV CANCER, V13, P258, DOI 10.1038/nrc3484; Becerra SP, 2008, J BIOL CHEM, V283, P33310, DOI 10.1074/jbc.M801287200; Becerra SP, 2006, EXP EYE RES, V82, P739, DOI 10.1016/j.exer.2005.10.016; Becerra SP, 2004, EXP EYE RES, V78, P223, DOI 10.1016/j.exer.2003.10.013; BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; Bilak MM, 2002, J NEUROSCI, V22, P9378; Cao W, 1999, J NEUROSCI RES, V57, P789, DOI 10.1002/(SICI)1097-4547(19990915)57:6<789::AID-JNR4>3.3.CO;2-D; Cayouette M, 1999, NEUROBIOL DIS, V6, P523, DOI 10.1006/nbdi.1999.0263; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Craword SE, 2013, EXPERT OPIN DRUG DIS, V8, P769, DOI 10.1517/17460441.2013.794781; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Deshpande M, 2012, INT J ONCOL, V41, P219, DOI 10.3892/ijo.2012.1431; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; Gettins PGW, 2002, BIOL CHEM, V383, P1677, DOI 10.1515/BC.2002.188; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hauck SM, 2006, MOL CELL PROTEOMICS, V5, P324, DOI 10.1074/mcp.M500217-MCP200; Holekamp NM, 2002, AM J OPHTHALMOL, V134, P220, DOI 10.1016/S0002-9394(02)01549-0; Imai D, 2005, J CELL PHYSIOL, V202, P570, DOI 10.1002/jcp.20155; Marigo V, 2007, CELL CYCLE, V6, P652, DOI 10.4161/cc.6.6.4029; Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/NCHEMBIO.1359, 10.1038/nchembio.1359]; Meyer C, 2002, J BIOL CHEM, V277, P45400, DOI 10.1074/jbc.M208339200; Miyazaki M, 2003, GENE THER, V10, P1503, DOI 10.1038/sj.gt.3302028; Murakami Y, 2008, AM J PATHOL, V173, P1326, DOI 10.2353/ajpath.2008.080466; Notari L, 2005, INVEST OPHTH VIS SCI, V46, P2736, DOI 10.1167/iovs.04-1489; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Ogata N, 2004, AM J OPHTHALMOL, V137, P1129, DOI 10.1016/j.ajo.2003.11.080; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Siew N, 2000, BIOINFORMATICS, V16, P776, DOI 10.1093/bioinformatics/16.9.776; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Subramanian P, 2013, J BIOL CHEM, V288, P23928, DOI 10.1074/jbc.M113.487884; Subramanian P, 2010, ADV EXP MED BIOL, V664, P29, DOI 10.1007/978-1-4419-1399-9_4; Wang YJ, 2013, ASN NEURO, V5, DOI 10.1042/AN20130028; WU YQ, 1995, PROTEIN EXPRES PURIF, V6, P447, DOI 10.1006/prep.1995.1060	38	25	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25241	25253		10.1074/jbc.M115.645846	http://dx.doi.org/10.1074/jbc.M115.645846			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26304116	Green Published, hybrid			2022-12-28	WOS:000362962800004
J	Cuskin, F; Basle, A; Ladeveze, S; Day, AM; Gilbert, HJ; Davies, GJ; Potocki-Veronese, G; Lowe, EC				Cuskin, Fiona; Basle, Arnaud; Ladeveze, Simon; Day, Alison M.; Gilbert, Harry J.; Davies, Gideon J.; Potocki-Veronese, Gabrielle; Lowe, Elisabeth C.			The GH130 Family of Mannoside Phosphorylases Contains Glycoside Hydrolases That Target beta-1,2-Mannosidic Linkages in Candida Mannan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-O-BETA-D-MANNOSYL-D-GLUCOSE PHOSPHORYLASE; PSEUDOMONAS-CELLULOSA; RESIDUES; ALBICANS; POLYSACCHARIDES; MECHANISM; DISCOVERY; CATALYSIS; XYLANASE; BINDING	The depolymerization of complex glycans is an important biological process that is of considerable interest to environmentally relevant industries. beta-Mannose is a major component of plant structural polysaccharides and eukaryotic N-glycans. These linkages are primarily cleaved by glycoside hydrolases, although recently, a family of glycoside phosphorylases, GH130, have also been shown to target beta-1,2- and beta-1,4-mannosidic linkages. In these phosphorylases, bond cleavage was mediated by a single displacement reaction in which phosphate functions as the catalytic nucleophile. A cohort of GH130 enzymes, however, lack the conserved basic residues that bind the phosphate nucleophile, and it was proposed that these enzymes function as glycoside hydrolases. Here we show that two Bacteroides enzymes, BT3780 and BACOVA_03624, which lack the phosphate binding residues, are indeed beta-mannosidases that hydrolyze beta-1,2-mannosidic linkages through an inverting mechanism. Because the genes encoding these enzymes are located in genetic loci that orchestrate the depolymerization of yeast alpha-mannans, it is likely that the two enzymes target the beta-1,2-mannose residues that cap the glycan produced by Candida albicans. The crystal structure of BT3780 in complex with mannose bound in the -1 and +1 subsites showed that a pair of glutamates, Glu(227) and Glu(268), hydrogen bond to O-1 of alpha-mannose, and either of these residues may function as the catalytic base. The candidate catalytic acid and the other residues that interact with the active site mannose are conserved in both GH130 mannoside phosphorylases and beta-1,2-mannosidases. Functional phylogeny identified a conserved lysine, Lys(199) in BT3780, as a key specificity determinant for beta-1,2-mannosidic linkages.	[Cuskin, Fiona; Basle, Arnaud; Day, Alison M.; Gilbert, Harry J.; Lowe, Elisabeth C.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Ladeveze, Simon; Potocki-Veronese, Gabrielle] Univ Toulouse, INSA UPS INP, LISBP, F-31077 Toulouse, France; [Ladeveze, Simon; Potocki-Veronese, Gabrielle] CNRS, UMR5504, F-31400 Toulouse, France; [Ladeveze, Simon; Potocki-Veronese, Gabrielle] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England	Newcastle University - UK; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); University of York - UK	Gilbert, HJ (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	harry.gilbert@ncl.ac.uk	Veronese, Gabrielle/GTF-3473-2022; Davies, Gideon J/A-9042-2011	Davies, Gideon J/0000-0002-7343-776X; Cuskin, Fiona/0000-0003-4287-4921; Lowe, Elisabeth/0000-0001-9812-0614; Basle, Arnaud/0000-0002-4899-3086	Wellcome Trust [WT097907AIA]; Biotechnology and Biological Sciences Research Council [BB/K016393/1, BB/G016127/1]; European Research Council "Glycopoise"; BBSRC [BB/K016393/1, BB/G016127/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council "Glycopoise"; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grant WT097907AIA (to H. J. G. A. B., F. C., and E. C. L), Biotechnology and Biological Sciences Research Council Grants BB/K016393/1 (to A. M. D.) and BB/G016127/1 (to G. J. D.), and grants from the European Research Council "Glycopoise" (to G. J. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Armand S., 1995, BIOCHEMISTRY-US, V34, P15619, DOI DOI 10.1021/BI00048A003; BARRAS F, 1992, FEBS LETT, V300, P145, DOI 10.1016/0014-5793(92)80183-H; Bolam DN, 1996, BIOCHEMISTRY-US, V35, P16195, DOI 10.1021/bi961866d; Brett C. T., 1996, TOPICS PLANT FUNCTIO; Cardozo FTGS, 2013, INT J BIOL MACROMOL, V57, P265, DOI 10.1016/j.ijbiomac.2013.03.026; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiku K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114882; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Gorin P A, 1968, Adv Carbohydr Chem Biochem, V23, P367; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; Jaito N, 2014, BIOSCI BIOTECH BIOCH, V78, P263, DOI 10.1080/09168451.2014.882760; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawahara R, 2012, J BIOL CHEM, V287, P42389, DOI 10.1074/jbc.M112.390336; Kostylev M, 2011, APPL ENVIRON MICROB, V77, P6274, DOI 10.1128/AEM.05532-11; Ladeveze S, 2015, ACTA CRYSTALLOGR D, V71, P1335, DOI 10.1107/S1399004715006604; Ladeveze S, 2013, J BIOL CHEM, V288, P32370, DOI 10.1074/jbc.M113.483628; Lee JS, 2009, CARBOHYD POLYM, V78, P162, DOI 10.1016/j.carbpol.2009.04.036; LI RK, 1993, J BIOL CHEM, V268, P18293; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; McIntosh LP, 1996, BIOCHEMISTRY-US, V35, P9958, DOI 10.1021/bi9613234; MIYAKAWA Y, 1992, INFECT IMMUN, V60, P2493, DOI 10.1128/IAI.60.6.2493-2499.1992; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Nakae S, 2013, J MOL BIOL, V425, P4468, DOI 10.1016/j.jmb.2013.08.002; Neer EJ, 1996, CELL, V84, P175, DOI 10.1016/S0092-8674(00)80969-1; Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080; Nurizzo D, 2002, STRUCTURE, V10, P547, DOI 10.1016/S0969-2126(02)00742-6; Ralton JE, 2003, J BIOL CHEM, V278, P40757, DOI 10.1074/jbc.M307660200; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; SHERMAN F, 1991, METHODS ENZYMOL, V194, P3; Tailford LE, 2008, NAT CHEM BIOL, V4, P306, DOI 10.1038/nchembio.81; Thompson AJ, 2012, P NATL ACAD SCI USA, V109, P781, DOI 10.1073/pnas.1111482109; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang YL, 2008, J BIOL CHEM, V283, P31551, DOI 10.1074/jbc.M803409200	45	24	24	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25023	25033		10.1074/jbc.M115.681460	http://dx.doi.org/10.1074/jbc.M115.681460			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26286752	Green Published, hybrid			2022-12-28	WOS:000362598300031
J	Maurya, SR; Mahalakshmi, R				Maurya, Svetlana Rajkumar; Mahalakshmi, Radhakrishnan			N-helix and Cysteines Inter-regulate Human Mitochondrial VDAC-2 Function and Biochemistry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; ANTI-APOPTOTIC PROTEINS; OUTER-MEMBRANE; VOLTAGE-DEPENDENCE; STABILITY; TERMINUS; CONFORMATION; PEPTIDE; MODULATION; HYSTERESIS	Human voltage-dependent anion channel-2 (hVDAC-2) functions primarily as the crucial anti-apoptotic protein in the outer mitochondrial membrane, and additionally as a gated bidirectional metabolite transporter. The N-terminal helix (NTH), involved in voltage sensing, bears an additional 11-residue extension (NTE) only in hVDAC-2. In this study, we assign a unique role for the NTE as influencing the chaperone-independent refolding kinetics and overall thermodynamic stability of hVDAC-2. Our electrophysiology data shows that the N-helix is crucial for channel activity, whereas NTE sensitizes this isoform to voltage gating. Additionally, hVDAC-2 possesses the highest cysteine content, possibly for regulating reactive oxygen species content. We identify interdependent contributions of the N-helix and cysteines to channel function, and the measured stability in micellar environments with differing physicochemical properties. The evolutionary demand for the NTE in the presence of cysteines clearly emerges from our biochemical and functional studies, providing insight into factors that functionally demarcate hVDAC-2 from the other VDACs.	[Maurya, Svetlana Rajkumar; Mahalakshmi, Radhakrishnan] Indian Inst Sci Educ & Res, Dept Biol Sci, Mol Biophys Lab, Bhopal 462023, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Mahalakshmi, R (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Transit Campus ITI Govindpura, Bhopal 462023, India.	maha@iiserb.ac.in	Maurya, Svetlana/H-3664-2018; Mahalakshmi, Radhakrishnan/B-3143-2008	Maurya, Svetlana/0000-0002-4700-2711; Mahalakshmi, Radhakrishnan/0000-0003-1549-7550	Wellcome Trust/Department of Biotechnology India Alliance Grant [IA/I/14/1/501305]; Council of Scientific and Industrial Research, India; Wellcome Trust/Department of Biotechnology India Alliance Intermediate fellowship	Wellcome Trust/Department of Biotechnology India Alliance Grant; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Wellcome Trust/Department of Biotechnology India Alliance Intermediate fellowship	This work was supported by the Wellcome Trust/Department of Biotechnology India Alliance Grant IA/I/14/1/501305 (to R. M.). The authors declare that they have no conflict of interest with the contents of this article.; Supported by senior research fellowship from the Council of Scientific and Industrial Research, India.; Recipient of the Wellcome Trust/Department of Biotechnology India Alliance Intermediate fellowship. To whom correspondence should be addressed. Tel.: 91-755-4092318; Fax: 91-755-4092392; E-mail: maha@iiserb.ac.in.	Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Ahn VE, 2004, EMBO J, V23, P2931, DOI 10.1038/sj.emboj.7600320; Andrews BT, 2013, J PHYS CHEM LETT, V4, P180, DOI 10.1021/jz301893w; Aram L, 2010, BIOCHEM J, V427, P445, DOI 10.1042/BJ20091690; Bauer AJ, 2011, BIOCHEMISTRY-US, V50, P3408, DOI 10.1021/bi2003247; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; De Pinto V, 2008, J BIOENERG BIOMEMBR, V40, P139, DOI 10.1007/s10863-008-9140-3; De Pinto V, 2007, CHEMBIOCHEM, V8, P744, DOI 10.1002/cbic.200700009; Eddy MT, 2015, J BIOMOL NMR, V61, P299, DOI 10.1007/s10858-015-9903-1; Gattin Z, 2015, J BIOMOL NMR, V61, P311, DOI 10.1007/s10858-014-9876-5; Geula S, 2012, BIOCHEM J, V444, P475, DOI 10.1042/BJ20112079; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guardiani C, 2015, BIOCHEMISTRY-US, V54, P5646, DOI 10.1021/acs.biochem.5b00469; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Huysmans GHM, 2007, J MOL BIOL, V373, P529, DOI 10.1016/j.jmb.2007.07.072; Iyer BR, 2015, BIOCHEMISTRY-US, V54, P5712, DOI 10.1021/acs.biochem.5b00543; Kaufmann TC, 2006, BIOPHYS J, V90, P310, DOI 10.1529/biophysj.105.070193; Kozuch J, 2014, PHYS CHEM CHEM PHYS, V16, P9546, DOI 10.1039/c4cp00167b; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIU MY, 1992, J BIOENERG BIOMEMBR, V24, P41, DOI 10.1007/BF00769529; Makwana KM, 2013, PHYS CHEM CHEM PHYS, V15, P15321, DOI 10.1039/c3cp52770k; MANNELLA CA, 1990, EXPERIENTIA, V46, P137, DOI 10.1007/BF02027309; Maurya SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092183; Maurya SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087701; Maurya SR, 2013, J BIOL CHEM, V288, P25584, DOI 10.1074/jbc.M113.493692; Mertins B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047938; Messina A, 2012, BBA-BIOMEMBRANES, V1818, P1466, DOI 10.1016/j.bbamem.2011.10.005; Minetti CASA, 2006, ARCH BIOCHEM BIOPHYS, V453, P32, DOI 10.1016/j.abb.2006.03.023; Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110; Moon CP, 2011, J MOL BIOL, V413, P484, DOI 10.1016/j.jmb.2011.08.041; Oliver RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062488; PENG S, 1992, BIOPHYS J, V62, P123, DOI 10.1016/S0006-3495(92)81799-X; Pocanschi CL, 2013, EUR BIOPHYS J BIOPHY, V42, P103, DOI 10.1007/s00249-013-0887-z; Popp B, 1996, J BIOL CHEM, V271, P13593, DOI 10.1074/jbc.271.23.13593; Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007; Reina S, 2013, BBA-BIOENERGETICS, V1827, P793, DOI 10.1016/j.bbabio.2013.03.007; Reina S, 2010, FEBS LETT, V584, P2837, DOI 10.1016/j.febslet.2010.04.066; Renault TT, 2015, MOL CELL, V57, P69, DOI 10.1016/j.molcel.2014.10.028; REYMANN S, 1995, BIOCHEM MOL MED, V54, P75, DOI 10.1006/bmme.1995.1011; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schneider R, 2010, ANGEW CHEM INT EDIT, V49, P1882, DOI 10.1002/anie.200906241; Schredelseker J, 2014, J BIOL CHEM, V289, P12566, DOI 10.1074/jbc.M113.497438; Shoshan-Barmatz V, 2015, BBA-BIOMEMBRANES, V1848, P2547, DOI 10.1016/j.bbamem.2014.10.040; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song JM, 1998, J BIOL CHEM, V273, P24406, DOI 10.1074/jbc.273.38.24406; STANLEY S, 1995, J BIOL CHEM, V270, P16694, DOI 10.1074/jbc.270.28.16694; Teijido O, 2014, J BIOL CHEM, V289, P23670, DOI 10.1074/jbc.M114.576314; Teijido O, 2012, J BIOL CHEM, V287, P11437, DOI 10.1074/jbc.M111.314229; Tewari D, 2015, BBA-BIOMEMBRANES, V1848, P151, DOI 10.1016/j.bbamem.2014.10.014; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Wimley WC, 2004, J MOL BIOL, V342, P703, DOI 10.1016/j.jmb.2004.06.093; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Zachariae U, 2012, STRUCTURE, V20, P1540, DOI 10.1016/j.str.2012.06.015; ZIMMERBERG J, 1986, NATURE, V323, P36, DOI 10.1038/323036a0	60	23	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30240	+		10.1074/jbc.M115.693978	http://dx.doi.org/10.1074/jbc.M115.693978			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26487717	Green Published, hybrid			2022-12-28	WOS:000366738200004
J	Cheng, D; Zhao, YJ; Wang, SW; Jia, WW; Kang, JH; Zhu, JY				Cheng, De; Zhao, Yuanjun; Wang, Shuwen; Jia, Wenwen; Kang, Jiuhong; Zhu, Jiyue			Human Telomerase Reverse Transcriptase (hTERT) Transcription Requires Sp1/Sp3 Binding to the Promoter and a Permissive Chromatin Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC; HISTONE DEACETYLASE; IMMORTAL CELLS; GENE; ACTIVATION; REPRESSION; CANCER; SP1; ROLES; DNA	The transcription of human telomerase gene hTERT is regulated by transcription factors (TFs), including Sp1 family proteins, and its chromatin environment. To understand its regulation in a relevant chromatin context, we employed bacterial artificial chromosome reporters containing 160 kb of human genomic sequence containing the hTERT gene. Upon chromosomal integration, the bacterial artificial chromosomes recapitulated endogenous hTERT expression, contrary to transient reporters. Sp1/Sp3 expression did not correlate with hTERT promoter activity, and these TFs bound to the hTERT promoters in both telomerase-positive and telomerase-negative cells. Mutation of the proximal GC-box resulted in a dramatic decrease of hTERT promoter activity, and mutations of all five GC-boxes eliminated its transcriptional activity. Neither mutations of GC-boxes nor knockdown of endogenous Sp1 impacted promoter binding by other TFs, including E-box-binding proteins, and histone acetylation and trimethylation of histone H3K9 at the hTERT promoter in telomerase-positive and -negative cells. The result indicated that promoter binding by Sp1/Sp3 was essential, but not a limiting step, for hTERT transcription. hTERT transcription required a permissive chromatin environment. Importantly, our data also revealed different functions of GC-boxes and E-boxes in hTERT-regulation; although GC-boxes were essential for promoter activity, factors bound to the E-boxes functioned to de-repress hTERT promoter.	[Cheng, De; Wang, Shuwen; Zhu, Jiyue] Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, Spokane, WA 99210 USA; [Zhao, Yuanjun; Zhu, Jiyue] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Jia, Wenwen; Kang, Jiuhong] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Washington State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Tongji University	Zhu, JY (corresponding author), Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, POB 1495, Spokane, WA 99210 USA.	jiyue.zhu@wsu.edu	zhu, ji/HDM-1538-2022; Regan, Clinton/E-6250-2012		National Institutes of Health [R01GM071725]; National Science Foundation of China [31210103905]; Health Sciences and Services Authority (HSSA) of Spokane County; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071725] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Sciences and Services Authority (HSSA) of Spokane County; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01GM071725 (to J. Z.), National Science Foundation of China Grant 31210103905 (to J. K.), and Health Sciences and Services Authority (HSSA) of Spokane County. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Aisner DL, 2002, CURR OPIN GENET DEV, V12, P80, DOI 10.1016/S0959-437X(01)00268-4; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; Blasco MA, 1996, NAT GENET, V12, P200, DOI 10.1038/ng0296-200; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Davie JR, 2008, ADV ENZYME REGUL, V48, P189, DOI 10.1016/j.advenzreg.2007.11.016; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Ducrest AL, 2001, CANCER RES, V61, P7594; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; Hebbar PB, 2008, J BIOL CHEM, V283, P4595, DOI 10.1074/jbc.M709121200; Hodny Z, 2000, BIOCHEM J, V346, P93, DOI 10.1042/0264-6021:3460093; Horikawa I, 2002, MOL BIOL CELL, V13, P2585, DOI 10.1091/mbc.E01-11-0107; Horikawa L, 2005, P NATL ACAD SCI USA, V102, P18437, DOI 10.1073/pnas.0508964102; JEONG SW, 1994, NUCLEIC ACIDS RES, V22, P370, DOI 10.1093/nar/22.3.370; Jia WW, 2011, FASEB J, V25, P979, DOI 10.1096/fj.10-173989; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Shay JW, 2010, FEBS LETT, V584, P3819, DOI 10.1016/j.febslet.2010.05.026; Sjottem E, 1997, J MOL BIOL, V267, P490, DOI 10.1006/jmbi.1997.0893; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Takakura M, 1999, CANCER RES, V59, P551; Takakura M, 2001, NUCLEIC ACIDS RES, V29, P3006, DOI 10.1093/nar/29.14.3006; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wang SW, 2010, MOL BIOL CELL, V21, P821, DOI 10.1091/mbc.E09-06-0456; Wang SW, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp511; Wang SW, 2009, NUCLEIC ACIDS RES, V37, P2618, DOI 10.1093/nar/gkp125; Wang SW, 2009, MOL BIOTECHNOL, V42, P110, DOI 10.1007/s12033-009-9142-3; Wang SW, 2004, GENE, V343, P69, DOI 10.1016/j.gene.2004.09.006; Wang SW, 2004, J BIOL CHEM, V279, P55401, DOI 10.1074/jbc.M411352200; Wang SW, 2003, J BIOL CHEM, V278, P18842, DOI 10.1074/jbc.M209544200; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Won J, 2002, J BIOL CHEM, V277, P38230, DOI 10.1074/jbc.M206064200; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Zhao YJ, 2014, NUCLEIC ACIDS RES, V42, P10385, DOI 10.1093/nar/gku721; Zhu JY, 2010, PROTEIN CELL, V1, P22, DOI 10.1007/s13238-010-0014-1; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723	39	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30193	30203		10.1074/jbc.M115.662221	http://dx.doi.org/10.1074/jbc.M115.662221			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26487723	Green Published, hybrid			2022-12-28	WOS:000366614700048
J	Wu, CL; Wang, Y; Jin, B; Chen, H; Xie, BS; Mao, ZB				Wu, Cheng-Lin; Wang, Yu; Jin, Bo; Chen, Hao; Xie, Bu-Shan; Mao, Ze-Bin			Senescence-associated Long Non-coding RNA (SALNR) Delays Oncogene-induced Senescence through NF90 Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR SENESCENCE; MESSENGER-RNA; REPLICATIVE SENESCENCE; HUMAN-DISEASE; EXPRESSION; FIBROBLASTS; CANCER; CELLS; STABILIZATION; TRANSCRIPTION	Long non-coding RNAs (lncRNAs) have recently emerged as key players in many physiologic and pathologic processes. Although many lncRNAs have been identified, few lncRNAs have been characterized functionally in aging. In this study, we used human fibroblast cells to investigate genome-wide lncRNA expression during cellular senescence. Weidentified 968 down-regulated lncRNAs and 899 up-regulated lncRNAs in senescent cells compared with young cells. Among these lncRNAs, we characterized a senescence-associated lncRNA (SALNR), whose expression was reduced during cellular senescence and in premalignant colon adenomas. Overexpression of SALNR delayed cellular senescence in fibroblast cells. Furthermore, we found that SALNR interacts with NF90 (nuclear factor of activated T-cells, 90 kDa), an RNA-binding protein suppressing miRNA biogenesis. We demonstrated that NF90 is a SALNR downstream target, whose inhibition led to premature senescence and enhanced expressions of senescence-associated miRNAs. Moreover, our data showed that Ras-induced stress promotes NF90 nucleolus translocation and suppresses its ability to suppress senescence-associated miRNA biogenesis, which could be rescued by SALNR overexpression. These data suggest that lncRNA SALNR modulates cellular senescence at least partly through changing NF90 activity.	[Wu, Cheng-Lin; Jin, Bo; Chen, Hao; Mao, Ze-Bin] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China; [Wu, Cheng-Lin; Jin, Bo; Chen, Hao; Mao, Ze-Bin] Peking Univ, Hlth Sci Ctr, Beijing Key Lab Posttranslat Modificat & Cellular, Beijing 100191, Peoples R China; [Wang, Yu] NYU, Med Ctr, Dept Urol, New York, NY 10016 USA; [Wang, Yu] NYU, Med Ctr, Dept Microbiol, New York, NY 10016 USA; [Xie, Bu-Shan] Nanchang Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanchang 330000, Peoples R China	Peking University; Peking University; New York University; New York University; Nanchang University	Mao, ZB (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 38 Xueyuan Rd, Beijing 100191, Peoples R China.	zbmao@bjmu.edu.cn			National Basic Research Programs of China [2013CB530801, 2011CB966203]; Natural Science Foundation of China [81471406]	National Basic Research Programs of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Programs of China Grants 2013CB530801 and 2011CB966203 and Natural Science Foundation of China Grant 81471406. The authors declare that they have no conflicts of interest with the contents of this article.	Abdelmohsen K, 2013, AGING CELL, V12, P890, DOI 10.1111/acel.12115; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Dai CY, 2000, GASTROENTEROLOGY, V119, P929, DOI 10.1053/gast.2000.17952; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dias AP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1103; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Harries LW, 2012, BIOCHEM SOC T, V40, P902, DOI 10.1042/BST20120020; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Kiesler P, 2010, J BIOL CHEM, V285, P8256, DOI 10.1074/jbc.M109.041004; Kotoglou P, 2009, CELL STRESS CHAPERON, V14, P391, DOI 10.1007/s12192-008-0093-6; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lanigan F, 2011, ONCOGENE, V30, P2901, DOI 10.1038/onc.2011.34; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Liu FJ, 2012, AGEING RES REV, V11, P41, DOI 10.1016/j.arr.2011.06.001; Mancini M, 2012, AGING-US, V4, P843, DOI 10.18632/aging.100508; Nelson DM, 2014, AGE, V36, P1049, DOI 10.1007/s11357-014-9637-0; O'Sullivan J, 2006, CANCER EPIDEM BIOMAR, V15, P573, DOI 10.1158/1055-9965.EPI-05-0542; Pont AR, 2012, MOL CELL, V47, P5, DOI 10.1016/j.molcel.2012.04.019; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Shamanna RA, 2011, MOL CELL BIOL, V31, P4832, DOI 10.1128/MCB.05849-11; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Sui WG, 2013, J NEPHROL, V26, P731, DOI 10.5301/jn.5000201; Suram A, 2012, EMBO J, V31, P2839, DOI 10.1038/emboj.2012.132; TANG ZQ, 1994, MECH AGEING DEV, V73, P57, DOI 10.1016/0047-6374(94)90038-8; Tominaga-Yamanaka K, 2012, AGING-US, V4, P695, DOI 10.18632/aging.100497; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang WG, 2001, MOL CELL BIOL, V21, P5889, DOI 10.1128/MCB.21.17.5889-5898.2001; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wei S, 1999, CANCER RES, V59, P1539; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Yan B, 2012, DNA CELL BIOL, V31, pS34, DOI 10.1089/dna.2011.1544; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Yu J, 2012, CLIN CANCER RES, V18, P981, DOI 10.1158/1078-0432.CCR-11-2347; Zhuo DX, 2010, J BIOL CHEM, V285, P31491, DOI 10.1074/jbc.M109.068387	41	29	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30175	30192		10.1074/jbc.M115.661785	http://dx.doi.org/10.1074/jbc.M115.661785			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26491010	hybrid, Green Published			2022-12-28	WOS:000366614700047
J	Gizzi, AMC; Prucca, CG; Gaveglio, VL; Renner, ML; Pasquare, SJ; Caputto, BL				Cardozo Gizzi, Andres M.; Prucca, Cesar G.; Gaveglio, Virginia L.; Renner, Marianne L.; Pasquare, Susana J.; Caputto, Beatriz L.			The Catalytic Efficiency of Lipin 1 beta Increases by Physically Interacting with the Proto-oncoprotein c-Fos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID PHOSPHATASE; SUBCELLULAR-LOCALIZATION; PHOSPHOLIPID-METABOLISM; LYSOPHOSPHATIDIC ACID; ENDOPLASMIC-RETICULUM; SYNTHESIS ACTIVATION; PC12 CELLS; PROTEINS; PHOSPHORYLATION; ENZYMES	Phosphatidic acid (PA) is a central precursor for membrane phospholipid biosynthesis. The lipin family is a magnesium-dependent type I PA phosphatase involved in de novo synthesis of neutral lipids and phospholipids. The regulation of lipin activity may govern the pathways by which these lipids are synthesized and control the cellular levels of important signaling lipids. Moreover, the proto-oncoprotein c-Fos has an emerging role in glycerolipid synthesis regulation; by interacting with key synthesizing enzymes it is able to increase overall phospho-and glycolipid synthesis. We studied the lipin 1 beta enzyme activity in a cell-free system using PA/Triton X-100 mixed micelles as substrate, analyzing it in the presence/absence of c-Fos. We found that lipin 1 beta k(cat) value increases around 40% in the presence of c-Fos, with no change in the lipin 1 beta affinity for the PA/Triton X-100 mixed micelles. We also probed a physical interaction between both proteins. Although the c-Fos domain involved in lipin activation is its basic domain, the interaction domain is mapped to the N-terminal c-Fos. In conclusion, we provide evidence for a novel positive regulator of lipin 1 beta PA phosphatase activity that is not achieved via altering its subcellular localization or affinity for membranes but rather through directly increasing its catalytic efficiency.	[Cardozo Gizzi, Andres M.; Prucca, Cesar G.; Renner, Marianne L.; Caputto, Beatriz L.] Univ Nacl Cordoba, Fac Ciencias Quim, Consejo Nacl Invest Cient & Tecn, Ctr Invest Quim Biol Cordoba,Dept Quim Biol, RA-5000 Cordoba, Argentina; [Gaveglio, Virginia L.; Pasquare, Susana J.] Univ Nacl Sur, Inst Invest Bioquim Bahia Blanca, Consejo Nacl Invest Cient & Tecn CONICET, RA-8000 Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South	Caputto, BL (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Consejo Nacl Invest Cient & Tecn, Ctr Invest Quim Biol Cordoba,Dept Quim Biol, Ciudad Univ,X5000HUA, RA-5000 Cordoba, Argentina.	bcaputto@fcq.unc.edu.ar	Prucca, César Germán/AAC-4630-2021; Renner, Marianne/H-5315-2011; Prucca, César/AAQ-4401-2020	Prucca, César Germán/0000-0003-4165-4660; Cardozo Gizzi, Andres Mauricio/0000-0003-3894-1845	Instituto Nacional de Cancer; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (SeCyT); Agencia Nacional de Promocion Cientifica y Tecnologica, Secretaria de Ciencia, Tecnologia e Innovacion Productiva de Argentina	Instituto Nacional de Cancer; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (SeCyT)(Secretaria de Ciencia y Tecnologia (SECYT)); Agencia Nacional de Promocion Cientifica y Tecnologica, Secretaria de Ciencia, Tecnologia e Innovacion Productiva de Argentina	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica, Secretaria de Ciencia, Tecnologia e Innovacion Productiva de Argentina, Instituto Nacional de Cancer, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (SeCyT). The authors declare that they have no conflicts of interest with the contents of this article.	Pecchio ARA, 2011, MOL BIOL CELL, V22, P4716, DOI 10.1091/mbc.E11-03-0259; ARVIDSON GA, 1968, EUR J BIOCHEM, V4, P478, DOI 10.1111/j.1432-1033.1968.tb00237.x; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Bonifacino J. S., 2001, CURR PROTOC PROTEIN; Borioli GA, 2001, BIOCHEM BIOPH RES CO, V280, P9, DOI 10.1006/bbrc.2000.4081; Brose N, 2004, CURR OPIN NEUROBIOL, V14, P328, DOI 10.1016/j.conb.2004.05.006; Bussolino DF, 2001, FASEB J, V15, P556; Caputto BL, 2014, BBA-MOL CELL BIOL L, V1841, P1241, DOI 10.1016/j.bbalip.2014.05.007; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Crespo PM, 2008, J BIOL CHEM, V283, P31163, DOI 10.1074/jbc.M709257200; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; DEGARCIA SJP, 1986, BIOCHIM BIOPHYS ACTA, V875, P195, DOI 10.1016/0005-2760(86)90168-2; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Ferrero GO, 2012, ONCOGENE, V31, P3381, DOI 10.1038/onc.2011.510; Ferrero GO, 2014, BIOCHEM J, V461, P521, DOI 10.1042/BJ20131376; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; KOVARY K, 1992, MOL CELL BIOL, V12, P5015, DOI 10.1128/MCB.12.11.5015; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; Liu ZR, 2014, PROTEIN SCI, V23, P539, DOI 10.1002/pro.2443; Mahuren JD, 2001, ANAL BIOCHEM, V298, P241, DOI 10.1006/abio.2001.5402; Malnou CE, 2007, J BIOL CHEM, V282, P31046, DOI 10.1074/jbc.M702833200; Motrich RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053211; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Pasquare SJ, 2004, LIPIDS, V39, P553, DOI 10.1007/s11745-004-1262-y; Pasquare SJ, 2001, EXP GERONTOL, V36, P1387, DOI 10.1016/S0531-5565(01)00106-1; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Portal MM, 2007, ONCOGENE, V26, P3551, DOI 10.1038/sj.onc.1210137; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; SASTRY PS, 1966, CAN J BIOCHEM CELL B, V44, P459, DOI 10.1139/o66-056; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zerpa GAD, 1999, J NEUROCHEM, V73, P1228, DOI 10.1046/j.1471-4159.1999.0731228.x	55	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29578	29592		10.1074/jbc.M115.678821	http://dx.doi.org/10.1074/jbc.M115.678821			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26475860	Green Published, hybrid			2022-12-28	WOS:000366613400039
J	Kremer, KN; Dudakovic, A; Hess, AD; Smith, BD; Karp, JE; Kaufmann, SH; Westendorf, JJ; van Wijnen, AJ; Hedin, KE				Kremer, Kimberly N.; Dudakovic, Amel; Hess, Allan D.; Smith, B. Douglas; Karp, Judith E.; Kaufmann, Scott H.; Westendorf, Jennifer J.; van Wijnen, Andre J.; Hedin, Karen E.			Histone Deacetylase Inhibitors Target the Leukemic Microenvironment by Enhancing a Nherf1-Protein Phosphatase 1 alpha-TAZ Signaling Pathway in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; STEM-CELL DIFFERENTIATION; MESENCHYMAL STROMAL CELLS; BONE-MARROW; IN-VIVO; TRANSCRIPTIONAL COACTIVATOR; MYELODYSPLASTIC SYNDROME; MAMMALIAN-CELLS; HIPPO PATHWAY	Disrupting the protective signals provided by the bone marrow microenvironment will be critical for more effective combination drug therapies for acute myeloid leukemia (AML). Cells of the osteoblast lineage that reside in the endosteal niche have been implicated in promoting survival of AML cells. Here, we investigated how to prevent this protective interaction. We previously showed that SDF-1, a chemokine abundant in the bone marrow, induces apoptosis of AML cells, unless the leukemic cells receive protective signals provided by differentiating osteoblasts (8, 10). Wenow identify a novel signaling pathway in differentiating osteoblasts that can be manipulated to disrupt the osteoblast-mediated protection of AML cells. Treating differentiating osteoblasts with histone deacetylase inhibitors (HDACi) abrogated their ability to protect co-cultured AML cells from SDF-1-induced apoptosis. HDACi prominently up-regulated expression of the Nherf1 scaffold protein, which played a major role in preventing osteoblast-mediated protection of AML cells. Protein phosphatase-1 alpha (PP1 alpha) was identified as a novel Nherf1 interacting protein that acts as the downstream mediator of this response by promoting nuclear localization of the TAZ transcriptional modulator. Moreover, independent activation of either PP1 alpha or TAZ was sufficient to prevent osteoblast-mediated protection of AML cells even in the absence of HDACi. Together, these results indicate that HDACi target the AML microenvironment by enhancing activation of the Nherf1-PP1 alpha -TAZ pathway in osteoblasts. Selective drug targeting of this osteoblast signaling pathway may improve treatments of AML by rendering leukemic cells in the bone marrow more susceptible to apoptosis.	[Kremer, Kimberly N.; Hedin, Karen E.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN USA; [Dudakovic, Amel; Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Coll Med, Dept Orthoped Surg, Rochester, MN USA; [Kaufmann, Scott H.] Mayo Clin, Coll Med, Dept Oncol, Rochester, MN USA; [Kaufmann, Scott H.] Mayo Clin, Coll Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Coll Med, Ctr Regenerat Med, Rochester, MN USA; [Hess, Allan D.; Smith, B. Douglas; Karp, Judith E.] Sidney Kimmel Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine	Hedin, KE (corresponding author), Guggenheim Bldg 3rd Floor,200 First St Southwest, Rochester, MN 55905 USA.	hedin.karen@mayo.edu	van Wijnen, Andre J./AAG-3578-2019; Regan, Clinton/E-6250-2012	van Wijnen, Andre J./0000-0002-4458-0946; Kaufmann, Scott/0000-0002-4900-7145; Dudakovic, Amel/0000-0002-8850-3977; Hedin, Karen/0000-0003-1010-923X	Mayo Clinic Foundation for Medical Research; Joanne G. and Gary N. Owen Fund in Immunology Research; Alma B. Stevenson Endowment Fund for Medical Research; National Institutes of Health [R01 CA166741, U01 CA70095, R01 AR049069]; NATIONAL CANCER INSTITUTE [R01CA166741, U01CA070095, P30CA015083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069] Funding Source: NIH RePORTER	Mayo Clinic Foundation for Medical Research; Joanne G. and Gary N. Owen Fund in Immunology Research; Alma B. Stevenson Endowment Fund for Medical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Mayo Clinic Foundation for Medical Research, the Joanne G. and Gary N. Owen Fund in Immunology Research, the Alma B. Stevenson Endowment Fund for Medical Research, and National Institutes of Health Grants R01 CA166741 (to S. H. K) and U01 CA70095 (to J. E. K) and R01 AR049069 (to A. J. v. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Byun MR, 2014, CELL DEATH DIFFER, V21, P854, DOI 10.1038/cdd.2014.8; Byun MR, 2014, J BIOL CHEM, V289, P9926, DOI 10.1074/jbc.M113.522870; Byun MR, 2012, BONE, V50, P364, DOI 10.1016/j.bone.2011.10.035; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Chen Y, 2012, BLOOD, V119, P4971, DOI 10.1182/blood-2011-11-389957; Choy MS, 2012, BIOCHEM SOC T, V40, P969, DOI 10.1042/BST20120094; De Toni F, 2006, ONCOGENE, V25, P3113, DOI 10.1038/sj.onc.1209346; Dudakovic A, 2015, J CELL PHYSIOL, V230, P52, DOI 10.1002/jcp.24680; Dudakovic A, 2013, J BIOL CHEM, V288, P28783, DOI 10.1074/jbc.M113.489732; Garcia-Manero G, 2008, BLOOD, V112, P981, DOI 10.1182/blood-2007-10-115873; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Garcia-Manero G, 2012, BEST PRACT RES CL HA, V25, P427, DOI 10.1016/j.beha.2012.10.005; Garcia-Manero G, 2012, J CLIN ONCOL, V30, P2204, DOI 10.1200/JCO.2011.38.3265; Giles F, 2006, CLIN CANCER RES, V12, P4628, DOI 10.1158/1078-0432.CCR-06-0511; Gojo I, 2013, CLIN CANCER RES, V19, P1838, DOI 10.1158/1078-0432.CCR-12-3165; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kirschbaum M, 2014, BRIT J HAEMATOL, V167, P185, DOI 10.1111/bjh.13016; Kode A, 2014, NATURE, V506, P240, DOI 10.1038/nature12883; Kojima K, 2011, BLOOD, V118, P4431, DOI 10.1182/blood-2011-02-334136; Konopleva M, 2009, DRUG RESIST UPDATE, V12, P103, DOI 10.1016/j.drup.2009.06.001; Krause DS, 2013, NAT MED, V19, P1513, DOI 10.1038/nm.3364; Kremer KN, 2014, J CELL BIOCHEM, V115, P1128, DOI 10.1002/jcb.24755; Kremer KN, 2013, J BIOL CHEM, V288, P22899, DOI 10.1074/jbc.M113.449926; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liersch R, 2012, BLOOD, V119, P5215, DOI 10.1182/blood-2011-11-389692; Liu CY, 2011, J BIOL CHEM, V286, P5558, DOI 10.1074/jbc.M110.194019; Liu Chenying, 2011, Int J Biochem Mol Biol, V2, P247; Liu L, 2012, J BIOL CHEM, V287, P43312, DOI 10.1074/jbc.M112.422766; McGee-Lawrence ME, 2011, BONE, V48, P1117, DOI 10.1016/j.bone.2011.01.007; Mihara K, 2003, BRIT J HAEMATOL, V120, P846, DOI 10.1046/j.1365-2141.2003.04217.x; Ninomiya M, 2007, LEUKEMIA, V21, P136, DOI 10.1038/sj.leu.2404432; Nwajei Felix, 2013, Adv Hematol, V2013, P953982, DOI 10.1155/2013/953982; Petruccelli LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020987; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Prebet T, 2011, EXPERT OPIN INV DRUG, V20, P287, DOI 10.1517/13543784.2011.542750; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Schroeder TM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-362; Silva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053766; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Tabe Y, 2014, BRIT J HAEMATOL, V164, P767, DOI 10.1111/bjh.12725; Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Wang B, 2013, BONE, V52, P268, DOI 10.1016/j.bone.2012.10.001; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; Weinman EJ, 2001, AM J PHYSIOL-RENAL, V281, pF374, DOI 10.1152/ajprenal.2001.281.2.F374; Xing WR, 2010, MOL CELL BIOL, V30, P711, DOI 10.1128/MCB.00610-09	54	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29478	29492		10.1074/jbc.M115.668160	http://dx.doi.org/10.1074/jbc.M115.668160			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26491017	Green Published, hybrid			2022-12-28	WOS:000366613400031
J	Losdyck, E; Hornakova, T; Springuel, L; Degryse, S; Gielen, O; Cools, J; Constantinescu, SN; Flex, E; Tartaglia, M; Renauld, JC; Knoops, L				Losdyck, Elisabeth; Hornakova, Tekla; Springuel, Lorraine; Degryse, Sandrine; Gielen, Olga; Cools, Jan; Constantinescu, Stefan N.; Flex, Elisabetta; Tartaglia, Marco; Renauld, Jean-Christophe; Knoops, Laurent			Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Janus kinase (JAK); leukemia; oncogene; signal transduction; tyrosine-protein kinase (tyrosine kinase); JAK inhibitor	ACUTE MEGAKARYOBLASTIC LEUKEMIA; SIGNAL-TRANSDUCTION; FERM DOMAIN; N-TERMINUS; MUTATIONS; ACTIVATION; CELLS; GAMMA; TRANSFORMATION; SELECTIVITY	JAK1 and JAK3 are recurrently mutated in acute lymphoblastic leukemia. These tyrosine kinases associate with heterodimeric cytokine receptors such as IL-7 receptor or IL-9 receptor, in which JAK1 is appended to the specific chain, and JAK3 is appended to the common gamma chain. Here, we studied the role of these receptor complexes in mediating the oncogenic activity of JAK3 mutants. Although JAK3(V674A) and the majority of other JAK3 mutants needed to bind to a functional cytokine receptor complex to constitutively activate STAT5, JAK3(L857P) was unexpectedly found to not depend on such receptor complexes for its activity, which was induced without receptor or JAK1 co-expression. Introducing a mutation in the FERM domain that abolished JAK-receptor interaction did not affect JAK3(L857P) activity, whereas it inhibited the other receptor-dependent mutants. The same cytokine receptor independence as for JAK3(L857P) was observed for homologous Leu(857) mutations of JAK1 and JAK2 and for JAK3(L875H). This different cytokine receptor requirement correlated with different functional properties in vivo and with distinct sensitivity to JAK inhibitors. Transduction of murine hematopoietic cells with JAK3(V674A) led homogenously to lymphoblastic leukemias in BALB/c mice. In contrast, transduction with JAK3(L857P) induced various types of lymphoid and myeloid leukemias. Moreover, ruxolitinib, which preferentially blocks JAK1 and JAK2, abolished the proliferation of cells transformed by the receptor-dependent JAK3(V674A), yet proved much less potent on cells expressing JAK3(L857P). These particular cells were, in contrast, more sensitive to JAK3-specific inhibitors. Altogether, our results showed that different JAK3 mutations induce constitutive activation through distinct mechanisms, pointing to specific therapeutic perspectives.	[Losdyck, Elisabeth; Hornakova, Tekla; Springuel, Lorraine; Constantinescu, Stefan N.; Renauld, Jean-Christophe; Knoops, Laurent] Catholic Univ Louvain, Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium; [Losdyck, Elisabeth; Hornakova, Tekla; Springuel, Lorraine; Constantinescu, Stefan N.; Renauld, Jean-Christophe; Knoops, Laurent] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Degryse, Sandrine; Gielen, Olga; Cools, Jan] Katholieke Univ Leuven, VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Degryse, Sandrine; Gielen, Olga; Cools, Jan] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Flex, Elisabetta] Ist Super Sanita, I-00161 Rome, Italy; [Knoops, Laurent] Clin Univ St Luc, Hematol Unit, B-1200 Brussels, Belgium; [Tartaglia, Marco] Osped Pediat Bambino Gesu, IRCCS, Genet Disorders & Rare Dis Res Div, I-00146 Rome, Italy	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Istituto Superiore di Sanita (ISS); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; IRCCS Bambino Gesu	Knoops, L (corresponding author), Catholic Univ Louvain, de Duve Inst, Ave Hippocrate 74, B-1200 Brussels, Belgium.	laurent.knoops@uclouvain.be	Tartaglia, Marco/K-2955-2018; Degryse, Sandrine/M-8722-2015; Flex, Elisabetta/A-5958-2017; Renauld, Jean-Christophe/B-7268-2012	Tartaglia, Marco/0000-0001-7736-9672; Degryse, Sandrine/0000-0003-2815-3634; Flex, Elisabetta/0000-0002-6802-1356; Constantinescu, Stefan N./0000-0002-8599-2699; Cools, Jan/0000-0001-6626-5843; Renauld, Jean-Christophe/0000-0003-1736-2131	Belgian Program on Interuniversity Poles of Attraction [IAP-P7/43]; Belgian State, Prime Minister's Office, Science Policy Programming; Actions de Recherche Concertees of the Communaute Francaise de Belgique Grant [ARC10/15-027]; Fondation contre le Cancer, Belgium; Foundation Salus Sanguinis, Belgium; Operation Televie, Belgium; Associazione Italiana per la Ricerca sul Cancro [IG2009-8803, IG2012-3360]; Fund for Medical Scientific Research, Belgium; Atlantic Philanthropies New York; Fonds National de la Recherche Scientifique Belgium-Televie grant	Belgian Program on Interuniversity Poles of Attraction(Belgian Federal Science Policy Office); Belgian State, Prime Minister's Office, Science Policy Programming; Actions de Recherche Concertees of the Communaute Francaise de Belgique Grant; Fondation contre le Cancer, Belgium; Foundation Salus Sanguinis, Belgium; Operation Televie, Belgium; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fund for Medical Scientific Research, Belgium(Fonds de la Recherche Scientifique - FNRS); Atlantic Philanthropies New York; Fonds National de la Recherche Scientifique Belgium-Televie grant(Fonds de la Recherche Scientifique - FNRS)	This work was supported in part by Grant IAP-P7/43 from the Belgian Program on Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming (to S. N. C.); Actions de Recherche Concertees of the Communaute Francaise de Belgique Grant ARC10/15-027 (to S. N. C.); the Fondation contre le Cancer, Belgium (to S. N. C.); the Foundation Salus Sanguinis, Belgium; the Operation Televie, Belgium; Associazione Italiana per la Ricerca sul Cancro Grants IG2009-8803 and IG2012-3360 (to M. T.); the Fund for Medical Scientific Research, Belgium (to S. N. C.); and the Atlantic Philanthropies New York (to S. N. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Fonds National de la Recherche Scientifique Belgium-Televie grant.	[Anonymous], 2004, AM J TRANSPLANT, V4, P51, DOI 10.1046/j.1600-6143.2003.00281.x; Bains T, 2012, LEUKEMIA, V26, P2144, DOI 10.1038/leu.2012.74; Bellanger D, 2014, LEUKEMIA, V28, P417, DOI 10.1038/leu.2013.271; Cacalano NA, 1999, EMBO J, V18, P1549, DOI 10.1093/emboj/18.6.1549; Degryse S, 2014, BLOOD, V124, P3092, DOI 10.1182/blood-2014-04-566687; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Gerland K, 2000, MOL CELL ENDOCRINOL, V168, P1, DOI 10.1016/S0303-7207(00)00314-2; Gordon GM, 2010, BIOCHEM J, V432, P255, DOI 10.1042/BJ20100774; Haan C, 2001, J BIOL CHEM, V276, P37451, DOI 10.1074/jbc.M106135200; Haan C, 2011, CHEM BIOL, V18, P314, DOI 10.1016/j.chembiol.2011.01.012; He M, 2012, CLIN CANCER RES, V18, P1790, DOI 10.1158/1078-0432.CCR-11-2361; Hornakova T, 2011, HAEMATOL-HEMATOL J, V96, P845, DOI 10.3324/haematol.2010.036350; Hornakova T, 2009, J BIOL CHEM, V284, P6773, DOI 10.1074/jbc.M807531200; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kudlacz E, 2008, EUR J PHARMACOL, V582, P154, DOI 10.1016/j.ejphar.2007.12.024; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Lupardus PJ, 2014, P NATL ACAD SCI USA, V111, P8025, DOI 10.1073/pnas.1401180111; Lupardus PJ, 2011, STRUCTURE, V19, P45, DOI 10.1016/j.str.2010.10.010; Malka Y, 2008, J BIOL CHEM, V283, P33569, DOI 10.1074/jbc.M803125200; Riera L, 2011, LEUKEMIA LYMPHOMA, V52, P1742, DOI 10.3109/10428194.2011.574757; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Sakaguchi H, 2013, NAT GENET, V45, P937, DOI 10.1038/ng.2698; Springuel L, 2014, BLOOD, V124, P3924, DOI 10.1182/blood-2014-05-576652; Tang W, 2001, BIOCHEM BIOPH RES CO, V283, P598, DOI 10.1006/bbrc.2001.4824; Thoma G, 2011, J MED CHEM, V54, P284, DOI 10.1021/jm101157q; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; Yamaguchi F, 2014, ONCOL LETT, V7, P357, DOI 10.3892/ol.2013.1705; Yamaguchi F, 2012, LUNG CANCER, V78, P201, DOI 10.1016/j.lungcan.2012.08.014; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117; Yi CA, 2015, FUTURE ONCOL, V11, P719, DOI [10.2217/fon.14.272, 10.2217/FON.14.272]; Zhou YJ, 2001, MOL CELL, V8, P959, DOI 10.1016/S1097-2765(01)00398-7	33	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29022	29034		10.1074/jbc.M115.670224	http://dx.doi.org/10.1074/jbc.M115.670224			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26446793	Green Published, hybrid			2022-12-28	WOS:000365762300040
J	Lussier, MP; Sanz-Clemente, A; Roche, KW				Lussier, Marc P.; Sanz-Clemente, Antonio; Roche, Katherine W.			Dynamic Regulation of N-Methyl-d-aspartate (NMDA) and alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors by Posttranslational Modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA receptor AMPAR); glutamate receptor; post-translational modification (PTM); protein palmitoylation; ubiquitin; N-methyl-D-aspartate receptor (NMDA receptor NMDAR)	CASEIN KINASE 2; ACTIVITY-DEPENDENT PHOSPHORYLATION; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; TYROSINE PHOSPHORYLATION; DIFFERENTIAL REGULATION; PROTEIN PALMITOYLATION; NEURONAL DEVELOPMENT; SUBUNIT COMPOSITION; SURFACE EXPRESSION	Many molecular mechanisms underlie the changes in synaptic glutamate receptor content that are required by neuronal networks to generate cellular correlates of learning and memory. During the last decade, posttranslational modifications have emerged as critical regulators of synaptic transmission and plasticity. Notably, phosphorylation, ubiquitination, and palmitoylation control the stability, trafficking, and synaptic expression of glutamate receptors in the central nervous system. In the current review, we will summarize some of the progress made by the neuroscience community regarding our understanding of phosphorylation, ubiquitination, and palmitoylation of the NMDA and AMPA subtypes of glutamate receptors.	[Lussier, Marc P.] Univ Quebec, Dept Chim, Montreal, PQ H3C 3P8, Canada; [Sanz-Clemente, Antonio] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA; [Roche, Katherine W.] NINDS, Receptor Biol Sect, NIH, Bethesda, MD 20892 USA	University of Quebec; University of Quebec Montreal; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Roche, KW (corresponding author), NINDS, Bldg 35,Rm 2C-903,9000 Rockville Pike, Bethesda, MD 20892 USA.	rochek@ninds.nih.gov	Roche, Katherine/W-9893-2019; Sala, Carlo/A-2493-2009; Sanz-Clemente, Antonio/AAF-7124-2019	Sala, Carlo/0000-0003-0662-9523; Sanz-Clemente, Antonio/0000-0002-1256-4722; Lussier, Marc/0000-0001-5568-0072; Roche, Katherine/0000-0001-7282-6539	Universite du Quebec a Montreal Start-up Funds; National Institutes of Health NIA Grant [1K99AG041225]; NINDS Intramural Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG041225] Funding Source: NIH RePORTER	Universite du Quebec a Montreal Start-up Funds; National Institutes of Health NIA Grant; NINDS Intramural Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Universite du Quebec a Montreal Start-up Funds (to M.P.L.) and by National Institutes of Health NIA Grant 1K99AG041225 (to A.S.C.) and the NINDS Intramural Program (to K.W.R.). This is the first article in the Thematic Minireview series "Molecular Mechanisms of Synaptic Plasticity." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; BLACKSTONE C, 1994, J NEUROSCI, V14, P7585; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Chen BS, 2012, CELL REP, V2, P1120, DOI 10.1016/j.celrep.2012.09.024; Chen BS, 2009, NEURON, V62, P471, DOI 10.1016/j.neuron.2009.04.015; Chowdhury D, 2013, J NEUROSCI, V33, P4151, DOI 10.1523/JNEUROSCI.2721-12.2013; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Ciechanover A, 2004, IUBMB LIFE, V56, P193, DOI 10.1080/1521654042000223616; Ciesla J, 2011, ACTA BIOCHIM POL, V58, P137; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ehlers MD, 2003, TRENDS NEUROSCI, V26, P4, DOI 10.1016/S0166-2236(02)00013-9; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ehlers MD, 2013, BIOCHEM SOC T, V41, P1365, DOI 10.1042/BST20130081; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fu AKY, 2011, NAT NEUROSCI, V14, P181, DOI 10.1038/nn.2715; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gautam V, 2013, NEUROPHARMACOLOGY, V74, P96, DOI 10.1016/j.neuropharm.2013.04.035; Gauthier-Campbell C, 2004, MOL BIOL CELL, V15, P2205, DOI 10.1091/mbc.E03-07-0493; Grau C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00331; Hayashi T, 2004, J NEUROSCI, V24, P6152, DOI 10.1523/JNEUROSCI.0799-04.2004; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hosokawa T, 2015, NEURON, V85, P60, DOI 10.1016/j.neuron.2014.11.026; Jenkins MA, 2012, CHANNELS, V6, P60, DOI 10.4161/chan.18648; Jurd R, 2008, J BIOL CHEM, V283, P301, DOI 10.1074/jbc.M705580200; Kato AS, 2010, TRENDS NEUROSCI, V33, P241, DOI 10.1016/j.tins.2010.02.004; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Lavezzari G, 2003, NEUROPHARMACOLOGY, V45, P729, DOI 10.1016/S0028-3908(03)00308-3; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lin A, 2011, J NEUROCHEM, V119, P27, DOI 10.1111/j.1471-4159.2011.07221.x; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lu W, 2012, CURR OPIN NEUROBIOL, V22, P470, DOI 10.1016/j.conb.2011.09.008; Lu W, 2010, P NATL ACAD SCI USA, V107, P22266, DOI 10.1073/pnas.1016289107; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Luscher C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005710; Lussier MP, 2014, EUR J NEUROSCI, V39, P1148, DOI 10.1111/ejn.12494; Lussier MP, 2012, P NATL ACAD SCI USA, V109, P19426, DOI 10.1073/pnas.1217477109; Lussier MP, 2011, J NEUROSCI, V31, P3077, DOI 10.1523/JNEUROSCI.5944-10.2011; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; MCGLADEMCCULLOH E, 1993, NATURE, V362, P640, DOI 10.1038/362640a0; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; MOSS SJ, 1993, NEUROCHEM RES, V18, P105, DOI 10.1007/BF00966929; Murphy JA, 2014, J NEUROSCI, V34, P869, DOI 10.1523/JNEUROSCI.4538-13.2014; Na CH, 2012, J PROTEOME RES, V11, P4722, DOI 10.1021/pr300536k; Nasu-Nishimura Y, 2010, J BIOL CHEM, V285, P2847, DOI 10.1074/jbc.M109.081141; Nicoll RA, 2013, NEUROPHARMACOLOGY, V74, P18, DOI 10.1016/j.neuropharm.2013.02.010; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Planey SL, 2009, MOL MEMBR BIOL, V26, P14, DOI 10.1080/09687680802646703; Plattner F, 2014, NEURON, V81, P1070, DOI 10.1016/j.neuron.2014.01.022; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Sanz-Clemente A, 2013, CELL REP, V3, P607, DOI 10.1016/j.celrep.2013.02.011; Sanz-Clemente A, 2013, NEUROSCIENTIST, V19, P62, DOI 10.1177/1073858411435129; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Schwarz LA, 2010, J NEUROSCI, V30, P16718, DOI 10.1523/JNEUROSCI.3686-10.2010; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Scudder SL, 2014, J NEUROSCI, V34, P16637, DOI 10.1523/JNEUROSCI.2452-14.2014; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Standley S, 2000, CELL MOL LIFE SCI, V57, P1508, DOI 10.1007/PL00000635; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; TAN SE, 1994, J NEUROSCI, V14, P1123, DOI 10.1523/JNEUROSCI.14-03-01123.1994; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Thomas GM, 2013, BIOCHEM SOC T, V41, P72, DOI 10.1042/BST20120223; van der Sluijs P, 2011, SEMIN CELL DEV BIOL, V22, P499, DOI 10.1016/j.semcdb.2011.06.008; Van Dolah DK, 2011, BIOL PSYCHIAT, V69, P1035, DOI 10.1016/j.biopsych.2010.11.025; Venne AS, 2014, PROTEOMICS, V14, P513, DOI 10.1002/pmic.201300344; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Widagdo J, 2015, CELL REP, V10, P783, DOI 10.1016/j.celrep.2015.01.015; WYLLIE DJA, 1994, NEURON, V13, P635, DOI 10.1016/0896-6273(94)90031-0; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-458; Yuen EY, 2012, NEURON, V73, P962, DOI 10.1016/j.neuron.2011.12.033	100	98	100	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28596	28603		10.1074/jbc.R115.652750	http://dx.doi.org/10.1074/jbc.R115.652750			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26453298	Green Published, hybrid			2022-12-28	WOS:000365762300002
J	Rajasekhar, P; Poole, DP; Liedtke, W; Bunnett, NW; Veldhuis, NA				Rajasekhar, Pradeep; Poole, Daniel P.; Liedtke, Wolfgang; Bunnett, Nigel W.; Veldhuis, Nicholas A.			P2Y(1) Receptor Activation of the TRPV4 Ion Channel Enhances Purinergic Signaling in Satellite Glial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; G protein-coupled receptor (GPCR); inflammation; purinergic receptor; transient receptor potential channels (TRP channels); Satellite glial cells; nociception	PROTEIN-KINASE-C; MOUSE TRIGEMINAL GANGLIA; CAPSAICIN RECEPTOR; NEUROPATHIC PAIN; PROTEASE-ACTIVATED-RECEPTOR-2 SENSITIZES; MECHANICAL HYPERALGESIA; POTENTIAL VANILLOID-4; DEPENDENT MECHANISMS; INFLAMMATORY PAIN; SENSORY GANGLIA	Transient receptor potential (TRP) ion channels of peripheral sensory pathways are important mediators of pain, itch, and neurogenic inflammation. They are expressed by primary sensory neurons and by glial cells in the central nervous system, but their expression and function in satellite glial cells (SGCs) of sensory ganglia have not been explored. SGCs tightly ensheath neurons of sensory ganglia and can regulate neuronal excitability in pain and inflammatory states. Using a modified dissociation protocol, we isolated neurons with attached SGCs from dorsal root ganglia of mice. SGCs, which were identified by expression of immunoreactive Kir4.1 and glutamine synthetase, were closely associated with neurons, identified using the pan-neuronal marker NeuN. A subpopulation of SGCs expressed immunoreactive TRP vanilloid 4 (TRPV4) and responded to the TRPV4-selective agonist GSK1016790A by an influx of Ca2+ ions. SGCs did not express functional TRPV1, TRPV3, or TRP ankyrin 1 channels. Responses to GSK1016790A were abolished by the TRPV4 antagonist HC067047 and were absent in SGCs from Trpv4(-/-) mice. The P2Y(1)-selective agonist 2-methylthio-ADP increased [Ca2+](i) in SGCs, and responses were prevented by the P2Y1-selective antagonist MRS2500. P2Y(1) receptor-mediated responses were enhanced in TRPV4-expressing SGCs and HEK293 cells, suggesting that P2Y(1) couples to and activates TRPV4. PKC inhibitors prevented P2Y(1) receptor activation of TRPV4. Our results provide the first evidence for expression of TRPV4 in SGCs and demonstrate that TRPV4 is a purinergic receptor-operated channel in SGCs of sensory ganglia.	[Rajasekhar, Pradeep; Poole, Daniel P.; Bunnett, Nigel W.; Veldhuis, Nicholas A.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Rajasekhar, Pradeep; Poole, Daniel P.; Bunnett, Nigel W.; Veldhuis, Nicholas A.] Monash Univ, Australian Res Council Ctr Excellence Convergent, Parkville, Vic 3052, Australia; [Bunnett, Nigel W.] Monash Univ, Dept Anaesthesia & Peri Operat Med, Parkville, Vic 3052, Australia; [Poole, Daniel P.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia; [Veldhuis, Nicholas A.] Univ Melbourne, Dept Genet, Parkville, Vic 3010, Australia; [Bunnett, Nigel W.] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3010, Australia; [Liedtke, Wolfgang] Duke Univ, Sch Med, Dept Neurol, Durham, NC 27710 USA	Monash University; Monash University; Monash University; University of Melbourne; University of Melbourne; University of Melbourne; Duke University	Bunnett, NW (corresponding author), Monash Inst Pharmaceut Sci, 381 Royal Parade, Parkville, Vic 3052, Australia.	nigel.bunnett@monash.edu; nicholas.veldhuis@monash.edu	Liedtke, Wolfgang/GNH-1878-2022; Poole, Daniel/AET-6645-2022	Poole, Daniel/0000-0002-6168-8422; Veldhuis, Nicholas/0000-0002-8902-9365; Bunnett, Nigel W./0000-0003-3367-0644; Rajasekhar, Pradeep/0000-0002-1983-7244	National Health and Medical Research Council [63303, 1049682, 1031886]; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology; Monash University; Takeda Pharmaceuticals Inc.	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology(Australian Research Council); Monash University(Monash University); Takeda Pharmaceuticals Inc.(Takeda Pharmaceutical Company Ltd)	This work was supported by National Health and Medical Research Council Grants 63303, 1049682, and 1031886; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology; and Monash University (to N. W. B.). Research in the authors' laboratory was funded in part by Takeda Pharmaceuticals Inc.	Adapala RK, 2011, AM J PHYSIOL-HEART C, V301, pH757, DOI 10.1152/ajpheart.00142.2011; Alessandri-Haber N, 2004, J NEUROSCI, V24, P4444, DOI 10.1523/JNEUROSCI.0242-04.2004; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Alessandri-Haber N, 2008, J NEUROSCI, V28, P1046, DOI 10.1523/JNEUROSCI.4497-07.2008; Aley KO, 2000, J NEUROSCI, V20, P4680, DOI 10.1523/JNEUROSCI.20-12-04680.2000; Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Belzer V, 2010, NEURON GLIA BIOL, V6, P237, DOI 10.1017/S1740925X1100007X; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Blum E, 2014, NEUROSCIENCE, V274, P209, DOI 10.1016/j.neuroscience.2014.05.029; Brierley SM, 2008, GASTROENTEROLOGY, V134, P2059, DOI 10.1053/j.gastro.2008.01.074; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Cao DS, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-5; Cenac N, 2015, GASTROENTEROLOGY, V149, P433, DOI 10.1053/j.gastro.2015.04.011; Cenac N, 2010, GUT, V59, P481, DOI 10.1136/gut.2009.192567; Ceruti S, 2008, CELL CALCIUM, V43, P576, DOI 10.1016/j.ceca.2007.10.003; Ceruti S, 2011, J NEUROSCI, V31, P3638, DOI 10.1523/JNEUROSCI.6440-10.2011; Chen Y, 2008, P NATL ACAD SCI USA, V105, P16773, DOI 10.1073/pnas.0801793105; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; De Simone R, 2010, J NEUROCHEM, V115, P450, DOI 10.1111/j.1471-4159.2010.06937.x; Domercq M, 2006, J BIOL CHEM, V281, P30684, DOI 10.1074/jbc.M606429200; Dublin P, 2007, BRAIN BEHAV IMMUN, V21, P592, DOI 10.1016/j.bbi.2006.11.011; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Facer P, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-11; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Ferrari LF, 2015, J NEUROSCI, V35, P6107, DOI 10.1523/JNEUROSCI.5085-14.2015; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Filosa JA, 2013, J CARDIOVASC PHARM, V61, P113, DOI 10.1097/FJC.0b013e318279ba42; Grant AD, 2007, J PHYSIOL-LONDON, V578, P715, DOI 10.1113/jphysiol.2006.121111; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Guler AD, 2002, J NEUROSCI, V22, P6408; Hamanaka K, 2010, AM J PHYSIOL-LUNG C, V299, pL353, DOI 10.1152/ajplung.00315.2009; Haraguchi K, 2012, J NEUROSCI, V32, P3931, DOI 10.1523/JNEUROSCI.4703-11.2012; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Hechler B, 2006, J PHARMACOL EXP THER, V316, P556, DOI 10.1124/jpet.105.094037; Huang TJ, 2002, DIABETOLOGIA, V45, P560, DOI 10.1007/s00125-002-0785-x; Jarvis MF, 2010, TRENDS NEUROSCI, V33, P48, DOI 10.1016/j.tins.2009.10.003; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Katagiri A, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-23; Konno M, 2012, GLIA, V60, P761, DOI 10.1002/glia.22306; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Magni G, 2015, GLIA, V63, P1256, DOI 10.1002/glia.22819; Magni G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/495789; Mamenko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022824; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mercado J, 2014, J GEN PHYSIOL, V143, P559, DOI 10.1085/jgp.201311050; Mundell SJ, 2006, MOL PHARMACOL, V70, P1132, DOI 10.1124/mol.106.023549; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Ohara PT, 2009, NEUROSCIENTIST, V15, P450, DOI 10.1177/1073858409336094; Ohsawa K, 2007, GLIA, V55, P604, DOI 10.1002/glia.20489; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Poole DP, 2013, J BIOL CHEM, V288, P5790, DOI 10.1074/jbc.M112.438184; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; Shibasaki K, 2014, J BIOL CHEM, V289, P14470, DOI 10.1074/jbc.M114.557132; Shinozaki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04329; Sokabe T, 2010, J BIOL CHEM, V285, P18749, DOI 10.1074/jbc.M110.103606; Sonkusare SK, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005052; Souza GR, 2013, P NATL ACAD SCI USA, V110, P11193, DOI 10.1073/pnas.1307445110; Suadicani SO, 2010, NEURON GLIA BIOL, V6, P43, DOI 10.1017/S1740925X09990408; Suzuki M, 2003, NEUROSCI LETT, V353, P189, DOI 10.1016/j.neulet.2003.09.041; Takeda M, 2011, PAIN, V152, P2147, DOI 10.1016/j.pain.2011.05.023; Tang X, 2010, NEUROSCIENCE, V166, P397, DOI 10.1016/j.neuroscience.2010.01.005; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; Veldhuis NA, 2015, PHARMACOL REV, V67, P36, DOI 10.1124/pr.114.009555; Veldhuis NA, 2012, J BIOL CHEM, V287, P21765, DOI 10.1074/jbc.M112.342022; Verkhratsky A, 2014, REV PHYSIOL BIOCH P, V166, P1, DOI 10.1007/112_2013_15; Vit JP, 2008, J NEUROSCI, V28, P4161, DOI 10.1523/JNEUROSCI.5053-07.2008; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wagner L, 2014, NEUROSCI LETT, V578, P143, DOI 10.1016/j.neulet.2014.06.047; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Weick M, 2003, NEUROSCIENCE, V120, P969, DOI 10.1016/S0306-4522(03)00388-9; Zeng Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119912; Zhang HJ, 2009, GLIA, V57, P1588, DOI 10.1002/glia.20872; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	80	33	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29051	29062		10.1074/jbc.M115.689729	http://dx.doi.org/10.1074/jbc.M115.689729			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26475857	Green Published, hybrid			2022-12-28	WOS:000365762300043
J	Kopecna, J; de Vaca, IC; Adams, NBP; Davison, PA; Brindley, AA; Hunter, CN; Guallar, V; Sobotka, R				Kopecna, Jana; Cabeza de Vaca, Israel; Adams, Nathan B. P.; Davison, Paul A.; Brindley, Amanda A.; Hunter, C. Neil; Guallar, Victor; Sobotka, Roman			Porphyrin Binding to Gun4 Protein, Facilitated by a Flexible Loop, Controls Metabolite Flow through the Chlorophyll Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAGNESIUM CHELATASE; TETRAPYRROLE BIOSYNTHESIS; MG-CHELATASE; SUBUNIT; EXPRESSION; FERROCHELATASE; REGULATOR; PROMOTE; MUTANT; LEVEL	In oxygenic phototrophs, chlorophylls, hemes, and bilins are synthesized by a common branched pathway. Given the phototoxic nature of tetrapyrroles, this pathway must be tightly regulated, and an important regulatory role is attributed to magnesium chelatase enzyme at the branching between the heme and chlorophyll pathway. Gun4 is a porphyrin-binding protein known to stimulate in vitro the magnesium chelatase activity, but how the Gun4-porphyrin complex acts in the cell was unknown. To address this issue, we first performed simulations to determine the porphyrin-docking mechanism to the cyanobacterial Gun4 structure. After correcting crystallographic loop contacts, we determined the binding site for magnesium protoporphyrin IX. Molecular modeling revealed that the orientation of alpha 6/alpha 7 loop is critical for the binding, and the magnesium ion held within the porphyrin is coordinated by Asn-211 residue. We also identified the basis for stronger binding in the Gun4-1 variant and for weaker binding in the W192A mutant. The W192A-Gun4 was further characterized in magnesium chelatase assay showing that tight porphyrin binding in Gun4 facilitates its interaction with the magnesium chelatase ChlH subunit. Finally, we introduced the W192A mutation into cells and show that the Gun4-porphyrin complex is important for the accumulation of ChlH and for channeling metabolites into the chlorophyll biosynthetic pathway.	[Kopecna, Jana; Sobotka, Roman] Acad Sci Czech Republ, Inst Microbiol, Trebon 37981, Czech Republic; [Sobotka, Roman] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Cabeza de Vaca, Israel; Guallar, Victor] Inst Res Biomed Res Program, Ctr Genom Regulat, Joint Barcelona Supercomp Ctr, Barcelona 08034, Spain; [Adams, Nathan B. P.; Davison, Paul A.; Brindley, Amanda A.; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Guallar, Victor] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); University of Sheffield; ICREA	Guallar, V (corresponding author), Inst Microbiol Opatovicky Mlyn, Trebon 37981, Czech Republic.	victor.guallar@bsc.es; sobotka@alga.cz	Guallar, Victor/B-1579-2013; Sobotka, Roman/J-3077-2014	Guallar, Victor/0000-0002-4580-1114; Sobotka, Roman/0000-0001-5909-3879; Adams, Nathan/0000-0003-3080-3448	Czech Science Foundation [P501/12/G055]; National Programme of Sustainability I Grant [LO1416]; ERC [2009-Adg25027-PELE]; Project Algain [EE2.3.30.0059]; Biotechnology and Biological Sciences Research Council [BB/G021546/1, BB/M000265/1]; European Research Council [338895]; ICREA Funding Source: Custom; BBSRC [BB/G021546/1, BB/M000265/1] Funding Source: UKRI	Czech Science Foundation(Grant Agency of the Czech Republic); National Programme of Sustainability I Grant; ERC(European Research Council (ERC)European Commission); Project Algain; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Project P501/12/G055 of the Czech Science Foundation, by National Programme of Sustainability I Grant LO1416, by ERC Grant 2009-Adg25027-PELE (to V. G.). This work was also supported by Project Algain Grant EE2.3.30.0059 (to J. K.), Awards BB/G021546/1 and BB/M000265/1 from the Biotechnology and Biological Sciences Research Council (to N. B. P. A., P. A. D., A. A. B., and C. N. H.), and Advanced Award 338895 from the European Research Council (to C. N. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams NBP, 2014, BIOCHEM J, V464, P315, DOI 10.1042/BJ20140463; Adams NBP, 2014, BIOCHEM J, V457, P163, DOI 10.1042/BJ20130834; Adhikari ND, 2011, PLANT CELL, V23, P1449, DOI 10.1105/tpc.110.082503; Adhikari ND, 2009, J BIOL CHEM, V284, P24783, DOI 10.1074/jbc.M109.025205; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Borrelli KW, 2005, J CHEM THEORY COMPUT, V1, P1304, DOI 10.1021/ct0501811; Brzezowski P, 2014, PLANT J, V79, P285, DOI 10.1111/tpj.12560; Case D. A., 2021, AMBER 2022; Chen XM, 2015, MOL PLANT, V8, P1125, DOI 10.1016/j.molp.2015.04.013; Czarnecki O, 2012, J EXP BOT, V63, P1675, DOI 10.1093/jxb/err437; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; Formighieri C, 2012, MOL PLANT, V5, P1242, DOI 10.1093/mp/sss051; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; Gravenstein P. B., 2013, F1000RES, V2, P142; Guallar V, 2004, J MOL BIOL, V337, P227, DOI 10.1016/j.jmb.2003.11.016; Hernandez-Ortega A, 2011, BIOCHEM J, V436, P341, DOI 10.1042/BJ20102090; Jensen PE, 1996, J BIOL CHEM, V271, P16662, DOI 10.1074/jbc.271.28.16662; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Kopecna J, 2015, PLANT PHYSIOL, V169, P1307, DOI 10.1104/pp.15.01150; Kopecna J, 2012, PLANT PHYSIOL, V160, P2239, DOI 10.1104/pp.112.207274; Kotev M, 2015, BIOPHYS J, V108, P116, DOI 10.1016/j.bpj.2014.11.3453; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; Luo T, 2012, PLANT PHYSIOL, V159, P118, DOI 10.1104/pp.112.195446; Madadkar-Sobhani A, 2013, NUCLEIC ACIDS RES, V41, pW322, DOI 10.1093/nar/gkt454; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Papenbrock J, 1999, PLANTA, V208, P264, DOI 10.1007/s004250050558; Papenbrock J, 2001, PLANT J, V28, P41, DOI 10.1046/j.1365-313X.2001.01126.x; Papenbrock J, 2000, PLANT PHYSIOL, V122, P1161, DOI 10.1104/pp.122.4.1161; Papenbrock J, 2000, PLANT J, V22, P155, DOI 10.1046/j.1365-313x.2000.00724.x; Peter E, 2009, MOL PLANT, V2, P1198, DOI 10.1093/mp/ssp072; Pilny J, 2015, BIOPROTOCOL, V5, pe1390, DOI DOI 10.21769/BI0PR0T0C.1390; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; Sobotka R, 2005, J BIOL CHEM, V280, P31595, DOI 10.1074/jbc.M505976200; Sobotka R, 2008, J BIOL CHEM, V283, P25794, DOI 10.1074/jbc.M803787200; Sobotka R, 2008, J BACTERIOL, V190, P2086, DOI 10.1128/JB.01678-07; Sobotka R, 2014, PHOTOSYNTH RES, V119, P223, DOI 10.1007/s11120-013-9797-2; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Tabrizi ST, 2015, ACTA CRYSTALLOGR F, V71, P1094, DOI 10.1107/S2053230X15012248; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151	43	22	23	8	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28477	28488		10.1074/jbc.M115.664987	http://dx.doi.org/10.1074/jbc.M115.664987			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26446792	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-28	WOS:000365761900041
J	Herrera, C; Tremblay, JM; Shoemaker, CB; Mantis, NJ				Herrera, Cristina; Tremblay, Jacqueline M.; Shoemaker, Charles B.; Mantis, Nicholas J.			Mechanisms of Ricin Toxin Neutralization Revealed through Engineered Homodimeric and Heterodimeric Camelid Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PASSIVELY PROTECTS MICE; ANTHRAX TOXIN; BINDING; CHAIN; NANOBODIES; POLIOVIRUS; CHALLENGE; AFFINITY; IMMUNITY; LECTINS	Novel antibody constructs consisting of two or more different camelid heavy-chain only antibodies (VHHs) joined via peptide linkers have proven to have potent toxin-neutralizing activity in vivo against Shiga, botulinum, Clostridium difficile, anthrax, and ricin toxins. However, the mechanisms by which these so-called bispecific VHH heterodimers promote toxin neutralization remain poorly understood. In the current study we produced a new collection of ricin-specific VHH heterodimers, as well as VHH homodimers, and characterized them for their ability neutralize ricin in vitro and in vivo. We demonstrate that the VHH heterodimers, but not homodimers were able to completely protect mice against ricin challenge, even though the two classes of antibodies (heterodimers and homodimers) had virtually identical affinities for ricin holotoxin and similar IC50 values in a Vero cell cytotoxicity assay. The VHH heterodimers did differ from the homodimers in their ability to promote toxin aggregation in solution, as revealed through analytical ultracentrifugation. Moreover, the VHH heterodimers that were most effective at promoting ricin aggregation in solution were also the most effective at blocking ricin attachment to cell surfaces. Collectively, these data suggest that heterodimeric VHH-based neutralizing agents may function through the formation of antibody-toxin complexes that are impaired in their ability to access host cell receptors.	[Herrera, Cristina; Mantis, Nicholas J.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY 12208 USA; [Herrera, Cristina; Mantis, Nicholas J.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA; [Tremblay, Jacqueline M.; Shoemaker, Charles B.] Tufts Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, North Grafton, MA 01536 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Mantis, NJ (corresponding author), Wadsworth Ctr, Div Infect Dis, 120 New Scotland Ave, Albany, NY 12208 USA.	nicholas.mantis@health.ny.gov	Regan, Clinton/E-6250-2012	Mantis, Nicholas/0000-0002-5083-8640	National Institutes of Health [R03 AI097688]; NIAID [HHSN272201400021C, U54-AI057159]; Carson Carr Diversity Scholarship from the University at Albany; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI097688, U54AI057159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Carson Carr Diversity Scholarship from the University at Albany; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R03 AI097688 and Contract numbers HHSN272201400021C (to N. M. J.) and U54-AI057159 (to C. B. S.) from the NIAID. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of NIAID or National Institutes of Health.; Supported by a Carson Carr Diversity Scholarship from the University at Albany.	Abdiche YN, 2008, PROTEIN SCI, V17, P1326, DOI 10.1110/ps.035402.108; Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; BRIOEN P, 1983, VIROLOGY, V127, P463, DOI 10.1016/0042-6822(83)90159-9; Chen C, 2015, MBIO, V6, DOI 10.1128/mBio.00734-15; Chow SK, 2013, CELL HOST MICROBE, V13, P417, DOI 10.1016/j.chom.2013.03.001; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; FRENOY JP, 1986, BIOCHEM J, V240, P221, DOI 10.1042/bj2400221; Froude JW, 2011, MABS-AUSTIN, V3, P517, DOI 10.4161/mabs.3.6.17621; Galimidi RP, 2015, CELL, V160, P433, DOI 10.1016/j.cell.2015.01.016; Herrera C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099788; Katsamba PS, 2006, ANAL BIOCHEM, V352, P208, DOI 10.1016/j.ab.2006.01.034; Mantis NJ, 2012, CURR TOP MICROBIOL, V354, P181, DOI 10.1007/82_2011_122; Moayeri M, 2015, J BIOL CHEM, V290, P6584, DOI 10.1074/jbc.M114.627943; Mukherjee J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106422; Mukherjee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029941; Murase T, 2014, J BIOL CHEM, V289, P2331, DOI 10.1074/jbc.M113.505917; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; O'Hara JM, 2012, VACCINE, V30, P1239, DOI 10.1016/j.vaccine.2011.12.058; Reisler Ronald B, 2012, Adv Prev Med, V2012, P149737, DOI 10.1155/2012/149737; Rudolph MJ, 2014, J MOL BIOL, V426, P3057, DOI 10.1016/j.jmb.2014.05.026; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; SANDVIG K, 1976, J BIOL CHEM, V251, P3977; Sandvig K, 2013, HISTOCHEM CELL BIOL, V140, P317, DOI 10.1007/s00418-013-1111-z; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Sheoran AS, 2015, INFECT IMMUN, V83, P286, DOI 10.1128/IAI.02360-14; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Sully EK, 2014, TOXICON, V92, P36, DOI 10.1016/j.toxicon.2014.09.006; Sully EK, 2014, CLIN VACCINE IMMUNOL, V21, P777, DOI 10.1128/CVI.00003-14; THOMAS AAM, 1986, J VIROL, V59, P479, DOI 10.1128/JVI.59.2.479-485.1986; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; Unger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07850; Vance DJ, 2015, VACCINE, V33, P417, DOI 10.1016/j.vaccine.2014.11.036; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207; Wolfe DN, 2013, HUM VACC IMMUNOTHER, V9, P1591, DOI 10.4161/hv.24063; Yang ZY, 2014, J INFECT DIS, V210, P964, DOI 10.1093/infdis/jiu196; Yermakova A, 2014, MBIO, V5, DOI 10.1128/mBio.00995-13; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075	38	24	27	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27880	+		10.1074/jbc.M115.658070	http://dx.doi.org/10.1074/jbc.M115.658070			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26396190	Green Published, hybrid			2022-12-28	WOS:000365757500037
J	Shoji, M; Arakaki, Y; Esumi, T; Kohnomi, S; Yamamoto, C; Suzuki, Y; Takahashi, E; Konishi, S; Kido, H; Kuzuhara, T				Shoji, Masaki; Arakaki, Yumie; Esumi, Tomoyuki; Kohnomi, Shuntaro; Yamamoto, Chihiro; Suzuki, Yutaka; Takahashi, Etsuhisa; Konishi, Shiro; Kido, Hiroshi; Kuzuhara, Takashi			Bakuchiol Is a Phenolic Isoprenoid with Novel Enantiomer-selective Anti-influenza A Virus Activity Involving Nrf2 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-A VIRUS; PSORALEA-CORYLIFOLIA; IN-VITRO; VIRAL REPLICATION; GENE-EXPRESSION; CELL-LINE; OSELTAMIVIR; NEURAMINIDASE; HEMAGGLUTININ; INDUCTION	Influenza represents a substantial threat to human health and requires novel therapeutic approaches. Bakuchiol is a phenolic isoprenoid compound present in Babchi (Psoralea corylifolia L.) seeds. We examined the anti-influenza viral activity of synthetic bakuchiol using Madin-Darby canine kidney cells. We found that the naturally occurring form, (+)-(S)-bakuchiol, and its enantiomer, (-)-(R)-bakuchiol, inhibited influenza A viral infection and growth and reduced the expression of viral mRNAs and proteins in these cells. Furthermore, these compounds markedly reduced the mRNA expression of the host cell influenza A virus-induced immune response genes, interferon-beta and myxovirus-resistant protein 1. Interestingly, (+)-(S)bakuchiol had greater efficacy than (-)-(R)-bakuchiol, indicating that chirality influenced anti-influenza virus activity. In vitro studies indicated that bakuchiol did not strongly inhibit the activities of influenza surface proteins or the M2 ion channel, expressed in Chinese hamster ovary cells. Analysis of luciferase reporter assay data unexpectedly indicated that bakuchiol may induce some host cell factor(s) that inhibited firefly and Renilla luciferases. Next generation sequencing and KeyMolnet analysis of influenza A virus-infected and non-infected cells exposed to bakuchiol revealed activation of transcriptional regulation by nuclear factor erythroid 2-related factor (Nrf), and an Nrf2 reporter assay showed that (+)-(S)-bakuchiol activated Nrf2. Additionally, (+)-(S)-bakuchiol up-regulated the mRNA levels of two Nrf2-induced genes, NAD(P)H quinone oxidoreductase 1 and glutathione S-transferase A3. These findings demonstrated that bakuchiol had enantiomer-selective anti-influenza viral activity involving a novel effect on the host cell oxidative stress response.	[Shoji, Masaki; Arakaki, Yumie; Kuzuhara, Takashi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima 7708514, Japan; [Esumi, Tomoyuki; Yamamoto, Chihiro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Inst Pharmacognosy, Tokushima 7708514, Japan; [Kohnomi, Shuntaro; Konishi, Shiro] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Dept Neurophysiol, Kagawa 7692193, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778568, Japan; [Takahashi, Etsuhisa; Kido, Hiroshi] Univ Tokushima, Inst Enzyme Res, Div Enzyme Chem, Tokushima 7708503, Japan	Tokushima Bunri University; Tokushima Bunri University; Tokushima Bunri University; University of Tokyo; Tokushima University	Kuzuhara, T (corresponding author), Tokushima Bunri Univ, Fac Pharmaceut Sci, Biochem Lab, Tokushima 7708514, Japan.	kuzuhara@ph.bunri-u.ac.jp	Konishi, Shiro/ABA-5905-2020	Kuzuhara, Takashi/0000-0003-0565-6060	Japan Society for the Promotion of Science (JSPS) [25460574]; Tokushima Bunri University for Educational Reform and Collaborative Research Grant [TBU2013-2-1]; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED;  [26860083]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokushima Bunri University for Educational Reform and Collaborative Research Grant; Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); 	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C) 25460574 (to T. K.), Grant-in-Aid for Young Scientists (B) 26860083 (to M. S.), Tokushima Bunri University for Educational Reform and Collaborative Research Grant TBU2013-2-1 (to M. S.), and the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED (to H. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adhikari S, 2003, CHEM RES TOXICOL, V16, P1062, DOI 10.1021/tx034082r; Balannik V, 2009, BIOCHEMISTRY-US, V48, P11872, DOI 10.1021/bi9014488; Chen Hong-li, 2010, Yaoxue Xuebao, V45, P467; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Chen J, 1999, P NATL ACAD SCI USA, V96, P8967, DOI 10.1073/pnas.96.16.8967; Chen Z, 2010, EUR J PHARMACOL, V643, P170, DOI 10.1016/j.ejphar.2010.06.025; Chung S, 2010, PSYCHIAT INVEST, V7, P302, DOI 10.4306/pi.2010.7.4.302; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Esumi T, 2013, SYNLETT, V24, P1845, DOI 10.1055/s-0033-1338968; Furuse Y, 2009, ANTIMICROB AGENTS CH, V53, P4457, DOI 10.1128/AAC.00650-09; Haraguchi H, 2000, PLANTA MED, V66, P569, DOI 10.1055/s-2000-8605; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hiasa M, 2013, BRIT J PHARMACOL, V169, P115, DOI 10.1111/bph.12102; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Iwai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019825; Johnson J, 2009, INVEST OPHTH VIS SCI, V50, P2398, DOI 10.1167/iovs.08-2088; Kanematsu S, 2014, GENE, V533, P520, DOI 10.1016/j.gene.2013.08.005; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Katsura H, 2001, ANTIMICROB AGENTS CH, V45, P3009, DOI 10.1128/AAC.45.11.3009-3013.2001; Kensler TW, 1999, CHEM RES TOXICOL, V12, P113, DOI 10.1021/tx980185b; Kesic MJ, 2011, FREE RADICAL BIO MED, V51, P444, DOI 10.1016/j.freeradbiomed.2011.04.027; Kim KA, 2013, TOXICOL APPL PHARM, V269, P109, DOI 10.1016/j.taap.2013.03.017; Kitching A, 2009, EUROSURVEILLANCE, V14, P2; Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013; Kuchipudi SV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-230; L'Huillier AG, 2011, PHARMACOGENOMICS, V12, P1493, DOI [10.2217/PGS.11.91, 10.2217/pgs.11.91]; Lee SW, 2012, PLANTA MED, V78, P903, DOI 10.1055/s-0031-1298482; Lim SH, 2009, BRIT J NUTR, V101, P1031, DOI 10.1017/S0007114508066750; Manandhar S, 2007, EUR J PHARMACOL, V577, P17, DOI 10.1016/j.ejphar.2007.08.018; MEHTA G, 1966, TETRAHEDRON LETT, P4561; Merrell MD, 2008, DRUG METAB DISPOS, V36, P1716, DOI 10.1124/dmd.108.020867; Murakami S, 2008, J VIROL, V82, P1605, DOI 10.1128/JVI.01876-07; Muto NA, 2012, JPN J VET RES, V60, P71; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Pae HO, 2001, INT IMMUNOPHARMACOL, V1, P1849, DOI 10.1016/S1567-5769(01)00110-2; Polakova K, 2015, CLIN COSMET INVESTI, V8, P187, DOI 10.2147/CCID.S81691; Reece PA, 2007, J MED VIROL, V79, P1577, DOI 10.1002/jmv.20951; Rossman JS, 2010, J VIROL, V84, P5078, DOI 10.1128/JVI.00119-10; Sato Hiromi, 2005, Curr Drug Discov Technol, V2, P89, DOI 10.2174/1570163054064701; Seitz C, 2010, J GEN VIROL, V91, P1754, DOI 10.1099/vir.0.020370-0; Shoji M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066337; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Sun NJ, 1998, J NAT PROD, V61, P362, DOI 10.1021/np970488q; Takahashi E, 2012, J VIROL, V86, P10924, DOI 10.1128/JVI.01207-12; Terrier O, 2013, J GEN VIROL, V94, P985, DOI 10.1099/vir.0.049528-0; Tsvetkov P, 2010, CELL DEATH DIFFER, V17, P103, DOI 10.1038/cdd.2009.67; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; Wu WX, 2010, VIROLOGY, V396, P178, DOI 10.1016/j.virol.2009.10.016; Wu ZLL, 2009, BIOCHEM BIOPH RES CO, V379, P749, DOI 10.1016/j.bbrc.2008.12.139; Zhao G, 2008, BIOCHEM PHARMACOL, V75, P1835, DOI 10.1016/j.bcp.2008.01.014; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029120	62	32	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					28001	28017		10.1074/jbc.M115.669465	http://dx.doi.org/10.1074/jbc.M115.669465			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26446794	Green Published, hybrid			2022-12-28	WOS:000365757500046
J	La Venuta, G; Zeitler, M; Steringer, JP; Muller, HM; Nickel, W				La Venuta, Giuseppe; Zeitler, Marcel; Steringer, Julia P.; Mueller, Hans-Michael; Nickel, Walter			The Startling Properties of Fibroblast Growth Factor 2: How to Exit Mammalian Cells without a Signal Peptide at Hand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							UNCONVENTIONAL PROTEIN SECRETION; HEPARAN-SULFATE PROTEOGLYCANS; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 TAT PROTEIN; PLASMA-MEMBRANE; TEC KINASES; TRANSLOCATION; SURFACE; FGF-2; FIBROBLAST-GROWTH-FACTOR-2	For a long time, protein transport into the extracellular space was believed to strictly depend on signal peptide-mediated translocation into the lumen of the endoplasmic reticulum. More recently, this view has been challenged, and the molecular mechanisms of unconventional secretory processes are beginning to emerge. Here, we focus on unconventional secretion of fibroblast growth factor 2 (FGF2), a secretory mechanism that is based upon direct protein translocation across plasma membranes. Through a combination of genome-wide RNAi screening approaches and biochemical reconstitution experiments, the basic machinery of FGF2 secretion was identified and validated. This includes the integral membrane protein ATP1A1, the phosphoinositide phosphatidylinositol-4,5-bisphosphate (PI(4,5)P-2), and Tec kinase, as well as membrane-proximal heparan sulfate proteoglycans on cell surfaces. Hallmarks of unconventional secretion of FGF2 are: (i) sequential molecular interactions with the inner leaflet along with Tec kinase-dependent tyrosine phosphorylation of FGF2, (ii) PI(4,5)P-2-dependent oligomerization and membrane pore formation, and (iii) extracellular trapping of FGF2 mediated by heparan sulfate proteoglycans on cell surfaces. Here, we discuss new developments regarding this process including the mechanism of FGF2 oligomerization during membrane pore formation, the functional role of ATP1A1 in FGF2 secretion, and the possibility that other proteins secreted by unconventional means make use of a similar mechanism to reach the extracellular space. Furthermore, given the prominent role of extracellular FGF2 in tumor-induced angiogenesis, we will discuss possibilities to develop highly specific inhibitors of FGF2 secretion, a novel approach that may yield lead compounds with a high potential to develop into anti-cancer drugs.	[La Venuta, Giuseppe; Zeitler, Marcel; Steringer, Julia P.; Mueller, Hans-Michael; Nickel, Walter] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Nickel, W (corresponding author), Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany.	walter.nickel@bzh.uni-heidelberg.de		Muller, Hans-Michael/0000-0002-2384-7285	German Research Council [DFG-SFB 638, DFG-SFB/TRR 83, DFG Ni 423/6-1, DFG-GRK1188]; AID-NET program of the Federal Ministry for Education and Research of Germany; DFG Cluster of Excellence, CellNetworks	German Research Council(German Research Foundation (DFG)); AID-NET program of the Federal Ministry for Education and Research of Germany; DFG Cluster of Excellence, CellNetworks	This work was supported by the German Research Council (DFG-SFB 638, DFG-SFB/TRR 83, DFG Ni 423/6-1 and DFG-GRK1188) and the AID-NET program of the Federal Ministry for Education and Research of Germany, as well as the DFG Cluster of Excellence, CellNetworks. The authors declare that they have no conflicts of interest with the contents of this article.	Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Bellino S, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-49; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Campbell GR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-50; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Dahl JP, 2000, BIOCHEMISTRY-US, V39, P14877, DOI 10.1021/bi001073y; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Ebert AD, 2010, TRAFFIC, V11, P813, DOI 10.1111/j.1600-0854.2010.01059.x; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ensoli B, 2006, AIDS, V20, P2245, DOI 10.1097/QAD.0b013e3280112cd1; Ensoli F, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0151-y; Florkiewicz RZ, 1998, J BIOL CHEM, V273, P544, DOI 10.1074/jbc.273.1.544; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Lewis CM, 2001, CURR OPIN IMMUNOL, V13, P317, DOI 10.1016/S0952-7915(00)00221-1; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Malhotra V, 2013, EMBO J, V32, P1660, DOI 10.1038/emboj.2013.104; Muller HM, 2015, J BIOL CHEM, V290, P8925, DOI 10.1074/jbc.M114.622456; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; Nickel W, 2011, TRAFFIC, V12, P799, DOI 10.1111/j.1600-0854.2011.01187.x; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Piccioli P, 2013, SEMIN IMMUNOL, V25, P425, DOI 10.1016/j.smim.2013.10.007; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rayne F, 2010, CELL BIOL INT, V34, P409, DOI 10.1042/CBI20090376; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Ribatti D, 2007, CYTOKINE GROWTH F R, V18, P327, DOI 10.1016/j.cytogfr.2007.04.011; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Rubartelli A, 1998, IMMUNOL TODAY, V19, P543, DOI 10.1016/S0167-5699(98)01351-6; RUBEN S, 1989, J VIROL, V63, P1; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; Shi B, 1998, J NEUROVIROL, V4, P281, DOI 10.3109/13550289809114529; Steringer JP, 2015, J MOL BIOL, V427, P1202, DOI 10.1016/j.jmb.2014.07.012; Steringer JP, 2012, J BIOL CHEM, V287, P27659, DOI 10.1074/jbc.M112.381939; Temmerman K, 2008, TRAFFIC, V9, P1204, DOI 10.1111/j.1600-0854.2008.00749.x; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Torrado LC, 2009, J CELL SCI, V122, P3322, DOI 10.1242/jcs.049791; Touat M, 2015, CLIN CANCER RES, V21, P2684, DOI 10.1158/1078-0432.CCR-14-2329; Trudel C, 2000, J CELL PHYSIOL, V185, P260, DOI 10.1002/1097-4652(200011)185:2<260::AID-JCP11>3.0.CO;2-X; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Wegehingel S, 2008, FEBS LETT, V582, P2387, DOI 10.1016/j.febslet.2008.05.042; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yang WC, 2000, IMMUNITY, V12, P373, DOI 10.1016/S1074-7613(00)80189-2; Yoshimura SH, 2008, J CELL SCI, V121, P2159, DOI 10.1242/jcs.022905; Zacherl S, 2015, J BIOL CHEM, V290, P3654, DOI 10.1074/jbc.M114.590067; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103; Zeitler M, 2015, J BIOL CHEM, V290, P21976, DOI 10.1074/jbc.M115.667097; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740	58	31	31	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27015	27020		10.1074/jbc.R115.689257	http://dx.doi.org/10.1074/jbc.R115.689257			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26416892	Green Published, hybrid			2022-12-28	WOS:000364794000014
J	Ferrer-Mayorga, G; Alvarez-Diaz, S; Valle, N; De Las Rivas, J; Mendes, M; Barderas, R; Canals, F; Tapia, O; Casal, JI; Lafarga, M; Munoz, A				Ferrer-Mayorga, Gemma; Alvarez-Diaz, Silvia; Valle, Noelia; De Las Rivas, Javier; Mendes, Marta; Barderas, Rodrigo; Canals, Francesc; Tapia, Olga; Ignacio Casal, J.; Lafarga, Miguel; Munoz, Alberto			Cystatin D Locates in the Nucleus at Sites of Active Transcription and Modulates Gene and Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLORECTAL-CANCER; CYSTEINE CATHEPSINS; POOR-PROGNOSIS; RUNX FAMILY; CELLS; HETEROCHROMATIN; METASTASIS; LOCALIZES; INVASION; ROLES	Cystatin D is an inhibitor of lysosomal and secreted cysteine proteases. Strikingly, cystatin D has been found to inhibit proliferation, migration, and invasion of colon carcinoma cells indicating tumor suppressor activity that is unrelated to protease inhibition. Here, we demonstrate that a proportion of cystatin D locates within the cell nucleus at specific transcriptionally active chromatin sites. Consistently, transcriptomic analysis show that cystatin D alters gene expression, including that of genes encoding transcription factors such as RUNX1, RUNX2, and MEF2C in HCT116 cells. In concordance with transcriptomic data, quantitative proteomic analysis identified 292 proteins differentially expressed in cystatin D-expressing cells involved in cell adhesion, cytoskeleton, and RNA synthesis and processing. Furthermore, using cytokine arrays we found that cystatin D reduces the secretion of several protumor cytokines such as fibroblast growth factor-4, CX3CL1/fractalkine, neurotrophin 4 oncostatin-M, pulmonary and activation-regulated chemokine/CCL18, and transforming growth factor B3. These results support an unanticipated role of cystatin D in the cell nucleus, controlling the transcription of specific genes involved in crucial cellular functions, which may mediate its protective action in colon cancer.	[Ferrer-Mayorga, Gemma; Alvarez-Diaz, Silvia; Valle, Noelia; Munoz, Alberto] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain; [De Las Rivas, Javier] Univ Salamanca, Consejo Super Invest Cient, Ctr Invest Canc, E-37007 Salamanca, Spain; [Mendes, Marta; Barderas, Rodrigo; Ignacio Casal, J.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Canals, Francesc] Vall Hebron Univ Hosp, Vall Hebron Inst Oncol, Prote Lab, E-08035 Barcelona, Spain; [Tapia, Olga; Lafarga, Miguel] Univ Cantabria, Inst Invest Valdecilla, Fac Med, Dept Anat & Biol Celular, E-39011 Santander, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Munoz, A (corresponding author), Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.	amunoz@iib.uam.es	Mendes, Marta L/P-4062-2018; Lafarga, Miguel/K-3733-2014; Miquel, Josep Maria/AAG-3508-2019; Valle, Noelia/AAA-2975-2019; Casal, Ignacio/M-2312-2014; De Las Rivas, Javier/G-5936-2014; Mendes, Marta/AAM-9766-2021; Tapia, Olga/AAH-8651-2020; Alvarez-Diaz, Silvia/P-4948-2018; Barderas, Rodrigo/K-3560-2014; Munoz, Alberto/O-6393-2014; Tapia, Olga/AAN-2427-2020	Mendes, Marta L/0000-0002-3528-7123; Valle, Noelia/0000-0002-3377-5035; Casal, Ignacio/0000-0003-1085-2840; De Las Rivas, Javier/0000-0002-0984-9946; Mendes, Marta/0000-0002-3528-7123; Tapia, Olga/0000-0002-0802-7975; Alvarez-Diaz, Silvia/0000-0002-8897-1893; Barderas, Rodrigo/0000-0003-3539-7469; Munoz, Alberto/0000-0003-3890-4251; Lafarga, Miguel/0000-0003-3402-1152	Spanish Ministry of Economy and Competitiveness-Fondo Europeo de Desarrollo Regional (FEDER) [SAF2013-43468-R]; Comunidad de Madrid Grant Colomics2 [S2010/BMD-2344]; FEDER-Instituto de Salud Carlos III Grant [RD12/0036/0021]	Spanish Ministry of Economy and Competitiveness-Fondo Europeo de Desarrollo Regional (FEDER); Comunidad de Madrid Grant Colomics2(Comunidad de Madrid); FEDER-Instituto de Salud Carlos III Grant	This work was supported by Spanish Ministry of Economy and Competitiveness-Fondo Europeo de Desarrollo Regional (FEDER) Grant SAF2013-43468-R, Comunidad de Madrid Grant Colomics2 S2010/BMD-2344, and FEDER-Instituto de Salud Carlos III Grant RD12/0036/0021. The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal AK, 2010, FOLIA HISTOCHEM CYTO, V48, P323, DOI 10.2478/v10042-10-0067-2; Alvarez-Diaz S, 2009, J CLIN INVEST, V119, P2343, DOI 10.1172/JCI37205; BALBIN M, 1993, HUM GENET, V90, P668; Barderas R, 2012, CANCER RES, V72, P2780, DOI 10.1158/0008-5472.CAN-11-4090; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolin Celeste, 2012, Genes Cancer, V3, P117, DOI 10.1177/1947601912458284; Bulynko YA, 2006, MOL CELL BIOL, V26, P4172, DOI 10.1128/MCB.00135-06; Carlsson E, 2012, BRIT J CANCER, V106, P517, DOI 10.1038/bjc.2011.553; Carmo-Fonseca M, 2002, CELL, V108, P513, DOI 10.1016/S0092-8674(02)00650-5; Ceru S, 2010, J BIOL CHEM, V285, P10078, DOI 10.1074/jbc.M109.034793; Chimge NO, 2013, ONCOGENE, V32, P2121, DOI 10.1038/onc.2012.328; Chuang LSH, 2013, INT J CANCER, V132, P1260, DOI 10.1002/ijc.27964; Corcione A, 2012, J LEUKOCYTE BIOL, V92, P51, DOI 10.1189/jlb.0112035; Cox JL, 2009, FRONT BIOSCI-LANDMRK, V14, P463, DOI 10.2741/3255; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Fontanillo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024289; FREIJE JP, 1991, J BIOL CHEM, V266, P20538; Freitas N, 2009, CURR GENOMICS, V10, P550, DOI 10.2174/138920209789503941; Geiger T, 2011, NAT PROTOC, V6, P147, DOI 10.1038/nprot.2010.192; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irving JA, 2002, J BIOL CHEM, V277, P13192, DOI 10.1074/jbc.M108460200; Kim M, 2012, MOL CANCER RES, V10, P11, DOI 10.1158/1541-7786.MCR-11-0256; Kosaka N, 2009, DEV DYNAM, V238, P265, DOI 10.1002/dvdy.21699; Luque-Garcia JL, 2010, PROTEOMICS, V10, P940, DOI 10.1002/pmic.200900441; Maubach G, 2008, MOL BIOL CELL, V19, P4238, DOI 10.1091/mbc.E08-03-0291; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Ochieng J, 2010, J HEALTH CARE POOR U, V21, P51, DOI 10.1353/hpu.0.0257; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; Pelaez-Garcia A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063695; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Risueno A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-221; Rivenbark AG, 2009, FRONT BIOSCI-LANDMRK, V14, P453, DOI 10.2741/3254; Scheitz CJF, 2012, EMBO J, V31, P4124, DOI 10.1038/emboj.2012.270; Slattery ML, 2011, CARCINOGENESIS, V32, P318, DOI 10.1093/carcin/bgq245; Traweger A, 2003, J BIOL CHEM, V278, P2692, DOI 10.1074/jbc.M206821200; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu XR, 2012, J SURG ONCOL, V106, P130, DOI 10.1002/jso.23056; Xu XH, 2012, J GASTROINTEST SURG, V16, P1493, DOI 10.1007/s11605-012-1921-7; Yuen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054211	43	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26533	26548		10.1074/jbc.M115.660175	http://dx.doi.org/10.1074/jbc.M115.660175			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26364852	Green Published, hybrid			2022-12-28	WOS:000364793600021
J	Pandhare, J; Dash, S; Jones, B; Villalta, F; Dash, C				Pandhare, Jui; Dash, Sabyasachi; Jones, Bobby; Villalta, Fernando; Dash, Chandravanu			A Novel Role of Proline Oxidase in HIV-1 Envelope Glycoprotein-induced Neuronal Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SIGNAL-TRANSDUCTION; CHEMOKINE RECEPTOR; GENETIC-VARIATION; OXIDATIVE STRESS; CELL SURVIVAL; APOPTOSIS; P53; NEUROPATHOGENESIS; METABOLISM	Proline oxidase (POX) catalytically converts proline to pyrroline- 5-carboxylate. This catabolic conversion generates reactive oxygen species (ROS) that triggers cellular signaling cascades including autophagy and apoptosis. This study for the first time demonstrates a role of POX in HIV-1 envelope glycoprotein (gp120)-induced neuronal autophagy. HIV-1 gp120 is a neurotoxic factor and is involved in HIV-1-associated neurological disorders. However, the mechanism of gp120-mediated neurotoxicity remains unclear. Using SH-SY5Y neuroblastoma cells as a model, this study demonstrates that gp120 treatment induced POX expression and catalytic activity. Concurrently, gp120 also increased intracellular ROS levels. However, increased ROS had a minimal effect on neuronal apoptosis. Further investigation indicated that the immediate cellular response to increased ROS paralleled with induction of autophagy markers, beclin-1 and LC3-II. These data lead to the hypothesis that neuronal autophagy is activated as a cellular protective response to the toxic effects of gp120. A direct and functional role of POX in gp120-mediated neuronal autophagy was examined by inhibition and overexpression studies. Inhibition of POX activity by a competitive inhibitor "dehydroproline" decreased ROS levels concomitant with reduced neuronal autophagy. Conversely, overexpression of POX in neuronal cells increased ROS levels and activated ROS-dependent autophagy. Mechanistic studies suggest that gp120 induces POX by targeting p53. Luciferase reporter assays confirm that p53 drives POX transcription. Furthermore, data demonstrate that gp120 induces p53 via binding to the CXCR4 co-receptor. Collectively, these results demonstrate a novel role of POX as a stress response metabolic regulator in HIV-1 gp120-associated neuronal autophagy.	[Pandhare, Jui; Dash, Sabyasachi; Jones, Bobby; Villalta, Fernando; Dash, Chandravanu] Meharry Med Coll, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA; [Pandhare, Jui; Dash, Sabyasachi; Jones, Bobby; Villalta, Fernando; Dash, Chandravanu] Meharry Med Coll, Sch Grad Studies & Res, Nashville, TN 37208 USA; [Jones, Bobby; Villalta, Fernando] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Dash, Chandravanu] Meharry Med Coll, Dept Biochem & Canc, Nashville, TN 37208 USA	Meharry Medical College; Meharry Medical College; Meharry Medical College; Meharry Medical College	Pandhare, J (corresponding author), 1005 Dr DB Todd Jr,Blvd Old Hosp Bldg,Rm 5023, Nashville, TN 37208 USA.	jpandhare@mmc.edu	Dash, Sabyasachi/ABG-1337-2020; Regan, Clinton/E-6250-2012	Dash, Sabyasachi/0000-0003-3966-9396; Villalta, Fernando/0000-0002-6232-0574; Dash, Chandravanu/0000-0003-4466-8355; Pandhare, Jui/0000-0002-0356-064X	National Institutes of Health [G12MD007586]; Vanderbilt Clinical and Translational Science Award [UL1RR024975]; Center for Research Resources [U54 RR026140]; NIMHD (National Institute of Minority Health and Health Disparities); NIMHD (Meharry Translational Research Center for Research Resources) [U54 Grant MD007593]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975, U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007281, P30AI110527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA030896, R03DA033892, R24DA021471, R03DA037779, R00DA024558] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586, U54MD007593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Clinical and Translational Science Award; Center for Research Resources; NIMHD (National Institute of Minority Health and Health Disparities); NIMHD (Meharry Translational Research Center for Research Resources); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We acknowledge National Institutes of Health Grants G12MD007586 (to RCMI (Research Centers in Minority Institutions)), UL1RR024975 (a Vanderbilt Clinical and Translational Science Award), and U54 RR026140 (Center for Research Resources) and U54 Grant MD007593 NIMHD (National Institute of Minority Health and Health Disparities; Meharry Translational Research Center for Research Resources), which support the core facilities used for flow cytometry, microscopy, and other experiments.	Acquas E, 2004, NEUROTOX RES, V5, P605; ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; Agrawal L, 2010, BRAIN RES, V1306, P116, DOI 10.1016/j.brainres.2009.09.113; Albright AV, 2003, J NEUROVIROL, V9, P222, DOI 10.1080/13550280390194073; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Bardi G, 2006, J NEUROVIROL, V12, P211, DOI 10.1080/13550280600848373; BRIDGER GJ, 1995, J MED CHEM, V38, P366, DOI 10.1021/jm00002a019; Castedo M, 2003, ANN NY ACAD SCI, V1010, P19, DOI 10.1196/annals.1299.004; Castedo M, 2001, J EXP MED, V194, P1097, DOI 10.1084/jem.194.8.1097; Chen G, 2012, AUTOPHAGY, V8, P1577, DOI 10.4161/auto.21376; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Clifford DB, 2000, ARCH NEUROL-CHICAGO, V57, P321, DOI 10.1001/archneur.57.3.321; Clift IC, 2014, MOL PHARMACOL, V85, P542, DOI 10.1124/mol.113.089714; Cohen SM, 1997, BRAIN RES, V761, P271, DOI 10.1016/S0006-8993(97)00352-1; DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668, DOI 10.1128/AAC.38.4.668; Donald SP, 2001, CANCER RES, V61, P1810; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; FREMEAU RT, 1992, NEURON, V8, P915, DOI 10.1016/0896-6273(92)90206-S; Garden GA, 2005, BIOCHEM BIOPH RES CO, V331, P799, DOI 10.1016/j.bbrc.2005.03.185; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Hu SX, 2009, J NEUROVIROL, V15, P401, DOI 10.3109/13550280903296346; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Jacquet H, 2005, MOL PSYCHIATR, V10, P479, DOI 10.1038/sj.mp.4001597; Jana A, 2004, J NEUROSCI, V24, P9531, DOI 10.1523/JNEUROSCI.3085-04.2004; Jayadev S, 2007, J NEUROIMMUNE PHARM, V2, P359, DOI 10.1007/s11481-007-9095-x; Joska JA, 2010, J NEUROVIROL, V16, P101, DOI 10.3109/13550281003682513; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Khan MZ, 2003, J NEUROVIROL, V9, P300, DOI 10.1080/13550280390201010; Khan MZ, 2005, MOL CELL NEUROSCI, V30, P58, DOI 10.1016/j.mcn.2005.05.007; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Lee Jin-A, 2012, Exp Neurobiol, V21, P1, DOI 10.5607/en.2012.21.1.1; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Li LL, 2015, CELL MOL NEUROBIOL, V35, P615, DOI 10.1007/s10571-015-0166-x; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; Liu W, 2012, AUTOPHAGY, V8, P1407, DOI 10.4161/auto.21152; Liu W, 2012, CANCER RES, V72, P3677, DOI 10.1158/0008-5472.CAN-12-0080; Louboutin JP, 2012, SCI WORLD J, P1, DOI 10.1100/2012/482575; Maxwell SA, 2000, P NATL ACAD SCI USA, V97, P13009, DOI 10.1073/pnas.230445997; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Mocchetti I, 2012, NEUROTOX RES, V21, P79, DOI 10.1007/s12640-011-9279-2; Nath A, 2002, J INFECT DIS, V186, pS193, DOI 10.1086/344528; Pandhare J, 2006, J BIOL CHEM, V281, P2044, DOI 10.1074/jbc.M507867200; Pandhare J, 2009, J CELL BIOCHEM, V107, P759, DOI 10.1002/jcb.22174; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Perfettini JL, 2005, CELL DEATH DIFFER, V12, P916, DOI 10.1038/sj.cdd.4401584; Phang JM, 2008, AMINO ACIDS, V35, P681, DOI 10.1007/s00726-008-0063-4; Phang JM, 2008, J NUTR, V138, p2008S, DOI 10.1093/jn/138.10.2008S; Phang JM, 2010, ANNU REV NUTR, V30, P441, DOI 10.1146/annurev.nutr.012809.104638; Phang JM, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00060; PHANG JM, 1985, CURR TOP CELL REGUL, V25, P91; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Rao VR, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-13; Renick SE, 1999, J NEUROSCI, V19, P21, DOI 10.1523/JNEUROSCI.19-01-00021.1999; Scherz-Shouval R, 2010, P NATL ACAD SCI USA, V107, P18511, DOI 10.1073/pnas.1006124107; Steiner J, 2006, ANTIOXID REDOX SIGN, V8, P2089, DOI 10.1089/ars.2006.8.2089; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Tanida I, 2011, MICROBIOL IMMUNOL, V55, P1, DOI 10.1111/j.1348-0421.2010.00271.x; Thomas AG, 2009, J NEUROVIROL, V15, P449, DOI 10.3109/13550280903350598; Twu C, 2002, P NATL ACAD SCI USA, V99, P14386, DOI 10.1073/pnas.212327899; Valcour V, 2004, NEUROLOGY, V63, P822, DOI 10.1212/01.WNL.0000134665.58343.8D; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7; Vivithanaporn P, 2010, NEUROLOGY, V75, P1150, DOI 10.1212/WNL.0b013e3181f4d5bb; Wan Zhi-Tao, 2010, Virologica Sinica, V25, P307, DOI 10.1007/s12250-010-3148-7; Wyse ATS, 2011, METAB BRAIN DIS, V26, P159, DOI 10.1007/s11011-011-9246-x; Xilouri M, 2010, CNS NEUROL DISORD-DR, V9, P701, DOI 10.2174/187152710793237421; Yang YJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013427; YEH GC, 1988, J BIOL CHEM, V263, P13083; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zabirnyk O, 2010, CARCINOGENESIS, V31, P446, DOI 10.1093/carcin/bgp299; Zhou DJ, 2011, J INFECT DIS, V203, P1647, DOI 10.1093/infdis/jir163	79	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25439	25451		10.1074/jbc.M115.652776	http://dx.doi.org/10.1074/jbc.M115.652776			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26330555	Green Published, hybrid			2022-12-28	WOS:000362962800020
J	Maier, E; Mittermeir, M; Ess, S; Neuper, T; Schmiedlechner, A; Duschl, A; Horejs-Hoeck, J				Maier, Elisabeth; Mittermeir, Michaela; Ess, Stefanie; Neuper, Theresa; Schmiedlechner, Angela; Duschl, Albert; Horejs-Hoeck, Jutta			Prerequisites for Functional Interleukin 31 Signaling and Its Feedback Regulation by Suppressor of Cytokine Signaling 3 (SOCS3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED ACTIVATION; TRANSDUCER GP130; RECEPTOR; EXPRESSION; KINASE; REGION; IL-31; CELLS; ASSOCIATION; RECRUITMENT	Interleukin-31 (IL-31) is a T helper type 2 cell-derived cytokine tightly associated with inflammatory skin disorders. IL-31-induced signaling is mediated by a receptor complex composed of oncostatin M receptor beta and the cytokine-specific receptor subunit IL-31R alpha, of which there are several isoforms. The latter can be classified as long or short isoforms with respect to their intracellular domain. At present, the signaling capabilities of the different isoforms remain inchoately understood, and potential mechanisms involved in negative regulation of IL-31R alpha signaling have so far not been studied in detail. Here, we show that both the long and short isoforms of IL-31R alpha are capable of inducing STAT signaling. However, the presence of a functional JAK-binding box within IL-31R alpha is an essential prerequisite for functional IL-31-mediated STAT3 signaling. Moreover, both the long and short isoforms require on costatin M receptor beta for their activity. We also show that IL-31 induces expression of four suppressor of cytokine signaling family members and provide evidence that SOCS3 acts as a potent feedback inhibitor of IL-31-induced signaling. Taken together, this study identifies crucial requirements for IL-31 signaling and shows its counter-regulation by SOCS3.	[Maier, Elisabeth; Mittermeir, Michaela; Ess, Stefanie; Neuper, Theresa; Schmiedlechner, Angela; Duschl, Albert; Horejs-Hoeck, Jutta] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Salzburg University	Horejs-Hoeck, J (corresponding author), Salzburg Univ, Dept Mol Biol, Hellbrunner Str 34, A-5020 Salzburg, Austria.	jutta.horejs_hoeck@sbg.ac.at	Duschl, Albert/E-5872-2011; Horejs-Hoeck, Jutta/AAF-1735-2019; Horejs-Hoeck, Jutta/E-5010-2011	Duschl, Albert/0000-0002-7034-9860; Horejs-Hoeck, Jutta/0000-0002-0984-204X; Horejs-Hoeck, Jutta/0000-0002-0984-204X	Austrian Science Fund FWF [P 23933, P 25696]; Austrian Science Fund (FWF) [P 23933] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund FWF Grants P 23933 and P 25696.The authors declare that they have no conflicts of interest with the contents of this article.	Boulay JL, 2003, IMMUNITY, V19, P159, DOI 10.1016/S1074-7613(03)00211-5; Burysek L, 2002, J BIOL CHEM, V277, P33509, DOI 10.1074/jbc.M201941200; Chattopadhyay S, 2007, J BIOL CHEM, V282, P3014, DOI 10.1074/jbc.M609655200; Cornelissen C, 2012, EUR J CELL BIOL, V91, P552, DOI 10.1016/j.ejcb.2011.07.006; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Dambacher J, 2007, GUT, V56, P1257, DOI 10.1136/gut.2006.118679; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Diveu C, 2003, J BIOL CHEM, V278, P49850, DOI 10.1074/jbc.M307286200; Diveu C, 2004, EUR CYTOKINE NETW, V15, P291; Dreuw A, 2004, J BIOL CHEM, V279, P36112, DOI 10.1074/jbc.M401122200; Ghilardi N, 2002, J BIOL CHEM, V277, P16831, DOI 10.1074/jbc.M201140200; Haan C, 2000, BIOCHEM J, V349, P261, DOI 10.1042/0264-6021:3490261; Hebenstreit D, 2005, MOL IMMUNOL, V42, P295, DOI 10.1016/j.molimm.2004.09.004; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hintzen C, 2008, J BIOL CHEM, V283, P19465, DOI 10.1074/jbc.M710157200; Horejs-Hoeck J, 2012, J IMMUNOL, V188, P5319, DOI 10.4049/jimmunol.1101044; Kershaw NJ, 2014, GROWTH FACTORS, V32, P1, DOI 10.3109/08977194.2013.877005; Kershaw NJ, 2013, NAT STRUCT MOL BIOL, V20, P469, DOI 10.1038/nsmb.2519; Krebs DL, 2000, J CELL SCI, V113, P2813; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Kubo M, 2013, EUR J IMMUNOL, V43, P1702, DOI 10.1002/eji.201343748; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; MURAKAMI M, 1993, SCIENCE, V260, P1808, DOI 10.1126/science.8511589; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Pezet A, 1997, MOL CELL ENDOCRINOL, V129, P199, DOI 10.1016/S0303-7207(97)00063-4; Posselt G, 2011, J IMMUNOL, V187, P2875, DOI 10.4049/jimmunol.1003348; Radtke S, 2002, J BIOL CHEM, V277, P11297, DOI 10.1074/jbc.M100822200; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Schwarz H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113840; Shiao YM, 2013, J INVEST DERMATOL, V133, P1375, DOI 10.1038/jid.2012.484; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; TANNER JW, 1995, J BIOL CHEM, V270, P6523, DOI 10.1074/jbc.270.12.6523; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	36	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24747	24759		10.1074/jbc.M115.661306	http://dx.doi.org/10.1074/jbc.M115.661306			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26306032	Green Published, hybrid			2022-12-28	WOS:000362598300011
J	Wong, K; Kozlov, G; Zhang, YL; Gehring, K				Wong, Kathy; Kozlov, Guennadi; Zhang, Yinglu; Gehring, Kalle			Structure of the Legionella Effector, lpg1496, Suggests a Role in Nucleotide Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; SYSTEM; IDENTIFICATION; TRANSLOCATION; CONSERVATION; MACROPHAGES; VIRULENCE; DISEASE; DOMAIN	Pathogenic Gram-negative bacteria use specialized secretion systems that translocate bacterial proteins, termed effectors, directly into host cells where they interact with host proteins and biochemical processes for the benefit of the pathogen. lpg1496 is a previously uncharacterized effector of Legionella pneumophila, the causative agent of Legionnaires disease. Here, we crystallized three nucleotide binding domains from lpg1496. The C-terminal domain, which is conserved among the SidE family of effectors, is formed of two largely alpha-helical lobes with a nucleotide binding cleft. A structural homology search has shown similarity to phosphodiesterases involved in cleavage of cyclic nucleotides. We have also crystallized a novel domain that occurs twice in the N-terminal half of the protein that we term the KLAMP domain due to the presence of homologous domains in bacterial histidine kinase-like ATP binding region-containing proteins and S-adenosylmethionine-dependent methyltransferase proteins. Both KLAMP structures are very similar but selectively bind 3',5'-cAMP and ADP. A co-crystal of the KLAMP1 domain with 3',5'-cAMP reveals the contribution of Tyr-61 and Tyr-69 that produces pi-stacking interactions with the adenine ring of the nucleotide. Our study provides the first structural insights into two novel nucleotide binding domains associated with bacterial virulence.	[Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, 3649 Promenade Sir William Osier,Rm 473, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	National Science Foundation (NSF); NIGMS, National Institutes of Health (NIH)/via NSF Award [DMR-0225180]; Center for Research Resources, NIH [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NIGMS, National Institutes of Health (NIH)/via NSF Award; Center for Research Resources, NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Miroslaw Cygler (University of Saskatchewan) for the initial construct of lpg1496, Dr. Irena Ekiel for helpful discussions, and the laboratory of Dr. Alexander Yakunin (University of Toronto) for screening potential substrates of lpg1496. Data were acquired at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS). CHESS is supported by the National Science Foundation (NSF) and NIGMS, National Institutes of Health (NIH)/via NSF Award DMR-0225180, and the MacCHESS resource is supported by Center for Research Resources, NIH Award RR-01646.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Chang B, 2005, INFECT IMMUN, V73, P4272, DOI 10.1128/IAI.73.7.4272-4280.2005; Coers J, 2000, MOL MICROBIOL, V38, P719, DOI 10.1046/j.1365-2958.2000.02176.x; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Goddard D., 2008, SPARKY 3; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOSTETTER MK, 1995, BIOCHEM MOL MED, V55, P122, DOI 10.1006/bmme.1995.1042; Jeong KC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004695; Kurinov IV, 2004, ARZNEIMITTELFORSCH, V54, P692; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Ninio S, 2005, MOL MICROBIOL, V55, P912, DOI 10.1111/j.1365-2958.2004.04435.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ROSENSTREICH DL, 1977, J INFECT DIS, V136, pS239, DOI 10.1093/infdis/136.Supplement.S239; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Wang H, 2007, MOL MICROBIOL, V66, P1029, DOI 10.1111/j.1365-2958.2007.05976.x	30	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24727	24737		10.1074/jbc.M115.671263	http://dx.doi.org/10.1074/jbc.M115.671263			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26294765	Green Published, hybrid			2022-12-28	WOS:000362598300009
J	Estrella, NL; Clark, AL; Desjardins, CA; Nocco, SE; Naya, FJ				Estrella, Nelsa L.; Clark, Amanda L.; Desjardins, Cody A.; Nocco, Sarah E.; Naya, Francisco J.			MEF2D Deficiency in Neonatal Cardiomyocytes Triggers Cell Cycle Re-entry and Programmed Cell Death in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; MYOCYTE ENHANCER FACTOR-2; LARGE GENE LISTS; CARDIAC-HYPERTROPHY; SIGNALING PATHWAYS; MOUSE HEART; PROLIFERATION; AKT; APOPTOSIS; MUSCLE	The cardiomyocyte cell cycle is a poorly understood process. Mammalian cardiomyocytes permanently withdraw from the cell cycle shortly after birth but can re-enter the cell cycle and proliferate when subjected to injury within a brief temporal window in the neonatal period. Thus, investigating the mechanisms of cell cycle regulation in neonatal cardiomyocytes may provide critical insight into the molecular events that prevent adult myocytes from proliferating in response to injury or stress. MEF2D is a key transcriptional mediator of pathological remodeling in the adult heart downstream of various stress-promoting insults, However, the specific gene programs regulated by MEF2D in cardioniyocytes are unknown. By performing genome-wide transcriptome analysis using MEF2D-depleted neonatal cardiomyocytes, we found a significant impairment in the cell cycle, characterized by the up-regulation of numerous positive cell cycle regulators. Expression of Pten, the primary negative regulator of PI3K1Akt, was significantly reduced in 1\4E1'2D-deficient cardiomyocytes and found to be a direct target gene of MEF2D. Consistent with these findings mutant cardioniyocytes showed activation of the PI3K/Akt survival pathway. Paradoxically, prolonged deficiency of MEF2D in neonatal cardiornyocytes did not trigger proliferation but instead resulted in programmed cell death, which is likely mediated by the EH transcription factor. These results demonstrate a critical role for MEF2D in cell cycle regulation of post-mitotic, neonatal cardiomyocytes in vitro.	[Estrella, Nelsa L.; Clark, Amanda L.; Desjardins, Cody A.; Nocco, Sarah E.; Naya, Francisco J.] Boston Univ, Dept Biol, Program Cell & Mol Biol, Boston, MA 02215 USA	Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, 24 Cummington Mall, Boston, MA 02215 USA.	fnaya@bu.edu			National Heart, Lung, and Blood Institute, National Institutes of Health [HL73304]; Beckman Scholars Program; Boston University Bioinformatics CTSI [U54-TR001012]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001012] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073304] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Beckman Scholars Program; Boston University Bioinformatics CTSI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Heart, Lung, and Blood Institute, National Institutes of Health Grant HL73304 (to F. J. N.) and a diversity supplement (parent Grant HL73304) (to N. L. E.). This work was also supported by the Beckman Scholars Program (to S. E. N.) and Boston University Bioinformatics CTSI Grant U54-TR001012. The authors declare that they have no conflicts of interest with the contents of this article.	Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Chan SF, 2014, J NEUROSCI, V34, P4640, DOI 10.1523/JNEUROSCI.2510-12.2014; Chen JH, 2013, CIRC RES, V112, P1557, DOI 10.1161/CIRCRESAHA.112.300658; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Ebelt H, 2005, CIRC RES, V96, P509, DOI 10.1161/01.RES.0000159705.17322.57; el Azzouzi H, 2010, EUR J HEART FAIL, V12, P4, DOI 10.1093/eurjhf/hfp165; Estrella NL, 2015, J BIOL CHEM, V290, P1256, DOI 10.1074/jbc.M114.589838; Estrella N, 2014, CELL MOL LIFE SCI, V71, P1641, DOI 10.1007/s00018-013-1512-0; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Ewen EP, 2011, J BIOL CHEM, V286, P29644, DOI 10.1074/jbc.M111.268094; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Konno T, 2010, P NATL ACAD SCI USA, V107, P18097, DOI 10.1073/pnas.1012826107; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lin ZQ, 2015, CIRC RES, V116, P35, DOI 10.1161/CIRCRESAHA.115.304457; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; Matsui T, 2001, CIRCULATION, V104, P330; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Oudit GY, 2008, CARDIOVASC RES, V78, P505, DOI 10.1093/cvr/cvn041; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; RUMYANTSEV PP, 1977, INT REV CYTOL, V51, P187; Sengupta A, 2013, CIRC RES, V112, P267, DOI 10.1161/CIRCRESAHA.112.277442; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Zacchigna S, 2014, CARDIOVASC RES, V102, P312, DOI 10.1093/cvr/cvu057; Zebrowski DC, 2013, REV PHYSIOL BIOCH P, V165, P67, DOI 10.1007/112_2013_12	48	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24367	24380		10.1074/jbc.M115.666461	http://dx.doi.org/10.1074/jbc.M115.666461			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26294766	Green Published, hybrid			2022-12-28	WOS:000362218900025
J	Sommerfeld, A; Mayer, PGK; Cantore, M; Haussinger, D				Sommerfeld, Annika; Mayer, Patrick G. K.; Cantore, Miriam; Haeussinger, Dieter			Regulation of Plasma Membrane Localization of the Na+-Taurocholate Cotransporting Polypeptide (Ntcp) by Hyperosmolarity and Tauroursodeoxycholate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SALT EXPORT PUMP; ORGANIC ANION TRANSPORTER; CYCLIC ADENOSINE-MONOPHOSPHATE; MULTIDRUG-RESISTANCE PROTEIN-2; INDUCED HEPATOCYTE APOPTOSIS; PRIMARY BILIARY-CIRRHOSIS; ISOLATED RAT HEPATOCYTES; BILE-ACID SECRETION; URSODEOXYCHOLIC ACID	In perfused rat liver, hepatocyte shrinkage induces a Fyn-dependent retrieval of the bile salt export pump (Bsep) and multidrug resistance-associated protein 2 (Mrp2) from the canalicular membrane (Cantore, M., Reinehr, R., Sommerfeld, A., Becker, M., and Haussinger, D. (2011) J. Biol. Chem. 286, 45014-45029) leading to cholestasis. However little is known about the effects of hyperosmolarity on short term regulation of the Na+-taurocholate cotransporting polypeptide (Ntcp), the major bile salt uptake system at the sinusoidal membrane of hepatocytes. The aim of this study was to analyze hyperosmotic Ntcp regulation and the underlying signaling events. Hyperosmolarity induced a significant retrieval of Ntcp from the basolateral-membrane, which was accompanied by an activating phosphorylation of the Src kinases Fyn and Yes but not of c-Src. Hyperosmotic internalization of Ntcp was sensitive to SU6656 and PP-2, suggesting that Fyn mediates Ntcp retrieval from the basolateral membrane. Hyperosmotic internalization of Ntcp was also found in livers from wild-type mice but not in p47phox knock-out mice. Tauroursodeoxycholate (TUDC) and cAMP reversed hyperosmolarity-induced Fyn activation and triggered re-insertion of the hyperosmotically retrieved Ntcp into the membrane. This was associated with dephosphorylation of the Ntcp on serine residues. Insertion of Ntcp by TUDC was sensitive to the integrin inhibitory hexapeptide GRGDSP and inhibition of protein kinase A. TUDC also reversed the hyperosmolarity-induced retrieval of bile salt export pump from the canalicular membrane. These findings suggest a coordinated and oxidative stress-and Fyn-dependent retrieval of sinusoidal and canalicular bile salt transport systems from the corresponding membranes. Ntcp insertion was also identified as a novel target of beta(1)-integrin-dependent TUDC action, which is frequently used in the treatment of cholestatic liver disease.	[Sommerfeld, Annika; Mayer, Patrick G. K.; Cantore, Miriam; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Haussinger, D (corresponding author), Univ Dusseldorf, Clin Gastroenterol Hepatol & Infect Dis, Moorenstr 5, D-40225 Dusseldorf, Germany.	haeussin@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft through Collaborative Research Center [974]	Deutsche Forschungsgemeinschaft through Collaborative Research Center	This work was supported by Deutsche Forschungsgemeinschaft through Collaborative Research Center 974 (Dusseldorf) "Communication and System Relevance in Liver Injury and Regeneration." The authors declare that they have no conflicts of interest with the contents of this article.	Akita H, 2001, BBA-BIOMEMBRANES, V1511, P7, DOI 10.1016/S0005-2736(00)00355-2; Anwer MS, 2014, HEPATOLOGY, V60, P1090, DOI 10.1002/hep.27088; Anwer MS, 2014, PFLUG ARCH EUR J PHY, V466, P77, DOI 10.1007/s00424-013-1367-0; Anwer MS, 2005, J BIOL CHEM, V280, P33687, DOI 10.1074/jbc.M502151200; Becker S, 2007, CELL PHYSIOL BIOCHEM, V19, P89, DOI 10.1159/000099197; Beuers U, 2001, HEPATOLOGY, V33, P1206, DOI 10.1053/jhep.2001.24034; Beuers U, 1999, HEPATOLOGY, V29, P477, DOI 10.1002/hep.510290227; BEUERS U, 1992, HEPATOLOGY, V16, P707, DOI 10.1002/hep.1840160315; Beuers U, 2015, J HEPATOL, V62, pS25, DOI 10.1016/j.jhep.2015.02.023; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bouezzedine F, 2015, VIROLOGY, V481, P34, DOI 10.1016/j.virol.2015.02.026; BUSCH GL, 1994, P NATL ACAD SCI USA, V91, P9165, DOI 10.1073/pnas.91.19.9165; Cantore M, 2011, J BIOL CHEM, V286, P45014, DOI 10.1074/jbc.M111.292896; Donner MG, 2007, AM J PHYSIOL-GASTR L, V293, pG1134, DOI 10.1152/ajpgi.00079.2007; Elferink RO, 2002, BBA-MOL BASIS DIS, V1586, P129; Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Gohlke H, 2013, HEPATOLOGY, V57, P1117, DOI 10.1002/hep.25992; Graf D, 2002, GASTROENTEROLOGY, V122, P1411, DOI 10.1053/gast.2002.32976; Graf D, 2006, HEPATOLOGY, V44, P1206, DOI 10.1002/hep.21368; GRUNE S, 1993, J BIOL CHEM, V268, P17734; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Haussinger D, 2003, GASTROENTEROLOGY, V124, P1476, DOI 10.1016/S0016-5085(03)00274-9; Haussinger D, 1996, Prog Liver Dis, V14, P29; HAUSSINGER D, 1992, BIOCHEM J, V288, P681; HAUSSINGER D, 1993, BIOCHEM J, V291, P355; HOFMANN AF, 1994, SCAND J GASTROENTERO, V29, P1, DOI 10.3109/00365529409103618; Koopen NR, 1998, HEPATOLOGY, V27, P537, DOI 10.1002/hep.510270231; Kubitz R, 1997, GASTROENTEROLOGY, V113, P1438, DOI 10.1053/gast.1997.v113.pm9352844; Kubitz R, 1999, GASTROENTEROLOGY, V116, P401, DOI 10.1016/S0016-5085(99)70138-1; Kurz AK, 2001, GASTROENTEROLOGY, V121, P407, DOI 10.1053/gast.2001.26262; Kurz AK, 2000, BIOCHEM J, V350, P207, DOI 10.1042/0264-6021:3500207; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; LEUSCHNER U, 1989, GASTROENTEROLOGY, V97, P1268, DOI 10.1016/0016-5085(89)91698-3; McConkey M, 2004, J BIOL CHEM, V279, P20882, DOI 10.1074/jbc.M309988200; MEIJER AJ, 1975, J BIOL CHEM, V250, P7728; Misra S, 2003, AM J PHYSIOL-GASTR L, V285, pG316, DOI 10.1152/ajpgi.00048.2003; Muhlfeld S, 2012, HEPATOLOGY, V56, P2387, DOI 10.1002/hep.25955; Mukhopadhayay S, 1997, AM J PHYSIOL-GASTR L, V273, pG842, DOI 10.1152/ajpgi.1997.273.4.G842; Mukhopadhyay S, 1998, HEPATOLOGY, V28, P1629, DOI 10.1002/hep.510280624; Noe B, 1996, GASTROENTEROLOGY, V110, P858, DOI 10.1053/gast.1996.v110.pm8608896; Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587; Nunes P, 2015, P NATL ACAD SCI USA, V112, pE3104, DOI 10.1073/pnas.1421290112; Park SW, 2012, AM J PHYSIOL-GASTR L, V303, pG657, DOI 10.1152/ajpgi.00529.2011; Paumgartner G, 2002, HEPATOLOGY, V36, P525, DOI 10.1053/jhep.2002.36088; Perez LM, 2006, TOXICOL SCI, V91, P150, DOI 10.1093/toxsci/kfj113; Poupon R, 2012, CLIN RES HEPATOL GAS, V36, pS3, DOI 10.1016/S2210-7401(12)70015-3; POUPON RE, 1991, NEW ENGL J MED, V324, P1548, DOI 10.1056/NEJM199105303242204; Reinehr R, 2003, FASEB J, V17, P731, DOI 10.1096/fj.02-0915fje; Reinehr R, 2003, GASTROENTEROLOGY, V125, P839, DOI 10.1016/S0016-5085(03)01055-2; Reinehr R, 2005, GASTROENTEROLOGY, V129, P2009, DOI 10.1053/j.gastro.2005.09.023; Reinehr R, 2006, J BIOL CHEM, V281, P23150, DOI 10.1074/jbc.M601451200; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Roelofsen H, 1998, J CELL SCI, V111, P1137; Roman ID, 2003, TOXICOL SCI, V71, P276, DOI 10.1093/toxsci/71.2.276; SAHA N, 1993, BIOCHEM J, V296, P701, DOI 10.1042/bj2960701; Sarkar S, 2006, TRAFFIC, V7, P1078, DOI 10.1111/j.1600-0854.2006.00447.x; Schliess F, 1997, GASTROENTEROLOGY, V113, P1306, DOI 10.1053/gast.1997.v113.pm9322526; Schliess F, 2007, FEBS J, V274, P5799, DOI 10.1111/j.1742-4658.2007.06100.x; Schmitt M, 2001, HEPATOLOGY, V33, P509, DOI 10.1053/jhep.2001.22648; Schmitt M, 2000, BIOL CHEM, V381, P487, DOI 10.1515/BC.2000.063; Schonhoff CM, 2008, HEPATOLOGY, V48, P1665, DOI 10.1002/hep.22495; Schonhoff CM, 2013, HEPATOLOGY, V58, P284, DOI 10.1002/hep.26333; Schonhoff CM, 2009, AM J PHYSIOL-GASTR L, V297, pG1259, DOI 10.1152/ajpgi.00177.2009; Sies H, 1978, Methods Enzymol, V52, P48; Sommerfeld A, 2015, CELL PHYSIOL BIOCHEM, V36, P866, DOI 10.1159/000430262; STIEGER B, 1994, GASTROENTEROLOGY, V107, P1781, DOI 10.1016/0016-5085(94)90821-4; Stross C, 2013, AM J PHYSIOL-GASTR L, V305, pG722, DOI 10.1152/ajpgi.00056.2013; Stross C, 2010, AM J PHYSIOL-GASTR L, V299, pG320, DOI 10.1152/ajpgi.00180.2010; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Trauner M, 1998, J CLIN INVEST, V101, P2092, DOI 10.1172/JCI1680; Vaz FM, 2015, HEPATOLOGY, V61, P260, DOI 10.1002/hep.27240; Vos TA, 1998, HEPATOLOGY, V28, P1637, DOI 10.1002/hep.510280625; Warskulat U, 1999, BIOL CHEM, V380, P1273, DOI 10.1515/BC.1999.162; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Webster CRL, 2002, J BIOL CHEM, V277, P28578, DOI 10.1074/jbc.M201937200; Webster CRL, 2002, AM J PHYSIOL-GASTR L, V283, pG44, DOI 10.1152/ajpgi.00530.2001; Webster CRL, 2000, J BIOL CHEM, V275, P29754, DOI 10.1074/jbc.M002831200; Xia W, 2014, P NATL ACAD SCI USA, V111, P17863, DOI 10.1073/pnas.1420645111; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	80	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24237	24254		10.1074/jbc.M115.666883	http://dx.doi.org/10.1074/jbc.M115.666883			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26306036	hybrid, Green Published			2022-12-28	WOS:000362218900016
J	Zhao, XX; Zhang, YB; Ni, PL; Wu, ZL; Yan, YC; Li, YP				Zhao, Xin-Xi; Zhang, Yun-Bin; Ni, Pei-Li; Wu, Zhi-Li; Yan, Yuan-Chang; Li, Yi-Ping			Protein Arginine Methyltransferase 6 (Prmt6) Is Essential for Early Zebrafish Development through the Direct Suppression of gadd45a Stress Sensor Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; c-Jun N-terminal kinase (JNK); histone methylation; p38; zebrafish; gadd45a; prmt6	TRANSCRIPTIONAL REPRESSION; EMBRYONIC-DEVELOPMENT; H3K4 TRIMETHYLATION; ZYGOTIC TRANSITION; GENOME ACTIVATION; TUMOR-SUPPRESSOR; HISTONE H3R2; METHYLATION; EXPRESSION; APOPTOSIS	Histone lysine methylation is important in early zebrafish development; however, the role of histone arginine methylation in this process remains unclear. H3R2me2a, generated by protein arginine methyltransferase 6 (Prmt6), is a repressive mark. To explore the role of Prmt6 and H3R2me2a during zebrafish embryogenesis, we identified the maternal characteristic of prmt6 and designed two prmt6-specific morpholino-oligos (MOs) to study its importance in early development, application of which led to early epiboly defects and significantly reduced the level of H3R2me2a marks. prmt6 mRNA could rescue the epiboly defects and the H3R2me2a reduction in the prmt6 morphants. Functionally, microarray data demonstrated that growth arrest and DNA damage-inducible, , a (gadd45a) was a significantly up-regulated gene in MO-treated embryos, the activity of which was linked to the activation of the p38/JNK pathway and apoptosis. Importantly, gadd45a MO and p38/JNK inhibitors could partially rescue the defect of prmt6 morphants, the downstream targets of Prmt6, and the apoptosis ratios of the prmt6 morphants. Moreover, the results of ChIP quantitative real time PCR and luciferase reporter assay indicated that gadd45a is a repressive target of Prmt6. Taken together, these results suggest that maternal Prmt6 is essential to early zebrafish development by directly repressing gadd45a.	[Zhao, Xin-Xi; Zhang, Yun-Bin; Ni, Pei-Li; Wu, Zhi-Li; Yan, Yuan-Chang; Li, Yi-Ping] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl,State Key Lab Cell Bi, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Li, YP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai Key Lab Mol Androl,State Key Lab Cell Bi, Shanghai 200031, Peoples R China.	Yipingli@sibcb.ac.cn			Major State Basic Research Development Program of China (973 Program) [2011CB966301, 2011CB915502]; Science and Technology Commission of Shanghai Municipality [11140900100]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Major State Basic Research Development Program of China (973 Program) Grants 2011CB966301 and 2011CB915502 and Science and Technology Commission of Shanghai Municipality Grant 11140900100. The authors declare that they have no conflict of interest.	Abell AN, 2007, J BIOL CHEM, V282, P30476, DOI 10.1074/jbc.M705783200; Arico JK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001391; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Bruns AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048539; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Casadio F, 2013, P NATL ACAD SCI USA, V110, P14894, DOI 10.1073/pnas.1312925110; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; Di Lorenzo A, 2014, NUCLEIC ACIDS RES, V42, P8297, DOI 10.1093/nar/gku530; El-Andaloussi N, 2006, MOL CELL, V22, P51, DOI 10.1016/j.molcel.2006.02.013; Evans TG, 2005, CELL STRESS CHAPERON, V10, P66, DOI 10.1379/CSC-79R.1; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Herglotz J, 2013, ONCOGENE, V32, P2565, DOI 10.1038/onc.2012.274; Hsu RJ, 2011, J BIOL CHEM, V286, P6855, DOI 10.1074/jbc.M110.161638; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Ikegami R, 1999, DEV BIOL, V209, P409, DOI 10.1006/dbio.1999.9243; KANE DA, 1993, DEVELOPMENT, V119, P447; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Kleinschmidt MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041446; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Lee MT, 2013, NATURE, V503, P360, DOI 10.1038/nature12632; Lee YH, 2012, STEM CELLS DEV, V21, P2613, DOI 10.1089/scd.2011.0330; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5; Michaud-Levesque J, 2009, J BIOL CHEM, V284, P21338, DOI 10.1074/jbc.M109.005322; Miyake Z, 2007, MOL CELL BIOL, V27, P2765, DOI 10.1128/MCB.01435-06; Miyamoto K, 2013, SCIENCE, V341, P1002, DOI 10.1126/science.1240376; Nakajima K, 2000, J BIOL CHEM, V275, P10484, DOI 10.1074/jbc.275.14.10484; Neault M, 2012, NUCLEIC ACIDS RES, V40, P9513, DOI 10.1093/nar/gks764; Phalke S, 2012, NUCLEIC ACIDS RES, V40, P9534, DOI 10.1093/nar/gks858; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Song SM, 2013, DEV CELL, V24, P486, DOI 10.1016/j.devcel.2013.01.016; Stein C, 2012, NUCLEIC ACIDS RES, V40, P9522, DOI 10.1093/nar/gks767; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Wang YC, 2012, FEBS J, V279, P932, DOI 10.1111/j.1742-4658.2012.08490.x; Xiao YM, 2013, MAR BIOTECHNOL, V15, P716, DOI 10.1007/s10126-013-9520-5; Yabu T, 2015, CELL DEATH DIFFER, V22, P258, DOI 10.1038/cdd.2014.128; Yamashita M, 2003, COMP BIOCHEM PHYS B, V136, P731, DOI 10.1016/j.cbpc.2003.08.013; Zhang WW, 2015, J MOL CELL BIOL, V7, P489, DOI 10.1093/jmcb/mjv040; Zhong JX, 2014, CELL DEATH DIFFER, V21, P1013, DOI 10.1038/cdd.2014.22	48	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					402	412		10.1074/jbc.M115.666347	http://dx.doi.org/10.1074/jbc.M115.666347			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26487724	hybrid, Green Published			2022-12-28	WOS:000367589500033
J	van der Kant, R; Jonker, CTH; Wijdeven, RH; Bakker, J; Janssen, L; Klumperman, J; Neefjes, J				van der Kant, Rik; Jonker, Caspar T. H.; Wijdeven, Ruud H.; Bakker, Jeroen; Janssen, Lennert; Klumperman, Judith; Neefjes, Jacques			Characterization of the Mammalian CORVET and HOPS Complexes and Their Modular Restructuring for Endosome Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOPHAGOSOME-LYSOSOME FUSION; C-VPS COMPLEX; TETHERING COMPLEX; ENDOCYTIC TRAFFICKING; RENAL DYSFUNCTION; MEMBRANE-FUSION; PROTEIN COMPLEX; GTPASE ARL8B; ARC SYNDROME; BIOGENESIS	Trafficking of cargo through the endosomal system depends on endosomal fusion events mediated by SNARE proteins, Rab-GTPases, and multisubunit tethering complexes. The CORVET and HOPS tethering complexes, respectively, regulate early and late endosomal tethering and have been characterized in detail in yeast where their sequential membrane targeting and assembly is well understood. Mammalian CORVET and HOPS subunits significantly differ from their yeast homologues, and novel proteins with high homology to CORVET/HOPS subunits have evolved. However, an analysis of the molecular interactions between these subunits in mammals is lacking. Here, we provide a detailed analysis of interactions within the mammalian CORVET and HOPS as well as an additional endosomal-targeting complex (VIPAS39-VPS33B) that does not exist in yeast. We show that core interactions within CORVET and HOPS are largely conserved but that the membrane-targeting module in HOPS has significantly changed to accommodate binding to mammalian-specific RAB7 interacting lysosomal protein (RILP). Arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome-associated mutations in VPS33B selectively disrupt recruitment to late endosomes by RILP or binding to its partner VIPAS39. Within the shared core of CORVET/HOPS, we find that VPS11 acts as a molecular switch that binds either CORVET-specific TGFBRAP1 or HOPS-specific VPS39/RILP thereby allowing selective targeting of these tethering complexes to early or late endosomes to time fusion events in the endo/lysosomal pathway.	[van der Kant, Rik; Wijdeven, Ruud H.; Bakker, Jeroen; Janssen, Lennert; Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Jonker, Caspar T. H.; Klumperman, Judith] Ctr Mol Med, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	Netherlands Cancer Institute	van der Kant, R (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	Rikkant@gmail.com; j.neefjes@nki.nl	Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; Janssen, Lennert/0000-0001-9705-0204; van der Kant, Rik/0000-0002-7023-0106	European Research Council; TOP grant from The Netherlands Organization for Scientific Research, Chemical Sciences	European Research Council(European Research Council (ERC)European Commission); TOP grant from The Netherlands Organization for Scientific Research, Chemical Sciences	This work was supported by a European Research Council Advanced Grant and a TOP grant from The Netherlands Organization for Scientific Research, Chemical Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Akbar MA, 2009, MOL BIOL CELL, V20, P1705, DOI 10.1091/mbc.E08-03-0282; Bem D, 2015, BLOOD, V126, P133, DOI 10.1182/blood-2014-12-614677; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chirivino D, 2011, MOL BIOL CELL, V22, P375, DOI 10.1091/mbc.E10-09-0796; Cullinane AR, 2010, NAT GENET, V42, P303, DOI 10.1038/ng.538; Felici A, 2003, EMBO J, V22, P4465, DOI 10.1093/emboj/cdg428; Garg S, 2011, IMMUNITY, V35, P182, DOI 10.1016/j.immuni.2011.06.009; Gissen P, 2005, HUM MOL GENET, V14, P1261, DOI 10.1093/hmg/ddi137; Gissen P, 2004, NAT GENET, V36, P400, DOI 10.1038/ng1325; Graham SC, 2013, P NATL ACAD SCI USA, V110, P13345, DOI 10.1073/pnas.1307074110; Jiang P, 2014, MOL BIOL CELL, V25, P1327, DOI 10.1091/mbc.E13-08-0447; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Khatter D, 2015, J CELL SCI, V128, P1746, DOI 10.1242/jcs.162651; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; Lachmann J., 2014, CELL LOGIST, V4, DOI DOI 10.4161/21592780.2014.970840; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Lin XS, 2014, SCI REP-UK, V4, DOI 10.1038/srep07282; Lo B, 2005, BLOOD, V106, P4159, DOI 10.1182/blood-2005-04-1356; Lobingier BT, 2012, MOL BIOL CELL, V23, P4611, DOI 10.1091/mbc.E12-05-0343; McEwan DG, 2015, CELL HOST MICROBE, V17, P58, DOI 10.1016/j.chom.2014.11.011; McEwan DG, 2015, MOL CELL, V57, P39, DOI 10.1016/j.molcel.2014.11.006; Messller S, 2011, IMMUNOBIOLOGY, V216, P343, DOI 10.1016/j.imbio.2010.07.006; Nakamura N, 1997, J BIOL CHEM, V272, P11344; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Ostrowicz CW, 2010, TRAFFIC, V11, P1334, DOI 10.1111/j.1600-0854.2010.01097.x; Perini ED, 2014, TRAFFIC, V15, P1366, DOI 10.1111/tra.12232; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; Pols MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2360; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; Schindler C, 2015, NAT CELL BIOL, V17, P639, DOI 10.1038/ncb3129; Smith H, 2012, HUM MUTAT, V33, P1656, DOI 10.1002/humu.22155; Solinger JA, 2014, MOL BIOL CELL, V25, P3909, DOI 10.1091/mbc.E13-12-0710; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Suzuki T, 2003, P NATL ACAD SCI USA, V100, P1146, DOI 10.1073/pnas.0237292100; Tornieri K, 2013, HUM MOL GENET, V22, P5215, DOI 10.1093/hmg/ddt378; van der Kant R, 2013, J CELL SCI, V126, P3462, DOI 10.1242/jcs.129270; van Luijn MM, 2015, BRAIN, V138, P1531, DOI 10.1093/brain/awv080; VENNEGOOR C, 1985, INT J CANCER, V35, P287, DOI 10.1002/ijc.2910350302; Wartosch L, 2015, TRAFFIC, V16, P727, DOI 10.1111/tra.12283; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Wurmser AE, 2000, J CELL BIOL, V151, P551, DOI 10.1083/jcb.151.3.551; Wurthner JU, 2001, J BIOL CHEM, V276, P19495, DOI 10.1074/jbc.M006473200; Zhu GD, 2009, MOL BIOL CELL, V20, P1223, DOI 10.1091/mbc.E08-07-0728	48	61	61	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30280	30290		10.1074/jbc.M115.688440	http://dx.doi.org/10.1074/jbc.M115.688440			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26463206	hybrid, Green Published			2022-12-28	WOS:000366738200009
J	Eimer, E; Frobel, J; Blummel, AS; Muller, M				Eimer, Ekaterina; Froebel, Julia; Bluemmel, Anne-Sophie; Mueller, Matthias			TatE as a Regular Constituent of Bacterial Twin-arginine Protein Translocases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEC-INDEPENDENT PROTEIN; ESCHERICHIA-COLI; TRANSPORT-SYSTEM; FOLDED PROTEINS; SIGNAL PEPTIDE; COMPONENT; EXPORT; BINDING; MEMBRANE; SUBUNIT	Twin-arginine translocation (Tat) systems mediate the transmembrane translocation of completely folded proteins that possess a conserved twin-arginine (RR) motif in their signal sequences. Many Tat systems consist of three essential membrane components named TatA, TatB, and TatC. It is not understood why some bacteria, in addition, constitutively express a functional paralog of TatA called TatE. Here we show, in live Escherichia coli cells, that, upon expression of a Tat substrate protein, fluorescently labeled TatE-GFP relocates from a rather uniform distribution in the plasma membrane into a number of discrete clusters. Clustering strictly required an intact RR signal peptide and the presence of the TatABC subunits, suggesting that TatE-GFP associates with functional Tat translocases. In support of this notion, site-specific photo cross-linking revealed interactions of TatE with TatA, TatB, and TatC. The same approach also disclosed a pronounced tendency of TatE and TatA to hetero-oligomerize. Under in vitro conditions, we found that TatE replaces TatA inefficiently. Our collective results are consistent with TatE being a regular constituent of the Tat translocase in E. coli.	[Eimer, Ekaterina; Froebel, Julia; Bluemmel, Anne-Sophie; Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Eimer, Ekaterina; Bluemmel, Anne-Sophie] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Bluemmel, Anne-Sophie] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Muller, M (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany.	matthias.mueller@biochemie.uni-freiburg.de			German Research Foundation [SFB746]; Excellence Initiative (Spemann Graduate School) of the German Research Foundation [GSC-4]	German Research Foundation(German Research Foundation (DFG)); Excellence Initiative (Spemann Graduate School) of the German Research Foundation	This study was supported by SFB746 Grant P13 and the Excellence Initiative (Grant GSC-4, Spemann Graduate School) of the German Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alami M, 2002, J BIOL CHEM, V277, P20499, DOI 10.1074/jbc.M201711200; Alcock F, 2013, P NATL ACAD SCI USA, V110, pE3650, DOI 10.1073/pnas.1306738110; Aldridge C, 2014, J CELL BIOL, V205, P51, DOI 10.1083/jcb.201311057; Aldridge C, 2012, J BIOL CHEM, V287, P34752, DOI 10.1074/jbc.M112.385666; Baglieri J, 2012, J BIOL CHEM, V287, P7335, DOI 10.1074/jbc.M111.326355; Behrendt J, 2014, BIOCHEMISTRY-US, V53, P2344, DOI 10.1021/bi500169s; Berks BC, 2014, CURR OPIN STRUC BIOL, V27, P32, DOI 10.1016/j.sbi.2014.03.003; Blummel AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8234; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Celedon JM, 2013, BBA-MOL CELL RES, V1833, P341, DOI 10.1016/j.bbamcr.2012.06.028; Celedon JM, 2012, J CELL BIOL, V197, P523, DOI 10.1083/jcb.201201096; Cleon F, 2015, MOL MICROBIOL, V98, P111, DOI 10.1111/mmi.13106; Cline K, 2015, J BIOL CHEM, V290, P16530, DOI 10.1074/jbc.R114.626820; Frobel J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2308; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Goosens VJ, 2014, BBA-MOL CELL RES, V1843, P1698, DOI 10.1016/j.bbamcr.2013.10.008; Heikkila MP, 2001, J BACTERIOL, V183, P1663, DOI 10.1128/JB.183.5.1663-1671.2001; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Kikuchi Y, 2006, APPL ENVIRON MICROB, V72, P7183, DOI 10.1128/AEM.01528-06; Kudva R, 2013, RES MICROBIOL, V164, P505, DOI 10.1016/j.resmic.2013.03.016; LESLEY SA, 1991, J BIOL CHEM, V266, P2632; Ma XY, 2013, PLANT CELL, V25, P999, DOI 10.1105/tpc.112.107409; Ma XY, 2010, EMBO J, V29, P1477, DOI 10.1038/emboj.2010.44; Moser Michael, 2007, V390, P63; Patel R, 2014, BBA-MOL CELL RES, V1843, P1620, DOI 10.1016/j.bbamcr.2014.02.013; Ramasamy S, 2013, STRUCTURE, V21, P777, DOI 10.1016/j.str.2013.03.004; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Rose P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069488; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Taubert J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119761; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4; Zoufaly S, 2012, J BIOL CHEM, V287, P13430, DOI 10.1074/jbc.M112.343798	40	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29281	29289		10.1074/jbc.M115.696005	http://dx.doi.org/10.1074/jbc.M115.696005			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26483541	Green Published, hybrid			2022-12-28	WOS:000366613400016
J	Yamada, K; Gherasim, C; Banerjee, R; Koutmos, M				Yamada, Kazuhiro; Gherasim, Carmen; Banerjee, Ruma; Koutmos, Markos			Structure of Human B-12 Trafficking Protein CblD Reveals Molecular Mimicry and Identifies a New Subfamily of Nitro-FMN Reductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN METHIONINE SYNTHASE; COMPLEMENTATION GROUP; VITAMIN-B-12; MMACHC; MUTATIONS; DEFECT; DOMAIN; DEFICIENCY; ACTIVATION; PREDICTION	In mammals, B-12 (or cobalamin) is an essential cofactor required by methionine synthase and methylmalonyl-CoA mutase. A complex intracellular pathway supports the assimilation of cobalamin into its active cofactor forms and delivery to its target enzymes. MMADHC(the methylmalonic aciduria and homocystinuria type D protein), commonly referred to as CblD, is a key chaperone involved in intracellular cobalamin trafficking, and mutations in CblD cause methylmalonic aciduria and/or homocystinuria. Herein, we report the first crystal structure of the globular C-terminal domain of human CblD, which is sufficient for its interaction with MMADHC (the methylmalonic aciduria and homocystinuria type C protein), or CblC, and for supporting the cytoplasmic cobalamin trafficking pathway. CblD contains an alpha+beta fold that is structurally reminiscent of the nitro-FMN reductase superfamily. Two of the closest structural relatives of CblD are CblC, a multifunctional enzyme important for cobalamin trafficking, and the activation domain of methionine synthase. CblD, CblC, and the activation domain of methionine synthase share several distinguishing features and, together with two recently described corrinoid-dependent reductive dehalogenases, constitute a new subclass within the nitro-FMN reductase superfamily. We demonstrate that CblD enhances oxidation of cob(II) alamin bound to CblC and that disease-causing mutations in CblD impair the kinetics of this reaction. The striking structural similarity of CblD to CblC, believed to be contiguous in the cobalamin trafficking pathway, suggests the co-option of molecular mimicry as a strategy for achieving its function.	[Yamada, Kazuhiro; Koutmos, Markos] Uniformed Serv Univ Hlth Sci, Dept Biochem, Bethesda, MD 20814 USA; [Gherasim, Carmen; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	Uniformed Services University of the Health Sciences - USA; University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu; markos.koutmos@usuhs.edu	Regan, Clinton/E-6250-2012	Koutmos, Markos/0000-0003-0933-6312	National Institutes of Health [DK45776]; American Heart Association [13SDG14560056]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776, R29DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK45776 (to R.B.). This work was also supported by American Heart Association Grant 13SDG14560056 (to M.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; Bommer M, 2014, SCIENCE, V346, P455, DOI 10.1126/science.1258118; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deme JC, 2012, MOL GENET METAB, V107, P352, DOI 10.1016/j.ymgme.2012.07.001; Dobson CM, 2002, HUM MOL GENET, V11, P3361, DOI 10.1093/hmg/11.26.3361; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; Dowling DP, 2012, ANNU REV BIOPHYS, V41, P403, DOI 10.1146/annurev-biophys-050511-102225; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Froese DS, 2012, BIOCHEMISTRY-US, V51, P5083, DOI 10.1021/bi300150y; FUJII K, 1977, ARCH BIOCHEM BIOPHYS, V178, P662, DOI 10.1016/0003-9861(77)90238-7; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Gherasim C, 2013, BIOCHIMIE, V95, P1023, DOI 10.1016/j.biochi.2013.02.003; Gulati S, 1996, HUM MOL GENET, V5, P1859, DOI 10.1093/hmg/5.12.1859; Hannibal L, 2011, MOL GENET METAB, V103, P226, DOI 10.1016/j.ymgme.2011.03.008; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Kim J, 2009, J BIOL CHEM, V284, P33418, DOI 10.1074/jbc.M109.057877; KOLHOUSE JF, 1977, P NATL ACAD SCI USA, V74, P921, DOI 10.1073/pnas.74.3.921; Koutmos M, 2011, J BIOL CHEM, V286, P29780, DOI 10.1074/jbc.M111.261370; Koutmos M, 2009, P NATL ACAD SCI USA, V106, P18527, DOI 10.1073/pnas.0906132106; Leclerc D, 1996, HUM MOL GENET, V5, P1867, DOI 10.1093/hmg/5.12.1867; Lerner-Ellis JP, 2009, HUM MUTAT, V30, P1072, DOI 10.1002/humu.21001; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Mah W, 2013, MOL GENET METAB, V108, P112, DOI 10.1016/j.ymgme.2012.11.284; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MELLMAN IS, 1977, P NATL ACAD SCI USA, V74, P916, DOI 10.1073/pnas.74.3.916; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Payne KAP, 2015, NATURE, V517, P513, DOI 10.1038/nature13901; Plesa M, 2011, MOL GENET METAB, V102, P139, DOI 10.1016/j.ymgme.2010.10.011; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]; Stucki M, 2012, HUM MOL GENET, V21, P1410, DOI 10.1093/hmg/ddr579; Suormala T, 2004, J BIOL CHEM, V279, P42742, DOI 10.1074/jbc.M407733200; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Wang JW, 2004, ACTA CRYSTALLOGR D, V60, P1244, DOI 10.1107/S0907444904010674; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolthers KR, 2007, FEBS J, V274, P738, DOI 10.1111/j.1742-4658.2006.05618.x; Yu HC, 2013, AM J HUM GENET, V93, P506, DOI 10.1016/j.ajhg.2013.07.022	48	17	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29155	29166		10.1074/jbc.M115.682435	http://dx.doi.org/10.1074/jbc.M115.682435			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26364851	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000366613400004
J	Moritz, AE; Rastedt, DE; Stanislowski, DJ; Shetty, M; Smith, MA; Vaughan, RA; Foster, JD				Moritz, Amy E.; Rastedt, Danielle E.; Stanislowski, Daniel J.; Shetty, Madhur; Smith, Margaret A.; Vaughan, Roxanne A.; Foster, James D.			Reciprocal Phosphorylation and Palmitoylation Control Dopamine Transporter Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-translational modification (PTM); protein acylation; protein kinase C (PKC); protein palmitoylation; protein phosphorylation; DHHC; acyl protein transferases	PROTEIN-KINASE-C; TRAFFICKING-INDEPENDENT REGULATION; NEUROTRANSMITTER TRANSPORTERS; DEPENDENT ENDOCYTOSIS; PHORBOL ESTERS; COCAINE; AMPHETAMINE; BINDING; INTERNALIZATION; RECEPTOR	Background: The dopamine transporter establishes synaptic transmitter levels and strength of dopamine neurotransmission. Results: Reciprocal modification of specific DAT phosphorylation and palmitoylation sites dictates steady-state and regulated transport capacity in the absence of trafficking. Conclusion: The balance between phosphorylation and palmitoylation controls DA transport kinetics. Significance: This is a previously unknown mode of transporter regulation that may be a point of dysregulation in dopamine imbalance disorders. The dopamine transporter is a neuronal protein that drives the presynaptic reuptake of dopamine (DA) and is the major determinant of transmitter availability in the brain. Dopamine transporter function is regulated by protein kinase C (PKC) and other signaling pathways through mechanisms that are complex and poorly understood. Here we investigate the role of Ser-7 phosphorylation and Cys-580 palmitoylation in mediating steady-state transport kinetics and PKC-stimulated transport down-regulation. Using both mutational and pharmacological approaches, we demonstrate that these post-translational modifications are reciprocally regulated, leading to transporter populations that display high phosphorylation-low palmitoylation or low phosphorylation-high palmitoylation. The balance between the modifications dictates transport capacity, as conditions that promote high phosphorylation or low palmitoylation reduce transport V-max and enhance PKC-stimulated down-regulation, whereas conditions that promote low phosphorylation or high palmitoylation increase transport V-max and suppress PKC-stimulated down-regulation. Transitions between these functional states occur when endocytosis is blocked or undetectable, indicating that the modifications kinetically regulate the velocity of surface transporters. These findings reveal a novel mechanism for control of DA reuptake that may represent a point of dysregulation in DA imbalance disorders.	[Moritz, Amy E.; Rastedt, Danielle E.; Stanislowski, Daniel J.; Shetty, Madhur; Smith, Margaret A.; Vaughan, Roxanne A.; Foster, James D.] Univ N Dakota, Dept Basic Sci, Sch Med & Hlth Sci, Grand Forks, ND 58202 USA	University of North Dakota Grand Forks	Vaughan, RA (corresponding author), Univ N Dakota, Dept Basic Sci, Sch Med & Hlth Sci, Grand Forks, ND 58202 USA.	roxanne.vaughan@med.und.edu; james.d.foster@med.und.edu	Regan, Clinton/E-6250-2012	Shetty, Madhur/0000-0002-6476-2261	National Institutes of Health [R15 DA031991, R01 DA13147, P20 RR017699, P20 RR016741]; ND EPSCOR Doctoral Dissertation Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA031991, R01DA013147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ND EPSCOR Doctoral Dissertation Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants R15 DA031991 (to J. D. F.), R01 DA13147 (to R. A. V.), P20 RR017699 (to the University of North Dakota from the COBRE program of the National Center for Research Resources), and P20 RR016741 (to the University of North Dakota from the INBRE program of the National Center for Research Resources. This work was also supported by an ND EPSCOR Doctoral Dissertation Fellowship (to D. E. R.). The authors declare that they have no conflicts of interest with the content of this article.	Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Blakely RD, 2014, NEUROCHEM INT, V73, P1, DOI 10.1016/j.neuint.2014.04.008; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Bowton E, 2010, J NEUROSCI, V30, P6048, DOI 10.1523/JNEUROSCI.5094-09.2010; Carvelli L, 2008, P NATL ACAD SCI USA, V105, P14192, DOI 10.1073/pnas.0802214105; Cervinski MA, 2010, NEUROSCIENCE, V170, P408, DOI 10.1016/j.neuroscience.2010.07.025; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Davda D, 2013, ACS CHEM BIOL, V8, P1912, DOI 10.1021/cb400380s; Dehnes Y, 2014, NEUROCHEM INT, V73, P4, DOI 10.1016/j.neuint.2014.02.003; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Figueiredo J, 2014, CURR CANCER DRUG TAR, V14, P2, DOI 10.2174/15680096113136660106; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Foster JD, 2012, J BIOL CHEM, V287, P29702, DOI 10.1074/jbc.M112.367706; Foster JD, 2011, J BIOL CHEM, V286, P5175, DOI 10.1074/jbc.M110.187872; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; Gaffaney JD, 2004, MOL PHARMACOL, V65, P692, DOI 10.1124/mol.65.3.692; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gowrishankar R, 2014, NEUROCHEM INT, V73, P42, DOI 10.1016/j.neuint.2013.10.016; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Guptaroy B, 2011, MOL PHARMACOL, V79, P520, DOI 10.1124/mol.110.069039; Hansen FH, 2014, J CLIN INVEST, V124, P3107, DOI 10.1172/JCI73778; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hong WMC, 2013, FASEB J, V27, P2995, DOI 10.1096/fj.12-218727; Hornemann T, 2015, J INHERIT METAB DIS, V38, P179, DOI 10.1007/s10545-014-9753-0; Huff RA, 1997, J NEUROCHEM, V68, P225; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Mazei-Robison MS, 2005, NEUROPHARMACOLOGY, V49, P737, DOI 10.1016/j.neuropharm.2005.08.012; Melikian HE, 1999, J NEUROSCI, V19, P7699; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Moffett S, 1996, J BIOL CHEM, V271, P21490, DOI 10.1074/jbc.271.35.21490; Moritz AE, 2013, J BIOL CHEM, V288, P20, DOI 10.1074/jbc.M112.407874; Navaroli DM, 2011, J NEUROSCI, V31, P13758, DOI 10.1523/JNEUROSCI.2649-11.2011; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Pramod AB, 2013, MOL ASPECTS MED, V34, P197, DOI 10.1016/j.mam.2012.07.002; Rao A, 2012, FASEB J, V26, P1921, DOI 10.1096/fj.11-196113; Rastedt D. E., 2014, FASEB J, V28, P803; RICHFIELD EK, 1993, MOL PHARMACOL, V43, P100; Riddle EL, 2005, AAPS J, V7, pE847, DOI 10.1208/aapsj070481; Sakrikar D, 2012, J NEUROSCI, V32, P5385, DOI 10.1523/JNEUROSCI.6033-11.2012; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schmitt KC, 2010, ANN NY ACAD SCI, V1187, P316, DOI 10.1111/j.1749-6632.2009.05148.x; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2013, TRAFFIC, V14, P709, DOI 10.1111/tra.12059; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; Spector D. L., 1998, CELLS LAB MANUAL; Steiner JA, 2008, TRAFFIC, V9, P1393, DOI 10.1111/j.1600-0854.2008.00757.x; Thwar PK, 2007, SYNAPSE, V61, P500, DOI 10.1002/syn.20390; Vaughan R A, 1998, Adv Pharmacol, V42, P1042; VAUGHAN RA, 1995, MOL PHARMACOL, V47, P956; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Vaughan RA, 2013, TRENDS PHARMACOL SCI, V34, P489, DOI 10.1016/j.tips.2013.07.005; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	67	33	33	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29095	29105		10.1074/jbc.M115.667055	http://dx.doi.org/10.1074/jbc.M115.667055			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26424792	Green Published, hybrid			2022-12-28	WOS:000365762300047
J	Silverstein, N; Ewers, D; Forrest, LR; Fahlke, C; Kanner, BI				Silverstein, Nechama; Ewers, David; Forrest, Lucy R.; Fahlke, Christoph; Kanner, Baruch I.			Molecular Determinants of Substrate Specificity in Sodium-coupled Glutamate Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glutamate; membrane transporter reconstitution; neurotransmitter transport; site-directed mutagenesis; sodium transport	DEPENDENT ASPARTATE TRANSPORTER; RAT-BRAIN; ACID TRANSPORTER; FUNCTIONAL-CHARACTERIZATION; PYROCOCCUS-HORIKOSHII; INDIVIDUAL SUBUNITS; MEMBRANE-VESICLES; CRYSTAL-STRUCTURE; CHLORIDE CHANNEL; BINDING	Crystal structures of the archaeal homologue Glt(Ph) have provided important insights into the molecular mechanism of transport of the excitatory neurotransmitter glutamate. Whereas mammalian glutamate transporters can translocate both glutamate and aspartate, Glt(Ph) is only one capable of aspartate transport. Most of the amino acid residues that surround the aspartate substrate in the binding pocket of Glt(Ph) are highly conserved. However, in the brain transporters, Thr-352 and Met-362 of the reentrant hairpin loop 2 are replaced by the smaller Ala and Thr, respectively. Therefore, we have studied the effects of T352A and M362T on binding and transport of aspartate and glutamate by Glt(Ph). Substrate-dependent intrinsic fluorescence changes were monitored in transporter constructs containing the L130W mutation. Glt(Ph)-L130W/T352A exhibited an approximate to 15-fold higher apparent affinity for l-glutamate than the wild type transporter, and the M362T mutation resulted in an increased affinity of approximate to 40-fold. An even larger increase of the apparent affinity for l-glutamate, around 130-fold higher than that of wild type, was observed with the T352A/M362T double mutant. Radioactive uptake experiments show that Glt(Ph)-T352A not only transports aspartate but also l-glutamate. Remarkably, Glt(Ph)-M362T exhibited l-aspartate but not l-glutamate transport. The double mutant retained the ability to transport l-glutamate, but its kinetic parameters were very similar to those of Glt(Ph)-T352A alone. The differential impact of mutation on binding and transport of glutamate suggests that hairpin loop 2 not only plays a role in the selection of the substrate but also in its translocation.	[Silverstein, Nechama; Kanner, Baruch I.] Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91120 Jerusalem, Israel; [Ewers, David; Fahlke, Christoph] Forschungszentrum Julich, Inst Complex Syst, D-52425 Julich, Germany; [Ewers, David] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Forrest, Lucy R.] NINDS, Computat Struct Biol Sect, NIH, Bethesda, MD 20894 USA	Hebrew University of Jerusalem; Helmholtz Association; Research Center Julich; Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Biochem & Mol Biol, POB 12272, IL-91120 Jerusalem, Israel.	baruch.kanner@mail.huji.ac.il	Ewers, David/AAG-8478-2021; Fahlke, Christoph/G-3635-2013; Forrest, Lucy/E-8113-2016	Ewers, David/0000-0003-1037-1027; Fahlke, Christoph/0000-0001-8602-9952; Forrest, Lucy/0000-0003-1855-7985	National Institutes of Health from NINDS [NS 16708]; Division of Intramural Research of the National Institutes of Health, NINDS; Deutsche Forschungsgemeinschaft [FA301/9]; United States-Israel Binational Science Foundation [2011268]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016708, ZIANS003139, R56NS016708] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; Division of Intramural Research of the National Institutes of Health, NINDS; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS 16708 from NINDS (to B. I. K.), the Division of Intramural Research of the National Institutes of Health, NINDS (to L. R. F.), Deutsche Forschungsgemeinschaft Grant FA301/9 (to C. F.), and United States-Israel Binational Science Foundation Grant 2011268 (to B. I. K.). The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Ewers D, 2013, P NATL ACAD SCI USA, V110, P12486, DOI 10.1073/pnas.1300772110; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Focke PJ, 2011, J NEUROSCI, V31, P6255, DOI 10.1523/JNEUROSCI.6096-10.2011; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Hanelt I, 2015, J BIOL CHEM, V290, P15962, DOI 10.1074/jbc.M115.656876; Jensen S, 2013, NAT STRUCT MOL BIOL, V20, P1224, DOI 10.1038/nsmb.2663; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Machtens JP, 2015, CELL, V160, P542, DOI 10.1016/j.cell.2014.12.035; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2009, J BIOL CHEM, V284, P17540, DOI 10.1074/jbc.M109.005926; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2012, J BIOL CHEM, V287, P17198, DOI 10.1074/jbc.M112.355040; Verdon G, 2014, ELIFE, V3, DOI 10.7554/eLife.02283; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	41	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28988	28996		10.1074/jbc.M115.682666	http://dx.doi.org/10.1074/jbc.M115.682666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26475859	Green Published, hybrid			2022-12-28	WOS:000365762300037
J	Catterall, WA				Catterall, William A.			Finding Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VOLTAGE-GATED SODIUM; CALCIUM-ANTAGONIST RECEPTOR; SUBUNIT-SPECIFIC ANTIBODIES; MUSCLE TRANSVERSE TUBULES; BETA-SCORPION TOXIN; GATING PORE CURRENT; SEA-ANEMONE TOXIN; IIA NA+ CHANNELS; RAT-BRAIN; SKELETAL-MUSCLE		[Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@uw.edu	Regan, Clinton/E-6250-2012		National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health [R01 NS15751, R01 NS22625, R01 NS25704]; National Institutes of Health; National Science Foundation; Muscular Dystrophy Association; American Heart Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025704, R01NS015751, R01NS022625] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Muscular Dystrophy Association(Muscular Dystrophy Association); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research in my laboratory at the University of Washington on the biochemistry, structure, and Junction of sodium and calcium channels has been generously funded by three long-running research grants from the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (R01 NS15751, R01 NS22625, and R01 NS25704) and by additional grants from the National Institutes of Health, the National Science Foundation, the Muscular Dystrophy Association, and the American Heart Association. Special thanks go to long-time collaborators Ruth Westenbroek (Research Associate Professor of Pharmacology) and Todd Scheuer (Research Professor Emeritus of Pharmacology) for their crucial insights and key technical contributions to our research progress. Special thanks go as well to my structural biology collaborators at the University of Washington, Rachel Klevit (Professor of Biochemistry), David Baker (Professor of Biochemistry and In ye of the Howard Hughes Medical Institute), and King Zheng (Professor of Pharmacology and Investigator of the Howard Hughes Medical Institute), whose generosity and expertise have made it possible for us to pursue our structure-function studies to the atomic level. Finally, it has been a pleasure to write this Reflections article for the JBC I joined the American Society for Biological Chemistry as a graduate student member in 1969, and I published my thesis research in the JBC, as well as most of the early biochemical studies of sodium channels that are featured here The American Society for Biochemistry and Molecular Biology and the JBC continue as major forces in science, with a purview that has broadened from biochemistry to encompass much of modern biomedical science, including my favorite topics of cell signaling; membrane biology, neurobiology, and molecular pharmacology.	ADELMAN WJ, 1969, J GEN PHYSIOL, V54, P589, DOI 10.1085/jgp.54.5.589; AGNEW WS, 1980, BIOCHEM BIOPH RES CO, V92, P860, DOI 10.1016/0006-291X(80)90782-2; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P565, DOI 10.1113/jphysiol.1984.sp015351; ALMERS W, 1984, J PHYSIOL-LONDON, V353, P585, DOI 10.1113/jphysiol.1984.sp015352; [Anonymous], 2000, YAL MED, V35; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BARCHI RL, 1983, J NEUROCHEM, V40, P1377, DOI 10.1111/j.1471-4159.1983.tb13580.x; BENESKI DA, 1980, P NATL ACAD SCI-BIOL, V77, P639, DOI 10.1073/pnas.77.1.639; BENZER TI, 1972, P NATL ACAD SCI USA, V69, P3634, DOI 10.1073/pnas.69.12.3634; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; CATTERALL WA, 1986, TRENDS NEUROSCI, V9, P7, DOI 10.1016/0166-2236(86)90004-4; CATTERALL WA, 1980, ANNU REV PHARMACOL, V20, P15, DOI 10.1146/annurev.pa.20.040180.000311; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; CATTERALL WA, 1979, J BIOL CHEM, V254, P1379; CATTERALL WA, 1979, J GEN PHYSIOL, V74, P375, DOI 10.1085/jgp.74.3.375; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Catterall WA, 2015, MOL PHARMACOL, V88, P141, DOI 10.1124/mol.114.097659; Catterall WA, 2010, NEUROSCI LETT, V486, P107, DOI 10.1016/j.neulet.2010.08.085; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Chakrabarti N, 2013, P NATL ACAD SCI USA, V110, P11331, DOI 10.1073/pnas.1309452110; COURAUD F, 1982, TOXICON, V20, P9, DOI 10.1016/0041-0101(82)90138-6; CURTIS BM, 1984, BIOCHEMISTRY-US, V23, P2113, DOI 10.1021/bi00305a001; CURTIS BM, 1986, BIOCHEMISTRY-US, V25, P3077, DOI 10.1021/bi00359a002; CURTIS BM, 1983, J BIOL CHEM, V258, P7280; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; DeCaen PG, 2011, P NATL ACAD SCI USA, V108, P18825, DOI 10.1073/pnas.1116449108; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; FLOCKERZI V, 1986, NATURE, V323, P66, DOI 10.1038/323066a0; Fu Y, 2014, P NATL ACAD SCI USA, V111, P16598, DOI 10.1073/pnas.1419129111; Fu Y, 2013, P NATL ACAD SCI USA, V110, P19621, DOI 10.1073/pnas.1319421110; GOLDIN AL, 1986, P NATL ACAD SCI USA, V83, P7503, DOI 10.1073/pnas.83.19.7503; GONOI T, 1984, J NEUROSCI, V4, P2836; GORDON D, 1988, BIOCHEMISTRY-US, V27, P7032, DOI 10.1021/bi00418a054; GORDON D, 1987, P NATL ACAD SCI USA, V84, P8682, DOI 10.1073/pnas.84.23.8682; Gurevitz M, 2012, TOXICON, V60, P502, DOI 10.1016/j.toxicon.2012.03.022; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; HARTSHORNE RP, 1985, P NATL ACAD SCI USA, V82, P240, DOI 10.1073/pnas.82.1.240; HARTSHORNE RP, 1984, J BIOL CHEM, V259, P1667; HARTSHORNE RP, 1981, P NATL ACAD SCI-BIOL, V78, P4620, DOI 10.1073/pnas.78.7.4620; HARTSHORNE RP, 1982, J BIOL CHEM, V257, P3888; HENDERSON R, 1973, J PHYSIOL-LONDON, V235, P783, DOI 10.1113/jphysiol.1973.sp010417; Heron SE, 2007, NEUROTHERAPEUTICS, V4, P295, DOI 10.1016/j.nurt.2007.01.009; HESS P, 1984, NATURE, V309, P453, DOI 10.1038/309453a0; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hirschberg B, 1995, J GEN PHYSIOL, V106, P1053, DOI 10.1085/jgp.106.6.1053; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; HOSEY MM, 1987, BIOCHEM BIOPH RES CO, V147, P1137; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1994, NEURON, V12, P1183, DOI 10.1016/0896-6273(94)90436-7; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kass RS, 2005, J CLIN INVEST, V115, P1986, DOI 10.1172/JCI26011; Kellenberger S, 1996, J BIOL CHEM, V271, P30971, DOI 10.1074/jbc.271.48.30971; Kellenberger S, 1997, J GEN PHYSIOL, V109, P607, DOI 10.1085/jgp.109.5.607; Kellenberger S, 1997, J GEN PHYSIOL, V109, P589, DOI 10.1085/jgp.109.5.589; Kuzmenkin A, 2004, J GEN PHYSIOL, V124, P349, DOI 10.1085/jgp.200409139; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; NODA M, 1986, NATURE, V322, P826, DOI 10.1038/322826a0; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; Pavlov E, 2005, BIOPHYS J, V89, P232, DOI 10.1529/biophysj.104.056994; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; REBER BFX, 1987, J BIOL CHEM, V262, P11369; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; RITCHIE JM, 1976, J PHYSIOL-LONDON, V261, P477, DOI 10.1113/jphysiol.1976.sp011569; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Rohl CA, 1999, BIOCHEMISTRY-US, V38, P855, DOI 10.1021/bi9823380; RUDY B, 1978, J PHYSIOL-LONDON, V283, P1; SALKOFF L, 1987, SCIENCE, V237, P744, DOI 10.1126/science.2441469; SCHEUER T, 1990, SCIENCE, V247, P854, DOI 10.1126/science.2154850; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; SIEBER M, 1987, EUR J BIOCHEM, V167, P117, DOI 10.1111/j.1432-1033.1987.tb13311.x; SIEBER M, 1987, BIOMED BIOCHIM ACTA, V46, pS357; SIGWORTH FJ, 1980, NATURE, V287, P447, DOI 10.1038/287447a0; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Sokolov S, 2010, J GEN PHYSIOL, V136, P225, DOI 10.1085/jgp.201010414; Sokolov S, 2008, P NATL ACAD SCI USA, V105, P19980, DOI 10.1073/pnas.0810562105; STRIESSNIG J, 1987, FEBS LETT, V212, P247, DOI 10.1016/0014-5793(87)81354-6; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; SUTKOWSKI EM, 1990, J BIOL CHEM, V265, P12393; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TALVENHEIMO JA, 1982, J BIOL CHEM, V257, P1868; TAMKUN MM, 1984, J BIOL CHEM, V259, P1676; Tang L, 2014, NATURE, V505, P56, DOI 10.1038/nature12775; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; van den Maagdenberg AMJM, 2004, NEURON, V41, P701, DOI 10.1016/S0896-6273(04)00085-6; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Venance SL, 2006, BRAIN, V129, P8, DOI 10.1093/brain/awh639; VINCENT JP, 1980, P NATL ACAD SCI-BIOL, V77, P1646, DOI 10.1073/pnas.77.3.1646; Wang JT, 2011, P NATL ACAD SCI USA, V108, P15426, DOI 10.1073/pnas.1112320108; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; WOLLNER DA, 1987, J BIOL CHEM, V262, P14709; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zhang JZ, 2012, J BIOL CHEM, V287, P30719, DOI 10.1074/jbc.M112.370742; Zhang JZ, 2011, J BIOL CHEM, V286, P33641, DOI 10.1074/jbc.M111.282509; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	118	5	5	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28357	28373		10.1074/jbc.X115.683383	http://dx.doi.org/10.1074/jbc.X115.683383			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26432640	Green Published, hybrid			2022-12-28	WOS:000365761900031
J	Mehler, M; Eckert, CE; Busche, A; Kulhei, J; Michaelis, J; Becker-Baldus, J; Wachtveitl, J; Dotsch, V; Glaubitz, C				Mehler, Michaela; Eckert, Carl Elias; Busche, Alena; Kulhei, Jennifer; Michaelis, Jonas; Becker-Baldus, Johanna; Wachtveitl, Josef; Doetsch, Volker; Glaubitz, Clemens			Assembling a Correctly Folded and Functional Heptahelical Membrane Protein by Protein Trans-splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; EXPRESSED POLYPEPTIDE FRAGMENTS; PHOTOCHEMICAL-REACTION CYCLE; DNAE INTEIN; GREEN PROTEORHODOPSIN; NOSTOC-PUNCTIFORME; PROTON PUMP; BACTERIORHODOPSIN; SPECTROSCOPY; RHODOPSIN	Protein trans-splicing using split inteins is well established as a useful tool for protein engineering. Here we show, for the first time, that this method can be applied to a membrane protein under native conditions. We provide compelling evidence that the heptahelical proteorhodopsin can be assembled from two separate fragments consisting of helical bundles A and B and C, D, E, F, and G via a splicing site located in the BC loop. The procedure presented here is on the basis of dual expression and ligation in vivo. Global fold, stability, and photodynamics were analyzed in detergent by CD, stationary, as well as time-resolved optical spectroscopy. The fold within lipid bilayers has been probed by high field and dynamic nuclear polarization-enhanced solid-state NMR utilizing a C-13-labeled retinal cofactor and extensively C-13-N-15-labeled protein. Our data show unambiguously that the ligation product is identical to its non-ligated counterpart. Furthermore, our data highlight the effects of BC loop modifications onto the photocycle kinetics of proteorhodopsin. Our data demonstrate that a correctly folded and functionally intact protein can be produced in this artificial way. Our findings are of high relevance for a general understanding of the assembly of membrane proteins for elucidating intramolecular interactions, and they offer the possibility of developing novel labeling schemes for spectroscopic applications.	[Mehler, Michaela; Busche, Alena; Kulhei, Jennifer; Michaelis, Jonas; Becker-Baldus, Johanna; Doetsch, Volker; Glaubitz, Clemens] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Mehler, Michaela; Busche, Alena; Kulhei, Jennifer; Michaelis, Jonas; Becker-Baldus, Johanna; Doetsch, Volker; Glaubitz, Clemens] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Eckert, Carl Elias; Wachtveitl, Josef] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Glaubitz, C (corresponding author), Goethe Univ Frankfurt, Inst Biophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	glaubitz@em.uni-frankfurt.de	Wachtveitl, Josef/A-7590-2017; Glaubitz, Clemens/D-5714-2011	Wachtveitl, Josef/0000-0002-8496-8240; Glaubitz, Clemens/0000-0002-3554-6586; Becker-Baldus, Johanna/0000-0003-1995-7323; Dotsch, Volker/0000-0001-5720-212X; Michaelis, Jonas Benjamin/0000-0001-9548-2337	Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 807, GL 307/4-1]; State of Hesse	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); State of Hesse	This work was supported by Deutsche Forschungsgemeinschaft (DFG)/Sonderforschungsbereich Grant 807 "Transport and Communication across Membranes." The DNP experiments were supported by an equipment grant provided by DFG Grant GL 307/4-1 and Cluster of Excellence Macromolecular Complexes Frankfurt. The Centre for Biomolecular Magnetic Resonance is funded through the State of Hesse. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Ali H, 2007, BIOCONJUGATE CHEM, V18, P1294, DOI 10.1021/bc070055r; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Bergo VB, 2009, J BIOL CHEM, V284, P2836, DOI 10.1074/jbc.M803792200; Brenzel S, 2009, CHEMBIOCHEM, V10, P983, DOI 10.1002/cbic.200900039; Busche AEL, 2009, ANGEW CHEM INT EDIT, V48, P6128, DOI 10.1002/anie.200901488; Cheriyan M, 2013, J BIOL CHEM, V288, P6202, DOI 10.1074/jbc.M112.433094; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; Friedrich T, 2002, J MOL BIOL, V321, P821, DOI 10.1016/S0022-2836(02)00696-4; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Hempelmann F, 2011, J AM CHEM SOC, V133, P4645, DOI 10.1021/ja111116a; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; Hoffmann M, 2006, J AM CHEM SOC, V128, P10808, DOI 10.1021/ja062082i; Hohwy M, 1998, J CHEM PHYS, V108, P2686, DOI 10.1063/1.475661; HUANG KS, 1981, J BIOL CHEM, V256, P3802; Iwai H, 2006, FEBS LETT, V580, P1853, DOI 10.1016/j.febslet.2006.02.045; Lee WK, 2009, BIOCHEM BIOPH RES CO, V390, P815, DOI 10.1016/j.bbrc.2009.10.055; Lin SW, 1998, J BIOL CHEM, V273, P24583, DOI 10.1074/jbc.273.38.24583; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Mao JF, 2014, J AM CHEM SOC, V136, P17578, DOI 10.1021/ja5097946; Marti T, 1998, J BIOL CHEM, V273, P9312, DOI 10.1074/jbc.273.15.9312; Mehler M, 2013, BIOPHYS J, V105, P385, DOI 10.1016/j.bpj.2013.06.014; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Neumann J, 2014, ARCH BIOCHEM BIOPHYS, V564, P281, DOI 10.1016/j.abb.2014.07.017; Nielsen SM, 1998, EUR J BIOCHEM, V251, P217, DOI 10.1046/j.1432-1327.1998.2510217.x; Ozawa T, 2001, CURR OPIN CHEM BIOL, V5, P578, DOI 10.1016/S1367-5931(00)00244-1; PERLER FB, 1994, NUCLEIC ACIDS RES, V22, P1125, DOI 10.1093/nar/22.7.1125; Pfleger N, 2008, J BIOMOL NMR, V40, P15, DOI 10.1007/s10858-007-9203-5; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7; Ran TT, 2013, ACTA CRYSTALLOGR D, V69, P1965, DOI 10.1107/S0907444913017575; Reckel S, 2011, ANGEW CHEM INT EDIT, V50, P11942, DOI 10.1002/anie.201105648; RIDGE KD, 1995, P NATL ACAD SCI USA, V92, P3204, DOI 10.1073/pnas.92.8.3204; Sabehi G, 2003, ENVIRON MICROBIOL, V5, P842, DOI 10.1046/j.1462-2920.2003.00493.x; Schubeis T, 2015, CHEMBIOCHEM, V16, P51, DOI 10.1002/cbic.201402446; Shi LC, 2009, J MOL BIOL, V386, P1078, DOI 10.1016/j.jmb.2009.01.011; Song CS, 2006, J AM CHEM SOC, V128, P11385, DOI 10.1021/ja061284b; Varo G, 2003, BIOPHYS J, V84, P1202, DOI 10.1016/S0006-3495(03)74934-0; Verhoefen MK, 2011, BBA-BIOENERGETICS, V1807, P1583, DOI 10.1016/j.bbabio.2011.09.001; Volkmann G, 2010, MOL BIOSYST, V6, P2110, DOI 10.1039/c0mb00034e; WRUBEL W, 1994, FEBS LETT, V349, P433, DOI 10.1016/0014-5793(94)00719-5; Yang JY, 2009, J AM CHEM SOC, V131, P11644, DOI 10.1021/ja9030215; Yoshitsugu M, 2008, ANGEW CHEM INT EDIT, V47, P3923, DOI 10.1002/anie.200705989; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003; Zuger S, 2005, NAT BIOTECHNOL, V23, P736, DOI 10.1038/nbt1097	45	9	9	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27712	27722		10.1074/jbc.M115.681205	http://dx.doi.org/10.1074/jbc.M115.681205			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26405032	Green Published, hybrid			2022-12-28	WOS:000365757500024
J	Beccari, L; Marco-Ferreres, R; Tabanera, N; Manfredi, A; Souren, M; Wittbrodt, B; Conte, I; Wittbrodt, J; Bovolenta, P				Beccari, Leonardo; Marco-Ferreres, Raquel; Tabanera, Noemi; Manfredi, Anna; Souren, Marcel; Wittbrodt, Beate; Conte, Ivan; Wittbrodt, Jochen; Bovolenta, Paola			A trans-Regulatory Code for the Forebrain Expression of Six3.2 in the Medaka Fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE REGULATORY NETWORKS; RETINAL PROGENITOR CELLS; EYE DEVELOPMENT; NEURAL PLATE; DNA-BINDING; VERTEBRATE RETINA; LENS DEVELOPMENT; BIPOLAR CELLS; MOUSE RETINA; HMG DOMAIN	Background: The transcription factor Six3 is key element of forebrain specification, but its upstream regulators are unknown. Results: A systematic search in medaka fish identifies and functionally characterizes novel Six3 regulators. Conclusion: The spatio-temporal regulation of Six3 depends on a few trans-acting factors. Significance: This study provides new information on how forebrain neuronal diversity is originated.	[Beccari, Leonardo; Marco-Ferreres, Raquel; Tabanera, Noemi; Bovolenta, Paola] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Beccari, Leonardo; Marco-Ferreres, Raquel; Tabanera, Noemi; Bovolenta, Paola] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28049, Spain; [Beccari, Leonardo; Marco-Ferreres, Raquel; Tabanera, Noemi; Manfredi, Anna; Conte, Ivan; Bovolenta, Paola] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Conte, Ivan] Telethon Inst Genet & Med, I-80078 Naples, Italy; [Souren, Marcel; Wittbrodt, Beate; Wittbrodt, Jochen] Heidelberg Univ, Ctr Organismal Studies, D-69120 Heidelberg, Germany	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Ruprecht Karls University Heidelberg	Beccari, L (corresponding author), Univ Geneva, Fac Sci, Dept Genet & Evolut, Sci 3,30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	leonardo.beccari@unige.ch; pbovolenta@cbm.csic.es	Wittbrodt, Joachim/D-4735-2014; Beccari, Leonardo/AAC-8373-2020; Manfredi, Anna/ABC-8588-2021	Wittbrodt, Joachim/0000-0001-8550-7377; Beccari, Leonardo/0000-0001-6472-5105; Conte, Ivan/0000-0002-8968-9021; Tabanera, Noemi/0000-0002-8815-7728; Bovolenta, Paola/0000-0002-1870-751X; Marco-Ferreres, Raquel/0000-0002-6109-3840	Spanish Ministerio de Economia y Competitividad (MINECO) [BFU2010-16031, BFU2013-43213-P]; FEDER Funds; Comunidad Autonoma de Madrid (CAM) Grant [CELL-DD S2010/BMD-2315]; Fundaluce; Fundacion ONCE; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) del Instituto Carlos III (ISCIII); Fundacion Ramon Areces	Spanish Ministerio de Economia y Competitividad (MINECO); FEDER Funds(European Commission); Comunidad Autonoma de Madrid (CAM) Grant; Fundaluce; Fundacion ONCE; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) del Instituto Carlos III (ISCIII); Fundacion Ramon Areces	This work was supported by Spanish Ministerio de Economia y Competitividad (MINECO) Grants BFU2010-16031 and BFU2013-43213-P, cofounded by FEDER Funds; Comunidad Autonoma de Madrid (CAM) Grant CELL-DD S2010/BMD-2315; Fundaluce; Fundacion ONCE; the Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER) del Instituto Carlos III (ISCIII); and an Institutional Grant from the Fundacion Ramon Areces. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez-Medina R, 2008, DEVELOPMENT, V135, P237, DOI 10.1242/dev.012054; Ando H, 2005, DEV BIOL, V287, P456, DOI 10.1016/j.ydbio.2005.09.023; Andoniadou CL, 2011, DEVELOPMENT, V138, P4931, DOI 10.1242/dev.066597; Appolloni I, 2008, CEREB CORTEX, V18, P553, DOI 10.1093/cercor/bhm092; Asahara H, 1999, MOL CELL BIOL, V19, P8219; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Beccari L, 2013, MECH DEVELOP, V130, P95, DOI 10.1016/j.mod.2012.10.004; Beccari L, 2012, DEVELOPMENT, V139, P151, DOI 10.1242/dev.067660; Braun MM, 2003, DEVELOPMENT, V130, P5579, DOI 10.1242/dev.00685; Brzezinski JA, 2013, DEV BIOL, V384, P194, DOI 10.1016/j.ydbio.2013.10.006; Calvo KR, 1999, ONCOGENE, V18, P8033, DOI 10.1038/sj.onc.1203377; Carl M, 2002, DEVELOPMENT, V129, P4057; Chao CH, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-35; Chow RL, 1999, DEVELOPMENT, V126, P4213; Conte I, 2005, DEV DYNAM, V234, P718, DOI 10.1002/dvdy.20463; Conte I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r137; Conte I, 2010, DEVELOPMENT, V137, P2307, DOI 10.1242/dev.045294; Danno H, 2008, P NATL ACAD SCI USA, V105, P5408, DOI 10.1073/pnas.0710954105; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; Domene S, 2008, HUM MOL GENET, V17, P3919, DOI 10.1093/hmg/ddn294; Dorsky RI, 2003, DEVELOPMENT, V130, P1937, DOI 10.1242/dev.00402; Dyer MA, 2003, CELL CYCLE, V2, P350, DOI 10.4161/cc.2.4.429; Erickson T, 2007, DEV BIOL, V301, P504, DOI 10.1016/j.ydbio.2006.08.022; Ferran JL, 2007, J COMP NEUROL, V505, P379, DOI 10.1002/cne.21493; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Ferri A, 2013, DEVELOPMENT, V140, P1250, DOI 10.1242/dev.073411; Fuhrmann S, 2009, INVEST OPHTH VIS SCI, V50, P432, DOI 10.1167/iovs.08-2270; Geng X, 2008, DEV CELL, V15, P236, DOI 10.1016/j.devcel.2008.07.003; Gestri G, 2005, DEVELOPMENT, V132, P2401, DOI 10.1242/dev.01814; GIESE K, 1991, GENE DEV, V5, P2567, DOI 10.1101/gad.5.12b.2567; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; Goudreau G, 2002, P NATL ACAD SCI USA, V99, P8719, DOI 10.1073/pnas.132195699; Gustavson MD, 2004, MOL CARCINOGEN, V41, P125, DOI 10.1002/mc.20049; Heine P, 2008, DEVELOPMENT, V135, P805, DOI 10.1242/dev.012088; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Inbal A, 2007, NEURON, V55, P407, DOI 10.1016/j.neuron.2007.06.037; Inoue M, 2007, GENES CELLS, V12, P1049, DOI 10.1111/j.1365-2443.2007.01114.x; Inoue T, 2002, DEVELOPMENT, V129, P831; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; JAYNES JB, 1991, EMBO J, V10, P1427, DOI 10.1002/j.1460-2075.1991.tb07663.x; Jeong Y, 2008, NAT GENET, V40, P1348, DOI 10.1038/ng.230; JOHN A, 1995, DEVELOPMENT, V121, P1801; Kawakami K, 1996, FEBS LETT, V393, P259, DOI 10.1016/0014-5793(96)00899-X; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kobayashi D, 2002, DEVELOPMENT, V129, P83; Kondoh H, 2004, INT J DEV BIOL, V48, P819, DOI 10.1387/ijdb.041868hk; Lacbawan F, 2009, J MED GENET, V46, P389, DOI 10.1136/jmg.2008.063818; Lagutin O, 2001, DEV DYNAM, V221, P342, DOI 10.1002/dvdy.1148; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Laurent A, 2007, MECH DEVELOP, V124, P364, DOI 10.1016/j.mod.2007.01.008; Lavado A, 2008, DEVELOPMENT, V135, P441, DOI 10.1242/dev.010082; Lengler J, 2005, OPHTHALMIC RES, V37, P301, DOI 10.1159/000087774; Lengler J, 2001, BIOCHEM BIOPH RES CO, V287, P372, DOI 10.1006/bbrc.2001.5605; Longobardi E, 2014, DEV DYNAM, V243, P59, DOI 10.1002/dvdy.24016; Loosli F, 1999, GENE DEV, V13, P649, DOI 10.1101/gad.13.6.649; Lopez-Rios J, 2003, DEVELOPMENT, V130, P185, DOI 10.1242/dev.00185; Rivas ML, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003252; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Maurya AK, 2011, DEVELOPMENT, V138, P755, DOI 10.1242/dev.062521; McCollum CW, 2007, DEV BIOL, V309, P373, DOI 10.1016/j.ydbio.2007.07.004; Mizutani CM, 2006, PLOS BIOL, V4, P1777, DOI 10.1371/journal.pbio.0040313; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Oliver G, 1995, DEVELOPMENT, V121, P4045; Oron-Karni V, 2008, DEVELOPMENT, V135, P4037, DOI 10.1242/dev.028308; Paek H, 2009, DEVELOPMENT, V136, P2457, DOI 10.1242/dev.032656; Pasquier L, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023416; Phillips BT, 2006, DEV BIOL, V294, P376, DOI 10.1016/j.ydbio.2006.03.001; Purcell P, 2005, GENE EXPR PATTERNS, V6, P110, DOI 10.1016/j.modgep.2005.04.010; Rodriguez-Seguel E, 2009, DEV BIOL, V329, P258, DOI 10.1016/j.ydbio.2009.02.028; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Schmitt S, 2009, INVEST OPHTH VIS SCI, V50, P5901, DOI 10.1167/iovs.08-3067; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Smith AN, 2009, DEVELOPMENT, V136, P2977, DOI 10.1242/dev.037341; Souren M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r92; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Suh CS, 2010, FEBS J, V277, P1761, DOI 10.1111/j.1742-4658.2010.07599.x; Thiaville MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036054; Tribulo C, 2003, DEVELOPMENT, V130, P6441, DOI 10.1242/dev.00878; Wang S, 2014, DEV CELL, V30, P513, DOI 10.1016/j.devcel.2014.07.018; Wargelius A, 2003, BIOCHEM BIOPH RES CO, V309, P475, DOI 10.1016/j.bbrc.2003.07.010; Zhu CQC, 2002, DEVELOPMENT, V129, P2835; Znosko WA, 2010, DEV BIOL, V342, P11, DOI 10.1016/j.ydbio.2010.03.011	84	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26927	26942		10.1074/jbc.M115.681254	http://dx.doi.org/10.1074/jbc.M115.681254			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26378230	Green Published, hybrid			2022-12-28	WOS:000364794000005
J	Brenner, S; Bercovich, Z; Feiler, Y; Keshet, R; Kahana, C				Brenner, Shirley; Bercovich, Zippi; Feiler, Yulia; Keshet, Rom; Kahana, Chaim			Dual Regulatory Role of Polyamines in Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CLONAL EXPANSION; BINDING PROTEIN-BETA; ADIPOCYTE DIFFERENTIATION; C/EBP-BETA; 3T3-L1 PREADIPOCYTES; PPAR-GAMMA; ORNITHINE-DECARBOXYLASE; GENE-EXPRESSION; ADIPOSE-TISSUE; CELL-LINE	Background: Polyamines are required for the process of adipogenesis. Results: Polyamine depletion causes inactivation of C/EBP that is correlated with elevation of CHOP, and independently causes inhibition of mitotic clonal expansion. Conclusion: Polyamines are required for both main hubs of adipogenesis; completion of MCE and activation of C/EBP. Significance: Our results assist clarifying the mechanism by which polyamines support adipogenesis. Adipogenesis is a complex process, accompanied by a chain of interdependent events. Disruption of key events in this cascade may interfere with the correct formation of adipose tissue. Polyamines were demonstrated necessary for adipogenesis; however, the underlying mechanism by which they act has not been established. Here, we examined the effect of polyamine depletion on the differentiation of 3T3-L1 preadipocytes. Our results demonstrate that polyamines are required early in the adipogenic process. Polyamine depletion inhibited the second division of the mitotic clonal expansion (MCE), and inhibited the expression of PPAR gamma and C/EBP alpha, the master regulators of adipogenesis. However, it did not affect the expression of their transcriptional activator, C/EBP beta. Additionally, polyamine depletion resulted in elevation of mRNA and protein levels of the stress-induced C/EBP homologous protein (CHOP), whose dominant negative function is known to inhibit C/EBP beta DNA binding activity. Conditional knockdown of CHOP in polyamine-depleted preadipocytes restored PPAR gamma and C/EBP alpha expression, but failed to recover MCE and differentiation. Thus, our results suggest that the need for MCE in the adipogenic process is independent from the requirement for PPAR gamma and C/EBP alpha expression. We conclude that de novo synthesis of polyamines during adipogenesis is required for down-regulation of CHOP to allow C/EBP beta activation, and for promoting MCE.	[Brenner, Shirley; Bercovich, Zippi; Feiler, Yulia; Keshet, Rom; Kahana, Chaim] Weizmann Inst Sci, Dept Mol Genet, IL-7610001 Rehovot, Israel	Weizmann Institute of Science	Kahana, C (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-7610001 Rehovot, Israel.	chaim.kahana@weizmann.ac.il			Israel Academy of Science and Humanities	Israel Academy of Science and Humanities	This work was supported by a grant from the Israel Academy of Science and Humanities. The authors declare that they have no conflicts of interest with the contents of this article.	BATCHVAROVA N, 1995, EMBO J, V14, P4654, DOI 10.1002/j.1460-2075.1995.tb00147.x; BETHELL DR, 1981, BIOCHEM BIOPH RES CO, V102, P272, DOI 10.1016/0006-291X(81)91517-5; CANELLAKIS ZN, 1989, YALE J BIOL MED, V62, P481; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; COLEMAN RA, 1978, J BIOL CHEM, V253, P7256; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; ERWIN BG, 1984, AM J PHYSIOL, V246, pC293, DOI 10.1152/ajpcell.1984.246.3.C293; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Hyvonen MT, 2013, BIOCHEM J, V453, P467, DOI 10.1042/BJ20130263; Ishii I, 2012, AMINO ACIDS, V42, P619, DOI 10.1007/s00726-011-1037-5; Kim J, 2007, P NATL ACAD SCI USA, V104, P1800, DOI 10.1073/pnas.0611137104; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Landau G, 2012, J BIOL CHEM, V287, P35825, DOI 10.1074/jbc.M112.381335; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; MACKALL JC, 1976, J BIOL CHEM, V251, P6462; METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050; Park MH, 1997, BIOL SIGNAL, V6, P115; PEGG AE, 1988, CANCER RES, V48, P759; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; POULIN R, 1992, J BIOL CHEM, V267, P150; Rochford JJ, 2004, MOL CELL BIOL, V24, P9863, DOI 10.1128/MCB.24.22.9863-9872.2004; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Tang QQ, 2004, BIOCHEM BIOPH RES CO, V318, P213, DOI 10.1016/j.bbrc.2004.04.017; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Tang QQ, 1999, GENE DEV, V13, P2231, DOI 10.1101/gad.13.17.2231; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Vuohelainen S, 2010, J CELL MOL MED, V14, P1683, DOI 10.1111/j.1582-4934.2009.00808.x; Zhang J, 2014, INT J MOL MED, V33, P1209, DOI 10.3892/ijmm.2014.1695; Zhang JW, 2004, P NATL ACAD SCI USA, V101, P43, DOI 10.1073/pnas.0307229101	39	18	18	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27384	27392		10.1074/jbc.M115.686980	http://dx.doi.org/10.1074/jbc.M115.686980			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26396188	Green Published, hybrid			2022-12-28	WOS:000364794000044
J	Mohanty, S; Jobichen, C; Chichili, VPR; Velazquez-Campoy, A; Low, BC; Hogue, CWV; Sivaraman, J				Mohanty, Soumya; Jobichen, Chacko; Chichili, Vishnu Priyanka Reddy; Velazquez-Campoy, Adrian; Low, Boon Chuan; Hogue, Christopher W. V.; Sivaraman, J.			Structural Basis for a Unique ATP Synthase Core Complex from Nanoarcheaum equitans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; BINDING CHANGE MECHANISM; V-TYPE; IGNICOCCUS-HOSPITALIS; CRYSTAL-STRUCTURE; F-TYPE; CENTRAL STALK; SUBUNIT B; EVOLUTION; F-1-ATPASE	Background: Structural asymmetry upon nucleotide binding is crucial for catalytic activity of ATP synthases. Results: The structures of apo and bound A(3)B(3) hexamer of N. equitans ATP synthase show conformational inflexibility. Conclusion: The N. equitans A(3)B(3) hexamer is an inactive form. Significance: The structure of inactive form of N. equitans ATP synthase A(3)B(3) is shown for the first time. ATP synthesis is a critical and universal life process carried out by ATP synthases. Whereas eukaryotic and prokaryotic ATP synthases are well characterized, archaeal ATP synthases are relatively poorly understood. The hyperthermophilic archaeal parasite, Nanoarcheaum equitans, lacks several subunits of the ATP synthase and is suspected to be energetically dependent on its host, Ignicoccus hospitalis. This suggests that this ATP synthase might be a rudimentary machine. Here, we report the crystal structures and biophysical studies of the regulatory subunit, NeqB, the apo-NeqAB, and NeqAB in complex with nucleotides, ADP, and adenylyl-imidodiphosphate (non-hydrolysable analog of ATP). NeqB is approximate to 20 amino acids shorter at its C terminus than its homologs, but this does not impede its binding with NeqA to form the complex. The heterodimeric NeqAB complex assumes a closed, rigid conformation irrespective of nucleotide binding; this differs from its homologs, which require conformational changes for catalytic activity. Thus, although N. equitans possesses an ATP synthase core A(3)B(3) hexameric complex, it might not function as a bona fide ATP synthase.	[Mohanty, Soumya; Jobichen, Chacko; Chichili, Vishnu Priyanka Reddy; Low, Boon Chuan; Hogue, Christopher W. V.; Sivaraman, J.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Velazquez-Campoy, Adrian] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst BIFI, Joint Unit Inst Phys Chem Rocasolano IQFR Spanish, Zaragoza 50018, Spain; [Velazquez-Campoy, Adrian] Univ Zaragoza, Dept Biochem & Mol & Cell Biol, Zaragoza 50018, Spain; [Velazquez-Campoy, Adrian] Govt Aragon, Fdn ARAID, Zaragoza 50018, Spain; [Low, Boon Chuan; Hogue, Christopher W. V.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore	National University of Singapore; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; University of Zaragoza; National University of Singapore	Low, BC (corresponding author), Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore.	dbslowbc@nus.edu.sg; dbsjayar@nus.edu.sg	Velazquez-Campoy, Adrian/E-7946-2012; Jobichen, Chacko/AAR-7637-2020; Hogue, Christopher W V/AAZ-3934-2020; Low, Boon Chuan/H-8049-2012; Jobichen, Chacko/D-1978-2014; Low, Boon Chuan/AAU-7685-2021	Velazquez-Campoy, Adrian/0000-0001-5702-4538; Hogue, Christopher W V/0000-0002-3107-5246; Low, Boon Chuan/0000-0003-0756-096X; Jobichen, Chacko/0000-0001-5927-1815; Low, Boon Chuan/0000-0003-0756-096X; J, Sivaraman/0000-0001-9781-5326	Academic Research Fund, National University of Singapore [WBS R154000616112]	Academic Research Fund, National University of Singapore(National University of Singapore)	This work was supported in part by Academic Research Fund (WBS R154000616112), National University of Singapore. The authors declare that they have no conflicts of interest with the contents of this article.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alam MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074291; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BOYER PD, 1989, FASEB J, V3, P2164, DOI 10.1096/fasebj.3.10.2526771; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; Burghardt T, 2009, BIOCHEM SOC T, V37, P127, DOI 10.1042/BST0370127; Capaldi RA, 2000, J EXP BIOL, V203, P29; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen C, 2006, J BIOL CHEM, V281, P13777, DOI 10.1074/jbc.M513369200; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Coskun U, 2004, J BIOL CHEM, V279, P22759, DOI 10.1074/jbc.M313741200; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Das S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-186; Deppenmeier Uwe, 2008, V45, P123, DOI 10.1007/400_2006_026; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fillingame RH, 1997, J EXP BIOL, V200, P217; Giannone RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022942; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Grabe M, 2000, BIOPHYS J, V78, P2798, DOI 10.1016/S0006-3495(00)76823-8; Groth G, 2001, J BIOL CHEM, V276, P1345, DOI 10.1074/jbc.M008015200; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; HILARIO E, 1993, BIOSYSTEMS, V31, P111, DOI 10.1016/0303-2647(93)90038-E; Hofmann K., 1996, BOXSHADE VERSION 3 2; Indyk L, 1998, METHOD ENZYMOL, V295, P350; Jahn U, 2004, ARCH MICROBIOL, V182, P404, DOI 10.1007/s00203-004-0725-x; Jahn U, 2008, J BACTERIOL, V190, P1743, DOI 10.1128/JB.01731-07; Kishikawa J, 2014, J BIOL CHEM, V289, P403, DOI 10.1074/jbc.M113.523498; Kuper U, 2010, P NATL ACAD SCI USA, V107, P3152, DOI 10.1073/pnas.0911711107; Kumar A, 2008, ACTA CRYSTALLOGR D, V64, P1110, DOI 10.1107/S090744490802790X; Kumar A, 2010, J MOL BIOL, V396, P301, DOI 10.1016/j.jmb.2009.11.046; Kumar A, 2009, PROTEINS, V75, P807, DOI 10.1002/prot.22289; Lebedev AA, 2014, ACTA CRYSTALLOGR D, V70, P2430, DOI 10.1107/S1399004714014795; Lewalter K, 2006, BBA-BIOENERGETICS, V1757, P437, DOI 10.1016/j.bbabio.2006.04.027; Lingl A, 2003, EXTREMOPHILES, V7, P249, DOI 10.1007/s00792-003-0318-7; Maher MJ, 2009, EMBO J, V28, P3771, DOI 10.1038/emboj.2009.310; Manimekalai MSS, 2011, J MOL BIOL, V408, P736, DOI 10.1016/j.jmb.2011.03.010; Manimekalai MSS, 2009, J STRUCT BIOL, V166, P38, DOI 10.1016/j.jsb.2008.12.004; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Muller V, 2004, J BIOENERG BIOMEMBR, V36, P115, DOI 10.1023/B:JOBB.0000019603.68282.04; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Muller V, 1999, J BIOENERG BIOMEMBR, V31, P15, DOI 10.1023/A:1005451311009; Nagamatsu Y, 2013, J MOL BIOL, V425, P2699, DOI 10.1016/j.jmb.2013.04.022; NELSON N, 1989, J BIOENERG BIOMEMBR, V21, P553, DOI 10.1007/BF00808113; NELSON N, 1992, BIOCHIM BIOPHYS ACTA, V1100, P109; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Podar M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r158; Rachel Reinhard, 2002, Archaea, V1, P9, DOI 10.1155/2002/307480; SCHAFER G, 1992, BIOCHIM BIOPHYS ACTA, V1101, P232, DOI 10.1016/0005-2728(92)90233-R; Shao E, 2003, J BIOL CHEM, V278, P12985, DOI 10.1074/jbc.M212096200; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; Tellinghuisen J, 2008, ANAL BIOCHEM, V373, P395, DOI 10.1016/j.ab.2007.08.039; Tellinghuisen J, 2012, ANAL BIOCHEM, V424, P211, DOI 10.1016/j.ab.2011.12.035; Uchihashi T, 2011, SCIENCE, V333, P755, DOI 10.1126/science.1205510; Velazquez-Campoy A, 2015, J THERM ANAL CALORIM, V122, P1477, DOI 10.1007/s10973-015-4775-x; Vonck J, 2009, J BIOL CHEM, V284, P10110, DOI 10.1074/jbc.M808498200; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504	71	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27280	27296		10.1074/jbc.M115.677492	http://dx.doi.org/10.1074/jbc.M115.677492			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26370083	Green Published, hybrid			2022-12-28	WOS:000364794000036
J	Landreh, M; Rising, A; Presto, J; Jornvall, H; Johansson, J				Landreh, Michael; Rising, Anna; Presto, Jenny; Jornvall, Hans; Johansson, Jan			Specific Chaperones and Regulatory Domains in Control of Amyloid Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROSURFACTANT PROTEIN-C; SPIDER SILK PROTEINS; BRICHOS DOMAIN; BETA-PEPTIDE; FIBRIL FORMATION; SYNTHETIC SURFACTANT; MOLECULAR CHAPERONES; TERMINAL DOMAIN; AGGREGATION; TOXICITY	Many proteins can form amyloid-like fibrils in vitro, but only about 30 amyloids are linked to disease, whereas some proteins form physiological amyloid-like assemblies. This raises questions of how the formation of toxic protein species during amyloido-genesis is prevented or contained in vivo. Intrinsic chaperoning or regulatory factors can control the aggregation in different protein systems, thereby preventing unwanted aggregation and enabling the biological use of amyloidogenic proteins. The molecular actions of these chaperones and regulators provide clues to the prevention of amyloid disease, as well as to the harnessing of amyloidogenic proteins in medicine and biotechnology.	[Landreh, Michael] Univ Oxford, Dept Chem, Oxford OX1 5QY, England; [Rising, Anna; Presto, Jenny; Johansson, Jan] Karolinska Inst, Novum, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc NVS, S-14157 Huddinge, Sweden; [Rising, Anna; Johansson, Jan] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Biomed Ctr, S-75123 Uppsala, Sweden; [Jornvall, Hans] Karolinska Inst, Dept Med Biochem & Biophys MBB, SE-17177 Stockholm, Sweden; [Johansson, Jan] Tallinn Univ, Inst Math & Nat Sci, EE-10120 Tallinn, Estonia	University of Oxford; Karolinska Institutet; Swedish University of Agricultural Sciences; Karolinska Institutet; Tallinn University	Jornvall, H (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys MBB, SE-17177 Stockholm, Sweden.	Hans.Jornvall@ki.se; Janne.Johansson@ki.se	Rising, Anna/ABE-8822-2020	Rising, Anna/0000-0002-1872-1207; Landreh, Michael/0000-0002-7958-4074; Presto, Jenny/0000-0001-5102-6815; Johansson, Jan/0000-0002-8719-4703	Swedish Research Council; Mobilitas Project [MTT16]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Mobilitas Project	This work was supported by the Swedish Research Council and by the Mobilitas Project (MTT16). This is the fifth article in the Thematic Minireview series "Protein Interactions, Structures, and Networks." The authors declare that they have no conflicts of interest with the contents of this article.	Altieri F, 2014, BIOCHIMIE, V106, P91, DOI 10.1016/j.biochi.2014.08.004; Andersson M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001921; Arimon M, 2008, J MOL BIOL, V384, P1157, DOI 10.1016/j.jmb.2008.09.063; Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Del Campo M, 2014, NEUROBIOL AGING, V35, P1596, DOI 10.1016/j.neurobiolaging.2014.01.007; Dicko C, 2004, BIOMACROMOLECULES, V5, P704, DOI 10.1021/bm034307c; Doyle SM, 2013, NAT REV MOL CELL BIO, V14, P617, DOI 10.1038/nrm3660; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Evans ML, 2015, MOL CELL, V57, P445, DOI 10.1016/j.molcel.2014.12.025; Evans ML, 2014, BBA-MOL CELL RES, V1843, P1551, DOI 10.1016/j.bbamcr.2013.09.010; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fitzen M, 2009, RAPID COMMUN MASS SP, V23, P3591, DOI 10.1002/rcm.4282; Frederick KK, 2014, CHEM BIOL, V21, P295, DOI 10.1016/j.chembiol.2013.12.013; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Gustafsson M, 1999, FEBS LETT, V464, P138, DOI 10.1016/S0014-5793(99)01692-0; Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hedlund Joel, 2009, BMC Res Notes, V2, P180, DOI 10.1186/1756-0500-2-180; Hermansson E, 2014, DIS MODEL MECH, V7, P659, DOI 10.1242/dmm.014787; Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Johansson H, 2009, J MOL BIOL, V389, P227, DOI 10.1016/j.jmb.2009.04.021; Johansson H, 2009, PROTEIN SCI, V18, P1175, DOI 10.1002/pro.123; Johansson J, 2003, J APPL PHYSIOL, V95, P2055, DOI 10.1152/japplphysiol.00153.2003; JOHANSSON J, 1994, BIOCHEMISTRY-US, V33, P6015, DOI 10.1021/bi00185a042; Johansson J, 2010, BIOCHEM BIOPH RES CO, V402, P515, DOI 10.1016/j.bbrc.2010.10.062; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; Kim J, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-15; Knight SD, 2013, BIOCHEMISTRY-US, V52, P7523, DOI 10.1021/bi400908x; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Kronqvist N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4254; Kurudenkandy FR, 2014, J NEUROSCI, V34, P11416, DOI 10.1523/JNEUROSCI.1195-14.2014; Landreh M, 2012, BIOCHEM J, V447, P185, DOI 10.1042/BJ20120919; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Luo JH, 2014, J BIOL CHEM, V289, P27766, DOI 10.1074/jbc.M114.574947; Luo JH, 2013, CHEM COMMUN, V49, P6507, DOI 10.1039/c3cc42325e; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nerelius C, 2010, BIOCHEM BIOPH RES CO, V396, P2, DOI 10.1016/j.bbrc.2010.02.105; Nerelius C, 2009, BIOCHEMISTRY-US, V48, P3778, DOI 10.1021/bi900135c; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Parra E, 2015, CHEM PHYS LIPIDS, V185, P153, DOI 10.1016/j.chemphyslip.2014.09.002; Peng SW, 2010, BIOCHEM BIOPH RES CO, V393, P356, DOI 10.1016/j.bbrc.2009.12.122; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Rising A, 2015, NAT CHEM BIOL, V11, P309, DOI [10.1038/NCHEMBIO.1789, 10.1038/nchembio.1789]; Rising A, 2014, ACTA BIOMATER, V10, P1627, DOI 10.1016/j.actbio.2013.09.030; Saibil HR, 2012, P NATL ACAD SCI USA, V109, P14906, DOI 10.1073/pnas.1211976109; Salvesen B, 2014, NEONATOLOGY, V105, P128, DOI 10.1159/000356065; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Sato A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039392; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schwarze S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3815; Seehase M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047631; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Slotta U, 2007, MACROMOL BIOSCI, V7, P183, DOI 10.1002/mabi.200600201; Soergjerd KM, 2013, BIOCHEMISTRY-US, V52, P3532, DOI 10.1021/bi301705c; Stein KC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004337; Szyperski T, 1998, PROTEIN SCI, V7, P2533, DOI 10.1002/pro.5560071206; Taylor JD, 2011, STRUCTURE, V19, P1307, DOI 10.1016/j.str.2011.05.015; Tian PF, 2015, J AM CHEM SOC, V137, P22, DOI 10.1021/ja5093634; True HL, 2006, TRENDS GENET, V22, P110, DOI 10.1016/j.tig.2005.12.004; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; van der Putten H, 2013, NEUROTHERAPEUTICS, V10, P416, DOI 10.1007/s13311-013-0186-5; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Wang X, 2010, P NATL ACAD SCI USA, V107, P163, DOI 10.1073/pnas.0908714107; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Willander H, 2012, J BIOL CHEM, V287, P31608, DOI 10.1074/jbc.M112.393157; Willander H, 2012, P NATL ACAD SCI USA, V109, P2325, DOI 10.1073/pnas.1114740109; Willander H, 2011, FEBS J, V278, P3893, DOI 10.1111/j.1742-4658.2011.08209.x; Xiao SB, 2013, PHYS CHEM CHEM PHYS, V15, P8765, DOI 10.1039/c3cp00067b; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	90	26	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26430	26436		10.1074/jbc.R115.653097	http://dx.doi.org/10.1074/jbc.R115.653097			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354437	Green Published, hybrid			2022-12-28	WOS:000364793600010
J	Itakura, M; Nakajima, H; Kubo, T; Semi, Y; Kume, S; Higashida, S; Kaneshige, A; Kuwamura, M; Harada, N; Kita, A; Azuma, YT; Yamaji, R; Inui, T; Takeuchi, T				Itakura, Masanori; Nakajima, Hidemitsu; Kubo, Takeya; Semi, Yuko; Kume, Satoshi; Higashida, Shusaku; Kaneshige, Akihiro; Kuwamura, Mitsuru; Harada, Naoki; Kita, Akinori; Azuma, Yasu-Taka; Yamaji, Ryoichi; Inui, Takashi; Takeuchi, Tadayoshi			Glyceraldehyde-3-phosphate Dehydrogenase Aggregates Accelerate Amyloid-beta Amyloidogenesis in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; A-BETA; NUCLEAR TRANSLOCATION; MOUSE MODELS; GAPDH; ACTIVATION; PEPTIDE; ASSOCIATION; MECHANISM; TOXICITY	Alzheimer disease (AD) is a progressive neurodegenerative disorder characterized by loss of neurons and formation of pathological extracellular deposits induced by amyloid-beta peptide (A beta). Numerous studies have established A beta amyloidogenesis as a hallmark of AD pathogenesis, particularly with respect to mitochondrial dysfunction. We have previously shown that glycolytic glyceraldehyde-3-phosphate dehydrogenase (GAPDH) forms amyloid-like aggregates upon exposure to oxidative stress and that these aggregates contribute to neuronal cell death. Here, we report that GAPDH aggregates accelerate A beta amyloidogenesis and subsequent neuronal cell death both in vitro and in vivo. Co-incubation of A beta 40 with small amounts of GAPDH aggregates significantly enhanced A beta 40 amyloidogenesis, as assessed by in vitro thioflavin-T assays. Similarly, structural analyses using Congo red staining, circular dichroism, and atomic force microscopy revealed that GAPDH aggregates induced A beta 40 amyloidogenesis. In PC12 cells, GAPDH aggregates augmented A beta 40-induced cell death, concomitant with disruption of mitochondrial membrane potential. Furthermore, mice injected intracerebroventricularly with A beta 40 co-incubated withGAPDHaggregates exhibited A beta 40-induced pyramidal cell death and gliosis in the hippocampal CA3 region. These observations were accompanied by nuclear translocation of apoptosis-inducing factor and cytosolic release of cytochrome c from mitochondria. Finally, in the 3 x Tg-AD mouse model of AD, GAPDH/A beta co-aggregation and mitochondrial dysfunction were consistently detected in an age- dependent manner, and A beta aggregate formation was attenuated by GAPDH siRNA treatment. Thus, this study suggests that GAPDH aggregates accelerate A beta amyloidogenesis, subsequently leading to mitochondrial dysfunction and neuronal cell death in the pathogenesis of AD.	[Itakura, Masanori; Nakajima, Hidemitsu; Kubo, Takeya; Semi, Yuko; Higashida, Shusaku; Kaneshige, Akihiro; Kita, Akinori; Azuma, Yasu-Taka; Takeuchi, Tadayoshi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Lab Vet Pharmacol, Izumisano, Osaka 5988531, Japan; [Kuwamura, Mitsuru] Osaka Prefecture Univ, Lab Vet Pathol, Izumisano, Osaka 5988531, Japan; [Kume, Satoshi; Inui, Takashi] Osaka Prefecture Univ, Lab Biol Macromol, Osaka 5998531, Japan; [Harada, Naoki; Yamaji, Ryoichi] Osaka Prefecture Univ, Nutr Chem Lab, Osaka 5998531, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Nakajima, H (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Lab Vet Pharmacol, Izumisano, Osaka 5988531, Japan.	hnakajima@vet.osakafu-u.ac.jp	Harada, Naoki/AAP-2868-2020; Inui, Takashi/G-1069-2011	Harada, Naoki/0000-0003-3846-388X; Azuma, Yasu-Taka/0000-0002-3515-171X; Nakajima, Hidemitsu/0000-0002-0441-1929	Japan Society for the Promotion of Science [22580339, 25450428]; Japan Science and Technology Agency [AS232Z02185G, AS242Z02311Q]; Adaptable and Seamless Technology Transfer Program through target-driven RD;  [02120076]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Adaptable and Seamless Technology Transfer Program through target-driven RD; 	This work was supported in part by Grants-in-aid for Scientific Research 22580339 and 25450428 (to H. N.) from the Japan Society for the Promotion of Science, by Grants-in-aid from the Japan Science and Technology Agency for exploratory research in A-STEP AS232Z02185G and AS242Z02311Q (to H. N.), he Adaptable and Seamless Technology Transfer Program through target-driven R&D, and by Grant-in-aid for Scientific Research on Innovative Areas 02120076 (to T. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.08.002; Bodles AM, 2000, EUR J BIOCHEM, V267, P2186, DOI 10.1046/j.1432-1327.2000.01219.x; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Butterfield DA, 2013, ANTIOXID REDOX SIGN, V19, P823, DOI 10.1089/ars.2012.5027; Butterfield DA, 2010, J ALZHEIMERS DIS, V20, P369, DOI 10.3233/JAD-2010-1375; Butterfield SM, 2010, ANGEW CHEM INT EDIT, V49, P5628, DOI 10.1002/anie.200906670; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Dong YF, 2011, FASEB J, V25, P2911, DOI 10.1096/fj.11-182873; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Foley AM, 2015, J ALZHEIMERS DIS, V44, P787, DOI 10.3233/JAD-142208; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; GANTER C, 1990, BIOCHEMISTRY-US, V29, P9395, DOI 10.1021/bi00492a013; Goto A, 2009, NEUROCHEM INT, V54, P330, DOI 10.1016/j.neuint.2008.12.012; Grace EA, 2002, NEUROSCIENCE, V114, P265, DOI 10.1016/S0306-4522(02)00241-5; Gursky O, 2000, BBA-PROTEIN STRUCT M, V1476, P93, DOI 10.1016/S0167-4838(99)00228-9; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HARKANY T, 1995, BRAIN RES, V698, P270, DOI 10.1016/0006-8993(95)01013-L; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hong H, 2004, LIFE SCI, V74, P2959, DOI 10.1016/j.lfs.2003.09.074; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Ishitani R, 2003, PROG NEURO-PSYCHOPH, V27, P291, DOI 10.1016/S0278-5846(03)00024-1; Ishitani R, 1998, MOL PHARMACOL, V53, P701, DOI 10.1124/mol.53.4.701; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lin PI, 2006, NEUROLOGY, V67, P64, DOI 10.1212/01.wnl.0000223438.90113.4e; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nakajima H, 2015, J BIOL CHEM, V290, P14493, DOI 10.1074/jbc.M114.635607; Nakajima H, 2009, BIOCHEM BIOPH RES CO, V390, P1066, DOI 10.1016/j.bbrc.2009.10.118; Nakajima H, 2009, J BIOL CHEM, V284, P34331, DOI 10.1074/jbc.M109.027698; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ono K, 2005, BIOCHEM BIOPH RES CO, V336, P444, DOI 10.1016/j.bbrc.2005.08.148; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Perluigi M, 2010, J NEUROSCI RES, V88, P3498, DOI 10.1002/jnr.22500; Pierce A, 2008, J MOL BIOL, V382, P1195, DOI 10.1016/j.jmb.2008.07.088; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SIMMONS LK, 1994, MOL PHARMACOL, V45, P373; SLOVITER RS, 1989, J COMP NEUROL, V280, P183, DOI 10.1002/cne.902800203; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Tsuchiya K, 2005, EUR J NEUROSCI, V21, P317, DOI 10.1111/j.1460-9568.2005.03870.x; Tsuchiya K, 2004, LIFE SCI, V74, P3245, DOI 10.1016/j.lfs.2003.11.029; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Wirths O, 2012, LIFE SCI, V91, P1148, DOI 10.1016/j.lfs.2012.02.001; Xu GL, 2013, HUM MOL GENET, V22, P2765, DOI 10.1093/hmg/ddt121; Yamaji R, 2003, BBA-MOL CELL RES, V1593, P269, DOI 10.1016/S0167-4889(02)00397-X; Yamaji R, 2005, BBA-GEN SUBJECTS, V1726, P261, DOI 10.1016/j.bbagen.2005.07.013; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	65	45	46	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26072	26087		10.1074/jbc.M115.669291	http://dx.doi.org/10.1074/jbc.M115.669291			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26359500	Green Published, hybrid			2022-12-28	WOS:000363527300028
J	Mpakali, A; Giastas, P; Mathioudakis, N; Mavridis, IM; Saridakis, E; Stratikos, E				Mpakali, Anastasia; Giastas, Petros; Mathioudakis, Nikolas; Mavridis, Irene M.; Saridakis, Emmanuel; Stratikos, Efstratios			Structural Basis for Antigenic Peptide Recognition and Processing by Endoplasmic Reticulum (ER) Aminopeptidase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYLOSING-SPONDYLITIS; CRYSTAL-STRUCTURE; ERAP1; SUSCEPTIBILITY; ASSOCIATION; DISTINCT; DISEASE; COMPLEX; PROTEIN; POLYMORPHISM	Endoplasmic reticulum (ER) aminopeptidases process antigenic peptide precursors to generate epitopes for presentation by MHC class I molecules and help shape the antigenic peptide repertoire and cytotoxic T-cell responses. To perform this function, ER aminopeptidases have to recognize and process a vast variety of peptide sequences. To understand how these enzymes recognize substrates, we determined crystal structures of ER aminopeptidase 2 (ERAP2) in complex with a substrate analogue and a peptidic product to 2.5 and 2.7 angstrom, respectively, and compared them to the apo-form structure determined to 3.0 angstrom. The peptides were found within the internal cavity of the enzyme with no direct access to the outside solvent. The substrate analogue extends away from the catalytic center toward the distal end of the internal cavity, making interactions with several shallow pockets along the path. A similar configuration was evident for the peptidic product, although decreasing electron density toward its C terminus indicated progressive disorder. Enzymatic analysis confirmed that visualized interactions can either positively or negatively impact in vitro trimming rates. Opportunistic side-chain interactions and lack of deep specificity pockets support a limited-selectivity model for antigenic peptide processing by ERAP2. In contrast to proposed models for the homologous ERAP1, no specific recognition of the peptide C terminus by ERAP2 was evident, consistent with functional differences in length selection and self-activation between these two enzymes. Our results suggest that ERAP2 selects substrates by sequestering them in its internal cavity and allowing opportunistic interactions to determine trimming rates, thus combining substrate permissiveness with sequence bias.	[Mpakali, Anastasia; Giastas, Petros; Mathioudakis, Nikolas; Mavridis, Irene M.; Saridakis, Emmanuel; Stratikos, Efstratios] Natl Ctr Sci Res Demokritos, Athens 15310, Greece	National Centre of Scientific Research "Demokritos"	Saridakis, E (corresponding author), Natl Ctr Sci Res Demokritos, Athens 15310, Greece.	e.saridakis@inn.demokritos.gr; stratos@rrp.demokritos.gr	Giastas, Petros/AAD-8770-2021; Mpakali, Anastasia/AAW-9773-2021; Stratikos, Efstratios/N-2969-2014	Stratikos, Efstratios/0000-0002-3566-2309; Mpakali, Anastasia/0000-0003-0869-9680; Giastas, Petros/0000-0002-3490-8223	European Union (European Social Fund); Greek National funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework: Research Funding Program of the General Secretariat for Research and Technology Grant [ERC-14]; European Community [283570]	European Union (European Social Fund)(European Social Fund (ESF)European Commission); Greek National funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework: Research Funding Program of the General Secretariat for Research and Technology Grant; European Community(European Commission)	This work was supported by the European Union (European Social Fund) and Greek National funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework: Research Funding Program of the General Secretariat for Research and Technology Grant ERC-14. This work was also supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X Grant 283570. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aldhamen YA, 2015, J INNATE IMMUN, V7, P275, DOI 10.1159/000368899; AlexanderMiller MA, 1996, INT IMMUNOL, V8, P641, DOI 10.1093/intimm/8.5.641; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Birtley JR, 2012, BIOCHEMISTRY-US, V51, P286, DOI 10.1021/bi201230p; Blanchard N, 2010, J IMMUNOL, V184, P3033, DOI 10.4049/jimmunol.0903712; Cagliani R, 2010, HUM MOL GENET, V19, P4705, DOI 10.1093/hmg/ddq401; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Cortes A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8146; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evnouchidou I, 2012, J IMMUNOL, V189, P2383, DOI 10.4049/jimmunol.1200918; Evnouchidou I, 2011, J IMMUNOL, V186, P1909, DOI 10.4049/jimmunol.1003337; Evnouchidou I, 2009, CURR PHARM DESIGN, V15, P3656, DOI 10.2174/138161209789271816; Evnouchidou I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003658; Fruci D, 2014, TISSUE ANTIGENS, V84, P177, DOI 10.1111/tan.12410; Gandhi A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00186; Garcia-Medel N, 2014, MOL CELL PROTEOMICS, V13, P3367, DOI 10.1074/mcp.M114.039214; Garcia-Medel N, 2012, MOL CELL PROTEOMICS, V11, P1416, DOI 10.1074/mcp.M112.019588; Georgiadou D, 2010, J IMMUNOL, V185, P1584, DOI 10.4049/jimmunol.0902502; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Hattori A, 2012, BIOL PHARM BULL, V35, P601, DOI 10.1248/bpb.35.601; Hisatsune C, 2015, MOL CELL, V58, P1015, DOI 10.1016/j.molcel.2015.04.008; Infantes S, 2010, J IMMUNOL, V184, P3351, DOI 10.4049/jimmunol.0901560; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Kenna TJ, 2015, RHEUMATOLOGY, V54, P1549, DOI 10.1093/rheumatology/kev218; Kim S, 2011, NAT IMMUNOL, V12, P984, DOI 10.1038/ni.2097; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Lazard S, 2015, MOL IMMUNOL, V68, P72, DOI 10.1016/j.molimm.2015.04.014; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; Lorente E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079596; Maksymowych WP, 2009, ARTHRITIS RHEUM, V60, P1317, DOI 10.1002/art.24467; Mpakali A, 2015, J IMMUNOL, V195, P2842, DOI 10.4049/jimmunol.1501103; Nguyen TT, 2011, NAT STRUCT MOL BIOL, V18, P604, DOI 10.1038/nsmb.2021; Rastall DPW, 2014, INT IMMUNOL, V26, P685, DOI 10.1093/intimm/dxu078; Reeves E, 2014, P NATL ACAD SCI USA, V111, P17594, DOI 10.1073/pnas.1408882111; Saridakis E, 2000, PROTEIN SCI, V9, P755; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Seregin SS, 2013, AUTOIMMUNITY, V46, P497, DOI 10.3109/08916934.2013.819855; Stamogiannos A, 2015, MOL IMMUNOL, V67, P426, DOI 10.1016/j.molimm.2015.07.010; Stratikos E, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00363; Stratikos E, 2013, MOL IMMUNOL, V55, P212, DOI 10.1016/j.molimm.2013.03.002; Tsui FWL, 2010, ANN RHEUM DIS, V69, P733, DOI 10.1136/ard.2008.103804; Tsujimoto M, 2005, BBA-PROTEINS PROTEOM, V1751, P9, DOI 10.1016/j.bbapap.2004.09.011; Weimershaus M, 2013, CURR OPIN IMMUNOL, V25, P90, DOI 10.1016/j.coi.2012.10.001; York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860; Zervoudi E, 2013, P NATL ACAD SCI USA, V110, P19890, DOI 10.1073/pnas.1309781110; Zervoudi E, 2011, BIOCHEM J, V435, P411, DOI 10.1042/BJ20102049	53	54	55	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26021	26032		10.1074/jbc.M115.685909	http://dx.doi.org/10.1074/jbc.M115.685909			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26381406	Green Published, hybrid			2022-12-28	WOS:000363527300023
J	Rhee, SH; Ma, EL; Lee, Y; Tache, Y; Pothoulakis, C; Im, E				Rhee, Sang Hoon; Ma, Elise L.; Lee, Yunna; Tache, Yvette; Pothoulakis, Charalabos; Im, Eunok			Corticotropin Releasing Hormone and Urocortin 3 Stimulate Vascular Endothelial Growth Factor Expression through the cAMP/CREB Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE-RECEPTOR-5 ENGAGEMENT; INTESTINAL INFLAMMATION; GENE-EXPRESSION; SPLICE VARIANT; RECEPTOR; VEGF; CELLS; HYPOXIA; ANGIOGENESIS	Colonic epithelium is the first line of defense against various pathological offenses in the gut. Previous studies have shown that the peptides of the corticotropin-releasing hormone (CRH) family modulate vascular endothelial growth factor (VEGF)-A production in other cells. Here we sought to investigate whether CRH and urocortin (Ucn) 3 regulate VEGF-A secretion in colonocytes through CRH receptors and to elucidate the underlying mechanism of action. CRH and Ucn 3 significantly increased the expression levels of VEGF-A mRNA and protein through CRH receptor 1 and 2, respectively, in human colonic epithelial cells and primary mouse intestinal epithelial cells. Underlying mechanisms involve activation of adenylyl cyclase with subsequent increase of intracellular cAMP level and increased DNA binding activity of transcription factor CREB on VEGF-A promoter region. Finally, genetic deficiency of CREB decreased intestinal inflammation and VEGF-A expression in a dextran sodium sulfate-induced colitis model. These results show that activation of CRH receptors by CRH ligands stimulates VEGF-A expression in intestinal epithelial cells through the cAMP/CREB pathway. Since VEGF-A boosts inflammatory responses through angiogenesis, these data suggest that CREB may be a key effector of CRH and Ucn 3-dependent inflammatory angiogenesis.	[Rhee, Sang Hoon; Ma, Elise L.; Tache, Yvette; Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Sect Inflammatory Bowel Dis, Los Angeles, CA 90095 USA; [Rhee, Sang Hoon; Ma, Elise L.; Tache, Yvette; Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Inflammatory Bowel Dis, Div Digest Dis, Los Angeles, CA 90095 USA; [Lee, Yunna; Im, Eunok] Pusan Natl Univ, Coll Pharm, Busan 609735, South Korea	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pusan National University	Im, E (corresponding author), Pusan Natl Univ, Coll Pharm, Busan 609735, South Korea.	eoim@pusan.ac.kr	Regan, Clinton/E-6250-2012		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2057432]; National Institutes of Health [R01DK101671]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301, R01DK101671] Funding Source: NIH RePORTER	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2014R1A1A2057432, to E. I.) and by the National Institutes of Health (R01DK101671, to C. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Anton PM, 2004, P NATL ACAD SCI USA, V101, P8503, DOI 10.1073/pnas.0402693101; Bale TL, 2002, P NATL ACAD SCI USA, V99, P7734, DOI 10.1073/pnas.102187099; Bates DO, 2002, CANCER RES, V62, P4123; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Cao J, 2005, J IMMUNOL, V174, P7665, DOI 10.4049/jimmunol.174.12.7665; Carvalho AT, 2007, WORLD J GASTROENTERO, V13, P2166, DOI 10.3748/wjg.v13.i15.2166; Choi YJ, 2013, FASEB J, V27, P243, DOI 10.1096/fj.12-217596; Choi YJ, 2010, J BIOL CHEM, V285, P37570, DOI 10.1074/jbc.M110.158394; CLAFFEY KP, 1992, J BIOL CHEM, V267, P16317; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; GARRIDO C, 1993, GROWTH FACTORS, V8, P109, DOI 10.3109/08977199309046931; Grammatopoulos DK, 2012, BRIT J PHARMACOL, V166, P85, DOI 10.1111/j.1476-5381.2011.01631.x; Hao ZR, 2008, P NATL ACAD SCI USA, V105, P3939, DOI 10.1073/pnas.0712366105; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Hsu SY, 2001, NAT MED, V7, P605, DOI 10.1038/87936; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Im E, 2005, MOL BIOL CELL, V16, P3488, DOI 10.1091/mbc.E04-11-1029; Im E, 2006, EMBO J, V25, P2075, DOI 10.1038/sj.emboj.7601100; Im E, 2014, INTEST RES, V12, P96, DOI 10.5217/ir.2014.12.2.96; Im E, 2010, GASTROENTEROLOGY, V138, P2457, DOI 10.1053/j.gastro.2010.02.055; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jeon SH, 2007, MOL CELLS, V23, P23; Kokkotou E, 2006, J IMMUNOL, V177, P3355, DOI 10.4049/jimmunol.177.5.3355; LABRIE F, 1982, SCIENCE, V216, P1007, DOI 10.1126/science.6281886; Lee JS, 2009, J NEUROSCI, V29, P8493, DOI 10.1523/JNEUROSCI.1321-09.2009; Levy AP, 1996, J BIOL CHEM, V271, P2746, DOI 10.1074/jbc.271.5.2746; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; McEvoy AN, 2002, ANN NY ACAD SCI, V966, P119, DOI 10.1111/j.1749-6632.2002.tb04209.x; Million M, 1999, AM J PHYSIOL-GASTR L, V276, pG1027, DOI 10.1152/ajpgi.1999.276.4.G1027; Mukhopadhyay D, 1997, MOL CELL BIOL, V17, P5629, DOI 10.1128/MCB.17.9.5629; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; Rhee SH, 2008, GASTROENTEROLOGY, V135, P518, DOI 10.1053/j.gastro.2008.04.022; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Rhee SH, 2004, J BIOL CHEM, V279, P25179, DOI 10.1074/jbc.M400967200; Scaldaferri F, 2009, GASTROENTEROLOGY, V136, P585, DOI 10.1053/j.gastro.2008.09.064; Tache Y, 2007, J CLIN INVEST, V117, P33, DOI 10.1172/JCI30085; Takahashi A, 2002, MOL CELL BIOL, V22, P4803, DOI 10.1128/MCB.22.13.4803-4814.2002; Tezval H, 2009, WORLD J UROL, V27, P825, DOI 10.1007/s00345-009-0417-x; Tezval H, 2009, PROSTATE, V69, P443, DOI 10.1002/pros.20892; Tolstanova G, 2009, J PHARMACOL EXP THER, V328, P749, DOI 10.1124/jpet.108.145128; Tsiolakidou G, 2008, DIGEST LIVER DIS, V40, P673, DOI 10.1016/j.dld.2008.02.010; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; Wakahashi S, 2008, ENDOCRINE, V33, P144, DOI 10.1007/s12020-008-9071-0; Wang JJ, 2010, CANCER INVEST, V28, P146, DOI 10.3109/07357900903179617; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934	50	14	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26194	26203		10.1074/jbc.M115.678979	http://dx.doi.org/10.1074/jbc.M115.678979			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26350463	Green Published, hybrid			2022-12-28	WOS:000363527300037
J	Fenyk, S; Townsend, PD; Dixon, CH; Spies, GB; Campillo, AD; Slootweg, EJ; Westerhof, LB; Gawehns, FKK; Knight, MR; Sharples, GJ; Goverse, A; Palsson, LO; Takken, FLW; Cann, MJ				Fenyk, Stepan; Townsend, Philip D.; Dixon, Christopher H.; Spies, Gerhard B.; Campillo, Alba de San Eustaquio; Slootweg, Erik J.; Westerhof, Lotte B.; Gawehns, Fleur K. K.; Knight, Marc R.; Sharples, Gary J.; Goverse, Aska; Palsson, Lars-Olof; Takken, Frank L. W.; Cann, Martin J.			The Potato Nucleotide-binding Leucine-rich Repeat (NLR) Immune Receptor Rx1 Is a Pathogen-dependent DNA-deforming Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION ORIGIN RECOGNITION; CIRCULAR-DICHROISM SPECTRA; RESONANCE ENERGY-TRANSFER; PLANT-DISEASE RESISTANCE; NB-ARC DOMAIN; CRYSTAL-STRUCTURE; CELL-DEATH; VIRUS-RESISTANCE; TIR DOMAIN; CAENORHABDITIS-ELEGANS	Plant nucleotide-binding leucine-rich repeat (NLR) proteins enable cells to respond to pathogen attack. Several NLRs act in the nucleus; however, conserved nuclear targets that support their role in immunity are unknown. Previously, we noted a structural homology between the nucleotide-binding domain of NLRs and DNA replication origin-binding Cdc6/Orc1 proteins. Here we show that the NB-ARC (nucleotide-binding, Apaf-1, R-proteins, and CED-4) domain of the Rx1 NLR of potato binds nucleic acids. Rx1 induces ATP-dependent bending and melting of DNA in vitro, dependent upon a functional P-loop. In situ full-length Rx1 binds nuclear DNA following activation by its cognate pathogen-derived effector protein, the coat protein of potato virus X. In line with its obligatory nucleocytoplasmic distribution, DNA binding was only observed when Rx1 was allowed to freely translocate between both compartments and was activated in the cytoplasm. Immune activation induced by an unrelated NLR-effector pair did not trigger an Rx1-DNA interaction. DNAbinding is therefore not merely a consequence of immune activation. These data establish a role for DNA distortion in Rx1 immune signaling and defineDNAas a molecular target of an activated NLR.	[Fenyk, Stepan; Townsend, Philip D.; Dixon, Christopher H.; Spies, Gerhard B.; Campillo, Alba de San Eustaquio; Knight, Marc R.; Sharples, Gary J.; Cann, Martin J.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Fenyk, Stepan; Townsend, Philip D.; Dixon, Christopher H.; Spies, Gerhard B.; Campillo, Alba de San Eustaquio; Knight, Marc R.; Sharples, Gary J.; Cann, Martin J.] Univ Durham, Biophys Sci Inst, Durham DH1 3LE, England; [Palsson, Lars-Olof] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Slootweg, Erik J.; Westerhof, Lotte B.; Goverse, Aska] Wageningen Univ, Dept Plant Sci, Nematol Lab, NL-6708 PB Wageningen, Netherlands; [Gawehns, Fleur K. K.; Takken, Frank L. W.] Univ Amsterdam, Swammerdam Inst Life Sci, Mol Plant Pathol, NL-1098 XH Amsterdam, Netherlands	Durham University; Durham University; Durham University; Wageningen University & Research; University of Amsterdam	Cann, MJ (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England.	m.j.cann@durham.ac.uk	Sharples, Gary/B-8638-2016; Townsend, Phiip/J-3761-2018; Pålsson, Lars-Olof A/F-3877-2012; Cann, Martin/G-2864-2012; Takken, Frank/C-8051-2012	Sharples, Gary/0000-0003-2495-0062; Townsend, Phiip/0000-0001-9235-3492; Pålsson, Lars-Olof A/0000-0003-3592-8506; Knight, Marc/0000-0002-4830-8608; Slootweg, Erik J./0000-0001-9935-7728; Cann, Martin/0000-0001-6305-8769; Gawehns, Fleur/0000-0002-9236-966X; Takken, Frank/0000-0003-2655-3108	Biotechnology and Biological Sciences Research Council [BB/I0119994/1, BB/M007405/1]; European Union; Top Technology Institute Green Genetics; Dutch Science Foundation for Earth and Life Sciences; Biotechnology and Biological Sciences Research Council [1220464] Funding Source: researchfish; BBSRC [BB/M007405/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Top Technology Institute Green Genetics; Dutch Science Foundation for Earth and Life Sciences; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/I0119994/1 and BB/M007405/1 (to M. J.C., G. J. S., and M. R. K.), European Union funded Integrated Project BIOEXPLOIT (to A. G., E. J. S., F. L. W. T., and F. K. K. G.), and Top Technology Institute Green Genetics and the Dutch Science Foundation for Earth and Life Sciences (to A. G. and L. B. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Albrecht M, 2006, BIOCHEM BIOPH RES CO, V339, P459, DOI 10.1016/j.bbrc.2005.10.074; Bai SW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002752; Bendahmane A, 1995, PLANT J, V8, P933, DOI 10.1046/j.1365-313X.1995.8060933.x; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Capaldi SA, 2004, NUCLEIC ACIDS RES, V32, P4821, DOI 10.1093/nar/gkh819; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; Cesari S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00606; Chang C, 2013, PLANT CELL, V25, P1158, DOI 10.1105/tpc.113.109942; Chattopadhyaya R, 2008, J BIOMOL STRUCT DYN, V25, P357, DOI 10.1080/07391102.2008.10507184; Cheng YT, 2009, PLANT CELL, V21, P2503, DOI 10.1105/tpc.108.064519; Cremazy FGE, 2005, EXP CELL RES, V309, P390, DOI 10.1016/j.yexcr.2005.06.007; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fenyk S, 2012, J BIOL CHEM, V287, P4023, DOI 10.1074/jbc.M111.314450; Fernandez-Cid A, 2013, MOL CELL, V50, P577, DOI 10.1016/j.molcel.2013.03.026; Finzi L, 2010, J BIOL CHEM, V285, P18973, DOI 10.1074/jbc.R109.062612; Fogg JM, 2012, Q REV BIOPHYS, V45, P257, DOI 10.1017/S0033583512000054; Foyer CH, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0226; Gaudier M, 2007, SCIENCE, V317, P1213, DOI 10.1126/science.1143664; Gaudreault M, 2009, METHODS MOL BIOL, V543, P15, DOI 10.1007/978-1-60327-015-1_2; Germain H, 2011, NEW PHYTOL, V189, P678, DOI 10.1111/j.1469-8137.2010.03544.x; GOHLKE C, 1994, P NATL ACAD SCI USA, V91, P11660, DOI 10.1073/pnas.91.24.11660; GOULDEN MG, 1993, VIROLOGY, V197, P293, DOI 10.1006/viro.1993.1590; Grainge I, 2006, J MOL BIOL, V363, P355, DOI 10.1016/j.jmb.2006.07.076; Green V, 2013, MOL MICROBIOL, V89, P1240, DOI 10.1111/mmi.12343; GRINVALD A, 1974, ANAL BIOCHEM, V59, P583, DOI 10.1016/0003-2697(74)90312-1; Harris CJ, 2013, P NATL ACAD SCI USA, V110, P21189, DOI 10.1073/pnas.1311134110; Heidrich K, 2011, SCIENCE, V334, P1401, DOI 10.1126/science.1211641; Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim H, 2012, NUCLEIC ACIDS RES, V40, P371, DOI 10.1093/nar/gkr736; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Lee DG, 2000, EMBO J, V19, P4774, DOI 10.1093/emboj/19.17.4774; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Liu JY, 2000, MOL CELL, V6, P637, DOI 10.1016/S1097-2765(00)00062-9; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Maekawa T, 2011, NAT IMMUNOL, V12, P818, DOI 10.1038/ni.2083; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Parkhurst LJ, 2001, BIOPOLYMERS, V61, P180; Peart JR, 2002, P NATL ACAD SCI USA, V99, P10865, DOI 10.1073/pnas.152330599; Qi SQ, 2010, CELL, V141, P446, DOI 10.1016/j.cell.2010.03.017; Rairdan GJ, 2008, PLANT CELL, V20, P739, DOI 10.1105/tpc.107.056036; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Remus D, 2004, EMBO J, V23, P897, DOI 10.1038/sj.emboj.7600077; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Riedl SJ, 2005, NATURE, V434, P926, DOI 10.1038/nature03465; Roberts M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003465; SANGER F, 1978, J MOL BIOL, V125, P225, DOI 10.1016/0022-2836(78)90346-7; Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061; Scofield SR, 1996, SCIENCE, V274, P2063, DOI 10.1126/science.274.5295.2063; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Shrivastava D, 2011, BIOINFORMATION, V5, P326, DOI 10.6026/97320630005326; Singleton MR, 2004, J MOL BIOL, V343, P547, DOI 10.1016/j.jmb.2004.08.044; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Slootweg EJ, 2013, PLANT PHYSIOL, V162, P1510, DOI 10.1104/pp.113.218842; Spehr M, 2004, J BIOL CHEM, V279, P40194, DOI 10.1074/jbc.M403913200; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Swiderski MR, 2009, MOL PLANT MICROBE IN, V22, P157, DOI 10.1094/MPMI-22-2-0157; Takken FLW, 2009, SCIENCE, V324, P744, DOI 10.1126/science.1171666; Takken FLW, 2012, CURR OPIN PLANT BIOL, V15, P375, DOI 10.1016/j.pbi.2012.05.001; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461; Tang GQ, 2011, J BIOL CHEM, V286, P38805, DOI 10.1074/jbc.M111.261966; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; Westerhof LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046460; Williams SJ, 2011, MOL PLANT MICROBE IN, V24, P897, DOI 10.1094/MPMI-03-11-0052; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Wu CH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00134; Xu QP, 2009, PROTEINS, V74, P1041, DOI 10.1002/prot.22325; Yan N, 2005, NATURE, V437, P831, DOI 10.1038/nature04002; Yokoyama H, 2003, J BIOL CHEM, V278, P2767, DOI 10.1074/jbc.M210899200; Zhu ZH, 2010, P NATL ACAD SCI USA, V107, P13960, DOI 10.1073/pnas.1002828107	92	31	33	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24945	24960		10.1074/jbc.M115.672121	http://dx.doi.org/10.1074/jbc.M115.672121			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26306038	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000362598300026
J	Litschko, C; Romano, MR; Pinto, V; Claus, H; Vogel, U; Berti, F; Gerardy-Schahn, R; Fiebig, T				Litschko, Christa; Romano, Maria Rosaria; Pinto, Vittoria; Claus, Heike; Vogel, Ulrich; Berti, Francesco; Gerardy-Schahn, Rita; Fiebig, Timm			The Capsule Polymerase CsIB of Neisseria meningitidis Serogroup L Catalyzes the Synthesis of a Complex Trimeric Repeating Unit Comprising Glycosidic and Phosphodiester Linkages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENINGOCOCCAL CONJUGATE VACCINE; TRANSPORTER-DEPENDENT PATHWAYS; LIPOPOLYSACCHARIDE O-ANTIGENS; NUCLEAR-MAGNETIC-RESONANCE; 2 ACTIVE-SITES; ESCHERICHIA-COLI; PASTEURELLA-MULTOCIDA; ACTINOBACILLUS-PLEUROPNEUMONIAE; STRUCTURAL DETERMINATION; POLYSACCHARIDE ANTIGENS	Neisseria rneningitidis is a human pathogen causing bacterial meningitis and sepsis. The capsular polysaccharide surrounding N. meningitidis is a major virulence factor. The capsular polysaccharide consists of polyhexosarnine phosphates in N. meningitidis serogroups A and X. The capsule polymerases (CPs) of these serogroups are members of the Stealth protein family comprising o-hexose-1-phosphate transferases from bacterial and protozoan pathogens. CsIA, one of two putative CPs of the pathophysiologically less relevant N. meningitidis serogroup is one of the smallest known Stealth proteins and caught our attention for structure-function analyses. Because the N. meningitidis serogroup I. capsule polymer consists of a trimeric repeating unit ([-> 3)-beta-D-GUNAc-(1 -> 3)-beta-D-GlcNAc-(1 -> 3)-alpha-D-GIcNAc-(10P03Hn), we speculated that the two predicted CPs (CsIA and Cs113) work together in polymer production. Consequently, both enzymes were cloned, overexpressed, and purified as recombinant proteins. Contrary to our expectation, enzymatic testing identified CsIB to be sufficient to catalyze the synthesis of the complex trimeric N rneningitidis serogroup I. capsule polymer repeating unit. No polymerase activity was detected for CsIA, although the enzyme facilitated the hydrolysis of UDP-GIcNAc. Bioinformatics analyses identified two glycosyltransferase (GT) domains in Cs113. The N-terminal domain modeled with 100% confidence onto a number of GT-A folded proteins, whereas the C-terminal domain modeled with 100% confidence onto TagF, a GT-B folded teichoic acid polymerase from Staphylococcus epiderrnidis. Amino acid positions known to have critical catalytic functions in the template pro- teins were conserved in Cs1B, and their point mutation abolished enzyme activity. Cs113 represents an enzyme of so far unique complexity regarding both the catalyzed reaction and enzyme architecture.	[Litschko, Christa; Gerardy-Schahn, Rita; Fiebig, Timm] Hannover Med Sch, Inst Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Romano, Maria Rosaria; Pinto, Vittoria; Berti, Francesco] GSK Vaccines, Res, I-53100 Siena, Italy; [Claus, Heike; Vogel, Ulrich] Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany	Hannover Medical School; GlaxoSmithKline; University of Wurzburg	Fiebig, T (corresponding author), Hannover Med Sch, Inst Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Fiebig.Timm@mh-hannover.de		Fiebig, Timm/0000-0002-2021-7296; Litschko, Christa/0000-0001-9114-4832	LOM (impact-oriented funding) funds	LOM (impact-oriented funding) funds	This work was supported by LOM (impact-oriented funding) funds to the Institute for Cellular Chemistry. F. B., M. R. R., and V. P. are full-time employees of GSK Vaccines. There are no patents or products in development. The other authors declare that they have no conflicts of interest with the contents of this article.	Alcala B, 2002, EMERG INFECT DIS, V8, P1512, DOI 10.3201/eid0812.020081; ASHTON FE, 1983, J CLIN MICROBIOL, V17, P722, DOI 10.1128/JCM.17.5.722-727.1983; Barnett TC, 2015, CURR OPIN IMMUNOL, V36, P1, DOI 10.1016/j.coi.2015.04.002; Beddek AJ, 2009, INFECT IMMUN, V77, P2989, DOI 10.1128/IAI.00181-09; Berti F, 2012, VACCINE, V30, P6409, DOI 10.1016/j.vaccine.2012.08.021; BEYNON LM, 1991, CARBOHYD RES, V212, P219, DOI 10.1016/0008-6215(91)84059-N; BHATTACHARJEE AK, 1976, CAN J BIOCHEM CELL B, V54, P1, DOI 10.1139/o76-001; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; Bohm R, 2010, CHEMBIOCHEM, V11, P170, DOI 10.1002/cbic.200900659; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; BUNDLE DR, 1973, CARBOHYD RES, V26, P268, DOI 10.1016/S0008-6215(00)85053-3; BUNDLE DR, 1974, J BIOL CHEM, V249, P2275; Caini S, 2013, VACCINE, V31, P1597, DOI 10.1016/j.vaccine.2013.01.015; Claus H, 2009, MOL MICROBIOL, V71, P960, DOI 10.1111/j.1365-2958.2008.06580.x; DeAngelis PL, 2004, J BACTERIOL, V186, P8529, DOI 10.1128/JB.186.24.8529-8532.2004; Deangelis PL, 2003, J BIOL CHEM, V278, P35199, DOI 10.1074/jbc.M306431200; DeAngelis PL, 2002, J BIOL CHEM, V277, P7209, DOI 10.1074/jbc.M112130200; Djingarey MH, 2012, VACCINE, V30, pB40, DOI 10.1016/j.vaccine.2011.12.073; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Fiebig T, 2014, J BIOL CHEM, V289, P19395, DOI 10.1074/jbc.M114.575142; Fiebig T, 2014, GLYCOBIOLOGY, V24, P150, DOI 10.1093/glycob/cwt102; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; Freiberger F, 2013, CHEMBIOCHEM, V14, P1949, DOI 10.1002/cbic.201300367; Garralda ME, 2009, PEDIATR CRIT CARE ME, V10, P675, DOI 10.1097/PCC.0b013e3181ae785a; Greenfield LK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412577; Greenfield LK, 2012, J BIOL CHEM, V287, P35078, DOI 10.1074/jbc.M112.401000; Harrison LH, 2010, J INFECT DIS, V201, P1208, DOI 10.1086/651505; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Hill DJ, 2010, CLIN SCI, V118, P547, DOI 10.1042/CS20090513; JENNINGS HJ, 1983, CARBOHYD RES, V112, P105, DOI 10.1016/0008-6215(83)88270-6; Jessing SG, 2008, VET MICROBIOL, V129, P350, DOI 10.1016/j.vetmic.2007.12.003; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Kane TA, 2006, J BIOL CHEM, V281, P33192, DOI 10.1074/jbc.M606897200; Kavoosi M, 2007, BIOTECHNOL BIOENG, V98, P599, DOI 10.1002/bit.21396; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kertesz DA, 1998, J INFECT DIS, V177, P1754, DOI 10.1086/517439; Keys TG, 2014, NAT CHEM BIOL, V10, P437, DOI 10.1038/nchembio.1501; Keys TG, 2013, GLYCOBIOLOGY, V23, P613, DOI 10.1093/glycob/cwt003; Keys TG, 2012, ANAL BIOCHEM, V427, P107, DOI 10.1016/j.ab.2012.05.011; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; LaForce FM, 2011, HEALTH AFFAIR, V30, P1049, DOI 10.1377/hlthaff.2011.0328; Lam TT, 2011, RES MICROBIOL, V162, P483, DOI 10.1016/j.resmic.2011.04.002; Liston SD, 2015, J BIOL CHEM, V290, P1075, DOI 10.1074/jbc.M114.622480; LIU TY, 1971, J BIOL CHEM, V246, P2849; Lovering AL, 2010, NAT STRUCT MOL BIOL, V17, P582, DOI 10.1038/nsmb.1819; Muindi KM, 2014, GLYCOBIOLOGY, V24, P139, DOI 10.1093/glycob/cwt091; Nadel S, 2012, ARCH DIS CHILD, V97, P993, DOI 10.1136/archdischild-2012-302036; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pace D, 2013, EXPERT OPIN BIOL TH, V13, P11, DOI 10.1517/14712598.2012.725718; PERRY MB, 1990, SERODIAG IMMUN INF D, V4, P299, DOI 10.1016/0888-0786(90)90018-J; Romanow A, 2014, J BIOL CHEM, V289, P33945, DOI 10.1074/jbc.M114.597773; Romanow A, 2013, J BIOL CHEM, V288, P11718, DOI 10.1074/jbc.M113.452276; Satola SW, 2003, INFECT IMMUN, V71, P7202, DOI 10.1128/IAI.71.12.7202-7207.2003; Schertzer JW, 2005, J BIOL CHEM, V280, P36683, DOI 10.1074/jbc.M507153200; Sethi Maya K, 2013, Methods Mol Biol, V1022, P307, DOI 10.1007/978-1-62703-465-4_23; Simoes MJ, 2009, EPIDEMIOL INFECT, V137, P161, DOI 10.1017/S0950268808001106; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016/j.vaccine.2009.04.070; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; Taha MK, 2000, LANCET, V356, P2159, DOI 10.1016/S0140-6736(00)03502-9; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Tzeng YL, 2016, CRIT REV MICROBIOL, V42, P759, DOI 10.3109/1040841X.2015.1022507; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Willis LM, 2013, P NATL ACAD SCI USA, V110, P20753, DOI 10.1073/pnas.1312637110; Willis LM, 2013, CARBOHYD RES, V378, P35, DOI 10.1016/j.carres.2013.05.007; Willis LM, 2013, P NATL ACAD SCI USA, V110, P7868, DOI 10.1073/pnas.1222317110; Xie OL, 2013, VACCINE, V31, P2852, DOI 10.1016/j.vaccine.2013.04.036; Xu ZF, 2010, J BACTERIOL, V192, P5625, DOI 10.1128/JB.00535-10; Zhu HF, 2012, J CLIN MICROBIOL, V50, P46, DOI 10.1128/JCM.00918-11	71	15	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24355	24366		10.1074/jbc.M115.678094	http://dx.doi.org/10.1074/jbc.M115.678094			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26286750	Green Published, hybrid			2022-12-28	WOS:000362218900024
J	O'Brien, ES; Nucci, NV; Fuglestad, B; Tommos, C; Wand, AJ				O'Brien, Evan S.; Nucci, Nathaniel V.; Fuglestad, Brian; Tommos, Cecilia; Wand, A. Joshua			Defining the Apoptotic Trigger THE INTERACTION OF CYTOCHROME c AND CARDIOLIPIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-VISCOSITY FLUIDS; HIGH-RESOLUTION NMR; ENCAPSULATED PROTEINS; STRUCTURAL TRANSITIONS; PEROXIDASE-ACTIVITY; HYDRATION DYNAMICS; CRYSTAL-STRUCTURE; IONIC-STRENGTH; NUCLEIC-ACIDS; XPLOR-NIH	The interaction between cytochrome c and the anionic lipid cardiolipin has been proposed as a primary event in the apoptotic signaling cascade. Numerous studies that have examined the interaction of cytochrome c with cardiolipin embedded in a variety of model phospholipid membranes have suggested that partial unfolding of the protein is a precursor to the apoptotic response. However, these studies lacked site resolution and used model systems with negligible or a positive membrane curvature, which is distinct from the large negative curvature of the invaginations of the inner mitochondrial membrane where cytochrome c resides. We have used reverse micelle encapsulation to mimic the potential effects of confinement on the interaction of cytochrome c with cardiolipin. Encapsulation of oxidized horse cytochrome c in 1-decanoylrac-glycerol/lauryldimethylamine-N-oxide/hexanol reverse micelles prepared in pentane yields NMR spectra essentially identical to the protein in free aqueous solution. The structure of encapsulated ferricytochrome c was determined to high precision (<r.m.s. deviation>(bb) similar to 0.23 angstrom) using NMR-based methods and is closely similar to the cryogenic crystal structure (<r.m.s. deviation>(bb) similar to 1.2 angstrom). Incorporation of cardiolipin into the reverse micelle surfactant shell causes localized chemical shift perturbations of the encapsulated protein, providing the first view of the cardiolipin/cytochrome c interaction interface at atomic resolution. Three distinct sites of interaction are detected: the so-called A-and L-sites, plus a previously undocumented interaction centered on residues Phe-36, Gly-37, Thr58, Trp-59, and Lys-60. Importantly, in distinct contrast to earlier studies of this interaction, the protein is not significantly disturbed by the binding of cardiolipin in the context of the reverse micelle.	Univ Penn, Johnson Res Fdn, Philadelphia, PA 19104 USA; Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wand, AJ (corresponding author), 905 Stellar Chance Labs,422 Curie Blvd, Philadelphia, PA 19104 USA.	wand@upenn.edu	Regan, Clinton/E-6250-2012; O'Brien, Evan/J-2098-2017	O'Brien, Evan/0000-0002-2260-7722; Nucci, Nathaniel/0000-0001-8034-4492; Fuglestad, Brian/0000-0001-8304-8269	National Science Foundation [MOB-1158038]; National Institutes of Health [GM079190, GM008275]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275, R01GM079190] Funding Source: NIH RePORTER; Direct For Biological Sciences [1158038] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by the National Science Foundation Grant MOB-1158038 (to A. J. W.) and National Institutes of Health Grant GM079190 (to C. T.). A. J. W. discloses a competing financial interest as a Member of Daedalus Innovations LLC, a manufacturer of reverse micelle and high pressure NMR apparatus.; Predoctoral trainee supported by National Institutes of Health Grant GM008275.	Babu CR, 2001, J AM CHEM SOC, V123, P2691, DOI 10.1021/ja005766d; Banci L, 2004, J BIOMOL NMR, V28, P249, DOI 10.1023/B:JNMR.0000013703.30623.f7; Banci L, 1997, BIOCHEMISTRY-US, V36, P9867, DOI 10.1021/bi970724w; Bazan S, 2013, J BIOL CHEM, V288, P401, DOI 10.1074/jbc.M112.425876; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; Bertini I, 2008, DALTON T, P3782, DOI 10.1039/b719526e; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dodevski I, 2014, J AM CHEM SOC, V136, P3465, DOI 10.1021/ja410716w; Englander SW, 2014, P NATL ACAD SCI USA, V111, P15873, DOI 10.1073/pnas.1411798111; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Goddard D., 2008, SPARKY 3; Halle B, 2004, PHILOS T R SOC B, V359, P1207, DOI 10.1098/rstb.2004.1499; Hanske J, 2012, P NATL ACAD SCI USA, V109, P125, DOI 10.1073/pnas.1112312108; Hong YN, 2012, J AM CHEM SOC, V134, P18713, DOI 10.1021/ja307426k; Hyberts SG, 2013, J BIOMOL NMR, V55, P167, DOI 10.1007/s10858-012-9698-2; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kalanxhi E, 2007, BIOCHEM J, V407, P179, DOI 10.1042/BJ20070459; Kapralov AA, 2007, BIOCHEMISTRY-US, V46, P14232, DOI 10.1021/bi701237b; Kawai C, 2005, J BIOL CHEM, V280, P34709, DOI 10.1074/jbc.M412532200; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Liu WX, 2009, PROTEIN SCI, V18, P670, DOI 10.1002/pro.72; Liu WX, 2003, PROTEIN SCI, V12, P2104, DOI 10.1110/ps.03211303; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; McClelland LJ, 2014, P NATL ACAD SCI USA, V111, P6648, DOI 10.1073/pnas.1323828111; Milne JS, 1998, PROTEIN SCI, V7, P739, DOI 10.1002/pro.5560070323; Muenzner J, 2013, J PHYS CHEM B, V117, P12878, DOI 10.1021/jp402104r; Nucci NV, 2014, J MAGN RESON, V241, P137, DOI 10.1016/j.jmr.2013.10.006; Nucci NV, 2011, J AM CHEM SOC, V133, P12326, DOI 10.1021/ja202033k; Nucci NV, 2011, NAT STRUCT MOL BIOL, V18, P245, DOI 10.1038/nsmb.1955; Oellerich S, 2004, J PHYS CHEM B, V108, P3871, DOI 10.1021/jp036799t; Otting G, 2010, ANNU REV BIOPHYS, V39, P387, DOI 10.1146/annurev.biophys.093008.131321; Pandiscia LA, 2015, J PHYS CHEM B, V119, P1334, DOI 10.1021/jp5104752; Peterson RW, 2004, J AM CHEM SOC, V126, P9498, DOI 10.1021/ja047900q; Peterson RW, 2005, PROTEIN SCI, V14, P2919, DOI 10.1110/ps.051535405; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; QI PX, 1994, NAT STRUCT BIOL, V1, P378, DOI 10.1038/nsb0694-378; RACKOVSKY S, 1984, P NATL ACAD SCI USA, V81, P5901, DOI 10.1073/pnas.81.18.5901; Rafferty SP, 1996, BIOCHEMISTRY-US, V35, P10784, DOI 10.1021/bi960430v; Rumbley JN, 2002, BIOCHEMISTRY-US, V41, P13894, DOI 10.1021/bi026543y; RYTOMAA M, 1994, J BIOL CHEM, V269, P1770; SANISHVILI R, 1995, STRUCTURE, V3, P707, DOI 10.1016/S0969-2126(01)00205-2; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sinibaldi F, 2008, BIOCHEMISTRY-US, V47, P6928, DOI 10.1021/bi800048v; Sinibaldi F, 2013, BIOCHEMISTRY-US, V52, P4578, DOI 10.1021/bi400324c; TAKANO T, 1980, P NATL ACAD SCI-BIOL, V77, P6371, DOI 10.1073/pnas.77.11.6371; Valentine KG, 2010, STRUCTURE, V18, P9, DOI 10.1016/j.str.2009.11.010; Vaux DL, 2011, BBA-MOL CELL RES, V1813, P546, DOI 10.1016/j.bbamcr.2010.08.002; Wand AJ, 1998, P NATL ACAD SCI USA, V95, P15299, DOI 10.1073/pnas.95.26.15299; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou HX, 2001, BIOCHEMISTRY-US, V40, P11289, DOI 10.1021/bi0155504	55	50	50	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30879	30887		10.1074/jbc.M115.689406	http://dx.doi.org/10.1074/jbc.M115.689406			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26487716	hybrid, Green Published			2022-12-28	WOS:000367199000020
J	Meier, DT; Tu, LH; Zraika, S; Hogan, MF; Templin, AT; Hull, RL; Raleigh, DP; Kahn, SE				Meier, Daniel T.; Tu, Ling-Hsien; Zraika, Sakeneh; Hogan, Meghan F.; Templin, Andrew T.; Hull, Rebecca L.; Raleigh, Daniel P.; Kahn, Steven E.			Matrix Metalloproteinase-9 Protects Islets from Amyloid-induced Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL APOPTOSIS; FIBRIL FORMATION; POLYPEPTIDE; AMYLIN; DEPOSITION; INHIBITORS; MECHANISM; PROVIDES; CYTOTOXICITY; AGGREGATION	Deposition of human islet amyloid polypeptide (hIAPP, also known as amylin) as islet amyloid is a characteristic feature of the pancreas in type 2 diabetes, contributing to increased beta-cell apoptosis and reduced beta-cell mass. Matrix metalloproteinase-9 (MMP-9) is active in islets and cleaves hIAPP. We investigated whether hIAPP fragments arising from MMP-9 cleavage retain the potential to aggregate and cause toxicity, and whether over-expressing MMP-9 in amyloid-prone islets reduces amyloid burden and the resulting beta-cell toxicity. Synthetic hIAPP was incubated with MMP-9 and the major hIAPP fragments observed by MS comprised residues 1-15, 1-25, 16-37, 16-25, and 26-37. The fragments 1-15, 1-25, and 26-37 did not form amyloid fibrils in vitro and they were not cytotoxic when incubated with b cells. Mixtures of these fragments with full-length hIAPP did not modulate the kinetics of fibril formation by full-length hIAPP. In contrast, the 16-37 fragment formed fibrils more rapidly than full-length hIAPP but was less cytotoxic. Co-incubation of MMP-9 and fragment 16-37 ablated amyloidogenicity, suggesting that MMP-9 cleaves hIAPP 16-37 into non-amyloidogenic fragments. Consistent with MMP-9 cleavage resulting in largely non-amyloidogenic degradation products, adenoviral overexpression of MMP-9 in amyloid-prone islets reduced amyloid deposition and beta-cell apoptosis. These findings suggest that increasing islet MMP-9 activity might be a strategy to limit beta-cell loss in type 2 diabetes.	[Meier, Daniel T.; Zraika, Sakeneh; Hogan, Meghan F.; Templin, Andrew T.; Hull, Rebecca L.; Kahn, Steven E.] VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; [Meier, Daniel T.; Zraika, Sakeneh; Hogan, Meghan F.; Templin, Andrew T.; Hull, Rebecca L.; Kahn, Steven E.] Univ Washington, Seattle, WA 98108 USA; [Tu, Ling-Hsien] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Tu, Ling-Hsien; Raleigh, Daniel P.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Raleigh, Daniel P.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Academia Sinica - Taiwan; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of London; University College London	Kahn, SE (corresponding author), VA Puget Sound Hlth Care Syst 151, 1660 S Columbian Way, Seattle, WA 98108 USA.	skahn@uw.edu	Hogan, Meghan/AAD-4425-2020; Hull-Meichle, Rebecca L./CAG-5879-2022; Regan, Clinton/E-6250-2012	Tu, Ling-Hsien/0000-0001-6130-3978; Hull, Rebecca/0000-0001-9690-4087; Templin, Andrew/0000-0002-6241-9304; Kahn, Steven/0000-0001-7307-9002; Zeman-Meier, Daniel/0000-0003-3348-4657; raleigh, daniel/0000-0003-3248-7493; Hogan, Meghan/0000-0002-5767-1599	Dept. of Veterans Affairs [BX001060]; NIH [DK-007247, DK-017047, DK-020595, DK-080945, DK-088082, DK-098506, GM-078114, HL-007028]; Swiss National Foundation Fellowship; Dick and Julia McAbee Endowed Fellowship in Diabetes from the University of Washington; American Diabetes Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047, P60DK020595, K99DK080945, T32DK007247, R01DK088082, R00DK080945, P30DK020595, R01DK098506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078114] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001060] Funding Source: NIH RePORTER	Dept. of Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Foundation Fellowship; Dick and Julia McAbee Endowed Fellowship in Diabetes from the University of Washington; American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Dept. of Veterans Affairs Grant BX001060, NIH Grants DK-007247, DK-017047, DK-020595, DK-080945, DK-088082, DK-098506, GM-078114, and HL-007028. The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Swiss National Foundation Fellowship and the Dick and Julia McAbee Endowed Fellowship in Diabetes from the University of Washington.; Supported by an American Diabetes Association Mentor-based Fellowship.	Abedini A, 2006, ANAL BIOCHEM, V351, P181, DOI 10.1016/j.ab.2005.11.029; Abedini A, 2007, J AM CHEM SOC, V129, P11300, DOI 10.1021/ja072157y; Abedini A, 2013, FEBS LETT, V587, P1119, DOI 10.1016/j.febslet.2013.01.017; Andersson A, 2008, EXP DIABETES RES, DOI 10.1155/2008/562985; Aston-Mourney K, 2013, J BIOL CHEM, V288, P3553, DOI 10.1074/jbc.M112.438457; Bendrik C, 2008, CANCER RES, V68, P3405, DOI 10.1158/0008-5472.CAN-08-0295; Bennett RG, 2003, DIABETES, V52, P2315, DOI 10.2337/diabetes.52.9.2315; BETSHOLTZ C, 1989, FEBS LETT, V251, P261, DOI 10.1016/0014-5793(89)81467-X; Buchanan LE, 2013, P NATL ACAD SCI USA, V110, P19285, DOI 10.1073/pnas.1314481110; Cao P, 2013, FEBS LETT, V587, P1106, DOI 10.1016/j.febslet.2013.01.046; Cao P, 2010, BIOCHEMISTRY-US, V49, P872, DOI 10.1021/bi901751b; Chen MS, 2013, CHEM COMMUN, V49, P1799, DOI 10.1039/c2cc33432a; Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]; DALESSIO DA, 1994, DIABETES, V43, P1457, DOI 10.2337/diabetes.43.12.1457; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; GLENNER GG, 1988, BIOCHEM BIOPH RES CO, V155, P608, DOI 10.1016/S0006-291X(88)80538-2; Guan H, 2012, DIABETOLOGIA, V55, P2989, DOI 10.1007/s00125-012-2678-y; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; MacArthur DLA, 1999, DIABETOLOGIA, V42, P1219, DOI 10.1007/s001250051295; Marek P, 2008, CHEMBIOCHEM, V9, P1372, DOI 10.1002/cbic.200800052; Marek P, 2010, ORG LETT, V12, P4848, DOI 10.1021/ol101981b; Marek P, 2010, J MOL BIOL, V400, P878, DOI 10.1016/j.jmb.2010.05.041; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Meier DT, 2015, J HISTOCHEM CYTOCHEM, V63, P663, DOI 10.1369/0022155415585995; Moriarty DF, 1999, BIOCHEMISTRY-US, V38, P1811, DOI 10.1021/bi981658g; Nilsson MR, 1999, J MOL BIOL, V294, P1375, DOI 10.1006/jmbi.1999.3286; Potter KJ, 2010, P NATL ACAD SCI USA, V107, P4305, DOI 10.1073/pnas.0909024107; Potter KJ, 2009, BBA-GEN SUBJECTS, V1790, P566, DOI 10.1016/j.bbagen.2009.02.013; Scrocchi LA, 2002, J MOL BIOL, V318, P697, DOI 10.1016/S0022-2836(02)00164-X; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Tomita T, 1997, MODERN PATHOL, V10, P47; Tucker MJ, 2006, BIOPOLYMERS, V83, P571, DOI 10.1002/bip.20587; Udayasankar J, 2009, DIABETOLOGIA, V52, P145, DOI 10.1007/s00125-008-1185-7; Verchere CB, 1996, P NATL ACAD SCI USA, V93, P3492, DOI 10.1073/pnas.93.8.3492; Weise K, 2010, CHEMBIOCHEM, V11, P1280, DOI 10.1002/cbic.201000039; Westermark GT, 2008, NEW ENGL J MED, V359, P977, DOI 10.1056/NEJMc0802893; Westermark GT, 2012, TRANSPLANTATION, V93, P219, DOI 10.1097/TP.0b013e31823e46ef; WESTERMARK P, 1972, UPSALA J MED SCI, V77, P91, DOI 10.1517/03009734000000014; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; Zraika S, 2009, DIABETOLOGIA, V52, P626, DOI 10.1007/s00125-008-1255-x; Zraika S, 2010, J BIOL CHEM, V285, P18177, DOI 10.1074/jbc.M109.082032	49	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30475	30485		10.1074/jbc.M115.676692	http://dx.doi.org/10.1074/jbc.M115.676692			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26483547	Green Published, hybrid			2022-12-28	WOS:000366738200024
J	Mailu, BM; Li, L; Arthur, J; Nelson, TM; Ramasamy, G; Fritz-Wolf, K; Becker, K; Gardner, MJ				Mailu, Boniface M.; Li, Ling; Arthur, Jen; Nelson, Todd M.; Ramasamy, Gowthaman; Fritz-Wolf, Karin; Becker, Katja; Gardner, Malcolm J.			Plasmodium Apicoplast Gln-tRNA(Gln) Biosynthesis Utilizes a Unique GatAB Amidotransferase Essential for Erythrocytic Stage Parasites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; GLUTAMINYL-TRANSFER-RNA; PLASTID-LIKE DNA; ASPARAGINYL-TRANSFER-RNA; AMINO-ACID; THERMUS-THERMOPHILUS; MALARIA PARASITES; GENOME SEQUENCE; ASP-TRNA(ASN) AMIDOTRANSFERASE; GLU-TRNA(GLN) AMIDOTRANSFERASE	The malaria parasite Plasmodium falciparum apicoplast indirect aminoacylation pathway utilizes a non-discriminating glutamyl-tRNA synthetase to synthesize Glu-tRNA(Gln) and a glutaminyl-tRNA amidotransferase to convert Glu-tRNA(Gln) to Gln-tRNA(Gln). Here, we show that Plasmodium falciparum and other apicomplexans possess a unique heterodimeric glutamyl-tRNA amidotransferase consisting of GatA and GatB subunits (GatAB). We localized the P. falciparum GatA and GatB subunits to the apicoplast in blood stage parasites and demonstrated that recombinant GatAB converts Glu-tRNA(Gln) to Gln-tRNA(Gln) in vitro. We demonstrate that the apicoplast GatAB-catalyzed reaction is essential to the parasite blood stages because we could not delete the Plasmodium berghei gene encoding GatA in blood stage parasites in vivo. A phylogenetic analysis placed the split between Plasmodium GatB, archaeal GatE, and bacterial GatB prior to the phylogenetic divide between bacteria and archaea. Moreover, Plasmodium GatA also appears to have emerged prior to the bacterial-archaeal phylogenetic divide. Thus, although GatAB is found in Plasmodium, it emerged prior to the phylogenetic separation of archaea and bacteria.	[Mailu, Boniface M.; Li, Ling; Arthur, Jen; Nelson, Todd M.; Ramasamy, Gowthaman; Gardner, Malcolm J.] Ctr Infect Dis Res, Seattle, WA 98109 USA; [Gardner, Malcolm J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Fritz-Wolf, Karin; Becker, Katja] Univ Giessen, Interdisciplinary Res Ctr, Dept Biochem & Mol Biol, D-35392 Giessen, Germany; [Fritz-Wolf, Karin] Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR); University of Washington; University of Washington Seattle; Justus Liebig University Giessen; Max Planck Society	Gardner, MJ (corresponding author), J Craig Venter Inst, 4120 Capricorn Lane, La Jolla, CA 92037 USA.	mjgardner1@mac.com			King Abdullah University of Science and Technology OCRF (GCR) [FIC/2010/09]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081097] Funding Source: NIH RePORTER	King Abdullah University of Science and Technology OCRF (GCR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Geoffrey McFadden for providing anti-ACP antibody, J. Lapointe and A. Weiner for plasmids expressing CCA-adding enzyme, and Y. M. Hou for the pGFIB vector. We thank MR4 for providing P. falciparum 3D7 parasites contributed by Dan Carucci and Alister Craig. The unpublished P. berghei genome sequence data were produced by the Pathogen Sequencing Group at the Wellcome Trust Sanger Institute and can be obtained on line. The unpublished C. velia and V. brassicaformis ortholog sequences were graciously provided by Arnab Pain and Hifzur Ansari of King Abdullah University of Science and Technology. The Chromera and Vitrella sequencing project was funded by a King Abdullah University of Science and Technology OCRF (GCR) award (FIC/2010/09) to Arnab Pain. We also thank Jonathan Eisen and Dongying Wu for their consulting on the phylogenetic analyses.	Akochy PM, 2004, J BACTERIOL, V186, P767, DOI 10.1128/JB.186.3.767-776.2004; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Araiso Y, 2014, NUCLEIC ACIDS RES, V42, P6052, DOI 10.1093/nar/gku234; Arisue N, 2012, MOL BIOL EVOL, V29, P2095, DOI 10.1093/molbev/mss082; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bailly M, 2007, MOL CELL, V28, P228, DOI 10.1016/j.molcel.2007.08.017; Bailly M, 2006, NUCLEIC ACIDS RES, V34, P6083, DOI 10.1093/nar/gkl622; Becker HD, 2000, BIOCHEMISTRY-US, V39, P3216, DOI 10.1021/bi992573y; Becker HD, 1997, BIOCHEMISTRY-US, V36, P8785, DOI 10.1021/bi970392v; Becker HD, 2000, FEBS LETT, V476, P140, DOI 10.1016/S0014-5793(00)01697-5; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; Bhatt TK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-644; Bour T, 2009, J BIOL CHEM, V284, P18893, DOI 10.1074/jbc.M109.015297; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Brown JR, 1999, J MOL EVOL, V49, P485, DOI 10.1007/PL00006571; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cathopoulis TJT, 2007, ANAL BIOCHEM, V360, P151, DOI 10.1016/j.ab.2006.10.019; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Chuawong P, 2006, BIOCHEMISTRY-US, V45, P8079, DOI 10.1021/bi060189c; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Curnow AW, 1998, P NATL ACAD SCI USA, V95, P12838, DOI 10.1073/pnas.95.22.12838; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Duchene AM, 2005, P NATL ACAD SCI USA, V102, P16484, DOI 10.1073/pnas.0504682102; FEAGIN JE, 1992, NUCLEIC ACIDS RES, V20, P879, DOI 10.1093/nar/20.4.879; Feng L, 2005, J BIOL CHEM, V280, P8150, DOI 10.1074/jbc.M411098200; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Frechin M, 2009, GENE DEV, V23, P1119, DOI 10.1101/gad.518109; GARDNER MJ, 1994, GENE, V144, P307, DOI 10.1016/0378-1119(94)90395-6; GARDNER MJ, 1991, MOL BIOCHEM PARASIT, V44, P115, DOI 10.1016/0166-6851(91)90227-W; GARDNER MJ, 1991, MOL BIOCHEM PARASIT, V48, P77, DOI 10.1016/0166-6851(91)90166-4; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Goodman CD, 2013, EXPERT OPIN THER TAR, V17, P167, DOI 10.1517/14728222.2013.739158; Gunther S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005510; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Harpel MR, 2002, BIOCHEMISTRY-US, V41, P6398, DOI 10.1021/bi012126u; Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1; Jackson KE, 2011, TRENDS PARASITOL, V27, P467, DOI 10.1016/j.pt.2011.05.005; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Labaied M, 2007, MOL BIOCHEM PARASIT, V153, P158, DOI 10.1016/j.molbiopara.2007.03.001; LAMOUR V, 1994, P NATL ACAD SCI USA, V91, P8670, DOI 10.1073/pnas.91.18.8670; LAPOINTE J, 1986, J BACTERIOL, V165, P88, DOI 10.1128/jb.165.1.88-93.1986; Mailu BM, 2013, J BIOL CHEM, V288, P32539, DOI 10.1074/jbc.M113.507467; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; Mikolajczak SA, 2008, MOL BIOCHEM PARASIT, V158, P213, DOI 10.1016/j.molbiopara.2007.12.006; Min B, 2002, P NATL ACAD SCI USA, V99, P2678, DOI 10.1073/pnas.012027399; Nagaraja VA, 2009, INT J PARASITOL, V39, P559, DOI 10.1016/j.ijpara.2008.10.011; Nakamura A, 2010, NUCLEIC ACIDS RES, V38, P672, DOI 10.1093/nar/gkp955; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pino P, 2010, MOL MICROBIOL, V76, P706, DOI 10.1111/j.1365-2958.2010.07128.x; Plaimas K, 2013, INFECT GENET EVOL, V20, P389, DOI 10.1016/j.meegid.2013.09.019; PREISER P, 1995, NUCLEIC ACIDS RES, V23, P4329, DOI 10.1093/nar/23.21.4329; Raczniak G, 2001, J BIOL CHEM, V276, P45862, DOI 10.1074/jbc.M109494200; Ralph SA, 2004, NAT REV MICROBIOL, V2, P203, DOI 10.1038/nrmicro843; Rampias T, 2010, NUCLEIC ACIDS RES, V38, P5774, DOI 10.1093/nar/gkq336; Roy H, 2003, P NATL ACAD SCI USA, V100, P9837, DOI 10.1073/pnas.1632156100; Salazar JC, 2003, P NATL ACAD SCI USA, V100, P13863, DOI 10.1073/pnas.1936123100; Salazar JC, 2001, FEBS LETT, V500, P129, DOI 10.1016/S0014-5793(01)02600-X; Schmitt E, 2005, STRUCTURE, V13, P1421, DOI 10.1016/j.str.2005.06.016; Seeber F, 2002, INT J PARASITOL, V32, P1207, DOI 10.1016/S0020-7519(02)00022-X; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; Sheppard K, 2008, METHODS, V44, P139, DOI 10.1016/j.ymeth.2007.06.010; Sheppard K, 2007, J BIOL CHEM, V282, P11866, DOI 10.1074/jbc.M700398200; Shin S, 2002, EMBO J, V21, P2509, DOI 10.1093/emboj/21.11.2509; Skouloubris S, 2003, P NATL ACAD SCI USA, V100, P11297, DOI 10.1073/pnas.1932482100; SRIVASTAVA DK, 1986, SCIENCE, V234, P1081, DOI 10.1126/science.3775377; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tumbula DL, 2000, NATURE, V407, P106, DOI 10.1038/35024120; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wilson RJM, 1996, J MOL BIOL, V261, P155, DOI 10.1006/jmbi.1996.0449; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138; Zuegge J, 2001, GENE, V280, P19, DOI 10.1016/S0378-1119(01)00776-4	86	10	10	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29629	29641		10.1074/jbc.M115.655100	http://dx.doi.org/10.1074/jbc.M115.655100			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26318454	hybrid, Green Published			2022-12-28	WOS:000366613400043
J	Choi, JH; Kim, SY; Kim, SK; Kemp, MG; Sancar, A				Choi, Jun-Hyuk; Kim, So-Young; Kim, Sook-Kyung; Kemp, Michael G.; Sancar, Aziz			An Integrated Approach for Analysis of the DNA Damage Response in Mammalian Cells NUCLEOTIDE EXCISION REPAIR, DNA DAMAGE CHECKPOINT, AND APOPTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; carcinogenesis; cell signaling; checkpoint control; DNA damage; DNA damage response; DNA repair; nucleotide excision repair; DNA damage checkpoint; chemotherapy	PROTEIN CROSS-LINKS; 6-4 PHOTOPRODUCTS; THYMINE DIMER; FORMALDEHYDE; RECOGNITION; CISPLATIN; NUCLEASE; OLIGONUCLEOTIDES; INDUCTION; ADDUCTS	DNA damage by UV and UV-mimetic agents elicits a set of inter-related responses in mammalian cells, including DNA repair, DNA damage checkpoints, and apoptosis. Conventionally, these responses are analyzed separately using different methodologies. Here we describe a unified approach that is capable of quantifying all three responses in parallel using lysates from the same population of cells. We show that a highly sensitive in vivo excision repair assay is capable of detecting nucleotide excision repair of a wide spectrum of DNA lesions (UV damage, chemical carcinogens, and chemotherapeutic drugs) within minutes of damage induction. This method therefore allows for a real-time measure of nucleotide excision repair activity that can be monitored in conjunction with other components of the DNA damage response, including DNA damage checkpoint and apoptotic signaling. This approach therefore provides a convenient and reliable platform for simultaneously examining multiple aspects of the DNA damage response in a single population of cells that can be applied for a diverse array of carcinogenic and chemotherapeutic agents.	[Choi, Jun-Hyuk; Kim, So-Young; Kim, Sook-Kyung] Korea Res Inst Stand & Sci, Ctr Bioanal, Dept Metrol Qual Life, Taejon 305340, South Korea; [Choi, Jun-Hyuk; Kim, Sook-Kyung] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon 305350, South Korea; [Kemp, Michael G.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Korea Research Institute of Standards & Science (KRISS); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Choi, JH (corresponding author), Univ Sci & Technol, Dept Bioanalyt Sci, Taejon 305350, South Korea.	junchoi@kriss.re.kr; aziz_sancar@med.unc.edu	Kemp, Michael G./AAT-1545-2021; Regan, Clinton/E-6250-2012	Kemp, Michael G./0000-0001-8203-0745; 	National Institutes of Health [GM32833]; Korea Research Institute of Standards and Science [15011024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Research Institute of Standards and Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM32833 (to A. S.) and the Korea Research Institute of Standards and Science under the project "Development of Bio-clinical Measurement Standards" (15011024) (to J-H. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Choi JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1179; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; de Graaf B, 2009, DNA REPAIR, V8, P1207, DOI 10.1016/j.dnarep.2009.06.007; Gaddameedhi S, 2010, CANCER RES, V70, P4922, DOI 10.1158/0008-5472.CAN-10-0095; GRAFSTROM RC, 1984, CANCER RES, V44, P4323; Gunz D, 1996, J BIOL CHEM, V271, P25089, DOI 10.1074/jbc.271.41.25089; Hess MT, 1996, NUCLEIC ACIDS RES, V24, P824, DOI 10.1093/nar/24.5.824; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P10394, DOI 10.1073/pnas.91.22.10394; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Kemp MG, 2014, J BIOL CHEM, V289, P26574, DOI 10.1074/jbc.M114.597088; Kemp MG, 2012, J BIOL CHEM, V287, P22889, DOI 10.1074/jbc.M112.374447; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Lindsey-Boltz LA, 2014, J BIOL CHEM, V289, P5074, DOI 10.1074/jbc.M113.542787; MITCHELL DL, 1988, MUTAT RES, V194, P227, DOI 10.1016/0167-8817(88)90024-7; MITCHELL DL, 1988, PHOTOCHEM PHOTOBIOL, V48, P51; Moggs JG, 1996, J BIOL CHEM, V271, P7177, DOI 10.1074/jbc.271.12.7177; MU D, 1994, NUCLEIC ACIDS RES, V22, P4869, DOI 10.1093/nar/22.23.4869; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Nakano T, 2009, J BIOL CHEM, V284, P27065, DOI 10.1074/jbc.M109.019174; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Reardon JT, 2006, CELL CYCLE, V5, P1366, DOI 10.4161/cc.5.13.2892; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sanderson BJS, 1996, MUTAT RES-FUND MOL M, V355, P41, DOI 10.1016/0027-5107(96)00021-8; Sirbu BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012724; Speit G, 2000, MUTAGENESIS, V15, P85, DOI 10.1093/mutage/15.1.85; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; Swenberg JA, 2013, TOXICOL PATHOL, V41, P181, DOI 10.1177/0192623312466459; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tomasz M, 1997, PHARMACOL THERAPEUT, V76, P73, DOI 10.1016/S0163-7258(97)00088-0; Wang D, 2003, BIOCHEMISTRY-US, V42, P6747, DOI 10.1021/bi034264k; WANI AA, 1987, PHOTOCHEM PHOTOBIOL, V46, P477, DOI 10.1111/j.1751-1097.1987.tb04798.x; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Zamble DB, 1996, BIOCHEMISTRY-US, V35, P10004, DOI 10.1021/bi960453+	43	29	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28812	28821		10.1074/jbc.M115.690354	http://dx.doi.org/10.1074/jbc.M115.690354			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26438822	Green Published, hybrid			2022-12-28	WOS:000365762300023
J	Lewis, KM; Ronish, LA; Rios, E; Kang, C				Lewis, Kevin M.; Ronish, Leslie A.; Rios, Eduardo; Kang, ChulHee			Characterization of Two Human Skeletal Calsequestrin Mutants Implicated in Malignant Hyperthermia and Vacuolar Aggregate Myopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; calcium-binding protein; malignant hyperthermia; sarcoplasmic reticulum (SR); skeletal muscle; calsequestrin; vacuolar aggregate myopathy	CALCIUM BUFFERING PROPERTIES; SARCOPLASMIC-RETICULUM; CA2+ REGULATION; CASQ1 GENE; MUSCLE; RELEASE; PROTEIN; POLYMERIZATION; BINDING; STORE	Calsequestrin 1 is the principal Ca2+ storage protein of the sarcoplasmic reticulum of skeletal muscle. Its inheritable D244G mutation causes a myopathy with vacuolar aggregates, whereas its M87T variant is weakly associated with malignant hyperthermia. We characterized the consequences of these mutations with studies of the human proteins in vitro. Equilibrium dialysis and turbidity measurements showed that D244G and, to a lesser extent, M87T partially lose Ca2+ binding exhibited by wild type calsequestrin 1 at high Ca2+ concentrations. D244G aggregates abruptly and abnormally, a property that fully explains the protein inclusions that characterize its phenotype. D244G crystallized in low Ca2+ concentrations lacks two Ca2+ ions normally present in wild type that weakens the hydrophobic core of Domain II. D244G crystallized in high Ca2+ concentrations regains its missing ions and Domain II order but shows a novel dimeric interaction. The M87T mutation causes a major shift of the -helix bearing the mutated residue, significantly weakening the back-to-back interface essential for tetramerization. D244G exhibited the more severe structural and biophysical property changes, which matches the different pathophysiological impacts of these mutations.	[Lewis, Kevin M.; Kang, ChulHee] Washington State Univ, Dept Chem, Pullman, WA 99164 USA; [Ronish, Leslie A.; Kang, ChulHee] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Rios, Eduardo] Rush Univ, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA	Washington State University; Washington State University; Rush University	Kang, C (corresponding author), Washington State Univ, Fulmer 265, Pullman, WA 99164 USA.	chkang@wsu.edu	Regan, Clinton/E-6250-2012	Kang, ChulHee/0000-0002-0693-7860; Lewis, Kevin/0000-0003-3403-9520	National Institutes of Health [1R01GM11125401]; M. J. Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. J. Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1R01GM11125401 (to E. R and C. K.) and the M. J. Murdock Charitable Trust (to C. K.). The authors declare that they have no conflicts of interest with the content of this article.	Adam G., 1968, STRUCTURAL CHEM MOL, P198; Boncompagni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039962; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faggioni M, 2012, PEDIATR CARDIOL, V33, P959, DOI 10.1007/s00246-012-0256-1; Fenelon K, 2012, J GEN PHYSIOL, V140, P403, DOI 10.1085/jgp.201110730; Frisch M, 2004, GAUSSVIEW VERSION 3; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Kang ChulHee, 2002, Methods Mol Biol, V172, P281; Koput J, 2002, J PHYS CHEM A, V106, P9595, DOI 10.1021/jp026283u; Kraeva N, 2013, ANESTHESIOLOGY, V118, P344, DOI [10.1097/01.anes.0000530185.78660.da, 10.1097/ALN.0b013e318279f925]; MacLennan DH, 1998, NAT STRUCT BIOL, V5, P409, DOI 10.1038/nsb0698-409; MACLENNAN DH, 1971, P NATL ACAD SCI USA, V68, P1231, DOI 10.1073/pnas.68.6.1231; Manno C, 2013, J PHYSIOL-LONDON, V591, P423, DOI 10.1113/jphysiol.2012.243444; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park HJ, 2003, J BIOL CHEM, V278, P16176, DOI 10.1074/jbc.M300120200; Park HJ, 2004, J BIOL CHEM, V279, P18026, DOI 10.1074/jbc.M311553200; Perni S, 2013, J BIOL CHEM, V288, P31358, DOI 10.1074/jbc.M113.507749; Peterson KA, 2002, J CHEM PHYS, V117, P10548, DOI 10.1063/1.1520138; Qin J, 2009, BIOPHYS J, V97, P1961, DOI 10.1016/j.bpj.2009.07.030; Rios E, 2015, J GEN PHYSIOL, V145, P459, DOI 10.1085/jgp.201411321; Rossi D, 2014, HUM MUTAT, V35, P1163, DOI 10.1002/humu.22631; Royer L, 2009, J PHYSIOL-LONDON, V587, P3101, DOI 10.1113/jphysiol.2009.171934; Sanchez EJ, 2012, J BIOL CHEM, V287, P11592, DOI 10.1074/jbc.M111.335075; Schrodinger LLC, 2015, SCHROD SUIT 2015 2 P; Sztretye M, 2011, J GEN PHYSIOL, V138, P231, DOI 10.1085/jgp.201010592; Sztretye M, 2011, J GEN PHYSIOL, V138, P211, DOI 10.1085/jgp.201010591; Tomasi M, 2012, AM J PHYSIOL-CELL PH, V302, pC575, DOI 10.1152/ajpcell.00119.2011	28	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28665	28674		10.1074/jbc.M115.686261	http://dx.doi.org/10.1074/jbc.M115.686261			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26416891	Green Published, hybrid			2022-12-28	WOS:000365762300008
J	Sgourakis, NG; May, NA; Boyd, LF; Ying, JF; Bax, A; Margulies, DH				Sgourakis, Nikolaos G.; May, Nathan A.; Boyd, Lisa F.; Ying, Jinfa; Bax, Ad; Margulies, David H.			A Novel MHC-I Surface Targeted for Binding by the MCMV m06 Immunoevasin Revealed by Solution NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antigen presentation; herpesvirus; major histocompatibility complex (MHC); nuclear magnetic resonance (NMR); protein-protein interaction; surface plasmon resonance (SPR); MCMV; immunoevasin; m06; gp48	MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE CYTOMEGALOVIRUS GLYCOPROTEIN; RESIDUAL DIPOLAR COUPLINGS; IMMUNE EVASION PROTEINS; MURINE CYTOMEGALOVIRUS; ANTIGEN PRESENTATION; CRYSTAL-STRUCTURE; PERDEUTERATED PROTEINS; HETERONUCLEAR NMR; PEPTIDE BINDING	As part of its strategy to evade detection by the host immune system, murine cytomegalovirus (MCMV) encodes three proteins that modulate cell surface expression of major histocompatibility complex class I (MHC-I) molecules: the MHC-I homolog m152/gp40 as well as the m02-m16 family members m04/gp34 and m06/gp48. Previous studies of the m04 protein revealed a divergent Ig-like fold that is unique to immunoevasins of the m02-m16 family. Here, we engineer and characterize recombinant m06 and investigate its interactions with full-length and truncated forms of the MHC-I molecule H2-L-d by several techniques. Furthermore, we employ solution NMR to map the interaction footprint of the m06 protein on MHC-I, taking advantage of a truncated H2-L-d, mini-H2-L-d, consisting of only the 12 platform domain. Mini-H2-L-d refolded in vitro with a high affinity peptide yields a molecule that shows outstanding NMR spectral features, permitting complete backbone assignments. These NMR-based studies reveal that m06 binds tightly to a discrete site located under the peptide-binding platform that partially overlaps with the (2)-microglobulin interface on the MHC-I heavy chain, consistent with in vitro binding experiments showing significantly reduced complex formation between m06 and (2)-microglobulin-associated MHC-I. Moreover, we carry out NMR relaxation experiments to characterize the picosecond-nanosecond dynamics of the free mini-H2-L-d MHC-I molecule, revealing that the site of interaction is highly ordered. This study provides insight into the mechanism of the interaction of m06 with MHC-I, suggesting a structural manipulation of the target MHC-I molecule at an early stage of the peptide-loading pathway.	[Sgourakis, Nikolaos G.; Ying, Jinfa; Bax, Ad] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [May, Nathan A.; Boyd, Lisa F.; Margulies, David H.] NIAID, Mol Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bax, A (corresponding author), NIDDK, Chem Phys Lab, NIH, Bldg 5,Rm 126,5 Mem Dr, Bethesda, MD 20892 USA.	bax@nih.gov; dhm@nih.gov		Margulies, David/0000-0001-8530-7375	NIDDK; NIAID, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI112573, ZIAAI001028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075095] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the intramural research programs of the NIDDK and NIAID, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Babic M, 2010, J EXP MED, V207, P2663, DOI 10.1084/jem.20100921; Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; Beerbaum M, 2013, J BIOMOL NMR, V57, P167, DOI 10.1007/s10858-013-9777-z; Berry R, 2014, J BIOL CHEM, V289, P23753, DOI 10.1074/jbc.M114.584128; Bouvier M, 1998, NAT STRUCT BIOL, V5, P377, DOI 10.1038/nsb0598-377; Bubeck A, 2002, J BIOL CHEM, V277, P2216, DOI 10.1074/jbc.M104178200; CARRENO BM, 1995, J IMMUNOL, V155, P4726; Chen JZ, 2003, MICROBES INFECT, V5, P233, DOI 10.1016/S1286-4579(03)00016-9; COLLINS EJ, 1995, P NATL ACAD SCI USA, V92, P1218, DOI 10.1073/pnas.92.4.1218; Corbett AJ, 2007, J GEN VIROL, V88, P758, DOI 10.1099/vir.0.82623-0; CORR M, 1992, J EXP MED, V176, P1681, DOI 10.1084/jem.176.6.1681; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fitzkee NC, 2010, J BIOMOL NMR, V48, P65, DOI 10.1007/s10858-010-9441-9; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Gewurz BE, 2001, J VIROL, V75, P5197, DOI 10.1128/JVI.75.11.5197-5204.2001; Goddard T. D., 2008, SPARKY3; Hawse WF, 2014, J IMMUNOL, V192, P2885, DOI 10.4049/jimmunol.1302953; Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952; Hebert AM, 2001, BIOCHEMISTRY-US, V40, P5233, DOI 10.1021/bi002392s; Hee CS, 2013, IMMUNOGENETICS, V65, P157, DOI 10.1007/s00251-012-0667-4; HOCHMAN JH, 1988, J IMMUNOL, V140, P2322; Holtappels R, 2006, J VIROL, V80, P7613, DOI 10.1128/JVI.00723-06; Jones LL, 2006, J BIOL CHEM, V281, P25734, DOI 10.1074/jbc.M604343200; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kimpler LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099139; Kleijnen MF, 1997, EMBO J, V16, P685, DOI 10.1093/emboj/16.4.685; Lakomek NA, 2012, J BIOMOL NMR, V53, P209, DOI 10.1007/s10858-012-9626-5; Lemmermann NAW, 2012, MED MICROBIOL IMMUN, V201, P497, DOI 10.1007/s00430-012-0257-y; Li LN, 2012, NAT STRUCT MOL BIOL, V19, P1176, DOI 10.1038/nsmb.2396; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; Lu XJ, 2006, J VIROL, V80, P6048, DOI 10.1128/JVI.00534-06; Mage MG, 2012, J IMMUNOL, V189, P1391, DOI 10.4049/jimmunol.1200831; Massi F, 2004, J AM CHEM SOC, V126, P2247, DOI 10.1021/ja038721w; McCoy WH, 2013, MOL IMMUNOL, V55, P156, DOI 10.1016/j.molimm.2012.11.011; MURRE C, 1984, J EXP MED, V160, P167, DOI 10.1084/jem.160.1.167; Natarajan K, 1999, IMMUNITY, V11, P591, DOI 10.1016/S1074-7613(00)80134-X; OZATO K, 1980, J IMMUNOL, V125, P2473; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; PEDERSEN LO, 1995, EUR J IMMUNOL, V25, P1609, DOI 10.1002/eji.1830250621; Pinto AK, 2006, J IMMUNOL, V177, P3225, DOI 10.4049/jimmunol.177.5.3225; POWERS R, 1991, J MAGN RESON, V94, P209, DOI 10.1016/0022-2364(91)90312-H; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Rossi P, 2015, PROTEINS, V83, P309, DOI 10.1002/prot.24719; Sahu D, 2007, J AM CHEM SOC, V129, P13232, DOI 10.1021/ja074604f; Sgourakis NG, 2014, STRUCTURE, V22, P1263, DOI 10.1016/j.str.2014.05.018; SMITH JD, 1992, J EXP MED, V175, P191, DOI 10.1084/jem.175.1.191; Smith LM, 2013, VIROLOGY, V435, P258, DOI 10.1016/j.virol.2012.08.041; Smith LM, 2006, VIROLOGY, V352, P450, DOI 10.1016/j.virol.2006.04.031; Trinh CH, 2002, P NATL ACAD SCI USA, V99, P9771, DOI 10.1073/pnas.152337399; van de Weijer ML, 2015, SEMIN IMMUNOL, V27, P125, DOI 10.1016/j.smim.2015.03.010; Varani L, 2007, P NATL ACAD SCI USA, V104, P13080, DOI 10.1073/pnas.0703702104; Wang R, 2012, P NATL ACAD SCI USA, V109, pE3578, DOI 10.1073/pnas.1214088109; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P117; Ying JF, 2007, J BIOMOL NMR, V37, P195, DOI 10.1007/s10858-006-9120-z; Yu YYL, 1999, J IMMUNOL, V163, P4427; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Ziegler H, 2000, EMBO J, V19, P870, DOI 10.1093/emboj/19.5.870; Zweckstetter M, 2002, J BIOMOL NMR, V23, P127, DOI 10.1023/A:1016316415261; Zweckstetter M, 2001, J BIOMOL NMR, V20, P365, DOI 10.1023/A:1011263920003	66	4	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28857	28868		10.1074/jbc.M115.689661	http://dx.doi.org/10.1074/jbc.M115.689661			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26463211	Green Published, hybrid			2022-12-28	WOS:000365762300027
J	Ikonomov, OC; Sbrissa, D; Connpton, LM; Kumar, R; Tisdale, EJ; Chen, XQ; Shisheva, A				Ikonomov, Ognian C.; Sbrissa, Diego; Connpton, Lauren M.; Kumar, Rita; Tisdale, Ellen J.; Chen, Xuequn; Shisheva, Assia			The Protein Complex of Neurodegeneration-related Phosphoinositide Phosphatase Sac3 and ArPIKfyve Binds the Lewy Body-associated Synphilin-1, Preventing Its Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; AGGRESOME FORMATION; MAMMALIAN ORTHOLOG; FIG4 CAUSES; PIKFYVE; INCLUSIONS; MUTATION; DEGRADATION; TRANSPORT	The 5-phosphoinositide phosphatase Sac3, in which loss-of-function mutations are linked to neurodegenerative disorders, forms a stable cytosolic complex with the scaffolding protein ArPIKfyve. The ArPIKfyve-Sac3 heterodimer interacts with the phosphoinositide 5-kinase PIKfyve in a ubiquitous ternary complex that couples PtdIns(3,5) P2 synthesis with turnover at endosomal membranes, thereby regulating the housekeeping endocytic transport in eukaryotes. Neuron-specific associations of the ArPIKfyve-Sac3 heterodimer, which may shed light on the neuropathological mechanisms triggered by Sac3 dysfunction, are unknown. Here we conducted mass spectrometry analysis for brain-derived interactors of ArPIKfyve-Sac3 and unraveled the alpha-synuclein-interacting protein Synphilin-1 (Sph1) as a new component of the ArPIKfyve-Sac3 complex. Sph1, a predominantly neuronal protein that facilitates aggregation of alpha-synuclein, is a major component of Lewy body inclusions in neurodegenerative alpha-synucleinopathies. Modulations in ArPIKfyve/Sac3 protein levels by RNA silencing or overexpression in several mammalian cell lines, including human neuronal SH-SY5Y or primary mouse cortical neurons, revealed that the ArPIKfyve-Sac3 complex specifically altered the aggregation properties of Sph1-GFP. This effect required an active Sac3 phosphatase and proceeded through mechanisms that involved increased Sph1-GFP partitioning into the cytosol and removal of Sph1-GFP aggregates by basal autophagy but not by the proteasomal system. If uncoupled from ArPIKfyve elevation, over-expressed Sac3 readily aggregated, markedly enhancing the aggregation potential of Sph1-GFP. These data identify a novel role of the ArPIKfyve-Sac3 complex in the mechanisms controlling aggregate formation of Sph1 and suggest that Sac3 protein deficiency or overproduction may facilitate aggregation of aggregation-prone proteins, thereby precipitating the onset of multiple neuronal disorders.	[Ikonomov, Ognian C.; Sbrissa, Diego; Connpton, Lauren M.; Kumar, Rita; Chen, Xuequn; Shisheva, Assia] Wayne State Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Kumar, Rita] Wayne State Sch Med, Dept Emergency Med, Detroit, MI 48201 USA; [Tisdale, Ellen J.] Wayne State Sch Med, Dept Pharmacol, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University	Shisheva, A (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, 540 E Canfield Ave, Detroit, MI 48201 USA.	ashishev@med.wayne.edu	Regan, Clinton/E-6250-2012	Kumar, Rita/0000-0002-9573-7667	National Institutes of Health [DK58058, GM068813]; Wayne State University; Wayne State University School of Medicine Research Offices; American Diabetes Association [7-13-BS-161]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068813] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wayne State University; Wayne State University School of Medicine Research Offices; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK58058 (to A. S.) and GM068813 (to E. J. T) This work was also supported by Wayne State University, the Wayne State University School of Medicine Research Offices, and the American Diabetes Association 7-13-BS-161 (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bandopadhyay R, 2005, NEUROBIOL DIS, V20, P401, DOI 10.1016/j.nbd.2005.03.021; Baulac S, 2014, NEUROLOGY, V82, P1068, DOI 10.1212/WNL.0000000000000241; Beyer K, 2009, INT J MOL SCI, V10, P724, DOI 10.3390/ijms10030724; Bonifati Vincenzo, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS4, DOI 10.1016/S1353-8020(11)70004-9; Campeau PM, 2013, AM J HUM GENET, V92, P781, DOI 10.1016/j.ajhg.2013.03.020; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; Drouet V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/289728; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Eyal A, 2006, CELL CYCLE, V5, P2082, DOI 10.4161/cc.5.18.3209; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Feng HZ, 2012, J BIOL CHEM, V287, P29753, DOI 10.1074/jbc.M112.373191; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Gwinn K, 2011, MOVEMENT DISORD, V26, P2134, DOI 10.1002/mds.23776; Houlden H, 2012, ACTA NEUROPATHOL, V124, P325, DOI 10.1007/s00401-012-1013-5; Hsiao VC, 2005, J CELL SCI, V118, P2057, DOI 10.1242/jcs.02339; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2015, BBA-MOL CELL RES, V1853, P1240, DOI 10.1016/j.bbamcr.2015.01.008; Ikonomov OC, 2013, BIOCHEM BIOPH RES CO, V440, P342, DOI 10.1016/j.bbrc.2013.09.080; Ikonomov OC, 2011, J BIOL CHEM, V286, P13404, DOI 10.1074/jbc.M111.222364; Ikonomov OC, 2010, J BIOL CHEM, V285, P26760, DOI 10.1074/jbc.C110.154658; Ikonomov OC, 2009, J BIOL CHEM, V284, P35794, DOI 10.1074/jbc.M109.037515; Ikonomov OC, 2009, J BIOL CHEM, V284, P23961, DOI 10.1074/jbc.M109.025361; Jin HG, 2008, NEUROSCI LETT, V445, P12, DOI 10.1016/j.neulet.2008.08.073; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; Kara E, 2014, JAMA NEUROL, V71, P1162, DOI 10.1001/jamaneurol.2014.994; Katsuse O, 2003, J NEUROL SCI, V211, P29, DOI 10.1016/S0022-510X(03)00037-6; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Kon T, 2014, NEUROPATHOLOGY, V34, P19, DOI 10.1111/neup.12056; Krenz A, 2009, J NEUROCHEM, V108, P139, DOI 10.1111/j.1471-4159.2008.05755.x; Lee G, 2002, J NEUROCHEM, V83, P346, DOI 10.1046/j.1471-4159.2002.01136.x; Lenk GM, 2014, METHOD ENZYMOL, V534, P245, DOI 10.1016/B978-0-12-397926-1.00014-7; Lenk GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002104; Li J., 2013, GENEREVIEWS; Muenter MD, 1998, ANN NEUROL, V43, P768, DOI 10.1002/ana.410430612; Nagano Y, 2003, J BIOL CHEM, V278, P51504, DOI 10.1074/jbc.M306347200; Nakajima J, 2013, J HUM GENET, V58, P822, DOI 10.1038/jhg.2013.104; Nuber S, 2010, NEUROGENETICS, V11, P107, DOI 10.1007/s10048-009-0212-2; O'Farrell C, 2002, NEUROSCI LETT, V322, P9, DOI 10.1016/S0304-3940(02)00068-X; O'Farrell C, 2001, MOL BRAIN RES, V97, P94, DOI 10.1016/S0169-328X(01)00292-3; Opazo F, 2008, J NEUROCHEM, V106, P529, DOI 10.1111/j.1471-4159.2008.05407.x; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; Reifler A, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-21; Sanderson TH, 2015, NEUROSCIENCE, V301, P71, DOI 10.1016/j.neuroscience.2015.05.078; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Sbrissa D, 2008, J MOL BIOL, V384, P766, DOI 10.1016/j.jmb.2008.10.009; Sharma S, 2013, NEUROCHEM INT, V63, P201, DOI 10.1016/j.neuint.2013.06.005; SHISHEVA A, 1995, EUR J CELL BIOL, V68, P143; Shisheva A, 2015, BIOESSAYS, V37, P267, DOI 10.1002/bies.201400129; Shisheva A, 2012, CURR TOP MICROBIOL, V362, P127, DOI 10.1007/978-94-007-5025-8_7; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Swinnen E, 2011, BIOCHEM SOC T, V39, P1476, DOI 10.1042/BST0391476; Szargel R, 2008, CELL MOL LIFE SCI, V65, P80, DOI 10.1007/s00018-007-7343-0; Tanji K, 2006, AM J PATHOL, V169, P553, DOI 10.2353/ajpath.2006.051067; Tsai CP, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.009; Vaccari I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002319; Verdiani S, 2013, AMYOTROPH LAT SCL FR, V14, P228, DOI 10.3109/21678421.2012.760605; Volpicelli-Daley LA, 2014, MOL BIOL CELL, V25, P4010, DOI 10.1091/mbc.E14-02-0741; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wakabayashi K, 2000, ANN NEUROL, V47, P521, DOI 10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.3.CO;2-2; Wakabayashi K, 2013, MOL NEUROBIOL, V47, P495, DOI 10.1007/s12035-012-8280-y; Wong E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2244; Xu W, 2015, NEUROBIOL AGING, V36, P1505, DOI 10.1016/j.neurobiolaging.2014.10.042; Zaarur N, 2008, J BIOL CHEM, V283, P27575, DOI 10.1074/jbc.M802216200; Zhang XB, 2008, BRAIN, V131, P1990, DOI 10.1093/brain/awn114; Zhang YJ, 2012, BRAIN, V135, P2736, DOI 10.1093/brain/aws196; Zolov SN, 2012, P NATL ACAD SCI USA, V109, P17472, DOI 10.1073/pnas.1203106109	70	6	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28515	28529		10.1074/jbc.M115.669929	http://dx.doi.org/10.1074/jbc.M115.669929			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26405034	hybrid, Green Published			2022-12-28	WOS:000365761900044
J	Pfaffen, S; Bradley, JM; Abdulqadir, R; Firme, MR; Moore, GR; Le Brun, NE; Murphy, MEP				Pfaffen, Stephanie; Bradley, Justin M.; Abdulqadir, Raz; Firme, Marlo R.; Moore, Geoffrey R.; Le Brun, Nick E.; Murphy, Michael E. P.			A Diatom Ferritin Optimized for Iron Oxidation but Not Iron Storage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CHLAMYDOMONAS-REINHARDTII; PHOTOOXIDATIVE STRESS; FERROXIDASE CENTER; CENTRAL CAVITY; BACTERIOFERRITIN; MINERALIZATION; EVOLUTION; BINDING; ECFTNA	Ferritin from the marine pennate diatom Pseudo-nitzschia multiseries (PmEr N) plays a key role in sustaining growth in iron-limited ocean environments. The di-iron catalytic ferroxidase center of PmFTN (sites A and B) has a nearby third iron site (site C) in an arrangement typically observed in prokaryotic ferritins. Here we demonstrate that Glu-44, a site C ligand, and Glu-130, a residue that bridges iron bound at sites B and C, limit the rate of post-oxidation reorganization of iron coordination and the rate at which Fe3+ exits the ferroxidase center for storage within the mineral core. The latter, in particular, severely limits the overall rate of iron mineralization. Thus, the diatom ferritin is optimized for initial Fe' + oxidation but not for mineralization, pointing to a role for this protein in buffering iron availability and facilitating iron-sparing rather than only longterm iron storage.	[Pfaffen, Stephanie; Firme, Marlo R.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Bradley, Justin M.; Abdulqadir, Raz; Moore, Geoffrey R.; Le Brun, Nick E.] Univ E Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich NR4 7TJ, Norfolk, England	University of British Columbia; University of East Anglia	Le Brun, NE (corresponding author), Univ E Anglia, Sch Chem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	n.le-brun@uea.ac.uk; michael.murphy@ubc.ca	Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014; Abdulqadir, Raz/0000-0003-4014-8213; Le Brun, Nick/0000-0001-9780-4061	Natural Sciences and Engineering Research Council of Canada Discovery Grant; Canadian Foundation for Innovation; United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I021884/1]; Emeritus Fellowship from the Leverhulme Trust [EM-2014-088]; Kurdistan local government; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I021884/1] Funding Source: researchfish; BBSRC [BB/I021884/1] Funding Source: UKRI	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Emeritus Fellowship from the Leverhulme Trust; Kurdistan local government; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant and the Canadian Foundation for Innovation (to M. E. P. M.) and the United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) through Grant BB/I021884/1 (to G. R. M. and N. E. L. B.). This work was also supported by an Emeritus Fellowship from the Leverhulme Trust (EM-2014-088) (to G. R. M.) and a scholarship from the Kurdistan local government (to R. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrews SC, 2010, BBA-GEN SUBJECTS, V1800, P691, DOI 10.1016/j.bbagen.2010.05.010; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Baaghil S, 2003, BIOCHEMISTRY-US, V42, P14047, DOI 10.1021/bi035253u; Bertini I, 2012, J AM CHEM SOC, V134, P6169, DOI 10.1021/ja210084n; Bou-Abdallah F, 2014, BIOCHEMISTRY-US, V53, P483, DOI 10.1021/bi401517f; Bradley JM, 2014, J BIOL INORG CHEM, V19, P775, DOI 10.1007/s00775-014-1136-3; Busch A, 2008, PLANT J, V55, P201, DOI 10.1111/j.1365-313X.2008.03490.x; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Crichton RR, 2010, BBA-GEN SUBJECTS, V1800, P706, DOI 10.1016/j.bbagen.2010.03.019; Ebrahimi KH, 2013, CHEMBIOCHEM, V14, P1123, DOI 10.1002/cbic.201300149; Ebrahimi KH, 2012, NAT CHEM BIOL, V8, P941, DOI [10.1038/NCHEMBIO.1071, 10.1038/nchembio.1071]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Glaesener AG, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00337; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Le Brun NE, 2010, BBA-GEN SUBJECTS, V1800, P732, DOI 10.1016/j.bbagen.2010.04.002; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; Long JC, 2008, PHOTOCHEM PHOTOBIOL, V84, P1395, DOI 10.1111/j.1751-1097.2008.00451.x; MacPherson IS, 2010, PROTEIN ENG DES SEL, V23, P137, DOI 10.1093/protein/gzp084; Marchetti A, 2009, NATURE, V457, P467, DOI 10.1038/nature07539; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pfaffen S, 2013, J BIOL CHEM, V288, P14917, DOI 10.1074/jbc.M113.454496; Treffry A, 1998, FEBS LETT, V432, P213, DOI 10.1016/S0014-5793(98)00867-9; Turano P, 2010, P NATL ACAD SCI USA, V107, P545, DOI 10.1073/pnas.0908082106; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wong SG, 2015, J BIOL CHEM, V290, P3732, DOI 10.1074/jbc.M114.623082; Yasmin S, 2011, J BIOL CHEM, V286, P3473, DOI 10.1074/jbc.M110.175034	27	24	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28416	28427		10.1074/jbc.M115.669713	http://dx.doi.org/10.1074/jbc.M115.669713			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26396187	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000365761900035
J	Barritt, JD; Viles, JH				Barritt, Joseph D.; Viles, John H.			Truncated Amyloid-beta((11-40/42)) from Alzheimer Disease Binds Cu2+ with a Femtomolar Affinity and Influences Fiber Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; VISIBLE CIRCULAR-DICHROISM; HUMAN SERUM-ALBUMIN; PEPTIDES IN-VITRO; PRION PROTEIN; COORDINATION GEOMETRY; MASS-SPECTROMETRY; SENILE PLAQUES; COPPER-BINDING; METAL-BINDING	Alzheimer disease coincides with the formation of extracellular amyloid plaques composed of the amyloid-beta (A beta) peptide. A beta is typically 40 residues long (A beta((1-40))) but can have variable C and N termini. Naturally occurring N-terminally truncated A beta((11-40/42)) is found in the cerebrospinal fluid and has a similar abundance to A beta((1-42)), constituting one-fifth of the plaque load. Based on its specific N-terminal sequence we hypothesized that truncated A beta((11-40/42)) would have an elevated affinity for Cu2+. Various spectroscopic techniques, complemented with transmission electron microscopy, were used to determine the properties of the Cu2+ -A beta((11-40/42)) interaction and how Cu2+ influences amyloid fiber formation. We show that Cu2+ -A beta((11-40)) forms a tetragonal complex with a 34 +/- 5 fM dissociation constant at pH 7.4. This affinity is 3 orders of magnitude tighter than Cu2+ binding to A beta((1-40/42)) and more than an order of magnitude tighter than that of serum albumin, the extracellular Cu2+ transport protein. Furthermore, A beta((11-40/42)) forms fibers twice as fast as A beta((1-40)) with a very different morphology, forming bundles of very short amyloid rods. Substoichiometric Cu2+ drastically perturbs A beta((11-40/42)) assembly, stabilizing much longer fibers. The very tight fM affinity of Cu2+ for A beta((11-40/42)) explains the high levels of Cu2+ observed in Alzheimer disease plaques.	[Barritt, Joseph D.; Viles, John H.] Univ London, Sch Biol & Chem Sci, London E1 4NS, England	University of London	Viles, JH (corresponding author), Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	j.viles@qmul.ac.uk		Barritt, Joseph/0000-0002-4311-5305	Queen Mary University of London college studentship; BBSRC [BB/M023877/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M023877/1] Funding Source: researchfish	Queen Mary University of London college studentship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Queen Mary University of London college studentship. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Hilaly YK, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-83; Alies B, 2013, ANAL CHEM, V85, P1501, DOI 10.1021/ac302629u; Alies B, 2012, INORG CHEM, V51, P12988, DOI 10.1021/ic302097d; Bal W, 1998, J INORG BIOCHEM, V70, P33, DOI 10.1016/S0162-0134(98)00010-5; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Dawson R. M. C., 1986, DATA BIOCH RES, P409; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Gala L, 2014, MOLECULES, V19, P980, DOI 10.3390/molecules19010980; Gunderson WA, 2012, J AM CHEM SOC, V134, P18330, DOI 10.1021/ja306946q; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HARTTER DE, 1988, SYNAPSE, V2, P412, DOI 10.1002/syn.890020408; Hatcher LQ, 2008, J PHYS CHEM B, V112, P8160, DOI 10.1021/jp710806s; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Jiang DL, 2013, BIOCHEMISTRY-US, V52, P547, DOI 10.1021/bi301053h; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KARDOS J, 1989, NEUROSCI LETT, V103, P139, DOI 10.1016/0304-3940(89)90565-X; Karr JW, 2008, BIOCHEMISTRY-US, V47, P5006, DOI 10.1021/bi702423h; Karr JW, 2005, BIOCHEMISTRY-US, V44, P5478, DOI 10.1021/bi047611e; Klewpatinond M, 2008, J BIOL CHEM, V283, P1870, DOI 10.1074/jbc.M708472200; Klewpatinond M, 2007, FEBS LETT, V581, P1430, DOI 10.1016/j.febslet.2007.02.068; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kuipers BJH, 2007, J AGR FOOD CHEM, V55, P5445, DOI 10.1021/jf070337l; Kummer MP, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt258; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LAU SJ, 1971, J BIOL CHEM, V246, P5938; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Linder MC, 1998, AM J CLIN NUTR, V67, p965S, DOI 10.1093/ajcn/67.5.965S; Liu KN, 2006, ACTA NEUROPATHOL, V112, P163, DOI 10.1007/s00401-006-0077-5; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; MASUOKA J, 1993, J BIOL CHEM, V268, P21533; Matheou CJ, 2015, BIOCHEM J, V466, P233, DOI 10.1042/BJ20141168; Matlack KES, 2014, P NATL ACAD SCI USA, V111, P4013, DOI 10.1073/pnas.1402228111; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Mital M, 2015, ANGEW CHEM INT EDIT, V54, P10460, DOI 10.1002/anie.201502644; MORI H, 1992, J BIOL CHEM, V267, P17082; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Parthasarathy S, 2011, J AM CHEM SOC, V133, P3390, DOI 10.1021/ja1072178; PATEL SU, 1993, J AM CHEM SOC, V115, P9285, DOI 10.1021/ja00073a053; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; Prince M, 2009, ALZHEIMERS DIS INT W, P1; Rozga M, 2007, J BIOL INORG CHEM, V12, P913, DOI 10.1007/s00775-007-0244-8; Sanokawa-Akakura R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008626; Sarell CJ, 2010, J BIOL CHEM, V285, P41533, DOI 10.1074/jbc.M110.171355; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schutz AK, 2015, ANGEW CHEM INT EDIT, V54, P331, DOI 10.1002/anie.201408598; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Sharma AK, 2013, METALLOMICS, V5, P1529, DOI 10.1039/c3mt00161j; Singh I, 2013, P NATL ACAD SCI USA, V110, P14771, DOI 10.1073/pnas.1302212110; Singh Sandeep Kumar, 2013, Int J Alzheimers Dis, V2013, P567128, DOI 10.1155/2013/567128; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Sparks DL, 2003, P NATL ACAD SCI USA, V100, P11065, DOI 10.1073/pnas.1832769100; Stanyon HF, 2014, FEBS J, V281, P3945, DOI 10.1111/febs.12934; Stanyon HF, 2014, BIOCHEMISTRY-US, V53, P3934, DOI 10.1021/bi500643b; Strozyk D, 2009, NEUROBIOL AGING, V30, P1069, DOI 10.1016/j.neurobiolaging.2007.10.012; Sudoh S, 1998, J NEUROCHEM, V71, P1535; Sullivan CP, 2011, NEUROSCI LETT, V505, P109, DOI 10.1016/j.neulet.2011.09.071; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; TSANGARIS JM, 1970, J AM CHEM SOC, V92, P4255, DOI 10.1021/ja00717a020; Tycko R, 2004, CURR OPIN STRUC BIOL, V14, P96, DOI 10.1016/j.sbi.2003.12.002; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Viles JH, 2012, COORDIN CHEM REV, V256, P2271, DOI 10.1016/j.ccr.2012.05.003; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Whittemore NA, 2005, BIOCHEMISTRY-US, V44, P4434, DOI 10.1021/bi048292u; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Younan ND, 2015, BIOCHEMISTRY-US, V54, P4297, DOI 10.1021/acs.biochem.5b00309	78	46	47	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27791	27802		10.1074/jbc.M115.684084	http://dx.doi.org/10.1074/jbc.M115.684084			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26408196	Green Published, hybrid			2022-12-28	WOS:000365757500030
J	Follmer, C; Coelho-Cerqueira, E; Yatabe-Franco, DY; Araujo, GDT; Pinheiro, AS; Domont, GB; Eliezer, D				Follmer, Cristian; Coelho-Cerqueira, Eduardo; Yatabe-Franco, Danilo Y.; Araujo, Gabriel D. T.; Pinheiro, Anderson S.; Domont, Gilberto B.; Eliezer, David			Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of alpha-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOAMINE-OXIDASE-B; PARKINSONS-DISEASE; SELECTIVE NEURODEGENERATION; AMINO-GROUPS; IN-VITRO; AGGREGATION; OXIDATION; MECHANISM; HELIX; INHIBITION	Oxidative deamination of dopamine produces the highly toxic aldehyde 3,4-dihydroxyphenylacetaldehyde (DOPAL), enhanced production of which is found in post-mortem brains of Parkinson disease patients. When injected into the substantia nigra of rat brains, DOPAL causes the loss of dopaminergic neurons accompanied by the accumulation of potentially toxic oligomers of the presynaptic protein alpha-synuclein (aS), potentially explaining the synergistic toxicity described for dopamine metabolism and aS aggregation. In this work, we demonstrate that DOPAL interacts with aS via formation of Schiff-base and Michael-addition adducts with Lys residues, in addition to causing oxidation of Met residues to Met-sulfoxide. DOPAL modification leads to the formation of small aS oligomers that may be cross-linked by DOPAL. Both monomeric and oligomeric DOPAL adducts potently inhibit the formation of mature amyloid fibrils by unmodified aS. The binding of aS to either lipid vesicles or detergent micelles, which results in a gain of alpha-helix structure in its N-terminal lipid-binding domain, protects the protein against DOPAL adduct formation and, consequently, inhibits DOPAL-induced aS oligomerization. Functionally, aS-DOPAL monomer exhibits a reduced affinity for small unilamellar vesicles with lipid composition similar to synaptic vesicles, in addition to diminished membrane-induced alpha-helical content in comparison with the unmodified protein. These results suggest that DOPAL could compromise the functionality of aS, even in the absence of protein oligomerization, by affecting the interaction of aS with lipid membranes and hence its role in the regulation of synaptic vesicle traffic in neurons.	[Follmer, Cristian; Coelho-Cerqueira, Eduardo; Yatabe-Franco, Danilo Y.] Univ Fed Rio de Janeiro, Dept Phys Chem, Inst Chem, BR-21941909 Rio De Janeiro, Brazil; [Araujo, Gabriel D. T.; Pinheiro, Anderson S.; Domont, Gilberto B.] Univ Fed Rio de Janeiro, Dept Biochem, Inst Chem, BR-21941909 Rio De Janeiro, Brazil; [Follmer, Cristian; Eliezer, David] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Cornell University	Follmer, C (corresponding author), Univ Fed Rio de Janeiro, Dept Phys Chem, BR-21941909 Rio De Janeiro, Brazil.	follmer@iq.ufrj.br; dae2005@med.cornell.edu	Pinheiro, Anderson S/B-6350-2014; Follmer, Cristian/O-6134-2016; Regan, Clinton/E-6250-2012; Pinheiro, Anderson/AAL-5299-2021	Follmer, Cristian/0000-0001-6178-0432; Pinheiro, Anderson/0000-0001-5118-6931	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); National Institutes of Health [R37AG019391]; NATIONAL INSTITUTE ON AGING [R37AG019391] Funding Source: NIH RePORTER	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and National Institutes of Health Grant R37AG019391 (to D. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anderson DG, 2011, J BIOL CHEM, V286, P26978, DOI 10.1074/jbc.M111.249532; Bartels T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103727; Bermel W, 2006, J AM CHEM SOC, V128, P3918, DOI 10.1021/ja0582206; Bisaglia M, 2010, BIOCHEM BIOPH RES CO, V394, P424, DOI 10.1016/j.bbrc.2010.03.044; Burke WJ, 2008, ACTA NEUROPATHOL, V115, P193, DOI 10.1007/s00401-007-0303-9; Burke WJ, 2003, BRAIN RES, V989, P205, DOI 10.1016/S0006-8993(03)03354-7; Burre J, 2012, J NEUROSCI, V32, P15227, DOI 10.1523/JNEUROSCI.3545-12.2012; Bussell R, 2004, BIOCHEMISTRY-US, V43, P4810, DOI 10.1021/bi036135+; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Carmo-Goncalves P, 2014, AMYLOID, V21, P163, DOI 10.3109/13506129.2014.912208; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Coelho-Cerqueira E, 2014, BIOORG MED CHEM LETT, V24, P3194, DOI 10.1016/j.bmcl.2014.04.072; Coelho-Cerqueira E, 2013, FEBS J, V280, P4915, DOI 10.1111/febs.12471; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIXON HBF, 1968, BIOCHEM J, V109, P312, DOI 10.1042/bj1090312; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Eliezer David, 2012, Methods Mol Biol, V895, P127, DOI 10.1007/978-1-61779-927-3_10; Fares MB, 2014, HUM MOL GENET, V23, P4491, DOI 10.1093/hmg/ddu165; FILLOUX F, 1993, EXP NEUROL, V119, P79, DOI 10.1006/exnr.1993.1008; Fitzmaurice AG, 2013, P NATL ACAD SCI USA, V110, P636, DOI 10.1073/pnas.1220399110; Follmer C, 2007, BIOCHEMISTRY-US, V46, P472, DOI 10.1021/bi061871+; Follmer C, 2014, EXPERT REV NEUROTHER, V14, P703, DOI 10.1586/14737175.2014.920235; Fowler JS, 1997, NEUROBIOL AGING, V18, P431, DOI 10.1016/S0197-4580(97)00037-7; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; Goldstein DS, 2011, EUR J NEUROL, V18, P703, DOI 10.1111/j.1468-1331.2010.03246.x; Goldstein DS, 2013, J NEUROCHEM, V126, P591, DOI 10.1111/jnc.12345; Guang HM, 2006, ACTA PHARMACOL SIN, V27, P760, DOI 10.1111/j.1745-7254.2006.00336.x; Hasegawa T, 2006, FEBS LETT, V580, P2147, DOI 10.1016/j.febslet.2006.03.018; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Lamensdorf I, 2000, J NEUROSCI RES, V60, P552, DOI 10.1002/(SICI)1097-4547(20000515)60:4<552::AID-JNR14>3.0.CO;2-U; Langston JW, 2006, ANN NEUROL, V59, P591, DOI 10.1002/ana.20834; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Leong SL, 2009, FREE RADICAL BIO MED, V46, P1328, DOI 10.1016/j.freeradbiomed.2009.02.009; Li HT, 2005, FEBS J, V272, P3661, DOI 10.1111/j.1742-4658.2005.04792.x; Lin D, 2005, CHEM RES TOXICOL, V18, P1219, DOI 10.1021/tx050080q; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Maltsev AS, 2013, J AM CHEM SOC, V135, P2943, DOI 10.1021/ja312415q; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Qin ZJ, 2007, J BIOL CHEM, V282, P5862, DOI 10.1074/jbc.M608126200; Rauniyar N, 2009, PROTEOMICS, V9, P5188, DOI 10.1002/pmic.200900116; Rees JN, 2009, CHEM RES TOXICOL, V22, P1256, DOI 10.1021/tx9000557; SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304; Shvadchak VV, 2011, FEBS LETT, V585, P3513, DOI 10.1016/j.febslet.2011.10.006; Shvadchak VV, 2011, J BIOL CHEM, V286, P13023, DOI 10.1074/jbc.M110.204776; Snead David, 2014, Exp Neurobiol, V23, P292, DOI 10.5607/en.2014.23.4.292; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Umanah GKE, 2009, BIOCHEMISTRY-US, V48, P2033, DOI 10.1021/bi802061z; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Ysselstein D, 2015, NEUROBIOL DIS, V79, P150, DOI 10.1016/j.nbd.2015.04.007; Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y; Zarbiv Y, 2014, NEUROBIOL DIS, V70, P90, DOI 10.1016/j.nbd.2014.05.031; Zhou WB, 2010, BBA-MOL BASIS DIS, V1802, P322, DOI 10.1016/j.bbadis.2009.12.004	62	71	72	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27660	27679		10.1074/jbc.M115.686584	http://dx.doi.org/10.1074/jbc.M115.686584			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26381411	hybrid, Green Published			2022-12-28	WOS:000365757500020
J	Moree, B; Yin, GW; Lazaro, DF; Munari, F; Strohaker, T; Giller, K; Becker, S; Outeiro, TF; Zweckstetter, M; Salafsky, J				Moree, Ben; Yin, Guowei; Lazaro, Diana F.; Munari, Francesca; Strohaeker, Timo; Giller, Karin; Becker, Stefan; Outeiro, Tiago F.; Zweckstetter, Markus; Salafsky, Joshua			Small Molecules Detected by Second-Harmonic Generation Modulate the Conformation of Monomeric alpha-Synuclein and Reduce Its Aggregation in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY DISORDERED PROTEINS; PARKINSONS-DISEASE; DRUG DISCOVERY; IN-VITRO; TOXICITY; NEURONS; MODELS; ORIENTATION; MICROSCOPY; TISSUES	Proteins are structurally dynamic molecules that perform specialized functions through unique conformational changes accessible in physiological environments. An ability to specifically and selectively control protein function via conformational modulation is an important goal for development of novel therapeutics and studies of protein mechanism in biological networks and disease. Here we applied a second-harmonic generation-based technique for studying protein conformation in solution and in real time to the intrinsically disordered, Parkinson disease related protein alpha-synuclein. From a fragment library, we identified small molecule modulators that bind to monomeric alpha-synuclein in vitro and significantly reduce alpha-synuclein aggregation in a neuronal cell culture model. Our results indicate that the conformation of alpha-synuclein is linked to the aggregation of protein in cells. They also provide support for a therapeutic strategy of targeting specific conformations of the protein to suppress or control its aggregation.	[Moree, Ben; Salafsky, Joshua] Biodesy Inc, San Francisco, CA 94080 USA; [Yin, Guowei; Munari, Francesca; Strohaeker, Timo; Giller, Karin; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Lazaro, Diana F.; Outeiro, Tiago F.] Univ Med Ctr, Ctr Nanoscale Microscopy & Mol Physiol Brain, D-37075 Gottingen, Germany; [Lazaro, Diana F.; Outeiro, Tiago F.] Univ Med Ctr Gottingen, Dept Neurodegenerat & Restorat Res, D-37073 Gottingen, Germany; [Munari, Francesca; Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Salafsky, J (corresponding author), 384 Oyster Point Blvd 8, San Francisco, CA 94080 USA.	joshua.salafsky@biodesy.com	Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/M-8106-2019; Outeiro, Tiago/L-7351-2019	Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727; Zweckstetter, Markus/0000-0002-2536-6581; Moree, Ben/0000-0002-8811-7400; Munari, Francesca/0000-0002-8217-1481	Deutsche Forschungsgemeinschaft (DFG) [ZW 71/2-2, ZW 71/3-2]; Rapid Response Innovation Award grants; Biodesy from the Michael J. Fox Foundation for Parkinson's Research; DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Rapid Response Innovation Award grants; Biodesy from the Michael J. Fox Foundation for Parkinson's Research; DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft (DFG) Grant ZW 71/2-2,3-2 (to M. Z.) and in part by three Rapid Response Innovation Award grants (to J. S.) and Biodesy from the Michael J. Fox Foundation for Parkinson's Research. B. M. is an employee of Biodesy, Inc. J. S. is the Founder and Chief Scientific Officer of Biodesy, Inc.; Supported by the DFG Center for Nanoscale Microscopy and Molecular Physiology of the Brain.	Ahmad B, 2012, J BIOL CHEM, V287, P9193, DOI 10.1074/jbc.M111.325548; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Braga CA, 2011, J MOL BIOL, V405, P254, DOI 10.1016/j.jmb.2010.10.027; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Craik D J, 1997, Methods Mol Biol, V60, P195; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Erlanson DA, 2012, TOP CURR CHEM, V317, P1, DOI 10.1007/128_2011_180; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; FREUND I, 1986, BIOPHYS J, V50, P693, DOI 10.1016/S0006-3495(86)83510-X; GODDARD TD, 2007, SPARKY; Goh CS, 2004, CURR OPIN STRUC BIOL, V14, P104, DOI 10.1016/j.sbi.2004.01.005; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; Heinz T. F., 1991, NONLINEAR SURFACE EL, P353; HEINZ TF, 1983, PHYS REV A, V28, P1883, DOI 10.1103/PhysRevA.28.1883; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Huahai H., 2006, DATA MINING 2006, P885; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; KOSHLAND DE, 1958, FED PROC, V17, P1145; Kritzer JA, 2009, NAT CHEM BIOL, V5, P655, DOI 10.1038/nchembio.193; Lamberto GR, 2009, P NATL ACAD SCI USA, V106, P21057, DOI 10.1073/pnas.0902603106; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lazaro DF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004741; Lee EN, 2004, BIOCHEMISTRY-US, V43, P3704, DOI 10.1021/bi0356707; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; Moreaux L, 2003, OPT LETT, V28, P625, DOI 10.1364/OL.28.000625; Moree B, 2015, BIOPHYS J, V109, P806, DOI 10.1016/j.bpj.2015.07.016; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Salafsky JS, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2218846; Salafsky JS, 2007, PHYS CHEM CHEM PHYS, V9, P5704, DOI 10.1039/b710505c; Salafsky JS, 2008, J PHYS CHEM B, V112, P15103, DOI 10.1021/jp803703m; Salafsky JS, 2001, CHEM PHYS LETT, V342, P485, DOI 10.1016/S0009-2614(01)00623-6; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Tardiff DF, 2012, J BIOL CHEM, V287, P4107, DOI 10.1074/jbc.M111.308668; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Toth G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087133; Uversky VN, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00018; Uversky VN, 2014, CHEM REV, V114, P6557, DOI 10.1021/cr500288y; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Zhuang X, 1999, PHYS REV B, V59, P12632, DOI 10.1103/PhysRevB.59.12632	61	41	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27582	27593		10.1074/jbc.M114.636027	http://dx.doi.org/10.1074/jbc.M114.636027			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26396193	Green Published, hybrid			2022-12-28	WOS:000365757500014
J	Birk, A; Rinne, A; Bunemann, M				Birk, Alexandra; Rinne, Andreas; Buenemann, Moritz			Membrane Potential Controls the Efficacy of Catecholamine-induced beta(1)-Adrenoceptor Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; DOPAMINE D-2S RECEPTOR; DIRECT VOLTAGE CONTROL; NERVOUS-SYSTEM; ACTIVATION; PHOSPHORYLATION; SENSITIVITY; DEPENDENCE; KINETICS; BINDING	Background: The activity of several G(q)- and G(1)-coupled receptors is modulated by the membrane potential. Results: Voltage modulates catecholamine-mediated activation of G(s)-coupled beta(1)- and beta(2)-adrenoceptors. Conclusion: Voltage-dependence of beta(1)-AR is due to alterations in the efficacy of catecholamines. Significance: By modulating catecholamine efficacy on beta(1)-ARs, voltage can modify receptor activity on a very fast time scale. G protein-coupled receptors (GPCRs) are membrane-located proteins and, therefore, are exposed to changes in membrane potential (V-M) in excitable tissues. These changes have been shown to alter receptor activation of certain G(i)-and G(q)-coupled GPCRs. By means of a combination of whole-cell patch-clamp and Forster resonance energy transfer (FRET) in single cells, we demonstrate that the activation of the G(s)-coupled (1)-adrenoreceptor (beta(1)-AR) by the catecholamines isoprenaline (Iso) and adrenaline (Adr) is regulated by V-M. This voltage-dependence is also transmitted to G protein and arrestin 3 signaling. Voltage-dependence of beta(2)-AR activation, however, was weak compared with beta(1)-AR voltage-dependence. Drug efficacy is a major target of beta(1)-AR voltage-dependence as depolarization attenuated receptor activation, even under saturating concentrations of agonists, with significantly faster kinetics than the deactivation upon agonist withdrawal. Also the efficacy of the endogenous full agonist adrenaline was reduced by depolarization. This is a unique finding since reports of natural full agonists at other voltage-dependent GPCRs only show alterations in affinity during depolarization. Based on a Boltzmann function fit to the relationship of V-M and receptor-arrestin 3 interaction we determined the voltage-dependence with highest sensitivity in the physiological range of membrane potential. Our data suggest that under physiological conditions voltage regulates the activity of agonist-occupied beta(1)-adrenoceptors on a very fast time scale.	[Birk, Alexandra; Buenemann, Moritz] Univ Marburg, Inst Pharmacol & Clin Pharm, Biochem Pharmacol Ctr Marburg, D-35043 Marburg, Germany; [Rinne, Andreas] Ruhr Univ Bochum, Inst Physiol, D-44801 Bochum, Germany	Philipps University Marburg; Ruhr University Bochum	Bunemann, M (corresponding author), Univ Marburg, Inst Pharmacol & Clin Pharm, Biochem Pharmacol Ctr Marburg, Karl von Frisch Str 1, D-35043 Marburg, Germany.	moritz.buenemann@staff.uni-marburg.de	Rinne, Andreas/G-7986-2017; Rinne, Andreas/AAO-1685-2020	Rinne, Andreas/0000-0003-3535-2498; Rinne, Andreas/0000-0003-3535-2498; Buenemann, Moritz/0000-0002-2259-4378	Deutsche Forschungsgemeinschaft [SFB593]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft as part of the SFB593 "Mechanisms of Cellular Compartmentalization and the Relevance for disease." The authors declare that they have no conflicts of interest with the contents of this article.	Ahles A, 2015, J BIOL CHEM, V290, P1760, DOI 10.1074/jbc.M114.607333; Ben Chaim Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074354; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bond R. A., 2015, IUPHAR BPS GUIDE PHA; Gurung IS, 2008, BRIT J PHARMACOL, V154, P882, DOI 10.1038/bjp.2008.97; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Kirstein SL, 2004, PHARMACOL REV, V56, P31, DOI 10.1124/pr.56.1.2; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; LOHSE MJ, 1993, BIOCHIM BIOPHYS ACTA, V1179, P171, DOI 10.1016/0167-4889(93)90139-G; Lohse MJ, 2003, LIFE SCI, V74, P397, DOI 10.1016/j.lfs.2003.09.026; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Mahaut-Smith MP, 2008, TRENDS PHARMACOL SCI, V29, P421, DOI 10.1016/j.tips.2008.05.007; Martinez-Pinna J, 2005, J BIOL CHEM, V280, P1490, DOI 10.1074/jbc.M407783200; Martinez-Pinna J, 2010, J PHYSIOL-LONDON, V588, P1683, DOI 10.1113/jphysiol.2009.183418; Moreno-Galindo E. G., 2011, J PHYSL, V7, P1755; Navarro-Polanco RA, 2011, J PHYSIOL-LONDON, V589, P1741, DOI 10.1113/jphysiol.2010.204107; Ohana L, 2006, J BIOL CHEM, V281, P24204, DOI 10.1074/jbc.M513447200; Parnas I, 2010, PFLUG ARCH EUR J PHY, V460, P975, DOI 10.1007/s00424-010-0872-7; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rinne A, 2013, P NATL ACAD SCI USA, V110, P1536, DOI 10.1073/pnas.1212656110; Rochais F, 2007, J CLIN INVEST, V117, P229, DOI 10.1172/JCI30012; Sahlholm K, 2008, SYNAPSE, V62, P476, DOI 10.1002/syn.20509; Sahlholm K, 2012, BBA-BIOMEMBRANES, V1818, P3081, DOI 10.1016/j.bbamem.2012.07.027; Sahlholm K, 2011, NEUROPHARMACOLOGY, V61, P937, DOI 10.1016/j.neuropharm.2011.06.022; Sahlholm K, 2008, BIOCHEM BIOPH RES CO, V377, P1216, DOI 10.1016/j.bbrc.2008.10.117; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Tateyama M, 2013, NEUROPHARMACOLOGY, V65, P173, DOI 10.1016/j.neuropharm.2012.10.006; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838	30	16	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27311	27320		10.1074/jbc.M115.665000	http://dx.doi.org/10.1074/jbc.M115.665000			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26408198	Green Published, hybrid			2022-12-28	WOS:000364794000038
J	Cannistraro, VJ; Pondugula, S; Song, Q; Taylor, JS				Cannistraro, Vincent J.; Pondugula, Santhi; Song, Qian; Taylor, John-Stephen			Rapid Deamination of Cyclobutane Pyrimidine Dimer Photoproducts at TCG Sites in a Translationally and Rotationally Positioned Nucleosome in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE DNA GLYCOSYLASE; CHROMATIN-STRUCTURE; CORE PARTICLE; ANGSTROM RESOLUTION; ULTRAVIOLET-LIGHT; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GAMMA-RADIATION; POLYMERASE ETA; UV-MUTAGENESIS	Sunlight-induced C to T mutation hot spots in skin cancers occur primarily at methylated CpG sites that coincide with sites of UV-induced cyclobutane pyrimidine dimer (CPD) formation. The C and 5-methyl-C in CPDs are not stable and deaminate to U and T, respectively, which leads to the insertion of A by the DNA damage bypass polymerase eta, thereby defining a probable mechanism for the origin of UV-induced C to T mutations. Deamination rates for T(m)CG CPDs have been found to vary 12-fold with rotational position in a nucleosome in vitro. To determine the influence of nucleosome structure on deamination rates in vivo, we determined the deamination rates of CPDs at TCG sites in a stably positioned nucleosome within the FOS promoter in HeLa cells. A procedure for in vivo hydroxyl radical footprinting with Fe-EDTA was developed, and, together with results from a cytosine methylation protection assay, we determined the translational and rotational positions of the TCG sites. Consistent with the in vitro observations, deamination was slower for one CPD located at an intermediate rotational position compared with two other sites located at outside positions, and all were much faster than for CPDs at non-TCG sites. Photoproduct formation was also highly suppressed at one site, possibly due to its interaction with a histone tail. Thus, it was shown that CPDs of TCG sites deaminate the fastest in vivo and that nucleosomes can modulate both their formation and deamination, which could contribute to the UV mutation hot spots and cold spots.	[Cannistraro, Vincent J.; Pondugula, Santhi; Song, Qian; Taylor, John-Stephen] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL)	Taylor, JS (corresponding author), Washington Univ, Dept Chem, St Louis, MO 63130 USA.	taylor@wustl.edu	Taylor, John-Stephen/AAA-3218-2020	Taylor, John-Stephen/0000-0002-8615-7257	National Cancer Institute, National Institutes of Health [R01 CA40463]; NATIONAL CANCER INSTITUTE [R01CA040463] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Cancer Institute, National Institutes of Health Grant R01 CA40463 (to J.-S. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Adilakshmi T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl291; Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Blomquist P, 1996, J BIOL CHEM, V271, P153, DOI 10.1074/jbc.271.1.153; Burger A, 2003, MUTAT RES-FUND MOL M, V522, P145, DOI 10.1016/S0027-5107(02)00310-X; Bykov VJ, 1999, J INVEST DERMATOL, V112, P326, DOI 10.1046/j.1523-1747.1999.00523.x; Cannistraro VJ, 2009, J MOL BIOL, V392, P1145, DOI 10.1016/j.jmb.2009.07.048; Darst RP, 2013, NUCLEIC ACIDS RES, V41, P2993, DOI 10.1093/nar/gkt033; Darst RP, 2012, METHODS MOL BIOL, V833, P125, DOI 10.1007/978-1-61779-477-3_9; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Delmas AL, 2011, CARCINOGENESIS, V32, P1625, DOI 10.1093/carcin/bgr193; DEVRIES E, 1987, EMBO J, V6, P161, DOI 10.1002/j.1460-2075.1987.tb04734.x; DIXON WJ, 1991, METHOD ENZYMOL, V208, P380; FIX D, 1981, MOL GEN GENET, V182, P7, DOI 10.1007/BF00422759; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; Hara R, 2003, MOL CELL BIOL, V23, P4121, DOI 10.1128/MCB.23.12.4121-4125.2003; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; Herrera RE, 1997, CHROMOSOMA, V106, P284, DOI 10.1007/s004120050249; Ikehata H, 2014, DNA REPAIR, V22, P112, DOI 10.1016/j.dnarep.2014.07.012; Ikehata H, 2011, J RADIAT RES, V52, P115, DOI 10.1269/jrr.10175; KAPPEN LS, 1983, BIOCHEMISTRY-US, V22, P4872, DOI 10.1021/bi00290a002; Kladde MP, 1999, METHOD ENZYMOL, V304, P431; Komura J, 2003, BIOCHEMISTRY-US, V42, P15084, DOI 10.1021/bi034802t; Lee DH, 2003, J BIOL CHEM, V278, P10314, DOI 10.1074/jbc.M212696200; LEMAIRE DGE, 1993, BIOCHEMISTRY-US, V32, P2525, DOI 10.1021/bi00061a009; LJUNGMAN M, 1992, MOL CARCINOGEN, V5, P264, DOI 10.1002/mc.2940050406; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Morgan MT, 2007, J BIOL CHEM, V282, P27578, DOI 10.1074/jbc.M704253200; Mouret S, 2008, DNA REPAIR, V7, P704, DOI 10.1016/j.dnarep.2008.01.005; Mueller P R, 2001, Curr Protoc Mol Biol, VChapter 15, DOI 10.1002/0471142727.mb1503s56; Nabilsi NH, 2014, GENOME RES, V24, P329, DOI 10.1101/gr.161737.113; O'Donnell A, 2008, MOL CELL, V29, P780, DOI 10.1016/j.molcel.2008.01.019; Ottinger LM, 2000, J AM CHEM SOC, V122, P5901, DOI 10.1021/ja000285f; Pardo CE, 2015, METHODS MOL BIOL, V1288, P123, DOI 10.1007/978-1-4939-2474-5_9; Pardo CE, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq716; PEHRSON JR, 1989, P NATL ACAD SCI USA, V86, P9149, DOI 10.1073/pnas.86.23.9149; Peng W, 1996, BIOCHEMISTRY-US, V35, P10172, DOI 10.1021/bi960001x; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pondugula S, 2008, J CELL BIOCHEM, V105, P330, DOI 10.1002/jcb.21849; Ryabinina OP, 2011, DNA REPAIR, V10, P1014, DOI 10.1016/j.dnarep.2011.07.015; Schieferstein U, 1996, BIOCHEMISTRY-US, V35, P7705, DOI 10.1021/bi953011r; SchildPoulter C, 1996, NUCLEIC ACIDS RES, V24, P4751, DOI 10.1093/nar/24.23.4751; SETLOW RB, 1966, SCIENCE, V153, P379, DOI 10.1126/science.153.3734.379; Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177; Song Q, 2014, NUCLEIC ACIDS RES, V42, P13122, DOI 10.1093/nar/gku1049; Song Q, 2012, J BIOL CHEM, V287, P8021, DOI 10.1074/jbc.M111.333591; SUQUET C, 1993, J BIOL CHEM, V268, P23755; Syed SH, 2010, P NATL ACAD SCI USA, V107, P9620, DOI 10.1073/pnas.1000309107; Tornaletti S, 1996, MOL CARCINOGEN, V17, P192, DOI 10.1002/(SICI)1098-2744(199612)17:4<192::AID-MC2>3.0.CO;2-G; Tu YQ, 1998, J MOL BIOL, V284, P297, DOI 10.1006/jmbi.1998.2176; Valota A, 2003, INT J RADIAT BIOL, V79, P643, DOI 10.1080/09553000310001596977; Vu B, 2006, BIOCHEMISTRY-US, V45, P9327, DOI 10.1021/bi0602009; Wells D., 1989, Nucleic Acids Research, V17, P311; Worthington EN, 2003, J BIOL CHEM, V278, P39143, DOI 10.1074/jbc.M305792200; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106	60	16	17	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26597	26609		10.1074/jbc.M115.673301	http://dx.doi.org/10.1074/jbc.M115.673301			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354431	hybrid, Green Published			2022-12-28	WOS:000364793600026
J	Gong, LH; Liu, M; Zeng, T; Shi, XL; Yuan, C; Andreasen, PA; Huang, MD				Gong, Lihu; Liu, Min; Zeng, Tu; Shi, Xiaoli; Yuan, Cai; Andreasen, Peter A.; Huang, Mingdong			Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE COMPLEX; TERNARY COMPLEX; HIGH-RESOLUTION; UROKINASE-TYPE; SERPIN; ANTITHROMBIN; REVEALS; HEPARIN; SPECIFICITY; MECHANISM	Thrombosis is a leading cause of death worldwide. Recombinant tissue-type plasminogen activator (tPA) is the Food and Drug Administration-approved thrombolytic drug. tPA is rapidly inactivated by endogenous plasminogen activator inhibitor-1 (PAI-1). Engineering on tPA to reduce its inhibition by PAI-1 without compromising its thrombolytic effect is a continuous effort. Precise details, with atomic resolution, of the molecular interactions between tPA and PAI-1 remain unknown despite previous extensive studies. Here, we report the crystal structure of the tPA.PAI-1 Michaelis complex, which shows significant differences from the structure of its urokinase-type plasminogen activator analogue, the uPA.PAI-1 Michaelis complex. The PAI-1 reactive center loop adopts a unique kinked conformation. The structure provides detailed interactions between tPA 37- and 60-loops with PAI-1. On the tPA side, the S2 and S1 beta pockets open up to accommodate PAI-1. This study provides structural basis to understand the specificity of PAI-1 and to design newer generation of thrombolytic agents with reduced PAI-1 inactivation.	[Gong, Lihu; Liu, Min; Zeng, Tu; Shi, Xiaoli; Yuan, Cai; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China; [Gong, Lihu; Liu, Min; Zeng, Tu; Shi, Xiaoli; Yuan, Cai; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, Danish Chinese Ctr Proteases & Canc, Fuzhou 350002, Fujian, Peoples R China; [Gong, Lihu; Liu, Min; Huang, Mingdong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Andreasen, Peter A.] Aarhus Univ, Dept Mol Biol & Genet, Danish Chinese Ctr Proteases & Canc, DK-8000 Aarhus C, Denmark	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Aarhus University	Huang, MD (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China.	mhuang@fjirsm.ac.cn	Huang, Mingdong/J-4278-2017	Huang, Mingdong/0000-0003-0085-9141	National Natural Science Foundation of China [31170707, 31370737]; CAS/SAFEA; Chinese Academy of Sciences; Aarhus University Research Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Aarhus University Research Foundation	This work was supported by Grants 31170707 and 31370737 from the National Natural Science Foundation of China and the CAS/SAFEA. International Partnership Program for Creative Research Teams. The authors declare that they have no conflicts of interest with the contents of this article.; Awarded a Chinese Academy of Sciences visiting professorship for senior international scientists.; Awarded an Aarhus University Research Foundation visiting professorship.	Baruah DB, 2006, VASC PHARMACOL, V44, P1, DOI 10.1016/j.vph.2005.09.003; BENNETT WF, 1991, J BIOL CHEM, V266, P5191; BUSSO N, 1987, CANCER RES, V47, P364; Butenas S, 1997, BIOCHEMISTRY-US, V36, P2123, DOI 10.1021/bi9617670; Cazzolli G, 2014, P NATL ACAD SCI USA, V111, P15414, DOI 10.1073/pnas.1407528111; Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Dekker RJ, 1999, J MOL BIOL, V293, P613, DOI 10.1006/jmbi.1999.3178; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; Dupont DM, 2009, FRONT BIOSCI-LANDMRK, V14, P1337, DOI 10.2741/3312; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FESTOFF BW, 1990, J CELL PHYSIOL, V144, P272, DOI 10.1002/jcp.1041440213; Grotta JC, 2001, ARCH NEUROL-CHICAGO, V58, P2009, DOI 10.1001/archneur.58.12.2009; HAMSTEN A, 1985, NEW ENGL J MED, V313, P1557, DOI 10.1056/NEJM198512193132501; Hatcher MA, 2011, ANN PHARMACOTHER, V45, P364, DOI 10.1345/aph.1P525; Ibarra CA, 2004, J BIOL CHEM, V279, P3643, DOI 10.1074/jbc.M310601200; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; Johnson DJD, 2010, P NATL ACAD SCI USA, V107, P645, DOI 10.1073/pnas.0910144107; Katz BA, 2001, J MOL BIOL, V307, P1451, DOI 10.1006/jmbi.2001.4516; KEIJER J, 1991, BLOOD, V78, P401; KEYT BA, 1994, P NATL ACAD SCI USA, V91, P3670, DOI 10.1073/pnas.91.9.3670; Kohler HP, 2000, NEW ENGL J MED, V342, P1792, DOI 10.1056/NEJM200006153422406; Korin N, 2012, SCIENCE, V337, P738, DOI 10.1126/science.1217815; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamba D, 1996, J MOL BIOL, V258, P117, DOI 10.1006/jmbi.1996.0238; Lapchak Paul A, 2002, Curr Neurol Neurosci Rep, V2, P38, DOI 10.1007/s11910-002-0051-0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Li W, 2012, BLOOD, V120, P459, DOI 10.1182/blood-2012-03-415869; Lin ZH, 2013, CHEM BIOL, V20, P253, DOI 10.1016/j.chembiol.2013.01.002; Lin ZH, 2011, J BIOL CHEM, V286, P7027, DOI 10.1074/jbc.M110.204537; MADISON EL, 1990, J BIOL CHEM, V265, P21423; MADISON EL, 1990, P NATL ACAD SCI USA, V87, P3530, DOI 10.1073/pnas.87.9.3530; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nienaber V, 2000, J BIOL CHEM, V275, P7239, DOI 10.1074/jbc.275.10.7239; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raskob GE, 2014, THROMB RES, V134, P931, DOI 10.1016/j.thromres.2014.08.014; REFINO CJ, 1993, THROMB HAEMOSTASIS, V70, P313; Renatus M, 1997, EMBO J, V16, P4797, DOI 10.1093/emboj/16.16.4797; Renatus M, 1997, J BIOL CHEM, V272, P21713, DOI 10.1074/jbc.272.35.21713; Sharp AM, 1999, STRUCTURE, V7, P111, DOI 10.1016/S0969-2126(99)80018-5; Sichler K, 2003, J BIOL CHEM, V278, P4121, DOI 10.1074/jbc.M210722200; Stout TJ, 2000, BIOCHEMISTRY-US, V39, P8460, DOI 10.1021/bi000290w; Tachias K, 1997, J BIOL CHEM, V272, P14580, DOI 10.1074/jbc.272.23.14580; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Van de Craen B, 2012, THROMB RES, V130, P576, DOI 10.1016/j.thromres.2012.06.023; Vaughan Douglas E, 2011, Trans Am Clin Climatol Assoc, V122, P312; Vindigni A, 2000, PROTEIN SCI, V9, P619; Wang Qingcai, 2003, BMC Biochem, V4, P5, DOI 10.1186/1471-2091-4-5; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Yu HY, 2013, CHINESE J STRUC CHEM, V32, P961; Zhao BY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115872; Zhao GX, 2006, PROTEIN EXPRES PURIF, V49, P71, DOI 10.1016/j.pep.2006.05.005	58	33	37	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25795	25804		10.1074/jbc.M115.677567	http://dx.doi.org/10.1074/jbc.M115.677567			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26324706	hybrid, Green Published			2022-12-28	WOS:000363527300002
J	Edye, ME; Brough, D; Allan, SM				Edye, Michelle E.; Brough, David; Allan, Stuart M.			Acid-dependent Interleukin-1 (IL-1) Cleavage Limits Available Pro-IL-1 beta for Caspase-1 Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY RESPONSE; NLRP3 INFLAMMASOME; DANGER SIGNAL; RECEPTOR; PH; PROTEINASE-3; ACTIVATION; IL-1-BETA; ARTHRITIS; DISEASES	Noncommunicable diseases such as cardiovascular disease (stroke and heart attack), cancer, chronic respiratory disease, and diabetes are a leading cause of death and disability worldwide and are worsened by inflammation. IL-1 is a driver of inflammation and implicated in many noncommunicable diseases. Acidosis is also a key feature of the inflammatory microenvironment; therefore it is vital to explore IL-1 signaling under acidic conditions. A HEK-IL-1 reporter assay and brain endothelial cell line were used to explore activity of mature IL-1 alpha and IL-1 alpha at pH 7.4 and pH 6.2, an acidic pH that can be reached under inflammatory or ischemic conditions, alongside cathepsin D-cleaved 20-kDa IL-1 beta produced under acidic conditions. We report that mature IL-1 signaling at IL-1 receptor type 1 (IL-1R1) is maintained at pH 6.2, but the activity of the decoy receptor, IL-1R2, is reduced. Additionally, cathepsin D-cleaved 20-kDa IL-1 beta was minimally active at IL-1R1 and was not further cleaved to highly active 17-kDa IL-1 beta. Therefore formation of the 20-kDa form of IL-1 beta may prevent the generation of mature bioactive IL-1 beta and thus may limit inflammation.	[Edye, Michelle E.; Brough, David; Allan, Stuart M.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Brough, D (corresponding author), Univ Manchester, Fac Life Sci, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	david.brough@manchester.ac.uk	Allan, Stuart/AAL-1245-2020	Allan, Stuart/0000-0001-9646-4456; Brough, David/0000-0002-2250-2381; Edye, Michelle/0000-0003-0727-8366	Biotechnology and Biological Sciences Research Council; Pfizer; Biotechnology and Biological Sciences Research Council [1118598] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer(Pfizer); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council and Pfizer. The authors declare that they have no conflicts of interest with the contents of this article.	Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Angell SY, 2012, SCIENCE, V337, P1456, DOI 10.1126/science.1228293; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; BLACK RA, 1988, J BIOL CHEM, V263, P9437; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Denes A, 2011, CEREBROVASC DIS, V32, P517, DOI 10.1159/000332205; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Edye ME, 2013, J BIOL CHEM, V288, P30485, DOI 10.1074/jbc.M113.478941; Garlanda C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00180; Guma M, 2009, ARTHRITIS RHEUM-US, V60, P3642, DOI 10.1002/art.24959; HAZUDA DJ, 1991, J BIOL CHEM, V266, P7081; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Kellum JA, 2004, AM J PHYSIOL-REG I, V286, pR686, DOI 10.1152/ajpregu.00564.2003; Menkin V, 1937, AM J PATHOL, V13, P25; NEMOTO EM, 1981, STROKE, V12, P77, DOI 10.1161/01.STR.12.1.77; Netea MG, 2015, ANNU REV IMMUNOL, V33, P49, DOI 10.1146/annurev-immunol-032414-112306; Rajamaki K, 2013, J BIOL CHEM, V288, P13410, DOI 10.1074/jbc.M112.426254; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shimizu K, 2015, J IMMUNOL, V194, P3156, DOI 10.4049/jimmunol.1402155; Smith DE, 2003, IMMUNITY, V18, P87, DOI 10.1016/S1074-7613(02)00514-9; Takenouchi T., 2014, INFLAMMASOME, V1, P76, DOI DOI 10.2478/INFL-2014-0008; Takenouchi T, 2011, J NEUROCHEM, V117, P712, DOI 10.1111/j.1471-4159.2011.07240.x; WANG RIH, 1955, J NEUROPHYSIOL, V18, P130, DOI 10.1152/jn.1955.18.2.130; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Zheng Y, 2013, IMMUNITY, V38, P285, DOI 10.1016/j.immuni.2013.01.008	29	11	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25374	25381		10.1074/jbc.M115.667162	http://dx.doi.org/10.1074/jbc.M115.667162			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26324708	Green Published, hybrid			2022-12-28	WOS:000362962800015
J	Mishanina, TV; Yadav, PK; Ballou, DP; Banerjee, R				Mishanina, Tatiana V.; Yadav, Prannod K.; Ballou, David P.; Banerjee, Ruma			Transient Kinetic Analysis of Hydrogen Sulfide Oxidation Catalyzed by Human Sulfide Quinone Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFANE SULFUR; H2S BIOGENESIS; THIOSULFATE; OXIDASE	The first step in the mitochondrial sulfide oxidation pathway is catalyzed by sulfide quinone oxidoreductase (SQR), which belongs to the family of flavoprotein disulfide oxidoreductases. During the catalytic cycle, the flavin cofactor is intermittently reduced by sulfide and oxidized by ubiquinone, linking H2S oxidation to the electron transfer chain and to energy metabolism. Human SQR can use multiple thiophilic acceptors, including sulfide, sulfite, and glutathione, to form as products, hydrodisulfide, thiosulfate, and glutathione persulfide, respectively. In this study, we have used transient kinetics to examine the mechanism of the flavin reductive half-reaction and have determined the redox potential of the bound flavin to be -123 +/- 7 mV. We observe formation of an unusually intense charge-transfer (CT) complex when the enzyme is exposed to sulfide and unexpectedly, when it is exposed to sulfite. In the canonical reaction, sulfide serves as the sulfur donor and sulfite serves as the acceptor, forming thiosulfate. We show that thiosulfate is also formed when sulfide is added to the sulfite-induced CT intermediate, representing a new mechanism for thiosulfate formation. The CT complex is formed at a kinetically competent rate by reaction with sulfide but not with sulfite. Our study indicates that sulfide addition to the active site disulfide is preferred under normal turnover conditions. However, under pathological conditions when sulfite concentrations are high, sulfite could compete with sulfide for addition to the active site disulfide, leading to attenuation of SQR activity and to an alternate route for thiosulfate formation.	[Mishanina, Tatiana V.; Yadav, Prannod K.; Ballou, David P.; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Regan, Clinton/E-6250-2012; Yadav, Pramod K./A-6166-2010	Yadav, Pramod K./0000-0003-0026-1684; Mishanina, Tatiana/0000-0001-7400-3501	National Institutes of Health [GM112455]; American Heart Association [14POST18760003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM112455 (to R. B.) and by a postdoctoral fellowship from the American Heart Association (14POST18760003) (to P. K. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAMOVITZ AS, 1976, J BIOL CHEM, V251, P5327; Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Banerjee R, 2015, METHOD ENZYMOL, V554, P189, DOI 10.1016/bs.mie.2014.11.016; Brito JA, 2009, BIOCHEMISTRY-US, V48, P5613, DOI 10.1021/bi9003827; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; HEVESI L, 1973, BIOCHEMISTRY-US, V12, P290, DOI 10.1021/bi00726a018; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; Kabil O, 2014, ANNU REV NUTR, V34, P171, DOI 10.1146/annurev-nutr-071813-105654; Kabil O, 2014, BBA-PROTEINS PROTEOM, V1844, P1355, DOI 10.1016/j.bbapap.2014.01.002; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kimura H, 2010, ANTIOXID REDOX SIGN, V12, P1111, DOI 10.1089/ars.2009.2919; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Marcia M, 2009, P NATL ACAD SCI USA, V106, P9625, DOI 10.1073/pnas.0904165106; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; Polhemus DJ, 2014, CIRC RES, V114, P730, DOI 10.1161/CIRCRESAHA.114.300505; POWELL MA, 1986, SCIENCE, V233, P563, DOI 10.1126/science.233.4763.563; SAHLMAN L, 1986, EUR J BIOCHEM, V156, P479, DOI 10.1111/j.1432-1033.1986.tb09606.x; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; SHIH VE, 1977, NEW ENGL J MED, V297, P1022, DOI 10.1056/NEJM197711102971902; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; THORPE C, 1976, J BIOL CHEM, V251, P7726; URBAN PF, 1969, EUR J BIOCHEM, V9, P519, DOI 10.1111/j.1432-1033.1969.tb00640.x; Vitvitsky V, 2015, J BIOL CHEM, V290, P8310, DOI 10.1074/jbc.M115.639831; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8813, DOI 10.1021/bi000349z; WILLIAMSON G, 1982, J BIOL CHEM, V257, P4314; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	35	44	45	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25072	25080		10.1074/jbc.M115.682369	http://dx.doi.org/10.1074/jbc.M115.682369			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26318450	hybrid, Green Published			2022-12-28	WOS:000362598300035
J	Nicastro, R; Tripodi, F; Gaggini, M; Castoldi, A; Reghellin, V; Nonnis, S; Tedeschi, G; Coccetti, P				Nicastro, Raffaele; Tripodi, Farida; Gaggini, Marco; Castoldi, Andrea; Reghellin, Veronica; Nonnis, Simona; Tedeschi, Gabriella; Coccetti, Paola			Snf1 Phosphorylates Adenylate Cyclase and Negatively Regulates Protein Kinase A-dependent Transcription in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE STARVATION; BUDDING YEAST; NUCLEAR-LOCALIZATION; INTERACTION NETWORK; UPSTREAM KINASES; PYRUVATE-KINASE; MIG1 REPRESSOR; CELL-GROWTH; IN-VITRO; SNF1/AMPK	In eukaryotes, nutrient availability and metabolism are coordinated by sensing mechanisms and signaling pathways, which influence a broad set of cellular functions such as transcription and metabolic pathways to match environmental conditions. In yeast, PKA is activated in the presence of high glucose concentrations, favoring fast nutrient utilization, shutting down stress responses, and boosting growth. On the contrary, Snf1/AMPK is activated in the presence of low glucose or alternative carbon sources, thus promoting an energy saving program through transcriptional activation and phosphorylation of metabolic enzymes. The PKA and Snf1/AMPK pathways share common downstream targets. Moreover, PKA has been reported to negatively influence the activation of Snf1/AMPK. We report a new cross-talk mechanism with a Snf1-dependent regulation of the PKA pathway. We show that Snf1 and adenylate cyclase (Cyr1) interact in a nutrient-independent manner. Moreover, we identify Cyr1 as a Snf1 substrate and show that Snf1 activation state influences Cyr1 phosphorylation pattern, cAMP intracellular levels, and PKA-dependent transcription.	[Nicastro, Raffaele; Tripodi, Farida; Gaggini, Marco; Castoldi, Andrea; Reghellin, Veronica; Coccetti, Paola] Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy; [Nicastro, Raffaele; Tripodi, Farida; Gaggini, Marco; Castoldi, Andrea; Reghellin, Veronica; Coccetti, Paola] SYSBIO, Ctr Syst Biol, I-20126 Milan, Italy; [Nonnis, Simona; Tedeschi, Gabriella] Univ Milan, Dipartimento Patol Animale Igiene & Sanita Pubbl, I-20133 Milan, Italy; [Nonnis, Simona; Tedeschi, Gabriella] Filarete Fdn, I-20139 Milan, Italy	University of Milano-Bicocca; University of Milan	Coccetti, P (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, Piazza Sci 2, I-20126 Milan, Italy.	paola.coccetti@unimib.it	Nicastro, Raffaele/T-1078-2019; Nonnis, Simona/I-6198-2017; Coccetti, Paola/Y-2365-2019; Tripodi, Farida/I-3759-2019; Tedeschi, Gabriella/I-6247-2017	Nonnis, Simona/0000-0002-3453-7282; Coccetti, Paola/0000-0001-5898-5883; Tedeschi, Gabriella/0000-0003-2082-6443; Nicastro, Raffaele/0000-0002-5420-2228; Tripodi, Farida/0000-0003-1246-979X	Italian Government; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) of the Italian Roadmap for European Strategy Forum on Research Infrastructures Research Infrastructures; MIUR; SysBioNet	Italian Government; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) of the Italian Roadmap for European Strategy Forum on Research Infrastructures Research Infrastructures; MIUR(Ministry of Education, Universities and Research (MIUR)); SysBioNet	This work was supported by grants from the Italian Government and from the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)-funded SysBioNet project of the Italian Roadmap for European Strategy Forum on Research Infrastructures Research Infrastructures (to P.C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by fellowships from MIUR.; Supported by a fellowship from SysBioNet.	Alberghina L, 2012, BIOTECHNOL ADV, V30, P52, DOI 10.1016/j.biotechadv.2011.07.010; Barrett L, 2012, EUKARYOT CELL, V11, P119, DOI 10.1128/EC.05061-11; Belotti F, 2011, FEBS LETT, V585, P3914, DOI 10.1016/j.febslet.2011.10.032; Braun KA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005000; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Busnelli S, 2013, BBA-MOL CELL RES, V1833, P3254, DOI 10.1016/j.bbamcr.2013.09.014; Busti S, 2010, SENSORS-BASEL, V10, P6195, DOI 10.3390/s100606195; Chandrashekarappa DG, 2013, J BIOL CHEM, V288, P89, DOI 10.1074/jbc.M112.422659; CHERRY JR, 1989, CELL, V56, P409, DOI 10.1016/0092-8674(89)90244-4; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Cytrynska M, 2001, FEMS MICROBIOL LETT, V203, P223, DOI 10.1016/S0378-1097(01)00354-8; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; ESTRUCH F, 1992, GENETICS, V132, P639; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gorner W, 2002, EMBO J, V21, P135, DOI 10.1093/emboj/21.1.135; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hedbacker K, 2004, MOL CELL BIOL, V24, P1836, DOI 10.1128/MCB.24.5.1836-1843.2004; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hong SP, 2007, J BIOL CHEM, V282, P16838, DOI 10.1074/jbc.M700146200; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Petkova MI, 2010, J BIOL CHEM, V285, P19521, DOI 10.1074/jbc.M109.085282; KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lesage P, 1996, MOL CELL BIOL, V16, P1921, DOI 10.1128/mcb.16.5.1921; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Livas D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-405; Ludin K, 1998, P NATL ACAD SCI USA, V95, P6245, DOI 10.1073/pnas.95.11.6245; Ma PS, 1999, MOL BIOL CELL, V10, P91, DOI 10.1091/mbc.10.1.91; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Nicastro R, 2015, BBA-MOL CELL RES, V1853, P1615, DOI 10.1016/j.bbamcr.2015.03.014; Pessina S, 2010, CELL CYCLE, V9, P2189, DOI 10.4161/cc.9.11.11847; Portela P, 2002, J BIOL CHEM, V277, P30477, DOI 10.1074/jbc.M201094200; Portela P, 2006, BIOCHEM J, V396, P117, DOI 10.1042/BJ20051642; RandezGil F, 1997, MOL CELL BIOL, V17, P2502, DOI 10.1128/MCB.17.5.2502; Ratnakumar S, 2009, GENETICS, V182, P735, DOI 10.1534/genetics.109.103432; REIFENBERGER E, 1995, MOL MICROBIOL, V16, P157, DOI 10.1111/j.1365-2958.1995.tb02400.x; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; Tomas-Cobos L, 2002, BIOCHEM J, V368, P657, DOI 10.1042/BJ20020984; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; Tripodi F, 2015, BBA-GEN SUBJECTS, V1850, P620, DOI 10.1016/j.bbagen.2014.12.010; Van de Velde S, 2008, EUKARYOT CELL, V7, P286, DOI 10.1128/EC.00276-07; Vanhalewyn M, 1999, MOL MICROBIOL, V33, P363, DOI 10.1046/j.1365-2958.1999.01479.x; Vincent O, 1998, EMBO J, V17, P7002, DOI 10.1093/emboj/17.23.7002; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; Young ET, 2012, J BIOL CHEM, V287, P29021, DOI 10.1074/jbc.M112.380147; Zaman S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.2	56	32	33	4	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24715	24726		10.1074/jbc.M115.658005	http://dx.doi.org/10.1074/jbc.M115.658005			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26309257	hybrid, Green Published			2022-12-28	WOS:000362598300008
J	Jin, ES; Sherry, AD; Malloy, CR				Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.			Lactate Contributes to Glyceroneogenesis and Glyconeogenesis in Skeletal Muscle by Reversal of Pyruvate Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE; ACID CYCLE; GLYCERIDE-GLYCEROL; GLYCOGEN-SYNTHESIS; ADIPOSE TISSUE; CARBOXYLASE; GLUCOSE; HEART; RAT; INVERTEBRATES	Phosphoenolpyruvate (PEP) generated from pyruvate is required for de novo synthesis of glycerol and glycogen in skeletal muscle. One possible pathway involves synthesis of PEP from the citric acid cycle intermediates via PEP carboxykinase, whereas another could involve reversal of pyruvate kinase (PK). Earlier studies have reported that reverse flux through PK can contribute carbon precursors for glycogen synthesis in muscle, but the physiological importance of this pathway remains uncertain especially in the setting of high plasma glucose. In addition, although PEP is a common intermediate for both glyconeogenesis and glyceroneogenesis, the importance of reverse PK in de novo glycerol synthesis has not been examined. Here we studied the contribution of reverse PK to synthesis of glycogen and the glycerol moiety of acylglycerols in skeletal muscle of animals with high plasma glucose. Rats received a single intraperitoneal bolus of glucose, glycerol, and lactate under a fed or fasted state. Only one of the three substrates was C-13-labeled in each experiment. After 3 h of normal awake activity, the animals were sacrificed, and the contribution from each substrate to glycogen and the glycerol moiety of acylglycerols was evaluated. The fraction of C-13 labeling in glycogen and the glycerol moiety exceeded the possible contribution from either plasma glucose or muscle oxaloacetate. The reverse PK served as a common route for both glyconeogenesis and glyceroneogenesis in the skeletal muscle of rats with high plasma glucose. The activity of pyruvate carboxylase was low in muscle, and no PEP carboxykinase activity was detected.	[Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Jin, Eunsook S.; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Sherry, A. Dean; Malloy, Craig R.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Sherry, A. Dean] Univ Texas Dallas, Dept Chem, Richardson, TX 75080 USA; [Malloy, Craig R.] Vet Affairs North Hlth Care Syst, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Jin, ES (corresponding author), Adv Imaging Res Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eunsook.jin@utsouthwestern.edu	Regan, Clinton/E-6250-2012; Sherry, Dean/P-2348-2018	Sherry, Dean/0000-0001-7150-8301; Malloy, Craig/0000-0001-5077-0642	National Institutes of Health [DK078933, DK099289, DK58398, RR 002584, EB 015908, HL34557]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034557, R37HL034557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK078933, R01DK099289, P01DK058398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK078933 and DK099289 (to E. S. J.), DK58398, RR 002584, and EB 015908 (to C. R. M.), and HL34557 (to A. D. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BALLARD FJ, 1967, J BIOL CHEM, V242, P2746; BONEN A, 1990, American Journal of Physiology, V258, pE693; BRODAL B, 1990, INT J BIOCHEM, V22, P753, DOI 10.1016/0020-711X(90)90011-Q; CONNETT RJ, 1979, AM J PHYSIOL, V237, pC231, DOI 10.1152/ajpcell.1979.237.5.C231; CRABTREE B, 1972, BIOCHEM J, V130, P391, DOI 10.1042/bj1300391; DAVIS EJ, 1980, EUR J BIOCHEM, V110, P255, DOI 10.1111/j.1432-1033.1980.tb04863.x; Dobson GP, 2002, J BIOL CHEM, V277, P27176, DOI 10.1074/jbc.M111422200; DYSON RD, 1975, J BIOL CHEM, V250, P3316; ELIA M, 1993, CLIN SCI, V84, P99, DOI 10.1042/cs0840099; Fairchild TJ, 2003, MED SCI SPORT EXER, V35, P595, DOI 10.1249/01.MSS.0000058436.46584.8E; Guo ZK, 1999, J BIOL CHEM, V274, P23702, DOI 10.1074/jbc.274.34.23702; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Jin ES, 2005, AM J PHYSIOL-ENDOC M, V288, pE654, DOI 10.1152/ajpendo.00365.2004; Jin ES, 2004, ANAL BIOCHEM, V327, P149, DOI 10.1016/j.ab.2003.12.036; Jin ES, 2013, J BIOL CHEM, V288, P14488, DOI 10.1074/jbc.M113.461947; Jin ES, 2013, J BIOL CHEM, V288, P2914, DOI 10.1074/jbc.M112.409441; Jin ES, 2009, AM J PHYSIOL-ENDOC M, V296, pE748, DOI 10.1152/ajpendo.90935.2008; KEECH DB, 1963, J BIOL CHEM, V238, P2609; LANCHA AH, 1994, BIOCHEM MOL BIOL INT, V32, P483; MCLANE JA, 1979, J BIOL CHEM, V254, P6548; MCQUATE JT, 1959, J BIOL CHEM, V234, P2151; Meyerhof O, 1938, BIOCHEM Z, V298, P396; NEWSHOLME EA, 1969, BIOCHEM J, V112, P465, DOI 10.1042/bj1120465; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; RESHEF L, 1969, J BIOL CHEM, V244, P1994; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Tucker R, 2007, EUR J APPL PHYSIOL, V101, P771, DOI 10.1007/s00421-007-0458-z; Watford M, 2000, NUTR REV, V58, P145, DOI 10.1111/j.1753-4887.2000.tb01849.x	28	8	8	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30486	30497		10.1074/jbc.M115.689174	http://dx.doi.org/10.1074/jbc.M115.689174			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26491014	Green Published, hybrid			2022-12-28	WOS:000366738200025
J	Wu, QL; Cao, XO; Yan, D; Wang, DY; Aballay, A				Wu, Qiuli; Cao, Xiou; Yan, Dong; Wang, Dayong; Aballay, Alejandro			Genetic Screen Reveals Link between the Maternal Effect Sterile Gene mes-1 and Pseudomonas aeruginosa-induced Neurodegeneration in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE NEURON DEGENERATION; UNFOLDED PROTEIN RESPONSE; C-ELEGANS; INNATE IMMUNITY; LIFE-SPAN; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; DAF-16; CHEMOTAXIS; ACTIVATION	Increasing evidence indicates that immune responses to microbial infections may contribute to neurodegenerative diseases. Here, we show that Pseudomonas aeruginosa infection of Caenorhabditis elegans causes a number of neural changes that are hallmarks of neurodegeneration. Using an unbiased genetic screen to identify genes involved in the control of P. aeruginosa-induced neurodegeneration, we identified mes-1, which encodes a receptor tyrosine kinase-like protein that is required for unequal cell divisions in the early embryonic germ line. We showed that sterile but not fertile mes-1 animals were resistant to neurodegeneration induced by P. aeruginosa infection. Similar results were observed using animals carrying a mutation in the maternal effect gene pgl-1, which is required for postembryonic germ line development, and the germ line-deficient strains glp-1 and glp-4. Additional studies indicated that the FOXO transcription factor DAF-16 is required for resistance to P. aeruginosa-induced neurodegeneration in germ line-deficient strains. Thus, our results demonstrate that P. aeruginosa infection results in neurodegeneration phenotypes in C. elegans that are controlled by the germ line in a cell-nonautonomous manner.	[Wu, Qiuli; Cao, Xiou; Yan, Dong; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Wu, Qiuli; Wang, Dayong] Southeast Univ, Sch Med, Nanjing 210009, Jiangsu, Peoples R China	Duke University; Southeast University - China	Aballay, A (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	a.aballay@duke.edu	Cao, Xiou/K-4619-2019; Yan, Dong/AAA-6559-2020; Regan, Clinton/E-6250-2012	Yan, Dong/0000-0002-7542-1251; Cao, Xiou/0000-0001-7202-6582	National Institutes of Health [GM070977]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant GM070977. To whom correspondence should be addressed. Tel.: 919-668-1783; Fax: 919-684-2790; E-mail: a.aballay@duke.edu.	Alper S, 2010, J BIOL CHEM, V285, P1822, DOI 10.1074/jbc.M109.057323; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Bargmann C. I., 2006, WORMBOOK; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Benedetto A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001084; Berkowitz LA, 2000, DEVELOPMENT, V127, P4419; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; BRENNER S, 1974, GENETICS, V77, P71; Brody AH, 2013, NEUROTOXICOLOGY, V34, P74, DOI 10.1016/j.neuro.2012.10.007; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Chen L, 2011, NEURON, V70, P51, DOI 10.1016/j.neuron.2011.02.039; Chen P, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00018; Chew Yee Lian, 2013, Commun Integr Biol, V6, pe25288, DOI 10.4161/cib.25288; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Du M, 2009, ENVIRON TOXICOL PHAR, V27, P314, DOI 10.1016/j.etap.2008.11.011; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Hobert O, 2010, WORMBOOK; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Meisel JD, 2014, CELL, V159, P267, DOI 10.1016/j.cell.2014.09.011; Mocko JB, 2010, NEUROBIOL DIS, V40, P120, DOI 10.1016/j.nbd.2010.03.019; Negga R, 2012, NEUROTOX RES, V21, P281, DOI 10.1007/s12640-011-9274-7; O'Meara MM, 2009, GENETICS, V181, P1679, DOI 10.1534/genetics.108.097832; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pan CL, 2011, P NATL ACAD SCI USA, V108, P9274, DOI 10.1073/pnas.1011711108; Peng Chiu-Ying, 2011, Commun Integr Biol, V4, P696; Pepper ASR, 2003, GENETICS, V163, P115; Saeki S, 2001, J EXP BIOL, V204, P1757; Shivers RP, 2008, CURR OPIN MICROBIOL, V11, P251, DOI 10.1016/j.mib.2008.05.014; Singh V, 2006, CELL CYCLE, V5, P2443, DOI 10.4161/cc.5.21.3434; Singh V, 2012, J BIOL CHEM, V287, P33191, DOI 10.1074/jbc.M112.398362; Singh V, 2009, J BIOL CHEM, V284, P35580, DOI 10.1074/jbc.M109.060905; Sinha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101970; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Sun JR, 2012, EMBO REP, V13, P855, DOI 10.1038/embor.2012.100; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; TeKippe M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011777; Toth ML, 2012, J NEUROSCI, V32, P8778, DOI 10.1523/JNEUROSCI.1494-11.2012; VanDuyn N, 2013, J NEUROCHEM, V124, P147, DOI 10.1111/jnc.12072; VanDuyn N, 2010, TOXICOL SCI, V118, P613, DOI 10.1093/toxsci/kfq285; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zheng GH, 2011, ACS CHEM BIOL, V6, P1332, DOI 10.1021/cb200290e	45	19	20	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29231	29239		10.1074/jbc.M115.674259	http://dx.doi.org/10.1074/jbc.M115.674259			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26475858	Green Published, hybrid			2022-12-28	WOS:000366613400010
J	Haapasalo, K; van Kessel, K; Nissila, E; Metso, J; Johansson, T; Miettinen, S; Varjosalo, M; Kirveskari, J; Kuusela, P; Chroni, A; Jauhiainen, M; van Strijp, J; Jokiranta, TS				Haapasalo, Karita; van Kessel, Kok; Nissila, Eija; Metso, Jari; Johansson, Tiira; Miettinen, Sini; Varjosalo, Markku; Kirveskari, Juha; Kuusela, Pentti; Chroni, Angelika; Jauhiainen, Matti; van Strijp, Jos; Jokiranta, T. Sakari			Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein E (ApoE); complement; complement system; high density lipoprotein (HDL); inflammation; factor H	HEMOLYTIC-UREMIC SYNDROME; MACULAR DEGENERATION; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; STREPTOCOCCUS-PYOGENES; ALZHEIMERS-DISEASE; PROTEIN BETA-1H; DEPOSIT DISEASE; HUMAN PLASMA; ASSOCIATION; ACTIVATION	The alternative pathway of complement is an important part of the innate immunity response against foreign particles invading the human body. To avoid damage to host cells, it needs to be efficiently down-regulated by plasma factor H (FH) as exemplified by various diseases caused by mutations in its domains 19-20 (FH19-20) and 5-7 (FH5-7). These regions are also the main interaction sites for microbial pathogens that bind host FH to evade complement attack. We previously showed that inhibition of FH binding by a recombinant FH5-7 construct impairs survival of FH binding pathogens in human blood. In this study we found that upon exposure to full blood, the addition of FH5-7 reduces survival of, surprisingly, also those microbes that are not able to bind FH. This effect was mediated by inhibition of complement regulation and subsequently enhanced neutrophil phagocytosis by FH5-7. We found that although FH5-7 does not reduce complement regulation in the actual fluid phase of plasma, it reduces regulation on HDL particles in plasma. Using affinity chromatography and mass spectrometry we revealed that FH interacts with serum apolipoprotein E (apoE) via FH5-7 domains. Furthermore, binding of FH5-7 to HDL was dependent on the concentration of apoE on the HDL particles. These findings explain why the addition of FH5-7 to plasma leads to excessive complement activation and phagocytosis of microbes in full anticoagulated blood. In conclusion, our data show how FH interacts with apoE molecules via domains 5-7 and regulates alternative pathway activation on plasma HDL particles.	[Haapasalo, Karita; Nissila, Eija; Johansson, Tiira; Jokiranta, T. Sakari] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Haapasalo, Karita; Nissila, Eija; Johansson, Tiira; Jokiranta, T. Sakari] Univ Helsinki, Res Programs Unit, Immunobiol, FIN-00014 Helsinki, Finland; [Haapasalo, Karita; van Kessel, Kok; van Strijp, Jos] Univ Med Ctr Utrecht, Med Microbiol, NL-3584 CX Utrecht, Netherlands; [Metso, Jari; Jauhiainen, Matti] Natl Inst Hlth & Welf, Biomedicum, Dept Mol Med, FI-00290 Helsinki, Finland; [Miettinen, Sini; Varjosalo, Markku] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Kirveskari, Juha; Kuusela, Pentti] Univ Helsinki, Cent Hosp Lab, HUSLAB, FIN-00290 Helsinki, Finland; [Chroni, Angelika] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens 15310, Greece	University of Helsinki; University of Helsinki; Utrecht University; Utrecht University Medical Center; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; National Centre of Scientific Research "Demokritos"	Haapasalo, K (corresponding author), Univ Med Ctr Utrecht, HP G02-628,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	K.J.Haapasalo-Tuomainen@umcutrecht.nl	Nissila, Eija/AEQ-3909-2022; van Strijp, Jos A.G./J-9549-2014; Varjosalo, Markku/K-6424-2015	Nissila, Eija/0000-0002-8089-1266; van Strijp, Jos A.G./0000-0001-6253-0830; Haapasalo, Karita/0000-0002-9619-625X; Varjosalo, Markku/0000-0002-1340-9732; Chroni, Angeliki/0000-0003-3107-1189	Finnish Cultural Foundation [00131060]; Academy of Finland [255922, 259793]; Sigrid Juselius Foundation [ERC 250172]; European Research Council; Center of Excellence in Microbial Food Safety Research (CoE-MiFoSa)	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Research Council(European Research Council (ERC)European Commission); Center of Excellence in Microbial Food Safety Research (CoE-MiFoSa)	This work was supported by Finnish Cultural Foundation Grant 00131060, Academy of Finland Grants 255922 and 259793, Sigrid Juselius Foundation Grant ERC 250172 (Microbes Inside from the European Research Council, the Center of Excellence in Microbial Food Safety Research (CoE-MiFoSa)). The authors declare that they have no conflicts of interest with the contents of this article.	Abrera-Abeleda MA, 2006, J MED GENET, V43, P582, DOI 10.1136/jmg.2005.038315; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Chroni A, 2008, BIOCHEMISTRY-US, V47, P9071, DOI 10.1021/bi800469r; Clark SJ, 2014, J IMMUNOL, V193, P4962, DOI 10.4049/jimmunol.1401613; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Giannakis E, 2003, EUR J IMMUNOL, V33, P962, DOI 10.1002/eji.200323541; Haapasalo K, 2012, J IMMUNOL, V188, P426, DOI 10.4049/jimmunol.1102545; Haapasalo K, 2008, MOL MICROBIOL, V70, P583, DOI 10.1111/j.1365-2958.2008.06347.x; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Johnson LV, 2011, P NATL ACAD SCI USA, V108, P18277, DOI 10.1073/pnas.1109703108; Jokiranta TS, 1999, J IMMUNOL, V163, P4590; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Li XP, 2003, BIOCHEMISTRY-US, V42, P10406, DOI 10.1021/bi027093c; MERI S, 1992, J EXP MED, V175, P939, DOI 10.1084/jem.175.4.939; Meri T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003308; Morrow JA, 1999, PROTEIN EXPRES PURIF, V16, P224, DOI 10.1006/prep.1999.1069; PACKMAN CH, 1985, BIOCHIM BIOPHYS ACTA, V812, P107, DOI 10.1016/0005-2736(85)90527-9; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; Pangburn MK, 2002, J IMMUNOL, V169, P4702, DOI 10.4049/jimmunol.169.9.4702; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; RALL SC, 1986, METHOD ENZYMOL, V128, P273; Ramadass M, 2014, J IMMUNOL, V192, P1220, DOI 10.4049/jimmunol.1302288; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; SALACINSKI PRP, 1981, ANAL BIOCHEM, V117, P136, DOI 10.1016/0003-2697(81)90703-X; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Sethi S, 2009, KIDNEY INT, V75, P952, DOI 10.1038/ki.2008.657; Siggins S, 2003, J LIPID RES, V44, P1698, DOI 10.1194/jlr.M300059-JLR200; Surewaard BGJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002606; Troelstra A, 1997, J LEUKOCYTE BIOL, V61, P173, DOI 10.1002/jlb.61.2.173; VAKEVA A, 1994, IMMUNOLOGY, V82, P28; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; Yu JM, 2007, BIOCHEMISTRY-US, V46, P8451, DOI 10.1021/bi700459a; Zetterberg M, 2008, AM J MED GENET B, V147B, P720, DOI 10.1002/ajmg.b.30668	38	23	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28977	28987		10.1074/jbc.M115.669226	http://dx.doi.org/10.1074/jbc.M115.669226			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26468283	Green Published, hybrid			2022-12-28	WOS:000365762300036
J	Kurasin, M; Kuusk, S; Kuusk, P; Sorlie, M; Valjamae, P				Kurasin, Mihhail; Kuusk, Silja; Kuusk, Piret; Sorlie, Morten; Vaeljamaee, Priit			Slow Off-rates and Strong Product Binding Are Required for Processivity and Efficient Degradation of Recalcitrant Chitin by Family 18 Chitinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellobiohydrolase; cellulose; chitin; chitinase; processivity; off-rate; product binding	TRICHODERMA-REESEI CELLOBIOHYDROLASE; LYTIC POLYSACCHARIDE MONOOXYGENASE; MODELING ENZYMATIC-HYDROLYSIS; SERRATIA-MARCESCENS; THERMOBIFIDA-FUSCA; CELLULOSE HYDROLYSIS; THERMOMONOSPORA-FUSCA; CRYSTALLINE CELLULOSE; MICROCRYSTALLINE CELLULOSE; CEL7A CELLOBIOHYDROLASES	Processive glycoside hydrolases are the key components of enzymatic machineries that decompose recalcitrant polysaccharides, such as chitin and cellulose. The intrinsic processivity (P-Intr) of cellulases has been shown to be governed by the rate constant of dissociation from polymer chain (k(off)). However, the reported k(off) values of cellulases are strongly dependent on the method used for their measurement. Here, we developed a new method for determining k(off), based on measuring the exchange rate of the enzyme between a non-labeled and a C-14-labeled polymeric substrate. The method was applied to the study of the processive chitinase ChiA from Serratia marcescens. In parallel, ChiA variants with weaker binding of the N-acetylglucosamine unit either in substrate-binding site -3 (ChiA-W167A) or the product-binding site +1 (ChiA-W275A) were studied. Both ChiA variants showed increased off-rates and lower apparent processivity on -chitin. The rate of the production of insoluble reducing groups on the reduced -chitin was an order of magnitude higher than k(off), suggesting that the enzyme can initiate several processive runs without leaving the substrate. On crystalline chitin, the general activity of the wild type enzyme was higher, and the difference was magnifying with hydrolysis time. On amorphous chitin, the variants clearly outperformed the wild type. A model is proposed whereby strong interactions with polymer in the substrate-binding sites (low off-rates) and strong binding of the product in the product-binding sites (high pushing potential) are required for the removal of obstacles, like disintegration of chitin microfibrils.	[Kurasin, Mihhail; Kuusk, Silja; Vaeljamaee, Priit] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Kuusk, Piret] Univ Tartu, Inst Phys, EE-51010 Tartu, Estonia; [Sorlie, Morten] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	University of Tartu; University of Tartu; University of Tartu Institute of Physics; Norwegian University of Life Sciences	Valjamae, P (corresponding author), Riia 23b-202, EE-51010 Tartu, Estonia.	priit.valjamae@ut.ee	Väljamäe, Priit/O-6468-2018	Väljamäe, Priit/0000-0002-1035-9493	Norwegian Financial Mechanism Grant [EMP171]; Danish Agency for Science, Technology, and Innovation; Programme Commission on Sustainable Energy and Environment [2104-07-0028]; Estonian Science Foundation [9227]	Norwegian Financial Mechanism Grant; Danish Agency for Science, Technology, and Innovation; Programme Commission on Sustainable Energy and Environment; Estonian Science Foundation	This work was supported by Norwegian Financial Mechanism Grant EMP171, Danish Agency for Science, Technology, and Innovation, Programme Commission on Sustainable Energy and Environment Grant 2104-07-0028, and Estonian Science Foundation Grant 9227. The authors declare that they have no conflict of interests with the contents of this article.	Aronson NN, 2003, BIOCHEM J, V376, P87, DOI 10.1042/bj20030273; Bansal P, 2009, BIOTECHNOL ADV, V27, P833, DOI 10.1016/j.biotechadv.2009.06.005; Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Breyer WA, 2001, PROTEIN SCI, V10, P1699, DOI 10.1110/ps.10301; BRURBERG MB, 1994, FEMS MICROBIOL LETT, V124, P399, DOI 10.1016/0378-1097(94)00462-5; CHANZY H, 1983, FEBS LETT, V153, P113, DOI 10.1016/0014-5793(83)80129-X; Colussi F, 2015, J BIOL CHEM, V290, P2444, DOI 10.1074/jbc.M114.624163; Cruys-Bagger N, 2013, BIOCHEMISTRY-US, V52, P8938, DOI 10.1021/bi401210n; Cruys-Bagger N, 2013, FEBS J, V280, P3952, DOI 10.1111/febs.12397; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Eriksson T, 2002, APPL BIOCHEM BIOTECH, V101, P41, DOI 10.1385/ABAB:101:1:41; Hamre AG, 2015, FEBS LETT, V589, P1807, DOI 10.1016/j.febslet.2015.05.034; Hamre AG, 2014, FEBS LETT, V588, P4620, DOI 10.1016/j.febslet.2014.10.034; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Horn SJ, 2004, CARBOHYD POLYM, V56, P35, DOI 10.1016/j.carbpol.2003.11.011; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Horn SJ, 2012, METHOD ENZYMOL, V510, P69, DOI 10.1016/B978-0-12-415931-0.00005-7; Igarashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4975; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Imai T, 1998, FEBS LETT, V432, P113, DOI 10.1016/S0014-5793(98)00845-X; Jalak J, 2012, J BIOL CHEM, V287, P28802, DOI 10.1074/jbc.M112.381624; Jalak J, 2010, BIOTECHNOL BIOENG, V106, P871, DOI 10.1002/bit.22779; Jeoh T, 2013, CARBOHYD POLYM, V97, P581, DOI 10.1016/j.carbpol.2013.05.027; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; Jung J, 2013, J BIOL CHEM, V288, P24164, DOI 10.1074/jbc.M113.455758; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Kostylev M, 2014, BIOTECHNOL BIOENG, V111, P664, DOI 10.1002/bit.25139; Kostylev M, 2014, APPL ENVIRON MICROB, V80, P339, DOI 10.1128/AEM.02706-13; Kostylev M, 2013, BIOCHEMISTRY-US, V52, P5656, DOI 10.1021/bi400358v; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Kuttiyawong K, 2008, CARBOHYD RES, V343, P2754, DOI 10.1016/j.carres.2008.05.020; Kuusk S, 2015, J BIOL CHEM, V290, P11678, DOI 10.1074/jbc.M114.635631; Li YC, 2007, APPL ENVIRON MICROB, V73, P3165, DOI 10.1128/AEM.02960-06; Luterbacher JS, 2015, BIOTECHNOL BIOENG, V112, P21, DOI 10.1002/bit.25329; Luterbacher JS, 2015, BIOTECHNOL BIOENG, V112, P32, DOI 10.1002/bit.25328; Luterbacher JS, 2013, BIOTECHNOL BIOENG, V110, P108, DOI 10.1002/bit.24597; Medve J, 1998, BIOTECHNOL BIOENG, V59, P621, DOI 10.1002/(SICI)1097-0290(19980905)59:5&lt;621::AID-BIT13&gt;3.0.CO;2-C; Moran-Mirabal JM, 2013, BIOTECHNOL BIOENG, V110, P47, DOI 10.1002/bit.24604; Moran-Mirabal JM, 2011, BIOPHYS CHEM, V155, P20, DOI 10.1016/j.bpc.2011.02.003; Nakagawa YS, 2015, FEBS J, V282, P1065, DOI 10.1111/febs.13203; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; Norberg AL, 2011, FEBS LETT, V585, P2339, DOI 10.1016/j.febslet.2011.06.002; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Praestgaard E, 2011, FEBS J, V278, P1547, DOI 10.1111/j.1742-4658.2011.08078.x; ReverbelLeroy C, 1997, J BACTERIOL, V179, P46, DOI 10.1128/jb.179.1.46-52.1997; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Santa-Maria M, 2010, BIOMACROMOLECULES, V11, P2000, DOI 10.1021/bm100366h; Shang BZ, 2014, ACS CATAL, V4, P2216, DOI 10.1021/cs500126q; Shang BZ, 2013, J BIOL CHEM, V288, P29081, DOI 10.1074/jbc.M113.497412; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; Shu ZY, 2014, BIOCHEMISTRY-US, V53, P7650, DOI 10.1021/bi501059n; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; Sorensen TH, 2015, J BIOL CHEM, V290, P22193, DOI 10.1074/jbc.M115.658930; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; Valjamae P, 1998, EUR J BIOCHEM, V253, P469, DOI 10.1046/j.1432-1327.1998.2530469.x; Valjamae P, 1999, EUR J BIOCHEM, V266, P327, DOI 10.1046/j.1432-1327.1999.00853.x; Velleste R, 2010, CELLULOSE, V17, P125, DOI 10.1007/s10570-009-9356-3; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; WALKER LP, 1990, ENZYME MICROB TECH, V12, P378, DOI 10.1016/0141-0229(90)90168-P; WALKER LP, 1992, BIOTECHNOL BIOENG, V40, P1019, DOI 10.1002/bit.260400905; WHITE AR, 1981, P NATL ACAD SCI-BIOL, V78, P1047, DOI 10.1073/pnas.78.2.1047; Wilson David B, 2012, Methods Mol Biol, V908, P93, DOI 10.1007/978-1-61779-956-3_9; WOODWARD J, 1992, ENZYME MICROB TECH, V14, P625, DOI 10.1016/0141-0229(92)90037-O; Zakariassen H, 2010, CARBOHYD POLYM, V82, P779, DOI 10.1016/j.carbpol.2010.05.051; Zakariassen H, 2010, CARBOHYD POLYM, V81, P14, DOI 10.1016/j.carbpol.2010.01.048; Zakariassen H, 2009, J BIOL CHEM, V284, P10610, DOI 10.1074/jbc.M900092200; Zhang S, 2000, EUR J BIOCHEM, V267, P3101, DOI 10.1046/j.1432-1327.2000.01315.x	78	28	28	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29074	29085		10.1074/jbc.M115.684977	http://dx.doi.org/10.1074/jbc.M115.684977			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26468285	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000365762300045
J	Prade, E; Bittner, HJ; Sarkar, R; del Amo, JML; Althoff-Ospelt, G; Multhaup, G; Hildebrand, PW; Reif, B				Prade, Elke; Bittner, Heiko J.; Sarkar, Riddhiman; Lopez del Amo, Juan Miguel; Althoff-Ospelt, Gerhard; Multhaup, Gerd; Hildebrand, Peter W.; Reif, Bernd			Structural Mechanism of the Interaction of Alzheimer Disease A beta Fibrils with the Non-steroidal Anti-inflammatory Drug (NSAID) Sulindac Sulfide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid; drug design; protein structure; solid-state NMR; magic angle spinning; ligand interactions	AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE MODULATORS; MOLECULAR-STRUCTURE; EXPERIMENTAL CONSTRAINTS; TRANSMEMBRANE DOMAIN; COMMON MECHANISM; PEPTIDE; RESONANCE; MODEL; OLIGOMERIZATION	Alzheimer disease is the most severe neurodegenerative disease worldwide. In the past years, a plethora of small molecules interfering with amyloid- (A) aggregation has been reported. However, their mode of interaction with amyloid fibers is not understood. Non-steroidal anti-inflammatory drugs (NSAIDs) are known -secretase modulators; they influence A populations. It has been suggested that NSAIDs are pleiotrophic and can interact with more than one pathomechanism. Here we present a magic angle spinning solid-state NMR study demonstrating that the NSAID sulindac sulfide interacts specifically with Alzheimer disease A fibrils. We find that sulindac sulfide does not induce drastic architectural changes in the fibrillar structure but intercalates between the two -strands of the amyloid fibril and binds to hydrophobic cavities, which are found consistently in all analyzed structures. The characteristic Asp(23)-Lys(28) salt bridge is not affected upon interacting with sulindac sulfide. The primary binding site is located in the vicinity of residue Gly(33), a residue involved in Met(35) oxidation. The results presented here will assist the search for pharmacologically active molecules that can potentially be employed as lead structures to guide the design of small molecules for the treatment of Alzheimer disease.	[Prade, Elke; Sarkar, Riddhiman; Reif, Bernd] Tech Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci, D-85747 Garching, Germany; [Bittner, Heiko J.; Hildebrand, Peter W.] Univ Med Berlin, Inst Med Phys & Biophys, Mol Modeling, D-10117 Berlin, Germany; [Lopez del Amo, Juan Miguel] CIC Energigune, Minano 01510, Alava, Spain; [Althoff-Ospelt, Gerhard] Bruker BioSpin, D-76287 Rheinstetten, Germany; [Multhaup, Gerd] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Reif, Bernd] Deutsch Forschungszentrum Gesundheit & Umwelt, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany	Technical University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; CIC Energigune; Bruker Corporation; Bruker BioSpin GmbH; McGill University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Reif, B (corresponding author), Tech Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci, Lichtenbergstr 4, D-85747 Garching, Germany.	reif@tum.de	del Amo, Juan Miguel Lopez/I-9392-2012	del Amo, Juan Miguel Lopez/0000-0002-2315-5414; Reif, Bernd/0000-0001-7368-7198; Sarkar, Riddhiman/0000-0001-9055-7897	German Research Foundation [SFB-1035, SFB740]; Norddeutscher Verbund fur Hoch- und Hochstleistungsrechner [bec00085]	German Research Foundation(German Research Foundation (DFG)); Norddeutscher Verbund fur Hoch- und Hochstleistungsrechner	This work was performed in the framework of SFB-1035/Project-B07 and SFB740/Project-B6 (German Research Foundation). The computer time necessary for calculation of docking experiments was provided by Norddeutscher Verbund fur Hoch- und Hochstleistungsrechner Project bec00085.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; [Anonymous], 2014, SCHROD REL 2014 1 MA; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Barrett PJ, 2011, BIOCHEMISTRY-US, V50, P10328, DOI 10.1021/bi201371j; Beel AJ, 2009, BIOCHEMISTRY-US, V48, P11837, DOI 10.1021/bi901839d; Ben Khalifa N, 2010, CELL ADHES MIGR, V4, P268, DOI 10.4161/cam.4.2.11476; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; BLOEMBERGEN N, 1949, PHYSICA, V15, P386, DOI 10.1016/0031-8914(49)90114-7; Botev A, 2011, BIOCHEMISTRY-US, V50, P828, DOI 10.1021/bi1014002; Brunelle P, 2002, J ALZHEIMERS DIS, V4, P283, DOI 10.3233/JAD-2002-4403; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Castellani F, 2003, BIOCHEMISTRY-US, V42, P11476, DOI 10.1021/bi034903r; Chen W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4037; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Choi JS, 2010, P NATL ACAD SCI USA, V107, P21990, DOI 10.1073/pnas.1006091107; Coan KED, 2008, J AM CHEM SOC, V130, P9606, DOI 10.1021/ja802977h; Dasari M, 2011, CHEMBIOCHEM, V12, P407, DOI 10.1002/cbic.201000602; Delaunay B, 1934, B ACAD SCI URSS, V6, P793; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Goede A, 1997, J COMPUT CHEM, V18, P1113, DOI 10.1002/(SICI)1096-987X(19970715)18:9<1113::AID-JCC1>3.0.CO;2-U; GULLION T, 1989, J MAGN RESON, V81, P196, DOI 10.1016/0022-2364(89)90280-1; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; HAGERMAN AE, 1981, J BIOL CHEM, V256, P4494; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; HING AW, 1993, J MAGN RESON SER A, V103, P151, DOI 10.1006/jmra.1993.1146; HING AW, 1992, J MAGN RESON, V96, P205, DOI 10.1016/0022-2364(92)90305-Q; Hirohata M, 2005, NEUROPHARMACOLOGY, V49, P1088, DOI 10.1016/j.neuropharm.2005.07.004; Hou LM, 2002, J BIOL CHEM, V277, P40173, DOI 10.1074/jbc.C200338200; Husch J, 2011, EUR J PHARM SCI, V44, P103, DOI 10.1016/j.ejps.2011.06.010; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Jaroniec CP, 2002, J AM CHEM SOC, V124, P10728, DOI 10.1021/ja026385y; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kanski J, 2002, BBA-MOL BASIS DIS, V1586, P190, DOI 10.1016/S0925-4439(01)00097-7; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lichtenberger LM, 2012, BBA-MOL CELL BIOL L, V1821, P994, DOI 10.1016/j.bbalip.2012.04.002; Lopez del Amo JM, 2012, J MOL BIOL, V421, P517, DOI 10.1016/j.jmb.2012.01.013; Lopez del Amo JM, 2012, ANGEW CHEM INT EDIT, V51, P6136, DOI 10.1002/anie.201200965; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Masuda Y, 2011, BIOORGAN MED CHEM, V19, P5967, DOI 10.1016/j.bmc.2011.08.052; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Mithu VS, 2014, J BIOL CHEM, V289, P11122, DOI 10.1074/jbc.M113.519447; Moreno MM, 2009, BBA-BIOMEMBRANES, V1788, P1296, DOI 10.1016/j.bbamem.2009.01.016; Nadezhdin KD, 2012, FEBS LETT, V586, P1687, DOI 10.1016/j.febslet.2012.04.062; Niu Z, 2014, ANGEW CHEM INT EDIT, V53, P9294, DOI 10.1002/anie.201311106; Olsson F, 2014, J BIOL CHEM, V289, P1540, DOI 10.1074/jbc.M113.498246; Ono K, 2012, J BIOL CHEM, V287, P14631, DOI 10.1074/jbc.M111.325456; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Prade E, 2014, NEW DEV NMR, V3, P533; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; Ramamoorthy A, 2013, BIOPHYS J, V105, P287, DOI 10.1016/j.bpj.2013.05.004; Rauk A, 2000, J AM CHEM SOC, V122, P9761, DOI 10.1021/ja994436u; Rauk A., 2000, J AM CHEM SOC, V122, P4185, DOI DOI 10.1021/JA9939688; Rezaei-Ghaleh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020289; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Rother K, 2009, NUCLEIC ACIDS RES, V37, pD393, DOI 10.1093/nar/gkn769; Sato M, 2013, J BIOL CHEM, V288, P23212, DOI 10.1074/jbc.M113.464222; Schutz AK, 2011, ANGEW CHEM INT EDIT, V50, P5956, DOI 10.1002/anie.201008276; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tsai J, 2002, BIOINFORMATICS, V18, P985, DOI 10.1093/bioinformatics/18.7.985; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; Wanngren J, 2012, J BIOL CHEM, V287, P32640, DOI 10.1074/jbc.M112.376541; Weggen S, 2003, J BIOL CHEM, V278, P31831, DOI 10.1074/jbc.M303592200; Yesuvadian R, 2014, BIOCHEM BIOPH RES CO, V447, P590, DOI 10.1016/j.bbrc.2014.04.041; Yoo SI, 2011, ANGEW CHEM INT EDIT, V50, P5110, DOI 10.1002/anie.201007824; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F	83	21	22	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28737	28745		10.1074/jbc.M115.675215	http://dx.doi.org/10.1074/jbc.M115.675215			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26416887	Green Published, hybrid			2022-12-28	WOS:000365762300017
J	Gjaltema, RAF; de Rond, S; Rots, MG; Bank, RA				Gjaltema, Rutger A. F.; de Rond, Saskia; Rots, Marianne G.; Bank, Ruud A.			Procollagen Lysyl Hydroxylase 2 Expression Is Regulated by an Alternative Downstream Transforming Growth Factor beta-1 Activation Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDINOLINE CROSS-LINKS; HISTONE DEACETYLASE 2; TGF-BETA; MOLECULAR-MECHANISMS; GENE-TRANSCRIPTION; EPIGENETIC MODIFICATIONS; KIDNEY FIBROSIS; SKIN FIBROSIS; CHROMATIN; METHYLATION	PLOD2 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2) hydroxylates lysine residues in collagen telopeptides and is essential for collagen pyridinoline cross-link formation. PLOD2 expression and subsequent pyridinoline cross-links are increased in fibrotic pathologies by transforming growth factor beta-1 (TGF beta 1). In this report we examined the molecular processes underlying TGF beta 1-induced PLOD2 expression. We found that binding of the TGF beta 1 pathway related transcription factors SMAD:3 and SP1-mediated TGF beta 1 enhanced PLOD2 expression and could be correlated to an increase of acetylated histone H3 and H4 at the PLOD2 promoter. Interestingly, the classical co-activators of SMAD3 complexes, p300 and CBP, were not responsible for the enhanced H3 and H4 acetylation. Depletion of SMAD3 reduced PLOD2 acetylated H3 and H4, indicating that another as of yet unidentified histone acetyltransferase binds to SMAD 3 at PLOD2. Assessing histone methylation marks at the PLOD2 promoter depicted an increase of the active histone mark H3K79me2, a decrease of the repressive H4K2Ome3 mark, but no role for the generally strong transcription-related modifications: H3K4me3, H3K9me3 and H3K27me3. Collectively, our findings reveal that TGF beta 1 induces a SP1- and SMAD3-dependent recruitment of histone modifying enzymes to the PLOD2 promoter other than the currently known TGF beta 1 downstream co-activators and epigenetic modifications. This also suggests that additional activation strategies are used downstream of the TGF beta 1 pathway, and hence their unraveling could be of great importance to fully understand TGF beta 1 activation of genes.	[Gjaltema, Rutger A. F.; de Rond, Saskia; Bank, Ruud A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, MATRIX Res Grp, NL-9713 GZ Groningen, Netherlands; [Gjaltema, Rutger A. F.; Rots, Marianne G.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Epigenet Editing Res Grp, NL-9713 GZ Groningen, Netherlands	University of Groningen; University of Groningen	Bank, RA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Hanzepl 1 EA11, NL-9713 GZ Groningen, Netherlands.	r.a.bank@umcg.nl			Netherlands Institute for Regenerative Medicine (NIRM) [FES0908]; NWO/VIDI [91786373]	Netherlands Institute for Regenerative Medicine (NIRM); NWO/VIDI(Netherlands Organization for Scientific Research (NWO))	This work was supported by Netherlands Institute for Regenerative Medicine (NIRM) Grant FES0908 (to R. A. B.) and NWO/VIDI 91786373 (to M. G. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Balestrini JL, 2012, INTEGR BIOL-UK, V4, P410, DOI 10.1039/c2ib00149g; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blanco MA, 2012, CELL RES, V22, P1339, DOI 10.1038/cr.2012.89; Bozoky B, 2013, INT J CANCER, V133, P286, DOI 10.1002/ijc.28035; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Brinckmann J, 1999, J INVEST DERMATOL, V113, P617, DOI 10.1046/j.1523-1747.1999.00735.x; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Choi JK, 2009, BIOCHEM CELL BIOL, V87, P139, DOI 10.1139/O08-112; Coward WR, 2014, FASEB J, V28, P3183, DOI 10.1096/fj.13-241760; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dong SM, 2005, J NEUROPATH EXP NEUR, V64, P948, DOI 10.1097/01.jnen.0000186940.14779.90; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Evertts AG, 2013, MOL BIOL CELL, V24, P3025, DOI 10.1091/mbc.E12-07-0529; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Ghosh AK, 2007, J CELL PHYSIOL, V213, P663, DOI 10.1002/jcp.21162; Goding CR, 2014, NAT REV CANCER, V14, P568, DOI 10.1038/nrc3781; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Henry RA, 2015, ACS CHEM BIOL, V10, P146, DOI 10.1021/cb500726b; Ihn H, 2006, RHEUMATOLOGY, V45, P157, DOI 10.1093/rheumatology/kei124; Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091; Jacinto FV, 2009, ONCOGENE, V28, P4212, DOI 10.1038/onc.2009.267; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Ko YA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r108; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Liu C, 2014, J BIOL CHEM, V289, P7082, DOI 10.1074/jbc.M113.543769; Mia MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091559; MORIGUCHI T, 1979, J INVEST DERMATOL, V72, P143, DOI 10.1111/1523-1747.ep12530609; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Namazi MR, 2011, INT J DERMATOL, V50, P85, DOI 10.1111/j.1365-4632.2010.04678.x; Noda T, 2012, LIVER INT, V32, P110, DOI 10.1111/j.1478-3231.2011.02619.x; O'Connor EJF, 2012, J INVEST DERMATOL, V132, P1293, DOI 10.1038/jid.2011.432; Perugorria MJ, 2012, HEPATOLOGY, V56, P1129, DOI 10.1002/hep.25754; Qin HX, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-73; Qiu P, 2006, BIOCHEM BIOPH RES CO, V348, P351, DOI 10.1016/j.bbrc.2006.07.009; Rajkumar T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-80; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; REISER K, 1992, FASEB J, V6, P2439, DOI 10.1096/fasebj.6.7.1348714; Remst DFG, 2013, OSTEOARTHR CARTILAGE, V21, P157, DOI 10.1016/j.joca.2012.10.002; Remst DFG, 2014, CELL TISSUE RES, V355, P163, DOI 10.1007/s00441-013-1740-5; RICARDBLUM S, 1993, CELL MOL BIOL, V39, P723; Ryu JK, 2013, ASIAN J ANDROL, V15, P640, DOI 10.1038/aja.2013.61; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sheen-Chen SM, 2014, J GASTROENTEROL, V49, P1285, DOI 10.1007/s00535-013-0892-0; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Sun GD, 2010, J AM SOC NEPHROL, V21, P2069, DOI 10.1681/ASN.2010060633; Takaluoma K, 2007, MATRIX BIOL, V26, P396, DOI 10.1016/j.matbio.2007.01.002; Tampe B, 2014, J AM SOC NEPHROL, V25, P905, DOI 10.1681/ASN.2013070723; Tee WW, 2014, DEVELOPMENT, V141, P2376, DOI 10.1242/dev.096982; van der Slot AJ, 2005, BBA-MOL BASIS DIS, V1741, P95, DOI 10.1016/j.bbadis.2004.09.009; van der Slot AJ, 2004, MATRIX BIOL, V23, P251, DOI 10.1016/j.matbio.2004.06.001; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; van der Slot-Verhoeven AJ, 2005, BBA-MOL BASIS DIS, V1740, P60, DOI 10.1016/j.bbadis.2005.02.007; Veloso A, 2014, GENOME RES, V24, P896, DOI 10.1101/gr.171405.113; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Watson CJ, 2014, HUM MOL GENET, V23, P2176, DOI 10.1093/hmg/ddt614; Wiegand C, 2013, WOUND REPAIR REGEN, V21, P793, DOI 10.1111/wrr.12111; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI [10.1042/bse0520113, 10.1042/BSE0520113]; Yuan H, 2013, AM J PHYSIOL-RENAL, V304, pF601, DOI 10.1152/ajprenal.00523.2012; Zhang W, 2000, J BIOL CHEM, V275, P39237, DOI 10.1074/jbc.M003339200	66	40	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28465	28476		10.1074/jbc.M114.634311	http://dx.doi.org/10.1074/jbc.M114.634311			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26432637	Green Published, hybrid			2022-12-28	WOS:000365761900040
J	Sunita, S; Schwartz, SL; Conn, GL				Sunita, S.; Schwartz, Samantha L.; Conn, Graeme L.			The Regulatory and Kinase Domains but Not the Interdomain Linker Determine Human Double-stranded RNA-activated Kinase (PKR) Sensitivity to Inhibition by Viral Non-coding RNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; RANDOM MUTAGENESIS LIBRARIES; MEGAPRIMER PCR; DIMERIZATION; VIRUS; REVEALS; BINDING; PHOSPHORYLATION; MECHANISM; PURIFICATION	Double-stranded RNA (dsRNA)-activated protein kinase (PKR) is an important component of the innate immune system that presents a crucial first line of defense against viral infection. PKR has a modular architecture comprising a regulatory N-terminal dsRNA binding domain and a C-terminal kinase domain interposed by an unstructured similar to 80-residue interdomain linker (IDL). Guided by sequence alignment, we created IDL deletions in human PKR (hPKR) and regulatory/kinase domain swap human-rat chimeric PKRs to assess the contributions of each domain and the IDL to regulation of the kinase activity by RNA. Using circular dichroism spectroscopy, limited proteolysis, kinase assays, and isothermal titration calorimetry, we show that each PKR protein is properly folded with similar domain boundaries and that each exhibits comparable polyinosinic-cytidylic (poly(rI:rC)) dsRNA activation profiles and binding affinities for adenoviral virus-associated RNA I (VA RNA(I)) and HIV-1 trans-activation response (TAR) RNA. From these results we conclude that the IDL of PKR is not required for RNA binding or mediating changes in protein conformation or domain interactions necessary for PKR regulation by RNA. In contrast, inhibition of rat PKR by VA RNAI and TAR RNA was found to be weaker than for hPKR by 7- and > 300-fold, respectively, and each human-rat chimeric domain-swapped protein showed intermediate levels of inhibition. These findings indicate that PKR sequence or structural elements in the kinase domain, present in hPKR but absent in rat PKR, are exploited by viral non-coding RNAs to accomplish efficient inhibition of PKR.	[Sunita, S.; Schwartz, Samantha L.; Conn, Graeme L.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Conn, GL (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	gconn@emory.edu		Conn, Graeme/0000-0002-2419-380X; subramanian, sunita/0000-0002-0858-9193; Schwartz, Samantha/0000-0002-3378-0184	National Science Foundation Major Research Instrumentation Program (MRI) program [104177]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097803] Funding Source: NIH RePORTER	National Science Foundation Major Research Instrumentation Program (MRI) program(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to our colleagues in the Conn laboratory and members of Dr. Christine Dunham is group fir many useful discussions during this work and preparation of the manuscript. The Auto-iTC<INF>200</INF> instrument was purchased with support from the National Science Foundation Major Research Instrumentation Program (MRI) program (Grant 104177), the Winship Cancer Institute's shared resource program, and the Biochemistry Department of Emory University.	Anderson E, 2008, BIOCHEMISTRY-US, V47, P4887, DOI 10.1021/bi702211j; CLARKE PA, 1991, NUCLEIC ACIDS RES, V19, P243, DOI 10.1093/nar/19.2.243; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dauber B, 2009, VIRUSES-BASEL, V1, P523, DOI 10.3390/v1030523; de la Cruz-Herrera CF, 2014, J BIOL CHEM, V289, P26357, DOI 10.1074/jbc.M114.560961; Dey M, 2014, J BIOL CHEM, V289, P5747, DOI 10.1074/jbc.M113.527796; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Elde NC, 2009, NATURE, V457, P485, DOI 10.1038/nature07529; Gabel F, 2006, J MOL BIOL, V359, P610, DOI 10.1016/j.jmb.2006.03.049; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871; Gokhale RS, 1999, SCIENCE, V284, P482, DOI 10.1126/science.284.5413.482; Gurevich VV, 1996, METHOD ENZYMOL, V275, P382; Heinicke LA, 2009, J MOL BIOL, V390, P319, DOI 10.1016/j.jmb.2009.05.005; Ikebe M, 1998, J BIOL CHEM, V273, P17702, DOI 10.1074/jbc.273.28.17702; KOSTURA M, 1989, MOL CELL BIOL, V9, P1576, DOI 10.1128/MCB.9.4.1576; LaFevre-Bernt M, 1998, J BIOL CHEM, V273, P32129, DOI 10.1074/jbc.273.48.32129; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; LANGLAND JO, 1992, J BIOL CHEM, V267, P10729; Launer-Felty K, 2015, BIOPHYS J, V108, P748, DOI 10.1016/j.bpj.2014.12.014; Lee K, 2011, RNA, V17, P1076, DOI 10.1261/rna.2701111; Lee Yong Sun, 2015, Genomics & Informatics, V13, P26, DOI 10.5808/GI.2015.13.2.26; Lemaire PA, 2005, J MOL BIOL, V345, P81, DOI 10.1016/j.jmb.2004.10.031; Lemaire PA, 2006, BIOCHEMISTRY-US, V45, P9074, DOI 10.1021/bi060567d; Linpinsel Jo L, 2012, Methods Mol Biol, V941, P43, DOI 10.1007/978-1-62703-113-4_4; Ma YL, 1996, J VIROL, V70, P5083, DOI 10.1128/JVI.70.8.5083-5099.1996; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; McKenna SA, 2007, J BIOL CHEM, V282, P11474, DOI 10.1074/jbc.M700301200; Miyazaki K, 2002, BIOTECHNIQUES, V33, P1033, DOI 10.2144/02335st03; Miyazaki K, 2011, METHOD ENZYMOL, V498, P399, DOI 10.1016/B978-0-12-385120-8.00017-6; Nanduri S, 1998, EMBO J, V17, P5458, DOI 10.1093/emboj/17.18.5458; PATEL RC, 1995, P NATL ACAD SCI USA, V92, P8283, DOI 10.1073/pnas.92.18.8283; Peery T, 1997, METHODS, V11, P371, DOI 10.1006/meth.1996.0435; Robertson HD, 1996, BIOCHIMIE, V78, P909, DOI 10.1016/S0300-9084(97)86712-0; ROY S, 1991, J VIROL, V65, P632, DOI 10.1128/JVI.65.2.632-640.1991; SHARP TV, 1993, NUCLEIC ACIDS RES, V21, P4483, DOI 10.1093/nar/21.19.4483; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Ung TL, 2001, EMBO J, V20, P3728, DOI 10.1093/emboj/20.14.3728; Vachon VK, 2016, VIRUS RES, V212, P39, DOI 10.1016/j.virusres.2015.06.018; VanOudenhove J, 2009, J MOL BIOL, V387, P910, DOI 10.1016/j.jmb.2009.02.019; Vattem KM, 2001, EUR J BIOCHEM, V268, P3674, DOI 10.1046/j.1432-1327.2001.02273.x; Wahid AM, 2008, J BIOL CHEM, V283, P17485, DOI 10.1074/jbc.M802300200; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wilson JL, 2014, J BIOL CHEM, V289, P23233, DOI 10.1074/jbc.M114.550046; Wu SY, 1997, J BIOL CHEM, V272, P1291, DOI 10.1074/jbc.272.2.1291	47	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28156	28165		10.1074/jbc.M115.679738	http://dx.doi.org/10.1074/jbc.M115.679738			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26432638	hybrid, Green Published			2022-12-28	WOS:000365761900011
J	Desmond, PF; Muriel, J; Markwardt, ML; Rizzo, MA; Bloch, RJ				Desmond, Patrick F.; Muriel, Joaquin; Markwardt, Michele L.; Rizzo, Mark A.; Bloch, Robert J.			Identification of Small Ankyrin 1 as a Novel Sarco(endo)plasmic Reticulum Ca2+-ATPase 1 (SERCA1) Regulatory Protein in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE POLARIZATION MICROSCOPY; CARDIAC SARCOPLASMIC-RETICULUM; CALCIUM-ATPASE; FUNCTIONAL ASSOCIATION; TRANSMEMBRANE HELICES; SARCOLIPIN DECREASES; CA2+ HOMEOSTASIS; NMR-SPECTROSCOPY; MESSENGER-RNA; PHOSPHOLAMBAN	Small ankyrin 1 (sAnk1) is a 17-kDa transmembrane (TM) protein that binds to the cytoskeletal protein, obscurin, and stabilizes the network sarcoplasmic reticulum in skeletal muscle. We report that sAnk1 shares homology in its TM amino acid sequence with sarcolipin, a small protein inhibitor of the sarco-(endo) plasmic reticulum Ca2+-ATPase (SERCA). Here we investigate whether sAnk1 and SERCA1 interact. Our results indicate that sAnk1 interacts specifically with SERCA1 in sarcoplasmic reticulum vesicles isolated from rabbit skeletal muscle, and in COS7 cells transfected to express these proteins. This interaction was demonstrated by co-immunoprecipitation and an anisotropy-based FRET method. Binding was reduced similar to 2-fold by the replacement of all of the TM amino acids of sAnk1 with leucines by mutagenesis. This suggests that, like sarcolipin, sAnk1 interacts with SERCA1 at least in part via its TM domain. Binding of the cytoplasmic domain of sAnk1 to SERCA1 was also detected in vitro. ATPase activity assays show that co-expression of sAnk1 with SERCA1 leads to a reduction of the apparent Ca2+ affinity of SERCA1 but that the effect of sAnk1 is less than that of sarcolipin. The sAnk1 TM mutant has no effect on SERCA1 activity. Our results suggest that sAnk1 interacts with SERCA1 through its TM and cytoplasmic domains to regulate SERCA1 activity and modulate sequestration of Ca2+ in the sarcoplasmic reticulum lumen. The identification of sAnk1 as a novel regulator of SERCA1 has significant implications for muscle physiology and the development of therapeutic approaches to treat heart failure and muscular dystrophies linked to Ca2+ misregulation.	[Desmond, Patrick F.; Muriel, Joaquin; Markwardt, Michele L.; Rizzo, Mark A.; Bloch, Robert J.] Univ Maryland, Dept Physiol, Baltimore, MD 21230 USA; [Desmond, Patrick F.; Bloch, Robert J.] Univ Maryland, Program Biochem & Mol Biol, Baltimore, MD 21230 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bloch, RJ (corresponding author), HSF1 Rm 580C,685 W Baltimore St, Baltimore, MD 21201 USA.	rbloch@umaryland.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [RO1 DK077140, RO1 AR056330]; Training Program in Integrative Membrane Biology [T32 GM08181]; Interdisciplinary Training Program in Muscle Biology [T32 AR 007592]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Program in Integrative Membrane Biology; Interdisciplinary Training Program in Muscle Biology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants RO1 DK077140 (to M. A. R.) and RO1 AR056330 (to R. J. B.).; Supported with funds from the Training Program in Integrative Membrane Biology (T32 GM08181, Dr. M. Trudeau, Principal Investigator) and the Interdisciplinary Training Program in Muscle Biology (T32 AR 007592, Dr. M. Schneider, Principle Investigator). The authors declare that they have no conflicts of interest with the contents of this article.	Abrol N, 2014, J BIOL CHEM, V289, P25855, DOI 10.1074/jbc.M114.562579; Ackermann MA, 2011, J CELL SCI, V124, P3619, DOI 10.1242/jcs.085159; Adachi T, 2010, ADV PHARMACOL, V59, P165, DOI 10.1016/S1054-3589(10)59006-9; Afara MR, 2006, BIOCHEMISTRY-US, V45, P8617, DOI 10.1021/bi0523761; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Armani A, 2006, EXP CELL RES, V312, P3546, DOI 10.1016/j.yexcr.2006.07.027; Asahi M, 1999, J BIOL CHEM, V274, P32855, DOI 10.1074/jbc.274.46.32855; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; Babu GJ, 2005, CARDIOVASC RES, V65, P177, DOI 10.1016/j.cardiores.2004.08.012; Bagnato P, 2003, J CELL BIOL, V160, P245, DOI 10.1083/jcb.200208109; BIRKENMEIER CS, 1993, J BIOL CHEM, V268, P9533; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bombardier E, 2013, FEBS LETT, V587, P1687, DOI 10.1016/j.febslet.2013.04.019; Borzok MA, 2007, J BIOL CHEM, V282, P32384, DOI 10.1074/jbc.M704089200; BRIGGS FN, 1992, J BIOL CHEM, V267, P26056; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Buffy JJ, 2006, J MOL BIOL, V358, P420, DOI 10.1016/j.jmb.2006.02.005; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Diaz ME, 2005, CELL CALCIUM, V38, P391, DOI 10.1016/j.ceca.2005.06.017; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V290, P178, DOI 10.1016/0005-2736(72)90062-4; Fajardo VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084304; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Fu MH, 2009, AM J PHYSIOL-HEART C, V296, pH1175, DOI 10.1152/ajpheart.01276.2008; Gade P, 2012, P NATL ACAD SCI USA, V109, P10316, DOI 10.1073/pnas.1119273109; Gayan-Ramirez G, 2000, J PHYSIOL-LONDON, V524, P387, DOI 10.1111/j.1469-7793.2000.t01-2-00387.x; Giacomello E, 2015, AM J PHYSIOL-CELL PH, V308, pC123, DOI 10.1152/ajpcell.00090.2014; Gokhin DS, 2011, J CELL BIOL, V194, P105, DOI 10.1083/jcb.201011128; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; HARRER JM, 1994, MOL CELL BIOCHEM, V140, P185, DOI 10.1007/BF00926757; Hellstern S, 2001, J BIOL CHEM, V276, P30845, DOI 10.1074/jbc.M102495200; Honarnejad K, 2012, INT J BIOCHEM CELL B, V44, P1983, DOI 10.1016/j.biocel.2012.07.019; Hopitzan AA, 2006, MOL BIOL EVOL, V23, P46, DOI 10.1093/molbev/msj004; Hutter MC, 2002, CHEMBIOCHEM, V3, P1200, DOI 10.1002/1439-7633(20021202)3:12<1200::AID-CBIC1200>3.0.CO;2-H; Kabbara AA, 1999, CELL CALCIUM, V25, P227, DOI 10.1054/ceca.1999.0023; Kerr JP, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00089; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Kontrogianni-Konstantopoulos A, 2000, MOL BIOL CELL, V11, P3805, DOI 10.1091/mbc.11.11.3805; Kontrogianni-Konstantopoulos A, 2004, AM J PHYSIOL-CELL PH, V287, pC209, DOI 10.1152/ajpcell.00497.2003; Kontrogianni-Konstantopoulos A, 2003, MOL BIOL CELL, V14, P1138, DOI 10.1091/mbc.E02-07-0411; Kontrogianni-Konstantopoulos A, 2003, J BIOL CHEM, V278, P3985, DOI 10.1074/jbc.M209012200; Kontrogianni-Konstantopoulos A, 2009, PHYSIOL REV, V89, P1217, DOI 10.1152/physrev.00017.2009; Kosk-Kosicka Danuta, 2013, Methods Mol Biol, V937, P343; KOSS KL, 1995, CIRC RES, V77, P342, DOI 10.1161/01.RES.77.2.342; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Lange S, 2009, J CELL SCI, V122, P2640, DOI 10.1242/jcs.046193; Launikonis BS, 2005, J PHYSIOL-LONDON, V567, P523, DOI 10.1113/jphysiol.2005.087973; Lencesova L, 2004, J BIOL CHEM, V279, P2885, DOI 10.1074/jbc.M310365200; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; MacLennan DH, 2003, ANN NY ACAD SCI, V986, P472, DOI 10.1111/j.1749-6632.2003.tb07231.x; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Morita T, 2008, BIOCHEM BIOPH RES CO, V369, P188, DOI 10.1016/j.bbrc.2007.11.098; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Periasamy M, 2007, MUSCLE NERVE, V35, P430, DOI 10.1002/mus.20745; Piston DW, 2008, METHOD CELL BIOL, V85, P415, DOI 10.1016/S0091-679X(08)85018-2; Porter NC, 2005, MOL MEMBR BIOL, V22, P421, DOI 10.1080/09687860500244262; Rizzo MA, 2005, BIOPHYS J, V88, pL14, DOI 10.1529/biophysj.104.055442; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Sahoo SK, 2015, J BIOL CHEM, V290, P14057, DOI 10.1074/jbc.M115.636738; Schmidt AG, 2002, CARDIOVASC RES, V56, P248, DOI 10.1016/S0008-6363(02)00541-2; Seidel K, 2008, BIOCHEMISTRY-US, V47, P4369, DOI 10.1021/bi7024194; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Shen XH, 2007, J BIOL CHEM, V282, P37864, DOI 10.1074/jbc.M705702200; Simmerman HKB, 1996, J BIOL CHEM, V271, P5941, DOI 10.1074/jbc.271.10.5941; SOMLYO AV, 1981, J CELL BIOL, V90, P577, DOI 10.1083/jcb.90.3.577; Stammers AN, 2015, CAN J PHYSIOL PHARM, V93, P843, DOI 10.1139/cjpp-2014-0463; Tada M, 1998, TRENDS CARDIOVAS MED, V8, P330, DOI 10.1016/S1050-1738(98)00032-2; TOYOFUKU T, 1994, J BIOL CHEM, V269, P3088; TOYOFUKU T, 1993, J BIOL CHEM, V268, P2809; TOYOFUKU T, 1994, J BIOL CHEM, V269, P22929; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Traaseth NJ, 2007, P NATL ACAD SCI USA, V104, P14676, DOI 10.1073/pnas.0701016104; Vangheluwe P, 2005, BIOCHEM J, V389, P151, DOI 10.1042/BJ20050068; Vangheluwe P, 2006, J MOL CELL CARDIOL, V41, P308, DOI 10.1016/j.yjmcc.2006.05.014; WATANABE Y, 1991, J BIOCHEM, V110, P40, DOI 10.1093/oxfordjournals.jbchem.a123540; Yu JT, 2009, PROG NEUROBIOL, V89, P240, DOI 10.1016/j.pneurobio.2009.07.009; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou DX, 1997, J CELL BIOL, V136, P621, DOI 10.1083/jcb.136.3.621; Ziman AP, 2010, BIOPHYS J, V99, P2705, DOI 10.1016/j.bpj.2010.08.032	90	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27854	27867		10.1074/jbc.M115.676585	http://dx.doi.org/10.1074/jbc.M115.676585			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26405035	hybrid, Green Published			2022-12-28	WOS:000365757500035
J	Li, LL; Wang, YJ; Gao, W; Yuan, C; Zhang, SN; Zhou, H; Huang, M; Yao, X				Li, Lingling; Wang, Yujie; Gao, Wei; Yuan, Cheng; Zhang, Sini; Zhou, Hong; Huang, Mao; Yao, Xin			Klotho Reduction in Alveolar Macrophages Contributes to Cigarette Smoke Extract-induced Inflammation in Chronic Obstructive Pulmonary Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROINFLAMMATORY CYTOKINE RELEASE; OXIDATIVE STRESS; EPITHELIAL-CELLS; ACTIVATION; PROTEIN; KIDNEY; SENESCENCE; EXPRESSION; COPD	Abnormal inflammation and accelerated decline in lung function occur in patients with chronic obstructive pulmonary disease (COPD). Klotho, an anti-aging protein, has an anti-inflammatory function. However, the role of Klotho has never been investigated in COPD. The aim of this study is to investigate the possible role of Klotho by alveolar macrophages in airway inflammation in COPD. Klotho levels were assessed in the lung samples and peripheral blood mononuclear cells of non-smokers, smokers, and patients with COPD. The regulation of Klotho expression by cigarette smoke extract (CSE) was studied in vitro, and small interfering RNA (siRNA) and recombinant Klotho were employed to investigate the role of Klotho on CSE-induced inflammation. Klotho expression was reduced in alveolar macrophages in the lungs and peripheral blood mononuclear cells of COPD patients. CSE decreased Klotho expression and release from MH-S cells. Knockdown of endogenous Klotho augmented the expression of the inflammatory mediators, such as MMP-9, IL-6, and TNF-alpha, by MH-S cells. Exogenous Klotho inhibited the expression of CSE-induced inflammatory mediators. Furthermore, we showed that Klotho interacts with I kappa B alpha of the NF-kappa B pathway. Dexamethasone treatment increased the expression and release level of Klotho in MH-S cells. Our findings suggest that Klotho plays a role in sustained inflammation of the lungs, which in turn may have therapeutic implications in COPD.	[Li, Lingling; Wang, Yujie; Gao, Wei; Yuan, Cheng; Zhang, Sini; Huang, Mao; Yao, Xin] Nanjing Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanjing 210029, Jiangsu, Peoples R China; [Li, Lingling] Yijishan Hosp, Wannan Med Coll, Dept Resp Med, Wuhu 241000, Peoples R China; [Zhou, Hong] Nanjing Med Univ, Dept Immunol, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Wannan Medical College; Nanjing Medical University	Yao, X (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Resp Med, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	xyao1998@126.com			National Natural Science Foundation of China [81070025, 81470237]; Jiangsu Health Promotion Project; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231802]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Health Promotion Project; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China Grants 81070025 and 81470237, the Jiangsu Health Promotion Project, and the Priority Academic Program Development of Jiangsu Higher Education Institutions Grant JX10231802. The authors declare that they have no conflicts of interest with the contents of this article.	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Banerjee S, 2013, CELL PHYSIOL BIOCHEM, V31, P659, DOI 10.1159/000350085; Barnes Peter J, 2004, COPD, V1, P59, DOI 10.1081/COPD-120028701; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; BURCHFIEL CM, 1995, AM J RESP CRIT CARE, V151, P1778, DOI 10.1164/ajrccm.151.6.7767520; Chen TH, 2013, EUR J PHARMACOL, V698, P67, DOI 10.1016/j.ejphar.2012.09.032; Di Stefano A, 2002, EUR RESPIR J, V20, P556, DOI 10.1183/09031936.02.00272002; Funada Yasuhiro, 2004, Kobe Journal of Medical Sciences, V50, P59; Gao W, 2015, CLIN SCI, V129, P1011, DOI 10.1042/CS20150273; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang TT, 2001, MOL CELL BIOL, V21, P4737, DOI 10.1128/MCB.21.14.4737-4747.2001; Imai M, 2004, ENDOCRINE, V25, P229, DOI 10.1385/ENDO:25:3:229; Jeffery PK, 2000, CHEST, V117, p251S, DOI 10.1378/chest.117.5_suppl_1.251S; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; Moreno JA, 2011, J AM SOC NEPHROL, V22, P1315, DOI 10.1681/ASN.2010101073; Oh HJ, 2015, PERITON DIALYSIS INT, V35, P43, DOI 10.3747/pdi.2013.00150; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Pickens SR, 2011, ARTHRITIS RHEUM-US, V63, P914, DOI 10.1002/art.30232; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Saetta M, 2000, AM J RESP CRIT CARE, V161, P1016, DOI 10.1164/ajrccm.161.3.9907080; Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC; Shapiro SD, 1999, AM J RESP CRIT CARE, V160, pS29, DOI 10.1164/ajrccm.160.supplement_1.9; Shi YG, 2010, J BIOMED RES, V24, P6, DOI 10.1016/S1674-8301(10)60003-6; SNIDER GL, 1989, ANNU REV MED, V40, P411; Tan SJ, 2014, NEPHROLOGY, V19, P439, DOI 10.1111/nep.12268; Thurston RD, 2010, GASTROENTEROLOGY, V138, P1384, DOI 10.1053/j.gastro.2009.12.002; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Tuder RM, 2006, AM J RESP CRIT CARE, V174, P490, DOI 10.1164/rccm.200607-924ED; Vogelmeier C, 2007, AM J RESP CRIT CARE, V175, P1217, DOI 10.1164/rccm.200703-513ED; Yang J, 2003, BIOCHEM BIOPH RES CO, V301, P424, DOI 10.1016/S0006-291X(02)03056-5; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Zhao YH, 2011, DIABETES, V60, P1907, DOI 10.2337/db10-1262	38	48	50	4	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27890	+		10.1074/jbc.M115.655431	http://dx.doi.org/10.1074/jbc.M115.655431			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26385922	Green Published, hybrid			2022-12-28	WOS:000365757500038
J	Balagopalan, L; Kortum, RL; Coussens, NP; Barr, VA; Samelson, LE				Balagopalan, Lakshmi; Kortum, Robert L.; Coussens, Nathan P.; Barr, Valarie A.; Samelson, Lawrence E.			The Linker for Activation of T Cells (LAT) Signaling Hub: From Signaling Complexes to Microclusters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ANTIGEN RECEPTOR; MULTIPOINT BINDING; TYROSINE RESIDUES; PROTEIN COMPLEXES; LIPID RAFTS; GRB2; DOMAINS; SLP-76; PLC-GAMMA-1; RECRUITMENT	Since the cloning of the critical adapter, LAT (linker for activation of T cells), more than 15 years ago, a combination of multiple scientific approaches and techniques continues to provide valuable insights into the formation, composition, regulation, dynamics, and function of LAT-based signaling complexes. In this review, we will summarize current views on the assembly of signaling complexes nucleated by LAT. LAT forms numerous interactions with other signaling molecules, leading to cooperativity in the system. Furthermore, oligomerization of LAT by adapter complexes enhances intracellular signaling and is physiologically relevant. These results will be related to data from super-resolution microscopy studies that have revealed the smallest LAT-based signaling units and nanostructure.	[Balagopalan, Lakshmi] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kortum, Robert L.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [Coussens, Nathan P.] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)		samelsonl@helix.nih.gov			Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research (CCR); NATIONAL CANCER INSTITUTE [ZICBC010978] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research (CCR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, NCI, Center for Cancer Research (CCR). This is the fourth article in the Thematic Minireview series "Protein Interactions, Structures, and Networks." The authors declare that they have no conflicts of interest with the contents of this article.	Balagopalan L, 2011, P NATL ACAD SCI USA, V108, P2885, DOI 10.1073/pnas.1007098108; Balagopalan L, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005512; Bilal MY, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00141; Blom H, 2014, J INTERN MED, V276, P560, DOI 10.1111/joim.12278; Braiman A, 2006, EMBO J, V25, P774, DOI 10.1038/sj.emboj.7600978; Brignatz C, 2005, BBA-MOL CELL RES, V1746, P108, DOI 10.1016/j.bbamcr.2005.08.009; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2006, MOL CELL BIOL, V26, P7155, DOI 10.1128/MCB.00507-06; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Clayton AHA, 2008, GROWTH FACTORS, V26, P316, DOI 10.1080/08977190802442187; Coussens NP, 2013, MOL CELL BIOL, V33, P4140, DOI 10.1128/MCB.00410-13; Dombroski D, 2005, J IMMUNOL, V174, P1385, DOI 10.4049/jimmunol.174.3.1385; Dustin ML, 2012, ANNU REV BIOPHYS, V41, P543, DOI 10.1146/annurev-biophys-042910-155238; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Gagnon SJ, 2006, J MOL BIOL, V363, P228, DOI 10.1016/j.jmb.2006.08.045; Hartgroves LC, 2003, J BIOL CHEM, V278, P20389, DOI 10.1074/jbc.M301212200; Horejsi V, 2014, FEBS LETT, V588, P2392, DOI 10.1016/j.febslet.2014.05.047; Houtman JCD, 2004, BIOCHEMISTRY-US, V43, P4170, DOI 10.1021/bi0357311; Houtman JCD, 2006, NAT STRUCT MOL BIOL, V13, P798, DOI 10.1038/nsmb1133; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Hundt M, 2009, J IMMUNOL, V183, P1685, DOI 10.4049/jimmunol.0803921; Jang IK, 2010, P NATL ACAD SCI USA, V107, P10620, DOI 10.1073/pnas.0905039107; Kenworthy AK, 2008, EMBO REP, V9, P531, DOI 10.1038/embor.2008.92; Kortum RL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004494; Kortum RL, 2013, TRENDS IMMUNOL, V34, P259, DOI 10.1016/j.it.2013.02.004; Kortum RL, 2012, MOL CELL BIOL, V32, P2748, DOI 10.1128/MCB.00317-12; Kortum RL, 2011, P NATL ACAD SCI USA, V108, P12407, DOI 10.1073/pnas.1104295108; Kozer N, 2014, BIOCHEMISTRY-US, V53, P2594, DOI 10.1021/bi500182x; Lasserre R, 2011, J CELL BIOL, V195, P839, DOI 10.1083/jcb.201103105; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lin J, 2001, J BIOL CHEM, V276, P29588, DOI 10.1074/jbc.M102221200; Liu Q, 2003, MOL CELL, V11, P471, DOI 10.1016/S1097-2765(03)00046-7; Mingueneau M, 2009, IMMUNITY, V31, P197, DOI 10.1016/j.immuni.2009.05.013; Nag A, 2009, BIOPHYS J, V96, P2604, DOI 10.1016/j.bpj.2009.01.019; Nelson AJ, 2014, J MICROSC-OXFORD, V254, P1, DOI 10.1111/jmi.12115; Nunez-Cruz S, 2003, NAT IMMUNOL, V4, P999, DOI 10.1038/ni977; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Qian H, 2012, ANNU REV BIOPHYS, V41, P179, DOI 10.1146/annurev-biophys-050511-102240; Roncagalli R, 2014, NAT IMMUNOL, V15, P384, DOI 10.1038/ni.2843; Sangani D, 2009, MOL MEMBR BIOL, V26, P159, DOI 10.1080/09687680802637660; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Shen SD, 2010, J BIOL CHEM, V285, P35393, DOI 10.1074/jbc.M110.145052; Shen SD, 2009, J IMMUNOL, V182, P5596, DOI 10.4049/jimmunol.0803170; Sherman E, 2011, IMMUNITY, V35, P705, DOI 10.1016/j.immuni.2011.10.004; Soares H, 2013, IMMUNOL REV, V256, P118, DOI 10.1111/imr.12110; Sommers CL, 2001, J EXP MED, V194, P135, DOI 10.1084/jem.194.2.135; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; Sylvain NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001178; Walker F, 2012, GROWTH FACTORS, V30, P394, DOI 10.3109/08977194.2012.739619; Whitty A, 2008, NAT CHEM BIOL, V4, P435, DOI 10.1038/nchembio0808-435; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhu MH, 2005, J IMMUNOL, V174, P31, DOI 10.4049/jimmunol.174.1.31; Zhu NH, 2003, J IMMUNOL, V170, P325, DOI 10.4049/jimmunol.170.1.325	64	70	70	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26422	26429		10.1074/jbc.R115.665869	http://dx.doi.org/10.1074/jbc.R115.665869			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354432	Green Published, hybrid			2022-12-28	WOS:000364793600009
J	Bailey, CC; DeVaux, LB; Farzan, M				Bailey, Charles C.; DeVaux, Lindsey B.; Farzan, Michael			The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; MICROGLIAL RESPONSE; TYPE-4 ALLELE; TREM2; MUTATIONS; RISK; PHAGOCYTOSIS; RECOGNITION; CLEARANCE	The triggering receptor expressed on myeloid cells 2 (TREM2) is an Ig-like V-type receptor expressed by populations of myeloid cells in the central nervous system and periphery. Loss-of-function mutations in TREM2 cause a progressive, fatal neurodegenerative disorder called Nasu-Hakola disease. In addition, a TREM2 R47H coding variant was recently identified as a risk factor for late-onset Alzheimer disease. TREM2 binds various polyanionic molecules but no specific protein ligands have been identified. Here we show that TREM2 specifically binds apolipoprotein E, a well established participant in Alzheimer disease. TREM2-Ig fusions efficiently precipitate ApoE from cerebrospinal fluid and serum. TREM2 also binds recombinant ApoE in solution and immobilized ApoE as detected by ELISA. Furthermore, the Alzheimer disease-associated R47H mutation, and other artificial mutations introduced in the same location, markedly reduced the affinity of TREM2 for ApoE. These findings reveal a link between two Alzheimer disease risk factors and may provide important clues to the pathogenesis of Nasu-Hakola disease and other neurodegenerative disorders.	[Bailey, Charles C.; DeVaux, Lindsey B.; Farzan, Michael] Scripps Res Inst, Dept Immunobiol & Microbial Sci, Jupiter, FL 33458 USA	Scripps Research Institute	Bailey, CC (corresponding author), Scripps Res Inst, Dept Immunobiol & Microbial Sci, Jupiter, FL 33458 USA.	cbailey@scripps.edu		Farzan, Michael/0000-0002-2990-5319; Bailey, Charles/0000-0003-0200-3523	Scripps Research Institute Florida	Scripps Research Institute Florida	This work was supported by startup funds provided by the Scripps Research Institute Florida. The authors declare that they have no conflicts of interest with the contents of this article.	Borroni B, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.017; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4; Chouery E, 2008, HUM MUTAT, V29, pE194, DOI 10.1002/humu.20836; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cuyvers E, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.009; Daws MR, 2001, EUR J IMMUNOL, V31, P783, DOI 10.1002/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; Grainger DJ, 2004, J IMMUNOL, V173, P6366, DOI 10.4049/jimmunol.173.10.6366; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang T, 2014, NEUROPSYCHOPHARMACOL, V39, P2949, DOI 10.1038/npp.2014.164; Jin SC, 2014, HUM MOL GENET, V23, P5838, DOI 10.1093/hmg/ddu277; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Lane-Donovan C, 2014, NEURON, V83, P771, DOI 10.1016/j.neuron.2014.08.005; Lill CM, 2015, ALZHEIMERS DEMENT, V11, P1407, DOI 10.1016/j.jalz.2014.12.009; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NASU T, 1973, ACTA PATHOL JAPON, V23, P539; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Park JS, 2015, TRAFFIC, V16, P510, DOI 10.1111/tra.12264; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Rosenthal SL, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.04.012; Savage JC, 2015, J NEUROSCI, V35, P6532, DOI 10.1523/JNEUROSCI.4586-14.2015; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Zhong L, 2015, J BIOL CHEM, V290, P15866, DOI 10.1074/jbc.M115.645986	39	170	174	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26033	26042		10.1074/jbc.M115.677286	http://dx.doi.org/10.1074/jbc.M115.677286			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26374897	Green Published, hybrid			2022-12-28	WOS:000363527300024
J	Shinsky, SA; Cosgrove, MS				Shinsky, Stephen A.; Cosgrove, Michael S.			Unique Role of the WD-40 Repeat Protein 5 (WDR5) Subunit within the Mixed Lineage Leukemia 3 (MLL3) Histone Methyltransferase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; LYSINE 4; BIOLOGICAL MACROMOLECULES; H3K4 TRIMETHYLATION; STRUCTURAL BASIS; UCSF CHIMERA; FAMILY; GENE; METHYLATION; DOMAIN	The MLL3 (mixed lineage leukemia 3) protein is a member of the human SET1 family of histone H3 lysine 4 methyltransferases and contains the conserved WDR5 interaction (Win) motif and the catalytic suppressor of variegation, enhancer of zeste, trithorax (SET) domain. The human SET1 family includes MLL1-4 and SETd1A/B, which all interact with a conserved subcomplex containing WDR5, RbBP5, Ash2L, and DPY-30 (WRAD) to form the minimal core complex required for full methyltransferase activity. However, recent evidence suggests that the WDR5 subunit may not be utilized in an identical manner within all SET1 family core complexes. Although the roles of WDR5 within the MLL1 core complex have been extensively studied, not much is known about the roles of WDR5 in other SET1 family core complexes. In this investigation, we set out to characterize the roles of the WDR5 subunit in the MLL3 core complex. We found that unlike MLL1, the MLL3 SET domain assembles with the RbBP5/Ash2L heterodimer independently of the Win motif-WDR5 interaction. Furthermore, we observed that WDR5 inhibits the monomethylation activity of the MLL3 core complex, which is dependent on the Win motif. We also found evidence suggesting that the WRAD subcomplex catalyzes weak H3K4 monomethylation within the context of the MLL3 core complex. Furthermore, solution structures of the MLL3 core complex assembled with and without WDR5 by small angle x-ray scattering show similar overall topologies. Together, this work demonstrates a unique role for WDR5 in modulating the enzymatic activity of the MLL3 core complex.	[Shinsky, Stephen A.; Cosgrove, Michael S.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Cosgrove, MS (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	cosgrovm@upstate.edu	Regan, Clinton/E-6250-2012	Shinsky, Stephen/0000-0001-5437-1729	National Institutes of Health [2R01CA140522]; NATIONAL CANCER INSTITUTE [R01CA140522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01CA140522 (to M. S. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dharmarajan V, 2012, J BIOL CHEM, V287, P27275, DOI 10.1074/jbc.M112.364125; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; He XX, 2015, NUCLEIC ACIDS RES, V43, P3712, DOI 10.1093/nar/gkv214; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; JONES RS, 1993, MOL CELL BIOL, V13, P6357, DOI 10.1128/MCB.13.10.6357; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Liu CC, 2015, BIOCHEM J, V467, P415, DOI 10.1042/BJ20141392; Mersman DP, 2012, J BIOL CHEM, V287, P2652, DOI 10.1074/jbc.M111.280867; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2014, J BIOL CHEM, V289, P868, DOI 10.1074/jbc.M113.501064; Patel A, 2011, J BIOL CHEM, V286, P3359, DOI 10.1074/jbc.M110.174524; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shinsky SA, 2015, J BIOL CHEM, V290, P6361, DOI 10.1074/jbc.M114.627646; Shinsky SA, 2014, J MOL BIOL, V426, P2283, DOI 10.1016/j.jmb.2014.03.011; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; STASSEN MJ, 1995, MECH DEVELOP, V52, P209, DOI 10.1016/0925-4773(95)00402-M; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; van Nuland R, 2013, MOL CELL BIOL, V33, P2067, DOI 10.1128/MCB.01742-12; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yang YW, 2014, ELIFE, V3, DOI 10.7554/eLife.02046; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Zhang P, 2015, GENE DEV, V29, P123, DOI 10.1101/gad.254870.114; Zhao HY, 2011, METHODS, V54, P16, DOI 10.1016/j.ymeth.2011.01.010	56	19	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25819	25833		10.1074/jbc.M115.684142	http://dx.doi.org/10.1074/jbc.M115.684142			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26324722	Green Published, hybrid			2022-12-28	WOS:000363527300004
J	Sondergaard, MT; Tian, XX; Liu, YJ; Wang, RW; Chazin, WJ; Chen, SRW; Overgaard, MT				Sondergaard, Mads T.; Tian, Xixi; Liu, Yingjie; Wang, Ruiwu; Chazin, Walter J.; Chen, S. R. Wayne; Overgaard, Michael T.			Arrhythmogenic Calmodulin Mutations Affect the Activation and Termination of Cardiac Ryanodine Receptor-mediated Ca2+ Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; VENTRICULAR-TACHYCARDIA; MOLECULAR-BASIS; SUDDEN-DEATH; CALCIUM; BINDING; RYR2; SKELETAL; DOMAINS; DISSOCIATION	The intracellular Ca2+ sensor calmodulin (CaM) regulates the cardiac Ca2+ release channel/ryanodine receptor 2 (RyR2), and mutations in CaM cause arrhythmias such as catecholaminergic polymorphic ventricular tachycardia (CPVT) and long QT syndrome. Here, we investigated the effect of CaM mutations causing CPVT (N53I), long QT syndrome (D95V and D129G), or both (CaM N97S) on RyR2-mediated Ca2+ release. All mutations increased Ca2+ release and rendered RyR2 more susceptible to store overload-induced Ca2+ release (SOICR) by lowering the threshold of store Ca2+ content at which SOICR occurred and the threshold at which SOICR terminated. To obtain mechanistic insights, we investigated the Ca2+ binding of the N- and C-terminal domains (N-and C-domain) of CaM in the presence of a peptide corresponding to the CaM-binding domain of RyR2. The N53I mutation decreased the affinity of Ca2+ binding to the N-domain of CaM, relative to CaM WT, but did not affect the C-domain. Conversely, mutations N97S, D95V, and D129G had little or no effect on Ca2+ binding to the N-domain but markedly decreased the affinity of the C-domain for Ca2+. These results suggest that mutations D95V, N97S, and D129G alter the interaction between CaM and the CaMBD and thus RyR2 regulation. Because the N53I mutation minimally affected Ca2+ binding to the C-domain, it must cause aberrant regulation via a different mechanism. These results support aberrant RyR2 regulation as the disease mechanism for CPVT associated with CaM mutations and shows that CaM mutations not associated with CPVT can also affect RyR2. A model for the CaM-RyR2 interaction, where the Ca2+-saturated C-domain is constitutively bound to RyR2 and the N-domain senses increases in Ca2+ concentration, is proposed.	[Sondergaard, Mads T.; Overgaard, Michael T.] Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark; [Sondergaard, Mads T.; Tian, Xixi; Liu, Yingjie; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Pharmacol, Calgary, AB T2N 1N4, Canada; [Sondergaard, Mads T.; Tian, Xixi; Liu, Yingjie; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada; [Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Dept Biochem, Nashville, TN 37235 USA; [Chazin, Walter J.] Vanderbilt Univ, Struct Biol Ctr, Dept Chem, Nashville, TN 37235 USA	Aalborg University; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; Vanderbilt University; Vanderbilt University	Overgaard, MT (corresponding author), Aalborg Univ, Dept Chem & Biosci, Fredrik Bajers Vej 7H, DK-9220 Aalborg, Denmark.	mto@bio.aau.dk	Overgaard, Michael Toft/E-1354-2011	Overgaard, Michael Toft/0000-0002-1423-2481; Sondergaard, Mads Toft/0000-0001-6779-5109	Obelske Family Foundation; Novo Nordic Foundation; Lundbeck Foundation; Danish Council for Independent Research (Technology and Production Sciences); Vanderbilt University; Canadian Institutes of Health Research; Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut; Canada Foundation for Innovation; Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research; Alberta Innovates [201400104] Funding Source: researchfish	Obelske Family Foundation; Novo Nordic Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research (Technology and Production Sciences)(Det Frie Forskningsrad (DFF)); Vanderbilt University; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research; Alberta Innovates	This study was supported by research grants from the Obelske Family Foundation, the Novo Nordic Foundation, and the Lundbeck Foundation (to M. T. O.); by a postdoctoral fellowship from the Danish Council for Independent Research (Technology and Production Sciences) (to M. T. S.); by institutional support from Vanderbilt University (to W. J. C.); and by research grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut, the Canada Foundation for Innovation, and the Heart and Stroke Foundation/Libin Professorship in Cardiovascular Research (to S. R. W. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adair GS, 1925, J BIOL CHEM, V63, P529; Amin AS, 2013, J PHYSIOL-LONDON, V591, P4125, DOI 10.1113/jphysiol.2013.254920; Arnaiz-Cot JJ, 2013, J PHYSIOL-LONDON, V591, P4287, DOI 10.1113/jphysiol.2013.256123; Balshaw DM, 2001, J BIOL CHEM, V276, P20144, DOI 10.1074/jbc.M010771200; Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; Berridge M. J., 2014, BIOCHEM J, DOI [10.1042/csb0001003, DOI 10.1042/CSB0001003]; Berridge M. J., 2014, BIOCHEM J, DOI [10.1042/csb0001007, DOI 10.1042/CSB0001007]; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; CHEN SRW, 1994, J BIOL CHEM, V269, P22698; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; Crotti L, 2013, CIRCULATION, V127, P1009, DOI 10.1161/CIRCULATIONAHA.112.001216; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; Evans TIA, 2011, BIOPHYS CHEM, V159, P172, DOI 10.1016/j.bpc.2011.06.007; Fruen BR, 2003, BIOCHEMISTRY-US, V42, P2740, DOI 10.1021/bi0267689; Guo T, 2011, BIOPHYS J, V101, P2170, DOI 10.1016/j.bpj.2011.09.030; Gyorke S, 2008, CARDIOVASC RES, V77, P245, DOI 10.1093/cvr/cvm038; Huang XJ, 2013, J CELL SCI, V126, P4527, DOI 10.1242/jcs.133454; Huang XJ, 2012, J BIOL CHEM, V287, P30328, DOI 10.1074/jbc.M112.383109; Hwang HS, 2014, CIRC RES, V114, P1114, DOI 10.1161/CIRCRESAHA.114.303391; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jiang J, 2010, BIOCHEM J, V432, P89, DOI 10.1042/BJ20100505; Kimlicka L, 2011, SCI CHINA LIFE SCI, V54, P712, DOI 10.1007/s11427-011-4198-2; Lahat H, 2003, CIRCULATION, V107, pE29, DOI 10.1161/01.CIR.0000050555.40735.ED; Laitinen PJ, 2001, CIRCULATION, V103, P485, DOI 10.1161/01.CIR.103.4.485; Lau K, 2014, BIOCHEMISTRY-US, V53, P932, DOI 10.1021/bi401502x; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Limpitikul WB, 2014, J MOL CELL CARDIOL, V74, P115, DOI 10.1016/j.yjmcc.2014.04.022; Makita N, 2014, CIRC-CARDIOVASC GENE, V7, P466, DOI 10.1161/CIRCGENETICS.113.000459; Marsman RF, 2014, J AM COLL CARDIOL, V63, P259, DOI 10.1016/j.jacc.2013.07.091; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; Oda T, 2013, CIRC RES, V112, P487, DOI 10.1161/CIRCRESAHA.111.300290; Ono M, 2010, CARDIOVASC RES, V87, P609, DOI 10.1093/cvr/cvq108; Peersen OB, 1997, PROTEIN SCI, V6, P794; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Roux-Buisson N, 2012, HUM MOL GENET, V21, P2759, DOI 10.1093/hmg/dds104; Shea MA, 1996, BIOCHEMISTRY-US, V35, P2943, DOI 10.1021/bi951934g; Sondergaard MT, 2015, FEBS J, V282, P803, DOI 10.1111/febs.13184; Sorensen AB, 2013, FEBS J, V280, P5511, DOI 10.1111/febs.12337; Tian XX, 2013, BIOCHEM J, V455, P367, DOI 10.1042/BJ20130805; Van Petegem F, 2015, J MOL BIOL, V427, P31, DOI 10.1016/j.jmb.2014.08.004; Van Petegem F, 2012, J BIOL CHEM, V287, P31624, DOI 10.1074/jbc.R112.349068; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; Venetucci L, 2012, NAT REV CARDIOL, V9, P561, DOI 10.1038/nrcardio.2012.93; Xie LH, 2008, BIOPHYS J, V95, P3100, DOI 10.1529/biophysj.108.130955; Xiong LW, 2002, J BIOL CHEM, V277, P40862, DOI 10.1074/jbc.M206763200; Xu L, 2004, BIOPHYS J, V86, P797, DOI 10.1016/S0006-3495(04)74155-7; Xu XJ, 2010, BIOCHEM BIOPH RES CO, V394, P660, DOI 10.1016/j.bbrc.2010.03.046; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Yamaguchi N, 2007, J CLIN INVEST, V117, P1344, DOI 10.1172/JCI29515; Yang Y, 2014, CIRC RES, V114, P295, DOI 10.1161/CIRCRESAHA.114.302857; Zhang HW, 2003, J BIOL CHEM, V278, P8348, DOI 10.1074/jbc.M209565200; Zhang JQ, 2014, BIOCHEM J, V461, P99, DOI 10.1042/BJ20140126; Zima AV, 2008, CIRC RES, V103, pE105, DOI 10.1161/CIRCRESAHA.107.183236	58	42	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26151	26162		10.1074/jbc.M115.676627	http://dx.doi.org/10.1074/jbc.M115.676627			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26309258	Green Published, hybrid			2022-12-28	WOS:000363527300034
J	Lopes-Pacheco, M; Boinot, C; Sabirzhanova, I; Morales, MM; Guggino, WB; Cebotaru, L				Lopes-Pacheco, Miqueias; Boinot, Clement; Sabirzhanova, Inna; Morales, Marcelo M.; Guggino, William B.; Cebotaru, Liudmila			Combination of Correctors Rescue Delta F508-CFTR by Reducing Its Association with Hsp40 and Hsp27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; IN-VITRO; CFTR; MUTATION; DEGRADATION; MUTANT; PROTEOSTASIS; TRANSPORT; CHAPERONE	Correcting the processing of Delta F508-CFTR, the most common mutation in cystic fibrosis, is the major goal in the development of new therapies for this disease. Here, we determined whether Delta F508 could be rescued by a combination of small-molecule correctors, and identified the mechanism by which correctors rescue the trafficking mutant of cystic fibrosis transmembrane conductance regulator (CFTR). We transfected COS-7 cells with Delta F508, created HEK-293 stably expressing Delta F508, and utilized CFBE41o(-) cell lines stably transduced with Delta F508. As shown previously, Delta F508 expressed less protein, was unstable at physiological temperature, and rapidly degraded. When the cells were treated with the combination C18 + C4 the mature C-band was expressed at the cell surface. After treatment with C18 + C4, we saw a lower rate of protein disappearance after translation was stopped with cycloheximide. To understand how this rescue occurs, we evaluated the change in the binding of proteins involved in endoplasmic reticulum-associated degradation, such as Hsp27 (HspB1) and Hsp40 (DnaJ). We saw a dramatic reduction in binding to heat shock proteins 27 and 40 following combined corrector therapy. siRNA experiments confirmed that a reduction in Hsp27 or Hsp40 rescued CFTR in the Delta F508 mutant, but the rescue was not additive or synergistic with C4 + 18 treatment, indicating these correctors shared a common pathway for rescue involving a network of endoplasmic reticulum-associated degradation proteins.	[Lopes-Pacheco, Miqueias; Boinot, Clement; Sabirzhanova, Inna; Guggino, William B.; Cebotaru, Liudmila] Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA; [Lopes-Pacheco, Miqueias; Boinot, Clement; Sabirzhanova, Inna; Guggino, William B.; Cebotaru, Liudmila] Johns Hopkins Univ, Dept Physiol, Baltimore, MD 21205 USA; [Lopes-Pacheco, Miqueias; Morales, Marcelo M.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Rio De Janeiro, Brazil	Johns Hopkins University; Johns Hopkins University; Universidade Federal do Rio de Janeiro	Cebotaru, L (corresponding author), Wood Basic Sci Bldg,Rm 414,725 N Wolfe St, Baltimore, MD 21205 USA.	lcebotaru@jhmi.edu	Lopes-Pacheco, Miquéias/I-1290-2017; Lopes-Pacheco, Miquéias/AAM-7432-2020	Lopes-Pacheco, Miquéias/0000-0002-7444-9359; Lopes-Pacheco, Miquéias/0000-0002-7444-9359	United States CF Foundation; National Council for Scientific and Technological Development (CNPq/Program Science without Borders), Brazil	United States CF Foundation; National Council for Scientific and Technological Development (CNPq/Program Science without Borders), Brazil	This work was supported by the United States CF Foundation and the National Council for Scientific and Technological Development (CNPq/Program Science without Borders), Brazil (to M. L. -P.). The authors declare that they have no conflicts of interest with the contents of this article.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Ahner A, 2013, MOL BIOL CELL, V24, P74, DOI 10.1091/mbc.E12-09-0678; Amaral MD, 2013, CURR PHARM DESIGN, V19, P3497; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Balch W. E., 2011, COLD SPRING HARBOR P, V3; Cebotaru L, 2008, J BIOL CHEM, V283, P21926, DOI 10.1074/jbc.M709156200; Cebotaru L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085183; Cebotaru L, 2013, J BIOL CHEM, V288, P10505, DOI 10.1074/jbc.M112.420489; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cohen-Cymberknoh M, 2011, AM J RESP CRIT CARE, V183, P1463, DOI 10.1164/rccm.201009-1478CI; Farinha CM, 2002, BIOCHEM J, V366, P797, DOI 10.1042/BJ20011717; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Illek B, 2010, CELL PHYSIOL BIOCHEM, V26, P983, DOI 10.1159/000324011; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mickle JE, 1998, CLIN CHEST MED, V19, P443, DOI 10.1016/S0272-5231(05)70092-7; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RICH DP, 1993, RECEPTOR CHANNEL, V1, P221; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; Roth DM, 2011, CURR OPIN CELL BIOL, V23, P126, DOI 10.1016/j.ceb.2010.11.001; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106	33	30	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25636	25645		10.1074/jbc.M115.671925	http://dx.doi.org/10.1074/jbc.M115.671925			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26336106	hybrid, Green Published			2022-12-28	WOS:000362962800036
J	Mann, E; Ovchinnikova, OG; King, JD; Whitfield, C				Mann, Evan; Ovchinnikova, Olga G.; King, Jerry D.; Whitfield, Chris			Bacteriophage-mediated Glucosylation Can Modify Lipopolysaccharide O-Antigens Synthesized by an ATP-binding Cassette (ABC) Transporter-dependent Assembly Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SHIGELLA-FLEXNERI; SALMONELLA-TYPHIMURIUM; KLEBSIELLA-PNEUMONIAE; POLYSACCHARIDE; BIOSYNTHESIS; GENES; CHAIN; CORE; CONVERSION	Lysogenic bacteriophages may encode enzymes that modify the structures of lipopolysaccharide O-antigen glycans, altering the structure of the bacteriophage receptor and resulting in serotype conversion. This can enhance virulence and has implications for antigenic diversity and vaccine development. Side chain glucosylation is a common modification strategy found in a number of bacterial species. To date, glucosylation has only been observed in O-antigens synthesized by Wzy-dependent pathways, one of the two most prevalent O-antigen synthesis systems. Here we exploited a heterologous system to study the glucosylation potential of a model O-antigen produced in an ATP-binding cassette (ABC) transporter-dependent system. Although O-antigen production is cryptic in Escherichia coli K-12, because of a mutation in the synthesis genes, it possesses a prophage glucosylation cluster, which modifies the GlcNAc residue in an alpha-L-Rha-(1 -> 3)-D-GlcNAc motif found in the original O16 antigen. Raoultella terrigena ATCC 33257 produces an O-antigen possessing the same disaccharide motif, but its assembly uses an ABC transporter-dependent system. E. coli harboring the R. terrigena O-antigen biosynthesis genes produced an O-antigen displaying reduced reactivity toward antisera raised against the native R. terrigena repeat structure, indicative of an altered chemical structure. Structural determination using NMR revealed the addition of glucose side chains to the repeat units. O-antigen modification was dependent on a functional ABC transporter, consistent with modification in the periplasm, and was eliminated by deletion of the glucosylation genes from the E. coli chromosome, restoring native level antisera sensitivity and structure. There are therefore no intrinsic mechanistic barriers for bacteriophage-mediated O-antigen glucosylation in ABC transporter-dependent pathways.	[Mann, Evan; Ovchinnikova, Olga G.; King, Jerry D.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd East, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca		Mann, Evan/0000-0003-4685-7264	Natural Sciences and Engineering Research Council of Canada; Alexander Graham Bell Canada Graduate Scholarship from Natural Sciences and Engineering Research Council of Canada; Canada Research Chair	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alexander Graham Bell Canada Graduate Scholarship from Natural Sciences and Engineering Research Council of Canada; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This work was supported by funding (to C. W.) from the Natural Sciences and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada.; Recipient of a Canada Research Chair.	Adams MM, 2001, MICROBIOL-UK, V147, P851, DOI 10.1099/00221287-147-4-851; ALEXEYEV MF, 1995, BIOTECHNIQUES, V18, P52; Allison GE, 2000, TRENDS MICROBIOL, V8, P17, DOI 10.1016/S0966-842X(99)01646-7; Bogomolnaya LM, 2008, MOL MICROBIOL, V70, P1105, DOI 10.1111/j.1365-2958.2008.06461.x; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Davies MR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003568; Greenfield LK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412577; Guan S, 1999, MICROBIOL-UK, V145, P1263, DOI 10.1099/13500872-145-5-1263; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hagelueken G, 2015, NAT STRUCT MOL BIOL, V22, P50, DOI 10.1038/nsmb.2935; HAMMERLING G, 1970, EUR J BIOCHEM, V15, P48, DOI 10.1111/j.1432-1033.1970.tb00974.x; HELANDER IM, 1992, MOL MICROBIOL, V6, P2857, DOI 10.1111/j.1365-2958.1992.tb01465.x; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Iguchi A, 2015, DNA RES, V22, P101, DOI 10.1093/dnares/dsu043; Izquierdo L, 2003, J BACTERIOL, V185, P1634, DOI 10.1128/JB.185.5.1634-1641.2003; JANSSON PE, 1991, J CHEM INF COMP SCI, V31, P508, DOI 10.1021/ci00004a013; King JD, 2014, P NATL ACAD SCI USA, V111, P6407, DOI 10.1073/pnas.1400814111; Knirel YA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P901, DOI 10.1134/S0006297915070093; Kondakova A N, 2010, Bioorg Khim, V36, P429; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; Kubler-Kielb J, 2010, CARBOHYD RES, V345, P1600, DOI 10.1016/j.carres.2010.05.006; Kul'shin V A, 1987, Mol Gen Mikrobiol Virusol, P44; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x; LIU D, 1994, MICROBIOL-UK, V140, P49, DOI 10.1099/13500872-140-1-49; Lundborg M, 2010, GLYCOBIOLOGY, V20, P366, DOI 10.1093/glycob/cwp185; MACPHERSON DF, 1994, MOL MICROBIOL, V11, P281, DOI 10.1111/j.1365-2958.1994.tb00308.x; MAKELA PH, 1988, IMMUNOL LETT, V19, P217, DOI 10.1016/0165-2478(88)90145-9; MAKELA PH, 1966, J BACTERIOL, V91, P1115; Martinic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025557; Mavris M, 1997, MOL MICROBIOL, V26, P939, DOI 10.1046/j.1365-2958.1997.6301997.x; Mertens K, 2010, INNATE IMMUN-LONDON, V16, P366, DOI 10.1177/1753425909350057; NAKANO Y, 1995, GENE, V162, P157, DOI 10.1016/0378-1119(95)00320-6; NIKAIDO H, 1971, J BIOL CHEM, V246, P3902; Panis G, 2007, J BIOL CHEM, V282, P21798, DOI 10.1074/jbc.M701827200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rahman MM, 1997, J BACTERIOL, V179, P2126, DOI 10.1128/jb.179.7.2126-2131.1997; Rojas-Macias MA, 2015, GLYCOBIOLOGY, V25, P341, DOI 10.1093/glycob/cwu116; Rondini S, 2015, INFECT IMMUN, V83, P996, DOI 10.1128/IAI.03079-14; Ruan X, 2012, GLYCOBIOLOGY, V22, P288, DOI 10.1093/glycob/cwr150; RUDEN U, 1974, EUR J BIOCHEM, V48, P11, DOI 10.1111/j.1432-1033.1974.tb03737.x; SASAKI T, 1974, J BIOL CHEM, V249, P761; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; STEVENSON G, 1994, J BACTERIOL, V176, P4144, DOI 10.1128/JB.176.13.4144-4156.1994; STOCKER BAD, 1960, ANN I PASTEUR PARIS, V98, P505; Sun QZ, 2014, GLYCOBIOLOGY, V24, P305, DOI 10.1093/glycob/cwt115; TAKESHITA M, 1971, J BIOL CHEM, V246, P3920; Theillet FX, 2011, GLYCOBIOLOGY, V21, P109, DOI 10.1093/glycob/cwq136; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Willis LM, 2013, P NATL ACAD SCI USA, V110, P20753, DOI 10.1073/pnas.1312637110; WRIGHT A, 1971, J BACTERIOL, V105, P927, DOI 10.1128/JB.105.3.927-936.1971	58	20	20	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25561	25570		10.1074/jbc.M115.660803	http://dx.doi.org/10.1074/jbc.M115.660803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26330553	Green Published, hybrid			2022-12-28	WOS:000362962800030
J	Cai, JC; Zhao, JJ; Zhang, N; Xu, XN; Li, R; Yi, Y; Fang, LS; Zhang, L; Li, MF; Wu, JH; Zhang, H				Cai, Junchao; Zhao, JingJing; Zhang, Nu; Xu, Xiaonan; Li, Rang; Yi, Yang; Fang, Lishan; Zhang, Le; Li, Mengfeng; Wu, Jueheng; Zhang, Heng			MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; HIGH-GRADE ASTROCYTOMAS; NF-KAPPA-B; GLIOBLASTOMA-MULTIFORME; BREAST-CANCER; PROGNOSTIC-SIGNIFICANCE; BETA-CATENIN; IN-VITRO; ACTIVATION; GLIOMA	The molecular mechanism underlying constitutive activation of AKT signaling, which plays essential roles in astrocytoma progression, is not fully characterized. Increasing numbers of studies have reported that microRNAs are involved in the malignant behavior of astrocytoma cells via directly targeting multiple oncogenes or tumor suppressors. Here, we found that microRNA (miR)-542-3p expression was decreased in glioblastoma cell lines and astrocytoma tissues, and reduced levels of miR-542-3p expression correlated with high histopathological grades and poor prognosis of astrocytoma patients. Exogenous miR-542-3p suppressed glioblastoma cell invasion through not only targeting AKT1 itself but also directly down-regulating its two important upstream regulators, namely, integrin-linked kinase and PIK3R1. Notably, overexpressing miR-542-3p decreased AKT1 phosphorylation and directly and indirectly repressed nuclear translocation and transactivation activity of beta-catenin to exert its anti-invasive effect. Furthermore, the miR-542-3p expression level negatively correlated with AKT activity as well as levels of integrin-linked kinase and PIK3R1 in human astrocytoma specimens. These findings suggest that miR-542-3p acts as a negative regulator in astrocytoma progression and that miR-542-3p down-regulation contributes to aberrant activation of AKT signaling, leaving open the possibility that miR-542-3p may be a potential therapeutic target for high grade astrocytoma.	[Cai, Junchao; Xu, Xiaonan; Li, Rang; Fang, Lishan; Zhang, Le; Li, Mengfeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Peoples R China; [Yi, Yang] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou, Peoples R China; [Cai, Junchao; Xu, Xiaonan; Li, Rang; Fang, Lishan; Zhang, Le; Li, Mengfeng; Wu, Jueheng] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China; [Zhao, JingJing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Nu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Heng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurosurg Intens Care Unit, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wu, JH (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China.	wujh@mail.sysu.edu.cn; hengzi00@gmail.com	meng, li/GVT-2063-2022	Xu, Xiaonan/0000-0002-7366-580X	National Natural Science Foundation of China [81472351, 81001121, 81472574, 81330058, 81370072]; National Science and Technique Major Project [201305017, 2012ZX10004213, 311030]; Fundamental Research Funds for the Central Universities [11ykzd06]; Natural Science Foundation of Guangdong Province for Distinguished Young Scholars [S2013050014535]; Science and Technology Planning Project of Guangdong Province [S2012020006147]; Pearl River New Star Science and Technology Program of Guangzhou City [2013J2200022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technique Major Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Guangdong Province for Distinguished Young Scholars; Science and Technology Planning Project of Guangdong Province; Pearl River New Star Science and Technology Program of Guangzhou City	This work was supported by the National Natural Science Foundation of China (Grants 81472351, 81001121, 81472574, 81330058, and 81370072), National Science and Technique Major Project (Grants 201305017, 2012ZX10004213, and 311030), the Fundamental Research Funds for the Central Universities (Grant 11ykzd06), the Natural Science Foundation of Guangdong Province for Distinguished Young Scholars (Grant S2013050014535), The Key Project Supported by the Science and Technology Planning Project of Guangdong Province (Grant S2012020006147), and the Pearl River New Star Science and Technology Program of Guangzhou City (Grant 2013J2200022). The authors declare that they have no potential conflicts of interest.	Antonelli M, 2012, NEUROPATHOLOGY, V32, P133, DOI 10.1111/j.1440-1789.2011.01252.x; Arko L, 2010, PHARMACOL THERAPEUT, V128, P1, DOI 10.1016/j.pharmthera.2010.04.015; Balmaceda C, 2008, CANCER-AM CANCER SOC, V112, P1139, DOI 10.1002/cncr.23167; Bleeker FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005638; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cortez Valerie, 2011, Front Biosci (Schol Ed), V3, P788, DOI 10.2741/s187; Edwards LA, 2008, MOL CANCER THER, V7, P59, DOI 10.1158/1535-7163.MCT-07-0329; Filipenko NR, 2005, ONCOGENE, V24, P5837, DOI 10.1038/sj.onc.1208737; Fu YC, 2009, CANCER BIOL THER, V8, P1002, DOI 10.4161/cbt.8.11.8285; Garofalo M, 2013, DRUG RESIST UPDATE, V16, P47, DOI 10.1016/j.drup.2013.05.001; Han L, 2010, BRAIN RES, V1366, P9, DOI 10.1016/j.brainres.2010.09.097; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; He T, 2014, J PATHOL, V232, P499, DOI 10.1002/path.4324; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Kahlert UD, 2012, CANCER LETT, V325, P42, DOI 10.1016/j.canlet.2012.05.024; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kwiatkowska A, 2011, BBA-MOL CELL RES, V1813, P655, DOI 10.1016/j.bbamcr.2011.01.020; Li CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027053; Li H, 2009, INNATE IMMUN-LONDON, V15, P143, DOI 10.1177/1753425908101509; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Li J, 2010, INT J CANCER, V126, P1436, DOI 10.1002/ijc.24824; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matheny RW, 2009, EXP BIOL MED, V234, P1264, DOI 10.3181/0904-MR-138; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Murga C, 2002, ONCOGENE, V21, P207, DOI 10.1038/sj.onc.1205036; Oneyama C, 2012, ONCOGENE, V31, P1623, DOI 10.1038/onc.2011.367; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; Quayle SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049466; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Sonoda Y, 2001, CANCER RES, V61, P6674; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; Wang Y, 2008, SCAND J IMMUNOL, V68, P383, DOI 10.1111/j.1365-3083.2008.02147.x; Weber GL, 2011, ONCOTARGET, V2, P833; Williams SP, 2011, CANCER RES, V71, P5374, DOI 10.1158/0008-5472.CAN-10-3026; Yoon S, 2010, FEBS LETT, V584, P4048, DOI 10.1016/j.febslet.2010.08.025; Zhang BB, 2009, INT J CANCER, V125, P585, DOI 10.1002/ijc.24314; Zhang JX, 2010, ONCOL REP, V24, P65, DOI 10.3892/or_00000829	42	47	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24678	24688		10.1074/jbc.M115.649004	http://dx.doi.org/10.1074/jbc.M115.649004			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26286747	Green Published, hybrid			2022-12-28	WOS:000362598300005
J	Sparta, B; Pargett, M; Minguet, M; Distor, K; Bell, G; Albeck, JG				Sparta, Breanne; Pargett, Michael; Minguet, Marta; Distor, Kevin; Bell, George; Albeck, John G.			Receptor Level Mechanisms Are Required for Epidermal Growth Factor (EGF)-stimulated Extracellular Signal-regulated Kinase (ERK) Activity Pulses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; EARLY GENE-PRODUCTS; NEGATIVE-FEEDBACK; POSITIVE FEEDBACK; MULTISITE PHOSPHORYLATION; QUANTITATIVE-ANALYSIS; ACTIVATION; PROTEIN; RAS; DYNAMICS	In both physiological and cell culture systems, EGF-stimulated ERK activity occurs in discrete pulses within individual cells. Many feedback loops are present in the EGF receptor (EGFR)-ERK network, but the mechanisms driving pulsatile ERK kinetics are unknown. Here, we find that in cells that respond to EGF with frequency-modulated pulsatile ERK activity, stimulation through a heterologous TrkA receptor system results in non-pulsatile, amplitude-modulated activation of ERK. We further dissect the kinetics of pulse activity using a combination of FRET-and translocation-based reporters and find that EGFR activity is required to maintain ERK activity throughout the 10-20-minute lifetime of pulses. Together, these data indicate that feedbacks operating within the core Ras-Raf-MEK-ERK cascade are insufficient to drive discrete pulses of ERK activity and instead implicate mechanisms acting at the level of EGFR.	[Sparta, Breanne; Pargett, Michael; Minguet, Marta; Distor, Kevin; Albeck, John G.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Bell, George] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Albeck, JG (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, One Shields Ave, Davis, CA 95616 USA.	jgalbeck@ucdavis.edu			American Cancer Society [IRG-95-125-16]	American Cancer Society(American Cancer Society)	This work was supported in part by the American Cancer Society (IRG-95-125-16). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134708; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Ariotti N, 2010, MOL CELL BIOL, V30, P3795, DOI 10.1128/MCB.01615-09; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; BASU T, 1994, ONCOGENE, V9, P3483; Bessman NJ, 2014, CELL REP, V9, P1306, DOI 10.1016/j.celrep.2014.10.010; Birtwistle MR, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-109; Birtwistle MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027823; Blinov ML, 2006, BIOSYSTEMS, V83, P136, DOI 10.1016/j.biosystems.2005.06.014; Bluthgen N, 2006, FEBS J, V273, P895, DOI 10.1111/j.1742-4658.2006.05105.x; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Chickarmane V, 2007, J THEOR BIOL, V244, P68, DOI 10.1016/j.jtbi.2006.05.013; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Fujita Y, 2014, FEBS J, V281, P3177, DOI 10.1111/febs.12852; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Graham NA, 2004, J BIOL CHEM, V279, P23517, DOI 10.1074/jbc.M314055200; Hao N, 2013, SCIENCE, V339, P460, DOI 10.1126/science.1227299; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Hiratsuka T, 2015, ELIFE, V4, DOI 10.7554/eLife.05178; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; Janes KA, 2010, NAT METHODS, V7, P311, DOI [10.1038/nmeth.1442, 10.1038/NMETH.1442]; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Kang BH, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003624; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kleiman LB, 2011, MOL CELL, V43, P723, DOI 10.1016/j.molcel.2011.07.014; KNAUER DJ, 1984, J BIOL CHEM, V259, P5623; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Kwong LN, 2012, NAT MED, V18, P1503, DOI 10.1038/nm.2941; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Niepel M, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004379; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Regot S, 2014, CELL, V157, P1724, DOI 10.1016/j.cell.2014.04.039; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Shin SY, 2010, CANCER RES, V70, P6715, DOI 10.1158/0008-5472.CAN-10-1377; Shin SY, 2009, J CELL SCI, V122, P425, DOI 10.1242/jcs.036319; Shvartsman SY, 2002, AM J PHYSIOL-CELL PH, V282, pC545, DOI 10.1152/ajpcell.00260.2001; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Tang WYY, 2014, CELL REP, V8, P1722, DOI 10.1016/j.celrep.2014.08.026; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Vanhecke E, 2011, CLIN CANCER RES, V17, P1741, DOI 10.1158/1078-0432.CCR-10-1890; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008; Zwang YR, 2011, MOL CELL, V42, P524, DOI 10.1016/j.molcel.2011.04.017	57	55	55	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24784	24792		10.1074/jbc.M115.662247	http://dx.doi.org/10.1074/jbc.M115.662247			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26304118	hybrid, Green Published			2022-12-28	WOS:000362598300014
J	Merrick, WC				Merrick, William C.			eIF4F: A Retrospective	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							EUKARYOTIC TRANSLATION INITIATION; CAP-BINDING-PROTEIN; MESSENGER-RNA TRANSLATION; INFECTED HELA-CELLS; IRES-MEDIATED TRANSLATION; DEAD-BOX HELICASE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; FACTOR 4A; INHIBITS TRANSLATION	The original purification of the heterotrimeric eIF4F was published over 30 years ago (Grifo, J. A., Tahara, S. M., Morgan, M. A., Shatkin, A. J., and Merrick, W. C. (1983) J. Biol. Chem. 258, 5804-5810). Since that time, numerous studies have been performed with the three proteins specifically required for the translation initiation of natural mRNAs, eIF4A, eIF4B, and eIF4F. These have involved enzymatic and structural studies of the proteins and a number of site-directed mutagenesis studies. The regulation of translation exhibited through the mammalian target of rapamycin (mTOR) pathway is predominately seen as the phosphorylation of 4E-BP, an inhibitor of protein synthesis that functions by binding to the cap binding subunit of eIF4F (eIF4E). A hypothesis that requires the disassembly of eIF4F during translation initiation to yield free subunits (eIF4A, eIF4E, and eIF4G) is presented.	Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University	Merrick, WC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	wcm2@case.edu			School of Medicine, Case Western Reserve University	School of Medicine, Case Western Reserve University	This work was supported in part by the School of Medicine, Case Western Reserve University. The author declares that he has no conflicts of interest with the contents of this article.	ABRAMSON RD, 1988, J BIOL CHEM, V263, P6016; ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; ALTMANN M, 1995, EMBO J, V14, P3820, DOI 10.1002/j.1460-2075.1995.tb00051.x; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Bellsolell L, 2006, STRUCTURE, V14, P913, DOI 10.1016/j.str.2006.03.012; BERGMANN JE, 1979, J BIOL CHEM, V254, P1927; Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505; BOTH GW, 1975, CELL, V6, P185, DOI 10.1016/0092-8674(75)90009-4; Brown CJ, 2009, CELL CYCLE, V8, P1905, DOI 10.4161/cc.8.12.8742; Browning Karen S, 2015, Arabidopsis Book, V13, pe0176, DOI 10.1199/tab.0176; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Chuang RY, 1997, SCIENCE, V275, P1468, DOI 10.1126/science.275.5305.1468; Dennis MD, 2012, J BIOL CHEM, V287, P42890, DOI 10.1074/jbc.M112.404822; DUNCAN R, 1983, J BIOL CHEM, V258, P7228; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; Feoktistova K, 2013, P NATL ACAD SCI USA, V110, P13339, DOI 10.1073/pnas.1303781110; Fonseca BD, 2014, SEMIN CELL DEV BIOL, V36, P102, DOI 10.1016/j.semcdb.2014.09.014; Fraser CS, 2015, BIOCHIMIE, V114, P58, DOI 10.1016/j.biochi.2015.02.017; Garcia-Garcia C, 2015, SCIENCE, V348, P1486, DOI 10.1126/science.aaa5089; GODEFROYCOLBURN T, 1985, EUR J BIOCHEM, V147, P549; GODEFROYCOLBURN T, 1981, J BIOL CHEM, V256, P1762; Grifo J. A., 1982, THESIS; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; HANSEN J, 1982, J VIROL, V42, P200, DOI 10.1128/JVI.42.1.200-207.1982; HELLMANN GM, 1982, J BIOL CHEM, V257, P4056; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Hilliker A, 2011, MOL CELL, V43, P962, DOI 10.1016/j.molcel.2011.08.008; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; HU CB, 1994, P NATL ACAD SCI USA, V91, P3730, DOI 10.1073/pnas.91.9.3730; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jankowsky E, 2010, RSC BIOMOL SCI, P1, DOI 10.1039/9781849732215; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Komar AA, 2012, GENE, V502, P75, DOI 10.1016/j.gene.2012.04.039; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; LANKER S, 1992, J BIOL CHEM, V267, P21167; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; Lukhele S, 2013, STRUCTURE, V21, P2186, DOI 10.1016/j.str.2013.08.030; Malys N, 2011, CELL MOL LIFE SCI, V68, P991, DOI 10.1007/s00018-010-0588-z; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Meng HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086104; Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1; Merrick WC, 2010, J BIOL CHEM, V285, P21197, DOI 10.1074/jbc.R110.111476; Methot N, 1996, MOL CELL BIOL, V16, P5328; Mitchell SF, 2010, MOL CELL, V39, P950, DOI 10.1016/j.molcel.2010.08.021; Nielsen KH, 2009, RNA, V15, P67, DOI 10.1261/rna.1283109; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Ozes AR, 2011, J MOL BIOL, V412, P674, DOI 10.1016/j.jmb.2011.08.004; Otero LJ, 1999, EMBO J, V18, P3153, DOI 10.1093/emboj/18.11.3153; PADILLA M, 1978, J BIOL CHEM, V253, P5939; Papadopoulos E, 2014, P NATL ACAD SCI USA, V111, pE3187, DOI 10.1073/pnas.1410250111; Park EH, 2013, J BIOL CHEM, V288, P2340, DOI 10.1074/jbc.M112.398537; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pelletier J, 2015, CANCER RES, V75, P250, DOI 10.1158/0008-5472.CAN-14-2789; Perzlmaier AF, 2013, J BIOL CHEM, V288, P21537, DOI 10.1074/jbc.M113.472290; Peter D, 2015, MOL CELL, V57, P1074, DOI 10.1016/j.molcel.2015.01.017; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Rajagopal V, 2012, J BIOL CHEM, V287, P20301, DOI 10.1074/jbc.M112.347278; Ranji A, 2010, RNA BIOL, V7, P775, DOI 10.4161/rna.7.6.14249; RAY BK, 1985, J BIOL CHEM, V260, P7651; Richter NJ, 1999, J BIOL CHEM, V274, P35415, DOI 10.1074/jbc.274.50.35415; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Safaee N, 2012, MOL CELL, V48, P375, DOI 10.1016/j.molcel.2012.09.001; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; SONENBERG N, 1977, P NATL ACAD SCI USA, V74, P4288, DOI 10.1073/pnas.74.10.4288; SONENBERG N, 1978, P NATL ACAD SCI USA, V75, P4843, DOI 10.1073/pnas.75.10.4843; SONENBERG N, 1979, P NATL ACAD SCI USA, V76, P4345, DOI 10.1073/pnas.76.9.4345; Soto-Rifo R, 2012, EMBO J, V31, P3745, DOI 10.1038/emboj.2012.220; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Svitkin YV, 2005, MOL CELL BIOL, V25, P10556, DOI 10.1128/MCB.25.23.10556-10565.2005; Svitkin YV, 2001, RNA, V7, P1743; TAHARA SM, 1981, J BIOL CHEM, V256, P7691; TEMPLE G, 1975, BIOCHEM BIOPH RES CO, V63, P971, DOI 10.1016/0006-291X(75)90664-6; TRACHSEL H, 1980, P NATL ACAD SCI-BIOL, V77, P770, DOI 10.1073/pnas.77.2.770; von der Haar T, 2002, MOL MICROBIOL, V46, P531, DOI 10.1046/j.1365-2958.2002.03172.x; WEBB NR, 1984, BIOCHEMISTRY-US, V23, P177, DOI 10.1021/bi00297a001; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; YODERHILL J, 1993, J BIOL CHEM, V268, P5566; ZANKOWALCZEWSKA M, 1977, NUCLEIC ACIDS RES, V4, P3065, DOI 10.1093/nar/4.9.3065	90	89	89	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24091	24099		10.1074/jbc.R115.675280	http://dx.doi.org/10.1074/jbc.R115.675280			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26324716	Green Published, hybrid			2022-12-28	WOS:000362218900005
J	Yung, YL; Cheung, MY; Miao, R; Fong, YH; Li, KP; Yu, MH; Chye, ML; Wong, KB; Lam, HM				Yung, Yuk-Lin; Cheung, Ming-Yan; Miao, Rui; Fong, Yu-Hang; Li, Kwan-Pok; Yu, Mei-Hui; Chye, Mee-Len; Wong, Kam-Bo; Lam, Hon-Ming			Site-directed Mutagenesis Shows the Significance of Interactions with Phospholipids and the G-protein OsYchF1 for the Physiological Functions of the Rice GTPase-activating Protein 1 (OsGAP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C2 DOMAIN; MEMBRANE-BINDING; ARF-GAP; EXPRESSION; IDENTIFICATION; ASSOCIATION; GENES; MODEL; BAP1	The C2 domain is one of the most diverse phospholipid-binding domains mediating cellular signaling. One group of C2-domain proteins are plant-specific and are characterized by their small sizes and simple structures. We have previously reported that a member of this group, OsGAP1, is able to alleviate salt stress and stimulate defense responses, and bind to both phospholipids and an unconventional G-protein, OsYchF1. Here we solved the crystal structure of OsGAP1 to a resolution of 1.63 angstrom. Using site-directed mutagenesis, we successfully differentiated between the clusters of surface residues that are required for binding to phospholipids versus OsYchF1, which, in turn, is critical for its role in stimulating defense responses. On the other hand, the ability to alleviate salt stress by OsGAP1 is dependent only on its ability to bind OsYchF1 and is independent of its phospholipid-binding activity.	[Yung, Yuk-Lin; Cheung, Ming-Yan; Miao, Rui; Fong, Yu-Hang; Li, Kwan-Pok; Yu, Mei-Hui; Wong, Kam-Bo; Lam, Hon-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Yung, Yuk-Lin; Cheung, Ming-Yan; Miao, Rui; Li, Kwan-Pok; Yu, Mei-Hui; Lam, Hon-Ming] Chinese Univ Hong Kong, Partner State Key Lab Agrobiotechnol, Ctr Soybean Res, Shatin, Hong Kong, Peoples R China; [Fong, Yu-Hang; Wong, Kam-Bo] Chinese Univ Hong Kong, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China; [Miao, Rui; Chye, Mee-Len] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong	Lam, HM (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Soybean Res, Partner State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China.	honming@cuhk.edu.hk	Miao, Rui/AAD-4159-2020; Lam, Hon-Ming/A-9866-2008; Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021; Chye, Mee Len/A-2740-2010	Miao, Rui/0000-0003-0956-6310; Lam, Hon-Ming/0000-0002-6673-8740; Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373; Yung, Yuk-Lin/0000-0002-9175-2915; Chye, Mee Len/0000-0003-3505-3674	Hong Kong Research Grants Council (General Research Fund) [468013]; Hong Kong Research Grants Council (Area of Excellence) [AoE/M-05/12]	Hong Kong Research Grants Council (General Research Fund)(Hong Kong Research Grants Council); Hong Kong Research Grants Council (Area of Excellence)(Hong Kong Research Grants Council)	This work was supported by grants from the Hong Kong Research Grants Council (General Research Fund: 468013; Area of Excellence: AoE/M-05/12) (to H. M. L., K. B. W., and M. L. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bechtold N, 1998, METH MOL B, V82, P259; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; BREARS T, 1993, PLANT PHYSIOL, V103, P1285, DOI 10.1104/pp.103.4.1285; Cheung MY, 2008, NEW PHYTOL, V179, P530, DOI 10.1111/j.1469-8137.2008.02473.x; Cheung MY, 2013, PLANT CELL ENVIRON, V36, P2008, DOI 10.1111/pce.12108; Cheung MY, 2010, J BIOL CHEM, V285, P37359, DOI 10.1074/jbc.M110.172080; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fong YH, 2011, J BIOL CHEM, V286, P43241, DOI 10.1074/jbc.M111.296830; Fukuda M, 1996, J BIOL CHEM, V271, P8430, DOI 10.1074/jbc.271.14.8430; GAWLER DJ, 1995, BIOCHEM J, V307, P487, DOI 10.1042/bj3070487; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hokanson DE, 2012, MOL BIOL CELL, V23, P701, DOI 10.1091/mbc.E11-06-0521; Jensen RB, 2000, PLANT MOL BIOL, V44, P799, DOI 10.1023/A:1026509002161; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kojima T, 1996, J BIOCHEM-TOKYO, V120, P671; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kopka J, 1998, PLANT MOL BIOL, V36, P627, DOI 10.1023/A:1005915020760; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; MORAN R, 1980, PLANT PHYSIOL, V65, P478, DOI 10.1104/pp.65.3.478; Msanne J, 2011, PLANTA, V234, P97, DOI 10.1007/s00425-011-1387-y; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Ochoa WF, 2001, J MOL BIOL, V311, P837, DOI 10.1006/jmbi.2001.4910; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Rodriguez L, 2014, PLANT CELL, V26, P4802, DOI 10.1105/tpc.114.129973; Sato M, 2003, LIFE SCI, V73, P917, DOI 10.1016/S0024-3205(03)00355-2; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Stahelin RV, 2009, J LIPID RES, V50, pS299, DOI 10.1194/jlr.R800078-JLR200; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang HM, 2012, PLANT CELL ENVIRON, V35, P1932, DOI 10.1111/j.1365-3040.2012.02526.x; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yang HJ, 2007, PLANT PHYSIOL, V145, P135, DOI 10.1104/pp.107.100800; Yang HJ, 2006, PLANT J, V48, P238, DOI 10.1111/j.1365-313X.2006.02869.x; Yang WQ, 2008, MOL PLANT, V1, P770, DOI 10.1093/mp/ssn035; Zhang DP, 2010, GENE, V469, P18, DOI 10.1016/j.gene.2010.08.006; Zhuang X, 2005, PLANT CELL ENVIRON, V28, P147, DOI 10.1111/j.1365-3040.2004.01253.x	47	8	9	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23984	23996		10.1074/jbc.M115.655639	http://dx.doi.org/10.1074/jbc.M115.655639			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26286751	Green Published, hybrid			2022-12-28	WOS:000361816500042
J	Ahmed, M; Cheng, M; Zhao, Q; Goldgur, Y; Cheal, SM; Guo, HF; Larson, SM; Cheung, NKV				Ahmed, Mahiuddin; Cheng, Ming; Zhao, Qi; Goldgur, Yehuda; Cheal, Sarah M.; Guo, Hong-Fen; Larson, Steven M.; Cheung, Nai-Kong V.			Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COSTIMULATORY MOLECULE B7-H3; B7 FAMILY-MEMBER; INTERSTITIAL INFUSION; THERAPEUTIC ANTIBODY; CRYSTAL-STRUCTURE; PROSTATE-CANCER; CELL; EXPRESSION; TARGET; RECEPTOR	B7-H3 (CD276) is both an inhibitory ligand for natural killer cells and T cells and a tumor antigen that is widely expressed among human solid tumors. Anti-B7-H3 mouse monoclonal antibody 8H9 has been successfully used for radioimmunotherapy for patients with B7-H3(+) tumors. We present the humanization, affinity maturation, and epitope mapping of 8H9 based on structure determination, modeling, and yeast display methods. The crystal structure of ch8H9 Fab fragment was solved to 2.5-angstrom resolution and used as a template for humanization. By displaying the humanized 8H9 single chain Fv (scFv) on the surface of yeast, the affinity was matured by sequential random mutagenesis and fluorescence-activated cell sorting. Six mutations (three in the complementarity-determining region and three in the framework regions) were identified and incorporated into an affinity-matured humanized 8H9 construct (hu8H9-6m) and an affinity-matured chimeric 8H9 construct (ch8H9-6m). The hu8H9-6m scFv had a 160-fold improvement in affinity (0.9 nM K-D) compared with parental hu8H9 scFv (144 nM K-D). The IgG formats of ch8H9-6m and hu8H9-6m (nanomolar to subnanomolar K-D) had 2-9-fold enhancements in affinity compared with their parental forms, potent in vitro antibody-dependent cell-mediated cytotoxicity (0.1-0.3 mu g/ml EC50), and high tumor uptake in mouse xenografts. Based on in silico docking studies and experimental validation, the molecular epitope of 8H9 was determined to be dependent on the FG loop of B7-H3, a region critical to its function in immunologic blockade and unique among anti-B7-H3 antibodies published to date.	[Ahmed, Mahiuddin; Cheng, Ming; Zhao, Qi; Guo, Hong-Fen; Cheung, Nai-Kong V.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA; [Cheal, Sarah M.; Larson, Steven M.] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA; [Goldgur, Yehuda] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Larson, Steven M.] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Cheung, NKV (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10065 USA.	cheungn@mskcc.org		Zhao, Qi/0000-0002-5969-6407	National Institutes of Health Cancer Center Support Grant [P30 CA008748]; NIGMS, National Institutes of Health [P41 GM103403]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Dr. Jian Hu for excellent technical assistance. Experimental support was provided by the Memorial Sloan Kettering Cancer Center X-ray Crystallography Core facility, which is funded by National Institutes of Health Cancer Center Support Grant P30 CA008748. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by NIGMS, National Institutes of Health Grant P41 GM103403. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmed M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00372; Boorjian SA, 2008, CLIN CANCER RES, V14, P4800, DOI 10.1158/1078-0432.CCR-08-0731; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Calabro L, 2011, J CELL PHYSIOL, V226, P2595, DOI 10.1002/jcp.22600; Castriconi R, 2004, P NATL ACAD SCI USA, V101, P12640, DOI 10.1073/pnas.0405025101; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cheung IY, 2014, GENE CHROMOSOME CANC, V53, P803, DOI 10.1002/gcc.22189; Cheung NKV, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19864; Cheung NKV, 2003, HYBRIDOMA HYBRIDOM, V22, P209, DOI 10.1089/153685903322328938; Crispen PL, 2008, CLIN CANCER RES, V14, P5150, DOI 10.1158/1078-0432.CCR-08-0536; Godal R, 2010, BIOL BLOOD MARROW TR, V16, P612, DOI 10.1016/j.bbmt.2010.01.019; Gregorio A, 2008, HISTOPATHOLOGY, V53, P73, DOI 10.1111/j.1365-2559.2008.03070.x; Harlow E., 1999, USING ANTIBODIES LAB, P330; He P, 2011, EUR J NUCL MED MOL I, V38, P334, DOI 10.1007/s00259-010-1633-8; Hofmeyer KA, 2008, P NATL ACAD SCI USA, V105, P10277, DOI 10.1073/pnas.0805458105; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Juhl H, 1997, IMMUNOBIOLOGY, V197, P444, DOI 10.1016/S0171-2985(97)80078-2; Kramer K, 2007, J CLIN ONCOL, V25, P5465, DOI 10.1200/JCO.2007.11.1807; Kramer K, 2010, J NEURO-ONCOL, V97, P409, DOI 10.1007/s11060-009-0038-7; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P10483, DOI 10.1073/pnas.0804453105; Lemke D, 2012, CLIN CANCER RES, V18, P105, DOI 10.1158/1078-0432.CCR-11-0880; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Loo D, 2012, CLIN CANCER RES, V18, P3834, DOI 10.1158/1078-0432.CCR-12-0715; Loos M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-463; Luther N, 2010, MOL CANCER THER, V9, P1039, DOI 10.1158/1535-7163.MCT-09-0996; Luther N, 2008, NEUROSURGERY, V63, P1166, DOI 10.1227/01.NEU.0000334052.60634.84; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Modak S, 2005, CANCER BIOTHER RADIO, V20, P534, DOI 10.1089/cbr.2005.20.534; Modak S, 2001, CANCER RES, V61, P4048; Onda M, 2004, CANCER RES, V64, P1419, DOI 10.1158/0008-5472.CAN-03-0570; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Romagne F, 2009, BLOOD, V114, P2667, DOI 10.1182/blood-2009-02-206532; Roth TJ, 2007, CANCER RES, V67, P7893, DOI 10.1158/0008-5472.CAN-07-1068; SALACINSKI PRP, 1981, ANAL BIOCHEM, V117, P136, DOI 10.1016/0003-2697(81)90703-X; Sanchez R, 1997, PROTEINS, P50; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Sun X, 2003, GENE THER, V10, P1728, DOI 10.1038/sj.gt.3302070; Tarek N, 2012, J CLIN INVEST, V122, P3260, DOI 10.1172/JCI62749; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vigdorovich V, 2013, STRUCTURE, V21, P707, DOI 10.1016/j.str.2013.03.003; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070689; Wilcox RA, 2012, EUR J HAEMATOL, V88, P465, DOI 10.1111/j.1600-0609.2012.01766.x; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wu CP, 2006, WORLD J GASTROENTERO, V12, P457, DOI 10.3748/wjg.v12.i3.457; Xu H, 2009, CANCER RES, V69, P6275, DOI 10.1158/0008-5472.CAN-08-4517; Yamato I, 2009, BRIT J CANCER, V101, P1709, DOI 10.1038/sj.bjc.6605375; Zang X, 2007, P NATL ACAD SCI USA, V104, P19458, DOI 10.1073/pnas.0709802104; Zang XX, 2010, MODERN PATHOL, V23, P1104, DOI 10.1038/modpathol.2010.95; Zhao Q, 2015, LEUKEMIA, V29, P2238, DOI 10.1038/leu.2015.125; Zhao Q, 2015, J BIOL CHEM, V290, P13017, DOI 10.1074/jbc.M115.650903; Zhao Q, 2011, MOL CANCER THER, V10, P1677, DOI 10.1158/1535-7163.MCT-11-0281; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108; Zhou ZP, 2013, J NEURO-ONCOL, V111, P257, DOI 10.1007/s11060-012-1021-2	65	67	77	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30018	30029		10.1074/jbc.M115.679852	http://dx.doi.org/10.1074/jbc.M115.679852			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26487718	Green Published, hybrid			2022-12-28	WOS:000366614700033
J	Silva, IR; Serrao, VHB; Manzine, LR; Faim, LM; da Silva, MTA; Makki, R; Saidemberg, DM; Cornelio, ML; Palma, MS; Thiemann, OH				Silva, Ivan R.; Serrao, Vitor H. B.; Manzine, Livia R.; Faim, Livia M.; da Silva, Marco T. A.; Makki, Raphaela; Saidemberg, Daniel M.; Cornelio, Marinonio L.; Palma, Marrio S.; Thiemann, Otavio H.			Formation of a Ternary Complex for Selenocysteine Biosynthesis in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; ESCHERICHIA-COLI; SECONDARY STRUCTURE; PROTEIN-STRUCTURE; SYNTHASE SELA; TRANSFER-RNA; SELENIUM; IDENTITY	The synthesis of selenocysteine-containing proteins (selenoproteins) involves the interaction of selenocysteine synthase (SelA), tRNA (tRNA(Sec)), selenophosphate synthetase (SelD, SPS), a specific elongation factor (SelB), and a specific mRNA sequence known as selenocysteine insertion sequence (SECIS). Because selenium compounds are highly toxic in the cellular environment, the association of selenium with proteins throughout its metabolism is essential for cell survival. In this study, we demonstrate the interaction of SPS with the SelA-tRNA(Sec) complex, resulting in a 1.3-MDa ternary complex of 27.0 +/- 0.5 nm in diameter and 4.02 +/- 0.05 nm in height. To assemble the ternary complex, SPS undergoes a conformational change. We demonstrated that the glycine-rich N-terminal region of SPS is crucial for the SelA-tRNA(Sec)-SPS interaction and selenoprotein biosynthesis, as revealed by functional complementation experiments. Taken together, our results provide new insights into selenoprotein biosynthesis, demonstrating for the first time the formation of the functional ternary SelA-tRNA(Sec)-SPS complex. We propose that this complex is necessary for proper selenocysteine synthesis and may be involved in avoiding the cellular toxicity of selenium compounds.	[Silva, Ivan R.; Serrao, Vitor H. B.; Manzine, Livia R.; Faim, Livia M.; da Silva, Marco T. A.; Makki, Raphaela; Thiemann, Otavio H.] Univ Sao Paulo, Phys Inst Sao Carlos, Phys & Informat Dept, BR-13563120 Sao Carlos, SP, Brazil; [Serrao, Vitor H. B.] Univ Fed Sao Carlos, Dept Phys, BR-13565905 Sao Carlos, SP, Brazil; [Saidemberg, Daniel M.; Palma, Marrio S.] Sao Paulo State Univ, Biosci Inst Rio Claro, Dept Biol CEIS, BR-13506900 Rio Claro, SP, Brazil; [Cornelio, Marinonio L.] Sao Paulo State Univ, Inst Biosci Letters & Exact Sci IBILCE, Dept Phys, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Universidade Estadual Paulista; Universidade Estadual Paulista	Thiemann, OH (corresponding author), Univ Sao Paulo, Phys Inst Sao Carlos, Phys & Informat Dept, Joao Dagnone Av,1100 Jardim Santa Angelina, BR-13563120 Sao Carlos, SP, Brazil.	thiemann@ifsc.usp.br	Palma, Mario Sergio/E-7800-2012; Thiemann, Otavio H/D-9767-2012; Cornelio, Marinonio Lopes/AAC-9215-2020; e Silva, Ivan Rosa/B-5982-2016; Serrao, Vitor Hugo Balasco/AAM-2060-2020; Palma, Mario/N-3903-2019; Manzine, Livia/HDN-9987-2022; Rosa e Silva, Ivan/O-5567-2014	Palma, Mario Sergio/0000-0002-7363-8211; e Silva, Ivan Rosa/0000-0003-4037-2266; Serrao, Vitor Hugo Balasco/0000-0002-9398-2941; Rosa e Silva, Ivan/0000-0003-4732-1517	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57910-0]; CAPES; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [550514/2011-2]; FAPESP [2010/04429-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Research Grant 2008/57910-0 from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), CAPES and by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Grant 550514/2011-2). This work was also supported by FAPESP Fellowship 2010/04429-3 (to I. R. S.). The authors declare that they have no conflicts of interest with the contents of this article.	ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Collins R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030581; EHRENREICH A, 1992, EUR J BIOCHEM, V206, P767, DOI 10.1111/j.1432-1033.1992.tb16983.x; ENGELHARDT H, 1992, MOL MICROBIOL, V6, P3461, DOI 10.1111/j.1365-2958.1992.tb01781.x; Figueira ACM, 2011, MOL ENDOCRINOL, V25, P15, DOI 10.1210/me.2010-0202; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6324; GLASS RS, 1993, BIOCHEMISTRY-US, V32, P12555, DOI 10.1021/bi00210a001; Itoh Y, 2014, J MOL BIOL, V426, P1723, DOI 10.1016/j.jmb.2014.01.003; Itoh Y, 2013, SCIENCE, V340, P75, DOI 10.1126/science.1229521; Itoh Y, 2009, J MOL BIOL, V385, P1456, DOI 10.1016/j.jmb.2008.08.042; Kaiser JT, 2005, BIOCHEMISTRY-US, V44, P13315, DOI 10.1021/bi051110r; Lacourciere GM, 2000, J BIOL CHEM, V275, P23769, DOI 10.1074/jbc.M000926200; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Manzine LR, 2013, FEBS LETT, V587, P906, DOI 10.1016/j.febslet.2013.02.014; Manzine LR, 2013, PROTEIN EXPRES PURIF, V88, P80, DOI 10.1016/j.pep.2012.12.005; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Muller DJ, 2002, PROG BIOPHYS MOL BIO, V79, P1, DOI 10.1016/S0079-6107(02)00009-3; Noinaj N, 2012, J BACTERIOL, V194, P499, DOI 10.1128/JB.06012-11; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sculaccio SA, 2008, MOL BIOCHEM PARASIT, V162, P165, DOI 10.1016/j.molbiopara.2008.08.009; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Takahata M, 2008, J BIOCHEM, V143, P467, DOI 10.1093/jb/mvm247; TREWHELLA J, 1989, BIOCHEMISTRY-US, V28, P1294, DOI 10.1021/bi00429a052; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Yan Xuguang, 2009, V492, P255, DOI 10.1007/978-1-59745-493-3_15; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010	28	12	13	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29178	U103		10.1074/jbc.M114.613406	http://dx.doi.org/10.1074/jbc.M114.613406			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26378233	Green Published, hybrid			2022-12-28	WOS:000366613400006
J	Thys, RG; Wang, YH				Thys, Ryan Griffin; Wang, Yuh-Hwa			DNA Replication Dynamics of the GGGGCC Repeat of the C9orf72 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); DNA; DNA replication; DNA structure; genomic instability	ORIENTATION-DEPENDENT INSTABILITY; TRINUCLEOTIDE REPEATS; HEXANUCLEOTIDE REPEAT; LEADING-STRAND; CGG REPEATS; EXPANSION; STABILITY; FRAGILITY; DELETION; EXHIBIT	DNA has the ability to form a variety of secondary structures in addition to the normal B-form DNA, including hairpins and quadruplexes. These structures are implicated in a number of neurological diseases and cancer. Expansion of a GGGGCC repeat located at C9orf72 is associated with familial amyotrophic lateral sclerosis and frontotemporal dementia. This repeat expands from two to 24 copies in normal individuals to several hundreds or thousands of repeats in individuals with the disease. Biochemical studies have demonstrated that as little as four repeats have the ability to form a stable DNA secondary structure known as a G-quadruplex. Quadruplex structures have the ability to disrupt normal DNA processes such as DNA replication and transcription. Here we examine the role of GGGGCC repeat length and orientation on DNA replication using an SV40 replication system in human cells. Replication through GGGGCC repeats leads to a decrease in overall replication efficiency and an increase in instability in a length-dependent manner. Both repeat expansions and contractions are observed, and replication orientation is found to influence the propensity for expansions or contractions. The presence of replication stress, such as low-dose aphidicolin, diminishes replication efficiency but has no effect on instability. Two-dimensional gel electrophoresis analysis demonstrates a replication stall with as few as 20 GGGGCC repeats. These results suggest that replication of the GGGGCC repeat at C9orf72 is perturbed by the presence of expanded repeats, which has the potential to result in further expansion, leading to disease.	[Thys, Ryan Griffin; Wang, Yuh-Hwa] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Wang, YH (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, 1340 Jefferson Pk Ave, Charlottesville, VA USA.	yw4b@virginia.edu	Regan, Clinton/E-6250-2012	Thys, Ryan/0000-0003-2030-1946	National Institutes of Health [R01GM101192]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant R01GM101192 (to Y. H. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Balakumaran BS, 2000, HUM MOL GENET, V9, P93, DOI 10.1093/hmg/9.1.93; Burrow AA, 2010, NUCLEIC ACIDS RES, V38, P2865, DOI 10.1093/nar/gkp1245; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Cleary JD, 2002, NAT GENET, V31, P37, DOI 10.1038/ng870; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Edamura KN, 2005, AM J HUM GENET, V76, P302, DOI 10.1086/427928; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; GACY AM, 1995, CELL, V81, P533; Gerhardt J, 2014, J CELL BIOL, V206, P599, DOI 10.1083/jcb.201404157; Gerhardt J, 2014, MOL CELL, V53, P19, DOI 10.1016/j.molcel.2013.10.029; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hirst MC, 1998, NUCLEIC ACIDS RES, V26, P2353, DOI 10.1093/nar/26.10.2353; Iyer RR, 1999, J BIOL CHEM, V274, P3865, DOI 10.1074/jbc.274.6.3865; Kim JC, 2013, CURR OPIN GENET DEV, V23, P280, DOI 10.1016/j.gde.2013.04.009; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Metzgar D, 2002, GENOME RES, V12, P408, DOI 10.1101/gr.198602; Mirkin SM, 2002, NAT GENET, V31, P5, DOI 10.1038/ng0502-5; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Pearson CE, 1998, NUCLEIC ACIDS RES, V26, P816, DOI 10.1093/nar/26.3.816; Pelletier R, 2003, MOL CELL BIOL, V23, P1349, DOI 10.1128/MCB.23.4.1349-1357.2003; Petruska J, 1996, NUCLEIC ACIDS RES, V24, P1992, DOI 10.1093/nar/24.11.1992; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Rajeswari MR, 2012, J BIOSCIENCES, V37, P519, DOI 10.1007/s12038-012-9219-1; Reddy K, 2014, NUCLEIC ACIDS RES, V42, P10473, DOI 10.1093/nar/gku658; Reddy K, 2013, J BIOL CHEM, V288, P9860, DOI 10.1074/jbc.C113.452532; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rutherford NJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.005; Samadashwily GM, 1997, NAT GENET, V17, P298, DOI 10.1038/ng1197-298; Schiavone D, 2014, EMBO J, V33, P2507, DOI 10.15252/embj.201488398; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; Voineagu I, 2009, NAT STRUCT MOL BIOL, V16, P226, DOI 10.1038/nsmb.1527; White PJ, 1999, MOL CELL BIOL, V19, P5675	34	19	21	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28953	28962		10.1074/jbc.M115.660324	http://dx.doi.org/10.1074/jbc.M115.660324			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26463209	Green Published, hybrid			2022-12-28	WOS:000365762300034
J	Winkel, AF; Engel, CK; Margerie, D; Kannt, A; Szillat, H; Glombik, H; Kallus, C; Ruf, S; Gussregen, S; Riedel, J; Herling, AW; von Knethen, A; Weigert, A; Brune, B; Schmoll, D				Winkel, Angelika F.; Engel, Christian K.; Margerie, Daniel; Kannt, Aimo; Szillat, Hauke; Glombik, Heiner; Kallus, Christopher; Ruf, Sven; Guessregen, Stefan; Riedel, Jens; Herling, Andreas W.; von Knethen, Andreas; Weigert, Andreas; Bruene, Bernhard; Schmoll, Dieter			Characterization of RA839, a Noncovalent Small Molecule Binder to Keapl and Selective Activator of Nrf2 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTION; OXIDATIVE STRESS; SYNTHETIC OLEANANE; BARDOXOLONE METHYL; RECOGNITION MODEL; KEAP1-NRF2 SYSTEM; KIDNEY-DISEASE; DLG MOTIFS; TRITERPENOIDS; INHIBITOR	The activation of the transcription factor NE-E2-related factor 2 (Nrf2) maintains cellular homeostasis in response to oxidative stress by the regulation of multiple cytoprotective genes. Without stressors, the activity of Nrf2 is inhibited by its interaction with the Keapl (kelch-like ECH-associated protein 1). Here, we describe (3S)-1-[4-[(2,3,5,6-tetramethylphenyl) sulfonylamino]-1-naphthyl] pyrrolidine-3-carboxylic acid (RA839), a small molecule that binds noncovalently to the Nrf2-interacting kelch domain of Keapl with a K-d of similar to 6 mu M, as demonstrated by x-ray co-crystallization and isothermal titration calorimetry. Whole genome DNA arrays showed that at 10 mu M RA839 significantly regulated 105 probe sets in bone marrow-derived macrophages. Canonical pathway mapping of these probe sets revealed an activation of pathways linked with Nrf2 signaling. These pathways were also activated after the activation of Nrf2 by the silencing of Keap1 expression. RA839 regulated only two genes in Nrf2 knock-out macrophages. Similar to the activation of Nrf2 by either silencing of Keap1 expression or by the reactive compound 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid methyl ester (CDDO-Me), RA839 prevented the induction of both inducible nitric-oxide synthase expression and nitric oxide release in response to lipopolysaccharides in macrophages. In mice, RA839 acutely induced Nrf2 target gene expression in liver. RA839 is a selective inhibitor of the Keap1/Nrf2 interaction and a useful tool compound to study the biology of Nrf2.	[Winkel, Angelika F.; Engel, Christian K.; Margerie, Daniel; Kannt, Aimo; Szillat, Hauke; Glombik, Heiner; Kallus, Christopher; Ruf, Sven; Guessregen, Stefan; Riedel, Jens; Herling, Andreas W.; Schmoll, Dieter] Sanofi, R&D, D-65926 Frankfurt, Germany; [Kannt, Aimo] Heidelberg Univ, Med Fac Mannheim, D-69120 Mannheim, Germany; [von Knethen, Andreas; Weigert, Andreas; Bruene, Bernhard] Goethe Univ Frankfurt, Fac Med, Biochem 1, D-60590 Frankfurt, Germany	Sanofi-Aventis; Ruprecht Karls University Heidelberg; Goethe University Frankfurt	Schmoll, D (corresponding author), Sanofi, R&D, Diabet Div, Ind Pk Hoechst, D-65926 Frankfurt, Germany.	dieter.schmoll@sanofi.com	Kannt, Aimo/AAZ-6898-2020; Weigert, Andreas/E-6540-2010	Weigert, Andreas/0000-0002-7529-1952; Schmoll, Dieter/0000-0003-2578-3366; Kannt, Aimo/0000-0002-5197-2286				Anderka O, 2008, J BIOL CHEM, V283, P31333, DOI 10.1074/jbc.M805434200; Baird L, 2014, BIOTECHNOL ADV, V32, P1133, DOI 10.1016/j.biotechadv.2014.03.004; Chen H, 2014, J CLIN INVEST, V124, P2188, DOI 10.1172/JCI72151; Cleasby A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098896; de Zeeuw D, 2013, NEW ENGL J MED, V369, P2492, DOI 10.1056/NEJMoa1306033; Gao B, 2014, CLIN PHARMACOL-ADV A, V6, P19, DOI 10.2147/CPAA.S35078; Gjyshi O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004460; Gold R, 2012, NEW ENGL J MED, V367, P1098, DOI 10.1056/NEJMoa1114287; Hall ET, 2014, DIABETES, V63, P2904, DOI 10.2337/db14-0829; Halland N, 2015, J MED CHEM, V58, P4839, DOI 10.1021/jm501840b; Harris RC, 2013, AM J PHYSIOL-RENAL, V304, pF1086, DOI 10.1152/ajprenal.00693.2012; Haxaire C, 2012, AGING CELL, V11, P336, DOI 10.1111/j.1474-9726.2012.00792.x; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Hu LQ, 2013, BIOORG MED CHEM LETT, V23, P3039, DOI 10.1016/j.bmcl.2013.03.013; Jiang ZY, 2014, J MED CHEM, V57, P2736, DOI 10.1021/jm5000529; Kim SW, 2013, FREE RADICAL BIO MED, V65, P468, DOI 10.1016/j.freeradbiomed.2013.07.028; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kuchler L, 2014, ANTIOXID REDOX SIGN, V21, P2483, DOI 10.1089/ars.2013.5760; Kwak MK, 2010, TOXICOL APPL PHARM, V244, P66, DOI 10.1016/j.taap.2009.08.028; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Marcotte D, 2013, BIOORGAN MED CHEM, V21, P4011, DOI 10.1016/j.bmc.2013.04.019; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Park BK, 2011, NAT REV DRUG DISCOV, V10, P292, DOI 10.1038/nrd3408; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Qiu SL, 2014, J BIOL CHEM, V289, P9449, DOI 10.1074/jbc.M113.543447; Richter M, 2014, J TOXICOL SCI, V39, P353, DOI 10.2131/jts.39.353; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Takaya K, 2012, FREE RADICAL BIO MED, V53, P817, DOI 10.1016/j.freeradbiomed.2012.06.023; To C, 2010, J BIOL CHEM, V285, P27944, DOI 10.1074/jbc.M110.103036; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Tong KI, 2007, MOL CELL BIOL, V27, P7511, DOI 10.1128/MCB.00753-07; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Tran QT, 2009, CARCINOGENESIS, V30, P480, DOI 10.1093/carcin/bgn292; Weerachayaphorn J, 2014, J HEPATOL, V60, P160, DOI 10.1016/j.jhep.2013.08.015; Yates MS, 2007, ACTA PHARMACOL SIN, V28, P1331, DOI 10.1111/j.1745-7254.2007.00688.x; Zhang DD, 2013, ANTIOXID REDOX SIGN, V19, P517, DOI 10.1089/ars.2012.5118; Zoja C, 2014, NEPHROL DIAL TRANSPL, V29, pI19, DOI 10.1093/ndt/gft224; Zong J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053427	39	65	67	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28446	28455		10.1074/jbc.M115.678136	http://dx.doi.org/10.1074/jbc.M115.678136			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26459563	Green Published, hybrid			2022-12-28	WOS:000365761900038
J	Shimizu, M; Kaneko, Y; Ishihara, S; Mochizuki, M; Sakai, K; Yamada, M; Murata, S; Itoh, E; Yamamoto, T; Sugimura, Y; Hirano, T; Takaya, N; Kobayashi, T; Kato, M				Shimizu, Motoyuki; Kaneko, Yuhei; Ishihara, Saaya; Mochizuki, Mai; Sakai, Kiyota; Yamada, Miyuki; Murata, Shunsuke; Itoh, Eriko; Yamamoto, Tatsuya; Sugimura, Yu; Hirano, Tatsuya; Takaya, Naoki; Kobayashi, Tetsuo; Kato, Masashi			Novel beta-1,4-Mannanase Belonging to a New Glycoside Hydrolase Family in Aspergillus nidulans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNAN UTILIZATION SYSTEM; TRANSCRIPTIONAL REGULATOR; BIOCHEMICAL ANALYSES; BETA-MANNANASES; ENZYMES; MECHANISM; CELLULASE; MANR	Many filamentous fungi produce beta-mannan-degrading beta-1,4-mannanases that belong to the glycoside hydrolase 5 (GH5) and GH26 families. Here we identified a novel beta-1,4-mannanase (Man134A) that belongs to a new glycoside hydrolase (GH) family (GH134) in Aspergillus nidulans. Blast analysis of the amino acid sequence using the NCBI protein database revealed that this enzyme had no similarity to any sequences and no putative conserved domains. Protein homologs of the enzyme were distributed to limited fungal and bacterial species. Man134A released mannobiose (M-2), mannotriose (M-3), and mannotetraose (M-4) but not mannopentaose (M-5) or higher manno-oligosaccharides when galactose-free beta-mannan was the substrate from the initial stage of the reaction, suggesting that Man134A preferentially reacts with beta-mannan via a unique catalytic mode. Man134A had high catalytic efficiency (k(cat)/K-m) toward mannohexaose (M-6) compared with the endo-beta-1,4-mannanase Man5C and notably converted M-6 to M-2, M-3, and M-4, with M-3 being the predominant reaction product. The action of Man5C toward beta-mannans was synergistic. The growth phenotype of a Man134A disruptant was poor when beta-mannans were the sole carbon source, indicating that Man134A is involved in beta-mannan degradation in vivo. These findings indicate a hitherto undiscovered mechanism of beta-mannan degradation that is enhanced by the novel beta-1,4-mannanase, Man134A, when combined with other mannanolytic enzymes including various endo-beta-1,4-mannanases.	[Shimizu, Motoyuki; Kaneko, Yuhei; Ishihara, Saaya; Mochizuki, Mai; Sakai, Kiyota; Yamada, Miyuki; Murata, Shunsuke; Yamamoto, Tatsuya; Sugimura, Yu; Hirano, Tatsuya; Kato, Masashi] Meijo Univ, Fac Agr, Nagoya, Aichi 4688502, Japan; [Itoh, Eriko; Takaya, Naoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kobayashi, Tetsuo] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan	Meijo University; University of Tsukuba; Nagoya University	Shimizu, M (corresponding author), Meijo Univ, Fac Agr, Nagoya, Aichi 4688502, Japan.	moshimi@meijo-u.ac.jp	Kato, Masashi/AAG-3755-2021; Kobayashi, Tetsuo/I-6901-2014	Kato, Masashi/0000-0002-8951-3640; Kobayashi, Tetsuo/0000-0002-4008-454X	Science and Technology Research Promotion Program for agriculture, forestry, fisheries, and the food industry;  [21380055];  [25450116]	Science and Technology Research Promotion Program for agriculture, forestry, fisheries, and the food industry; ; 	This work was supported by a Grant-in-aids for Scientific Research (21380055 (to M. S.) and 25450116 (to M. K.). This work was also supported by the Science and Technology Research Promotion Program for agriculture, forestry, fisheries, and the food industry. The authors declare that they have no conflicts of interest with the contents of this article.	Barak S, 2014, INT J BIOL MACROMOL, V66, P74, DOI 10.1016/j.ijbiomac.2014.02.017; Bauer S, 2006, P NATL ACAD SCI USA, V103, P11417, DOI 10.1073/pnas.0604632103; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Chauhan PS, 2012, APPL MICROBIOL BIOT, V93, P1817, DOI 10.1007/s00253-012-3887-5; Chen ZW, 2012, J BIOL CHEM, V287, P25335, DOI 10.1074/jbc.M112.362640; Chiyanzu I, 2014, APPL BIOCHEM BIOTECH, V172, P3538, DOI 10.1007/s12010-014-0770-0; Coradetti ST, 2013, MICROBIOLOGYOPEN, V2, P595, DOI 10.1002/mbo3.94; Coradetti ST, 2012, P NATL ACAD SCI USA, V109, P7397, DOI 10.1073/pnas.1200785109; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; de Vries RP, 2001, MICROBIOL MOL BIOL R, V65, P497, DOI 10.1128/MMBR.65.4.497-522.2001; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Dilokpimol A, 2011, BBA-PROTEINS PROTEOM, V1814, P1720, DOI 10.1016/j.bbapap.2011.08.003; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; JUE CK, 1985, J BIOCHEM BIOPH METH, V11, P109, DOI 10.1016/0165-022X(85)90046-6; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Le Nours K, 2005, BIOCHEMISTRY-US, V44, P12700, DOI 10.1021/bi050779v; Li N., 2014, P 12 EUR C FUNG GEN, P219; Lu HQ, 2014, APPL MICROBIOL BIOT, V98, P2155, DOI 10.1007/s00253-013-5112-6; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Nunes FM, 2006, J AGR FOOD CHEM, V54, P3428, DOI 10.1021/jf052971+; Ogawa M, 2013, BIOSCI BIOTECH BIOCH, V77, P426, DOI 10.1271/bbb.120795; Ogawa M, 2012, FUNGAL GENET BIOL, V49, P987, DOI 10.1016/j.fgb.2012.09.006; Pawar PMA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00118; Recalde MP, 2012, PHYTOCHEMISTRY, V73, P57, DOI 10.1016/j.phytochem.2011.10.002; PULS J, 1993, PORT PR R M, V4, P1; Rosengren A, 2014, APPL MICROBIOL BIOT, V98, P10091, DOI 10.1007/s00253-014-5871-8; Schroder R, 2009, ANN BOT-LONDON, V104, P197, DOI 10.1093/aob/mcp120; Shimizu M, 2009, PROTEOMICS, V9, P7, DOI 10.1002/pmic.200701163; Shimizu M, 2013, BIOSCI BIOTECH BIOCH, V77, P1888, DOI 10.1271/bbb.130334; Shimizu M, 2012, MOL CELL BIOL, V32, P3743, DOI 10.1128/MCB.00032-12; Shimizu M, 2010, APPL ENVIRON MICROB, V76, P1507, DOI 10.1128/AEM.02135-09; Simkovic I, 2013, CARBOHYD POLYM, V95, P697, DOI 10.1016/j.carbpol.2013.03.040; Sims REH, 2010, BIORESOURCE TECHNOL, V101, P1570, DOI 10.1016/j.biortech.2009.11.046; Songsiriritthigul C, 2011, ACTA CRYSTALLOGR F, V67, P217, DOI 10.1107/S1744309110049067; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Takasaki K, 2004, J BIOL CHEM, V279, P12414, DOI 10.1074/jbc.M313761200; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teleman A, 2003, CARBOHYD RES, V338, P525, DOI 10.1016/S0008-6215(02)00491-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsukagoshi H, 2014, J BIOL CHEM, V289, P10843, DOI 10.1074/jbc.M114.555383; Zhao YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014608	43	43	45	3	37	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27914	27927		10.1074/jbc.M115.661645	http://dx.doi.org/10.1074/jbc.M115.661645			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26385921	Green Published, hybrid			2022-12-28	WOS:000365757500040
J	Bruck, I; Kaplan, DL				Bruck, Irina; Kaplan, Daniel L.			The Replication Initiation Protein Sld3/Treslin Orchestrates the Assembly of the Replication Fork Helicase during S Phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC DNA-REPLICATION; CYCLIN-DEPENDENT KINASES; SINGLE-STRANDED-DNA; SACCHAROMYCES-CEREVISIAE; MCM2-7 HELICASE; BUDDING YEAST; ORIGIN DNA; CHROMATIN BINDING; COMPLEX-FORMATION; FISSION YEAST	The initiation of DNA replication is a highly regulated process in eukaryotic cells, and central to the process of initiation is the assembly and activation of the replication fork helicase. The replication fork helicase is comprised of CMG (Cdc45, Mcm2-7, and GINS) in eukaryotic cells, and the mechanism underlying assembly of the CMG during S phase was studied in this article. We identified a point mutation of Sld3 that is specifically defective for Mcm3 and Mcm5 interaction (sld3-m10), and also identified a point mutation of Sld3 that is specifically defective for single-stranded DNA (ssDNA) interaction (sld3-m9). Expression of wild-type levels of sld3-m9 resulted in a severe DNA replication defect with no recruitment of GINS to Mcm2-7, whereas expression of wild-type levels of sld3-m10 resulted in a severe replication defect with no Cdc45 recruitment to Mcm2-7. We propose a model for Sld3-mediated control of replication initiation, wherein Sld3 manages the proper assembly of the CMG during S phase. We also find that the biochemical functions identified for Sld3 are conserved in human Treslin, suggesting that Treslin orchestrates assembly of the CMG in human cells.	[Bruck, Irina; Kaplan, Daniel L.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Kaplan, DL (corresponding author), 1115 W Call St, Tallahassee, FL 32306 USA.	Daniel.Kaplan@med.fsu.edu			Florida State University; National Science Foundation [1265431]	Florida State University; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Florida State University and National Science Foundation Grant 1265431 (to D.L.K.). The authors report no conflict of interest.	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bruck I, 2015, P NATL ACAD SCI USA, V112, P11223, DOI 10.1073/pnas.1509608112; Bruck I, 2015, J BIOL CHEM, V290, P1210, DOI 10.1074/jbc.M114.608232; Bruck I, 2014, J BIOL CHEM, V289, P1948, DOI 10.1074/jbc.M113.532085; Bruck I, 2011, J BIOL CHEM, V286, P36414, DOI 10.1074/jbc.M111.282822; Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Dhingra N, 2015, J BIOL CHEM, V290, P7586, DOI 10.1074/jbc.M115.640383; Dolan WP, 2004, CHROMOSOMA, V113, P145, DOI 10.1007/s00412-004-0302-8; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gregan J, 2003, MOL BIOL CELL, V14, P3876, DOI 10.1091/mbc.E03-02-0090; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Itou H, 2015, ACTA CRYSTALLOGR D, V71, P1649, DOI 10.1107/S1399004715010457; Jares P, 2000, GENE DEV, V14, P1528; Kamimura Y, 1998, MOL CELL BIOL, V18, P6102, DOI 10.1128/MCB.18.10.6102; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kang YH, 2012, P NATL ACAD SCI USA, V109, P6042, DOI 10.1073/pnas.1203734109; Kanke M, 2012, EMBO J, V31, P2182, DOI 10.1038/emboj.2012.68; Kanter DM, 2011, NUCLEIC ACIDS RES, V39, P2580, DOI 10.1093/nar/gkq1222; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Nakajima R, 2002, MOL BIOL CELL, V13, P1462, DOI 10.1091/mbc.02-01-0006; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Sanchez-Pulido L, 2010, CURR BIOL, V20, pR509, DOI 10.1016/j.cub.2010.05.021; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Sawyer SL, 2004, J MOL BIOL, V340, P195, DOI 10.1016/j.jmb.2004.04.066; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka S, 2013, MOL CELL BIOL, V33, P2614, DOI 10.1128/MCB.00431-13; Tanaka S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010371; Tanaka S, 2011, CURR BIOL, V21, P2055, DOI 10.1016/j.cub.2011.11.038; Tognetti S, 2015, CHROMOSOMA, V124, P13, DOI 10.1007/s00412-014-0489-2; van Deursen F, 2012, EMBO J, V31, P2195, DOI 10.1038/emboj.2012.69; Watase G, 2012, CURR BIOL, V22, P343, DOI 10.1016/j.cub.2012.01.023; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	57	13	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27414	27424		10.1074/jbc.M115.688424	http://dx.doi.org/10.1074/jbc.M115.688424			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26405041	Green Published, hybrid			2022-12-28	WOS:000364794000047
J	Fischer, M; Hopkins, AP; Severi, E; Hawkhead, J; Bawdon, D; Watts, AG; Hubbard, RE; Thomas, GH				Fischer, Marcus; Hopkins, Adam P.; Severi, Emmanuele; Hawkhead, Judith; Bawdon, Daniel; Watts, Andrew G.; Hubbard, Roderick E.; Thomas, Gavin H.			Tripartite ATP-independent Periplasmic (TRAP) Transporters Use an Arginine-mediated Selectivity Filter for High Affinity Substrate Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACYTOPLASMIC-SOLUTE-RECEPTOR; TREPONEMA-PALLIDUM LIPOPROTEINS; SIALIC-ACID TRANSPORTER; HAEMOPHILUS-INFLUENZAE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURES; VIRULENCE FACTOR; PROTEIN; FAMILY; SYSTEMS	Tripartite ATP-independent periplasmic (TRAP) transporters are secondary transporters that have evolved an obligate dependence on a substrate-binding protein (SBP) to confer unidirectional transport. Different members of the DctP family of TRAP SBPs have binding sites that recognize a diverse range of organic acid ligands but appear to only share a common electrostatic interaction between a conserved arginine and a carboxylate group in the ligand. We investigated the significance of this interaction using the sialic acid-specific SBP, SiaP, from the Haemophilus influenzae virulence-related SiaPQM TRAP transporter. Using in vitro, in vivo, and structural methods applied to SiaP, we demonstrate that the coordination of the acidic ligand moiety of sialic acid by the conserved arginine (Arg-147) is essential for the function of the transporter as a high affinity scavenging system. However, at high substrate concentrations, the transporter can function in the absence of Arg-147 suggesting that this bi-molecular interaction is not involved in further stages of the transport cycle. As well as being required for high affinity binding, we also demonstrate that the Arg-147 is a strong selectivity filter for carboxylate-containing substrates in TRAP transporters by engineering the SBP to recognize a non-carboxylate-containing substrate, sialylamide, through water-mediated interactions. Together, these data provide biochemical and structural support that TRAP transporters function predominantly as high affinity transporters for carboxylate-containing substrates.	[Fischer, Marcus; Severi, Emmanuele; Hubbard, Roderick E.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Hopkins, Adam P.; Hawkhead, Judith; Bawdon, Daniel; Thomas, Gavin H.] Univ York, Dept Biol, Area 10, York YO10 5YW, N Yorkshire, England; [Watts, Andrew G.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England	University of York - UK; University of York - UK; University of Bath	Thomas, GH (corresponding author), Univ York, Dept Biol, Area 10, POB 373, York YO10 5YW, N Yorkshire, England.	gavin.thomas@york.ac.uk	Fischer, Marcus/M-9841-2018; Thomas, Gavin Hugh/E-5753-2011	Fischer, Marcus/0000-0002-7179-2581; Thomas, Gavin Hugh/0000-0002-9763-1313; Watts, Andrew/0000-0003-4299-2717; Hopkins, Adam/0000-0002-1731-0350	Biotechnology and Biological Sciences Research Council [BBC509807, BBF0147591]; Wild Fund; BBSRC [BB/F014759/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C509807/1, BB/F014759/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wild Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BBC509807 and BBF0147591 (to G. H. T.), and funding from the Wild Fund (to M. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama N, 2009, J MOL BIOL, V392, P559, DOI 10.1016/j.jmb.2009.07.043; Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; ANDREWS PR, 1984, J MED CHEM, V27, P1648, DOI 10.1021/jm00378a021; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; Brautigam CA, 2012, J MOL BIOL, V420, P70, DOI 10.1016/j.jmb.2012.04.001; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Deka RK, 2012, J MOL BIOL, V416, P678, DOI 10.1016/j.jmb.2012.01.015; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fischer M, 2010, TRENDS MICROBIOL, V18, P471, DOI 10.1016/j.tim.2010.06.009; Forward JA, 1997, J BACTERIOL, V179, P5482, DOI 10.1128/jb.179.17.5482-5493.1997; Gonin S, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-11; Herrou J, 2007, J MOL BIOL, V373, P954, DOI 10.1016/j.jmb.2007.08.006; Hopkins AP, 2013, FEMS MICROBIOL LETT, V347, P14, DOI 10.1111/1574-6968.12213; Jenkins GA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-48; Johnston JW, 2008, J BIOL CHEM, V283, P855, DOI 10.1074/jbc.M706603200; Kuhlmann SI, 2008, BIOCHEMISTRY-US, V47, P9475, DOI 10.1021/bi8006719; Lecher J, 2009, J MOL BIOL, V389, P58, DOI 10.1016/j.jmb.2009.03.077; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Mulligan C, 2009, P NATL ACAD SCI USA, V106, P1778, DOI 10.1073/pnas.0809979106; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Paulsen IT, 2000, J MOL BIOL, V301, P75, DOI 10.1006/jmbi.2000.3961; Poretsky RS, 2010, ENVIRON MICROBIOL, V12, P616, DOI 10.1111/j.1462-2920.2009.02102.x; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Rucktooa P, 2007, J MOL BIOL, V370, P93, DOI 10.1016/j.jmb.2007.04.047; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; Severi E, 2008, J BIOL CHEM, V283, P4841, DOI 10.1074/jbc.M707822200; Severi E, 2010, FEMS MICROBIOL LETT, V304, P47, DOI 10.1111/j.1574-6968.2009.01881.x; Sowell SM, 2011, ISME J, V5, P856, DOI 10.1038/ismej.2010.168; Vetting MW, 2015, BIOCHEMISTRY-US, V54, P909, DOI 10.1021/bi501388y; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Williams TJ, 2014, TRENDS MICROBIOL, V22, P248, DOI 10.1016/j.tim.2014.03.004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winnen B, 2003, RES MICROBIOL, V154, P457, DOI 10.1016/S0923-2508(03)00126-8; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	36	20	20	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27113	27123		10.1074/jbc.M115.656603	http://dx.doi.org/10.1074/jbc.M115.656603			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26342690	Green Published, hybrid			2022-12-28	WOS:000364794000021
J	Huang, HC; Santoso, N; Power, D; Simpson, S; Dieringer, M; Miao, HY; Gurova, K; Giam, CZ; Elledge, SJ; Zhu, J				Huang, Huachao; Santoso, Netty; Power, Derek; Simpson, Sydney; Dieringer, Michael; Miao, Hongyu; Gurova, Katerina; Giam, Chou-Zen; Elledge, Stephen J.; Zhu, Jian			FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RNA-POLYMERASE-II; NEGATIVE ELONGATION-FACTOR; P-TEFB; POSTINTEGRATION LATENCY; CHROMATIN DYNAMICS; T-CELLS; TAT; REPLICATION; IDENTIFICATION	Background: FACT proteins SUPT16H and SSRP1 are identified as host factors that restrict HIV-1 replication. Results: Biochemical and genetic evidences that SUPT16H and SSRP1 affect HIV-1/HTLV-1 transcription and latency are provided. Conclusion: SUPT16H and SSRP1 suppress transcription of HIV-1/HTLV-1, and their presence may promote HIV-1 latency. Significance: Identification of host factors necessary for HIV-1 latency is critical, which may benefit the development of novel HIV-1 latency-reversing agents. Our functional genomic RNAi screens have identified the protein components of the FACT (facilitates chromatin transcription) complex, SUPT16H and SSRP1, as top host factors that negatively regulate HIV-1 replication. FACT interacts specifically with histones H2A/H2B to affect assembly and disassembly of nucleosomes, as well as transcription elongation. We further investigated the suppressive role of FACT proteins in HIV-1 transcription. First, depletion of SUPT16H or SSRP1 protein enhances Tat-mediated HIV-1 LTR (long terminal repeat) promoter activity. Second, HIV-1 Tat interacts with SUPT16H but not SSRP1 protein. However, both SUPT16H and SSRP1 are recruited to LTR promoter. Third, the presence of SUPT16H interferes with the association of Cyclin T1 (CCNT1), a subunit of P-TEFb, with the Tat-LTR axis. Removing inhibitory mechanisms to permit HIV-1 transcription is an initial and key regulatory step to reverse post-integrated latent HIV-1 proviruses for purging of reservoir cells. We therefore evaluated the role of FACT proteins in HIV-1 latency and reactivation. Depletion of SUPT16H or SSRP1 protein affects both HIV-1 transcriptional initiation and elongation and spontaneously reverses latent HIV-1 in U1/HIV and J-LAT cells. Similar effects were observed with a primary CD4+ T cell model of HIV-1 latency. FACT proteins also interfere with HTLV-1 Tax-LTR-mediated transcription and viral latency, indicating that they may act as general transcriptional suppressors for retroviruses. We conclude that FACT proteins SUPT16H and SSRP1 play a key role in suppressing HIV-1 transcription and promoting viral latency, which may serve as promising gene targets for developing novel HIV-1 latency-reversing agents.	[Huang, Huachao; Santoso, Netty; Power, Derek; Zhu, Jian] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Zhu, Jian] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Miao, Hongyu] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Simpson, Sydney; Dieringer, Michael] Univ Rochester, Sch Arts & Sci, Rochester, NY 14627 USA; [Gurova, Katerina] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Giam, Chou-Zen] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Elledge, Stephen J.] Brigham & Womens Hosp, Howard Hughes Med Inst, Div Genet, Boston, MA 02115 USA; [Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; Roswell Park Cancer Institute; Uniformed Services University of the Health Sciences - USA; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Zhu, J (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Dept Biochem & Biophys, 601 Elmwood Ave,Box 672, Rochester, NY 14642 USA.	Jian_Zhu@urmc.rochester.edu	Regan, Clinton/E-6250-2012	Simpson, Sydney/0000-0001-5895-3371	National Institutes of Health [R21AI116180, R01GM117838]; University of Rochester Centers for AIDS Research Grant from National Institutes of Health [P30AI078498]; University of Rochester Center for Integrative Bioinformatics and Experimental Mathematics pilot grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI078498, R21AI116180, R33AI116180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Centers for AIDS Research Grant from National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Rochester Center for Integrative Bioinformatics and Experimental Mathematics pilot grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health Grants R21AI116180 and R01GM117838 (to J.Z.) and in part by the University of Rochester Centers for AIDS Research Grant P30AI078498 from National Institutes of Health and the University of Rochester Center for Integrative Bioinformatics and Experimental Mathematics pilot grant. The authors declare that they have no conflicts of interest with the contents of this article.	Abe T, 2011, J BIOL CHEM, V286, P30504, DOI 10.1074/jbc.M111.264721; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Barton KM, 2013, CLIN PHARMACOL THER, V93, P46, DOI 10.1038/clpt.2012.202; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bosque A, 2011, METHODS, V53, P54, DOI 10.1016/j.ymeth.2010.10.002; Bosque A, 2009, BLOOD, V113, P58, DOI 10.1182/blood-2008-07-168393; Brady J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-69; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brewster NK, 1998, J BIOL CHEM, V273, P21972, DOI 10.1074/jbc.273.34.21972; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Cho WK, 2007, J VIROL, V81, P11179, DOI 10.1128/JVI.00408-07; Cho WK, 2010, J VIROL, V84, P12801, DOI 10.1128/JVI.00943-10; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Dinant C, 2013, MOL CELL, V51, P469, DOI 10.1016/j.molcel.2013.08.007; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; Easley R, 2010, BBA-GENE REGUL MECH, V1799, P275, DOI 10.1016/j.bbagrm.2009.08.008; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Garcia H, 2013, CELL REP, V4, P159, DOI 10.1016/j.celrep.2013.06.013; Han JH, 2010, GENE DEV, V24, P1485, DOI 10.1101/gad.1887310; Han YF, 2008, CELL HOST MICROBE, V4, P134, DOI 10.1016/j.chom.2008.06.008; Han YF, 2004, J VIROL, V78, P6122, DOI 10.1128/JVI.78.12.6122-6133.2004; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Jadlowsky JK, 2014, MOL CELL BIOL, V34, P1911, DOI 10.1128/MCB.01013-13; Karn J, 2011, CURR OPIN HIV AIDS, V6, P4, DOI 10.1097/COH.0b013e328340ffbb; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Khan SZ, 2011, J BIOL CHEM, V286, P22943, DOI 10.1074/jbc.M110.201194; Klichko V, 2006, J VIROL, V80, P4570, DOI 10.1128/JVI.80.9.4570-4579.2006; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Larsson M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-31; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; Li YP, 2007, J BIOL CHEM, V282, P6936, DOI 10.1074/jbc.M603822200; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Morillo-Huesca M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000964; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Philip S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004040; Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200; Power D, 2015, VIROLOGY, V481, P142, DOI 10.1016/j.virol.2015.02.046; Rafati H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001206; Sanchez-Duffhues G, 2011, CURR DRUG TARGETS, V12, P348, DOI 10.2174/138945011794815266; Schiralli Lester Gillian M, 2012, Mol Biol Int, V2012, P614120, DOI 10.1155/2012/614120; Shan L, 2013, BIOESSAYS, V35, P544, DOI 10.1002/bies.201200170; Siliciano RF, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007096; Tan BCM, 2004, J BIOL CHEM, V279, P9321, DOI 10.1074/jbc.M311477200; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; Van Duyne R, 2011, J MOL BIOL, V411, P581, DOI 10.1016/j.jmb.2011.06.001; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; VERDIN E, 1991, J VIROL, V65, P6790, DOI 10.1128/JVI.65.12.6790-6799.1991; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Winkler DD, 2011, J BIOL CHEM, V286, P18369, DOI 10.1074/jbc.R110.180778; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200; Zhi HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002025; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zhou MS, 2006, J VIROL, V80, P4781, DOI 10.1128/JVI.80.10.4781-4791.2006; Zhu J, 2014, CELL REP, V9, P752, DOI 10.1016/j.celrep.2014.09.031; Zhu J, 2012, CELL REP, V2, P807, DOI 10.1016/j.celrep.2012.09.008	73	36	37	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27297	27310		10.1074/jbc.M115.652339	http://dx.doi.org/10.1074/jbc.M115.652339			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26378236	Green Published, hybrid			2022-12-28	WOS:000364794000037
J	Stanne, T; Narayanan, MS; Ridewood, S; Ling, A; Witmer, K; Kushwaha, M; Wiesler, S; Wickstead, B; Wood, J; Rudenko, G				Stanne, Tara; Narayanan, Mani Shankar; Ridewood, Sophie; Ling, Alexandra; Witmer, Kathrin; Kushwaha, Manish; Wiesler, Simone; Wickstead, Bill; Wood, Jennifer; Rudenko, Gloria			Identification of the ISWI Chromatin Remodeling Complex of the Early Branching Eukaryote Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-I; INDUCIBLE EXPRESSION SYSTEM; AFRICAN TRYPANOSOMES; VSG EXPRESSION; GENE-EXPRESSION; TRANSCRIPTIONAL CONTROL; EPIGENETIC REGULATION; ANTIGENIC VARIATION; SITE CONTROL; DNA-DAMAGE	Background: Eukaryotes typically encode a range of ISWI chromatin remodeling complexes with different functions. Results: We have identified and analyzed three novel ISWI partners in the early branching eukaryote Trypanosoma brucei. Conclusion:T. brucei appears to have a single major ISWI complex. Significance: This unusually simple ISWI configuration could be a consequence of the relative lack of transcriptional regulation in this ancient eukaryote. ISWI chromatin remodelers are highly conserved in eukaryotes and are important for the assembly and spacing of nucleosomes, thereby controlling transcription initiation and elongation. ISWI is typically associated with different subunits, forming specialized complexes with discrete functions. In the unicellular parasite Trypanosoma brucei, which causes African sleeping sickness, TbISWI down-regulates RNA polymerase I (Pol I)-transcribed variant surface glycoprotein (VSG) gene expression sites (ESs), which are monoallelically expressed. Here, we use tandem affinity purification to determine the interacting partners of TbISWI. We identify three proteins that do not show significant homology with known ISWI-associated partners. Surprisingly, one of these is nucleoplasmin-like protein (NLP), which we had previously shown to play a role in ES control. In addition, we identify two novel ISWI partners, regulator of chromosome condensation 1-like protein (RCCP) and phenylalanine/tyrosine-rich protein (FYRP), both containing protein motifs typically found on chromatin proteins. Knockdown of RCCP or FYRP in bloodstream form T. brucei results in derepression of silent variant surface glycoprotein ESs, as had previously been shown for TbISWI and NLP. All four proteins are expressed and interact with each other in both major life cycle stages and show similar distributions at Pol I-transcribed loci. They are also found at Pol II strand switch regions as determined with ChIP. ISWI, NLP, RCCP, and FYRP therefore appear to form a single major ISWI complex in T. brucei (TbIC). This reduced complexity of ISWI regulation and the presence of novel ISWI partners highlights the early divergence of trypanosomes in evolution.	[Stanne, Tara; Narayanan, Mani Shankar; Ridewood, Sophie; Ling, Alexandra; Witmer, Kathrin; Kushwaha, Manish; Wiesler, Simone; Wood, Jennifer; Rudenko, Gloria] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Cell & Mol Biol, London SW7 2AZ, England; [Wickstead, Bill] Univ Nottingham, Sch Life Sci, Nottingham NG7 2UH, England	Imperial College London; University of Nottingham	Rudenko, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Cell & Mol Biol, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	gloria.rudenko@imperial.ac.uk	Kushwaha, Manish/E-4901-2010	Kushwaha, Manish/0000-0002-8850-3272; Witmer, Kathrin/0000-0002-3159-7386; Ridewood, Sophie/0000-0002-1845-361X; Wickstead, Bill/0000-0002-4620-9091; Rudenko, Gloria/0000-0003-1884-4933	Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/J01477X/1] Funding Source: researchfish; BBSRC [BB/J01477X/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Anosova I, 2015, NUCLEIC ACIDS RES, V43, P5208, DOI 10.1093/nar/gkv365; Aydin OZ, 2014, CELL CYCLE, V13, P3016, DOI 10.4161/15384101.2014.956551; BANGS JD, 1993, J CELL SCI, V105, P1101; Bartholomew B, 2014, ANNU REV BIOCHEM, V83, P671, DOI 10.1146/annurev-biochem-051810-093157; Bartholomew B, 2014, CURR OPIN STRUC BIOL, V24, P150, DOI 10.1016/j.sbi.2014.01.010; Berriman M, 2002, MOL BIOCHEM PARASIT, V122, P131, DOI 10.1016/S0166-6851(02)00092-0; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; BRUN R, 1979, ACTA TROP, V36, P289; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Cherry CM, 2010, CELL STEM CELL, V6, P557, DOI 10.1016/j.stem.2010.04.018; Chioda M, 2010, DEVELOPMENT, V137, P3513, DOI 10.1242/dev.048405; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Clayton CE, 2014, MOL BIOCHEM PARASIT, V195, P96, DOI 10.1016/j.molbiopara.2014.06.005; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Clayton C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003680; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Cross GAM, 2014, MOL BIOCHEM PARASIT, V195, P59, DOI 10.1016/j.molbiopara.2014.06.004; Dirscherl SS, 2004, BIOCHEM CELL BIOL, V82, P482, DOI 10.1139/O04-044; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Emelyanov AV, 2012, GENE DEV, V26, P603, DOI 10.1101/gad.180604.111; England JR, 2010, J MOL BIOL, V398, P518, DOI 10.1016/j.jmb.2010.03.037; Erdel F, 2011, FEBS J, V278, P3608, DOI 10.1111/j.1742-4658.2011.08282.x; Fadda A, 2014, MOL MICROBIOL, V94, P307, DOI 10.1111/mmi.12764; Figueiredo LM, 2010, EUKARYOT CELL, V9, P148, DOI 10.1128/EC.00282-09; Figueiredo LM, 2009, NAT REV MICROBIOL, V7, P504, DOI 10.1038/nrmicro2149; Franco JR, 2014, CLIN EPIDEMIOL, V6, P257, DOI 10.2147/CLEP.S39728; Garcia-Alai MM, 2010, PROTEIN SCI, V19, P1432, DOI 10.1002/pro.404; Glover L, 2013, CELL MICROBIOL, V15, P1984, DOI 10.1111/cmi.12215; Gunzl A, 2015, GENE, V556, P68, DOI 10.1016/j.gene.2014.09.047; Guetg C, 2010, EMBO J, V29, P2135, DOI 10.1038/emboj.2010.17; Gunzl A, 2003, EUKARYOT CELL, V2, P542, DOI 10.1128/EC.2.3.542-551.2003; Gunzl Arthur, 2009, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471140864.ps1919s55; Hadjebi O, 2008, BBA-MOL CELL RES, V1783, P1467, DOI 10.1016/j.bbamcr.2008.03.015; Hanai K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000011; Hartlepp KF, 2005, MOL CELL BIOL, V25, P9886, DOI 10.1128/MCB.25.22.9886-9896.2005; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; Hertz-Fowler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003527; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hughes K, 2007, EMBO J, V26, P2400, DOI 10.1038/sj.emboj.7601678; Hutchins JRA, 2004, CURR BIOL, V14, P1099, DOI 10.1016/j.cub.2004.05.021; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Klement K, 2014, J CELL BIOL, V207, P717, DOI 10.1083/jcb.201405077; Koster MJE, 2015, CELL, V161, P724, DOI 10.1016/j.cell.2015.04.033; Krajewski WA, 2013, BIOCHEMISTRY-US, V52, P6940, DOI 10.1021/bi400634r; Kramer S, 2012, MOL BIOCHEM PARASIT, V181, P61, DOI 10.1016/j.molbiopara.2011.10.002; Lange M, 2011, EPIGENOMICS-UK, V3, P567, DOI [10.2217/EPI.11.83, 10.2217/epi.11.83]; Makde RD, 2010, NATURE, V467, P562, DOI 10.1038/nature09321; Manelyte L, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004157; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Mellor J, 2004, BBA-GENE STRUCT EXPR, V1677, P100, DOI 10.1016/j.bbaexp.2003.10.014; Moore WJ, 2002, CURR BIOL, V12, P1442, DOI 10.1016/S0960-9822(02)01076-X; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Narayanan MS, 2013, NUCLEIC ACIDS RES, V41, P2981, DOI 10.1093/nar/gks1469; Narayanan MS, 2011, NUCLEIC ACIDS RES, V39, P2018, DOI 10.1093/nar/gkq950; Narlikar GJ, 2010, CURR OPIN CHEM BIOL, V14, P660, DOI 10.1016/j.cbpa.2010.08.001; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; Pepin D, 2007, TRENDS ENDOCRIN MET, V18, P215, DOI 10.1016/j.tem.2007.05.004; Petty E, 2013, TRENDS GENET, V29, P621, DOI 10.1016/j.tig.2013.06.006; Racki LR, 2008, CURR OPIN GENET DEV, V18, P137, DOI 10.1016/j.gde.2008.01.007; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; RUDENKO G, 1990, MOL CELL BIOL, V10, P3492, DOI 10.1128/MCB.10.7.3492; Rudenko G, 2010, ESSAYS BIOCHEM, V48, P201, DOI [10.1042/BSE0480201, 10.1042/bse0480201]; Sadeghifar F, 2015, NUCLEIC ACIDS RES, V43, P4477, DOI 10.1093/nar/gkv312; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Seki T, 1996, J BIOCHEM, V120, P207; Sheader K, 2005, P NATL ACAD SCI USA, V102, P8716, DOI 10.1073/pnas.0501886102; Sheader K, 2004, J BIOL CHEM, V279, P13363, DOI 10.1074/jbc.M312307200; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Stanne TM, 2011, EUKARYOT CELL, V10, P964, DOI 10.1128/EC.05048-11; Stanne TM, 2010, EUKARYOT CELL, V9, P136, DOI 10.1128/EC.00281-09; Strohner R, 2001, EMBO J, V20, P4892, DOI 10.1093/emboj/20.17.4892; Toto M, 2014, CHROMOSOMA, V123, P91, DOI 10.1007/s00412-013-0447-4; Vanolst L, 2005, DEVELOPMENT, V132, P4327, DOI 10.1242/dev.02014; Vary JC, 2003, MOL CELL BIOL, V23, P80, DOI 10.1128/MCB.23.1.80-91.2003; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wright JR, 2010, MOL BIOCHEM PARASIT, V172, P141, DOI 10.1016/j.molbiopara.2010.03.013; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Yokoyama H, 2009, J CELL BIOL, V187, P813, DOI 10.1083/jcb.200906020; Zhu XY, 2012, GENOME, V55, P269, DOI [10.1139/G2012-012, 10.1139/g2012-012]	86	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26954	26967		10.1074/jbc.M115.679019	http://dx.doi.org/10.1074/jbc.M115.679019			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26378228	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000364794000007
J	Bacik, JP; Klesmith, JR; Whitehead, TA; Jarboe, LR; Unkefer, CJ; Mark, BL; Michalczyk, R				Bacik, John-Paul; Klesmith, Justin R.; Whitehead, Timothy A.; Jarboe, Laura R.; Unkefer, Clifford J.; Mark, Brian L.; Michalczyk, Ryszard			Producing Glucose 6-Phosphate from Cellulosic Biomass STRUCTURAL INSIGHTS INTO LEVOGLUCOSAN BIOCONVERSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGNOCELLULOSIC BIOMASS; ORGANIC-MATTER; KINASE; DYNAMICS; TRIS; PURIFICATION; SPECIFICITY; INTEGRATION; KINETICS; AEROSOL	The most abundant carbohydrate product of cellulosic biomass pyrolysis is the anhydrosugar levoglucosan (1,6-anhydro-beta-D-glucopyranose), which can be converted to glucose 6-phosphate by levoglucosan kinase (LGK). In addition to the canonical kinase phosphotransfer reaction, the conversion requires cleavage of the 1,6-anhydro ring to allow ATP-dependent phosphorylation of the sugar O6 atom. Using x-ray crystallography, we show that LGK binds two magnesium ions in the active site that are additionally coordinated with the nucleotide and water molecules to result in ideal octahedral coordination. To further verify the metal binding sites, we co-crystallized LGK in the presence of manganese instead of magnesium and solved the structure de novo using the anomalous signal from four manganese atoms in the dimeric structure. The first metal is required for catalysis, whereas our work suggests that the second is either required or significantly promotes the catalytic rate. Although the enzyme binds its sugar substrate in a similar orientation to the structurally related 1,6-anhydro-N-acetylmuramic acid kinase (AnmK), it forms markedly fewer bonding interactions with the substrate. In this orientation, the sugar is in an optimal position to couple phosphorylation with ring cleavage. We also observed a second alternate binding orientation for levoglucosan, and in these structures, ADP was found to bind with lower affinity. These combined observations provide an explanation for the high Km of LGK for levoglucosan. Greater knowledge of the factors that contribute to the catalytic efficiency of LGK can be used to improve applications of this enzyme for levoglucosan-derived biofuel production.	[Bacik, John-Paul; Unkefer, Clifford J.; Michalczyk, Ryszard] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Klesmith, Justin R.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Whitehead, Timothy A.] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Whitehead, Timothy A.] Michigan State Univ, Dept Biosyst & Agr Engn, E Lansing, MI 48824 USA; [Jarboe, Laura R.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA; [Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	United States Department of Energy (DOE); Los Alamos National Laboratory; Michigan State University; Michigan State University; Michigan State University; Iowa State University; University of Manitoba	Bacik, JP (corresponding author), Los Alamos Natl Lab, Biosci Div, TA03,Bldg 4200,MS T007, Los Alamos, NM 87545 USA.	jbacik@lanl.gov		Bacik, John-Paul/0000-0001-9315-5332; Klesmith, Justin/0000-0003-2908-9355; Mark, Brian/0000-0002-7344-1355; Michalczyk, Ryszard/0000-0001-8839-6473	Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council; Canadian Institutes of Health Research; University of Saskatchewan; U. S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, NIGMS [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER; Office Of The Director [1101284] Funding Source: National Science Foundation	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; U. S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	We thank Shaun Labiuk, Pavel Afonine, and the Canadian Light Source as well as the staff at the SLAC National Accelerator Laboratory for assistance in data collection and processing. We thank the Los Alamos National Laboratory Principal Associate Directorate for Science, Technology and Engineering for institutional investment in key equipment that enabled NMR measurements reported here. The Canadian Light Source is supported by Natural Sciences and Engineering Research Council of Canada (NSERC), the National Research Council, Canadian Institutes of Health Research, and the University of Saskatchewan. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U. S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, NIGMS (including Grant P41GM103393). We also thank Brian Broom-Peltz for technical assistance and Dr. Virginia A. Unkefer for help with editing the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bacik JP, 2014, J BIOL CHEM, V289, P4504, DOI 10.1074/jbc.M113.521633; Bacik JP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198317; Bai J, 2013, CHEMOSPHERE, V93, P2004, DOI 10.1016/j.chemosphere.2013.07.021; Bao ZQ, 2011, STRUCTURE, V19, P675, DOI 10.1016/j.str.2011.02.016; Bernstein BE, 1997, NATURE, V385, P275, DOI 10.1038/385275a0; Chen JCH, 2012, P NATL ACAD SCI USA, V109, P15301, DOI 10.1073/pnas.1208341109; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chuang MT, 2013, ATMOS ENVIRON, V78, P72, DOI 10.1016/j.atmosenv.2012.06.056; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Dai JH, 2009, WORLD J MICROB BIOT, V25, P1589, DOI 10.1007/s11274-009-0048-9; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Desmarais WT, 2002, STRUCTURE, V10, P1063, DOI 10.1016/S0969-2126(02)00810-9; Downing M., 2011, US BILLION TON UPDAT; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ghalanbor Z, 2008, PROTEIN PEPTIDE LETT, V15, P212, DOI 10.2174/092986608783489616; GordonWeeks R, 1997, PLANT PHYSIOL, V114, P901, DOI 10.1104/pp.114.3.901; GUPTA RK, 1983, BIOCHEM BIOPH RES CO, V117, P210, DOI 10.1016/0006-291X(83)91562-0; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; HIRAI M, 1977, BIOCHIM BIOPHYS ACTA, V480, P357, DOI 10.1016/0005-2744(77)90028-6; Hopmans EC, 2013, ORG GEOCHEM, V58, P86, DOI 10.1016/j.orggeochem.2013.02.003; Hurley JH, 1996, ANNU REV BIOPH BIOM, V25, P137; Jacobsen DM, 2012, J AM CHEM SOC, V134, P15357, DOI 10.1021/ja304419t; Jarboe LR, 2011, APPL MICROBIOL BIOT, V91, P1519, DOI 10.1007/s00253-011-3495-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kehrwald N, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.18196; KITAMURA Y, 1991, AGR BIOL CHEM TOKYO, V55, P523, DOI 10.1080/00021369.1991.10870618; Knicker H, 2013, GEODERMA, V197, P43, DOI 10.1016/j.geoderma.2012.12.021; Kupfer R, 2001, BIOCHEMISTRY-US, V40, P11490, DOI 10.1021/bi010914d; Lai CY, 2014, ATMOS ENVIRON, V91, P32, DOI 10.1016/j.atmosenv.2014.03.054; Layton DS, 2011, BIORESOURCE TECHNOL, V102, P8318, DOI 10.1016/j.biortech.2011.06.011; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Levine J.S., 1991, EOS TRANSAC AM GEOPH, DOI DOI 10.1029/90E000289; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Mullaugh KM, 2014, CHEMOSPHERE, V107, P51, DOI 10.1016/j.chemosphere.2014.03.014; NAKAHARA K, 1994, BIOSCI BIOTECH BIOCH, V58, P2193, DOI 10.1271/bbb.58.2193; Ning JY, 2008, WORLD J MICROB BIOT, V24, P15, DOI 10.1007/s11274-007-9432-5; Nishimasu H, 2007, J BIOL CHEM, V282, P9923, DOI 10.1074/jbc.M610678200; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Phitsuwan P, 2013, BIOMASS BIOENERG, V58, P390, DOI 10.1016/j.biombioe.2013.08.027; Regni C, 2004, STRUCTURE, V12, P55, DOI 10.1016/j.str.2003.11.015; Sachett LG, 2011, EUR J MED CHEM, V46, P5212, DOI 10.1016/j.ejmech.2011.08.016; SALAS M, 1965, J BIOL CHEM, V240, P561; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Tsai YI, 2013, ATMOS ENVIRON, V78, P93, DOI 10.1016/j.atmosenv.2012.09.040; Uehara T, 2005, J BACTERIOL, V187, P3643, DOI 10.1128/JB.187.11.3643-3649.2005; Vancampenhout K, 2012, SOIL BIOL BIOCHEM, V50, P40, DOI 10.1016/j.soilbio.2012.03.005; Vicente A, 2013, ATMOS ENVIRON, V71, P295, DOI 10.1016/j.atmosenv.2013.01.062; Wallner P, 2013, INT J HYG ENVIR HEAL, V216, P280, DOI 10.1016/j.ijheh.2012.05.001; Zhuang XL, 2002, PROTEIN EXPRES PURIF, V26, P71, DOI 10.1016/S1046-5928(02)00501-6; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	52	13	16	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26638	26648		10.1074/jbc.M115.674614	http://dx.doi.org/10.1074/jbc.M115.674614			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354439	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000364793600029
J	Sheldon, KL; Gurnev, PA; Bezrukov, SM; Sackett, DL				Sheldon, Kely L.; Gurnev, Philip A.; Bezrukov, Sergey M.; Sackett, Dan L.			Tubulin Tail Sequences and Post-translational Modifications Regulate Closure of Mitochondrial Voltage-dependent Anion Channel (VDAC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-HEMOLYSIN; MEMBRANE; POLYMERIZATION; TERMINI; CELLS; PORE	It was previously shown that tubulin dimer interaction with the mitochondrial outer membrane protein voltage-dependent anion channel (VDAC) blocks traffic through the channel and reduces oxidative metabolism and that this requires the unstructured anionic C-terminal tail peptides found on both alpha- and beta-tubulin subunits. It was unclear whether the alpha- and beta-tubulin tails contribute equally to VDAC blockade and what effects might be due to sequence variations in these tail peptides or to tubulin post-translational modifications, which mostly occur on the tails. The nature of the contribution of the tubulin body beyond acting as an anchor for the tails had not been clarified either. Here we present peptide-protein chimeras to address these questions. These constructs allow us to easily combine a tail peptide with different proteins or combine different tail peptides with a particular protein. The results show that a single tail grafted to an inert protein is sufficient to produce channel closure similar to that observed with tubulin. We show that the beta-tail is more than an order of magnitude more potent than the alpha-tail and that the lower alpha-tail activity is largely due to the presence of a terminal tyrosine. Detyrosination activates the alpha-tail, and activation is reversed by the removal of the glutamic acid penultimate to the tyrosine. Nitration of tyrosine reverses the tyrosine inhibition of binding and even induces prolonged VDAC closures. Our results demonstrate that small changes in sequence or post-translational modification of the unstructured tails of tubulin result in substantial changes in VDAC closure.	[Sheldon, Kely L.; Gurnev, Philip A.; Bezrukov, Sergey M.; Sackett, Dan L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Phys Biol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Sheldon, KL (corresponding author), Emory Univ, Div Cardiol, Dept Med, Sch Med, 307 Woodruff Mem Bldg,1639 Pierce Dr, Atlanta, GA 30322 USA.	ksheldo@emory.edu; sackettd@mail.nih.gov			Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008765, ZIAHD000072] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD. The authors declare that they have no conflicts of interest with the contents of this article.	Aiken J, 2014, CURR BIOL, V24, P1295, DOI 10.1016/j.cub.2014.03.078; Bisig CG, 2002, EUR J BIOCHEM, V269, P5037, DOI 10.1046/j.1432-1033.2002.03220.x; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Eiserich JP, 1999, P NATL ACAD SCI USA, V96, P6365, DOI 10.1073/pnas.96.11.6365; Freedman H, 2011, PROTEINS, V79, P2968, DOI 10.1002/prot.23155; Gurnev PA, 2014, BIOPHYS J, V106, P556, DOI 10.1016/j.bpj.2013.12.028; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; Lafanechere L, 1998, J CELL SCI, V111, P171; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Movileanu L, 2005, BIOPHYS J, V89, P1030, DOI 10.1529/biophysj.104.057406; Murray J, 2008, ADV DRUG DELIVER REV, V60, P1497, DOI 10.1016/j.addr.2008.05.003; PATURLELAFANECHERE L, 1994, J CELL SCI, V107, P1529; ROBINSON JM, 1995, J CELL SCI, V108, P645; Rostovtseva TK, 2012, J BIOL CHEM, V287, P29589, DOI 10.1074/jbc.M112.378778; ROTHWELL SW, 1993, J CELL PHYSIOL, V154, P582, DOI 10.1002/jcp.1041540317; SACKETT DL, 1985, J BIOL CHEM, V260, P43; SACKETT DL, 1986, J BIOL CHEM, V261, P9070; Sheldon KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025539; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Szabo I, 1998, FASEB J, V12, P495, DOI 10.1096/fasebj.12.6.495; Tan WZ, 2007, BIOPHYS J, V93, P1184, DOI 10.1529/biophysj.107.105379; Uversky VN, 2013, FEBS LETT, V587, P1891, DOI 10.1016/j.febslet.2013.04.042; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Wolff J, 2009, BBA-BIOMEMBRANES, V1788, P1415, DOI 10.1016/j.bbamem.2009.03.013	25	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26784	26789		10.1074/jbc.M115.678854	http://dx.doi.org/10.1074/jbc.M115.678854			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26306046	Green Published, hybrid			2022-12-28	WOS:000364793600040
J	Lei, HY; Zhou, XL; Ruan, ZR; Sun, WC; Eriani, G; Wang, ED				Lei, Hui-Yan; Zhou, Xiao-Long; Ruan, Zhi-Rong; Sun, Wei-Cheng; Eriani, Gilbert; Wang, En-Duo			Calpain Cleaves Most Components in the Multiple Aminoacyl-tRNA Synthetase Complex and Affects Their Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; P43 COMPONENT; TRANSLATION; AUTOPHAGY; ACTIVATION; EXPRESSION; APOPTOSIS; MTOR; DIFFERENTIATION	Nine aminoacyl-tRNA synthetases (aaRSs) and three scaffold proteins form a super multiple aminoacyl-tRNA synthetase complex (MSC) in the human cytoplasm. Domains that have been added progressively to MSC components during evolution are linked by unstructured flexible peptides, producing an elongated and multiarmed MSC structure that is easily attacked by proteases in vivo. A yeast two-hybrid screen for proteins interacting with LeuRS, a representative MSC member, identified calpain 2, a calcium-activated neutral cysteine protease. Calpain 2 and calpain 1 could partially hydrolyze most MSC components to generate specific fragments that resembled those reported previously. The cleavage sites of calpain in ArgRS, GlnRS, and p43 were precisely mapped. After cleavage, their N-terminal regions were removed. Sixty-three amino acid residues were removed from the N terminus of ArgRS to form ArgRS Delta N63; GlnRS formed GlnRS Delta N198, and p43 formed p43 Delta N106. GlnRS Delta N198 had a much weaker affinity for its substrates, tRNA(Gln) and glutamine. p43 Delta N106 was the same as the previously reported p43-derived apoptosis-released factor. The formation of p43 Delta N106 by calpain depended on Ca2+ and could be specifically inhibited by calpeptin and by RNAi of the regulatory subunit of calpain in vivo. These results showed, for the first time, that calpain plays an essential role in dissociating the MSC and might regulate the canonical and non-canonical functions of certain components of the MSC.	[Lei, Hui-Yan; Zhou, Xiao-Long; Ruan, Zhi-Rong; Sun, Wei-Cheng; Wang, En-Duo] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Lei, Hui-Yan; Zhou, Xiao-Long; Ruan, Zhi-Rong; Sun, Wei-Cheng; Wang, En-Duo] Univ Chinese Acad Sci, Beijing 100039, Peoples R China; [Sun, Wei-Cheng; Wang, En-Duo] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Eriani, Gilbert] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Architecture & Reactivite ARN,UPR9002, F-67084 Strasbourg, France	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Wang, ED (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	edwang@sibcb.ac.cn	Ruan, Zhi-Rong/GYI-8935-2022	Eriani, Gilbert/0000-0002-8518-4675; Ruan, Zhi-Rong/0000-0002-1806-2942; Lei, Huiyan/0000-0001-8274-7690	National Key Basic Research Foundation of China [2012CB911000]; National Natural Science Foundation of China [31130064, 91440204]; Committee of Science and Technology in Shanghai Grant [12JC1409700]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology in Shanghai Grant	This work was supported by National Key Basic Research Foundation of China Grant 2012CB911000, National Natural Science Foundation of China Grants 31130064 and 91440204, and Committee of Science and Technology in Shanghai Grant 12JC1409700. The authors declare that they have no conflicts of interest with the contents of this article.	Beltran L, 2011, P NATL ACAD SCI USA, V108, P16217, DOI 10.1073/pnas.1107692108; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Chakraborti S, 2012, INDIAN J BIOCHEM BIO, V49, P316; Choi JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001351; Chondrogianni N, 2015, AGEING RES REV, V23, P37, DOI 10.1016/j.arr.2014.12.003; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; Decuypere JP, 2011, AUTOPHAGY, V7, P1472, DOI 10.4161/auto.7.12.17909; Demarchi F, 2006, J CELL BIOL, V175, P595, DOI 10.1083/jcb.200601024; DENNEY RM, 1977, ARCH BIOCHEM BIOPHYS, V183, P156, DOI 10.1016/0003-9861(77)90430-1; DEUTSCHER MP, 1984, J CELL BIOL, V99, P373, DOI 10.1083/jcb.99.2.373; Dias J, 2013, J BIOL CHEM, V288, P23979, DOI 10.1074/jbc.M113.489922; ESCALANTE C, 1993, J BIOL CHEM, V268, P6014; Fu YY, 2014, P NATL ACAD SCI USA, V111, P15084, DOI 10.1073/pnas.1408836111; Grant TD, 2012, NUCLEIC ACIDS RES, V40, P3723, DOI 10.1093/nar/gkr1223; Guo M, 2014, TOP CURR CHEM, V344, P89, DOI 10.1007/128_2013_424; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hata S, 2012, J BIOCHEM, V151, P417, DOI 10.1093/jb/mvs002; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Kim JH, 2014, J CELL SCI, V127, P4483, DOI 10.1242/jcs.154930; Kim JH, 2014, TOP CURR CHEM, V344, P119, DOI 10.1007/128_2013_479; Kim K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081734; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Ledoux S, 2008, METHODS, V44, P74, DOI 10.1016/j.ymeth.2007.08.001; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Mellgren R. L., 1990, INTRACELLULAR CALCIU, P91; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; NORCUM MT, 1989, J BIOL CHEM, V264, P15043; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Perona JJ, 2014, TOP CURR CHEM, V344, P1, DOI 10.1007/128_2013_456; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Sajish M, 2015, NATURE, V519, P370, DOI 10.1038/nature14028; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Shalak V, 2007, J BIOL CHEM, V282, P10935, DOI 10.1074/jbc.M611737200; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Sorimachi H, 2011, P JPN ACAD B-PHYS, V87, P287, DOI 10.2183/pjab.87.287; Tan Y, 2006, J BIOL CHEM, V281, P17689, DOI 10.1074/jbc.M601978200; Vosler PS, 2011, P NATL ACAD SCI USA, V108, P18102, DOI 10.1073/pnas.1112635108; Wang CF, 2012, MOL CELL BIOL, V32, P3321, DOI 10.1128/MCB.00296-12; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Yang F, 2014, J BIOL CHEM, V289, P20953, DOI 10.1074/jbc.M114.562454; Yao P, 2014, TOP CURR CHEM, V344, P167, DOI 10.1007/128_2013_422; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; Zheng YG, 2006, BIOCHEMISTRY-US, V45, P1338, DOI 10.1021/bi051675n; Zhou XL, 2008, J BIOL CHEM, V283, P36608, DOI 10.1074/jbc.M806745200	50	8	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26314	26327		10.1074/jbc.M115.681999	http://dx.doi.org/10.1074/jbc.M115.681999			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26324710	Green Published, hybrid			2022-12-28	WOS:000363527300047
J	Jastrzebska, B; Chen, YY; Orban, T; Jin, H; Hofmann, L; Palczewski, K				Jastrzebska, Beata; Chen, Yuanyuan; Orban, Tivadar; Jin, Hui; Hofmann, Lukas; Palczewski, Krzysztof			Disruption of Rhodopsin Dimerization with Synthetic Peptides Targeting an Interaction Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; TRANSMEMBRANE PEPTIDES; TRANSDUCIN INTERACTION; PROJECTION STRUCTURE; OPIOID RECEPTOR; GPCR; OLIGOMERIZATION; DIMERS; ACTIVATION	Although homo- and heterodimerizations of G protein-coupled receptors (GPCRs) are well documented, GPCR monomers are able to assemble in different ways, thus causing variations in the interactive interface between receptor monomers among different GPCRs. Moreover, the functional consequences of this phenomenon, which remain to be clarified, could be specific for different GPCRs. Synthetic peptides derived from transmembrane (TM) domains can interact with a full-length GPCR, blocking dimer formation and affecting its function. Here we used peptides corresponding to TM helices of bovine rhodopsin (Rho) to investigate the Rho dimer interface and functional consequences of its disruption. Incubation of Rho with TM1, TM2, TM4, and TM5 peptides in rod outer segment (ROS) membranes shifted the resulting detergent-solubilized protein migration through a gel filtration column toward smaller molecular masses with a reduced propensity for dimer formation in a cross-linking reaction. Binding of these TM peptides to Rho was characterized by both mass spectrometry and a label-free assay from which dissociation constants were calculated. A BRET (bioluminescence resonance energy transfer) assay revealed that the physical interaction between Rho molecules expressed in membranes of living cells was blocked by the same four TM peptides identified in our in vitro experiments. Although disruption of the Rho dimer/oligomer had no effect on the rates of G protein activation, binding of G(t) to the activated receptor stabilized the dimer. However, TM peptide-induced disruption of dimer/oligomer decreased receptor stability, suggesting that Rho supramolecular organization could be essential for ROS stabilization and receptor trafficking.	[Jastrzebska, Beata; Chen, Yuanyuan; Orban, Tivadar; Jin, Hui; Hofmann, Lukas; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Jastrzebska, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	bxj27@case.edu; kxp65@case.edu	Regan, Clinton/E-6250-2012; Hofmann, Lukas/AAN-2880-2021	Hofmann, Lukas/0000-0003-0157-0526; Chen, Yuanyuan/0000-0001-9625-1610	National Institutes of Health [EY008061, EY019478]; Swiss National Science Foundation [P1SKP3_158634]; NATIONAL EYE INSTITUTE [R01EY008061, R01EY019478, K99EY024992, R29EY008061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008061 and EY019478. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Doc.Mobility Fellowship P1SKP3_158634 from the Swiss National Science Foundation.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/NCHEMBIO.396, 10.1038/nchembio.396]; Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Breitwieser GE, 2004, CIRC RES, V94, P17, DOI 10.1161/01.RES.0000110420.68526.19; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chabre M, 2003, NATURE, V426, P30, DOI 10.1038/426030b; Chabre M, 2009, TRENDS PHARMACOL SCI, V30, P182, DOI 10.1016/j.tips.2009.01.003; Chen YY, 2014, J BIOL CHEM, V289, P9288, DOI 10.1074/jbc.M114.551713; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Comar WD, 2014, J AM CHEM SOC, V136, P8342, DOI 10.1021/ja501948w; Corley SC, 2011, BIOPHYS J, V100, P2946, DOI 10.1016/j.bpj.2011.05.015; Cottet Martin, 2012, Front Endocrinol (Lausanne), V3, P92, DOI 10.3389/fendo.2012.00092; Dell'Orco D, 2011, BIOCHEM J, V440, P263, DOI 10.1042/BJ20110871; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Fanelli F, 2013, PROG MOL BIOL TRANSL, V117, P105, DOI 10.1016/B978-0-12-386931-9.00005-2; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Ferre S, 2015, TRENDS PHARMACOL SCI, V36, P145, DOI 10.1016/j.tips.2015.01.002; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Goc A, 2008, BIOCHEMISTRY-US, V47, P12409, DOI 10.1021/bi8015444; Gorinski N, 2012, MOL PHARMACOL, V82, P448, DOI 10.1124/mol.112.079137; Gunkel M, 2015, STRUCTURE, V23, P628, DOI 10.1016/j.str.2015.01.015; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2006, BIOCHEMISTRY-US, V45, P14706, DOI 10.1021/bi061107n; Hayashi R, 2006, J BIOCHEM, V139, P981, DOI 10.1093/jb/mvj117; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Ianoul A, 2005, NAT CHEM BIOL, V1, P196, DOI 10.1038/nchembio726; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200; Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200; Jastrzebska Beata, 2015, Methods Mol Biol, V1271, P221, DOI 10.1007/978-1-4939-2330-4_15; Jastrzebska B, 2013, AMINO ACIDS, V45, P1303, DOI 10.1007/s00726-013-1593-y; Jastrzebska B, 2013, J STRUCT BIOL, V182, P164, DOI 10.1016/j.jsb.2013.02.014; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Jastrzebska B, 2011, J STRUCT BIOL, V176, P387, DOI 10.1016/j.jsb.2011.08.016; Jastrzebska B, 2010, BIOCHEM J, V428, P1, DOI 10.1042/BJ20100270; Knepp AM, 2012, BIOCHEMISTRY-US, V51, P1819, DOI 10.1021/bi3001598; Kota P, 2006, P NATL ACAD SCI USA, V103, P3054, DOI 10.1073/pnas.0510982103; Lambert NA, 2014, J PHYSIOL-LONDON, V592, P2443, DOI 10.1113/jphysiol.2014.272997; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; Lee WK, 2009, BIOCHEM BIOPH RES CO, V390, P815, DOI 10.1016/j.bbrc.2009.10.055; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Mancia F, 2008, EMBO REP, V9, P363, DOI 10.1038/embor.2008.27; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mansoor SE, 2006, P NATL ACAD SCI USA, V103, P3060, DOI 10.1073/pnas.0511010103; Marsango S, 2015, J BIOL CHEM, V290, P15146, DOI 10.1074/jbc.M114.630681; Maurice P, 2011, TRENDS PHARMACOL SCI, V32, P514, DOI 10.1016/j.tips.2011.05.006; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; Milligan G, 2008, BRIT J PHARMACOL, V153, pS216, DOI 10.1038/sj.bjp.0707490; Milligan G, 2003, LIFE SCI, V74, P181, DOI 10.1016/j.lfs.2003.09.005; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Muller DJ, 2008, PHARMACOL REV, V60, P43, DOI 10.1124/pr.107.07111; Nemoto W, 2005, PROTEINS, V58, P644, DOI 10.1002/prot.20332; Ng HKH, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00010; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Okada Tetsuji, 2006, P243; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Periole X, 2012, J AM CHEM SOC, V134, P10959, DOI 10.1021/ja303286e; Ramon E, 2003, VISION RES, V43, P3055, DOI 10.1016/j.visres.2003.08.009; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rivero-Muller A, 2013, PROG MOL BIOL TRANSL, V117, P163, DOI 10.1016/B978-0-12-386931-9.00007-6; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Salahpour Ali, 2012, Front Endocrinol (Lausanne), V3, P105, DOI 10.3389/fendo.2012.00105; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; SCHERTLER GFX, 1995, P NATL ACAD SCI USA, V92, P11578, DOI 10.1073/pnas.92.25.11578; Selent J, 2011, CURR MED CHEM, V18, P4588, DOI 10.2174/092986711797379320; Simpson LM, 2010, CURR OPIN PHARMACOL, V10, P30, DOI 10.1016/j.coph.2009.11.001; Tena-Campos M, 2014, CURR PROTEIN PEPT SC, V15, P648, DOI 10.2174/1389203715666140901094248; Vela L, 2011, ASSAY DRUG DEV TECHN, V9, P532, DOI 10.1089/adt.2010.0345; Vobornik D, 2009, BIOCHEM BIOPH RES CO, V382, P85, DOI 10.1016/j.bbrc.2009.02.144; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wimley WC, 2000, BIOCHEMISTRY-US, V39, P4432, DOI 10.1021/bi992746j; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xue L, 2015, NAT CHEM BIOL, V11, P134, DOI [10.1038/nchembio.1711, 10.1038/NCHEMBIO.1711]	89	62	62	1	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25728	25744		10.1074/jbc.M115.662684	http://dx.doi.org/10.1074/jbc.M115.662684			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26330551	hybrid, Green Published			2022-12-28	WOS:000362962800044
J	Soderholm, A; Guo, XH; Newton, MS; Evans, GB; Nasvall, J; Patrick, WM; Selmer, M				Soderholm, Annika; Guo, Xiaohu; Newton, Matilda S.; Evans, Gary B.; Nasvall, Joakim; Patrick, Wayne M.; Selmer, Maria			Two-step Ligand Binding in a (beta alpha)(8) Barrel Enzyme SUBSTRATE-BOUND STRUCTURES SHED NEW LIGHT ON THE CATALYTIC CYCLE OF HisA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPTOPHAN BIOSYNTHESIS; THERMOTOGA-MARITIMA; GENE-TRANSFER; EVOLUTION; HISTIDINE; SPECIFICITY; ISOMERASE; FOLD	HisA is a (beta alpha)(8) barrel enzyme that catalyzes the Amadori rearrangement of N'-[(5'-phosphoribosyl)formimino]-5-amino-imidazole-4-carboxamide ribonucleotide (ProFAR) to N'-((5'-phosphoribulosyl) formimino)-5-aminoimidazole-4-carboxamide-ribonucleotide (PRFAR) in the histidine biosynthesis pathway, and it is a paradigm for the study of enzyme evolution. Still, its exact catalytic mechanism has remained unclear. Here, we present crystal structures of wild type Salmonella enterica HisA (SeHisA) in its apo-state and of mutants D7N and D7N/D176A in complex with two different conformations of the labile substrate ProFAR, which was structurally visualized for the first time. Site-directed mutagenesis and kinetics demonstrated that Asp-7 acts as the catalytic base, and Asp-176 acts as the catalytic acid. The SeHisA structures with ProFAR display two different states of the long loops on the catalytic face of the structure and demonstrate that initial binding of ProFAR to the active site is independent of loop interactions. When the long loops enclose the substrate, ProFAR adopts an extended conformation where its non-reacting half is in a product-like conformation. This change is associated with shifts in a hydrogen bond network including His-47, Asp-129, Thr-171, and Ser-202, all shown to be functionally important. The closed conformation structure is highly similar to the bifunctional HisA homologue PriA in complex with PRFAR, thus proving that structure and mechanism are conserved between HisA and PriA. This study clarifies the mechanistic cycle of HisA and provides a striking example of how an enzyme and its substrate can undergo coordinated conformational changes before catalysis.	[Soderholm, Annika; Guo, Xiaohu; Selmer, Maria] Uppsala Univ, Dept Cell & Mol Biol, BMC, S-75124 Uppsala, Sweden; [Newton, Matilda S.; Patrick, Wayne M.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand; [Evans, Gary B.] Victoria Univ Wellington, Ferrier Res Inst, Lower Hutt 5046, New Zealand; [Nasvall, Joakim] Uppsala Univ, Dept Med Biochem & Microbiol, BMC, S-75123 Uppsala, Sweden	Uppsala University; University of Otago; Victoria University Wellington; Uppsala University	Patrick, WM (corresponding author), Univ Otago, Dept Biochem, POB 56, Dunedin 9054, New Zealand.	wayne.patrick@otago.ac.nz; maria.selmer@icm.uu.se	Guo, Xiaohu/N-5903-2017; Evans, Gary/B-8343-2011; Näsvall, Joakim/F-8750-2018	Evans, Gary/0000-0002-6973-2002; Näsvall, Joakim/0000-0002-6831-3105; Newton, Matilda/0000-0003-2213-3587; guo, xiaohu/0000-0001-8093-9437; Patrick, Wayne/0000-0002-2718-8053; Soderholm, Annika/0000-0003-3444-5203	Swedish Research Council; Swedish Foundation for Strategic Research; Marsden Fund; European Community [283570]; Otago Doctoral Scholarship; Rutherford Discovery Fellowship	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); European Community(European Commission); Otago Doctoral Scholarship; Rutherford Discovery Fellowship	This work was supported by grants from the Swedish Research Council and the Swedish Foundation for Strategic Research (to M.S.) and by a grant from the Marsden Fund (to W. M. P.). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (Grant Agreement 283570). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Barona-Gomez F, 2003, EMBO REP, V4, P296, DOI 10.1038/sj.embor.embor771; BLAMEY JM, 1994, BIOCHEMISTRY-US, V33, P1000, DOI 10.1021/bi00170a019; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; DAVISSON VJ, 1994, J ORG CHEM, V59, P137, DOI 10.1021/jo00080a022; Due AV, 2011, P NATL ACAD SCI USA, V108, P3554, DOI 10.1073/pnas.1015996108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GARRICKS.L, 1970, GENETICS, V66, P231; Henn-Sax M, 2002, BIOCHEMISTRY-US, V41, P12032, DOI 10.1021/bi026092h; Hocker B, 2001, CURR OPIN BIOTECH, V12, P376, DOI 10.1016/S0958-1669(00)00230-5; Hocker B, 2001, NAT STRUCT BIOL, V8, P32; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jurgens C, 2000, P NATL ACAD SCI USA, V97, P9925, DOI 10.1073/pnas.160255397; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KLEM TJ, 1993, BIOCHEMISTRY-US, V32, P5177, DOI 10.1021/bi00070a029; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Kuper J, 2005, EMBO REP, V6, P134, DOI 10.1038/sj.embor.7400330; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Martin R. G., 1971, METHODS ENZYMOL    B, V17, P3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nasvall J, 2012, SCIENCE, V338, P384, DOI 10.1126/science.1226521; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Noda-Garcia L, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0378-1; Noda-Garcia L, 2013, MOL BIOL EVOL, V30, P2024, DOI 10.1093/molbev/mst115; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Reisinger B, 2012, PROTEIN ENG DES SEL, V25, P751, DOI 10.1093/protein/gzs080; Setiyaputra S, 2011, J MOL BIOL, V408, P291, DOI 10.1016/j.jmb.2011.02.048; Wright H, 2008, BIOCHEM BIOPH RES CO, V365, P16, DOI 10.1016/j.bbrc.2007.10.101	31	11	11	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24657	24668		10.1074/jbc.M115.678086	http://dx.doi.org/10.1074/jbc.M115.678086			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26294764	hybrid, Green Published			2022-12-28	WOS:000362598300003
J	Kuwabara, K; Nishitsuji, K; Uchimura, K; Hung, SC; Mizuguchi, M; Nakajima, H; Mikawa, S; Kobayashi, N; Saito, H; Sakashita, N				Kuwabara, Kaori; Nishitsuji, Kazuchika; Uchimura, Kenji; Hung, Shang-Cheng; Mizuguchi, Makoto; Nakajima, Hiroyuki; Mikawa, Shiho; Kobayashi, Norihiro; Saito, Hiroyuki; Sakashita, Naomi			Cellular Interaction and Cytotoxicity of the Iowa Mutation of Apolipoprotein A-I (ApoA-I-Iowa) Amyloid Mediated by Sulfate Moieties of Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; BASEMENT-MEMBRANE; FIBRIL-FORMATION; PROTEOGLYCANS; BETA; GLYCOSAMINOGLYCANS; BINDING; PLAQUES; VARIANT; GROWTH	The single amino acid mutation G26R in human apolipoprotein A-I (apoA-I) is associated with familial amyloid polyneuropathy III. ApoA-I carrying this mutation (apoA-IIowa) forms amyloid fibrils in vitro. Heparan sulfate (HS) is a glycosaminoglycan that is abundant at the cell surface and in the extracellular matrix. Although HS and its highly sulfated domains are involved in aggregation of amyloid-beta and accumulate in cerebral amyloid plaques of patients with Alzheimer disease and mouse models of this disease, the role of HS in familial amyloid polyneuropathy III has never been addressed. Here, we used cell models to investigate the possible role of HS in the cytotoxicity of apoA-IIowa amyloid. Wild-type CHO cells, but not pgsD-677 cells, an HS-deficient CHO mutant, demonstrated uptake of apoA-IIowa amyloid after incubation with the amyloid. Addition of sulfated glycosaminoglycans to culture media prevented interaction with and cytotoxicity of apoA-IIowa amyloid to CHO cells. Elimination of cell surface HS or inhibition of HS sulfation with chemical reagents interfered with interaction of apoA-IIowa amyloid with CHO cells. We also found that cellular interaction and cytotoxicity of apoA-IIowa amyloid were significantly attenuated in CHO cells that stably expressed the human extracellular endoglucosamine 6-sulfatases HSulf-1 and HSulf-2. Our results thus suggest that cell surface HS mediates cytotoxicity of apoA-IIowa amyloid and that enzymatic remodeling of HS mitigates the cytotoxicity.	[Kuwabara, Kaori; Nishitsuji, Kazuchika; Mizuguchi, Makoto; Nakajima, Hiroyuki; Sakashita, Naomi] Univ Tokushima, Inst Biomed Sci, Dept Mol Pathol, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan; [Kuwabara, Kaori; Nakajima, Hiroyuki; Mikawa, Shiho; Saito, Hiroyuki] Univ Tokushima, Inst Biomed Sci, Dept Mol Phys Pharmaceut, Grad Sch, Tokushima 7708505, Japan; [Uchimura, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, Nagoya, Aichi 4668550, Japan; [Hung, Shang-Cheng] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Kobayashi, Norihiro] Kobe Pharmaceut Univ, Dept Bioanalyt Chem, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Tokushima University; Tokushima University; Nagoya University; Academia Sinica - Taiwan; Kobe Pharmaceutical University	Nishitsuji, K (corresponding author), Univ Tokushima, Inst Biomed Sci, Dept Mol Pathol, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	nishitsuji@tokushima-u.ac.jp	Uchimura, Kenji/AFV-1802-2022; Uchimura, Kenji/C-9635-2014	Uchimura, Kenji/0000-0003-3009-248X; Uchimura, Kenji/0000-0003-3009-248X	Japan Society for the Promotion of Science [B-25293006, C-23590448, 26670190, B-15K19488]; Research Program for Development of Intelligent Tokushima Artificial Exosome (iTEX) from Tokushima University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Program for Development of Intelligent Tokushima Artificial Exosome (iTEX) from Tokushima University	This work was supported in part by Grant-in-aid for Scientific Research B-25293006 (to H. S.), Grant C-23590448 and Grant-in-aid for Challenging Exploratory Research 26670190 (to N. S.), and Grant-in-aid for Young Scientists B-15K19488 (to K. N.) from the Japan Society for the Promotion of Science, and the Research Program for Development of Intelligent Tokushima Artificial Exosome (iTEX) from Tokushima University. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi E, 2013, J BIOL CHEM, V288, P2848, DOI 10.1074/jbc.M112.428052; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brouillette CG, 2001, BBA-MOL CELL BIOL L, V1531, P4, DOI 10.1016/S1388-1981(01)00081-6; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; GALLAGHER JT, 1985, BIOCHEM J, V230, P665, DOI 10.1042/bj2300665; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Gomaraschi M, 2011, CLIN CHIM ACTA, V412, P1262, DOI 10.1016/j.cca.2011.03.027; Groffen AJA, 1999, NEPHROL DIAL TRANSPL, V14, P2119, DOI 10.1093/ndt/14.9.2119; Guan J, 2014, EMBO MOL MED, V6, P1493, DOI 10.15252/emmm.201404190; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Hosono-Fukao T, 2012, AM J PATHOL, V180, P2056, DOI 10.1016/j.ajpath.2012.01.015; Hossain MM, 2010, GLYCOBIOLOGY, V20, P175, DOI 10.1093/glycob/cwp159; Valle-Delgado JJ, 2010, FASEB J, V24, P4250, DOI 10.1096/fj.09-153551; Kisilevsky R, 2007, AMYLOID, V14, P21, DOI 10.1080/13506120601116419; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Morrow JA, 1999, PROTEIN EXPRES PURIF, V16, P224, DOI 10.1006/prep.1999.1069; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; Nagamine S, 2012, J BIOL CHEM, V287, P9579, DOI 10.1074/jbc.M111.290262; Najjam S, 1997, CYTOKINE, V9, P1013, DOI 10.1006/cyto.1997.0246; NICHOLS WC, 1988, BIOCHEM BIOPH RES CO, V156, P762, DOI 10.1016/S0006-291X(88)80909-4; NICHOLS WC, 1990, GENOMICS, V8, P318, DOI 10.1016/0888-7543(90)90288-6; Niikura Y, 2002, J BIOCHEM, V132, P53, DOI 10.1093/oxfordjournals.jbchem.a003198; Nishitsuji K, 2011, J BIOL CHEM, V286, P6393, DOI 10.1074/jbc.M110.172106; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Omura R, 2014, J LIPID RES, V55, P2423, DOI 10.1194/jlr.D049445; PERLMUTTER LS, 1990, BRAIN RES, V508, P13, DOI 10.1016/0006-8993(90)91111-S; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Ramella NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022532; ROBINSON J, 1984, J BIOL CHEM, V259, P3818; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Rowczenio D, 2011, AM J PATHOL, V179, P1978, DOI 10.1016/j.ajpath.2011.06.024; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; SEGREST JP, 1992, J LIPID RES, V33, P141; SNOW AD, 1989, ACTA NEUROPATHOL, V77, P337, DOI 10.1007/BF00687367; SNOW AD, 1990, AM J PATHOL, V137, P1253; SNOW AD, 1988, AM J PATHOL, V133, P456; SNOW AD, 1985, LAB INVEST, V53, P37; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; Supattapone S, 2004, J MOL MED, V82, P348, DOI 10.1007/s00109-004-0534-3; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tanaka M, 2008, BIOCHEMISTRY-US, V47, P2172, DOI 10.1021/bi702332b; Traynor CA, 2013, NEPHROLOGY, V18, P549, DOI 10.1111/nep.12108; Uchimura Kenji, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-2; VANALLEN MW, 1969, NEUROLOGY, V19, P10, DOI 10.1212/WNL.19.1.10; VIGUSHIN DM, 1994, Q J MED, V87, P149; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Watson DJ, 1997, J BIOL CHEM, V272, P31617, DOI 10.1074/jbc.272.50.31617; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; YOUNG ID, 1989, ACTA NEUROPATHOL, V78, P202, DOI 10.1007/BF00688210	67	21	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24210	24221		10.1074/jbc.M115.652545	http://dx.doi.org/10.1074/jbc.M115.652545			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26292220	Green Published, hybrid			2022-12-28	WOS:000362218900014
J	Li, SJ; Liang, YH; Mariano, J; Metzger, MB; Stringer, DK; Hristova, VA; Li, J; Randazzo, PA; Tsai, YC; Ji, XH; Weissman, AM				Li, Shengjian; Liang, Yu-He; Mariano, Jennifer; Metzger, Meredith B.; Stringer, Daniel K.; Hristova, Ventzislava A.; Li, Jess; Randazzo, Paul A.; Tsai, Yien Che; Ji, Xinhua; Weissman, Allan M.			Insights into Ubiquitination from the Unique Clamp-like Binding of the RING E3 AO7 to the E2 UbcH5B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYME; ALLOSTERIC ACTIVATION; STRUCTURAL BASIS; SUMO CHAIN; LIGASE; COMPLEX; DOMAIN; MECHANISM; UBIQUITYLATION; REVEALS	RING proteins constitute the largest class of E3 ubiquitin ligases. Unlike most RINGs, AO7 (RNF25) binds the E2 ubiquitin-conjugating enzyme, UbcH5B (UBE2D2), with strikingly high affinity. We have defined, by co-crystallization, the distinctive means by which AO7 binds UbcH5B. AO7 contains a structurally unique UbcH5B binding region (U5BR) that is connected by an 11-amino acid linker to its RING domain, forming a clamp surrounding the E2. The U5BR interacts extensively with a region of UbcH5B that is distinct from both the active site and the RING-interacting region, referred to as the backside of the E2. An apparent paradox is that the high-affinity binding of the AO7 clamp to UbcH5B, which is dependent on the U5BR, decreases the rate of ubiquitination. We establish that this is a consequence of blocking the stimulatory, non-covalent, binding of ubiquitin to the backside of UbcH5B. Interestingly, when non-covalent backside ubiquitin binding cannot occur, the AO7 clamp now enhances the rate of ubiquitination. The high-affinity binding of the AO7 clamp to UbcH5B has also allowed for the co-crystallization of previously described and functionally important RING mutants at the RING-E2 interface. We show that mutations having marked effects on function only minimally affect the intermolecular interactions between the AO7 RING and UbcH5B, establishing a high degree of complexity in activation through the RING-E2 interface.	[Li, Shengjian; Mariano, Jennifer; Metzger, Meredith B.; Stringer, Daniel K.; Hristova, Ventzislava A.; Tsai, Yien Che; Weissman, Allan M.] NCI, Lab Prot Dynam & Signaling, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Liang, Yu-He; Ji, Xinhua] NCI, Macromol Crystallog Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Li, Jess] NCI, Struct Biophys Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Randazzo, Paul A.] NCI, Lab Cell & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ji, XH (corresponding author), NCI, Macromol Crystallog Lab, Ctr Canc Res, 1050 Boyles St, Frederick, MD 21702 USA.	jix@mail.nih.gov; weissmaa@mail.nih.gov	Ji, Xinhua/C-9664-2012	Ji, Xinhua/0000-0001-6942-1514; Metzger, Meredith/0000-0002-6248-0009; Tsai, Yien Che/0000-0001-9624-1092	Werner H. Kristen Student Internship Program; NATIONAL CANCER INSTITUTE [ZIABC010326] Funding Source: NIH RePORTER	Werner H. Kristen Student Internship Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Marzena Dyba and Sergey Tarasov of the Biophysics Resource, Structural Biophysics Laboratory, Center for Cancer Research for assistance with MST and Mei Yang for providing reagents. Some experiments were carried out with assistance from Erin Marshall and Alex Roumeliotis (both supported by the Werner H. Kristen Student Internship Program). We thank R. Andrew Byrd, Ranabir Das, and Stanley Lipkowitz for invaluable discussions and critical reading of this manuscript. Wealso thank Ranabir Das and R. Andrew Byrd for NMR analyses and Gary Pauly for FlAsH-EDT2.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Berndsen CE, 2013, NAT CHEM BIOL, V9, P154, DOI [10.1038/NCHEMBIO.1159, 10.1038/nchembio.1159]; Brown NG, 2015, P NATL ACAD SCI USA, V112, P5272, DOI 10.1073/pnas.1504161112; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Buetow L, 2015, MOL CELL, V58, P297, DOI 10.1016/j.molcel.2015.02.017; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Cenciarelli C, 1996, J BIOL CHEM, V271, P8709, DOI 10.1074/jbc.271.15.8709; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dowil RT, 2011, J BIOL CHEM, V286, P14913, DOI 10.1074/jbc.M110.158808; Downes BP, 2006, J BIOL CHEM, V281, P27145, DOI 10.1074/jbc.M602283200; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HAAS AL, 1985, J BIOL CHEM, V260, P2464; Haririnia A, 2007, J MOL BIOL, V368, P753, DOI 10.1016/j.jmb.2007.02.037; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Jensen JP, 1995, J BIOL CHEM, V270, P30408, DOI 10.1074/jbc.270.51.30408; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leboucher GP, 2012, MOL CELL, V47, P547, DOI 10.1016/j.molcel.2012.05.041; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Metzger MB, 2013, MOL CELL, V50, P516, DOI 10.1016/j.molcel.2013.04.004; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nakatani Y, 2013, BIOCHEM J, V450, P629, DOI 10.1042/BJ20121702; Nguyen L, 2014, BIOCHEMISTRY-US, V53, P4004, DOI 10.1021/bi500072v; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Prudden J, 2009, NAT STRUCT MOL BIOL, V16, P509, DOI 10.1038/nsmb.1582; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Saitoh H, 1997, P NATL ACAD SCI USA, V94, P3736, DOI 10.1073/pnas.94.8.3736; Sekiyama N, 2010, PROTEINS, V78, P1491, DOI 10.1002/prot.22667; Soss SE, 2013, BIOCHEMISTRY-US, V52, P2991, DOI 10.1021/bi3015949; Tsai YC, 2012, MOL BIOL CELL, V23, P4484, DOI 10.1091/mbc.E12-08-0631; Turco E, 2015, J BIOL CHEM, V290, P5298, DOI 10.1074/jbc.M114.626788; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Williams C, 2012, EMBO J, V31, P391, DOI 10.1038/emboj.2011.411; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	66	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30225	30239		10.1074/jbc.M115.685867	http://dx.doi.org/10.1074/jbc.M115.685867			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26475854	Green Published, hybrid			2022-12-28	WOS:000366738200003
J	Ramkumar, P; Lee, CM; Moradian, A; Sweredoski, MJ; Hess, S; Sharrocks, AD; Haines, DS; Reddy, EP				Ramkumar, Poornima; Lee, Clement M.; Moradian, Annie; Sweredoski, Michael J.; Hess, Sonja; Sharrocks, Andrew D.; Haines, Dale S.; Reddy, E. Premkumar			JNK-associated Leucine Zipper Protein Functions as a Docking Platform for Polo-like Kinase 1 and Regulation of the Associating Transcription Factor Forkhead Box Protein K1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE-KINASE-1 PLK1; PLK1-PBIP1 INTERACTION; SCAFFOLDING PROTEIN; CELL-MIGRATION; DOMAIN; FOXK1; PHOSPHORYLATION; IDENTIFICATION; LOCALIZATION; KINETOCHORES	JLP (JNK-associated leucine zipper protein) is a scaffolding protein that interacts with various signaling proteins associated with coordinated regulation of cellular process such as endocytosis, motility, neurite outgrowth, cell proliferation, and apoptosis. Here we identified PLK1 (Polo-like kinase 1) as a novel interaction partner of JLP through mass spectrometric approaches. Our results indicate that JLP is phospho-primed by PLK1 on Thr-351, which is recognized by the Polo box domain of PLK1 leading to phosphorylation of JLP at additional sites. Stable isotope labeling by amino acids in cell culture and quantitative LC-MS/MS analysis was performed to identify PLK1-dependent JLP-interacting proteins. Treatment of cells with the PLK1 kinase inhibitor BI2536 suppressed binding of the Forkhead box protein K1 (FOXK1) transcriptional repressor to JLP. JLP was found to interact with PLK1 and FOXK1 during mitosis. Moreover, knockdown of PLK1 affected the interaction between JLP and FOXK1. FOXK1 is a known transcriptional repressor of the CDK inhibitor p21/WAF1, and knockdown of JLP resulted in increased FOXK1 protein levels and a reduction of p21 transcript levels. Our results suggest a novel mechanism by which FOXK1 protein levels and activity are regulated by associating with JLP and PLK1.	[Ramkumar, Poornima; Lee, Clement M.; Reddy, E. Premkumar] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Haines, Dale S.] Temple Univ, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19122 USA; [Moradian, Annie; Sweredoski, Michael J.; Hess, Sonja] CALTECH, Beckman Inst, Proteome Explorat Lab, Pasadena, CA 91125 USA; [Sharrocks, Andrew D.] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England	Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; California Institute of Technology; University of Manchester	Reddy, EP (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, 1425 Madison Ave,Rm 15-20C, New York, NY 10029 USA.	ep.reddy@mssm.edu	Lee, Clement M./E-7104-2012; Regan, Clinton/E-6250-2012; Reddy, E. Premkumar/F-6233-2011	Lee, Clement M./0000-0003-3486-8492; 	National Institutes of Health [RO1CA158209]; Gordon and Betty Moore Foundation [GBMF775]; Beckman Institute; Wellcome Trust; NATIONAL CANCER INSTITUTE [R01CA158209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health RO1CA158209 (to E. P. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Gordon and Betty Moore Foundation Grant GBMF775 and the Beckman Institute.; Supported by a grant from the Wellcome Trust.	Bucur Octavian, 2014, Discoveries (Craiova), V2; Cheng KY, 2003, EMBO J, V22, P5757, DOI 10.1093/emboj/cdg558; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Carcer G, 2011, CELL CYCLE, V10, P2255, DOI 10.4161/cc.10.14.16494; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Freddie CT, 2007, NUCLEIC ACIDS RES, V35, P5203, DOI 10.1093/nar/gkm528; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Gantulga D, 2008, J BIOCHEM, V144, P693, DOI 10.1093/jb/mvn123; Haines DS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016444; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hawke TJ, 2003, J BIOL CHEM, V278, P4015, DOI 10.1074/jbc.M209200200; Jatiani Shashidhar S, 2010, Genes Cancer, V1, P331, DOI 10.1177/1947601910371337; Ji Zongling, 2015, Mol Syst Biol, V11, P782, DOI 10.15252/msb.20145936; Kalli A, 2013, J PROTEOME RES, V12, P3071, DOI 10.1021/pr3011588; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kang YH, 2011, J BIOL CHEM, V286, P19744, DOI 10.1074/jbc.M111.224105; Katoh M, 2004, INT J ONCOL, V25, P1495; Katoh M, 2004, INT J MOL MED, V14, P127; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Kothe M, 2007, BIOCHEMISTRY-US, V46, P5960, DOI 10.1021/bi602474j; Laszlo B, 2010, FEBS J, V277, P4348, DOI 10.1111/j.1742-4658.2010.07864.x; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; Lee JE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006460; Lee KS, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-4; Lee KS, 2008, CELL CYCLE, V7, P141, DOI 10.4161/cc.7.2.5272; Li X, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145504; Marais A, 2010, J BIOL CHEM, V285, P35728, DOI 10.1074/jbc.M110.154005; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nguyen Q, 2005, J BIOL CHEM, V280, P30185, DOI 10.1074/jbc.M505499200; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Shi XZ, 2012, J CELL SCI, V125, P5329, DOI 10.1242/jcs.105239; Shi XZ, 2012, MOL CELL BIOCHEM, V366, P251, DOI 10.1007/s11010-012-1302-2; Takahashi T, 2003, CANCER SCI, V94, P148, DOI 10.1111/j.1349-7006.2003.tb01411.x; Takino T, 2005, J BIOL CHEM, V280, P37772, DOI 10.1074/jbc.M505241200; Tuvshintugs B, 2014, GENES CELLS, V19, P692, DOI 10.1111/gtc.12170; Wang WQ, 2015, DEV CELL, V32, P707, DOI 10.1016/j.devcel.2015.01.031; Weichert W, 2005, WORLD J GASTROENTERO, V11, P5644, DOI 10.3748/wjg.v11.i36.5644; Xu H, 2010, J BIOL CHEM, V285, P3548, DOI 10.1074/jbc.M109.064113; Yuan CF, 2014, CELL CYCLE, V13, P807, DOI 10.4161/cc.27727	48	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29617	29628		10.1074/jbc.M115.664649	http://dx.doi.org/10.1074/jbc.M115.664649			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468278	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000366613400042
J	Alvarez-Castelao, B; Schuman, EM				Alvarez-Castelao, Beatriz; Schuman, Erin M.			The Regulation of Synaptic Protein Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						neuron; protein degradation; protein synthesis; protein turnover; synapse; synaptic plasticity	LONG-TERM POTENTIATION; NEWLY SYNTHESIZED PROTEINS; MESSENGER-RNA; AMPA RECEPTOR; TRANSLATIONAL CONTROL; GLUTAMATE RECEPTORS; DENDRITIC SPINES; IN-SITU; UBIQUITIN; DEGRADATION	Emerging evidence indicates that protein synthesis and degradation are necessary for the remodeling of synapses. These two processes govern cellular protein turnover, are tightly regulated, and are modulated by neuronal activity in time and space. The anisotropic anatomy of the neurons presents a challenge for the study of protein turnover, but the understanding of protein turnover in neurons and its modulation in response to activity can help us to unravel the fine-tuned changes that occur at synapses in response to activity. Here we review the key experimental evidence demonstrating the role of protein synthesis and degradation in synaptic plasticity, as well as the turnover rates of specific neuronal proteins.	[Alvarez-Castelao, Beatriz; Schuman, Erin M.] Max Planck Inst Brain Res, Dept Synapt Plast, D-60438 Frankfurt, Germany	Max Planck Society	Schuman, EM (corresponding author), Max Planck Inst Brain Res, Dept Synapt Plast, Max Von Laue Str 4, D-60438 Frankfurt, Germany.	erin.schuman@brain.mpg.de	Alvarez-castelao, Beatriz/ABG-8826-2021; alvarez-castelao, beatriz/W-1707-2018; Schuman, Erin M/D-6204-2011	alvarez-castelao, beatriz/0000-0001-7505-1855; 	Marie Curie Intra-European Fellowship (IEF) for Career Development; Max Planck Society; European Research Council; DFG [CRC 902, CRC1080]; Molecular Principles of RNA-based Regulation; Molecular and Cellular Mechanisms of Neural Homeostasis; DFG Cluster of Excellence for Macromolecular Complexes, Goethe University, Frankfurt	Marie Curie Intra-European Fellowship (IEF) for Career Development; Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); Molecular Principles of RNA-based Regulation; Molecular and Cellular Mechanisms of Neural Homeostasis; DFG Cluster of Excellence for Macromolecular Complexes, Goethe University, Frankfurt	Supported by a Marie Curie Intra-European Fellowship (IEF) for Career Development.; Supported by the Max Planck Society. An Advanced Investigator Award from the European Research Council; DFG CRC 902, Molecular Principles of RNA-based Regulation; DFG CRC1080, Molecular and Cellular Mechanisms of Neural Homeostasis; and the DFG Cluster of Excellence for Macromolecular Complexes, Goethe University, Frankfurt. To whom correspondence should be addressed. E-mail: erin.schuman@brain.mpg.de.	Asano S, 2015, SCIENCE, V347, P439, DOI 10.1126/science.1261197; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Barrera I, 2008, NEUROCHEM INT, V52, P1167, DOI 10.1016/j.neuint.2007.12.006; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; Biesemann C, 2014, EMBO J, V33, P157, DOI 10.1002/embj.201386120; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; BLAUSTEIN MP, 1975, J PHYSIOL-LONDON, V247, P589, DOI 10.1113/jphysiol.1975.sp010949; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Boisvert FM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011429; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; Brooks SA, 2010, WIRES RNA, V1, P240, DOI 10.1002/wrna.11; Buhr F, 2015, ANGEW CHEM INT EDIT, V54, P3717, DOI 10.1002/anie.201410940; Butko MT, 2012, NAT NEUROSCI, V15, P1742, DOI 10.1038/nn.3246; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; CHICUREL ME, 1993, J NEUROSCI, V13, P4054; Chotiner JK, 2003, NEUROSCIENCE, V116, P743, DOI 10.1016/S0306-4522(02)00797-2; Claydon AJ, 2012, MOL CELL PROTEOMICS, V11, P1551, DOI 10.1074/mcp.O112.022186; Cohen LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063191; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Dieck ST, 2015, NAT METHODS, V12, P411, DOI [10.1038/nmeth.3319, 10.1038/NMETH.3319]; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Durairaj G, 2014, BIOMOLECULES, V4, P827, DOI 10.3390/biom4030827; EAGLE H, 1959, J BIOL CHEM, V234, P592; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; El Hokayem J, 2014, MOL NEUROBIOL, V49, P827, DOI 10.1007/s12035-013-8563-y; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; FEIG S, 1993, J NEUROSCI, V13, P1010; Fierro-Monti I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080423; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Hamilton AM, 2012, NEURON, V74, P1023, DOI 10.1016/j.neuron.2012.04.031; Hanus C, 2013, NAT REV NEUROSCI, V14, P638, DOI 10.1038/nrn3546; Havik B, 2003, EUR J NEUROSCI, V17, P2679, DOI 10.1046/j.1460-9568.2003.02712.x; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; HENDIL KB, 1988, BIOCHEM INT, V17, P471; Hinz FI, 2012, ACS CHEM NEUROSCI, V3, P40, DOI 10.1021/cn2000876; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huang J, 2015, NEURON, V86, P726, DOI 10.1016/j.neuron.2015.03.049; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; James AB, 2006, J NEUROSCI, V26, P1624, DOI 10.1523/JNEUROSCI.4199-05.2006; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jimenez CR, 2002, J NEUROCHEM, V81, P735, DOI 10.1046/j.1471-4159.2002.00873.x; Jovanovic M, 2015, SCIENCE, V347, DOI 10.1126/science.1259038; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Karpova A, 2006, J NEUROSCI, V26, P4949, DOI 10.1523/JNEUROSCI.4573-05.2006; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Kjoller C, 2000, NEUROCHEM INT, V37, P7, DOI 10.1016/S0197-0186(00)00008-5; LAJTHA A, 1976, BIOCHIM BIOPHYS ACTA, V425, P511, DOI 10.1016/0005-2787(76)90015-0; Laroia G, 2002, NUCLEIC ACIDS RES, V30, P3052, DOI 10.1093/nar/gkf444; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee YS, 2012, P NATL ACAD SCI USA, V109, P15520, DOI 10.1073/pnas.1116224109; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Mammen AL, 1997, J NEUROSCI, V17, P7351; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Matsumoto M, 2007, NEUROSCI RES, V57, P411, DOI 10.1016/j.neures.2006.11.015; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Peters A, 1996, J NEUROCYTOL, V25, P687, DOI 10.1007/BF02284835; Pick JE, 2013, LEARN MEMORY, V20, P11, DOI 10.1101/lm.027383.112; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Rizzoli SO, 2014, EMBO J, V33, P788, DOI 10.1002/embj.201386357; Saka SK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4664; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Soule J, 2012, J BIOL CHEM, V287, P22354, DOI 10.1074/jbc.M112.376491; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Specht CG, 2008, BIOESSAYS, V30, P1062, DOI 10.1002/bies.20831; Stegmuller J, 2006, NEURON, V50, P389, DOI 10.1016/j.neuron.2006.03.034; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tai HC, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00012; Will TJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004520; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Yamamoto N, 1999, J NEUROCHEM, V73, P2415, DOI 10.1046/j.1471-4159.1999.0732415.x; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699	91	73	73	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28623	28630		10.1074/jbc.R115.657130	http://dx.doi.org/10.1074/jbc.R115.657130			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26453306	Green Published, hybrid			2022-12-28	WOS:000365762300005
J	Daou, S; Hammond-Martel, I; Mashtalir, N; Barbour, H; Gagnon, J; Iannantuono, NVG; Nkwe, NS; Motorina, A; Pak, H; Yu, H; Wurtele, H; Milot, E; Mallette, FA; Carbone, M; Affar, E				Daou, Salima; Hammond-Martel, Ian; Mashtalir, Nazar; Barbour, Haithem; Gagnon, Jessica; Iannantuono, Nicholas V. G.; Nkwe, Nadine Sen; Motorina, Alena; Pak, Helen; Yu, Helen; Wurtele, Hugo; Milot, Eric; Mallette, Frederick A.; Carbone, Michele; Affar, El Bachir			The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell proliferation; cellular senescence; deubiquitylation (deubiquitination); epigenetics; ASXL; BAP1; Calypso; histone H2A ubiquitination; Polycomb Group Proteins	GERMLINE BAP1 MUTATIONS; TUMOR-SUPPRESSOR BAP1; ADDITIONAL-SEX-COMBS; STRAND BREAK REPAIR; BRCA1-ASSOCIATED PROTEIN-1; MYELOID TRANSFORMATION; UBIQUITIN HYDROLASE; ASXL1 MUTATIONS; UVEAL MELANOMA; TARGET GENES	The deubiquitinase (DUB) and tumor suppressor BAP1 catalyzes ubiquitin removal from histone H2A Lys-119 and coordinates cell proliferation, but how BAP1 partners modulate its function remains poorly understood. Here, we report that BAP1 forms two mutually exclusive complexes with the transcriptional regulators ASXL1 and ASXL2, which are necessary for maintaining proper protein levels of this DUB. Conversely, BAP1 is essential for maintaining ASXL2, but not ASXL1, protein stability. Notably, cancer-associated loss of BAP1 expression results in ASXL2 destabilization and hence loss of its function. ASXL1 and ASXL2 use their ASXM domains to interact with the C-terminal domain (CTD) of BAP1, and these interactions are required for ubiquitin binding and H2A deubiquitination. The deubiquitination-promoting effect of ASXM requires intramolecular interactions between catalytic and non-catalytic domains of BAP1, which generate a composite ubiquitin-binding interface (CUBI). Notably, the CUBI engages multiple interactions with ubiquitin involving (i) the ubiquitin carboxyl hydrolase catalytic domain of BAP1, which interacts with the hydrophobic patch of ubiquitin, and (ii) the CTD domain, which interacts with a charged patch of ubiquitin. Significantly, we identified cancer-associated mutations of BAP1 that disrupt the CUBI and notably an in-frame deletion in the CTD that inhibits its interaction with ASXL1/2 and DUB activity and deregulates cell proliferation. Moreover, we demonstrated that BAP1 interaction with ASXL2 regulates cell senescence and that ASXL2 cancer-associated mutations disrupt BAP1 DUB activity. Thus, inactivation of the BAP1/ASXL2 axis might contribute to cancer development.	[Daou, Salima; Hammond-Martel, Ian; Mashtalir, Nazar; Barbour, Haithem; Gagnon, Jessica; Iannantuono, Nicholas V. G.; Nkwe, Nadine Sen; Motorina, Alena; Pak, Helen; Yu, Helen; Wurtele, Hugo; Milot, Eric; Mallette, Frederick A.; Affar, El Bachir] Univ Montreal, Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada; [Daou, Salima; Hammond-Martel, Ian; Mashtalir, Nazar; Barbour, Haithem; Gagnon, Jessica; Iannantuono, Nicholas V. G.; Nkwe, Nadine Sen; Motorina, Alena; Pak, Helen; Yu, Helen; Wurtele, Hugo; Milot, Eric; Mallette, Frederick A.; Affar, El Bachir] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Carbone, Michele] Univ Hawaii Canc Ctr, Thorac Oncol Program, Honolulu, HI 96813 USA	Universite de Montreal; Universite de Montreal; Cancer Research Center of Hawaii	Affar, E (corresponding author), Univ Montreal, Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada.	aelbachir.hmr@ssss.gouv.qc.ca	Mallette, Frédérick A./J-6646-2019	Mallette, Frédérick A./0000-0001-7932-0338; BARBOUR, Haithem/0000-0002-4373-3728	Canadian Institutes of Health Research [MOP-115132, MOP-133442]; Natural Sciences and Engineering Research Council of Canada [355814-2010]; Islamic Development Bank; Ministry of Higher Education; Scientific Research of Tunisia; Cole Foundation; Fonds de la Recherche du Quebec-Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Islamic Development Bank(Islamic Development Bank); Ministry of Higher Education(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR)); Scientific Research of Tunisia; Cole Foundation; Fonds de la Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by Canadian Institutes of Health Research Grant MOP-115132, Natural Sciences and Engineering Research Council of Canada Grant 355814-2010 (to E.B.A.), and Canadian Institutes of Health Research Grant MOP-133442 (to F.A.M.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Ph.D. scholarship from the Islamic Development Bank.; Recipient of a Ph.D. scholarship from the Ministry of Higher Education and from Scientific Research of Tunisia and the Cole Foundation.; Recipient of an M.Sc. scholarship from the Fonds de la Recherche du Quebec-Sante.; Recipient of a Ph.D. scholarship from the Canadian Institutes of Health Research Grant.	Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; Balasubramani A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8307; Belle JI, 2014, INT J BIOCHEM CELL B, V50, P161, DOI 10.1016/j.biocel.2014.03.004; Bosch A, 2014, ONCOTARGET, V5, P2065, DOI 10.18632/oncotarget.1779; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Carbone M, 2013, NAT REV CANCER, V13, P153, DOI 10.1038/nrc3459; Cho YS, 2006, J BIOL CHEM, V281, P17588, DOI 10.1074/jbc.M512616200; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Eletr ZM, 2014, BBA-MOL CELL RES, V1843, P114, DOI 10.1016/j.bbamcr.2013.06.027; Eletr ZM, 2013, FEBS LETT, V587, P3906, DOI 10.1016/j.febslet.2013.10.035; Fisher CL, 2006, GENE, V369, P109, DOI 10.1016/j.gene.2005.10.033; Gildea JJ, 2000, GENETICS, V156, P645; Goldstein AM, 2011, NAT GENET, V43, P925, DOI 10.1038/ng.956; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hammond-Martel I, 2012, CELL SIGNAL, V24, P410, DOI 10.1016/j.cellsig.2011.10.009; Hammond-Martel I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014027; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Ismail IH, 2014, CANCER RES, V74, P4282, DOI 10.1158/0008-5472.CAN-13-3109; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Ji ZL, 2014, NUCLEIC ACIDS RES, V42, P6232, DOI 10.1093/nar/gku274; Katoh M, 2013, BRIT J CANCER, V109, P299, DOI 10.1038/bjc.2013.281; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lee HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6128; Lee JW, 2007, CANCER LETT, V257, P252, DOI 10.1016/j.canlet.2007.08.004; Lee SW, 2010, J BIOL CHEM, V285, P18, DOI 10.1074/jbc.M109.065862; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Luis NM, 2011, CELL STEM CELL, V9, P233, DOI 10.1016/j.stem.2011.07.013; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Mashtalir N, 2014, MOL CELL, V54, P392, DOI 10.1016/j.molcel.2014.03.002; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Milne TA, 1999, MOL GEN GENET, V261, P753, DOI 10.1007/s004380050018; Minsky N, 2004, MOL CELL, V16, P631, DOI 10.1016/j.molcel.2004.10.016; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Morrow ME, 2013, BIOCHEMISTRY-US, V52, P3564, DOI 10.1021/bi4003106; Murali R, 2013, PATHOLOGY, V45, P1, DOI 10.1097/PAT.0b013e32835af69c; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nishikawa H, 2009, CANCER RES, V69, P111, DOI 10.1158/0008-5472.CAN-08-3355; Okino Y, 2015, J BIOL CHEM, V290, P1580, DOI 10.1074/jbc.M114.609834; Pan H, 2015, INT J BIOCHEM CELL B, V60, P176, DOI 10.1016/j.biocel.2015.01.001; Park UH, 2011, J BIOL CHEM, V286, P1354, DOI 10.1074/jbc.M110.177816; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sahtoe DD, 2015, MOL CELL, V57, P887, DOI 10.1016/j.molcel.2014.12.039; Sanchez-Pulido L, 2012, BIOINFORMATICS, V28, P1953, DOI 10.1093/bioinformatics/bts319; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; VanderLinden RT, 2015, MOL CELL, V57, P901, DOI 10.1016/j.molcel.2015.01.016; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xu F, 2011, ANN HEMATOL, V90, P643, DOI 10.1007/s00277-010-1128-5; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yu H, 2014, P NATL ACAD SCI USA, V111, P285, DOI 10.1073/pnas.1309085110; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10	65	71	73	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28643	28663		10.1074/jbc.M115.661553	http://dx.doi.org/10.1074/jbc.M115.661553			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26416890	Green Published, hybrid			2022-12-28	WOS:000365762300007
J	Perusek, L; Sahu, B; Parmar, T; Maeno, H; Arai, E; Le, YZ; Subauste, CS; Chen, Y; Palczewski, K; Maeda, A				Perusek, Lindsay; Sahu, Bhubanananda; Parmar, Tanu; Maeno, Hiroshi; Arai, Eisuke; Le, Yun-Zheng; Subauste, Carlos S.; Chen, Yu; Palczewski, Krzysztof; Maeda, Akiko			Di-retinoid-pyridinium-ethanolamine (A2E) Accumulation and the Maintenance of the Visual Cycle Are Independent of Atg7-mediated Autophagy in the Retinal Pigmented Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aging; autophagy; autophagy-related protein 7 (ATG7); retina; retinal degeneration; A2E; ABCA4; Stargardt disease	CHAPERONE-MEDIATED AUTOPHAGY; LIPOFUSCIN FLUOROPHORE A2E; PLURIPOTENT STEM-CELLS; HUMAN RPE CELLS; MACULAR DEGENERATION; OUTER SEGMENTS; MICROGLIAL ACTIVATION; OXIDATIVE STRESS; IN-VIVO; MICE	Autophagy is an evolutionarily conserved catabolic mechanism that relieves cellular stress by removing/recycling damaged organelles and debris through the action of lysosomes. Compromised autophagy has been implicated in many neurodegenerative diseases, including retinal degeneration. Here we examined retinal phenotypes resulting from RPE-specific deletion of the autophagy regulatory gene Atg7 by generating Atg7(flox/flox);VMD2-rtTA-cre+ mice to determine whether autophagy is essential for RPE functions including retinoid recycling. Atg7-deficient RPE displayed abnormal morphology with increased RPE thickness, cellular debris and vacuole formation indicating that autophagy is important in maintaining RPE homeostasis. In contrast, 11-cis-retinal content, ERGs and retinal histology were normal in mice with Atg7-deficient RPE in both fasted and fed states. Because A2E accumulation in the RPE is associated with pathogenesis of both Stargardt disease and age-related macular degeneration (AMD) in humans, deletion of Abca4 was introduced into Atg7(flox/flox);VMD2-rtTA-cre+ mice to investigate the role of autophagy during A2E accumulation. Comparable A2E concentrations were detected in the eyes of 6-month-old mice with and without Atg7 from both Abca4(-/-) and Abca4(+/+) backgrounds. To identify other autophagy-related molecules involved in A2E accumulation, we performed gene expression array analysis on A2E-treated human RPE cells and found up-regulation of four autophagy related genes; DRAM1, NPC1, CASP3, and EIF2AK3/PERK. These observations indicate that Atg7-mediated autophagy is dispensable for retinoid recycling and A2E deposition; however, autophagy plays a role in coping with stress caused by A2E accumulation.	[Perusek, Lindsay; Sahu, Bhubanananda; Parmar, Tanu; Maeno, Hiroshi; Arai, Eisuke; Maeda, Akiko] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Chen, Yu; Palczewski, Krzysztof; Maeda, Akiko] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Chen, Yu; Palczewski, Krzysztof; Maeda, Akiko] Case Western Reserve Univ, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Subauste, Carlos S.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Med Endocrinol, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Oklahoma City, OK 73104 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Maeda, A (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.	aam19@case.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [5P30AR039750]; Ohio Department of Development - Center for Innovative Immunosuppressive Therapeutics [TECH 09-023];  [P30 EY11373]; NATIONAL EYE INSTITUTE [R24EY021126, R01EY022658, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR039750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio Department of Development - Center for Innovative Immunosuppressive Therapeutics; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Dr. Leslie T. Webster, Jr, Vipulkumar Parmar (Case Western Reserve University) for helpful comments on the manuscript, the Visual Sciences Research Center Core Facility (supported by P30 EY11373), in particular Scott Howell and Sarah Lindstrom for their help with microscopy, and the flow cytometry facility in the Department of Dermatology's Skin Diseases Research Center (SDRC) for assistance with confocal microscopy. The Department of Dermatology's Skin Diseases Research Center (SDRC) is supported in part by the National Institutes of Health Grant (5P30AR039750) and the Ohio Department of Development - Center for Innovative Immunosuppressive Therapeutics (TECH 09-023).	Basu S, 2014, AUTOPHAGY, V10, P1193, DOI 10.4161/auto.28768; Besirli CG, 2011, INVEST OPHTH VIS SCI, V52, P4193, DOI 10.1167/iovs.10-7090; BIRNBACH CD, 1994, OPHTHALMOLOGY, V101, P1211; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Claudepierre T, 2010, MOL CELL NEUROSCI, V43, P164, DOI 10.1016/j.mcn.2009.10.007; Diemer T, 2008, ADV EXP MED BIOL, V613, P321, DOI 10.1007/978-0-387-74904-4_37; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Guha S, 2014, ADV EXP MED BIOL, V801, P105, DOI 10.1007/978-1-4614-3209-8_14; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Holz FG, 1999, INVEST OPHTH VIS SCI, V40, P737; Holz FG, 1999, OPHTHALMOLOGE, V96, P781, DOI 10.1007/s003470050496; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Iriyama A, 2008, J BIOL CHEM, V283, P11947, DOI 10.1074/jbc.M708989200; Jo C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4496; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kohno H, 2013, J BIOL CHEM, V288, P15326, DOI 10.1074/jbc.M112.448712; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Lakkaraju A, 2007, P NATL ACAD SCI USA, V104, P11026, DOI 10.1073/pnas.0702504104; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; Lee SY, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.266; Ma WX, 2013, NEUROBIOL AGING, V34, P943, DOI 10.1016/j.neurobiolaging.2012.06.010; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda T, 2013, J BIOL CHEM, V288, P34484, DOI 10.1074/jbc.M113.518571; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mitter SK, 2014, AUTOPHAGY, V10, P1989, DOI 10.4161/auto.36184; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Morishita H, 2013, J BIOL CHEM, V288, P11436, DOI 10.1074/jbc.M112.437103; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Saadat KASM, 2014, FEBS OPEN BIO, V4, P1007, DOI 10.1016/j.fob.2014.11.003; Schutt F, 2000, INVEST OPHTH VIS SCI, V41, P2303; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Taneike M, 2010, AUTOPHAGY, V6, P600, DOI 10.4161/auto.6.5.11947; Toops KA, 2015, MOL BIOL CELL, V26, P1, DOI 10.1091/mbc.E14-05-1028; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Wu HJ, 2014, INT J BIOL SCI, V10, P1072, DOI 10.7150/ijbs.9719; Yannuzzi LA, 2004, AM J OPHTHALMOL, V137, P511, DOI 10.1016/j.ajo.2003.12.035; Yao JY, 2014, INVEST OPHTH VIS SCI, V55, P3237, DOI 10.1167/iovs.13-13336; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	61	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29035	29044		10.1074/jbc.M115.682310	http://dx.doi.org/10.1074/jbc.M115.682310			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26468292	hybrid, Green Published			2022-12-28	WOS:000365762300041
J	Spence, EF; Soderling, SH				Spence, Erin F.; Soderling, Scott H.			Actin Out: Regulation of the Synaptic Cytoskeleton	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						actin; adhesion; Arp2; 3 complex; cofilin; dendritic spine; formin; Rho (Rho GTPase); synapse; synaptic plasticity; WASH	LONG-TERM POTENTIATION; DENDRITIC-SPINE MORPHOLOGY; LINKED MENTAL-RETARDATION; RECESSIVE INTELLECTUAL DISABILITY; AMPA RECEPTORS; N-CADHERIN; HIPPOCAMPAL SYNAPSES; CAPPING PROTEIN; BINDING-PROTEIN; ALPHA-CATENIN	The small size of dendritic spines belies the elaborate role they play in excitatory synaptic transmission and ultimately complex behaviors. The cytoskeletal architecture of the spine is predominately composed of actin filaments. These filaments, which at first glance might appear simple, are also surprisingly complex. They dynamically assemble into different structures and serve as a platform for orchestrating the elaborate responses of the spine during spinogenesis and experience-dependent plasticity. Multiple mutations associated with human neurodevelopmental and psychiatric disorders involve genes that encode regulators of the synaptic cytoskeleton. A major, unresolved question is how the disruption of specific actin filament structures leads to the onset and progression of complex synaptic and behavioral phenotypes. This review will cover established and emerging mechanisms of actin cytoskeletal remodeling and how this influences specific aspects of spine biology that are implicated in disease.	[Spence, Erin F.; Soderling, Scott H.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Soderling, Scott H.] Duke Univ, Sch Med, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Duke University	Soderling, SH (corresponding author), Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA.	scott.soderling@duke.edu			National Institutes of Health Grants [MH103374, NS059957]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH103374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059957, F31NS092402, R56NS059957] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants MH103374 and NS059957 (to S.H.S.). This is the third article in the Thematic Minire-view series "Molecular Mechanisms of Synaptic Plasticity." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Allison DW, 1998, J NEUROSCI, V18, P2423; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Bosch M, 2014, NEURON, V82, P444, DOI 10.1016/j.neuron.2014.03.021; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Burianek LE, 2013, SEMIN CELL DEV BIOL, V24, P258, DOI 10.1016/j.semcdb.2012.12.005; Calabrese B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094787; Carlson BR, 2011, J NEUROSCI, V31, P2447, DOI 10.1523/JNEUROSCI.4433-10.2011; Chazeau A, 2015, MOL BIOL CELL, V26, P859, DOI 10.1091/mbc.E14-06-1086; Chazeau A, 2014, EMBO J, V33, P2745, DOI 10.15252/embj.201488837; Chen BY, 2014, CELL, V156, P195, DOI 10.1016/j.cell.2013.11.048; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Choy RWY, 2014, NEURON, V82, P55, DOI 10.1016/j.neuron.2014.02.018; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Edwards M, 2014, NAT REV MOL CELL BIO, V15, P677, DOI 10.1038/nrm3869; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Erlendsson S, 2014, J BIOL CHEM, V289, P25327, DOI 10.1074/jbc.M114.548743; Ewers H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113916; Fan YJ, 2011, J NEUROSCI, V31, P10228, DOI 10.1523/JNEUROSCI.0115-11.2011; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Goodson M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002970; Gray V, 2006, NEUROPSYCHOLOGIA, V44, P679, DOI 10.1016/j.neuropsychologia.2005.08.007; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; Hanley JG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00381; Harbour ME, 2010, J CELL SCI, V123, P3703, DOI 10.1242/jcs.071472; Harris ES, 2004, CURR BIOL, V14, pR520, DOI 10.1016/j.cub.2004.06.043; Hazai D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075248; Hirabayashi Takahiro, 2014, Adv Neurobiol, V8, P293; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kasri NN, 2009, GENE DEV, V23, P1289, DOI 10.1101/gad.1783809; Kerr JM, 2012, J NEUROSCI, V32, P658, DOI 10.1523/JNEUROSCI.2927-11.2012; Kim CH, 1999, J NEUROSCI, V19, P4314; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Kim IH, 2015, NAT NEUROSCI, V18, P883, DOI 10.1038/nn.4015; Kim IH, 2014, ELIFE, V3, DOI 10.7554/eLife.02839; Kim IH, 2013, J NEUROSCI, V33, P6081, DOI 10.1523/JNEUROSCI.0035-13.2013; Kim TJ, 2015, CURR BIOL, V25, P218, DOI 10.1016/j.cub.2014.11.017; Kim Y, 2006, NATURE, V442, P814, DOI 10.1038/nature04976; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Lamprecht R, 2006, NAT NEUROSCI, V9, P481, DOI 10.1038/nn1672; Law R, 2014, AM J HUM GENET, V95, P721, DOI 10.1016/j.ajhg.2014.10.016; Madasu Y, 2015, MOL BIOL CELL, V26, P1308, DOI 10.1091/mbc.E14-10-1448; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Medina M, 2000, GENOMICS, V63, P157, DOI 10.1006/geno.1999.6090; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Menna E, 2013, EMBO J, V32, P1730, DOI 10.1038/emboj.2013.107; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Munsie LN, 2015, HUM MOL GENET, V24, P1691, DOI 10.1093/hmg/ddu582; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; Nakano-Kobayashi A, 2014, J NEUROSCI, V34, P8665, DOI 10.1523/JNEUROSCI.0894-14.2014; Nakao S, 2008, J CELL BIOL, V182, P395, DOI 10.1083/jcb.200802069; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Opazo P, 2011, MOL CELL NEUROSCI, V46, P1, DOI 10.1016/j.mcn.2010.08.014; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; Rocca DL, 2008, NAT CELL BIOL, V10, P259, DOI 10.1038/ncb1688; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Ropers F, 2011, HUM MOL GENET, V20, P2585, DOI 10.1093/hmg/ddr158; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Russell TA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5858; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Srivastava DP, 2012, J BIOL CHEM, V287, P35964, DOI 10.1074/jbc.M112.363358; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Tachibana K, 2000, J CELL BIOL, V150, P1161, DOI 10.1083/jcb.150.5.1161; Tai K, 2010, BRAIN RES, V1344, P13, DOI 10.1016/j.brainres.2010.04.065; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Tonnesen J, 2014, NAT NEUROSCI, V17, P678, DOI 10.1038/nn.3682; Tucci V, 2014, J CLIN INVEST, V124, P1468, DOI 10.1172/JCI70372; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; van Spronsen M, 2010, CURR NEUROL NEUROSCI, V10, P207, DOI 10.1007/s11910-010-0104-8; VANHARREVELD A, 1975, EXP NEUROL, V49, P736, DOI 10.1016/0014-4886(75)90055-2; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Yamagata Y, 2009, J NEUROSCI, V29, P7607, DOI 10.1523/JNEUROSCI.0707-09.2009; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Yu X, 2004, NEUROPHARMACOLOGY, V47, P779, DOI 10.1016/j.neuropharm.2004.07.031; Yuste R, 2013, ANNU REV NEUROSCI, V36, P429, DOI 10.1146/annurev-neuro-062111-150455; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798; Zhou ZK, 2011, J NEUROSCI, V31, P819, DOI 10.1523/JNEUROSCI.3869-10.2011	100	104	106	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28613	28622		10.1074/jbc.R115.655118	http://dx.doi.org/10.1074/jbc.R115.655118			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26453304	Green Published, hybrid			2022-12-28	WOS:000365762300004
J	VanSchouwen, B; Selvaratnam, R; Giri, R; Lorenz, R; Herberg, FW; Kim, C; Melacini, G				VanSchouwen, Bryan; Selvaratnam, Rajeevan; Giri, Rajanish; Lorenz, Robin; Herberg, Friedrich W.; Kim, Choel; Melacini, Giuseppe			Mechanism of cAMP Partial Agonism in Protein Kinase G (PKG)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cell signaling; cyclic AMP (cAMP); cyclic GMP (cGMP); molecular dynamics; nuclear magnetic resonance (NMR); protein kinase G (PKG); agonism	CGMP-SELECTIVE ACTIVATION; NMR CHEMICAL-SHIFTS; CYCLIC-AMP; BINDING DOMAIN; COVARIANCE ANALYSIS; SUBSTRATE-BINDING; REVEALS; AUTOINHIBITION; DYNAMICS; CELLS	Protein kinase G (PKG) is a major receptor of cGMP and controls signaling pathways often distinct from those regulated by cAMP. Hence, the selective activation of PKG by cGMP versus cAMP is critical. However, the mechanism of cGMP-versus-cAMP selectivity is only limitedly understood. Although the C-terminal cyclic nucleotide-binding domain B of PKG binds cGMP with higher affinity than cAMP, the intracellular concentrations of cAMP are typically higher than those of cGMP, suggesting that the cGMP-versus-cAMP selectivity of PKG is not controlled uniquely through affinities. Here, we show that cAMP is a partial agonist for PKG, and we elucidate the mechanism for cAMP partial agonism through the comparative NMR analysis of the apo, cGMP-, and cAMP-bound forms of the PKG cyclic nucleotide-binding domain B. We show that although cGMP activation is adequately explained by a two-state conformational selection model, the partial agonism of cAMP arises from the sampling of a third, partially autoinhibited state.	[VanSchouwen, Bryan; Selvaratnam, Rajeevan; Giri, Rajanish; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada; [Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada; [Lorenz, Robin; Herberg, Friedrich W.] Univ Kassel, Dept Biochem, D-34132 Kassel, Germany; [Kim, Choel] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kim, Choel] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	McMaster University; McMaster University; Universitat Kassel; Baylor College of Medicine; Baylor College of Medicine	Melacini, G (corresponding author), McMaster Univ, Dept Chem & Chem Biol, 1280 Main St West, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca	Herberg, Friedrich W/B-5572-2015; Giri, Rajanish/Q-6530-2018	Herberg, Friedrich W/0000-0001-7117-7653; Giri, Rajanish/0000-0002-2046-836X; Selvaratnam, Rajeevan/0000-0003-4457-616X	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Kassel University; Federal Ministry of Education and Research [0316177F]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090161] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Kassel University; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Canadian Institutes of Health Research (to G. M.) and by the Natural Sciences and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the graduate program "Functionomics" at Kassel University.; Supported by Federal Ministry of Education and Research Grant 0316177F No Pain.	Akimoto M, 2014, J BIOL CHEM, V289, P22205, DOI 10.1074/jbc.M114.572164; Akimoto M, 2013, P NATL ACAD SCI USA, V110, P14231, DOI 10.1073/pnas.1312644110; Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Blumenthal DK, 2014, J BIOL CHEM, V289, P28505, DOI 10.1074/jbc.M114.584177; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; Boulton S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07306; Boulton S, 2014, BIOCHEM SOC T, V42, P302, DOI 10.1042/BST20130282; Cheng CY, 2009, J BIOL CHEM, V284, P35916, DOI 10.1074/jbc.M109.059493; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; De S, 2012, BIOCHEMISTRY-US, V51, P8583, DOI 10.1021/bi3008214; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Francis SH, 1999, CRIT REV CL LAB SCI, V36, P275, DOI 10.1080/10408369991239213; Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907; Goddard T., 2006, SPARKY NMR ASSIGNMEN; Greenwood AI, 2014, BIOCHEMISTRY-US, V53, P3593, DOI 10.1021/bi500031e; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Huang GY, 2014, BIOCHEMISTRY-US, V53, P6725, DOI 10.1021/bi501012v; Huang GY, 2014, STRUCTURE, V22, P116, DOI 10.1016/j.str.2013.09.021; Jayaraman B, 2007, BIOCHEMISTRY-US, V46, P12174, DOI 10.1021/bi701281e; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim Jeong Joo, 2011, PLoS One, V6, pe18413, DOI 10.1371/journal.pone.0018413; Kim J, 2015, P NATL ACAD SCI USA, V112, P3716, DOI 10.1073/pnas.1502299112; Masterson LR, 2011, J MOL BIOL, V412, P155, DOI 10.1016/j.jmb.2011.06.041; Mazhab-Jafari MT, 2007, J AM CHEM SOC, V129, P14482, DOI 10.1021/ja0753703; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Nussinov R, 2014, J AM CHEM SOC, V136, P17692, DOI 10.1021/ja510028c; Nussinov R, 2014, TRENDS PHARMACOL SCI, V35, P256, DOI 10.1016/j.tips.2014.03.006; Nussinov R, 2014, BIOPHYS CHEM, V186, P22, DOI 10.1016/j.bpc.2013.10.002; Osborne BW, 2011, STRUCTURE, V19, P1317, DOI 10.1016/j.str.2011.06.012; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Selvaratnam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048707; Selvaratnam R, 2012, BIOPHYS J, V102, P630, DOI 10.1016/j.bpj.2011.12.030; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Smith JK, 2000, J BIOL CHEM, V275, P154, DOI 10.1074/jbc.275.1.154; Srivastava AK, 2014, STRUCTURE, V22, P1735, DOI 10.1016/j.str.2014.09.010; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; VanSchouwen B, 2015, J BIOL CHEM, V290, P17642, DOI 10.1074/jbc.M115.651877; VanSchouwen B, 2011, J BIOL CHEM, V286, P42655, DOI 10.1074/jbc.M111.277723; Wall ME, 2003, P NATL ACAD SCI USA, V100, P2380, DOI 10.1073/pnas.0534892100; White RE, 2000, CIRC RES, V86, P897, DOI 10.1161/01.RES.86.8.897; Wolter S, 2011, BIOCHEM BIOPH RES CO, V415, P563, DOI 10.1016/j.bbrc.2011.10.093; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345	51	37	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28631	28641		10.1074/jbc.M115.685305	http://dx.doi.org/10.1074/jbc.M115.685305			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26370085	hybrid, Green Published			2022-12-28	WOS:000365762300006
J	Woolfrey, KM; Dell'Acqua, ML				Woolfrey, Kevin M.; Dell'Acqua, Mark L.			Coordination of Protein Phosphorylation and Dephosphorylation in Synaptic Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						A-kinase anchoring protein (AKAP); Ca2+; calmodulin-dependent protein kinase II (CaMKII); calcineurin; calcium channel; excitation-transcription coupling; glutamate receptor; phosphoprotein phosphatase 1 (PP1); protein kinase A (PKA); scaffold protein; synaptic plasticity	AMPA RECEPTOR TRAFFICKING; KINASE-II; CREB PHOSPHORYLATION; CHANNEL ACTIVITY; CALCIUM-CHANNEL; AKAP150-ANCHORED PKA; HIPPOCAMPAL-NEURONS; CAMKII BINDING; CA2+ CHANNELS; CALCIUM/CALMODULIN	A central theme in nervous system function is equilibrium: synaptic strengths wax and wane, neuronal firing rates adjust up and down, and neural circuits balance excitation with inhibition. This push/pull regulatory theme carries through to the molecular level at excitatory synapses, where protein function is controlled through phosphorylation and dephosphorylation by kinases and phosphatases. However, these opposing enzymatic activities are only part of the equation as scaffolding interactions and assembly of multi-protein complexes are further required for efficient, localized synaptic signaling. This review will focus on coordination of postsynaptic serine/threonine kinase and phosphatase signaling by scaffold proteins during synaptic plasticity.	[Woolfrey, Kevin M.; Dell'Acqua, Mark L.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Dell'Acqua, ML (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, Anschutz Med Campus,12800 E 19th Ave, Aurora, CO 80045 USA.	mark.dellacqua@ucdenver.edu			National Institutes of Health Grants [NS040701, MH102338]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040701, R56NS040701] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS040701 and MH102338 (to M.L.D.). This is the second article in the Thematic Mini-review series "Molecular Mechanisms of Synaptic Plasticity." The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Alvarez-Castelao B, 2015, J BIOL CHEM, V290, P28623, DOI 10.1074/jbc.R115.657130; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Araki Y, 2015, NEURON, V85, P173, DOI 10.1016/j.neuron.2014.12.023; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bemben MA, 2014, NAT NEUROSCI, V17, P56, DOI 10.1038/nn.3601; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Borgesius NZ, 2011, J NEUROSCI, V31, P10141, DOI 10.1523/JNEUROSCI.5105-10.2011; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; CARR DW, 1992, J BIOL CHEM, V267, P16816; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Delint-Ramirez I, 2011, J BIOL CHEM, V286, P32962, DOI 10.1074/jbc.M111.243899; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Diering GH, 2014, NEURON, V84, P790, DOI 10.1016/j.neuron.2014.09.024; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dittmer PJ, 2014, CELL REP, V7, P1410, DOI 10.1016/j.celrep.2014.04.039; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Gomez LL, 2002, J NEUROSCI, V22, P7027; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Havekes R, 2012, J NEUROSCI, V32, P18137, DOI 10.1523/JNEUROSCI.3612-12.2012; Hell JW, 2014, NEURON, V81, P249, DOI 10.1016/j.neuron.2013.12.024; Hou HL, 2013, J CELL BIOL, V203, P521, DOI 10.1083/jcb.201303035; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Hu XD, 2006, J NEUROCHEM, V98, P1841, DOI 10.1111/j.1471-4159.2006.04070.x; Hu XD, 2007, J NEUROSCI, V27, P4674, DOI 10.1523/JNEUROSCI.5365-06.2007; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Keith DJ, 2012, J NEUROSCI, V32, P7119, DOI 10.1523/JNEUROSCI.0784-12.2012; Kim S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001900; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; Leonard AS, 2002, J BIOL CHEM, V277, P48441, DOI 10.1074/jbc.M205164200; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Lin YC, 2008, P NATL ACAD SCI USA, V105, P15791, DOI 10.1073/pnas.0804399105; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Lu W, 2012, CURR OPIN NEUROBIOL, V22, P470, DOI 10.1016/j.conb.2011.09.008; Lu W, 2010, P NATL ACAD SCI USA, V107, P22266, DOI 10.1073/pnas.1016289107; Lu Y, 2008, J PHYSIOL-LONDON, V586, P4155, DOI 10.1113/jphysiol.2008.151662; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Lussier MP, 2015, J BIOL CHEM, V290, P28596, DOI 10.1074/jbc.R115.652750; Ma H, 2014, CELL, V159, P281, DOI 10.1016/j.cell.2014.09.019; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McAvoy T, 1999, BIOCHEMISTRY-US, V38, P12943, DOI 10.1021/bi991227d; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Murphy JG, 2014, CELL REP, V7, P1577, DOI 10.1016/j.celrep.2014.04.027; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Nonaka M, 2014, NEURON, V84, P92, DOI 10.1016/j.neuron.2014.08.049; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Qian H, 2012, J NEUROPHYSIOL, V107, P2703, DOI 10.1152/jn.00374.2011; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Sanderson JL, 2011, NEUROSCIENTIST, V17, P321, DOI 10.1177/1073858410384740; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; Siddoway BA, 2013, J NEUROSCI, V33, P11206, DOI 10.1523/JNEUROSCI.5241-12.2013; Spence EF, 2015, J BIOL CHEM, V290, P28613, DOI 10.1074/jbc.R115.655118; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1997, J BIOL CHEM, V272, P13467, DOI 10.1074/jbc.272.21.13467; Strack S, 1997, J NEUROCHEM, V68, P2119; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Toomre D, 2010, ANNU REV CELL DEV BI, V26, P285, DOI 10.1146/annurev-cellbio-100109-104048; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Weisenhaus M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010325; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Wiegert JS, 2007, J BIOL CHEM, V282, P29621, DOI 10.1074/jbc.M701448200; Woolfrey KM, 2015, J NEUROSCI, V35, P442, DOI 10.1523/JNEUROSCI.2243-14.2015; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Zhai SY, 2013, SCIENCE, V342, P1107, DOI 10.1126/science.1245622; Zhang J, 2012, NEURON, V76, P1133, DOI 10.1016/j.neuron.2012.10.019; Zhang MX, 2013, J BIOL CHEM, V288, P17918, DOI 10.1074/jbc.M112.449462	103	75	78	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28604	28612		10.1074/jbc.R115.657262	http://dx.doi.org/10.1074/jbc.R115.657262			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26453308	hybrid, Green Published			2022-12-28	WOS:000365762300003
J	De, S; Bubnys, A; Alonzo, F; Hyun, J; Lary, JW; Cole, JL; Torres, VJ; Olson, R				De, Swastik; Bubnys, Adele; Alonzo, Francis, III; Hyun, Jinsol; Lary, Jeffrey W.; Cole, James L.; Torres, Victor J.; Olson, Rich			The Relationship between Glycan Binding and Direct Membrane Interactions in Vibrio cholerae Cytolysin, a Channel-forming Toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE-FORMATION-MECHANISM; HEPTAMERIC TRANSMEMBRANE PORE; PANTON-VALENTINE LEUKOCIDIN; HUMAN C5A RECEPTORS; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; ALPHA-TOXIN; EL-TOR; CONFORMATIONAL-CHANGES; PERFRINGOLYSIN-O	Bacterial pore-forming toxins (PFTs) are structurally diverse pathogen-secreted proteins that form cell-damaging channels in the membranes of host cells. Most PFTs are released as watersoluble monomers that first oligomerize on the membrane before inserting a transmembrane channel. To modulate specificity and increase potency, many PFTs recognize specific cell surface receptors that increase the local toxin concentration on cell membranes, thereby facilitating channel formation. Vibrio cholerae cytolysin (VCC) is a toxin secreted by the human pathogen responsible for pandemic cholera disease and acts as a defensive agent against the host immune system. Although it has been shown that VCC utilizes specific glycan receptors on the cell surface, additional direct contacts with the membrane must also play a role in toxin binding. To better understand the nature of these interactions, we conducted a systematic investigation of the membrane-binding surface of VCC to identify additional membrane interactions important in cell targeting. Through cell-based assays on several human-derived cell lines, we show that VC( is unlikely to utilize high affinity protein receptors as do structurally similar toxins from Staphylococcus aureus. Next, we identified a number of specific amino acid residues that greatly diminish the VCC potency against cells and investigated the interplay between glycan binding and these direct lipid contacts. Finally, we used model membranes to parse the importance of these key residues in lipid and cholesterol binding. Our study provides a complete functional map of the VCC membrane-binding surface and insights into the integration of sugar, lipid, and cholesterol binding interactions.	[De, Swastik; Bubnys, Adele; Hyun, Jinsol; Olson, Rich] Wesleyan Univ, Dept Mol Biol & Biochem, Mol Biophys Program, Middletown, CT 06459 USA; [Alonzo, Francis, III; Torres, Victor J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Lary, Jeffrey W.; Cole, James L.] Univ Connecticut, Biotechnol Bioserv Ctr, Storrs, CT 06269 USA; [Cole, James L.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Cole, James L.] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA	Wesleyan University; New York University; University of Connecticut; University of Connecticut; University of Connecticut	Olson, R (corresponding author), Wesleyan Univ, Dept Mol Biol & Biochem, 52 Lawn Ave, Middletown, CT 06459 USA.	rolson@wesleyan.edu	De, Swastik/X-4996-2019	Torres, Victor/0000-0002-7126-0489; De, Swastik/0000-0002-9302-724X	NIAID, National Institutes of Health [R15 AI101977]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI101977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008271] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIAID, National Institutes of Health Grant R15 AI101977. The authors declare that they have no conflicts of interest with the contents of this article.	Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; Braman J, 1996, Methods Mol Biol, V57, P31; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; DuMont AL, 2014, TRENDS MICROBIOL, V22, P21, DOI 10.1016/j.tim.2013.10.004; DuMont AL, 2013, INFECT IMMUN, V81, P1830, DOI 10.1128/IAI.00095-13; Epand RM, 2010, SUBCELL BIOCHEM, V51, P253, DOI 10.1007/978-90-481-8622-8_9; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Flanagan JJ, 2009, BIOCHEMISTRY-US, V48, P3977, DOI 10.1021/bi9002309; Folettit D, 2013, J MOL BIOL, V425, P1641, DOI 10.1016/j.jmb.2013.02.008; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Guillet V, 2004, J BIOL CHEM, V279, P41028, DOI 10.1074/jbc.M406904200; Heuck AP, 2007, J BIOL CHEM, V282, P22629, DOI 10.1074/jbc.M703207200; HONDA T, 1979, INFECT IMMUN, V26, P1020, DOI 10.1128/IAI.26.3.1020-1027.1979; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Howlader MTH, 2010, APPL ENVIRON MICROB, V76, P860, DOI 10.1128/AEM.02175-09; Kaus K, 2014, J MOL BIOL, V426, P2800, DOI 10.1016/j.jmb.2014.05.021; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Laventie BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092094; Levan S, 2013, J MOL BIOL, V425, P944, DOI 10.1016/j.jmb.2012.12.016; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Lohner S, 2009, FASEB J, V23, P2521, DOI 10.1096/fj.08-127688; Los FCO, 2013, MICROBIOL MOL BIOL R, V77, P173, DOI 10.1128/MMBR.00052-12; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Paul K, 2012, FEBS J, V279, P4039, DOI 10.1111/j.1742-4658.2012.08809.x; Pedelacq JD, 1999, STRUCTURE, V7, P277, DOI 10.1016/S0969-2126(99)80038-0; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Queen J, 2012, INFECT IMMUN, V80, P2905, DOI 10.1128/IAI.00356-12; Rai AK, 2015, MOL MICROBIOL, V97, P1051, DOI 10.1111/mmi.13084; Rai AK, 2013, J BIOL CHEM, V288, P1665, DOI 10.1074/jbc.M112.430181; Reyes-Robles T, 2013, CELL HOST MICROBE, V14, P453, DOI 10.1016/j.chom.2013.09.005; Saha N, 1997, J BIOL CHEM, V272, P162, DOI 10.1074/jbc.272.1.162; Savva CG, 2013, J BIOL CHEM, V288, P3512, DOI 10.1074/jbc.M112.430223; Schwiering M, 2013, BBA-BIOMEMBRANES, V1828, P1962, DOI 10.1016/j.bbamem.2013.04.005; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Spaan AN, 2015, J IMMUNOL, V195, P1034, DOI 10.4049/jimmunol.1500604; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Sutton-Smith M, 2007, GLYCOBIOLOGY, V17, P553, DOI 10.1093/glycob/cwm025; Valeva A, 2008, MED MICROBIOL IMMUN, V197, P285, DOI 10.1007/s00430-007-0061-2; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; WALKER B, 1995, CHEM BIOL, V2, P99, DOI 10.1016/1074-5521(95)90282-1; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108; Zitzer A, 1999, J BIOL CHEM, V274, P1375, DOI 10.1074/jbc.274.3.1375; ZITZER A, 1995, MED MICROBIOL IMMUN, V184, P37, DOI 10.1007/BF00216788; Zitzer A, 2000, BBA-BIOMEMBRANES, V1509, P264, DOI 10.1016/S0005-2736(00)00303-5	51	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28402	28415		10.1074/jbc.M115.675967	http://dx.doi.org/10.1074/jbc.M115.675967			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26416894	Green Published, hybrid			2022-12-28	WOS:000365761900034
J	Rajkovic, J; Poreba, M; Caglic, D; Vidmar, R; Wilk, A; Borowik, A; Salvesen, G; Turk, V; Drag, M; Turk, B				Rajkovic, Jelena; Poreba, Marcin; Caglic, Dejan; Vidmar, Robert; Wilk, Aleksandra; Borowik, Agata; Salvesen, Guy; Turk, Vito; Drag, Marcin; Turk, Boris			Biochemical Characterization and Substrate Specificity of Autophagin-2 from the Parasite Trypanosoma cruzi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS-MODEL; UNEXPECTED SPECIFICITY; CYSTEINE PROTEINASES; SECONDARY STRUCTURE; ACTIVATION; DIFFERENTIATION; CATHEPSINS; LYSOSOMES; PROTEASES; MECHANISM	The genome of the parasite Trypanosoma cruzi encodes two copies of autophagy-related cysteine proteases, Atg4.1 and Atg4.2. T. cruzi autophagin-2 (TcAtg4.2) carries the majority of proteolytic activity and is responsible for processing Atg8 proteins near the carboxyl terminus, exposing a conserved glycine. This enables progression of autophagy and differentiation of the parasite, which is required for successful colonization of humans. The mechanism of substrate hydrolysis by Atg4 was found to be highly conserved among the species as critical mutations in the TcAtg4.2, including mutation of the conserved Gly-244 residue in the hinge region enabling flexibility of the regulatory loop, and deletion of the regulatory loop, completely abolished processing capacity of the mutants. Using the positional scanning-substrate combinatorial library (PS-SCL) we determined that TcAtg4.2 tolerates a broad spectrum of amino acids in the P4 and P3 positions, similar to the human orthologue autophagin-1 (HsAtg4B). In contrast, both human and trypanosome Atg4 orthologues exhibited exclusive preference for aromatic amino acid residues in the P2 position, and for Gly in the P1 position, which is absolutely conserved in the natural Atg8 substrates. Using an extended P2 substrate library, which also included the unnatural amino acid cyclohexylalanine (Cha) derivative of Phe, we generated highly selective tetrapeptide substrates acetyl- Lys-Lys-Cha-Gly-AEC (Ac-KKChaG-AFC) and acetyl-Lys-Thr-Cha-Gly-AFC (Ac-KTChaG-AF(.). Although these substrates were cleaved by cathepsins, making them unsuitable for analysis of complex cellular systems, they were recognized exclusively by TcAtg4.2, but not by HsAtg4B nor by the structurally related human proteases SENP1, SENP2, and UCH-L3.	[Rajkovic, Jelena; Caglic, Dejan; Vidmar, Robert; Turk, Vito; Turk, Boris] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, SI-1000 Ljubljana, Slovenia; [Rajkovic, Jelena; Vidmar, Robert] Jozef Stefan Int Postgrad Sch, SI-1000 Ljubljana, Slovenia; [Turk, Boris] Ctr Excellence Integrated Approaches Chem & Biol, SI-1000 Ljubljana, Slovenia; [Caglic, Dejan] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Salvesen, Guy] Scripps Res Inst, Sanford Burnham Med Res Inst, Program Cell Death & Survival Networks, La Jolla, CA 92037 USA; [Poreba, Marcin; Wilk, Aleksandra; Borowik, Agata; Drag, Marcin] Wroclaw Univ Technol, Fac Chem, Dept Bioorgan Chem, PL-50370 Wroclaw, Poland; [Turk, Boris] Univ Ljubljana, Fac Chem & Chem Technol, SI-1000 Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Scripps Research Institute; Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute; Wroclaw University of Science & Technology; University of Ljubljana	Turk, B (corresponding author), Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Jamova Cesta 39, SI-1000 Ljubljana, Slovenia.	boris.turk@ijs.si	Regan, Clinton/E-6250-2012; Caglic, Dejan/A-1868-2009; Vidmar, Robert/O-9075-2017	Turk, Boris/0000-0002-9007-5764; Vidmar, Robert/0000-0001-5068-3119	Slovene Research Agency [P1-0140]; Polish Ministry of Science and Higher Education for the Faculty of Chemistry at Wroclaw University of Technology; National Institutes of Health [R01GM09040]; NATIONAL CANCER INSTITUTE [R01CA163743] Funding Source: NIH RePORTER	Slovene Research Agency(Slovenian Research Agency - Slovenia); Polish Ministry of Science and Higher Education for the Faculty of Chemistry at Wroclaw University of Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Slovene Research Agency Grant P1-0140 (to B. T.), a statutory activity subsidy from the Polish Ministry of Science and Higher Education for the Faculty of Chemistry at Wroclaw University of Technology, and National Institutes of Health Grant R01GM09040. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez VE, 2008, AUTOPHAGY, V4, P361, DOI 10.4161/auto.5592; Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barquilla A, 2008, P NATL ACAD SCI USA, V105, P14579, DOI 10.1073/pnas.0802668105; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Cazzulo JJ, 2001, CURR PHARM DESIGN, V7, P1143, DOI 10.2174/1381612013397528; Chen JL, 2008, J BIOL CHEM, V283, P34432, DOI 10.1074/jbc.M804239200; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; Drag M, 2008, BIOCHEM J, V415, P367, DOI 10.1042/BJ20080779; Drag M, 2008, BIOCHEM J, V409, P461, DOI 10.1042/BJ20070940; Duszenko M, 2011, AUTOPHAGY, V7, P127, DOI 10.4161/auto.7.2.13310; Fernandez AF, 2015, J CLIN INVEST, V125, P33, DOI 10.1172/JCI73940; GRIERSON AW, 1994, J GEN VIROL, V75, P2761, DOI 10.1099/0022-1317-75-10-2761; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Herman M, 2006, AUTOPHAGY, V2, P107, DOI 10.4161/auto.2.2.2369; Kasperkiewicz P, 2014, P NATL ACAD SCI USA, V111, P2518, DOI 10.1073/pnas.1318548111; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kosec G, 2006, BIOCELL, V30, P479; KUHELJ R, 1995, EUR J BIOCHEM, V229, P533, DOI 10.1111/j.1432-1033.1995.0533k.x; Lecaille F, 2001, EUR J BIOCHEM, V268, P2733, DOI 10.1046/j.1432-1327.2001.02172.x; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li M, 2011, J BIOL CHEM, V286, P7327, DOI 10.1074/jbc.M110.199059; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Lv XH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06010; Ma JZ, 2013, BIOINFORMATICS, V29, P257, DOI 10.1093/bioinformatics/btt210; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Meijer WH, 2007, AUTOPHAGY, V3, P106, DOI 10.4161/auto.3595; Mihelic M, 2008, J BIOL CHEM, V283, P14453, DOI 10.1074/jbc.M801283200; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Noda NN, 2009, CHEM REV, V109, P1587, DOI 10.1021/cr800459r; Papandreou I, 2008, CELL DEATH DIFFER, V15, P1572, DOI 10.1038/cdd.2008.84; Polajnar M, 2013, BIOL CHEM, V394, P783, DOI 10.1515/hsz-2012-0278; Poreba M, 2014, CELL DEATH DIFFER, V21, P1482, DOI 10.1038/cdd.2014.64; Poreba M, 2014, AMINO ACIDS, V46, P931, DOI 10.1007/s00726-013-1654-2; RANCOURT C, 1994, P NATL ACAD SCI USA, V91, P844, DOI 10.1073/pnas.91.3.844; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shapiro IM, 2014, AUTOPHAGY, V10, P7, DOI 10.4161/auto.26679; Shu CW, 2010, AUTOPHAGY, V6, P936, DOI 10.4161/auto.6.7.13075; Stennicke HR, 2000, METHOD ENZYMOL, V322, P91; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Wada Y, 2014, CURR OPIN GENET DEV, V27, P60, DOI 10.1016/j.gde.2014.03.010; Wang SK, 2014, EMBO REP, V15, P1053, DOI 10.15252/embr.201338343; Wang YB, 2009, J BIOL CHEM, V284, P1694, DOI 10.1074/jbc.M807890200; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WHO, 2010, 63 WHO WORLD HLTH AS; Williams RAM, 2009, AUTOPHAGY, V5, P159, DOI 10.4161/auto.5.2.7328; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	69	5	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28231	28244		10.1074/jbc.M115.687764	http://dx.doi.org/10.1074/jbc.M115.687764			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26446788	hybrid, Green Published			2022-12-28	WOS:000365761900017
J	Sasset, L; Petris, G; Cesaratto, F; Burrone, OR				Sasset, Linda; Petris, Gianluca; Cesaratto, Francesca; Burrone, Oscar R.			The VCP/p97 and YOD1 Proteins Have Different Substrate-dependent Activities in Endoplasmic Reticulum-associated Degradation (ERAD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P97 AAA-ATPASE; I HEAVY-CHAINS; MEMBRANE-PROTEIN; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; DEUBIQUITINATING ENZYME; SECRETORY PATHWAY; CHOLERA-TOXIN; DISLOCATION; UBIQUITIN	Endoplasmic reticulum-associated degradation (ERAD) is an essential quality control mechanism of the folding state of proteins in the secretory pathway that targets unfolded/misfolded polypeptides for proteasomal degradation. The cytosolic p97/valosin-containing protein is an essential ATPase for degradation of ERAD substrates. It has been considered necessary during retro-translocation to extract proteins from the endoplasmic reticulum that are otherwise supposed to accumulate in the endoplasmic reticulum lumen. The activity of the p97-associated deubiquitinylase YOD1 is also required for substrate disposal. We used the in vivo biotinylation retro-translocation assay in mammalian cells under conditions of impaired p97 or YOD1 activity to directly discriminate their requirements and diverse functions in ERAD. Using different ERAD substrates, we found that both proteins participate in two distinct retro-translocation steps. For CD4 and MHC-I alpha, which are induced to degradation by the HIV-1 protein Vpu and by the CMV immunoevasins US2 and US11, respectively, p97 and YOD1 have a retro-translocation-triggering role. In contrast, for three other spontaneous ERAD model substrates (NS1, NHK-alpha 1AT, and BST-2/Tetherin), p97 and YOD1 are required in the downstream events of substrate deglycosylation and proteasomal degradation.	[Sasset, Linda; Cesaratto, Francesca; Burrone, Oscar R.] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy; [Petris, Gianluca] Univ Trento, CIBIO, I-38123 Mattarello, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trento	Petris, G (corresponding author), Univ Trento, CIBIO, Via Regole 101, I-38123 Mattarello, Italy.	gianluca.petris@unitn.it; burrone@icgeb.org	Sasset, Linda/AAC-3131-2020; Petris, Gianluca/N-9754-2018	Sasset, Linda/0000-0001-5298-2374; Petris, Gianluca/0000-0002-2420-6359	ICGEB predoctoral fellowships	ICGEB predoctoral fellowships	Supported by ICGEB predoctoral fellowships.	Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; Baker BM, 2007, J BIOL CHEM, V282, P26845, DOI 10.1074/jbc.M704315200; Ballar P, 2008, BIOCHEM SOC T, V36, P818, DOI 10.1042/BST0360818; Bernardi KM, 2013, MOL BIOL CELL, V24, P3545, DOI 10.1091/mbc.E13-06-0332; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chou TF, 2011, AUTOPHAGY, V7, P1091, DOI 10.4161/auto.7.9.16489; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Claessen JHL, 2010, J BIOL CHEM, V285, P20732, DOI 10.1074/jbc.M110.120766; Dantuma NP, 2012, TRENDS CELL BIOL, V22, P483, DOI 10.1016/j.tcb.2012.06.003; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Elkabetz Y, 2004, J BIOL CHEM, V279, P3980, DOI 10.1074/jbc.M309938200; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hassink GC, 2006, J BIOL CHEM, V281, P30063, DOI 10.1074/jbc.M602248200; Hendershot L, 1996, P NATL ACAD SCI USA, V93, P5269, DOI 10.1073/pnas.93.11.5269; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lee RJ, 2004, EMBO J, V23, P2206, DOI 10.1038/sj.emboj.7600232; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Leitzgen K, 1997, J BIOL CHEM, V272, P3117, DOI 10.1074/jbc.272.5.3117; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Omura T, 2008, J PHARMACOL SCI, V106, P512, DOI 10.1254/jphs.08005FP; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Petris G, 2014, J BIOL CHEM, V289, P1, DOI 10.1074/jbc.M113.512368; Petris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023712; Predonzani A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-41; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Rutledge AC, 2009, ARTERIOSCL THROM VAS, V29, P579, DOI 10.1161/ATVBAHA.108.181859; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Story CM, 1999, P NATL ACAD SCI USA, V96, P8516, DOI 10.1073/pnas.96.15.8516; Vecchi L, 2012, J BIOL CHEM, V287, P20007, DOI 10.1074/jbc.M112.355107; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wolff S, 2014, CELL, V157, P52, DOI 10.1016/j.cell.2014.03.007; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X	68	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28175	28188		10.1074/jbc.M115.656660	http://dx.doi.org/10.1074/jbc.M115.656660			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26463207	Green Published, hybrid			2022-12-28	WOS:000365761900013
J	Wofford, JD; Lindahl, PA				Wofford, Joshua D.; Lindahl, Paul A.			Mitochondrial Iron-Sulfur Cluster Activity and Cytosolic Iron Regulate Iron Traffic in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR; YEAST; PROTEIN; AFT1; ACCUMULATION; TRANSPORTER; BINDING; STORAGE; GENES; YAP5	Background: A mathematical model of iron trafficking and regulation in yeast cells was developed. Results: The model simulated experimental data from the literature fairly well. Conclusion: Both cytosolic iron and an exported product of mitochondrial iron-sulfur cluster activity appear to regulate iron traffic. Significance: The model has some predictive power that can be used to probe the mechanism of mitochondrial iron diseases. An ordinary differential equation-based mathematical model was developed to describe trafficking and regulation of iron in growing fermenting budding yeast. Accordingly, environmental iron enters the cytosol and moves into mitochondria and vacuoles. Dilution caused by increasing cell volume is included. Four sites are regulated, including those in which iron is imported into the cytosol, mitochondria, and vacuoles, and the site at which vacuolar Fe-II is oxidized to Fe-III. The objective of this study was to determine whether cytosolic iron (Fe-cyt) and/or a putative sulfur-based product of iron-sulfur cluster (ISC) activity was/were being sensed in regulation. The model assumes that the matrix of healthy mitochondria is anaerobic, and that in ISC mutants, O-2 diffuses into the matrix where it reacts with non-heme high spin Fe-II ions, oxidizing them to nanoparticles and generating reactive oxygen species. This reactivity causes a further decline in ISC/heme biosynthesis, which ultimately gives rise to the diseased state. The ordinary differential equations that define this model were numerically integrated, and concentrations of each component were plotted versus the concentration of iron in the growth medium and versus the rate of ISC/heme biosynthesis. Model parameters were optimized by fitting simulations to literature data. The model variant that assumed that both Fe-cyt and ISC biosynthesis activity were sensed in regulation mimicked observed behavior best. Such "dual sensing" probably arises in real cells because regulation involves assembly of an ISC on a cytosolic protein using Fe-cyt and a sulfur species generated in mitochondria during ISC biosynthesis and exported into the cytosol.	[Wofford, Joshua D.; Lindahl, Paul A.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Lindahl, Paul A.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Lindahl, PA (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	lindahl@chem.tamu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [GM084266]; Robert A. Welch Foundation [A1170]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM084266. This work was also supported by Robert A. Welch Foundation Grant A1170. The authors declare that they have no conflicts of interest with the contents of this article.	Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Brown NM, 2002, J BIOL CHEM, V277, P7246, DOI 10.1074/jbc.M110282200; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chen OS, 2002, P NATL ACAD SCI USA, V99, P12321, DOI 10.1073/pnas.192449599; Cockrell A, 2014, BIOCHEMISTRY-US, V53, P2926, DOI 10.1021/bi500002n; Cosper MM, 2002, FEBS LETT, V529, P332, DOI 10.1016/S0014-5793(02)03390-2; Courel M, 2005, MOL CELL BIOL, V25, P6760, DOI 10.1128/MCB.25.15.6760-6771.2005; Foster AW, 2014, MOL MICROBIOL, V93, P317, DOI 10.1111/mmi.12661; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Haurie V, 2003, J BIOL CHEM, V278, P45391, DOI 10.1074/jbc.M307447200; Holmes-Hampton GP, 2013, BIOCHEMISTRY-US, V52, P105, DOI 10.1021/bi3015339; Holmes-Hampton GP, 2010, BIOCHEMISTRY-US, V49, P4227, DOI 10.1021/bi1001823; Kosman DJ, 2013, COORDIN CHEM REV, V257, P210, DOI 10.1016/j.ccr.2012.06.030; Koyama T., 1989, OXYGEN TRANSPORT TIS, P763; Kriek M, 2003, PROTEIN EXPRES PURIF, V28, P241, DOI 10.1016/S1046-5928(02)00680-0; Lee JY, 2014, SCIENCE, V343, P1133, DOI 10.1126/science.1246489; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2012, J BIOL CHEM, V287, P35709, DOI 10.1074/jbc.M112.395533; Li LT, 2011, J BIOL CHEM, V286, P38488, DOI 10.1074/jbc.M111.286666; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Miao R, 2008, BIOCHEMISTRY-US, V47, P9888, DOI 10.1021/bi801047q; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Outten CE, 2013, CURR OPIN MICROBIOL, V16, P662, DOI 10.1016/j.mib.2013.07.020; Pandey A, 2015, J BIOL CHEM, V290, P640, DOI 10.1074/jbc.M114.610402; Park J, 2014, BIOCHEMISTRY-US, V53, P3940, DOI 10.1021/bi500148y; Park J, 2013, BIOCHEMISTRY-US, V52, P9413, DOI 10.1021/bi4010304; Pedro-Segura E, 2008, J BIOL CHEM, V283, P28527, DOI 10.1074/jbc.M804910200; Poor CB, 2014, P NATL ACAD SCI USA, V111, P4043, DOI 10.1073/pnas.1318869111; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; Rietzschel N, 2015, MOL CELL BIOL, V35, P370, DOI 10.1128/MCB.01033-14; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Rutherford JC, 2001, P NATL ACAD SCI USA, V98, P14322, DOI 10.1073/pnas.261381198; Schaedler TA, 2014, J BIOL CHEM, V289, P23264, DOI 10.1074/jbc.M114.553438; Srinivasan V, 2014, SCIENCE, V343, P1137, DOI 10.1126/science.1246729; Urbanowski JL, 1999, J BIOL CHEM, V274, P38061, DOI 10.1074/jbc.274.53.38061; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x	46	18	18	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26968	26977		10.1074/jbc.M115.676668	http://dx.doi.org/10.1074/jbc.M115.676668			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26306041	Green Published, hybrid			2022-12-28	WOS:000364794000008
J	Chang, CC; Pirozzi, G; Wen, SH; Chung, IH; Chiu, BL; Errico, S; Luongo, M; Lombardi, ML; Ferrone, S				Chang, Chien-Chung; Pirozzi, Giuseppe; Wen, Shao-Hsuan; Chung, I-Hsin; Chiu, Bau-Lin; Errico, Simona; Luongo, Monica; Lombardi, Maria Luisa; Ferrone, Soldano			Multiple Structural and Epigenetic Defects in the Human Leukocyte Antigen Class I Antigen Presentation Pathway in a Recurrent Metastatic Melanoma Following Immunotherapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; ANTIIDIOTYPIC MONOCLONAL-ANTIBODIES; HLA HAPLOTYPE LOSS; ENDOPLASMIC-RETICULUM; IMMUNE SELECTION; MALIGNANT-CELLS; DOWN-REGULATION; SOLID TUMORS; LUNG-CANCER; TAPASIN	Scant information is available about the molecular basis of multiple HLA class I antigen-processing machinery defects in malignant cells, although this information contributes to our understanding of the molecular immunoescape mechanisms utilized by tumor cells and may suggest strategies to counteract them. In the present study we reveal a combination of IFN-gamma-irreversible structural and epigenetic defects in HLA class I antigen-processing machinery in a recurrent melanoma metastasis after immunotherapy. These defects include loss of tapasin and one HLA haplotype as well as selective silencing of HLA-A3 gene responsiveness to IFN-gamma. Tapasin loss is caused by a germline frameshift mutation in exon 3 (TAPBP(684delA)) along with a somatic loss of the other gene copy. Selective silencing of HLA-A3 gene and its IFN-gamma responsiveness is associated with promoter CpG methylation nearby site-alpha and TATA box, reversible after DNA methyltransferase 1 depletion. This treatment combined with tapasin reconstitution and IFN-gamma stimulation restored the highest level of HLA class I expression and its ability to elicit cytotoxic T cell responses. These results represent a novel tumor immune evasion mechanism through impairing multiple components at various levels in the HLA class I antigen presentation pathway. These findings may suggest a rational design of combinatorial cancer immunotherapy harnessing DNA demethylation and IFN-gamma response.	[Chang, Chien-Chung; Wen, Shao-Hsuan; Chung, I-Hsin; Chiu, Bau-Lin] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu 30013, Taiwan; [Pirozzi, Giuseppe; Errico, Simona; Luongo, Monica; Lombardi, Maria Luisa] Natl Canc Inst, Dept Expt Oncol, I-80131 Naples, Italy; [Ferrone, Soldano] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Surg, Boston, MA 02114 USA; [Ferrone, Soldano] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Orthoped Surg, Boston, MA 02114 USA	National Tsing Hua University; IRCCS Fondazione Pascale; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Chang, CC (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, 101 Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.	ccchang@life.nthu.edu.tw		Errico, Simona/0000-0002-2873-9339	Ministry of Science and Technology [NSC97-2320-B-007-001-MY3, NSC98-2320-B-007-004-MY3, MOST 103-2320-B-007-005]; Department of Health and Human Services, Public Health Service, National Institutes of Health [RO1 CA138188]; MURST, Cluster 03; NATIONAL CANCER INSTITUTE [R01CA138188] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Department of Health and Human Services, Public Health Service, National Institutes of Health; MURST, Cluster 03(Ministry of Education, Universities and Research (MIUR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Ministry of Science and Technology Grants NSC97-2320-B-007-001-MY3, NSC98-2320-B-007-004-MY3, and MOST 103-2320-B-007-005 (to C.-C. C), Department of Health and Human Services, Public Health Service, National Institutes of Health Grant RO1 CA138188 (NCI; to S. F.), and MURST, Cluster 03 (to M. L. L). The authors declare that they have no conflicts of interest with the content of this article.	Bandoh N, 2005, TISSUE ANTIGENS, V66, P185, DOI 10.1111/j.1399-0039.2005.00462.x; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Belicha-Villanueva A, 2008, IMMUNOLOGY, V124, P112, DOI 10.1111/j.1365-2567.2007.02746.x; Campoli M, 2008, ONCOGENE, V27, P5869, DOI 10.1038/onc.2008.273; Chang CC, 2005, ADV CANCER RES, V93, P189, DOI 10.1016/S0065-230X(05)93006-6; Chang CC, 2005, J IMMUNOL, V174, P1462, DOI 10.4049/jimmunol.174.3.1462; Chang CC, 2007, CANCER IMMUNOL IMMUN, V56, P227, DOI 10.1007/s00262-006-0183-1; Chang CC, 2006, J BIOL CHEM, V281, P18763, DOI 10.1074/jbc.M511525200; Chen HL, 1996, NAT GENET, V13, P210, DOI 10.1038/ng0696-210; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dai W, 2015, CANCER MED-US, V4, P1079, DOI 10.1002/cam4.451; Dissemond J, 2003, ARCH DERMATOL RES, V295, P43, DOI 10.1007/s00403-003-0393-8; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Gollob JA, 2006, CLIN CANCER RES, V12, P4619, DOI 10.1158/1078-0432.CCR-06-0883; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hsueh EC, 2003, SEMIN CANCER BIOL, V13, P401, DOI 10.1016/j.semcancer.2003.09.003; Jimenez P, 1999, INT J CANCER, V83, P91, DOI 10.1002/(SICI)1097-0215(19990924)83:1<91::AID-IJC17>3.0.CO;2-4; Kloor M, 2005, CANCER RES, V65, P6418, DOI 10.1158/0008-5472.CAN-05-0044; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; KUSAMA M, 1989, J IMMUNOL, V143, P3844; LAMPSON LA, 1983, J IMMUNOL, V130, P2471; Lee YG, 2013, BRIT J HAEMATOL, V161, P339, DOI 10.1111/bjh.12256; LEHMANN F, 1995, EUR J IMMUNOL, V25, P340, DOI 10.1002/eji.1830250206; Lehner PJ, 1998, IMMUNITY, V8, P221, DOI 10.1016/S1074-7613(00)80474-4; Leone P, 2013, JNCI-J NATL CANCER I, V105, P1172, DOI 10.1093/jnci/djt184; Leonhardt RM, 2014, J IMMUNOL, V192, P2480, DOI 10.4049/jimmunol.1302637; Mani S, 2010, ADV GENET, V70, P327, DOI [10.1016/B978-0-12-380866-0.60012-5, 10.1016/S0065-2660(10)70012-2]; Momburg F, 2002, MOL IMMUNOL, V39, P217, DOI 10.1016/S0161-5890(02)00103-7; MoreauAubry A, 1997, INT J ONCOL, V10, P841; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; Ogino T, 2003, TISSUE ANTIGENS, V62, P385, DOI 10.1034/j.1399-0039.2003.00114.x; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; PEROSA F, 1988, HUM IMMUNOL, V23, P255, DOI 10.1016/0198-8859(88)90061-4; Perosa F, 2003, J IMMUNOL, V171, P1918, DOI 10.4049/jimmunol.171.4.1918; Ramal LM, 2000, TISSUE ANTIGENS, V55, P443, DOI 10.1034/j.1399-0039.2000.550507.x; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Rodriguez T, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-34; Seliger B, 2001, CANCER RES, V61, P8647; Sernee MF, 1998, MOL IMMUNOL, V35, P177, DOI 10.1016/S0161-5890(98)00026-1; Serrano A, 2001, INT J CANCER, V94, P243, DOI 10.1002/ijc.1452; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Sheyhidin I, 2014, ASIAN PAC J CANCER P, V15, P10299, DOI 10.7314/APJCP.2014.15.23.10299; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; STAM NJ, 1986, J IMMUNOL, V137, P2299; Tan P, 2002, J IMMUNOL, V168, P1950, DOI 10.4049/jimmunol.168.4.1950; van den Elsen PJ, 1998, IMMUNOGENETICS, V48, P208, DOI 10.1007/s002510050425; Wang X, 2003, TISSUE ANTIGENS, V62, P139, DOI 10.1034/j.1399-0039.2003.00087.x; Wang XH, 2005, J IMMUNOL METHODS, V299, P139, DOI 10.1016/j.jim.2005.02.006; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7; Yabe T, 2002, BLOOD, V100, P1496, DOI 10.1182/blood-2001-12-0252; Yamshchikov GV, 2005, J IMMUNOL, V174, P6863, DOI 10.4049/jimmunol.174.11.6863	53	49	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26562	26575		10.1074/jbc.M115.676130	http://dx.doi.org/10.1074/jbc.M115.676130			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26381407	hybrid, Green Published			2022-12-28	WOS:000364793600023
J	Mandal, CC; Das, F; Ganapathy, S; Harris, SE; Choudhury, GG; Ghosh-Choudhury, N				Mandal, Chandi C.; Das, Falguni; Ganapathy, Suthakar; Harris, Stephen E.; Choudhury, Goutam Ghosh; Ghosh-Choudhury, Nandini			Bone Morphogenetic Protein-2 ( BMP-2) Activates NFATc1 Transcription Factor via an Autoregulatory Loop Involving Smad/Akt/Ca2+ Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; PHOSPHATIDYLINOSITOL 3-KINASE; RECEPTOR ACTIVATOR; NF-ATC; OSTEOBLASTIC CELLS; CALCIUM; EXPRESSION; KINASE; DIFFERENTIATION; RANKL	Background: Mutations in NFATc1 and BMP-2 genes result in bone abnormalities in mice. Results: BMP-2 activates intracellular Ca2+ release, thus activating calcineurin phosphatase to induce NFATc1 expression involving canonical Smad and noncanonical PI 3-kinase in osteoblasts. Conclusion: BMP-2-stimulated Ca-2 -calcineurin-NFATc1 axis potentiates osteoblast differentiation. Significance: NFATc1 autoregulates its expression in response to BMP-2 in osteoblasts.	[Choudhury, Goutam Ghosh; Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Vet Affairs Res, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, South Texas Vet Hlth Care Syst, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Mandal, Chandi C.; Ganapathy, Suthakar; Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Das, Falguni; Choudhury, Goutam Ghosh] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Harris, Stephen E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Ghosh-Choudhury, N (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA.	choudhury@uthscsa.edu		Mandal, Chandi/0000-0002-2292-6635	Veterans Affairs Merit Review grants; National Institutes of Health [RO1 AR52425, RO1 DK50190]; Cancer Prevention Research Institute of Texas fellowship; Veterans Affairs Senior Research Career Scientist Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190] Funding Source: NIH RePORTER	Veterans Affairs Merit Review grants(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas fellowship; Veterans Affairs Senior Research Career Scientist Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Veterans Affairs Merit Review grants and National Institutes of Health Grant RO1 AR52425 (to N.G.-C.)and National Institutes of Health Grant RO1 DK50190 and Veterans Affairs Merit Review grants (to G.G.C.). The authors do not have any conflict of interests. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Recipient of a Cancer Prevention Research Institute of Texas fellowship. Present address: Dept. of Biochemistry, School of Life Sciences, Central University of Rajasthan, Ajmer 305801, India.r Recipient of a Veterans Affairs Senior Research Career Scientist Award.	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Blair HC, 2011, BIOFACTORS, V37, P159, DOI 10.1002/biof.143; BODEN SD, 1990, ORTHOP CLIN N AM, V21, P31; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Capulli M, 2014, ARCH BIOCHEM BIOPHYS, V561, P3, DOI 10.1016/j.abb.2014.05.003; Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6; Chuvpilo S, 2002, IMMUNITY, V16, P881, DOI 10.1016/S1074-7613(02)00329-1; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dvorak MM, 2004, CELL CALCIUM, V35, P249, DOI 10.1016/j.ceca.2003.10.014; Eapen A, 2010, J BIOL CHEM, V285, P36339, DOI 10.1074/jbc.M110.145607; Fruman David A., 1996, Methods (Orlando), V9, P146, DOI 10.1006/meth.1996.0020; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Ghosh-Choudhury N, 2007, J BIOL CHEM, V282, P4983, DOI 10.1074/jbc.M606706200; Ghosh-Choudhury N, 2006, J BIOL CHEM, V281, P20160, DOI 10.1074/jbc.M511071200; Ghosh-Choudhury N, 2013, J BIOL CHEM, V288, P24503, DOI 10.1074/jbc.M113.455733; GhoshChoudhury N, 1996, ENDOCRINOLOGY, V137, P331, DOI 10.1210/en.137.1.331; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Itoh K, 2001, ENDOCRINOLOGY, V142, P3656, DOI 10.1210/en.142.8.3656; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lee HL, 2011, BONE, V49, P242, DOI 10.1016/j.bone.2011.04.006; Lu WJ, 2010, AM J PHYSIOL-CELL PH, V299, pC1370, DOI 10.1152/ajpcell.00040.2010; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Mandal CC, 2011, BIOCHEM J, V433, P393, DOI 10.1042/BJ20100357; Mandal CC, 2009, ENDOCRINOLOGY, V150, P4989, DOI 10.1210/en.2009-0026; Mandal CC, 2012, CARCINOGENESIS, V33, P1897, DOI 10.1093/carcin/bgs198; Mandal CC, 2011, J BIOL CHEM, V286, P11314, DOI 10.1074/jbc.M110.193714; Mandal CC, 2010, CALCIFIED TISSUE INT, V87, P533, DOI 10.1007/s00223-010-9419-3; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Massague J, 2000, GENE DEV, V14, P627; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Nesti LJ, 2007, J CELL BIOCHEM, V101, P348, DOI 10.1002/jcb.21180; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Shah AK, 1999, BIOL CELL, V91, P131, DOI 10.1016/S0248-4900(99)80037-9; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takami M, 2000, ENDOCRINOLOGY, V141, P4711, DOI 10.1210/en.141.12.4711; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Yang WC, 2013, J CELL SCI, V126, P4085, DOI 10.1242/jcs.118596; Zhang GH, 1997, P SOC EXP BIOL MED, V216, P117; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134	49	34	36	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2016	291	3					1148	1161		10.1074/jbc.M115.668939	http://dx.doi.org/10.1074/jbc.M115.668939			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA8PR	26472929	Green Published, hybrid			2022-12-28	WOS:000368068300011
J	Aduri, NG; Prabhala, BK; Ernst, HA; Jorgensen, FS; Olsen, L; Mirza, O				Aduri, Nanda G.; Prabhala, Bala K.; Ernst, Heidi A.; Jorgensen, Flemming S.; Olsen, Lars; Mirza, Osman			Salt Bridge Swapping in the EXXERFXYY Motif of Proton-coupled Oligopeptide Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROKARYOTIC PEPTIDE TRANSPORTER; E. COLI; SUBSTRATE SPECIFICITIES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; KNOCKOUT MICE; POT FAMILY; WILD-TYPE; YJDL; MECHANISM	Proton-coupled oligopeptide transporters (POTs) couple the inward transport of di-or tripeptides with an inwardly directed transport of protons. Evidence from several studies of different POTs has pointed toward involvement of a highly conserved sequence motif, E1XXE2RFXYY (from here on referred to as E1XXE2R), located on Helix I, in interactions with the proton. In this study, we investigated the intracellular substrate accumulation by motif variants with all possible combinations of glutamate residues changed to glutamine and arginine changed to a tyrosine, the latter being a natural variant found in the Escherichia coli POT YjdL. We found that YjdL motif variants with E1XXE2R, E1XXE2Y, E(1)XXQ(2)Y, or Q(1)XXE(2)Y were able to accumulate peptide, whereas those with E(1)XXQ(2)R, Q(1)XXE(2)R, or Q(1)XXQ(2)Y were unable to accumulate peptide, and Q(1)XXQ(2)R abolished uptake. These results suggest a mechanism that involves swapping of an intramotif salt bridge, i.e. R-E-2 to R-E-1, which is consistent with previous structural studies. Molecular dynamics simulations of the motif variants E1XXE2R and E(1)XXQ(2)R support this mechanism. The simulations showed that upon changing conformation arginine pushes Helix V, through interactions with the highly conserved FYING motif, further away from the central cavity in what could be a stabilization of an inward facing conformation. As E-2 has been suggested to be the primary site for protonation, these novel findings show how protonation may drive conformational changes through interactions of two highly conserved motifs.	[Aduri, Nanda G.; Prabhala, Bala K.; Ernst, Heidi A.; Jorgensen, Flemming S.; Olsen, Lars; Mirza, Osman] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark	University of Copenhagen	Olsen, L (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark.	lo@sund.ku.dk; om@sund.ku.dk	Olsen, Lars/AAY-8278-2020; Ernst, Heidi Asschenfeldt/R-2335-2016	Ernst, Heidi Asschenfeldt/0000-0001-5458-2454; Aduri, Nanda Gowtham/0000-0003-4301-7446; Prabhala, Bala Krishna/0000-0002-0165-3113; Mirza, Osman Asghar/0000-0001-9435-0690; Jorgensen, Flemming Steen/0000-0001-8040-2998; Olsen, Lars/0000-0002-7607-7130	Danish research councils for health and science	Danish research councils for health and science	This work was supported by the Danish research councils for health and science. The authors declare that they have no conflicts of interest with the contents of this article.	Brodin B, 2002, PHARMACOL TOXICOL, V90, P285, DOI 10.1034/j.1600-0773.2002.900601.x; Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005; Daniel H, 1996, J MEMBRANE BIOL, V154, P197, DOI 10.1007/s002329900144; Doki S, 2013, P NATL ACAD SCI USA, V110, P11343, DOI 10.1073/pnas.1301079110; Ernst HA, 2009, BIOCHEM BIOPH RES CO, V389, P112, DOI 10.1016/j.bbrc.2009.08.098; Fang G, 2000, J BACTERIOL, V182, P2530, DOI 10.1128/JB.182.9.2530-2535.2000; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; Guettou F, 2014, NAT STRUCT MOL BIOL, V21, P728, DOI 10.1038/nsmb.2860; Guettou F, 2013, EMBO REP, V14, P804, DOI 10.1038/embor.2013.107; Hammes UZ, 2010, J BIOL CHEM, V285, P39710, DOI 10.1074/jbc.M110.141457; Ito K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3502; Jensen JM, 2014, INT J BIOCHEM CELL B, V55, P311, DOI 10.1016/j.biocel.2014.09.016; Jensen JM, 2012, PROTEIN PEPTIDE LETT, V19, P282; Jensen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047780; Jensen JM, 2012, PEPTIDES, V38, P89, DOI 10.1016/j.peptides.2012.08.012; Kottra G, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.165; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Lyons JA, 2014, EMBO REP, V15, P886, DOI 10.15252/embr.201338403; Malle E, 2011, J BIOL CHEM, V286, P23121, DOI 10.1074/jbc.M111.239657; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Nielsen CU, 2003, CURR DRUG TARGETS, V4, P373, DOI 10.2174/1389450033491028; Nour-Eldin HH, 2013, CURR OPIN BIOTECH, V24, P263, DOI 10.1016/j.copbio.2012.09.006; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Omkvist DH, 2010, AAPS J, V12, P385, DOI 10.1208/s12248-010-9195-z; Osawa H, 2006, BIOCHEM J, V393, P267, DOI 10.1042/BJ20050920; Parker JL, 2014, NATURE, V507, P68, DOI 10.1038/nature13116; Pieri M, 2009, INT J BIOCHEM CELL B, V41, P2204, DOI 10.1016/j.biocel.2009.04.014; Prabhala BK, 2014, FEBS LETT, V588, P560, DOI 10.1016/j.febslet.2014.01.004; RONG LA, 1995, J BIOL CHEM, V270, P6456, DOI 10.1074/jbc.270.12.6456; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schrodinger LLC, 2013, MAESTR DESM INT TOOL; Schrodinger LLC, 2013, SCHROD 2013 2; Schrodinger LLC, 2013, PROT PREP WIZ 2013 2; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Sun J, 2014, NATURE, V507, P73, DOI 10.1038/nature13074; Theis S, 2001, PROTEIN EXPRES PURIF, V22, P436, DOI 10.1006/prep.2001.1455; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Uchiyama T, 2003, PHARM RES, V20, P1911, DOI 10.1023/B:PHAM.0000008036.05892.e9; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Wallingford CT, 2013, GAUSSIAN INC; Weitz D, 2007, J BIOL CHEM, V282, P2832, DOI 10.1074/jbc.M604866200; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Yang B, 2013, DRUG METAB DISPOS, V41, P1867, DOI 10.1124/dmd.113.052597; Yang B, 2013, DRUG METAB DISPOS, V41, P608, DOI 10.1124/dmd.112.049239; Zhao Y, 2014, STRUCTURE, V22, P1152, DOI 10.1016/j.str.2014.06.008	47	17	17	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29931	29940		10.1074/jbc.M115.675603	http://dx.doi.org/10.1074/jbc.M115.675603			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26483552	Green Published, hybrid			2022-12-28	WOS:000366614700025
J	Camell, CD; Nguyen, KY; Jurczak, MJ; Christian, BE; Shulman, GI; Shadel, GS; Dixit, VD				Camell, Christina D.; Nguyen, Kim Y.; Jurczak, Michael J.; Christian, Brooke E.; Shulman, Gerald I.; Shadel, Gerald S.; Dixit, Vishwa Deep			Macrophage-specific de Novo Synthesis of Ceramide Is Dispensable for Inflammasome-driven Inflammation and Insulin Resistance in Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE INFLAMMATION; NLRP3 INFLAMMASOME; T-CELLS; METABOLISM; INHIBITION; ACTIVATION; TRIGGER; BIOSYNTHESIS; MECHANISMS; INDUCTION	Dietary lipid overload and calorie excess during obesity is a low grade chronic inflammatory state with diminished ability to appropriately metabolize glucose or lipids. Macrophages are critical in maintaining adipose tissue homeostasis, in part by regulating lipid metabolism, energy homeostasis, and tissue remodeling. During high fat diet-induced obesity, macrophages are activated by lipid derived "danger signals" such as ceramides and palmitate and promote the adipose tissue inflammation in an Nlrp3 inflammasome-dependent manner. Given that the metabolic fate of fatty acids in macrophages is not entirely elucidated, we have hypothesized that de novo synthesis of ceramide, through the rate-limiting enzyme serine palmitoyltransferase long chain (Sptlc)-2, is required for saturated fatty acid-driven Nlrp3 inflammasome activation in macrophages. Here we report that mitochondrial targeted overexpression of catalase, which is established to mitigate oxidative stress, controls ceramide-induced Nlrp3 inflammasome activation but does not affect the ATP-mediated caspase-1 cleavage. Surprisingly, myeloid cell-specific deletion of Sptlc2 is not required for palmitate-driven Nlrp3 inflammasome activation. Furthermore, the ablation of Sptlc2 in macrophages did not impact macrophage polarization or obesity-induced adipose tissue leukocytosis. Consistent with these data, investigation of insulin resistance using hyperinsulinemic-euglycemic clamps revealed no significant differences in obese mice lacking ceramide de novo synthesis machinery in macrophages. These data suggest that alternate metabolic pathways control fatty acid-derived ceramide synthesis in macrophage and the Nlrp3 inflammasome activation in obesity.	[Camell, Christina D.; Nguyen, Kim Y.; Dixit, Vishwa Deep] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; [Camell, Christina D.; Nguyen, Kim Y.; Dixit, Vishwa Deep] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Jurczak, Michael J.; Shulman, Gerald I.; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Christian, Brooke E.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Shadel, Gerald S.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Dixit, VD (corresponding author), Yale Univ, Sch Med, Comparat Med Sect, 310 Cedar St, New Haven, CT 06520 USA.	Vishwa.Dixit@yale.edu	Shulman, Gerald I./P-7176-2019; Christian, Brooke Elizabeth/ABA-8019-2021; Regan, Clinton/E-6250-2012	Shulman, Gerald I./0000-0003-1529-5668; Jurczak, Michael/0000-0002-6335-6915; Christian, Brooke/0000-0002-1495-5639	National Institutes of Health [DK090556, AG043608, AI105097, AG047632, NRSA NS077723, DK-40936, DK-059635, DK-45735]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI105097, R01AI105097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090556, P30DK045735, U2CDK059635, R01DK040936, U24DK059635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS077723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047632, R01AG043608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants DK090556, AG043608, and AI105097 (to V.D.D.); AG047632 (to G.S.S.); NRSA NS077723 (to B.E.C.); DK-40936, DK-059635, and DK-45735 (to G.I.S.); and AG043608 (to C.D.C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Blachnio-Zabielska AU, 2012, J CELL PHYSIOL, V227, P550, DOI 10.1002/jcp.22745; Chakraborty M, 2013, J CLIN INVEST, V123, P1784, DOI 10.1172/JCI60415; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Haneklaus M, 2013, CURR OPIN IMMUNOL, V25, P40, DOI 10.1016/j.coi.2012.12.004; Henao-Mejia J, 2014, ANNU REV PHYSIOL, V76, P57, DOI 10.1146/annurev-physiol-021113-170324; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Li ZQ, 2009, J BIOL CHEM, V284, P27010, DOI 10.1074/jbc.M109.042028; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Mitsutake S, 2012, FEBS LETT, V586, P1300, DOI 10.1016/j.febslet.2012.03.032; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nicholls HT, 2011, DIABETES, V60, P1100, DOI 10.2337/db10-1353; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Samad F, 2011, ADV EXP MED BIOL, V721, P67, DOI 10.1007/978-1-4614-0650-1_5; Schilling JD, 2013, J BIOL CHEM, V288, P2923, DOI 10.1074/jbc.M112.419978; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shah C, 2008, J BIOL CHEM, V283, P13538, DOI 10.1074/jbc.M709950200; Stienstra R, 2011, P NATL ACAD SCI USA, V108, P15324, DOI 10.1073/pnas.1100255108; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vetrano AM, 2005, J BIOL CHEM, V280, P35372, DOI 10.1074/jbc.M503991200; Villena J, 2008, FREE RADICAL BIO MED, V44, P1146, DOI 10.1016/j.freeradbiomed.2007.12.017; Wang J, 2014, AM J PHYSIOL-ENDOC M, V306, pE756, DOI 10.1152/ajpendo.00549.2013; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Winer DA, 2014, CELL MOL LIFE SCI, V71, P1033, DOI 10.1007/s00018-013-1486-y; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xia JY, 2015, CELL METAB, V22, P266, DOI 10.1016/j.cmet.2015.06.007; Xia JY, 2014, BIOCHIMIE, V96, P130, DOI 10.1016/j.biochi.2013.08.013; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	48	39	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29402	29413		10.1074/jbc.M115.680199	http://dx.doi.org/10.1074/jbc.M115.680199			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26438821	Green Published, hybrid			2022-12-28	WOS:000366613400025
J	Wang, YS; Zheng, ZF; Zhang, JY; Wang, Y; Kong, RR; Liu, JY; Zhang, Y; Deng, HK; Du, XJ; Ke, Y				Wang, Yingshuang; Zheng, Zongfang; Zhang, Jingyi; Wang, You; Kong, Ruirui; Liu, Jiangying; Zhang, Ying; Deng, Hongkui; Du, Xiaojuan; Ke, Yang			A Novel Retinoblastoma Protein (RB) E3 Ubiquitin Ligase (NRBE3) Promotes RB Degradation and Is Transcriptionally Regulated by E2F1 Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUSCEPTIBILITY GENE-PRODUCT; CELL-CYCLE CONTROL; BREAST-CANCER; TUMOR-SUPPRESSOR; THERAPEUTIC RESPONSE; PROTEASOME PATHWAY; DEPENDENT DEGRADATION; ONCOPROTEIN MDM2; FAMILY PROTEINS; E7	Retinoblastoma protein (RB) plays critical roles in tumor suppression and is degraded through the proteasomal pathway. However, E3 ubiquitin ligases responsible for proteasome-mediated degradation of RB are largely unknown. Here we characterize a novel RB E3 ubiquitin ligase (NRBE3) that binds RB and promotes RB degradation. NRBE3 contains an LXCXE motif and bound RB in vitro. NRBE3 interacted with RB in cells when proteasome activity was inhibited. NRBE3 promoted RB ubiquitination and degradation via the ubiquitin-proteasome pathway. Importantly, purified NRBE3 ubiquitinated recombinant RB in vitro, and a U-box was identified as essential for its E3 activity. Surprisingly, NRBE3 was transcriptionally activated by E2F1/DP1. Consequently, NRBE3 affected the cell cycle by promoting G1/S transition. Moreover, NRBE3 was up-regulated in breast cancer tissues. Taken together, we identified NRBE3 as a novel ubiquitin E3 ligase for RB that might play a role as a potential oncoprotein in human cancers.	[Wang, Yingshuang; Zheng, Zongfang; Zhang, Jingyi; Wang, You; Kong, Ruirui; Liu, Jiangying; Zhang, Ying; Deng, Hongkui; Du, Xiaojuan; Ke, Yang] Peking Univ, Beijing Canc Hosp & Inst, Sch Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China; [Wang, Yingshuang; Zheng, Zongfang; Wang, You; Kong, Ruirui; Liu, Jiangying; Zhang, Ying; Ke, Yang] Peking Univ, Beijing Canc Hosp & Inst, Sch Oncol, Genet Lab, Beijing 100142, Peoples R China; [Deng, Hongkui; Du, Xiaojuan] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Cell Biol, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University	Du, XJ (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Cell Biol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	duxiaojuan100@bjmu.edu.cn; keyang@hsc.pku.edu.cn	Du, Xiaojuan/AAY-1186-2021		National Natural Science Foundation of China [30571038, 81372222]; Innovation team of the Ministry of Education [IRT13001]; Beijing Municipal Natural Science Foundation [7122032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation team of the Ministry of Education; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China Grants 30571038 and 81372222, the Innovation team of the Ministry of Education (Grant IRT13001), and Beijing Municipal Natural Science Foundation Grant 7122032. The authors declare that they have no conflict of interest with the contents of this article.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Adams PD, 1999, MOL CELL BIOL, V19, P1068; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Boyer SN, 1996, CANCER RES, V56, P4620; Brown DR, 1998, EMBO J, V17, P2513, DOI 10.1093/emboj/17.9.2513; Casimiro Mathew C, 2012, Genes Cancer, V3, P649, DOI 10.1177/1947601913479022; CAVENEE WK, 1985, SCIENCE, V228, P501, DOI 10.1126/science.3983638; Chemes LB, 2010, FEBS J, V277, P973, DOI 10.1111/j.1742-4658.2009.07540.x; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Deshpande A, 2006, CURR MOL MED, V6, P809; Dick FA, 2000, MOL CELL BIOL, V20, P3715, DOI 10.1128/MCB.20.10.3715-3727.2000; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dublin EA, 1998, INT J CANCER, V79, P71, DOI 10.1002/(SICI)1097-0215(19980220)79:1<71::AID-IJC14>3.0.CO;2-K; DYSON N, 1992, J VIROL, V66, P4606, DOI 10.1128/JVI.66.7.4606-4611.1992; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ertel A, 2010, CELL CYCLE, V9, P4153, DOI 10.4161/cc.9.20.13454; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FLEMINGTON EK, 1993, P NATL ACAD SCI USA, V90, P6914, DOI 10.1073/pnas.90.15.6914; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Henley SA, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-10; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Higashitsuji H, 2000, NAT MED, V6, P96, DOI 10.1038/71600; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu LL, 2011, J BIOL CHEM, V286, P3119, DOI 10.1074/jbc.M110.157842; HU NP, 1994, ONCOGENE, V9, P1021; Huh K, 2007, J VIROL, V81, P9737, DOI 10.1128/JVI.00881-07; Hui R, 2000, CLIN CANCER RES, V6, P2777; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Jain AK, 2009, CELL CYCLE, V8, P3668, DOI 10.4161/cc.8.22.9979; JONES RE, 1990, J BIOL CHEM, V265, P12782; Jung YS, 2012, FEBS LETT, V586, P1397, DOI 10.1016/j.febslet.2012.03.052; Kalejta RF, 2003, MOL CELL BIOL, V23, P1885, DOI 10.1128/MCB.23.6.1885-1895.2003; Kaye FJ, 2002, ONCOGENE, V21, P6908, DOI 10.1038/sj.onc.1205834; Kehn K, 2005, ONCOGENE, V24, P525, DOI 10.1038/sj.onc.1208105; Knight JS, 2005, P NATL ACAD SCI USA, V102, P18562, DOI 10.1073/pnas.0503886102; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Laj A, 1999, MOL CELL BIOL, V19, P6632; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; Marine JC, 2012, NAT REV CANCER, V12, P455, DOI 10.1038/nrc3271; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nordquist KA, 2010, BIOCHEMISTRY-US, V49, P347, DOI 10.1021/bi901620v; Oh KJ, 2010, VIROLOGY, V396, P118, DOI 10.1016/j.virol.2009.10.018; Pan WJ, 2001, CANCER RES, V61, P2885; Patterson Cam, 2002, Sci STKE, V2002, ppe4; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Viatour P, 2011, DIS MODEL MECH, V4, P581, DOI 10.1242/dmm.008060; Wang J, 2001, ONCOGENE, V20, P4740, DOI 10.1038/sj.onc.1204655; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Wikenheiser-Brokamp KA, 2006, CELL MOL LIFE SCI, V63, P767, DOI 10.1007/s00018-005-5487-3; Wu JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031692; Yang L, 2005, BIOCHEM BIOPH RES CO, V334, P884, DOI 10.1016/j.bbrc.2005.06.179; Zheng Zong-fang, 2009, Beijing Da Xue Xue Bao Yi Xue Ban, V41, P613	79	12	12	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28200	28213		10.1074/jbc.M115.655597	http://dx.doi.org/10.1074/jbc.M115.655597			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26442585	Green Published, hybrid			2022-12-28	WOS:000365761900015
J	Couoh-Cardel, S; Milgrom, E; Wilkens, S				Couoh-Cardel, Sergio; Milgrom, Elena; Wilkens, Stephan			Affinity Purification and Structural Features of the Yeast Vacuolar ATPase V-o Membrane Sector	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; N-TERMINAL DOMAIN; H+-ATPASE; SUBUNIT-C; CRYSTAL-STRUCTURE; PROTON CHANNEL; SACCHAROMYCES-CEREVISIAE; 3-DIMENSIONAL STRUCTURE; PROTEIN; PUMP	The membrane sector (V-o) of the proton pumping vacuolar ATPase (V-ATPase, V1Vo-ATPase) from Saccharomyces cerevisiae was purified to homogeneity, and its structure was characterized byEMof single molecules and two-dimensional crystals. Projection images of negatively stained V-o two-dimensional crystals showed a ring-like structure with a large asymmetric mass at the periphery of the ring. A cryo-EM reconstruction of V-o from single-particle images showed subunits a and d in close contact on the cytoplasmic side of the proton channel. A comparison of three-dimensional reconstructions of free V-o and V-o as part of holo V1Vo revealed that the cytoplasmic N-terminal domain of subunit a (a(NT)) must undergo a large conformational change upon enzyme disassembly or (re) assembly from V-o, V-1, and subunit C. Isothermal titration calorimetry using recombinant subunit d and a(NT) revealed that the two proteins bind each other with a Kd of similar to 5 mu M. Treatment of the purified V-o sector with 1-palmitoyl-2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)] resulted in selective release of subunit d, allowing purification of a V-o Delta d complex. Passive proton translocation assays revealed that both V-o and V-o Delta d are impermeable to protons. We speculate that the structural change in subunit a upon release of V-1 from V-o during reversible enzyme dissociation plays a role in blocking passive proton translocation across free V-o and that the interaction between a(NT) and d seen in free V-o functions to stabilize the V-o sector for efficient reassembly of V1Vo.	[Couoh-Cardel, Sergio; Milgrom, Elena; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu		Couoh-Cardel, Sergio/0000-0002-5186-4648	National Science Foundation; NIGMS/National Institutes of Health under National Science Foundation [DMR-1332208]; NIGMS/National Institutes of Health [GM-103485]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485, R01GM058600] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIGMS/National Institutes of Health under National Science Foundation; NIGMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Patricia Kane for reagents and help with yeast molecular biology and Nicholas J. Stam, Stuti Sharma, and Dr. Rebecca A. Oot for discussions. We thank Dr. Karlett Parra for the plasmid encoding yeast V-ATPase subunit d and Dr. Lee Parsons for generating the subunit d expression construct. We also thank Robert Carroll for generating the a<INF>NT(1</INF> <INF>372)</INF> expression construct and Dr. Richard Gillilan for help with BioSAXS data collection. Part of this work is on the basis of research conducted at the Cornell High-Energy Synchrotron Source (CHESS), which is supported by the National Science Foundation and the NIGMS/National Institutes of Health under National Science Foundation Award DMR-1332208, using the Macromolecular Diffraction at CHESS (MacCHESS) facility, which is supported by Award GM-103485 from the NIGMS/National Institutes of Health.	Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Blake-Palmer KG, 2009, CURR OPIN NEPHROL HY, V18, P433, DOI 10.1097/MNH.0b013e32832e9c58; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Brown D, 1997, J EXP BIOL, V200, P257; Compton MA, 2006, J BIOL CHEM, V281, P15312, DOI 10.1074/jbc.M600890200; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Ediger B, 2009, J BIOL CHEM, V284, P19522, DOI 10.1074/jbc.M109.013375; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Johnson RM, 2010, ANAL BIOCHEM, V398, P203, DOI 10.1016/j.ab.2009.12.020; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; KANE PM, 1995, J BIOL CHEM, V270, P17025; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kartner N, 2014, EXPERT OPIN DRUG DIS, V9, P505, DOI 10.1517/17460441.2014.902155; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Lee JY, 2008, J BIOL CHEM, V283, P5769, DOI 10.1074/jbc.M707028200; Li SC, 2014, MOL BIOL CELL, V25, P1251, DOI 10.1091/mbc.E13-10-0563; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MOSHER ME, 1983, J BACTERIOL, V156, P1078, DOI 10.1128/JB.156.3.1078-1092.1983; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Oot RA, 2012, J BIOL CHEM, V287, P13396, DOI 10.1074/jbc.M112.343962; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; Rawson S, 2015, STRUCTURE, V23, P461, DOI 10.1016/j.str.2014.12.016; SCHNEIDER E, 1985, EMBO J, V4, P515, DOI 10.1002/j.1460-2075.1985.tb03658.x; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; Stewart Alastair G, 2013, Bioarchitecture, V3, P2, DOI 10.4161/bioa.23301; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Thudium CS, 2012, CURR PROTEIN PEPT SC, V13, P141; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang Y, 2007, J BIOL CHEM, V282, P34058, DOI 10.1074/jbc.M704331200; Wang YR, 2004, J BIOL CHEM, V279, P44628, DOI 10.1074/jbc.M407345200; Wilkens S, 2005, MICRON, V36, P109, DOI 10.1016/j.micron.2004.10.002; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Wilkens S, 2005, ADV PROTEIN CHEM, V71, P345, DOI 10.1016/S0065-3233(04)71009-8; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; ZHANG JM, 1992, J BIOL CHEM, V267, P9773; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365	63	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27959	27971		10.1074/jbc.M115.662494	http://dx.doi.org/10.1074/jbc.M115.662494			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26416888	Green Published, hybrid			2022-12-28	WOS:000365757500043
J	Deranieh, RM; Shi, YH; Tarsio, M; Chen, Y; McCaffery, JM; Kane, PM; Greenberg, ML				Deranieh, Rania M.; Shi, Yihui; Tarsio, Maureen; Chen, Yan; McCaffery, J. Michael; Kane, Patricia M.; Greenberg, Miriam L.			Perturbation of the Vacuolar ATPase A NOVEL CONSEQUENCE OF INOSITOL DEPLETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASE; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; LIPID KINASE; V-0 SUBUNIT; H+-ATPASE; YEAST; MEMBRANE; PROTEIN	Depletion of inositol has profound effects on cell function and has been implicated in the therapeutic effects of drugs used to treat epilepsy and bipolar disorder. We have previously shown that the anticonvulsant drug valproate (VPA) depletes inositol by inhibiting myo-inositol-3-phosphate synthase, the enzyme that catalyzes the first and rate-limiting step of inositol biosynthesis. To elucidate the cellular consequences of inositol depletion, we screened the yeast deletion collection for VPA-sensitive mutants and identified mutants in vacuolar sorting and the vacuolar ATPase (V-ATPase). Inositol depletion caused by starvation of ino1 Delta cells perturbed the vacuolar structure and decreased V-ATPase activity and proton pumping in isolated vacuolar vesicles. VPA compromised the dynamics of phosphatidylinositol 3,5-bisphosphate (PI3,5P(2)) and greatly reduced V-ATPase proton transport in inositol-deprived wild-type cells. Osmotic stress, known to increase PI3,5P(2) levels, did not restore PI3,5P(2) homeostasis nor did it induce vacuolar fragmentation in VPA-treated cells, suggesting that perturbation of the V-ATPase is a consequence of altered PI3,5P(2) homeostasis under ino-sitol-limiting conditions. This study is the first to demonstrate that inositol depletion caused by starvation of an inositol synthesis mutant or by the inositol-depleting drug VPA leads to perturbation of the V-ATPase.	[Deranieh, Rania M.; Shi, Yihui; Chen, Yan; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Tarsio, Maureen; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [McCaffery, J. Michael] Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA	Wayne State University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Johns Hopkins University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	mlgreen@sun.science.wayne.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [DK 081367, GM 50322]; Fulbright Scholarship; Wayne State University Graduate Research Fellowship; Graduate Research Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright Scholarship; Wayne State University Graduate Research Fellowship; Graduate Research Funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK 081367 (to M. L. G.) and Grant GM 50322 (to P. M. K.). This work was also supported by a Fulbright Scholarship, a Wayne State University Graduate Research Fellowship, and Graduate Research Funds (to R. M. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; BECKER GW, 1977, J BIOL CHEM, V252, P8684; BERRIDGE MJ, 1989, PROC R SOC SER B-BIO, V238, P235, DOI 10.1098/rspb.1989.0079; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; BOWDEN CL, 1995, J CLIN PSYCHIAT, V56, P3; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Cagnac O, 2010, J BIOL CHEM, V285, P33914, DOI 10.1074/jbc.M110.116590; Calabresi P, 2007, TRENDS PHARMACOL SCI, V28, P188, DOI 10.1016/j.tips.2007.02.005; Chan CY, 2012, J BIOL CHEM, V287, P10236, DOI 10.1074/jbc.M111.321133; Chang HJ, 2002, GENETICS, V162, P29; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Cooke FT, 1998, CURR BIOL, V8, P1219, DOI 10.1016/S0960-9822(07)00513-1; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cunningham MO, 2003, NEUROPHARMACOLOGY, V45, P907, DOI 10.1016/S0028-3908(03)00270-3; Deranieh RM, 2013, J BIOL CHEM, V288, P26822, DOI 10.1074/jbc.M113.479121; Deranieh RM, 2009, BIOCHEM SOC T, V37, P1099, DOI 10.1042/BST0371099; Di Giovanni J, 2010, NEURON, V67, P268, DOI 10.1016/j.neuron.2010.06.024; Diakov TT, 2013, JOVE-J VIS EXP, DOI 10.3791/50261; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Duex JE, 2006, J CELL BIOL, V172, P693, DOI 10.1083/jcb.200512105; Efe JA, 2005, CURR OPIN CELL BIOL, V17, P402, DOI 10.1016/j.ceb.2005.06.002; El Far O, 2011, J NEUROCHEM, V117, P603, DOI 10.1111/j.1471-4159.2011.07234.x; El Far O, 2011, M S-MED SCI, V27, P28, DOI 10.1051/medsci/201127128; Gary JD, 2002, MOL BIOL CELL, V13, P1238, DOI 10.1091/mbc.01-10-0498; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; HANSON BA, 1980, J BACTERIOL, V142, P79, DOI 10.1128/JB.142.1.79-89.1980; HELL JW, 1988, EMBO J, V7, P3023, DOI 10.1002/j.1460-2075.1988.tb03166.x; HENRY SA, 1977, J BACTERIOL, V130, P472, DOI 10.1128/JB.130.1.472-484.1977; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Ho CY, 2015, J BIOL CHEM, V290, P9919, DOI 10.1074/jbc.M114.613984; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Jesch SA, 2010, J BIOL CHEM, V285, P41947, DOI 10.1074/jbc.M110.188607; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiranek V, 1998, MICROBIOL-UK, V144, P2739, DOI 10.1099/00221287-144-10-2739; Ju SL, 2003, MOL MICROBIOL, V49, P1595, DOI 10.1046/j.1365-2958.2003.03641.x; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; KANE PM, 1995, J BIOL CHEM, V270, P17025; KANE PM, 1992, J BIOL CHEM, V267, P447; Kartner N, 2010, J BIOL CHEM, V285, P37476, DOI 10.1074/jbc.M110.123281; Kotoulas A, 2011, MOL VIS, V17, P2776; Li SC, 2014, MOL BIOL CELL, V25, P1251, DOI 10.1091/mbc.E13-10-0563; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; Lowe M, 2005, TRAFFIC, V6, P711, DOI 10.1111/j.1600-0854.2005.00311.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martin ED, 2004, EPILEPSIA, V45, P436, DOI 10.1111/j.0013-9580.2004.58303.x; Martin ED, 2004, NEUROPHARMACOLOGY, V46, P555, DOI 10.1016/j.neuropharm.2003.10.013; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Michell RH, 2013, FEBS J, V280, P6281, DOI 10.1111/febs.12452; Mira NP, 2010, OMICS, V14, P525, DOI 10.1089/omi.2010.0072; MORIYAMA Y, 1990, J BIOCHEM, V108, P689, DOI 10.1093/oxfordjournals.jbchem.a123264; MORIYAMA Y, 1992, J EXP BIOL, V172, P171; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Oluwatosin YE, 1998, MOL CELL BIOL, V18, P1534, DOI 10.1128/MCB.18.3.1534; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; Poea-Guyon S, 2013, J CELL BIOL, V203, P283, DOI 10.1083/jcb.201303104; Rieder SE, 1996, MOL BIOL CELL, V7, P985, DOI 10.1091/mbc.7.6.985; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; Shimohama S, 1998, NEUROSCI LETT, V245, P159, DOI 10.1016/S0304-3940(98)00209-2; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Tabke K, 2014, BIOCHEM J, V462, P185, DOI 10.1042/BJ20131293; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Weisman LS, 2003, ANNU REV GENET, V37, P435, DOI 10.1146/annurev.genet.37.050203.103207; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525; Yoshida S, 2010, NEUROSCI RES, V68, P322, DOI 10.1016/j.neures.2010.08.010; Zhang ZS, 2010, NEURON, V68, P1097, DOI 10.1016/j.neuron.2010.11.035; Zieger M, 2012, MOL BIOL CELL, V23, P3438, DOI 10.1091/mbc.E12-05-0347	84	15	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27460	27472		10.1074/jbc.M115.683706	http://dx.doi.org/10.1074/jbc.M115.683706			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26324718	hybrid, Green Published			2022-12-28	WOS:000365757500003
J	Guo, YY; Feng, WJ; Sy, SMH; Huen, MSY				Guo, Yingying; Feng, Wanjuan; Sy, Shirley M. H.; Huen, Michael S. Y.			ATM-dependent Phosphorylation of the Fanconi Anemia Protein PALB2 Promotes the DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRCA2-INTERACTING PROTEIN; ANALYSIS REVEALS; CANCER; BRCA2; REPLICATION; MUTATIONS; PARTNER; KINASE; REPAIR; DEFECT	The Fanconi anemia protein PALB2, also known as FANCN, protects genome integrity by regulating DNA repair and cell cycle checkpoints. Exactly how PALB2 functions may be temporally coupled with detection and signaling of DNA damage is not known. Intriguingly, we found that PALB2 is transformed into a hyperphosphorylated state in response to ionizing radiation (IR). IR treatment specifically triggered PALB2 phosphorylation at Ser-157 and Ser-376 in manners that required the master DNA damage response kinase Ataxia telangiectasia mutated, revealing potential mechanistic links between PALB2 and the Ataxia telangiectasia mutated-dependent DNA damage responses. Consistently, dysregulated PALB2 phosphorylation resulted in sustained activation of DDRs. Full-blown PALB2 phosphorylation also required the breast and ovarian susceptible gene product BRCA1, highlighting important roles of the BRCA1-PALB2 interaction in orchestrating cellular responses to genotoxic stress. In summary, our phosphorylation analysis of tumor suppressor protein PALB2 uncovers new layers of regulatory mechanisms in the maintenance of genome stability and tumor suppression.	[Guo, Yingying; Feng, Wanjuan; Sy, Shirley M. H.; Huen, Michael S. Y.] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Sy, Shirley M. H.; Huen, Michael S. Y.] Univ Hong Kong, LKS Fac Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China; [Huen, Michael S. Y.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Sy, SMH (corresponding author), Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.	mhsy@hku.hk; huen.michael@hku.hk		Huen, Michael Shing-Yan/0000-0003-1774-2425; guo, yingying/0000-0002-7829-6935; Sy, Ming Hui/0000-0002-2731-6692	Research Grants Council Hong Kong [HKU_786512M]; NSFC Young Scientist Fund [31301115]; University Postgraduate Fellowship from The University of Hong Kong	Research Grants Council Hong Kong(Hong Kong Research Grants Council); NSFC Young Scientist Fund; University Postgraduate Fellowship from The University of Hong Kong(University of Hong Kong)	The work was supported in part by the Research Grants Council Hong Kong Project number HKU_786512M (to M. S. Y. H.) and NSFC Young Scientist Fund Project number 31301115 (to W. F.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of the University Postgraduate Fellowship from The University of Hong Kong.	Antoniou AC, 2014, NEW ENGL J MED, V371, P497, DOI [10.1056/NEJMoa1400382, 10.1056/NEJMc1410673]; Bakhoum SF, 2014, CANCER DISCOV, V4, P1281, DOI 10.1158/2159-8290.CD-14-0403; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Buisson R, 2014, CELL REP, V6, P553, DOI 10.1016/j.celrep.2014.01.009; Buisson R, 2012, NUCLEIC ACIDS RES, V40, P10312, DOI 10.1093/nar/gks807; Buisson R, 2010, NAT STRUCT MOL BIOL, V17, P1247, DOI 10.1038/nsmb.1915; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dray E, 2010, NAT STRUCT MOL BIOL, V17, P1255, DOI 10.1038/nsmb.1916; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Gardini A, 2014, EMBO J, V33, P890, DOI 10.1002/embj.201385567; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; Lee DH, 2014, MOL CELL, V54, P512, DOI 10.1016/j.molcel.2014.03.020; Ma JL, 2012, MOL CELL BIOL, V32, P1506, DOI 10.1128/MCB.06271-11; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Menzel T, 2011, EMBO REP, V12, P705, DOI 10.1038/embor.2011.99; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Murphy AK, 2014, J CELL BIOL, V206, P493, DOI 10.1083/jcb.201404111; Nikkila J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3578; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Simhadri S, 2014, J BIOL CHEM, V289, P24617, DOI 10.1074/jbc.M114.566141; Sy SMH, 2009, J BIOL CHEM, V284, P18302, DOI 10.1074/jbc.M109.016717; Sy SMH, 2009, J BIOL CHEM, V284, P21127, DOI 10.1074/jbc.C109.023937; Sy SMH, 2009, P NATL ACAD SCI USA, V106, P7155, DOI 10.1073/pnas.0811159106; Tischkowitz M, 2010, CANCER RES, V70, P7353, DOI 10.1158/0008-5472.CAN-10-1012; Tischkowitz MD, 2009, GASTROENTEROLOGY, V137, P1183, DOI 10.1053/j.gastro.2009.06.055; Weterings E, 2007, J CELL BIOL, V179, P183, DOI 10.1083/jcb.200705106; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Zhang F, 2009, MOL CANCER RES, V7, P1110, DOI 10.1158/1541-7786.MCR-09-0123; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	40	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27545	27556		10.1074/jbc.M115.672626	http://dx.doi.org/10.1074/jbc.M115.672626			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26420486	Green Published, hybrid			2022-12-28	WOS:000365757500011
J	Diner, BA; Lum, KK; Cristea, IM				Diner, Benjamin A.; Lum, Krystal K.; Cristea, Ileana M.			The Emerging Role of Nuclear Viral DNA Sensors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SIMPLEX-VIRUS TYPE-1; CYCLIC GMP-AMP; PROTEASOME-DEPENDENT DEGRADATION; IMMEDIATE-EARLY PROMOTER; I INTERFERON RESPONSE; INNATE IMMUNE SENSOR; TOLL-LIKE RECEPTOR-9; EPSTEIN-BARR-VIRUS; CYTOSOLIC DNA; CELL-DEATH	Detecting pathogenic DNA by intracellular receptors termed "sensors" is critical toward galvanizing host immune responses and eliminating microbial infections. Emerging evidence has challenged the dogma that sensing of viral DNA occurs exclusively in sub-cellular compartments normally devoid of cellular DNA. The interferon-inducible protein IFI16 was shown to bind nuclear viral DNA and initiate immune signaling, culminating in antiviral cytokine secretion. Here, we review the newly characterized nucleus-originating immune signaling pathways, their links to other crucial host defenses, and unique mechanisms by which viruses suppress their functions. We frame these findings in the context of human pathologies associated with nuclear replicating DNA viruses.	[Diner, Benjamin A.; Lum, Krystal K.; Cristea, Ileana M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Cristea, IM (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Washington Rd, Princeton, NJ 08544 USA.	icristea@princeton.edu			National Institutes of Health [DP1DA026192, R01 GM114141, R21AI102187]; American Heart Association (AHA) [14PRE18890044]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI102187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114141, T32GM007388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants DP1DA026192, R01 GM114141, and R21AI102187 (to I. M. C.) and by an American Heart Association (AHA) predoctoral fellowship 14PRE18890044 (to B. A. D.). This is the third article in the Thematic Minireview series "Protein Interactions, Structures, and Networks." The authors declare that they have no conflicts of interest with the contents of this article.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Ansari MA, 2013, J VIROL, V87, P8606, DOI 10.1128/JVI.00805-13; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Billiau A, 2006, ANTIVIR RES, V71, P108, DOI 10.1016/j.antiviral.2006.03.006; Blomster HA, 2010, J BIOL CHEM, V285, P19324, DOI 10.1074/jbc.M110.106955; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; Chelbi-Alix MK, 1999, ONCOGENE, V18, P935, DOI 10.1038/sj.onc.1202366; Coban C., 2014, BIOL DNA SENSOR, P257; Crawford DH, 2001, PHILOS T R SOC B, V356, P461, DOI 10.1098/rstb.2000.0783; Cristea IM, 2010, J VIROL, V84, P7803, DOI 10.1128/JVI.00139-10; Cuchet-Lourenco D, 2013, J VIROL, V87, P13422, DOI 10.1128/JVI.02474-13; Delale T, 2005, J IMMUNOL, V175, P6723, DOI 10.4049/jimmunol.175.10.6723; Diner BA, 2015, MOL CELL PROTEOMICS, V14, P2341, DOI 10.1074/mcp.M114.047068; Diner BA, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145808; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Ding Y, 2004, ONCOGENE, V23, P4556, DOI 10.1038/sj.onc.1207592; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; E XF, 2014, VIRUSES-BASEL, V6, P2155, DOI 10.3390/v6052155; Everett RD, 2005, J VIROL, V79, P5078, DOI 10.1128/JVI.79.8.5078-5089.2005; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334; Frobert E, 2014, ANTIVIR RES, V111, P36, DOI 10.1016/j.antiviral.2014.08.013; Furr SR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-99; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; GLASGOW LA, 1962, J EXP MED, V115, P503, DOI 10.1084/jem.115.3.503; Glass M, 2013, J VIROL, V87, P2174, DOI 10.1128/JVI.02950-12; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hansen K, 2014, EMBO J, V33, P1654, DOI 10.15252/embj.201488029; Haque A, 2014, INNATE IMMUN-LONDON, V20, P40, DOI 10.1177/1753425913481636; Hasan UA, 2007, J IMMUNOL, V178, P3186, DOI 10.4049/jimmunol.178.5.3186; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Horan KA, 2013, J IMMUNOL, V190, P2311, DOI 10.4049/jimmunol.1202749; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; ISAACS A, 1963, LANCET, V2, P113; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jakobsen MR, 2013, P NATL ACAD SCI USA, V110, pE4571, DOI 10.1073/pnas.1311669110; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Johnson KE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004503; Johnson KE, 2013, J VIROL, V87, P5005, DOI 10.1128/JVI.00082-13; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kojaoghlanian T, 2003, REV MED VIROL, V13, P155, DOI 10.1002/rmv.386; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lam E, 2014, J VIROL, V88, P974, DOI 10.1128/JVI.02702-13; Li T, 2013, CELL HOST MICROBE, V14, P591, DOI 10.1016/j.chom.2013.10.007; Li T, 2012, P NATL ACAD SCI USA, V109, P10558, DOI 10.1073/pnas.1203447109; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lukashchuk V, 2010, J VIROL, V84, P4026, DOI 10.1128/JVI.02597-09; McFadden K, 2013, CURR TOP MICROBIOL, V371, P229, DOI 10.1007/978-3-642-37765-5_9; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Moens U, 2015, VIRUSES-BASEL, V7, P1871, DOI 10.3390/v7041871; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Morrone SR, 2014, P NATL ACAD SCI USA, V111, pE62, DOI 10.1073/pnas.1313577111; Negorev DG, 2009, J VIROL, V83, P5168, DOI 10.1128/JVI.02083-08; Newhart A, 2012, J CELL SCI, V125, P5489, DOI 10.1242/jcs.110148; Nour AM, 2011, J BIOL CHEM, V286, P17921, DOI 10.1074/jbc.M110.210575; Orzalli MH, 2015, P NATL ACAD SCI USA, V112, pE1773, DOI 10.1073/pnas.1424637112; Orzalli MH, 2013, P NATL ACAD SCI USA, V110, pE4492, DOI 10.1073/pnas.1316194110; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Parkinson J, 1999, J VIROL, V73, P650, DOI 10.1128/JVI.73.1.650-657.1999; Rasmussen SB, 2007, J VIROL, V81, P13315, DOI 10.1128/JVI.01167-07; ROTEM Z, 1963, NATURE, V197, P564, DOI 10.1038/197564a0; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Singh VV, 2013, J VIROL, V87, P4417, DOI 10.1128/JVI.03282-12; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Tudor D, 2005, VACCINE, V23, P1258, DOI 10.1016/j.vaccine.2004.09.001; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; van Gent M, 2011, J IMMUNOL, V186, P1694, DOI 10.4049/jimmunol.0903120; Vancikova Z., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P179; Veeranki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027040; Verrier Eloi R, 2014, Hepatology, V60, P1098, DOI 10.1002/hep.27187; Waddell G. H., 1962, THESIS; Wang JP, 2012, J VIROL, V86, P2273, DOI 10.1128/JVI.06010-11; Weinstock H, 2004, PERSPECT SEX REPRO H, V36, P6, DOI 10.1111/j.1931-2393.2004.tb00002.x; Woodhall DL, 2006, J BIOL CHEM, V281, P37652, DOI 10.1074/jbc.M604273200; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu XM, 2014, NUCLEIC ACIDS RES, V42, P8243, DOI 10.1093/nar/gku569; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yu HR, 2011, CELL MOL IMMUNOL, V8, P181, DOI 10.1038/cmi.2010.84; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhen J, 2014, MEDIAT INFLAMM, V2014, P9, DOI DOI 10.1155/2014/190860; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	99	52	53	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26412	26421		10.1074/jbc.R115.652289	http://dx.doi.org/10.1074/jbc.R115.652289			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354430	hybrid, Green Published			2022-12-28	WOS:000364793600008
J	Atagi, Y; Liu, CC; Painter, MM; Chen, XF; Verbeeck, C; Zheng, HH; Li, X; Rademakers, R; Kang, SS; Xu, HX; Younkin, S; Das, P; Fryer, JD; Bu, GJ				Atagi, Yuka; Liu, Chia-Chen; Painter, Meghan M.; Chen, Xiao-Fen; Verbeeck, Christophe; Zheng, Honghua; Li, Xia; Rademakers, Rosa; Kang, Silvia S.; Xu, Huaxi; Younkin, Steven; Das, Pritam; Fryer, John D.; Bu, Guojun			Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; TYPE-4 ALLELE; R47H VARIANT; RISK-FACTOR; A-BETA; BRAIN; ASSOCIATION; CLEARANCE; APOE	Several heterozygous missense mutations in the triggering receptor expressed on myeloid cells 2 (TREM2) have recently been linked to risk for a number of neurological disorders including Alzheimer disease (AD), Parkinson disease, and frontotemporal dementia. These discoveries have re-ignited interest in the role of neuroinflammation in the pathogenesis of neurodegenerative diseases. TREM2 is highly expressed in microglia, the resident immune cells of the central nervous system. Along with its adaptor protein, DAP12, TREM2 regulates inflammatory cytokine release and phagocytosis of apoptotic neurons. Here, we report apolipoprotein E (apoE) as a novel ligand for TREM2. Using a biochemical assay, we demonstrated high-affinity binding of apoE to human TREM2. The functional significance of this binding was highlighted by increased phagocytosis of apoE-bound apoptotic N2a cells by primary microglia in a manner that depends on TREM2 expression. Moreover, when the AD-associated TREM2-R47H mutant was used in biochemical assays, apoE binding was vastly reduced. Our data demonstrate that apoE-TREM2 interaction in microglia plays critical roles in modulating phagocytosis of apoE-bound apoptotic neurons and establish a critical link between two proteins whose genes are strongly linked to the risk for AD.	[Atagi, Yuka; Liu, Chia-Chen; Painter, Meghan M.; Verbeeck, Christophe; Li, Xia; Rademakers, Rosa; Kang, Silvia S.; Younkin, Steven; Das, Pritam; Fryer, John D.; Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Fryer, John D.; Bu, Guojun] Mayo Clin, Neurobiol Dis Grad Program, Jacksonville, FL 32224 USA; [Liu, Chia-Chen; Chen, Xiao-Fen; Zheng, Honghua; Xu, Huaxi; Bu, Guojun] Xiamen Univ, Coll Med, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361005, Fujian, Peoples R China	Mayo Clinic; Mayo Clinic; Xiamen University	Bu, GJ (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	bu.guojun@mayo.edu	Xu, Huaxi/AAV-7177-2021; Regan, Clinton/E-6250-2012		National Institutes of Health [R01AG027924, R01AG035355, R01AG046205, P01AG30128, P01NS074969, P50AG016574]; Alzheimer's Association; Cure Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG030128, RF1AG051504, R01AG027924, P50AG016574, R01AG035355, R01AG046205, RF1AG046205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Cure Alzheimer's Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AG027924, R01AG035355, R01AG046205, P01AG30128, P01NS074969, and P50AG016574 (to G. B.), and grants from the Alzheimer's Association and Cure Alzheimer's Fund (to G. B.). We declare no competing financial interests.	Benitez BA, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.018; Borroni B, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.017; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Casey CS, 2015, J BIOL CHEM, V290, P14208, DOI 10.1074/jbc.M114.625251; Chaussenot A, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.07.022; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cuyvers E, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.009; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Giraldo M, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.02.016; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2013, JAMA NEUROL, V70, P78, DOI 10.1001/jamaneurol.2013.579; Hickman SE, 2014, BIOCHEM PHARMACOL, V88, P495, DOI 10.1016/j.bcp.2013.11.021; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Ito H, 2012, EUR J IMMUNOL, V42, P176, DOI 10.1002/eji.201141679; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang T, 2014, NEUROPSYCHOPHARMACOL, V39, P2949, DOI 10.1038/npp.2014.164; Jin SC, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0016-9; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Kanekiyo T, 2012, J NEUROSCI, V32, P16458, DOI 10.1523/JNEUROSCI.3987-12.2012; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Kondo T, 2002, NEUROLOGY, V59, P1105, DOI 10.1212/WNL.59.7.1105; Korvatska O, 2015, JAMA NEUROL, V72, P920, DOI 10.1001/jamaneurol.2015.0979; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Marques F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-38; Morikawa M, 2005, NEUROBIOL DIS, V19, P66, DOI 10.1016/j.nbd.2004.11.005; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Neumann H, 2013, NEW ENGL J MED, V368, P182, DOI 10.1056/NEJMe1213157; Ortega-Cubero S, 2015, PARKINSONISM RELAT D, V21, P306, DOI 10.1016/j.parkreldis.2014.12.010; Page KJ, 1998, NEUROSCIENCE, V85, P1161, DOI 10.1016/S0306-4522(97)00661-1; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Petegnief V, 2001, NEUROSCIENCE, V104, P223, DOI 10.1016/S0306-4522(01)00046-X; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Rosenthal SL, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.04.012; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tai LM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-2; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Zhong L, 2015, J BIOL CHEM, V290, P15866, DOI 10.1074/jbc.M115.645986; Zhu W, 2010, J NEUROCHEM, V114, P386, DOI 10.1111/j.1471-4159.2010.06763.x	53	269	274	4	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26043	26050		10.1074/jbc.M115.679043	http://dx.doi.org/10.1074/jbc.M115.679043			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26374899	hybrid, Green Published			2022-12-28	WOS:000363527300025
J	Kannan, MB; Dodard-Friedman, I; Blank, V				Kannan, Meenakshi B.; Dodard-Friedman, Isadore; Blank, Volker			Stringent Control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) Protein Degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and Glycogen Synthase Kinase 3 (GSK3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NF-E2; UBIQUITIN LIGASE; LEUCINE-ZIPPER; TUMOR-SUPPRESSOR; CELL-CYCLE; MULTIUBIQUITIN CHAIN; IN-VIVO; GENE; MAF; PHOSPHORYLATION	The NFE2L3 transcription factor has been implicated in various cellular processes, including carcinogenesis, stress response, differentiation, and inflammation. Previously it has been shown that NFE2L3 has a rapid turnover and is stabilized by proteasomal inhibitors. The mechanisms regulating the degradation of this protein have not been investigated. Here we report ubiquitination of NFE2L3 and demonstrate that F-box/WD repeat-containing protein 7 (FBW7 or FBWX7), a component of Skp1, Cullin 1, F-box containing complex (SCF)-type E3 ligase, is the E3 ligase mediating the degradation of NFE2L3. We showed that FBW7 interacts with NFE2L3 and that dimerization of FBW7 is required for the degradation of the transcription factor. We also demonstrate that the kinase glycogen synthase kinase 3 (GSK3) mediates the FBW7-dependent ubiquitination of NFE2L3. We show phosphorylation of NFE2L3 by GSK3 and its significance in the regulation of NFE2L3 by the tumor suppressor FBW7. FBW7 abrogated NFE2L3-mediated repression of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene antioxidant response element (ARE). Our findings reveal FBW7 and GSK3 as novel regulators of the NFE2L3 transcription factor and a potential mechanism by which FBW7 might regulate detoxification and the cellular response to stress.	[Kannan, Meenakshi B.; Dodard-Friedman, Isadore; Blank, Volker] McGill Univ, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Blank, Volker] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada; [Blank, Volker] McGill Univ, Dept Physiol, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; McGill University	Blank, V (corresponding author), McGill Univ, Dept Med, Lady Davis Inst Med Res, 3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada.	volker.blank@mcgill.ca			Canadian Institutes of Health Research [MOP-97932]; Canadian Institutes of Health Research/Fonds de la Recherche en Sante (CIHR/FRSQ) training grant in cancer research of McGill Integrated Cancer Research Training Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research/Fonds de la Recherche en Sante (CIHR/FRSQ) training grant in cancer research of McGill Integrated Cancer Research Training Program(Canadian Institutes of Health Research (CIHR))	This research was funded by Canadian Institutes of Health Research Grant MOP-97932 (to V. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a studentship from Canadian Institutes of Health Research/Fonds de la Recherche en Sante (CIHR/FRSQ) training grant in cancer research of the McGill Integrated Cancer Research Training Program.	ANDREWS NC, 1993, P NATL ACAD SCI USA, V90, P11488, DOI 10.1073/pnas.90.24.11488; ANDREWS NC, 1994, PEDIATR RES, V36, P419, DOI 10.1203/00006450-199410000-00001; ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Biswas C, 2014, J BIOL CHEM, V289, P26882, DOI 10.1074/jbc.M114.567685; Biswas M, 2010, TOXICOL APPL PHARM, V244, P16, DOI 10.1016/j.taap.2009.07.034; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; CHAN JY, 1993, P NATL ACAD SCI USA, V90, P11371, DOI 10.1073/pnas.90.23.11371; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chenais B, 2005, MOL ENDOCRINOL, V19, P125, DOI 10.1210/me.2003-0379; Chevillard G, 2011, CELL MOL LIFE SCI, V68, P3337, DOI 10.1007/s00018-011-0747-x; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jeyapaul J, 2000, BIOCHEM PHARMACOL, V59, P1433, DOI 10.1016/S0006-2952(00)00256-2; KERPPOLA TK, 1994, ONCOGENE, V9, P675; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kingston Robert E, 2003, Curr Protoc Cell Biol, VChapter 20, DOI 10.1002/0471143030.cb2003s19; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kobayashi A, 1999, J BIOL CHEM, V274, P6443, DOI 10.1074/jbc.274.10.6443; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Lee TL, 2008, BIOCHEM BIOPH RES CO, V375, P326, DOI 10.1016/j.bbrc.2008.07.164; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Nouhi Z, 2007, FEBS LETT, V581, P5401, DOI 10.1016/j.febslet.2007.10.041; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rajagopalan H, 2004, CELL CYCLE, V3, P693; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Welcker M, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-7; Welcker M, 2013, GENE DEV, V27, P2531, DOI 10.1101/gad.229195.113; WOODGETT JR, 1984, BIOCHIM BIOPHYS ACTA, V788, P339, DOI 10.1016/0167-4838(84)90047-5; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200	51	15	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26292	26302		10.1074/jbc.M115.666446	http://dx.doi.org/10.1074/jbc.M115.666446			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26306035	hybrid, Green Published			2022-12-28	WOS:000363527300045
J	Hu, ZD; Wang, Y; Huang, FQ; Chen, RR; Li, CJ; Wang, F; Goto, J; Kwiatkowski, DJ; Wdzieczak-Bakala, J; Tu, PF; Liu, JM; Zha, XJ; Zhang, HB				Hu, Zhongdong; Wang, Ying; Huang, Fuqiang; Chen, Rongrong; Li, Chunjia; Wang, Fang; Goto, June; Kwiatkowski, David J.; Wdzieczak-Bakala, Joanna; Tu, Pengfei; Liu, Jianmiao; Zha, Xiaojun; Zhang, Hongbing			Brain-expressed X-linked 2 Is Pivotal for Hyperactive Mechanistic Target of Rapamycin (mTOR)-mediated Tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; TUBEROUS SCLEROSIS COMPLEX; MAMMALIAN TARGET; BREAST-CANCER; DEPENDENT REGULATION; AEROBIC GLYCOLYSIS; TUMOR ANGIOGENESIS; MALIGNANT GLIOMA; UP-REGULATION	Frequent alteration of upstream proto-oncogenes and tumor suppressor genes activates mechanistic target of rapamycin (mTOR) and causes cancer. However, the downstream effectors of mTOR remain largely elusive. Here we report that brain-expressed X-linked 2 (BEX2) is a novel downstream effector of mTOR. Elevated BEX2 in Tsc2(-/-) mouse embryonic fibroblasts, Pten(-/-) mouse embryonic fibroblasts, Tsc2-deficient rat uterine leiomyoma cells, and brains of neuronal specific Tsc1 knockout mice were abolished by mTOR inhibitor rapamycin. Furthermore, BEX2 was also increased in the liver of a hepatic specific Pten knock-out mouse and the kidneys of Tsc2 heterozygous deletion mice, and a patient with tuberous sclerosis complex (TSC). mTOR up-regulation of BEX2 was mediated in parallel by both STAT3 and NF-kappa B. BEX2 was involved in mTOR up-regulation of VEGF production and angiogenesis. Depletion of BEX2 blunted the tumorigenesis of cells with activated mTOR. Therefore, enhanced STAT3/NF-kappa B-BEX2-VEGF signaling pathway contributes to hyperactive mTOR-induced tumorigenesis. BEX2 may be targeted for the treatment of the cancers with aberrantly activated mTOR signaling pathway.	[Hu, Zhongdong; Huang, Fuqiang; Chen, Rongrong; Li, Chunjia; Wang, Fang; Zhang, Hongbing] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Physiol, State Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Hu, Zhongdong; Huang, Fuqiang; Chen, Rongrong; Li, Chunjia; Wang, Fang; Zhang, Hongbing] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Sch Basic Med, Beijing 100005, Peoples R China; [Hu, Zhongdong; Huang, Fuqiang; Chen, Rongrong; Li, Chunjia; Wang, Fang; Zhang, Hongbing] Peking Union Med Coll, Beijing 100005, Peoples R China; [Hu, Zhongdong; Tu, Pengfei] Beijing Univ Chinese Med, Modern Res Ctr Tradit Chinese Med, Beijing 100029, Peoples R China; [Wang, Ying] Beijing Jishuitan Hosp, Beijing Inst Traumatol & Orthopaed, Dept Mol Orthopaed, Beijing 100035, Peoples R China; [Goto, June] Cincinnati Childrens Hosp Med Ctr, Div Pediat Neurosurg, Cincinnati, OH 45229 USA; [Kwiatkowski, David J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Translat Med, Boston, MA 02115 USA; [Wdzieczak-Bakala, Joanna] CNRS, Inst Chim Subst Nat, UPR2301, F-91198 Gif Sur Yvette, France; [Liu, Jianmiao] Huazhong Univ Sci & Technol, Minist Educ, Coll Life Sci & Technol, Sinofrance Lab Drug Screening,Key Lab Mol Biophy, Wuhan 430074, Peoples R China; [Zha, Xiaojun] Anhui Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Hefei 230032, Peoples R China; [Zha, Xiaojun] Minist Natl Sci & Technol, State Key Lab Incubat Base Dermatol, Hefei 230032, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing University of Chinese Medicine; Cincinnati Children's Hospital Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Huazhong University of Science & Technology; Anhui Medical University	Zha, XJ (corresponding author), Anhui Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, 81 Meishan Rd, Hefei 230032, Peoples R China.	zhaxiaojunpumc@gmail.com; hbzhang2006@gmail.com	Tu, Peng Fei/E-2089-2018	Goto, June/0000-0002-4000-9750; zha, xiaojun/0000-0003-4006-0748	National Basic Research Program of China 973 Program [2015CB553802]; Ministry of Science and Technology of China 863 Program [2012AA02A201]; National Natural Science Foundation of China [81101524, 81130085, 81372475, 81403147]	National Basic Research Program of China 973 Program(National Basic Research Program of China); Ministry of Science and Technology of China 863 Program(Ministry of Science and Technology, ChinaNational High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China 973 Program (Grant 2015CB553802), the Ministry of Science and Technology of China 863 Program (Grant 2012AA02A201), and the National Natural Science Foundation of China (Grants 81101524, 81130085, 81372475, and 81403147). The authors declare that they have no conflicts of interest with the contents of this article.	Albert V, 2015, CURR OPIN CELL BIOL, V33, P55, DOI 10.1016/j.ceb.2014.12.001; Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Alvarez E, 2005, GENE, V357, P18, DOI 10.1016/j.gene.2005.05.012; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; El-Hashemite N, 2003, CANCER RES, V63, P5173; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Fang J, 2007, CELL SIGNAL, V19, P2487, DOI 10.1016/j.cellsig.2007.07.025; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Finlay GA, 2004, J BIOL CHEM, V279, P23114, DOI 10.1074/jbc.M401912200; Foltz G, 2006, CANCER RES, V66, P6665, DOI 10.1158/0008-5472.CAN-05-4453; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hagedorn M, 2005, P NATL ACAD SCI USA, V102, P1643, DOI 10.1073/pnas.0408622102; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Johnston PA, 2011, MOL INTERV, V11, P18, DOI 10.1124/mi.11.1.4; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; KONDO S, 1994, BBA-MOL CELL RES, V1221, P211, DOI 10.1016/0167-4889(94)90016-7; Kwiatkowski D.J., 2010, TUBEROUS SCLEROSIS C; Le Mercier M, 2009, NEOPLASIA, V11, P485, DOI 10.1593/neo.81526; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meikle L, 2007, J NEUROSCI, V27, P5546, DOI 10.1523/JNEUROSCI.5540-06.2007; Naderi A, 2007, CANCER RES, V67, P6725, DOI 10.1158/0008-5472.CAN-06-4394; Naderi A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-111; Naderi A, 2010, INT J CANCER, V126, P1596, DOI 10.1002/ijc.24866; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Peng H, 2013, ONCOGENE, V32, P4702, DOI 10.1038/onc.2012.481; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wang Y, 2013, AUTOPHAGY, V9, P2069, DOI 10.4161/auto.26447; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yu B, 2009, CANCER RES, V69, P7704, DOI 10.1158/0008-5472.CAN-09-0808; Zha XJ, 2015, CANCER LETT, V359, P97, DOI 10.1016/j.canlet.2015.01.001; Zha XJ, 2011, CANCER RES, V71, P13, DOI 10.1158/0008-5472.CAN-10-1668; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhong H, 2000, CANCER RES, V60, P1541; Zhou XP, 2013, J MOL NEUROSCI, V50, P78, DOI 10.1007/s12031-012-9864-8	50	28	28	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25756	25765		10.1074/jbc.M115.665208	http://dx.doi.org/10.1074/jbc.M115.665208			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26296882	Green Published, hybrid			2022-12-28	WOS:000362962800046
J	Molina, ML; Giudici, AM; Poveda, JA; Fernandez-Ballester, G; Montoya, E; Renart, ML; Fernandez, AM; Encinar, JA; Riquelme, G; Morales, A; Gonzalez-Ros, JM				Luisa Molina, M.; Marcela Giudici, A.; Poveda, Jose A.; Fernandez-Ballester, Gregorio; Montoya, Estefania; Lourdes Renart, M.; Fernandez, Asia M.; Encinar, Jose A.; Riquelme, Gloria; Morales, Andres; Gonzalez-Ros, Jose M.			Competing Lipid-Protein and Protein-Protein Interactions Determine Clustering and Gating Patterns in the Potassium Channel from Streptomyces lividans (KcsA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE NATIVE ELECTROPHORESIS; K+ CHANNEL; FORCE-FIELD; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MOLECULAR-BASIS; BINDING-SITES; SWISS-MODEL; PATCH-CLAMP; MEMBRANE	There is increasing evidence to support the notion that membrane proteins, instead of being isolated components floating in a fluid lipid environment, can be assembled into supramolecular complexes that take part in a variety of cooperative cellular functions. The interplay between lipid-protein and protein-protein interactions is expected to be a determinant factor in the assembly and dynamics of such membrane complexes. Here we report on a role of anionic phospholipids in determining the extent of clustering of KcsA, a model potassium channel. Assembly/disassembly of channel clusters occurs, at least partly, as a consequence of competing lipid-protein and protein-protein interactions at nonannular lipid binding sites on the channel surface and brings about profound changes in the gating properties of the channel. Our results suggest that these latter effects of anionic lipids are mediated via the Trp67-Glu71-Asp80 inactivation triad within the channel structure and its bearing on the selectivity filter.	[Luisa Molina, M.; Marcela Giudici, A.; Poveda, Jose A.; Fernandez-Ballester, Gregorio; Montoya, Estefania; Lourdes Renart, M.; Fernandez, Asia M.; Encinar, Jose A.; Gonzalez-Ros, Jose M.] Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante 03202, Spain; [Riquelme, Gloria] Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago 1027, Chile; [Morales, Andres] Univ Alicante, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain	Universidad Miguel Hernandez de Elche; Universidad de Chile; Universitat d'Alacant	Gonzalez-Ros, JM (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Alicante 03202, Spain.	gonzalez.ros@umh.es	Encinar, José A/F-2946-2013; Carvajal, Asia Fernandez/G-8877-2015; Encinar, José Antonio/AAE-9141-2020; Morales, Andrés/M-5128-2015; Gallego, María Luisa Molina/K-4810-2017; Poveda Larrosa, Jose Antonio/H-5925-2015	Encinar, José A/0000-0002-7219-3863; Encinar, José Antonio/0000-0002-7219-3863; Morales, Andrés/0000-0002-1526-3327; Gallego, María Luisa Molina/0000-0001-9190-6948; Montoya, Estefania/0000-0003-2866-4733; Gonzalez Ros, Jose Manuel/0000-0002-4804-6855; Renart, Maria Lourdes/0000-0002-6717-4756; Giudici, Ana Marcela/0000-0002-3753-4861; Fernandez-Carvajal, Asia/0000-0003-2741-1427; Poveda Larrosa, Jose Antonio/0000-0003-0722-3752	Spanish Ministerio de Ciencia e Innovacion [BFU2011-25920, BFU2012-31359]; Consolider-Ingenio Grant [CSD2-2008-00005]; Ministerio de Ciencia e Innovacion Jose Castillejo Program	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consolider-Ingenio Grant; Ministerio de Ciencia e Innovacion Jose Castillejo Program(Ministry of Science and Innovation, Spain (MICINN))	This work was supported in part by grants from the Spanish Ministerio de Ciencia e Innovacion Grants BFU2011-25920 and BFU2012-31359 and Consolider-Ingenio 2010 Grant CSD2-2008-00005. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by funds from the Ministerio de Ciencia e Innovacion Jose Castillejo Program for short research stays.	Barrera FN, 2008, BIOCHEMISTRY-US, V47, P2123, DOI 10.1021/bi700778c; Blunck R, 2006, J GEN PHYSIOL, V128, P569, DOI 10.1085/jgp.200609638; Botelho AV, 2006, BIOPHYS J, V91, P4464, DOI 10.1529/biophysj.106.082776; Cao Y, 2011, NATURE, V471, P336, DOI 10.1038/nature09731; Chakrapani S, 2007, J GEN PHYSIOL, V130, P479, DOI 10.1085/jgp.200709844; Cheng MH, 2009, J PHYS CHEM B, V113, P6964, DOI 10.1021/jp900714b; Chiantia S, 2005, LANGMUIR, V21, P6317, DOI 10.1021/la050115m; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2011, BIOPHYS J, V100, P2387, DOI 10.1016/j.bpj.2011.01.073; Demmers JAA, 2003, FEBS LETT, V541, P28, DOI 10.1016/S0014-5793(03)00282-5; Deol SS, 2006, BIOPHYS J, V90, P822, DOI 10.1529/biophysj.105.071407; Dibb KM, 2003, J BIOL CHEM, V278, P49537, DOI 10.1074/jbc.M307723200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Goforth RL, 2003, J GEN PHYSIOL, V121, P477, DOI 10.1085/jgp.200308797; Grage SL, 2011, BIOPHYS J, V100, P1252, DOI 10.1016/j.bpj.2011.01.023; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamill OP, 1991, CEREB CORTEX, V1, P48, DOI 10.1093/cercor/1.1.48; Hegermann J, 2006, MICROBIOL-SGM, V152, P2831, DOI 10.1099/mic.0.29002-0; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Imai S, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.401265; Iwamoto M, 2013, P NATL ACAD SCI USA, V110, P749, DOI 10.1073/pnas.1217323110; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Giudici AM, 2013, BBA-BIOMEMBRANES, V1828, P193, DOI 10.1016/j.bbamem.2012.09.020; Marius P, 2005, BIOPHYS J, V89, P4081, DOI 10.1529/biophysj.105.070755; Marius P, 2008, BIOPHYS J, V94, P1689, DOI 10.1529/biophysj.107.117507; Marius P, 2012, BBA-BIOMEMBRANES, V1818, P90, DOI 10.1016/j.bbamem.2011.09.017; MCCORMICK JI, 1988, J BIOL CHEM, V263, P8111; Meuser D, 1999, FEBS LETT, V462, P447, DOI 10.1016/S0014-5793(99)01579-3; Molina ML, 2008, J BIOL CHEM, V283, P18076, DOI 10.1074/jbc.M710132200; Molina ML, 2006, J BIOL CHEM, V281, P18837, DOI 10.1074/jbc.M600342200; Molina ML, 2004, BIOCHEMISTRY-US, V43, P14924, DOI 10.1021/bi048889+; Mueller NS, 2012, MOL MEMBR BIOL, V29, P186, DOI 10.3109/09687688.2012.687461; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Nicke A, 1999, J RECEPT SIGNAL TR R, V19, P493, DOI 10.3109/10799899909036667; Raja M, 2009, BIOPHYS CHEM, V142, P46, DOI 10.1016/j.bpc.2009.03.005; RIQUELME G, 1990, BIOCHEMISTRY-US, V29, P11215, DOI 10.1021/bi00503a009; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Seeger HM, 2009, J PHYS CHEM B, V113, P16654, DOI 10.1021/jp907505m; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Splitt H, 2000, FEBS LETT, V472, P83, DOI 10.1016/S0014-5793(00)01429-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Triano I, 2010, BIOCHEMISTRY-US, V49, P5397, DOI 10.1021/bi1003712; UNDROVINAS AI, 1992, CIRC RES, V71, P1231, DOI 10.1161/01.RES.71.5.1231; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; van Dalen A, 2002, FEBS LETT, V525, P33, DOI 10.1016/S0014-5793(02)03061-2; Vinothkumar KR, 2006, J BIOL CHEM, V281, P4795, DOI 10.1074/jbc.M508993200; Weingarth M, 2013, J AM CHEM SOC, V135, P3983, DOI 10.1021/ja3119114; Zakharian E, 2004, BIOCHEM BIOPH RES CO, V322, P1059, DOI 10.1016/j.bbrc.2004.08.027; Zakharian E, 2004, BIOCHEM BIOPH RES CO, V316, P429, DOI 10.1016/j.bbrc.2004.02.069; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	64	17	17	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25745	25755		10.1074/jbc.M115.669598	http://dx.doi.org/10.1074/jbc.M115.669598			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26336105	Green Published, hybrid			2022-12-28	WOS:000362962800045
J	Hajarnis, SS; Patel, V; Aboudehen, K; Attanasio, M; Cobo-Stark, P; Pontoglio, M; Igarashi, P				Hajarnis, Sachin S.; Patel, Vishal; Aboudehen, Karam; Attanasio, Massimo; Cobo-Stark, Patricia; Pontoglio, Marco; Igarashi, Peter			Transcription Factor Hepatocyte Nuclear Factor-1 beta (HNF-1 beta) Regulates MicroRNA-200 Expression through a Long Noncoding RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC KIDNEY-DISEASE; EPITHELIAL-MESENCHYMAL TRANSITION; TISSUE-SPECIFIC EXPRESSION; DNA METHYLATION; MIR-200 FAMILY; FUNCTIONAL POLYCYSTIN-1; HUMAN GENOME; RENAL CYSTS; GENE; PKD1	The transcription factor hepatocyte nuclear factor-1 beta (HNF-1 beta) regulates tissue-specific gene expression in the kidney and other epithelial organs. Mutations of HNF-1 beta produce kidney cysts, and previous studies have shown that HNF-1 beta regulates the transcription of cystic disease genes, including Pkd2 and Pkhd1. Here, we combined chromatin immunoprecipitation and next-generation sequencing (ChIP-Seq) with microarray analysis to identify microRNAs (miRNAs) that are directly regulated by HNF-1 beta in renal epithelial cells. These studies identified members of the epithelial-specific miR-200 family (miR-200b/200a/429) as novel transcriptional targets of HNF-1 beta. HNF-1 beta binds to two evolutionarily conserved sites located 28 kb upstream to miR-200b. Luciferase reporter assays showed that the HNF-1 beta binding sites were located within a promoter that was active in renal epithelial cells. Mutations of the HNF-1 beta binding sites abolished promoter activity. RT-PCR analysis revealed that a long noncoding RNA (lncRNA) is transcribed from the promoter and encodes the miR-200 cluster. Inhibition of the lncRNA with siRNAs decreased the levels of miR-200 but did not affect expression of the Ttll10 host gene. The expression of the lncRNA and miR-200 was decreased in kidneys from HNF-1 beta knock-out mice and renal epithelial cells expressing dominant-negative mutant HNF-1 beta. The expression of miR-200 targets, Zeb2 and Pkd1, was increased in HNF-1 beta knock-out kidneys and in cells expressing mutant HNF-1 beta. Overexpression of miR-200 decreased the expression of Zeb2 and Pkd1 in HNF-1 beta mutant cells. These studies reveal a novel pathway whereby HNF-1 beta directly contributes to the control of miRNAs that are involved in epithelial-mesenchymal transition and cystic kidney disease.	[Hajarnis, Sachin S.; Patel, Vishal; Aboudehen, Karam; Attanasio, Massimo; Cobo-Stark, Patricia; Igarashi, Peter] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Igarashi, Peter] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Pontoglio, Marco] Univ Paris 05, Inst Cochin, CNRS UMR 8104, INSERM U1016,Dept Genet & Dev, F-75014 Paris, France	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Igarashi, P (corresponding author), Univ Minnesota, Sch Med, Dept Med, 420 Delaware St SE,MMC 194, Minneapolis, MN 55455 USA.	igarashi@umn.edu	Regan, Clinton/E-6250-2012; Patel, Vishal/GMW-7076-2022	Patel, Vishal/0000-0003-2875-4659; Cobo-Stark, Patricia/0000-0002-8113-6211; Igarashi, Peter/0000-0001-8698-1185; aboudehen, karam/0000-0003-4975-464X; Attanasio, Massimo/0000-0002-1278-3650	National Institutes of Health [UL1TR001105]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090326, R01DK102572, T32DK007257, K08DK084311, R37DK042921, P30DK079328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Chao Xing and Mohammed Kanchwala in the McDermott Bioinformatics Core at UT Southwestern (National Institutes of Health Grant UL1TR001105) for assistance with data analysis.	Alvarez ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077468; Bai Y, 2002, AM J PHYSIOL-RENAL, V283, pF839, DOI 10.1152/ajprenal.00128.2002; Ballarino M, 2015, MOL CELL BIOL, V35, P728, DOI 10.1128/MCB.01394-14; Bingham C, 2004, NEPHROL DIAL TRANSPL, V19, P2703, DOI 10.1093/ndt/gfh348; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005; Cheret C, 2002, J MOL BIOL, V322, P929, DOI 10.1016/S0022-2836(02)00816-1; Coffinier C, 1999, MECH DEVELOP, V89, P211, DOI 10.1016/S0925-4773(99)00221-X; DESIMONE V, 1991, EMBO J, V10, P1435, DOI 10.1002/j.1460-2075.1991.tb07664.x; Dey BK, 2014, GENE DEV, V28, P491, DOI 10.1101/gad.234419.113; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duns G, 2013, GENE CHROMOSOME CANC, V52, P165, DOI 10.1002/gcc.22016; Flynn RA, 2014, CELL STEM CELL, V14, P752, DOI 10.1016/j.stem.2014.05.014; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Hiesberger T, 2004, J CLIN INVEST, V113, P814, DOI 10.1172/JCI200420083; Hiesberger T, 2005, J BIOL CHEM, V280, P10578, DOI 10.1074/jbc.M414121200; Hopp K, 2012, J CLIN INVEST, V122, P4257, DOI 10.1172/JCI64313; Igarashi P, 1996, J BIOL CHEM, V271, P9666, DOI 10.1074/jbc.271.16.9666; Jin L, 2012, J PHARMACOL EXP THER, V340, P648, DOI 10.1124/jpet.111.187161; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kikuchi R, 2007, MOL PHARMACOL, V72, P1619, DOI 10.1124/mol.107.039701; Kikuchi R, 2006, MOL PHARMACOL, V70, P887, DOI 10.1124/mol.106.025494; Knouf EC, 2012, NUCLEIC ACIDS RES, V40, P499, DOI 10.1093/nar/gkr731; Kolesnikoff N, 2014, J BIOL CHEM, V289, P11194, DOI 10.1074/jbc.M113.529172; Kurbegovic A, 2010, HUM MOL GENET, V19, P1174, DOI 10.1093/hmg/ddp588; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Legnini I, 2014, MOL CELL, V53, P506, DOI 10.1016/j.molcel.2013.12.012; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Lokmane L, 2010, DEVELOPMENT, V137, P347, DOI 10.1242/dev.042226; Ma ZD, 2007, P NATL ACAD SCI USA, V104, P20386, DOI 10.1073/pnas.0705957104; Marques AC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r131; Massa F, 2013, DEVELOPMENT, V140, P886, DOI 10.1242/dev.086546; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; OTT MO, 1991, MECH DEVELOP, V36, P47, DOI 10.1016/0925-4773(91)90071-D; Pandey P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-624; Patel V, 2013, P NATL ACAD SCI USA, V110, P10765, DOI 10.1073/pnas.1301693110; Patel V, 2012, J AM SOC NEPHROL, V23, P1941, DOI 10.1681/ASN.2012030321; Pieraccioli M, 2013, CELL CYCLE, V12, P2309, DOI 10.4161/cc.25405; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pritchard L, 2000, HUM MOL GENET, V9, P2617, DOI 10.1093/hmg/9.18.2617; Rebouissou S, 2005, HUM MOL GENET, V14, P603, DOI 10.1093/hmg/ddi057; Rossetti S, 2009, KIDNEY INT, V75, P848, DOI 10.1038/ki.2008.686; Saji T, 2008, J PHARMACOL EXP THER, V324, P784, DOI 10.1124/jpet.107.128249; Spaderna Simone, 2009, Gastroenterology, V136, P1835, DOI 10.1053/j.gastro.2009.03.009; Sun ZX, 2001, GENE DEV, V15, P3217, DOI 10.1101/gad946701; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Wild W, 2000, P NATL ACAD SCI USA, V97, P4695, DOI 10.1073/pnas.080010897; Yoshino H, 2013, J HUM GENET, V58, P508, DOI 10.1038/jhg.2013.31; Zhang YL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000414	54	38	39	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24793	24805		10.1074/jbc.M115.670646	http://dx.doi.org/10.1074/jbc.M115.670646			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26292219	Green Published, hybrid			2022-12-28	WOS:000362598300015
J	Hu, N; Qiu, YL; Dong, F				Hu, Nan; Qiu, Yaling; Dong, Fan			Role of Erk1/2 Signaling in the Regulation of Neutrophil Versus Mon ocyte Development in Response to G-CSF and M-CSF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; TRANSCRIPTION FACTOR PU.1; HEMATOPOIETIC STEM-CELLS; EPIDERMAL-GROWTH-FACTOR; FACTOR-RECEPTOR; C/EBP-ALPHA; MONOCYTE DIFFERENTIATION; LINEAGE COMMITMENT; PROGENITOR CELLS; PC12 CELLS	Lineage specification in the hematopoietic system depends on the expression of lineage specific transcription factors. However, the role of hematopoietic cytokines in this process has been controversial and little is known about the intracellular signaling mechanisms by which cytokines instruct lineage choice. G-CSF and M-CSF are two lineage-specific cytokines that play a dominant role in granulopoiesis and monopoiesis, respectively. We show here that a G-CSFR mutant in which tyrosine 729 had been mutated to phenylalanine (Y7291) promoted monocyte rather than neutrophil development in myeloid precursors, which was associated with prolonged activation of Erkl /2 and augmented activation of downstream targets c-Fos and Egr 1. Inhibition of Erk1/2 activation or knockdown of c-Fos or Egrl largely rescued neutrophil development in cells expressing G-CSFR Y729 F. We also show that M-CSF, but not G-CSF, stimulated strong and sustained activation of Erk1/2 in mouse lineage marker negative (Lin(-)) bone marrow cells. Significantly, inhibition of Erk1/2 signaling in these cells favored neutrophil over monocyte development in response to M-CSF. Thus, prolonged Erk1/2 activation resulted in monocyte development following G-CSF induction whereas inhibition of Erk1 /2 signaling promoted neutrophil development at the expense of monocyte formation in response to M-CSF. These results reveal an important mechanism by which G-CST and M-CSF instruct neutrophil versus monocyte lineage choice, i.e. differential activation of Erk1/2 pathway.	[Hu, Nan; Qiu, Yaling; Dong, Fan] Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Dong, F (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	fan.dong@utoledo.edu			National Institutes of Health from the NHLBI [R15HL112183]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL112183] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant R15HL112183 (to F. D.) from the NHLBI. The authors declare that they have no conflicts of interest with the contents of this article.	Akbarzadeh S, 2002, BLOOD, V99, P879, DOI 10.1182/blood.V99.3.879; Al-Sarraj A, 2005, J CELL BIOCHEM, V94, P153, DOI 10.1002/jcb.20305; Bourette RP, 2007, ONCOGENE, V26, P234, DOI 10.1038/sj.onc.1209777; Bourgin-Hierle C, 2008, LEUKEMIA, V22, P161, DOI 10.1038/sj.leu.2404986; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Cai CM, 2007, MOL CANCER RES, V5, P725, DOI 10.1158/1541-7786.MCR-06-0430; Cai DH, 2008, ONCOGENE, V27, P2772, DOI 10.1038/sj.onc.1210940; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; DONG F, 1993, MOL CELL BIOL, V13, P7774, DOI 10.1128/MCB.13.12.7774; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Fisher RC, 1998, MOL CELL BIOL, V18, P4347, DOI 10.1128/MCB.18.7.4347; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; FUKUNAGA R, 1993, CELL, V74, P1079, DOI 10.1016/0092-8674(93)90729-A; Gosse SG, 2005, CELL SIGNAL, V17, P1352, DOI 10.1016/j.cellsig.2005.02.002; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; Grasset MF, 2010, J LEUKOCYTE BIOL, V87, P127, DOI 10.1189/jlb.0309151; Hermans MHA, 2003, BLOOD, V101, P2584, DOI 10.1182/blood-2002-07-2062; Heyworth CM, 1990, GROWTH FACTORS, V2, P197, DOI 10.3109/08977199009071506; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Huber R, 2014, CELL MOL LIFE SCI, V71, P63, DOI 10.1007/s00018-013-1322-4; Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754; Jack GD, 2009, BLOOD, V114, P2172, DOI 10.1182/blood-2008-11-191536; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Krishnaraju K, 2001, BLOOD, V97, P1298, DOI 10.1182/blood.V97.5.1298; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lidonnici MR, 2010, CANCER RES, V70, P7949, DOI 10.1158/0008-5472.CAN-10-1667; LORD KA, 1993, MOL CELL BIOL, V13, P841, DOI 10.1128/MCB.13.2.841; Matsumura I, 1998, MOL CELL BIOL, V18, P4282, DOI 10.1128/MCB.18.7.4282; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; NGUYEN TT, 1993, J BIOL CHEM, V268, P9803; Nishiyama C, 2004, FEBS LETT, V561, P63, DOI 10.1016/S0014-5793(04)00116-4; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Robb L, 2007, ONCOGENE, V26, P6715, DOI 10.1038/sj.onc.1210756; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; Schonheit J, 2013, CELL REP, V3, P1617, DOI 10.1016/j.celrep.2013.04.007; Terry RL, 2014, CELL IMMUNOL, V291, P16, DOI 10.1016/j.cellimm.2014.02.008; Ward AC, 1999, J BIOL CHEM, V274, P14956, DOI 10.1074/jbc.274.21.14956; Ward AC, 2000, LEUKEMIA, V14, P973, DOI 10.1038/sj.leu.2401808; Ward AC, 1999, BLOOD, V93, P113, DOI 10.1182/blood.V93.1.113.401k33_113_124; Yamada T, 2001, BLOOD, V97, P2300, DOI 10.1182/blood.V97.8.2300; YOSHIKAWA A, 1995, EMBO J, V14, P5288, DOI 10.1002/j.1460-2075.1995.tb00213.x; Zhuang DZ, 2006, J BIOL CHEM, V281, P10745, DOI 10.1074/jbc.M510924200; Zhuang DZ, 2005, J LEUKOCYTE BIOL, V78, P1008, DOI 10.1189/jlb.0105032	51	15	16	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24561	24573		10.1074/jbc.M115.668871	http://dx.doi.org/10.1074/jbc.M115.668871			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26296889	Green Published, hybrid			2022-12-28	WOS:000362218900040
J	Inada, M; Takita, M; Yokoyama, S; Watanabe, K; Tominari, T; Matsumoto, C; Hirata, M; Maru, Y; Maruyama, T; Sugimoto, Y; Narumiya, S; Uematsu, S; Akira, S; Murphy, G; Nagase, H; Miyaura, C				Inada, Masaki; Takita, Morichika; Yokoyama, Satoshi; Watanabe, Kenta; Tominari, Tsukasa; Matsumoto, Chiho; Hirata, Michiko; Maru, Yoshiro; Maruyama, Takayuki; Sugimoto, Yukihiko; Narumiya, Shuh; Uematsu, Satoshi; Akira, Shizuo; Murphy, Gillian; Nagase, Hideaki; Miyaura, Chisato			Direct Melanoma Cell Contact Induces Stromal Cell Autocrine Prostaglandin E2-EP4 Receptor Signaling That Drives Tumor Growth, Angiogenesis, and Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; OSTEOCLAST DIFFERENTIATION; GENETIC DELETION; BONE-RESORPTION; E-2 PRODUCTION; EXPRESSION; EP4; LIGAND; FIBROBLASTS; OSTEOLYSIS	The stromal cells associated with tumors such as melanoma are significant determinants of tumor growth and metastasis. Using membrane-bound prostaglandin E synthase 1 (mPges1(-/-)) mice, we show that prostaglandin E-2 (PGE(2)) production by host tissues is critical for B16 melanoma growth, angiogenesis, and metastasis to both bone and soft tissues. Concomitant studies in vitro showed that PGE(2) production by fibroblasts is regulated by direct interaction with B16 cells. Autocrine activity of PGE(2) further regulates the production of angiogenic factors by fibroblasts, which are key to the vascularization of both primary and metastatic tumor growth. Similarly, cell-cell interactions between B16 cells and host osteoblasts modulate mPGES-1 activity and PGE(2) production by the osteoblasts. PGE(2), in turn, acts to stimulate receptor activator of NF-kappa B ligand expression, leading to osteoclast differentiation and bone erosion. Using eicosanoid receptor antagonists, we show that PGE(2) acts on osteoblasts and fibroblasts in the tumor microenvironment through the EP4 receptor. Metastatic tumor growth and vascularization in soft tissues was abrogated by an EP4 receptor antagonist. EP4-null Ptger4(-/-) mice do not support B16 melanoma growth. In vitro, an EP4 receptor antagonist modulated PGE(2) effects on fibroblast production of angiogenic factors. Our data show that B16 melanoma cells directly influence host stromal cells to generate PGE(2) signals governing neoangiogenesis and metastatic growth in bone via osteoclast erosive activity as well as angiogenesis in soft tissue tumors.	[Inada, Masaki; Takita, Morichika; Yokoyama, Satoshi; Watanabe, Kenta; Tominari, Tsukasa; Matsumoto, Chiho; Hirata, Michiko; Miyaura, Chisato] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Inada, Masaki; Tominari, Tsukasa; Murphy, Gillian; Nagase, Hideaki; Miyaura, Chisato] Tokyo Univ Agr & Technol, Global Innovat Res Org, Koganei, Tokyo 1848588, Japan; [Takita, Morichika; Maru, Yoshiro] Tokyo Womens Med Univ, Dept Pharmacol, Tokyo 1628666, Japan; [Maruyama, Takayuki] Ono Pharmaceut Co Ltd, Minase Res Inst, Osaka 6188585, Japan; [Sugimoto, Yukihiko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Chem, Kumamoto 8620973, Japan; [Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan; [Uematsu, Satoshi; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Osaka 5650871, Japan; [Uematsu, Satoshi] Chiba Univ, Sch Med, Dept Mucosal Immunol, Chiba 2608670, Japan; [Uematsu, Satoshi] Univ Tokyo, Inst Med Sci, Ctr Mucosal Vaccines, Div Innate Immune Regulat Int Res & Dev, Tokyo 1088639, Japan; [Murphy, Gillian] Univ Cambridge, Li Ka Shing Ctr, Cambridge Inst, Dept Oncol,Canc Res UK, Cambridge CB2 0RE, England; [Nagase, Hideaki] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7FY, England	Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology; Tokyo Women's Medical University; Ono Pharmaceutical Co Ltd; Kumamoto University; Kyoto University; Osaka University; Chiba University; University of Tokyo; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Oxford	Miyaura, C (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, 2-24-16 Nakamachi, Koganei, Tokyo 1848588, Japan.	miyaura@cc.tuat.ac.jp	miyaura, chisato/D-1864-2013; Hirata, Michiko/D-2351-2013; Takita, Morichika/I-2927-2019; inada, masaki/D-1581-2013; Akira, Shizuo/C-3134-2009; Sugimoto, Yukihiko/AAV-6470-2021; Tominari, Tsukasa/B-6054-2015	miyaura, chisato/0000-0002-2548-8191; Hirata, Michiko/0000-0002-5291-6112; inada, masaki/0000-0002-5066-8506; Sugimoto, Yukihiko/0000-0001-6973-932X; Tominari, Tsukasa/0000-0001-5683-8951	National Institute of Health [AR40994]; Arthritis Research UK; Cancer Research UK; Global Innovation Research Organization in Tokyo University of Agriculture and Technology;  [25460062];  [23590069]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Research UK(Versus Arthritis); Cancer Research UK(Cancer Research UK); Global Innovation Research Organization in Tokyo University of Agriculture and Technology; ; ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research 25460062 (to C. M.) and 23590069 (to M. I.), National Institute of Health Grant AR40994 (to H. N.), Arthritis Research UK (to H. N.), Cancer Research UK (to G. M.), and the Global Innovation Research Organization in Tokyo University of Agriculture and Technology (to M. I. and H. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcolea S, 2012, J LIPID RES, V53, P630, DOI 10.1194/jlr.M019695; Amano H, 2003, J EXP MED, V197, P221, DOI 10.1084/jem.20021408; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Berger W, 1999, INT J CANCER, V83, P415, DOI 10.1002/(SICI)1097-0215(19991029)83:3<415::AID-IJC19>3.0.CO;2-Y; Brandner JM, 2013, PATHOLOGY, V45, P443, DOI 10.1097/PAT.0b013e328363b3bd; Brown JE, 2012, NAT REV CLIN ONCOL, V9, P110, DOI 10.1038/nrclinonc.2011.197; Elander N, 2008, BIOCHEM BIOPH RES CO, V372, P249, DOI 10.1016/j.bbrc.2008.05.026; Elder DJE, 1998, NAT MED, V4, P392, DOI 10.1038/nm0498-392; Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200; Giri D, 1999, CLIN CANCER RES, V5, P1063; Guo XY, 2008, J BIOL CHEM, V283, P19864, DOI 10.1074/jbc.M800798200; Hatazawa R., 2007, Inflammopharmacology, V15, P214, DOI 10.1007/s10787-007-1595-z; Holt DM, 2012, J IMMUNOTHER, V35, P179, DOI 10.1097/CJI.0b013e318247a5e9; Inada M, 2006, J IMMUNOL, V177, P1879, DOI 10.4049/jimmunol.177.3.1879; Jain S, 2008, CANCER RES, V68, P7750, DOI 10.1158/0008-5472.CAN-07-6689; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li HJ, 2012, CANCER DISCOV, V2, P840, DOI 10.1158/2159-8290.CD-12-0101; Lipton A, 2011, BONE, V48, P96, DOI 10.1016/j.bone.2010.10.161; Ma XR, 2006, CANCER RES, V66, P2923, DOI 10.1158/0008-5472.CAN-05-4348; MIYAURA C, 1995, J BONE MINER RES, V10, P1365; Miyaura C, 2000, J BIOL CHEM, V275, P19819, DOI 10.1074/jbc.M002079200; Morony S, 2001, CANCER RES, V61, P4432; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nakanishi M, 2008, CANCER RES, V68, P3251, DOI 10.1158/0008-5472.CAN-07-6100; Ohshiba T, 2003, BRIT J CANCER, V88, P1318, DOI 10.1038/sj.bjc.6600858; Ohshiba T, 2003, BIOCHEM BIOPH RES CO, V300, P957, DOI 10.1016/S0006-291X(02)02937-6; Plotkin LI, 2015, CURR OSTEOPOROS REP, V13, P67, DOI 10.1007/s11914-015-0255-2; Polnaszek N, 2003, CANCER RES, V63, P5754; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Relf M, 1997, CANCER RES, V57, P963; Ristimaki A, 2002, CANCER RES, V62, P632; Rundhaug JE, 2011, CANCER METAST REV, V30, P465, DOI 10.1007/s10555-011-9317-9; Segi E, 1998, BIOCHEM BIOPH RES CO, V246, P7, DOI 10.1006/bbrc.1998.8461; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Suzawa T, 2000, ENDOCRINOLOGY, V141, P1554, DOI 10.1210/en.141.4.1554; Takita M, 2007, FEBS LETT, V581, P565, DOI 10.1016/j.febslet.2007.01.005; Uematsu S, 2002, J IMMUNOL, V168, P5811, DOI 10.4049/jimmunol.168.11.5811; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wicki A, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13550; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Wu JJ, 2011, J BIOL CHEM, V286, P33954, DOI 10.1074/jbc.M110.187344; Yang L, 2006, CANCER RES, V66, P9665, DOI 10.1158/0008-5472.CAN-06-1271; Yang SF, 2010, J BIOL CHEM, V285, P29808, DOI 10.1074/jbc.M110.108183; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zhang J, 2003, CANCER RES, V63, P7883	46	27	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29781	29793		10.1074/jbc.M115.669481	http://dx.doi.org/10.1074/jbc.M115.669481			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26475855	hybrid, Green Published			2022-12-28	WOS:000366614700013
J	Mishra, NK; Habeck, M; Kirchner, C; Haviv, H; Peleg, Y; Eisenstein, M; Apell, HJ; Karlish, SJD				Mishra, Neeraj Kumar; Habeck, Michael; Kirchner, Corinna; Haviv, Haim; Peleg, Yoav; Eisenstein, Miriam; Apell, Hans Juergen; Karlish, Steven J. D.			Molecular Mechanisms and Kinetic Effects of FXYD1 and Phosphomimetic Mutants on Purified Human Na,K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						docking; fluorescence; kinetics; membrane protein; Na; K plus -ATPase; FXYD protein; phosphomimetic mutant; regulatory mechanism	PROTEIN-PROTEIN DOCKING; NA+-K+-ATPASE; SODIUM-POTASSIUM PUMP; RAT CARDIAC MYOCYTES; TRANSFER-PCR TPCR; KINASE-C; PHOSPHOLEMMAN FXYD1; CRYSTAL-STRUCTURE; PICHIA-PASTORIS; NA/K ATPASE	Phospholemman (FXYD1) is a single-transmembrane protein regulator of Na,K-ATPase, expressed strongly in heart, skeletal muscle, and brain and phosphorylated by protein kinases A and C at Ser-68 and Ser-63, respectively. Binding of FXYD1 reduces Na,K-ATPase activity, and phosphorylation at Ser-68 or Ser-63 relieves the inhibition. Despite the accumulated information on physiological effects, whole cell studies provide only limited information on molecular mechanisms. As a complementary approach, we utilized purified human Na,K-ATPase (11 and 21) reconstituted with FXYD1 or mutants S63E, S68E, and S63E,S68E that mimic phosphorylation at Ser-63 and Ser-68. Compared with control 11, FXYD1 reduces V-max and turnover rate and raises K0.5Na. The phosphomimetic mutants reverse these effects and reduce K0.5Na below control K0.5Na. Effects on 21 are similar but smaller. Experiments in proteoliposomes reconstituted with 11 show analogous effects of FXYD1 on K0.5Na, which are abolished by phosphomimetic mutants and also by increasing mole fractions of DOPS in the proteoliposomes. Stopped-flow experiments using the dye RH421 show that FXYD1 slows the conformational transition E-2(2K)ATP E-1(3Na)ATP but does not affect 3NaE(1)P E(2)P3Na. This regulatory effect is explained simply by molecular modeling, which indicates that a cytoplasmic helix (residues 60-70) docks between the N and P domains in the E-2 conformation, but docking is weaker in E-1 (also for phosphomimetic mutants). Taken together with previous work showing that FXYD1 also raises binding affinity for the Na+-selective site III, these results provide a rather comprehensive picture of the regulatory mechanism of FXYD1 that complements the physiological studies.	[Mishra, Neeraj Kumar; Habeck, Michael; Haviv, Haim; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel; [Eisenstein, Miriam] Weizmann Inst Sci, Dept Chem Res Support, IL-7610001 Rehovot, Israel; [Peleg, Yoav] Weizmann Inst Sci, Israel Struct Prote Ctr, IL-7610001 Rehovot, Israel; [Kirchner, Corinna; Apell, Hans Juergen] Univ Konstanz, Dept Biol, D-78464 Constance, Germany	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; University of Konstanz	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel.	Steven.Karlish@weizmann.ac.il		Habeck, Michael/0000-0002-4586-0499; Mishra, Neeraj/0000-0002-6762-1747	German-Israeli Foundation for Science and Development [922-165.9]; Dana and Yossie Hollander Center for Structural Biology; Minerva Foundation	German-Israeli Foundation for Science and Development(German-Israeli Foundation for Scientific Research and Development); Dana and Yossie Hollander Center for Structural Biology; Minerva Foundation	This work was supported by the German-Israeli Foundation for Science and Development Grant 922-165.9 (to H.-J. A. and S. J. K.). The Israel Structural Proteomics Center is supported by the Dana and Yossie Hollander Center for Structural Biology. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Minerva Foundation.	APELL HJ, 1987, BIOCHIM BIOPHYS ACTA, V903, P480, DOI 10.1016/0005-2736(87)90055-1; Belogus T, 2009, J BIOL CHEM, V284, P31038, DOI 10.1074/jbc.M109.050054; Ben-Shimon A, 2010, J MOL BIOL, V402, P259, DOI 10.1016/j.jmb.2010.07.021; Berchanski A, 2004, PROTEINS, V56, P130, DOI 10.1002/prot.20145; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bossuyt J, 2005, BIOPHYS J, V88, p9A; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; BUHLER R, 1991, J MEMBRANE BIOL, V121, P141, DOI 10.1007/BF01870529; Cirri E, 2013, J MEMBRANE BIOL, V246, P967, DOI 10.1007/s00232-013-9600-5; Cirri E, 2011, BIOCHEMISTRY-US, V50, P3736, DOI 10.1021/bi2001714; Clarke RJ, 2003, ANN NY ACAD SCI, V986, P159, DOI 10.1111/j.1749-6632.2003.tb07154.x; Cornelius F, 2003, NEWS PHYSIOL SCI, V18, P119, DOI 10.1152/nips.01434.2003; Cornelius F, 1999, BIOPHYS J, V77, P934, DOI 10.1016/S0006-3495(99)76944-4; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Erijman A, 2014, METHODS MOL BIOL, V1116, P89, DOI 10.1007/978-1-62703-764-8_7; Erijman A, 2011, J STRUCT BIOL, V175, P171, DOI 10.1016/j.jsb.2011.04.005; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Floyd RV, 2010, ANN ANAT, V192, P7, DOI 10.1016/j.aanat.2009.09.003; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Habeck M, 2015, J BIOL CHEM, V290, P4829, DOI 10.1074/jbc.M114.611384; Habeck M, 2009, BIOCHEMISTRY-US, V48, P9147, DOI 10.1021/bi901148k; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; Han F, 2010, AM J PHYSIOL-CELL PH, V299, pC1363, DOI 10.1152/ajpcell.00027.2010; Han F, 2009, AM J PHYSIOL-CELL PH, V297, pC699, DOI 10.1152/ajpcell.00063.2009; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Haviv H, 2013, J BIOL CHEM, V288, P10073, DOI 10.1074/jbc.M112.446997; Heifetz A, 2003, PROTEIN ENG, V16, P179, DOI 10.1093/proeng/gzg021; Heifetz A, 2002, PROTEIN SCI, V11, P571, DOI 10.1110/ps.26002; JORGENSEN PL, 1988, METHOD ENZYMOL, V156, P29; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kapri-Pardes E, 2011, J BIOL CHEM, V286, P42888, DOI 10.1074/jbc.M111.293852; KARLISH SJD, 1980, J BIOENERG BIOMEMBR, V12, P111, DOI 10.1007/BF00744678; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V525, P252, DOI 10.1016/0005-2744(78)90219-X; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V527, P115, DOI 10.1016/0005-2744(78)90261-9; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kowalsman N, 2007, BIOINFORMATICS, V23, P421, DOI 10.1093/bioinformatics/btl524; Kowalsman N, 2009, PROTEINS, V77, P297, DOI 10.1002/prot.22436; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Lifshitz Y, 2006, J BIOL CHEM, V281, P15790, DOI 10.1074/jbc.M601993200; Mishra NK, 2011, J BIOL CHEM, V286, P9699, DOI 10.1074/jbc.M110.184234; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; Pavlovic D, 2007, FASEB J, V21, P1539, DOI 10.1096/fj.06-7269com; Pavlovic D, 2013, J MOL CELL CARDIOL, V61, P83, DOI 10.1016/j.yjmcc.2013.05.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRESTI CF, 1985, J BIOL CHEM, V260, P3879; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Teriete P, 2007, BIOCHEMISTRY-US, V46, P6774, DOI 10.1021/bi700391b; WALAAS SI, 1988, BIOCHIM BIOPHYS ACTA, V968, P127, DOI 10.1016/0167-4889(88)90052-3; WALAAS SI, 1994, BIOCHEM J, V304, P635, DOI 10.1042/bj3040635; Zhang XQ, 2006, J APPL PHYSIOL, V100, P212, DOI 10.1152/japplphysiol.00757.2005	58	12	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28746	28759		10.1074/jbc.M115.687913	http://dx.doi.org/10.1074/jbc.M115.687913			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26429909	Green Published, hybrid			2022-12-28	WOS:000365762300018
J	Gardner, PR; Gardner, DP; Gardner, AP				Gardner, Paul R.; Gardner, Daniel P.; Gardner, Alexander P.			Globins Scavenge Sulfur Trioxide Anion Radical	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDE DIOXYGENASE FUNCTION; OUTER MITOCHONDRIAL-MEMBRANE; ELECTRON-TRANSFER REACTIONS; OM CYTOCHROME-B; NITRIC-OXIDE; REDUCTION POTENTIALS; SACCHAROMYCES-CEREVISIAE; NITROSATIVE STRESS; REDOX POTENTIALS; PULSE-RADIOLYSIS	Background: Sulfite, an intermediate in sulfur metabolism, can be oxidized to the potentially toxic sulfur trioxide anion radical (STAR). Results: Diverse globins efficiently reduced STAR in vitro, and flavohemoglobin protected yeast from STAR toxicity. Conclusion: Globins can function as STAR scavengers. Significance: The data suggest roles for diverse globins in protecting cells against sulfite stress. Ferrous myoglobin was oxidized by sulfur trioxide anion radical (STAR) during the free radical chain oxidation of sulfite. Oxidation was inhibited by the STAR scavenger GSH and by the heme ligand CO. Bimolecular rate constants for the reaction of STAR with several ferrous globins and biomolecules were determined by kinetic competition. Reaction rate constants for myoglobin, hemoglobin, neuroglobin, and flavohemoglobin are large at 38, 120, 2,600, and >= 7,500 x 10(6) m(-1) s(-1), respectively, and correlate with redox potentials. Measured rate constants for O-2, GSH, ascorbate, and NAD(P)H are also large at -100, 10, 130, and 30 x 10(6) M-1 s(-1), respectively, but nevertheless allow for favorable competition by globins and a capacity for STAR scavenging in vivo. Saccharomyces cerevisiae lacking sulfite oxidase and deleted of flavohemoglobin showed an O-2-dependent growth impairment with nonfermentable substrates that was exacerbated by sulfide, a precursor to mitochondrial sulfite formation. Higher O-2 exposures inactivated the superoxide-sensitive mitochondrial aconitase in cells, and hypoxia elicited both aconitase and NADP(+)-isocitrate dehydrogenase activity losses. Roles for STAR-derived peroxysulfate radical, superoxide radical, and sulfo-NAD(P) in the mechanism of STAR toxicity and flavohemoglobin protection in yeast are suggested.	[Gardner, Paul R.; Gardner, Daniel P.; Gardner, Alexander P.] Miami Valley Biotech, Dayton, OH 45402 USA		Gardner, PR (corresponding author), Miami Valley Biotech, Ste 2445,1001 E Second St, Dayton, OH 45402 USA.	paul.gardner@mvbiotech.com	Regan, Clinton/E-6250-2012	Gardner, Paul/0000-0001-8189-0903; Gardner, Alexander/0000-0001-6103-9556; Gardner, Daniel/0000-0002-3520-8202	National Institutes of Health [R01 GM65090, P30 CA016058]; National Science Foundation [CHE-1040302]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported in part by National Institutes of Health Grants R01 GM65090 (to P.R.G.) and P30 CA016058 and National Science Foundation Grant CHE-1040302 to the Mass Spectrometry and Proteomics Facility at the Ohio State University Campus Chemical Instruments Center. The authors declare that they have no conflicts of interest with the contents of this article.	Avram D, 1996, GENETICS, V144, P511; AWTREY AD, 1951, J AM CHEM SOC, V73, P1842, DOI 10.1021/ja01148a504; Backstrom HLJ, 1927, J AM CHEM SOC, V49, P1460, DOI 10.1021/ja01405a011; Ball EG, 1933, J BIOL CHEM, V102, P691; Berges J, 2012, J PHYS CHEM B, V116, P9352, DOI 10.1021/jp304741e; Bigelow Samuel L., 1898, Z PHYS CHEM, V26, P493; Borodulin RR, 2013, NITRIC OXIDE-BIOL CH, V35, P35, DOI 10.1016/j.niox.2013.07.004; Brody MS, 1999, BIOCHEMISTRY-US, V38, P6668, DOI 10.1021/bi9902539; Buisson N, 1998, J BIOL CHEM, V273, P9527, DOI 10.1074/jbc.273.16.9527; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Buxton G. V., 1989, AIR POLLUTION REPORT, P245; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; Carmona M, 2006, J AGR FOOD CHEM, V54, P973, DOI 10.1021/jf052297w; Cassanova N, 2005, J BIOL CHEM, V280, P7645, DOI 10.1074/jbc.M411478200; CHOU KC, 1982, J AM CHEM SOC, V104, P1409, DOI 10.1021/ja00369a043; COOPER CE, 1994, BIOCHEM SOC T, V22, P709, DOI 10.1042/bst0220709; Das TN, 1999, J PHYS CHEM A, V103, P3581, DOI 10.1021/jp9900234; DEFELIPPIS MR, 1989, BIOCHEMISTRY-US, V28, P4847, DOI 10.1021/bi00437a049; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dunn CJ, 1999, J INORG BIOCHEM, V75, P241, DOI 10.1016/S0162-0134(99)00093-8; ELVING PJ, 1982, BIOELECTROCH BIOENER, V9, P365, DOI 10.1016/0302-4598(82)80026-3; ERBENRUSS M, 1987, RADIAT ENVIRON BIOPH, V26, P289, DOI 10.1007/BF01221974; ESCHENBRUCH R, 1974, AM J ENOL VITICULT, V25, P157; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; FRIDOVICH I, 1958, J BIOL CHEM, V233, P1581; FRIDOVICH I, 1961, J BIOL CHEM, V236, P1836; FRIDOVICH I, 1960, J BIOL CHEM, V235, P1835; Fuller E. C., 1941, J AM CHEM SOC, V63, P1644; Gardner AM, 2000, J BIOL CHEM, V275, P12581, DOI 10.1074/jbc.275.17.12581; Gardner AM, 2010, J BIOL CHEM, V285, P23850, DOI 10.1074/jbc.M110.132340; Gardner PR, 2008, METHOD ENZYMOL, V436, P217, DOI 10.1016/S0076-6879(08)36012-1; Gardner PR, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/683729; Gardner PR, 2000, J BIOL CHEM, V275, P31581, DOI 10.1074/jbc.M004141200; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Haynes W. M., 2012, CRC HDB CHEM PHYS; HAYON E, 1972, J AM CHEM SOC, V94, P47, DOI 10.1021/ja00756a009; Heber U, 1998, INT REV CYTOL, V177, P255; Helmick RA, 2005, ANTIMICROB AGENTS CH, V49, P1837, DOI 10.1128/AAC.49.5.1837-1843.2005; Huie R. E., 1989, RADIAT PHYS CHEM, V33, P293; HUIE RE, 1985, CHEM-BIOL INTERACT, V53, P233, DOI 10.1016/S0009-2797(85)80099-5; HUIE RE, 1984, J PHYS CHEM-US, V88, P5665, DOI 10.1021/j150667a042; ITO A, 1980, J BIOCHEM, V87, P73, DOI 10.1093/oxfordjournals.jbchem.a132754; ITO A, 1980, J BIOCHEM, V87, P63, DOI 10.1093/oxfordjournals.jbchem.a132753; Jorgensen LV, 1997, FREE RADICAL RES, V27, P73, DOI 10.3109/10715769709097840; JOVANOVIC SV, 1986, J PHYS CHEM-US, V90, P1935, DOI 10.1021/j100400a039; JOVANOVIC SV, 1995, J AM CHEM SOC, V117, P9881, DOI 10.1021/ja00144a014; Koppenol W. H., 1985, ADV FREE RADICALS BI, V1, P91, DOI DOI 10.1016/8755-9668(85)90005-5; KUOCHEN C, 1974, SCI SINICA, V17, P664; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Liu AY, 2015, INT J MOL SCI, V16, P20082, DOI 10.3390/ijms160820082; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; Madej E, 2007, ARCH BIOCHEM BIOPHYS, V462, P94, DOI 10.1016/j.abb.2007.03.002; MARGOLIASH E, 1954, BIOCHEM J, V56, P529, DOI 10.1042/bj0560529; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; Melideo SL, 2014, BIOCHEMISTRY-US, V53, P4739, DOI 10.1021/bi500650h; Mendel RR, 2013, J BIOL CHEM, V288, P13165, DOI 10.1074/jbc.R113.455311; Navaratnam S, 1998, J CHEM SOC FARADAY T, V94, P2577, DOI 10.1039/a803477j; NETA P, 1985, ENVIRON HEALTH PERSP, V64, P209, DOI 10.2307/3430011; PERUTZ MF, 1990, ANNU REV PHYSIOL, V52, P1; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Ranguelova K, 2013, FREE RADICAL BIO MED, V60, P98, DOI 10.1016/j.freeradbiomed.2013.01.022; Ranguelova K, 2012, FREE RADICAL BIO MED, V52, P1264, DOI 10.1016/j.freeradbiomed.2012.01.016; Ranguelova K, 2010, J BIOL CHEM, V285, P24195, DOI 10.1074/jbc.M109.069054; Ranguelova K, 2010, ENVIRON HEALTH PERSP, V118, P970, DOI 10.1289/ehp.0901533; Ranguelova K, 2009, FREE RADICAL BIO MED, V47, P128, DOI 10.1016/j.freeradbiomed.2009.04.006; ROBINSON HC, 1964, BIOCHEM J, V93, P487, DOI 10.1042/bj0930487; RODKEY FL, 1950, J BIOL CHEM, V182, P17; SADATSHAFAI T, 1981, RADIAT PHYS CHEM, V17, P283, DOI 10.1016/0146-5724(81)90096-0; Sarver A, 2005, MOL BIOL CELL, V16, P4781, DOI 10.1091/mbc.E05-05-0436; Schmidt M, 2003, J BIOL CHEM, V278, P1932, DOI 10.1074/jbc.M209909200; SMITH L, 1963, BIOCHEMISTRY-US, V2, P1432, DOI 10.1021/bi00906a040; SURDHAR PS, 1986, J PHYS CHEM-US, V90, P5915, DOI 10.1021/j100280a091; Taylor JF, 1942, J BIOL CHEM, V144, P15; Titoff A, 1903, Z PHYS CHEM-STOCH VE, V45, P641; Tortora V, 2007, FREE RADICAL BIO MED, V42, P1075, DOI 10.1016/j.freeradbiomed.2007.01.007; Ullmann BD, 2004, EUKARYOT CELL, V3, P715, DOI 10.1128/EC.3.3.715-723.2004; VERHAGEN MFJM, 1995, BBA-GEN SUBJECTS, V1244, P99, DOI 10.1016/0304-4165(94)00201-8; Vinogradov SN, 2013, BBA-PROTEINS PROTEOM, V1834, P1789, DOI 10.1016/j.bbapap.2013.03.021; Wallace MA, 2004, J BIOL CHEM, V279, P32055, DOI 10.1074/jbc.M403590200; WILLIAMS NH, 1982, AUST J CHEM, V35, P1133, DOI 10.1071/CH9821133; WURFEL M, 1990, FEBS LETT, V268, P146, DOI 10.1016/0014-5793(90)80994-T; Wyman J, 1941, J BIOL CHEM, V139, P877; Young SW, 1902, J AM CHEM SOC, V24, P297, DOI 10.1021/ja02018a001; ZAGORSKI ZP, 1971, J PHYS CHEM-US, V75, P3510, DOI 10.1021/j100692a004; Zhao XJ, 1996, J BIOL CHEM, V271, P25131, DOI 10.1074/jbc.271.41.25131	86	14	14	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27204	27214		10.1074/jbc.M115.679621	http://dx.doi.org/10.1074/jbc.M115.679621			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26381408	hybrid, Green Published			2022-12-28	WOS:000364794000029
J	Liu, SH; Su, TT; Zhang, C; Zhang, WM; Zhu, DY; Su, J; Wei, TD; Wang, K; Huang, Y; Guo, LM; Xu, SJ; Zhou, NY; Gu, LC				Liu, Shiheng; Su, Tiantian; Zhang, Cong; Zhang, Wen-Mao; Zhu, Deyu; Su, Jing; Wei, Tiandi; Wang, Kang; Huang, Yan; Guo, Liming; Xu, Sujuan; Zhou, Ning-Yi; Gu, Lichuan			Crystal Structure of PnpCD, a Two-subunit Hydroquinone 1,2-Dioxygenase, Reveals a Novel Structural Class of Fe2+-dependent Dioxygenases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARA-NITROPHENOL; OXYGEN ACTIVATION; DEGRADATION; BIODEGRADATION; EVOLUTION; PRODUCT; PROTEIN; GENE; PCPA; 3-HYDROXYANTHRANILATE-3,4-DIOXYGENASE	Aerobic microorganisms have evolved a variety of pathways to degrade aromatic and heterocyclic compounds. However, only several classes of oxygenolytic fission reaction have been identified for the critical ring cleavage dioxygenases. Among them, the most well studied dioxygenases proceed via catecholic intermediates, followed by noncatecholic hydroxy-substituted aromatic carboxylic acids. Therefore, the recently reported hydroquinone 1,2-dioxygenases add to the diversity of ring cleavage reactions. Two-subunit hydroquinone 1,2-dioxygenase PnpCD, the key enzyme in the hydroquinone pathway ofpara-nitrophenol degradation, catalyzes the ring cleavage of hydroquinone to y-hydroxymuconic semialdehyde. Here, we report three PnpCll structures, named apo-PnpCD, PnpCD-Fe3+, and PnpCDCd(2+)-HBN (substrate analog hydroxyenzonitrile), respectively. Structural analysis showed that both the PnpC and the (-terminal domains of Pnpll comprise a conserved cupin fold, whereas PnpC cannot form a competent metal binding pocket as can Pnpll cupin. Four residues of PnpD (His-256, Asn-258, Glu-262, and His-303) were observed to coordinate the iron ion. The Asn258 coordination is particularly interesting because this coordinating residue has never been observed in the homologous cupin structures of PnpCD. Asn-258 is proposed to play a pivotal role in binding the iron prior to the enzymatic reaction, but it might lose coordination to the iron when the reaction begins. Pnpll also consists of an intriguing N-terminal domain that might have functions other than nucleic acid binding in its structural homologs. In summary, PnpCll has no apparent evolutionary relationship with other iron-dependent dioxygenases and therefore defines a new structural class. The study of PnpCD might add to the understanding of the ring cleavage of dioxygenases.	[Liu, Shiheng; Su, Tiantian; Zhang, Cong; Zhu, Deyu; Wei, Tiandi; Wang, Kang; Huang, Yan; Xu, Sujuan; Gu, Lichuan] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Zhou, Ning-Yi] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Zhou, Ning-Yi] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China; [Zhou, Ning-Yi] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Agr & Environm Microbiol, Wuhan 430071, Peoples R China; [Su, Jing] Qilu Univ Technol, Coll Food Sci & Engn, Jinan 250353, Shandong, Peoples R China; [Guo, Liming] Rizhao Ctr Dis Prevent & Control, Rizhao Hlth Bur, Rizhao 276826, Shandong, Peoples R China	Shandong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Qilu University of Technology	Zhou, NY (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China.	ningyi.zhou@sjtu.edu.cn; lcgu@sdu.edu.cn			National Natural Science Foundation of China [31070655]; Shandong Provincial Funds for Distinguished Young Scientists [JQ201307]; Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT13028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Funds for Distinguished Young Scientists; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by National Natural Science Foundation of China Grant 31070655, Shandong Provincial Funds for Distinguished Young Scientists Grant JQ201307, and Program for Changjiang Scholars and Innovative Research Team in University Grant PCSIRT13028. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agency for Toxic Substances and Disease Registry, 1992, TOX PROF NITR 2 NITR; Cappadocia L, 2012, NUCLEIC ACIDS RES, V40, P258, DOI 10.1093/nar/gkr740; Colabroy KL, 2005, BIOCHEMISTRY-US, V44, P7623, DOI 10.1021/bi0473455; Dai Y, 1999, J BIOL CHEM, V274, P1193, DOI 10.1074/jbc.274.3.1193; Desveaux D, 2000, PLANT CELL, V12, P1477, DOI 10.1105/tpc.12.8.1477; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Emerson JP, 2008, P NATL ACAD SCI USA, V105, P7347, DOI 10.1073/pnas.0711179105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferraroni M, 2005, J BIOL CHEM, V280, P21144, DOI 10.1074/jbc.M500666200; Fetzner S, 2012, APPL ENVIRON MICROB, V78, P2505, DOI 10.1128/AEM.07651-11; Figge K, 1983, Regul Toxicol Pharmacol, V3, P199, DOI 10.1016/0273-2300(83)90028-4; Grube M, 2008, J IND MICROBIOL BIOT, V35, P1545, DOI 10.1007/s10295-008-0456-0; Hayes RP, 2013, MOL MICROBIOL, V88, P523, DOI 10.1111/mmi.12204; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jeoung JH, 2013, P NATL ACAD SCI USA, V110, P12625, DOI 10.1073/pnas.1302144110; Ju KS, 2010, MICROBIOL MOL BIOL R, V74, P250, DOI 10.1128/MMBR.00006-10; Khuri S, 2001, MOL BIOL EVOL, V18, P593, DOI 10.1093/oxfordjournals.molbev.a003840; Kolvenbach BA, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-8; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Kovaleva EG, 2007, SCIENCE, V316, P453, DOI 10.1126/science.1134697; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyauchi K, 1999, J BACTERIOL, V181, P6712, DOI 10.1128/JB.181.21.6712-6719.1999; Moonen MJH, 2008, J BACTERIOL, V190, P5199, DOI 10.1128/JB.01945-07; Ohtsubo Y, 1999, FEBS LETT, V459, P395, DOI 10.1016/S0014-5793(99)01305-8; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Shen WJ, 2010, BIORESOURCE TECHNOL, V101, P7516, DOI 10.1016/j.biortech.2010.04.052; SPAIN JC, 1995, ANNU REV MICROBIOL, V49, P523, DOI 10.1146/annurev.mi.49.100195.002515; SPAIN JC, 1991, APPL ENVIRON MICROB, V57, P812, DOI 10.1128/AEM.57.3.812-819.1991; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Titus GP, 2000, NAT STRUCT BIOL, V7, P542; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; Vikram S, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-30; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xun LY, 1999, BIOCHEM BIOPH RES CO, V266, P322, DOI 10.1006/bbrc.1999.1805; Yin Y, 2010, CURR MICROBIOL, V61, P471, DOI 10.1007/s00284-010-9640-3; Zhang JJ, 2009, J BACTERIOL, V191, P2703, DOI 10.1128/JB.01566-08; Zhang WM, 2015, APPL ENVIRON MICROB, V81, P220, DOI 10.1128/AEM.02720-14; Zhang Y, 2005, BIOCHEMISTRY-US, V44, P7632, DOI 10.1021/bi047353l; ZIERIS FJ, 1988, ARCH ENVIRON CON TOX, V17, P165, DOI 10.1007/BF01056021	46	11	11	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24547	24560		10.1074/jbc.M115.673558	http://dx.doi.org/10.1074/jbc.M115.673558			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26304122	Green Published, hybrid			2022-12-28	WOS:000362218900039
J	Ceschin, J; Hurlimann, HC; Saint-Marc, C; Albrecht, D; Violo, T; Moenner, M; Daignan-Fornier, B; Pinson, B				Ceschin, Johanna; Huerlimann, Hans Caspar; Saint-Marc, Christelle; Albrecht, Delphine; Violo, Typhaine; Moenner, Michel; Daignan-Fornier, Bertrand; Pinson, Benoit			Disruption of Nucleotide Homeostasis by the Antiproliferative Drug 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside Monophosphate (AICAR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PURINE INTERMEDIATE; YEAST; PURIFICATION; ERYTHROCYTES; ACCUMULATION; INHIBITION; GLYCOLYSIS; PHOSPHATE; RIBOSIDE	5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside monophosphate (AICAR) is a natural metabolite with potent anti-proliferative and low energy mimetic properties. At high concentration, AICAR is toxic for yeast and mammalian cells, but the molecular basis of this toxicity is poorly understood. Here, we report the identification of yeast purine salvage pathway mutants that are synthetically lethal with AICAR accumulation. Genetic suppression revealed that this synthetic lethality is in part due to low expression of adenine phosphoribosyl transferase under high AICAR conditions. In addition, metabolite profiling points to the AICAR/NTP balance as crucial for optimal utilization of glucose as a carbon source. Indeed, we found that AICAR toxicity in yeast and human cells is alleviated when glucose is replaced by an alternative carbon source. Together, our metabolic analyses unveil the AICAR/NTP balance as a major factor of AICAR antiproliferative effects.	[Ceschin, Johanna; Huerlimann, Hans Caspar; Saint-Marc, Christelle; Albrecht, Delphine; Violo, Typhaine; Moenner, Michel; Daignan-Fornier, Bertrand; Pinson, Benoit] Univ Bordeaux, F-33077 Bordeaux, France; [Ceschin, Johanna; Huerlimann, Hans Caspar; Saint-Marc, Christelle; Albrecht, Delphine; Violo, Typhaine; Moenner, Michel; Daignan-Fornier, Bertrand; Pinson, Benoit] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33077 Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Daignan-Fornier, B (corresponding author), CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, 1 Rue C St Saens CS 61390, F-33077 Bordeaux, France.	b.daignan-fornier@ibgc.cnrs.fr		ceschin, johanna/0000-0001-7771-531X; albrecht, delphine/0000-0002-8026-3251; DOUILLET, Delphine/0000-0002-9529-1255; Pinson, Benoit/0000-0003-2936-9058	Association de la Recherche contre le Cancer [SFI-2012-120-5915]; Ligue contre le Cancer Project LARGE	Association de la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue contre le Cancer Project LARGE	This work was supported by Association de la Recherche contre le Cancer Grant SFI-2012-120-5915 (to B. D.-F.) and Ligue contre le Cancer Project LARGE (to M.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Alfonzo JD, 1997, BBA-PROTEIN STRUCT M, V1341, P173, DOI 10.1016/S0167-4838(97)00068-X; Breton A, 2008, GENETICS, V178, P815, DOI 10.1534/genetics.107.083295; Ceballos-Picot I, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-014-0219-0; Ceschin J, 2014, J BIOL CHEM, V289, P16844, DOI 10.1074/jbc.M114.551192; Daignan-Fornier B, 2012, METABOLITES, V2, DOI 10.3390/metabo2020292; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gauthier S, 2008, MOL MICROBIOL, V68, P1583, DOI 10.1111/j.1365-2958.2008.06261.x; Guetsova ML, 1997, GENETICS, V147, P383; Guetsova ML, 1999, J BACTERIOL, V181, P2984, DOI 10.1128/JB.181.9.2984-2986.1999; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Hurlimann HC, 2011, J BIOL CHEM, V286, P30994, DOI 10.1074/jbc.M111.262659; JAVAUX F, 1995, BIOCHEM J, V305, P913, DOI 10.1042/bj3050913; KNUDSEN RC, 1972, J BACTERIOL, V112, P569, DOI 10.1128/JB.112.1.569-575.1972; KONRAD M, 1988, J BIOL CHEM, V263, P19468; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; MERKLER DJ, 1989, J BIOL CHEM, V264, P21422; Pinson B, 2009, GENE DEV, V23, P1399, DOI 10.1101/gad.521809; Rebora K, 2005, GENETICS, V170, P61, DOI 10.1534/genetics.104.039396; Rebora K, 2001, MOL CELL BIOL, V21, P7901, DOI 10.1128/MCB.21.23.7901-7912.2001; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Saint-Marc C, 2009, GENETICS, V183, P529, DOI 10.1534/genetics.109.105858; Sherman F., 1986, METHODS YEAST GENETI; SIDI Y, 1985, J CLIN INVEST, V76, P2416, DOI 10.1172/JCI112255; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Tibbetts AS, 1997, ARCH BIOCHEM BIOPHYS, V340, P195, DOI 10.1006/abbi.1997.9919; Vincent EE, 2015, ONCOGENE, V34, P3627, DOI 10.1038/onc.2014.301; VINCENT MF, 1992, BIOCHEM J, V281, P267, DOI 10.1042/bj2810267	29	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23947	23959		10.1074/jbc.M115.656017	http://dx.doi.org/10.1074/jbc.M115.656017			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26283791	Green Published, hybrid			2022-12-28	WOS:000361816500039
J	Chen, ZH; Su, LK; Xu, QA; Katz, J; Michalek, SM; Fan, MW; Feng, X; Zhang, P				Chen, Zhihong; Su, Lingkai; Xu, Qingan; Katz, Jenny; Michalek, Suzanne M.; Fan, Mingwen; Feng, Xu; Zhang, Ping			IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; PORPHYROMONAS-GINGIVALIS; RHEUMATOID-ARTHRITIS; BONE-RESORPTION; INFLAMMATORY RESPONSE; PERIODONTAL-DISEASE; SIGNALING MECHANISM; TNF-ALPHA; DIFFERENTIATION	Toll-like receptors (TLR) and the receptor for interleukin-1 (IL-1R) signaling play an important role in bacteria-mediated bone loss diseases including periodontitis, rheumatoid arthritis, and osteomyelitis. Recent studies have shown that TLR ligands inhibit the receptor activator of NF-kappa B ligand (RANKL)-induced osteoclast differentiation from un-committed osteoclast precursors, whereas IL-1 potentiates RANKL-induced osteoclast formation. However, IL-1R and TLR belong to the same IL-1R/TLR superfamily, and activate similar intracellular signaling pathways. Here, we investigate the molecular mechanisms underlying the distinct effects of IL-1 and Porphyromonas gingivalis lipopolysaccharide (LPS-PG) on RANKL-induced osteoclast formation. Our results show that LPS-PG and IL-1 differentially regulate RANKL-induced activation of osteoclast genes encoding Car2, Ctsk, MMP9, and TRAP, as well as expression of NFATc1, a master transcription factor of osteoclastogenesis. Regulation of osteoclast genes and NFATc1 by LPS-PG and IL-1 is dependent on MyD88, an important signaling adaptor for both TLR and IL-1R family members. Furthermore, LPS-PG and IL-1 differentially regulate RANKL-costimulatory receptor OSCAR (osteoclast-associated receptor) expression and Ca2+ oscillations induced by RANKL. Moreover, LPS-PG completely abrogates RANKL-induced gene expression of B lymphocyte-induced maturation protein-1 (Blimp1), a global transcriptional repressor of anti-osteoclastogenic genes encoding Bcl6, IRF8, and MafB. However, IL-1 enhances RANKL-induced blimp1 gene expression but suppresses the gene expression of bcl6, irf8, and mafb. Our study reveals the involvement of multiple signaling molecules in the differential regulation of RANKL-induced osteoclastogenesis by TLR2 and IL-1 signaling. Understanding the signaling cross-talk among TLR, IL-1R, and RANK is critical for identifying therapeutic strategies to control bacteria-mediated bone loss.	[Chen, Zhihong; Su, Lingkai; Xu, Qingan; Katz, Jenny; Zhang, Ping] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL 35294 USA; [Michalek, Suzanne M.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Feng, Xu] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Chen, Zhihong] Zhejiang Univ, Sch & Hosp Stomatol, Dept Prosthodont, Hangzhou 310006, Zhejiang, Peoples R China; [Xu, Qingan; Fan, Mingwen] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan 430079, Hubei, Peoples R China; [Xu, Qingan; Fan, Mingwen] Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan 430079, Hubei, Peoples R China	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Zhejiang University; Wuhan University; Wuhan University	Zhang, P (corresponding author), 845 19th St South,BBRB 711, Birmingham, AL 35294 USA.	pingz@uab.edu		Zhang, Ping/0000-0002-4585-9893	National Institutes of Health from the NIDCR [DE022401]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE022401, R90DE023056] Funding Source: NIH RePORTER	National Institutes of Health from the NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE022401 from the NIDCR (to P. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Amcheslavsky A, 2007, J BONE MINER RES, V22, P1301, DOI 10.1359/JBMR.070501; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Assuma R, 1998, J IMMUNOL, V160, P403; Bainbridge BW, 2006, CELL MICROBIOL, V8, P120, DOI 10.1111/j.1462-5822.2005.00605.x; Bar-Shavit Z, 2008, AUTOIMMUNITY, V41, P195, DOI 10.1080/08916930701694469; Barreto-Chang Odmara L, 2009, J Vis Exp, DOI 10.3791/1067; Braun T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3380; Brentano Fabia, 2009, V517, P329, DOI 10.1007/978-1-59745-541-1_20; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Cappellen D, 2002, J BIOL CHEM, V277, P21971, DOI 10.1074/jbc.M200434200; Cella M, 2003, J EXP MED, V198, P645, DOI 10.1084/jem.20022220; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Colonna M, 2007, ADV EXP MED BIOL, V602, P97; Deguine Jacques, 2014, F1000Prime Rep, V6, P97, DOI 10.12703/P6-97; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Feng X, 2005, IUBMB LIFE, V57, P389, DOI 10.1080/15216540500137669; Goldring SR, 2000, CURR OPIN RHEUMATOL, V12, P195, DOI 10.1097/00002281-200005000-00006; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Herman S, 2008, ARTHRITIS RHEUM-US, V58, P3041, DOI 10.1002/art.23943; Holden JA, 2014, INFECT IMMUN, V82, P4190, DOI 10.1128/IAI.02325-14; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Huang Qi-Quan, 2009, Curr Rheumatol Rep, V11, P357; Ivashkiv LB, 2011, ANN NY ACAD SCI, V1237, P88, DOI 10.1111/j.1749-6632.2011.06217.x; Ji JD, 2009, J IMMUNOL, V183, P7223, DOI 10.4049/jimmunol.0900072; Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320; Jules J, 2012, J BIOL CHEM, V287, P15728, DOI 10.1074/jbc.M111.296228; Kato H, 2014, ARCH ORAL BIOL, V59, P167, DOI 10.1016/j.archoralbio.2013.11.008; Kim GS, 2005, J BONE MINER RES, V20, P1342, DOI 10.1359/JBMR.050320; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kopp E, 2003, CURR OPIN IMMUNOL, V15, P396, DOI 10.1016/S0952-7915(03)00080-3; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lee YM, 2010, INT IMMUNOL, V22, P805, DOI 10.1093/intimm/dxq431; Li SS, 2014, J CLIN INVEST, V124, P5057, DOI 10.1172/JCI71882; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Loiarro M, 2013, J BIOL CHEM, V288, P30210, DOI 10.1074/jbc.M113.490946; Lorenzo J, 2008, ENDOCR REV, V29, P403, DOI 10.1210/er.2007-0038; Ma T, 2004, CYTOKINE, V26, P138, DOI 10.1016/j.cyto.2004.02.001; Leite FRM, 2015, INFLAMMATION, V38, P1, DOI 10.1007/s10753-014-0001-4; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Miyauchi Y, 2010, J EXP MED, V207, P751, DOI 10.1084/jem.20091957; Montes AH, 2006, CLIN EXP IMMUNOL, V143, P404, DOI 10.1111/j.1365-2249.2005.03002.x; Moon JB, 2012, J IMMUNOL, V188, P163, DOI 10.4049/jimmunol.1101254; Narayanan KB, 2015, APOPTOSIS, V20, P196, DOI 10.1007/s10495-014-1073-1; Nishikaw K, 2010, P NATL ACAD SCI USA, V107, P3117, DOI 10.1073/pnas.0912779107; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Seo T, 2012, J MICROBIOL, V50, P311, DOI 10.1007/s12275-012-2146-x; Slocum C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004215; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Strand V, 2004, RHEUMATOLOGY, V43, P10, DOI 10.1093/rheumatology/keh202; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wei S, 2002, J BIOL CHEM, V277, P6622, DOI 10.1074/jbc.M104957200; Yang J, 2009, J LEUKOCYTE BIOL, V86, P823, DOI 10.1189/jlb.0309206; Yang SY, 2007, J CELL SCI, V120, P3362, DOI 10.1242/jcs.008300; Zhang D, 2008, INNATE IMMUN-LONDON, V14, P99, DOI 10.1177/1753425907088244; Zhang P, 2005, INFECT IMMUN, V73, P3990, DOI 10.1128/IAI.73.7.3990-3998.2005; Zhang P, 2011, J BIOL CHEM, V286, P24159, DOI 10.1074/jbc.M110.198085; Zhao BH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3379; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211	77	24	27	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30163	30174		10.1074/jbc.M115.663518	http://dx.doi.org/10.1074/jbc.M115.663518			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26483549	Green Published, hybrid			2022-12-28	WOS:000366614700046
J	Kumar, M; Govindan, S; Zhang, MJ; Khairallah, RJ; Martin, JL; Sadayappan, S; de Tombe, PP				Kumar, Mohit; Govindan, Suresh; Zhang, Mengjie; Khairallah, Ramzi J.; Martin, Jody L.; Sadayappan, Sakthivel; de Tombe, Pieter P.			Cardiac Myosin-binding Protein C and Troponin-I Phosphorylation Independently Modulate Myofilament Length-dependent Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAINS; KINASE-A; CALCIUM SENSITIVITY; STRIATED-MUSCLE; THIN-FILAMENTS; HYPERTROPHIC CARDIOMYOPATHY; FORCE; MUTATION; IMPACT; TITIN	beta-Adrenergic stimulation in heart leads to increased contractility and lusitropy via activation of protein kinase A (PKA). In the cardiac sarcomere, both cardiac myosin binding protein C (cMyBP-C) and troponin-I (cTnI) are prominent myofilament targets of PKA. Treatment of permeabilized myocardium with PKA induces enhanced myofilament length-dependent activation (LDA), the cellular basis of the Frank-Starling cardiac regulatory mechanism. It is not known, however, which of these targets mediates the altered LDA and to what extent. Here, we employed two genetic mouse models in which the three PKA sites in cMyBP-C were replaced with either phospho-mimic (DDD) or phospho-null (AAA) residues. AAA-or DDD-permeabilized myocytes (n = 12-17) were exchanged (similar to 93%) for recombinant cTnI in which the two PKA sites were mutated to either phosphomimic (DD) or phospho-null (AA) residues. Force-[Ca2+] relationships were determined at two sarcomere lengths (SL = 1.9 mu m and SL = 2.3 mu m). Data were fit to a modified Hill equation for each individual cell preparation at each SL. LDA was indexed as Delta EC50, the difference in [Ca2+] required to achieve 50% force activation at the two SLs. We found that PKA-mediated phosphorylation of cMyBP-C and cTnI each independently contribute to enhance myofilament length-dependent activation properties of the cardiac sarcomere, with relative contributions of similar to 67 and similar to 33% for cMyBP-C for cTnI, respectively. We conclude that beta-adrenergic stimulation enhances the Frank-Starling regulatory mechanism predominantly via cMyBP-C PKA-mediated phosphorylation. We speculate that this molecular mechanism enhances cross-bridge formation at long SL while accelerating cross-bridge detachment and relaxation at short SLs.	[Kumar, Mohit; Govindan, Suresh; Zhang, Mengjie; Khairallah, Ramzi J.; Martin, Jody L.; Sadayappan, Sakthivel; de Tombe, Pieter P.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Div Hlth Sci, Maywood, IL 60153 USA	Loyola University Chicago	de Tombe, PP (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, Div Hlth Sci, 2160 S First Ave, Maywood, IL 60153 USA.	pdetombe@luc.edu	Kumar, Mohit/AAM-6405-2021; Regan, Clinton/E-6250-2012	Kumar, Mohit/0000-0002-3554-0563; Sadayappan, Sakthivel/0000-0003-2006-7678	National Institutes of Health [HL62426, HL101297, HL75494, HL105826, HL114749, HL120643]; American Hearth Association [13POST14720024, 14GRNT20490025]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075494, P30HL101297, F32HL120643, K02HL114749, P01HL062426, R01HL105826] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Hearth Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL62426, HL101297, and HL75494 (to P. P. d T), HL105826 and HL114749 (to S. S.), and HL120643 (to R. K.). This work was also supported by American Hearth Association Grants 13POST14720024 (to S. G.) and 14GRNT20490025 (to S. S). The authors declare that they have no conflicts of interest with the contents of this article.	Barefield D, 2015, J MOL CELL CARDIOL, V79, P234, DOI 10.1016/j.yjmcc.2014.11.018; Belin RJ, 2011, PFLUG ARCH EUR J PHY, V462, P795, DOI 10.1007/s00424-011-1024-4; Belknap B, 2014, BIOCHEMISTRY-US, V53, P6717, DOI 10.1021/bi500787f; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Borbely A, 2005, CIRCULATION, V111, P774, DOI 10.1161/01.CIR.0000155257.33485.6D; Burgoyne T, 2008, CARDIOVASC RES, V77, P707, DOI 10.1093/cvr/cvm117; Cazorla O, 2006, CARDIOVASC RES, V69, P370, DOI 10.1016/j.cardiores.2005.11.009; Cazorla O, 2001, CIRC RES, V88, P1028, DOI 10.1161/hh1001.090876; Chandra M, 2001, AM J PHYSIOL-HEART C, V280, pH705, DOI 10.1152/ajpheart.2001.280.2.H705; Cheng YH, 2014, BIOPHYS J, V107, P1675, DOI 10.1016/j.bpj.2014.08.008; Cingolani HE, 2013, AM J PHYSIOL-HEART C, V304, pH175, DOI 10.1152/ajpheart.00508.2012; de Tombe PP, 2010, J MOL CELL CARDIOL, V48, P851, DOI 10.1016/j.yjmcc.2009.12.017; DETOMBE PP, 1995, CIRC RES, V76, P734, DOI 10.1161/01.RES.76.5.734; deTombe PP, 1996, AM J PHYSIOL-HEART C, V271, pH73, DOI 10.1152/ajpheart.1996.271.1.H73; Dobesh DP, 2002, AM J PHYSIOL-HEART C, V282, pH1055, DOI 10.1152/ajpheart.00667.2001; Fan DS, 1997, CIRCULATION, V95, P2312, DOI 10.1161/01.CIR.95.9.2312; Hanft LM, 2013, J PHYSIOL-LONDON, V591, P4535, DOI 10.1113/jphysiol.2013.258400; Hanft LM, 2009, AM J PHYSIOL-HEART C, V296, pH1524, DOI 10.1152/ajpheart.00864.2008; Hidalgo C, 2013, TRENDS CARDIOVAS MED, V23, P165, DOI 10.1016/j.tcm.2012.10.005; Hwang PM, 2014, P NATL ACAD SCI USA, V111, P14412, DOI 10.1073/pnas.1410775111; Kampourakis T, 2014, P NATL ACAD SCI USA, V111, P18763, DOI 10.1073/pnas.1413922112; KENTISH JC, 1986, CIRC RES, V58, P755, DOI 10.1161/01.RES.58.6.755; Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117; Konhilas JP, 2002, J PHYSIOL-LONDON, V544, P225, DOI 10.1113/jphysiol.2002.024505; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; Luther PK, 2008, J MOL BIOL, V384, P60, DOI 10.1016/j.jmb.2008.09.013; Luther PK, 2011, P NATL ACAD SCI USA, V108, P11423, DOI 10.1073/pnas.1103216108; Mamidi R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00461; Mateja RD, 2012, BIOPHYS J, V103, pL13, DOI 10.1016/j.bpj.2012.05.034; Methawasin M, 2014, CIRCULATION, V129, P1924, DOI 10.1161/CIRCULATIONAHA.113.005610; Moss RL, 2015, CIRC RES, V116, P183, DOI 10.1161/CIRCRESAHA.116.300561; Mun JY, 2014, P NATL ACAD SCI USA, V111, P2170, DOI 10.1073/pnas.1316001111; Nagayama T, 2007, CIRCULATION, V116, P2399, DOI 10.1161/CIRCULATIONAHA.107.706523; Nixon BR, 2012, J BIOL CHEM, V287, P19136, DOI 10.1074/jbc.M111.323048; Pfuhl M, 2012, J MUSCLE RES CELL M, V33, P83, DOI 10.1007/s10974-012-9291-z; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Rao VS, 2013, J PHYSIOL-LONDON, V591, P475, DOI 10.1113/jphysiol.2012.241604; Razumova MV, 2006, J BIOL CHEM, V281, P35846, DOI 10.1074/jbc.M606949200; Reconditi M, 2014, J PHYSIOL-LONDON, V592, P1119, DOI 10.1113/jphysiol.2013.267849; Rosas PC, 2015, CIRC-HEART FAIL, V8, P582, DOI 10.1161/CIRCHEARTFAILURE.114.001550; Rundell VLM, 2005, AM J PHYSIOL-HEART C, V288, pH896, DOI 10.1152/ajpheart.00407.2004; Rybakova IN, 2011, J BIOL CHEM, V286, P2008, DOI 10.1074/jbc.M110.170605; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sequeira V, 2013, CIRC RES, V112, P1491, DOI 10.1161/CIRCRESAHA.111.300436; Solaro RJ, 2013, CIRC RES, V112, P355, DOI 10.1161/CIRCRESAHA.112.268672; Tachampa K, 2007, CIRC RES, V101, P1081, DOI 10.1161/CIRCRESAHA.107.165258; Vikhorev PG, 2014, BIOPHYS J, V107, P2369, DOI 10.1016/j.bpj.2014.10.024; Wijnker PJM, 2013, AM J PHYSIOL-HEART C, V304, pH260, DOI 10.1152/ajpheart.00498.2012; Witayavanitkul N, 2014, J BIOL CHEM, V289, P8818, DOI 10.1074/jbc.M113.541128; Zhang M., 2015, AM J PHYSL HEART CIR, DOI 0.1152/ajpheart.00598.2015	51	36	35	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29241	29249		10.1074/jbc.M115.686790	http://dx.doi.org/10.1074/jbc.M115.686790			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26453301	hybrid, Green Published			2022-12-28	WOS:000366613400012
J	Olsvik, HL; Lamark, T; Takagi, K; Larsen, KB; Evjen, G; Overvatn, A; Mizushima, T; Johansen, T				Olsvik, Hallvard L.; Lamark, Trond; Takagi, Kenji; Larsen, Kenneth Bowitz; Evjen, Gry; Overvatn, Aud; Mizushima, Tsunehiro; Johansen, Terje			FYCO1 Contains a C-terminally Extended, LC3A/B-preferring LC3-interacting Region (LIR) Motif Required for Efficient Maturation of Autophagosomes during Basal Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE AUTOPHAGY; STRUCTURAL BASIS; PROTEIN; LC3; DEGRADATION; GABARAP; COMPLEX; ATG8; P62; RECRUITMENT	FYCO1 (FYVE and coiled-coil protein 1) is a transport adaptor that binds to phosphatidylinositol 3-phosphate, to Rab7, and to LC3 (microtubule-associated protein 1 light chain 3) to mediate transport of late endosomes and autophagosomes along microtubules in the plus end direction. We have previously shown that FYCO1 binds to LC3B via a 19-amino acid sequence containing a putative core LC3-interacting region (LIR) motif. Here, we show that FYCO1 preferentially binds to LC3A and -B. By peptide array-based two-dimensional mutational scans of the binding to LC3B, we found FYCO1 to contain a C-terminally extended LIR domain. We determined the crystal structure of a complex between a 13-amino acid LIR peptide from FYCO1 and LC3B at 1.53 angstrom resolution. By combining the structural information with mutational analyses, both the basis for the C-terminally extended LIR and the specificity for LC3A/B binding were revealed. FYCO1 contains a 9-amino acid-long F-type LIR motif. In addition to the canonical aromatic residue at position 1 and the hydrophobic residue at position 3, an acidic residue and a hydrophobic residue at positions 8 and 9, respectively, are important for efficient binding to LC3B explaining the C-terminal extension. The specificity for binding to LC3A/B is due to the interaction between Asp1285 in FYCO1 and His(57) in LC3B. To address the functional significance of the LIR motif of FYCO1, we generated FYCO1 knock-out cells that subsequently were reconstituted with GFP-FYCO1 WT and LIR mutant constructs. Our data show that FYCO1 requires a functional LIR motif to facilitate efficient maturation of autophagosomes under basal conditions, whereas starvation-induced autophagy was unaffected.	[Olsvik, Hallvard L.; Lamark, Trond; Larsen, Kenneth Bowitz; Evjen, Gry; Overvatn, Aud; Johansen, Terje] UiT Arctic Univ Norway, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway; [Takagi, Kenji; Mizushima, Tsunehiro] Univ Hyogo, Grad Sch Life Sci, Picobiol Inst, Kobe, Hyogo 6512197, Japan	UiT The Arctic University of Tromso; University of Hyogo	Johansen, T (corresponding author), UiT Arctic Univ Norway, Inst Med Biol, Mol Canc Res Grp, N-9037 Tromso, Norway.	terje.johansen@uit.no	Johansen, Terje/N-2971-2015; Johansen, Terje/AAY-1753-2021; Larsen, Kenneth/HDO-5510-2022	Johansen, Terje/0000-0003-1451-9578; Johansen, Terje/0000-0003-1451-9578; Evjen, Gry/0000-0002-8313-0593; Lamark, Trond/0000-0001-6338-3342; Olsvik, Hallvard/0000-0003-3489-7461; Mizushima, Tsunehiro/0000-0002-6631-2889	FRIBIO of the Norwegian Research Council [196898, 214448]; FRIBIOMED of the Norwegian Research Council [196898, 214448]; Norwegian Cancer Society [71043-PR-2006-0320]	FRIBIO of the Norwegian Research Council; FRIBIOMED of the Norwegian Research Council; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by grants from the FRIBIO and FRIBIOMED programs of the Norwegian Research Council (Grants 196898 and 214448) and by the Norwegian Cancer Society (Grant 71043-PR-2006-0320) (to T. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Chen JJ, 2011, AM J HUM GENET, V88, P827, DOI 10.1016/j.ajhg.2011.05.008; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fu MM, 2014, DEV CELL, V29, P577, DOI 10.1016/j.devcel.2014.04.015; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Geeraert C, 2010, J BIOL CHEM, V285, P24184, DOI 10.1074/jbc.M109.091553; Genau HM, 2015, MOL CELL, V57, P995, DOI 10.1016/j.molcel.2014.12.040; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Itoh T, 2011, J CELL BIOL, V192, P839, DOI 10.1083/jcb.201008107; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; Lystad AH, 2014, EMBO REP, V15, P557, DOI 10.1002/embr.201338003; Ma J, 2014, J IMMUNOL, V192, P1356, DOI 10.4049/jimmunol.1302835; Ma PX, 2013, J BIOL CHEM, V288, P37204, DOI 10.1074/jbc.M113.528067; Manil-Segalen M, 2014, DEV CELL, V28, P43, DOI 10.1016/j.devcel.2013.11.022; Maruyama Y, 2014, BIOCHEM BIOPH RES CO, V446, P309, DOI 10.1016/j.bbrc.2014.02.093; McEwan DG, 2015, MOL CELL, V57, P39, DOI 10.1016/j.molcel.2014.11.006; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mrakovic A, 2012, TRAFFIC, V13, P1667, DOI 10.1111/tra.12003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Raiborg C, 2015, NATURE, V520, P234, DOI 10.1038/nature14359; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rogov VV, 2013, BIOCHEM J, V454, P459, DOI 10.1042/BJ20121907; Rozenknop A, 2011, J MOL BIOL, V410, P477, DOI 10.1016/j.jmb.2011.05.003; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Shvets E, 2011, AUTOPHAGY, V7, P683, DOI 10.4161/auto.7.7.15279; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki H, 2014, STRUCTURE, V22, P47, DOI 10.1016/j.str.2013.09.023; Szalai P, 2015, EXP CELL RES, V333, P21, DOI 10.1016/j.yexcr.2015.02.003; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292	46	78	80	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29361	29374		10.1074/jbc.M115.686915	http://dx.doi.org/10.1074/jbc.M115.686915			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468287	hybrid, Green Published			2022-12-28	WOS:000366613400022
J	Wandernoth, PM; Mannowetz, N; Szczyrba, J; Grannemann, L; Wolf, A; Becker, HM; Sly, WS; Wennemuth, G				Wandernoth, Petra M.; Mannowetz, Nadja; Szczyrba, Jaroslaw; Grannemann, Laura; Wolf, Anne; Becker, Holger M.; Sly, William S.; Wennemuth, Gunther			Normal Fertility Requires the Expression of Carbonic Anhydrases II and IV in Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; MALE REPRODUCTIVE-TRACT; GENE-EXPRESSION; LUMINAL ACIDIFICATION; EPIDIDYMAL MATURATION; ANDROGEN REGULATION; SODIUM-BICARBONATE; MOUSE SPERMATOZOA; CA-II; RAT	HCO3- is a key factor in the regulation of sperm motility. High concentrations of HCO3- in the female genital tract induce an increase in sperm beat frequency, which speeds progress of the sperm through the female reproductive tract. Carbonic anhydrases (CA), which catalyze the reversible hydration of CO2 to HCO3-, represent potential candidates in the regulation of the HCO3- homeostasis in sperm and the composition of the male and female genital tract fluids. We show that two CA isoforms, CAII and CAIV, are distributed along the epididymal epithelium and appear with the onset of puberty. Expression analyses reveal an up-regulation of CAII and CAIV in the different epididymal sections of the knockout lines. In sperm, we find that CAII is located in the principal piece, whereas CAIV is present in the plasma membrane of the entire sperm tail. CAII and CAIV single knockout animals display an imbalanced HCO3- homeostasis, resulting in substantially reduced sperm motility, swimming speed, and HCO3--enhanced beat frequency. The CA activity remaining in the sperm of CAII- and CAIV-null mutants is 35% and 68% of that found in WT mice. Sperm of the double knockout mutant mice show responses to stimulus by HCO3- or CO2 that were delayed in onset and reduced in magnitude. In comparison with sperm from CAII and CAIV double knockout animals, pharmacological loss of CAIV in sperm from CAII knockout animals, show an even lower response to HCO3-. These results suggest that CAII and CAIV are required for optimal fertilization.	[Wandernoth, Petra M.; Mannowetz, Nadja; Szczyrba, Jaroslaw; Grannemann, Laura; Wennemuth, Gunther] Univ Duisburg Essen, Univ Hosp, Inst Anat, D-45122 Essen, Germany; [Wolf, Anne] Univ Saarland, Med Ctr, Dept Internal Med 1, D-66421 Homburg, Germany; [Becker, Holger M.] Univ Kaiserslautern, Dept Biol, Div Zool Membrane Transport, D-67663 Kaiserslautern, Germany; [Sly, William S.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	University of Duisburg Essen; Saarland University; University of Kaiserslautern; Saint Louis University	Wennemuth, G (corresponding author), Univ Clin Essen, Dept Anat, Hufelandstr 55, D-45122 Essen, Germany.	gunther.wennemuth@uk-essen.de	Becker, Holger/AAB-4322-2020; Dankert, Jaroslaw Thomas/A-2400-2017; Dankert, Jaroslaw Thomas/GWV-8070-2022	Dankert, Jaroslaw Thomas/0000-0002-5950-0742; Dankert, Jaroslaw Thomas/0000-0002-5950-0742; Wennemuth, Gunther/0000-0003-3313-2475	Deutsche Forschungsgemeinschaft [WE 2344/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft Grant WE 2344/9-1 (to G. W.). The authors declare that they have no conflicts of interest with the contents of this article.	ACOTT TS, 1984, BIOL REPROD, V30, P926, DOI 10.1095/biolreprod30.4.926; AU CL, 1980, J PHYSIOL-LONDON, V309, P419, DOI 10.1113/jphysiol.1980.sp013517; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; BABCOCK DF, 1983, P NATL ACAD SCI-BIOL, V80, P1327, DOI 10.1073/pnas.80.5.1327; Babcock DF, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0067-3; BADGER MR, 1989, PLANT PHYSIOL, V89, P51, DOI 10.1104/pp.89.1.51; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF437, DOI 10.1152/ajprenal.2001.280.3.F437; BOATMAN DE, 1991, BIOL REPROD, V44, P806, DOI 10.1095/biolreprod44.5.806; Breton S, 2001, JOP, V2, P159; Breton S, 1996, NAT MED, V2, P470, DOI 10.1038/nm0496-470; Caldarelli A, 2005, J STEROID BIOCHEM, V97, P251, DOI 10.1016/j.jsbmb.2005.05.010; Carlson AE, 2007, DEV BIOL, V312, P183, DOI 10.1016/j.ydbio.2007.09.017; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Cordat E, 2009, BIOCHEM J, V417, P423, DOI 10.1042/BJ20081634; Curtis MP, 2012, J THEOR BIOL, V309, P1, DOI 10.1016/j.jtbi.2012.05.035; Dacheux JL, 2014, REPRODUCTION, V147, pR27, DOI 10.1530/REP-13-0420; Dacheux JL, 2012, SYST BIOL REPROD MED, V58, P197, DOI 10.3109/19396368.2012.663233; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; DEMOTT RP, 1992, BIOL REPROD, V46, P779, DOI 10.1095/biolreprod46.5.779; DOBYAN DC, 1982, AM J PHYSIOL, V243, pF311, DOI 10.1152/ajprenal.1982.243.4.F311; Ekstedt E, 2004, J MOL HISTOL, V35, P167; GRABER ML, 1986, ANAL BIOCHEM, V156, P202, DOI 10.1016/0003-2697(86)90174-0; HARKONEN PL, 1988, BIOL REPROD, V38, P377, DOI 10.1095/biolreprod38.2.377; Hassan MI, 2013, BIOORGAN MED CHEM, V21, P1570, DOI 10.1016/j.bmc.2012.04.044; Hermo L, 2005, J HISTOCHEM CYTOCHEM, V53, P699, DOI 10.1369/jhc.4A6575.2005; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; Jensen LJ, 1999, BIOL REPROD, V60, P573, DOI 10.1095/biolreprod60.3.573; Jensen LJ, 1999, BIOL REPROD, V61, P973, DOI 10.1095/biolreprod61.4.973; Johnston DS, 2007, ASIAN J ANDROL, V9, P522, DOI 10.1111/j.1745-7262.2007.00317.x; Johnston DS, 2005, BIOL REPROD, V73, P404, DOI 10.1095/biolreprod.105.039719; Jones RC, 1996, REPROD FERT DEVELOP, V8, P553, DOI 10.1071/RD9960553; Kaunisto K, 1999, BIOL REPROD, V61, P1521, DOI 10.1095/biolreprod61.6.1521; KAUNISTO K, 1990, HISTOCHEMISTRY, V94, P381; KAUNISTO K, 1995, BIOL REPROD, V52, P1350, DOI 10.1095/biolreprod52.6.1350; Kaunisto KM, 2002, J ANDROL, V23, P237; Kirchhoff C, 1999, INT REV CYTOL, V188, P133; Klier M, 2011, J BIOL CHEM, V286, P27781, DOI 10.1074/jbc.M111.255331; Krishnamurthy VM, 2008, CHEM REV, V108, P946, DOI 10.1021/cr050262p; Kujala M, 2007, REPRODUCTION, V133, P775, DOI 10.1530/rep.1.00964; Lishko PV, 2012, ANNU REV PHYSIOL, V74, P453, DOI 10.1146/annurev-physiol-020911-153258; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Liu YJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mannowetz N, 2011, INT J ANDROL, V34, P153, DOI 10.1111/j.1365-2605.2010.01067.x; Mannowetz N, 2012, J CELL PHYSIOL, V227, P2154, DOI 10.1002/jcp.22949; Miki K, 2013, CURR BIOL, V23, P443, DOI 10.1016/j.cub.2013.02.007; Nishigaki T, 2014, BIOCHEM BIOPH RES CO, V450, P1149, DOI 10.1016/j.bbrc.2014.05.100; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; OKAMURA N, 1985, J BIOL CHEM, V260, P9699; Pan PW, 2006, J PHYSIOL-LONDON, V571, P319, DOI 10.1113/jphysiol.2005.102590; PARKKILA S, 1993, BIOL REPROD, V49, P326, DOI 10.1095/biolreprod49.2.326; PARKKILA S, 1993, J HISTOCHEM CYTOCHEM, V41, P751, DOI 10.1177/41.5.8468457; PARKKILA S, 1991, HISTOCHEMISTRY, V95, P477, DOI 10.1007/BF00315743; Pastor-Soler N, 2005, PHYSIOLOGY, V20, P417, DOI 10.1152/physiol.00036.2005; PHELPS BM, 1990, J CELL BIOL, V111, P1839, DOI 10.1083/jcb.111.5.1839; Pholpramool C, 2011, CLIN EXP PHARMACOL P, V38, P353, DOI 10.1111/j.1440-1681.2011.05525.x; Saxena DK, 2002, REPRODUCTION, V123, P435, DOI 10.1530/rep.0.1230435; Schwarz A, 2013, CELL TISSUE RES, V353, P549, DOI 10.1007/s00441-013-1633-7; Shum WWC, 2009, J EXP BIOL, V212, P1753, DOI 10.1242/jeb.027284; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Sullivan R, 2013, REPRODUCTION, V146, pR21, DOI 10.1530/REP-13-0058; Tulsiani D R P, 2011, Minerva Ginecol, V63, P103; Turner RM, 2006, REPROD FERT DEVELOP, V18, P25, DOI 10.1071/RD05120; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wandernoth PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015061; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; WHITE DR, 1989, GAMETE RES, V22, P163, DOI 10.1002/mrd.1120220205; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P14132, DOI 10.1073/pnas.241245898	74	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29202	29216		10.1074/jbc.M115.698597	http://dx.doi.org/10.1074/jbc.M115.698597			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26487715	hybrid, Green Published			2022-12-28	WOS:000366613400008
J	Zheng, LL; Wang, FY; Cong, XX; Shen, Y; Rao, XS; Huang, DS; Fan, W; Yi, P; Wang, XB; Zheng, L; Zhou, YT; Luo, Y				Zheng, Li Ling; Wang, Fei Ya; Cong, Xiao Xia; Shen, Yue; Rao, Xi Sheng; Huang, Dao Sheng; Fan, Wei; Yi, Peng; Wang, Xin Bao; Zheng, Lei; Zhou, Yi Ting; Luo, Yan			Interaction of Heat Shock Protein Cpn10 with the Cyclin E/Cdk2 Substrate Nuclear Protein Ataxia-Telangiectasia (NPAT) Is Involved in Regulating Histone Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAJAL BODIES; GENE-EXPRESSION; DNA-SYNTHESIS; HSP10; P220(NPAT); ACTIVATION; PROMOTER; COMPLEX; E-CDK2; HSP90	Precise modulation of histone gene transcription is critical for cell cycle progression. As a direct substrate of Cyclin E/CDK2, nuclear protein ataxia-telangiectasia (NPAT) is a crucial factor in regulating histone transcription and cell cycle progression. Here we identified that Cpn10/HSPE, a 10-kDa heat shock protein, is a novel interacting partner of NPAT. A pool of Cpn10 is colocalized with NPAT foci during G1 and S phases in nuclei. Gain-and loss-of-function experiments unraveled an essential role of Cpn10 in histone transcription. Aconserved DLFD motif within Cpn10 was critical for targeting NPAT and modulating histone transcription. More importantly, knockdown of Cpn10 disrupted the focus formation of both NPAT and FADD-like interleukin-1 beta-converting enzyme-associated huge protein without affecting Coilin-positive Cajal bodies. Finally, Cpn10 is important for S phase progression and cell proliferation. Taken together, our finding revealed a novel role of Cpn10 in the spatial regulation of NPAT signaling and disclosed a previously unappreciated link between the heat shock protein and histone transcription regulation.	[Zheng, Li Ling; Wang, Fei Ya; Cong, Xiao Xia; Rao, Xi Sheng; Huang, Dao Sheng; Fan, Wei; Yi, Peng; Zhou, Yi Ting; Luo, Yan] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Biochem & Mol Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Cong, Xiao Xia; Rao, Xi Sheng; Huang, Dao Sheng; Fan, Wei; Yi, Peng; Zhou, Yi Ting] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Ctr Stem Cell & Regenerat Med,Key Lab Tissue Engn, Hangzhou 310058, Zhejiang, Peoples R China; [Shen, Yue] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthopaed Surg, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Xin Bao] Zhejiang Canc Hosp, Dept Abdominal Tumor Surg, Hangzhou 310022, Zhejiang, Peoples R China; [Zheng, Lei] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21231 USA; [Zheng, Lei] Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD 21231 USA	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang Cancer Hospital; Johns Hopkins University; Johns Hopkins University	Zhou, YT (corresponding author), Zhejiang Univ, Sch Med, Ctr Stem Cell & Regenerat Med, Dept Biochem & Mol Biol, 866 Yu Hang Tang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	zhouyt@zju.edu.cn; luoyan2011@zju.edu.cn	Huang, Daosheng/AAU-4548-2021	Huang, Daosheng/0000-0002-1267-2037; Zhou, Yi-Ting/0000-0003-4543-3099; Zheng, Liling/0000-0002-0378-2816	National Basic Research Program of China (973 Program) [2014CB542003]; National Natural Science Fund of China [31201017, 31371476]; Key Scientific and Technological Innovation Team of Zhejiang Province Grant [2013TD11]; National Natural Science Foundation of China [J1103603]; Zhejiang Provincial Natural Science Foundation of China [LY13C070001, LY13C070002, Y205757]; Medical Research Fund of Zhejiang Province Grant [2009A029]; Zhejiang Cancer Hospital	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Key Scientific and Technological Innovation Team of Zhejiang Province Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Medical Research Fund of Zhejiang Province Grant; Zhejiang Cancer Hospital	This work was supported by National Basic Research Program of China (973 Program) Grant 2014CB542003; National Natural Science Fund of China Grants 31201017 and 31371476; Key Scientific and Technological Innovation Team of Zhejiang Province Grant 2013TD11; National Natural Science Foundation of China Grant J1103603; Zhejiang Provincial Natural Science Foundation of China Grants LY13C070001, LY13C070002, and Y205757; Medical Research Fund of Zhejiang Province Grant 2009A029; and outstanding research personnel training funds of Zhejiang Cancer Hospital. The authors declare that they have no conflicts of interest with the contents of this article.	Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14808, DOI 10.1073/pnas.0604227103; Bongiorno-Borbone L, 2008, CELL CYCLE, V7, P2357, DOI 10.4161/cc.6344; Cappello F, 2004, EUR J HISTOCHEM, V48, P261; Cappello F, 2003, CANCER LETT, V196, P35, DOI 10.1016/S0304-3835(03)00212-X; Cappello F, 2003, ANTICANCER RES, V23, P1325; Corrao S, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140125; Czarnecka AM, 2006, CELL STRESS CHAPERON, V11, P287, DOI 10.1379/CSC-200.1; Deran M, 2008, MOL CELL BIOL, V28, P435, DOI 10.1128/MCB.00607-07; Gao G, 2003, MOL CELL BIOL, V23, P2821, DOI 10.1128/MCB.23.8.2821-2833.2003; Ghobrial IM, 2005, BLOOD, V105, P3722, DOI 10.1182/blood-2004-10-3999; Imai T, 1997, GENOMICS, V42, P388, DOI 10.1006/geno.1997.4769; Lin KM, 2004, FASEB J, V18, P1004, DOI 10.1096/fj.03-0348fje; Longshaw VM, 2004, J CELL SCI, V117, P701, DOI 10.1242/jcs.00905; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; Machyna M, 2013, WIRES RNA, V4, P17, DOI 10.1002/wrna.1139; Medina R, 2006, BIOCHEMISTRY-US, V45, P15915, DOI 10.1021/bi061425m; Miele A, 2005, MOL CELL BIOL, V25, P6140, DOI 10.1128/MCB.25.14.6140-6153.2005; Mitra P, 2009, J CELL PHYSIOL, V219, P438, DOI 10.1002/jcp.21687; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Nizami Z, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000653; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Park SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112130; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Ran QT, 2000, BIOCHEM BIOPH RES CO, V275, P174, DOI 10.1006/bbrc.2000.3237; Sadacharan SK, 2001, HISTOCHEM CELL BIOL, V116, P507, DOI 10.1007/s00418-001-0344-4; Shan YX, 2003, J MOL CELL CARDIOL, V35, P1135, DOI 10.1016/S0022-2828(03)00229-3; SITTMAN DB, 1983, P NATL ACAD SCI-BIOL, V80, P1849, DOI 10.1073/pnas.80.7.1849; Tsai YCC, 2012, J BIOL CHEM, V287, P20471, DOI 10.1074/jbc.M112.365411; Wang A, 2004, BIOCHEM BIOPH RES CO, V325, P1509, DOI 10.1016/j.bbrc.2004.10.198; Wei Y, 2003, MOL CELL BIOL, V23, P3669, DOI 10.1128/MCB.23.10.3669-3680.2003; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; WU RS, 1981, CELL, V27, P321, DOI 10.1016/0092-8674(81)90415-3; Ye X, 2003, MOL CELL BIOL, V23, P8586, DOI 10.1128/MCB.23.23.8586-8600.2003; Yi P, 2015, MOL BIOL CELL, V26, P29, DOI 10.1091/mbc.E14-03-0797; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zhao JY, 2004, CELL CYCLE, V3, P695; Zhao JY, 1998, GENE DEV, V12, P456, DOI 10.1101/gad.12.4.456; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; Zhu H, 2014, J BIOL CHEM, V289, P27432, DOI 10.1074/jbc.M114.560334	39	10	10	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29290	29300		10.1074/jbc.M115.659201	http://dx.doi.org/10.1074/jbc.M115.659201			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26429916	hybrid, Green Published			2022-12-28	WOS:000366613400017
J	Luo, XR; Nie, J; Wang, SW; Chen, ZJ; Chen, WJ; Li, D; Hu, H; Li, B				Luo, Xuerui; Nie, Jia; Wang, Shuaiwei; Chen, Zuojia; Chen, WanJun; Li, Dan; Hu, Hui; Li, Bin			Poly(ADP-ribosyl)ation of FOXP3 Protein Mediated by PARP-1 Protein Regulates the Function of Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation; forkhead box P3 (FOXP3); immunosuppression; inhibitor; posttranscriptional regulation; T cell; regulatory T cell	TRANSCRIPTION; POLYMERASE; MODULATION; BINDING	Poly(ADP-ribose) polymerase 1 (PARP-1) is an ADP-ribosylating enzyme participating in diverse cellular functions. The roles of PARP-1 in the immune system, however, have not been well understood. Here we find that PARP-1 interacts with FOXP3 and induces its poly(ADP-ribosyl)ation. By using PARP-1 inhibitors, we show that reduced poly(ADP-ribosyl)ation of FOXP3 results in not only FOXP3 stabilization and increased FOXP3 downstream genes but also enhanced suppressive function of regulatory T cells. Our results suggest that PARP-1 negatively regulates the suppressive function of Treg cells at the posttranslational level via FOXP3 poly(ADP-ribosyl)ation. This finding has implications for developing PARP-1 inhibitors as potential agents for the prevention and treatment of autoimmune diseases.	[Luo, Xuerui; Nie, Jia; Wang, Shuaiwei; Chen, Zuojia; Li, Dan; Li, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [Chen, WanJun] NIDCR, Mucosal Immunol Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Hu, Hui] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Alabama System; University of Alabama Birmingham	Li, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.	binli@sibs.ac.cn	lI, Bin/AAR-4966-2021; Chen, Zuojia/AAM-9465-2020	lI, Bin/0000-0002-7640-8884; Wang, Shuaiwei/0000-0002-1659-8962	Chinese National Program on Key Basic Research Project [2014CB541800, 2014CB541900]; NSFC [81330072, 31300711, 31370863, 31170825, 31200646, 31200647]; Shanghai Key Grant [14JC1406100]; Shanghai Three-year Plan on Promoting TCM Development Grant [ZY3-LCPT-2-1003]	Chinese National Program on Key Basic Research Project; NSFC(National Natural Science Foundation of China (NSFC)); Shanghai Key Grant; Shanghai Three-year Plan on Promoting TCM Development Grant	This work was supported by Chinese National Program on Key Basic Research Project Grants 2014CB541800, 2014CB541900, NSFC 81330072, 31300711, 31370863, 31170825, 31200646, and 31200647; Shanghai Key Grant 14JC1406100; and Shanghai Three-year Plan on Promoting TCM Development Grant ZY3-LCPT-2-1003. The authors declare that they have no conflicts of interest with the contents of this article.	Aldinucci A, 2007, J IMMUNOL, V179, P305, DOI 10.4049/jimmunol.179.1.305; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Curtin Nicola J., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S146239940500904X; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Hauschildt S, 1997, ADV EXP MED BIOL, V419, P249; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; KIEHLBAUCH CC, 1993, ANAL BIOCHEM, V208, P26, DOI 10.1006/abio.1993.1004; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li ZY, 2014, J BIOL CHEM, V289, P26872, DOI 10.1074/jbc.M114.586651; Lonn P, 2010, MOL CELL, V40, P521, DOI 10.1016/j.molcel.2010.10.029; Mabley JG, 2001, INFLAMM RES, V50, P561, DOI 10.1007/PL00000234; Meng NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062723; Nasta F, 2010, J IMMUNOL, V184, P3470, DOI 10.4049/jimmunol.0901568; Ruf A, 1998, J MOL BIOL, V278, P57, DOI 10.1006/jmbi.1998.1673; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Valdor R, 2008, MOL IMMUNOL, V45, P1863, DOI 10.1016/j.molimm.2007.10.044	25	40	41	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28675	28682		10.1074/jbc.M115.661611	http://dx.doi.org/10.1074/jbc.M115.661611			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26429911	Green Published, hybrid			2022-12-28	WOS:000365762300009
J	Chen, LJ; Hambright, WS; Na, R; Ran, QT				Chen, Liuji; Hambright, William Sealy; Na, Ren; Ran, Qitao			Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NONAPOPTOTIC CELL-DEATH; TRANSGENIC MICE; OXIDATIVE DAMAGE; APOPTOSIS; GPX4; GENERATION; PROTECTS; PHGPX	Glutathione peroxidase 4 (GPX4), an antioxidant defense enzyme active in repairing oxidative damage to lipids, is a key inhibitor of ferroptosis, a non-apoptotic form of cell death involving lipid reactive oxygen species. Here we show that GPX4 is essential for motor neuron health and survival in vivo. Conditional ablation of Gpx4 in neurons of adult mice resulted in rapid onset and progression of paralysis and death. Pathological inspection revealed that the paralyzed mice had a dramatic degeneration of motor neurons in the spinal cord but had no overt neuron degeneration in the cerebral cortex. Consistent with the role of GPX4 as a ferroptosis inhibitor, spinal motor neuron degeneration induced by Gpx4 ablation exhibited features of ferroptosis, including no caspase-3 activation, no TUNEL staining, activation of ERKs, and elevated spinal inflammation. Supplementation with vitamin E, another inhibitor of ferroptosis, delayed the onset of paralysis and death induced by Gpx4 ablation. Also, lipid peroxidation and mitochondrial dysfunction appeared to be involved in ferroptosis of motor neurons induced by Gpx4 ablation. Taken together, the dramatic motor neuron degeneration and paralysis induced by Gpx4 ablation suggest that ferroptosis inhibition by GPX4 is essential for motor neuron health and survival in vivo.	[Chen, Liuji; Hambright, William Sealy; Na, Ren; Ran, Qitao] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Ran, Qitao] South Texas Vet Hlth Care Syst, Res Serv, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Ran, QT (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	ran@uthscsa.edu			Department of Veterans Affairs; Alzheimer's Association; William and Ella Owens Medical Research Foundation; NATIONAL INSTITUTE ON AGING [T32AG021890] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Alzheimer's Association(Alzheimer's Association); William and Ella Owens Medical Research Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a merit review grant from the Department of Veterans Affairs, a grant from the Alzheimer's Association, and an award from The William and Ella Owens Medical Research Foundation. To whom correspondence should be addressed: Dept. of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78229. Tel.: 210-567-3842; Fax: 210-567-6781; E-mail: ran@uthscsa.edu.	Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Chen LJ, 2014, NEUROBIOL AGING, V35, P2552, DOI 10.1016/j.neurobiolaging.2014.05.007; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Girotti AW, 1998, J LIPID RES, V39, P1529; Guegan C, 2003, J CLIN INVEST, V111, P153, DOI 10.1172/JCI200317610; Heimer-McGinn V, 2011, GENESIS, V49, P942, DOI 10.1002/dvg.20777; Imai H, 2003, BIOCHEM BIOPH RES CO, V305, P278, DOI 10.1016/S0006-291X(03)00734-4; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Liang HY, 2007, BIOCHEM BIOPH RES CO, V356, P893, DOI 10.1016/j.bbrc.2007.03.045; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Ran QT, 2004, J BIOL CHEM, V279, P55137, DOI 10.1074/jbc.M410387200; Ran QT, 2003, FREE RADICAL BIO MED, V35, P1101, DOI 10.1016/S0891-5849(03)00466-0; Sathasivam S, 2005, LANCET NEUROL, V4, P500, DOI 10.1016/S1474-4422(05)70142-3; Tomik B, 2005, FOLIA NEUROPATHOL, V43, P75; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yamazaki M, 2005, NEUROPATHOLOGY, V25, P381, DOI 10.1111/j.1440-1789.2005.00648.x; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118	23	237	248	8	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28097	28106		10.1074/jbc.M115.680090	http://dx.doi.org/10.1074/jbc.M115.680090			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26400084	Green Published, hybrid			2022-12-28	WOS:000365761900006
J	Dudakovic, A; Camilleri, ET; Xu, FH; Riester, SM; McGee-Lawrence, ME; Bradley, EW; Paradise, CR; Lewallen, EA; Thaler, R; Deyle, DR; Larson, AN; Lewallen, DG; Dietz, AB; Stein, GS; Montecino, MA; Westendorf, JJ; van Wijnen, AJ				Dudakovic, Amel; Camilleri, Emily T.; Xu, Fuhua; Riester, Scott M.; McGee-Lawrence, Meghan E.; Bradley, Elizabeth W.; Paradise, Christopher R.; Lewallen, Eric A.; Thaler, Roman; Deyle, David R.; Larson, A. Noelle; Lewallen, David G.; Dietz, Allan B.; Stein, Gary S.; Montecino, Martin A.; Westendorf, Jennifer J.; van Wijnen, Andre J.			Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERTEBRAL FRACTURE RISK; MESENCHYMAL STEM-CELLS; DEACETYLASE INHIBITORS; POSTMENOPAUSAL WOMEN; TRANSCRIPTIONAL ACTIVATION; OSTEOBLAST DIFFERENTIATION; METHYLATION; RUNX2; GENE; CHROMATIN	Epigenetic control of gene expression is critical for normal fetal development. However, chromatin-related mechanisms that activate bone-specific programs during osteogenesis have remained underexplored. Therefore, we investigated the expression profiles of a large cohort of epigenetic regulators (>300) during osteogenic differentiation of human mesenchymal cells derived from the stromal vascular fraction of adipose tissue (AMSCs). Molecular analyses establish that the polycomb group protein EZH2 (enhancer of zeste homolog 2) is down-regulated during osteoblastic differentiation of AMSCs. Chemical inhibitor and siRNA knockdown studies show that EZH2, a histone methyltransferase that catalyzes trimethylation of histone 3 lysine 27 (H3K27me3), suppresses osteogenic differentiation. Blocking EZH2 activity promotes osteoblast differentiation and suppresses adipogenic differentiation of AMSCs. High throughput RNA sequence (mRNASeq) analysis reveals that EZH2 inhibition stimulates cell cycle inhibitory proteins and enhances the production of extracellular matrix proteins. Conditional genetic loss of Ezh2 in uncommitted mesenchymal cells (Prrx1-Cre) results in multiple defects in skeletal patterning and bone formation, including shortened forelimbs, craniosynostosis, and clinodactyly. Histological analysis and mRNASeq profiling suggest that these effects are attributable to growth plate abnormalities and premature cranial suture closure because of precocious maturation of osteoblasts. We conclude that the epigenetic activity of EZH2 is required for skeletal patterning and development, but EZH2 expression declines during terminal osteoblast differentiation and matrix production.	[Dudakovic, Amel; Camilleri, Emily T.; Xu, Fuhua; Riester, Scott M.; Bradley, Elizabeth W.; Paradise, Christopher R.; Lewallen, Eric A.; Thaler, Roman; Larson, A. Noelle; Lewallen, David G.; Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Deyle, David R.] Mayo Clin, Dept Med Genet, Rochester, MN 55905 USA; [Dietz, Allan B.] Mayo Clin, Lab Med & Pathol, Rochester, MN 55905 USA; [McGee-Lawrence, Meghan E.] Georgia Regents Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Stein, Gary S.] Univ Vermont, Sch Med, Dept Biochem, Burlington, VT 05405 USA; [Montecino, Martin A.] Univ Andres Bello, Centro Invest Biomed & Fondo Financiamiento, Ctr Invest Areas Prioritarias, Ctr Genome Regulat, Santiago 8370146, Chile	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University System of Georgia; Augusta University; University of Vermont; Universidad Andres Bello	van Wijnen, AJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.	vanwijnen.andre@mayo.edu	van Wijnen, Andre J./AAG-3578-2019; Larson, A. Noelle/AAC-7158-2019; Regan, Clinton/E-6250-2012; Dietz, Allan/AAI-6976-2021	van Wijnen, Andre J./0000-0002-4458-0946; Dietz, Allan/0000-0003-3410-9621; Lewallen, Eric/0000-0002-0777-7336; Larson, A. Noelle/0000-0001-6542-6975; Bradley, Elizabeth/0000-0002-8814-5524; Dudakovic, Amel/0000-0002-8850-3977; Camilleri, Emily/0000-0001-8982-6770; McGee-Lawrence, Meghan/0000-0002-2728-5849	National Institutes of Health [F32 AR066508, R01 AR049069, R01 AR068103, R01 DE020194, T32 AR056950, R03 AR065753, R03 AR066342, K01 AR065397, R01 AR039588]; Center for Clinical and Translational Science [UL1 TR000135]; Center for Regenerative Medicine at Mayo Clinic; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias [15090007]; Stryker Mako; Pipeline Biomedical; Zimmer; Ketai Medical Devices; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067707, R01AR068103, K01AR065397, T32AR056950, R03AR066342, R03AR065753, F32AR066508, R01AR049069, R01AR039588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE020194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Clinical and Translational Science; Center for Regenerative Medicine at Mayo Clinic; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias; Stryker Mako; Pipeline Biomedical; Zimmer; Ketai Medical Devices; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants F32 AR066508 (to A. D.), R01 AR049069 (to A. J. V. W.), R01 AR068103 (to J. J. W.), R01 DE020194 (to J. J. W.), T32 AR056950 (to J. J. W. and E. A. L.), R03 AR065753 (to D. R. D.), R03 AR066342 (to A. N. L.), K01 AR065397 (to E. W. B.), and R01 AR039588 (to G. S. S.). Additional support was provided by Center for Clinical and Translational Science Grant UL1 TR000135 and intramural grants from the Center for Regenerative Medicine at Mayo Clinic, as well as Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias Grant 15090007 (to M. A. M.) and the generous philanthropic support of William H. and Karen J. Eby and the charitable foundation in their names. Dr. Allan Dietz has a commercial interest in Mill Creek Life Sciences, which manufactures the clinical grade commercial platelet lysate product used for maintaining adipose tissue-derived mesenchymal stem cells. Dr. David Lewallen reports personal fees and other from Stryker Mako, Pipeline Biomedical, Zimmer, and Ketai Medical Devices. In addition, Dr. David Lewallen has patents on selected hip and knee implants with royalties paid by Zimmer and is employed part time as the Medical Director for the American Joint Replacement registry.	Bekker PJ, 2004, J BONE MINER RES, V19, P1059, DOI 10.1359/JBMR.040305; Bellido T, 2011, BONE, V49, P50, DOI 10.1016/j.bone.2010.08.008; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Cakouros D, 2012, MOL CELL BIOL, V32, P1433, DOI 10.1128/MCB.06315-11; Canalis E, 2010, J CLIN ENDOCR METAB, V95, P1496, DOI 10.1210/jc.2009-2677; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chiechio S, 2009, MOL PHARMACOL, V75, P1014, DOI 10.1124/mol.108.054346; Chouliaras L, 2010, PROG NEUROBIOL, V90, P498, DOI 10.1016/j.pneurobio.2010.01.002; Chuang DM, 2005, ANN NY ACAD SCI, V1053, P195, DOI 10.1196/annals.1344.018; Crespo-Diaz R, 2011, CELL TRANSPLANT, V20, P797, DOI 10.3727/096368910X543376; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dennison E, 2000, HORM RES, V54, P58, DOI 10.1159/000053299; Di Bernardo G, 2009, STEM CELLS DEV, V18, P573, DOI 10.1089/scd.2008.0172; Dudakovic A, 2015, J CELL PHYSIOL, V230, P52, DOI 10.1002/jcp.24680; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Dudakovic A, 2013, J BIOL CHEM, V288, P28783, DOI 10.1074/jbc.M113.489732; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Ettinger B, 2006, MENOPAUSE, V13, P340, DOI 10.1097/01.gme.0000222475.93345.b3; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Gibson WT, 2012, AM J HUM GENET, V90, P110, DOI 10.1016/j.ajhg.2011.11.018; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Gori F, 2006, DEV BIOL, V295, P498, DOI 10.1016/j.ydbio.2006.02.031; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Hewagama A, 2009, J AUTOIMMUN, V33, P3, DOI 10.1016/j.jaut.2009.03.007; Hui TQ, 2014, J ENDODONT, V40, P1132, DOI 10.1016/j.joen.2014.01.031; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Khan O, 2012, IMMUNOL CELL BIOL, V90, P85, DOI 10.1038/icb.2011.100; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lee JY, 2006, MOL CELLS, V22, P182; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Liu LH, 2012, BIOINFORMATICS, V28, P2205, DOI 10.1093/bioinformatics/bts340; Liu SF, 2013, PROCEEDINGS OF 2013 IEEE INTERNATIONAL CONFERENCE ON GREY SYSTEMS AND INTELLIGENT SERVICES (GSIS), P1, DOI 10.1109/GSIS.2013.6714728; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Mader EK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-20; Marchesi I, 2014, CELL CYCLE, V13, P516, DOI 10.4161/cc.27921; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McGee-Lawrence ME, 2011, GENE, V474, P1, DOI 10.1016/j.gene.2010.12.003; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Papapoulos SE, 2006, BONE, V38, P613, DOI 10.1016/j.bone.2006.01.141; PECK WA, 1993, AM J MED, V94, P646; Pike JW, 2011, J BONE MINER RES, V26, P1155, DOI 10.1002/jbmr.317; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Reszka AA, 2004, MINI-REV MED CHEM, V4, P711; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Schwarz D, 2014, DEVELOPMENT, V141, P867, DOI 10.1242/dev.094342; Silverman SL, 2008, J BONE MINER RES, V23, P1923, DOI 10.1359/JBMR.080710; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tatton-Brown K, 2011, ONCOTARGET, V2, P1127, DOI 10.18632/oncotarget.385; Villagra A, 2002, J CELL BIOCHEM, V85, P112, DOI 10.1002/jcb.10113; WEAVER DD, 1974, J PEDIATR-US, V84, P547, DOI 10.1016/S0022-3476(74)80675-X; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Wu H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r52; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180; Yang XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005011; Zaidi SK, 2014, CANCER RES, V74, P420, DOI 10.1158/0008-5472.CAN-13-2837; Zhu L, 2013, BIOCHEM BIOPH RES CO, V432, P612, DOI 10.1016/j.bbrc.2013.02.036; 2006, MENOPAUSE, V13, P368	68	105	109	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27604	27617		10.1074/jbc.M115.672345	http://dx.doi.org/10.1074/jbc.M115.672345			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26424790	hybrid, Green Published			2022-12-28	WOS:000365757500016
J	Li, DC; Nichols, CG; Sala-Rabanal, M				Li, Dan C.; Nichols, Colin G.; Sala-Rabanal, Monica			Role of a Hydrophobic Pocket in Polyamine Interactions with the Polyspecific Organic Cation Transporter OCT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-BINDING; SENSORINEURAL DEAFNESS; INWARD RECTIFICATION; PHYSIOLOGICAL ROLES; POTASSIUM CHANNELS; LACTOSE PERMEASE; ESCHERICHIA-COLI; MOLECULAR-BASIS; AMINO-ACIDS; MUTATIONS	Organic cation transporter 3 (OCT3, SLC22A3) is a polyspecific, facilitative transporter expressed in astrocytes and in placental, intestinal, and blood-brain barrier epithelia, and thus elucidating the molecular mechanisms underlying OCT3 substrate recognition is critical for the rational design of drugs targeting these tissues. The pharmacology of OCT3 is distinct from that of other OCTs, and here we investigated the role of a hydrophobic cavity tucked within the translocation pathway in OCT3 transport properties. Replacement of an absolutely conserved Asp by charge reversal (D478E), neutralization (D478N), or even exchange (D478E) abolished MPP+ uptake, demonstrating this residue to be obligatory for OCT3-mediated transport. Mutations at non-conserved residues lining the putative binding pocket of OCT3 to the corresponding residue in OCT1 (L166F, F450L, and E451Q) reduced the rate of MPP+ transport, but recapitulated the higher sensitivity pharmacological profile of OCT1. Thus, interactions of natural polyamines (putrescine, spermidine, spermine) and polyamine-like potent OCT1 blockers (1,10-diaminodecane, decamethonium, bistriethylaminodecane, and 1,10-bisquinuclidinedecane) with wild-type OCT3 were weak, but were significantly potentiated in the mutant OCT3s. Conversely, a reciprocal mutation in OCT1 (F161L) shifted the polyamine-sensitivity phenotype toward that of OCT3. Further analysis indicated that OCT1 and OCT3 can recognize essentially the same substrates, but the strength of substrate-transporter interactions is weaker in OCT3, as informed by the distinct makeup of the hydrophobic cleft. The residues identified here are key contributors to both the observed differences between OCT3 and OCT1 and to the mechanisms of substrate recognition by OCTs in general.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, CIMED, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Sala-Rabanal, M (corresponding author), 660 South Euclid, St Louis, MO 63110 USA.	msala@wustl.edu	Regan, Clinton/E-6250-2012; Sala-Rabanal, Monica/AAU-2383-2021	Li, Dan/0000-0003-3000-5681	National Institutes of Health [HL54171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL54171 (to C. G. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Ahlin G, 2008, J MED CHEM, V51, P5932, DOI 10.1021/jm8003152; Bednarczyk D, 2003, MOL PHARMACOL, V63, P489, DOI 10.1124/mol.63.3.489; Benedikt J, 2012, NEUROREPORT, V23, P1021, DOI 10.1097/WNR.0b013e32835aa04b; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Busch AE, 1998, MOL PHARMACOL, V54, P342, DOI 10.1124/mol.54.2.342; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Choi MK, 2008, DRUG METAB PHARMACOK, V23, P243, DOI 10.2133/dmpk.23.243; Ciarimboli G, 2011, EXPERT OPIN DRUG MET, V7, P159, DOI 10.1517/17425255.2011.547474; Cui M, 2009, P NATL ACAD SCI USA, V106, P8043, DOI 10.1073/pnas.0900358106; Gorboulev V, 1999, MOL PHARMACOL, V56, P1254, DOI 10.1124/mol.56.6.1254; Gorboulev V, 1997, DNA CELL BIOL, V16, P871, DOI 10.1089/dna.1997.16.871; Gorbunov D, 2008, MOL PHARMACOL, V73, P50, DOI 10.1124/mol.107.040170; Hendrickx R, 2013, J MED CHEM, V56, P7232, DOI 10.1021/jm400966v; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Higashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102234; Hosoya K, 2011, CLIN EXP NEPHROL, V15, P478, DOI 10.1007/s10157-011-0460-y; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Inazu M, 2003, J NEUROCHEM, V84, P43, DOI 10.1046/j.1471-4159.2003.01566.x; Inyushin M, 2010, EPILEPSIA, V51, P1707, DOI 10.1111/j.1528-1167.2010.02592.x; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Koepsell H, 2011, BIOL CHEM, V392, P95, DOI 10.1515/BC.2011.009; Kucheryavykh YV, 2008, GLIA, V56, P775, DOI 10.1002/glia.20652; Kurata HT, 2004, J GEN PHYSIOL, V124, P541, DOI 10.1085/jgp.200409159; Lips KS, 2005, AM J RESP CELL MOL, V33, P79, DOI 10.1165/rcmb.2004-0363OC; Loussouarn G, 2005, MOL PHARMACOL, V68, P298, DOI 10.1124/mol.105.012377; Muller J, 2005, BIOCHEM PHARMACOL, V70, P1851, DOI 10.1016/j.bcp.2005.09.011; Muth A, 2014, J MED CHEM, V57, P348, DOI 10.1021/jm401174a; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Nishimura Masuhiro, 2005, Drug Metab Pharmacokinet, V20, P452, DOI 10.2133/dmpk.20.452; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pelis RM, 2006, J BIOL CHEM, V281, P35272, DOI 10.1074/jbc.M606561200; Popp C, 2005, MOL PHARMACOL, V67, P1600, DOI 10.1124/mol.104.008839; Sala-Rabanal M, 2013, MOL PHARMACEUT, V10, P1450, DOI 10.1021/mp400024d; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Sata R, 2005, J PHARMACOL EXP THER, V315, P888, DOI 10.1124/jpet.105.086827; Schmitt BM, 2005, J BIOL CHEM, V280, P24481, DOI 10.1074/jbc.M414550200; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Suhre WM, 2005, MOL PHARMACOL, V67, P1067, DOI 10.1124/mol.104.004713; Volk C, 2009, MOL PHARMACOL, V76, P275, DOI 10.1124/mol.109.054783; Wright SH, 2005, TOXICOL APPL PHARM, V204, P309, DOI 10.1016/j.taap.2004.10.021; Wright SH, 2004, PHYSIOL REV, V84, P987, DOI 10.1152/physrev.00040.2003; Zhang XH, 2005, J BIOL CHEM, V280, P34813, DOI 10.1074/jbc.M506342200; Zolk O, 2012, ANN MED, V44, P119, DOI 10.3109/07853890.2010.549144; Zolk O, 2009, N-S ARCH PHARMACOL, V379, P337, DOI 10.1007/s00210-008-0369-5	46	7	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27633	27643		10.1074/jbc.M115.668913	http://dx.doi.org/10.1074/jbc.M115.668913			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26405039	Green Published, hybrid			2022-12-28	WOS:000365757500018
J	Owen, CD; Lukacik, P; Potter, JA; Sleator, O; Taylor, GL; Walsh, MA				Owen, C. David; Lukacik, Petra; Potter, Jane A.; Sleator, Olivia; Taylor, Garry L.; Walsh, Martin A.			Streptococcus pneumoniae NanC STRUCTURAL INSIGHTS INTO THE SPECIFICITY AND MECHANISM OF A SIALIDASE THAT PRODUCES A SIALIDASE INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; CRYSTAL-STRUCTURE; INFLUENZA-VIRUS; TRANS-SIALIDASE; NEURAMINIDASE; BACTERIAL; ACID; COLONIZATION; OSELTAMIVIR; INHIBITION	Streptococcus pneumoniae is an important human pathogen that causes a range of disease states. Sialidases are important bacterial virulence factors. There are three pneumococcal sialidases: NanA, NanB, and NanC. NanC is an unusual sialidase in that its primary reaction product is 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (Neu5Ac2en, also known as DANA), a nonspecific hydrolytic sialidase inhibitor. The production of Neu5Ac2en from alpha 2-3-linked sialosides by the catalytic domain is confirmed within a crystal structure. A covalent complex with 3-fluoro-beta-N-acetylneuraminic acid is also presented, suggesting a common mechanism with other sialidases up to the final step of product formation. A conformation change in an active site hydrophobic loop on ligand binding constricts the entrance to the active site. In addition, the distance between the catalytic acid/base (Asp-315) and the ligand anomeric carbon is unusually short. These features facilitate a novel sialidase reaction in which the final step of product formation is direct abstraction of the C3 proton by the active site aspartic acid, forming Neu5Ac2en. NanC also possesses a carbohydrate-binding module, which is shown to bind alpha 2-3- and alpha 2-6-linked sialosides, as well as N-acetylneuraminic acid, which is captured in the crystal structure following hydration of Neu5Ac2en by NanC. Overall, the pneumococcal sialidases show remarkable mechanistic diversity while maintaining a common structural scaffold.	[Owen, C. David; Potter, Jane A.; Taylor, Garry L.] Univ St Andrews, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland; [Lukacik, Petra; Walsh, Martin A.] Harwell Sci & Innovat Campus, Diamond Light Source, Didcot OX11 0FA, Oxon, England; [Lukacik, Petra] Harwell Sci & Innovat Campus, Res Complex Harwell, Didcot OX11 0FA, Oxon, England; [Sleator, Olivia; Walsh, Martin A.] European Synchrotron Radiat Facil, Med Res Council France, F-38043 Grenoble, France	University of St Andrews; Diamond Light Source; European Synchrotron Radiation Facility (ESRF)	Taylor, GL (corresponding author), Univ St Andrews, Biomed Sci Res Complex, St Andrews KY16 9ST, Fife, Scotland.	glt2@st-andrews.ac.uk; martin.walsh@diamond.ac.uk	Lukacik, Petra/AAY-3775-2021; Walsh, Martin A/I-1566-2013	Lukacik, Petra/0000-0002-3179-7273; Walsh, Martin A/0000-0001-5683-1151; Taylor, Garry/0000-0001-9486-566X; Owen, David/0000-0001-5774-8202	Biotechnology and Biological Sciences Research Council (UK); Medical Research Council (UK); Biotechnology and Biological Sciences Research Council [1099850] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (UK) and the Medical Research Council (UK). The authors declare that they have no conflicts of interest with the contents of this article.	Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Brittan JL, 2012, MOL ORAL MICROBIOL, V27, P270, DOI 10.1111/j.2041-1014.2012.00658.x; Buschiazzo A, 2000, EMBO J, V19, P16, DOI 10.1093/emboj/19.1.16; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Connaris H, 2009, J BIOL CHEM, V284, P7339, DOI 10.1074/jbc.M807398200; Cornick JE, 2012, MICROBES INFECT, V14, P573, DOI 10.1016/j.micinf.2012.01.012; CRENNELL S, 1994, STRUCTURE, V2, P535, DOI 10.1016/S0969-2126(00)00053-8; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Gut H, 2008, FEBS LETT, V582, P3348, DOI 10.1016/j.febslet.2008.08.026; Gut H, 2011, J MOL BIOL, V409, P496, DOI 10.1016/j.jmb.2011.04.016; Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08; Hayre JK, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-19; HOLZER CT, 1993, GLYCOCONJUGATE J, V10, P40, DOI 10.1007/BF00731185; Hsiao YS, 2009, BIOCHEM BIOPH RES CO, V380, P467, DOI 10.1016/j.bbrc.2009.01.108; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Janapatla RP, 2013, CLIN MICROBIOL INFEC, V19, P480, DOI 10.1111/j.1469-0691.2012.03894.x; Jefferson T, 2010, COCHRANE DB SYST REV; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liu HT, 2009, PROTEIN EXPRES PURIF, V63, P102, DOI 10.1016/j.pep.2008.09.008; Long JP, 2004, INFECT IMMUN, V72, P4309, DOI 10.1128/IAI.72.7.4309-4313.2004; Luo Y, 1998, STRUCTURE, V6, P521, DOI 10.1016/S0969-2126(98)00053-7; Magesh S, 2008, BIOORG MED CHEM LETT, V18, P532, DOI 10.1016/j.bmcl.2007.11.084; Manco S, 2006, INFECT IMMUN, V74, P4014, DOI 10.1128/IAI.01237-05; Marion C, 2011, INFECT IMMUN, V79, P1262, DOI 10.1128/IAI.00832-10; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCullers JA, 2004, J INFECT DIS, V190, P519, DOI 10.1086/421525; McCullers JA, 2003, J INFECT DIS, V187, P1000, DOI 10.1086/368163; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Muchmore EA, 1998, AM J PHYS ANTHROPOL, V107, P187, DOI 10.1002/(SICI)1096-8644(199810)107:2<187::AID-AJPA5>3.3.CO;2-M; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Newstead SL, 2008, J BIOL CHEM, V283, P9080, DOI 10.1074/jbc.M710247200; Okike IO, 2014, LANCET INFECT DIS, V14, P301, DOI 10.1016/S1473-3099(13)70332-3; Olarte L, 2015, CLIN INFECT DIS, V61, P767, DOI 10.1093/cid/civ368; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park KH, 2013, BBA-PROTEINS PROTEOM, V1834, P1510, DOI 10.1016/j.bbapap.2013.04.028; Parker D, 2009, INFECT IMMUN, V77, P3722, DOI 10.1128/IAI.00228-09; Parker RB, 2012, ACS CHEM BIOL, V7, P1509, DOI 10.1021/cb300241v; Pettigrew MM, 2006, INFECT IMMUN, V74, P3360, DOI 10.1128/IAI.01442-05; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Quistgaard EM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-46; Rennie Robert P, 2012, Handb Exp Pharmacol, P45, DOI 10.1007/978-3-642-28951-4_4; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Seki M, 2004, CLIN EXP IMMUNOL, V137, P35, DOI 10.1111/j.1365-2249.2004.02481.x; Smutova V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106320; Stierand K, 2007, CHEMMEDCHEM, V2, P853, DOI 10.1002/cmdc.200700010; Tailford LE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8624; Tanaka A, 2015, ANTIVIR THER, V20, P11, DOI 10.3851/IMP2744; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Uchiyama S, 2009, J EXP MED, V206, P1845, DOI 10.1084/jem.20090386; Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107; von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Walther E, 2015, INT J MED MICROBIOL, V305, P289, DOI 10.1016/j.ijmm.2014.12.004; Watts AG, 2006, J BIOL CHEM, V281, P4149, DOI 10.1074/jbc.M510677200; Watts AG, 2003, J AM CHEM SOC, V125, P7532, DOI 10.1021/ja0344967; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wolfe S, 2015, EPIDEMIOLOGY PREVENT; Word JM, 2000, PROTEIN SCI, V9, P2251, DOI 10.1110/ps.9.11.2251; Xu GG, 2008, ACTA CRYSTALLOGR F, V64, P772, DOI 10.1107/S1744309108024044; Xu GG, 2011, J AM CHEM SOC, V133, P1718, DOI 10.1021/ja110733q; Xu GG, 2008, J MOL BIOL, V384, P436, DOI 10.1016/j.jmb.2008.09.032	77	30	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27736	27748		10.1074/jbc.M115.673632	http://dx.doi.org/10.1074/jbc.M115.673632			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26370075	Green Published, hybrid			2022-12-28	WOS:000365757500026
J	Rhayem, Y; Le Stunff, C; Khalek, WA; Auzan, C; Bertherat, J; Linglart, A; Couvineau, A; Silve, C; Clauser, E				Rhayem, Yara; Le Stunff, Catherine; Khalek, Waed Abdel; Auzan, Colette; Bertherat, Jerome; Linglart, Agnes; Couvineau, Alain; Silve, Caroline; Clauser, Eric			Functional Characterization of PRKAR1A Mutations Reveals a Unique Molecular Mechanism Causing Acrodysostosis but Multiple Mechanisms Causing Carney Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; IDENTIFIES PDE4D MUTATIONS; HORMONE RESISTANCE; REGULATORY SUBUNIT; COUPLED RECEPTORS; GENE; DELETION; MUTANT; BRET	The main target of cAMP is PKA, the main regulatory subunit of which (PRKAR1A) presents mutations in two genetic disorders: acrodysostosis and Carney complex. In addition to the initial recurrent mutation (R368X) of the PRKAR1A gene, several missense and nonsense mutations have been observed recently in acrodysostosis with hormonal resistance. These mutations are located in one of the two cAMP-binding domains of the protein, and their functional characterization is presented here. Expression of each of the PRKAR1A mutants results in a reduction of forskolin-induced PKA activation (measured by a reporter assay) and an impaired ability of cAMP to dissociate PRKAR1A from the catalytic PKA subunits by BRET assay. Modeling studies and sensitivity to cAMP analogs specific for domain A (8-piperidinoadenosine 3',5'-cyclic monophosphate) or domain B (8-(6-aminohexyl)aminoadenosine-3',5'-cyclic monophosphate) indicate that the mutations impair cAMP binding locally in the domain containing the mutation. Interestingly, two of these mutations affect amino acids for which alternative amino acid substitutions have been reported to cause the Carney complex phenotype. To decipher the molecular mechanism through which homologous substitutions can produce such strikingly different clinical phenotypes, we studied these mutations using the same approaches. Interestingly, the Carney mutants also demonstrated resistance to cAMP, but they expressed additional functional defects, including accelerated PRKAR1A protein degradation. These data demonstrate that a cAMP binding defect is the common molecular mechanism for resistance of PKA activation in acrodysosotosis and that several distinct mechanisms lead to constitutive PKA activation in Carney complex.	[Rhayem, Yara; Khalek, Waed Abdel; Auzan, Colette; Clauser, Eric] Univ Paris 05, INSERM U970, Paris Ctr Rech Cardiovasc, F-75015 Paris, France; [Rhayem, Yara; Silve, Caroline; Clauser, Eric] Hop Cochin, AP HP, Serv Biochim & Genet Mol, F-75014 Paris, France; [Bertherat, Jerome] Hop Cochin, AP HP, Serv Endocrinol, F-75014 Paris, France; [Le Stunff, Catherine; Silve, Caroline] Univ Paris 11, Hop Bicetre, INSERM U1169, F-94270 Le Kremlin Bicetre, France; [Bertherat, Jerome] Univ Paris 05, INSERM U1060, Inst Cochin, F-75014 Paris, France; [Linglart, Agnes] Hop Bicetre, AP HP, Serv Endocrinol Pediat, F-94270 Le Kremlin Bicetre, France; [Couvineau, Alain] Univ Paris Diderot, Fac Med, ERL CNRS 8252, UMR INSERM 1149, F-75018 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Clauser, E (corresponding author), INSERM U970, PARCC, 56 Rue Leblanc, F-75015 Paris, France.	eric.clauser@inserm.fr	LE STUNFF, CATHERINE/Y-3270-2018; couvineau, alain/G-3641-2013; couvineau, alain/T-3466-2019; Linglart, Agnès/A-8047-2016	LE STUNFF, CATHERINE/0000-0001-8419-0451; couvineau, alain/0000-0003-2912-5168; couvineau, alain/0000-0003-2912-5168; Linglart, Agnès/0000-0003-3455-002X; BERTHERAT, Jerome/0000-0003-2551-3008	INSERM; Assistance Publique, Hopitaux de Paris	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Assistance Publique, Hopitaux de Paris	This work was supported by recurrent funding from INSERM and Assistance Publique, Hopitaux de Paris.	Achour L, 2011, METHODS MOL BIOL, V756, P183, DOI 10.1007/978-1-61779-160-4_9; Bae E, 2005, J BIOL CHEM, V280, P30943, DOI 10.1074/jbc.M504216200; Bataille MG, 2014, EUR J ENDOCRINOL, V170, P151, DOI 10.1530/EJE-13-0740; Bertherat J, 2009, J CLIN ENDOCR METAB, V94, P2085, DOI 10.1210/jc.2008-2333; Bossis I, 2004, ENDOCRINOLOGY, V145, P5452, DOI 10.1210/en.2004-0900; Greene EL, 2008, HUM MUTAT, V29, P633, DOI 10.1002/humu.20688; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Lee H, 2012, AM J HUM GENET, V90, P746, DOI 10.1016/j.ajhg.2012.03.004; Lefkimmiatis K, 2014, PHARMACOL THERAPEUT, V143, P295, DOI 10.1016/j.pharmthera.2014.03.008; Linglart A, 2012, J CLIN ENDOCR METAB, V97, pE2328, DOI 10.1210/jc.2012-2326; Linglart A, 2011, NEW ENGL J MED, V364, P2218, DOI 10.1056/NEJMoa1012717; Michot C, 2012, AM J HUM GENET, V90, P740, DOI 10.1016/j.ajhg.2012.03.003; Muhn F, 2013, CLIN GENET, V84, P531, DOI 10.1111/cge.12106; Nagasaki K, 2012, J CLIN ENDOCR METAB, V97, pE1808, DOI 10.1210/jc.2012-1369; Parnot C, 2002, TRENDS ENDOCRIN MET, V13, P336, DOI 10.1016/S1043-2760(02)00628-8; Prinz A, 2006, CELL SIGNAL, V18, P1616, DOI 10.1016/j.cellsig.2006.01.013; Schwede F, 2000, BIOCHEMISTRY-US, V39, P8803, DOI 10.1021/bi000304y; Silve C, 2012, Bonekey Rep, V1, P225, DOI 10.1038/bonekey.2012.225; SKALHEGG BS, 1992, J BIOL CHEM, V267, P15707; Solberg R, 1997, ENDOCRINOLOGY, V138, P169, DOI 10.1210/en.138.1.169; SPAULDING SW, 1993, ENDOCR REV, V14, P632, DOI 10.1210/er.14.5.632; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; WETTERS TV, 1983, MOL CELL BIOL, V3, P250, DOI 10.1128/MCB.3.2.250	29	23	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27816	27828		10.1074/jbc.M115.656553	http://dx.doi.org/10.1074/jbc.M115.656553			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26405036	Green Published, hybrid			2022-12-28	WOS:000365757500032
J	Walzer, SA; Egerer-Sieber, C; Sticht, H; Sevvana, M; Hohl, K; Milbradt, J; Muller, YA; Marschall, M				Walzer, Sascha A.; Egerer-Sieber, Claudia; Sticht, Heinrich; Sevvana, Madhumati; Hohl, Katharina; Milbradt, Jens; Muller, Yves A.; Marschall, Manfred			Crystal Structure of the Human Cytomegalovirus pUL50-pUL53 Core Nuclear Egress Complex Provides Insight into a Unique Assembly Scaffold for Virus-Host Protein Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMINA; KINASES; PUL50; ALIGNMENT	Nuclear replication of cytomegalovirus relies on elaborate mechanisms of nucleocytoplasmic egress of viral particles. Thus, the role of two essential and conserved viral nuclear egress proteins, pUL50 and pUL53, is pivotal. pUL50 and pUL53 heterodimerize and form a core nuclear egress complex (NEC), which is anchored to the inner nuclear membrane and provides a scaffold for the assembly of a multimeric viral-cellular NEC. Here, we report the crystal structure of the pUL50-pUL53 heterodimer (amino acids 1-175 and 50-292, respectively) at 2.44 angstrom resolution. Both proteins adopt a globular fold with mixed alpha and beta secondary structure elements. pUL53-specific features include a zinc-binding site and a hook-like N-terminal extension, the latter representing a hallmark element of the pUL50-pUL53 interaction. The hook-like extension (amino acids 59-87) embraces pUL50 and contributes 1510 angstrom(2) to the total interface area (1880 angstrom(2)). The pUL50 structure overall resembles the recently published NMR structure of the murine cytomegalovirus homolog pM50 but reveals a considerable repositioning of the very C-terminal alpha-helix of pUL50 upon pUL53 binding. pUL53 shows structural resemblance with the GHKL domain of bacterial sensory histidine kinases. A close examination of the crystal structure indicates partial assembly of pUL50-pUL53 heterodimers to hexameric ring-like structures possibly providing additional scaffolding opportunities for NEC. In combination, the structural information on pUL50-pUL53 considerably improves our understanding of the mechanism of HCMV nuclear egress. It may also accelerate the validation of the NEC as a unique target for developing a novel type of antiviral drug and improved options of broad-spectrum antiherpesviral therapy.	[Walzer, Sascha A.; Egerer-Sieber, Claudia; Sevvana, Madhumati; Hohl, Katharina; Muller, Yves A.] Univ Erlangen Nurnberg, Div Biotechnol, Dept Biol, D-91054 Erlangen, Germany; [Sticht, Heinrich] Univ Erlangen Nurnberg, Div Bioinformat, Inst Biochem, D-91054 Erlangen, Germany; [Milbradt, Jens; Marschall, Manfred] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Muller, YA (corresponding author), Univ Erlangen Nurnberg, Div Biotechnol, Dept Biol, D-91054 Erlangen, Germany.	yves.muller@fau.de; manfred.marschall@viro.med.uni-erlangen.de	Muller, Yves A/R-5397-2016; Sevvana, Madhumati/S-3297-2019	Muller, Yves A/0000-0003-0519-8928; Sevvana, Madhumati/0000-0003-4992-6296; Sticht, Heinrich/0000-0001-5644-045X; Milbradt, Jens/0000-0003-2172-7471	Deutsche Forschungsgemeinschaft [SFB796, MA1289/8-1]; Wilhelm Sander-Stiftung [2011.085.1-2]; Bayerische Forschungsstiftung (ForBIMed-Biomarker in der Infektionsmedizin/I1)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Sander-Stiftung; Bayerische Forschungsstiftung (ForBIMed-Biomarker in der Infektionsmedizin/I1)	This work was supported by Deutsche Forschungsgemeinschaft via SFB796 (A2, A3/Z1, C3) and MA1289/8-1 and by Wilhelm Sander-Stiftung (2011.085.1-2) and Bayerische Forschungsstiftung (ForBIMed-Biomarker in der Infektionsmedizin/I1). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bigalke JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5131; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Funk C, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004957; Gres AT, 2015, SCIENCE, V349, P99, DOI 10.1126/science.aaa5936; Griffiths P, 2015, J PATHOL, V235, P288, DOI 10.1002/path.4437; Hamilton ST, 2014, REV MED VIROL, V24, P420, DOI 10.1002/rmv.1814; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuny CV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001092; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee CP, 2010, REV MED VIROL, V20, P214, DOI 10.1002/rmv.643; Leigh KE, 2015, P NATL ACAD SCI USA, V112, P9010, DOI 10.1073/pnas.1511140112; Lemnitzer F, 2013, CELL MICROBIOL, V15, P335, DOI 10.1111/cmi.12080; Lotzerich M, 2006, J VIROL, V80, P73, DOI 10.1128/JVI.80.1.73-84.2006; Marschall M, 2005, J BIOL CHEM, V280, P33357, DOI 10.1074/jbc.M502672200; Marschall M, 2011, ADV VIRUS RES, V80, P69, DOI 10.1016/B978-0-12-385987-7.00004-X; Marschall M, 2009, FUTURE MICROBIOL, V4, P731, DOI [10.2217/fmb.09.40, 10.2217/FMB.09.40]; Mettenleiter TC, 2013, CELL MICROBIOL, V15, P170, DOI 10.1111/cmi.12044; Milbradt J, 2007, J GEN VIROL, V88, P2642, DOI 10.1099/vir.0.82924-0; Milbradt J, 2014, MOL CELL PROTEOMICS, V13, P2132, DOI 10.1074/mcp.M113.035782; Milbradt J, 2012, J BIOL CHEM, V287, P24004, DOI 10.1074/jbc.M111.331207; Milbradt J, 2010, J BIOL CHEM, V285, P13979, DOI 10.1074/jbc.M109.063628; Milbradt J, 2009, J GEN VIROL, V90, P579, DOI 10.1099/vir.0.005231-0; Mocarski Jr E, 2013, FIELDS VIROLOGY, V2, P1960; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Ruiz FM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129691; Sam MD, 2009, J VIROL, V83, P2996, DOI 10.1128/JVI.02441-08; Schmeiser C, 2013, J GEN VIROL, V94, P2056, DOI 10.1099/vir.0.052571-0; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sharma M, 2015, J VIROL, V89, P523, DOI 10.1128/JVI.02426-14; Sharma M, 2014, J VIROL, V88, P10982, DOI 10.1128/JVI.01391-14; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tandon R, 2012, TRENDS MICROBIOL, V20, P392, DOI 10.1016/j.tim.2012.04.008; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	43	54	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27452	27458		10.1074/jbc.C115.686527	http://dx.doi.org/10.1074/jbc.C115.686527			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26432641	hybrid, Green Published			2022-12-28	WOS:000365757500002
J	Zhou, JL; Ueda, K; Zhao, J; Sparrow, JR				Zhou, Jilin; Ueda, Keiko; Zhao, Jin; Sparrow, Janet R.			Correlations between Photodegradation of Bisretinoid Constituents of Retina and Dicarbonyl Adduct Deposition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; PIGMENT EPITHELIAL-CELLS; HUMAN BRUCHS MEMBRANE; MACULAR DEGENERATION; OXIDATIVE STRESS; MATRIX METALLOPROTEINASES; CROSS-LINKING; MOUSE MODEL; FUNDUS AUTOFLUORESCENCE; LIPOFUSCIN PIGMENTS	Non-enzymatic collagen cross-linking and carbonyl adduct deposition are features of Bruch's membrane aging in the eye, and disturbances in extracellular matrix turnover are considered to contribute to Bruch's membrane thickening. Because bisretinoid constituents of the lipofuscin of retinal pigment epithelial (RPE) cells are known to photodegrade to mixtures of aldehyde-bearing fragments and small dicarbonyls (glyoxal (GO) and methylglyoxal (MG)), we investigated RPE lipofuscin as a source of the reactive species that covalently modify protein side chains. Abca4(-/-) and Rdh8(-/-)/Abca4(-/-) mice that are models of accelerated bisretinoid formation were studied and pre-exposure of mice to 430 nm light enriched for dicarbonyl release by bisretinoid photodegradation. MG protein adducts were elevated in posterior eyecups of mutant mice, whereas carbonylation of an RPE-specific protein was observed in Abca4(-/-) but not in wild-type mice under the same conditions. Immunolabeling of cryostat-sectioned eyes harvested from Abca4(-/-) mice revealed that carbonyl adduct deposition in Bruch's membrane was accentuated. Cell-based assays corroborated these findings in mice. Moreover, the receptor for advanced glycation end products that recognizes MG and GO adducts and glyoxylase 1 that metabolizes MG and GO were up-regulated in Abca4(-/-) mice. Additionally, in acellular assays, peptides were cross-linked in the presence of A2E (adduct of two vitamin A aldehyde and ethanolamine) photodegradation products, and in a zymography assay, reaction of collagen IV with products of A2E photodegradation resulted in reduced cleavage by the matrix metalloproteinases MMP2 and MMP9. In conclusion, these mechanistic studies demonstrate a link between the photodegradation of RPE bisretinoid fluorophores and aging changes in underlying Bruch's membrane that can confer risk of age-related macular degeneration.	[Zhou, Jilin; Ueda, Keiko; Zhao, Jin; Sparrow, Janet R.] Columbia Univ, Med Ctr, Dept Ophthalmol, New York, NY 10032 USA; [Sparrow, Janet R.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Sparrow, JR (corresponding author), Columbia Univ, Dept Ophthalmol, 635 W 165th St, New York, NY 10032 USA.	jrs88@columbia.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [EY12951, P30EY019007]; Foundation Fighting Blindness; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY012951, P30EY019007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants EY12951 and P30EY019007, Foundation Fighting Blindness, and a grant from Research to Prevent Blindness (to the Dept. of Ophthalmology, Columbia University). The authors declare that they have no conflicts of interest with the contents of this article.	Abordo EA, 1999, BIOCHEM PHARMACOL, V58, P641, DOI 10.1016/S0006-2952(99)00132-X; ALEXANDER JP, 1990, INVEST OPHTH VIS SCI, V31, P2520; Alge-Priglinger CS, 2009, INVEST OPHTH VIS SCI, V50, P5495, DOI 10.1167/iovs.08-3193; Allaman I, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00023; Bento CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015062; Bondeva T, 2011, AM J PHYSIOL-RENAL, V301, pF852, DOI 10.1152/ajprenal.00575.2010; Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003; CANELLAS PF, 1981, J IMMUNOL METHODS, V47, P375, DOI 10.1016/0022-1759(81)90294-5; Cano M, 2011, AM J PATHOL, V179, P850, DOI 10.1016/j.ajpath.2011.04.010; Chellan P, 2001, J BIOL CHEM, V276, P3895, DOI 10.1074/jbc.M008626200; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Cousins SW, 2003, INVEST OPHTH VIS SCI, V44, P1221, DOI 10.1167/iovs.02-0285; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Curcio CA, 2010, J LIPID RES, V51, P451, DOI 10.1194/jlr.R002238; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Flynn E, 2014, INVEST OPHTH VIS SCI, V55, P5643, DOI 10.1167/iovs.14-14136; Glenn JV, 2009, INVEST OPHTH VIS SCI, V50, P441, DOI 10.1167/iovs.08-1724; Gliem M, 2015, INVEST OPHTH VIS SCI, V56, P2664, DOI 10.1167/iovs.14-15733; Grillo MA, 2008, AMINO ACIDS, V35, P29, DOI 10.1007/s00726-007-0606-0; Guo L, 1999, INVEST OPHTH VIS SCI, V40, P2676; Hageman GS, 1999, MOL VIS, V5; Handa JT, 1999, INVEST OPHTH VIS SCI, V40, P775; Howes KA, 2004, INVEST OPHTH VIS SCI, V45, P3713, DOI 10.1167/iovs.04-0404; HUNT RC, 1993, INVEST OPHTH VIS SCI, V34, P3179; Hussain AA, 2010, EXP EYE RES, V90, P703, DOI 10.1016/j.exer.2010.02.013; Hussain AA, 2011, INVEST OPHTH VIS SCI, V52, P4459, DOI 10.1167/iovs.10-6678; Ishibashi T, 1998, ARCH OPHTHALMOL-CHIC, V116, P1629, DOI 10.1001/archopht.116.12.1629; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Kumar A, 2010, INVEST OPHTH VIS SCI, V51, P2664, DOI 10.1167/iovs.09-4195; Kurz A, 2011, CELL MOL LIFE SCI, V68, P721, DOI 10.1007/s00018-010-0483-7; Linares M, 2011, J PROTEOME RES, V10, P1719, DOI 10.1021/pr101014e; Litwinoff EMS, 2015, CLIN PHARMACOL THER, V98, P135, DOI 10.1002/cpt.148; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Manigrasso MB, 2014, TRENDS ENDOCRIN MET, V25, P15, DOI 10.1016/j.tem.2013.08.002; Martens S, 2015, NAT CELL BIOL, V17, P841, DOI 10.1038/ncb3198; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Meade SJ, 2003, BIOORGAN MED CHEM, V11, P853, DOI 10.1016/S0968-0896(02)00564-3; Miller AG, 2003, BIOORGAN MED CHEM, V11, P843, DOI 10.1016/S0968-0896(02)00565-5; Mott JD, 1997, KIDNEY INT, V52, P1302, DOI 10.1038/ki.1997.455; Nagai N, 2009, INVEST OPHTH VIS SCI, V50, P1903, DOI 10.1167/iovs.08-2383; Odani H, 1998, FEBS LETT, V427, P381, DOI 10.1016/S0014-5793(98)00416-5; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Pageon H, 2015, BIORESEARCH OPEN ACC, V4, P54, DOI 10.1089/biores.2014.0053; Pang JJ, 2005, MOL VIS, V11, P152; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; PAULEIKHOFF D, 1990, AM J OPHTHALMOL, V109, P38, DOI 10.1016/S0002-9394(14)75576-X; Rabbani N, 2015, BIOCHEM BIOPH RES CO, V458, P221, DOI 10.1016/j.bbrc.2015.01.140; Rabbani N, 2014, NAT PROTOC, V9, P1969, DOI 10.1038/nprot.2014.129; Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; SCHMIDT AM, 1994, P NATL ACAD SCI USA, V91, P8807, DOI 10.1073/pnas.91.19.8807; Schmidt AM, 2015, VASC PHARMACOL, V72, P1, DOI 10.1016/j.vph.2015.06.011; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; Simons BL, 2002, PROTEIN SCI, V11, P1558, DOI 10.1110/ps.4390102; Sivak JM, 2002, PROG RETIN EYE RES, V21, P1, DOI 10.1016/S1350-9462(01)00015-5; Sparrow JR, 2013, INVEST OPHTH VIS SCI, V54, P2812, DOI 10.1167/iovs.12-11490; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2010, PHOTOCH PHOTOBIO SCI, V9, P1480, DOI 10.1039/c0pp00207k; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Talent JM, 1998, ANAL BIOCHEM, V263, P31, DOI 10.1006/abio.1998.2752; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Tian J, 2005, P NATL ACAD SCI USA, V102, P11846, DOI 10.1073/pnas.0504759102; Voziyan P, 2014, CLIN CHEM LAB MED, V52, P39, DOI 10.1515/cclm-2012-0818; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wilker SC, 2001, ANAL BIOCHEM, V290, P353, DOI 10.1006/abio.2001.4992; Wu L, 2014, INVEST OPHTH VIS SCI, V55, P1910, DOI 10.1167/iovs.14-13867; Wu L, 2010, ADV EXP MED BIOL, V664, P533, DOI 10.1007/978-1-4419-1399-9_61; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Wu Y, 2009, J BIOL CHEM, V284, P20155, DOI 10.1074/jbc.M109.021345; Xue MZ, 2012, BIOCHEM J, V443, P213, DOI 10.1042/BJ20111648; Yamada Y, 2006, EXP EYE RES, V82, P840, DOI 10.1016/j.exer.2005.10.005; Yoon KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041309; Yoon KD, 2011, MOL VIS, V17, P1839; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200; Zarbin MA, 2010, RETINA-J RET VIT DIS, V30, P1350, DOI 10.1097/IAE.0b013e3181f57e30; Zhang XY, 2008, INVEST OPHTH VIS SCI, V49, P3622, DOI 10.1167/iovs.07-1559; Zhou JL, 2006, REJUV RES, V9, P256, DOI 10.1089/rej.2006.9.256; Zhou JL, 2005, EXP EYE RES, V80, P567, DOI 10.1016/j.exer.2004.11.009	90	18	18	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27215	27227		10.1074/jbc.M115.680363	http://dx.doi.org/10.1074/jbc.M115.680363			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26400086	Green Published, hybrid			2022-12-28	WOS:000364794000030
J	Feige, MJ; Behnke, J; Mittag, T; Hendershot, LM				Feige, Matthias J.; Behnke, Julia; Mittag, Tanja; Hendershot, Linda M.			Dimerization-dependent Folding Underlies Assembly Control of the Clonotypic alpha beta T Cell Receptor Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN LIGHT-CHAIN; ENDOPLASMIC-RETICULUM; ANTIGEN RECEPTOR; QUALITY-CONTROL; DISULFIDE BOND; IN-VIVO; SURFACE EXPRESSION; HEAVY-CHAINS; TCR CHAINS; PROTEIN	In eukaryotic cells, secretory pathway proteins must pass stringent quality control checkpoints before exiting the endoplasmic reticulum (ER). Acquisition of native structure is generally considered to be the most important prerequisite for ER exit. However, structurally detailed protein folding studies in the ER are few. Furthermore, aberrant ER quality control decisions are associated with a large and increasing number of human diseases, highlighting the need for more detailed studies on the molecular determinants that result in proteins being either secreted or retained. Here we used the clonotypic alpha beta chains of the T cell receptor (TCR) as a model to analyze lumenal determinants of ER quality control with a particular emphasis on how proper assembly of oligomeric proteins can be monitored in the ER. A combination of in vitro and in vivo approaches allowed us to provide a detailed model for alpha beta TCR assembly control in the cell. We found that folding of the TCR alpha chain constant domain C alpha is dependent on alpha beta heterodimerization. Furthermore, our data show that some variable regions associated with either chain can remain incompletely folded until chain pairing occurs. Together, these data argue for template-assisted folding at more than one point in the TCR alpha/beta assembly process, which allows specific recognition of unassembled clonotypic chains by the ER chaperone machinery and, therefore, reliable quality control of this important immune receptor. Additionally, it highlights an unreported possible limitation in the alpha and beta chain combinations that comprise the T cell repertoire.	[Feige, Matthias J.; Behnke, Julia; Hendershot, Linda M.] St Jude Childrens Res Hosp, Dept Tumor Cell Biol, Memphis, TN 38105 USA; [Mittag, Tanja] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Hendershot, LM (corresponding author), St Jude Childrens Res Hosp, Dept Tumor Cell Biol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	linda.hendershot@stjude.org	Hendershot, Linda/N-8124-2018	Hendershot, Linda/0000-0002-5473-0274; Feige, Matthias/0000-0001-5435-4312; Mittag, Tanja/0000-0002-1827-3811	Hartwell Center; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI097733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054068] Funding Source: NIH RePORTER	Hartwell Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Johannes Buchner, Technische Universitat Munchen, for support of several in vitro experiments. We also thank the protein production facility, the Hartwell Center, and the mass spectrometry core of St. Jude Children's Research Hospital for support.	Arnaud J, 1997, INT IMMUNOL, V9, P615, DOI 10.1093/intimm/9.4.615; Behnke J, 2015, J MOL BIOL, V427, P1589, DOI 10.1016/j.jmb.2015.02.011; Behnke J, 2014, J BIOL CHEM, V289, P2899, DOI 10.1074/jbc.M113.507491; BERGMAN LW, 1979, J BIOL CHEM, V254, P8869; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2004, MOL IMMUNOL, V40, P1295, DOI 10.1016/j.molimm.2003.11.017; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Daniels R, 2003, MOL CELL, V11, P79, DOI 10.1016/S1097-2765(02)00821-3; DAVID V, 1993, J BIOL CHEM, V268, P9585; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delgado P, 2005, J EXP MED, V201, P555, DOI 10.1084/jem.20041133; Dietrich J, 1999, EUR J IMMUNOL, V29, P1719, DOI 10.1002/(SICI)1521-4141(199905)29:05<1719::AID-IMMU1719>3.3.CO;2-D; Fayadat L, 2003, MOL BIOL CELL, V14, P1268, DOI 10.1091/mbc.E02-06-0363; Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Feigel MJ, 2013, MOL CELL, V51, P297, DOI 10.1016/j.molcel.2013.07.013; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Gardner TG, 2000, ARCH BIOCHEM BIOPHYS, V378, P182, DOI 10.1006/abbi.2000.1804; GASCOIGNE NRJ, 1990, J BIOL CHEM, V265, P9296; Gershenson A, 2011, CURR OPIN STRUC BIOL, V21, P32, DOI 10.1016/j.sbi.2010.11.001; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; HALL C, 1991, INT IMMUNOL, V3, P359, DOI 10.1093/intimm/3.4.359; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; HENDERSHOT LM, 1995, MOL BIOL CELL, V6, P283, DOI 10.1091/mbc.6.3.283; HEWITT CRA, 1992, J EXP MED, V175, P1493, DOI 10.1084/jem.175.6.1493; HOCHSTENBACH F, 1992, P NATL ACAD SCI USA, V89, P4734, DOI 10.1073/pnas.89.10.4734; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; KEARSE KP, 1995, IMMUNITY, V2, P391; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; MALLABIABARRENA A, 1992, NATURE, V357, P593, DOI 10.1038/357593a0; MANOLIOS N, 1990, SCIENCE, V249, P274, DOI 10.1126/science.2142801; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; MINAMI Y, 1987, P NATL ACAD SCI USA, V84, P2688, DOI 10.1073/pnas.84.9.2688; Minegishi Y, 1999, P NATL ACAD SCI USA, V96, P3041, DOI 10.1073/pnas.96.6.3041; Molinari M, 2000, SCIENCE, V288, P331, DOI 10.1126/science.288.5464.331; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; PILLAI S, 1987, NATURE, V329, P172, DOI 10.1038/329172a0; Shimizu Y, 2009, P NATL ACAD SCI USA, V106, P17013, DOI 10.1073/pnas.0811591106; SHIN J, 1993, SCIENCE, V259, P1901, DOI 10.1126/science.8456316; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189; van Leeuwen J. E, 1996, J BIOL CHEM, V271, P9660; VanLeeuwen JEM, 1996, J BIOL CHEM, V271, P25345, DOI 10.1074/jbc.271.41.25345; von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571; Wang N, 2005, MOL BIOL CELL, V16, P3740, DOI 10.1091/mbc.E05-05-0381; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800	56	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26821	26831		10.1074/jbc.M115.689471	http://dx.doi.org/10.1074/jbc.M115.689471			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26400083	Green Published, hybrid			2022-12-28	WOS:000364793600044
J	Login, FH; Wolf-Watz, H				Login, Frederic H.; Wolf-Watz, Hans			YscU/FlhB of Yersinia pseudotuberculosis Harbors a C-terminal Type III Secretion Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEINS; SALMONELLA-TYPHIMURIUM; SUBSTRATE-SPECIFICITY; NEEDLE COMPLEX; ORDER TRANSITION; MESSENGER-RNA; YOP PROTEINS; YSCU; ENTEROCOLITICA; BACTERIAL	All type III secretion systems (T3SS) harbor a member of the YscU/FlhB family of proteins that is characterized by an auto-proteolytic process that occurs at a conserved cytoplasmic NPTH motif. We have previously demonstrated that YscU(CC), the C-terminal peptide generated by auto-proteolysis of Yersinia pseudotuberculosis YscU, is secreted by the T3SS when bacteria are grown in Ca2+ -depleted medium at 37 degrees C. Here, we investigated the secretion of this early T3S-substrate and showed that YscU(CC) encompasses a specific C-terminal T3S signal within the 15 last residues (U-15). U-15 promoted C-terminal secretion of reporter proteins like GST and YopE lacking its native secretion signal. Similar to the "classical" N-terminal secretion signal, U-15 interacted with the ATPase YscN. Although U-15 is critical for YscU(CC) secretion, deletion of the C-terminal secretion signal of YscU(CC) did neither affect Yop secretion nor Yop translocation. However, these deletions resulted in increased secretion of YscF, the needle subunit. Thus, these results suggest that YscU via its C-terminal secretion signal is involved in regulation of the YscF secretion.	Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res, SE-90187 Umea, Sweden; Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea Ctr Microbial Res, SE-90187 Umea, Sweden	Umea University; Umea University	Wolf-Watz, H (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.	hans.wolf-watz@molbiol.umu.se			Swedish Research Council; Umea Centre for Microbial Research (UCMR), Umea University, Sweden; Nordic EMBL partnership for Molecular Medicine Sweden (MIMS)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea Centre for Microbial Research (UCMR), Umea University, Sweden; Nordic EMBL partnership for Molecular Medicine Sweden (MIMS)	This work was supported by the Swedish Research Council, The Nordic EMBL partnership for Molecular Medicine Sweden (MIMS) and the Umea Centre for Microbial Research (UCMR), Umea University, Sweden. The authors declare that they have no conflicts of interest with the contents of this article.	Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; ALLAOUI A, 1994, J BACTERIOL, V176, P4534, DOI 10.1128/JB.176.15.4534-4542.1994; Allison SE, 2014, J BIOL CHEM, V289, P23734, DOI 10.1074/jbc.M114.578476; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Bjornfot AC, 2009, J BACTERIOL, V191, P4259, DOI 10.1128/JB.01730-08; BOLIN I, 1985, INFECT IMMUN, V48, P234; Botteaux A, 2010, MICROBIOL-SGM, V156, P2807, DOI 10.1099/mic.0.039651-0; Chen L, 2013, CELL REP, V3, P709, DOI 10.1016/j.celrep.2013.02.025; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9; Feldman MF, 2002, MOL MICROBIOL, V46, P1183, DOI 10.1046/j.1365-2958.2002.03241.x; Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200; Frost S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049349; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kimura SR, 2001, BIOPHYS J, V80, P635, DOI 10.1016/S0006-3495(01)76044-4; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; KUTSUKAKE K, 1994, J BACTERIOL, V176, P7625, DOI 10.1128/JB.176.24.7625-7629.1994; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002; Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x; Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x; Lountos GT, 2009, PROTEIN SCI, V18, P467, DOI 10.1002/pro.56; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Metcalf KJ, 2014, APPL ENVIRON MICROB, V80, P5927, DOI 10.1128/AEM.01330-14; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Panthel K, 2008, INT J MED MICROBIOL, V298, P99, DOI 10.1016/j.ijmm.2007.07.002; PORTNOY DA, 1984, INFECT IMMUN, V43, P108, DOI 10.1128/IAI.43.1.108-114.1984; PORTNOY DA, 1981, J BACTERIOL, V148, P877, DOI 10.1128/JB.148.3.877-883.1981; Radics J, 2014, NAT STRUCT MOL BIOL, V21, P82, DOI 10.1038/nsmb.2722; Riordan KE, 2008, J BACTERIOL, V190, P6204, DOI 10.1128/JB.00467-08; Riordan KE, 2008, MOL MICROBIOL, V68, P1485, DOI 10.1111/j.1365-2958.2008.06247.x; Rodgers L, 2008, J BIOL CHEM, V283, P20857, DOI 10.1074/jbc.M802339200; ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x; ROSQVIST R, 1990, MOL MICROBIOL, V4, P657, DOI 10.1111/j.1365-2958.1990.tb00635.x; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Schraidt O, 2011, SCIENCE, V331, P1192, DOI 10.1126/science.1199358; Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731; Sorg JA, 2006, P NATL ACAD SCI USA, V103, P16490, DOI 10.1073/pnas.0605974103; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Thomas NA, 2005, MOL MICROBIOL, V57, P1762, DOI 10.1111/j.1365-2958.2005.04802.x; Vinatzer BA, 2005, MOL PLANT MICROBE IN, V18, P877, DOI 10.1094/MPMI-18-0877; Wang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059754; Wang YJ, 2011, BIOINFORMATICS, V27, P777, DOI 10.1093/bioinformatics/btr021; Weise CF, 2014, BIOPHYS J, V107, P1950, DOI 10.1016/j.bpj.2014.09.005; Wilharm G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-27; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; Yang Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S47; Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x	53	5	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26282	26291		10.1074/jbc.M114.633677	http://dx.doi.org/10.1074/jbc.M114.633677			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26338709	Green Published, hybrid			2022-12-28	WOS:000363527300044
J	Wang, WQ; McReynolds, MR; Goncalves, JF; Shu, MY; Dhondt, I; Braeckman, BP; Lange, SE; Kho, K; Detwiler, AC; Pacella, MJ; Hanna-Rose, W				Wang, Wenqing; McReynolds, Melanie R.; Goncalves, Jimmy F.; Shu, Muya; Dhondt, Ineke; Braeckman, Bart P.; Lange, Stephanie E.; Kho, Kelvin; Detwiler, Ariana C.; Pacella, Marisa J.; Hanna-Rose, Wendy			Comparative Metabolomic Profiling Reveals That Dysregulated Glycolysis Stemming from Lack of Salvage NAD(+) Biosynthesis Impairs Reproductive Development in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE RIBOSIDE; DIPHOSPHOPYRIDINE NUCLEOTIDE; MITOCHONDRIAL; INHIBITION; CELLS; MECHANISM; SIRTUINS; ENZYMES; PATHWAYS; NUTRIENT	Temporal developmental progression is highly coordinated in Caenorhabditis elegans. However, loss of nicotinamidase PNC-1 activity slows reproductive development, uncoupling it from its typical progression relative to the soma. Using LC/MS we demonstrate that pnc-1 mutants do not salvage the nicotinamide released by NAD(+) consumers to resynthesize NAD(+), resulting in a reduction in global NAD(+) bioavailability. We manipulate NAD(+) levels to demonstrate that a minor deficit in NAD(+) availability is incompatible with a normal pace of gonad development. The NAD(+) deficit compromises NAD(+) consumer activity, but we surprisingly found no functional link between consumer activity and reproductive development. As a result we turned to a comparative metabolomics approach to identify the cause of the developmental phenotype. We reveal widespread metabolic perturbations, and using complementary pharmacological and genetic approaches, we demonstrate that a glycolytic block accounts for the slow pace of reproductive development. Interestingly, mitochondria are protected from both the deficiency in NAD(+) biosynthesis and the effects of reduced glycolytic output. We suggest that compensatory metabolic processes that maintain mitochondrial activity in the absence of efficient glycolysis are incompatible with the requirements for reproductive development, which requires high levels of cell division. In addition to demonstrating metabolic requirements for reproductive development, this work also has implications for understanding the mechanisms behind therapeutic interventions that target NAD(+) salvage biosynthesis for the purposes of inhibiting tumor growth.	[Wang, Wenqing; McReynolds, Melanie R.; Goncalves, Jimmy F.; Shu, Muya; Lange, Stephanie E.; Kho, Kelvin; Detwiler, Ariana C.; Pacella, Marisa J.; Hanna-Rose, Wendy] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Dhondt, Ineke; Braeckman, Bart P.] Univ Ghent, Dept Biol, Lab Aging Physiol & Mol Evolut, B-9000 Ghent, Belgium	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Ghent University	Hanna-Rose, W (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, 104D Life Sci Bldg, University Pk, PA 16802 USA.	wxh21@psu.edu	Kho, Kelvin/AAO-8974-2020	Kho, Kelvin/0000-0002-4245-9675; Detwiler, Ariana/0000-0002-9311-5899	National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086786] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Penn State Metabolomics Core Facility of Huck Institutes of the Life Sciences for technical assistance and advice. We thank Anne Hart for the sirtuin triple mutant strains. tm alleles were provided by the Mitani laboratory through the National Bio-Resource Project of the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Japan. Other strains were provided by the Caenorhabditis Genetics Center, which is funded by National Institutes of Health Office of Research Infrastructure Programs (Grant P40 OD010440).	Ahringer J., 2006, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.47.1, 10.1895/wormbook.1.47.1]; Alano CC, 2007, J NEUROSCI RES, V85, P3378, DOI 10.1002/jnr.21479; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; BRENNER S, 1974, GENETICS, V77, P71; Canto C, 2011, COLD SH Q B, V76, P291, DOI 10.1101/sqb.2012.76.010439; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cea M, 2012, BLOOD, V120, P3519, DOI 10.1182/blood-2012-03-416776; Chi YL, 2013, CURR OPIN CLIN NUTR, V16, P657, DOI 10.1097/MCO.0b013e32836510c0; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Crook M, 2014, DEV DYNAM, V243, P965, DOI [10.1002/dvdy.24139, 10.1002/DVDY.24139]; Denu JM, 2005, TRENDS BIOCHEM SCI, V30, P479, DOI 10.1016/j.tibs.2005.07.004; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; Dolle C, 2013, CURR TOP MED CHEM, V13, P2907; French JB, 2010, BIOCHEMISTRY-US, V49, P10421, DOI 10.1021/bi1012518; Fu LS, 2014, NEURAL REGEN RES, V9, P1509, DOI 10.4103/1673-5374.139475; Gossmann TI, 2012, FEBS J, V279, P3355, DOI 10.1111/j.1742-4658.2012.08559.x; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Huang L, 2006, DEV BIOL, V300, P599, DOI 10.1016/j.ydbio.2006.08.024; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Kim HJ, 2014, AGING DIS, V5, P150, DOI 10.14336/AD.2014.0500150; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5; Mouchiroud L, 2013, CRIT REV BIOCHEM MOL, V48, P397, DOI 10.3109/10409238.2013.789479; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Porter RM, 2014, EXP DERMATOL, V23, P543, DOI 10.1111/exd.12467; PREISS J, 1958, J BIOL CHEM, V233, P488; PREISS J, 1958, J BIOL CHEM, V233, P493; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Rongvaux A, 2003, BIOESSAYS, V25, P683, DOI 10.1002/bies.10297; Ruggieri S, 2015, BBA-PROTEINS PROTEOM, V1854, P1138, DOI 10.1016/j.bbapap.2015.02.021; Sampath D, 2015, PHARMACOL THERAPEUT, V151, P16, DOI 10.1016/j.pharmthera.2015.02.004; Sauve AA, 2003, BIOCHEMISTRY-US, V42, P9249, DOI 10.1021/bi034959l; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Sauve AA, 2012, CURR OPIN CHEM BIOL, V16, P535, DOI 10.1016/j.cbpa.2012.10.003; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Vrablik TL, 2011, DEV BIOL, V349, P387, DOI 10.1016/j.ydbio.2010.11.014; Vrablik TL, 2009, DEVELOPMENT, V136, P3637, DOI 10.1242/dev.028431; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469	46	16	17	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26163	26179		10.1074/jbc.M115.662916	http://dx.doi.org/10.1074/jbc.M115.662916			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26350462	Green Published, hybrid			2022-12-28	WOS:000363527300035
J	Park, Y; Han, GS; Mileykovskaya, E; Garrett, TA; Carman, GM				Park, Yeonhee; Han, Gil-Soo; Mileykovskaya, Eugenia; Garrett, Teresa A.; Carman, George M.			Altered Lipid Synthesis by Lack of Yeast Pah1 Phosphatidate Phosphatase Reduces Chronological Life Span	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MEMBRANE GROWTH; PROTEIN-KINASE-C; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; TRIACYLGLYCEROL-METABOLISM; OXIDATIVE-PHOSPHORYLATION; ADENOSINE-TRIPHOSPHATASE; SUPEROXIDE-DISMUTASE; MITOCHONDRIAL ATPASE; MEDIATED REGULATION	In Saccharomyces cerevisiae, Pah1 phosphatidate phosphatase, which catalyzes the dephosphorylation of phosphatidate to yield diacylglycerol, plays a crucial role in the synthesis of the storage lipid triacylglycerol. This evolutionarily conserved enzyme also plays a negative regulatory role in controlling de novo membrane phospholipid synthesis through its consumption of phosphatidate. We found that the pah1 Delta mutant was defective in the utilization of non-fermentable carbon sources but not in oxidative phosphorylation; the mutant did not exhibit major changes in oxygen consumption rate, mitochondrial membrane potential, F1F0-ATP synthase activity, or gross mitochondrial morphology. The pah1 Delta mutant contained an almost normal complement of major mitochondrial phospholipids with some alterations in molecular species. Although oxidative phosphorylation was not compromised in the pah1 Delta mutant, the cellular levels of ATP in quiescent cells were reduced by 2-fold, inversely correlating with a 4-fold increase in membrane phospholipids. In addition, the quiescent pah1 Delta mutant cells had 3-fold higher levels of mitochondrial superoxide and cellular lipid hydroperoxides, had reduced activities of superoxide dismutase 2 and catalase, and were hypersensitive to hydrogen peroxide. Consequently, the pah1 Delta mutant had a shortened chronological life span. In addition, the loss of Tsa1 thioredoxin peroxidase caused a synthetic growth defect with the pah1 Delta mutation. The shortened chronological life span of the pah1 Delta mutant along with its growth defect on non-fermentable carbon sources and hypersensitivity to hydrogen peroxide was suppressed by the loss of Dgk1 diacylglycerol kinase, indicating that the underpinning of pah1 Delta mutant defects was the excess synthesis of membrane phospholipids.	[Park, Yeonhee; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Dept Food Sci, New Brunswick, NJ 08901 USA; [Park, Yeonhee; Han, Gil-Soo; Carman, George M.] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Mileykovskaya, Eugenia] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Garrett, Teresa A.] Vassar Coll, Dept Chem, Poughkeepsie, NY 12604 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Texas System; University of Texas Health Science Center Houston; Vassar College	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu		Mileykovskaya, Eugenia/0000-0002-8775-4467	National Institutes of Health Grant from USPHS [GM028140]; National Science Foundation Major Research Instrumentation Award [1039659]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health Grant from USPHS; National Science Foundation Major Research Instrumentation Award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM028140 (to G. M. C.) from the USPHS. This work was also supported by National Science Foundation Major Research Instrumentation Award 1039659 (to T. A. G). The authors declare that they have no conflicts of interest with the contents of this article.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; ANGUS WW, 1972, ARCH BIOCHEM BIOPHYS, V151, P483, DOI 10.1016/0003-9861(72)90525-5; Arnold I, 1999, J BIOL CHEM, V274, P36, DOI 10.1074/jbc.274.1.36; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; Baba T, 2014, J BIOL CHEM, V289, P11497, DOI 10.1074/jbc.M113.531921; Baile MG, 2014, J BIOL CHEM, V289, P1768, DOI 10.1074/jbc.M113.525733; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BEERS RF, 1952, J BIOL CHEM, V195, P133; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonawitz ND, 2006, MOL CELL BIOL, V26, P4818, DOI 10.1128/MCB.02360-05; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Bozzola J. J, 1999, ELECT MICROSCOPY PRI; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulat E, 2011, J BIOL CHEM, V286, P33819, DOI 10.1074/jbc.M111.269779; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CHAE HZ, 1993, J BIOL CHEM, V268, P16815; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chang YF, 2008, PROG LIPID RES, V47, P333, DOI 10.1016/j.plipres.2008.03.004; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Garrett TA, 2009, J LIPID RES, V50, P1589, DOI 10.1194/jlr.M800549-JLR200; Gaspar ML, 2011, J BIOL CHEM, V286, P1696, DOI 10.1074/jbc.M110.172296; Genova ML, 2015, ANTIOXID REDOX SIGN, V23, P208, DOI 10.1089/ars.2014.6214; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Goldsteins G, 2008, J BIOL CHEM, V283, P8446, DOI 10.1074/jbc.M706111200; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; HANSON BA, 1980, J LIPID RES, V21, P309; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; HENRY SA, 1973, J BACTERIOL, V116, P1293, DOI 10.1128/JB.116.3.1293-1303.1973; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jesch SA, 2010, J BIOL CHEM, V285, P41947, DOI 10.1074/jbc.M110.188607; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindegaard B, 2007, INT J OBESITY, V31, P449, DOI 10.1038/sj.ijo.0803434; Liu J, 2013, AGING CELL, V12, P833, DOI 10.1111/acel.12107; Longo VD, 1999, ARCH BIOCHEM BIOPHYS, V365, P131, DOI 10.1006/abbi.1999.1158; Lussier M, 1997, GENETICS, V147, P435; MACINO G, 1979, J BIOL CHEM, V254, P4617; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Michot C, 2013, BBA-MOL BASIS DIS, V1832, P2103, DOI 10.1016/j.bbadis.2013.07.021; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nadra K, 2012, MOL CELL BIOL, V32, P4794, DOI 10.1128/MCB.00512-12; Natter K, 2013, BBA-MOL CELL BIOL L, V1831, P314, DOI 10.1016/j.bbalip.2012.09.003; NIKI E, 1991, AM J CLIN NUTR, V53, pS201, DOI 10.1093/ajcn/53.1.201S; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Parrella E, 2008, METHODS, V46, P256, DOI 10.1016/j.ymeth.2008.10.004; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; Qi WJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002836; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; Rose MD., 1990, METHODS YEAST GENETI; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Ruiz C, 1999, YEAST, V15, P1001; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Skipski V P, 1975, Methods Enzymol, V35, P396, DOI 10.1016/0076-6879(75)35178-1; SOMLO M, 1968, EUR J BIOCHEM, V5, P276, DOI 10.1111/j.1432-1033.1968.tb00368.x; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; TODD RD, 1980, J BIOL CHEM, V255, P5461; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang PX, 2014, CELL METAB, V20, P267, DOI 10.1016/j.cmet.2014.05.003; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200	117	34	37	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25382	25394		10.1074/jbc.M115.680314	http://dx.doi.org/10.1074/jbc.M115.680314			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26338708	Green Published, hybrid			2022-12-28	WOS:000362962800016
J	Yagi, H; Conroy, PJ; Leung, EWW; Law, RHP; Trapani, JA; Voskoboinik, I; Whisstock, JC; Norton, RS				Yagi, Hiromasa; Conroy, Paul J.; Leung, Eleanor W. W.; Law, Ruby H. P.; Trapani, Joseph A.; Voskoboinik, Ilia; Whisstock, James C.; Norton, Raymond S.			Structural Basis for Ca2+-mediated Interaction of the Perforin C2 Domain with Lipid Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; BINDING DOMAIN; CALCIUM; SYNAPTOTAGMIN; GRANZYMES; PROTEINS; FORMS	Natural killer cells and cytotoxic T-lymphocytes deploy perforin and granzymes to kill infected host cells. Perforin, secreted by immune cells, binds target membranes to form pores that deliver pro-apoptotic granzymes into the target cell. A crucial first step in this process is interaction of its C2 domain with target cell membranes, which is a calcium-dependent event. Some aspects of this process are understood, but many molecular details remain unclear. To address this, we investigated the mechanism of Ca2+ and lipid binding to the C2 domain by NMR spectroscopy and x-ray crystallography. Calcium titrations, together with dodecylphosphocholine micelle experiments, confirmed that multiple Ca2+ ions bind within the calcium-binding regions, activating perforin with respect to membrane binding. We have also determined the affinities of several of these binding sites and have shown that this interaction causes a significant structural rearrangement in CBR1. Thus, it is proposed that Ca2+ binding at the weakest affinity site triggers changes in the C2 domain that facilitate its interaction with lipid membranes.	[Yagi, Hiromasa; Leung, Eleanor W. W.; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Conroy, Paul J.; Law, Ruby H. P.; Whisstock, James C.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Conroy, Paul J.; Law, Ruby H. P.; Whisstock, James C.] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Melbourne, Vic 3800, Australia; [Trapani, Joseph A.; Voskoboinik, Ilia] Peter MacCallum Canc Ctr, Canc Immunol Program, East Melbourne, Vic 3002, Australia; [Trapani, Joseph A.; Voskoboinik, Ilia] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Voskoboinik, Ilia] Univ Melbourne, Dept Genet & Pathol, Parkville, Vic 3052, Australia	Monash University; Monash University; Monash University; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne	Whisstock, JC (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia.	james.whisstock@monash.edu; ray.norton@monash.edu	Yagi, Hiromasa/H-9253-2017; Conroy, Paul/L-1320-2019	Conroy, Paul/0000-0002-9748-4704; law, ruby/0000-0001-5432-5781; Trapani, Joseph/0000-0003-0983-1532; Voskoboinik, Ilia/0000-0002-6410-009X; Norton, Raymond/0000-0001-8893-0584; Whisstock, James/0000-0003-4200-5611	Australian National Health and Medical Research Council [1042858]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Australian National Health and Medical Research Council Grant 1042858. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of fellowship support from the Australian National Health and Medical Research Council.	Aivar P, 2014, J NEUROSCI, V34, P2989, DOI 10.1523/JNEUROSCI.2826-13.2014; Arcaro A, 1998, J BIOL CHEM, V273, P33082, DOI 10.1074/jbc.273.49.33082; Brennan AJ, 2011, IMMUNITY, V34, P879, DOI 10.1016/j.immuni.2011.04.007; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conroy PJ, 2014, J BIOL CHEM, V289, P15384, DOI 10.1074/jbc.M114.562470; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Essen LO, 1997, BIOCHEMISTRY-US, V36, P2753, DOI 10.1021/bi962466t; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; FOGHANDERSEN N, 1978, CLIN CHEM, V24, P1545; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Hornemann S, 2009, J BIOL CHEM, V284, P22713, DOI 10.1074/jbc.M109.000430; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Lopez JA, 2013, BLOOD, V121, P2659, DOI 10.1182/blood-2012-07-446146; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Pepio AM, 1998, J BIOL CHEM, V273, P19040, DOI 10.1074/jbc.273.30.19040; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; PODACK ER, 1985, P NATL ACAD SCI USA, V82, P8629, DOI 10.1073/pnas.82.24.8629; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Shin OH, 2010, NAT STRUCT MOL BIOL, V17, P280, DOI 10.1038/nsmb.1758; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Traore DAK, 2013, BIOCHEM J, V456, P323, DOI 10.1042/BJ20130999; TSCHOPP J, 1986, NATURE, V322, P831, DOI 10.1038/322831a0; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; YOUNG JDE, 1986, P NATL ACAD SCI USA, V83, P150, DOI 10.1073/pnas.83.1.150	37	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25213	25226		10.1074/jbc.M115.668384	http://dx.doi.org/10.1074/jbc.M115.668384			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26306037	Green Published, hybrid			2022-12-28	WOS:000362962800002
J	Bockus, LB; Humphries, KM				Bockus, Lee B.; Humphries, Kenneth M.			cAMP-dependent Protein Kinase (PKA) Signaling Is Impaired in the Diabetic Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVOUS-SYSTEM; FATTY-ACIDS; FAILURE; CARDIOMYOPATHY; HYPERTROPHY; GLYCOLYSIS; PATHOPHYSIOLOGY; EXPRESSION; RESPONSES; PRESSURE	Diabetes mellitus causes cardiac dysfunction and heart failure that is associated with metabolic abnormalities and autonomic impairment. Autonomic control of ventricular function occurs through regulation of cAMP-dependent protein kinase (PKA). The diabetic heart has suppressed beta-adrenergic responsiveness, partly attributable to receptor changes, yet little is known about how PKA signaling is directly affected. Control and streptozotocin-induced diabetic mice were therefore administered 8-bromo-cAMP (8Br-cAMP) acutely to activate PKA in a receptor-independent manner, and cardiac hemodynamic function and PKA signaling were evaluated. In response to 8Br-cAMP treatment, diabetic mice had impaired inotropic and lusitropic responses, thus demonstrating postreceptor defects. This impaired signaling was mediated by reduced PKA activity and PKA catalytic subunit content in the cytoplasm and myofilaments. Compartment-specific loss of PKA was reflected by reduced phosphorylation of discrete substrates. In response to 8Br-cAMP treatment, the glycolytic activator PFK-2 was robustly phosphorylated in control animals but not diabetics. Control adult cardiomyocytes cultured in lipid-supplemented media developed similar changes in PKA signaling, suggesting that lipotoxicity is a contributor to diabetes-induced beta-adrenergic signaling dysfunction. This work demonstrates that PKA signaling is impaired in diabetes and suggests that treating hyper-lipidemia is vital for proper cardiac signaling and function.	Oklahoma Med Res Fdn, Aging & Metab Res Program, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Humphries, KM (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	kenneth-humphries@omrf.org		Humphries, Kenneth/0000-0002-6167-3175	National Institute of General Medical Sciences of the National Institutes of Health [P20GM104934]; Oklahoma Center for the Advancement of Science and Technology Grant [HR13-183]; American Heart Association [14GRNT20510031]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104934] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Oklahoma Center for the Advancement of Science and Technology Grant; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by an Institutional Development Award from the National Institute of General Medical Sciences of the National Institutes of Health through Grant P20GM104934, by Oklahoma Center for the Advancement of Science and Technology Grant HR13-183, and by American Heart Association Grant 14GRNT20510031. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADAMS JA, 1995, BIOCHEMISTRY-US, V34, P2447, DOI 10.1021/bi00008a007; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Asrih M, 2012, AM J PHYSIOL-ENDOC M, V302, pE872, DOI 10.1152/ajpendo.00427.2011; Bugger H, 2014, DIABETOLOGIA, V57, P660, DOI 10.1007/s00125-014-3171-6; Dalton GD, 2006, NEUROPEPTIDES, V40, P23, DOI 10.1016/j.npep.2005.10.002; Depre C, 1998, J CLIN INVEST, V101, P390, DOI 10.1172/JCI1168; Dincer UD, 2001, DIABETES, V50, P455, DOI 10.2337/diabetes.50.2.455; Donthi RV, 2004, J BIOL CHEM, V279, P48085, DOI 10.1074/jbc.M405510200; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589; Gilbert RE, 2015, LANCET, V385, P2107, DOI 10.1016/S0140-6736(14)61402-1; Hausken ZE, 1998, METH MOL B, V88, P47; Hicks KK, 1998, J AUTONOM NERV SYST, V69, P21, DOI 10.1016/S0165-1838(98)00004-6; Hoit BD, 1999, J CARD FAIL, V5, P324, DOI 10.1016/S1071-9164(99)91337-4; Humphries KM, 2007, J BIOL CHEM, V282, P22072, DOI 10.1074/jbc.M702582200; Hwang Sun-Ii, 2013, Methods Mol Biol, V1002, P25, DOI 10.1007/978-1-62703-360-2_3; KANNEL WB, 1974, AM J CARDIOL, V34, P29, DOI 10.1016/0002-9149(74)90089-7; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; MCFARLAND BH, 1971, ARCH BIOCHEM BIOPHYS, V145, P456, DOI 10.1016/S0003-9861(71)80005-X; McMurray JJV, 2014, LANCET DIABETES ENDO, V2, P843, DOI 10.1016/S2213-8587(14)70031-2; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Pappachan JM, 2013, WORLD J DIABETES, V4, P177, DOI 10.4239/wjd.v4.i5.177; PAULSON DJ, 1981, RES COMMUN CHEM PATH, V33, P559; Pop-Busui R, 2010, DIABETES CARE, V33, P434, DOI 10.2337/dc09-1294; Ros S, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-8; SANDBERG M, 1991, BIOCHEM J, V279, P521, DOI 10.1042/bj2790521; Tamada A, 1998, AM J PHYSIOL-HEART C, V274, pH1849, DOI 10.1152/ajpheart.1998.274.6.H1849; Tillquist MN, 2012, CURR DIABETES REP, V12, P305, DOI 10.1007/s11892-012-0274-7; Vadvalkar SS, 2013, BIOCHEM J, V449, P253, DOI 10.1042/BJ20121038; VANDENENDE R, 1994, FUNDAM CLIN PHARM, V8, P408; Wang QW, 2008, AM J PHYSIOL-HEART C, V294, pH2889, DOI 10.1152/ajpheart.91501.2007; Watt MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1, DOI 10.1152/ajpendo.00418.2011; Yang JH, 2014, J MOL CELL CARDIOL, V66, P83, DOI 10.1016/j.yjmcc.2013.11.001; YU Z, 1994, AM J PHYSIOL, V266, pH2334, DOI 10.1152/ajpheart.1994.266.6.H2334	37	32	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29250	29258		10.1074/jbc.M115.681767	http://dx.doi.org/10.1074/jbc.M115.681767			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468277	hybrid, Green Published			2022-12-28	WOS:000366613400013
J	Finch-Edmondson, ML; Strauss, RP; Passman, AM; Sudol, M; Yeoh, GC; Callus, BA				Finch-Edmondson, Megan L.; Strauss, Robyn P.; Passman, Adam M.; Sudol, Marius; Yeoh, George C.; Callus, Bernard A.			TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YES-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR; INHIBITS APOPTOSIS; PROLIFERATION; DOMAIN; ACTIVATION; ONCOGENE; GROWTH; PHOSPHORYLATION; IDENTIFICATION	The mammalian Hippo signaling pathway regulates cell growth and survival and is frequently dysregulated in cancer. YAP and TAZ are transcriptional coactivators that function as effectors of this signaling pathway. Aberrant YAP and TAZ activity is reported in several human cancers, and normally the expression and nuclear localization of these proteins is tightly regulated. We sought to establish whether a direct relationship exists between YAP and TAZ. Using knockdown and overexpression experiments we show YAP inversely regulates the abundance of TAZ protein by proteasomal degradation. Interestingly this phenomenon was uni-directional since TAZ expression did not affect YAP abundance. Structure/function analyses suggest that YAP-induced TAZ degradation is a consequence of YAP-targeted gene transcription involving TEAD factors. Subsequent investigation of known regulators of TAZ degradation using specific inhibitors revealed a role for heat shock protein 90 and glycogen synthase kinase 3 but not casein kinase 1 nor LATS in YAP-mediated TAZ loss. Importantly, this phenomenon is conserved from mouse to human; however, interestingly, different YAP isoforms varied in their ability to degrade TAZ. Since shRNA-mediated TAZ depletion in HeLa and D645 cells caused apoptotic cell death, we propose that isoform-specific YAP-mediated TAZ degradation may contribute to the contradicting roles reported for YAP overexpression. This study identifies a novel mechanism of TAZ regulation by YAP, which has significant implications for our understanding of Hippo pathway regulation, YAP-isoform specific signaling, and the role of these proteins in cell proliferation, apoptosis, and tumorigenesis.	[Finch-Edmondson, Megan L.; Yeoh, George C.; Callus, Bernard A.] Univ Western Australia, Sch Chem & Biochem, Nedlands, WA 6009, Australia; [Strauss, Robyn P.; Passman, Adam M.; Sudol, Marius; Yeoh, George C.] Harry Perkins Inst Med Res, Med Res Ctr, Nedlands, WA 6009, Australia; [Callus, Bernard A.] Notre Dame Univ, Sch Hlth Sci, Fremantle, WA 6959, Australia; [Finch-Edmondson, Megan L.; Sudol, Marius] Natl Univ Singapore, Dept Physiol, NUS Yong Loo Lin Sch Med, Singapore 117411, Singapore; [Finch-Edmondson, Megan L.; Sudol, Marius] Natl Univ Singapore, Mechanobiol Inst MBI, Singapore 117411, Singapore; [Sudol, Marius] ASTAR, IMCB, Singapore 138673, Singapore	University of Western Australia; Harry Perkins Institute of Medical Research; University of Notre Dame Australia; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Finch-Edmondson, ML (corresponding author), Natl Univ Singapore, Mechanobiol Inst MBI, T Lab, 10-01 5A Engn Dr 1, Singapore, Singapore.	phsmlf@nus.edu.sg	; Finch-Edmondson, Megan/S-7340-2017	Strauss, Robyn/0000-0002-5571-5797; Finch-Edmondson, Megan/0000-0002-9628-5842; Passman, Adam/0000-0003-3212-6938	Worldwide Cancer Research [09-0084]; Cancer Council of Western Australia [APP1010749, APP1067515]; Australian Postgraduate Award from the University of Western Australia (UWA); top-up scholarships from the University of Western Australia (UWA); National Stem Cell Foundation of Australia; Prescott Postgraduate Scholarship; University Postgraduate Award from UWA; Cancer Council of Western Australia	Worldwide Cancer Research; Cancer Council of Western Australia(Cancer Council Western Australia); Australian Postgraduate Award from the University of Western Australia (UWA); top-up scholarships from the University of Western Australia (UWA); National Stem Cell Foundation of Australia; Prescott Postgraduate Scholarship; University Postgraduate Award from UWA; Cancer Council of Western Australia(Cancer Council Western Australia)	This work was supported by Grant 09-0084 from Worldwide Cancer Research (formerly known as Association of International Cancer Research) and a Research Fellowship and Grants APP1010749 and APP1067515 from the Cancer Council of Western Australia awarded (to B. A. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an Australian Postgraduate Award and top-up scholarships from the University of Western Australia (UWA) and the National Stem Cell Foundation of Australia. To whom correspondence should be addressed: Mechanobiology Inst. (MBI) T-Lab, National University of Singapore 10-01 5A Engineering Dr. 1, 117411. Tel.: +65-8458-5290; E-mail: phsmlf@nus.edu.sg.; Recipient of a Prescott Postgraduate Scholarship.; Recipient of a University Postgraduate Award from UWA, and top-up scholarships from UWA and the Cancer Council of Western Australia.	Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Callus BA, 2008, CELL DEATH DIFFER, V15, P213, DOI 10.1038/sj.cdd.4402245; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Diep CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032783; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Fu D, 2014, ENDOCR-RELAT CANCER, V21, P297, DOI 10.1530/ERC-13-0339; Gaffney CJ, 2012, GENE, V509, P215, DOI 10.1016/j.gene.2012.08.025; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Huntoon CJ, 2010, CANCER RES, V70, P8642, DOI 10.1158/0008-5472.CAN-10-1345; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Lee MJ, 2014, J INVEST DERMATOL, V134, P518, DOI 10.1038/jid.2013.339; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Levy D, 2008, MOL CELL, V29, P350, DOI 10.1016/j.molcel.2007.12.022; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Melvin AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078082; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Oka T, 2010, BIOCHEM J, V432, P461, DOI 10.1042/BJ20100870; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Strano S, 2005, MOL CELL, V18, P447, DOI 10.1016/j.molcel.2005.04.008; SUDOL M, 1994, ONCOGENE, V9, P2145; Vigneron AM, 2010, GENE DEV, V24, P2430, DOI 10.1101/gad.1954310; Wang L., 2013, PLOS ONE; Wang L, 2014, TUMOR BIOL, V35, P463, DOI 10.1007/s13277-013-1064-9; Yang N, 2012, CELL CYCLE, V11, P2922, DOI 10.4161/cc.21386; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhao B., 2008, GENE DEV, V22, P1; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606; Zhou Z, 2011, MOL MED REP, V4, P1075, DOI 10.3892/mmr.2011.543	48	52	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27928	27938		10.1074/jbc.M115.692285	http://dx.doi.org/10.1074/jbc.M115.692285			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26432639	hybrid, Green Published			2022-12-28	WOS:000365757500041
J	Howe, V; Chua, NK; Stevenson, J; Brown, AJ				Howe, Vicky; Chua, Ngee Kiat; Stevenson, Julian; Brown, Andrew J.			The Regulatory Domain of Squalene Monooxygenase Contains a Re-entrant Loop and Senses Cholesterol via a Conformational Change	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN TOPOLOGY; ELEMENT-BINDING PROTEINS; E3 UBIQUITIN LIGASE; HMG-COA REDUCTASE; ENDOPLASMIC-RETICULUM; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; CONSENSUS PREDICTION; COMPLETE GENOMES; DEGRADATION; MUTAGENESIS	Squalene monooxygenase (SM) is an important control point in cholesterol synthesis beyond 3-hydroxy-3-methylglutaryl-CoA reductase. Although it is known to associate with the endoplasmic reticulum, its topology has not been determined. We have elucidated the membrane topology of the sterol-responsive domain of SM comprising the first 100 amino acids fused to GFP (SM N100-GFP) by determining the accessibility of 16 introduced cysteines to the cysteine-reactive, membrane-impermeable reagent PEG-maleimide. We have identified a region integrally associated with the endoplasmic reticulum membrane that is likely to interact with cholesterol or respond to cholesterol-induced membrane effects. By comparing cysteine accessibility with and without cholesterol treatment, we further present evidence to suggest that cholesterol induces a conformational change in SM N100-GFP. This change is likely to lead to its targeted degradation by the ubiquitin-proteasome system because degradation is blunted by treatment with the chemical chaperone glycerol, which retains SM N100-GFP in its native conformation. Furthermore, degradation can be disrupted by insertion of two N-terminal myc tags, implicating the N terminus in this process. Together, this information provides new molecular insights into the regulation of this critical control point in cholesterol synthesis.	[Howe, Vicky; Chua, Ngee Kiat; Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Stevenson, Julian] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	University of New South Wales Sydney; University of California System; University of California Berkeley	Brown, AJ (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au	Chua, Ngee Kiat/AAG-6793-2021	Chua, Ngee Kiat/0000-0003-2785-2767; Howe, Vicky/0000-0002-7319-0664	National Health and Medical Research Council [1060515]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by National Health and Medical Research Council Grant 1060515. The authors declare that they have no conflicts of interest with the contents of this article.	Aronson DE, 2011, TRAFFIC, V12, P543, DOI 10.1111/j.1600-0854.2011.01168.x; Bernsel A, 2008, P NATL ACAD SCI USA, V105, P7177, DOI 10.1073/pnas.0711151105; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Fajerman I, 2004, BIOCHEM BIOPH RES CO, V314, P505, DOI 10.1016/j.bbrc.2003.12.116; Feramisco JD, 2004, J BIOL CHEM, V279, P8487, DOI 10.1074/jbc.M312623200; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Herr RA, 2009, TRAFFIC, V10, P1301, DOI 10.1111/j.1600-0854.2009.00946.x; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hulce JJ, 2013, NAT METHODS, V10, P259, DOI [10.1038/nmeth.2368, 10.1038/NMETH.2368]; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Kristiana I, 2012, J BIOL CHEM, V287, P33897, DOI 10.1074/jbc.M112.360537; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LENAZ G, 1987, BIOSCIENCE REP, V7, P823, DOI 10.1007/BF01119473; Martelli PL, 2003, BIOINFORMATICS, V19, pi205, DOI 10.1093/bioinformatics/btg1027; Maurer-Stroh S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r55; Maurer-Stroh S, 2002, J MOL BIOL, V317, P541, DOI 10.1006/jmbi.2002.5426; Park SE, 2015, SCIENCE, V347, P1249, DOI 10.1126/science.aaa3844; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pierleoni A, 2011, NUCLEIC ACIDS RES, V39, pW375, DOI 10.1093/nar/gkr282; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; SAKAKIBARA J, 1995, J BIOL CHEM, V270, P17, DOI 10.1074/jbc.270.1.17; Sanchis J, 2008, APPL MICROBIOL BIOT, V81, P387, DOI 10.1007/s00253-008-1678-9; Scaglione KM, 2013, J BIOL CHEM, V288, P18784, DOI 10.1074/jbc.C113.477596; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sharpe LJ, 2014, TRENDS BIOCHEM SCI, V39, P527, DOI 10.1016/j.tibs.2014.08.008; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Stevenson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083888; Sun LP, 2007, P NATL ACAD SCI USA, V104, P6519, DOI 10.1073/pnas.0700907104; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Viklund H, 2006, J MOL BIOL, V361, P591, DOI 10.1016/j.jmb.2006.06.037; Vittal V, 2015, NAT CHEM BIOL, V11, P83, DOI [10.1038/NCHEMBIO.1700, 10.1038/nchembio.1700]; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wang Y, 2008, J BIOL CHEM, V283, P20696, DOI 10.1074/jbc.M803258200; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yan CH, 2010, PROTEIN J, V29, P350, DOI 10.1007/s10930-010-9259-z; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zerenturk EJ, 2014, BIOSCIENCE REP, V34, P107, DOI 10.1042/BSR20130127	56	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27533	27544		10.1074/jbc.M115.675181	http://dx.doi.org/10.1074/jbc.M115.675181			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26434806	Green Published, hybrid			2022-12-28	WOS:000365757500010
J	Lewandowski, SL; Janardhan, HP; Trivedi, CM				Lewandowski, Sara L.; Janardhan, Harish P.; Trivedi, Chinmay M.			Histone Deacetylase 3 Coordinates Deacetylase-independent Epigenetic Silencing of Transforming Growth Factor-beta 1 (TGF-beta 1) to Orchestrate Second Heart Field Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CARDIAC MYOCYTE PROLIFERATION; EHLERS-DANLOS-SYNDROME; OUTFLOW TRACT; EXTRACELLULAR-MATRIX; VALVE DEVELOPMENT; MARFAN-SYNDROME; AORTIC-VALVE; MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS	About two-thirds of human congenital heart disease involves second heart field-derived structures. Histone-modifying enzymes, histone deacetylases (HDACs), regulate the epigenome; however, their functions within the second heart field remain elusive. Here we demonstrate that histone deacetylase 3 (HDAC3) orchestrates epigenetic silencing of Tgf-beta 1, a causative factor in congenital heart disease pathogenesis, in a deacetylase-independent manner to regulate development of second heart field-derived structures. In murine embryos lacking HDAC3 in the second heart field, increased TGF-beta 1 bioavailability is associated with ascending aortic dilatation, outflow tract malrotation, overriding aorta, double outlet right ventricle, aberrant semilunar valve development, bicuspid aortic valve, ventricular septal defects, and embryonic lethality. Activation of TGF-beta signaling causes aberrant endothelial-to-mesenchymal transition and altered extracellular matrix homeostasis in HDAC3-null outflow tracts and semilunar valves, and pharmacological inhibition of TGF-beta rescues these defects. HDAC3 recruits components of the PRC2 complex, methyltransferase EZH2, EED, and SUZ12, to the NCOR complex to enrich trimethylation of Lys-27 on histone H3 at the Tgf-beta 1 regulatory region and thereby maintains epigenetic silencing of Tgf-beta 1 specifically within the second heart field-derived mesenchyme. Wild-type HDAC3 or catalytically inactive HDAC3 expression rescues aberrant endothelial-to-mesenchymal transition and epigenetic silencing of Tgf-beta 1 in HDAC3-null outflow tracts and semilunar valves. These findings reveal that epigenetic dysregulation within the second heart field is a predisposing factor for congenital heart disease.	[Lewandowski, Sara L.; Janardhan, Harish P.; Trivedi, Chinmay M.] Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Trivedi, CM (corresponding author), Albert Sherman Ctr, AS7-1047,368 Plantat St, Worcester, MA 01605 USA.	chinmay.trivedi@umassmed.edu	Lewandowski, Sara/J-2988-2017; JANARDHAN, HARISH PALLETI/AAA-4945-2019; Trivedi, Chinmay M/ABA-4097-2021	Lewandowski, Sara/0000-0002-5830-9962; Trivedi, Chinmay/0000-0002-3544-0474; Palleti Janardhan, Harish/0000-0002-9923-9147	NHLBI, National Institutes of Health [R01 HL118100]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118100] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health, Grant R01 HL118100 (to C. M. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Adrain C, 2012, NAT REV MOL CELL BIO, V13, P489, DOI 10.1038/nrm3392; Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; [Anonymous], 2013, PHEATMAP PRETTY HEAT; Bajolle F, 2008, DEV BIOL, V313, P25, DOI 10.1016/j.ydbio.2007.09.023; Bartram U, 2001, CIRCULATION, V103, P2745; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; BUNTINX IM, 1991, J MED GENET, V28, P267, DOI 10.1136/jmg.28.4.267; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Doetschman T, 2012, CELL TISSUE RES, V347, P203, DOI 10.1007/s00441-011-1241-3; Dupuis LE, 2014, DEV DYNAM, V243, P601, DOI 10.1002/dvdy.24100; Evans SM, 2010, CIRC RES, V107, P1428, DOI 10.1161/CIRCRESAHA.110.227405; Fielitz J, 2001, J AM COLL CARDIOL, V37, P1443, DOI 10.1016/S0735-1097(01)01170-6; GARCIAMARTINEZ V, 1993, DEV BIOL, V159, P706, DOI 10.1006/dbio.1993.1276; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; High FA, 2009, J CLIN INVEST, V119, P1986, DOI 10.1172/JCI38922; Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145; Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Kelly RG, 2012, CURR TOP DEV BIOL, V100, P33, DOI 10.1016/B978-0-12-387786-4.00002-6; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lakkis MM, 1998, DEVELOPMENT, V125, P4359; LEIER CV, 1980, ANN INTERN MED, V92, P171, DOI 10.7326/0003-4819-92-2-171; Lewandowski SL, 2014, HUM MOL GENET, V23, P3801, DOI 10.1093/hmg/ddu093; Lincoln J, 2011, BIRTH DEFECTS RES A, V91, P526, DOI 10.1002/bdra.20799; Liu AC, 2008, AM J PATHOL, V173, P1275, DOI 10.2353/ajpath.2008.080365; Lockhart M, 2011, BIRTH DEFECTS RES A, V91, P535, DOI 10.1002/bdra.20810; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; MacCarrick G, 2014, GENET MED, V16, P576, DOI 10.1038/gim.2014.11; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McCulley DJ, 2008, DEV DYNAM, V237, P3200, DOI 10.1002/dvdy.21743; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Morissette R, 2014, CIRC-CARDIOVASC GENE, V7, P80, DOI 10.1161/CIRCGENETICS.113.000280; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Neeb Z, 2013, WIRES DEV BIOL, V2, P499, DOI 10.1002/wdev.98; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Niu Z, 2005, J BIOL CHEM, V280, P32531, DOI 10.1074/jbc.M501372200; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Potthoff M. J., 2007, THESIS; PULKKINEN L, 1990, J BIOL CHEM, V265, P17780; R Core Team, 2012, R LANG ENV STAT COMP; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Singh N, 2011, CIRC RES, V109, P1240, DOI 10.1161/CIRCRESAHA.111.255067; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Tao G, 2012, CURR TOP DEV BIOL, V100, P203, DOI 10.1016/B978-0-12-387786-4.00006-3; Trivedi CM, 2008, J BIOL CHEM, V283, P26484, DOI 10.1074/jbc.M803686200; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Trivedi CM, 2010, DEV CELL, V19, P450, DOI 10.1016/j.devcel.2010.08.012; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa; WALTENBERGER J, 1993, AM J PATHOL, V142, P71; Wang H, 2014, NAT REV CARDIOL, V11, P715, DOI 10.1038/nrcardio.2014.162; Ward C, 2005, DEV BIOL, V284, P72, DOI 10.1016/j.ydbio.2005.05.003; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yamamura H, 1997, DEV BIOL, V186, P58, DOI 10.1006/dbio.1997.8559; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yasuda H, 2003, CIRCULATION, V108, P291, DOI 10.1161/01.cir.0000087449.03964.fb	79	42	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27067	27089		10.1074/jbc.M115.684753	http://dx.doi.org/10.1074/jbc.M115.684753			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26420484	hybrid, Green Published			2022-12-28	WOS:000364794000018
J	Tsukamoto, H; Kubo, Y; Farrens, DL; Koyanagi, M; Terakita, A; Furutani, Y				Tsukamoto, Hisao; Kubo, Yoshihiro; Farrens, David L.; Koyanagi, Mitsumasa; Terakita, Akihisa; Furutani, Yuji			Retinal Attachment Instability Is Diversified among Mammalian Melanopsins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GANGLION-CELLS; CONFORMATIONAL-CHANGE; COUPLED RHODOPSIN; CRYSTAL-STRUCTURE; VISUAL PIGMENT; CONE OPSINS; LIGAND-FREE; LIGHT; EXPRESSION; PHOTOTRANSDUCTION	Melanopsins play a key role in non-visual photoreception in mammals. Their close phylogenetic relationship to the photopigments in invertebrate visual cells suggests they have evolved to acquire molecular characteristics that are more suited for their non-visual functions. Here we set out to identify such characteristics by comparing the molecular properties of mammalian melanopsin to those of invertebrate melanopsin and visual pigment. Our data show that the Schiff base linking the chromophore retinal to the protein is more susceptive to spontaneous cleavage in mammalian melanopsins. We also find this stability is highly diversified between mammalian species, being particularly unstable for human melanopsin. Through mutagenesis analyses, we find that this diversified stability is mainly due to parallel amino acid substitutions in extracellular regions. We propose that the different stability of the retinal attachment in melanopsins may contribute to functional tuning of non-visual photoreception in mammals.	[Tsukamoto, Hisao; Furutani, Yuji] Natl Inst Nat Sci, Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, Okazaki, Aichi 4448585, Japan; [Tsukamoto, Hisao; Furutani, Yuji] SOKENDAI, Dept Struct Mol Sci, Hayama, Kanagawa 2400193, Japan; [Kubo, Yoshihiro] Natl Inst Nat Sci, Natl Inst Physiol Sci, Dept Mol Physiol, Div Biophys & Neurobiol, Okazaki, Aichi 4448585, Japan; [Kubo, Yoshihiro] SOKENDAI, Dept Physiol Sci, Hayama, Kanagawa 2400193, Japan; [Farrens, David L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Koyanagi, Mitsumasa; Terakita, Akihisa] Osaka City Univ, Grad Sch Sci, Dept Biol & Geosci, Osaka 5588585, Japan	National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Oregon Health & Science University; Osaka Metropolitan University	Tsukamoto, H (corresponding author), Natl Inst Nat Sci, Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, 38 Nishigo Naka, Okazaki, Aichi 4448585, Japan.	tsukamoh@ims.ac.jp	Furutani, Yuji/J-8337-2019; Regan, Clinton/E-6250-2012	Furutani, Yuji/0000-0001-5284-8773; Koyanagi, Mitsumasa/0000-0002-7741-918X; Kubo, Yoshihiro/0000-0001-6707-0837; Terakita, Akihisa/0000-0002-8379-8913	JSPS KAKENHI Grant [25840122]; National Institutes of Health [NEI R01EY015436]; Novartis Foundation (Japan) for the Promotion of Science; Uehara Memorial Foundation; Cooperative Study Program of National Institute for Physiological Sciences; Grants-in-Aid for Scientific Research [26640047, 26291070, 15H05777] Funding Source: KAKEN; NATIONAL EYE INSTITUTE [R01EY015436] Funding Source: NIH RePORTER	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Foundation (Japan) for the Promotion of Science(Novartis); Uehara Memorial Foundation(Uehara Memorial Foundation); Cooperative Study Program of National Institute for Physiological Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by JSPS KAKENHI Grant 25840122 (to H. T.), National Institutes of Health Grant NEI R01EY015436 (to D. L. F.), the Novartis Foundation (Japan) for the Promotion of Science, Uehara Memorial Foundation, and the Cooperative Study Program of National Institute for Physiological Sciences. The authors declare that they have no conflict of interest regarding this study.	Ala-Laurila P, 2009, J BIOL CHEM, V284, P16492, DOI 10.1074/jbc.M109.004697; Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Cameron EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113138; Chew KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098356; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Davies WIL, 2011, CELL MOL LIFE SCI, V68, P4115, DOI 10.1007/s00018-011-0785-4; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Doyle SE, 2006, P NATL ACAD SCI USA, V103, P10432, DOI 10.1073/pnas.0600934103; Emanuel AJ, 2015, NEURON, V85, P1043, DOI 10.1016/j.neuron.2015.02.011; Fahrenkrug J, 2014, J BIOL CHEM, V289, P35482, DOI 10.1074/jbc.M114.586529; Farrens DL, 2012, RESONANCE, V17, P1165, DOI 10.1007/s12045-012-0133-5; Ferrer C, 2012, J NEUROSCI, V32, P17977, DOI 10.1523/JNEUROSCI.3069-12.2012; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Fujiwara Y, 2002, J GEN PHYSIOL, V120, P677, DOI 10.1085/jgp.20028663; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Gross AK, 2003, BIOCHEMISTRY-US, V42, P2009, DOI 10.1021/bi020613j; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hughes S, 2015, CELL MOL LIFE SCI, V72, P165, DOI 10.1007/s00018-014-1664-6; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Jacobs GH, 2013, VISUAL NEUROSCI, V30, P39, DOI 10.1017/S0952523812000429; Janz JM, 2004, J BIOL CHEM, V279, P55886, DOI 10.1074/jbc.M408766200; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; Jin SN, 2003, NAT NEUROSCI, V6, P731, DOI 10.1038/nn1070; Jones KA, 2013, NAT CHEM BIOL, V9, P630, DOI [10.1038/NCHEMBIO.1333, 10.1038/nchembio.1333]; Kawamura S, 2004, J MOL EVOL, V58, P314, DOI 10.1007/s00239-003-2553-z; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; Kono M, 2006, FEBS LETT, V580, P229, DOI 10.1016/j.febslet.2005.12.002; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Koyanagi M, 2008, P NATL ACAD SCI USA, V105, P15576, DOI 10.1073/pnas.0806215105; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Kubo Y, 1998, SCIENCE, V279, P1722, DOI 10.1126/science.279.5357.1722; Lucas RJ, 2006, P NATL ACAD SCI USA, V103, P10153, DOI 10.1073/pnas.0603955103; Matsuyama T, 2012, BIOCHEMISTRY-US, V51, P5454, DOI 10.1021/bi3004999; Mawad K, 2008, J BIOL RHYTHM, V23, P387, DOI 10.1177/0748730408323063; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Mure LS, 2007, J BIOL RHYTHM, V22, P411, DOI 10.1177/0748730407306043; Nagata T, 2012, SCIENCE, V335, P469, DOI 10.1126/science.1211667; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Newman LA, 2003, BIOCHEMISTRY-US, V42, P12734, DOI 10.1021/bi035418z; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Provencio I., 2012, WILEY INTERDISCIPLIN, P228, DOI [DOI 10.1002/WMTS.29, 10.1002/wmts.29]; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Ramon E, 2003, J BIOL CHEM, V278, P6427, DOI 10.1074/jbc.M210929200; Ramon E, 2009, PHOTOCHEM PHOTOBIOL, V85, P509, DOI 10.1111/j.1751-1097.2008.00504.x; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Torii M, 2007, FEBS LETT, V581, P5327, DOI 10.1016/j.febslet.2007.10.019; Travis GH, 2005, NEURON, V46, P840, DOI 10.1016/j.neuron.2005.06.003; Tsukamoto H, 2013, J BIOL CHEM, V288, P28207, DOI 10.1074/jbc.M113.472464; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212; Tu DC, 2006, P NATL ACAD SCI USA, V103, P10426, DOI 10.1073/pnas.0600917103; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Walker MT, 2008, P NATL ACAD SCI USA, V105, P8861, DOI 10.1073/pnas.0711397105	71	13	13	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27176	27187		10.1074/jbc.M115.666305	http://dx.doi.org/10.1074/jbc.M115.666305			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26416885	hybrid, Green Published			2022-12-28	WOS:000364794000027
J	Cattin, ME; Wang, J; Weldrick, JJ; Roeske, CL; Mak, E; Thorn, SL; DaSilva, JN; Wang, YB; Lusis, AJ; Burgon, PG				Cattin, Marie-Elodie; Wang, Jessica; Weldrick, Jonathan J.; Roeske, Cassandra L.; Mak, Esther; Thorn, Stephanie L.; DaSilva, Jean N.; Wang, Yibin; Lusis, Aldon J.; Burgon, Patrick G.			Deletion of MLIP (Muscle-enriched A-type Lamin-interacting Protein) Leads to Cardiac Hyperactivation of Akt/Mammalian Target of Rapamycin (mTOR) and Impaired Cardiac Adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PTEN; MAMMALIAN TARGET; TRANSGENIC MICE; GLUCOSE-UPTAKE; HEART-FAILURE; IN-VIVO; HYPERTROPHY; KINASE; DISEASE; AKT	Aging and diseases generally result from tissue inability to maintain homeostasis through adaptation. The adult heart is particularly vulnerable to disequilibrium in homeostasis because its regenerative abilities are limited. Here, we report that MLIP (muscle enriched A-type lamin-interacting protein), a unique protein of unknown function, is required for proper cardiac adaptation. Mlip(-/-) mice exhibited normal cardiac function despite myocardial metabolic abnormalities and cardiac-specific overactivation of Akt/mTOR pathways. Cardiac-specific MLIP overexpression led to an inhibition of Akt/mTOR, providing evidence of a direct impact of MLIP on these key signaling pathways. Mlip(-/-) hearts showed an impaired capacity to adapt to stress (isoproterenol-induced hypertrophy), likely because of deregulated Akt/mTOR activity. Genome-wide association studies showed a genetic association between Mlip and early response to cardiac stress, supporting the role of MLIP in cardiac adaptation. Together, these results revealed that MLIP is required for normal myocardial adaptation to stress through integrated regulation of the Akt/mTOR pathways.	[Cattin, Marie-Elodie; Weldrick, Jonathan J.; Roeske, Cassandra L.; Mak, Esther; Thorn, Stephanie L.; DaSilva, Jean N.; Burgon, Patrick G.] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada; [Wang, Jessica] Univ Calif Los Angeles, Dept Med, Div Cardiol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Wang, Yibin] Univ Calif Los Angeles, Dept Anesthesiol Physiol & Med, Div Cardiol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lusis, Aldon J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Div Cardiol, Human Genet & Med,David Geffen Sch Med, Los Angeles, CA 90095 USA; [Weldrick, Jonathan J.; Thorn, Stephanie L.; DaSilva, Jean N.; Burgon, Patrick G.] Univ Ottawa, Dept Cellular & Mol Med, Fac Med, Ottawa, ON K1N 6N5, Canada; [Weldrick, Jonathan J.; Thorn, Stephanie L.; DaSilva, Jean N.; Burgon, Patrick G.] Univ Ottawa, Dept Med Cardiol, Fac Med, Ottawa, ON K1N 6N5, Canada	University of Ottawa; University of Ottawa Heart Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Ottawa; University of Ottawa	Burgon, PG (corresponding author), Univ Ottawa, Inst Heart, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.	pburgon@ottawaheart.ca	Thorn, Stephanie/AAD-6988-2022; Wang, Jessica/O-1805-2014; Regan, Clinton/E-6250-2012; Burgon, Patrick/ABB-1027-2021	Wang, Jessica/0000-0001-7348-0509; Wang, Yibin/0000-0003-0852-0767	Canadian Institutes of Health Research [MOP119470]; Heart and Stroke Foundation of Canada [000007]; National Institutes of Health [HL123295, HL114437]; University of Ottawa Cardiac Research Endowed Fellowship; University of Ottawa Heart Institute Foundation; University of Ottawa's Faculty of Medicine Cardiac Endowment Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123295, R01HL114437] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Ottawa Cardiac Research Endowed Fellowship; University of Ottawa Heart Institute Foundation; University of Ottawa's Faculty of Medicine Cardiac Endowment Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by Canadian Institutes of Health Research Grant MOP119470 (to P. G. B.), Heart and Stroke Foundation of Canada Grant 000007 (to P. G. B.), and National Institutes of Health Grants HL123295 and HL114437 (to A. J. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a University of Ottawa Cardiac Research Endowed Fellowship.; Supported by a Graduate Award from the University of Ottawa Heart Institute Foundation and the University of Ottawa's Faculty of Medicine Cardiac Endowment Funds.	Ahmady E, 2011, J BIOL CHEM, V286, P19702, DOI 10.1074/jbc.M110.165548; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bertrand AT, 2011, BIOCHEM SOC T, V39, P1687, DOI 10.1042/BST20110670; Buss SJ, 2009, J AM COLL CARDIOL, V54, P2435, DOI 10.1016/j.jacc.2009.08.031; Chen X, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/868753; Choi JC, 2012, J BIOL CHEM, V287, P40513, DOI 10.1074/jbc.M112.404541; Choi JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003875; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Dorn GW, 2010, PHYSIOL REV, V90, P1013, DOI 10.1152/physrev.00001.2010; Farber CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002038; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley SA, 2014, BIOCHEM J, V459, P275, DOI 10.1042/BJ20131344; Hayasaka M, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12254; Hershberger RE, 2010, GENET MED, V12, P655, DOI 10.1097/GIM.0b013e3181f2481f; Huang ZP, 2012, CIRC RES, V110, P818, DOI 10.1161/CIRCRESAHA.111.259663; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kelleher AR, 2013, AM J PHYSIOL-ENDOC M, V304, pE229, DOI 10.1152/ajpendo.00409.2012; Kim AS, 2009, ACTA PHYSIOL, V196, P37, DOI 10.1111/j.1748-1716.2009.01978.x; Lee CT, 2014, CAN J PHYSIOL PHARM, V92, P307, DOI 10.1139/cjpp-2013-0107; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Liu L, 2012, AM J TRANSL RES, V4, P175; Lundby A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003506; Lyon RC, 2015, CIRC RES, V116, P1462, DOI 10.1161/CIRCRESAHA.116.304937; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Palermo J, 1996, CIRC RES, V78, P504, DOI 10.1161/01.RES.78.3.504; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Rau CD, 2015, CURR OPIN CARDIOL, V30, P222, DOI 10.1097/HCO.0000000000000160; Rau CD, 2015, CIRC-CARDIOVASC GENE, V8, P40, DOI 10.1161/CIRCGENETICS.113.000732; Schiekofer S, 2006, PHYSIOL GENOMICS, V27, P156, DOI 10.1152/physiolgenomics.00234.2005; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sciarretta S, 2014, CIRC RES, V114, P549, DOI 10.1161/CIRCRESAHA.114.302022; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Song XX, 2010, AM J PHYSIOL-CELL PH, V299, pC1256, DOI 10.1152/ajpcell.00338.2010; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Steinbusch LKM, 2011, CELL MOL LIFE SCI, V68, P2525, DOI 10.1007/s00018-011-0690-x; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Thorn SL, 2013, J NUCL MED, V54, P1637, DOI 10.2967/jnumed.112.110114; Thorn SL, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-48; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xu SH, 2014, AGING DIS, V5, P263, DOI 10.14336/AD.2014.0500263; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhang WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026581; Zhu Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054221, 10.1371/journal.pone.0071727]; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	52	18	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26699	U404		10.1074/jbc.M115.678433	http://dx.doi.org/10.1074/jbc.M115.678433			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26359501	Green Published, hybrid			2022-12-28	WOS:000364793600033
J	Katsuma, S; Sugano, Y; Kiuchi, T; Shimada, T				Katsuma, Susumu; Sugano, Yudai; Kiuchi, Takashi; Shimada, Toru			Two Conserved Cysteine Residues Are Required for the Masculinizing Activity of the Silkworm Masc Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING; SEQUENCE ALIGNMENT; INTERACTING RNA; MESSENGER-RNA; W-CHROMOSOME; IDENTIFICATION; SEX	We have recently discovered that the Masculinizer (Masc) gene encodes a CCCH tandem zinc finger protein, which controls both masculinization and dosage compensation in the silkworm Bombyx mori. In this study, we attempted to identify functional regions or residues that are required for the masculinizing activity of the Masc protein. We constructed a series of plasmids that expressed the Masc derivatives and transfected them into a B. mori ovary-derived cell line, BmN-4. To assess the masculinizing activity of the Masc derivatives, we investigated the splicing patterns of B. mori doublesex (Bmdsx) and the expression levels of B. mori IGF-II mRNA-binding protein, a splicing regulator of Bmdsx, in Masc cDNA-transfected BmN-4 cells. We found that two zinc finger domains are not required for the masculinizing activity. We also identified that the C-terminal 288 amino acid residues are sufficient for the masculinizing activity of the Masc protein. Further detailed analyses revealed that two cysteine residues, Cys-301 and Cys-304, in the highly conserved region among lepidopteran Masc proteins are essential for the masculinizing activity in BmN-4 cells. Finally, we showed that Masc is a nuclear protein, but its nuclear localization is not tightly associated with the masculinizing activity.	[Katsuma, Susumu; Sugano, Yudai; Kiuchi, Takashi; Shimada, Toru] Univ Tokyo, Dept Agr & Environm Biol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Katsuma, S (corresponding author), Univ Tokyo, Dept Agr & Environm Biol, Grad Sch Agr & Life Sci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	katsuma@ss.ab.a.u-tokyo.ac.jp	Shimada, Toru/AAZ-2703-2021; Kiuchi, Takashi/AAG-4913-2020; Shimada, Toru/A-2033-2011	Shimada, Toru/0000-0002-5791-0000; Kiuchi, Takashi/0000-0003-3616-1650; Shimada, Toru/0000-0002-5791-0000; Katsuma, Susumu/0000-0001-7096-3038	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry Grant [26034A]; KAKENHI Grant [15H02482]	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry Grant; KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry Grant 26034A (to S. K.) and KAKENHI Grant 15H02482 (to S. K., T. K., and T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe H, 2008, GENETICA, V133, P269, DOI 10.1007/s10709-007-9210-1; Abe H, 2005, CYTOGENET GENOME RES, V110, P144, DOI 10.1159/000084946; Blackshear PJ, 2014, J INTERF CYTOK RES, V34, P297, DOI 10.1089/jir.2013.0150; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Fukui T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005048; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hasimoto H., 1933, JPN J GENET, V8, P245; IMANISHI S, 1988, Journal of Sericultural Science of Japan, V57, P184; Ishihara G, 2013, VIRUS RES, V174, P52, DOI 10.1016/j.virusres.2013.02.014; Iwasaki YW, 2015, ANNU REV BIOCHEM, V84, P405, DOI 10.1146/annurev-biochem-060614-034258; Kawamoto M, 2015, GENE, V560, P50, DOI 10.1016/j.gene.2015.01.036; Kawaoka S, 2011, RNA, V17, P2144, DOI 10.1261/rna.027565.111; Kawaoka S, 2011, RNA, V17, P1401, DOI 10.1261/rna.2709411; Kawaoka S, 2009, RNA, V15, P1258, DOI 10.1261/rna.1452209; Kelly SM, 2010, J BIOL CHEM, V285, P26022, DOI 10.1074/jbc.M110.141127; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; Lee J, 2015, INSECT MOL BIOL, V24, P561, DOI 10.1111/imb.12181; Pomeranz MC, 2010, PLANT PHYSIOL, V152, P151, DOI 10.1104/pp.109.145656; Qu J, 2014, PLANT J, V78, P452, DOI 10.1111/tpj.12485; Suzuki MG, 2010, MOL CELL BIOL, V30, P5776, DOI 10.1128/MCB.00444-10; Suzuki MG, 2005, EVOL DEV, V7, P58, DOI 10.1111/j.1525-142X.2005.05007.x; Suzuki MG, 2003, DEV GENES EVOL, V213, P345, DOI 10.1007/s00427-003-0334-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka Y, 1916, J COLL AGR SAPPORO, V6, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	27	22	22	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26114	26124		10.1074/jbc.M115.685362	http://dx.doi.org/10.1074/jbc.M115.685362			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26342076	Green Published, hybrid			2022-12-28	WOS:000363527300031
J	Kolappan, S; Ng, D; Yang, GX; Harn, T; Craig, L				Kolappan, Subramania; Ng, Dixon; Yang, Guixiang; Harn, Tony; Craig, Lisa			Crystal Structure of the Minor Pilin CofB, the Initiator of CFA/III Pilus Assembly in Enterotoxigenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II SECRETION SYSTEM; FACTOR ANTIGEN-III; TOXIN-COREGULATED-PILUS; IV PILUS; PSEUDOMONAS-AERUGINOSA; COLONIZATION FACTOR; NEISSERIA-MENINGITIDIS; PATHOGENIC NEISSERIA; PROTEIN SECRETION; X-RAY	Type IV pili are extracellular polymers of the major pilin subunit. These subunits are held together in the pilus filament by hydrophobic interactions among their N-terminal alpha-helices, which also anchor the pilin subunits in the inner membrane prior to pilus assembly. Type IV pilus assembly involves a conserved group of proteins that span the envelope of Gram-negative bacteria. Among these is a set of minor pilins, so named because they share their hydrophobic N-terminal polymerization/membrane anchor segment with the major pilins but are much less abundant. Minor pilins influence pilus assembly and retraction, but their precise functions are not well defined. The Type IV pilus systems of enterotoxigenic Escherichia coli and Vibrio cholerae are among the simplest of Type IV pilus systems and possess only a single minor pilin. Here we show that the enterotoxigenic E. coli minor pilins CofB and LngB are required for assembly of their respective Type IV pili, CFA/III and Longus. Low levels of the minor pilins are optimal for pilus assembly, and CofB can be detected in the pilus fraction. We solved the 2.0 angstrom crystal structure of N-terminally truncated CofB, revealing a pilin-like protein with an extended C-terminal region composed of two discrete domains connected by flexible linkers. The C-terminal region is required for CofB to initiate pilus assembly. We propose a model for CofB-initiated pilus assembly with implications for understanding filament growth in more complex Type IV pilus systems as well as the related Type II secretion system.	[Kolappan, Subramania; Ng, Dixon; Yang, Guixiang; Harn, Tony; Craig, Lisa] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Craig, L (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	licraig@sfu.ca		Craig, Lisa/0000-0001-8515-9915	Canadian Institutes of Health Research Grant [MOP-125959]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant MOP-125959 (to L. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Aas FE, 2007, MOL MICROBIOL, V63, P69, DOI 10.1111/j.1365-2958.2006.05482.x; Anantha RP, 1998, INFECT IMMUN, V66, P122, DOI 10.1128/IAI.66.1.122-131.1998; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aroeti B, 2012, GUT MICROBES, V3, P267, DOI 10.4161/gmic.19814; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bernard SC, 2014, NAT MED, V20, P725, DOI 10.1038/nm.3563; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Blank TE, 2001, J BACTERIOL, V183, P4435, DOI 10.1128/JB.183.15.4435-4450.2001; Bleves S, 1998, MOL MICROBIOL, V27, P31, DOI 10.1046/j.1365-2958.1998.00653.x; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Brissac T, 2012, INFECT IMMUN, V80, P3297, DOI 10.1128/IAI.00369-12; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burrows LL, 2005, MOL MICROBIOL, V57, P878, DOI 10.1111/j.1365-2958.2005.04703.x; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Cehovin A, 2013, P NATL ACAD SCI USA, V110, P3065, DOI 10.1073/pnas.1218832110; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiang P, 2008, MICROBIOL-SGM, V154, P114, DOI 10.1099/mic.0.2007/011320-0; Cisneros DA, 2012, MOL MICROBIOL, V86, P805, DOI 10.1111/mmi.12033; Cisneros DA, 2012, EMBO J, V31, P1041, DOI 10.1038/emboj.2011.454; Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Douzi B, 2012, PHILOS T R SOC B, V367, P1059, DOI 10.1098/rstb.2011.0204; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS DG, 1977, INFECT IMMUN, V18, P330, DOI 10.1128/IAI.18.2.330-337.1977; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Franz LP, 2011, ACTA CRYSTALLOGR D, V67, P124, DOI 10.1107/S0907444910051954; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; GIRON JA, 1994, MOL MICROBIOL, V12, P71, DOI 10.1111/j.1365-2958.1994.tb00996.x; Gold VAM, 2015, ELIFE, V4, DOI 10.7554/eLife.07380; Gomez-Duarte OG, 2007, J BACTERIOL, V189, P9145, DOI 10.1128/JB.00722-07; Gonzalez A, 2008, J APPL CRYSTALLOGR, V41, P176, DOI 10.1107/S0021889807057822; Hartung S, 2011, J BIOL CHEM, V286, P44254, DOI 10.1074/jbc.M111.297242; Helaine S, 2005, MOL MICROBIOL, V55, P65, DOI 10.1111/j.1365-2958.2004.04372.x; Helaine S, 2007, P NATL ACAD SCI USA, V104, P15888, DOI 10.1073/pnas.0707581104; HONDA T, 1984, INFECT IMMUN, V43, P959, DOI 10.1128/IAI.43.3.959-965.1984; HONDA T, 1989, INFECT IMMUN, V57, P3452, DOI 10.1128/IAI.57.11.3452-3457.1989; HONDA T, 1989, INFECT IMMUN, V57, P2799, DOI 10.1128/IAI.57.9.2799-2803.1989; Horiuchi T, 1998, J BACTERIOL, V180, P4613, DOI 10.1128/JB.180.17.4613-4620.1998; Imhaus AF, 2014, EMBO J, V33, P1767, DOI 10.15252/embj.201488031; Jain S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016624; Kabsch H., 1993, J APPL CRYSTALLOGR, V26, P795; KAUFMAN MR, 1991, GENE DEV, V5, P1834, DOI 10.1101/gad.5.10.1834; Kawahara K, 2015, ACTA CRYSTALLOGR F, V71, P663, DOI 10.1107/S2053230X15005890; Kirn TJ, 2005, INFECT IMMUN, V73, P4461, DOI 10.1128/IAI.73.8.4461-4470.2005; Kolappan S, 2012, J BACTERIOL, V194, P2725, DOI 10.1128/JB.00282-12; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Kuchma SL, 2012, J BACTERIOL, V194, P5388, DOI 10.1128/JB.00899-12; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LEVINE MM, 1984, INFECT IMMUN, V44, P409, DOI 10.1128/IAI.44.2.409-420.1984; Li J, 2012, J MOL BIOL, V418, P47, DOI 10.1016/j.jmb.2012.02.017; Lieberman JA, 2012, J BACTERIOL, V194, P1646, DOI 10.1128/JB.06330-11; Lim MS, 2010, MOL MICROBIOL, V77, P755, DOI 10.1111/j.1365-2958.2010.07244.x; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Mazariego-Espinosa K, 2010, J BACTERIOL, V192, P2791, DOI 10.1128/JB.01595-09; McLaughlin LS, 2012, CURR OPIN STRUC BIOL, V22, P208, DOI 10.1016/j.sbi.2012.02.005; Megli CJ, 2011, J MOL BIOL, V409, P146, DOI 10.1016/j.jmb.2011.03.027; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; Misic AM, 2010, J MOL BIOL, V400, P1011, DOI 10.1016/j.jmb.2010.05.066; Morand PC, 2004, EMBO J, V23, P2009, DOI 10.1038/sj.emboj.7600200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen Y, 2010, J MOL BIOL, V395, P491, DOI 10.1016/j.jmb.2009.10.070; NUNN DN, 1991, P NATL ACAD SCI USA, V88, P3281, DOI 10.1073/pnas.88.8.3281; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Park HSM, 2001, MOL MICROBIOL, V42, P293, DOI 10.1046/j.1365-2958.2001.02629.x; PASLOSKE BL, 1988, MOL MICROBIOL, V2, P489, DOI 10.1111/j.1365-2958.1988.tb00055.x; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Piepenbrink KH, 2014, J BIOL CHEM, V289, P4334, DOI 10.1074/jbc.M113.534404; Reichow SL, 2011, CHANNELS, V5, P215, DOI 10.4161/chan.5.3.15268; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Schmidt SA, 2001, J BACTERIOL, V183, P4848, DOI 10.1128/JB.183.16.4848-4859.2001; STROM MS, 1992, J BACTERIOL, V174, P7345, DOI 10.1128/jb.174.22.7345-7351.1992; STROM MS, 1991, J BIOL CHEM, V266, P1656; Takhar HK, 2013, J BIOL CHEM, V288, P9721, DOI 10.1074/jbc.M113.453506; TANIGUCHI T, 1995, INFECT IMMUN, V63, P724, DOI 10.1128/IAI.63.2.724-728.1995; Taniguchi T, 2001, INFECT IMMUN, V69, P5864, DOI 10.1128/IAI.69.9.5864-5873.2001; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; Tripathi SA, 2007, J BACTERIOL, V189, P4401, DOI 10.1128/JB.00008-07; Winther-Larsen HC, 2005, MOL MICROBIOL, V56, P903, DOI 10.1111/j.1365-2958.2005.04591.x; Yanez ME, 2008, J MOL BIOL, V375, P471, DOI 10.1016/j.jmb.2007.10.035; Nguyen Y, 2015, J BIOL CHEM, V290, P601, DOI 10.1074/jbc.M114.616904; Yuen ASW, 2013, MOL MICROBIOL, V90, P898, DOI 10.1111/mmi.12407; ZHANG HZ, 1994, J BACTERIOL, V176, P6885, DOI 10.1128/JB.176.22.6885-6891.1994	94	16	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25805	25818		10.1074/jbc.M115.676106	http://dx.doi.org/10.1074/jbc.M115.676106			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26324721	hybrid, Green Published			2022-12-28	WOS:000363527300003
J	Trefely, S; Khoo, PS; Krycer, JR; Chaudhuri, R; Fazakerley, DJ; Parker, BL; Sultani, G; Lee, J; Stephan, JP; Torres, E; Jung, K; Kuijl, C; James, DE; Junutula, JR; Stockli, J				Trefely, Sophie; Khoo, Poh-Sim; Krycer, James R.; Chaudhuri, Rima; Fazakerley, Daniel J.; Parker, Benjamin L.; Sultani, Ghazal; Lee, James; Stephan, Jean-Philippe; Torres, Eric; Jung, Kenneth; Kuijl, Coenraad; James, David E.; Junutula, Jagath R.; Stoeckli, Jacqueline			Kinome Screen Identifies PFKFB3 and Glucose Metabolism as Important Regulators of the Insulin/Insulin-like Growth Factor (IGF)-1 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; GLUCOSE-TRANSPORTER-4 TRANSLOCATION; INDUCIBLE 6-PHOSPHOFRUCTO-2-KINASE; FRUCTOSE 2,6-BISPHOSPHATE; MYOSIN-II; IGF-I; AKT; GLUT4	The insulin/insulin-like growth factor (IGF)-1 signaling pathway (ISP) plays a fundamental role in long term health in a range of organisms. Protein kinases including Akt and ERK are intimately involved in the ISP. To identify other kinases that may participate in this pathway or intersect with it in a regulatory manner, we performed a whole kinome (779 kinases) siRNA screen for positive or negative regulators of the ISP, using GLUT4 translocation to the cell surface as an output for pathway activity. We identified PFKFB3, a positive regulator of glycolysis that is highly expressed in cancer cells and adipocytes, as a positive ISP regulator. Pharmacological inhibition of PFKFB3 suppressed insulin-stimulated glucose uptake, GLUT4 translocation, and Akt signaling in 3T3-L1 adipocytes. In contrast, overexpression of PFKFB3 in HEK293 cells potentiated insulin-dependent phosphorylation of Akt and Akt substrates. Furthermore, pharmacological modulation of glycolysis in 3T3-L1 adipocytes affected Akt phosphorylation. These data add to an emerging body of evidence that metabolism plays a central role in regulating numerous biological processes including the ISP. Our findings have important implications for diseases such as type 2 diabetes and cancer that are characterized by marked disruption of both metabolism and growth factor signaling.	[Trefely, Sophie; Khoo, Poh-Sim; Sultani, Ghazal] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Lee, James; Stephan, Jean-Philippe; Torres, Eric; Jung, Kenneth; Kuijl, Coenraad; Junutula, Jagath R.] Genentech Inc, San Francisco, CA 94080 USA; [Krycer, James R.; Chaudhuri, Rima; Fazakerley, Daniel J.; Parker, Benjamin L.; James, David E.; Stoeckli, Jacqueline] Univ Sydney, Sch Mol Biosci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [James, David E.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Garvan Institute of Medical Research; Roche Holding; Genentech; University of Sydney; University of Sydney	James, DE (corresponding author), Univ Sydney, Sydney Med Sch, Sch Mol Biosci, Charles Perkins Ctr, Sydney, NSW 2006, Australia.	david.james@sydney.edu.au; jagathjr@gmail.com; jacqueline.stoeckli@sydney.edu.au	Trefely, Sophie/AAL-9434-2020; Stoeckli, Jacqueline/Z-4443-2019; Junutula, Jagath Reddy/ABD-4753-2020; Stoeckli, Jacqueline/D-7053-2016; Fazakerley, Daniel/J-2652-2019	Stoeckli, Jacqueline/0000-0002-6446-7350; Junutula, Jagath Reddy/0000-0002-5942-4428; Stoeckli, Jacqueline/0000-0002-6446-7350; Fazakerley, Daniel/0000-0001-8241-2903; Trefely, Sophie/0000-0003-3816-6869; Kuijl, Coen/0000-0003-4378-1428; James, David/0000-0001-5946-5257; Krycer, James/0000-0003-1536-7270	National Health and Medical Research Council (NHMRC) [GNT1068469, GNT1086850]; Australian Postgraduate Award scholarships	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award scholarships	This work was supported in part by National Health and Medical Research Council (NHMRC) project Grants GNT1068469 (to J. S.) and GNT1086850 (to D. E. J.). The contents of the published material are solely the responsibility of the individual authors and do not reflect the views of NHMRC.; Supported by Australian Postgraduate Award scholarships.	Abe Y, 2006, BIOCHEM BIOPH RES CO, V344, P377, DOI 10.1016/j.bbrc.2006.03.071; Abe Y, 2001, J BIOL CHEM, V276, P44003, DOI 10.1074/jbc.M105669200; Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Atsumi T, 2005, DIABETES, V54, P3349, DOI 10.2337/diabetes.54.12.3349; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brewer PD, 2011, J BIOL CHEM, V286, P26287, DOI 10.1074/jbc.M111.253880; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Bulow MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04048; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; CHALLISS RAJ, 1983, BIOSCIENCE REP, V3, P675, DOI 10.1007/BF01172878; Chan TO, 2012, CELL CYCLE, V11, P475, DOI 10.4161/cc.11.3.19059; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Cordero-Espinoza L, 2013, J BIOL CHEM, V288, P36020, DOI 10.1074/jbc.M113.510289; Davey JR, 2012, TRAFFIC, V13, P1429, DOI 10.1111/j.1600-0854.2012.01397.x; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; De Saedeleer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046571; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; Eguez L, 2005, CELL METAB, V2, P263, DOI 10.1016/j.cmet.2005.09.005; Facchin S, 2007, CELL MOL LIFE SCI, V64, P2680, DOI 10.1007/s00018-007-7179-7; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; Fulcher FK, 2008, EXP CELL RES, V314, P3264, DOI 10.1016/j.yexcr.2008.08.007; Garcia-Guerra L, 2010, DIABETES, V59, P2407, DOI 10.2337/db10-0771; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; HALESTRAP AP, 1976, BIOCHEM J, V156, P181, DOI 10.1042/bj1560181; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hernandez R, 2001, FEBS LETT, V494, P225, DOI 10.1016/S0014-5793(01)02353-5; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hodson L, 2013, DIABETES, V62, P1417, DOI 10.2337/db12-1032; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Hoy AJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE67, DOI 10.1152/ajpendo.90945.2008; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Huo YQ, 2012, J BIOL CHEM, V287, P21492, DOI 10.1074/jbc.M112.370379; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Klarer AC, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-2; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Krook A, 1998, DIABETES, V47, P1281, DOI 10.2337/diabetes.47.8.1281; Lalioti V, 2009, P NATL ACAD SCI USA, V106, P4249, DOI 10.1073/pnas.0900218106; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Li YF, 2005, MOL CELL BIOCHEM, V277, P117, DOI 10.1007/s11010-005-5535-1; Lim J, 2010, GENE DEV, V24, P1496, DOI 10.1101/gad.1904610; Lin K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002618; Liu F, 2009, BIOCHEM J, V418, P413, DOI 10.1042/BJ20082051; Lodeiro M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004686; Lu XM, 2013, INT J MOL MED, V31, P740, DOI 10.3892/ijmm.2013.1241; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; Mehta A, 2009, MOL CELL BIOCHEM, V329, P3, DOI 10.1007/s11010-009-0114-5; Nosaka K, 2001, BBA-GENE STRUCT EXPR, V1517, P293, DOI 10.1016/S0167-4781(00)00247-5; Okada S, 2008, J BIOL CHEM, V283, P35455, DOI 10.1074/jbc.M806531200; Owen O. E., 1981, U.S Patent, Patent No. 4254222; Park S, 2005, INT J VEHICLE DES, V37, P1, DOI 10.1504/IJVD.2005.006092; Prabhu AV, 2013, FEBS LETT, V587, P983, DOI 10.1016/j.febslet.2013.02.040; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; ROTHMAN DL, 1992, J CLIN INVEST, V89, P1069, DOI 10.1172/JCI115686; Ruan GX, 2013, J BIOL CHEM, V288, P21161, DOI 10.1074/jbc.M113.474619; Sabater D, 2014, SCI REP-UK, V4, DOI 10.1038/srep03663; Sakakibara R, 1997, J BIOCHEM-TOKYO, V122, P122; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Seo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024179; Seton-Rogers S, 2014, NAT REV DRUG DISCOV, V13, DOI 10.1038/nrd4267; Shewan AM, 2000, BIOCHEM J, V350, P99, DOI 10.1042/0264-6021:3500099; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Spielman LJ, 2014, J NEUROIMMUNOL, V273, P8, DOI 10.1016/j.jneuroim.2014.06.004; Steimle PA, 2005, BIOCHEM BIOPH RES CO, V331, P1560, DOI 10.1016/j.bbrc.2005.04.082; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Stockli J, 2015, DIABETES, V64, P1914, DOI 10.2337/db13-1489; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; Tan SX, 2012, J BIOL CHEM, V287, P6128, DOI 10.1074/jbc.M111.318238; Tan SX, 2010, BIOCHEM J, V432, P191, DOI 10.1042/BJ20100750; Telang S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-95; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Turban S, 2011, FEBS LETT, V585, P269, DOI 10.1016/j.febslet.2010.12.022; Usui I, 2004, EMBO J, V23, P2821, DOI 10.1038/sj.emboj.7600297; Valiente M, 2005, J BIOL CHEM, V280, P28936, DOI 10.1074/jbc.M504761200; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Vijayakumar MV, 2010, J BIOSCIENCES, V35, P525, DOI 10.1007/s12038-010-0060-0; Wani R, 2011, P NATL ACAD SCI USA, V108, P10550, DOI 10.1073/pnas.1011665108; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; WEILAND M, 1991, J CELL PHYSIOL, V149, P428, DOI 10.1002/jcp.1041490311; Wheeler DB, 2004, NAT METHODS, V1, P127, DOI 10.1038/NMETH711; WILSON CM, 1995, FEBS LETT, V368, P19, DOI 10.1016/0014-5793(95)00589-2; Xie N., 2015, AM J RESP CRIT CARE, DOI [10.1164/rccm.201504-0780OC, DOI 10.1164/RCCM.201504-0780OC]; Xintaropoulou C, 2015, ONCOTARGET, V6, P25677, DOI 10.18632/oncotarget.4499; Xu YM, 2014, ARTERIOSCL THROM VAS, V34, P1231, DOI 10.1161/ATVBAHA.113.303041; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yao JE, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-95; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	104	37	37	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25834	25846		10.1074/jbc.M115.658815	http://dx.doi.org/10.1074/jbc.M115.658815			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26342081	hybrid, Green Published			2022-12-28	WOS:000363527300005
J	Bernard, K; Logsdon, NJ; Ravi, S; Xie, N; Persons, BP; Rangarajan, S; Zmijewski, JW; Mitra, K; Liu, G; Darley-Usmar, VM; Thannickal, VJ				Bernard, Karen; Logsdon, Naomi J.; Ravi, Saranya; Xie, Na; Persons, Benjamin P.; Rangarajan, Sunad; Zmijewski, Jaroslaw W.; Mitra, Kasturi; Liu, Gang; Darley-Usmar, Victor M.; Thannickal, Victor J.			Metabolic Reprogramming Is Required for Myofibroblast Contractility and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR-A; SKELETAL-MUSCLE; GROWTH-FACTOR; TGF-BETA; PULMONARY-FIBROSIS; MITOCHONDRIAL BIOGENESIS; GLUCOSE-METABOLISM; ENERGY-METABOLISM; COACTIVATOR PGC-1	Contraction is crucial in maintaining the differentiated phenotype of myofibroblasts. Contraction is an energy-dependent mechanism that relies on the production of ATP by mitochondria and/or glycolysis. Although the role of mitochondrial biogenesis in the adaptive responses of skeletal muscle to exercise is well appreciated, mechanisms governing energetic adaptation of myofibroblasts are not well understood. Our study demonstrates induction of mitochondrial biogenesis and aerobic glycolysis in response to the differentiation-inducing factor transforming growth factor beta 1 (TGF-beta 1). This metabolic reprogramming is linked to the activation of the p38 mitogen-activated protein kinase (MAPK) pathway. Inhibition of p38 MAPK decreased accumulation of active peroxisome proliferator- activated receptor gamma coactivator 1 alpha in the nucleus and altered the translocation of mitochondrial transcription factor A to the mitochondria. Genetic or pharmacologic approaches that block mitochondrial biogenesis or glycolysis resulted in decreased contraction and reduced expression of TGF-beta 1-induced alpha-smooth muscle actin and collagen alpha-2(I) but not of fibronectin or collagen alpha-1(I). These data indicate a critical role for TGF-beta 1-induced metabolic reprogramming in regulating myofibroblast-specific contractile signaling and support the concept of integrating bioenergetics with cellular differentiation.	[Bernard, Karen; Logsdon, Naomi J.; Xie, Na; Persons, Benjamin P.; Rangarajan, Sunad; Zmijewski, Jaroslaw W.; Liu, Gang; Thannickal, Victor J.] Univ Alabama Birmingham, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Ravi, Saranya; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Mitra, Kasturi] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Ravi, Saranya; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Ctr Free Rad Biol & Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bernard, K (corresponding author), Div Pulm Allergy & Crit Care Med, 901 19th St South,BMRII 464, Birmingham, AL 35294 USA.	kbernard@uab.edu	Rangarajan, Sunad/AAQ-5285-2021	Rangarajan, Sunad/0000-0001-5313-4828; Liu, Gang/0000-0003-2615-131X; , Gang/0000-0002-6999-7633; Darley-Usmar, Victor/0000-0001-8921-7086	National Institutes of Health Grants [P01 HL114470, R01 AG046210]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114470, T32HL105346, R01HL105473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046210] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL114470 and R01 AG046210. The authors declare that they have no conflicts of interest with the content of this article.	Amat R, 2009, J BIOL CHEM, V284, P21872, DOI 10.1074/jbc.M109.022749; Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Carter AB, 1999, J BIOL CHEM, V274, P30858, DOI 10.1074/jbc.274.43.30858; Chacko BK, 2010, BIOCHEM J, V432, P9, DOI 10.1042/BJ20100308; CHEN W, 1992, BIOCHIMIE, V74, P867, DOI 10.1016/0300-9084(92)90070-U; Cheresh P, 2013, BBA-MOL BASIS DIS, V1832, P1028, DOI 10.1016/j.bbadis.2012.11.021; DAVIES KJA, 1981, ARCH BIOCHEM BIOPHYS, V209, P539, DOI 10.1016/0003-9861(81)90312-X; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Dong XC, 2002, J BIOL CHEM, V277, P43309, DOI 10.1074/jbc.M206958200; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Erecinska M, 1977, Adv Exp Med Biol, V94, P271; Felton VM, 2009, AM J PHYSIOL-LUNG C, V297, pL805, DOI 10.1152/ajplung.00009.2009; FITTS RH, 1975, AM J PHYSIOL, V228, P1029, DOI 10.1152/ajplegacy.1975.228.4.1029; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Fu MHH, 2009, PHYSIOL GENOMICS, V40, P34, DOI 10.1152/physiolgenomics.00115.2009; GELLERICH FN, 1993, BIOCHIM BIOPHYS ACTA, V1142, P217, DOI 10.1016/0005-2728(93)90150-E; Gordon JW, 2001, J APPL PHYSIOL, V90, P389, DOI 10.1152/jappl.2001.90.1.389; GUPPY M, 1993, EUR J BIOCHEM, V212, P95, DOI 10.1111/j.1432-1033.1993.tb17637.x; HARDING AE, 1991, TRENDS NEUROSCI, V14, P132, DOI 10.1016/0166-2236(91)90081-5; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; KAYAR SR, 1986, EUR J APPL PHYSIOL O, V54, P578, DOI 10.1007/BF00943344; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Kraft CS, 2006, AM J PHYSIOL-CELL PH, V290, pC1119, DOI 10.1152/ajpcell.00463.2005; LARSSON NG, 1994, BIOCHEM BIOPH RES CO, V200, P1374, DOI 10.1006/bbrc.1994.1603; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; LOOS JA, 1973, EXP CELL RES, V79, P136, DOI 10.1016/0014-4827(73)90498-9; Manthey CL, 1998, J LEUKOCYTE BIOL, V64, P409, DOI 10.1002/jlb.64.3.409; Negmadjanov U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123046; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nemoto S, 1998, MOL CELL BIOL, V18, P3518, DOI 10.1128/MCB.18.6.3518; PARISI MA, 1993, MOL CELL BIOL, V13, P1951, DOI 10.1128/MCB.13.3.1951; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Phan SH, 2003, AM J RESP CELL MOL, V29, pS87; Piomboni P, 2012, INT J ANDROL, V35, P109, DOI 10.1111/j.1365-2605.2011.01218.x; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; Roberts DJ, 2015, CELL DEATH DIFFER, V22, P248, DOI 10.1038/cdd.2014.173; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Scharenberg MA, 2014, J CELL SCI, V127, P1079, DOI 10.1242/jcs.142075; Smith PC, 2006, J PERIODONTAL RES, V41, P418, DOI 10.1111/j.1600-0765.2006.00886.x; Sun M, 2012, SCAND J MED SCI SPOR, V22, P764, DOI 10.1111/j.1600-0838.2011.01314.x; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Vander Heiden MG, 2000, P NATL ACAD SCI USA, V97, P4666, DOI 10.1073/pnas.090082297; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang Y, 2014, ALLERGY, V69, P699, DOI 10.1111/all.12403; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	66	103	105	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25427	25438		10.1074/jbc.M115.646984	http://dx.doi.org/10.1074/jbc.M115.646984			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26318453	hybrid, Green Published			2022-12-28	WOS:000362962800019
J	Sasaki, N; Itakura, Y; Toyoda, M				Sasaki, Norihiko; Itakura, Yoko; Toyoda, Masashi			Ganglioside GM1 Contributes to the State of Insulin Resistance in Senescent Human Arterial Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATHEROSCLEROSIS; RECEPTOR; OVEREXPRESSION; INHIBITION; MECHANISMS; YOUNG	Vascular endothelial cells (ECs) play central roles in physiologically important functions of blood vessels and contribute to the maintenance of vascular integrity. Therefore, it is considered that the impairment of EC functions leads to the development of vascular diseases. However, the molecular mechanisms of the EC dysfunctions that accompany senescence and aging have not yet been clarified. The carbohydrate antigens carried by glycoconjugates (e.g. glycoproteins, glycosphingolipids, and proteoglycans) mainly present on the cell surface serve not only as marker molecules but also as functional molecules. In this study, we have investigated the abundance and functional roles of glycosphingolipids in human ECs during senescence and aging. Among glycosphingolipids, ganglioside GM1 was highly expressed in abundance on the surface of replicatively and prematurely senescent ECs and also of ECs derived from an elderly subject. Insulin signaling, which regulates important functions of ECs, is impaired in senescent and aged ECs. Actually, by down-regulating GM1 on senescent ECs and overloading exogenous GM1 onto non-senescent ECs, we showed that an increased abundance of GM1 functionally contributes to the impairment of insulin signaling in ECs. Taken together, these findings provide the first evidence that GM1 increases in abundance on the cell surface of ECs under the conditions of cellular senescence and aging and causes insulin resistance in ECs. GM1 may be an attractive target for the detection, prevention, and therapy of insulin resistance and related vascular diseases, particularly in older people.	[Sasaki, Norihiko; Itakura, Yoko; Toyoda, Masashi] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Med Vasc Med, Itabashi Ku, Tokyo 1730015, Japan	Tokyo Metropolitan Institute of Gerontology	Toyoda, M (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Med Vasc Med, Itabashi Ku, Sakaecho 35-2, Tokyo 1730015, Japan.	mtoyoda@tmig.or.jp	Itakura, Yoko/AAM-5166-2020		Japan Society for the Promotion of Science KAKENHI [24890298]; Terumo Life Science Foundation (general subsidy)	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Terumo Life Science Foundation (general subsidy)	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant 24890298, grant-in-aid for young scientists (start-up), grant-in-aid for scientific research (C), and grant-in-aid for challenging exploratory research, and Terumo Life Science Foundation (2013 general subsidy). The authors declare that they have no conflicts of interest with the contents of this article.	Aerts JM, 2003, PHILOS T R SOC B, V358, P905, DOI 10.1098/rstb.2003.1273; Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Bietrix F, 2010, ARTERIOSCL THROM VAS, V30, P931, DOI 10.1161/ATVBAHA.109.201673; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Bremer E G, 1984, Adv Exp Med Biol, V174, P381; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Cai Y, 2014, MOL CELL BIOCHEM, V391, P117, DOI 10.1007/s11010-014-1993-7; Dong Y, 2010, CANCER SCI, V101, P2039, DOI 10.1111/j.1349-7006.2010.01613.x; Favero G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/801896; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Furukawa K, 2011, NEUROCHEM RES, V36, P1578, DOI 10.1007/s11064-011-0494-2; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; Hewitt G, 2013, METHODS MOL BIOL, V1048, P31, DOI 10.1007/978-1-62703-556-9_4; Jiang L, 2014, BBA-BIOMEMBRANES, V1838, P1255, DOI 10.1016/j.bbamem.2014.01.003; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kubota T, 2011, CELL METAB, V13, P294, DOI 10.1016/j.cmet.2011.01.018; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lingwood CA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004788; Ma H, 2006, CARDIOVASC RES, V69, P57, DOI 10.1016/j.cardiores.2005.08.019; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Mitsuda T, 2002, J BIOL CHEM, V277, P11239, DOI 10.1074/jbc.M107756200; Muniyappa R, 2007, CURR OPIN CLIN NUTR, V10, P523, DOI 10.1097/MCO.0b013e32819f8ecd; OHSAWA T, 1989, MECH AGEING DEV, V50, P169, DOI 10.1016/0047-6374(89)90012-2; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Rask-Madsen C, 2010, CELL METAB, V11, P379, DOI 10.1016/j.cmet.2010.03.013; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; Varki A., 2009, ESSENTIALS GLYCOBIOL; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	31	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25475	25486		10.1074/jbc.M115.684274	http://dx.doi.org/10.1074/jbc.M115.684274			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26338710	Green Published, hybrid			2022-12-28	WOS:000362962800023
J	Yamaoka, H; Tachibanaki, S; Kawamura, S				Yamaoka, Hiromi; Tachibanaki, Shuji; Kawamura, Satoru			Dephosphorylation during Bleach and Regeneration of Visual Pigment in Carp Rod and Cone Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORECEPTOR DARK-ADAPTATION; RHODOPSIN PHOSPHORYLATION; MULTIPLE PHOSPHORYLATION; LIGHT ADAPTATION; IN-VIVO; ARRESTIN; CELLS; TRANSDUCIN; RETINA; PHOTOTRANSDUCTION	On absorption of light by vertebrate visual pigment, the chromophore, 11-cis retinal, is isomerized to all-trans retinal to activate the phototransduction cascade, which leads to a hyperpolarizing light response. Activated pigment is inactivated by phosphorylation on the protein moiety, opsin. Isomerized alltrans retinal is ultimately released from opsin, and the pigment is regenerated by binding to 11-cis retinal. In this pigment regeneration cycle, the phosphates incorporated should be removed in order that the pigment regains the capability of activating the phototransduction cascade. However, it is not clear yet how pigment dephosphorylation takes place in the regeneration cycle. First in this study, we tried to estimate the dephosphorylation activity in living carp rods and cones and found that the activity, which is present mainly in the cytoplasm in both rods and cones, is three times higher in cones than in rods. Second, we examined at which stage the dephosphorylation takes place; before or after the release of all-trans retinal, during pigment regeneration, or alter pigment regeneration. For this purpose we prepared three types of phosphorylated substrates in purified carp rod and cone membranes: phosphorylated bleaching intermediate, phosphorylated opsin, and phosphorylated and regenerated pigment. We also examined the effect of pigment regeneration on the dephosphorylation. The results showed that the dephosphorylation does not show substrate preference in the regeneration cycle and suggested that the dephosphorylation takes place constantly. The results also suggest that, under bright light, some of the regenerated visual pigment remains phosphorylated to reduce the light sensitivity in cones.	[Yamaoka, Hiromi; Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Frontier Biosci, Yamada Oka 1-3, Suita, Osaka 5650871, Japan; [Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Kawamura, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamada Oka 1-3, Suita, Osaka 5650871, Japan.	kawamura@fbs.osaka-u.ac.jp		Kawamura, Satoru/0000-0003-2070-5940	Japan Society for the Promotion of Science [23227002, 24570085]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science Grants 23227002 (to S. K.) and 24570085 (to S. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Ala-Laurila P, 2009, J BIOL CHEM, V284, P16492, DOI 10.1074/jbc.M109.004697; ARMSTRONG CG, 1995, J CELL SCI, V108, P3367; Arshavsky VY, 2002, TRENDS NEUROSCI, V25, P124, DOI 10.1016/S0166-2236(00)02094-4; Brown BM, 2002, BIOCHEMISTRY-US, V41, P13526, DOI 10.1021/bi0204490; BROWN PK, 1963, J CELL BIOL, V19, P79, DOI 10.1083/jcb.19.1.79; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; Kawamura S., 2014, VERTEBRATE PHOTORECE, P23; KELLEHER DJ, 1988, MOL PHARMACOL, V34, P452; Kennedy MJ, 2004, NEURON, V41, P915, DOI 10.1016/S0896-6273(04)00086-8; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; KUHN H, 1974, NATURE, V250, P588, DOI 10.1038/250588a0; Kutuzov MA, 1996, EUR J BIOCHEM, V238, P613, DOI 10.1111/j.1432-1033.1996.0613w.x; Lee KA, 2010, BIOCHEMISTRY-US, V49, P2454, DOI 10.1021/bi1001085; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Miyazono S, 2008, P NATL ACAD SCI USA, V105, P16051, DOI 10.1073/pnas.0806593105; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; OKANO T, 1989, BIOCHEMISTRY-US, V28, P8848, DOI 10.1021/bi00448a025; PALCZEWSKI K, 1989, BIOCHEMISTRY-US, V28, P415, DOI 10.1021/bi00428a001; PALCZEWSKI K, 1989, J BIOL CHEM, V264, P15770; Peet JA, 2004, J CELL SCI, V117, P3049, DOI 10.1242/jcs.01167; Peskin James C., 1942, JOUR GEN PHYSIOL, V26, P27, DOI 10.1085/jgp.26.1.27; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Tachibanaki S, 2012, J BIOL CHEM, V287, P41186, DOI 10.1074/jbc.M112.403717; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; TAYLOR JW, 1969, VISION RES, V9, P443, DOI 10.1016/0042-6989(69)90133-3; Tomizuka J, 2015, J BIOL CHEM, V290, P9399, DOI 10.1074/jbc.M114.634543; WILDEN U, 1995, BIOCHEMISTRY-US, V34, P1446, DOI 10.1021/bi00004a040; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029	33	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24381	24390		10.1074/jbc.M115.674101	http://dx.doi.org/10.1074/jbc.M115.674101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26286749	hybrid, Green Published			2022-12-28	WOS:000362218900026
J	Abdouh, M; Hanna, R; El Hajjar, J; Flamier, A; Bernier, G				Abdouh, Mohamed; Hanna, Roy; El Hajjar, Jida; Flamier, Anthony; Bernier, Gilbert			The Polycomb Repressive Complex 1 Protein BMI1 Is Required for Constitutive Heterochromatin Formation and Silencing in Mammalian Somatic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						BRCA1; heterochromatin; lamin; polycomb; ubiquitylation (ubiquitination); BMI1; histone H2A	EMBRYONIC STEM-CELLS; DNA-DAMAGE RESPONSE; GROUP GENE BMI1; PERICENTRIC HETEROCHROMATIN; H2A UBIQUITYLATION; PRC2 RECRUITMENT; UBIQUITIN LIGASE; X-INACTIVATION; SELF-RENEWAL; HISTONE H2A	Background: BMI1 silences the expression of genes located at the facultative heterochromatin. Results: BMI1 is abundant at repetitive genomic regions, including the pericentromeric heterochromatin (PCH), where it is required for compaction and silencing. Conclusion: BMI1 is essential for PCH formation. Significance: BMI1 function at PCH is important to understand how BMI1 regulates genomic stability. The polycomb repressive complex 1 (PRC1), containing the core BMI1 and RING1A/B proteins, mono-ubiquitinylates histone H2A (H2A(ub)) and is associated with silenced developmental genes at facultative heterochromatin. It is, however, assumed that the PRC1 is excluded from constitutive heterochromatin in somatic cells based on work performed on mouse embryonic stem cells and oocytes. We show here that BMI1 is required for constitutive heterochromatin formation and silencing in human and mouse somatic cells. BMI1 was highly enriched at intergenic and pericentric heterochromatin, co-immunoprecipitated with the architectural heterochromatin proteins HP1, DEK1, and ATRx, and was required for their localization. In contrast, BRCA1 localization was BMI1-independent and partially redundant with that of BMI1 for H2A(ub) deposition, constitutive heterochromatin formation, and silencing. These observations suggest a dynamic and developmentally regulated model of PRC1 occupancy at constitutive heterochromatin, and where BMI1 function in somatic cells is to stabilize the repetitive genome.	[Bernier, Gilbert] Univ Montreal, Dept Neurosci, Montreal, PQ H1T 2M4, Canada; Hop Maison Neuve Rosemont, Stem Cell & Dev Biol Lab, Montreal, PQ H1T 2M4, Canada	Universite de Montreal; Universite de Montreal	Bernier, G (corresponding author), Univ Montreal, Dept Neurosci, 5415 Boul Assomption, Montreal, PQ H1T 2M4, Canada.	gbernier.hmr@ssss.gouv.qc.ca	Hanna, Roy/E-2645-2015	Hanna, Roy/0000-0002-1284-7941; Abdouh, Mohamed/0000-0003-0702-9335	Natural Science and Engineering Research Council of Canada; University of Montreal Molecular Biology Program	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Montreal Molecular Biology Program	This work was supported in part by a grant from the Natural Science and Engineering Research Council of Canada. The authors declare that they have no conflict of interest regarding the content of this manuscript.; Supported by fellowships from the University of Montreal Molecular Biology Program.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Black JC, 2011, EPIGENETICS-US, V6, P13, DOI 10.4161/epi.6.1.13331; Blackledge NP, 2014, CELL, V157, P1445, DOI 10.1016/j.cell.2014.05.004; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chagraoui J, 2011, P NATL ACAD SCI USA, V108, P5284, DOI 10.1073/pnas.1014263108; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Cooper S, 2014, CELL REP, V7, P1456, DOI 10.1016/j.celrep.2014.04.012; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; HEWISH DR, 1973, BIOCHEM BIOPH RES CO, V52, P504, DOI 10.1016/0006-291X(73)90740-7; Huh MS, 2012, J CLIN INVEST, V122, P4412, DOI 10.1172/JCI63765; Hwang WL, 2014, NATURE, V512, P213, DOI 10.1038/nature13380; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kalb R, 2014, CELL REP, V8, P999, DOI 10.1016/j.celrep.2014.07.025; Kappes F, 2011, GENE DEV, V25, P673, DOI 10.1101/gad.2036411; Kim J, 2013, MOL CELL, V49, P1121, DOI 10.1016/j.molcel.2013.01.034; Kim M, 2004, NUCLEIC ACIDS RES, V32, P5742, DOI 10.1093/nar/gkh912; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; KORNBERG RD, 1989, METHOD ENZYMOL, V170, P3; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Larson K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002473; Lassman AB, 2004, NEURON GLIA BIOL, V1, P157, DOI 10.1017/S1740925X04000249; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Maison C, 2011, NAT GENET, V43, P220, DOI 10.1038/ng.765; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; ORIAN JM, 1992, BRIT J CANCER, V66, P106, DOI 10.1038/bjc.1992.225; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pinheiro I, 2012, CELL, V150, P948, DOI 10.1016/j.cell.2012.06.048; Prasanth SG, 2010, P NATL ACAD SCI USA, V107, P15093, DOI 10.1073/pnas.1009945107; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Roman-Trufero M, 2009, STEM CELLS, V27, P1559, DOI 10.1002/stem.82; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Saksouk N, 2014, MOL CELL, V56, P580, DOI 10.1016/j.molcel.2014.10.001; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Sewalt RGAB, 2002, MOL CELL BIOL, V22, P5539, DOI 10.1128/MCB.22.15.5539-5553.2002; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Smigova J, 2011, NUCLEUS-AUSTIN, V2, P219, DOI 10.4161/nucl.2.3.15737; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tadeu AMB, 2008, EMBO J, V27, P2510, DOI 10.1038/emboj.2008.175; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Thakar A, 2010, J BIOMOL STRUCT DYN, V27, P399, DOI 10.1080/07391102.2010.10507326; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Visser HPJ, 2001, BRIT J HAEMATOL, V112, P950, DOI 10.1046/j.1365-2141.2001.02641.x; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Watson LA, 2013, J CLIN INVEST, V123, P2049, DOI 10.1172/JCI65634; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Wu LP, 2013, MOL CELL, V49, P1108, DOI 10.1016/j.molcel.2013.01.033; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	78	29	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2016	291	1					182	197		10.1074/jbc.M115.662403	http://dx.doi.org/10.1074/jbc.M115.662403			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DA1XP	26468281	Green Published, hybrid			2022-12-28	WOS:000367589500015
J	Ostrowski, A; Gundogdu, M; Ferenbach, AT; Lebedev, AA; van Aalten, DMF				Ostrowski, Adam; Gundogdu, Mehmet; Ferenbach, Andrew T.; Lebedev, Andrey A.; van Aalten, Daan M. F.			Evidence for a Functional O-Linked N-Acetylglucosamine (O-GlcNAc) System in the Thermophilic Bacterium Thermobaculum terrenum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL INSIGHTS; XENOPUS-LAEVIS; X-CHROMOSOME; PROTEIN; TRANSFERASE; GLYCOSYLATION; PHOSPHORYLATION; GLCNACYLATION; MECHANISM; SEQUENCE	Post-translational modification of proteins is a ubiquitous mechanism of signal transduction in all kingdoms of life. One such modification is addition of O-linked N-acetylglucosamine to serine or threonine residues, known as O-GlcNAcylation. This unusual type of glycosylation is thought to be restricted to nucleocytoplasmic proteins of eukaryotes and is mediated by a pair of O-GlcNAc-transferase and O-GlcNAc hydrolase enzymes operating on a large number of substrate proteins. Protein O-GlcNAcylation is responsive to glucose and flux through the hexosamine biosynthetic pathway. Thus, a close relationship is thought to exist between the level of O-GlcNAc proteins within and the general metabolic state of the cell. Although isolated apparent orthologues of these enzymes are present in bacterial genomes, their biological functions remain largely unexplored. It is possible that understanding the function of these proteins will allow development of reductionist models to uncover the principles of O-GlcNAc signaling. Here, we identify orthologues of both O-GlcNAc cycling enzymes in the genome of the thermophilic eubacterium Thermobaculum terrenum. The O-GlcNAcase and O-GlcNAc-transferase are co-expressed and, like their mammalian orthologues, localize to the cytoplasm. The O-GlcNAcase orthologue possesses activity against O-GlcNAc proteins and model substrates. We describe crystal structures of both enzymes, including an O-GlcNAcase peptide complex, showing conservation of active sites with the human orthologues. Although in vitro activity of the O-GlcNAc-transferase could not be detected, treatment of T. terrenum with an O-GlcNAc-transferase inhibitor led to inhibition of growth. T. terrenum may be the first example of a bacterium possessing a functional O-GlcNAc system.	[Ostrowski, Adam; Gundogdu, Mehmet; van Aalten, Daan M. F.] Univ Dundee, Sch Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland; [Ferenbach, Andrew T.; van Aalten, Daan M. F.] Univ Dundee, Sch Life Sci, MRC, Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [Lebedev, Andrey A.] Rutherford Appleton Lab, Sci Technol Facil Council, Didcot OX11 0FA, Oxon, England	University of Dundee; University of Dundee; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	van Aalten, DMF (corresponding author), Univ Dundee, Sch Life Sci, Div Mol Microbiol, Dow St, Dundee DD1 5EH, Scotland.	d.m.f.vanaalten@dundee.ac.uk		van Aalten, Daan/0000-0002-1499-6908; Ferenbach, Andrew/0000-0002-1562-7987; Gundogdu, Mehmet/0000-0003-0061-5243	Wellcome Trust Senior Research Fellowship [WT087590MA]; University of Dundee Translational Medical Research Fund Ph.D. fellowship; MRC [G0900138, MR/M004139/1] Funding Source: UKRI; Medical Research Council [G0900138, MR/M004139/1] Funding Source: researchfish	Wellcome Trust Senior Research Fellowship(Wellcome Trust); University of Dundee Translational Medical Research Fund Ph.D. fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Wellcome Trust Senior Research Fellowship WT087590MA (to D. M. F. v. A.). The authors declare no conflict of interest.; Supported by a University of Dundee Translational Medical Research Fund Ph.D. fellowship.	Bauer C, 2015, J BIOL CHEM, V290, P4801, DOI 10.1074/jbc.M114.605881; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Botero LM, 2004, ARCH MICROBIOL, V181, P269, DOI 10.1007/s00203-004-0647-7; Cairns LS, 2014, J BACTERIOL, V196, P2216, DOI 10.1128/JB.01599-14; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charoensuksai P, 2015, BIOCHEM J, V466, P587, DOI 10.1042/BJ20141072; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dehennaut V, 2007, J BIOL CHEM, V282, P12527, DOI 10.1074/jbc.M700444200; Dehennaut V, 2009, GLYCOCONJUGATE J, V26, P301, DOI 10.1007/s10719-008-9166-0; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Dorfmueller HC, 2010, CHEM BIOL, V17, P1250, DOI 10.1016/j.chembiol.2010.09.014; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Frank LA, 2014, HUM REPROD, V29, P1292, DOI 10.1093/humrep/deu066; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HART GW, 1989, ANNU REV BIOCHEM, V58, P841; Hartweck LM, 2002, GENETICS, V161, P1279; HOLT GD, 1986, J BIOL CHEM, V261, P8049; JOHNSON LN, 1993, ANNU REV BIOPH BIOM, V22, P199, DOI 10.1146/annurev.bb.22.060193.001215; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kunisawa T, 2011, INT J SYST EVOL MICR, V61, P1944, DOI 10.1099/ijs.0.026088-0; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lebedev AA, 2014, ACTA CRYSTALLOGR D, V70, P2430, DOI 10.1107/S1399004714014795; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Macauley MS, 2005, J BIOL CHEM, V280, P25313, DOI 10.1074/jbc.M413819200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Martinez-Fleites C, 2010, BBA-GEN SUBJECTS, V1800, P122, DOI 10.1016/j.bbagen.2009.07.019; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Olivier-Van Stichelen S, 2014, FASEB J, V28, P3325, DOI 10.1096/fj.13-243535; Ostrowski A, 2013, BIOCHEM J, V456, P1, DOI [10.1042/BJ20131081, 10.1042/BJ201301081]; Ostrowski A, 2011, J BACTERIOL, V193, P4821, DOI 10.1128/JB.00223-11; Park J, 2009, BBA-PROTEINS PROTEOM, V1794, P254, DOI 10.1016/j.bbapap.2008.10.003; Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Radermacher PT, 2014, P NATL ACAD SCI USA, V111, P5592, DOI 10.1073/pnas.1322396111; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Rexach JE, 2010, NAT CHEM BIOL, V6, P645, DOI [10.1038/NCHEMBIO.412, 10.1038/nchembio.412]; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Schimpl M, 2012, CHEM BIOL, V19, P173, DOI 10.1016/j.chembiol.2012.01.011; Schimpl M, 2010, BIOCHEM J, V432, P1, DOI 10.1042/BJ20101338; Selvan N, 2015, J BIOL CHEM, V290, P11969, DOI 10.1074/jbc.M114.628750; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Sokol KA, 2015, J BACTERIOL, V197, P354, DOI 10.1128/JB.01948-14; Sousa PRM, 2013, CHEM BIOL DRUG DES, V81, P284, DOI 10.1111/cbdd.12078; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Vocadlo DJ, 2012, CURR OPIN CHEM BIOL, V16, P488, DOI 10.1016/j.cbpa.2012.10.021; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	67	18	18	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30291	30305		10.1074/jbc.M115.689596	http://dx.doi.org/10.1074/jbc.M115.689596			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26491011	Green Published, hybrid			2022-12-28	WOS:000366738200010
J	Saikia, M; Hatzoglou, M				Saikia, Mridusmita; Hatzoglou, Maria			The Many Virtues of tRNA-derived Stress-induced RNAs (tiRNAs): Discovering Novel Mechanisms of Stress Response and Effect on Human Health	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; SMALL NONCODING RNAS; BREAST-CANCER; OXIDATIVE STRESS; GENE-EXPRESSION; CYTOCHROME-C; ANGIOGENIN; FRAGMENTS; METHYLTRANSFERASE; TRANSLATION	In mammalian cells, mature tRNAs are cleaved by stress-activated ribonuclease angiogenin to generate 5'- and 3'-tRNA halves: a novel class of small non-coding RNAs of 30-40 nucleotides in length. The biogenesis and biological functions of tRNA halves are emerging areas of research. This review will discuss the most recent findings on: (i) the mechanism and regulation of their biogenesis, (ii) their mechanism of action (we will specifically discuss their role in the protein synthesis inhibition and the intrinsic pathway of apoptosis), and (iii) their effects on the human physiology and disease conditions.	[Saikia, Mridusmita] Cornell Univ, Coll Human Ecol, Div Nutr Sci, Ithaca, NY 14853 USA; [Hatzoglou, Maria] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA	Cornell University; Case Western Reserve University	Saikia, M (corresponding author), Cornell Univ, Coll Human Ecol, Div Nutr Sci, Ithaca, NY 14853 USA.	ms2855@cornell.edu; mxh8@case.edu		Saikia, Mridusmita/0000-0002-5848-3303	National Institutes of Health [RO1 DK53307, R37 DK60596]; American Heart Association [14POST20100022]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK060596, R01DK053307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants RO1 DK53307 and R37 DK60596 (to M. H.) and American Heart Association Grant 14POST20100022 (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Abbasi-Moheb L, 2012, AM J HUM GENET, V90, P847, DOI 10.1016/j.ajhg.2012.03.021; Akat KM, 2014, P NATL ACAD SCI USA, V111, P11151, DOI 10.1073/pnas.1401724111; Anderson J, 2000, P NATL ACAD SCI USA, V97, P5173, DOI 10.1073/pnas.090102597; Anderson J, 1998, GENE DEV, V12, P3650, DOI 10.1101/gad.12.23.3650; Anderson P, 2014, FEBS LETT, V588, P4297, DOI 10.1016/j.febslet.2014.09.001; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bendotti C, 2012, PROG NEUROBIOL, V97, P101, DOI 10.1016/j.pneurobio.2011.10.001; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; BOREK E, 1977, CANCER RES, V37, P3362; Brzezicha B, 2006, NUCLEIC ACIDS RES, V34, P6034, DOI 10.1093/nar/gkl765; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Collie GW, 2011, CHEM SOC REV, V40, P5867, DOI 10.1039/c1cs15067g; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Czech A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003767; Davies AH, 2011, ONCOGENE, V30, P3649, DOI 10.1038/onc.2011.82; Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589; Dhahbi Joseph M, 2014, Biomark Cancer, V6, P37, DOI 10.4137/BIC.S20764; Dhahbi JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-298; Dhahbi JM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00074; Durdevic Z, 2013, CELL REP, V4, P931, DOI 10.1016/j.celrep.2013.07.046; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Falsey A R, 2005, Exp Lung Res, V31 Suppl 1, P77; Favaloro B, 2012, AGING-US, V4, P330, DOI 10.18632/aging.100459; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Fujii T, 2008, CANCER RES, V68, P1504, DOI 10.1158/0008-5472.CAN-07-2362; Gatto B, 2009, CURR MED CHEM, V16, P1248, DOI 10.2174/092986709787846640; Gebetsberger J, 2013, RNA BIOL, V10, P1798, DOI 10.4161/rna.27177; Gebetsberger J, 2012, ARCHAEA, V2012, DOI 10.1155/2012/260909; GEHRKE CW, 1979, CANCER RES, V39, P1150; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Goodarzi H, 2015, CELL, V161, P790, DOI 10.1016/j.cell.2015.02.053; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; Haiser HJ, 2008, NUCLEIC ACIDS RES, V36, P732, DOI 10.1093/nar/gkm1096; Hanada T, 2013, NATURE, V495, P474, DOI 10.1038/nature11923; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Honda S, 2015, P NATL ACAD SCI USA, V112, pE3816, DOI 10.1073/pnas.1510077112; Hussain S, 2013, GENOME BIOL, V14, DOI 10.1186/gb4143; Huttenhofer A, 2005, TRENDS GENET, V21, P289, DOI 10.1016/j.tig.2005.03.007; Ivanov P, 2014, P NATL ACAD SCI USA, V111, P18201, DOI 10.1073/pnas.1407361111; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Kaboli PJ, 2015, PHARMACOL RES, V97, P104, DOI 10.1016/j.phrs.2015.04.015; Karaca E, 2014, CELL, V157, P636, DOI 10.1016/j.cell.2014.02.058; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Khan MA, 2012, AM J HUM GENET, V90, P856, DOI 10.1016/j.ajhg.2012.03.023; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kishikawa H, 2008, EXPERT OPIN THER TAR, V12, P1229, DOI 10.1517/14728222.12.10.1229 ; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kulikov AV, 2012, CELL MOL LIFE SCI, V69, P1787, DOI 10.1007/s00018-011-0895-z; LAKINGS DB, 1977, CANCER RES, V37, P285; Lasham A, 2012, JNCI-J NATL CANCER I, V104, P133, DOI 10.1093/jnci/djr512; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Li SP, 2012, J CELL PHYSIOL, V227, P2822, DOI 10.1002/jcp.23051; Li Shuping, 2010, Int J Biochem Mol Biol, V1, P26; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; Martinez FJ, 2012, J MED GENET, V49, P380, DOI 10.1136/jmedgenet-2011-100686; Mattick JS, 2001, EMBO REP, V2, P986, DOI 10.1093/embo-reports/kve230; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Mishima E, 2014, J AM SOC NEPHROL, V25, P2316, DOI 10.1681/ASN.2013091001; Nourazarian AR, 2014, ASIAN PAC J CANCER P, V15, P4745, DOI 10.7314/APJCP.2014.15.12.4745; Okada S, 1996, PATHOL INT, V46, P311, DOI 10.1111/j.1440-1827.1996.tb03617.x; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Peng HY, 2012, CELL RES, V22, P1609, DOI 10.1038/cr.2012.141; Pizzo E, 2013, J CELL SCI, V126, P4308, DOI 10.1242/jcs.134551; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Russo N, 1996, P NATL ACAD SCI USA, V93, P804, DOI 10.1073/pnas.93.2.804; Saikia M, 2014, MOL CELL BIOL, V34, P2450, DOI 10.1128/MCB.00136-14; Saikia M, 2012, J BIOL CHEM, V287, P42708, DOI 10.1074/jbc.M112.371799; Saikia M, 2010, RNA, V16, P1317, DOI 10.1261/rna.2057810; SAXENA SK, 1992, J BIOL CHEM, V267, P21982; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Schaffer AE, 2014, CELL, V157, P651, DOI 10.1016/j.cell.2014.03.049; Sebastia J, 2009, CELL DEATH DIFFER, V16, P1238, DOI 10.1038/cdd.2009.52; Sobala A, 2011, WIRES RNA, V2, P853, DOI 10.1002/wrna.96; SPEER J, 1979, CANCER, V44, P2120, DOI 10.1002/1097-0142(197912)44:6<2120::AID-CNCR2820440623>3.0.CO;2-6; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tello-Montoliu A, 2006, J THROMB HAEMOST, V4, P1864, DOI 10.1111/j.1538-7836.2006.01995.x; Testa U, 2007, HAEMATOL-HEMATOL J, V92, P81, DOI 10.3324/haematol.10279; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Tuck AC, 2011, TRENDS GENET, V27, P422, DOI 10.1016/j.tig.2011.06.001; van Es MA, 2011, ANN NEUROL, V70, P964, DOI 10.1002/ana.22611; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Vojtech L, 2014, NUCLEIC ACIDS RES, V42, P7290, DOI 10.1093/nar/gku347; Wang QR, 2013, MOL THER, V21, P368, DOI 10.1038/mt.2012.237; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Zhang SD, 2009, PLANT PHYSIOL, V150, P378, DOI 10.1104/pp.108.134767; Zhou Y, 2009, BIOCHEM BIOPH RES CO, V385, P160, DOI 10.1016/j.bbrc.2009.05.031; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	97	64	64	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29761	29768		10.1074/jbc.R115.694661	http://dx.doi.org/10.1074/jbc.R115.694661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26463210	Green Published, hybrid			2022-12-28	WOS:000366614700011
J	Wang, CP; Hascall, VC; Zhang, FM; Linhardt, RJ; Abbadi, A; Wang, AM				Wang, Christina P.; Hascall, Vincent C.; Zhang, Fuming; Linhardt, Robert J.; Abbadi, Amina; Wang, Aimin			The Responses of Hyperglycemic Dividing Mesangial Cells to Heparin Are Mediated by the Non-reducing Terminal Trisaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; diabetic nephropathy; endoplasmic reticulum stress (ER stress); glucose metabolism; heparanase; heparin; hyaluronan; inflammation; monocyte adhesive hyaluronan matrix; trisaccharide	CARBOHYDRATE ELECTROPHORESIS FACE; C-FOS INDUCTION; HYALURONAN MATRIX; SULFATE; GLYCOSAMINOGLYCANS; MICROANALYSIS; SPECIFICITY; ADHESIVE; LYASES	Our previous studies showed: (i) that growth-arrested G(0)/G(1) rat mesangial cells stimulated to divide in hyperglycemic medium initiate intracellular hyaluronan synthesis that induces autophagy and the cyclin D3-induced formation of a monocyte-adhesive extracellular hyaluronan matrix after completing cell division; and (ii) that heparin inhibits the intracellular hyaluronan and autophagy responses, but after completing division, induces hyaluronan synthesis at the plasma membrane with the formation of a larger monocyte-adhesive hyaluronan matrix. This study shows: (i) that the non-terminal trisaccharide of heparin is sufficient to initiate the same responses as intact heparin, (ii) that a fully sulfated tetrasaccharide isolated from bacterial heparin lyase 1 digests of heparin that contains a -2S-iduronate on the non-reducing end does not initiate the same responses as intact heparin, and (iii) that removal of the -2S-iduronate to expose the fully sulfated trisaccharide (GlcNS(6S)-IdoUA(2S)-GlcNS(6S)) does initiate the same responses as intact heparin. These results provide evidence that mammalian heparanase digestion of heparin and heparan sulfate exposes a cryptic motif on the non-reducing termini that is recognized by a receptor on dividing cells.	[Wang, Christina P.; Hascall, Vincent C.; Abbadi, Amina; Wang, Aimin] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA; [Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem, Troy, NY 12180 USA	Cleveland Clinic Foundation; Rensselaer Polytechnic Institute	Wang, AM (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, ND20, Cleveland, OH 44195 USA.	wanga@ccf.org			NHLBI, National Institutes of Health [P01 HL107147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062934] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Hyaluronan Matrices in Vascular Pathologies Program is funded in its entirety by the NHLBI, National Institutes of Health, Grant P01 HL107147.	Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Calabro A, 2001, OSTEOARTHR CARTILAGE, V9, pS16, DOI 10.1053/joca.2001.0439; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; DESAI UR, 1993, BIOCHEMISTRY-US, V32, P8140, DOI 10.1021/bi00083a012; GAMBARO G, 1992, KIDNEY INT, V42, P285, DOI 10.1038/ki.1992.288; GAMBARO G, 1994, KIDNEY INT, V46, P797, DOI 10.1038/ki.1994.335; HEGELE RG, 1989, CLIN INVEST MED, V12, P181; Lauer ME, 2007, J BIOL CHEM, V282, P843, DOI 10.1074/jbc.M608823200; LINDAHL U, 1991, THROMB HAEMOSTASIS, V66, P44; LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026; MENE P, 1989, PHYSIOL REV, V69, P1347, DOI 10.1152/physrev.1989.69.4.1347; MERCHANT ZM, 1985, BIOCHEM J, V229, P369, DOI 10.1042/bj2290369; Miralem T, 1996, J BIOL CHEM, V271, P17100, DOI 10.1074/jbc.271.29.17100; Miralem T, 1996, AM J PHYSIOL-RENAL, V270, pF960, DOI 10.1152/ajprenal.1996.270.6.F960; Okada Y, 2002, J BIOL CHEM, V277, P42488, DOI 10.1074/jbc.M206510200; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; TEMPLETON DM, 1990, J BIOL CHEM, V265, P21764; Wang A, 1999, METABOLISM, V48, P1220, DOI 10.1016/S0026-0495(99)90259-7; Wang A, 2015, MATRIX BIOL, V48, P36, DOI 10.1016/j.matbio.2015.04.003; Wang AM, 2014, J BIOL CHEM, V289, P9418, DOI 10.1074/jbc.M113.541441; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang AM, 1996, KIDNEY INT, V49, P437, DOI 10.1038/ki.1996.63; WANG AM, 1994, J CELL PHYSIOL, V159, P295, DOI 10.1002/jcp.1041590213; WIGHT TN, 1991, CELL BIOL EXTRACELLU, P45, DOI DOI 10.1007/978-1-4615-3770-0_3	26	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29045	29050		10.1074/jbc.M115.677401	http://dx.doi.org/10.1074/jbc.M115.677401			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26378235	hybrid, Green Published			2022-12-28	WOS:000365762300042
J	Garrone, A; Archipowa, N; Zipfel, PF; Hermann, G; Dietzek, B				Garrone, Alessio; Archipowa, Nataliya; Zipfel, Peter F.; Hermann, Gudrun; Dietzek, Benjamin			Plant Protochlorophyllide Oxidoreductases A and B CATALYTIC EFFICIENCY AND INITIAL REACTION STEPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCITED-STATE DYNAMICS; CHLOROPHYLL BIOSYNTHESIS; LIGHT; NADPH; COMPLEX; PROTEIN; BARLEY; IDENTIFICATION; PURIFICATION; PORA	The enzyme protochlorophyllide oxidoreductase (POR, EC 1.3.1.33) has a key role in plant development. It catalyzes one of the later steps in chlorophyll synthesis, the light-induced reduction of protochlorophyllide (PChlide) into chlorophyllide (Chlide) in the presence of NADPH. Two isozymes of plant POR, POR A and POR B from barley, which differ in their function during plant life, are compared with respect to their substrate binding affinity, catalytic efficiency, and catalytic mechanism. POR B as compared with POR A shows an 5-fold higher binding affinity for PChlide and an about 6-fold higher catalytic efficiency measured as k(cat)/K-m. Based on the reaction intermediates, which can be trapped at low temperatures the same reaction mechanism operates in both POR A and POR B. In contrast to results reported for POR enzymes from cyanobacteria, the initial light-driven step, which occurs at temperatures below 180 K already involves the full chemistry of the photoreduction and yields the reaction product, Chlide, in an enzyme-bound form. The subsequent dark reactions, which include cofactor (NADP(+)) release and cofactor(NADPH) rebinding, show different temperature dependences for PORA and PORB and suggest a higher conformational flexibility of POR B in the surrounding active center. Both the higher substrate binding affinity and well adapted enzyme dynamics are held responsible for the increased catalytic activity of POR B as compared with POR A.	[Garrone, Alessio; Archipowa, Nataliya; Hermann, Gudrun; Dietzek, Benjamin] Leibniz Inst Nat Prod Res & Infect Biol, Dept Biochem & Biophys, D-07743 Jena, Germany; [Garrone, Alessio; Archipowa, Nataliya; Hermann, Gudrun; Dietzek, Benjamin] Leibniz Inst Nat Prod Res & Infect Biol, Dept Phys Chem, D-07743 Jena, Germany; [Garrone, Alessio; Dietzek, Benjamin] Leibniz Inst Nat Prod Res & Infect Biol, Leibniz Inst Photon Technol, D-07743 Jena, Germany; [Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, D-07743 Jena, Germany; [Zipfel, Peter F.; Hermann, Gudrun] Univ Jena, D-07743 Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Leibniz Institut fur Photonische Technologien; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Hermann, G (corresponding author), Univ Jena, Inst Biochem & Biophys, Philosophenweg 12, D-07743 Jena, Germany.	Gudrun.Hermann@uni-jena.de			Deutsche Forschungsgemeinschaft, Jena School for Microbial Communication (JSMC)	Deutsche Forschungsgemeinschaft, Jena School for Microbial Communication (JSMC)	This work was supported by a grant from the Deutsche Forschungsgemeinschaft, Jena School for Microbial Communication (JSMC) (to A. G., G. H., and B. D.). The authors declare that they have no conflicts of interest with the contents of this article.	ARMSTRONG GA, 1995, PLANT PHYSIOL, V108, P1505, DOI 10.1104/pp.108.4.1505; BAKER ME, 1994, BIOCHEM J, V300, P605; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; BEGLEY TP, 1989, J AM CHEM SOC, V111, P3095, DOI 10.1021/ja00190a071; Buhr F, 2008, P NATL ACAD SCI USA, V105, P12629, DOI 10.1073/pnas.0803950105; Colindres-Rojas M, 2011, BIOPHYS J, V100, P260, DOI 10.1016/j.bpj.2010.11.054; Dietzek B, 2009, CHEMPHYSCHEM, V10, P144, DOI 10.1002/cphc.200800536; Gabruk M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116990; Hanf R, 2012, CHEMPHYSCHEM, V13, P2013, DOI 10.1002/cphc.201200194; Hanf R, 2011, J PHYS CHEM A, V115, P7873, DOI 10.1021/jp2035899; Heyes DJ, 2008, BIOCHEMISTRY-US, V47, P10991, DOI 10.1021/bi801521c; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2000, FEBS LETT, V483, P47, DOI 10.1016/S0014-5793(00)02081-0; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2004, BIOCHEMISTRY-US, V43, P8265, DOI 10.1021/bi049576h; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Holtorf H, 1996, PLANT MOL BIOL, V31, P387, DOI 10.1007/BF00021799; HOLTORF H, 1995, P NATL ACAD SCI USA, V92, P3254, DOI 10.1073/pnas.92.8.3254; Klement H, 1999, EUR J BIOCHEM, V265, P862, DOI 10.1046/j.1432-1327.1999.00627.x; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; Martin GEM, 1997, BIOCHEM J, V325, P139, DOI 10.1042/bj3250139; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Pattanayak GK, 2002, BIOCHEM BIOPH RES CO, V291, P921, DOI 10.1006/bbrc.2002.6543; Reinbothe C, 2003, J BIOL CHEM, V278, P807, DOI 10.1074/jbc.M209738200; Reinbothe C, 1997, P NATL ACAD SCI USA, V94, P8890, DOI 10.1073/pnas.94.16.8890; Reinbothe C, 1999, NATURE, V397, P80, DOI 10.1038/16283; Reinbothe C, 2010, TRENDS PLANT SCI, V15, P614, DOI 10.1016/j.tplants.2010.07.002; REINBOTHE S, 1995, PLANT CELL, V7, P161, DOI 10.1105/tpc.7.2.161; REINBOTHE S, 1995, PLANT CELL, V7, P1933, DOI 10.1105/tpc.7.11.1933; Reinbothe S, 1996, PLANT CELL, V8, P763, DOI 10.1105/tpc.8.5.763; REINBOTHE S, 1995, J CELL BIOL, V129, P299, DOI 10.1083/jcb.129.2.299; Scrutton NS, 2012, PHYS CHEM CHEM PHYS, V14, P8818, DOI 10.1039/c2cp23789j; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Su QX, 2001, PLANT MOL BIOL, V47, P805, DOI 10.1023/A:1013699721301; Sytina OA, 2010, J PHYS CHEM B, V114, P4335, DOI 10.1021/jp9089326; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; WILKS HM, 1995, P NATL ACAD SCI USA, V92, P724, DOI 10.1073/pnas.92.3.724; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Yang J, 2004, PLANT BIOLOGY, V6, P537, DOI 10.1055/s-2004-821270; Yin L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0262; Yong AG, 2013, TUTOR QUANT METHODS, V9, P79, DOI 10.20982/tqmp.09.2.p079; Yuan M, 2012, J PLANT PHYSIOL, V169, P1311, DOI 10.1016/j.jplph.2012.05.010	45	20	20	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28530	28539		10.1074/jbc.M115.663161	http://dx.doi.org/10.1074/jbc.M115.663161			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26408201	hybrid, Green Published			2022-12-28	WOS:000365761900045
J	Pecze, L; Blum, W; Schwaller, B				Pecze, Laszlo; Blum, Walter; Schwaller, Beat			Routes of Ca2+ Shuttling during Ca2+ Oscillations FOCUS ON THE ROLE OF MITOCHONDRIAL Ca2+ HANDLING AND CYTOSOLIC Ca2+ BUFFERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE INSP(3); CALCIUM OSCILLATIONS; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; INTRACELLULAR CA2+; LUMINAL CA2+; CALRETININ; CELLS; PROTEIN; RECEPTOR	In some cell types, Ca2+ oscillations are strictly dependent on Ca2+ influx across the plasma membrane, whereas in others, oscillations also persist in the absence of Ca2+ influx. We observed that, in primary mesothelial cells, the plasmalemmal Ca2+ influx played a pivotal role. However, when the Ca' transport across the plasma membrane by the "lanthanum insulation method" was blocked prior to the induction of the serum-induced Ca2+ oscillations, mitochondrial Ca2+ transport was found to be able to substitute for the plasmalernmal Ca2+ exchange function, thus rendering the oscillations independent of extracellular Ca2+. However, in a physiological situation, the Ca2+-buffering capacity of mitochondria was found not to be essential for Ca2+ oscillations. Moreover, brief spontaneous Ca2+ changes were observed in the mitochondrial Ca2+ concentration without apparent changes in the cytosolic Ca2+ concentration, indicating the presence of a mitochondrial autonomous Ca2+ signaling mechanism. In the presence of calretinin, a Ca2+-buffering protein, the amplitude of cytosolic spikes during oscillations was decreased, and the amount of Ca2+ ions taken up by mitochondria was reduced. Thus, the increased calretinin expression observed in mesothelioma cells and in certain colon cancer might be correlated to the increased resistance of these tumor cells to proapoptotic/pronecrotic signals. We identified and characterized (experimentally and by modeling) three Ca2+ shuttling pathways in primary rnesothelial cells during Ca2+ oscillations: Ca2+ shuttled between (i) the endoplasmic reticulum (ER) and mitochondria, (ii) the ER and the extracellular space, and (iii) the ER and cytoplasmic Ca2+ buffers.	[Pecze, Laszlo; Blum, Walter; Schwaller, Beat] Univ Fribourg, Dept Med, Anat, CH-1700 Fribourg, Switzerland	University of Fribourg	Pecze, L (corresponding author), Univ Fribourg, Dept Med, Anat, Route Albert Gockel 1, CH-1700 Fribourg, Switzerland.	laszlo.pecze@unifr.ch	Blum, Walter/A-5996-2016	Blum, Walter/0000-0003-2219-9180; Schwaller, Beat/0000-0002-8277-7555	Swiss National Science Foundation [130680, 147697]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was partially supported by Swiss National Science Foundation Grants 130680 and 147697 (Sinergia) (to B. S.). The authors declare that they have no conflicts of interest with the contents of this article.	ALBALDAWI NF, 1995, CELL CALCIUM, V17, P422, DOI 10.1016/0143-4160(95)90088-8; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Blum W, 2015, IN VITRO CELL DEV-AN, V51, P714, DOI 10.1007/s11626-015-9885-z; Blum W, 2013, INT J CANCER, V133, P2077, DOI 10.1002/ijc.28218; Bot J, 2003, PATHOL RES PRACT, V199, P341, DOI 10.1078/0344-0338-00427; Boyer J, 2006, CANCER RES, V66, P2765, DOI 10.1158/0008-5472.CAN-05-2693; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; Caride AJ, 2001, J BIOL CHEM, V276, P39797, DOI 10.1074/jbc.M104380200; Castaldo P, 2009, PROG NEUROBIOL, V87, P58, DOI 10.1016/j.pneurobio.2008.09.017; Chandrasekera PC, 2009, AM J PHYSIOL-CELL PH, V296, pC1105, DOI 10.1152/ajpcell.00650.2008; CHAUDRY IH, 1982, YALE J BIOL MED, V55, P1; Christel CJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406363; CLAPHAM DE, 1993, ADV SEC MESS PHOSPH, V28, P161; CONNELL ND, 1983, CELL, V34, P245, DOI 10.1016/0092-8674(83)90155-1; D'Orlando C, 2001, BRAIN RES, V909, P145, DOI 10.1016/S0006-8993(01)02671-3; De Marchi U, 2014, J BIOL CHEM, V289, P20377, DOI 10.1074/jbc.M113.540898; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Doglioni C, 1996, AM J SURG PATHOL, V20, P1037, DOI 10.1097/00000478-199609000-00001; Ducreux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044837; DUPONT G, 1993, CELL CALCIUM, V14, P311, DOI 10.1016/0143-4160(93)90052-8; Dupont G, 2008, BIOPHYS J, V95, P2193, DOI 10.1529/biophysj.108.133777; Dupont G, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004226; Estrada M, 2006, J CELL SCI, V119, P733, DOI 10.1242/jcs.02775; Faas GC, 2007, PLOS BIOL, V5, P2646, DOI 10.1371/journal.pbio.0050311; Fink CC, 2000, BIOPHYS J, V79, P163, DOI 10.1016/S0006-3495(00)76281-3; Foreman MA, 2006, J CELL PHYSIOL, V206, P664, DOI 10.1002/jcp.20521; Frame MK, 1997, EXP CELL RES, V230, P197, DOI 10.1006/excr.1996.3409; Fridlyand LE, 2003, AM J PHYSIOL-ENDOC M, V285, pE138, DOI 10.1152/ajpendo.00194.2002; Gander JC, 1996, EXP CELL RES, V225, P399, DOI 10.1006/excr.1996.0191; Gander JC, 1996, CELL CALCIUM, V20, P63, DOI 10.1016/S0143-4160(96)90051-2; Gotzos V, 1999, AM J SURG PATHOL, V23, P701, DOI 10.1097/00000478-199906000-00010; GOUSTIN AS, 1986, CANCER RES, V46, P1015; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Haynes CL, 2006, BIOPHYS CHEM, V123, P20, DOI 10.1016/j.bpc.2006.04.005; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; HORNE JH, 1995, BIOCHEMISTRY-US, V34, P12738, DOI 10.1021/bi00039a033; HOUAMED K, 2004, DIABETES MELLITUS FU, P51; Hrabakova R, 2013, J PROTEOME RES, V12, P455, DOI 10.1021/pr300819m; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Ivannikov MV, 2013, BIOPHYS J, V104, P2353, DOI 10.1016/j.bpj.2013.03.064; JOSEPH SK, 1989, BIOCHEM J, V258, P261, DOI 10.1042/bj2580261; Kaasik A, 2007, AM J PHYSIOL-CELL PH, V292, pC157, DOI 10.1152/ajpcell.00272.2006; Kaftan EJ, 1997, J GEN PHYSIOL, V110, P529, DOI 10.1085/jgp.110.5.529; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; LICHTSTEIN D, 1979, P NATL ACAD SCI USA, V76, P650, DOI 10.1073/pnas.76.2.650; LUKAS W, 1994, NEUROSCIENCE, V61, P307, DOI 10.1016/0306-4522(94)90233-X; Mak DOD, 2001, J GEN PHYSIOL, V117, P435, DOI 10.1085/jgp.117.5.435; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Marhl M, 1998, BIOPHYS CHEM, V71, P125, DOI 10.1016/S0301-4622(97)00139-7; MARTIN SC, 1994, FEBS LETT, V352, P32, DOI 10.1016/0014-5793(94)00913-9; Milo R, 2013, BIOESSAYS, V35, P1050, DOI 10.1002/bies.201300066; MISSIAEN L, 1994, J BIOL CHEM, V269, P7238; Pecze L, 2015, BBA-MOL CELL RES, V1853, P632, DOI 10.1016/j.bbamcr.2014.12.025; Pecze L, 2013, BBA-MOL CELL RES, V1833, P1680, DOI 10.1016/j.bbamcr.2012.08.018; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Schwaller B, 2004, ANTICANCER RES, V24, P4003; Schwaller B, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00003; Schwaller B, 2012, ADV EXP MED BIOL, V740, P1, DOI 10.1007/978-94-007-2888-2_1; See V, 2004, J CELL BIOL, V166, P661, DOI 10.1083/jcb.200402136; Shuttleworth TJ, 2003, BIOCHEM SOC T, V31, P916; Sienaert I, 1997, J BIOL CHEM, V272, P25899, DOI 10.1074/jbc.272.41.25899; Sienaert I, 1996, J BIOL CHEM, V271, P27005, DOI 10.1074/jbc.271.43.27005; Sneyd J, 2004, P NATL ACAD SCI USA, V101, P1392, DOI 10.1073/pnas.0303472101; SOMOGYI R, 1991, J BIOL CHEM, V266, P11068; Tanimura A, 1996, J BIOL CHEM, V271, P30904, DOI 10.1074/jbc.271.48.30904; Tanimura A, 2009, J BIOL CHEM, V284, P8901, DOI 10.1074/jbc.M805865200; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Turovsky EA, 2012, BIOCHEM MOSC SUPPL S, V6, P26, DOI 10.1134/S199074781106016X; VANBREEMEN C, 1972, CIRC RES, V30, P44, DOI 10.1161/01.RES.30.1.44; Waldeck-Weiermair M, 2011, J BIOL CHEM, V286, P28444, DOI 10.1074/jbc.M111.244517; Walsh C, 2009, BBA-BIOENERGETICS, V1787, P1374, DOI 10.1016/j.bbabio.2009.01.007; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; WOOD A, 1993, J NEUROSCI, V13, P3319; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Wu YW, 2014, CELL CALCIUM, V55, P119, DOI 10.1016/j.ceca.2013.12.006; Young RC, 2001, AM J OBSTET GYNECOL, V184, P1228, DOI 10.1067/mob.2001.113872; YULE DI, 1988, FEBS LETT, V239, P358, DOI 10.1016/0014-5793(88)80951-7; Zimmermann B, 2000, J PHYSIOL-LONDON, V525, P707, DOI 10.1111/j.1469-7793.2000.t01-1-00707.x	87	14	16	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28214	28230		10.1074/jbc.M115.663179	http://dx.doi.org/10.1074/jbc.M115.663179			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26396196	hybrid, Green Published			2022-12-28	WOS:000365761900016
J	Anashkin, VA; Salminen, A; Tuominen, HK; Orlov, VN; Lahti, R; Baykov, AA				Anashkin, Viktor A.; Salminen, Anu; Tuominen, Heidi K.; Orlov, Victor N.; Lahti, Reijo; Baykov, Alexander A.			Cystathionine beta-Synthase (CBS) Domain-containing Pyrophosphatase as a Target for Diadenosine Polyphosphates in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYMATIC-SYNTHESIS; ESCHERICHIA-COLI; HEAT-SHOCK; BINDING; 5',5'''-P-1,P-4-TETRAPHOSPHATE; PROTEINS; APPPPA; TRIPHOSPHATE; KINETICS; STRESS	Among numerous proteins containing pairs of regulatory cystathionine beta-synthase (CBS) domains, family II pyrophosphatases (CBS-PPases) are unique in that they generally contain an additional DRTGG domain between the CBS domains. Adenine nucleotides bind to the CBS domains in CBS-PPases in a positively cooperative manner, resulting in enzyme inhibition (AMP or ADP) or activation (ATP). Here we show that linear P-1,P-n-diadenosine 5'-polyphosphates (Ap(n)As, where n is the number of phosphate residues) bind with nanomolar affinity to DRTGG domain-containing CBS-PPases of Desulfitobacterium hafniense, Clostridium novyi, and Clostridium perfringens and increase their activity up to 30-, 5-, and 7-fold, respectively. Ap(4)A, Ap(5)A, and Ap(6)A bound noncooperatively and with similarly high affinities to CBS-PPases, whereas Ap(3)A bound in a positively cooperative manner and with lower affinity, like mononucleotides. All Ap(n)As abolished kinetic cooperativity (non-Michaelian behavior) of CBS-PPases. The enthalpy change and binding stoichiometry, as determined by isothermal calorimetry, were similar to 10 kcal/mol nucleotide and 1 mol/mol enzyme dimer for Ap(4)A and Ap(5)A but 5.5 kcal/mol and 2 mol/mol for Ap(3)A, AMP, ADP, and ATP, suggesting different binding modes for the two nucleotide groups. In contrast, Eggerthella lenta and Moorella thermoacetica CBS-PPases, which contain noDRTGG domain, were not affected by Ap(n)As and showed no enthalpy change, indicating the importance of the DTRGG domain for Ap(n)A binding. These findings suggest that Ap(n)As can control CBS-PPase activity and hence affect pyrophosphate level and biosynthetic activity in bacteria.	[Anashkin, Viktor A.; Salminen, Anu; Tuominen, Heidi K.; Lahti, Reijo] Univ Turku, Dept Biochem, FIN-20014 Turku, Finland; [Anashkin, Viktor A.; Orlov, Victor N.; Baykov, Alexander A.] Moscow MV Lomonosov State Univ, Belozersky Inst Phys Chem Biol, Moscow 119899, Russia; [Anashkin, Viktor A.; Orlov, Victor N.; Baykov, Alexander A.] Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119899, Russia	Finland National Institute for Health & Welfare; University of Turku; Lomonosov Moscow State University; Lomonosov Moscow State University	Lahti, R (corresponding author), Univ Turku, Dept Biochem, Vatselankatu 2, FIN-20014 Turku, Finland.	reijo.lahti@utu.fi; baykov@genebee.msu.su	Tuominen, Heidi/A-7075-2010; Anashkin, Viktor/C-1893-2014; Орлов, Виктор/AAH-3795-2019; Baykov, Alexander/AAH-5301-2021; Baykov, Alexander A/C-7981-2012	Tuominen, Heidi/0000-0003-2412-7658; Орлов, Виктор/0000-0001-5641-864X; Anashkin, Victor/0000-0002-9890-6796; Baykov, Alexander/0000-0002-2495-8200	Academy of Finland [139031]; Russian Foundation for Basic Research [12-04-01002, 15-04-04828]	Academy of Finland(Academy of Finland); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by Academy of Finland Grant 139031 and Russian Foundation for Basic Research Grants 12-04-01002 and 15-04-04828. The authors declare that they have no conflicts of interest with the contents of this article.	Aguado-Llera D, 2010, FEBS LETT, V584, P4485, DOI 10.1016/j.febslet.2010.10.006; Azhar MA, 2014, BIOORG MED CHEM LETT, V24, P2928, DOI 10.1016/j.bmcl.2014.04.076; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; BAYKOV AA, 1981, ANAL BIOCHEM, V116, P1, DOI 10.1016/0003-2697(81)90313-4; BAYKOV AA, 1993, EUR J BIOCHEM, V217, P755, DOI 10.1111/j.1432-1033.1993.tb18303.x; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; Bisswanger H., 2008, ENZYME KINETICS PRIN, P14; BOCHNER BR, 1986, J BACTERIOL, V168, P931, DOI 10.1128/jb.168.2.931-935.1986; Conant AR, 2008, VASC PHARMACOL, V48, P157, DOI 10.1016/j.vph.2008.01.005; Ereno-Orbea J, 2013, ARCH BIOCHEM BIOPHYS, V540, P70, DOI 10.1016/j.abb.2013.10.008; Fabrichniy IP, 2007, J BIOL CHEM, V282, P1422, DOI 10.1074/jbc.M513161200; Fraga H, 2011, BBA-GEN SUBJECTS, V1810, P1195, DOI 10.1016/j.bbagen.2011.09.010; Garrison PN, 1992, AP4A OTHER DINUCLEOS, P29; Giraldez L, 2001, J NEUROSCI RES, V64, P174, DOI 10.1002/jnr.1063; GOERLICH O, 1982, EUR J BIOCHEM, V126, P135, DOI 10.1111/j.1432-1033.1982.tb06757.x; Gomez-Villafuertes R, 2004, J PHARMACOL EXP THER, V308, P1148, DOI 10.1124/jpet.103.061564; Guo W, 2011, BIOORG MED CHEM LETT, V21, P7175, DOI 10.1016/j.bmcl.2011.09.070; Guranowski A, 2000, PHARMACOL THERAPEUT, V87, P117, DOI 10.1016/S0163-7258(00)00046-2; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Heinonen J.K., 2001, BIOL ROLE INORGANIC, P123, DOI [10.1007/978-1-4615-1433-6_5, DOI 10.1007/978-1-4615-1433-6_5]; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Jamsen J, 2012, BIOCHEMISTRY-MOSCOW+, V77, P165, DOI 10.1134/S0006297912020071; Jamsen J, 2007, BIOCHEM J, V408, P327, DOI 10.1042/BJ20071017; Jiang YL, 2011, J BIOL CHEM, V286, P35906, DOI 10.1074/jbc.M111.228585; JOHNSTONE DB, 1991, EMBO J, V10, P3897, DOI 10.1002/j.1460-2075.1991.tb04959.x; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; LEE PC, 1983, P NATL ACAD SCI-BIOL, V80, P7496, DOI 10.1073/pnas.80.24.7496; Marques AFP, 1998, J NEUROCHEM, V71, P1241; McLean JE, 2004, BIOCHEM J, V379, P243, DOI 10.1042/BJ20031585; Nishimura A, 1997, GENES CELLS, V2, P401, DOI 10.1046/j.1365-2443.1997.1300328.x; Parfenyev AN, 2001, J BIOL CHEM, V276, P24511, DOI 10.1074/jbc.M101829200; PLATEAU P, 1994, ADV MICROB PHYSIOL, V36, P81, DOI 10.1016/S0065-2911(08)60177-0; REISS JR, 1965, J ORG CHEM, V30, P3381, DOI 10.1021/jo01021a029; Salminen A, 2014, J BIOL CHEM, V289, P22865, DOI 10.1074/jbc.M114.589473; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Sillero MAG, 2002, EUR J BIOCHEM, V269, P5323, DOI 10.1046/j.1432-1033.2002.03253.x; Tanner JA, 2006, BIOCHEMISTRY-US, V45, P3095, DOI 10.1021/bi052529k; Tommi K, 2013, FEBS LETT, V587, P1863, DOI 10.1016/j.febslet.2013.05.003; Tshori S., 2013, TOP CURR CHEM, V344, P10; Tuominen H, 2010, J MOL BIOL, V398, P400, DOI 10.1016/j.jmb.2010.03.019; VARSHAVSKY A, 1983, CELL, V34, P711, DOI 10.1016/0092-8674(83)90526-3; Vartanian AA, 2003, BIOCHEM PHARMACOL, V65, P227, DOI 10.1016/S0006-2952(02)01481-8; Wright M, 2006, FEBS J, V273, P3534, DOI 10.1111/j.1742-4658.2006.05361.x; ZAMECNIK PC, 1966, BIOCHEM BIOPH RES CO, V24, P91, DOI 10.1016/0006-291X(66)90415-3	44	15	16	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27594	27603		10.1074/jbc.M115.680272	http://dx.doi.org/10.1074/jbc.M115.680272			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26400082	Green Published, hybrid			2022-12-28	WOS:000365757500015
J	Stuck, MW; Conley, SM; Naash, MI				Stuck, Michael W.; Conley, Shannon M.; Naash, Muna I.			Retinal Degeneration Slow (RDS) Glycosylation Plays a Role in Cone Function and in the Regulation of RDS.ROM-1 Protein Complex Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORECEPTOR DISK MEMBRANES; MUTANT MICE; PERIPHERIN/RDS CAUSES; R172W MUTATION; ROD; OLIGOMERIZATION; MORPHOGENESIS; GENE; INSIGHTS; RESCUE	The photoreceptor-specific glycoprotein retinal degeneration slow (RDS, also called PRPH2) is necessary for the formation of rod and cone outer segments. Mutations in RDS cause rod and cone-dominant retinal disease, and it is well established that both cell types have different requirements for RDS. However, the molecular mechanisms for this difference remain unclear. Although RDS glycosylation is highly conserved, previous studies have revealed no apparent function for the glycan in rods. In light of the highly conserved nature of RDS glycosylation, we hypothesized that it is important for RDS function in cones and could underlie part of the differential requirement for RDS in the two photoreceptor subtypes. We generated a knockin mouse expressing RDS without the N-glycosylation site (N229S). Normal levels of RDS and the unglycosylated RDS binding partner rod outer segment membrane protein 1 (ROM-1) were found in N229S retinas. However, cone electroretinogram responses were decreased by 40% at 6 months of age. Because cones make up only 3-5% of photoreceptors in the wild-type background, N229S mice were crossed into the nrl(-/-) background (in which all rods are converted to cone-like cells) for biochemical analysis. In N229S/nrl(-/-) retinas, RDS and ROM-1 levels were decreased by similar to 60% each. These data suggest that glycosylation of RDS is required for RDS function or stability in cones, a difference that may be due to extracellular versus intradiscal localization of the RDS glycan in cones versus rods.	[Stuck, Michael W.; Conley, Shannon M.; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Naash, MI (corresponding author), Univ Houston, Dept Biomed Engn, 3517 Cullen Blvd,Room 2012, Houston, TX 77204 USA.	mnaash@central.uh.edu			NEI/National Institutes of Health [R01EY010609-MIN, T32EY023202-MWS]; Oklahoma Center for the Advancement of Science and Technology; Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE [R01EY010609, T32EY023202, P30EY001792] Funding Source: NIH RePORTER	NEI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Oklahoma Center for the Advancement of Science and Technology; Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI/National Institutes of Health Grants R01EY010609-MIN and T32EY023202-MWS, by the Oklahoma Center for the Advancement of Science and Technology (to S. M. C.), and by the Knights Templar Eye Foundation (to S. M. C.).	Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; Boesze-Battaglia K, 2007, BIOCHEMISTRY-US, V46, P1256, DOI 10.1021/bi061466i; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Cai X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005290; Chakraborty D, 2008, BIOCHEMISTRY-US, V47, P1144, DOI 10.1021/bi701807c; Chakraborty D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098939; Chakraborty D, 2010, HUM MOL GENET, V19, P4799, DOI 10.1093/hmg/ddq410; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Cheng T, 1997, J NEUROSCI, V17, P8118, DOI 10.1523/jneurosci.17-21-08118.1997; Cheng T, 1997, SOMAT CELL MOLEC GEN, V23, P165, DOI 10.1007/BF02721369; Conley SM, 2014, HUM MOL GENET, V23, P3102, DOI 10.1093/hmg/ddu014; Conley SM, 2012, CELL MOL LIFE SCI, V69, P1035, DOI 10.1007/s00018-011-0736-0; Conley SM, 2010, BIOCHEMISTRY-US, V49, P905, DOI 10.1021/bi901622w; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; DEMANT P, 1979, TISSUE ANTIGENS, V13, P53, DOI 10.1111/j.1399-0039.1979.tb01136.x; Ding XQ, 2005, BIOCHEMISTRY-US, V44, P4897, DOI 10.1021/bi048414i; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Edrington TCV, 2007, BIOCHEMISTRY-US, V46, P3862, DOI 10.1021/bi061999r; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Goldberg AFX, 1998, BIOCHEMISTRY-US, V37, P680, DOI 10.1021/bi972036i; Goldberg AFX, 1996, BIOCHEMISTRY-US, V35, P6144, DOI 10.1021/bi960259n; Goldberg AFX, 2006, INT REV CYTOL, V253, P131, DOI 10.1016/S0074-7696(06)53004-9; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; JANSEN HG, 1984, J COMP NEUROL, V224, P71, DOI 10.1002/cne.902240107; Kedzierski W, 1999, J NEUROCHEM, V72, P430, DOI 10.1046/j.1471-4159.1999.0720430.x; Khattree N, 2013, J CELL SCI, V126, P4659, DOI 10.1242/jcs.126888; Loewen CJR, 2003, MOL BIOL CELL, V14, P3400, DOI 10.1091/mbc.e03-02-0077; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003; SAGA M, 1993, HUM GENET, V92, P519, DOI 10.1007/BF00216463; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; SANYAL S, 1981, NEUROSCI LETT, V21, P23, DOI 10.1016/0304-3940(81)90051-3; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; Stuck MW, 2014, HUM MOL GENET, V23, P6260, DOI 10.1093/hmg/ddu345; Stuck MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032484; Sung CH, 2010, J CELL BIOL, V190, P953, DOI 10.1083/jcb.201006020; Tam BM, 2004, MOL BIOL CELL, V15, P2027, DOI 10.1091/mbc.e03-09-0650; Wrigley JDJ, 2002, BIOCHEM J, V368, P649, DOI 10.1042/BJ20020547	43	12	13	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27901	27913		10.1074/jbc.M115.683698	http://dx.doi.org/10.1074/jbc.M115.683698			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26420485	hybrid, Green Published			2022-12-28	WOS:000365757500039
J	Clarke, MW; Boddington, KF; Warnica, JM; Atkinson, J; McKenna, S; Madge, J; Barker, CH; Graether, SP				Clarke, Matthew W.; Boddington, Kelly F.; Warnica, Josephine M.; Atkinson, John; McKenna, Sarah; Madge, Jeffrey; Barker, Christine H.; Graether, Steffen P.			Structural and Functional Insights into the Cryoprotection of Membranes by the Intrinsically Disordered Dehydrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; EMPIRICAL PARAMETERS; FOLDING PROBLEM; STRESS-PROTEIN; SECONDARY STRUCTURE; CHILLING TOLERANCE; COLD-ACCLIMATION; NMR-SPECTROSCOPY; PHASE-TRANSITION; PLASMA-MEMBRANE	Background: Genetic evidence supports a protective role for plant dehydrins against drought and cold. Results: Dehydrins prevent membrane fusion and lower the transition temperature without altering membrane accessibility and fluidity. Conclusion: The lysine-rich segments are important for protecting membranes from freeze-thaw damage. Significance: An amphipathic helix with positively charged residues flanking the hydrophobic face may be a common motif for disordered stress proteins.	[Clarke, Matthew W.; Boddington, Kelly F.; Warnica, Josephine M.; Atkinson, John; McKenna, Sarah; Madge, Jeffrey; Barker, Christine H.; Graether, Steffen P.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Graether, SP (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	graether@uoguelph.ca	Graether, Steffen P./AFU-0892-2022; Graether, Steffen P./AAR-8849-2021	Graether, Steffen P./0000-0002-2356-3936; Graether, Steffen P./0000-0002-2356-3936	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by an Natural Sciences and Engineering Research Council of Canada Discovery Grant and by infrastructure support from the Canadian Foundation for Innovation and the Ontario Innovation Trust (to S. P. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Al Kayal T, 2012, SOFT MATTER, V8, P4524, DOI 10.1039/c2sm06906g; Allagulova CR, 2003, BIOCHEMISTRY-MOSCOW+, V68, P945, DOI 10.1023/A:1026077825584; ARNOLD K, 1992, BIOCHIM BIOPHYS ACTA, V1124, P88, DOI 10.1016/0005-2760(92)90130-N; BAKALTCHEVA I, 1994, BBA-BIOMEMBRANES, V1189, P38, DOI 10.1016/0005-2736(94)90277-1; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Buchko GW, 1998, BBA-LIPID LIPID MET, V1392, P101, DOI 10.1016/S0005-2760(98)00028-9; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; CARRIER D, 1985, BIOCHIM BIOPHYS ACTA, V820, P131, DOI 10.1016/0005-2736(85)90224-X; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P679, DOI 10.1016/B978-012164491-8/50010-5; CEVC G, 1981, BIOCHEMISTRY-US, V20, P4955, DOI 10.1021/bi00520a023; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Close TJ, 1996, PHYSIOL PLANTARUM, V97, P795, DOI 10.1111/j.1399-3054.1996.tb00546.x; Danyluk J, 1998, PLANT CELL, V10, P623, DOI 10.1105/tpc.10.4.623; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Eriksson SK, 2011, ECOL STUD-ANAL SYNTH, V215, P289, DOI 10.1007/978-3-642-19106-0_14; Eriksson SK, 2011, PLANT CELL, V23, P2391, DOI 10.1105/tpc.111.085183; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Findlater EE, 2009, BIOMOL NMR ASSIGN, V3, P273, DOI 10.1007/s12104-009-9192-2; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; GODAY A, 1994, PLANT CELL, V6, P351, DOI 10.1105/tpc.6.3.351; GOMES AV, 1993, BIOCHEMISTRY-US, V32, P5365, DOI 10.1021/bi00071a011; Graether SP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00576; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Hara M, 2003, PLANTA, V217, P290, DOI 10.1007/s00425-003-0986-7; Hara M, 2009, PLANT CELL ENVIRON, V32, P532, DOI 10.1111/j.1365-3040.2009.01947.x; HARRIGAN PR, 1990, CHEM PHYS LIPIDS, V52, P139, DOI 10.1016/0009-3084(90)90157-M; HEISE H, 1991, BIOCHIM BIOPHYS ACTA, V1061, P121, DOI 10.1016/0005-2736(91)90276-E; HOUDE M, 1995, PLANT J, V8, P583, DOI 10.1046/j.1365-313X.1995.8040583.x; Hughes S, 2011, PROTEIN SCI, V20, P42, DOI 10.1002/pro.534; Hughes SL, 2013, PLANT PHYSIOL, V163, P1376, DOI 10.1104/pp.113.226803; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Ismail AM, 1999, PLANT PHYSIOL, V120, P237, DOI 10.1104/pp.120.1.237; Ismail AM, 1997, CROP SCI, V37, P1270, DOI 10.2135/cropsci1997.0011183X003700040041x; Koag MC, 2003, PLANT PHYSIOL, V131, P309, DOI 10.1104/pp.011171; Koag MC, 2009, PLANT PHYSIOL, V150, P1503, DOI 10.1104/pp.109.136697; Kosova K, 2007, BIOL PLANTARUM, V51, P601, DOI 10.1007/s10535-007-0133-6; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; LENTZ BR, 1993, CHEM PHYS LIPIDS, V64, P99, DOI 10.1016/0009-3084(93)90060-G; Li SH, 2004, BIOPHYS CHEM, V109, P149, DOI 10.1016/j.bpc.2003.10.025; LIN CT, 1992, BIOCHEM BIOPH RES CO, V183, P1103, DOI 10.1016/S0006-291X(05)80304-3; Livernois AM, 2009, ANAL BIOCHEM, V392, P70, DOI 10.1016/j.ab.2009.05.023; MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; MUNOZ V, 1995, J MOL BIOL, V245, P275, DOI 10.1006/jmbi.1994.0023; OLSON F, 1979, BIOCHIM BIOPHYS ACTA, V557, P9, DOI 10.1016/0005-2736(79)90085-3; Petersen J, 2012, J EXP BOT, V63, P4919, DOI 10.1093/jxb/ers173; Rahman LN, 2010, BIOCHEM CELL BIOL, V88, P791, DOI [10.1139/O10-026, 10.1139/o10-026]; Rinne PLH, 1999, PLANTA, V209, P377, DOI 10.1007/s004250050740; Soulages JL, 2003, PLANT PHYSIOL, V131, P963, DOI 10.1104/pp.015891; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; Strandberg E, 2003, FEBS LETT, V544, P69, DOI 10.1016/S0014-5793(03)00475-7; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tolleter D, 2010, BBA-BIOMEMBRANES, V1798, P1926, DOI 10.1016/j.bbamem.2010.06.029; Tompa P, 2006, BIOPHYS J, V91, P2243, DOI 10.1529/biophysj.106.084723; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsunoda T, 2001, COLLOID SURFACE B, V20, P155, DOI 10.1016/S0927-7765(00)00188-0; Tulumello DV, 2009, BIOCHEMISTRY-US, V48, P12096, DOI 10.1021/bi9013819; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang YZ, 2014, PLANT SCI, V214, P113, DOI 10.1016/j.plantsci.2013.10.005; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Xie C, 2012, NEW PHYTOL, V195, P124, DOI 10.1111/j.1469-8137.2012.04136.x	68	40	41	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26900	26913		10.1074/jbc.M115.678219	http://dx.doi.org/10.1074/jbc.M115.678219			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26370084	hybrid, Green Published			2022-12-28	WOS:000364794000003
J	Fishel, R				Fishel, Richard			Mismatch Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; ESCHERICHIA-COLI MUTS; HUMAN EXONUCLEASE-I; DNA MISMATCH; ATPASE ACTIVITY; SALMONELLA-TYPHIMURIUM; ENDONUCLEASE ACTIVITY; RECOGNITION COMPLEX; CRYSTAL-STRUCTURE; MOLECULAR SWITCH	Highly conserved MutS homologs (MSH) and MutL homologs (MLH/PMS) are the fundamental components of mismatch repair (MMR). After decades of debate, it appears clear that the MSH proteins initiate MMR by recognizing a mismatch and forming multiple extremely stable ATP-bound sliding clamps that diffuse without hydrolysis along the adjacent DNA. The function(s) of MLH/PMS proteins is less clear, although they too bind ATP and are targeted to MMR by MSH sliding clamps. Structural analysis combined with recent real-time single molecule and cellular imaging technologies are providing new and detailed insight into the thermal-driven motions that animate the complete MMR mechanism.	[Fishel, Richard] Ohio State Univ, Wexner Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Fishel, Richard] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Fishel, Richard] Ohio State Univ, Biophys Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Fishel, R (corresponding author), 460 W 12th Ave, Columbus, OH 43210 USA.	rfishel@osu.edu			National Institutes of Health [CA67007]; NATIONAL CANCER INSTITUTE [R01CA067007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA67007 (to R. F.). This is the first article in the Thematic Minireview series "Protein Interactions, Structures, and Networks." The author declares that he has no conflicts of interest with the contents of this article.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Alani E, 2003, J BIOL CHEM, V278, P16088, DOI 10.1074/jbc.M213193200; Allen-Soltero S, 2014, MOL CELL BIOL, V34, P1521, DOI 10.1128/MCB.00960-13; Antony E, 2004, BIOCHEMISTRY-US, V43, P13115, DOI 10.1021/bi049010t; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Bowen N, 2013, P NATL ACAD SCI USA, V110, P18472, DOI 10.1073/pnas.1318971110; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Cho WK, 2012, STRUCTURE, V20, P1264, DOI 10.1016/j.str.2012.04.017; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; COOPER DL, 1993, J BIOL CHEM, V268, P11823; Drotschmann K, 2002, BIOL CHEM, V383, P969, DOI 10.1515/BC.2002.103; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; FANG WH, 1993, J BIOL CHEM, V268, P11838; Fishel R, 1998, GENE DEV, V12, P2096, DOI 10.1101/gad.12.14.2096; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fishel R, 2001, CANCER RES, V61, P7369; Forties RA, 2011, NUCLEIC ACIDS RES, V39, P8306, DOI 10.1093/nar/gkr422; Fox RF, 1998, PHYS REV E, V57, P2177, DOI 10.1103/PhysRevE.57.2177; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; GLAZER PM, 1987, MOL CELL BIOL, V7, P218, DOI 10.1128/MCB.7.1.218; Goellner EM, 2014, MOL CELL, V55, P291, DOI 10.1016/j.molcel.2014.04.034; Gong JG, 1999, NATURE, V399, P806; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Gorman J, 2012, P NATL ACAD SCI USA, V109, pE3074, DOI 10.1073/pnas.1211364109; Gradia S, 2000, J BIOL CHEM, V275, P3922, DOI 10.1074/jbc.275.6.3922; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Gupta S, 2012, NAT STRUCT MOL BIOL, V19, P72, DOI 10.1038/nsmb.2175; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Heinen CD, 2011, J BIOL CHEM, V286, P40287, DOI 10.1074/jbc.M111.297523; Hess MT, 2002, J BIOL CHEM, V277, P25545, DOI 10.1074/jbc.M202282200; HILL RF, 1970, MUTAT RES, V9, P341, DOI 10.1016/0027-5107(70)90135-1; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; Hombauer H, 2011, SCIENCE, V334, P1713, DOI 10.1126/science.1210770; Hombauer H, 2011, CELL, V147, P1040, DOI 10.1016/j.cell.2011.10.025; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Javaid S, 2009, MOL CELL, V36, P1086, DOI 10.1016/j.molcel.2009.12.010; Jeong C, 2011, NAT STRUCT MOL BIOL, V18, P379, DOI 10.1038/nsmb.2009; Junop MS, 2003, DNA REPAIR, V2, P387, DOI 10.1016/S1568-7864(02)00245-8; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kolodner RD, 2007, P NATL ACAD SCI USA, V104, P12953, DOI 10.1073/pnas.0705698104; LAHUE RS, 1987, P NATL ACAD SCI USA, V84, P1482, DOI 10.1073/pnas.84.6.1482; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lamers MH, 2003, EMBO J, V22, P746, DOI 10.1093/emboj/cdg064; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; LOEB LA, 1991, CANCER RES, V51, P3075; LU AL, 1983, P NATL ACAD SCI-BIOL, V80, P4639, DOI 10.1073/pnas.80.15.4639; Lujan SA, 2013, MOL CELL, V50, P437, DOI 10.1016/j.molcel.2013.03.017; Lynch HT, 2015, NAT REV CANCER, V15, P181, DOI 10.1038/nrc3878; MARINUS MG, 1976, J BACTERIOL, V128, P853, DOI 10.1128/JB.128.3.853-854.1976; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mazurek A, 2009, P NATL ACAD SCI USA, V106, P4177, DOI 10.1073/pnas.0808572106; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; Mendillo ML, 2007, J BIOL CHEM, V282, P16345, DOI 10.1074/jbc.M700858200; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Miller JH, 1998, MUTAT RES-DNA REPAIR, V409, P99, DOI 10.1016/S0921-8777(98)00049-4; MIYAKE T, 1960, GENETICS, V45, P755; MODRICH P, 1989, J BIOL CHEM, V264, P6597; Molloy S, 2005, NAT REV MICROBIOL, V3, P191, DOI 10.1038/nrmicro1123; NEVERS P, 1975, MOL GEN GENET, V139, P233, DOI 10.1007/BF00268974; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Park J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015496; Pluciennik A, 2007, P NATL ACAD SCI USA, V104, P12709, DOI 10.1073/pnas.0705129104; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Schmutte C, 1998, CANCER RES, V58, P4537; Schmutte C, 2001, J BIOL CHEM, V276, P33011, DOI 10.1074/jbc.M102670200; Shimada A, 2013, FEBS J, V280, P3467, DOI 10.1111/febs.12344; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; SIEGEL EC, 1967, J BACTERIOL, V94, P38, DOI 10.1128/JB.94.1.38-47.1967; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Spampinato C, 2000, J BIOL CHEM, V275, P9863, DOI 10.1074/jbc.275.13.9863; Spies M, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a022657; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; SU SS, 1989, GENOME, V31, P104, DOI 10.1139/g89-020; TIRABY JG, 1973, P NATL ACAD SCI USA, V70, P3541, DOI 10.1073/pnas.70.12.3541; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; TREFFERS HP, 1954, P NATL ACAD SCI USA, V40, P1064, DOI 10.1073/pnas.40.11.1064; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Viswanathan M, 1998, GENETICS, V149, P7; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; WELSH KM, 1987, J BIOL CHEM, V262, P15624; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; WITKIN EM, 1964, J MOL BIOL, V8, P610, DOI 10.1016/S0022-2836(64)80017-6; WU TH, 1994, J BACTERIOL, V176, P5393, DOI 10.1128/JB.176.17.5393-5400.1994; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004; Zhang H, 1999, CANCER RES, V59, P3021; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	98	127	130	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26395	26403		10.1074/jbc.R115.660142	http://dx.doi.org/10.1074/jbc.R115.660142			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354434	hybrid, Green Published			2022-12-28	WOS:000364793600006
J	Fukui, K; Ferris, HA; Kahn, CR				Fukui, Kenji; Ferris, Heather A.; Kahn, C. Ronald			Effect of Cholesterol Reduction on Receptor Signaling in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR; INTRANASAL INSULIN; ALZHEIMERS-DISEASE; BRAIN CHOLESTEROL; A-BETA; AUTOPHAGY; METABOLISM; PROTEINS; ROLES; CELLS	Diabetes mellitus is associated with a variety of complications, including alterations in the central nervous system (CNS). We have recently shown that diabetes results in a reduction of cholesterol synthesis in the brain due to decreased insulin stimulation of SREBP2-mediated cholesterol synthesis in neuronal and glial cells. In the present study, we explored the effects of the decrease in cholesterol on neuronal cell function using GT1-7 hypothalamic cells subjected to cholesterol depletion in vitro using three independent methods: 1) exposure to methyl-beta-cyclodextrin, 2) treatment with the HMG-CoA reductase inhibitor simvastatin, and 3) shRNA-mediated knockdown of SREBP2. All three methods produced 20-31% reductions in cellular cholesterol content, similar to the decrease in cholesterol synthesis observed in diabetes. All cholesterol-depleted neuron-derived cells, independent of the method of reduction, exhibited decreased phosphorylation/activation of IRS-1 and AKT following stimulation by insulin, insulin-like growth factor-1, or the neurotrophins (NGF and BDNF). ERK phosphorylation/activation was also decreased after methyl-beta-cyclodextrin and statin treatment but increased in cells following SREBP2 knockdown. In addition, apoptosis in the presence of amyloid-beta was increased. Reduction in cellular cholesterol also resulted in increased basal autophagy and impairment of induction of autophagy by glucose deprivation. Together, these data indicate that a reduction in neuron-derived cholesterol content, similar to that observed in diabetic brain, creates a state of insulin and growth factor resistance that could contribute to CNS-related complications of diabetes, including increased risk of neurodegenerative diseases, such as Alzheimer disease.	[Fukui, Kenji; Ferris, Heather A.; Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Kahn, CR (corresponding author), Joslin Diabet Ctr, One Joslin Pl, Boston, MA 02215 USA.	c.ronald.kahn@joslin.harvard.edu	Kahn, Ronald/AAY-2435-2021; Regan, Clinton/E-6250-2012; Ferris, Heather/L-4697-2019	Kahn, Ronald/0000-0002-7583-9228; Ferris, Heather/0000-0002-6321-3447	National Institutes of Health [5K08 DK097293, R01 DK031036, R01 DK033201, P30DK036836]; Sunstar Foundation, Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R37DK031036, R01DK033201, K08DK097293, R01DK031036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sunstar Foundation, Japan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5K08 DK097293 (to H. A. F.), R01 DK031036 and R01 DK033201 (to C. R. K.), and P30DK036836 (to the Joslin Diabetes and Endocrinology Research Center Flow Cytometry Core). This work was also supported by a research fellowship, Hiroo Kaneda Scholarship from Sunstar Foundation, Japan (to K. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Air EL, 2002, PHARMACOL BIOCHEM BE, V72, P423, DOI 10.1016/S0091-3057(01)00780-8; Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Benedict C, 2011, EXP GERONTOL, V46, P112, DOI 10.1016/j.exger.2010.08.026; Biessels GJ, 2008, LANCET NEUROL, V7, P184, DOI 10.1016/S1474-4422(08)70021-8; Biondi E, 2011, NEUROL SCI, V32, P195, DOI 10.1007/s10072-010-0440-0; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bomfim TR, 2012, J CLIN INVEST, V122, P1339, DOI 10.1172/JCI57256; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Cossec JC, 2010, BBA-MOL CELL BIOL L, V1801, P839, DOI 10.1016/j.bbalip.2010.03.010; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Fox TE, 2011, AM J PHYSIOL-ENDOC M, V300, pE600, DOI 10.1152/ajpendo.00641.2010; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jaeger PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011102; Kleinridders A, 2014, DIABETES, V63, P2232, DOI 10.2337/db14-0568; Linetti A, 2010, J CELL SCI, V123, P595, DOI 10.1242/jcs.060681; Lunemann JD, 2007, ANN NEUROL, V61, P476, DOI 10.1002/ana.21115; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Perez-Sala D, 2007, FRONT BIOSCI-LANDMRK, V12, P4456, DOI 10.2741/2401; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Shobab LA, 2005, LANCET NEUROL, V4, P841, DOI 10.1016/S1474-4422(05)70248-9; Solomon CS, 2002, BIOCHEM BIOPH RES CO, V291, P458, DOI 10.1006/bbrc.2002.6471; Stine WB, 2011, METHODS MOL BIOL, V670, P13, DOI 10.1007/978-1-60761-744-0_2; Suzuki R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001532; Suzuki R, 2010, CELL METAB, V12, P567, DOI 10.1016/j.cmet.2010.11.006; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; TERZI E, 1994, BIOCHEMISTRY-US, V33, P7434, DOI 10.1021/bi00189a051; Toth C, 2006, NEUROSCIENCE, V139, P429, DOI 10.1016/j.neuroscience.2005.11.065; Tung YT, 2012, J BIOSCIENCES, V37, P157, DOI 10.1007/s12038-011-9176-0; Uchiyama Y, 2009, METHOD ENZYMOL, V453, P33, DOI 10.1016/S0076-6879(08)04003-2; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323; Xu QG, 2004, EXP NEUROL, V188, P43, DOI 10.1016/j.expneurol.2004.03.008; Xu XQ, 1996, ARCH BIOCHEM BIOPHYS, V326, P233, DOI 10.1006/abbi.1996.0070; Yu WH, 2004, INT J BIOCHEM CELL B, V36, P2531, DOI 10.1016/j.biocel.2004.05.010; Zhang J, 2009, BIOPHYS J, V97, P1371, DOI 10.1016/j.bpj.2009.06.025; Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045	46	33	36	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26383	26392		10.1074/jbc.M115.664367	http://dx.doi.org/10.1074/jbc.M115.664367			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370080	Green Published, hybrid			2022-12-28	WOS:000364793600004
J	Wojdyla, JA; Cutts, E; Kaminska, R; Papadakos, G; Hopper, JTS; Stansfeld, PJ; Staunton, D; Robinson, CV; Kleanthous, C				Wojdyla, Justyna A.; Cutts, Erin; Kaminska, Renata; Papadakos, Grigorios; Hopper, Jonathan T. S.; Stansfeld, Phillip J.; Staunton, David; Robinson, Carol V.; Kleanthous, Colin			Structure and Function of the Escherichia coli Tol-Pal Stator Protein TolR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAGELLAR MOTOR; SECONDARY STRUCTURE; TERMINAL DOMAIN; KEY RESIDUES; FORCE-FIELD; ORGANIZATION; ELECTROSTATICS; RECOGNITION; ACTIVATION; EXPRESSION	TolR is a 15-kDa inner membrane protein subunit of the Tol-Pal complex in Gram-negative bacteria, and its function is poorly understood. Tol-Pal is recruited to cell division sites where it is involved in maintaining the integrity of the outer membrane. TolR is related to MotB, the peptidoglycan (PG)-binding stator protein from the flagellum, suggesting it might serve a similar role in Tol-Pal. The only structure thus far reported for TolR is of the periplasmic domain from Haemophilus influenzae in which N- and C-terminal residues had been deleted (TolR(62-133), Escherichia coli numbering). H. influenzae TolR(62-133) is a symmetrical dimer with a large deep cleft at the dimer interface. Here, we present the 1.7-angstrom crystal structure of the intact periplasmic domain of E. coli TolR (TolR(36-142)). E. coli TolR(36-142) is also dimeric, but the architecture of the dimer is radically different from that of TolR(62-133) due to the intertwining of its N and C termini. TolR monomers are rotated similar to 180 degrees relative to each other as a result of this strand swapping, obliterating the putative PG-binding groove seen in TolR(62-133). We found that removal of the strand-swapped regions (TolR(60-133)) exposes cryptic PG binding activity that is absent in the full-length domain. We conclude that to function as a stator in the Tol-Pal complex dimeric TolR must undergo large scale structural remodeling reminiscent of that proposed for MotB, where the N- and C-terminal sequences unfold in order for the protein to both reach and bind the PG layer similar to 90 angstrom away from the inner membrane.	[Wojdyla, Justyna A.; Cutts, Erin; Kaminska, Renata; Papadakos, Grigorios; Stansfeld, Phillip J.; Staunton, David; Kleanthous, Colin] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Hopper, Jonathan T. S.; Robinson, Carol V.] Univ Oxford, Dept Chem, Oxford OX1 3TA, England	University of Oxford; University of Oxford	Kleanthous, C (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	colin.kleanthous@bioch.ox.ac.uk	Stansfeld, Phill/C-6213-2011; Stansfeld, Phillip James/AAA-9228-2020	Stansfeld, Phill/0000-0001-8800-7669; Stansfeld, Phillip James/0000-0001-8800-7669; Kaminska, Renata/0000-0001-7252-379X; Papadakos, Grigorios/0000-0002-8666-0880; Cutts, Erin E./0000-0003-3290-4293; robinson, carol/0000-0001-7829-5505	Diamond Light Source; Wellcome Trust; Clarendon Fund (Oxford University); Biotechnology and Biological Sciences Research Council of the United Kingdom [BB/G020671/1]; BBSRC [BB/G020671/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G020671/2] Funding Source: researchfish	Diamond Light Source; Wellcome Trust(Wellcome TrustEuropean Commission); Clarendon Fund (Oxford University); Biotechnology and Biological Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by Diamond Light Source. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Wellcome Trust and the Clarendon Fund (Oxford University).; Supported by Grant BB/G020671/1 from Biotechnology and Biological Sciences Research Council of the United Kingdom. To whom correspondence should be addressed. Tel.: 44-1865-613370; Fax: 44-1865-613213; E-mail: colin.kleanthous@bioch.ox.ac.uk.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bonsor DA, 2007, J AM CHEM SOC, V129, P4800, DOI 10.1021/ja070153n; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; Braun TF, 2001, BIOCHEMISTRY-US, V40, P13051, DOI 10.1021/bi011264g; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cascales E, 2001, MOL MICROBIOL, V42, P795, DOI 10.1046/j.1365-2958.2001.02673.x; Cascales E, 2000, MOL MICROBIOL, V38, P904, DOI 10.1046/j.1365-2958.2000.02190.x; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Clavel T, 1996, MOL MICROBIOL, V19, P19, DOI 10.1046/j.1365-2958.1996.343880.x; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Dennis JJ, 1996, J BACTERIOL, V178, P7059, DOI 10.1128/jb.178.24.7059-7068.1996; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dubuisson JF, 2005, MICROBIOL-SGM, V151, P3337, DOI 10.1099/mic.0.28237-0; Edwards D., 1993, ESCHERICHIA COLI BAC, P369; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Gaspar JA, 2000, MOL MICROBIOL, V38, P262, DOI 10.1046/j.1365-2958.2000.02094.x; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Germon P, 2001, J BACTERIOL, V183, P4110, DOI 10.1128/JB.183.14.4110-4114.2001; Goemaere EL, 2007, J BIOL CHEM, V282, P17749, DOI 10.1074/jbc.M701002200; Goemaere EL, 2007, J MOL BIOL, V366, P1424, DOI 10.1016/j.jmb.2006.12.020; GUIHARD G, 1994, J BIOL CHEM, V269, P5874; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Journet L, 1999, J BACTERIOL, V181, P4476, DOI 10.1128/JB.181.15.4476-4484.1999; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaimer C, 2012, CURR OPIN MICROBIOL, V15, P751, DOI 10.1016/j.mib.2012.10.005; Kim EA, 2008, BIOCHEMISTRY-US, V47, P11332, DOI 10.1021/bi801347a; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; Kojima S, 2009, MOL MICROBIOL, V73, P710, DOI 10.1111/j.1365-2958.2009.06802.x; Krewulak KD, 2011, BIOCHEM CELL BIOL, V89, P87, DOI [10.1139/o10-141, 10.1139/O10-141]; Laue T. M., 1992, ANAL ULTRACENTIFUGAT, P990; MacKinnon SS, 2013, STRUCTURE, V21, P638, DOI 10.1016/j.str.2013.01.019; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Morimoto YV, 2014, BIOMOLECULES, V4, P217, DOI 10.3390/biom4010217; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Neill J, 2011, ACTA CRYSTALLOGR D, V67, P1009, DOI 10.1107/S0907444911041102; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Parsons LM, 2008, BIOCHEMISTRY-US, V47, P3131, DOI 10.1021/bi702283x; Parsons LM, 2006, BIOCHEMISTRY-US, V45, P2122, DOI 10.1021/bi052227i; Paterson GK, 2009, MICROBIOL-SGM, V155, P220, DOI 10.1099/mic.0.021576-0; Roujeinikova A, 2008, P NATL ACAD SCI USA, V105, P10348, DOI 10.1073/pnas.0803039105; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stansfeld PJ, 2013, STRUCTURE, V21, P810, DOI 10.1016/j.str.2013.03.005; Sturgis JN, 2001, J MOL MICROB BIOTECH, V3, P113; Ursinus A, 2004, J BACTERIOL, V186, P6728, DOI 10.1128/JB.186.20.6728-6737.2004; Zhang XYZ, 2009, J BIOL CHEM, V284, P4275, DOI 10.1074/jbc.M805257200	58	16	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26675	26687		10.1074/jbc.M115.671586	http://dx.doi.org/10.1074/jbc.M115.671586			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354441	hybrid, Green Published			2022-12-28	WOS:000364793600031
J	Cherian, MA; Baydoun, HH; Al-Saleem, J; Shkriabai, N; Kvaratskhelia, M; Green, P; Ratner, L				Cherian, Mathew A.; Baydoun, Hicham H.; Al-Saleem, Jacob; Shkriabai, Nikoloz; Kvaratskhelia, Mamuka; Green, Patrick; Ratner, Lee			Akt Pathway Activation by Human T-cell Leukemia Virus Type 1 Tax Oncoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-BINDING MOTIF; NF-KAPPA-B; TUMOR-SUPPRESSOR PROTEIN; HUMAN-PAPILLOMAVIRUS E6; PDZ DOMAIN; HTLV-2 TAX2; TRANSFORMING ACTIVITY; HUMAN HOMOLOG; GROWTH; PTEN	Human T-cell leukemia virus (HTLV) type 1, the etiological agent of adult T-cell leukemia, expresses the viral oncoprotein Tax1. In contrast, HTLV-2, which expresses Tax2, is non-leukemogenic. One difference between these homologous proteins is the presence of a C-terminal PDZ domain-binding motif (PBM) in Tax1, previously reported to be important for non-canonical NF kappa B activation. In contrast, this study finds no defect in non-canonical NF kappa B activity by deletion of the Tax1 PBM. Instead, Tax1 PBM was found to be important for Akt activation. Tax1 attenuates the effects of negative regulators of the PI3K-Akt-mammalian target of rapamycin pathway, phosphatase and tensin homologue (PTEN), and PHLPP. Tax1 competes with PTEN for binding to DLG-1, unlike a PBM deletion mutant of Tax1. Forced membrane expression of PTEN or PHLPP overcame the effects of Tax1, as measured by levels of Akt phosphorylation, and rates of Akt dephosphorylation. The current findings suggest that Akt activation may explain the differences in transforming activity of HTLV-1 and -2.	[Cherian, Mathew A.; Baydoun, Hicham H.; Ratner, Lee] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Al-Saleem, Jacob; Shkriabai, Nikoloz; Kvaratskhelia, Mamuka; Green, Patrick] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Shkriabai, Nikoloz; Kvaratskhelia, Mamuka] Ohio State Univ, Dept Pharmaceut & Pharmaceut Chem, Columbus, OH 43210 USA; [Green, Patrick] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA	Washington University (WUSTL); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ratner, L (corresponding author), Washington Univ, Sch Med, Dept Med, 660 S Euclid Ave,Box 8069, St Louis, MO 63110 USA.	lratner@dom.wustl.edu	Regan, Clinton/E-6250-2012	Cherian, Mathew/0000-0002-0380-2012; Ratner, Lee/0000-0003-2744-7294	National Institutes of Health [CA94056, CA100730, CA63413, T32 HL07088]; Lymphoma and Leukemia Foundation [LLS6067-10]; American Society of Hematology Research Training Award; Lymphoma Research Foundation [LRF307181203]; NATIONAL CANCER INSTITUTE [P01CA100730, P50CA094056, R01CA063417] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma and Leukemia Foundation; American Society of Hematology Research Training Award; Lymphoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA94056, CA100730, and CA63413 and Grant T32 HL07088 (to M. C.). This work was also supported by Lymphoma and Leukemia Foundation Grant LLS6067-10, American Society of Hematology Research Training Award for Fellows, and Lymphoma Research Foundation Grant LRF307181203 (to H. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi M, 2003, FEBS LETT, V554, P77, DOI 10.1016/S0014-5793(03)01109-8; Adey NB, 2000, CANCER RES, V60, P35; Akagi T, 1997, ONCOGENE, V14, P2071, DOI 10.1038/sj.onc.1201045; Arpin-Andre C, 2007, J BIOL CHEM, V282, P33132, DOI 10.1074/jbc.M702279200; Barre B, 2010, CELL CYCLE, V9, P4795, DOI 10.4161/cc.9.24.14245; Barre B, 2010, MOL CELL, V38, P524, DOI 10.1016/j.molcel.2010.03.018; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Ciminale V, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00398; Comb WC, 2012, MOL CELL, V45, P719, DOI 10.1016/j.molcel.2012.01.010; Contreras-Paredes A, 2009, VIROLOGY, V383, P78, DOI 10.1016/j.virol.2008.09.040; Currer R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00406; Dissinger N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112762; Endo K, 2002, J VIROL, V76, P2648, DOI 10.1128/JVI.76.6.2648-2653.2002; Feuer G, 2005, ONCOGENE, V24, P5996, DOI 10.1038/sj.onc.1208971; Fukuda R, 2005, P NATL ACAD SCI USA, V102, P15213, DOI 10.1073/pnas.0507184102; Gallo RC, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-17; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; GRASSMANN R, 1992, J VIROL, V66, P4570, DOI 10.1128/JVI.66.7.4570-4575.1992; Grm HS, 2004, J GEN VIROL, V85, P2815, DOI 10.1099/vir.0.80035-0; GROSSMAN WJ, 1995, P NATL ACAD SCI USA, V92, P1057, DOI 10.1073/pnas.92.4.1057; Higuchi M, 2007, J VIROL, V81, P11900, DOI 10.1128/JVI.00532-07; Higuchi M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-117; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Kwon H, 2005, J BIOL CHEM, V280, P35713, DOI 10.1074/jbc.M504848200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le SS, 1997, P NATL ACAD SCI USA, V94, P6670, DOI 10.1073/pnas.94.13.6670; Leslie NR, 2001, BIOCHEM J, V357, P427, DOI 10.1042/0264-6021:3570427; Li X, 2011, EMBO REP, V12, P818, DOI 10.1038/embor.2011.106; Lin EI, 2013, J NEUROSCI, V33, P12067, DOI 10.1523/JNEUROSCI.0816-13.2013; Makokha GN, 2013, CANCER SCI, V104, P313, DOI 10.1111/cas.12087; Molina JR, 2012, ONCOGENE, V31, P1264, DOI 10.1038/onc.2011.324; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Ohashi M, 2004, VIROLOGY, V320, P52, DOI 10.1016/j.virol.2003.11.014; Okajima M, 2008, VIRUS GENES, V37, P231, DOI 10.1007/s11262-008-0259-4; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; Peloponese JM, 2006, J BIOL CHEM, V281, P8927, DOI 10.1074/jbc.M510598200; POIESZ BJ, 1981, NATURE, V294, P268, DOI 10.1038/294268a0; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Ren T, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00287; Robek MD, 1999, J VIROL, V73, P4856, DOI 10.1128/JVI.73.6.4856-4865.1999; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Romanelli MG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00271; Schumm K, 2006, EMBO J, V25, P4820, DOI 10.1038/sj.emboj.7601343; Shoji T, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-83; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sotelo NS, 2012, J CELL BIOCHEM, V113, P2661, DOI 10.1002/jcb.24141; Suzuki T, 1999, ONCOGENE, V18, P5967, DOI 10.1038/sj.onc.1203008; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; Tsubata C, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-46; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Wu YT, 2011, J BIOL CHEM, V286, P14190, DOI 10.1074/jbc.M111.219923; Xiao GT, 2001, EMBO J, V20, P6805, DOI 10.1093/emboj/20.23.6805; Xie L, 2006, BLOOD, V107, P1980, DOI 10.1182/blood-2005-03-1333	54	19	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26270	26281		10.1074/jbc.M115.684746	http://dx.doi.org/10.1074/jbc.M115.684746			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26324707	Green Published, hybrid			2022-12-28	WOS:000363527300043
J	Rajendran, VM; Kumar, NSN; Tse, CM; Binder, HJ				Rajendran, Vazhaikkurichi M.; Kumar, Navalpur S. Nanda; Tse, Chung M.; Binder, Henry J.			Na-H Exchanger Isoform-2 (NHE2) Mediates Butyrate-dependent Na+ Absorption in Dextran Sulfate Sodium (DSS)-induced Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; ILEAL BRUSH-BORDER; DIFFERENTIAL REGULATION; ULCERATIVE-COLITIS; CHLORIDE TRANSPORT; MEMBRANE-VESICLES; PLASMA-MEMBRANE; DOWN-REGULATION; UP-REGULATION; K+ SECRETION	Diarrhea associated with ulcerative colitis (UC) occurs primarily as a result of reduced Na+ absorption. Although colonic Na+ absorption is mediated by both epithelial Na+ channels (ENaC) and Na-H exchangers (NHE), inhibition of NHE-mediated Na+ absorption is the primary cause of diarrhea in UC. As there are conflicting observations reported on NHE expression in human UC, the present study was initiated to identify whether NHE isoforms (NHE2 and NHE3) expression is altered and how Na+ absorption is regulated in DSS-induced inflammation in rat colon, a model that has been used to study UC. Western blot analyses indicate that neither NHE2 nor NHE3 expression is altered in apical membranes of inflamed colon. Na+ fluxes measured in vitro under voltage clamp conditions in controls demonstrate that both HCO3--dependent and butyrate-dependent Na+ absorption are inhibited by S3226 (NHE3-inhibitor), but not by HOE694 (NHE2-inhibitor) in normal animals. In contrast, in DSS-induced inflammation, butyrate-, but not HCO3--dependent Na+ absorption is present and is inhibited by HOE694, but not by S3226. These observations indicate that in normal colon NHE3 mediates both HCO3--dependent and butyrate-dependent Na+ absorption, whereas DSS-induced inflammation activates NHE2, which mediates butyrate-dependent (but not HCO3--dependent) Na+ absorption. In in vivo loop studies HCO3--Ringer and butyrate-Ringer exhibit similar rates of water absorption in normal rats, whereas in DSS-induced inflammation luminal butyrate- Ringer reversed water secretion observed with HCO3--Ringer to fluid absorption. Lumen butyrate-Ringer incubation activated NHE3-mediated Na+ absorption in DSS-induced colitis. These observations suggest that the butyrate activation of NHE2 would be a potential target to control UC-associated diarrhea.	[Rajendran, Vazhaikkurichi M.; Kumar, Navalpur S. Nanda] W Virginia Univ, Sch Med, Dept Biochem & Mol Biol, Morgantown, WV 26506 USA; [Tse, Chung M.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Binder, Henry J.] Yale Univ, Dept Internal Med, New Haven, CT 06520 USA	West Virginia University; Johns Hopkins University; Yale University	Rajendran, VM (corresponding author), W Virginia Univ, Sch Med, One Med Ctr Dr,POB 9142, Morgantown, WV 26506 USA.	vrajendran@hsc.wvu.edu			National Institutes of Health Grant from NIDDK [DK-018777]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104791, R01DK018777] Funding Source: NIH RePORTER	National Institutes of Health Grant from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-018777 from the NIDDK (to V. M. R.). The authors declare that they do not have any conflict of interest with the content of this article.	Amasheh S, 2004, GASTROENTEROLOGY, V126, P1711, DOI 10.1053/j.gastro.2004.03.010; Biemesderfer D, 1997, AM J PHYSIOL-RENAL, V273, pF289, DOI 10.1152/ajprenal.1997.273.2.F289; Binder HJ, 2010, ANNU REV PHYSIOL, V72, P297, DOI 10.1146/annurev-physiol-021909-135817; Binder HJ, 2005, J CLIN GASTROENTEROL, V39, pS53, DOI 10.1097/01.mcg.0000155521.81382.3a; Binder HJ, 1991, LARGE INTESTINE PHYS, P141; Breuer RI, 1997, GUT, V40, P485, DOI 10.1136/gut.40.4.485; BUGAUT M, 1987, COMP BIOCHEM PHYS B, V86, P439, DOI 10.1016/0305-0491(87)90433-0; Chen T, 2015, J BIOL CHEM, V290, P1952, DOI 10.1074/jbc.M114.590174; CHO JH, 1994, AM J PHYSIOL, V267, pC796, DOI 10.1152/ajpcell.1994.267.3.C796; COUNILLON L, 1993, MOL PHARMACOL, V44, P1041; DELCASTILLO JR, 1991, AM J PHYSIOL, V261, pG1005, DOI 10.1152/ajpgi.1991.261.6.G1005; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Donowitz M, 2013, MOL ASPECTS MED, V34, P236, DOI 10.1016/j.mam.2012.05.001; Donowitz M, 2009, J EXP BIOL, V212, P1638, DOI 10.1242/jeb.028605; FORBUSH B, 1983, ANAL BIOCHEM, V128, P159, DOI 10.1016/0003-2697(83)90356-1; Greig E, 2000, ANN NY ACAD SCI, V915, P327; HARIG JM, 1989, NEW ENGL J MED, V320, P23, DOI 10.1056/NEJM198901053200105; Hecht G, 2004, AM J PHYSIOL-GASTR L, V287, pG370, DOI 10.1152/ajpgi.00432.2003; Hodges K, 2008, CELL MICROBIOL, V10, P1735, DOI 10.1111/j.1462-5822.2008.01163.x; Hodges K, 2006, AM J PHYSIOL-GASTR L, V291, pG959, DOI 10.1152/ajpgi.00274.2005; Ikuma M, 1999, AM J PHYSIOL-GASTR L, V276, pG539, DOI 10.1152/ajpgi.1999.276.2.G539; Kanthesh BM, 2013, AM J PHYSIOL-CELL PH, V305, pC972, DOI 10.1152/ajpcell.00165.2013; KNICKELBEIN R, 1985, AM J PHYSIOL, V249, pG236, DOI 10.1152/ajpgi.1985.249.2.G236; KNICKELBEIN R, 1983, AM J PHYSIOL, V245, pG504, DOI 10.1152/ajpgi.1983.245.4.G504; Krishnan S, 2003, AM J PHYSIOL-CELL PH, V285, pC1246, DOI 10.1152/ajpcell.00598.2002; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McNamara BP, 2001, J CLIN INVEST, V107, P621, DOI 10.1172/JCI11138; Moe OW, 1999, J AM SOC NEPHROL, V10, P2412; Musch MW, 2001, AM J PHYSIOL-GASTR L, V280, pG687, DOI 10.1152/ajpgi.2001.280.4.G687; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; RAJENDRAN VM, 1994, J MEMBRANE BIOL, V141, P51; RAJENDRAN VM, 1990, J BIOL CHEM, V265, P8408; Saemann MD, 2000, FASEB J, V14, P2380; Sandle GI, 2012, AM J PHYSIOL-CELL PH, V303, pC328, DOI 10.1152/ajpcell.00099.2012; SANDLE GI, 1990, GASTROENTEROLOGY, V99, P97, DOI 10.1016/0016-5085(90)91235-X; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Schwark JR, 1998, PFLUG ARCH EUR J PHY, V436, P797, DOI 10.1007/s004240050704; Soergel K H, 1989, Acta Vet Scand Suppl, V86, P107; STIEGER B, 1986, J MEMBRANE BIOL, V91, P19, DOI 10.1007/BF01870211; Subramanya SB, 2007, AM J PHYSIOL-GASTR L, V293, pG857, DOI 10.1152/ajpgi.00462.2006; Sullivan S, 2009, INFLAMM BOWEL DIS, V15, P261, DOI 10.1002/ibd.20743; Vidyasagar S, 2002, J PHYSIOL-LONDON, V539, P163, DOI 10.1113/jphysiol.2001.013056; Weber TE, 2006, VET IMMUNOL IMMUNOP, V113, P139, DOI 10.1016/j.vetimm.2006.04.006; Yang LM, 2006, J BIOL CHEM, V281, P9859, DOI 10.1074/jbc.M512046200; Yeruva S, 2010, INFLAMM BOWEL DIS, V16, P1149, DOI 10.1002/ibd.21183; Yip RGC, 1999, LIFE SCI, V66, P91, DOI 10.1016/S0024-3205(99)00314-8	47	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25487	25496		10.1074/jbc.M115.654277	http://dx.doi.org/10.1074/jbc.M115.654277			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26350456	hybrid, Green Published			2022-12-28	WOS:000362962800024
J	Froese, DS; Kopec, J; Fitzpatrick, F; Schuller, M; McCorvie, TJ; Chalk, R; Plessl, T; Fettelschoss, V; Fowler, B; Baumgartner, MR; Yue, WW				Froese, D. Sean; Kopec, Jolanta; Fitzpatrick, Fiona; Schuller, Marion; McCorvie, Thomas J.; Chalk, Rod; Plessl, Tanja; Fettelschoss, Victoria; Fowler, Brian; Baumgartner, Matthias R.; Yue, Wyatt W.			Structural Insights into the MMACHC-MMADHC Protein Complex Involved in Vitamin B-12 Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CBLD DEFECT; DEFICIENCY; DISORDERS; ISOFORMS; FEATURES; REVEALS; DOMAIN	Conversion of vitamin B-12 (cobalamin, Cbl) into the cofactor forms methyl-Cbl (MeCbl) and adenosyl-Cbl (AdoCbl) is required for the function of two crucial enzymes, mitochondrial methylmalonyl-CoA mutase and cytosolic methionine synthase, respectively. The intracellular proteins MMACHC and MMADHC play important roles in processing and targeting the Cbl cofactor to its destination enzymes, and recent evidence suggests that they may interact while performing these essential trafficking functions. To better understand the molecular basis of this interaction, we have mapped the crucial protein regions required, indicate that Cbl is likely processed by MMACHC prior to interaction with MMADHC, and identify patient mutations on both proteins that interfere with complex formation, via different mechanisms. We further report the crystal structure of the MMADHC C-terminal region at 2.2 angstrom resolution, revealing a modified nitroreductase fold with surprising homology to MMACHC despite their poor sequence conservation. Because MMADHC-demonstrates no known enzymatic activity, we propose it as the first protein known to repurpose the nitroreductase fold solely for protein-protein interaction. Using small angle x-ray scattering, we reveal the MMACHC-MMADHC complex as a 1: 1 heterodimer and provide a structural model of this interaction, where the interaction region overlaps with the MMACHC-Cbl binding site. Together, our findings provide novel structural evidence and mechanistic insight into an essential biological process, whereby an intracellular "trafficking chaperone" highly specific for a trace element cofactor functions via protein-protein interaction, which is disrupted by inherited disease mutations.	[Froese, D. Sean; Plessl, Tanja; Fettelschoss, Victoria; Fowler, Brian; Baumgartner, Matthias R.] Univ Childrens Hosp, Div Metab, CH-8032 Zurich, Switzerland; [Froese, D. Sean; Plessl, Tanja; Fettelschoss, Victoria; Fowler, Brian; Baumgartner, Matthias R.] Univ Childrens Hosp, Childrens Res Ctr, CH-8032 Zurich, Switzerland; [Froese, D. Sean; Baumgartner, Matthias R.] Univ Zurich, Clin Res Prior Program Rare Dis, Radiz Rare Dis Initiat Zurich, CH-8032 Zurich, Switzerland; [Kopec, Jolanta; Fitzpatrick, Fiona; Schuller, Marion; McCorvie, Thomas J.; Chalk, Rod; Yue, Wyatt W.] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7DQ, England; [Baumgartner, Matthias R.] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland	University Children's Hospital Zurich; University Children's Hospital Zurich; University of Zurich; University of Oxford; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Baumgartner, MR (corresponding author), Univ Childrens Hosp, Div Metab, Steinwiesstr 75, CH-8032 Zurich, Switzerland.	matthias.baumgartner@kispi.uzh.ch; wyatt.yue@sgc.ox.ac.uk	Froese, Sean/J-6665-2017; Froese, D. Sean Sean/AAW-6899-2021; Kopec, Jolanta/E-7117-2010; Baumgartner, Matthias/Q-2855-2017	Froese, Sean/0000-0003-1557-3517; Froese, D. Sean Sean/0000-0003-1557-3517; Kopec, Jolanta/0000-0002-0889-9845; Baumgartner, Matthias/0000-0002-9270-0826; McCorvie, Thomas/0000-0002-1502-7113; Fitzpatrick, Fiona/0000-0002-1634-7733; Schuller, Marion/0000-0002-1551-0359	Swiss National Science Foundation [SNSF 31003A_156907, SNSF 31003A_138521]; Rare Disease Initiative Zurich; Clinical Research Priority Program, University of Zurich; AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada; Glaxo-SmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; Engineering and Physical Sciences Research Council [1368548] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Rare Disease Initiative Zurich; Clinical Research Priority Program, University of Zurich; AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Glaxo-SmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Swiss National Science Foundation (Grants SNSF 31003A_156907 and SNSF 31003A_138521) (to D. S. F., M. R. B., B. F. and T. P.). This work was also supported by the Rare Disease Initiative Zurich, Clinical Research Priority Program, University of Zurich (to D. S. F. and M. R. B.). The Structural Genomics Consortium is a registered charity (Number 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, Glaxo-SmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust (092809/Z/10/Z). The authors declare that they have no conflicts of interest with the contents of this article.	Baumgartner MR, 2013, HAND CLINIC, V113, P1799, DOI 10.1016/B978-0-444-59565-2.00049-6; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Deme JC, 2012, MOL GENET METAB, V107, P352, DOI 10.1016/j.ymgme.2012.07.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forster S, 2010, J APPL CRYSTALLOGR, V43, P639, DOI 10.1107/S0021889810008289; Fofou-Caillierez MB, 2013, HUM MOL GENET, V22, P4591, DOI 10.1093/hmg/ddt308; Fowler B, 2008, J INHERIT METAB DIS, V31, P350, DOI 10.1007/s10545-008-0839-4; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Froese DS, 2010, MOL GENET METAB, V100, P29, DOI 10.1016/j.ymgme.2010.02.005; Froese DS, 2009, MOL GENET METAB, V98, P338, DOI 10.1016/j.ymgme.2009.07.014; Froese DS, 2012, BIOCHEMISTRY-US, V51, P5083, DOI 10.1021/bi300150y; Froese DS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001651; Gherasim C, 2015, J BIOL CHEM, V290, P11393, DOI 10.1074/jbc.M115.637132; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Gherasim C, 2013, BIOCHIMIE, V95, P1023, DOI 10.1016/j.biochi.2013.02.003; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; Harding CO, 1997, AM J MED GENET, V71, P384, DOI 10.1002/(SICI)1096-8628(19970905)71:4<384::AID-AJMG3>3.0.CO;2-U; Horster F, 2007, PEDIATR RES, V62, P225; Jusufi J, 2014, J INHERIT METAB DIS, V37, P841, DOI 10.1007/s10545-014-9709-4; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Kim J, 2009, J BIOL CHEM, V284, P33418, DOI 10.1074/jbc.M109.057877; Koutmos M, 2011, J BIOL CHEM, V286, P29780, DOI 10.1074/jbc.M111.261370; Lerner-Ellis JP, 2009, HUM MUTAT, V30, P1072, DOI 10.1002/humu.21001; Li Z, 2014, J BIOL CHEM, V289, P16487, DOI 10.1074/jbc.M114.567339; Mah W, 2013, MOL GENET METAB, V108, P112, DOI 10.1016/j.ymgme.2012.11.284; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Plesa M, 2011, MOL GENET METAB, V102, P139, DOI 10.1016/j.ymgme.2010.10.011; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Stucki M, 2012, HUM MOL GENET, V21, P1410, DOI 10.1093/hmg/ddr579; Suormala T, 2004, J BIOL CHEM, V279, P42742, DOI 10.1074/jbc.M407733200; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Wassenaar TA, 2012, J GRID COMPUT, V10, P743, DOI 10.1007/s10723-012-9246-z; Watkins D., 2014, ONLINE METABOLIC MOL; Yamada K, 2015, J BIOL CHEM, V290, P29155, DOI 10.1074/jbc.M115.682435	40	25	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29167	29177		10.1074/jbc.M115.683268	http://dx.doi.org/10.1074/jbc.M115.683268			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26483544	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000366613400005
J	Molza, AE; Mangat, K; Le Rumeur, E; Hubert, JF; Menhart, N; Delalande, O				Molza, Anne-Elisabeth; Mangat, Khushdeep; Le Rumeur, Elisabeth; Hubert, Jean-Fracnois; Menhart, Nick; Delalande, Olivier			Structural Basis of Neuronal Nitric-oxide Synthase Interaction with Dystrophin Repeats 16 and 17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; X-RAY; DOMAIN; NNOS; GENE; FLEXIBILITY; SCATTERING; PHENOTYPE; SEVERITY	Duchenne muscular dystrophy is a lethal genetic defect that is associated with the absence of dystrophin protein. Lack of dystrophin protein completely abolishes muscular nitric-oxide synthase (NOS) function as a regulator of blood flow during muscle contraction. In normal muscles, nNOS function is ensured by its localization at the sarcolemma through an interaction of its PDZ domain with dystrophin spectrin-like repeats R16 and R17. Early studies suggested that repeat R17 is the primary site of interaction but ignored the involved nNOS residues, and the R17 binding site has not been described at an atomic level. In this study, we characterized the specific amino acids involved in the binding site of nNOS-PDZ with dystrophin R16-17 using combined experimental biochemical and structural in silico approaches. First, 32 alanine-scanning mutagenesis variants of dystrophin R16-17 indicated the regions where mutagenesis modified the affinity of the dystrophin interaction with the nNOS-PDZ. Second, using small angle x-ray scattering-based models of dystrophin R16-17 and molecular docking methods, we generated atomic models of the dystrophin R16-17 center dot nNOS-PDZ complex that correlated well with the alanine scanning identified regions of dystrophin. The structural regions constituting the dystrophin interaction surface involve the A/B loop and the N-terminal end of helix B of repeat R16 and the N-terminal end of helix A' and a small fraction of helix B' and a large part of the helix C' of repeat R17. The interaction surface of nNOS-PDZ involves its main beta-sheet and its specific C-terminal beta-finger.	[Molza, Anne-Elisabeth; Le Rumeur, Elisabeth; Hubert, Jean-Fracnois; Delalande, Olivier] Univ Rennes 1, F-35043 Rennes, France; [Molza, Anne-Elisabeth; Le Rumeur, Elisabeth; Hubert, Jean-Fracnois; Delalande, Olivier] IGDR, UMR CNRS 6290, Rennes, France; [Mangat, Khushdeep; Menhart, Nick] IIT, Chicago, IL 60616 USA	Universite de Rennes; Illinois Institute of Technology	Delalande, O (corresponding author), Univ Rennes 1, Fac Sci Pharmaceut & Biol, IGDR, UMR CNRS 6290,Equipe SIM,Platforme PRISM, 2 Av Pr Leon Bernard CS 34317, F-35043 Rennes, France.	olivier.delalande@univ-rennes1.fr	Mangat, Khushdeep/AAE-6593-2022		Association Francaise Contre les Myopathies; AFM-Telethon; Rennes Metropole; Grand Equipement National de Calcul Intensif-GENCI program (DARI DYSIM); Muscular Dystrophy Association, USA [217640]	Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); AFM-Telethon(Association Francaise contre les Myopathies); Rennes Metropole(Region Bretagne); Grand Equipement National de Calcul Intensif-GENCI program (DARI DYSIM); Muscular Dystrophy Association, USA(Muscular Dystrophy Association)	This work was supported in part by the Association Francaise Contre les Myopathies, AFM-Telethon, Rennes Metropole, the Grand Equipement National de Calcul Intensif-GENCI program (projet DARI DYSIM), and Muscular Dystrophy Association, USA Grant 217640.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Campbell MG, 2014, P NATL ACAD SCI USA, V111, pE3614, DOI 10.1073/pnas.1413763111; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Ferey N, 2012, PROTEIN-PROTEIN INTERACTIONS - COMPUTATIONAL AND EXPERIMENTAL TOOLS, P27; Flanigan KM, 2009, HUM MUTAT, V30, P1657, DOI 10.1002/humu.21114; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Gentil C, 2012, HUM MOL GENET, V21, P3449, DOI 10.1093/hmg/dds176; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Giudice E, 2013, BIOCHEMISTRY-US, V52, P7777, DOI 10.1021/bi400794p; Harper SQ, 2013, P NATL ACAD SCI USA, V110, P387, DOI 10.1073/pnas.1220256110; Harper SQ, 2002, NAT MED, V8, P253, DOI 10.1038/nm0302-253; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ipsaro JJ, 2010, BLOOD, V115, P4843, DOI 10.1182/blood-2010-01-261396; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1990, J BIOL CHEM, V265, P4560; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Lai Y, 2013, P NATL ACAD SCI USA, V110, P525, DOI 10.1073/pnas.1211431109; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Le Rumeur E, 2010, BBA-PROTEINS PROTEOM, V1804, P1713, DOI 10.1016/j.bbapap.2010.05.001; Mirza A, 2010, BBA-PROTEINS PROTEOM, V1804, P1796, DOI 10.1016/j.bbapap.2010.03.009; Molza AE, 2014, FARADAY DISCUSS, V169, P45, DOI 10.1039/c3fd00134b; Nicolas A, 2015, HUM MOL GENET, V24, P1267, DOI 10.1093/hmg/ddu537; Nicolas A, 2012, ORPHANET J RARE DIS, V7, DOI [10.1186/1750-1172-7-45, 10.1186/1750-1172-7-42]; Perez J, 2012, CURR OPIN STRUC BIOL, V22, P670, DOI 10.1016/j.sbi.2012.07.014; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Sato K, 2008, Acta Myol, V27, P30; Schneider S, 2012, METHODS MOL BIOL, V819, P221, DOI 10.1007/978-1-61779-465-0_15; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Tengan CH, 2012, INT J MOL SCI, V13, P17160, DOI 10.3390/ijms131217160; Tochio H, 1999, NAT STRUCT BIOL, V6, P417; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Wang Y, 1999, CRIT REV NEUROBIOL, V13, P21, DOI 10.1615/CritRevNeurobiol.v13.i1.20; Wein N, 2015, PEDIATR CLIN N AM, V62, P723, DOI 10.1016/j.pcl.2015.03.008; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001	43	18	18	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29531	29541		10.1074/jbc.M115.680660	http://dx.doi.org/10.1074/jbc.M115.680660			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26378238	Green Published, hybrid			2022-12-28	WOS:000366613400035
J	Mohibi, S; Srivastava, S; Wang-France, J; Mirza, S; Zhao, XS; Band, H; Band, V				Mohibi, Shakur; Srivastava, Shashank; Wang-France, Jun; Mirza, Sameer; Zhao, Xiangshan; Band, Hamid; Band, Vimla			Alteration/Deficiency in Activation 3 (ADA3) Protein, a Cell Cycle Regulator, Associates with the Centromere through CENP-B and Regulates Chromosome Segregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE ACETYLTRANSFERASE COMPLEXES; KINETOCHORE-MICROTUBULE INTERFACE; FISSION YEAST; ALPHOID DNA; NULL MICE; ACETYLATION; SATELLITE; SEQUENCE; BINDING; IDENTIFICATION	ADA3 (alteration/deficiency in activation 3) is a conserved component of several transcriptional co-activator and histone acetyltransferase (FIAT) complexes. Recently, we generated Ada3 knock-out mice and demonstrated that deletion of Ada3 leads to early embryonic lethality. The use of Ada3(FL/FL) mouse embryonic fibroblasts with deletion of Ada3 using adenovirus Cre showed a critical role of ADA3 in cell cycle progression through mitosis. Here, we demonstrate an association of ADA3 with the higher order repeat region of the a-satellite region on human X chromosome centromeres that is consistent with its role in mitosis, Given the role of centromere proteins (CENPs) in mitosis, we next analyzed whether ADA3 associates with the centromere through CENPs. Both an in vivo proximity ligation assay and immunolluorescence studies confirmed the association of ADA3 with CENP-B protein, a highly conserved centromeric protein that binds to the 17-bp DNA sequences on a-satellite DNA. Deletional analysis showed that ADA3 directly associates with CENP-B through its N terminus, and a CENP-B binding-deficient mutant of ADA3 was incompetent in cell proliferation rescue. Notably, knockdown of ADA3 decreased binding of CENP-B onto the centromeres, suggesting that ADA3 is required for the loading of CENP-B onto the centromeres. Finally, we show that deletion of Ada3 from Ada3(FL/FL) mouse embryonic fibroblasts exhibited various chromosome segregation defects. Taken together, we demonstrate a novel ADA3 interaction with CENP-B-centromere that may account for its previously known function in mitosis. This study, together with its known function in maintaining genomic stability and its mis-localization in cancers, suggests an important role of ADA3 in mitosis.	[Mohibi, Shakur; Srivastava, Shashank; Wang-France, Jun; Mirza, Sameer; Zhao, Xiangshan; Band, Hamid; Band, Vimla] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Coll Med, Dept Biochem & Mol Biol, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Band, Hamid; Band, Vimla] Univ Nebraska Med Ctr, Eppley Inst Canc & Allied Dis, Omaha, NE 68198 USA; [Band, Hamid; Band, Vimla] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Band, V (corresponding author), Univ Nebraska Med Ctr, Coll Med, Dept Genet Cell Biol & Anat, 985805 Nebraska Med Ctr, Omaha, NE 68198 USA.	vband@unmc.edu	Regan, Clinton/E-6250-2012; Band, Hamid/AAF-4701-2020; Mohibi, Shakur/AAR-7017-2021; Srivastava, Shashank/ABC-5991-2021	Mohibi, Shakur/0000-0001-5539-0841; Srivastava, Shashank/0000-0003-4395-4157	National Institutes of Health [CA96844, CA144027, CA87986, CA99163]; Department of Defense [W81XWH-07-1-0351, W81XWH-11-1-0171]; Fred and Pamela Buffett Cancer Center Support Grant [P30CA036727]; Nebraska Research Initiative and Eppley Cancer Center Grant [P30CA036727]; Susan G. Komen Postdoctoral Fellowship [KG111248]; NATIONAL CANCER INSTITUTE [R01CA096844, R01CA087986, R01CA099163, P30CA036727, R01CA144027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Fred and Pamela Buffett Cancer Center Support Grant; Nebraska Research Initiative and Eppley Cancer Center Grant; Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work in our laboratories was supported by National Institutes of Health Grants CA96844 and CA144027 (to V. B.) and CA87986 and CA99163 (to H. B.); Department of Defense Grants W81XWH-07-1-0351 and W81XWH-11-1-0171 (to V. B.); and Fred and Pamela Buffett Cancer Center Support Grant P30CA036727. The Confocal Core Facility is supported by the Nebraska Research Initiative and Eppley Cancer Center Grant P30CA036727. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Susan G. Komen Postdoctoral Fellowship KG111248.	Ando S, 2002, MOL CELL BIOL, V22, P2229, DOI 10.1128/MCB.22.7.2229-2241.2002; BAND V, 1990, P NATL ACAD SCI USA, V87, P463, DOI 10.1073/pnas.87.1.463; Bergmann JH, 2012, J CELL SCI, V125, P411, DOI 10.1242/jcs.090639; Candau R, 1996, J BIOL CHEM, V271, P5237; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Chan GK, 2005, TRENDS CELL BIOL, V15, P589, DOI 10.1016/j.tcb.2005.09.010; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Choo KHA, 2000, TRENDS CELL BIOL, V10, P182, DOI 10.1016/S0962-8924(00)01739-6; Choo KHA, 1997, AM J HUM GENET, V61, P1225, DOI 10.1086/301657; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dai XX, 2013, J PROTEOME RES, V12, P4167, DOI 10.1021/pr400498y; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; Earnshaw WC, 2015, NAT REV MOL CELL BIO, V16, P443, DOI 10.1038/nrm4001; Fachinetti D, 2015, DEV CELL, V33, P314, DOI 10.1016/j.devcel.2015.03.020; Fachinetti D, 2013, NAT CELL BIOL, V15, P1056, DOI 10.1038/ncb2805; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Gamper AM, 2009, MOL CELL BIOL, V29, P266, DOI 10.1128/MCB.00315-08; Ganem NJ, 2012, J CELL BIOL, V199, P871, DOI 10.1083/jcb.201210040; Germaniuk-Kurowska A, 2007, CANCER RES, V67, P11789, DOI 10.1158/0008-5472.CAN-07-2721; HORIUCHI J, 1995, MOL CELL BIOL, V15, P1203; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Hudson DF, 1998, J CELL BIOL, V141, P309, DOI 10.1083/jcb.141.2.309; Kapoor M, 1998, CHROMOSOMA, V107, P570, DOI 10.1007/s004120050343; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Li CW, 2008, BIOCHEM J, V413, P349, DOI 10.1042/BJ20071484; Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; Meng GY, 2004, J BIOL CHEM, V279, P54230, DOI 10.1074/jbc.M404482200; Minoda A, 2005, MOL BIOL CELL, V16, P316, DOI 10.1091/mbc.E04-06-0519; Mirza S, 2013, BREAST CANCER RES TR, V137, P721, DOI 10.1007/s10549-012-2363-3; Mirza S, 2012, CELL CYCLE, V11, P4266, DOI 10.4161/cc.22613; Mohibi S, 2012, J BIOL CHEM, V287, P29442, DOI 10.1074/jbc.M112.378901; Mravinac B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006602; MURO Y, 1992, J CELL BIOL, V116, P585, DOI 10.1083/jcb.116.3.585; Nag A, 2007, J BIOL CHEM, V282, P8812, DOI 10.1074/jbc.M610443200; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Nakagawa H, 2002, GENE DEV, V16, P1766, DOI 10.1101/gad.997702; Ohzeki J, 2002, J CELL BIOL, V159, P765, DOI 10.1083/jcb.200207112; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; Orpinell M, 2010, EMBO J, V29, P2381, DOI 10.1038/emboj.2010.125; Perez-Castro AV, 1998, DEV BIOL, V201, P135, DOI 10.1006/dbio.1998.9005; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; SULLIVAN KF, 1991, CHROMOSOMA, V100, P360, DOI 10.1007/BF00337514; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Vernarecci S, 2008, MOL CELL BIOL, V28, P988, DOI 10.1128/MCB.01366-07; Wang T, 2001, EMBO J, V20, P6404, DOI 10.1093/emboj/20.22.6404; YODA K, 1992, J CELL BIOL, V119, P1413, DOI 10.1083/jcb.119.6.1413; Zencir S, 2013, BIOCHEM J, V450, P311, DOI 10.1042/BJ20120452; Zhong L, 2013, METHODS MOL BIOL, V1077, P149, DOI 10.1007/978-1-62703-637-5_10	51	8	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28299	+		10.1074/jbc.M115.685511	http://dx.doi.org/10.1074/jbc.M115.685511			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26429915	Green Published, hybrid			2022-12-28	WOS:000365761900022
J	Shi, K; Carpenter, MA; Kurahashi, K; Harris, RS; Aihara, H				Shi, Ke; Carpenter, Michael A.; Kurahashi, Kayo; Harris, Reuben S.; Aihara, Hideki			Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTIDINE DEAMINASE; RETROVIRAL RESTRICTION; CYTOSINE DEAMINATION; AID/APOBEC FAMILY; FOREIGN DNA; HIV-1; BINDING; ENZYME; VIF; HYPERMUTATION	Functional and deep sequencing studies have combined to demonstrate the involvement of APOBEC3B in cancer mutagenesis. APOBEC3B is a single-stranded DNA cytosine deaminase that functions normally as a nuclear-localized restriction factor of DNA-based pathogens. However, it is overexpressed in cancer cells and elicits an intrinsic preference for 5'-Tc motifs in single-stranded DNA, which is the most frequently mutated dinucleotide in breast, head/neck, lung, bladder, cervical, and several other tumor types. In many cases, APOBEC3B mutagenesis accounts for the majority of both dispersed and clustered (kataegis) cytosine mutations. Here, we report the first structures of the APOBEC3B catalytic domain in multiple crystal forms. These structures reveal a tightly closed active site conformation and suggest that substrate accessibility is regulated by adjacent flexible loops. Residues important for catalysis are identified by mutation analyses, and the results provide insights into the mechanism of target site selection. We also report a nucleotide (dCMP)-bound crystal structure that informs a multistep model for binding single-stranded DNA. Overall, these high resolution crystal structures provide a framework for further mechanistic studies and the development of novel anti-cancer drugs to inhibit this enzyme, dampen tumor evolution, and minimize adverse outcomes such as drug resistance and metastasis.	[Shi, Ke; Carpenter, Michael A.; Kurahashi, Kayo; Harris, Reuben S.; Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Shi, Ke; Carpenter, Michael A.; Kurahashi, Kayo; Harris, Reuben S.; Aihara, Hideki] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Shi, Ke; Carpenter, Michael A.; Kurahashi, Kayo; Harris, Reuben S.; Aihara, Hideki] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Harris, Reuben S.] Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities	Harris, RS (corresponding author), Univ Minnesota, Howard Hughes Med Inst, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	rsh@umn.edu; aihar001@umn.edu		, Ke/0000-0003-4175-3714; Carpenter, Michael/0000-0001-9524-5323	National Institutes of Health from the NIGMS [GM095558, GM109770]; NIAID [AI064046]; NIGMS [GM091743, GM110734, P41 GM103403]; U.S. Department of Energy Office of Science User Facility [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI064046, R01AI064046, R56AI064046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095558, R01GM109770, R01GM110734, P41GM103403, P01GM091743] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM095558 and GM109770 from the NIGMS (to the Aihara lab), AI064046 from the NIAID and GM091743 from the NIGMS (to the Harris lab), GM110734 from the NIGMS (to M. A. C.), and P41 GM103403 from the NIGMS (to Advanced Photon Source NE CAT beamlines). Advanced Photon Source is a U.S. Department of Energy Office of Science User Facility operated by Argonne National Laboratory under contract DE-AC02-06CH11357. R. S. H. is a co-founder of ApoGen Biotechnologies Inc. The other authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Almog R, 2004, BIOCHEMISTRY-US, V43, P13715, DOI 10.1021/bi048928h; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Bogerd HP, 2007, VIROLOGY, V364, P486, DOI 10.1016/j.virol.2007.03.019; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bohn MF, 2015, STRUCTURE, V23, P903, DOI 10.1016/j.str.2015.03.016; Bohn MF, 2013, STRUCTURE, V21, P1042, DOI 10.1016/j.str.2013.04.010; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Carpenter MA, 2010, DNA REPAIR, V9, P579, DOI 10.1016/j.dnarep.2010.02.010; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fossat N, 2014, RNA BIOL, V11, P1233, DOI 10.1080/15476286.2014.996054; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Hache G, 2005, J BIOL CHEM, V280, P10920, DOI 10.1074/jbc.M500382200; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Henderson S, 2015, TRENDS MOL MED, V21, P274, DOI 10.1016/j.molmed.2015.02.007; Henderson S, 2014, CELL REP, V7, P1833, DOI 10.1016/j.celrep.2014.05.012; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Johansson E, 2002, BIOCHEMISTRY-US, V41, P2563, DOI 10.1021/bi011849a; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Kohli RM, 2010, J BIOL CHEM, V285, P40956, DOI 10.1074/jbc.M110.177402; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Kouno T, 2015, NAT STRUCT MOL BIOL, V22, P485, DOI 10.1038/nsmb.3033; Krzysiak TC, 2012, BIOCHEMISTRY-US, V51, P2008, DOI 10.1021/bi300021s; Lackey L, 2013, CELL CYCLE, V12, P762, DOI 10.4161/cc.23713; Lackey L, 2012, J MOL BIOL, V419, P301, DOI 10.1016/j.jmb.2012.03.011; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Li JH, 2014, J MOL BIOL, V426, P1296, DOI 10.1016/j.jmb.2013.12.014; Li M, 2012, ACS CHEM BIOL, V7, P506, DOI 10.1021/cb200440y; Losey HC, 2006, NAT STRUCT MOL BIOL, V13, P153, DOI 10.1038/nsmb1047; Macbeth MR, 2005, SCIENCE, V309, P1534, DOI 10.1126/science.1113150; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDougle RM, 2013, VIROLOGY, V441, P31, DOI 10.1016/j.virol.2013.03.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pak V, 2011, J VIROL, V85, P8538, DOI 10.1128/JVI.02645-10; Rathore A, 2013, J MOL BIOL, V425, P4442, DOI 10.1016/j.jmb.2013.07.040; Refsland EW, 2013, CURR TOP MICROBIOL, V371, P1, DOI 10.1007/978-3-642-37765-5_1; Robbiani DF, 2013, ANNU REV PATHOL-MECH, V8, P79, DOI 10.1146/annurev-pathol-020712-164004; Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Shindo Keisuke, 2012, Biology (Basel), V1, P260, DOI 10.3390/biology1020260; Sieuwerts AM, 2014, HORM CANCER-US, V5, P405, DOI 10.1007/s12672-014-0196-8; Siu KK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3593; Smith HC, 2012, SEMIN CELL DEV BIOL, V23, P258, DOI 10.1016/j.semcdb.2011.10.004; Stenglein MD, 2008, J VIROL, V82, P9591, DOI 10.1128/JVI.02471-07; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Walker BA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7997; Wang M, 2010, J EXP MED, V207, P141, DOI 10.1084/jem.20092238; Xu L., 2015, UROL ONCOL, V33, pe1, DOI DOI 10.1016/J.UR0L0NC.2015.05.009	65	73	76	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28120	28130		10.1074/jbc.M115.679951	http://dx.doi.org/10.1074/jbc.M115.679951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26416889	hybrid, Green Published			2022-12-28	WOS:000365761900008
J	VanLinden, MR; Dolle, C; Pettersen, IKN; Kulikova, VA; Niere, M; Agrimi, G; Dyrstad, SE; Palmieri, F; Nikiforov, AA; Tronstad, KJ; Ziegler, M				VanLinden, Magali R.; Dolle, Christian; Pettersen, Ina K. N.; Kulikova, Veronika A.; Niere, Marc; Agrimi, Gennaro; Dyrstad, Sissel E.; Palmieri, Ferdinando; Nikiforov, Andrey A.; Tronstad, Karl Johan; Ziegler, Mathias			Subcellular Distribution of NAD(+) between Cytosol and Mitochondria Determines the Metabolic Profile of Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; DEPLETION; BIOSYNTHESIS; INHIBITION; TRANSPORTER; CARRIER; FAMILY; COMPARTMENTATION; IDENTIFICATION; LOCALIZATION	The mitochondrial NAD pool is particularly important for the maintenance of vital cellular functions. Although at least in some fungi and plants, mitochondrial NAD is imported from the cytosol by carrier proteins, in mammals, the mechanism of how this organellar pool is generated has remained obscure. A transporter mediating NAD import into mammalian mitochondria has not been identified. In contrast, human recombinant NMNAT3 localizes to the mitochondrial matrix and is able to catalyze NAD(+) biosynthesis in vitro. However, whether the endogenous NMNAT3 protein is functionally effective at generating NAD(+) in mitochondria of intact human cells still remains to be demonstrated. To modulate mitochondrial NAD(+) content, we have expressed plant and yeast mitochondrial NAD(+) carriers in human cells and observed a profound increase in mitochondrial NAD(+). None of the closest human homologs of these carriers had any detectable effect on mitochondrial NAD(+) content. Surprisingly, constitutive redistribution of NAD(+) from the cytosol to the mitochondria by stable expression of the Arabidopsis thaliana mitochondrial NAD(+) transporter NDT2 in HEK293 cells resulted in dramatic growth retardation and a metabolic shift from oxidative phosphorylation to glycolysis, despite the elevated mitochondrial NAD(+) levels. These results suggest that a mitochondrial NAD(+) transporter, similar to the known one from A. thaliana, is likely absent and could even be harmful in human cells. We provide further support for the alternative possibility, namely intramitochondrial NAD(+) synthesis, by demonstrating the presence of endogenous NMNAT3 in the mitochondria of human cells.	[VanLinden, Magali R.; Dolle, Christian; Niere, Marc; Ziegler, Mathias] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Pettersen, Ina K. N.; Dyrstad, Sissel E.; Tronstad, Karl Johan] Univ Bergen, Dept Biomed, N-5020 Bergen, Norway; [Kulikova, Veronika A.; Nikiforov, Andrey A.] Peter Great St Petersburg Polytech Univ, Inst Nanobiotechnol, St Petersburg 195251, Russia; [Agrimi, Gennaro; Palmieri, Ferdinando] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, I-70125 Bari, Italy; [Palmieri, Ferdinando] Univ Bari, Ctr Excellence Comparat Genom, I-70125 Bari, Italy; [Nikiforov, Andrey A.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	University of Bergen; University of Bergen; Peter the Great St. Petersburg Polytechnic University; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Dolle, C (corresponding author), Haukeland Hosp, Dept Neurol, Jonas Lies Vei 83, N-5021 Bergen, Norway.	Christian.Doelle@uib.no	Nikiforov, Andrey A/B-6643-2012; Kulikova, Veronika/AAE-9110-2021; Agrimi, Gennaro/D-4001-2018	Nikiforov, Andrey A/0000-0002-5009-6130; Agrimi, Gennaro/0000-0002-5219-4412; Tronstad, Karl Johan/0000-0003-3496-3123; Ziegler, Mathias/0000-0001-6961-2396; Dyrstad, Sissel Elisabeth/0000-0002-7033-3519	Norwegian Research Council [NFR 214435/F20]; Norwegian Cancer Society; Russian Foundation for Basic Research [14-04-01765a, 14-04-32117 mol_a]; Italian Human ProteomeNet Grant [RBRN07BMCT_009]	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Italian Human ProteomeNet Grant	This work was supported by Norwegian Research Council Grant NFR 214435/F20, the Norwegian Cancer Society, Russian Foundation for Basic Research Grants 14-04-01765a and 14-04-32117 mol_a, and Italian Human ProteomeNet Grant RBRN07BMCT_009. The authors declare that they have no conflicts of interest with the contents of this article.	Agrimi G, 2012, BIOCHEM J, V443, P241, DOI 10.1042/BJ20111420; Agrimi G, 2011, APPL ENVIRON MICROB, V77, P2239, DOI 10.1128/AEM.01703-10; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2007, J NEUROSCI RES, V85, P3378, DOI 10.1002/jnr.21479; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; Barile M, 1996, BIOCHEM MOL BIOL INT, V38, P297; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Billington RA, 2008, AUTOPHAGY, V4, P385, DOI 10.4161/auto.5635; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Cappello AR, 2007, J MOL BIOL, V369, P400, DOI 10.1016/j.jmb.2007.03.048; Chiarugi A, 2002, SCIENCE, V297, P200, DOI 10.1126/science.1074592; Di Lisa F, 2001, IUBMB LIFE, V52, P255; Di Martino C, 2011, PLANTA, V234, P657, DOI 10.1007/s00425-011-1428-6; Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808; Di Stefano M, 2010, BLOOD CELL MOL DIS, V45, P33, DOI 10.1016/j.bcmd.2010.04.003; Dolle C, 2013, CURR TOP MED CHEM, V13, P2907; Dolle C, 2013, FEBS J, V280, P3530, DOI 10.1111/febs.12304; Dolle C, 2010, CELL MOL LIFE SCI, V67, P433, DOI 10.1007/s00018-009-0190-4; Felici R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076938; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Fouquerel E, 2014, CELL REP, V8, P1819, DOI 10.1016/j.celrep.2014.08.036; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Hikosaka K, 2014, J BIOL CHEM, V289, P14796, DOI 10.1074/jbc.M114.554378; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Kitaoka Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.391; Koch-Nolte F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.257mr1; Kristian T, 2011, J NEUROSCI RES, V89, P1946, DOI 10.1002/jnr.22626; Niere M, 2008, MOL CELL BIOL, V28, P814, DOI 10.1128/MCB.01766-07; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Olesen UH, 2010, MOL CANCER THER, V9, P1609, DOI 10.1158/1535-7163.MCT-09-1130; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Palmieri F, 2014, J INHERIT METAB DIS, V37, P565, DOI 10.1007/s10545-014-9708-5; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Reddy PH, 2011, CURR ALZHEIMER RES, V8, P393; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Titus SA, 2000, J BIOL CHEM, V275, P36811, DOI 10.1074/jbc.M005163200; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035	47	47	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27644	27659		10.1074/jbc.M115.654129	http://dx.doi.org/10.1074/jbc.M115.654129			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26432643	hybrid, Green Published			2022-12-28	WOS:000365757500019
J	Barroso, M; Tucker, H; Drake, L; Nichol, K; Drake, JR				Barroso, Margarida; Tucker, Heidi; Drake, Lisa; Nichol, Kathleen; Drake, James R.			Antigen-B Cell Receptor Complexes Associate with Intracellular major histocompatibility complex (MHC) Class II Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; FRET MICROSCOPY; IG-ALPHA/BETA; HLA-DM; RESOLUTION; MEMBRANES; BINDING; BETA	Antigen processing and MHC class II-restricted antigen presentation by antigen-presenting cells such as dendritic cells and B cells allows the activation of naive CD4+ T cells and cognate interactions between B cells and effector CD4+ T cells, respectively. B cells are unique among class II-restricted antigen-presenting cells in that they have a clonally restricted antigen-specific receptor, the B cell receptor (BCR), which allows the cell to recognize and respond to trace amounts of foreign antigen present in a sea of self-antigens. Moreover, engagement of peptide-class II complexes formed via BCR-mediated processing of cognate antigen has been shown to result in a unique pattern of B cell activation. Using a combined biochemical and imaging/FRET approach, we establish that internalized antigen-BCR complexes associate with intracellular class II molecules. We demonstrate that the M1-paired MHC class II conformer, shown previously to be critical for CD4 T cell activation, is incorporated selectively into these complexes and loaded selectively with peptide derived from BCR-internalized cognate antigen. These results demonstrate that, in B cells, internalized antigen-BCR complexes associate with intracellular MHC class II molecules, potentially defining a site of class II peptide acquisition, and reveal a selective role for the M1-paired class II conformer in the presentation of cognate antigen. These findings provide key insights into the molecular mechanisms used by B cells to control the source of peptides charged onto class II molecules, allowing the immune system to mount an antibody response focused on BCR-reactive cognate antigen.	[Barroso, Margarida] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Tucker, Heidi; Drake, Lisa; Nichol, Kathleen; Drake, James R.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA	Albany Medical College; Albany Medical College	Drake, JR (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, 47 New Scotland Ave,MC-151, Albany, NY 12208 USA.	drakej@mail.amc.edu	Regan, Clinton/E-6250-2012	Barroso, Margarida/0000-0002-0407-3181	National Institutes of Health [AI-097673, CA-161782]; NATIONAL CANCER INSTITUTE [R21CA161782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI097673] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI-097673 (to J. R. D.) and CA-161782 (to M. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Busman-Sahay K, 2011, J IMMUNOL, V186, P6710, DOI 10.4049/jimmunol.1100336; Cassard S, 1998, J IMMUNOL, V160, P1767; CHESNUT RW, 1986, ADV IMMUNOL, V39, P51; CHESNUT RW, 1985, CRC CR REV IMMUNOL, V5, P263; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; Dixon AM, 2014, J BIOL CHEM, V289, P11695, DOI 10.1074/jbc.M113.516997; Drake JR, 1997, J EXP MED, V186, P1299, DOI 10.1084/jem.186.8.1299; Eastman S, 1996, EUR J IMMUNOL, V26, P385, DOI 10.1002/eji.1830260218; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Hulpke S, 2013, TRENDS BIOCHEM SCI, V38, P412, DOI 10.1016/j.tibs.2013.06.003; Jin L, 2008, IMMUNOL LETT, V116, P184, DOI 10.1016/j.imlet.2007.11.023; Katkere B, 2012, J BIOL CHEM, V287, P16636, DOI 10.1074/jbc.M112.357640; Katkere B, 2010, J IMMUNOL, V185, P5032, DOI 10.4049/jimmunol.1001653; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; King G, 2010, MOL BIOSYST, V6, P1650, DOI 10.1039/c002241a; Lang P, 2001, SCIENCE, V291, P1537, DOI 10.1126/science.291.5508.1537; LANZAVECCHIA A, 1987, IMMUNOL REV, V99, P39, DOI 10.1111/j.1600-065X.1987.tb01171.x; Macmillan H, 2014, J IMMUNOL, V193, P2641, DOI 10.4049/jimmunol.1400075; Mellins ED, 2014, CURR OPIN IMMUNOL, V26, P115, DOI 10.1016/j.coi.2013.11.005; MITCHELL RN, 1995, J EXP MED, V181, P1705, DOI 10.1084/jem.181.5.1705; Nashar TO, 2006, J IMMUNOL, V176, P827, DOI 10.4049/jimmunol.176.2.827; Nashar TO, 2005, J IMMUNOL, V174, P1306, DOI 10.4049/jimmunol.174.3.1306; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; SADEGHNASSERI S, 1994, NATURE, V370, P647, DOI 10.1038/370647a0; Talati R, 2014, METHODS, V66, P139, DOI 10.1016/j.ymeth.2013.08.017; Vilen BJ, 1999, IMMUNITY, V10, P239, DOI 10.1016/S1074-7613(00)80024-2; Wallrabe H, 2007, MOL BIOL CELL, V18, P2226, DOI 10.1091/mbc.E06-08-0700; Wallrabe H, 2003, BIOPHYS J, V85, P559, DOI 10.1016/S0006-3495(03)74500-7; Zhang M, 2007, J IMMUNOL, V179, P4435, DOI 10.4049/jimmunol.179.7.4435	30	23	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27101	27112		10.1074/jbc.M115.649582	http://dx.doi.org/10.1074/jbc.M115.649582			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26400081	Green Published, hybrid			2022-12-28	WOS:000364794000020
J	Erikson, E; Wratil, PR; Frank, M; Ambiel, I; Pahnke, K; Pino, M; Azadi, P; Izquierdo-Useros, N; Martinez-Picado, J; Meier, C; Schnaar, RL; Crocker, PR; Reutter, W; Keppler, OT				Erikson, Elina; Wratil, Paul R.; Frank, Martin; Ambiel, Ina; Pahnke, Katharina; Pino, Maria; Azadi, Parastoo; Izquierdo-Useros, Nuria; Martinez-Picado, Javier; Meier, Chris; Schnaar, Ronald L.; Crocker, Paul R.; Reutter, Werner; Keppler, Oliver T.			Mouse Siglec-1 Mediates trans-Infection of Surface-bound Murine Leukemia Virus in a Sialic Acid N-Acyl Side Chain-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCAPSULAR SINUS MACROPHAGES; DC-SIGN; B-CELL; GLYCOLYLNEURAMINIC ACID; DENDRITIC CELLS; FORCE-FIELD; T-CELLS; SIALOADHESIN; BINDING; RECEPTOR	Background: Human Siglec-1 mediates HIV trans-infection by interaction with virion-associated sialylated gangliosides. Results: Here, Siglec-1 on mouse macrophages mediated trans-infection of surface-bound MLV. This could be inhibited by biosynthetic modification of sialic acids' N-acyl side chain in virus-producer cells. Conclusion: The N-acyl side chain is a critical determinant of Siglec-1-dependent MLV trans-infection. Significance: Glycoengineering allows manipulation of sialic acid-dependent virus/receptor interactions. Siglec-1 (sialoadhesin, CD169) is a surface receptor on human cells that mediates trans-enhancement of HIV-1 infection through recognition of sialic acid moieties in virus membrane gangliosides. Here, we demonstrate that mouse Siglec-1, expressed on the surface of primary macrophages in an interferon-alpha -responsive manner, captures murine leukemia virus (MLV) particles and mediates their transfer to proliferating lymphocytes. The MLV infection of primary B-cells was markedly more efficient than that of primary T-cells. The major structural protein of MLV particles, Gag, frequently co-localized with Siglec-1, and trans-infection, primarily of surface-bound MLV particles, efficiently occurred. To explore the role of sialic acid for MLV trans-infection at a submolecular level, we analyzed the potential of six sialic acid precursor analogs to modulate the sialylated ganglioside-dependent interaction of MLV particles with Siglec-1. Biosynthetically engineered sialic acids were detected in both the glycolipid and glycoprotein fractions of MLV producer cells. MLV released from cells carrying N-acyl-modified sialic acids displayed strikingly different capacities for Siglec-1-mediated capture and trans-infection; N-butanoyl, N-isobutanoyl, N-glycolyl, or N-pentanoyl side chain modifications resulted in up to 92 and 80% reduction of virus particle capture and trans-infection, respectively, whereas N-propanoyl or N-cyclopropylcarbamyl side chains had no effect. In agreement with these functional analyses, molecular modeling indicated reduced binding affinities for non-functional N-acyl modifications. Thus, Siglec-1 is a key receptor for macrophage/lymphocyte trans-infection of surface-bound virions, and the N-acyl side chain of sialic acid is a critical determinant for the Siglec-1/MLV interaction.	[Erikson, Elina; Ambiel, Ina; Keppler, Oliver T.] Goethe Univ Frankfurt, Inst Med Virol, Natl Reference Ctr Retroviruses, D-60596 Frankfurt, Germany; [Erikson, Elina; Keppler, Oliver T.] Heidelberg Univ, Dept Infect Dis, Virol, D-69120 Heidelberg, Germany; [Wratil, Paul R.; Reutter, Werner] Charite, Inst Lab Med, Klin Chem & Pathobiochem, D-12200 Berlin, Germany; [Frank, Martin] Biognos AB, S-40274 Gothenburg, Sweden; [Pahnke, Katharina; Meier, Chris] Univ Hamburg, Dept Chem, Fac Sci, Organ Chem, D-20146 Hamburg, Germany; [Pino, Maria; Izquierdo-Useros, Nuria; Martinez-Picado, Javier] Univ Autonoma Barcelona, AIDS Res Inst IrsiCaixa, Inst Invest Ciencies Salut Germans Trias & Pujol, Barcelona 08916, Spain; [Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Martinez-Picado, Javier] Inst Catalana Recerca & Estudis Avancats, Barcelona 08010, Spain; [Schnaar, Ronald L.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21218 USA; [Schnaar, Ronald L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21218 USA; [Crocker, Paul R.] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland	Goethe University Frankfurt; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Institut de Recerca de la Sida - IrsiCaixa; University System of Georgia; University of Georgia; ICREA; Johns Hopkins University; Johns Hopkins University; University of Dundee	Keppler, OT (corresponding author), Goethe Univ Frankfurt, Inst Med Virol, Natl Reference Ctr Retroviruses, Paul Ehrlich Str 40, D-60596 Frankfurt, Germany.	oliver.keppler@kgu.de	Schnaar, Ronald L/S-8967-2016; Meier, Chris/X-6105-2019; Izquierdo-Useros, Nuria/G-2534-2016; Regan, Clinton/E-6250-2012; Martinez-Picado, Javier/G-5507-2012	Schnaar, Ronald L/0000-0002-7701-5484; Izquierdo-Useros, Nuria/0000-0002-1039-1821; Martinez-Picado, Javier/0000-0002-4916-2129; Pino Claveria, Maria/0000-0003-4954-5215; Frank, Martin/0000-0002-1006-6746	National Institutes of Health [P41GM10349010, HL107151]; Robert Koch-Institute; Sonnenfeld-Stiftung Berlin; Spanish Secretariat for Research Grant [SAF2013-49042-R]; Goethe University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Koch-Institute; Sonnenfeld-Stiftung Berlin; Spanish Secretariat for Research Grant; Goethe University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	This work was supported, in whole or in part, by National Institutes of Health Grant P41GM10349010 (Research Resource for Biomedical Glycomics to Complex Carbohydrate Research Center, University of Georgia) to P. A. and HL107151 to R. L. S. This work was also supported by the Robert Koch-Institute to the National Reference Center for Retroviruses (to O. T. K.), the Sonnenfeld-Stiftung Berlin (to W. R.), Spanish Secretariat for Research Grant SAF2013-49042-R (to N. I. U. and J. M. P.), and Goethe University (to O. T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama H, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004751; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brinkman-Van der Linden ECM, 2000, J BIOL CHEM, V275, P8633, DOI 10.1074/jbc.275.12.8633; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0030004; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; COUTINHO A, 1973, NATURE-NEW BIOL, V245, P12, DOI 10.1038/newbio245012a0; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; CROCKER PR, 1990, BLOOD, V76, P1131; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; DWYER JM, 1981, CLIN EXP IMMUNOL, V46, P237; Gagiannis D, 2007, BBA-GEN SUBJECTS, V1770, P297, DOI 10.1016/j.bbagen.2006.09.023; Galuska SP, 2010, ANAL CHEM, V82, P4591, DOI 10.1021/ac100627e; Garcia E, 2005, TRAFFIC, V6, P488, DOI 10.1111/j.1600-0854.2005.00293.x; Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Goffinet C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-53; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Horstkorte R, 2004, FEBS LETT, V571, P99, DOI 10.1016/j.febslet.2004.06.067; Iannacone M, 2010, NATURE, V465, P1079, DOI 10.1038/nature09118; Inoue S, 2003, METHOD ENZYMOL, V362, P543; Izquierdo-Useros N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004146; Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001315; Izquierdo-Useros N, 2011, TRAFFIC, V12, P1702, DOI 10.1111/j.1600-0854.2011.01281.x; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jin J, 2011, J VIROL, V85, P7672, DOI 10.1128/JVI.00409-11; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; KAYSER H, 1992, J BIOL CHEM, V267, P16934; Kelm S, 1998, EUR J BIOCHEM, V255, P663, DOI 10.1046/j.1432-1327.1998.2550663.x; KELM S, 1994, GLYCOCONJUGATE J, V11, P576, DOI 10.1007/BF00731309; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; Keppler OT, 1998, BIOCHEM BIOPH RES CO, V253, P437, DOI 10.1006/bbrc.1998.9650; KEPPLER OT, 1995, J BIOL CHEM, V270, P1308, DOI 10.1074/jbc.270.3.1308; Klaas M, 2012, SEMIN IMMUNOPATHOL, V34, P353, DOI 10.1007/s00281-012-0310-3; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Kuka M, 2014, ANN NY ACAD SCI, V1319, P38, DOI 10.1111/nyas.12387; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Luchansky SJ, 2004, CHEMBIOCHEM, V5, P1706, DOI 10.1002/cbic.200400148; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; May AP, 1998, MOL CELL, V1, P719, DOI 10.1016/S1097-2765(00)80071-4; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Naito-Matsui Y, 2014, J BIOL CHEM, V289, P1564, DOI 10.1074/jbc.M113.523753; Oetke C, 2006, MOL CELL BIOL, V26, P1549, DOI 10.1128/MCB.26.4.1549-1557.2006; Oetke C, 2001, EUR J BIOCHEM, V268, P4553, DOI 10.1046/j.1432-1327.2001.02379.x; Pino M, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0160-x; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; Posch W, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005005; Prather RS, 2013, J VIROL, V87, P9538, DOI 10.1128/JVI.00177-13; Puryear WB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003291; Puryear WB, 2012, P NATL ACAD SCI USA, V109, P7475, DOI 10.1073/pnas.1201104109; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Rosenberg N., 1997, P475; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Schneider N, 2013, J COMPUT AID MOL DES, V27, P15, DOI 10.1007/s10822-012-9626-2; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Smith D. F., 2001, CURR PROTOC MOL BIOL; Sonnenburg JL, 2004, GLYCOBIOLOGY, V14, P339, DOI 10.1093/glycob/cwh039; Vinson M, 1996, J BIOL CHEM, V271, P9267, DOI 10.1074/jbc.271.16.9267; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wieser JR, 1996, FEBS LETT, V395, P170, DOI 10.1016/0014-5793(96)01029-0; Wratil PR, 2014, J BIOL CHEM, V289, P32056, DOI 10.1074/jbc.M114.608398; Yu HJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000134	67	28	28	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27345	27359		10.1074/jbc.M115.681338	http://dx.doi.org/10.1074/jbc.M115.681338			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26370074	Green Published, hybrid			2022-12-28	WOS:000364794000041
J	Kulikova, V; Shabalin, K; Nerinovski, K; Dolle, C; Niere, M; Yakimov, A; Redpath, P; Khodorkovskiy, M; Migaud, ME; Ziegler, M; Nikiforov, A				Kulikova, Veronika; Shabalin, Konstantin; Nerinovski, Kirill; Dolle, Christian; Niere, Marc; Yakimov, Alexander; Redpath, Philip; Khodorkovskiy, Mikhail; Migaud, Marie E.; Ziegler, Mathias; Nikiforov, Andrey			Generation, Release, and Uptake of the NAD Precursor Nicotinic Acid Riboside by Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLISM; DISEASE; 5'-NUCLEOTIDASE; BIOSYNTHESIS; PHOSPHORIBOSYLTRANSFERASE; ACTIVATION; PATHWAYS; PROTECTS; ENZYMES; HEALTH	NAD is essential for cellular metabolism and has a key role in various signaling pathways in human cells. To ensure proper control of vital reactions, NAD must be permanently resynthesized. Nicotinamide and nicotinic acid as well as nicotinamide riboside (NR) and nicotinic acid riboside (NAR) are the major precursors for NAD biosynthesis in humans. In this study, we explored whether the ribosides NR and NAR can be generated in human cells. We demonstrate that purified, recombinant human cytosolic 5'-nucleotidases (5-NTs) CN-II and CN-III, but not CN-IA, can dephosphorylate the mononucleotides nicotinamide mononucleotide and nicotinic acid mononucleotide (NAMN) and thus catalyze NR and NAR formation in vitro. Similar to their counterpart from yeast, Sdt1, the human 5-NTs require high (millimolar) concentrations of nicotinamide mononucleotide or NAMN for efficient catalysis. Overexpression of FLAG-tagged CN-II and CN-III in HEK293 and HepG2 cells resulted in the formation and release of NAR. However, NAR accumulation in the culture medium of these cells was only detectable under conditions that led to increased NAMN production from nicotinic acid. The amount of NAR released from cells engineered for increased NAMN production was sufficient to maintain viability of surrounding cells unable to use any other NAD precursor. Moreover, we found that untransfected HeLa cells produce and release sufficient amounts of NAR and NR under normal culture conditions. Collectively, our results indicate that cytosolic 5-NTs participate in the conversion of NAD precursors and establish NR and NAR as integral constituents of human NAD metabolism. In addition, they point to the possibility that different cell types might facilitate each other's NAD supply by providing alternative precursors.	[Kulikova, Veronika; Shabalin, Konstantin; Nerinovski, Kirill; Yakimov, Alexander; Khodorkovskiy, Mikhail; Nikiforov, Andrey] Peter Great St Petersburg Polytech Univ, St Petersburg 195251, Russia; [Shabalin, Konstantin; Yakimov, Alexander] Natl Res Ctr, Kurchatov Inst, Petersburg Nucl Phys Inst, Gatchina 188300, Russia; [Nerinovski, Kirill] St Petersburg State Univ, St Petersburg 199034, Russia; [Dolle, Christian; Niere, Marc; Ziegler, Mathias] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Redpath, Philip; Migaud, Marie E.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland; [Nikiforov, Andrey] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Peter the Great St. Petersburg Polytechnic University; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Saint Petersburg State University; University of Bergen; Queens University Belfast; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Ziegler, M (corresponding author), Univ Bergen, Dept Mol Biol, Thormohlensgate 55, N-5008 Bergen, Norway.	mathias.ziegler@mbi.uib.no; andrey.nikiforov@gmail.com	migaud, marie/C-9026-2015; Yakimov, Alexander/J-3336-2013; Yakimov, Alexander/I-4731-2019; Nikiforov, Andrey A/B-6643-2012; Nerinovski, Kirill/P-4607-2016; Kulikova, Veronika/AAE-9110-2021; Khodorkovskiy, Mikhail/G-2793-2011; Shabalin, Konstantin A/G-1821-2015	Yakimov, Alexander/0000-0003-0462-1157; Yakimov, Alexander/0000-0003-0462-1157; Nikiforov, Andrey A/0000-0002-5009-6130; Nerinovski, Kirill/0000-0002-7517-9784; Shabalin, Konstantin A/0000-0002-4590-2011; Khodorkovskii, Mikhail/0000-0003-0562-0156; Ziegler, Mathias/0000-0001-6961-2396	Russian Foundation for Basic Research [14-04-01765 a, 14-04-32117 mol_a]; Norwegian Research Council	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by Russian Foundation for Basic Research Grants 14-04-01765 a and 14-04-32117 mol_a and by the Norwegian Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Amici A, 2002, ARCH BIOCHEM BIOPHYS, V397, P184, DOI 10.1006/abbi.2001.2676; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019710; Bogan KL, 2009, J BIOL CHEM, V284, P34861, DOI 10.1074/jbc.M109.056689; Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Dolle C, 2013, CURR TOP MED CHEM, V13, P2907; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Gong B, 2013, NEUROBIOL AGING, V34, P1581, DOI 10.1016/j.neurobiolaging.2012.12.005; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hara N, 2007, J BIOL CHEM, V282, P24574, DOI 10.1074/jbc.M610357200; Hasmann M, 2003, CANCER RES, V63, P7436; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Hunsucker SA, 2005, PHARMACOL THERAPEUT, V107, P1, DOI 10.1016/j.pharmthera.2005.01.003; Hunsucker SA, 2001, J BIOL CHEM, V276, P10498, DOI 10.1074/jbc.M011218200; Ipata PL, 2013, CURR MED CHEM, V20, P4205; Ipata Piero Luigi, 2006, Purinergic Signal, V2, P669, DOI 10.1007/s11302-006-9009-z; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Koch-Nolte F, 2008, FRONT BIOSCI-LANDMRK, V13, P6716, DOI 10.2741/3184; Lu SP, 2011, J BIOL CHEM, V286, P14271, DOI 10.1074/jbc.M110.217885; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; Magni G, 2009, CURR MED CHEM, V16, P1372, DOI 10.2174/092986709787846505; Magni G, 2008, FRONT BIOSCI-LANDMRK, V13, P6135, DOI 10.2741/3143; Nikiforov A, 2015, CRIT REV BIOCHEM MOL, V50, P284, DOI 10.3109/10409238.2015.1028612; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; SPYCHALA J, 1988, J BIOL CHEM, V263, P18759; Trammell SAJ, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301012	30	53	60	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27124	27137		10.1074/jbc.M115.664458	http://dx.doi.org/10.1074/jbc.M115.664458			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26385918	hybrid, Green Published			2022-12-28	WOS:000364794000022
J	Boeszoermenyi, A; Nagy, HM; Arthanari, H; Pillip, CJ; Lindermuth, H; Luna, RE; Wagner, G; Zechner, R; Zangger, K; Oberer, M				Boeszoermenyi, Andras; Nagy, Harald Manuel; Arthanari, Haribabu; Pillip, Christoph Jens; Lindermuth, Hanna; Luna, Rafael Eulogio; Wagner, Gerhard; Zechner, Rudolf; Zangger, Klaus; Oberer, Monika			Structure of a CGI-58 Motif Provides the Molecular Basis of Lipid Droplet Anchoring	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; HORMONE-SENSITIVE LIPASE; COMPARATIVE GENE IDENTIFICATION-58; PROTEIN SECONDARY STRUCTURE; CHANARIN-DORFMAN-SYNDROME; CHEMICAL-SHIFT INDEX; CELLULAR FAT STORES; NMR-SPECTROSCOPY; MONOACYLGLYCEROL LIPASE; 3T3-L1 ADIPOCYTES	Triacylglycerols (TGs) stored in lipid droplets (LDs) are hydrolyzed in a highly regulated metabolic process called lipolysis to free fatty acids that serve as energy substrates for beta-oxidation, precursors for membrane lipids and signaling molecules. Comparative gene identification-58 (CGI-58) stimulates the enzymatic activity of adipose triglyceride lipase (ATGL), which catalyzes the hydrolysis of TGs to diacylglycerols and free fatty acids. In adipose tissue, protein-protein interactions between CGI-58 and the LD coating protein perilipin 1 restrain the ability of CGI-58 to activate ATGL under basal conditions. Phosphorylation of perilipin 1 disrupts these interactions and mobilizes CGI-58 for the activation of ATGL. We have previously demonstrated that the removal of a peptide at the N terminus (residues 10-31) of CGI-58 abrogates CGI-58 localization to LDs and CGI-58-mediated activation of ATGL. Here, we show that this tryptophan-rich N-terminal peptide serves as an independent LD anchor, with its three tryptophans serving as focal points of the left (harboring Trp(21) and Trp(25)) and right (harboring Trp(29)) anchor arms. The solution state NMR structure of a peptide comprising the LD anchor bound to dodecylphosphocholine micelles as LD mimic reveals that the left arm forms a concise hydrophobic core comprising tryptophans Trp(21) and Trp(25) and two adjacent leucines. Trp(29) serves as the core of a functionally independent anchor arm. Consequently, simultaneous tryptophan alanine permutations in both arms abolish localization and activity of CGI-58 as opposed to tryptophan substitutions that occur in only one arm.	[Boeszoermenyi, Andras; Nagy, Harald Manuel; Pillip, Christoph Jens; Lindermuth, Hanna; Zechner, Rudolf; Oberer, Monika] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Boeszoermenyi, Andras; Arthanari, Haribabu; Luna, Rafael Eulogio; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zangger, Klaus] Graz Univ, Inst Chem, A-8010 Graz, Austria; [Lindermuth, Hanna] Med Univ Graz, Inst Biophys, A-8010 Graz, Austria	University of Graz; Harvard University; Harvard Medical School; University of Graz; Medical University of Graz	Oberer, M (corresponding author), Graz Univ, Inst Mol Biosci, Humboldtstr 50-3, A-8010 Graz, Austria.	m.oberer@uni-graz.at	Regan, Clinton/E-6250-2012; Boeszoermenyi, Andras/AAD-9808-2020	Boeszoermenyi, Andras/0000-0001-9810-7241; Zechner, Rudolf/0000-0001-5483-1182; Zangger, Klaus/0000-0003-1682-1594; Arthanari, Haribabu/0000-0002-7281-1289; Oberer, Monika/0000-0003-2525-9513	National Institutes of Health [P41 EB002026]; NAWI Graz; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [F 3002, W 901] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NAWI Graz; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We acknowledge the assistance of Astrid Gruber, Petra Ebner, and Pia Gruber at early stages of the project and we are grateful to Jim Zhen-Yu Sun and Barbara Ogorek for helpful discussions. Also, we thank Luna Scientific Storytelling, LLC for invaluable input and advice during the preparation of this manuscript. The IMB-Graz Microscopy and Imaging Resource, BioTechMed, NAWI Graz is gratefully acknowledged for access to their facilities. Maintenance and operation of NMR instruments was supported in part by the National Institutes of Health Grant P41 EB002026. The authors gratefully acknowledge support from NAWI Graz.	Bertrand T, 2010, J MOL BIOL, V396, P663, DOI 10.1016/j.jmb.2009.11.060; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cerk IK, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.602599; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cornaciu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026349; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7; Dunne SJ, 1996, BIOCHEMISTRY-US, V35, P11975, DOI 10.1021/bi960821+; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Eichmann TO, 2012, J BIOL CHEM, V287, P41446, DOI 10.1074/jbc.M112.400416; Ellong EN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021889; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Franzmann M, 2009, CHEMBIOCHEM, V10, P2339, DOI 10.1002/cbic.200900347; Friedman EJ, 2011, J BIOL CHEM, V286, P30107, DOI 10.1074/jbc.M111.227256; Gandotra S, 2011, J BIOL CHEM, V286, P34998, DOI 10.1074/jbc.M111.278853; Gobl C, 2010, J PHYS CHEM B, V114, P4717, DOI 10.1021/jp9114089; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hartono YD, 2013, PROTEINS, V81, P933, DOI 10.1002/prot.24256; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Hofer P, 2015, J BIOL CHEM, V290, P18438, DOI 10.1074/jbc.M114.628958; Hyberts SG, 2013, J BIOMOL NMR, V55, P167, DOI 10.1007/s10858-012-9698-2; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Kwak BY, 2002, J BIOL CHEM, V277, P4343, DOI 10.1074/jbc.M109163200; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lee HC, 2015, BIOCHEMISTRY-US, V54, P2539, DOI 10.1021/acs.biochem.5b00207; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Mouchlis VD, 2015, P NATL ACAD SCI USA, V112, pE516, DOI 10.1073/pnas.1424651112; Nagy HM, 2014, BBA-MOL CELL BIOL L, V1841, P588, DOI 10.1016/j.bbalip.2014.01.005; Nasr ML, 2013, PROTEIN SCI, V22, P774, DOI 10.1002/pro.2257; Oberer M, 2011, CURR OPIN LIPIDOL, V22, P149, DOI 10.1097/MOL.0b013e328346230e; Patel S, 2014, P NATL ACAD SCI USA, V111, P9163, DOI 10.1073/pnas.1318791111; Radner FPW, 2014, BBA-MOL CELL BIOL L, V1841, P409, DOI 10.1016/j.bbalip.2013.07.013; Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f; Sahu-Osen A, 2015, J LIPID RES, V56, P109, DOI 10.1194/jlr.M055004; Schalk-Hihi C, 2011, PROTEIN SCI, V20, P670, DOI 10.1002/pro.596; Schrodinger LCC, 2022, PYMOL MOL GRAPHICS S; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Squizzato S, 2015, NUCLEIC ACIDS RES, V43, pW585, DOI 10.1093/nar/gkv316; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; SWINDELLS MB, 1995, NAT STRUCT BIOL, V2, P596, DOI 10.1038/nsb0795-596; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112; Zierler KA, 2014, CURR OPIN LIPIDOL, V25, P102, DOI 10.1097/MOL.0000000000000058; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	75	35	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26361	26372		10.1074/jbc.M115.682203	http://dx.doi.org/10.1074/jbc.M115.682203			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26350461	Green Published, hybrid			2022-12-28	WOS:000364793600002
J	Tang, CX; Ji, XY; Wu, L; Xiong, Y				Tang, Chenxiang; Ji, Xiaoyun; Wu, Li; Xiong, Yong			Impaired dNTPase Activity of SAMHD1 by Phosphomimetic Mutation of Thr-592	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES SYNDROME; RESTRICTION FACTOR SAMHD1; HIV-1 REVERSE TRANSCRIPTION; ACID BINDING-PROTEIN; INFECTION; PHOSPHORYLATION; REPLICATION; CELL; MACROPHAGES; INHIBITION	SAMHD1 is a cellular protein that plays key roles in HIV-1 restriction and regulation of cellular dNTP levels. Mutations in SAMHD1 are also implicated in the pathogenesis of chronic lymphocytic leukemia and Aicardi-Goutieres syndrome. The anti-HIV-1 activity of SAMHD1 is negatively modulated by phosphorylation at residue Thr-592. The mechanism underlying the effect of phosphorylation on anti-HIV-1 activity remains unclear. SAMHD1 forms tetramers that possess deoxyribonucleotide triphosphate triphosphohydrolase (dNTPase) activity, which is allosterically controlled by the combined action of GTP and all four dNTPs. Here we demonstrate that the phosphomimetic mutation T592E reduces the stability of the SAMHD1 tetramer and the dNTPase activity of the enzyme. To better understand the underlying mechanisms, we determined the crystal structures of SAMHD1 variants T592E and T592V. Although the neutral substitution T592V does not perturb the structure, the charged T592E induces large conformational changes, likely triggered by electrostatic repulsion from a distinct negatively charged environment surrounding Thr-592. The phosphomimetic mutation results in a significant decrease in the population of active SAMHD1 tetramers, and hence the dNTPase activity is substantially decreased. These results provide a mechanistic understanding of how SAMHD1 phosphorylation at residue Thr-592 may modulate its cellular and antiviral functions.	[Tang, Chenxiang; Ji, Xiaoyun; Xiong, Yong] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Wu, Li] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, Columbus, OH 43210 USA; [Wu, Li] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	Yale University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Xiong, Y (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	yong.xiong@yale.edu	Regan, Clinton/E-6250-2012; Wu, Li/ABB-2813-2020; Wu, Li/E-4330-2011	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; Ji, Xiaoyun/0000-0002-0801-8825	National Institutes of Health [AI102778, AI120845, AI104483]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104483, K99AI120845, R01AI102778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants AI102778 (to Y. X.), AI120845 (to X. J.), and AI104483 (to L. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Amie SM, 2013, J BIOL CHEM, V288, P25001, DOI 10.1074/jbc.C113.493619; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Clifford R, 2014, BLOOD, V123, P1021, DOI 10.1182/blood-2013-04-490847; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Davidson MB, 2012, EMBO J, V31, P895, DOI 10.1038/emboj.2011.485; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goncalves A, 2012, HUM MUTAT, V33, P1116, DOI 10.1002/humu.22087; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Hansen EC, 2014, P NATL ACAD SCI USA, V111, pE1843, DOI 10.1073/pnas.1401706111; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ji XY, 2014, P NATL ACAD SCI USA, V111, pE4305, DOI 10.1073/pnas.1412289111; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kim ET, 2013, J VIROL, V87, P12949, DOI 10.1128/JVI.02291-13; Kretschmer S, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204845; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Pauls E, 2014, AIDS, V28, P2213, DOI 10.1097/QAD.0000000000000399; Pauls E, 2014, J IMMUNOL, V193, P1988, DOI 10.4049/jimmunol.1400873; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Seamon KJ, 2015, NUCLEIC ACIDS RES, V43, P6486, DOI 10.1093/nar/gkv633; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Stillman B, 2013, P NATL ACAD SCI USA, V110, P14120, DOI 10.1073/pnas.1312901110; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Sze A, 2013, J MOL BIOL, V425, P4981, DOI 10.1016/j.jmb.2013.10.022; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029; Yan JP, 2015, J BIOL CHEM, V290, P13279, DOI 10.1074/jbc.M115.646588; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	44	61	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26352	26359		10.1074/jbc.M115.677435	http://dx.doi.org/10.1074/jbc.M115.677435			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26294762	Green Published, hybrid			2022-12-28	WOS:000364793600001
J	Kabeche, R; Madrid, M; Cansado, J; Moseley, JB				Kabeche, Ruth; Madrid, Marisa; Cansado, Jose; Moseley, James B.			Eisosomes Regulate Phosphatidylinositol 4,5-Bisphosphate (PI(4,5)P-2) Cortical Clusters and Mitogen-activated Protein (MAP) Kinase Signaling upon Osmotic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL INTEGRITY PATHWAY; PLECKSTRIN HOMOLOGY DOMAINS; EXCHANGE FACTOR ROM2; PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; BUDDING YEAST; ACTIN CYTOSKELETON; RHO1	Eisosomes are multiprotein structures that generate linear invaginations at the plasma membrane of yeast cells. The core component of eisosomes, the BAR domain protein Pil1, generates these invaginations through direct binding to lipids including phosphoinositides. Eisosomes promote hydrolysis of phosphatidylinositol 4,5 bisphosphate (PI(4,5)P-2) by functioning with synaptojanin, but the cellular processes regulated by this pathway have been unknown. Here, we found that PI(4,5)P-2 regulation by eisosomes inhibits the cell integrity pathway, a conserved MAPK signal transduction cascade. This pathway is activated by multiple environmental conditions including osmotic stress in the fission yeast Schizosaccharomyces pombe. Activation of theMAPKPmk1 was impaired by mutations in the phosphatidylinositol (PI) 5-kinase Its3, but this defect was suppressed by removal of eisosomes. Using fluorescent biosensors, we found that osmotic stress induced the formation of PI(4,5)P-2 clusters that were spatially organized by eisosomes in both fission yeast and budding yeast cells. These cortical clusters contained the PI 5-kinase Its3 and did not assemble in the its3-1 mutant. The GTPase Rho2, an upstream activator of Pmk1, also co-localized with PI(4,5)P-2 clusters under osmotic stress, providing a molecular link between these novel clusters and MAPK activation. Our findings have revealed that eisosomes regulate activation of MAPK signal transduction through the organization of cortical lipid-based microdomains.	[Kabeche, Ruth; Moseley, James B.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Madrid, Marisa; Cansado, Jose] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Yeast Physiol Grp, E-30071 Murcia, Spain	Dartmouth College; University of Murcia	Moseley, JB (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, 412 Remsen Bldg, Hanover, NH 03755 USA.	james.b.moseley@dartmouth.edu	Madrid, Marisa/AAV-2154-2020; Madrid, Marisa/K-7755-2014; Cansado, Jose/ABC-6872-2020; Cansado, Jose/K-5212-2014; Regan, Clinton/E-6250-2012	Madrid, Marisa/0000-0002-7970-2587; Madrid, Marisa/0000-0002-7970-2587; Cansado, Jose/0000-0002-2342-8152; 	National Institutes of Health [GM099774]; Norris Cotton Cancer Center; Pew Scholars Program in the Biomedical Sciences; Robert D. Watkins Fellowship from the American Society for Microbiology; Ministerio de Economia y Competitividad (Spain) [BFU2014-52828-P]; European Regional Development Fund (ERDF); European Union; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norris Cotton Cancer Center; Pew Scholars Program in the Biomedical Sciences; Robert D. Watkins Fellowship from the American Society for Microbiology; Ministerio de Economia y Competitividad (Spain); European Regional Development Fund (ERDF)(European Commission); European Union(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM099774 (to J. B. M.). This work was also supported by The Norris Cotton Cancer Center, The Pew Scholars Program in the Biomedical Sciences, a Robert D. Watkins Fellowship from the American Society for Microbiology (to R. K.), Ministerio de Economia y Competitividad (Spain) Grant BFU2014-52828-P (to J. C.), and European Regional Development Fund (ERDF) co-funding from the European Union. The authors declare that they have no conflicts of interest with the contents of this article.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barba G, 2008, CELL SIGNAL, V20, P748, DOI 10.1016/j.cellsig.2007.12.017; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Deng L, 2005, J BIOL CHEM, V280, P27561, DOI 10.1074/jbc.M502660200; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; Douglas LM, 2014, ANNU REV MICROBIOL, V68, P377, DOI 10.1146/annurev-micro-091313-103507; Frohlich F, 2014, MOL BIOL CELL, V25, P2797, DOI 10.1091/mbc.E13-11-0639; Garcia P, 2009, MOL BIOL CELL, V20, P721, DOI 10.1091/mbc.E08-07-0673; Goode BL, 2015, GENETICS, V199, P315, DOI 10.1534/genetics.112.145540; Green RA, 2011, CELL, V145, P470, DOI 10.1016/j.cell.2011.03.037; Guiney EL, 2015, MOL BIOL CELL, V26, P769, DOI 10.1091/mbc.E14-05-1019; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Helliwell SB, 1998, GENETICS, V148, P99; Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8; Homma K, 1998, J BIOL CHEM, V273, P15779, DOI 10.1074/jbc.273.25.15779; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Ikeda K, 2008, CELL CYCLE, V7, P358, DOI 10.4161/cc.7.3.5245; Kabeche R, 2014, J CELL SCI, V127, P1318, DOI 10.1242/jcs.143545; Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005; Karotki L, 2011, J CELL BIOL, V195, P889, DOI 10.1083/jcb.201104040; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kwiatkowska K, 2010, CELL MOL LIFE SCI, V67, P3927, DOI 10.1007/s00018-010-0432-5; Lee J. H., 2015, EUKARYOT CELL; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Ma Y, 2006, MOL BIOL CELL, V17, P5028, DOI 10.1091/mbc.E06-08-0688; Madrid M, 2006, J BIOL CHEM, V281, P2033, DOI 10.1074/jbc.M506467200; Madrid M, 2007, MOL BIOL CELL, V18, P4405, DOI 10.1091/mbc.E07-05-0484; Madrid M, 2015, J CELL SCI, V128, P266, DOI 10.1242/jcs.158295; Mascaraque V, 2013, MOL CELL PROTEOMICS, V12, P557, DOI 10.1074/mcp.M112.020438; Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298; Morales-Johansson H, 2004, J BIOL CHEM, V279, P39604, DOI 10.1074/jbc.M405589200; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Olivera-Couto A, 2012, MOL GENET GENOMICS, V287, P607, DOI 10.1007/s00438-012-0706-8; Olivera-Couto A, 2011, MOL BIOL CELL, V22, P2360, DOI 10.1091/mbc.E10-12-1021; Posor Y, 2015, BBA-MOL CELL BIOL L, V1851, P794, DOI 10.1016/j.bbalip.2014.09.014; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002; Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0; Spitzer NC, 2004, P NATL ACAD SCI USA, V101, P5311, DOI 10.1073/pnas.0401270101; Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Weinberg J, 2012, TRENDS CELL BIOL, V22, P1, DOI 10.1016/j.tcb.2011.09.001; Yan Y, 2011, DEVELOPMENT, V138, P1697, DOI 10.1242/dev.059279; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zhang D, 2012, CURR BIOL, V22, P2048, DOI 10.1016/j.cub.2012.08.047; Zhang YJ, 2000, J BIOL CHEM, V275, P35600, DOI 10.1074/jbc.M005575200; Ziolkowska NE, 2012, TRENDS CELL BIOL, V22, P151, DOI 10.1016/j.tcb.2011.12.002; Ziolkowska NE, 2011, NAT STRUCT MOL BIOL, V18, P854, DOI 10.1038/nsmb.2080	52	21	21	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25960	+		10.1074/jbc.M115.674192	http://dx.doi.org/10.1074/jbc.M115.674192			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26359496	Green Published, hybrid			2022-12-28	WOS:000363527300018
J	Chatterjee, A; Caballero-Franco, C; Bakker, D; Totten, S; Jardim, A				Chatterjee, Abhishek; Caballero-Franco, Celia; Bakker, Dannika; Totten, Stephanie; Jardim, Armando			Pore-forming Activity of the Escherichia coli Type III Secretion System Protein EspD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-INSERTION; INTIMATE ATTACHMENT; PEDESTAL FORMATION; EPITHELIAL-CELLS; TRANSLOCATION; CHOLESTEROL; EFFECTOR; TIR; DOMAIN; ROLES	Enterohemorrhagic Escherichia coli is a causative agent of gastrointestinal and diarrheal diseases. Pathogenesis associated with enterohemorrhagic E. coli involves direct delivery of virulence factors from the bacteria into epithelial cell cytosol via a syringe-like organelle known as the type III secretion system. The type III secretion system protein EspD is a critical factor required for formation of a translocation pore on the host cell membrane. Here, we show that recombinant EspD spontaneously integrates into large unilamellar vesicle (LUV) lipid bilayers; however, pore formation required incorporation of anionic phospholipids such as phosphatidylserine and an acidic pH. Leakage assays performed with fluorescent dextrans confirmed that EspD formed a structure with an inner diameter of similar to 2.5 nm. Protease mapping indicated that the two transmembrane helical hairpin of EspD penetrated the lipid layer positioning the N- and C-terminal domains on the extralumenal surface of LUVs. Finally, a combination of glutaraldehyde cross-linking and rate zonal centrifugation suggested that EspD in LUV membranes forms an similar to 280-320-kDa oligomeric structure consisting of similar to 6-7 subunits.	[Jardim, Armando] McGill Univ, Inst Parasitol, Quebec City, PQ H9X 3V9, Canada; McGill Univ, Ctr Host Parasite Interact, Quebec City, PQ H9X 3V9, Canada	McGill University; McGill University	Jardim, A (corresponding author), McGill Univ, Inst Parasitol, Macdonald Campus 21,111 Lakeshore Rd, Quebec City, PQ H9X 3V9, Canada.	armando.jardim@mcgill.ca			Natural Science and Engineering Research Council of Canada [RGPIN 238294-11]; Canada Foundation for Innovation New Opportunities Program; Regroupements Strategiques from the Fonds de Recherche sur Nature et les Technologies Quebec (FQRNT)	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation New Opportunities Program; Regroupements Strategiques from the Fonds de Recherche sur Nature et les Technologies Quebec (FQRNT)	This work was supported by Natural Science and Engineering Research Council of Canada Grant RGPIN 238294-11, Canada Foundation for Innovation New Opportunities Program, and a Regroupements Strategiques from the Fonds de Recherche sur Nature et les Technologies Quebec (FQRNT). The authors declare that they have no conflicts of interest with the contents of this article.	Abul-Milh M, 2001, INFECT IMMUN, V69, P7356, DOI 10.1128/IAI.69.12.7356-7364.2001; Allen-Vercoe E, 2006, CELL MICROBIOL, V8, P613, DOI 10.1111/j.1462-5822.2005.00654.x; Barrera FN, 2011, J MOL BIOL, V413, P359, DOI 10.1016/j.jmb.2011.08.010; Barta ML, 2012, J MOL BIOL, V417, P395, DOI 10.1016/j.jmb.2012.01.026; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Borthakur A, 2006, AM J PHYSIOL-GASTR L, V290, pG30, DOI 10.1152/ajpgi.00302.2005; Campellone KG, 2007, MOL MICROBIOL, V63, P1468, DOI 10.1111/j.1365-2958.2007.05602.x; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3265, DOI 10.1021/bi026696l; Chattopadhyay A, 2008, BIOPHYS J, V95, P166, DOI 10.1529/biophysj.107.124206; Crane JK, 2005, CELL DEATH DIFFER, V12, P115, DOI 10.1038/sj.cdd.4401531; Daniell SJ, 2003, MOL MICROBIOL, V49, P301, DOI 10.1046/j.1365-2958.2003.03555.x; Daniell SJ, 2001, INFECT IMMUN, V69, P4055, DOI 10.1128/IAI.69.6.4055-4064.2001; Dasanayake D, 2011, MOL MICROBIOL, V81, P734, DOI 10.1111/j.1365-2958.2011.07727.x; Dawson JP, 2002, J MOL BIOL, V316, P799, DOI 10.1006/jmbi.2001.5353; DeVinney R, 1999, CURR OPIN MICROBIOL, V2, P83, DOI 10.1016/S1369-5274(99)80014-9; Dohlich K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003881; DONNENBERG MS, 1993, J BACTERIOL, V175, P4670, DOI 10.1128/JB.175.15.4670-4680.1993; Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+; Foster DB, 2000, INFECT IMMUN, V68, P3108, DOI 10.1128/IAI.68.6.3108-3115.2000; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Geisse NA, 2004, BIOCHEM J, V381, P911, DOI 10.1042/BJ20031719; Gilbert RJC, 2014, TRENDS BIOCHEM SCI, V39, P510, DOI 10.1016/j.tibs.2014.09.002; Goosney DL, 2000, CURR BIOL, V10, P735, DOI 10.1016/S0960-9822(00)00543-1; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hartland EL, 2000, MOL MICROBIOL, V35, P1483, DOI 10.1046/j.1365-2958.2000.01814.x; Hayward RD, 2005, MOL MICROBIOL, V56, P590, DOI 10.1111/j.1365-2958.2005.04568.x; He X, 2013, SCI REP-UK, V3, DOI 10.1038/srep03416; Hodges K, 2006, AM J PHYSIOL-GASTR L, V291, pG959, DOI 10.1152/ajpgi.00274.2005; Hume PJ, 2003, MOL MICROBIOL, V49, P425, DOI 10.1046/j.1365-2958.2003.03559.x; Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; Jepson MA, 2003, CELL MICROBIOL, V5, P773, DOI 10.1046/j.1462-5822.2003.00315.x; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kaul P, 1996, PROTEIN SCI, V5, P687; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; Kresse AU, 1999, INFECT IMMUN, V67, P4834, DOI 10.1128/IAI.67.9.4834-4842.1999; Lafont F, 2002, EMBO J, V21, P4449, DOI 10.1093/emboj/cdf457; Lai LC, 1997, INFECT IMMUN, V65, P2211, DOI 10.1128/IAI.65.6.2211-2217.1997; LEENHOUTS JM, 1995, FEBS LETT, V370, P189, DOI 10.1016/0014-5793(95)00823-R; Luo WS, 2011, J BACTERIOL, V193, P2972, DOI 10.1128/JB.00153-11; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marteau P, 2001, APPL ENVIRON MICROB, V67, P4939, DOI 10.1128/AEM.67.10.4939-4942.2001; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; McGhie EJ, 2002, MOL MICROBIOL, V44, P1309, DOI 10.1046/j.1365-2958.2002.02958.x; MEL SF, 1993, BIOCHEMISTRY-US, V32, P2082, DOI 10.1021/bi00059a028; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329; Musse AA, 2006, J BIOL CHEM, V281, P885, DOI 10.1074/jbc.M511140200; Neves BC, 2003, INFECT IMMUN, V71, P2130, DOI 10.1128/IAI.71.4.2130-2141.2003; Nougayrede JP, 2003, CELL MICROBIOL, V5, P359, DOI 10.1046/j.1462-5822.2003.00281.x; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pallen MJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-9; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; Riff JD, 2005, INFECT IMMUN, V73, P7113, DOI 10.1128/IAI.73.11.7113-7125.2005; Romano FB, 2011, BIOCHEMISTRY-US, V50, P7117, DOI 10.1021/bi200905x; Rosenberger CM, 2000, CURR BIOL, V10, pR823, DOI 10.1016/S0960-9822(00)00788-0; ROSENSHINE I, 1992, EMBO J, V11, P3551, DOI 10.1002/j.1460-2075.1992.tb05438.x; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2; Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; Shaw RK, 2005, INFECT IMMUN, V73, P1243, DOI 10.1128/IAI.73.2.1243-1251.2005; Shaw RK, 2002, MICROBIOL-SGM, V148, P1355, DOI 10.1099/00221287-148-5-1355; Thomson AR, 2014, SCIENCE, V346, P485, DOI 10.1126/science.1257452; Tu XL, 2003, MOL MICROBIOL, V47, P595, DOI 10.1046/j.1365-2958.2003.03329.x; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Wachter C, 1999, MOL MICROBIOL, V31, P1695, DOI 10.1046/j.1365-2958.1999.01303.x; Wager B, 2013, BIOPHYS J, V104, P1445, DOI 10.1016/j.bpj.2013.02.018; Wainwright LA, 1998, MOL MICROBIOL, V27, P1247, DOI 10.1046/j.1365-2958.1998.00771.x; Wolff C, 1998, MOL MICROBIOL, V28, P143, DOI 10.1046/j.1365-2958.1998.00782.x; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1	72	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25579	25594		10.1074/jbc.M115.648204	http://dx.doi.org/10.1074/jbc.M115.648204			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26324713	Green Published, hybrid			2022-12-28	WOS:000362962800032
J	Wu, SY; Rothery, RA; Weiner, JH				Wu, Sheng-Yi; Rothery, Richard A.; Weiner, Joel H.			Pyranopterin Coordination Controls Molybdenum Electrochemistry in Escherichia coli Nitrate Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; MOLYBDOPTERIN GUANINE DINUCLEOTIDE; DIMETHYL-SULFOXIDE REDUCTASE; IRON-SULFUR CENTERS; DIMETHYLSULFOXIDE REDUCTASE; FORMATE DEHYDROGENASES; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; COFACTOR; ENZYMES	We test the hypothesis that pyranopterin (PPT) coordination plays a critical role in defining molybdenum active site redox chemistry and reactivity in the mononuclear molybdoenzymes. The molybdenum atom of Escherichia coli nitrate reductase A (NarGHI) is coordinated by two PPT-dithiolene chelates that are defined as proximal and distal based on their proximity to a [4Fe-4S] cluster known as FS0. We examined variants of two sets of residues involved in PPT coordination: (I) those interacting directly or indirectly with the pyran oxygen of the bicyclic distal PPT (NarG-Ser(719), NarG-His(1163), and NarG-His(1184)); and (ii) those involved in bridging the two PPTs and stabilizing the oxidation state of the proximal PPT (NarG-His(1092) and NarGHis(1098)). A S719A variant has essentially no effect on the overall Mo(VI/IV) reduction potential, whereas the H1163A and H1184A variants elicit large effects (Delta E-m values of -88 and -36 mV, respectively). Ala variants of His(1092) and His(1098) also elicit large Delta E-m values of -143 and -101 mV, respectively. An Arg variant of His(1092) elicits a small Delta E-m of +18 mV on the Mo(VI/IV) reduction potential. There is a linear correlation between the molybdenum E-m value and both enzyme activity and the ability to support anaerobic respiratory growth on nitrate. These data support a non-innocent role for the PPT moieties in controlling active site metal redox chemistry and catalysis.	[Wu, Sheng-Yi; Rothery, Richard A.; Weiner, Joel H.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Weiner, JH (corresponding author), Univ Alberta, Membrane Prot Dis Res Grp, Dept Biochem, 474 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	joel.weiner@UAlberta.ca		Rothery, Richard/0000-0003-3265-1783; Wu, Sheng-Yi/0000-0003-2336-0183	Canadian Institutes of Health Research [MOP15292]; Canada Foundation for Innovation; Alberta Heritage Foundation for Medical Research; Natural Science and Engineering Research Council-Collaborative Research and Training Experience Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Natural Science and Engineering Research Council-Collaborative Research and Training Experience Program	This work was supported by Canadian Institutes of Health Research Grant MOP15292, the Canada Foundation for Innovation, the Alberta Heritage Foundation for Medical Research, and the Natural Science and Engineering Research Council-Collaborative Research and Training Experience Program. The authors declare that they have no conflicts of interest with the contents of this article.	Basu P, 2011, COORDIN CHEM REV, V255, P1016, DOI 10.1016/j.ccr.2011.02.010; Baymann F, 2003, PHILOS T ROY SOC B, V358, P267, DOI 10.1098/rstb.2002.1184; Bertero MG, 2005, J BIOL CHEM, V280, P14836, DOI 10.1074/jbc.M410457200; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; CAMMACK R, 1990, BIOCHEMISTRY-US, V29, P8410, DOI 10.1021/bi00488a030; Cerqueira NMFSA, 2009, J COMPUT CHEM, V30, P2466, DOI 10.1002/jcc.21280; Chan CS, 2006, BIOCHEM BIOPH RES CO, V343, P244, DOI 10.1016/j.bbrc.2006.02.133; Coelho C, 2011, J MOL BIOL, V408, P932, DOI 10.1016/j.jmb.2011.03.016; Dietrich LEP, 2006, CURR BIOL, V16, pR395, DOI 10.1016/j.cub.2006.05.017; Elliott SJ, 2004, BIOCHEMISTRY-US, V43, P799, DOI 10.1021/bi035869j; Feng CJ, 2007, BBA-PROTEINS PROTEOM, V1774, P527, DOI 10.1016/j.bbapap.2007.03.006; Frangioni B, 2004, J AM CHEM SOC, V126, P1328, DOI 10.1021/ja0384072; GEORGE GN, 1989, BIOCHEM J, V259, P693, DOI 10.1042/bj2590693; GEORGE GN, 1985, BIOCHEM J, V227, P925, DOI 10.1042/bj2270925; Gonzalez PJ, 2013, COORDIN CHEM REV, V257, P315, DOI 10.1016/j.ccr.2012.05.020; Greatbanks SP, 1997, J CHEM SOC PERK T 2, P1529, DOI 10.1039/a700330g; Grimaldi S, 2013, BBA-BIOENERGETICS, V1827, P1048, DOI 10.1016/j.bbabio.2013.01.011; GUIGLIARELLI B, 1992, EUR J BIOCHEM, V207, P61, DOI 10.1111/j.1432-1033.1992.tb17020.x; Guigliarelli B, 1996, BIOCHEMISTRY-US, V35, P4828, DOI 10.1021/bi952459p; Hastings SF, 1998, EUR J BIOCHEM, V255, P317, DOI 10.1046/j.1432-1327.1998.2550317.x; Heffron K, 2001, BIOCHEMISTRY-US, V40, P3117, DOI 10.1021/bi002452u; Helton ME, 2001, J AM CHEM SOC, V123, P10389, DOI 10.1021/ja0100470; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; Jacques JGJ, 2014, BBA-BIOENERGETICS, V1837, P277, DOI 10.1016/j.bbabio.2013.10.013; JOHNSON JL, 1991, J BIOL CHEM, V266, P12140; JOHNSON JL, 1982, P NATL ACAD SCI-BIOL, V79, P6856, DOI 10.1073/pnas.79.22.6856; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Jormakka M, 2004, STRUCTURE, V12, P95, DOI 10.1016/j.str.2003.11.020; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; Kloer DP, 2006, STRUCTURE, V14, P1377, DOI 10.1016/j.str.2006.07.001; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanciano P, 2007, J BIOL CHEM, V282, P17468, DOI 10.1074/jbc.M700994200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magalon A, 2011, COORDIN CHEM REV, V255, P1159, DOI 10.1016/j.ccr.2010.12.031; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Matz KG, 2011, INORG CHEM, V50, P9804, DOI 10.1021/ic200783a; Matz KG, 2010, J AM CHEM SOC, V132, P7830, DOI 10.1021/ja100220x; MORPETH FF, 1985, BIOCHEMISTRY-US, V24, P40, DOI 10.1021/bi00322a007; Moura JJG, 2004, J BIOL INORG CHEM, V9, P791, DOI 10.1007/s00775-004-0573-9; Mtei RP, 2011, EUR J INORG CHEM, P5467, DOI 10.1002/ejic.201101084; Mtei RP, 2011, J AM CHEM SOC, V133, P9762, DOI 10.1021/ja109178q; OHNISHI T, 1981, J BIOL CHEM, V256, P5577; PASCAL MC, 1982, MOL GEN GENET, V188, P103, DOI 10.1007/BF00333001; Pushie MJ, 2011, COORDIN CHEM REV, V255, P1055, DOI 10.1016/j.ccr.2011.01.056; Rebelo JM, 2001, J BIOL INORG CHEM, V6, P791, DOI 10.1007/s007750100255; ROTHERY RA, 1995, J BACTERIOL, V177, P2057, DOI 10.1128/jb.177.8.2057-2063.1995; ROTHERY RA, 1991, BIOCHEMISTRY-US, V30, P8296, DOI 10.1021/bi00098a003; Rothery RA, 1999, J BIOL CHEM, V274, P13002, DOI 10.1074/jbc.274.19.13002; Rothery RA, 1998, J BIOL CHEM, V273, P7462, DOI 10.1074/jbc.273.13.7462; Rothery RA, 2004, BIOCHEMISTRY-US, V43, P5324, DOI 10.1021/bi049938l; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Rothery RA, 2015, J BIOL INORG CHEM, V20, P349, DOI 10.1007/s00775-014-1194-6; Rothery RA, 2012, P NATL ACAD SCI USA, V109, P14773, DOI 10.1073/pnas.1200671109; Rothery RA, 2010, J BIOL CHEM, V285, P8801, DOI 10.1074/jbc.M109.066027; Sambrook J., 2001, MOL CLONING LAB MANU; Schoepp-Cothenet B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00263; Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0; VINCENT SP, 1979, BIOCHEM J, V177, P757, DOI 10.1042/bj1770757; VINCENT SP, 1978, BIOCHEM J, V171, P639, DOI 10.1042/bj1710639; WALLACE BJ, 1977, BIOCHIM BIOPHYS ACTA, V461, P84, DOI 10.1016/0005-2728(77)90071-8; WARDMAN P, 1991, FREE RADICAL RES COM, V14, P57, DOI 10.3109/10715769109088942; Workun GJ, 2008, MICROBIOL MOL BIOL R, V72, P228, DOI 10.1128/MMBR.00041-07; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	63	20	21	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25164	25173		10.1074/jbc.M115.665422	http://dx.doi.org/10.1074/jbc.M115.665422			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26297003	hybrid, Green Published			2022-12-28	WOS:000362598300043
J	Wells, ML; Hicks, SN; Perera, L; Blackshear, PJ				Wells, Melissa L.; Hicks, Stephanie N.; Perera, Lalith; Blackshear, Perry J.			Functional Equivalence of an Evolutionarily Conserved RNA Binding Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; AU-RICH ELEMENT; MESSENGER-RNA; SCHIZOSACCHAROMYCES-POMBE; POSTTRANSCRIPTIONAL REGULATION; TRISTETRAPROLIN FAMILY; DEGRADATION; DOMAIN; DESTABILIZATION; DEADENYLATION	Members of the tristetraprolin (TIP) family of proteins participate in the regulation of mRNA turnover after initially binding to AU-rich elements in target mRNAs. Related proteins from most groups of eukaryotes contain a conserved tandem zinc finger (TZF) domain consisting of two closely spaced, similar CCCH zinc fingers that form the primary RNA binding domain. There is considerable sequence variation within the 'ern, domains from different family members within a single organism and from different organisms, raising questions about sequence-specific effects on RNA binding and decay promotion. We hypothesized that TZF domains from evolutionarily distant species are functionally interchangeable. The single family member expressed in the fission yeast Schizosaccharomyces pombe, Zfsl, promotes the turnover of several dozen transcripts, some of which are involved in cell-cell interactions. Using knockin techniques, we replaced the 'ern, domain of S. pornbe Zfsl with the equivalent domains from human TTP and the single family member proteins expressed in the silkworm Bombyx mori, the pathogenic yeast Candida mondii, and the plant Chromolaena odorata. We found that the TZF domains from these widely disparate species could completely substitute for the native S. pornbe TZF domain, as determined by measurement of target transcript levels and the flocculation phenotype characteristic of Zfs1 deletion. Recombinant TZF domain peptides from several of these species bound to an AU-rich RNA oligonucleotide with comparably high affinity. We conclude that the TZF domains from TTP family members in these evolutionarily widely divergent species are functionally interchangeable in mRNA binding and decay.	[Wells, Melissa L.; Hicks, Stephanie N.; Blackshear, Perry J.] NIEHS, Signal Transduct Lab, NIH, Res Triangle Pk, NC 27709 USA; [Perera, Lalith] NIEHS, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University	Blackshear, PJ (corresponding author), NIEHS, F1-13,111 Alexander Dr, Res Triangle Pk, NC 27709 USA.	black009@niehs.nih.gov	Blackshear, Perry J./C-6206-2019; Perera, Lalith/ABB-9995-2021; perera, Lalith/B-6879-2012	Blackshear, Perry J./0000-0002-9561-8529; perera, Lalith/0000-0003-0823-1631	NIEHS/National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES043010, ZIAES090080] Funding Source: NIH RePORTER	NIEHS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported, in whole or in part, by the intramural research program of the NIEHS/National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Blackshear PJ, 2014, J INTERF CYTOK RES, V34, P297, DOI 10.1089/jir.2013.0150; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Case D.A., 2022, AMBER; Choi YJ, 2014, J BIOL CHEM, V289, P35042, DOI 10.1074/jbc.M114.593491; Ciais D, 2013, CELL MOL LIFE SCI, V70, P2031, DOI 10.1007/s00018-012-1150-y; Cuthbertson BJ, 2008, J BIOL CHEM, V283, P2586, DOI 10.1074/jbc.M707154200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian MR, 2013, NAT STRUCT MOL BIOL, V20, P735, DOI 10.1038/nsmb.2572; Funakoshi M, 2009, YEAST, V26, P185, DOI 10.1002/yea.1658; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; KANOH J, 1995, MOL BIOL CELL, V6, P1185, DOI 10.1091/mbc.6.9.1185; Kedar VP, 2012, J BIOL CHEM, V287, P5459, DOI 10.1074/jbc.M111.312652; Lai WS, 2014, J BIOL CHEM, V289, P565, DOI 10.1074/jbc.M113.466326; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 2005, J BIOL CHEM, V280, P34365, DOI 10.1074/jbc.M506757200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; TAYLOR GA, 1991, NUCLEIC ACIDS RES, V19, P3454, DOI 10.1093/nar/19.12.3454; Wells ML, 2015, MOL MICROBIOL, V95, P1036, DOI 10.1111/mmi.12913; Wells ML, 2012, MOL CELL BIOL, V32, P4206, DOI 10.1128/MCB.00325-12	27	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24413	24423		10.1074/jbc.M115.673012	http://dx.doi.org/10.1074/jbc.M115.673012			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26292216	Green Published, hybrid			2022-12-28	WOS:000362218900029
J	Desmarais, SM; Tropini, C; Miguel, A; Cava, F; Monds, RD; de Pedro, MA; Huang, KC				Desmarais, Samantha M.; Tropini, Carolina; Miguel, Amanda; Cava, Felipe; Monds, Russell D.; de Pedro, Miguel A.; Huang, Kerwyn Casey			High-throughput, Highly Sensitive Analyses of Bacterial Morphogenesis Using Ultra Performance Liquid Chromatography	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING-PROTEINS; CELL-WALL; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PEPTIDOGLYCAN STRUCTURE; CHEMICAL-COMPOSITION; MUREIN STRUCTURE; L-FORMS; RESISTANCE; SHAPE	The bacterial cell wall is a network of glycan strands crosslinked by short peptides (peptidoglycan); it is responsible for the mechanical integrity of the cell and shape determination. Liquid chromatography can be used to measure the abundance of the muropeptide subunits composing the cell wall. Characteristics such as the degree of cross-linking and average glycan strand length are known to vary across species. However, a systematic comparison among strains of a given species has yet to be undertaken, making it difficult to assess the origins of variability in peptidoglycan composition. We present a protocol for muropeptide analysis using ultra performance liquid chromatography (UPLC) and demonstrate that UPLC achieves resolution comparable with that of HPLC while requiring orders of magnitude less injection volume and a fraction of the elution time. We also developed a software platform to automate the identification and quantification of chromatographic peaks, which we demonstrate has improved accuracy relative to other software. This combined experimental and computational methodology revealed that peptidoglycan composition was approximately maintained across strains from three Gram-negative species despite taxonomical and morphological differences. Peptidoglycan composition and density were maintained after we systematically altered cell size in Escherichia coli using the antibiotic A22, indicating that cell shape is largely decoupled from the biochemistry of peptidoglycan synthesis. High-throughput, sensitive UPLC combined with our automated software for chromatographic analysis will accelerate the discovery of peptidoglycan composition and the molecular mechanisms of cell wall structure determination.	[Desmarais, Samantha M.; Tropini, Carolina; Miguel, Amanda; Monds, Russell D.; Huang, Kerwyn Casey] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Huang, Kerwyn Casey] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Tropini, Carolina; Huang, Kerwyn Casey] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Cava, Felipe] Umea Univ, Umea Ctr Microbial Res, Dept Mol Biol, S-90187 Umea, Sweden; [Cava, Felipe] Umea Univ, Umea Ctr Microbial Res, Lab Mol Infect Med Sweden, S-90187 Umea, Sweden; [Monds, Russell D.; Huang, Kerwyn Casey] Stanford Univ, Bio X Program, Stanford, CA 94305 USA; [de Pedro, Miguel A.] Univ Autonoma Madrid, E-28049 Madrid, Spain	Stanford University; Stanford University; Stanford University; Umea University; Umea University; Stanford University; Autonomous University of Madrid	Huang, KC (corresponding author), Dept Bioengn, 443 Via Ortega,Shriram Bldg,Rm 007, Stanford, CA 94305 USA.	kchuang@stanford.edu	Tropini, Carolina/H-2992-2019; Cava, Felipe/L-2082-2017	Tropini, Carolina/0000-0002-7542-1577; Cava, Felipe/0000-0001-5995-718X	Stanford Interdisciplinary Graduate Fellowship; National Science Foundation; Laboratory for Infection Medicine Sweden; Knut and Alice Wallenberg Foundation; Swedish Research Council; Bio-X Senior Postdoctoral Fellowship; National Institutes of Health Director's New Innovator Award [DP2OD006466]; National Science Foundation [MCB-1149328]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006466] Funding Source: NIH RePORTER	Stanford Interdisciplinary Graduate Fellowship; National Science Foundation(National Science Foundation (NSF)); Laboratory for Infection Medicine Sweden; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Bio-X Senior Postdoctoral Fellowship; National Institutes of Health Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Stanford Interdisciplinary Graduate Fellowship (to C. T.), a National Science Foundation Graduate Research Fellowship (to A. M.), the Laboratory for Infection Medicine Sweden, the Knut and Alice Wallenberg Foundation, the Swedish Research Council (to F. C.), a Bio-X Senior Postdoctoral Fellowship (to R. D. M.), and National Institutes of Health Director's New Innovator Award DP2OD006466 and National Science Foundation CAREER Award MCB-1149328 (to K. C. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Barreteau H, 2009, J BACTERIOL, V191, P3657, DOI 10.1128/JB.01824-08; Barsanti L, 2011, NAT PROD REP, V28, P457, DOI 10.1039/c0np00018c; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; Billings G, 2014, MOL MICROBIOL, V93, P883, DOI 10.1111/mmi.12703; Blackburn NT, 2002, BIOCHEMISTRY-US, V41, P1001, DOI 10.1021/bi011833k; BOYLEN CW, 1968, J BACTERIOL, V96, P421, DOI 10.1128/JB.96.2.421-427.1968; Bruck S, 2011, J BACTERIOL, V193, P4425, DOI 10.1128/JB.01154-10; Bush K, 2012, REV SCI TECH OIE, V31, P43; Cabeen MT, 2009, EMBO J, V28, P1208, DOI 10.1038/emboj.2009.61; Czechowska K, 2014, P NATL ACAD SCI USA, V111, P7801, DOI 10.1073/pnas.1400782111; DELAROSA EJ, 1985, P NATL ACAD SCI USA, V82, P5632; Desmarais SM, 2014, JOVE-J VIS EXP, DOI 10.3791/51183; Desmarais SM, 2013, MOL MICROBIOL, V89, P1, DOI 10.1111/mmi.12266; DUCHENE M, 1989, J BACTERIOL, V171, P4130; Edelstein A., 2010, CURR PROTOC MOL BIOL, P20, DOI [DOI 10.1002/0471142727.MB1420S92, 10.1002/0471142727.mb1420s92]; Evans KL, 2013, J BACTERIOL, V195, P4415, DOI 10.1128/JB.00596-13; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; GARCIABUSTOS J, 1990, P NATL ACAD SCI USA, V87, P5415, DOI 10.1073/pnas.87.14.5415; GARCIABUSTOS JF, 1988, J BACTERIOL, V170, P2143, DOI 10.1128/jb.170.5.2143-2147.1988; Garimella R, 2009, BIOCHEMISTRY-US, V48, P9242, DOI 10.1021/bi900503k; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; GOODELL EW, 1977, EUR J BIOCHEM, V81, P205, DOI 10.1111/j.1432-1033.1977.tb11942.x; Hakenbeck R., 1983, TARGET PENICILLIN MU; HEILMANN HD, 1974, EUR J BIOCHEM, V43, P35, DOI 10.1111/j.1432-1033.1974.tb03381.x; HEILMANN HD, 1972, EUR J BIOCHEM, V31, P456, DOI 10.1111/j.1432-1033.1972.tb02552.x; Huang KC, 2008, P NATL ACAD SCI USA, V105, P19282, DOI 10.1073/pnas.0805309105; Joseleau-Petit D, 2007, J BACTERIOL, V189, P6512, DOI 10.1128/JB.00273-07; KANDLER O, 1968, J BACTERIOL, V96, P1935, DOI 10.1128/JB.96.6.1935-1939.1968; KITANO K, 1986, J BACTERIOL, V167, P759, DOI 10.1128/jb.167.3.759-765.1986; Koch AL, 2000, CRIT REV MICROBIOL, V26, P1, DOI 10.1080/10408410091154165; Koyama N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048981; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Lee TK, 2014, P NATL ACAD SCI USA, V111, P4554, DOI 10.1073/pnas.1313826111; Legaree BA, 2007, J ANTIMICROB CHEMOTH, V59, P411, DOI 10.1093/jac/dkl536; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; MARKIEWICZ Z, 1983, J BACTERIOL, V156, P649, DOI 10.1128/JB.156.2.649-655.1983; MIRELMAN D, 1981, ANTIMICROB AGENTS CH, V19, P687, DOI 10.1128/AAC.19.5.687; Moll A, 2014, J BACTERIOL, V196, P3937, DOI 10.1128/JB.02094-14; Monds RD, 2014, CELL REP, V9, P1528, DOI 10.1016/j.celrep.2014.10.040; OBERMANN W, 1994, MICROBIOL-UK, V140, P79, DOI 10.1099/13500872-140-1-79; Philippe N, 2009, J BACTERIOL, V191, P909, DOI 10.1128/JB.01419-08; Remans K, 2010, MICROBIOL-SGM, V156, P2597, DOI 10.1099/mic.0.040659-0; Ronholm J, 2012, GLYCOBIOLOGY, V22, P1311, DOI 10.1093/glycob/cws100; Schaberle TF, 2011, ANTIMICROB AGENTS CH, V55, P4283, DOI 10.1128/AAC.01372-10; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Scheurwater EM, 2007, PROTEIN EXPRES PURIF, V56, P128, DOI 10.1016/j.pep.2007.06.009; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; SUTOW AB, 1967, J BACTERIOL, V93, P1452, DOI 10.1128/JB.93.4.1452-1457.1967; TOUCHSTONE JC, 1993, J LIQ CHROMATOGR, V16, P1647, DOI 10.1080/10826079308021679; Tropini C, 2014, CELL REP, V9, P1520, DOI 10.1016/j.celrep.2014.10.027; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Uehara T, 2008, J BACTERIOL, V190, P3914, DOI 10.1128/JB.00207-08; Ursell TS, 2014, P NATL ACAD SCI USA, V111, pE1025, DOI 10.1073/pnas.1317174111; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Vollmer W, 1997, J BACTERIOL, V179, P1580, DOI 10.1128/jb.179.5.1580-1583.1997; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; WANG WS, 1968, J BACTERIOL, V95, P1851, DOI 10.1128/JB.95.5.1851-1856.1968; WEIDEL W, 1960, J GEN MICROBIOL, V22, P158, DOI 10.1099/00221287-22-1-158; Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4; Wolter DJ, 2013, CURR PHARM DESIGN, V19, P209, DOI 10.2174/138161213804070311; Wu Z, 2013, CARBOHYD POLYM, V96, P466, DOI 10.1016/j.carbpol.2013.04.028; Yang ZY, 2012, METHOD ENZYMOL, V516, P153, DOI 10.1016/B978-0-12-394291-3.00031-9; Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06; Young KD, 2010, ANNU REV MICROBIOL, V64, P223, DOI 10.1146/annurev.micro.112408.134102; Yount NY, 2013, ANN NY ACAD SCI, V1277, P127, DOI 10.1111/nyas.12005; Zegans ME, 2012, ANTIMICROB AGENTS CH, V56, P4112, DOI 10.1128/AAC.00373-12	71	22	22	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					31090	31100		10.1074/jbc.M115.661660	http://dx.doi.org/10.1074/jbc.M115.661660			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26468288	Green Published, hybrid			2022-12-28	WOS:000367199000037
J	Stolting, G; Bungert-Plumke, S; Franzen, A; Fahlke, C				Stoelting, Gabriel; Bungert-Pluemke, Stefanie; Franzen, Arne; Fahlke, Christoph			Carboxyl-terminal Truncations of CIC-Kb Abolish Channel Activation by Barttin Via Modified Common Gating and Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-CAUSING MUTATIONS; MUSCLE CHLORIDE CHANNELS; CALCIUM-SENSING RECEPTOR; SYNDROME TYPE-IV; FUNCTIONAL-CHARACTERIZATION; HYPOKALEMIC ALKALOSIS; TORPEDO ELECTROPLAX; SURFACE EXPRESSION; PORE VESTIBULE; BETA-SUBUNIT	ClC-K chloride channels are crucial for auditory transduction and urine concentration. Mutations in CLCNKB, the gene encoding the renal chloride channel hClC-Kb, cause Bartter syndrome type III, a human genetic condition characterized by polyuria, hypokalemia, and alkalosis. In recent years, several Bartter syndrome-associated mutations have been described that result in truncations of the intracellular carboxyl terminus of hClC-Kb. We here used a combination of whole-cell patch clamp, confocal imaging, co-immunoprecipitation, and surface biotinylation to study the functional consequences of a frequent CLCNKB mutation that creates a premature stop codon at Trp-610. We found that W610X leaves the association of hClC-Kb and the accessory subunit barttin unaffected, but impairs its regulation by barttin. W610X attenuates hClC-Kb surface membrane insertion. Moreover, W610X results in hClC-Kb channel opening in the absence of barttin and prevents further barttin-mediated activation. To describe how the carboxyl terminus modifies the regulation by barttin we used V166E rClC-K1. V166E rClC-K1 is active without barttin and exhibits prominent, barttin-regulated voltage-dependent gating. Electrophysiological characterization of truncated V166E rClC-K1 demonstrated that the distal carboxyl terminus is necessary for slow cooperative gating. Since barttin modifies this particular gating process, channels lacking the distal carboxyl-terminal domain are no longer regulated by the accessory subunit. Our results demonstrate that the carboxyl terminus of hClC-Kb is not part of the binding site for barttin, but functionally modifies the interplay with barttin. The loss-of-activation of truncated hClC-Kb channels in heterologous expression systems fully explains the reduced basolateral chloride conductance in affected kidneys and the clinical symptoms of Bartter syndrome patients.	[Stoelting, Gabriel; Bungert-Pluemke, Stefanie; Franzen, Arne; Fahlke, Christoph] Forschungszentrum Julich, Inst Complex Syst 4, Zellulare Biophys, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Stolting, G (corresponding author), Forschungszentrum Julich, Inst Complex Syst 4, Zellulare Biophys, D-52425 Julich, Germany.	g.stoelting@fz-juelich.de; c.fahlke@fz-juelich.de	Fahlke, Christoph/G-3635-2013; Stolting, Gabriel/G-3704-2014	Fahlke, Christoph/0000-0001-8602-9952; Franzen, Arne/0000-0002-8731-674X; Stolting, Gabriel/0000-0002-2339-0545	Deutsche Forschungsgemeinschaft [FA301/10-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (FA301/10-1, to Ch. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrini O., 2013, PFLUGERS ARCH, V466, P1713; Andrini O, 2015, AM J PHYSIOL-RENAL, V308, pF1324, DOI 10.1152/ajprenal.00004.2015; Barlassina C, 2007, HUM MOL GENET, V16, P1630, DOI 10.1093/hmg/ddm112; BARTTER FC, 1962, AM J MED, V33, P811, DOI 10.1016/0002-9343(62)90214-0; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Bettinelli A, 2007, AM J KIDNEY DIS, V49, P91, DOI 10.1053/j.ajkd.2006.10.001; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Cappola TP, 2011, P NATL ACAD SCI USA, V108, P2456, DOI 10.1073/pnas.1017494108; Carr G, 2003, BIOCHEM BIOPH RES CO, V310, P600, DOI 10.1016/j.bbrc.2003.09.057; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; Cleiren E, 2001, HUM MOL GENET, V10, P2861, DOI 10.1093/hmg/10.25.2861; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fahlke C, 2001, J BIOL CHEM, V276, P1759, DOI 10.1074/jbc.M007649200; Fahlke C, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00155; Fischer M, 2010, J AM SOC NEPHROL, V21, P1281, DOI 10.1681/ASN.2009121274; Fukuyama S, 2004, J CLIN ENDOCR METAB, V89, P5847, DOI 10.1210/jc.2004-0775; Garcia-Olivares J, 2008, J PHYSIOL-LONDON, V586, P5325, DOI 10.1113/jphysiol.2008.158097; Hayama A, 2003, HISTOCHEM CELL BIOL, V119, P485, DOI 10.1007/s00418-003-0535-2; Hebeisen S, 2005, BIOPHYS J, V89, P1710, DOI 10.1529/biophysj.104.056093; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Hebert SC, 2003, CURR OPIN NEPHROL HY, V12, P527, DOI 10.1097/00041552-200309000-00008; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Imbrici P, 2014, BBA-BIOMEMBRANES, V1838, P2484, DOI 10.1016/j.bbamem.2014.05.017; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Keck M, 2013, HUM MUTAT, V34, P1269, DOI 10.1002/humu.22361; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; L'Hoste S, 2013, BBA-BIOMEMBRANES, V1828, P2399, DOI 10.1016/j.bbamem.2013.06.012; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lee BH, 2012, NEPHROL DIAL TRANSPL, V27, P1516, DOI 10.1093/ndt/gfr475; Liantonio A, 2006, MOL PHARMACOL, V69, P165, DOI 10.1124/mol.105.017384; Lohi H, 2002, J BIOL CHEM, V277, P14246, DOI 10.1074/jbc.M111802200; Ludwig M, 2005, HUM GENET, V117, P228, DOI 10.1007/s00439-005-1303-2; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; Martinez GQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002746; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Nomura N, 2013, BIOCHEM BIOPH RES CO, V441, P544, DOI 10.1016/j.bbrc.2013.10.129; Nomura N, 2011, AM J PHYSIOL-RENAL, V301, pF297, DOI 10.1152/ajprenal.00604.2010; Nothmann D, 2011, J BIOL CHEM, V286, P3935, DOI 10.1074/jbc.M110.187492; Nozu K, 2010, J CLIN ENDOCR METAB, V95, pE511, DOI 10.1210/jc.2010-0392; Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Scholl U, 2006, P NATL ACAD SCI USA, V103, P11411, DOI 10.1073/pnas.0601631103; Schwappach B, 1998, J BIOL CHEM, V273, P15110, DOI 10.1074/jbc.273.24.15110; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; Stauber T, 2010, J BIOL CHEM, V285, P34537, DOI 10.1074/jbc.M110.162545; Steinke KV, 2015, J BIOL CHEM, V290, P17390, DOI 10.1074/jbc.M114.631705; Stolting G, 2014, PFLUG ARCH EUR J PHY, V466, P2191, DOI 10.1007/s00424-014-1490-6; Stolting G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00378; Stolting G, 2013, PFLUG ARCH EUR J PHY, V465, P1423, DOI 10.1007/s00424-013-1286-0; Tajima M, 2007, BIOCHEM BIOPH RES CO, V362, P858, DOI 10.1016/j.bbrc.2007.08.097; UCHIDA S, 1995, J CLIN INVEST, V95, P104, DOI 10.1172/JCI117626; Vandewalle A, 1997, AM J PHYSIOL-RENAL, V272, pF678, DOI 10.1152/ajprenal.1997.272.5.F678; Vargas-Poussou R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025781.16723.68; Velazquez H, 2003, AM J PHYSIOL-RENAL, V285, pF49, DOI 10.1152/ajprenal.00389.2002; Waldegger S., 2014, PFLUGERS ARCH, V444, P411; Watanabe S, 2002, LANCET, V360, P692, DOI 10.1016/S0140-6736(02)09842-2; Weinberger S, 2012, J PHYSIOL-LONDON, V590, P3449, DOI 10.1113/jphysiol.2012.232785; Wojciechowski D, 2015, J BIOL CHEM, V290, P18732, DOI 10.1074/jbc.M114.625376	63	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30406	30416		10.1074/jbc.M115.675827	http://dx.doi.org/10.1074/jbc.M115.675827			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26453302	Green Published, hybrid			2022-12-28	WOS:000366738200018
J	Li, BZ; Fu, JX; Chen, P; Ge, XP; Li, YL; Kuiatse, I; Wang, H; Wang, HH; Zhang, XD; Orlowski, RZ				Li, Bingzong; Fu, Jinxiang; Chen, Ping; Ge, Xueping; Li, Yali; Kuiatse, Isere; Wang, Hua; Wang, Huihan; Zhang, Xingding; Orlowski, Robert Z.			The Nuclear Factor (Erythroid-derived 2)-like 2 and Proteasome Maturation Protein Axis Mediate Bortezomib Resistance in Multiple Myeloma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELL TRANSPLANTATION; LOW-DOSE DEXAMETHASONE; RANDOMIZED PHASE-III; SIGNALING PATHWAY; THERAPEUTIC AGENTS; PLUS DEXAMETHASONE; OXIDATIVE STRESS; RECEPTOR-ALPHA; 20S PROTEASOME; LENALIDOMIDE	Resistance to the proteasome inhibitor bortezomib is an emerging clinical problem whose mechanisms have not been fully elucidated. We considered the possibility that this could be associated with enhanced proteasome activity in part through the action of the proteasome maturation protein (POMP). Bortezomib-resistant myeloma models were used to examine the correlation between POMP expression and bortezomib sensitivity. POMP expression was then modulated using genetic and pharmacologic approaches to determine the effects on proteasome inhibitor sensitivity in cell lines and in vivo models. Resistant cell lines were found to overexpress POMP, and while its suppression in cell lines enhanced bortezomib sensitivity, POMP overexpression in drug-naive cells conferred resistance. Overexpression of POMP was associated with increased levels of nuclear factor (erythroid-derived 2)-like (NRF2), and NRF2 was found to bind to and activate the POMP promoter. Knockdown of NRF2 in bortezomib-resistant cells reduced POMP levels and proteasome activity, whereas its overexpression in drug-naive cells increased POMP and proteasome activity. The NRF2 inhibitor all-trans-retinoic acid reduced cellular NRF2 levels and increased the anti-proliferative and pro-apoptotic activities of bortezomib in resistant cells, while decreasing proteasome capacity. Finally, the combination of all-trans-retinoic acid with bortezomib showed enhanced activity against primary patient samples and in a murine model of bortezomib-resistant myeloma. Taken together, these studies validate a role for the NRF2/POMP axis in bortezomib resistance and identify NRF2 and POMP as potentially attractive targets for chemosensitization to this proteasome inhibitor.	[Li, Bingzong; Fu, Jinxiang; Chen, Ping; Ge, Xueping; Li, Yali] Soochow Univ, Affiliated Hosp 2, Dept Hematol, Suzhou 215006, Jiangsu, Peoples R China; [Li, Bingzong; Kuiatse, Isere; Wang, Hua; Wang, Huihan; Zhang, Xingding; Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Soochow University - China; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Orlowski, RZ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, 1515 Holcombe Blvd,Unit 429, Houston, TX 77030 USA.	rorlowsk@mdanderson.org	li, bz/GVR-7133-2022; Zhang, Xingding/C-8780-2014; Regan, Clinton/E-6250-2012; li, bing/GWQ-9617-2022	Zhang, Xingding/0000-0002-2759-5185; Orlowski, Robert/0000-0002-5723-4129	National Institutes of Health [P50 CA142509]; National Institutes of Health Cancer Center Support Grant [CA16672]; National Natural Science Foundation of China [81172256, 81272631]; Applied Basic Research Programs of Suzhou City [SYS201546]; China Postdoctoral Science Foundation [2014M550307]; Florence Maude Thomas Cancer Research Professorship, National Institutes of Health [R01 CA184464, CA194264]; Brock Family Myeloma Research Fund; Yates Ortiz Myeloma Fund; Jay Solomon Myeloma Research Fund; Diane and John Grace Family Foundation; Millennium: The Takeda Oncology Co.; Onyx Pharmaceuticals; NATIONAL CANCER INSTITUTE [P50CA142509, P30CA016672, U10CA032102, R01CA184464, R01CA194264] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Programs of Suzhou City; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Florence Maude Thomas Cancer Research Professorship, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brock Family Myeloma Research Fund; Yates Ortiz Myeloma Fund; Jay Solomon Myeloma Research Fund; Diane and John Grace Family Foundation; Millennium: The Takeda Oncology Co.; Onyx Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant P50 CA142509 (to MD Anderson Cancer Center SPORE in Multiple Myeloma), National Institutes of Health Cancer Center Support Grant CA16672 (to MD Anderson Characterized Cell Line Core Facility). R. Z. O. has served on advisory boards for Millennium: The Takeda Oncology Co., which developed and markets bortezomib, and for Onyx Pharmaceuticals, which developed and markets carfilzomib, and has received research funding from both entities; however, these funds did not support the current line of investigation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Natural Science Foundation of China Grants 81172256 and 81272631, Applied Basic Research Programs of Suzhou City Grant SYS201546, and China Postdoctoral Science Foundation-funded Project 2014M550307.; Supported by the Florence Maude Thomas Cancer Research Professorship, National Institutes of Health Grants R01 CA184464 and CA194264, the Brock Family Myeloma Research Fund, the Yates Ortiz Myeloma Fund, the Jay Solomon Myeloma Research Fund, and the Diane and John Grace Family Foundation. To whom correspondence should be addressed: Dept. of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 429, Houston, TX 77030-4009. Tel.: 713-794-3234; Fax: 713-563-5067; E-mail: rorlowsk@mdanderson.org.	Anderson KC, 2013, J NATL COMPR CANC NE, V11, P11, DOI 10.6004/jnccn.2013.0004; Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Biran Noa, 2013, Clin Adv Hematol Oncol, V11, P489; Bjorklund CC, 2014, LEUKEMIA, V28, P373, DOI 10.1038/leu.2013.174; Cavo M, 2010, LANCET, V376, P2075, DOI 10.1016/S0140-6736(10)61424-9; Cenci S, 2006, EMBO J, V25, P1104, DOI 10.1038/sj.emboj.7601009; Chen D, 2011, CURR CANCER DRUG TAR, V11, P239, DOI 10.2174/156800911794519752; Chondrogianni N, 2007, EXP GERONTOL, V42, P899, DOI 10.1016/j.exger.2007.01.012; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; De Braekeleer E, 2014, EXPERT REV HEMATOL, V7, P347, DOI 10.1586/17474086.2014.903794; Fricke B, 2007, EMBO REP, V8, P1170, DOI 10.1038/sj.embor.7401091; Fuchs D, 2008, J CELL BIOCHEM, V103, P270, DOI 10.1002/jcb.21405; Harousseau JL, 2010, J CLIN ONCOL, V28, P4621, DOI 10.1200/JCO.2009.27.9158; Hrusovsky I, 2010, ONCOLOGY-BASEL, V79, P247, DOI 10.1159/000322866; Jakubowiak AJ, 2012, BLOOD, V120, P1801, DOI 10.1182/blood-2012-04-422683; Jang JW, 2014, STEM CELLS, V32, P2616, DOI 10.1002/stem.1764; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kuhn DJ, 2012, BLOOD, V120, P3260, DOI 10.1182/blood-2011-10-386789; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Kumar SK, 2012, LEUKEMIA, V26, P149, DOI 10.1038/leu.2011.196; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Laubach JP, 2009, LEUKEMIA LYMPHOMA, V50, P694, DOI 10.1080/10428190902866732; Lawasut P, 2012, CURR HEMATOL MALIG R, V7, P258, DOI 10.1007/s11899-012-0141-2; Leung-Hagesteijn C, 2013, CANCER CELL, V24, P289, DOI 10.1016/j.ccr.2013.08.009; Lichter DI, 2012, BLOOD, V120, P4513, DOI 10.1182/blood-2012-05-426924; Lu SQ, 2008, J PHARMACOL EXP THER, V326, P423, DOI 10.1124/jpet.108.138131; Lu S, 2010, INT J LAB HEMATOL, V32, pE123, DOI 10.1111/j.1751-553X.2009.01145.x; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Mahindra A, 2012, NAT REV CLIN ONCOL, V9, P135, DOI 10.1038/nrclinonc.2012.15; Marques AJ, 2009, CHEM REV, V109, P1509, DOI 10.1021/cr8004857; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Moriuchi Makiko, 2010, Tokai J Exp Clin Med, V35, P17; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Namani A, 2014, BBA-MOL CELL RES, V1843, P1875, DOI 10.1016/j.bbamcr.2014.05.003; Niesvizky R, 2013, CLIN CANCER RES, V19, P2248, DOI 10.1158/1078-0432.CCR-12-3352; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Orlowski RZ, 2007, J CLIN ONCOL, V25, P3892, DOI 10.1200/JCO.2006.10.5460; Orlowski RZ, 2013, CANCER CELL, V24, P275, DOI 10.1016/j.ccr.2013.08.014; Ozaki S, 2014, ACTA HAEMATOL-BASEL, V132, P211, DOI 10.1159/000357394; Paton-Hough J, 2015, BONE, V77, P57, DOI 10.1016/j.bone.2015.04.004; Pickering AM, 2012, J BIOL CHEM, V287, P10021, DOI 10.1074/jbc.M111.277145; Politou M, 2006, LEUKEMIA RES, V30, P240, DOI 10.1016/j.leukres.2005.06.014; Pozzi S, 2013, BRIT J HAEMATOL, V163, P40, DOI 10.1111/bjh.12465; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Siegel DS, 2012, BLOOD, V120, P2817, DOI 10.1182/blood-2012-05-425934; Sonneveld P, 2012, J CLIN ONCOL, V30, P2946, DOI 10.1200/JCO.2011.39.6820; Stessman HAF, 2013, MOL CANCER THER, V12, P1140, DOI 10.1158/1535-7163.MCT-12-1151; Wang M, 2013, BLOOD, V122, P3122, DOI 10.1182/blood-2013-07-511170; Wang XJ, 2007, P NATL ACAD SCI USA, V104, P19589, DOI 10.1073/pnas.0709483104; Witt E, 2000, J MOL BIOL, V301, P1, DOI 10.1006/jmbi.2000.3959; Wolf Jeffrey, 2008, Clin Adv Hematol Oncol, V6, P755; Zhang N, 2010, MOL BIOL CELL, V21, P4312, DOI 10.1091/mbc.E10-04-0310	57	50	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29854	29868		10.1074/jbc.M115.664953	http://dx.doi.org/10.1074/jbc.M115.664953			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26483548	Green Published, hybrid			2022-12-28	WOS:000366614700019
J	Nomikos, M; Sanders, JR; Parthimos, D; Buntwal, L; Calver, BL; Stamatiadis, P; Smith, A; Clue, M; Sideratou, Z; Swann, K; Lai, FA				Nomikos, Michail; Sanders, Jessica R.; Parthimos, Dimitris; Buntwal, Luke; Calver, Brian L.; Stamatiadis, Panagiotis; Smith, Adrian; Clue, Matthew; Sideratou, Zili; Swann, Karl; Lai, F. Anthony			Essential Role of the EF-hand Domain in Targeting Sperm Phospholipase C zeta to Membrane Phosphatidylinositol 4,5-Bisphosphate (PIP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN-HOMOLOGY-DOMAIN; PLC-ZETA; CA2+ OSCILLATIONS; MOUSE EGGS; EMBRYO DEVELOPMENT; MALE-INFERTILITY; POINT MUTATION; XY-LINKER; ACTIVATION; BINDING	Sperm-specific phospholipase C-zeta (PLC zeta) is widely considered to be the physiological stimulus that triggers intracellular Ca2+ oscillations and egg activation during mammalian fertilization. Although PLC zeta is structurally similar to PLC delta 1, it lacks a pleckstrin homology domain, and it remains unclear how PLC zeta targets its phosphatidylinositol 4,5-bisphosphate (PIP2) membrane substrate. Recently, the PLC delta 1 EF-hand domain was shown to bind to anionic phospholipids through a number of cationic residues, suggesting a potential mechanism for how PLCs might interact with their target membranes. Those critical cationic EF-hand residues in PLC delta 1 are notably conserved in PLC zeta. We investigated the potential role of these conserved cationic residues in PLC zeta by generating a series of mutants that sequentially neutralized three positively charged residues (Lys-49, Lys-53, and Arg-57) within the mouse PLC zeta EF-hand domain. Microinjection of the PLC zeta EF-hand mutants into mouse eggs enabled their Ca2+ oscillation inducing activities to be compared with wild-type PLC zeta. Furthermore, the mutant proteins were purified, and the in vitro PIP2 hydrolysis and binding properties were monitored. Our analysis suggests that PLC zeta binds significantly to PIP2, but not to phosphatidic acid or phosphatidylserine, and that sequential reduction of the net positive charge within the first EF-hand domain of PLC zeta significantly alters in vivo Ca2+ oscillation inducing activity and in vitro interaction with PIP2 without affecting its Ca2+ sensitivity. Our findings are consistent with theoretical predictions provided by a mathematical model that links oocyte Ca2+ frequency and the binding ability of different PLC zeta mutants to PIP2. Moreover, a PLC zeta mutant with mutations in the cationic residues within the first EF-hand domain and the XY linker region dramatically reduces the binding of PLC zeta to PIP2, leading to complete abolishment of its Ca2+ oscillation inducing activity.	[Nomikos, Michail; Sanders, Jessica R.; Parthimos, Dimitris; Buntwal, Luke; Calver, Brian L.; Stamatiadis, Panagiotis; Smith, Adrian; Clue, Matthew; Swann, Karl; Lai, F. Anthony] Cardiff Univ, Sch Med, Inst Mol & Expt Med, Cardiff CF14 4XN, S Glam, Wales; [Sideratou, Zili] Natl Ctr Sci Res Demokritos, Aghia Paraskevi 15310, Greece	Cardiff University; National Centre of Scientific Research "Demokritos"	Nomikos, M (corresponding author), Cardiff Univ, Sch Med, Inst Mol & Expt Med, Cardiff CF14 4XN, S Glam, Wales.	mixosn@yahoo.com; lait@cf.ac.uk	Sideratou, Zili/AAB-8498-2019	Nomikos, Michail/0000-0001-9761-6327; Parthimos, Dimitris/0000-0003-3852-323X; Lai, Tony/0000-0003-2852-8547; Swann, Karl/0000-0002-4355-1449; Sideratou, Zili/0000-0002-9314-2520	EU-FP7 Marie-Curie Intra-European Fellowship [628634]; Institute for Molecular and Experimental Medicine Research Scholarship	EU-FP7 Marie-Curie Intra-European Fellowship; Institute for Molecular and Experimental Medicine Research Scholarship	This work was supported by EU-FP7 Marie-Curie Intra-European Fellowship 628634 (to M. N.) and an Institute for Molecular and Experimental Medicine Research Scholarship (to J. R. S.). F. A. L. and K. S. hold patents on PLC zeta with Cardiff University.	Cai JF, 2013, J BIOL CHEM, V288, P37277, DOI 10.1074/jbc.M113.512186; Campbell K, 2006, DEV BIOL, V298, P225, DOI 10.1016/j.ydbio.2006.06.032; Cox LJ, 2002, REPRODUCTION, V124, P611, DOI 10.1530/rep.0.1240611; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Heytens E, 2009, HUM REPROD, V24, P2417, DOI 10.1093/humrep/dep207; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Kashir J, 2012, HUM REPROD, V27, P222, DOI 10.1093/humrep/der384; Knott JG, 2005, BIOL REPROD, V72, P992, DOI 10.1095/biolreprod.104.036244; Kouchi Z, 2005, J BIOL CHEM, V280, P21015, DOI 10.1074/jbc.M412123200; Kouchi Z, 2004, J BIOL CHEM, V279, P10408, DOI 10.1074/jbc.M313801200; Lomasney JW, 1996, J BIOL CHEM, V271, P25316, DOI 10.1074/jbc.271.41.25316; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; Nomikos M, 2005, J BIOL CHEM, V280, P31011, DOI 10.1074/jbc.M500629200; Nomikos M, 2007, J BIOL CHEM, V282, P16644, DOI 10.1074/jbc.M701072200; Nomikos M, 2015, BIOCHEM SOC T, V43, P371, DOI 10.1042/BST20140291; Nomikos M, 2014, MOL HUM REPROD, V20, P938, DOI 10.1093/molehr/gau056; Nomikos M, 2013, FEBS LETT, V587, P3609, DOI 10.1016/j.febslet.2013.10.008; Nomikos M, 2013, FERTIL STERIL, V99, P76, DOI 10.1016/j.fertnstert.2012.08.035; Nomikos M, 2012, BIOESSAYS, V34, P126, DOI 10.1002/bies.201100127; Nomikos M, 2011, BIOCHEM J, V438, P427, DOI 10.1042/BJ20110953; Nomikos M, 2011, J CELL SCI, V124, P2582, DOI 10.1242/jcs.083485; Nomikos M, 2011, BIOCHEM J, V434, P211, DOI 10.1042/BJ20101772; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Sanusi R, 2015, MOL HUM REPROD, V21, P783, DOI 10.1093/molehr/gav042; Saunders CM, 2002, DEVELOPMENT, V129, P3533; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Swann Karl, 2013, Methods Mol Biol, V957, P231, DOI 10.1007/978-1-62703-191-2_16; Swann Karl, 2009, V518, P17, DOI 10.1007/978-1-59745-202-1_2; Theodoridou M, 2013, MOL HUM REPROD, V19, P852, DOI 10.1093/molehr/gat070; Yoon SY, 2008, J CLIN INVEST, V118, P3671, DOI 10.1172/JCI36942; Yu YS, 2012, MOL BIOL CELL, V23, P371, DOI 10.1091/mbc.E11-08-0687	32	20	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29519	29530		10.1074/jbc.M115.658443	http://dx.doi.org/10.1074/jbc.M115.658443			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26429913	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000366613400034
J	Yagishita, S; Murayama, M; Ebihara, T; Maruyama, K; Takashima, A				Yagishita, Sosuke; Murayama, Miyuki; Ebihara, Tomoe; Maruyama, Kei; Takashima, Akihiko			Glycogen Synthase Kinase 3 beta-mediated Phosphorylation in the Most C-terminal Region of Protein Interacting with C Kinase 1 (PICK1) Regulates the Binding of PICK1 to Glutamate Receptor Subunit GluA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC PLASTICITY; PDZ DOMAIN; TAU; KINASE-3-BETA; TRAFFICKING; DEPRESSION; GSK-3-BETA; SUBSTRATE; GLUR2/3; DISEASE	Protein interacting with C kinase 1 (PICK1) is a synaptic protein interacting with the AMPA receptor subunits GluA2/3. The interaction between GluA2 and PICK1 is required for the removal of GluA2 from the synaptic plasma membrane during long-term depression (LTD). It has been suggested that glycogen synthase kinase 3 beta (GSK-3 beta) is activated during LTD, but the relationships between GluA2, PICK1, and GSK-3 beta are not well understood. In particular, the substrate(s) of GSK-3 beta have not yet been determined. Here we showed that PICK1 is a substrate of GSK-3 beta. We found that Ser(339), Ser(342), Ser(412), and Ser(416) of PICK1 were putative GSK-3 beta-mediated phosphorylation sites. Among these sites, Ser(416) played a crucial role in regulating the interaction between GluA2 and PICK1. We showed that replacing Ser(416) with Ala disrupted the GluA2-PICK1 interaction, whereas substituting Ser(416) with Glu or Asp retained this interaction. However, deletion of Ser(416) did not affect the GluA2-PICK1 interaction, and substitution of Ser(416) with Ala did not alter the PICK1-PICK1 interaction. Using image analysis in COS-7 cells with AcGFP1-fused PICK1, we showed that substitution of Ser(416) with Ala increased the formation of AcGFP1-positive clusters, suggesting an increase in the association of PICK1 with the membrane. This may have resulted in the dissociation of the GluA2-PICK1 complexes. Our results indicated that GSK-3 beta-mediated phosphorylation of PICK1 at Ser(416) was required for its association with the AMPA receptor subunit. Therefore, the GSK-3 beta-mediated phosphorylation of PICK1 may be a regulating factor during LTD induction.	[Yagishita, Sosuke; Murayama, Miyuki; Takashima, Akihiko] RIKEN Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama 3510198, Japan; [Yagishita, Sosuke; Ebihara, Tomoe; Maruyama, Kei] Saitama Med Univ, Fac Med, Dept Pharmacol, Moroyama, Saitama 3500495, Japan; [Takashima, Akihiko] Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Aging Neurobiol, Obu, Aichi 4748522, Japan	RIKEN; Saitama Medical University; National Center for Geriatrics & Gerontology	Yagishita, S (corresponding author), Saitama Med Univ, Fac Med, Dept Pharmacol, 38 Moro Hongo, Moroyama, Saitama 3500495, Japan.	syagi@saitama-med.ac.jp; kenneth@ncgg.go.jp			Ochiai Memorial Award; Kurata Memorial Hitachi Science and Technology Foundation;  [23700429];  [25460341]	Ochiai Memorial Award; Kurata Memorial Hitachi Science and Technology Foundation; ; 	This study was supported by Grant-in-Aid for Young Scientists (B) 23700429 (to S. Y.), a grant from Ochiai Memorial Award 2013 (to S. Y.), a Kurata Grant awarded by the Kurata Memorial Hitachi Science and Technology Foundation (to S. Y.), and Grant-in-Aid for Scientific Research (C) 25460341 (to K. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ammendrup-Johnsen I, 2012, BIOCHEMISTRY-US, V51, P586, DOI 10.1021/bi2014689; Billingsley ML, 1997, BIOCHEM J, V323, P577, DOI 10.1042/bj3230577; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Jeganathan S, 2008, J BIOL CHEM, V283, P32066, DOI 10.1074/jbc.M805300200; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kimura T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0144; Llorens-Martin M, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00046; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Takashima A, 1996, NEUROSCI LETT, V203, P33, DOI 10.1016/0304-3940(95)12257-5; Takashima A, 1998, P NATL ACAD SCI USA, V95, P9637, DOI 10.1073/pnas.95.16.9637; Takashima A, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P309; Takashima A, 2009, J PHARMACOL SCI, V109, P174, DOI 10.1254/jphs.08R29FM; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; Volk L, 2010, P NATL ACAD SCI USA, V107, P21784, DOI 10.1073/pnas.1016103107; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xu JY, 2006, NEUROSIGNALS, V15, P190, DOI 10.1159/000098482	29	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29438	29448		10.1074/jbc.M114.619668	http://dx.doi.org/10.1074/jbc.M114.619668			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26472923	Green Published, hybrid			2022-12-28	WOS:000366613400028
J	Rogasevskaia, TP; Coorssen, JR				Rogasevskaia, Tatiana P.; Coorssen, Jens R.			The Role of Phospholipase D in Regulated Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; docking; membrane fusion; phosphatidic acid; Phospholipase D; priming	CA2+-TRIGGERED MEMBRANE-FUSION; CALCIUM-TRIGGERED EXOCYTOSIS; SEA-URCHIN EGG; PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; LYSOPHOSPHATIDIC ACID; VESICLE FUSION; ENRICHED MICRODOMAINS; SPONTANEOUS CURVATURE; NEUROENDOCRINE CELLS	There are a diversity of interpretations concerning the possible roles of phospholipase D and its biologically active product phosphatidic acid in the late, Ca2+-triggered steps of regulated exocytosis. To quantitatively address functional and molecular aspects of the involvement of phospholipase D-derived phosphatidic acid in regulated exocytosis, we used an array of phospholipase D inhibitors for ex vivo and in vitro treatments of sea urchin eggs and isolated cortices and cortical vesicles, respectively, to study late steps of exocytosis, including docking/priming and fusion. The experiments with fluorescent phosphatidylcholine reveal a low level of phospholipase D activity associated with cortical vesicles but a significantly higher activity on the plasma membrane. The effects of phospholipase D activity and its product phosphatidic acid on the Ca2+ sensitivity and rate of fusion correlate with modulatory upstream roles in docking and priming rather than to direct effects on fusion per se.	[Rogasevskaia, Tatiana P.] Mt Royal Univ, Dept Biol, Calgary, AB T3E 6K6, Canada; [Coorssen, Jens R.] Univ Western Sydney, Sch Med, Dept Mol Physiol, Penrith, NSW 2751, Australia; [Coorssen, Jens R.] Univ Western Sydney, Mol Med Res Grp, Penrith, NSW 2751, Australia	Mount Royal University; Western Sydney University; Western Sydney University	Rogasevskaia, TP (corresponding author), Mt Royal Univ, Dept Biol, Calgary, AB T3E 6K6, Canada.	trogasevskaia@mtroyal.ca; j.coorssen@uws.edu.au			National Health and Medical Research Council (NHMRC) of Australia [APP1065328]; Molecular Medicine Research Group; School of Medicine (Western Sydney University); CIHR (Canada); Department of Biology (Mount Royal University); Department of Physiology and Pharmacology (University of Calgary)	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Molecular Medicine Research Group; School of Medicine (Western Sydney University); CIHR (Canada)(Canadian Institutes of Health Research (CIHR)); Department of Biology (Mount Royal University); Department of Physiology and Pharmacology (University of Calgary)	This work was supported by the National Health and Medical Research Council (NHMRC) of Australia (APP1065328), the Molecular Medicine Research Group and the School of Medicine (Western Sydney University), and the CIHR (Canada) (to J. R. C.). This work was also supported by the Department of Biology (Mount Royal University) and the Department of Physiology and Pharmacology (University of Calgary) (to T. P. R.). The authors declare that they have no conflict of interest with the content of this article.	Aas V, 2001, CELL COMMUN ADHES, V8, P125, DOI 10.3109/15419060109080712; Abbineni PS, 2013, BIOL BULL-US, V224, P200, DOI 10.1086/BBLv224n3p200; Andresen BT, 2002, FEBS LETT, V531, P65, DOI 10.1016/S0014-5793(02)03483-X; Arisz SA, 2009, BBA-MOL CELL BIOL L, V1791, P869, DOI 10.1016/j.bbalip.2009.04.006; Bader MF, 2009, BBA-MOL CELL BIOL L, V1791, P936, DOI 10.1016/j.bbalip.2009.02.016; Banno Y, 1997, J BIOL CHEM, V272, P5208, DOI 10.1074/jbc.272.8.5208; Blank PS, 1998, J GEN PHYSIOL, V112, P559, DOI 10.1085/jgp.112.5.559; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cazzolli R, 2006, IUBMB LIFE, V58, P457, DOI 10.1080/15216540600871142; Chasserot-Golaz S, 2010, CELL MOL NEUROBIOL, V30, P1335, DOI 10.1007/s10571-010-9577-x; Chernomordik LV, 2006, J CELL BIOL, V175, P201, DOI 10.1083/jcb.200607083; Chiou YL, 2012, J BIOSCIENCES, V37, P277, DOI 10.1007/s12038-012-9198-2; Choi WS, 2002, J IMMUNOL, V168, P5682, DOI 10.4049/jimmunol.168.11.5682; Chowdary TK, 2007, BIOCHEM J, V401, P437, DOI 10.1042/BJ20061046; Churchward MA, 2005, J CELL SCI, V118, P4833, DOI 10.1242/jcs.02601; Churchward MA, 2008, BIOPHYS J, V94, P3976, DOI 10.1529/biophysj.107.123984; Churchward Matthew A, 2008, J Chem Biol, V1, P79, DOI 10.1007/s12154-008-0007-1; Churchward MA, 2009, BIOCHEM J, V423, P1, DOI 10.1042/BJ20090969; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Coorssen JR, 1996, AM J PHYSIOL-CELL PH, V270, pC1153, DOI 10.1152/ajpcell.1996.270.4.C1153; Coorssen JR, 2002, ANAL BIOCHEM, V307, P54, DOI 10.1016/S0003-2697(02)00015-5; Coorssen JR, 1998, J CELL BIOL, V143, P1845, DOI 10.1083/jcb.143.7.1845; Coorssen JR, 2003, J CELL SCI, V116, P2087, DOI 10.1242/jcs.00374; CROSSLEY I, 1988, BIOCHEM J, V252, P257, DOI 10.1042/bj2520257; DECKER SJ, 1983, DEV BIOL, V96, P37, DOI 10.1016/0012-1606(83)90309-3; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Fujiwara S, 2006, EXP PHYSIOL, V91, P249, DOI 10.1113/expphysiol.2005.032482; Hibbert JE, 2006, INT J BIOCHEM CELL B, V38, P461, DOI 10.1016/j.biocel.2005.10.008; Hornberger TA, 2006, P NATL ACAD SCI USA, V103, P4741, DOI 10.1073/pnas.0600678103; Humeau Y, 2001, P NATL ACAD SCI USA, V98, P15300, DOI 10.1073/pnas.261358698; ISENBERG G, 1991, J MUSCLE RES CELL M, V12, P136, DOI 10.1007/BF01774032; Itagaki K, 2003, J BIOL CHEM, V278, P27540, DOI 10.1074/jbc.M301763200; IWASAKI Y, 1994, APPL MICROBIOL BIOT, V42, P290, DOI 10.1007/s002530050252; Iyer SS, 2004, J IMMUNOL, V173, P2615, DOI 10.4049/jimmunol.173.4.2615; Jensen RE, 2006, NAT CELL BIOL, V8, P1215, DOI 10.1038/ncb1106-1215; Kim Y, 2000, J BIOL CHEM, V275, P13621, DOI 10.1074/jbc.275.18.13621; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P2097, DOI 10.1021/bi0478502; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Lavieri R, 2009, BIOORG MED CHEM LETT, V19, P2240, DOI 10.1016/j.bmcl.2009.02.125; LINDAHL M, 1993, INFLAMMATION, V17, P573, DOI 10.1007/BF00914195; Liscovitch M, 1999, BBA-MOL CELL BIOL L, V1439, P245, DOI 10.1016/S1388-1981(99)00098-0; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; MATTER WF, 1992, BIOCHEM BIOPH RES CO, V186, P624, DOI 10.1016/0006-291X(92)90792-J; McDavid S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109203; McDermott M, 2004, BIOCHEM CELL BIOL, V82, P225, DOI 10.1139/o03-079; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Monovich L, 2007, BIOORG MED CHEM LETT, V17, P2310, DOI 10.1016/j.bmcl.2007.01.059; Ormerod KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036395; PAI JK, 1988, J BIOL CHEM, V263, P12472; Parry MJ, 2008, J AM CHEM SOC, V130, P12953, DOI 10.1021/ja800516w; Ponting CP, 1996, PROTEIN SCI, V5, P914; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Rituper BT, 2013, BBA-MOL CELL BIOL L, V1831, P1228, DOI 10.1016/j.bbalip.2013.04.007; Rogasevskaia T, 2006, J CELL SCI, V119, P2688, DOI 10.1242/jcs.03007; Rogasevskaia TP, 2012, CELL CALCIUM, V52, P259, DOI 10.1016/j.ceca.2012.03.006; Rogasevskaia Tatiana P, 2011, J Chem Biol, V4, P117, DOI 10.1007/s12154-011-0056-8; Sarri E, 2003, BIOCHEM J, V369, P319, DOI 10.1042/BJ20021347; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Siddhanta A, 2000, J BIOL CHEM, V275, P12023, DOI 10.1074/jbc.275.16.12023; SINGHAL RL, 1995, BIOCHEM BIOPH RES CO, V208, P425, DOI 10.1006/bbrc.1995.1355; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Sung TC, 1999, J BIOL CHEM, V274, P494, DOI 10.1074/jbc.274.1.494; Sung TC, 1999, J BIOL CHEM, V274, P3659, DOI 10.1074/jbc.274.6.3659; Szule JA, 2003, BBA-MOL CELL RES, V1641, P121, DOI 10.1016/S0167-4889(03)00095-8; Vitale N, 2002, ANN NY ACAD SCI, V971, P193, DOI 10.1111/j.1749-6632.2002.tb04463.x; Vitale N, 2010, BIOCHEM SOC T, V38, P167, DOI 10.1042/BST0380167; Vogel SS, 1996, J CELL BIOL, V134, P329, DOI 10.1083/jcb.134.2.329; Wang WJ, 2012, J PHYS CHEM B, V116, P7213, DOI 10.1021/jp303840a; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wang ZC, 1999, INFECT IMMUN, V67, P3768, DOI 10.1128/IAI.67.8.3768-3772.1999; Waselle L, 2005, MOL ENDOCRINOL, V19, P3097, DOI 10.1210/me.2004-0530; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zimmerberg J, 1999, J PHYSIOL-LONDON, V520, P15, DOI 10.1111/j.1469-7793.1999.00015.x; Zimmerberg J, 2000, BIOCHIMIE, V82, P303, DOI 10.1016/S0300-9084(00)00215-7	78	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28683	28696		10.1074/jbc.M115.681429	http://dx.doi.org/10.1074/jbc.M115.681429			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26433011	Green Published, hybrid			2022-12-28	WOS:000365762300010
J	Saelices, L; Johnson, LM; Liang, WY; Sawaya, MR; Cascio, D; Ruchala, P; Whitelegge, J; Jiang, L; Riek, R; Eisenberg, DS				Saelices, Lorena; Johnson, Lisa M.; Liang, Wilson Y.; Sawaya, Michael R.; Cascio, Duilio; Ruchala, Piotr; Whitelegge, Julian; Jiang, Lin; Riek, Roland; Eisenberg, David S.			Uncovering the Mechanism of Aggregation of Human Transthyretin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; inhibition mechanism; peptide interaction; protein aggregation; x-ray crystallography; mutational analysis; TTR; transthyretin amyloidosis	AMYLOID FIBRIL FORMATION; SENILE SYSTEMIC AMYLOIDOSIS; CONFORMATIONAL-CHANGES; PROTEIN TRANSTHYRETIN; TETRAMER DISSOCIATION; MAXIMUM-LIKELIHOOD; THYROXINE-BINDING; PROLINE MUTATIONS; BETA-STRANDS; IN-VITRO	The tetrameric thyroxine transport protein transthyretin (TTR) forms amyloid fibrils upon dissociation and monomer unfolding. The aggregation of transthyretin has been reported as the cause of the life-threatening transthyretin amyloidosis. The standard treatment of familial cases of TTR amyloidosis has been liver transplantation. Although aggregation-preventing strategies involving ligands are known, understanding the mechanism of TTR aggregation can lead to additional inhibition approaches. Several models of TTR amyloid fibrils have been proposed, but the segments that drive aggregation of the protein have remained unknown. Here we identify -strands F and H as necessary for TTR aggregation. Based on the crystal structures of these segments, we designed two non-natural peptide inhibitors that block aggregation. This work provides the first characterization of peptide inhibitors for TTR aggregation, establishing a novel therapeutic strategy.	[Saelices, Lorena; Johnson, Lisa M.; Liang, Wilson Y.; Sawaya, Michael R.; Cascio, Duilio; Jiang, Lin; Eisenberg, David S.] Univ Calif Los Angeles, Dept Chem & Biochem, Dept Biol Chem, Los Angeles, CA 90095 USA; [Saelices, Lorena; Johnson, Lisa M.; Liang, Wilson Y.; Sawaya, Michael R.; Cascio, Duilio; Jiang, Lin; Eisenberg, David S.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Saelices, Lorena; Riek, Roland] ETH Honggerberg, Swiss Fed Inst Technol Zurich ETH, Phys Chem, CH-8093 Zurich, Switzerland; [Ruchala, Piotr; Whitelegge, Julian] Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; [Ruchala, Piotr; Whitelegge, Julian] Jane & Terry Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Los Angeles	Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Dept Biol Chem, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu		Saelices Gomez, Lorena/0000-0002-1904-2150; Sawaya, Michael/0000-0003-0874-9043; RUCHALA, PIOTR/0000-0002-5574-2779; Riek, Roland/0000-0002-6333-066X	DOE [DE-FC02-02ER63421, DE-AC02-06CH11357]; National Center for Research Resources [5P41RR015301-10]; National Institute of General Medical Sciences from the National Institutes of Health [8 P41 GM103403-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG048120, R01AG029430, RF1AG048120] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Kevin Chung for help with the analysis of monomeric TTR, Rebecca Nelson for discussions, and Joshua A. Chou for technical assistance. We thank the Electron Imaging Center for NanoMachines of California NanoSystems Institute (CNSI) at UCLA for using TEM. We thank Michael Collazo of the UCLA Crystallization Facility and the UCLA-Department of Energy (DOE) X-ray Crystallography Core Facility. We thank M. Capel, K. Rajashankar, N. Sukumar, J. Schuermann, I. Kourinov, and F. Murphy at Northeastern Collaborative Access Team beamlines 24-ID at the Advanced Photon Source (APS). The UCLA-DOE X-ray Crystallography Core Facility is supported by DOE Grant DE-FC02-02ER63421. APS staff is supported by National Center for Research Resources Grant 5P41RR015301-10) and National Institute of General Medical Sciences Grant 8 P41 GM103403-10 from the National Institutes of Health. Use of the APS is supported by DOE Contract DE-AC02-06CH11357.	Abedini A, 2006, J MOL BIOL, V355, P274, DOI 10.1016/j.jmb.2005.10.052; Alhamadsheh MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002473; ALVES IL, 1993, J CLIN ENDOCR METAB, V77, P484, DOI 10.1210/jc.77.2.484; Babbes ARH, 2008, BIOCHEMISTRY-US, V47, P6969, DOI 10.1021/bi800636q; Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Castano Adam, 2012, Congest Heart Fail, V18, P315, DOI 10.1111/j.1751-7133.2012.00303.x; Chiu CC, 2013, BIOPHYS J, V105, P1227, DOI 10.1016/j.bpj.2013.07.029; Chung CM, 2001, AMYLOID, V8, P75, DOI 10.3109/13506120109007348; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; CORNWELL GG, 1983, AM J MED, V75, P618, DOI 10.1016/0002-9343(83)90443-6; Cruz M, 2004, J PEPT RES, V63, P324, DOI 10.1111/j.1399-3011.2004.00156.x; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Eldridge B, 2009, PROTEIN ENG DES SEL, V22, P691, DOI 10.1093/protein/gzp052; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Ivanova MI, 2014, P NATL ACAD SCI USA, V111, P197, DOI 10.1073/pnas.1320786110; Jacobson DR, 1997, NEW ENGL J MED, V336, P466, DOI 10.1056/NEJM199702133360703; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Jiang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00857; Jiang X, 2001, P NATL ACAD SCI USA, V98, P14943, DOI 10.1073/pnas.261419998; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kroth H, 2012, J BIOL CHEM, V287, P34786, DOI 10.1074/jbc.M112.357665; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Laidman J, 2006, ACCOUNTS CHEM RES, V39, P576, DOI 10.1021/ar050017s; Lim KH, 2013, J MOL BIOL, V425, P977, DOI 10.1016/j.jmb.2013.01.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Misumi Y, 2013, LAB INVEST, V93, P911, DOI 10.1038/labinvest.2013.83; MUNRO SL, 1989, J CLIN ENDOCR METAB, V68, P1141, DOI 10.1210/jcem-68-6-1141; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; Palaninathan SK, 2008, J MOL BIOL, V382, P1157, DOI 10.1016/j.jmb.2008.07.029; Pires RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044992; Quintas A, 2001, J BIOL CHEM, V276, P27207, DOI 10.1074/jbc.M101024200; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schormann N, 1998, AMYLOID, V5, P175, DOI 10.3109/13506129809003843; Sekijima Y, 2014, J CLIN PHARM THER, V39, P225, DOI 10.1111/jcpt.12145; Serag AA, 2002, NAT STRUCT BIOL, V9, P734, DOI 10.1038/nsb838; Shnyrov VL, 2000, BIOPHYS CHEM, V88, P61, DOI 10.1016/S0301-4622(00)00199-X; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; SIPE JD, 1994, CRIT REV CL LAB SCI, V31, P325, DOI 10.3109/10408369409084679; Soto C, 2000, LANCET, V355, P192, DOI 10.1016/S0140-6736(99)11419-3; Takahashi T, 2008, ACCOUNTS CHEM RES, V41, P1309, DOI 10.1021/ar8000475; Takeuchi M, 2007, PROTEINS, V66, P716, DOI 10.1002/prot.21252; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	58	85	86	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28932	28943		10.1074/jbc.M115.659912	http://dx.doi.org/10.1074/jbc.M115.659912			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26459562	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000365762300032
J	Yamaga, M; Kielar-Grevstad, DM; Martin, TFJ				Yamaga, Masaki; Kielar-Grevstad, D. Michelle; Martin, Thomas F. J.			Phospholipase C2 Activation Redirects Vesicle Trafficking by Regulating F-actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; exocytosis; membrane trafficking; phosphoinositide; phospholipase C; vesicles	DENSE-CORE VESICLES; PROTEIN-KINASE-C; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; CHROMAFFIN CELLS; PLASMA-MEMBRANE; CA2+-ACTIVATED SECRETION; NEUROENDOCRINE CELLS; SNARE BINDING; EXOCYTOSIS; CYTOSKELETON	PI(4,5)P-2 localizes to sites of dense core vesicle exocytosis in neuroendocrine cells and is required for Ca2+-triggered vesicle exocytosis, but the impact of local PI(4,5)P-2 hydrolysis on exocytosis is poorly understood. Previously, we reported that Ca2+-dependent activation of phospholipase C2 (PLC2) catalyzes PI(4,5)P-2 hydrolysis, which affected vesicle exocytosis by regulating the activities of the lipid-dependent priming factors CAPS (also known as CADPS) and ubiquitous Munc13-2 in PC12 cells. Here we describe an additional role for PLC2 in vesicle exocytosis as a Ca2+-dependent regulator of the actin cytoskeleton. Depolarization of neuroendocrine PC12 cells with 56 or 95 mm KCl buffers increased peak Ca2+ levels to approximate to 400 or approximate to 800 nm, respectively, but elicited similar numbers of vesicle exocytic events. However, 56 mm K+ preferentially elicited the exocytosis of plasma membrane-resident vesicles, whereas 95 mm K+ preferentially elicited the exocytosis of cytoplasmic vesicles arriving during stimulation. Depolarization with 95 mm K+ but not with 56 mm K+ activated PLC2 to catalyze PI(4,5)P-2 hydrolysis. The decrease in PI(4,5)P-2 promoted F-actin disassembly, which increased exocytosis of newly arriving vesicles. Consistent with its role as a Ca2+-dependent regulator of the cortical actin cytoskeleton, PLC2 localized with F-actin filaments. The results highlight the importance of PI(4,5)P-2 for coordinating cytoskeletal dynamics with vesicle exocytosis and reveal a new role for PLC2 as a Ca2+-dependent regulator of F-actin dynamics and vesicle trafficking.	[Yamaga, Masaki; Kielar-Grevstad, D. Michelle; Martin, Thomas F. J.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Martin, TFJ (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	tfmartin@wisc.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [DK025861, DK040428]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK025861, R01DK025861, R01DK040428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM119158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK025861 and DK040428 (to T. F. J. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; AUNIS D, 1988, J EXP BIOL, V139, P253; Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; Bai L, 2006, TRAFFIC, V7, P416, DOI 10.1111/j.1600-0854.2006.00394.x; Bauer CS, 2007, J NEUROSCI, V27, P212, DOI 10.1523/JNEUROSCI.4201-06.2007; Bittner MA, 2005, MOL PHARMACOL, V67, P1089, DOI 10.1124/mol.104.008474; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Chowdhury HH, 2000, PFLUG ARCH EUR J PHY, V439, pR148, DOI 10.1007/s004240000125; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; Chung SC, 2011, BIOORG MED CHEM LETT, V21, P3198, DOI 10.1016/j.bmcl.2011.04.069; Cremona O, 2001, J CELL SCI, V114, P1041; DELCASTILLO AR, 1992, J CELL BIOL, V119, P797, DOI 10.1083/jcb.119.4.797; EBERHARD DA, 1990, BIOCHEM J, V268, P15, DOI 10.1042/bj2680015; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Kabachinski G, 2014, MOL BIOL CELL, V25, P508, DOI 10.1091/mbc.E12-11-0829; Kanemaru K, 2010, GENE EXPR PATTERNS, V10, P119, DOI 10.1016/j.gep.2009.12.004; Khodthong C, 2011, CELL METAB, V14, P254, DOI 10.1016/j.cmet.2011.07.002; Kim YH, 1999, J BIOL CHEM, V274, P26127, DOI 10.1074/jbc.274.37.26127; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; Loyet KM, 1998, J BIOL CHEM, V273, P8337, DOI 10.1074/jbc.273.14.8337; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Nakahara M, 2005, J BIOL CHEM, V280, P29128, DOI 10.1074/jbc.M503817200; Oheim M, 2000, J MEMBRANE BIOL, V178, P163, DOI 10.1007/s002320010032; Olsen HL, 2003, P NATL ACAD SCI USA, V100, P5187, DOI 10.1073/pnas.0931282100; ORCI L, 1972, SCIENCE, V175, P1128, DOI 10.1126/science.175.4026.1128; Pene TD, 2005, J NEUROCHEM, V92, P780, DOI 10.1111/j.1471-4159.2004.02907.x; Popovics P, 2013, J NEUROCHEM, V124, P632, DOI 10.1111/jnc.12122; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; REBER BFX, 1991, J PHYSIOL-LONDON, V435, P145, DOI 10.1113/jphysiol.1991.sp018502; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Sakisaka T, 1997, MOL CELL BIOL, V17, P3841, DOI 10.1128/MCB.17.7.3841; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Shin OH, 2010, NAT STRUCT MOL BIOL, V17, P280, DOI 10.1038/nsmb.1758; Stewart AJ, 2007, NEUROENDOCRINOLOGY, V86, P243, DOI 10.1159/000107795; Trifaro JM, 2008, ACTA PHYSIOL, V192, P165, DOI 10.1111/j.1748-1716.2007.01808.x; Trifaro JM, 2000, BIOCHIMIE, V82, P339, DOI 10.1016/S0300-9084(00)00193-0; Tse FW, 1997, NEURON, V18, P121, DOI 10.1016/S0896-6273(01)80051-9; Tucker WC, 2003, J CELL BIOL, V162, P199, DOI 10.1083/jcb.200302060; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; VITALE ML, 1991, J CELL BIOL, V113, P1057, DOI 10.1083/jcb.113.5.1057; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Wen PJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1500; Zhou YX, 2008, BIOCHEMISTRY-US, V47, P4410, DOI 10.1021/bi800044n; Zhou YX, 2005, BIOCHEM J, V391, P667, DOI 10.1042/BJ20050839	60	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29010	29021		10.1074/jbc.M115.658328	http://dx.doi.org/10.1074/jbc.M115.658328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26432644	Green Published, hybrid			2022-12-28	WOS:000365762300039
J	Sengupta, S; Prajapati, RK; Mukhopadhyay, J				Sengupta, Shreya; Prajapati, Ranjit Kumar; Mukhopadhyay, Jayanta			Promoter Escape with Bacterial Two-component sigma Factor Suggests Retention of sigma Region Two in the Elongation Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE HOLOENZYME; TRANSCRIPTION INITIATION; OXALATE DECARBOXYLASE; PROTEINS; SUBUNIT; RELEASE	The transition from the formation of the RNA polymerase (RNAP)-promoter open complex step to the productive elongation complex step involves "promoter escape" of RNAP. From the structure of RNAP, a promoter escape model has been proposed that suggests that the interactions between sigma R4 and RNAP and sigma R4 and DNA are destabilized upon transition to elongation. This accounts for the reduced affinity of sigma to RNAP and stochastic release of sigma. However, as the loss of interaction of sigma R4 with RNAP results in the release of intact sigma, assessing this interaction remains challenging to be experimentally verified. Here we study the promoter escape model using a two-component sigma factor YvrI and YvrHa from Bacillus subtilis that independently contributes to the functions of sigma R4 and sigma R2 in a RNAP-promoter complex. Our results show that YvrI, which mimics sigma R4, is released gradually as transcription elongation proceeds, whereas YvrHa, which mimics sigma R2 is retained throughout the elongation complexes. Thus our result validates the proposed model for promoter escape and also suggests that promoter escape involves little or no change in the interaction of sigma R2 with RNAP.	[Sengupta, Shreya; Prajapati, Ranjit Kumar; Mukhopadhyay, Jayanta] Bose Inst, Dept Chem, Kolkata 700009, India	Department of Science & Technology (India); Bose Institute	Mukhopadhyay, J (corresponding author), Bose Inst, Dept Chem, 93-1 APC Rd, Kolkata 700009, India.	jayanta@jcbose.ac.in		Prajapati, Ranjit/0000-0002-9294-3537; SENGUPTA, SHREYA/0000-0002-7801-984X	Department of Biotechnology, Ministry of Science and Technology, India [BT/PR 5345/MED/29/648/2012]; CSIR India	Department of Biotechnology, Ministry of Science and Technology, India; CSIR India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Research Grant BT/PR 5345/MED/29/648/2012 from the Department of Biotechnology, Ministry of Science and Technology, India. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of fellowships from CSIR India.	Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; Brodolin K, 2004, NAT STRUCT MOL BIOL, V11, P551, DOI 10.1038/nsmb768; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; GILL SC, 1991, J MOL BIOL, V220, P307, DOI 10.1016/0022-2836(91)90015-X; HANSEN UM, 1980, J BIOL CHEM, V255, P9564; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; Kim YG, 2008, BIOCONJUGATE CHEM, V19, P786, DOI 10.1021/bc7002499; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; MacLellan SR, 2008, MOL MICROBIOL, V69, P954, DOI 10.1111/j.1365-2958.2008.06331.x; MacLellan SR, 2009, P NATL ACAD SCI USA, V106, P21323, DOI 10.1073/pnas.0910006106; MacLellan SR, 2009, J BACTERIOL, V191, P931, DOI 10.1128/JB.01435-08; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; METZGER W, 1993, J MOL BIOL, V232, P35, DOI 10.1006/jmbi.1993.1368; Moerke Nathan J, 2009, Curr Protoc Chem Biol, V1, P1, DOI 10.1002/9780470559277.ch090102; Mooney RA, 2003, GENE DEV, V17, P2839, DOI 10.1101/gad.1142203; Mukhopadhyay J, 2003, METHOD ENZYMOL, V371, P144; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2003, CURR OPIN STRUC BIOL, V13, P31, DOI 10.1016/S0959-440X(02)00005-2; Nickels BE, 2004, NAT STRUCT MOL BIOL, V11, P544, DOI 10.1038/nsmb757; Raffaelle M, 2005, MOL CELL, V20, P357, DOI 10.1016/j.molcel.2005.10.011; Rudra P, 2015, NUCLEIC ACIDS RES, V43, P5855, DOI 10.1093/nar/gkv516; STRANEY DC, 1985, CELL, V43, P449, DOI 10.1016/0092-8674(85)90175-8; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Wade JT, 2004, P NATL ACAD SCI USA, V101, P17777, DOI 10.1073/pnas.0404305101; Yang X, 2008, PROTEIN EXPRES PURIF, V59, P86, DOI 10.1016/j.pep.2008.01.006	26	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28575	28583		10.1074/jbc.M115.666008	http://dx.doi.org/10.1074/jbc.M115.666008			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26400263	hybrid, Green Published			2022-12-28	WOS:000365761900048
J	Young, SK; Willy, JA; Wu, C; Sachs, MS; Wek, RC				Young, Sara K.; Willy, Jeffrey A.; Wu, Cheng; Sachs, Matthew S.; Wek, Ronald C.			Ribosome Reinitiation Directs Gene-specific Translation and Regulates the Integrated Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA TRANSLATION; EIF2-ALPHA DEPHOSPHORYLATION; ENDOPLASMIC-RETICULUM; SELECTIVE-INHIBITION; INITIATION; PHOSPHORYLATION; CELLS; PROTEOSTASIS; EXPRESSION	In the integrated stress response, phosphorylation of eIF2 alpha (eIF2 alpha-P) reduces protein synthesis to conserve resources and facilitate preferential translation of transcripts that promote stress adaptation. Preferentially translated GADD34 (PPP1R15A) and constitutively expressed CReP (PPP1R15B) function to dephosphorylate eIF2 alpha-P and restore protein synthesis. The 5'-leaders of GADD34 and CReP contain two upstream ORFs (uORFs). Using biochemical and genetic approaches we show that features of these uORFs are central for their differential expression. In the absence of stress, translation of an inhibitory uORF in GADD34 acts as a barrier that prevents reinitiation at the GADD34 coding region. Enhanced eIF2a-P during stress directs ribosome bypass of the uORF, facilitating translation of the GADD34 coding region. CReP expression occurs independent of eIF2 alpha-P via an uORF that allows for translation reinitiation at the CReP coding region independent of stress. Importantly, alterations in the GADD34 uORF affect the status of eIF2 alpha-P, translational control, and cell adaptation to stress. These results show that properties of uORFs that permit ribosome reinitiation are critical for directing gene-specific translational control in the integrated stress response.	[Young, Sara K.; Willy, Jeffrey A.; Wek, Ronald C.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Wu, Cheng; Sachs, Matthew S.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Indiana University System; Indiana University Bloomington; Texas A&M University System; Texas A&M University College Station	Wek, RC (corresponding author), Indiana Univ Sch Med, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iu.edu	Regan, Clinton/E-6250-2012	Young-Baird, Sara/0000-0002-8915-3139; Sachs, Matthew/0000-0001-9891-9223	National Institutes of Health [GM049164]; Ralph W. and Grace M. Showalter Research Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164, R29GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter Research Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM049164 (to R. C. W.) and the Ralph W. and Grace M. Showalter Research Trust Fund.	Andreev DE, 2015, ELIFE, V4, DOI 10.7554/eLife.03971; Baird TD, 2014, MOL BIOL CELL, V25, P1686, DOI 10.1091/mbc.E14-02-0704; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Das I, 2015, SCIENCE, V348, P239, DOI 10.1126/science.aaa4484; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Malzer E, 2013, J CELL SCI, V126, P1406, DOI 10.1242/jcs.117614; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Teske BF, 2013, MOL BIOL CELL, V24, P2477, DOI 10.1091/mbc.E13-01-0067; Teske BF, 2011, METHOD ENZYMOL, V490, P333, DOI 10.1016/B978-0-12-385114-7.00019-2; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904	25	45	45	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28257	28271		10.1074/jbc.M115.693184	http://dx.doi.org/10.1074/jbc.M115.693184			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26446796	Green Published, hybrid			2022-12-28	WOS:000365761900019
J	Yu, FJ; Zheng, JJ; Mao, YQ; Dong, PH; Lu, ZQ; Li, GJ; Guo, CY; Liu, ZJ; Fan, XM				Yu, Fujun; Zheng, Jianjian; Mao, Yuqing; Dong, Peihong; Lu, Zhongqiu; Li, Guojun; Guo, Chuanyong; Liu, Zhanju; Fan, Xiaoming			Long Non-coding RNA Growth Arrest-specific Transcript 5 (GAS5) Inhibits Liver Fibrogenesis through a Mechanism of Competing Endogenous RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC STELLATE CELLS; TUMOR-SUPPRESSOR; POOR-PROGNOSIS; FEEDBACK LOOP; CANCER; PROLIFERATION; EXPRESSION; FIBROSIS; MIRNAS; ACTIVATION	Effective control of hepatic stellate cell (HSC) activation and proliferation is critical to the treatment of liver fibrosis, Long non-coding RNAs have been shown to play a pivotal role in the regulation of cellular processes. It has been reported that growth arrest-specific transcript 5 (GAS 5) acts as a crucial mediator in the control of cell proliferation and growth. However, little is known about the role and underlying mechanism of GAS5 in liver fibrosis. In this study, our results indicated that GAS5 expression was reduced in mouse, rat, and human fibrotic liver samples and in activated HSCs. Overexpression of GAS5 suppressed the activation of primary HSCs in vitro and alleviated the accumulation of collagen in fibrotic liver tissues in vivo. We identified GASS as a target of microRNA-222 (miR-222) and showed that miR-222 could inhibit the expression of GAS5. Interestingly, GAS5 could also repress miR-222 expression. A pulldown assay further validated that GAS5 could directly bind to miR-222. As a competing endogenous RNAs, GAS5 had no effect on primary miR-222 expression. In addition, GAS5 was mainly localized in the cytoplasm. Quantitative RT-PCR further demonstrated that the copy numbers of GAS5 per cell are higher than those of miR-222. GAS5 increased the level of p27 protein by functioning as a competing endogenous RNA for miR-222, thereby inhibiting the activation and proliferation of HSCs. Taken together, a new regulatory circuitry in liver fibrosis has been identified in which RNAs cross-talk by competing for shared microRNAs. Our findings may provide a new therapeutic strategy for liver fibrosis.	[Yu, Fujun; Mao, Yuqing; Fan, Xiaoming] Fudan Univ, Jinshan Hosp, Dept Gastroenterol, Shanghai 201508, Peoples R China; [Zheng, Jianjian] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou Key Lab Surg, Wenzhou 325000, Peoples R China; [Dong, Peihong] Wenzhou Med Univ, Affiliated Hosp 1, Dept Infect Dis, Wenzhou 325000, Peoples R China; [Lu, Zhongqiu] Wenzhou Med Univ, Affiliated Hosp 1, Dept Emergency, Wenzhou 325000, Peoples R China; [Li, Guojun] Ningbo Yinzhou Second Hosp, Dept Hepatol, Ningbo 315000, Zhejiang, Peoples R China; [Guo, Chuanyong; Liu, Zhanju] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Gastroenterol, Shanghai 200072, Peoples R China; [Fan, Xiaoming] Fudan Univ, Shanghai Med Coll, Dept Internal Med, Shanghai 201508, Peoples R China	Fudan University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Tongji University; Fudan University	Fan, XM (corresponding author), Fudan Univ, Jinshan Hosp, Dept Gastroenterol, 1508 Longhang Rd, Shanghai 201508, Peoples R China.	ktsqdph@163.com		Guo, Chuanyong/0000-0002-6527-4673; mao, yuqing/0000-0003-4573-6567; Zheng, Jianjian/0000-0001-8770-4219; yu, fujun/0000-0001-5321-7228; LU, Zhongqiu/0000-0002-0569-4182	Science and Technology Commission of Shanghai Municipality [11ZR1405700]; Key Clinical Disciplines Construction of Shanghai Municipality [ZK2012B20]; National Natural Science Foundation of China [81000176/H0317, 81100292/H0317, 81500458/H0317]; Zhejiang Provincial Natural Science Foundation of China [Y2090326, Y2110634, LY16H030012]; Wenzhou Municipal Science and Technology Bureau [Y20110033, Y20120127]; Wang Bao-En Liver Fibrosis Foundation [20120127]; Key Disciplines in Colleges and Universities of Zhejiang Province	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Key Clinical Disciplines Construction of Shanghai Municipality; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Wenzhou Municipal Science and Technology Bureau; Wang Bao-En Liver Fibrosis Foundation; Key Disciplines in Colleges and Universities of Zhejiang Province	This work was supported by Science and Technology Commission of Shanghai Municipality Grant 11ZR1405700; Key Clinical Disciplines Construction of Shanghai Municipality Grant ZK2012B20; National Natural Science Foundation of China Grants 81000176/H0317, 81100292/H0317, and 81500458/H0317; Zhejiang Provincial Natural Science Foundation of China Grants Y2090326, Y2110634, and LY16H030012; Wenzhou Municipal Science and Technology Bureau Grants Y20110033 and Y20120127; Wang Bao-En Liver Fibrosis Foundation Grant 20120127; and the Key Disciplines in Colleges and Universities of Zhejiang Province. The authors declare that they have no conflicts of interest with the contents of this article.	Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; COCCIA EM, 1992, MOL CELL BIOL, V12, P3514, DOI 10.1128/MCB.12.8.3514; Estep M, 2010, ALIMENT PHARM THER, V32, P487, DOI 10.1111/j.1365-2036.2010.04366.x; Gao Y, 2015, HUM MOL GENET, V24, P841, DOI 10.1093/hmg/ddu502; Gao Y, 2014, NUCLEIC ACIDS RES, V42, P13799, DOI 10.1093/nar/gku1160; Greco S, 2015, J MOL CELL CARDIOL, V83, P142, DOI DOI 10.1016/j.yjmcc.2015.01.011; Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025; Han XR, 2015, FASEB J, V29, P3054, DOI 10.1096/fj.14-259952; Hsu SJ, 2015, HEPATOLOGY, V61, P1672, DOI 10.1002/hep.27679; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Lakner AM, 2012, HEPATOLOGY, V56, P300, DOI 10.1002/hep.25613; Lambrecht J, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00209; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Legnini I, 2014, MOL CELL, V53, P506, DOI 10.1016/j.molcel.2013.12.012; Lemoinne S, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.7; Li A, 2015, EUR J PHARMACOL, V747, P71, DOI 10.1016/j.ejphar.2014.11.040; Mormone E, 2011, CHEM-BIOL INTERACT, V193, P225, DOI 10.1016/j.cbi.2011.07.001; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Mourtada-Maarabouni M, 2008, J CELL SCI, V121, P939, DOI 10.1242/jcs.024646; Ogawa T, 2012, GUT, V61, P1600, DOI 10.1136/gutjnl-2011-300717; Orabi AI, 2015, J BIOL CHEM, V290, P11309, DOI 10.1074/jbc.M115.647933; Piccoli MT, 2015, J MOL CELL CARDIOL, V89, P59, DOI 10.1016/j.yjmcc.2015.02.002; Pickard MR, 2013, BBA-MOL BASIS DIS, V1832, P1613, DOI 10.1016/j.bbadis.2013.05.005; Pippa R, 2012, ONCOGENE, V31, P4207, DOI 10.1038/onc.2011.582; Qiao HP, 2013, ASIAN PAC J CANCER P, V14, P1077, DOI 10.7314/APJCP.2013.14.2.1077; Qiu MT, 2013, TUMOR BIOL, V34, P613, DOI 10.1007/s13277-013-0658-6; Renganathan A, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-119; Roy S, 2015, HEPATOBIL SURG NUTR, V4, P24, DOI 10.3978/j.issn.2304-3881.2015.01.05; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sarkar N, 2015, INT J MOL SCI, V16, P17746, DOI 10.3390/ijms160817746; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Song J, 2014, J ORTHOP RES, V32, P1628, DOI 10.1002/jor.22718; Sun M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-319; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Wang K, 2014, CIRC RES, V114, P1377, DOI 10.1161/CIRCRESAHA.114.302476; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Wu ZM, 2014, CELL MOL BIOL LETT, V19, P561, DOI 10.2478/s11658-014-0212-6; Xiao YT, 2014, CELL SIGNAL, V26, P925, DOI 10.1016/j.cellsig.2014.01.003; Yacqub-Usman K, 2015, PROSTATE, V75, P693, DOI 10.1002/pros.22952; Yin DD, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0253-8; Yu FJ, 2015, LAB INVEST, V95, P781, DOI 10.1038/labinvest.2015.58; Zaghlool A, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-99; Zhang A, 2014, J MOL CELL BIOL, V6, P181, DOI 10.1093/jmcb/mju013; Zhang Z, 2013, CELL DEATH DIFFER, V20, P1558, DOI 10.1038/cdd.2013.110; Zhang ZP, 2013, J BIOL CHEM, V288, P37082, DOI 10.1074/jbc.M113.517953; Zheng JJ, 2014, FEBS J, V281, P88, DOI 10.1111/febs.12574; Zhu LJ, 2015, MOL CANCER RES, V13, P41, DOI 10.1158/1541-7786.MCR-14-0239	48	108	115	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28286	28298		10.1074/jbc.M115.683813	http://dx.doi.org/10.1074/jbc.M115.683813			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26446789	Green Published, hybrid			2022-12-28	WOS:000365761900021
J	Krisenko, MO; Higgins, RL; Ghosh, S; Zhou, Q; Trybula, JS; Wang, WH; Geahlen, RL				Krisenko, Mariya O.; Higgins, Renee L.; Ghosh, Soumitra; Zhou, Qing; Trybula, Joy S.; Wang, Wen-Horng; Geahlen, Robert L.			Syk Is Recruited to Stress Granules and Promotes Their Clearance through Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE SYK; CONTAINING PROTEIN P97; PRION-LIKE DOMAINS; MESSENGER-RNA; CELL-RECEPTOR; SH2 DOMAIN; B-CELLS; SURVIVAL; INHIBITION; EXPRESSION	Syk is a cytoplasmic kinase that serves multiple functions within the immune system to couple receptors for antigens and antigen-antibody complexes to adaptive and innate immune responses. Recent studies have identified additional roles for the kinase in cancer cells, where its expression can either promote or suppress tumor cell growth, depending on the context. Proteomic analyses of Syk-binding proteins identified several interacting partners also found to be recruited to stress granules. We show here that the treatment of cells with inducers of stress granule formation leads to the recruitment of Syk to these protein-RNA complexes. This recruitment requires the phosphorylation of Syk on tyrosine and results in the phosphorylation of proteins at or near the stress granule. Grb7 is identified as a Syk-binding protein involved in the recruitment of Syk to the stress granule. This recruitment promotes the formation of autophagosomes and the clearance of stress granules from the cell once the stress is relieved, enhancing the ability of cells to survive the stress stimulus.	[Geahlen, Robert L.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Geahlen, RL (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, 201 S Univ St, W Lafayette, IN 47907 USA.	geahlen@purdue.edu		Geahlen, Robert/0000-0001-8400-2924	Public Health Service from the National Institutes of Health [R01AI098132, R01CA115465]; National Institutes of Health, NCI [CCSG CA23168]; National Science Foundation Graduate Research Fellowship [DGE-1333468]; NATIONAL CANCER INSTITUTE [P30CA023168, R01CA115465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI098132] Funding Source: NIH RePORTER	Public Health Service from the National Institutes of Health; National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service Grants R01AI098132 and R01CA115465 (to R. L. G.) from the National Institutes of Health. The DNA sequencing facility was supported by National Institutes of Health, NCI, Grant CCSG CA23168 to the Purdue University Center for Cancer Research. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Science Foundation Graduate Research Fellowship DGE-1333468.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Baudot AD, 2009, ONCOGENE, V28, P3261, DOI 10.1038/onc.2009.179; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Caldwell RG, 1998, IMMUNITY, V9, P405, DOI 10.1016/S1074-7613(00)80623-8; Carnevale J, 2013, LEUKEMIA, V27, P2118, DOI 10.1038/leu.2013.89; Chen CH, 2011, MOL CELL BIOL, V31, P2984, DOI 10.1128/MCB.05043-11; Chen LF, 2013, CANCER CELL, V23, P826, DOI 10.1016/j.ccr.2013.05.002; Chen SN, 2010, BBA-REV CANCER, V1806, P220, DOI 10.1016/j.bbcan.2010.07.003; Choi KS, 2012, EXP MOL MED, V44, P109, DOI 10.3858/emm.2012.44.2.033; Dormann D, 2011, TRENDS NEUROSCI, V34, P339, DOI 10.1016/j.tins.2011.05.002; FUMAGALLI S, 1994, NATURE, V368, P871, DOI 10.1038/368871a0; Galan JA, 2011, J AM SOC MASS SPECTR, V22, P319, DOI 10.1007/s13361-010-0030-7; Geahlen RL, 2014, TRENDS PHARMACOL SCI, V35, P414, DOI 10.1016/j.tips.2014.05.007; Geahlen RL, 2009, BBA-MOL CELL RES, V1793, P1115, DOI 10.1016/j.bbamcr.2009.03.004; Groesch TD, 2006, J MOL BIOL, V356, P1222, DOI 10.1016/j.jmb.2005.11.095; Hart CP, 1999, CELL SIGNAL, V11, P453, DOI 10.1016/S0898-6568(99)00017-0; Iliuk AB, 2010, MOL CELL PROTEOMICS, V9, P2162, DOI 10.1074/mcp.M110.000091; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanie T, 2004, LEUKEMIA, V18, P548, DOI 10.1038/sj.leu.2403266; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Keshvara LM, 1998, J IMMUNOL, V161, P5276; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Krisenko MO, 2015, BBA-MOL CELL RES, V1853, P254, DOI 10.1016/j.bbamcr.2014.10.022; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lague MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042470; Levin SE, 2008, J BIOL CHEM, V283, P15419, DOI 10.1074/jbc.M709000200; Li W, 2004, MOL CELL BIOL, V24, P10718, DOI 10.1128/MCB.24.24.10718-10732.2004; Machida K, 2007, MOL CELL, V26, P899, DOI 10.1016/j.molcel.2007.05.031; Maycotte P, 2014, CANCER RES, V74, P2579, DOI 10.1158/0008-5472.CAN-13-3470; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.e06-12-1079; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Oellerich T, 2013, BLOOD, V121, P3889, DOI 10.1182/blood-2012-09-457887; Oh H, 2007, J BIOL CHEM, V282, P33760, DOI 10.1074/jbc.M704846200; Oligino L, 1997, J BIOL CHEM, V272, P29046, DOI 10.1074/jbc.272.46.29046; Porter CJ, 2005, EUR BIOPHYS J BIOPHY, V34, P454, DOI [10.1007/s00249-005-0480-1, 10.1007/s00249-005-0480-l]; Porter CJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-58; Prinos P, 2011, NAT STRUCT MOL BIOL, V18, P673, DOI 10.1038/nsmb.2040; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Tsai NP, 2008, EMBO J, V27, P715, DOI 10.1038/emboj.2008.19; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Uckun FM, 2010, P NATL ACAD SCI USA, V107, P2902, DOI 10.1073/pnas.0909086107; Udyavar AR, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S5-S1; Wang WH, 2014, MOL CELL BIOL, V34, P3788, DOI 10.1128/MCB.00937-14; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Xue L, 2012, P NATL ACAD SCI USA, V109, P5615, DOI 10.1073/pnas.1119418109; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhou F, 2006, MOL CELL BIOL, V26, P3478, DOI 10.1128/MCB.26.9.3478-3491.2006; Zhou Q, 2009, ONCOGENE, V28, P1348, DOI 10.1038/onc.2008.493	56	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27803	27815		10.1074/jbc.M115.642900	http://dx.doi.org/10.1074/jbc.M115.642900			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26429917	Green Published, hybrid			2022-12-28	WOS:000365757500031
J	McIntyre, J; McLenigan, MP; Frank, EG; Dai, XX; Yang, W; Wang, YS; Woodgate, R				McIntyre, Justyna; McLenigan, Mary P.; Frank, Ekaterina G.; Dai, Xiaoxia; Yang, Wei; Wang, Yinsheng; Woodgate, Roger			Posttranslational Regulation of Human DNA Polymerase i	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; LYSINE ACETYLTRANSFERASE KAT3B/P300; TRANSLESION SYNTHESIS; Y-FAMILY; STRUCTURAL BASIS; UBIQUITINATION SITES; OXIDATIVE STRESS; MAMMALIAN-CELLS; IOTA; ETA	Background: Many proteins are subject to posttranslational regulation, such as ubiquitination. Results: Human DNA polymerase iota (pol iota) can be monoubiquitinated at >27 unique sites, and exposure to naphthoquinones results in polyubiquitination of pol iota. Conclusion: Ubiquitination sites are located across the entire pol iota polypeptide as well as various structural motifs. Significance: Ubiquitination at these sites is likely to alter cellular functions of pol iota in vivo. Human DNA polymerases (pols) eta and i are Y-family DNA polymerase paralogs that facilitate translesion synthesis past damaged DNA. Both pol eta and poli can be monoubiquitinated in vivo. Pol eta has been shown to be ubiquitinated at one primary site. When this site is unavailable, three nearby lysines may become ubiquitinated. In contrast, mass spectrometry analysis of monoubiquitinated poli revealed that it is ubiquitinated at over 27 unique sites. Many of these sites are localized in different functional domains of the protein, including the catalytic polymerase domain, the proliferating cell nuclear antigen-interacting region, the Rev1-interacting region, and its ubiquitin binding motifs UBM1 and UBM2. Poli monoubiquitination remains unchanged after cells are exposed to DNA-damaging agents such as UV light (generating UV photoproducts), ethyl methanesulfonate (generating alkylation damage), mitomycin C (generating interstrand cross-links), or potassium bromate (generating direct oxidative DNA damage). However, when exposed to naphthoquinones, such as menadione and plumbagin, which cause indirect oxidative damage through mitochondrial dysfunction, poli becomes transiently polyubiquitinated via Lys(11)- and Lys(48)-linked chains of ubiquitin and subsequently targeted for degradation. Polyubiquitination does not occur as a direct result of the perturbation of the redox cycle as no polyubiquitination was observed after treatment with rotenone or antimycin A, which both inhibit mitochondrial electron transport. Interestingly, polyubiquitination was observed after the inhibition of the lysine acetyltransferase KATB3/p300. We hypothesize that the formation of polyubiquitination chains attached to poli occurs via the interplay between lysine acetylation and ubiquitination of ubiquitin itself at Lys(11) and Lys(48) rather than oxidative damage per se.	[Woodgate, Roger] NICHD, Lab Genom Integr, NIH, Bethesda, MD 20892 USA; [McIntyre, Justyna] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Dai, Xiaoxia; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Yang, Wei] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of California System; University of California Riverside; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Woodgate, R (corresponding author), NICHD, Lab Genom Integr, NIH, Bethesda, MD 20892 USA.	woodgate@nih.gov	McIntyre, Justyna/M-9186-2014; Regan, Clinton/E-6250-2012; Yang, Wei/ABB-4785-2020	McIntyre, Justyna/0000-0002-0382-4799; Yang, Wei/0000-0002-3591-2195; Dai, Xiaoxia/0000-0002-3514-5061	NICHD, National Institutes of Health Intramural Research Program; NIDDK, National Institutes of Health Intramural Research Program; Foundation for Polish Science [HOMING PLUS/2013-7/10]; National Institutes of Health [R01 DK082779]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082779] Funding Source: NIH RePORTER	NICHD, National Institutes of Health Intramural Research Program; NIDDK, National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NICHD, National Institutes of Health Intramural Research Program (to R.W.); the NIDDK, National Institutes of Health Intramural Research Program (to W.Y.); the Foundation for Polish Science HOMING PLUS/2013-7/10 (to J.M.); and National Institutes of Health Grant R01 DK082779 (to Y.W.). The authors declare that they have no conflicts of interest with the contents of this article.	BALLMAIER D, 1995, CARCINOGENESIS, V16, P335, DOI 10.1093/carcin/16.2.335; Bebenek K, 2001, SCIENCE, V291, P2156, DOI 10.1126/science.1058386; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bienko M, 2010, MOL CELL, V37, P396, DOI 10.1016/j.molcel.2009.12.039; Burschowsky D, 2011, J BIOL CHEM, V286, P1364, DOI 10.1074/jbc.M110.135038; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Cui GF, 2010, BIOCHEMISTRY-US, V49, P10198, DOI 10.1021/bi101303t; Dai XX, 2013, J PROTEOME RES, V12, P4167, DOI 10.1021/pr400498y; Danielsen J. M., 2011, MOL CELL PROTEOMICS, V10, pM110, DOI DOI 10.1074/mcp.M110.003590; Frank EG, 2002, NUCLEIC ACIDS RES, V30, P5284, DOI 10.1093/nar/gkf643; Frank EG, 2007, J BIOL CHEM, V282, P24689, DOI 10.1074/jbc.M702159200; Haracska L, 2005, MOL CELL BIOL, V25, P1183, DOI 10.1128/MCB.25.3.1183-1190.2005; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; JABUSCH JR, 1985, ARCH BIOCHEM BIOPHYS, V238, P170, DOI 10.1016/0003-9861(85)90153-5; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kanao R, 2015, DNA REPAIR, V29, P139, DOI 10.1016/j.dnarep.2015.02.006; Kannouche P, 2002, EMBO J, V21, P6246, DOI 10.1093/emboj/cdf618; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kayashima T, 2009, CANCER LETT, V278, P34, DOI 10.1016/j.canlet.2008.12.020; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kirouac KN, 2009, EMBO J, V28, P1644, DOI 10.1038/emboj.2009.122; Klaus V, 2010, ARCH BIOCHEM BIOPHYS, V496, P93, DOI 10.1016/j.abb.2010.02.002; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Li L, 1999, MOL CELL BIOL, V19, P5619; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Matsubara K, 2008, INT J MOL MED, V22, P381, DOI 10.3892/ijmm_00000034; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; McIntyre J, 2015, DNA REPAIR, V29, P166, DOI 10.1016/j.dnarep.2015.02.011; McIntyre J, 2013, NUCLEIC ACIDS RES, V41, P1649, DOI 10.1093/nar/gks1277; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Neuberger MS, 2007, J EXP MED, V204, P7, DOI 10.1084/jem.20062409; Ohashi E, 2009, GENES CELLS, V14, P101, DOI 10.1111/j.1365-2443.2008.01255.x; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Park WH, 2007, J CELL BIOCHEM, V102, P98, DOI 10.1002/jcb.21280; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; Petta TB, 2008, EMBO J, V27, P2883, DOI 10.1038/emboj.2008.210; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Prasad R, 2003, J BIOL CHEM, V278, P29649, DOI 10.1074/jbc.M305399200; Ravindra KC, 2009, J BIOL CHEM, V284, P24453, DOI 10.1074/jbc.M109.023861; Sabbioneda S, 2008, MOL BIOL CELL, V19, P5193, DOI 10.1091/mbc.E08-07-0724; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; SEGA GA, 1984, MUTAT RES, V134, P113, DOI 10.1016/0165-1110(84)90007-1; Seung SA, 1998, CHEM-BIOL INTERACT, V113, P133, DOI 10.1016/S0009-2797(98)00024-6; Temviriyanukul P, 2012, TOXICOL SCI, V127, P130, DOI 10.1093/toxsci/kfs074; Tissier A, 2000, GENE DEV, V14, P1642; Tissier A, 2004, DNA REPAIR, V3, P1503, DOI 10.1016/j.dnarep.2004.06.015; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Vasudevarao MD, 2014, J BIOL CHEM, V289, P7702, DOI 10.1074/jbc.M113.486522; Vidal AE, 2004, J BIOL CHEM, V279, P48360, DOI 10.1074/jbc.M406511200; Wagner S. A., 2011, MOL CELL PROTEOMICS, V10, pM111, DOI DOI 10.1074/MCP.M111.013284; Warren AJ, 1998, CANCER RES, V58, P453; Washington MT, 2004, MOL CELL BIOL, V24, P936, DOI 10.1128/MCB.24.2.936-943.2004; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yuan BF, 2011, J BIOL CHEM, V286, P17503, DOI 10.1074/jbc.M111.232835; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000	70	12	12	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27332	27344		10.1074/jbc.M115.675769	http://dx.doi.org/10.1074/jbc.M115.675769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26370087	Green Published, hybrid			2022-12-28	WOS:000364794000040
J	Mittal, SK; Cho, KJ; Ishido, S; Roche, PA				Mittal, Sharad K.; Cho, Kyung-Jin; Ishido, Satoshi; Roche, Paul A.			Interleukin 10 (IL-10)-mediated Immunosuppression: MARCH-I INDUCTION REGULATES ANTIGEN PRESENTATION BY MACROPHAGES BUT NOT DENDRITIC CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-II; NEGATIVE REGULATION; PEPTIDE COMPLEXES; IMMUNE-RESPONSES; DOWN-REGULATION; T-CELLS; IL-10; UBIQUITINATION; EXPRESSION; MONOCYTES	Efficient immune responses require regulated antigen presentation to CD4 T cells. IL-10 inhibits the ability of dendritic cells (DCs) and macrophages to stimulate antigen-specific CD4 T cells; however, the mechanisms by which IL-10 suppresses antigen presentation remain poorly understood. We now report that IL-10 stimulates expression of the E3 ubiquitin ligase March-I in activated macrophages, thereby down-regulating MHC-II, CD86, and antigen presentation to CD4 T cells. By contrast, IL-10 does not stimulate March-I expression in DCs, does not suppress MHC-II or CD86 expression on either resting or activated DCs, and does not affect antigen presentation by activated DCs. IL-10 does, however, inhibit the process of DC activation itself, thereby reducing the efficiency of antigen presentation in a March-I-independent manner. Thus, IL-10 suppression of antigen presenting cell function in macrophages is March-I-dependent, whereas in DCs, suppression is March- I-independent.	[Mittal, Sharad K.; Cho, Kyung-Jin; Roche, Paul A.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Ishido, Satoshi] Showa Pharmaceut Univ, Lab Integrat Infect Immun, Machida, Tokyo 1948543, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Showa Pharmaceutical University	Roche, PA (corresponding author), NIH, Bldg 10,Rm 4B36, Bethesda, MD 20892 USA.	paul.roche@nih.gov		Roche, Paul/0000-0002-8949-9172	Intramural Research Program of the National Institutes of Health; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Intramural Research Program of the National Institutes of Health (to P. A. R.), the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. I.), and the Japan Society for the Promotion of Science (to S. I.). The authors declare that they have no conflicts of interest with the contents of this article.	An HZ, 2005, BLOOD, V105, P4685, DOI 10.1182/blood-2005-01-0191; Avdic S, 2013, J VIROL, V87, P10273, DOI 10.1128/JVI.00912-13; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Chang J, 2009, P NATL ACAD SCI USA, V106, P18327, DOI 10.1073/pnas.0905815106; Chattopadhyay G, 2013, J IMMUNOL, V191, P5875, DOI 10.4049/jimmunol.1301693; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; Curtale G, 2013, P NATL ACAD SCI USA, V110, P11499, DOI 10.1073/pnas.1219852110; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Ding YZ, 2003, J IMMUNOL, V170, P1383, DOI 10.4049/jimmunol.170.3.1383; Gabhann JN, 2010, J IMMUNOL, V184, P2314, DOI 10.4049/jimmunol.0902589; Haase C, 2002, IMMUNOLOGY, V107, P489, DOI 10.1046/j.1365-2567.2002.01529.x; Hunt D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037330; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ishido S, 2009, CURR OPIN IMMUNOL, V21, P78, DOI 10.1016/j.coi.2009.01.002; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Kalinski P, 1998, J IMMUNOL, V161, P2804; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; KOERNER TJ, 1987, J IMMUNOL, V139, P239; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Lee SJ, 2007, J LEUKOCYTE BIOL, V82, P436, DOI 10.1189/jlb.1206739; Levesque SA, 2010, EUR J IMMUNOL, V40, P1473, DOI 10.1002/eji.200939741; Li JF, 2000, HUM IMMUNOL, V61, P486, DOI 10.1016/S0198-8859(00)00099-9; MALEFYT RD, 1991, J EXP MED, V174, P915; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Mittal SK, 2015, CURR OPIN IMMUNOL, V34, P22, DOI 10.1016/j.coi.2014.12.009; Ohmura-Hoshino M, 2009, J IMMUNOL, V183, P6893, DOI 10.4049/jimmunol.0902178; Pajkrt D, 1997, J IMMUNOL, V158, P3971; Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schrum AG, 2005, EUR J IMMUNOL, V35, P449, DOI 10.1002/eji.200425635; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; Vremec D, 2011, INNATE IMMUN-LONDON, V17, P338, DOI 10.1177/1753425910371396; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Walseng E, 2010, J BIOL CHEM, V285, P41749, DOI 10.1074/jbc.M110.157586; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665	39	79	82	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27158	27167		10.1074/jbc.M115.682708	http://dx.doi.org/10.1074/jbc.M115.682708			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26408197	hybrid, Green Published			2022-12-28	WOS:000364794000025
J	Appella, E; Jenkins, LMM; Guengerich, FP				Appella, Ettore; Jenkins, Lisa M. Miller; Guengerich, F. Peter			Introduction to Thematic Series: Protein Interactions, Structures, and Networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Protein interactions are fundamental to the proper functioning of cells, and aberrant formation or regulation of protein interactions is at the heart of many diseases, including cancer. The advancement of methods to study the identity, function, and regulation of protein complexes makes possible the understanding of how those complexes malfunction in human diseases. New methodologies in mass spectrometry, microscopy, and protein structural analysis are rapidly advancing the amount and quality of the data, as well as the level of detail that can be obtained from experiments. With this progress, the questions that can be addressed and the biological landscape are changing. This series of minireviews highlights methodological advances and how they have been applied in novel ways to explore the function and regulation of pathways and dynamic networks in cells.	[Appella, Ettore; Jenkins, Lisa M. Miller] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University	Appella, E (corresponding author), NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	appellae@mail.nih.gov	Jenkins, Lisa/AAI-2490-2021		NATIONAL CANCER INSTITUTE [ZICBC011430] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Balagopalan L, 2015, J BIOL CHEM, V290, P26422, DOI 10.1074/jbc.R115.665869; Diner BA, 2015, J BIOL CHEM, V290, P26412, DOI 10.1074/jbc.R115.652289; Fishel R, 2015, J BIOL CHEM, V290, P26395, DOI 10.1074/jbc.R115.660142; Hoffman EA, 2015, J BIOL CHEM, V290, P26404, DOI 10.1074/jbc.R115.651679; Landreh M, 2015, J BIOL CHEM, V290, P26430, DOI 10.1074/jbc.R115.653097; Phillips AH, 2015, J BIOL CHEM, V290, P26437, DOI 10.1074/jbc.R115.653675	6	0	0	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26393	26394		10.1074/jbc.R115.690370	http://dx.doi.org/10.1074/jbc.R115.690370			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354433	hybrid, Green Published			2022-12-28	WOS:000364793600005
J	Okazawa, Y; Miyazaki, T; Yokoi, G; Ishizaki, Y; Nishikawa, A; Tonozuka, T				Okazawa, Yuka; Miyazaki, Takatsugu; Yokoi, Gaku; Ishizaki, Yuichi; Nishikawa, Atsushi; Tonozuka, Takashi			Crystal Structure and Mutational Analysis of Isomaltodextranase, a Member of Glycoside Hydrolase Family 27	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; ARTHROBACTER-GLOBIFORMIS T6; BETA-L-ARABINOPYRANOSIDASE; HUMAN ALPHA-GALACTOSIDASE; X-RAY; ISOMALTO-DEXTRANASE; MOLECULAR-BASIS; ACTIVE-SITE; MECHANISM; SPECIFICITY	Arthrobacter globiformis T6 isomalto-dextranase (AgIMD) is an enzyme that liberates isomaltose from the non-reducing end of a polymer of glucose, dextran. AgIMD is classified as a member of the glycoside hydrolase family (GH) 27, which comprises mainly alpha-galactosidases and alpha-N-acetylgalactosaminidases, whereas AgIMD does not show alpha-galactosidase or alpha-N-acetylgalactosaminidase activities. Here, we determined the crystal structure of AgIMD. AgIMD consists of the following three domains: A, C, and D. Domains A and C are identified as a (beta/alpha)(8)-barrel catalytic domain and an antiparallel beta-structure, respectively, both of which are commonly found in GH27 enzymes. However, domain A of AgIMD has subdomain B, loop-1, and loop-2, all of which are not found in GH27 human alpha-galactosidase. AgIMD in a complex with trisaccharide panose shows that Asp-207, a residue in loop-1, is involved in subsite + 1. Kinetic parameters of the wild-type and mutant enzymes for the small synthetic saccharide p-nitrophenyl alpha-isomaltoside and the polysaccharide dextran were compared, showing that Asp-207 is important for the catalysis of dextran. Domain D is classified as carbohydrate-binding module (CBM) 35, and an isomaltose molecule is seen in this domain in the AgIMD-isomaltose complex. Domain D is highly homologous to CBM35 domains found in GH31 and GH66 enzymes. The results here indicate that some features found in GH13, -31, and -66 enzymes, such as subdomain B, residues at the subsite + 1, and the CBM35 domain, are also observed in the GH27 enzyme AgIMD and thus provide insights into the evolutionary relationships among GH13, -27, -31, -36, and -66 enzymes.	[Okazawa, Yuka; Miyazaki, Takatsugu; Yokoi, Gaku; Ishizaki, Yuichi; Nishikawa, Atsushi; Tonozuka, Takashi] Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Fuchu, Tokyo 1838509, Japan	Tokyo University of Agriculture & Technology	Tonozuka, T (corresponding author), Tokyo Univ Agr & Technol, Dept Appl Biol Sci, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	tonozuka@cc.tuat.ac.jp	Miyazaki, Takatsugu/M-1498-2016; Nishikawa, Atsushi/E-6766-2013; Tonozuka, Takashi/D-2268-2013	Miyazaki, Takatsugu/0000-0003-1809-0641; Nishikawa, Atsushi/0000-0003-4325-1160; Tonozuka, Takashi/0000-0002-5422-7548	Japan Society for the Promotion of Science [26660277]; Grants-in-Aid for Scientific Research [26660277] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-aid for Scientific Research 26660277 (to T. T.) of the Japan Society for the Promotion of Science. This work was performed with the approval of the Photon Factory Advisory Committee (No. 2014G512), the National Laboratory for High Energy Physics, Tsukuba, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abe A, 2005, FEBS J, V272, P6145, DOI 10.1111/j.1742-4658.2005.05013.x; Aghajari N, 2002, BIOCHEMISTRY-US, V41, P4273, DOI 10.1021/bi0160516; Akita M, 2004, ACTA CRYSTALLOGR D, V60, P572, DOI 10.1107/S090744490400006X; Allouch J, 2004, STRUCTURE, V12, P623, DOI 10.1016/j.str.2004.02.020; Chen M, 2014, J PHYS CHEM B, V118, P2306, DOI 10.1021/jp408767j; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Comfort DA, 2007, BIOCHEMISTRY-US, V46, P3319, DOI 10.1021/bi061521n; Copeland A, 2009, STAND GENOMIC SCI, V1, P119, DOI [10.4056/sigs.17259, 10.4056/sigs.29547]; Correia MAS, 2010, BIOCHEMISTRY-US, V49, P6193, DOI 10.1021/bi1006139; DAGNALL BH, 1995, BIOCHEM J, V311, P349, DOI 10.1042/bj3110349; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Guce AI, 2010, J BIOL CHEM, V285, P3625, DOI 10.1074/jbc.M109.060145; Hart DO, 2000, BIOCHEMISTRY-US, V39, P9826, DOI 10.1021/bi0008074; Hashimoto T., 2006, Journal of Applied Glycoscience, V53, P233; Hashimoto Y, 2001, J BACTERIOL, V183, P5050, DOI 10.1128/JB.183.17.5050-5057.2001; Hayacibara MF, 2004, CARBOHYD RES, V339, P2127, DOI 10.1016/j.carres.2004.05.031; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hondoh H, 2008, J MOL BIOL, V378, P913, DOI 10.1016/j.jmb.2008.03.016; Ichinose H, 2009, J BIOL CHEM, V284, P25097, DOI 10.1074/jbc.M109.022723; KACHURIN AM, 1995, BIOCHEM J, V308, P955, DOI 10.1042/bj3080955; Khalikova E, 2005, MICROBIOL MOL BIOL R, V69, P306, DOI 10.1128/MMBR.69.2.306-325.2005; KIM YK, 1995, BIOSCI BIOTECH BIOCH, V59, P1367, DOI 10.1271/bbb.59.1367; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lansky S, 2014, ACTA CRYSTALLOGR D, V70, P2994, DOI 10.1107/S139900471401863X; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lopez-Casado G, 2008, CURR OPIN PLANT BIOL, V11, P329, DOI 10.1016/j.pbi.2008.02.010; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; Miyazaki T, 2015, BIOCHEM J, V469, P145, DOI 10.1042/BJ20150261; Montanier C, 2009, P NATL ACAD SCI USA, V106, P3065, DOI 10.1073/pnas.0808972106; Nihira T, 2005, BIOCHEMISTRY-US, V44, P9456, DOI 10.1021/bi050079q; Okuyama M, 2006, FEBS LETT, V580, P2707, DOI 10.1016/j.febslet.2006.04.025; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rigden DJ, 2002, FEBS LETT, V523, P17, DOI 10.1016/S0014-5793(02)02879-X; SAWAI T, 1974, J BIOCHEM-TOKYO, V75, P105, DOI 10.1093/oxfordjournals.jbchem.a130363; SAWAI T, 1981, CARBOHYD RES, V89, P289, DOI 10.1016/S0008-6215(00)85254-4; Suzuki N, 2014, J BIOL CHEM, V289, P12040, DOI 10.1074/jbc.M114.547992; TAKAYANAGI T, 1987, AGR BIOL CHEM TOKYO, V51, P2337; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Tonozuka T., 2004, Journal of Applied Glycoscience, V51, P27; Tonozuka T, 2012, ENZYME MICROB TECH, V51, P359, DOI 10.1016/j.enzmictec.2012.08.004; Tsukagoshi H, 2014, J BIOL CHEM, V289, P10843, DOI 10.1074/jbc.M114.555383; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	48	11	13	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26339	26349		10.1074/jbc.M115.680942	http://dx.doi.org/10.1074/jbc.M115.680942			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26330557	hybrid, Green Published			2022-12-28	WOS:000363527300049
J	Dorr, A; Pierre, S; Zhang, DD; Henke, M; Holland, S; Scholich, K				Doerr, Angela; Pierre, Sandra; Zhang, Dong D.; Henke, Marina; Holland, Sabrina; Scholich, Klaus			MYCBP2 Is a Guanosine Exchange Factor for Ran Protein and Determines Its Localization in Neurons of Dorsal Root Ganglia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; GUANINE-NUCLEOTIDE EXCHANGE; ADENYLYL CYCLASES; SYNAPSE FORMATION; FORMATION REVEALS; AXON TERMINATION; BINDING-PROTEIN; LIGASE PAM; C-ELEGANS; EXPORT	The small GTPase Ran coordinates retrograde axonal transport in neurons, spindle assembly during mitosis, and the nucleo-cytoplasmic transport of mRNA. Its localization is tightly regulated by the GTPase-activating protein RanGAP1 and the nuclear guanosine exchange factor (GEF) RCC1. We show that loss of the neuronal E3 ubiquitin ligase MYCBP2 caused the up-regulation of Ran and RanGAP1 in dorsal root ganglia (DRG) under basal conditions and during inflammatory hyperalgesia. SUMOylated RanGAP1 physically interacted with MYCBP2 and inhibited its E3 ubiquitin ligase activity. Stimulation of neurons induced a RanGAP1-dependent translocation of MYCBP2 to the nucleus. In the nucleus of DRG neurons MYCBP2 co-localized with Ran and facilitated through its RCC1-like domain the GDP/GTP exchange of Ran. In accordance with the necessity of a GEF to promote GTP-binding and nuclear export of Ran, the nuclear localization of Ran was strongly increased in MYCBP2-deficient DRGs. The finding that other GEFs for Ran besides RCC1 exist gives new insights in the complexity of the regulation of the Ran signaling pathway.	[Doerr, Angela; Pierre, Sandra; Zhang, Dong D.; Henke, Marina; Holland, Sabrina; Scholich, Klaus] Klinikum Goethe Univ Frankfurt, Pharmazentrum Frankfurt, Inst Klin Pharmakol, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Scholich, K (corresponding author), Klinikum Goethe Univ Frankfurt, Pharmazentrum Frankfurt, Inst Klin Pharmakol, D-60590 Frankfurt, Germany.	scholich@em.uni-frankfurt.de		Holland, Sabrina M/0000-0003-4805-1803	German Research Association (DFG) [SCHO817/3, SFB1039-TP08]	German Research Association (DFG)(German Research Foundation (DFG))	This work was supported by German Research Association (DFG) Grants SCHO817/3 and SFB1039-TP08. The authors declare that they have no conflicts of interest with the contents of this article.	AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; BROWN JA, 1995, J BIOL CHEM, V270, P7411, DOI 10.1074/jbc.270.13.7411; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Ehnert C, 2004, J NEUROCHEM, V88, P948, DOI 10.1046/j.1471-4159.2003.02229.x; Gama L, 1999, BIOTECHNIQUES, V26, P814, DOI 10.2144/99265bm03; Gao XL, 2005, MOL PHARMACOL, V67, P42, DOI 10.1124/mol.104.005355; Garbarini N, 2008, CELL PHYSIOL BIOCHEM, V22, P31, DOI 10.1159/000149781; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Grill B, 2012, J NEUROSCI, V32, P2628, DOI 10.1523/JNEUROSCI.2901-11.2012; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; Holland S, 2011, J BIOL CHEM, V286, P3671, DOI 10.1074/jbc.M110.154765; Kalab P, 1999, CURR BIOL, V9, P481, DOI 10.1016/S0960-9822(99)80213-9; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kehlenbach RH, 2001, J BIOL CHEM, V276, P14524, DOI 10.1074/jbc.M011087200; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Maeurer C, 2009, CELL SIGNAL, V21, P293, DOI 10.1016/j.cellsig.2008.10.016; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MELCHIOR F, 1995, METHOD ENZYMOL, V257, P279; Moore MS, 1998, J BIOL CHEM, V273, P22857, DOI 10.1074/jbc.273.36.22857; Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200; Nagai Masahiro, 2012, Biomol Concepts, V3, P307, DOI 10.1515/bmc-2011-0068; Nakagawa K, 2005, GENES CELLS, V10, P835, DOI 10.1111/j.1365-2443.2005.00880.x; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Niederberger E, 2010, EXPERT REV PROTEOMIC, V7, P189, DOI 10.1586/EPR.10.1; Pham LV, 2008, J BIOL CHEM, V283, P5081, DOI 10.1074/jbc.M706307200; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; Pierre S, 2008, MOL CELL PROTEOMICS, V7, P2475, DOI 10.1074/mcp.M800201-MCP200; Qiao XY, 2010, J BIOL CHEM, V285, P5488, DOI 10.1074/jbc.M109.058024; Sazer S, 2000, J CELL SCI, V113, P1111; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schlumm F, 2013, J BIOL CHEM, V288, P8074, DOI 10.1074/jbc.M112.432773; Scholich K, 1999, SCIENCE, V283, P1328, DOI 10.1126/science.283.5406.1328; Scholich K, 2001, J BIOL CHEM, V276, P47583, DOI 10.1074/jbc.M107816200; Schulze H, 2008, J BIOL CHEM, V283, P14109, DOI 10.1074/jbc.M709397200; Sepp KJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000111; Talcott B, 2000, J BIOL CHEM, V275, P10099, DOI 10.1074/jbc.275.14.10099; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wong RW, 2006, P NATL ACAD SCI USA, V103, P19783, DOI 10.1073/pnas.0609582104; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Yang HT, 2002, DEV BRAIN RES, V136, P35, DOI 10.1016/S0165-3806(02)00311-5; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029; Yudin D, 2009, J CELL SCI, V122, P587, DOI 10.1242/jcs.015289; Zou CB, 2011, J BIOL CHEM, V286, P28019, DOI 10.1074/jbc.M111.253385	52	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25620	25635		10.1074/jbc.M115.646901	http://dx.doi.org/10.1074/jbc.M115.646901			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26304119	Green Published, hybrid			2022-12-28	WOS:000362962800035
J	Erickson, JR; Nichols, CB; Uchinoumi, H; Stein, ML; Bossuyt, J; Bers, DM				Erickson, Jeffrey R.; Nichols, C. Blake; Uchinoumi, Hitoshi; Stein, Matthew L.; Bossuyt, Julie; Bers, Donald M.			S-Nitrosylation Induces Both Autonomous Activation and Inhibition of Calcium/Calmodulin-dependent Protein Kinase II delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE VENTRICULAR MYOCYTES; RETICULUM CALCIUM LEAK; NITRIC-OXIDE; RYANODINE RECEPTOR; HEART-FAILURE; AUTOPHOSPHORYLATION SITES; CAMKII ACTIVATION; CELL APOPTOSIS; CALMODULIN; PHOSPHORYLATION	NO is known to modulate calcium handling and cellular signaling in the myocardium, but key targets for NO in the heart remain unidentified. Recent reports have implied that NO can activate calcium/calmodulin (Ca2+/CaM)-dependent protein kinase II (CaMKII) in neurons and the heart. Here we use our novel sensor of CaMKII activation, Camui, to monitor changes in the conformation and activation of cardiac CaMKII (CaMKII delta) activity after treatment with the NO donor S-nitrosoglutathione (GSNO). We demonstrate that exposure to NO after Ca2+/CaM binding to CaMKII delta results in autonomous kinase activation, which is abolished by mutation of the Cys-290 site. However, exposure of CaMKII delta to GSNO prior to Ca2+/CaM exposure strongly suppresses kinase activation and conformational change by Ca2+/CaM. This NO-induced inhibition was ablated by mutation of the Cys-273 site. We found parallel effects of GSNO on CaM/CaMKII delta binding and CaMKII delta-dependent ryanodine receptor activation in adult cardiac myocytes. We conclude that NO can play a dual role in regulating cardiac CaMKII delta activity.	[Erickson, Jeffrey R.] Univ Otago, Dept Physiol, Dunedin 9016, New Zealand; [Nichols, C. Blake; Uchinoumi, Hitoshi; Stein, Matthew L.; Bossuyt, Julie; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University of Otago; University of California System; University of California Davis	Bers, DM (corresponding author), Univ Calif Davis, Dept Pharmacol, 451 Hlth Sci Dr, Davis, CA 95616 USA.	dmbers@ucdavis.edu	Regan, Clinton/E-6250-2012	Bers, Donald/0000-0002-2237-9483; Bossuyt, Julie/0000-0001-8874-4765	National Institutes of Health [P01-HL080101, R01-HL030077, R01-HL103933, F32-HL126331]; Royal Marsden Grant [UOO1303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105242, R01HL092097, F32HL126331, R01HL103933, R01HL030077, P01HL080101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Marsden Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported, in whole or in part, by National Institutes of Health Grants P01-HL080101 and R01-HL030077 (to D. M. B.), R01-HL103933 (to J. B.), and F32-HL126331 (to C. B. N.). This work was also supported by Royal Marsden Grant UOO1303 (to J. R. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Bers DM, 2009, J CARDIOVASC PHARM, V54, P180, DOI 10.1097/FJC.0b013e3181a25078; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Burger DE, 2009, CIRCULATION, V120, P1345, DOI 10.1161/CIRCULATIONAHA.108.846402; COLBRAN RJ, 1993, J BIOL CHEM, V268, P7163; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; Coultrap SJ, 2014, FEBS LETT, V588, P4672, DOI 10.1016/j.febslet.2014.10.039; Coultrap SJ, 2014, J BIOL CHEM, V289, P19458, DOI 10.1074/jbc.M114.558254; Curran J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087495; Cutler MJ, 2012, P NATL ACAD SCI USA, V109, P18186, DOI 10.1073/pnas.1210565109; Erickson JR, 2008, J CARDIOVASC ELECTR, V19, P1332, DOI 10.1111/j.1540-8167.2008.01295.x; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00059; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Erickson JR, 2011, CIRC RES, V109, P729, DOI 10.1161/CIRCRESAHA.111.247148; Gonzalez DR, 2007, P NATL ACAD SCI USA, V104, P20612, DOI 10.1073/pnas.0706796104; Guo T, 2006, CIRC RES, V99, P398, DOI 10.1161/01.RES.0000236756.06252.13; Gutierrez DA, 2013, CARDIOVASC RES, V100, P392, DOI 10.1093/cvr/cvt201; Jian Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005046; Kohlhaas M, 2006, CIRC RES, V98, P235, DOI 10.1161/01.RES.0000200739.90811.9f; LAI Y, 1987, P NATL ACAD SCI USA, V84, P5710, DOI 10.1073/pnas.84.16.5710; Li YX, 2002, CIRC RES, V90, P309, DOI 10.1161/hh0302.105660; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Pellicena P, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00021; Picht E, 2007, AM J PHYSIOL-CELL PH, V293, pC1073, DOI 10.1152/ajpcell.00586.2006; Purohit A, 2013, CIRCULATION, V128, P1748, DOI 10.1161/CIRCULATIONAHA.113.003313; Rokita AG, 2012, CIRCULATION, V126, P2125, DOI 10.1161/CIRCULATIONAHA.112.124990; SU ZZ, 1995, J BIOL CHEM, V270, P29117, DOI 10.1074/jbc.270.49.29117; van Oort RJ, 2010, CIRCULATION, V122, P2669, DOI 10.1161/CIRCULATIONAHA.110.982298; Wang HL, 2010, J PHYSIOL-LONDON, V588, P2905, DOI 10.1113/jphysiol.2010.192617; Yang Y, 2014, CIRC RES, V114, P295, DOI 10.1161/CIRCRESAHA.114.302857; Yang YB, 2006, AM J PHYSIOL-HEART C, V291, pH3065, DOI 10.1152/ajpheart.00353.2006; Zhang DM, 2014, J PHYSIOL-LONDON, V592, P971, DOI 10.1113/jphysiol.2013.264697; Zhang T, 2004, CARDIOVASC RES, V63, P476, DOI 10.1016/j.cardiores.2004.04.026; Zhu LJ, 2014, VASC PHARMACOL, V60, P75, DOI 10.1016/j.vph.2014.01.001; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200	36	65	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25646	25656		10.1074/jbc.M115.650234	http://dx.doi.org/10.1074/jbc.M115.650234			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26316536	hybrid, Green Published			2022-12-28	WOS:000362962800037
J	Girard, JR; Tenthorey, JL; Morgan, DO				Girard, Juliet R.; Tenthorey, Jeanette L.; Morgan, David O.			An E2 Accessory Domain Increases Affinity for the Anaphase-promoting Complex and Ensures E2 Competition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; CHAIN ELONGATION; MECHANISM; LIGASE; ACTIVATION; SUBSTRATE; SUBUNIT; PROTEIN; APC/C; POLYUBIQUITINATION	The anaphase-promoting complex/cyclosome (APC/C) is a member of the RING family of E3 ubiquitin ligases, which promote ubiquitin transfer from an E2 ubiquitin-conjugating enzyme to a substrate. In budding yeast, the APC/C collaborates with two E2s, Ubc4 and Ubc1, to promote the initiation and elongation, respectively, of polyubiquitin chains on the substrate. Ubc4 and Ubc1 are thought to compete for the same site on the APC/C, but it is not clear how their affinities are balanced. Here, we demonstrate that a C-terminal ubiquitin-associated (UBA) domain enhances the affinity of Ubc1 for the APC/C. Deletion of the UBA domain reduced apparent APC/C affinity for Ubc1 and decreased polyubiquitin chain length. Surprisingly, the positive effect of the UBA domain was not due to an interaction with the acceptor ubiquitin attached to the APC/C substrate or the donor ubiquitin attached to Ubc1 itself. Instead, our evidence suggests that the UBA domain binds to a site on the APC/C core, thereby increasing Ubc1 affinity and enhancing its ability to compete with Ubc4. The UBA domain is required for normal Ubc1 function and E2 competition in vivo. Thus, the UBA domain of Ubc1 ensures efficient polyubiquitination of substrate by balancing Ubc1 affinity with that of Ubc4.	[Girard, Juliet R.; Tenthorey, Jeanette L.; Morgan, David O.] Univ Calif San Francisco, Dept Physiol & Biochem, San Francisco, CA 94143 USA; [Girard, Juliet R.; Tenthorey, Jeanette L.; Morgan, David O.] Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94143 USA; [Girard, Juliet R.; Morgan, David O.] Univ Calif San Francisco, Tetrad Grad Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, Dept Physiol & Biochem, San Francisco, CA 94143 USA.	david.morgan@ucsf.edu	Regan, Clinton/E-6250-2012	Morgan, David/0000-0001-8753-4416; Girard, Juliet/0000-0001-8274-2136	National Institutes of Health [R37-GM053270, R25-GM056847]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007810, R37GM053270, R25GM056847] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-GM053270 (to D. O. M.) and R25-GM056847 (to J. R. G.). This work was also supported by a fellowship from the National Science Foundation (to J. R. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Brown NG, 2015, P NATL ACAD SCI USA, V112, P5272, DOI 10.1073/pnas.1504161112; Brown NG, 2014, MOL CELL, V56, P246, DOI 10.1016/j.molcel.2014.09.009; Carroll CW, 2005, METHOD ENZYMOL, V398, P219, DOI 10.1016/S0076-6879(05)98018-X; Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066; Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Chang LF, 2014, CURR OPIN STRUC BIOL, V29, P1, DOI 10.1016/j.sbi.2014.08.003; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Foster SA, 2012, MOL CELL, V47, P921, DOI 10.1016/j.molcel.2012.07.031; Hobeika M, 2009, J BIOL CHEM, V284, P17575, DOI 10.1074/jbc.M109.004374; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Jung J, 2014, J BIOL CHEM, V289, P2577, DOI 10.1074/jbc.M113.534453; Kelly A, 2014, MOL CELL, V56, P232, DOI 10.1016/j.molcel.2014.09.010; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Merkley N, 2005, J BIOL CHEM, V280, P31732, DOI 10.1074/jbc.M505205200; Merkley N, 2003, J BIOMOL NMR, V26, P147, DOI 10.1023/A:1023571703783; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Peschard P, 2007, MOL CELL, V27, P474, DOI 10.1016/j.molcel.2007.06.023; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Schaefer JB, 2011, J BIOL CHEM, V286, P45186, DOI 10.1074/jbc.M111.310094; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Van Voorhis VA, 2014, CURR BIOL, V24, P1556, DOI 10.1016/j.cub.2014.05.052; Wang WP, 2013, NAT CELL BIOL, V15, P797, DOI 10.1038/ncb2755; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Wu T, 2010, P NATL ACAD SCI USA, V107, P1355, DOI 10.1073/pnas.0912802107	38	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24614	24625		10.1074/jbc.M115.678193	http://dx.doi.org/10.1074/jbc.M115.678193			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26306044	hybrid, Green Published			2022-12-28	WOS:000362218900044
J	Jiang, WH; Zhu, J; Zhuang, X; Zhang, XP; Luo, T; Esser, KA; Ren, HM				Jiang, Weihua; Zhu, Jing; Zhuang, Xun; Zhang, Xiping; Luo, Tao; Esser, Karyn A.; Ren, Hongmei			Lipin1 Regulates Skeletal Muscle Differentiation through Extracellular Signal-regulated Kinase (ERK) Activation and Cyclin D Complex-regulated Cell Cycle Withdrawal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID PHOSPHATASE; MYOBLAST DIFFERENTIATION; GENE-EXPRESSION; MYOGENIC CELLS; STEM-CELLS; REGENERATION; PHOSPHORYLATION; LOCALIZATION; LPIN1; TRANSCRIPTION	Lipin1, an intracellular protein, plays critical roles in controlling lipid synthesis and energy metabolism through its enzymatic activity and nuclear transcriptional functions. Several mouse models of skeletal muscle wasting are associated with lipin1 mutation or altered expression. Recent human studies have suggested that children with homozygous null mutations in the LPIN1 gene suffer from rhabdomyolysis. However, the underlying pathophysiologic mechanism is still poorly understood. In the present study we examined whether lipin1 contributes to regulating muscle regeneration. We characterized the time course of skeletal muscle regeneration in lipin1-deficient fld mice after injury. We found that fld mice exhibited smaller regenerated muscle fiber cross-sectional areas compared with wild-type mice in response to injury. Our results from a series of in vitro experiments suggest that lipin1 is up-regulated and translocated to the nucleus during myoblast differentiation and plays a key role in myogenesis by regulating the cytosolic activation of ERK1/2 to form a complex and a downstream effector cyclin D3-mediated cell cycle withdrawal. Overall, our study reveals a previously unknown role of lipin1 in skeletal muscle regeneration and expands our understanding of the cellular and molecular mechanisms underlying skeletal muscle regeneration.	[Jiang, Weihua; Zhu, Jing; Zhuang, Xun; Luo, Tao; Ren, Hongmei] Univ Kentucky, Saha Cardiovasc Ctr, Dept Internal Med, Div Cardiovasc Med, Lexington, KY 40536 USA; [Zhang, Xiping; Esser, Karyn A.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Ren, HM (corresponding author), Univ Kentucky, Saha Cardiovasc Ctr, Dept Internal Med, Div Cardiovasc Med, Lexington, KY 40536 USA.	hongmei.ren@uky.edu	LUO, TAO/G-5064-2018; Regan, Clinton/E-6250-2012	LUO, TAO/0000-0002-4144-4500; 	National Institutes of Health (Center of Biomedical Research Excellence on Obesity and Cardiovascular Diseases) [P20 GM103527-06]; NIH [AR061939]; American Heart Association [11BGIA7710059]; National Scientist Development Grant [12SDG12050697]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	National Institutes of Health (Center of Biomedical Research Excellence on Obesity and Cardiovascular Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Scientist Development Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 GM103527-06 (Center of Biomedical Research Excellence on Obesity and Cardiovascular Diseases) and NIH AR061939 (to K. A. E.). This work was also supported by American Heart Association Beginning Grant-in-aid 11BGIA7710059 and National Scientist Development Grant 12SDG12050697 (to H. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; CARLSON BM, 1983, MED SCI SPORT EXER, V15, P187; Cenciarelli C, 1999, MOL CELL BIOL, V19, P5203; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; DAKSIS JI, 1994, ONCOGENE, V9, P3635; De Luca G, 2013, STEM CELLS, V31, P2478, DOI 10.1002/stem.1487; Douglas DS, 2009, J NEUROSCI, V29, P12089, DOI 10.1523/JNEUROSCI.2029-09.2009; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; Ezhevsky SA, 1997, P NATL ACAD SCI USA, V94, P10699, DOI 10.1073/pnas.94.20.10699; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Gurung R, 2012, J CELL BIOCHEM, V113, P209, DOI 10.1002/jcb.23346; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Huh JE, 2011, INT IMMUNOPHARMACOL, V11, P46, DOI 10.1016/j.intimp.2010.10.003; KIESS M, 1995, ONCOGENE, V10, P159; Knight JDR, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-29; Kok BPC, 2014, J BIOL CHEM, V289, P10876, DOI 10.1074/jbc.M114.552612; Kok BPC, 2012, J LIPID RES, V53, P105, DOI 10.1194/jlr.M019430; Lazaro JB, 2002, GENE DEV, V16, P1792, DOI 10.1101/gad.U-9988R; Li J, 2006, BIOCHEM BIOPH RES CO, V345, P1425, DOI 10.1016/j.bbrc.2006.05.051; Liu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007031; Mariappan I, 2007, BIOCHEM BIOPH RES CO, V355, P981, DOI 10.1016/j.bbrc.2007.02.060; Micheli L, 2011, J BIOL CHEM, V286, P5691, DOI 10.1074/jbc.M110.162842; Michot C, 2012, J INHERIT METAB DIS, V35, P1119, DOI 10.1007/s10545-012-9461-6; Michot C, 2010, HUM MUTAT, V31, pE1564, DOI 10.1002/humu.21282; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nadra K, 2012, MOL CELL BIOL, V32, P4794, DOI 10.1128/MCB.00512-12; Parker MH, 2012, SKELET MUSCLE, V2, DOI [10.1186/2044-5040-2-4, 10.1186/2044-5040-2-6]; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Plotnikov A, 2011, MOL CELL BIOL, V31, P3515, DOI 10.1128/MCB.05424-11; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Richter T, 1999, J CLIN PATHOL, V52, P461, DOI 10.1136/jcp.52.6.461; Rodriguez J, 2010, J CELL BIOL, V191, P967, DOI 10.1083/jcb.201004067; Roskoski R, 2012, BIOCHEM BIOPH RES CO, V417, P5, DOI 10.1016/j.bbrc.2011.11.145; Sanoudou D, 2003, P NATL ACAD SCI USA, V100, P4666, DOI 10.1073/pnas.0330960100; Seno MMG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-345; SETH A, 1991, J BIOL CHEM, V266, P23521; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Shiomi K, 2011, GENE THER, V18, P857, DOI 10.1038/gt.2011.44; Sterrenburg E, 2004, NEUROMUSCULAR DISORD, V14, P507, DOI 10.1016/j.nmd.2004.03.008; Stratos I, 2012, J PINEAL RES, V52, P62, DOI 10.1111/j.1600-079X.2011.00919.x; Tseng BS, 2002, J APPL PHYSIOL, V93, P537, DOI 10.1152/japplphysiol.00202.2002; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Winter B, 2000, J CELL SCI, V113, P4211; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yeow K, 2002, BIOCHEM BIOPH RES CO, V293, P112, DOI 10.1016/S0006-291X(02)00190-0; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang KM, 2010, J CELL BIOL, V188, P39, DOI 10.1083/jcb.200904144; Zhao Y, 2005, AM J PHYSIOL-REG I, V289, pR164, DOI 10.1152/ajpregu.00847.2004	56	24	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23646	23655		10.1074/jbc.M115.686519	http://dx.doi.org/10.1074/jbc.M115.686519			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26296887	hybrid, Green Published			2022-12-28	WOS:000361816500015
J	Gristick, HB; Rome, ME; Chartron, JW; Rao, M; Hess, S; Shan, SO; Clemons, WM				Gristick, Harry B.; Rome, Michael E.; Chartron, Justin W.; Rao, Meera; Hess, Sonja; Shan, Shu-ou; Clemons, William M., Jr.			Mechanism of Assembly of a Substrate Transfer Complex during Tail-anchored Protein Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; MEMBRANE INSERTION; STRUCTURAL BASIS; GET3; RECOGNITION; ELECTROSTATICS; BINDING; SYSTEM	Tail-anchored (TA) proteins, defined as having a single transmembrane helix at their C terminus, are post-translationally targeted to the endoplasmic reticulum membrane by the guided entry of TA proteins (GET) pathway. In yeast, the handover of TA substrates is mediated by the heterotetrameric Get4/Get5 complex (Get4/5), which tethers the co-chaperone Sgt2 to the targeting factor, the Get3 ATPase. Binding of Get4/5 to Get3 is critical for efficient TA targeting; however, questions remain about the formation of the Get3.Get4/5 complex. Here we report crystal structures of a Get3.Get4/5 complex from Saccharomyces cerevisiae at 2.8 and 6.0 angstrom that reveal a novel interface between Get3 and Get4 dominated by electrostatic interactions. Kinetic and mutational analyses strongly suggest that these structures represent an on-pathway intermediate that rapidly assembles and then rearranges to the final Get3.Get4/5 complex. Furthermore, we provide evidence that the Get3.Get4/5 complex is dominated by a single Get4/5 heterotetramer bound to one monomer of a Get3 dimer, uncovering an intriguing asymmetry in the Get4/5 heterotetramer upon Get3 binding. Ultrafast diffusion-limited electrostatically driven Get3.Get4/5 association enables Get4/5 to rapidly sample and capture Get3 at different stages of the GET pathway.	[Gristick, Harry B.; Rome, Michael E.; Chartron, Justin W.; Rao, Meera; Shan, Shu-ou; Clemons, William M., Jr.] CALTECH, Beckman Inst, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Hess, Sonja] CALTECH, Beckman Inst, Proteome Explorat Lab, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Clemons, WM (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 East Calif Blvd, Pasadena, CA 91125 USA.	sshan@caltech.edu; clemons@caltech.edu	Clemons, William M/D-1026-2009; Chartron, Justin/L-9096-2019; Regan, Clinton/E-6250-2012	Clemons, William M/0000-0002-0021-889X; Chartron, Justin/0000-0003-1734-3424; Rao, Meera/0000-0001-8650-6253	National Science Foundation Graduate Research Fellowship [DGE-1144469]; National Institutes of Health [5T32GM007616-33, R01GM097572, R01GM107368]; Gordon and Betty Moore Foundation [GBMF775]; Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616, R01GM107368, R01GM097572] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Graduate Research Fellowship DGE-1144469 (to M. E. R.) and National Institutes of Health Training Grant 5T32GM007616-33 (to H. B. G. and M. R.) and Research Grants R01GM097572 (to W. M. C.) and R01GM107368 (to S. S.). The Proteome Exploration Laboratory was supported by Gordon and Betty Moore Foundation Grant GBMF775 and the Beckman Institute (to S. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Borgese N, 2007, CURR OPIN CELL BIOL, V19, P368, DOI 10.1016/j.ceb.2007.04.019; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Chartron JW, 2012, CURR OPIN STRUC BIOL, V22, P217, DOI 10.1016/j.sbi.2012.03.001; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gristick HB, 2014, NAT STRUCT MOL BIOL, V21, P437, DOI 10.1038/nsmb.2813; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hu JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008061; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Mateja A, 2015, SCIENCE, V347, P1152, DOI 10.1126/science.1261671; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Nguyen TX, 2013, J BIOL CHEM, V288, P13420, DOI 10.1074/jbc.M113.462812; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rome ME, 2014, P NATL ACAD SCI USA, V111, pE4929, DOI 10.1073/pnas.1411284111; Rome ME, 2013, P NATL ACAD SCI USA, V110, P7666, DOI 10.1073/pnas.1222054110; Sandikci A, 2013, NAT STRUCT MOL BIOL, V20, P843, DOI 10.1038/nsmb.2615; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Shan SO, 2005, FEBS LETT, V579, P921, DOI 10.1016/j.febslet.2004.11.049; Shao SC, 2011, ANNU REV CELL DEV BI, V27, P25, DOI 10.1146/annurev-cellbio-092910-154125; Stefer S, 2011, SCIENCE, V333, P758, DOI 10.1126/science.1207125; Suloway CJM, 2012, EMBO J, V31, P707, DOI 10.1038/emboj.2011.433; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028	39	8	8	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30006	30017		10.1074/jbc.M115.677328	http://dx.doi.org/10.1074/jbc.M115.677328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26451041	Green Published, hybrid			2022-12-28	WOS:000366614700032
J	Guerra-Moreno, A; Isasa, M; Bhanu, MK; Waterman, DP; Eapen, VV; Gygi, SP; Hanna, J				Guerra-Moreno, Angel; Isasa, Marta; Bhanu, Meera K.; Waterman, David P.; Eapen, Vinay V.; Gygi, Steven P.; Hanna, John			Proteomic Analysis Identifies Ribosome Reduction as an Effective Proteotoxic Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; REGULATORY PARTICLE; ARSENIC TRIOXIDE; ZINC-FINGER; PROTEIN; YEAST; BINDING; PROTEASOME; RESISTANCE	Stress responses are adaptive cellular programs that identify and mitigate potentially dangerous threats. Misfolded proteins are a ubiquitous and clinically relevant stress. Trivalent metalloids, such as arsenic, have been proposed to cause protein misfolding. Using tandem mass tag-based mass spectrometry, we show that trivalent arsenic results in widespread reorganization of the cell from an anabolic to a catabolic state. Both major pathways of protein degradation, the proteasome and autophagy, show increased abundance of pathway components and increased functional output, and are required for survival. Remarkably, cells also showed a down-regulation of ribosomes at the protein level. That this represented an adaptive response and not an adverse toxic effect was indicated by enhanced survival of ribosome mutants after arsenic exposure. These results suggest that a major source of toxicity of trivalent arsenic derives from misfolding of newly synthesized proteins and identifies ribosome reduction as a rapid, effective, and reversible proteotoxic stress response.	[Guerra-Moreno, Angel; Bhanu, Meera K.; Hanna, John] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Guerra-Moreno, Angel; Bhanu, Meera K.; Hanna, John] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Isasa, Marta; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Waterman, David P.; Eapen, Vinay V.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02254 USA; [Waterman, David P.; Eapen, Vinay V.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Brandeis University; Brandeis University	Hanna, J (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	jwhanna@partners.org	Regan, Clinton/E-6250-2012; Guerra-Moreno, Angel/K-6258-2015; Angel, Guerra-Moreno/AAF-7135-2021; Eapen, Valsamma N/N-9608-2017	Guerra-Moreno, Angel/0000-0003-2321-1129; Angel, Guerra-Moreno/0000-0003-2321-1129; Eapen, Valsamma N/0000-0001-6296-8306; Eapen, Vinay/0000-0002-8023-387X	National Institutes of Health [DP5-OD019800, GM97645, T32HL007627-30, R01-GM061766]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007122, R01GM061766] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD019800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants DP5-OD019800 (to J.H.) and GM97645(to S.P.G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Training Grant T32HL007627-30.; Supported by an National Institutes of Health Grant R01-GM061766 (to Dr. Jim Haber).	Bax R, 2006, RNA, V12, P2005, DOI 10.1261/rna.159406; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Berg J. M., 2010, BIOCHEMISTRY-US, P515; Bobrowicz P, 1997, YEAST, V13, P819, DOI 10.1002/(SICI)1097-0061(199707)13:9<819::AID-YEA142>3.0.CO;2-Y; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Hanna J, 2014, J BIOL CHEM, V289, P1876, DOI 10.1074/jbc.M113.534032; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hosiner D, 2009, MOL BIOL CELL, V20, P1048, DOI 10.1091/mbc.E08-04-0438; Hughes MF, 2002, TOXICOL LETT, V133, P1, DOI 10.1016/S0378-4274(02)00084-X; Ilina Y, 2008, BIOCHEM J, V415, P467, DOI 10.1042/BJ20080713; Jacobson T, 2012, J CELL SCI, V125, P5073, DOI 10.1242/jcs.107029; JUNGMANN J, 1993, NATURE, V361, P369, DOI 10.1038/361369a0; Kim MN, 2015, BBA-MOL CELL RES, V1853, P996, DOI 10.1016/j.bbamcr.2015.02.010; Kirkpatrick DS, 2003, TOXICOL APPL PHARM, V186, P101, DOI 10.1016/S0041-008X(02)00019-4; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lallemand-Breitenbach V, 2012, TRENDS MOL MED, V18, P36, DOI 10.1016/j.molmed.2011.10.001; Lander GC, 2013, CURR OPIN STRUC BIOL, V23, P243, DOI 10.1016/j.sbi.2013.02.004; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McAlister GC, 2012, ANAL CHEM, V84, P7469, DOI 10.1021/ac301572t; Pan XW, 2010, GENETICS, V186, P725, DOI 10.1534/genetics.110.117655; Paulo JA, 2015, PROTEOMICS, V15, P474, DOI 10.1002/pmic.201400155; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.0.CO;2-U; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Sa-Moura B, 2013, J BIOL CHEM, V288, P33682, DOI 10.1074/jbc.M113.521088; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Stryer L., 1995, BIOCHEMISTRY-US, P503; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; WARNER JR, 1989, MICROBIOL REV, V53, P256, DOI 10.1128/MMBR.53.2.256-271.1989; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424; Zhou XX, 2014, CHEM RES TOXICOL, V27, P690, DOI 10.1021/tx500022j	37	33	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29695	29706		10.1074/jbc.M115.684969	http://dx.doi.org/10.1074/jbc.M115.684969			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26491016	Green Published, hybrid			2022-12-28	WOS:000366614700003
J	Cho, HY; Maeng, SJ; Cho, HJ; Choi, YS; Chung, JM; Lee, S; Kim, HK; Kim, JH; Eom, CY; Kim, YG; Guo, M; Jung, HS; Kang, BS; Kim, S				Cho, Ha Yeon; Maeng, Seo Jin; Cho, Hyo Je; Choi, Yoon Seo; Chung, Jeong Min; Lee, Sangmin; Kim, Hoi Kyoung; Kim, Jong Hyun; Eom, Chi-Yong; Kim, Yeon-Gil; Guo, Min; Jung, Hyun Suk; Kang, Beom Sik; Kim, Sunghoon			Assembly of Multi-tRNA Synthetase Complex via Heterotetrameric Glutathione Transferase-homology Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; 3-DIMENSIONAL STRUCTURE; STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE; TRANSLATION; REVEALS; BINDING; MOTIF	Many multicomponent protein complexes mediating diverse cellular processes are assembled through scaffolds with specialized protein interaction modules. The multi-tRNA synthetase complex (MSC), consisting of nine different aminoacyl-tRNA synthetases and three non-enzymatic factors (AIMP1-3), serves as a hub for many signaling pathways in addition to its role in protein synthesis. However, the assembly process and structural arrangement of the MSC components are not well understood. Here we show the heterotetrameric complex structure of the glutathione transferase (GST) domains shared among the four MSCcomponents, methionyl-tRNA synthetase (MRS), glutaminyl-prolyl-tRNA synthetase (EPRS), AIMP2 and AIMP3. The MRS-AIMP3 and EPRS-AIMP2 using interface 1 are bridged via interface 2 of AIMP3 and EPRS to generate a unique linear complex of MRS-AIMP3: EPRS-AIMP2 at the molar ratio of (1: 1):(1: 1). Interestingly, the affinity at interface 2 of AIMP3: EPRS can be varied depending on the occupancy of interface 1, suggesting the dynamic nature of the linear GST tetramer. The four components are optimally arranged for maximal accommodation of additional domains and proteins. These characteristics suggest the GST tetramer as a unique and dynamic structural platform from which the MSC components are assembled. Considering prevalence of the GST-like domains, this tetramer can also provide a tool for the communication of the MSC with other GST-containing cellular factors.	[Cho, Ha Yeon; Maeng, Seo Jin; Cho, Hyo Je; Choi, Yoon Seo; Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, KNU Creat BioRes Grp, Taegu 702701, South Korea; [Chung, Jeong Min; Lee, Sangmin; Jung, Hyun Suk] Kangwon Natl Univ, Coll Nat Sci, Dept Biochem, Chunchon 200701, South Korea; [Kim, Hoi Kyoung; Kim, Jong Hyun; Kim, Sunghoon] Seoul Natl Univ, Grad Sch Convergence Technol, Med Bioconvergence Res Ctr, Dept Mol Med & Biopharmaceut Sci, Seoul 151742, South Korea; [Eom, Chi-Yong] Korea Basic Sci Inst, Western Seoul Ctr, NanoBio Convergence Res Team, Seoul 120750, South Korea; [Kim, Yeon-Gil] Pohang Univ Sci & Technol, Pohang Accelerator Lab, Pohang 790834, South Korea; [Guo, Min] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Kim, Sunghoon] Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China	Kyungpook National University; Kangwon National University; Seoul National University (SNU); Korea Basic Science Institute (KBSI); Pohang University of Science & Technology (POSTECH); Scripps Research Institute; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Kang, BS (corresponding author), 80 Daehak Ro, Daegu 702701, South Korea.	bskang2@knu.ac.kr; sungkim@snu.ac.kr	Kim, Sunghoon/AAE-8314-2020	kim, sunghoon/0000-0002-1570-3230	Global Frontier Project Grant of the National Research Foundation - Ministry of Science, ICT & Future Planning (MSIP) of Korea [NRF-2014M3A6A4062857]; NATIONAL CANCER INSTITUTE [R01CA178315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100136] Funding Source: NIH RePORTER	Global Frontier Project Grant of the National Research Foundation - Ministry of Science, ICT & Future Planning (MSIP) of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Global Frontier Project Grant NRF-2014M3A6A4062857 of the National Research Foundation funded by the Ministry of Science, ICT & Future Planning (MSIP) of Korea. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ahn HC, 2003, FEBS LETT, V542, P119, DOI 10.1016/S0014-5793(03)00362-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266; Crepin T, 2004, BIOCHEMISTRY-US, V43, P2635, DOI 10.1021/bi0356247; Dias J, 2013, J BIOL CHEM, V288, P23979, DOI 10.1074/jbc.M113.489922; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu YY, 2014, P NATL ACAD SCI USA, V111, P15084, DOI 10.1073/pnas.1408836111; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Guo M, 2014, TOP CURR CHEM, V344, P89, DOI 10.1007/128_2013_424; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; Kim JE, 2000, NUCLEIC ACIDS RES, V28, P2866, DOI 10.1093/nar/28.15.2866; Kim JH, 2014, TOP CURR CHEM, V344, P119, DOI 10.1007/128_2013_479; Kim KR, 2013, PROTEINS, V81, P1840, DOI 10.1002/prot.24306; Kim KJ, 2008, J BIOL CHEM, V283, P14032, DOI 10.1074/jbc.M800859200; Kim SO, 2012, J MOL CELL BIOL, V4, P258, DOI 10.1093/jmcb/mjs026; KOONIN EV, 1994, PROTEIN SCI, V3, P2045, DOI 10.1002/pro.5560031117; Kwon NH, 2011, P NATL ACAD SCI USA, V108, P19635, DOI 10.1073/pnas.1103922108; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; Nureki O, 2010, NUCLEIC ACIDS RES, V38, P7286, DOI 10.1093/nar/gkq605; Oakley AJ, 2005, CURR OPIN STRUC BIOL, V15, P716, DOI 10.1016/j.sbi.2005.10.005; Ofir-Birin Y, 2013, MOL CELL, V49, P30, DOI 10.1016/j.molcel.2012.10.010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Renault L, 2001, EMBO J, V20, P570, DOI 10.1093/emboj/20.3.570; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Rossjohn J, 1998, STRUCTURE, V6, P309, DOI 10.1016/S0969-2126(98)00034-3; Simos G, 1996, EMBO J, V15, P5437, DOI 10.1002/j.1460-2075.1996.tb00927.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Wu BJ, 2012, TRENDS PHARMACOL SCI, V33, P656, DOI 10.1016/j.tips.2012.09.007; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774	39	45	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29313	29328		10.1074/jbc.M115.690867	http://dx.doi.org/10.1074/jbc.M115.690867			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26472928	Green Published, hybrid			2022-12-28	WOS:000366613400019
J	Barrows, D; Schoenfeld, SM; Hodakoski, C; Silkov, A; Honig, B; Couvillon, A; Shymanets, A; Nurnberg, B; Asara, JM; Parsons, R				Barrows, Douglas; Schoenfeld, Sarah M.; Hodakoski, Cindy; Silkov, Antonina; Honig, Barry; Couvillon, Anthony; Shymanets, Aliaksei; Nuernberg, Bernd; Asara, John M.; Parsons, Ramon			p21-activated Kinases (PAKs) Mediate the Phosphorylation of PREX2 Protein to Initiate Feedback Inhibition of Rac1 GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-protein-coupled receptor (GPCR); guanine nucleotide exchange factor (GEF); insulin; phosphatidylinositide 3-kinase (PI 3-kinase); Rac (Rac GTPase); serine; threonine-protein kinase PAK 1 (PAK1); signal transduction; Phosphatidylinositol-3; 4; 5-trisphosphate-dependent RAC exchanger 2 (PREX2)	NUCLEOTIDE-EXCHANGE FACTOR; BETA-GAMMA-SUBUNITS; PLECKSTRIN HOMOLOGY DOMAIN; STIMULATED GLUCOSE-UPTAKE; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHOINOSITIDE 3-KINASE; POLARIZED GROWTH; SKELETAL-MUSCLE; BREAST-CANCER; INSULIN	Phosphatidylinositol 3,4,5-trisphosphate (PIP3)-dependent Rac exchanger 2 (PREX2) is a guanine nucleotide exchange factor (GEF) for the Ras-related C3 botulinum toxin substrate 1 (Rac1) GTPase, facilitating the exchange of GDP for GTP on Rac1. GTP-bound Rac1 then activates its downstream effectors, including p21-activated kinases (PAKs). PREX2 and Rac1 are frequently mutated in cancer and have key roles within the insulin-signaling pathway. Rac1 can be inactivated by multiple mechanisms; however, negative regulation by insulin is not well understood. Here, we show that in response to being activated after insulin stimulation, Rac1 initiates its own inactivation by decreasing PREX2 GEF activity. Following PREX2-mediated activation of Rac1 by the second messengers PIP3 or G, we found that PREX2 was phosphorylated through a PAK-dependent mechanism. PAK-mediated phosphorylation of PREX2 reduced GEF activity toward Rac1 by inhibiting PREX2 binding to PIP3 and G. Cell fractionation experiments also revealed that phosphorylation prevented PREX2 from localizing to the cellular membrane. Furthermore, the onset of insulin-induced phosphorylation of PREX2 was delayed compared with AKT. Altogether, we propose that second messengers activate the Rac1 signal, which sets in motion a cascade whereby PAKs phosphorylate and negatively regulate PREX2 to decrease Rac1 activation. This type of regulation would allow for transient activation of the PREX2-Rac1 signal and may be relevant in multiple physiological processes, including diseases such as diabetes and cancer when insulin signaling is chronically activated.	[Barrows, Douglas; Schoenfeld, Sarah M.; Hodakoski, Cindy; Parsons, Ramon] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Barrows, Douglas] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Silkov, Antonina; Honig, Barry] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Couvillon, Anthony] Cell Signaling Technol, Danvers, MA 01923 USA; [Shymanets, Aliaksei; Nuernberg, Bernd] Univ Tubingen, Eberhard Karls Univ Hosp & Clin, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, D-72074 Tubingen, Germany; [Shymanets, Aliaksei; Nuernberg, Bernd] Univ Tubingen, Interfac Ctr Pharmacogen & Pharmaceut Res, D-72074 Tubingen, Germany; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Howard Hughes Medical Institute; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Parsons, R (corresponding author), Icahn Sch Med Mt Sinai, Hess CSM Bldg,Floor 6,Rm 116,1470 Madison Ave, New York, NY 10029 USA.	ramon.parsons@mssm.edu	Regan, Clinton/E-6250-2012	Nurnberg, Bernd/0000-0002-5995-6555; Honig, Barry/0000-0002-1835-1031; Parsons, Ramon/0000-0002-6656-3514	National Institutes of Health [R01CA155117, R01CA184016, 5P01CA120964, 1S10OD010612, R01GM030518]; NATIONAL CANCER INSTITUTE [R01CA184016, R01CA155117, P01CA120964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030518] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants R01CA155117 (to R. P.), R01CA184016 (to R. P.), 5P01CA120964 (to J. M. A.), 1S10OD010612 (to J. M. A.), and R01GM030518 (to B. H.). The authors declare that they have no conflicts of interest with the contents of this article.	ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Baker NM, 2014, CLIN CANCER RES, V20, P4740, DOI 10.1158/1078-0432.CCR-13-1727; Balamatsias D, 2011, J BIOL CHEM, V286, P43229, DOI 10.1074/jbc.M111.306621; Barber MA, 2007, J BIOL CHEM, V282, P29967, DOI 10.1074/jbc.M701877200; Barber MA, 2012, BIOCHEM J, V443, P173, DOI 10.1042/BJ20112078; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Campbell AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053982; Montero JC, 2013, CELL SIGNAL, V25, P2281, DOI 10.1016/j.cellsig.2013.07.018; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen X, 2013, FEBS LETT, V587, P3729, DOI 10.1016/j.febslet.2013.09.044; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Chiang YTA, 2014, AM J PHYSIOL-ENDOC M, V306, pE707, DOI 10.1152/ajpendo.00506.2013; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; De la Mota-Peynado A, 2011, J BIOL CHEM, V286, P13603, DOI 10.1074/jbc.M110.181743; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; Dong XM, 2005, CURR BIOL, V15, P1874, DOI 10.1016/j.cub.2005.09.014; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Fleming IN, 1997, J BIOL CHEM, V272, P33105, DOI 10.1074/jbc.272.52.33105; Fleming IN, 1999, J BIOL CHEM, V274, P12753, DOI 10.1074/jbc.274.18.12753; Frieser SH, 2011, MOL BIOL CELL, V22, P3253, DOI 10.1091/mbc.E11-04-0314; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Guo B, 2014, MOL CANCER RES, V12, P313, DOI 10.1158/1541-7786.MCR-13-0507; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Haruta T, 2000, MOL ENDOCRINOL, V14, P783, DOI 10.1210/me.14.6.783; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hill K, 2006, METHOD ENZYMOL, V406, P26, DOI 10.1016/S0076-6879(06)06003-4; Hodakoski C, 2014, P NATL ACAD SCI USA, V111, P155, DOI 10.1073/pnas.1213773111; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Jebailey L, 2004, MOL ENDOCRINOL, V18, P359, DOI 10.1210/me.2003-0294; Khayat ZA, 2000, J CELL SCI, V113, P279; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Kuo CC, 2014, CURR BIOL, V24, P753, DOI 10.1016/j.cub.2014.02.024; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Kuziemko A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002175; Li Z, 2005, PROSTAG OTH LIPID M, V76, P95, DOI 10.1016/j.prostaglandins.2005.02.002; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1921, DOI 10.1074/jbc.M506035200; Mense SM, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005840; Montero JC, 2011, ONCOGENE, V30, P1059, DOI 10.1038/onc.2010.489; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Rosenfeldt H, 2004, FEBS LETT, V572, P167, DOI 10.1016/j.febslet.2004.06.097; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Shymanets A, 2013, J BIOL CHEM, V288, P31059, DOI 10.1074/jbc.M113.508234; Shymanets A, 2012, BIOCHEM J, V441, P851, DOI 10.1042/BJ20111664; Shymanets A, 2009, PROTEIN PEPTIDE LETT, V16, P1053, DOI 10.2174/092986609789055340; Simpson L, 2001, MOL CELL BIOL, V21, P3947, DOI 10.1128/MCB.21.12.3947-3958.2001; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Sylow L, 2014, CELL SIGNAL, V26, P323, DOI 10.1016/j.cellsig.2013.11.007; Sylow L, 2013, DIABETES, V62, P1865, DOI 10.2337/db12-1148; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Tsakiridis T, 1996, J BIOL CHEM, V271, P19664, DOI 10.1074/jbc.271.33.19664; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Urano D, 2008, CELL SIGNAL, V20, P1545, DOI 10.1016/j.cellsig.2008.04.009; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Welch HCE, 2005, CURR BIOL, V15, P1867, DOI 10.1016/j.cub.2005.09.050; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; Xu J, 2013, J BIOL CHEM, V288, P33263, DOI 10.1074/jbc.M113.508093	79	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28915	28931		10.1074/jbc.M115.668244	http://dx.doi.org/10.1074/jbc.M115.668244			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26438819	Green Published, hybrid			2022-12-28	WOS:000365762300031
J	Tiwari, SK; Seth, B; Agarwal, S; Yadav, A; Karmakar, M; Gupta, SK; Choubey, V; Sharma, A; Chaturvedi, RK				Tiwari, Shashi Kant; Seth, Brashket; Agarwal, Swati; Yadav, Anuradha; Karmakar, Madhumita; Gupta, Shailendra Kumar; Choubey, Vinay; Sharma, Abhay; Chaturvedi, Rajnish Kumar			Ethosuximide Induces Hippocampal Neurogenesis and Reverses Cognitive Deficits in an Amyloid-beta Toxin-induced Alzheimer Rat Model via the Phosphatidylinositol 3-Kinase (PI3K)/Akt/Wnt/beta-Catenin Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL STEM-CELLS; ADULT NEUROGENESIS; VALPROIC ACID; SELF-RENEWAL; SYNAPTIC PLASTICITY; CALCIUM CURRENTS; ABSENCE SEIZURES; GROWTH-FACTOR; LOW-THRESHOLD; PROLIFERATION	Neurogenesis involves generation of new neurons through finely tuned multistep processes, such as neural stem cell (NSC) proliferation, migration, differentiation, and integration into existing neuronal circuitry in the dentate gyrus of the hippocampus and subventricular zone. Adult hippocampal neurogenesis is involved in cognitive functions and altered in various neurodegenerative disorders, including Alzheimer disease (AD). Ethosuximide (ETH), an anticonvulsant drug is used for the treatment of epileptic seizures. However, the effects of ETH on adult hippocampal neurogenesis and the underlying cellular and molecular mechanism(s) are yet unexplored. Herein, we studied the effects of ETH on rat multipotent NSC proliferation and neuronal differentiation and adult hippocampal neurogenesis in an amyloid beta (A beta) toxin-induced rat model of AD-like phenotypes. ETH potently induced NSC proliferation and neuronal differentiation in the hippocampus-derived NSC in vitro. ETH enhanced NSC proliferation and neuronal differentiation and reduced A beta toxin-mediated toxicity and neurodegeneration, leading to behavioral recovery in the rat AD model. ETH inhibited A beta-mediated suppression of neurogenic and Akt/ Wnt/beta-catenin pathway gene expression in the hippocampus. ETH activated the PI3K.Akt and Wnt.beta-catenin transduction pathways that are known to be involved in the regulation of neurogenesis. Inhibition of the PI3K.Akt and Wnt.beta-catenin pathways effectively blocked the mitogenic and neurogenic effects of ETH. In silico molecular target prediction docking studies suggest that ETH interacts with Akt, Dkk-1, and GSK-3 beta. Our findings suggest that ETH stimulates NSC proliferation and differentiation in vitro and adult hippocampal neurogenesis via the PI3K.Akt and Wnt.beta-catenin signaling.	[Tiwari, Shashi Kant; Seth, Brashket; Agarwal, Swati; Yadav, Anuradha; Karmakar, Madhumita; Chaturvedi, Rajnish Kumar] Indian Inst Toxicol Res, CSIR, Dev Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, Lucknow 226001, Uttar Pradesh, India; [Tiwari, Shashi Kant; Seth, Brashket; Agarwal, Swati; Yadav, Anuradha; Chaturvedi, Rajnish Kumar] Indian Inst Toxicol Res, CSIR, Acad Sci & Innovat Res, Lucknow 226001, Uttar Pradesh, India; [Gupta, Shailendra Kumar] Indian Inst Toxicol Res, CSIR, Syst Toxicol & Hlth Risk Assessment Grp, Lucknow 226001, Uttar Pradesh, India; [Choubey, Vinay] Ctr Excellence Translat Med, Dept Pharmacol, EE-50411 Tartu, Estonia; [Choubey, Vinay] Univ Tartu, E-50411 Tartu, Estonia; [Sharma, Abhay] Inst Genom & Integrat Biol, CSIR, New Delhi 110025, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); University of Tartu; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Sharma, A (corresponding author), Inst Genom & Integrat Biol, CSIR, Mathura Rd, New Delhi 110025, India.	abhaysharma@igib.res.in; rajnish@iitr.res.in	Tiwari, Shashi Kant/R-8533-2018; Choubey, Vinay/H-3170-2015; Chaturvedi, Rajnish/AAZ-9955-2020	Tiwari, Shashi Kant/0000-0002-6121-6249; Choubey, Vinay/0000-0002-1953-5692; Chaturvedi, Rajnish Kumar/0000-0001-9591-7636; Sharma, Abhay/0000-0003-1306-1497; Gupta, Shailendra/0000-0002-3470-3260	Council of Scientific and Industrial Research (CSIR) Network [UNDO BSC0103]; Lady Tata Memorial Young Scientist Grant; Estonian Research Council [PUT513]; Senior Research Fellowship from the University Grants Commission, New Delhi, India; Senior Research Fellowship from CSIR, New Delhi	Council of Scientific and Industrial Research (CSIR) Network(Council of Scientific & Industrial Research (CSIR) - India); Lady Tata Memorial Young Scientist Grant; Estonian Research Council(Estonian Research Council); Senior Research Fellowship from the University Grants Commission, New Delhi, India; Senior Research Fellowship from CSIR, New Delhi	This work was supported by Council of Scientific and Industrial Research (CSIR) Network Grant UNDO BSC0103 and by a Lady Tata Memorial Young Scientist Grant (to R. K. C.) and PUT513 grant from Estonian Research Council (to V. C.). This work has CSIR-Indian Institute of Toxicology Research (IITR) Manuscript Communication number 3308. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Senior Research Fellowship from the University Grants Commission, New Delhi, India.; Recipient of a Senior Research Fellowship from CSIR, New Delhi.	Ahn YJ, 2014, FOOD CHEM TOXICOL, V64, P210, DOI 10.1016/j.fct.2013.11.033; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Bentue-Ferrer D., 2012, THERAPIE, V67, P391; BOKU S, 2011, BIOL PSYCHIAT, V35, P111, DOI DOI 10.1016/J.PNPBP.2010.09.019; Boku S, 2014, EUR J PHARMACOL, V723, P425, DOI 10.1016/j.ejphar.2013.10.060; BROWNE TR, 1975, NEUROLOGY, V25, P515, DOI 10.1212/WNL.25.6.515; Bruel-Jungerman E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007901; CALLAGHAN N, 1982, DEV MED CHILD NEUROL, V24, P830; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243; Chaturvedi RK, 2012, HUM MOL GENET, V21, P3474, DOI 10.1093/hmg/dds178; Chen J, 2010, BRAIN RES, V1313, P270, DOI 10.1016/j.brainres.2009.12.024; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Collins JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000230; COULTER DA, 1989, NEUROSCI LETT, V98, P74, DOI 10.1016/0304-3940(89)90376-5; COULTER DA, 1989, ANN NEUROL, V25, P582, DOI 10.1002/ana.410250610; DeCarolis NA, 2010, NEUROPHARMACOLOGY, V58, P884, DOI 10.1016/j.neuropharm.2009.12.013; Dong CX, 2014, BIRTH DEFECTS RES B, V101, P355, DOI 10.1002/bdrb.21119; Dozawa M, 2014, DEV DYNAM, V243, P1401, DOI 10.1002/dvdy.24173; Drew Michael R., 2007, CNS & Neurological Disorders-Drug Targets, V6, P205, DOI 10.2174/187152707780619353; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; Fournier NM, 2012, NEUROPHARMACOLOGY, V63, P642, DOI 10.1016/j.neuropharm.2012.04.033; Fukuda S, 2003, J NEUROSCI, V23, P9357; Gobbel GT, 2003, BRAIN RES, V980, P221, DOI 10.1016/S0006-8993(03)02977-9; Goren MZ, 2007, CNS DRUG REV, V13, P224, DOI 10.1111/j.1527-3458.2007.00009.x; Gulacsi AA, 2008, NAT NEUROSCI, V11, P1383, DOI 10.1038/nn.2226; Higashi M, 2008, STEM CELLS, V26, P1758, DOI 10.1634/stemcells.2007-1032; Hwang H, 2012, BRAIN DEV-JPN, V34, P344, DOI 10.1016/j.braindev.2011.08.007; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kang ML, 2013, INT J MOL SCI, V14, P6614, DOI 10.3390/ijms14046614; Kaufman KR, 2011, EPILEPSY BEHAV, V21, P1, DOI 10.1016/j.yebeh.2011.03.011; Kondziella D, 2011, NEUROREPORT, V22, P97, DOI 10.1097/WNR.0b013e328342d2fa; KOSTYUK PG, 1992, NEUROSCIENCE, V51, P755, DOI 10.1016/0306-4522(92)90515-4; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Laeng P, 2004, J NEUROCHEM, V91, P238, DOI 10.1111/j.1471-4159.2004.02725.x; Lazarov O, 2010, TRENDS NEUROSCI, V33, P569, DOI 10.1016/j.tins.2010.09.003; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Mares P, 1998, LIFE SCI, V63, pPL51, DOI 10.1016/S0024-3205(98)00266-5; Mares P, 1997, PHYSIOL RES, V46, P397; Martinez-Canabal A, 2013, HIPPOCAMPUS, V23, P66, DOI 10.1002/hipo.22054; Marxreiter F, 2013, CELL MOL LIFE SCI, V70, P459, DOI 10.1007/s00018-012-1062-x; Mathern GW, 2002, EPILEPSIA, V43, P68, DOI 10.1046/j.1528-1157.43.s.5.28.x; Mifsud J, 2001, BIOPHARM DRUG DISPOS, V22, P83, DOI 10.1002/bdd.266; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mishra D, 2012, TOXICOL SCI, V127, P84, DOI 10.1093/toxsci/kfs004; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Ortiz-Matamoros A, 2013, CURR NEUROPHARMACOL, V11, P465, DOI 10.2174/1570159X11311050001; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Peng Y, 2004, J BIOL CHEM, V279, P28509, DOI 10.1074/jbc.M402294200; Polack PO, 2009, EPILEPSIA, V50, P1816, DOI 10.1111/j.1528-1167.2009.02047.x; Ponnusamy R, 2006, BEHAV PHARMACOL, V17, P573, DOI 10.1097/01.fbp.0000236268.79923.18; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sawicka A, 2012, BIOCHIMIE, V94, P2193, DOI 10.1016/j.biochi.2012.04.018; Serrano P A, 1978, Arch Inst Cardiol Mex, V48, P437; Shankaran M, 2006, J PHARMACOL EXP THER, V319, P1172, DOI 10.1124/jpet.106.110510; SHERWIN AL, 1973, ARCH NEUROL-CHICAGO, V28, P178, DOI 10.1001/archneur.1973.00490210058007; Shioda N, 2009, INT REV NEUROBIOL, V85, P375, DOI 10.1016/S0074-7742(09)85026-5; Sinha C, 2006, NEUROTOXICOL TERATOL, V28, P472, DOI 10.1016/j.ntt.2006.03.005; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Steiner B, 2006, REGEN MED, V1, P15, DOI 10.2217/17460751.1.1.15; Tauffenberger A, 2013, NEUROBIOL AGING, V34, P2175, DOI 10.1016/j.neurobiolaging.2013.03.014; Tiwari SK, 2015, MOL NEUROBIOL, V51, P1395, DOI 10.1007/s12035-014-8817-3; Tiwari SK, 2014, ACS NANO, V8, P76, DOI 10.1021/nn405077y; Tse MT, 2012, NAT REV DRUG DISCOV, V11, DOI 10.1038/nrd3850; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wang L, 2006, J CEREBR BLOOD F MET, V26, P556, DOI 10.1038/sj.jcbfm.9600215; Wennstrom M, 2006, BIOL PSYCHIAT, V59, P178, DOI 10.1016/j.biopsych.2005.08.032; Williams AJ, 2006, J PHARMACOL EXP THER, V318, P947, DOI 10.1124/jpet.106.105999; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x; Zhang MY, 2014, NEUROBIOL AGING, V35, P2713, DOI 10.1016/j.neurobiolaging.2014.06.009; Zhang Q, 2011, MOLECULES, V16, P10146, DOI 10.3390/molecules161210146; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng MG, 2013, AMYLOID, V20, P13, DOI 10.3109/13506129.2012.755122	78	69	72	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28540	28558		10.1074/jbc.M115.652586	http://dx.doi.org/10.1074/jbc.M115.652586			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26420483	Green Published, hybrid			2022-12-28	WOS:000365761900046
J	M'Kadmi, C; Leyris, JP; Onfroy, L; Gales, C; Sauliere, A; Gagne, D; Damian, M; Mary, S; Maingot, M; Denoyelle, S; Verdie, P; Fehrentz, JA; Martinez, J; Baneres, JL; Marie, J				M'Kadmi, Celine; Leyris, Jean-Philippe; Onfroy, Lauriane; Gales, Celine; Sauliere, Aude; Gagne, Didier; Damian, Marjorie; Mary, Sophie; Maingot, Mathieu; Denoyelle, Severine; Verdie, Pascal; Fehrentz, Jean-Alain; Martinez, Jean; Baneres, Jean-Louis; Marie, Jacky			Agonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-HORMONE SECRETAGOGUE; PROTEIN-COUPLED RECEPTORS; PHARMACOLOGICAL IN-VITRO; CONSTITUTIVE ACTIVITY; FUNCTIONAL SELECTIVITY; BODY-WEIGHT; FOOD-INTAKE; POTENT; LIGANDS; 1,2,4-TRIAZOLE	Background: GHS-R1a activates multiple signaling pathways mediating feeding and addictive behaviors. Results: Some GHS-R1a ligands activate G(q) but not G(i/o) and fail to recruit beta-arrestin2; others act as selective inverse agonists at G(q) compared with G(13). Conclusion: Synthetic ligands can selectively activate or reverse G(q)-dependent signaling at GHS-R1a. Significance: Ligand-biased signaling can be exploited for the development of selective drugs to treat GHS-R1a-mediated disorders. The G protein-coupled receptor GHS-R1a mediates ghrelin-induced growth hormone secretion, food intake, and reward-seeking behaviors. GHS-R1a signals through G(q), G(i/o), G(13), and arrestin. Biasing GHS-R1a signaling with specific ligands may lead to the development of more selective drugs to treat obesity or addiction with minimal side effects. To delineate ligand selectivity at GHS-R1a signaling, we analyzed in detail the efficacy of a panel of synthetic ligands activating the different pathways associated with GHS-R1a in HEK293T cells. Besides beta-arrestin2 recruitment and ERK1/2 phosphorylation, we monitored activation of a large panel of G protein subtypes using a bioluminescence resonance energy transfer-based assay with G protein-activation biosensors. We first found that unlike full agonists, G(q) partial agonists were unable to trigger beta-arrestin2 recruitment and ERK1/2 phosphorylation. Using G protein-activation biosensors, we then demonstrated that ghrelin promoted activation of G(q), G(i1), G(i2), G(i3), G(oa), G(ob), and G(13) but not G(s) and G(12). Besides, we identified some GHS-R1a ligands that preferentially activated G(q) and antagonized ghrelin-mediated G(i)/G(o) activation. Finally, we unambiguously demonstrated that in addition to G(q), GHS-R1a also promoted constitutive activation of G(13). Importantly, we identified some ligands that were selective inverse agonists toward G(q) but not of G(13). This demonstrates that bias at GHS-R1a signaling can occur not only with regard to agonism but also to inverse agonism. Our data, combined with other in vivo studies, may facilitate the design of drugs selectively targeting individual signaling pathways to treat only the therapeutically relevant function.	[M'Kadmi, Celine; Gagne, Didier; Damian, Marjorie; Mary, Sophie; Maingot, Mathieu; Denoyelle, Severine; Verdie, Pascal; Fehrentz, Jean-Alain; Martinez, Jean; Baneres, Jean-Louis; Marie, Jacky] Univ Montpellier, CNRS, ENSCM, IBMM,UMR 5247,Fac Pharm, F-34093 Montpellier 05, France; [Leyris, Jean-Philippe] Hop St Eloi, Inst Neurosci Montpellier, F-34091 Montpellier 05, France; [Onfroy, Lauriane; Gales, Celine; Sauliere, Aude] Univ Toulouse 3, Inst Malad Metabol & Cardiovasc, Ctr Hosp Univ Toulouse, INSERM,U1048, F-31432 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Marie, J (corresponding author), Univ Montpellier, CNRS, ENSCM, IBMM,UMR 5247,Fac Pharm, 15 Ave Charles Flahault,BP 14491, F-34093 Montpellier 05, France.	jacky.marie@univ-montp1.fr	Martinez, Jean/R-9421-2019; verdie, pascal/AAM-4228-2020	Martinez, Jean/0000-0002-9267-4621; Baneres, jean-louis/0000-0001-7078-1285; GALES, Celine/0000-0002-4938-1583	INSERM; CNRS; Universite de Montpellier, Agence Nationale de la Recherche Grant [PCV08-323163]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Montpellier, Agence Nationale de la Recherche Grant(French National Research Agency (ANR))	This work was supported by grants from INSERM, CNRS, and Universite de Montpellier, Agence Nationale de la Recherche Grant PCV08-323163. The authors declare that they have no conflicts of interest with the contents of this article.	Akamizu T, 2012, EUR J INTERN MED, V23, P197, DOI 10.1016/j.ejim.2011.12.001; Bennett KA, 2009, MOL PHARMACOL, V76, P802, DOI 10.1124/mol.109.056101; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Callaghan B, 2014, PHARMACOL REV, V66, P984, DOI 10.1124/pr.113.008433; Camina JP, 2007, J CELL PHYSIOL, V213, P187, DOI 10.1002/jcp.21109; Chollet C, 2009, J PEPT SCI, V15, P711, DOI 10.1002/psc.1177; Costantini VJA, 2011, NEUROENDOCRINOLOGY, V94, P158, DOI 10.1159/000328968; Cruz CRY, 2008, VITAM HORM, V77, P47, DOI 10.1016/S0083-6729(06)77004-2; Damian M, 2015, P NATL ACAD SCI USA, V112, P1601, DOI 10.1073/pnas.1414618112; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; Delporte C., 2013, SCIENTIFICA, V2013, DOI DOI 10.1155/2013/518909; Els S, 2012, J MED CHEM, V55, P7437, DOI 10.1021/jm300414b; Evron T, 2014, J BIOL CHEM, V289, P33442, DOI 10.1074/jbc.M114.581397; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Guerlavais V, 2003, J MED CHEM, V46, P1191, DOI 10.1021/jm020985q; Halem HA, 2004, EUR J ENDOCRINOL, V151, pS71, DOI 10.1530/eje.0.151S071; Hansson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050409; Holliday ND, 2007, MOL ENDOCRINOL, V21, P3100, DOI 10.1210/me.2007-0254; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2004, TRENDS PHARMACOL SCI, V25, P113, DOI 10.1016/j.tips.2004.01.010; Holst B, 2007, J BIOL CHEM, V282, P15799, DOI 10.1074/jbc.M609796200; Holst B, 2006, MOL PHARMACOL, V70, P936, DOI 10.1124/mol.106.024422; Holubova M, 2013, PHYSIOL RES, V62, P435, DOI 10.33549/physiolres.932488; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Leyris JP, 2011, ANAL BIOCHEM, V408, P253, DOI 10.1016/j.ab.2010.09.030; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; Mary S, 2012, P NATL ACAD SCI USA, V109, P8304, DOI 10.1073/pnas.1119881109; Maudsley S, 2012, MINI-REV MED CHEM, V12, P831, DOI 10.2174/138955712800959071; Mear Y, 2014, J CLIN ENDOCR METAB, V99, pE2463, DOI 10.1210/jc.2014-2753; Menzies JRW, 2013, ENDOCR DEV, V25, P101, DOI 10.1159/000346058; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Moulin A, 2008, J MED CHEM, V51, P689, DOI 10.1021/jm701292s; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; Moulin A, 2007, CHEMMEDCHEM, V2, P1242, DOI 10.1002/cmdc.200700015; Moulin A, 2013, AMINO ACIDS, V44, P301, DOI 10.1007/s00726-012-1355-2; Mousseaux D, 2006, BRIT J PHARMACOL, V148, P350, DOI 10.1038/sj.bjp.0706727; Murphy MG, 2001, J CLIN ENDOCR METAB, V86, P1116, DOI 10.1210/jc.86.3.1116; Nass R, 2011, MOL CELL ENDOCRINOL, V340, P10, DOI 10.1016/j.mce.2011.03.021; Nelson CP, 2007, BIOCHEM PHARMACOL, V73, P737, DOI 10.1016/j.bcp.2006.09.005; Pantel J, 2006, J CLIN INVEST, V116, P760, DOI 10.1172/JCI25303; PATCHETT AA, 1995, P NATL ACAD SCI USA, V92, P7001, DOI 10.1073/pnas.92.15.7001; Pazos Y, 2008, VITAM HORM, V77, P89, DOI 10.1016/S0083-6729(06)77005-4; Petersen PS, 2009, ENDOCRINOLOGY, V150, P4920, DOI 10.1210/en.2008-1638; Sabbatini FM, 2010, CHEMMEDCHEM, V5, P1450, DOI 10.1002/cmdc.201000185; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Sivertsen B, 2013, BRIT J PHARMACOL, V170, P1349, DOI 10.1111/bph.12361; Sivertsen B, 2011, J BIOL CHEM, V286, P20845, DOI 10.1074/jbc.M110.173237; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yin Y, 2014, INT J MOL SCI, V15, P4837, DOI 10.3390/ijms15034837; Zhou L, 2014, CURR OPIN CELL BIOL, V27, P102, DOI 10.1016/j.ceb.2013.11.010	61	66	66	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27021	27039		10.1074/jbc.M115.659250	http://dx.doi.org/10.1074/jbc.M115.659250			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26363071	Green Published, hybrid			2022-12-28	WOS:000364794000015
J	King, K; Lin, NP; Cheng, YH; Chen, GH; Chein, RJ				King, Klim; Lin, Nai-Pin; Cheng, Yu-Hong; Chen, Gao-Hui; Chein, Rong-Jie			Isolation of Positive Modulator of Glucagon-like Peptide-1 Signaling from Trigonella foenum-graecum (Fenugreek) Seed	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 DIABETES-MELLITUS; PROTEIN-COUPLED-RECEPTORS; INCRETIN-BASED THERAPIES; GASTRIC-INHIBITORY POLYPEPTIDE; INSULIN-SECRETION; GLP-1; GLUCOSE; EXENATIDE; PEPTIDE-1(7-36)AMIDE; TRANSDUCTION	The glucagon-like peptide-1 receptor (GLP-1R) is expressed in many tissues and has been implicated in diverse physiological functions, such as energy homeostasis and cognition. GLP-1 analogs are approved for treatment of type 2 diabetes and are undergoing clinical trials for other disorders, including neurodegenerative diseases. GLP-1 analog therapies maintain chronically high plasma levels of the analog and can lead to loss of spatiotemporal control of GLP-1R activation. To avoid adverse effects associated with current therapies, we characterized positive modulators of GLP-1R signaling. We screened extracts from edible plants using an intracellular cAMP biosensor and GLP-1R endocytosis assays. Ethanol extracts from fenugreek seeds enhanced GLP-1 signaling. These seeds have previously been found to reduce glucose and glycated hemoglobin levels in humans. An active compound (N55) with a new N-linoleoyl-2-amino-gamma-butyrolactone structure was purified from fenugreek seeds. N55 promoted GLP-1-dependent cAMP production and GLP-1R endocytosis in a dose-dependent and saturable manner. N55 specifically enhanced GLP-1 potency more than 40-fold, but not that of exendin 4, to stimulate cAMP production. In contrast to the current allosteric modulators that bind to GLP-1R, N55 binds to GLP-1 peptide and facilitates trypsinmediated GLP-1 inactivation. These findings identify a new class of modulators of GLP-1R signaling and suggest that GLP-1 might be a viable target for drug discovery. Our results also highlight a feasible approach for screening bioactive activity of plant extracts.	[King, Klim; Cheng, Yu-Hong] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Lin, Nai-Pin; Chein, Rong-Jie] Acad Sinica, Inst Chem, Taipei 11529, Taiwan; [Chen, Gao-Hui] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan	King, K (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan.	bmkxk@ibms.sinica.edu.tw; rjchein@chem.sinica.edu.tw	Chein, Rong-Jie/F-1975-2015; Chein, Rong-Jie/F-4743-2015	Chein, Rong-Jie/0000-0002-0119-8288	Academia Sinica, Taiwan	Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by Academia Sinica, Taiwan. R.-J. C. and K. K. have filed a patent application covering chemical compositions and applications for developing N55 analogs.	Al-Okbi SY, 2014, TOXICOL IND HEALTH, V30, P738, DOI 10.1177/0748233712462468; Andersen NH, 2002, BIOORGAN MED CHEM, V10, P79, DOI 10.1016/S0968-0896(01)00263-2; Aviles-Olmos I, 2014, J PARKINSON DIS, V4, P337, DOI 10.3233/JPD-140364; Bae MJ, 2012, J ETHNOPHARMACOL, V144, P514, DOI 10.1016/j.jep.2012.09.030; Belaid-Nouira Y, 2013, NUTR NEUROSCI, V16, P218, DOI 10.1179/1476830512Y.0000000048; Butler PC, 2013, DIABETES CARE, V36, P2118, DOI 10.2337/dc12-2713; Calanna S, 2013, DIABETOLOGIA, V56, P965, DOI 10.1007/s00125-013-2841-0; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Cheng YH, 2015, J BIOL CHEM, V290, P14302, DOI 10.1074/jbc.M115.655662; Cordova A, 2002, J AM CHEM SOC, V124, P1842, DOI 10.1021/ja017270h; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Faerch K, 2015, DIABETES, V64, P2513, DOI 10.2337/db14-1751; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; GALLWITZ B, 1993, J MOL ENDOCRINOL, V10, P259, DOI 10.1677/jme.0.0100259; GEFEL D, 1990, ENDOCRINOLOGY, V126, P2164, DOI 10.1210/endo-126-4-2164; GOKE R, 1988, Z GASTROENTEROL, V26, P715; Gu GB, 2013, J COMP NEUROL, V521, P2235, DOI 10.1002/cne.23282; Haber SL, 2013, AM J HEALTH-SYST PH, V70, P1196, DOI 10.2146/ajhp120523; Hannan JMA, 2007, BRIT J NUTR, V97, P514, DOI 10.1017/S0007114507657869; Holscher C, 2014, J ENDOCRINOL, V221, pT31, DOI 10.1530/JOE-13-0221; Hudson CC, 2006, METHOD ENZYMOL, V414, P63, DOI 10.1016/S0076-6879(06)14005-7; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Lonborg J, 2012, CIRC-CARDIOVASC INTE, V5, P288, DOI 10.1161/CIRCINTERVENTIONS.112.968388; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Lu FR, 2008, CHIN J INTEGR MED, V14, P56, DOI 10.1007/s11655-007-9005; MADAR Z, 1988, EUR J CLIN NUTR, V42, P51; Madsen K, 2007, J MED CHEM, V50, P6126, DOI 10.1021/jm070861j; Mathern JR, 2009, PHYTOTHER RES, V23, P1543, DOI 10.1002/ptr.2795; Meier JJ, 2004, DIABETES, V53, P654, DOI 10.2337/diabetes.53.3.654; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Muscogiuri G, 2014, J ENDOCRINOL INVEST, V37, P1143, DOI 10.1007/s40618-014-0137-y; Nauck MA, 2011, DIABETOLOGIA, V54, P10, DOI 10.1007/s00125-010-1896-4; Nauck MA, 2011, AM J MED, V124, pS19, DOI 10.1016/j.amjmed.2010.11.002; Neelakantan N, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-7; Nolte WM, 2014, NAT CHEM BIOL, V10, P629, DOI 10.1038/nchembio.1581; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Runge S, 2007, BIOCHEMISTRY-US, V46, P5830, DOI 10.1021/bi062309m; Sauvaire Y, 1998, DIABETES, V47, P206, DOI 10.2337/diabetes.47.2.206; SHARMA RD, 1986, NUTR RES, V6, P1353, DOI 10.1016/S0271-5317(86)80020-3; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Uemura T, 2010, MOL NUTR FOOD RES, V54, P1596, DOI 10.1002/mnfr.200900609; Wang E, 2008, DIABETES EDUCATOR, V34, P645, DOI 10.1177/0145721708320559; Ward BP, 2013, MOL METAB, V2, P468, DOI 10.1016/j.molmet.2013.08.008; WIDMANN C, 1994, MOL PHARMACOL, V45, P1029; Zhang L, 2012, CURR MED CHEM, V19, P1602; Zhou J, 2012, CURR MED CHEM, V19, P3523, DOI 10.2174/092986712801323171	49	18	18	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26235	+		10.1074/jbc.M115.672097	http://dx.doi.org/10.1074/jbc.M115.672097			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26336108	hybrid, Green Published			2022-12-28	WOS:000363527300040
J	Simon, JM; Parker, JS; Liu, F; Rothbart, SB; Ait-Si-Ali, S; Strahl, BD; Jin, J; Davis, IJ; Mosley, AL; Pattenden, SG				Simon, Jeremy M.; Parker, Joel S.; Liu, Feng; Rothbart, Scott B.; Ait-Si-Ali, Slimane; Strahl, Brian D.; Jin, Jian; Davis, Ian J.; Mosley, Amber L.; Pattenden, Samantha G.			A Role for Widely Interspaced Zinc Finger (WIZ) in Retention of the G9a Methyltransferase on Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITION-EFFECT VARIEGATION; DROSOPHILA HETEROCHROMATIN PROTEIN; TRANSCRIPTION FACTOR-IIIA; MASS SPECTROMETRY DATA; DNA-BINDING PROTEIN; HISTONE H3; LYSINE-9 METHYLATION; SEQUENCE RECOGNITION; CHROMOSOMAL-PROTEIN; PROTEOMIC ANALYSIS	G9a and GLP lysine methyltransferases form a heterodimeric complex that is responsible for the majority of histone H3 lysine 9 mono-and di-methylation (H3K9me1/me2). Widely interspaced zinc finger (WIZ) associates with the G9a-GLP protein complex, but its role in mediating lysine methylation is poorly defined. Here, we show that WIZ regulates global H3K9me2 levels by facilitating the interaction of G9a with chromatin. Disrupting the association of G9a-GLP with chromatin by depleting WIZ resulted in altered gene expression and protein-protein interactions that were distinguishable from that of small molecule-based inhibition of G9a/GLP, supporting discrete functions of the G9a-GLP-WIZ chromatin complex in addition to H3K9me2 methylation.	[Simon, Jeremy M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Carolina Inst Dev Disabil, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Simon, Jeremy M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Parker, Joel S.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Parker, Joel S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Liu, Feng; Pattenden, Samantha G.] Univ N Carolina, Eshelman Sch Pharm, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC 27599 USA; [Rothbart, Scott B.] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA; [Ait-Si-Ali, Slimane] Univ Paris Diderot, Sorbonne Paris Cite, Lab Epigenet & Destin Cellulaire, CNRS,UMR7216, F-75013 Paris, France; [Strahl, Brian D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Strahl, Brian D.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Jin, Jian] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, Dept Oncol Sci, New York, NY 10029 USA; [Jin, Jian] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Davis, Ian J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pediat, Dept Genet, Chapel Hill, NC 27599 USA; [Davis, Ian J.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Mosley, Amber L.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Mosley, Amber L.] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Van Andel Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Pattenden, SG (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Ctr Integrat Chem Biol & Drug Discovery, Marsico Hall,125 Mason Farm, Chapel Hill, NC 27599 USA.	pattenden@unc.edu	Parker, Joel/AAG-1108-2019; Regan, Clinton/E-6250-2012; Strahl, Brian D/C-7601-2012	Strahl, Brian D/0000-0002-4947-6259; Davis, Ian/0000-0002-1552-0960	National Institutes of Health [CA181343, R01GM110058, R01CA166447, R01GM103893]; W. M. Keck Foundation; National Institutes of Health from NIGMS [R01GM100919]; Carolina Partnership; University Cancer Research Fund, University of North Carolina at Chapel Hill; NATIONAL CANCER INSTITUTE [R00CA181343, R01CA166447, K99CA181343] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108, UL1TR002529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103893, R01GM110058, R01GM100919] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Carolina Partnership; University Cancer Research Fund, University of North Carolina at Chapel Hill; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA181343 (to S. B. R.), R01GM110058 (to B. D. S.), R01CA166447 (to I. J. D), and R01GM103893 (to J. J.). This work was also supported by the W. M. Keck Foundation (to B. D. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health Grant R01GM100919 from NIGMS (awarded to Dr. Stephen Frye) and by the Carolina Partnership and the University Cancer Research Fund, University of North Carolina at Chapel Hill.	Alexandre E, 1996, MECH DEVELOP, V59, P191, DOI 10.1016/0925-4773(96)00594-1; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Baust C, 2002, MAMM GENOME, V13, P423, DOI 10.1007/s00335-002-2178-3; Bian CJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05606; Biggar KK, 2015, NAT REV MOL CELL BIO, V16, P5, DOI 10.1038/nrm3915; Bittencourt D, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-27; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Bunnage ME, 2013, NAT CHEM BIOL, V9, P195, DOI 10.1038/nchembio.1197; Caron C, 2003, EMBO REP, V4, P877, DOI 10.1038/sj.embor.embor917; Caubit X, 2000, MECH DEVELOP, V91, P445, DOI 10.1016/S0925-4773(99)00318-4; Chaturvedi CP, 2009, P NATL ACAD SCI USA, V106, P18303, DOI 10.1073/pnas.0906769106; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Choi H., 2012, CURR PROTOC BIOINFOR, V39; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; CLEARD F, 1995, NUCLEIC ACIDS RES, V23, P796, DOI 10.1093/nar/23.5.796; Cleard F, 1997, EMBO J, V16, P5280, DOI 10.1093/emboj/16.17.5280; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; Collins R, 2010, NUCLEIC ACIDS RES, V38, P3503, DOI 10.1093/nar/gkq081; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Del Rizzo PA, 2014, BBA-GENE REGUL MECH, V1839, P1404, DOI 10.1016/j.bbagrm.2014.06.008; Ding ZH, 2003, MOL CELL BIOL, V23, P250, DOI 10.1128/MCB.23.1.250-258.2003; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Florens Laurence, 2006, V328, P159; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Konze KD, 2014, CHEMMEDCHEM, V9, P549, DOI 10.1002/cmdc.201300450; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133j, 10.1021/cb400133J]; Lahn BT, 2002, P NATL ACAD SCI USA, V99, P8707, DOI 10.1073/pnas.082248899; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lassmann T, 2009, BIOINFORMATICS, V25, P2839, DOI 10.1093/bioinformatics/btp527; Lee DY, 2006, J BIOL CHEM, V281, P8476, DOI 10.1074/jbc.M511093200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier VK, 2015, MOL CELL PROTEOMICS, V14, P1435, DOI 10.1074/mcp.M114.044586; Manfroid I, 2004, DEVELOPMENT, V131, P1065, DOI 10.1242/dev.00977; Matsumoto K, 1998, MOL BRAIN RES, V61, P179, DOI 10.1016/S0169-328X(98)00216-2; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Mosley AL, 2013, MOL CELL PROTEOMICS, V12, P1530, DOI 10.1074/mcp.M112.024034; Mozzetta C, 2015, NAT REV MOL CELL BIO, V16, P499, DOI 10.1038/nrm4029; Mozzetta C, 2014, MOL CELL, V53, P277, DOI 10.1016/j.molcel.2013.12.005; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Oh ST, 2014, FEBS LETT, V588, P685, DOI 10.1016/j.febslet.2014.01.039; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Purcell DJ, 2011, J BIOL CHEM, V286, P41963, DOI 10.1074/jbc.M111.298463; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; REUTER G, 1990, NATURE, V344, P219, DOI 10.1038/344219a0; ROSENBERG UB, 1986, NATURE, V319, P336, DOI 10.1038/319336a0; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; SAUNDERS WS, 1993, J CELL SCI, V104, P573; Shankar SR, 2013, EPIGENETICS-US, V8, P16, DOI 10.4161/epi.23331; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; SINGH PB, 1991, NUCLEIC ACIDS RES, V19, P789, DOI 10.1093/nar/19.4.789; Smith-Kinnaman WR, 2014, MOL BIOSYST, V10, P1730, DOI 10.1039/c4mb00109e; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; TAKATSUJI H, 1992, EMBO J, V11, P241, DOI 10.1002/j.1460-2075.1992.tb05047.x; TAKATSUJI H, 1994, PLANT CELL, V6, P947, DOI 10.1105/tpc.6.7.947; Takatsuji H, 1996, J BIOL CHEM, V271, P23368, DOI 10.1074/jbc.271.38.23368; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Trojer P, 2009, J BIOL CHEM, V284, P8395, DOI 10.1074/jbc.M807818200; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ueda J, 2006, J BIOL CHEM, V281, P20120, DOI 10.1074/jbc.M603087200; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Waltzer L, 2001, EMBO J, V20, P137, DOI 10.1093/emboj/20.1.137; Weiss T, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-7; Weiss WA, 2007, NAT CHEM BIOL, V3, P739, DOI 10.1038/nchembio1207-739; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wu H, 2011, CELL RES, V21, P365, DOI 10.1038/cr.2010.157; Yu YX, 2012, MOL CELL, V46, P7, DOI 10.1016/j.molcel.2012.01.019; Yuan XJ, 2007, MOL CELL, V27, P585, DOI 10.1016/j.molcel.2007.06.021	85	20	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26088	26102		10.1074/jbc.M115.654459	http://dx.doi.org/10.1074/jbc.M115.654459			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26338712	Green Published, hybrid			2022-12-28	WOS:000363527300029
J	Lindsey-Boltz, LA; Kemp, MG; Hu, JC; Sancar, A				Lindsey-Boltz, Laura A.; Kemp, Michael G.; Hu, Jinchuan; Sancar, Aziz			Analysis of Ribonucleotide Removal from DNA by Human Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME INSTABILITY; HUMAN EXCINUCLEASE; DAMAGE-CHECKPOINT; ESCHERICHIA-COLI; TOPOISOMERASE-I; RNASE H2; CELLS; NUCLEASE; STRAND; OLIGONUCLEOTIDES	Ribonucleotides are incorporated into the genome during DNA replication. The enzyme RNase H2 plays a critical role in targeting the removal of these ribonucleotides from DNA, and defects in RNase H2 activity are associated with both genomic instability and the human autoimmune/inflammatory disorder Aicardi-Goutieres syndrome. Whether additional general DNA repair mechanisms contribute to ribonucleotide removal from DNA in human cells is not known. Because of its ability to act on a wide variety of substrates, we examined a potential role for canonical nucleotide excision repair in the removal of ribonucleotides from DNA. However, using highly sensitive dual incision/excision assays, we find that ribonucleotides are not efficiently targeted by the human nucleotide excision repair system in vitro or in cultured human cells. These results suggest that nucleotide excision repair is unlikely to play a major role in the cellular response to ribonucleotide incorporation in genomic DNA in human cells.	[Lindsey-Boltz, Laura A.; Kemp, Michael G.; Hu, Jinchuan; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Campus Box 7260, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	Lindsey-Boltz, Laura/A-3121-2010; Kemp, Michael G./AAT-1545-2021; Hu, Jinchuan/V-9913-2017; Regan, Clinton/E-6250-2012	Lindsey-Boltz, Laura/0000-0001-6493-8194; Kemp, Michael G./0000-0001-8203-0745; Hu, Jinchuan/0000-0001-7096-0195	National Institutes of Health [R01GM32833, R21ES024425]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES024425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM32833 and R21ES024425 (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Arana ME, 2012, DNA REPAIR, V11, P933, DOI 10.1016/j.dnarep.2012.09.006; Branum ME, 2001, J BIOL CHEM, V276, P25421, DOI 10.1074/jbc.M101032200; Cho JE, 2015, NUCLEIC ACIDS RES, V43, P9306, DOI 10.1093/nar/gkv824; Choi JH, 2015, J BIOL CHEM, V290, P28812, DOI 10.1074/jbc.M115.690354; Gunther C, 2015, J CLIN INVEST, V125, P413, DOI 10.1172/JCI78001; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; HUANG JC, 1994, J BIOL CHEM, V269, P19034; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P12213, DOI 10.1073/pnas.91.25.12213; Kemp MG, 2014, J BIOL CHEM, V289, P26574, DOI 10.1074/jbc.M114.597088; Kemp MG, 2012, J BIOL CHEM, V287, P22889, DOI 10.1074/jbc.M112.374447; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Lindsey-Boltz LA, 2014, J BIOL CHEM, V289, P5074, DOI 10.1074/jbc.M113.542787; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Pizzi S, 2015, HUM MOL GENET, V24, P649, DOI 10.1093/hmg/ddu485; Reardon JT, 2006, METHOD ENZYMOL, V408, P189, DOI 10.1016/S0076-6879(06)08012-8; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Reijns MAM, 2014, BIOCHEM SOC T, V42, P717, DOI 10.1042/BST20140079; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; SANCAR A, 1983, CELL, V33, P249, DOI 10.1016/0092-8674(83)90354-9; Sekiguchi J, 1997, MOL CELL, V1, P89, DOI 10.1016/S1097-2765(00)80010-6; Sparks JL, 2015, EMBO J, V34, P1259, DOI 10.15252/embj.201490868; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; Vaisman A, 2015, DNA REPAIR, V29, P74, DOI 10.1016/j.dnarep.2015.02.008; Vaisman A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003878; VREESWIJK MPG, 1994, J BIOL CHEM, V269, P31858; Williams JS, 2015, NAT STRUCT MOL BIOL, V22, P291, DOI 10.1038/nsmb.2989; Williams JS, 2014, DNA REPAIR, V19, P27, DOI 10.1016/j.dnarep.2014.03.029; Williams JS, 2013, MOL CELL, V49, P1010, DOI 10.1016/j.molcel.2012.12.021	35	16	17	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29801	29807		10.1074/jbc.M115.695254	http://dx.doi.org/10.1074/jbc.M115.695254			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26491008	Green Published, hybrid			2022-12-28	WOS:000366614700015
J	Cobb, MM; Austin, DC; Sack, JT; Trimmer, JS				Cobb, Melanie M.; Austin, Daniel C.; Sack, Jon T.; Trimmer, James S.			Cell Cycle-dependent Changes in Localization and Phosphorylation of the Plasma Membrane Kv2.1 K+ Channel Impact Endoplasmic Reticulum Membrane Contact Sites in COS-1 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED POTASSIUM CHANNEL; MOLECULAR-MECHANISMS; C-TERMINUS; EXPRESSION; INSULIN; MODULATION; ACTIVATION; CANCER; BRAIN; IDENTIFICATION	The plasma membrane (PM) comprises distinct subcellular domains with diverse functions that need to be dynamically coordinated with intracellular events, one of the most impactful being mitosis. The Kv2.1 voltage-gated potassium channel is conditionally localized to large PM clusters that represent specialized PM: endoplasmic reticulum membrane contact sites (PM: ER MCS), and overexpression of Kv2.1 induces more exuberant PM: ER MCS in neurons and in certain heterologous cell types. Localization of Kv2.1 at these contact sites is dynamically regulated by changes in phosphorylation at one or more sites located on its large cytoplasmic C terminus. Here, we show that Kv2.1 expressed in COS-1 cells undergoes dramatic cell cycle-dependent changes in its PM localization, having diffuse localization in interphase cells, and robust clustering during M phase. The mitosis-specific clusters of Kv2.1 are localized to PM: ER MCS, and M phase clustering of Kv2.1 induces more extensive PM: ER MCS. These cell cycle-dependent changes in Kv2.1 localization and the induction of PM: ER MCS are accompanied by increased mitotic Kv2.1 phosphorylation at several C-terminal phosphorylation sites. Phosphorylation of exogenously expressed Kv2.1 is significantly increased upon metaphase arrest in COS-1 and CHO cells, and in a pancreatic beta cell line that express endogenous Kv2.1. The M phase clustering of Kv2.1 at PM: ER MCS in COS-1 cells requires the same C-terminal targeting motif needed for conditional Kv2.1 clustering in neurons. The cell cycle-dependent changes in localization and phosphorylation of Kv2.1 were not accompanied by changes in the electrophysiological properties of Kv2.1 expressed in CHO cells. Together, these results provide novel insights into the cell cycle-dependent changes in PM protein localization and phosphorylation.	[Cobb, Melanie M.; Trimmer, James S.] Univ Calif Davis, Sch Med, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Austin, Daniel C.; Sack, Jon T.; Trimmer, James S.] Univ Calif Davis, Sch Med, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Sack, Jon T.] Univ Calif Davis, Sch Med, Dept Anesthesiol & Pain Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Trimmer, JS (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	jtrimmer@ucdavis.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 NS042225]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS042225 (to J. S. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Antonucci DE, 2001, NEUROSCIENCE, V108, P69, DOI 10.1016/S0306-4522(01)00476-6; Baver SB, 2012, NEUROSCIENCE, V217, P56, DOI 10.1016/j.neuroscience.2012.04.054; BekeleArcuri Z, 1996, NEUROPHARMACOLOGY, V35, P851, DOI 10.1016/0028-3908(96)00128-1; Bocksteins E, 2009, AM J PHYSIOL-CELL PH, V296, pC1271, DOI 10.1152/ajpcell.00088.2009; Cerda O, 2011, J BIOL CHEM, V286, P28738, DOI 10.1074/jbc.M111.251942; Cicenas J, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.61; Deng XL, 2007, CELL PROLIFERAT, V40, P656, DOI 10.1111/j.1365-2184.2007.00458.x; Deutsch E, 2012, MOL BIOL CELL, V23, P2917, DOI 10.1091/mbc.E12-01-0047; DREWE JA, 1992, J NEUROSCI, V12, P538; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; English AR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013227; Fox PD, 2015, J CELL SCI, V128, P2096, DOI 10.1242/jcs.166009; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Helle SCJ, 2013, BBA-MOL CELL RES, V1833, P2526, DOI 10.1016/j.bbamcr.2013.01.028; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Henne WM, 2015, CURR OPIN CELL BIOL, V35, P123, DOI 10.1016/j.ceb.2015.05.001; Herrington J, 2006, DIABETES, V55, P1034, DOI 10.2337/diabetes.55.04.06.db05-0788; Herve JC, 2015, BBA-BIOMEMBRANES, V1848, P2473, DOI 10.1016/j.bbamem.2015.06.017; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 2012, J GEN PHYSIOL, V140, P245, DOI 10.1085/jgp.201210874; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Hille B, 2015, BBA-MOL CELL BIOL L, V1851, P844, DOI 10.1016/j.bbalip.2014.09.010; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huang X, 2014, J CELL BIOL, V206, P151, DOI 10.1083/jcb.201404136; Huang X, 2012, GENE DEV, V26, P1780, DOI 10.1101/gad.193789.112; Ikematsu N, 2011, P NATL ACAD SCI USA, V108, P18132, DOI 10.1073/pnas.1106201108; Jacobson DA, 2007, CELL METAB, V6, P229, DOI 10.1016/j.cmet.2007.07.010; Kaufmann WA, 2009, J COMP NEUROL, V515, P215, DOI 10.1002/cne.22066; King AN, 2014, J COMP NEUROL, V522, P2594, DOI 10.1002/cne.23551; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Kruse M, 2012, J GEN PHYSIOL, V140, P189, DOI 10.1085/jgp.201210806; Lastraioli E, 2015, BBA-BIOMEMBRANES, V1848, P2685, DOI 10.1016/j.bbamem.2014.12.016; Lee A, 2014, J NEUROSCI, V34, P15159, DOI 10.1523/JNEUROSCI.3275-14.2014; LEE BS, 1991, J BIOL CHEM, V266, P11448; Levin M, 2014, MOL BIOL CELL, V25, P3835, DOI 10.1091/mbc.E13-12-0708; Li XY, 2013, J PHARMACOL EXP THER, V344, P407, DOI 10.1124/jpet.112.199083; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Mandikian D, 2014, J COMP NEUROL, V522, P3555, DOI 10.1002/cne.23641; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; McCullough S, 2005, J ANAT, V206, P415, DOI 10.1111/j.1469-7580.2005.00407.x; Medema RH, 2011, TRENDS BIOCHEM SCI, V36, P578, DOI 10.1016/j.tibs.2011.08.006; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Misonou H, 2008, J NEUROSCI, V28, P8529, DOI 10.1523/JNEUROSCI.1417-08.2008; Misonou H, 2006, J NEUROSCI, V26, P13505, DOI 10.1523/JNEUROSCI.3970-06.2006; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Nakahira K, 1996, J BIOL CHEM, V271, P7084, DOI 10.1074/jbc.271.12.7084; O'Connell KMS, 2006, J NEUROSCI, V26, P9609, DOI 10.1523/JNEUROSCI.1825-06.2006; O'Connell KMS, 2010, P NATL ACAD SCI USA, V107, P12351, DOI 10.1073/pnas.1003028107; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ouadid-Ahidouch H, 2004, AM J PHYSIOL-CELL PH, V287, pC125, DOI 10.1152/ajpcell.00488.2003; Ouadid-Ahidouch H, 2004, BIOCHEM BIOPH RES CO, V316, P244, DOI 10.1016/j.bbrc.2004.02.041; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Park Kang-Sik, 2007, Channels (Austin), V1, P59; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Patel AJ, 1997, EMBO J, V16, P6615, DOI 10.1093/emboj/16.22.6615; Prakriya M, 2013, CURR TOP MEMBR, V71, P1, DOI 10.1016/B978-0-12-407870-3.00001-9; Preisinger C, 2001, Sci STKE, V2001, ppe38; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Roe MW, 1996, J BIOL CHEM, V271, P32241, DOI 10.1074/jbc.271.50.32241; Sack JT, 2006, J GEN PHYSIOL, V128, P119, DOI 10.1085/jgp.200609492; Scannevin RH, 1996, J CELL BIOL, V135, P1619, DOI 10.1083/jcb.135.6.1619; Shah NH, 2014, J NEUROSCI, V34, P4326, DOI 10.1523/JNEUROSCI.5184-13.2014; SHI GY, 1994, J BIOL CHEM, V269, P23204; Skelin M, 2010, ALTEX-ALTERN ANIM EX, V27, P105; Smyth JT, 2012, CURR BIOL, V22, P1487, DOI 10.1016/j.cub.2012.05.057; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Song MY, 2012, J PROTEOME RES, V11, P1018, DOI 10.1021/pr200770v; Su JP, 2001, PFLUG ARCH EUR J PHY, V442, P49, DOI 10.1007/s004240000508; Suzuki T, 2004, INT J ONCOL, V25, P153; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; Tilley DC, 2014, P NATL ACAD SCI USA, V111, pE4789, DOI 10.1073/pnas.1406876111; Trapani JG, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-15; Trimmer J.S., 2015, HDB ION CHANNELS, P531; Trimmer JS, 2015, NEURON, V85, P238, DOI 10.1016/j.neuron.2014.12.042; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; UKOMADU C, 1992, NEURON, V8, P663, DOI 10.1016/0896-6273(92)90088-U; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; WARD GE, 1985, SCIENCE, V227, P768, DOI 10.1126/science.2857502; Wellman GC, 2003, CELL CALCIUM, V34, P211, DOI 10.1016/S0143-4160(03)00124-6; Wu XL, 2013, J BIOL CHEM, V288, P4128, DOI 10.1074/jbc.M112.440933; Xia FZ, 2004, J BIOL CHEM, V279, P24685, DOI 10.1074/jbc.M314314200; Zheng YJ, 2002, J BIOL CHEM, V277, P32268, DOI 10.1074/jbc.M202105200	92	16	16	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29189	29201		10.1074/jbc.M115.690198	http://dx.doi.org/10.1074/jbc.M115.690198			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26442584	Green Published, hybrid			2022-12-28	WOS:000366613400007
J	Shah, D; Romero, F; Zhu, Y; Duong, M; Sun, JX; Walsh, K; Summer, R				Shah, Dilip; Romero, Freddy; Zhu, Ying; Duong, Michelle; Sun, Jianxin; Walsh, Kenneth; Summer, Ross			C1q Deficiency Promotes Pulmonary Vascular Inflammation and Enhances the Susceptibility of the Lung Endothelium to Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACTANT PROTEIN-A; ANIMAL-MODELS; IN-VITRO; ADIPONECTIN; SERUM; COLLECTINS; CLEARANCE; BINDING; CELLS; C1Q-ADIPONECTIN	The collectin proteins are innate immune molecules found in high concentrations on the epithelial and endothelial surfaces of the lung. While these proteins are known to have important anti-inflammatory actions in the airways of the lung little is known of their functional importance in the pulmonary circulation. We recently demonstrated that the circulating collectin protein adiponectin has potent anti-inflammatory effects on the lung endothelium, leading us to reason that other structurally related proteins might have similar effects. To test this hypothesis, we investigated the anti-inflammatory actions of C1q in lung endothelial homeostasis and the pulmonary vascular response to LPS or HCl injury. We show that lung endothelium from C1q-deficient (C1q(-/-)) mice expresses higher baseline levels of the vascular adhesion markers ICAM-1, VCAM-1, and E-selectin when compared with wild-type mice. Further, we demonstrate that these changes are associated with enhanced susceptibility of the lung to injury as evident by increased expression of adhesion markers, enhanced production of pro-inflammatory cytokines, and augmented neutrophil recruitment. Additionally, we found that C1q(-/-) mice also exhibited enhanced endothelial barrier dysfunction after injury as manifested by decreased expression of junctional adherens proteins and enhanced vascular leakage. Mechanistically, C1q appears to mediate its effects by inhibiting phosphorylation of p38 mitogen-activated protein kinase (MAPK) and blocking nuclear translocation of the P65 subunit of nuclear factor (NF)-kappa B. In summary, our findings indicate a previously unrecognized role for C1q in pulmonary vascular homeostasis and provide added support for the hypothesis that circulating collectin proteins have protective effects on the lung endothelium.	[Shah, Dilip; Romero, Freddy; Zhu, Ying; Duong, Michelle; Sun, Jianxin; Summer, Ross] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA; [Shah, Dilip; Romero, Freddy; Zhu, Ying; Duong, Michelle; Sun, Jianxin; Summer, Ross] Thomas Jefferson Univ, Jane & Leonard Korman Lung Ctr, Philadelphia, PA 19107 USA; [Zhu, Ying] Second Mil Med Univ, Changhai Hosp, Dept Resp & Crit Care Med, Shanghai, Peoples R China; [Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Jefferson University; Jefferson University; Naval Medical University; Boston University	Summer, R (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St,JAH 368-F, Philadelphia, PA 19107 USA.	Ross.Summer@jefferson.edu	Regan, Clinton/E-6250-2012	Shah, Dilip/0000-0002-4248-5611	National Institutes of Health [R01HL105490]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This Research was supported by funding from National Institutes of Health Grant R01HL105490. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asaduzzaman M, 2008, CRIT CARE MED, V36, P482, DOI 10.1097/01.CCM.0B013E31816204FA; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Chang WC, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-64; Chavakis T, 2004, J BIOL CHEM, V279, P55602, DOI 10.1074/jbc.M404676200; Dahlke K, 2011, J IMMUNOL, V186, P3066, DOI 10.4049/jimmunol.1002741; Eisen DP, 2010, J INNATE IMMUN, V2, P114, DOI 10.1159/000228159; Fraser DA, 2006, J LEUKOCYTE BIOL, V80, P107, DOI 10.1189/jlb.1105683; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; Haczku A, 2008, J ALLERGY CLIN IMMUN, V122, P861, DOI 10.1016/j.jaci.2008.10.014; Han S, 2015, ANN AM THORAC SOC, V12, P765, DOI 10.1513/AnnalsATS.201411-507FR; Hansen S, 1998, IMMUNOBIOLOGY, V199, P165, DOI 10.1016/S0171-2985(98)80025-9; Hirata A, 2013, METABOLISM, V62, P376, DOI 10.1016/j.metabol.2012.08.009; HOLMSKOV U, 1994, IMMUNOL TODAY, V15, P67, DOI 10.1016/0167-5699(94)90136-8; Hong ES, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0209-0; KERR JS, 1986, IMMUNOL INVEST, V15, P473, DOI 10.3109/08820138609054918; Konter JM, 2012, J IMMUNOL, V188, P854, DOI 10.4049/jimmunol.1100426; Litvack ML, 2010, INNATE IMMUN-LONDON, V16, P191, DOI 10.1177/1753425910369271; Liu S, 2008, EUR J PHARMACOL, V584, P159, DOI 10.1016/j.ejphar.2008.02.009; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Melboucy-Belkhir Sara, 2014, Rev Prat, V64, P25; Muller-Redetzky HC, 2014, CELL TISSUE RES, V355, P657, DOI 10.1007/s00441-014-1821-0; Nakatsuji H, 2013, METABOLISM, V62, P109, DOI 10.1016/j.metabol.2012.06.006; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Reid KBM, 2005, THORAX, V60, P620, DOI 10.1136/thx.2004.036699; Romero F, 2015, AM J RESP CELL MOL, V53, P74, DOI 10.1165/rcmb.2014-0343OC; Sano H, 2006, RESPIROLOGY, V11, pS46, DOI 10.1111/j.1440-1843.2006.00808.x; Sano H, 2005, MOL IMMUNOL, V42, P279, DOI 10.1016/j.molimm.2004.07.014; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shah D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11362; Shah D, 2014, AM J PHYSIOL-LUNG C, V306, pL152, DOI 10.1152/ajplung.00229.2013; Summer R, 2009, AM J PHYSIOL-LUNG C, V297, pL432, DOI 10.1152/ajplung.90599.2008; Takahashi H, 2006, CURR PHARM DESIGN, V12, P589, DOI 10.2174/138161206775474387; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Wang HM, 2008, EUR SURG RES, V40, P305, DOI 10.1159/000121471; Williams MR, 2011, AM J PHYSIOL-CELL PH, V301, pC777, DOI 10.1152/ajpcell.00250.2011; Winkler C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-29; WISNIESKI JJ, 1995, MEDICINE, V74, P24, DOI 10.1097/00005792-199501000-00003; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Yamada M, 2004, EUR J IMMUNOL, V34, P221, DOI 10.1002/eji.200324026; Yan WS, 2002, SHOCK, V17, P433, DOI 10.1097/00024382-200205000-00016; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499	43	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29642	29651		10.1074/jbc.M115.690784	http://dx.doi.org/10.1074/jbc.M115.690784			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26487714	Green Published, hybrid			2022-12-28	WOS:000366613400044
J	Yang, XB; Gao, MM; Chen, GB; Pierce, BG; Lu, JH; Weng, NP; Mariuzza, RA				Yang, Xinbo; Gao, Mingming; Chen, Guobing; Pierce, Brian G.; Lu, Jinghua; Weng, Nan-ping; Mariuzza, Roy A.			Structural Basis for Clonal Diversity of the Public T Cell Response to a Dominant Human Cytomegalovirus Epitope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						complex; herpesvirus; major histocompatibility complex (MHC); T-cell receptor (TCR); x-ray crystallography	RECEPTOR RECOGNITION; IMMUNE-RESPONSE; TCR; SELECTION; PROTEIN; USAGE; CTL; REACTIVATION; REFINEMENT; INFLUENZA	Background: The human public T cell response to a dominant CMV epitope features high clonal diversity. Results: Structures of two public TCRs bound to this CMV epitope and HLA-A2 reveal different recognition strategies. Conclusion: These structures show how the same public complementarity-determining region 3 (CDR3) motif can associate with different variable regions and pair with different CDR3s. Significance: This structural interchangeability generates a clonally diverse public TCR repertoire. Cytomegalovirus (CMV) is a ubiquitous and persistent human pathogen that is kept in check by CD8(+) cytotoxic T lymphocytes. Individuals expressing the major histocompatibility complex (MHC) class I molecule HLA-A2 produce cytotoxic T lymphocytes bearing T cell receptors (TCRs) that recognize the immunodominant CMV epitope NLVPMVATV (NLV). The NLV-specific T cell repertoire is characterized by a high prevalence of TCRs that are frequently observed in multiple unrelated individuals. These public TCRs feature identical, or nearly identical, complementarity-determining region 3 (CDR3) and/or CDR3 sequences. The TCRs may express public CDR3 motifs alone, public CDR3 motifs alone, or dual public CDR3 motifs. In addition, the same public CDR3 motif may pair with different CDR3 motifs (and the reverse), giving rise to highly diverse NLV-specific TCR repertoires. To investigate the structural underpinnings of this clonal diversity, we determined crystal structures of two public TCRs (C7 and C25) in complex with NLV<bold>HLA</bold>-A2. These TCRs utilize completely different CDR3 and CDR3 motifs that, in addition, can associate with multiple variable and variable regions in NLV-specific T cell repertoires. The C7<bold>NLVHLA</bold>-A2 and C25<bold>NLVHLA</bold>-A2 complexes exhibit divergent TCR footprints on peptide-MHC such that C25 is more focused on the central portion of the NLV peptide than is C7. These structures combined with molecular modeling show how the public CDR3 motif of C25 may associate with different variable regions and how the public CDR3 motif of C7 may pair with different CDR3 motifs. This interchangeability of TCR V regions and CDR3 motifs permits multiple structural solutions to binding an identical peptide-MHC ligand and thereby the generation of a clonally diverse public T cell response to CMV.	[Yang, Xinbo; Gao, Mingming; Pierce, Brian G.; Mariuzza, Roy A.] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [Yang, Xinbo; Gao, Mingming; Mariuzza, Roy A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Chen, Guobing; Weng, Nan-ping] NIA, Lymphocyte Differentiat Sect, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA; [Lu, Jinghua] NIAID, Struct Immunol Sect, Immunogenet Lab, NIH, Rockville, MD 20852 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mariuzza, RA (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	rmariuzz@umd.edu	Chen, Guobing/D-9572-2012; Pierce, Brian/AAB-8965-2022; Weng, Nan-ping/AAC-5037-2020	Chen, Guobing/0000-0002-2401-6168; Pierce, Brian/0000-0003-4821-0368; 	United States Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036900, R01AI036900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000757] Funding Source: NIH RePORTER	United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the National Institute on Aging clinic core for collecting apheresis pack of normal donors. We also thank Peter D. Sun for generous assistance with x-ray data collection. The x-ray SER-CAT beamlines at the Advanced Photon Source were supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-Eng-38.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; BORYSIEWICZ LK, 1988, J EXP MED, V168, P919, DOI 10.1084/jem.168.3.919; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Cukalac T, 2015, IMMUNOL CELL BIOL, V93, P804, DOI 10.1038/icb.2015.44; Cukalac T, 2014, P NATL ACAD SCI USA, V111, P1485, DOI 10.1073/pnas.1323736111; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faroudi M, 2003, P NATL ACAD SCI USA, V100, P14145, DOI 10.1073/pnas.2334336100; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Furman D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2293; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Gras S, 2012, J IMMUNOL, V188, P311, DOI 10.4049/jimmunol.1102686; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; Kedzierska K, 2004, P NATL ACAD SCI USA, V101, P4942, DOI 10.1073/pnas.0401279101; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Klarenbeek PL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002889; Klausen MS, 2015, NUCLEIC ACIDS RES, V43, pW349, DOI 10.1093/nar/gkv535; La Gruta NL, 2013, CURR OPIN VIROL, V3, P447, DOI 10.1016/j.coviro.2013.06.011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Li HJ, 2012, CELL RES, V22, P33, DOI 10.1038/cr.2012.1; Liu YC, 2013, J BIOL CHEM, V288, P15442, DOI 10.1074/jbc.M112.447185; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Meyer-Olson D, 2004, J EXP MED, V200, P307, DOI 10.1084/jem.20040638; Miconnet I, 2012, CURR OPIN HIV AIDS, V7, P64, DOI 10.1097/COH.0b013e32834ddcae; Miles JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001198; Najarro K, 2015, J INFECT DIS, V212, P1261, DOI 10.1093/infdis/jiv202; Nguyen THO, 2014, J IMMUNOL, V192, P5039, DOI 10.4049/jimmunol.1303147; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Oelke M, 2003, NAT MED, V9, P619, DOI 10.1038/nm869; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peggs K, 2002, BLOOD, V99, P213, DOI 10.1182/blood.V99.1.213; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Pierce B, 2008, PROTEINS, V72, P270, DOI 10.1002/prot.21920; Pierce BG, 2013, PROTEIN SCI, V22, P35, DOI 10.1002/pro.2181; QUINNAN GV, 1984, REV INFECT DIS, V6, P156; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Roossinck MJ, 2011, NAT REV MICROBIOL, V9, P99, DOI 10.1038/nrmicro2491; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sissons JGP, 2002, J INFECTION, V44, P73, DOI 10.1053/jinf.2001.0948; Smith C, 2014, SCI REP-UK, V4, DOI 10.1038/srep03993; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Suessmuth Y, 2015, BLOOD, V125, P3835, DOI 10.1182/blood-2015-03-631853; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Yin YY, 2012, IMMUNOL REV, V250, P32, DOI 10.1111/imr.12002	56	23	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29106	29119		10.1074/jbc.M115.691311	http://dx.doi.org/10.1074/jbc.M115.691311			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26429912	Green Published, hybrid			2022-12-28	WOS:000365762300048
J	Lee, KH; Lee, CH; Jeong, J; Jang, AH; Yoo, CG				Lee, Kyoung-Hee; Lee, Chang-Hoon; Jeong, Jiyeong; Jang, An-Hee; Yoo, Chul-Gyu			Neutrophil Elastase Differentially Regulates Interleukin 8 (IL-8) and Vascular Endothelial Growth Factor (VEGF) Production by Cigarette Smoke Extract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ANTIPROTEASE IMBALANCE; OXIDATIVE STRESS; CELL APOPTOSIS; PART I; COPD; PATHOGENESIS; INFLAMMATION; EMPHYSEMA; RELEASE	Inflammation by IL-8-induced neutrophil recruitment and apoptosis of epithelial cells by decreased expression of VEGE have been suggested as one of the complicated pathogenic mechanisms of chronic obstructive pulmonary disease (COPD). The role of neutrophil elastase (NE) in the development of COPD is also well known. However, little is known about how they interact. The objective of this study was to elucidate the effect of NE on cigarette smoke extract (CSE)-induced IL-8 and VEGE production and its molecular mechanism in bronchial epithelial cells. CSE increased both IL-8 and VEGE production in human bronchial epithelial cells (BEAS-2B). Although NE significantly enhanced CSE-induced IL-8 production, it suppressed VEGF production. This differential regulation was not CSE-specific. The effect of NE on IL-8 production, but not VEGF, was ERK-dependent. Interestingly, in contrast to decreased VEGE protein expression, NE accelerated VEGF transcription by (SF, suggesting post-translational modification. When cells were incubated with purified NE, it was detected in the cytoplasm, suggesting the intracellular translocation of NE. Furthermore, NE fragmented recombinant human VEGE in vitro but not recombinant human IL-8. These results indicate that VEGF down-regulation is due to direct degradation by NE, which is translocated into cells. Similar to in vitro cell experiments, elastase treatment increased CST-induced IL-8; however, it suppressed VEGE production in bronchoalveolar lavage fluid of (SF-treated mice. Moreover, elastase treatment enhanced CSE-induced emphysema in mice. Considering the actions of IL-8 and VEGF, our results suggest that NE contributes to the pathogenesis of COPD by enhancing inflammation and apoptosis.	[Lee, Kyoung-Hee; Lee, Chang-Hoon; Jeong, Jiyeong; Jang, An-Hee; Yoo, Chul-Gyu] Seoul Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 110744, South Korea; [Lee, Chang-Hoon; Yoo, Chul-Gyu] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Yoo, CG (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 151, South Korea.	cgyoo@snu.ac.kr	Lee, Chang-Hoon/AAC-7650-2021					Abboud RT, 2008, INT J TUBERC LUNG D, V12, P361; Baker RR, 2004, FOOD CHEM TOXICOL, V42, pS3, DOI 10.1016/S0278-6915(03)00189-3; Beisswenger C, 2004, RESPIRATION, V71, P402, DOI 10.1159/000079647; Deslee G, 2010, AM J RESP CELL MOL, V43, P576, DOI 10.1165/rcmb.2009-0221OC; Farid M, 2013, TOXICOL LETT, V220, P126, DOI 10.1016/j.toxlet.2013.04.011; Fischer BM, 2011, INT J CHRONIC OBSTR, V6, P413, DOI 10.2147/COPD.S10770; Gregory AD, 2012, J BIOL CHEM, V287, P35341, DOI 10.1074/jbc.M112.385617; Gross NJ, 2012, CHEST, V142, P1300, DOI 10.1378/chest.11-2766; HUNNINGHAKE GW, 1981, SCIENCE, V212, P925, DOI 10.1126/science.7233186; Ishii T, 2001, AM J PHYSIOL-LUNG C, V280, pL1189, DOI 10.1152/ajplung.2001.280.6.L1189; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Lee JH, 2012, LUNG, V190, P69, DOI 10.1007/s00408-011-9326-z; Mak JCW, 2008, INT J TUBERC LUNG D, V12, P368; Mio T, 1997, AM J RESP CRIT CARE, V155, P1770, DOI 10.1164/ajrccm.155.5.9154890; Moretto N, 2009, AM J PHYSIOL-LUNG C, V296, pL839, DOI 10.1152/ajplung.90570.2008; Morissette Mathieu C, 2009, Int J Chron Obstruct Pulmon Dis, V4, P19; O'Donnell R, 2006, THORAX, V61, P448, DOI 10.1136/thx.2004.024463; Plataki Maria, 2006, Int J Chron Obstruct Pulmon Dis, V1, P161, DOI 10.2147/copd.2006.1.2.161; Rahman I, 2006, EUR RESPIR J, V28, P219, DOI 10.1183/09031936.06.00053805; Roth M, 2008, INT J TUBERC LUNG D, V12, P375; Sapey E, 2010, AM J RESP CRIT CARE, V182, P192, DOI 10.1164/rccm.200912-1846OC; Suzuki M, 2008, INHAL TOXICOL, V20, P349, DOI 10.1080/08958370701866412 ; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Thaikoottathil JV, 2009, EUR RESPIR J, V33, P835, DOI 10.1183/09031936.00080708; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Yang JJ, 2001, AM J PATHOL, V158, P581, DOI 10.1016/S0002-9440(10)64000-X; Yasuo M, 2011, EUR RESPIR J, V37, P775, DOI 10.1183/09031936.00022910	29	24	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28438	28445		10.1074/jbc.M115.663567	http://dx.doi.org/10.1074/jbc.M115.663567			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26453303	Green Published, hybrid			2022-12-28	WOS:000365761900037
J	Rojas, A; Aguilar, R; Henriquez, B; Lian, JB; Stein, JL; Stein, GS; van Wijnen, AJ; van Zundert, B; Allende, ML; Montecino, M				Rojas, Adriana; Aguilar, Rodrigo; Henriquez, Berta; Lian, Jane B.; Stein, Janet L.; Stein, Gary S.; van Wijnen, Andre J.; van Zundert, Brigitte; Allende, Miguel L.; Montecino, Martin			Epigenetic Control of the Bone-master Runx2 Gene during Osteoblast-lineage Commitment by the Histone Demethylase JARID1B/KDM5B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3 LYSINE 27; MESENCHYMAL STEM-CELLS; WD-40 REPEAT PROTEIN; OSTEOGENIC DIFFERENTIATION; RESPONSE ELEMENTS; OSTEOCALCIN GENE; METHYLATION; CHROMATIN; EXPRESSION; POLYCOMB	Transcription factor Runx2 controls bone development and osteoblast differentiation by regulating expression of a significant number of bone-related target genes. Here, we report that transcriptional activation and repression of the Runx2 gene via its osteoblast-specific P1 promoter (encoding mRNA for the Runx2/p57 isoform) is accompanied by selective deposition and elimination of histone marks during differentiation of mesenchymal cells to the osteogenic and myoblastic lineages. These epigenetic profiles are mediated by key components of the Trithorax/COMPASS-like and Polycomb group complexes together with histone arginine methylases like PRMT5 and lysine demethylases like JARID1B/KDM5B. Importantly, knockdown of the H3K4me2/:3 demethylase JARID1B, but not of the demethylases UTX and N066, prevents repression of the Runx2 P1 promoter during myogenic differentiation of mesenchymal cells. The epigenetically forced expression of Runx2/p57 and osteocalcin, a classical bone-related target gene, under myoblastic-differentiation is accompanied by enrichment of the H3K/Ime3 and H3K27ac marks at the Runx2 P1 promoter region. Our results identify JARID1B as a key component of a potent epigenetic switch that controls mesenchymal cell fate into myogenic and osteogenic lineages.	[Rojas, Adriana; Aguilar, Rodrigo; Henriquez, Berta; van Zundert, Brigitte; Montecino, Martin] Univ Andres Bello, Fac Biol Sci, Ctr Biomed Res, Santiago 8370146, Chile; [Rojas, Adriana; Aguilar, Rodrigo; Henriquez, Berta; van Zundert, Brigitte; Montecino, Martin] Univ Andres Bello, Fac Med, Santiago 8370146, Chile; [Rojas, Adriana; Allende, Miguel L.] Univ Chile, Fac Sci, Santiago 7800003, Chile; [Rojas, Adriana; Aguilar, Rodrigo; Allende, Miguel L.; Montecino, Martin] FONDAP Ctr Genome Regulat, Santiago, Chile; [Lian, Jane B.; Stein, Janet L.; Stein, Gary S.] Univ Vermont, Sch Med, Burlington, VT 05405 USA; [van Wijnen, Andre J.] Mayo Clin, Rochester, MN 55905 USA	Universidad Andres Bello; Universidad Andres Bello; Universidad de Chile; University of Vermont; Mayo Clinic	Montecino, M (corresponding author), Univ Andres Bello, Fac Ciencias Biol, Ctr Invest Biomed, Ave Republ 239, Santiago 8370146, Chile.	mmontecino@unab.cl	Regan, Clinton/E-6250-2012; Aguilar, Rodrigo/AAG-6178-2019; van Wijnen, Andre J./AAG-3578-2019; Allende, Miguel L/C-5167-2008	van Wijnen, Andre J./0000-0002-4458-0946; Allende, Miguel L/0000-0002-2783-2152; Aguilar, Rodrigo/0000-0003-0410-5478; Rojas, Adriana/0000-0001-8528-4433	Fondo de Finaciamiento de Centros de Investigacion en Areas Prioritarias [15090007]; Fondo Nacional de Ciencia y Tecnologia [FONDECYT 1130706]; NIH [R01 AR049069, R01 AR039588]; COLCIENCIAS; Institut de Genetica Humana, Pontificia Universidad Javeriana, Bogota, Colombia; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039588, R01AR049069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER	Fondo de Finaciamiento de Centros de Investigacion en Areas Prioritarias; Fondo Nacional de Ciencia y Tecnologia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Institut de Genetica Humana, Pontificia Universidad Javeriana, Bogota, Colombia; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from Fondo de Finaciamiento de Centros de Investigacion en Areas Prioritarias (15090007; to M. L. A. and M. M.), Fondo Nacional de Ciencia y Tecnologia (FONDECYT 1130706; to M. M.), and NIH Grants R01 AR049069 (to A. J. vW.) and R01 AR039588 (to G. S. S.). The authors declare that they have no conflicts of interest with the contents of this article; Supported in part by doctoral fellowships from COLCIENCIAS and Institut de Genetica Humana, Pontificia Universidad Javeriana, Bogota, 110231, Colombia.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Balint E, 2003, J CELL BIOCHEM, V89, P401, DOI 10.1002/jcb.10515; Banck MS, 2009, EPIGENETICS-US, V4, P100, DOI 10.4161/epi.4.2.7953; Banerjee C, 1996, P NATL ACAD SCI USA, V93, P4968, DOI 10.1073/pnas.93.10.4968; Barrett A, 2007, INT J CANCER, V121, P265, DOI 10.1002/ijc.22673; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bradley EW, 2011, CRIT REV EUKAR GENE, V21, P101; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cruzat F, 2009, BIOCHEMISTRY-US, V48, P7287, DOI 10.1021/bi9004792; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Ezura Y, 2009, ARTHRITIS RHEUM, V60, P1416, DOI 10.1002/art.24472; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gori F, 2004, ENDOCRINOLOGY, V145, P1050, DOI 10.1210/en.2003-1314; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Gori F, 2006, DEV BIOL, V295, P498, DOI 10.1016/j.ydbio.2006.02.031; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Henriquez B, 2011, J CELL PHYSIOL, V226, P3043, DOI 10.1002/jcp.22652; Hovhannisyan H, 2013, J CELL PHYSIOL, V228, P313, DOI 10.1002/jcp.22109; Kim S, 2014, MOL CELL, V56, P564, DOI 10.1016/j.molcel.2014.10.003; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pal S, 2004, MOL CELL BIOL, V24, P9630, DOI 10.1128/MCB.24.21.9630-9645.2004; Paredes R, 2004, MOL CELL BIOL, V24, P8847, DOI 10.1128/MCB.24.20.8847-8861.2004; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Secombe J, 2007, GENE DEV, V21, P537, DOI 10.1101/gad.1523007; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Stojic L, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-16; Tai PWL, 2014, GENE, V550, P1, DOI 10.1016/j.gene.2014.05.044; Tie F, 2012, MOL CELL BIOL, V32, P2323, DOI 10.1128/MCB.06392-11; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Ye L, 2012, CELL STEM CELL, V11, P50, DOI 10.1016/j.stem.2012.04.009; Zambotti A, 2002, J BIOL CHEM, V277, P41497, DOI 10.1074/jbc.M204271200; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhu ED, 2008, J BIOL CHEM, V283, P7361, DOI 10.1074/jbc.M703304200	65	48	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28329	28342		10.1074/jbc.M115.657825	http://dx.doi.org/10.1074/jbc.M115.657825			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26453309	hybrid, Green Published			2022-12-28	WOS:000365761900025
J	Gagnon, SML; Meloncelli, PJ; Zheng, RXB; Haji-Ghassemi, O; Johal, AR; Borisova, SN; Lowary, TL; Evans, SV				Gagnon, Susannah M. L.; Meloncelli, Peter J.; Zheng, Ruixiang B.; Haji-Ghassemi, Omid; Johal, Asha R.; Borisova, Svetlana N.; Lowary, Todd L.; Evans, Stephen V.			High Resolution Structures of the Human ABO(H) Blood Group Enzymes in Complex with Donor Analogs Reveal That the Enzymes Utilize Multiple Donor Conformations to Bind Substrates in a Stepwise Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-B GALACTOSYLTRANSFERASE; GROUP-A; GROUP GLYCOSYLTRANSFERASES; SPECIFICITY; TRANSFERASE; RECOGNITION; MECHANISM; ACCEPTOR; CLASSIFICATION; BIOSYNTHESIS	Homologous glycosyltransferases alpha-(1 -> 3)-N-acetylgalactosaminyltransferase (GTA) and alpha-(1 -> 3)-galactosyltransferase (GTB) catalyze the final step in ABO(H) blood group A and B antigen synthesis through sugar transfer from activated donor to the H antigen acceptor. These enzymes have a GT-A fold type with characteristic mobile polypeptide loops that cover the active site upon substrate binding and, despite intense investigation, many aspects of substrate specificity and catalysis remain unclear. The structures of GTA, GTB, and their chimeras have been determined to between 1.55 and 1.39 angstrom resolution in complex with natural donors UDP-Gal, UDP-Glc and, in an attempt to overcome one of the common problems associated with three-dimensional studies, the non-hydrolyzable donor analog UDP-phosphono-galactose (UDP-C-Gal). Whereas the uracil moieties of the donors are observed to maintain a constant location, the sugar moieties lie in four distinct conformations, varying from extended to the"tucked under" conformation associated with catalysis, each stabilized by different hydrogen bonding partners with the enzyme. Further, several structures show clear evidence that the donor sugar is disordered over two of the observed conformations and so provide evidence for stepwise insertion into the active site. Although the natural donors can both assume the tucked under conformation in complex with enzyme, UDP-C-Gal cannot. Whereas UDP-C-Gal was designed to be "isosteric" with natural donor, the small differences in structure imposed by changing the epimeric oxygen atom to carbon appear to render\ the enzyme incapable of binding the analog in the active conformation and so preclude its use as a substrate mimic in GTA and GTB.	[Gagnon, Susannah M. L.; Haji-Ghassemi, Omid; Johal, Asha R.; Borisova, Svetlana N.; Evans, Stephen V.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Meloncelli, Peter J.; Zheng, Ruixiang B.; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Meloncelli, Peter J.; Zheng, Ruixiang B.; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	University of Victoria; University of Alberta; University of Alberta	Evans, SV (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	svevans@uvic.ca	Lowary, Todd L/F-9608-2019	Lowary, Todd L/0000-0002-8331-8211; Evans, Stephen/0000-0002-0366-4027; Haji-Ghassemi, Omid/0000-0003-0116-005X	Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Technology Futures; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Technology Futures; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported in whole or part by a grant from the Natural Sciences and Engineering Research Council of Canada, Alberta Innovates Technology Futures, and the Canadian Institutes of Health Research. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada.; Recipient of a Senior Scholarship from the Michael Smith Foundation for Health Research.	Alfaro JA, 2008, J BIOL CHEM, V283, P10097, DOI 10.1074/jbc.M708669200; Angulo J, 2006, J AM CHEM SOC, V128, P13529, DOI 10.1021/ja063550r; Beaton SA, 2009, CHEM COMMUN, P238, DOI 10.1039/b808078j; Blume A, 2006, J BIOL CHEM, V281, P32728, DOI 10.1074/jbc.M600424200; Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Coutinho PM, 1999, ROY SOC CH, P3; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Gordon RD, 2006, J MOL BIOL, V360, P67, DOI 10.1016/j.jmb.2006.04.058; Hamasaki N, 2000, VOX SANG, V79, P191, DOI 10.1159/000056729; HEARN VM, 1968, BIOCHEM J, V109, P315, DOI 10.1042/bj1090315; Heissigerova H, 2003, GLYCOBIOLOGY, V13, P377, DOI 10.1093/glycob/cwg042; Hu YN, 2002, CHEM BIOL, V9, P1287, DOI 10.1016/S1074-5521(02)00295-8; Johal AR, 2014, GLYCOBIOLOGY, V24, P237, DOI 10.1093/glycob/cwt098; Johal AR, 2012, ACTA CRYSTALLOGR D, V68, P268, DOI 10.1107/S0907444912001801; KABAT EA, 1949, BACTERIOL REV, V13, P189, DOI 10.1128/MMBR.13.4.189-202.1949; Kamath VP, 1999, GLYCOCONJUGATE J, V16, P599; KOBATA A, 1968, BIOCHEM BIOPH RES CO, V32, P272, DOI 10.1016/0006-291X(68)90380-X; Landsteiner K, 2001, WIEN KLIN WOCHENSCHR, V113, P768; Lee HJ, 2005, J BIOL CHEM, V280, P525, DOI 10.1074/jbc.M410245200; Letts JA, 2006, J BIOL CHEM, V281, P3625, DOI 10.1074/jbc.M507620200; Letts JA, 2007, ACTA CRYSTALLOGR D, V63, P860, DOI 10.1107/S0907444907026479; LOWARY TL, 1993, CARBOHYD RES, V249, P163, DOI 10.1016/0008-6215(93)84068-H; Marcus SL, 2003, J BIOL CHEM, V278, P12403, DOI 10.1074/jbc.M212002200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MORGAN WTJ, 1959, BRIT MED BULL, V15, P109, DOI 10.1093/oxfordjournals.bmb.a069732; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Partha SK, 2010, J MOL BIOL, V403, P578, DOI 10.1016/j.jmb.2010.08.053; Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Rademacher C, 2010, GLYCOCONJUGATE J, V27, P349, DOI 10.1007/s10719-010-9282-5; Schuman B, 2010, J MOL BIOL, V402, P399, DOI 10.1016/j.jmb.2010.07.036; Seto NOL, 1999, EUR J BIOCHEM, V259, P770, DOI 10.1046/j.1432-1327.1999.00086.x; Seto NOL, 2000, CARBOHYD RES, V324, P161, DOI 10.1016/S0008-6215(99)00297-9; Seto NOL, 1997, J BIOL CHEM, V272, P14133, DOI 10.1074/jbc.272.22.14133; Sindhuwinata N, 2010, GLYCOBIOLOGY, V20, P718, DOI 10.1093/glycob/cwq019; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Soya N, 2009, GLYCOBIOLOGY, V19, P1224, DOI 10.1093/glycob/cwp114; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; WATKINS WM, 1980, REV FR TRANSFUS IMMU, V23, P531, DOI 10.1016/S0338-4535(80)80157-7; YAMAMOTO F, 1990, J BIOL CHEM, V265, P19257; YAMAMOTO F, 1990, NATURE, V345, P229, DOI 10.1038/345229a0; Yamamoto M, 2001, J BIOL CHEM, V276, P13701, DOI 10.1074/jbc.M010805200	50	12	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27040	27052		10.1074/jbc.M115.682401	http://dx.doi.org/10.1074/jbc.M115.682401			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26374898	hybrid, Green Published			2022-12-28	WOS:000364794000016
J	Bankapalli, K; Saladi, S; Awadia, SS; Goswami, AV; Samaddar, M; D'Silva, P				Bankapalli, Kondalarao; Saladi, SreeDivya; Awadia, Sahezeel S.; Goswami, Arvind Vittal; Samaddar, Madhuja; D'Silva, Patrick			Robust Glyoxalase activity of Hsp31, a ThiJ/DJ-1/PfpI Family Member Protein, Is Critical for Oxidative Stress Resistance in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA DJ-1 MUTANTS; PARKINSONS-DISEASE; MITOCHONDRIAL DYSFUNCTION; GLUTATHIONE-REDUCTASE; ESCHERICHIA-COLI; CROSS-LINKING; STATIONARY-PHASE; ALPHA-SYNUCLEIN; LENS PROTEINS; METHYLGLYOXAL	Methylglyoxal (MG) is a reactive metabolic intermediate generated during various cellular biochemical reactions, including glycolysis. The accumulation of MG indiscriminately modifies proteins, including important cellular antioxidant machinery, leading to severe oxidative stress, which is implicated in multiple neurodegenerative disorders, aging, and cardiac disorders. Although cells possess efficient glyoxalase systems for detoxification, their functions are largely dependent on the glutathione cofactor, the availability of which is self-limiting under oxidative stress. Thus, higher organisms require alternate modes of reducing the MG-mediated toxicity and maintaining redox balance. In this report, we demonstrate that Hsp31 protein, a member of the ThiJ/DJ-1/PfpI family in Saccharomyces cerevisiae, plays an indispensable role in regulating redox homeostasis. Our results show that Hsp31 possesses robust glutathione-independent methylglyoxalase activity and suppresses MG-mediated toxicity and ROS levels as compared with another paralog, Hsp34. On the other hand, glyoxalase-defective mutants of Hsp31 were found highly compromised in regulating the ROS levels. Additionally, Hsp31 maintains cellular glutathione and NADPH levels, thus conferring protection against oxidative stress, and Hsp31 relocalizes to mitochondria to provide cytoprotection to the organelle under oxidative stress conditions. Importantly, human DJ-1, which is implicated in the familial form of Parkinson disease, complements the function of Hsp31 by suppressing methylglyoxal and oxidative stress, thus signifying the importance of these proteins in the maintenance of ROS homeostasis across phylogeny.	[Bankapalli, Kondalarao; Saladi, SreeDivya; Awadia, Sahezeel S.; Goswami, Arvind Vittal; Samaddar, Madhuja; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	D'Silva, P (corresponding author), Indian Inst Sci, Dept Biochem, Biol Sci Bldg, Bangalore 560012, Karnataka, India.	patrick@biochem.iisc.ernet.in	Bankapalli, Kondalarao/GOH-1727-2022; Samaddar, Madhuja/AAJ-7908-2020; D'Silva, Patrick/L-6653-2019	Bankapalli, Kondalarao/0000-0002-0278-0931; Samaddar, Madhuja/0000-0001-5046-1604; Saladi, Sreedivya/0000-0001-7664-2622	Department of Science and Technology [DST/SJF/LSA-01/2011-2012]; Department of Biotechnology, India; Council of Scientific and Industrial Research, India	Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a Swarnajayanthi fellowship from the Department of Science and Technology (Grant ID: DST/SJF/LSA-01/2011-2012) and the Department of Biotechnology, India (to P. D.) and by a senior research fellowship from the Council of Scientific and Industrial Research, India (to K. B., A. V. G., and M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abordo EA, 1999, BIOCHEM PHARMACOL, V58, P641, DOI 10.1016/S0006-2952(99)00132-X; Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Ahmed N, 2002, BIOCHEM J, V364, P1; Apostolova N, 2010, BRIT J PHARMACOL, V160, P2069, DOI 10.1111/j.1476-5381.2010.00866.x; Biswas S, 1997, BIOCHEM J, V323, P343, DOI 10.1042/bj3230343; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Chen J, 2010, HUM MOL GENET, V19, P2395, DOI 10.1093/hmg/ddq113; Chen P, 2015, METALLOMICS, V7, P289, DOI [10.1039/c4mt00292j, 10.1039/C4MT00292J]; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cookson MR, 2010, HUM MOL GENET, V19, pR21, DOI 10.1093/hmg/ddq167; Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6; Damiano M, 2010, BBA-MOL BASIS DIS, V1802, P52, DOI 10.1016/j.bbadis.2009.07.012; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davie CA, 2008, BRIT MED BULL, V86, P109, DOI 10.1093/bmb/ldn013; Du J, 2000, J CELL BIOCHEM, V77, P333, DOI 10.1002/(SICI)1097-4644(20000501)77:2<333::AID-JCB15>3.0.CO;2-Q; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Goswami AV, 2012, HUM MOL GENET, V21, P3317, DOI 10.1093/hmg/dds162; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Grant CM, 1996, MOL MICROBIOL, V21, P171, DOI 10.1046/j.1365-2958.1996.6351340.x; Hasim S, 2014, J BIOL CHEM, V289, P1662, DOI 10.1074/jbc.M113.505784; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Im JY, 2012, HUM MOL GENET, V21, P3013, DOI 10.1093/hmg/dds131; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; John GB, 2002, EXP CELL RES, V278, P198, DOI 10.1006/excr.2002.5586; Kasai H, 1998, CARCINOGENESIS, V19, P1459, DOI 10.1093/carcin/19.8.1459; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Knox C, 1998, J BIOL CHEM, V273, P25587, DOI 10.1074/jbc.273.40.25587; Kwolek-Mirek M, 2009, CELL BIOL TOXICOL, V25, P363, DOI 10.1007/s10565-008-9090-x; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Lee KW, 1999, BBA-MOL BASIS DIS, V1453, P141, DOI 10.1016/S0925-4439(98)00097-0; Li N, 2009, J BIOL CHEM, V284, P23602, DOI 10.1074/jbc.M109.024323; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Menzies FM, 2005, CURR BIOL, V15, P1578, DOI 10.1016/j.cub.2005.07.036; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Mihoub M, 2015, BIOCHEM BIOPH RES CO, V463, P1305, DOI 10.1016/j.bbrc.2015.06.111; Miller-Fleming L, 2014, P NATL ACAD SCI USA, V111, P7012, DOI 10.1073/pnas.1319221111; Mlakar A, 1996, FREE RADICAL RES, V25, P525, DOI 10.3109/10715769609149074; Morgan PE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086564; Mujacic M, 2004, MOL MICROBIOL, V51, P849, DOI 10.1046/j.1365-2958.2003.03871.x; Mujacic M, 2007, APPL ENVIRON MICROB, V73, P1014, DOI 10.1128/AEM.02429-06; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; MURATA K, 1985, EUR J BIOCHEM, V151, P631, DOI 10.1111/j.1432-1033.1985.tb09151.x; NAIR S, 1991, CYTOMETRY, V12, P336, DOI 10.1002/cyto.990120408; Outten CE, 2004, J BIOL CHEM, V279, P7785, DOI 10.1074/jbc.M312421200; Park J, 2005, GENE, V361, P133, DOI 10.1016/j.gene.2005.06.040; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; RAY S, 1994, BIOCHEM J, V303, P69, DOI 10.1042/bj3030069; Richarme G, 2015, J BIOL CHEM, V290, P1885, DOI 10.1074/jbc.M114.597815; Rosca MG, 2002, AM J PHYSIOL-RENAL, V283, pF52, DOI 10.1152/ajprenal.00302.2001; Rose S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085436; Saha PP, 2014, J BIOL CHEM, V289, P10359, DOI 10.1074/jbc.M113.526665; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Shangari N, 2004, BIOCHEM PHARMACOL, V68, P1433, DOI 10.1016/j.bcp.2004.06.013; SHARPE JA, 1982, NEUROLOGY, V32, P1093, DOI 10.1212/WNL.32.10.1093; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Sinha D, 2010, HUM MOL GENET, V19, P1248, DOI 10.1093/hmg/ddq002; Skoneczna A, 2007, FREE RADICAL BIO MED, V42, P1409, DOI 10.1016/j.freeradbiomed.2007.01.042; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Srivastava S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.355; STORZ G, 1987, P NATL ACAD SCI USA, V84, P8917, DOI 10.1073/pnas.84.24.8917; Subedi KP, 2011, MOL MICROBIOL, V81, P926, DOI 10.1111/j.1365-2958.2011.07736.x; Suh KS, 2014, FREE RADICAL RES, V48, P206, DOI 10.3109/10715762.2013.859387; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Treichel JL, 2003, NEUROTOXICOLOGY, V24, P825, DOI 10.1016/S0161-813X(03)00059-7; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Vernekar AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6301; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; WELLSKNECHT KJ, 1995, BIOCHEMISTRY-US, V34, P3702, DOI 10.1021/bi00011a027; Williams AC, 2004, BIOL REPROD, V71, P1309, DOI 10.1095/biolreprod.104.028407; Wilson MA, 2004, P NATL ACAD SCI USA, V101, P1531, DOI 10.1073/pnas.0308089100; Wilson MA, 2014, P NATL ACAD SCI USA, V111, P6858, DOI 10.1073/pnas.1405511111; Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zhao QQ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-86; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200	86	58	62	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26491	26507		10.1074/jbc.M115.673624	http://dx.doi.org/10.1074/jbc.M115.673624			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370081	hybrid, Green Published			2022-12-28	WOS:000364793600018
J	Borschel, WF; Cummings, KA; Tindell, LK; Popescu, GK				Borschel, William F.; Cummings, Kirstie A.; Tindell, LeeAnn K.; Popescu, Gabriela K.			Kinetic Contributions to Gating by Interactions Unique to N-methyl-D-aspartate (NMDA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITIVE ALLOSTERIC MODULATORS; IONOTROPIC GLUTAMATE-RECEPTOR; LIGAND-BINDING CORE; SUBUNIT ARRANGEMENT; ION-CHANNEL; AMPA; ACTIVATION; DESENSITIZATION; MECHANISM; AFFINITY	Among glutamate-gated channels, NMDA receptors produce currents that subside with unusually slow kinetics, and this feature is essential to the physiology of central excitatory synapses. Relative to the homologous AMPA and kainate receptors, NMDA receptors have additional intersubunit contacts in the ligand binding domain that occur at both conserved and nonconserved sites. We examined GluN1/GluN2A single-channel currents with kinetic analyses and modeling to probe these class-specific intersubunit interactions for their role in glutamate binding and receptor gating. We found that substitutions that eliminate such interactions at non-conserved sites reduced stationary gating, accelerated deactivation, and imparted sensitivity to aniracetam, an AMPA receptor-selective positive modulator. Abolishing unique contacts at conserved sites also reduced stationary gating and accelerated deactivation. These results show that contacts specific to NMDA receptors, which brace the heterodimer interface within the ligand binding domain, stabilize actively gating receptor conformations and result in longer bursts and slower deactivations. They support the view that the strength of the heterodimer interface modulates gating in both NMDA and non-NMDA receptors and that unique interactions at this interface are responsible in part for basic differences between the kinetics of NMDA and non-NMDA currents at glutamatergic synapses.	[Borschel, William F.; Cummings, Kirstie A.; Tindell, LeeAnn K.; Popescu, Gabriela K.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Popescu, GK (corresponding author), SUNY Buffalo, Dept Biochem, 636 Biomed Res Bldg,3435 Main St, Buffalo, NY 14214 USA.	popescu@buffalo.edu	Regan, Clinton/E-6250-2012; popescu, gabriela k/AAB-6155-2022	popescu, gabriela k/0000-0003-4658-2002	National Institutes of Health [F31NS071782, F31NS086765, R01NS052669]; American Heart Association [EIA 0535268N]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS086765, F31NS071782, R01NS052669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants F31NS071782 (to W. F. B.), F31NS086765 (to K. A. C.), and R01NS052669 (to G. K. P.). This work was also supported by American Heart Association Grant EIA 0535268N (to G. K. P.).	Ahmed AH, 2011, J BIOL CHEM, V286, P35257, DOI 10.1074/jbc.M111.269001; Amico-Ruvio SA, 2010, BIOPHYS J, V98, P1160, DOI 10.1016/j.bpj.2009.12.4276; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; BENVENISTE M, 1991, BIOPHYS J, V59, P560, DOI 10.1016/S0006-3495(91)82272-X; Borschel WF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1512; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; COLQUHOUN D, 1981, PROC R SOC SER B-BIO, V211, P205, DOI 10.1098/rspb.1981.0003; DALE N, 1985, J PHYSIOL-LONDON, V363, P35, DOI 10.1113/jphysiol.1985.sp015694; Dravid SM, 2008, J PHYSIOL-LONDON, V586, P4425, DOI 10.1113/jphysiol.2008.158634; FAGG GE, 1984, P NATL ACAD SCI-BIOL, V81, P6876, DOI 10.1073/pnas.81.21.6876; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; GIBB AJ, 1992, J PHYSIOL-LONDON, V456, P143, DOI 10.1113/jphysiol.1992.sp019331; GIBB AJ, 1991, P ROY SOC B-BIOL SCI, V243, P39, DOI 10.1098/rspb.1991.0007; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; HOWE JR, 1991, J PHYSIOL-LONDON, V432, P143, DOI 10.1113/jphysiol.1991.sp018381; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Kaae BH, 2007, CHEM BIOL, V14, P1294, DOI 10.1016/j.chembiol.2007.10.012; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Kussius CL, 2010, J NEUROSCI, V30, P12474, DOI 10.1523/JNEUROSCI.3337-10.2010; Kussius CL, 2009, NAT NEUROSCI, V12, P1114, DOI 10.1038/nn.2361; Kussius CL, 2009, J NEUROSCI, V29, P6819, DOI 10.1523/JNEUROSCI.0281-09.2009; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; LESTER RAJ, 1992, J NEUROSCI, V12, P635; Lu CB, 2001, EXP NEUROL, V170, P180, DOI 10.1006/exnr.2001.7686; Mitchell NA, 2007, BIOPHYS J, V92, P2392, DOI 10.1529/biophysj.106.095091; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775; Popescu G, 2003, NAT NEUROSCI, V6, P476, DOI 10.1038/nn1044; Ptak CP, 2009, BIOCHEMISTRY-US, V48, P8594, DOI 10.1021/bi901127s; Qin F, 2004, BIOPHYS J, V87, P1657, DOI 10.1529/biophysj.103.037531; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Safferling M, 2001, BIOCHEMISTRY-US, V40, P13948, DOI 10.1021/bi011143g; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot4044, 10.1101/pdb.prot4085, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot3723]; Sobolevsky AI, 2015, J PHYSIOL-LONDON, V593, P29, DOI 10.1113/jphysiol.2013.264911; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Timm DE, 2011, MOL PHARMACOL, V80, P267, DOI 10.1124/mol.110.070243; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Weston MC, 2006, J NEUROSCI, V26, P7650, DOI 10.1523/JNEUROSCI.1519-06.2006; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; Zhang W, 2008, NAT NEUROSCI, V11, P1373, DOI 10.1038/nn.2214	51	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26846	26855		10.1074/jbc.M115.678656	http://dx.doi.org/10.1074/jbc.M115.678656			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370091	hybrid, Green Published			2022-12-28	WOS:000364793600046
J	Cai, YH; Bhuiya, MW; Shanklin, J; Liu, CJ				Cai, Yuanheng; Bhuiya, Mohammad-Wadud; Shanklin, John; Liu, Chang-Jun			Engineering a Monolignol 4-O-Methyltransferase with High Selectivity for the Condensed Lignin Precursor Coniferyl Alcohol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ITERATIVE SATURATION MUTAGENESIS; ACID O-METHYLTRANSFERASE; SWISS-MODEL; DIRECTED EVOLUTION; STRUCTURAL BASIS; BIOSYNTHESIS; EFFICIENCY; POPLARS; ENZYMES	Lignin, a rigid biopolymer in plant cell walls, is derived from the oxidative polymerization of three monolignols. The composition of monolignol monomers dictates the degree of lignin condensation, reactivity, and thus the degradability of plant cell walls. Guaiacyl lignin is regarded as the condensed structural unit. Polymerization of lignin is initiated through the deprotonation of the para-hydroxyl group of monolignols. Therefore, preferentially modifying the para-hydroxyl of a specific monolignol to deprive its dehydrogenation propensity would disturb the formation of particular lignin subunits. Here, we test the hypothesis that specific remodeling the active site of a monolignol 4-O-methyltransferase would create an enzyme that specifically methylates the condensed guaiacyl lignin precursor coniferyl alcohol. Combining crystal structural information with combinatorial active site saturation mutagenesis and starting with the engineered promiscuous enzyme, MOMT5(T133L/E165I/F175I/F166W/H169F), we incrementally remodeled its substrate binding pocket by the addition of four substitutions, i.e. M26H, S30R, V33S, and T319M, yielding a mutant enzyme capable of discriminately etherifying the para-hydroxyl of coniferyl alcohol even in the presence of excess sinapyl alcohol. The engineered enzyme variant has a substantially reduced substrate binding pocket that imposes a clear steric hindrance thereby excluding bulkier lignin precursors. The resulting enzyme variant represents an excellent candidate for modulating lignin composition and/or structure in planta.	[Cai, Yuanheng; Bhuiya, Mohammad-Wadud; Shanklin, John; Liu, Chang-Jun] Brookhaven Natl Lab, Biol Environm & Climate Sci Dept, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Liu, CJ (corresponding author), Brookhaven Natl Lab, Biol Environm & Climate Sci Dept, Upton, NY 11973 USA.	cliu@bnl.gov		Shanklin, John/0000-0002-6774-8043	Office of Basic Energy Sciences, United States Department of Energy [DEAC0298CH10886]	Office of Basic Energy Sciences, United States Department of Energy(United States Department of Energy (DOE))	We thank Dr. Eran Pichersky, University of Michigan, for sharing the initial parental enzyme C. breweri IEMT clone. The use of the x-ray beamline X29 and X25 of the National Synchrotron Light source in Brookhaven National Laboratory was supported by the Office of Basic Energy Sciences, United States Department of Energy under Contract DEAC0298CH10886.	Acevedo-Rocha CG, 2014, METHODS MOL BIOL, V1179, P103, DOI 10.1007/978-1-4939-1053-3_7; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bhuiya MW, 2010, J BIOL CHEM, V285, P277, DOI 10.1074/jbc.M109.036673; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bommarius AS, 2011, CURR OPIN CHEM BIOL, V15, P194, DOI 10.1016/j.cbpa.2010.11.011; Bonawitz ND, 2013, CURR OPIN BIOTECH, V24, P336, DOI 10.1016/j.copbio.2012.11.004; Cabane M, 2004, PLANT PHYSIOL, V134, P586, DOI 10.1104/pp.103.031765; Cobb RE, 2013, METHODS, V60, P81, DOI 10.1016/j.ymeth.2012.03.009; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Huntley SK, 2003, J AGR FOOD CHEM, V51, P6178, DOI 10.1021/jf034320o; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kille S, 2011, NAT CHEM, V3, P738, DOI [10.1038/nchem.1113, 10.1038/NCHEM.1113]; Lapierre C, 1999, PLANT PHYSIOL, V119, P153, DOI 10.1104/pp.119.1.153; Li X, 2010, PLANT CELL, V22, P1620, DOI 10.1105/tpc.110.074161; Liu CJ, 2006, PLANT CELL, V18, P3656, DOI 10.1105/tpc.106.041376; Liu CJ, 2014, PLANT BIOTECHNOL J, V12, P1154, DOI 10.1111/pbi.12250; Louie GV, 2010, PLANT CELL, V22, P4114, DOI 10.1105/tpc.110.077578; Neutelings G, 2011, PLANT SCI, V181, P379, DOI 10.1016/j.plantsci.2011.06.012; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Reetz MT, 2006, CHEM-EUR J, V12, P6031, DOI 10.1002/chem.200600459; Reetz MT, 2005, ANGEW CHEM INT EDIT, V44, P4192, DOI 10.1002/anie.200500767; Robinson AR, 2009, PLANT J, V58, P706, DOI 10.1111/j.1365-313X.2009.03808.x; Somerville C, 2007, CURR BIOL, V17, pR115, DOI 10.1016/j.cub.2007.01.010; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Wang JH, 1999, ARCH BIOCHEM BIOPHYS, V368, P172, DOI 10.1006/abbi.1999.1304; Wang JH, 1998, ARCH BIOCHEM BIOPHYS, V349, P153, DOI 10.1006/abbi.1997.0452; Zhang W, 2013, WORLD J MICROB BIOT, V29, P667, DOI 10.1007/s11274-012-1222-z; Zubieta C, 2002, PLANT CELL, V14, P1265, DOI 10.1105/tpc.001412	36	6	6	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26715	26724		10.1074/jbc.M115.684217	http://dx.doi.org/10.1074/jbc.M115.684217			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26378240	Green Published, hybrid			2022-12-28	WOS:000364793600034
J	Morishita, Y; Tsutsumi, K; Ohta, Y				Morishita, Yuji; Tsutsumi, Koji; Ohta, Yasutaka			Phosphorylation of Serine 402 Regulates RacGAP Protein Activity of FilGAP Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; RHO GTPASES; FILAMIN-A; ADHESION; KINASE; CROSSTALK; GAPS; GEFS	FilGAP is a Rho GTPase-activating protein (GAP) that specifically regulates Rac. FilGAP is phosphorylated by ROCK, and this phosphorylation stimulates its RacGAP activity. However, it is unclear how phosphorylation regulates cellular functions and localization of FilGAP. We found that non-phosphorylatable FilGAP (ST/A) mutant is predominantly localized to the cytoskeleton along actin filaments and partially co-localized with vinculin around cell periphery, whereas phosphomimetic FilGAP (ST/D) mutant is diffusely cytoplasmic. Moreover, phosphorylated FilGAP detected by Phos-tag is also mainly localized in the cytoplasm. Of the six potential phosphorylation sites in FilGAP tested, only mutation of serine 402 to alanine (S402A) resulted in decreased cell spreading on fibronectin. FilGAP phosphorylated at Ser-402 is localized to the cytoplasm but not at the cytoskeleton. Although Ser-402 is highly phosphorylated in serum-starved quiescent cells, dephosphorylation of Ser-402 is accompanied with the cell spreading on fibronectin. Treatment of the cells expressing wild-type FilGAP with calyculin A, a Ser/Thr phosphatase inhibitor, suppressed cell spreading on fibronectin, whereas cells transfected with FilGAP S402A mutant were not affected by calyculin A. Expression of constitutively activate Arf6 Q67L mutant stimulated membrane blebbing activity of both non-phosphorylatable (ST/A) and phosphomimetic (ST/D) FilGAP mutants. Conversely, depletion of endogenous Arf6 suppressed membrane blebbing induced by FilGAP (ST/A) and (ST/D) mutants. Our study suggests that Arf6 and phosphorylation of FilGAP may regulate FilGAP, and phosphorylation of Ser-402 may play a role in the regulation of cell spreading on fibronectin.	[Morishita, Yuji; Tsutsumi, Koji; Ohta, Yasutaka] Kitasato Univ, Sch Sci, Dept Biosci, Div Cell Biol,Minami Ku, Sagamihara, Kanagawa 2520373, Japan	Kitasato University	Ohta, Y (corresponding author), Kitasato Univ, Sch Sci, Dept Biosci, Div Cell Biol,Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	yohta@kitasato-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grant for All Kitasato Project Study; Kitasato University Research Grant for Young Researchers	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant for All Kitasato Project Study; Kitasato University Research Grant for Young Researchers	This work was supported by grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a Grant for All Kitasato Project Study, and a Kitasato University Research Grant for Young Researchers. The authors declare that they have no conflicts of interest with the contents of this article.	Bianchi M, 2005, BIOCHEM J, V391, P359, DOI 10.1042/BJ20050282; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hall EH, 2009, J BIOL CHEM, V284, P34713, DOI 10.1074/jbc.M109.059592; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kawaguchi K, 2014, J BIOL CHEM, V289, P9675, DOI 10.1074/jbc.M113.546051; Kiely PA, 2006, MOL CELL BIOL, V26, P4041, DOI 10.1128/MCB.01868-05; Kinoshita E, 2011, PROTEOMICS, V11, P319, DOI 10.1002/pmic.201000472; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Lawson Campbell D, 2014, Small GTPases, V5, pe27958, DOI 10.4161/sgtp.27958; McCormack J, 2013, J CELL SCI, V126, P379, DOI 10.1242/jcs.097923; Miller NLG, 2014, CURR MOL MED, V14, P221, DOI 10.2174/1566524014666140128110339; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Nieves B, 2010, J CELL SCI, V123, P1216, DOI 10.1242/jcs.056549; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; Saito K, 2012, MOL BIOL CELL, V23, P4739, DOI 10.1091/mbc.E12-04-0310; Shifrin Y, 2009, MOL BIOL CELL, V20, P1269, DOI 10.1091/mbc.E08-08-0872; Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006; van Buul JD, 2014, CELL ADHES MIGR, V8, P108, DOI 10.4161/cam.27599; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012	36	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26328	26338		10.1074/jbc.M115.666875	http://dx.doi.org/10.1074/jbc.M115.666875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26359494	hybrid, Green Published			2022-12-28	WOS:000363527300048
J	Chen, YF; Savinov, SN; Mielech, AM; Cao, T; Baker, SC; Mesecar, AD				Chen, Yafang; Savinov, Sergey N.; Mielech, Anna M.; Cao, Thu; Baker, Susan C.; Mesecar, Andrew D.			X-ray Structural and Functional Studies of the Three Tandemly Linked Domains of Non-structural Protein 3 (nsp3) from Murine Hepatitis Virus Reveal Conserved Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAPAIN-LIKE PROTEASE; RESPIRATORY-SYNDROME-CORONAVIRUS; UBIQUITIN-LIKE DOMAIN; SARS-CORONAVIRUS; CRYSTAL-STRUCTURE; DEUBIQUITINATING ACTIVITY; SUBSTRATE-SPECIFICITY; ADP-RIBOSE; INHIBITORS; UNIQUE	Murine hepatitis virus (MHV) has long served as a model system for the study of coronaviruses. Non-structural protein 3 (nsp3) is the largest nsp in the coronavirus genome, and it contains multiple functional domains that are required for coronavirus replication. Despite the numerous functional studies on MHV and its nsp3 domain, the structure of only one domain in nsp3, the small ubiquitin-like domain 1 (Ubl1), has been determined. We report here the x-ray structure of three tandemly linked domains of MHV nsp3, including the papain-like protease 2 (PLP2) catalytic domain, the ubiquitin-like domain 2 (Ubl2), and a third domain that we call the DPUP ((d) under bar omain (p) under bar receding (U) under bar bl2 and (P) under bar LP2) domain. DPUP has close structural similarity to the severe acute respiratory syndrome coronavirus unique domain C (SUD-C), suggesting that this domain may not be unique to the severe acute respiratory syndrome coronavirus. The PLP2 catalytic domain was found to have both deubiquitinating and deISGylating isopeptidase activities in addition to proteolytic activity. A computationally derived model of MHV PLP2 bound to ubiquitin was generated, and the potential interactions between ubiquitin and PLP2 were probed by site-directed mutagenesis. These studies extend substantially our structural knowledge of MHV nsp3, providing a platform for further investigation of the role of nsp3 domains in MHV viral replication.	[Chen, Yafang; Cao, Thu; Mesecar, Andrew D.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Savinov, Sergey N.; Mesecar, Andrew D.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Mesecar, Andrew D.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Mielech, Anna M.; Baker, Susan C.] Loyola Univ Chicago, Dept Microbiol & Immunol, Stritch Sch Med, Maywood, IL 60153 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Loyola University Chicago	Mesecar, AD (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	amesecar@purdue.edu	Chen, yafang/GVS-0304-2022		National Institutes of Health, NIAID [R01 AI085089]; Purdue Center for Cancer Research Macromolecular Crystallography and DNA Sequencing Shared Resources - National Institutes of Health Grant [P30 CA023168]; Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; Walther Cancer Foundation; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085089] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Purdue Center for Cancer Research Macromolecular Crystallography and DNA Sequencing Shared Resources - National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; Walther Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health, NIAID, Grant R01 AI085089 (to A. D. M. and S. C. B.). Crystallization and DNA sequencing were supported in part by the Purdue Center for Cancer Research Macromolecular Crystallography and DNA Sequencing Shared Resources, which are supported by National Institutes of Health Grant P30 CA023168. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the Department of Energy under Contract DE-AC02-06CH11357. Use of the Life Science-Collaborative Access Team Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by the Walther Cancer Foundation. To whom correspondence should be addressed.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Angelini MM, 2013, MBIO, V4, DOI 10.1128/mBio.00524-13; Baez-Santos YM, 2014, J VIROL, V88, P12511, DOI 10.1128/JVI.01294-14; Baez-Santos YM, 2014, J MED CHEM, V57, P2393, DOI 10.1021/jm401712t; Bailey-Elkin BA, 2014, J BIOL CHEM, V289, P34667, DOI 10.1074/jbc.M114.609644; Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Chen ZB, 2007, J VIROL, V81, P6007, DOI 10.1128/JVI.02747-06; Chou CY, 2014, ACTA CRYSTALLOGR D, V70, P572, DOI 10.1107/S1399004713031040; Cima G, 2014, JAVMA-J AM VET MED A, V245, P166; Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Deng XF, 2014, J VIROL, V88, P11825, DOI 10.1128/JVI.01749-14; Egloff MP, 2006, J VIROL, V80, P8493, DOI 10.1128/JVI.00713-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fehr AR, 2015, J VIROL, V89, P1523, DOI 10.1128/JVI.02596-14; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; Ghosh AK, 2010, J MED CHEM, V53, P4968, DOI 10.1021/jm1004489; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002; Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hurst KR, 2013, J VIROL, V87, P9159, DOI 10.1128/JVI.01275-13; Hurst-Hess KR, 2015, J VIROL, V89, P6033, DOI 10.1128/JVI.00197-15; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Johnson MA, 2010, J MOL BIOL, V400, P724, DOI 10.1016/j.jmb.2010.05.027; Keane SC, 2013, J VIROL, V87, P3502, DOI 10.1128/JVI.03112-12; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; Kong LY, 2015, J BIOL CHEM, V290, P7160, DOI 10.1074/jbc.M114.628636; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lei J, 2014, ANTIVIR RES, V109, P72, DOI 10.1016/j.antiviral.2014.06.011; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Lindner HA, 2007, ARCH BIOCHEM BIOPHYS, V466, P8, DOI 10.1016/j.abb.2007.07.006; Lindner HA, 2007, VIROLOGY, V362, P245, DOI 10.1016/j.virol.2006.12.035; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Mielech AM, 2015, J VIROL, V89, P4907, DOI 10.1128/JVI.00338-15; Mielech AM, 2014, VIRUS RES, V194, P184, DOI 10.1016/j.virusres.2014.01.025; Mielech AM, 2014, VIROLOGY, V450, P64, DOI 10.1016/j.virol.2013.11.040; Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041; Neuman BW, 2008, J VIROL, V82, P5279, DOI 10.1128/JVI.02631-07; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Piotrowski Y, 2009, PROTEIN SCI, V18, P6, DOI 10.1002/pro.15; Ratia K, 2006, P NATL ACAD SCI USA, V103, P5717, DOI 10.1073/pnas.0510851103; Ratia K, 2008, P NATL ACAD SCI USA, V105, P16119, DOI 10.1073/pnas.0805240105; Ratia K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004113; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saikatendu KS, 2005, STRUCTURE, V13, P1665, DOI 10.1016/j.str.2005.07.022; Serrano P, 2007, J VIROL, V81, P12049, DOI 10.1128/JVI.00969-07; Serrano P, 2009, J VIROL, V83, P12998, DOI 10.1128/JVI.01253-09; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Tan J, 2007, BIOCHEM BIOPH RES CO, V364, P877, DOI 10.1016/j.bbrc.2007.10.081; Tan JZ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000428; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; van Kasteren PB, 2013, P NATL ACAD SCI USA, V110, pE838, DOI 10.1073/pnas.1218464110; Wojdyla JA, 2010, J VIROL, V84, P10063, DOI 10.1128/JVI.00898-10; Wojdyla JA, 2009, ACTA CRYSTALLOGR D, V65, P1292, DOI 10.1107/S0907444909040074; Xing YL, 2013, J GEN VIROL, V94, P1554, DOI 10.1099/vir.0.051169-0; Yang XX, 2014, J GEN VIROL, V95, P614, DOI 10.1099/vir.0.059014-0; Zheng DH, 2008, CELL RES, V18, P1105, DOI 10.1038/cr.2008.294; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853; Ziebuhr J, 2006, ADV EXP MED BIOL, V581, P3	65	22	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25293	25306		10.1074/jbc.M115.662130	http://dx.doi.org/10.1074/jbc.M115.662130			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26296883	Green Published, hybrid			2022-12-28	WOS:000362962800009
J	Eiyama, A; Okamoto, K				Eiyama, Akinori; Okamoto, Koji			Protein N-terminal Acetylation by the NatA Complex Is Critical for Selective Mitochondrial Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLTRANSFERASES; MITOPHAGY; AUTOPHAGY; YEAST; ATG32; IDENTIFICATION; FISSION; STRAINS; GENES; DNA	Mitophagy is an evolutionarily conserved autophagy pathway that selectively degrades mitochondria. Although it is well established that this degradation system contributes to mitochondrial quality and quantity control, mechanisms underlying mitophagy remain largely unknown. Here, we report that protein N-terminal acetyltransferase A (NatA), an enzymatic complex composed of the catalytic subunit Ard1 and the adaptor subunit Nat1, is crucial for mitophagy in yeast. NatA is associated with the ribosome via Nat1 and acetylates the second amino acid residues of nascent polypeptides. Mitophagy, but not bulk autophagy, is strongly suppressed in cells lacking Ard1, Nat1, or both proteins. In addition, loss of NatA enzymatic activity causes impairment of mitochondrial degradation, suggesting that protein N-terminal acetylation by NatA is important for mitophagy. Ard1 and Nat1 mutants exhibited defects in induction of Atg32, a protein essential for mitophagy, and formation of mitochondria-specific autophagosomes. Notably, overexpression of Atg32 partially recovered mitophagy in NatA-null cells, implying that this acetyltransferase participates in mitophagy at least in part via Atg32 induction. Together, our data implicate NatA-mediated protein modification as an early regulatory step crucial for efficient mitophagy.	[Eiyama, Akinori; Okamoto, Koji] Osaka Univ, Grad Sch Frontier Biosci, Lab Mitochondrial Dynam, Suita, Osaka 5650871, Japan	Osaka University	Okamoto, K (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Lab Mitochondrial Dynam, Suita, Osaka 5650871, Japan.	kokamoto@fbs.osaka-u.ac.jp			Japan Society for the Promotion of Science [261682, 25291045]; Ministry of Education, Culture, Sports, Science, and Technology [15H01536]; Japan Society for the Promotion of Science Research Fellowship DC1 for Young Scientists; Grants-in-Aid for Scientific Research [25650067, 26111513] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science Research Fellowship DC1 for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science, Grants-in-aid from JSPS Fellows 261682 (to A. E.) and Scientific Research (B) 25291045 (to K.O.), and by Ministry of Education, Culture, Sports, Science, and Technology Grant-in-aid for Scientific Research on Innovative Areas 15H01536 (to K.O.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Japan Society for the Promotion of Science Research Fellowship DC1 for Young Scientists.	Aihara M, 2014, J CELL SCI, V127, P3184, DOI 10.1242/jcs.153254; Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Arnesen T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001074; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Asaumi M, 2005, J BIOCHEM, V137, P147, DOI 10.1093/jb/mvi014; Bockler S, 2014, DEV CELL, V28, P450, DOI 10.1016/j.devcel.2014.01.012; Brachmann CB, 1998, YEAST, V14, P115; Eiyama A, 2013, FEBS LETT, V587, P1787, DOI 10.1016/j.febslet.2013.04.030; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Kanki T, 2013, EMBO REP, V14, P788, DOI 10.1038/embor.2013.114; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kim J, 2001, J CELL BIOL, V153, P381, DOI 10.1083/jcb.153.2.381; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kondo-Okamoto N, 2012, J BIOL CHEM, V287, P10631, DOI 10.1074/jbc.M111.299917; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Mizushima N, 2011, COLD SH Q B, V76, P397, DOI 10.1101/sqb.2011.76.011023; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Okamoto K, 2014, J CELL BIOL, V205, P435, DOI 10.1083/jcb.201402054; Okamoto K, 2012, BBA-GEN SUBJECTS, V1820, P595, DOI 10.1016/j.bbagen.2011.08.001; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Plasman K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003301; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Polevoda B, 2008, J CELL BIOCHEM, V103, P492, DOI 10.1002/jcb.21418; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; SIKORSKI RS, 1989, GENETICS, V122, P19; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	38	23	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25034	25044		10.1074/jbc.M115.677468	http://dx.doi.org/10.1074/jbc.M115.677468			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26296886	Green Published, hybrid			2022-12-28	WOS:000362598300032
J	Handali, M; Roychowdhury, H; Neupane, DP; Yukl, ET				Handali, Melody; Roychowdhury, Hridindu; Neupane, Durga P.; Yukl, Erik T.			AztD, a Periplasmic Zinc Metallochaperone to an ATP-binding Cassette (ABC) Transporter System in Paracoccus denitrificans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; METAL-BINDING; ESCHERICHIA-COLI; BACTERIAL PATHOGENS; COG0523 FAMILY; HOMEOSTASIS; REGULATOR; AFFINITY; COPPER; ZNTA	Bacterial ATP-binding cassette (ABC) transporters of transition metals are essential for acquisition of necessary elements from the environment. A large number of Gram-negative bacteria, including human pathogens, have a fourth conserved gene of unknown function adjacent to the canonical permease, ATPase, and solute-binding protein (SBP) genes of the AztABC zinc transporter system. To assess the function of this putative accessory factor (AztD) from Paracoccus denitrificans, we have analyzed its transcriptional regulation, metal binding properties, and interaction with the SBP (AztC). Transcription of the aztD gene is significantly up-regulated under conditions of zinc starvation. Recombinantly expressed AztD purifies with slightly substoichiometric zinc from the periplasm of Escherichia coli and is capable of binding up to three zinc ions with high affinity. Size exclusion chromatography and a simple intrinsic fluorescence assay were used to determine that AztD as isolated is able to transfer bound zinc nearly quantitatively to apo-AztC. Transfer occurs through a direct, associative mechanism that prevents loss of metal to the solvent. These results indicate that AztD is a zinc chaperone to AztC and likely functions to maintain zinc homeostasis through interaction with the AztABC system. This work extends our understanding of periplasmic zinc trafficking and the function of chaperones in this process.	[Handali, Melody; Roychowdhury, Hridindu; Neupane, Durga P.; Yukl, Erik T.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	New Mexico State University	Yukl, ET (corresponding author), Dept Chem & Biochem, 1175 N Horseshoe Dr, Las Cruces, NM 88003 USA.	etyukl@nmsu.edu		Yukl, Erik/0000-0001-6519-6938	National Institutes of Health from NIGMS [1SC2GM111170-01]; Discovery Scholars Program for undergraduate research at New Mexico State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM111170] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Discovery Scholars Program for undergraduate research at New Mexico State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant 1SC2GM111170-01 from NIGMS and the Discovery Scholars Program for undergraduate research at New Mexico State University (summer undergraduate funding). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badarau A, 2013, CHEM COMMUN, V49, P8000, DOI 10.1039/c3cc42709a; Bagai I, 2008, BIOCHEMISTRY-US, V47, P11408, DOI 10.1021/bi801638m; Berducci G, 2004, FEBS LETT, V569, P289, DOI 10.1016/j.febslet.2004.06.008; Braymer JJ, 2014, CURR OPIN CHEM BIOL, V19, P59, DOI 10.1016/j.cbpa.2013.12.021; Chacon KN, 2014, P NATL ACAD SCI USA, V111, P15373, DOI 10.1073/pnas.1411475111; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Costello LC, 2004, J INORG BIOCHEM, V98, P664, DOI 10.1016/j.jinorgbio.2004.02.005; Dainty SJ, 2010, J BIOL INORG CHEM, V15, P77, DOI 10.1007/s00775-009-0555-z; de Seny D, 2001, J BIOL CHEM, V276, P45065, DOI 10.1074/jbc.M106447200; Djoko KY, 2015, J BIOL CHEM, V290, P18954, DOI 10.1074/jbc.R115.647099; Dutta SJ, 2006, BIOCHEMISTRY-US, V45, P5923, DOI 10.1021/bi0523456; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; Gabbianelli R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-36; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Graham AI, 2009, J BIOL CHEM, V284, P18377, DOI 10.1074/jbc.M109.001503; Haas CE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-470; Handali M, 2015, J BIOL CHEM, V290, P11878, DOI 10.1074/jbc.M115.645853; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Ilari A, 2014, BBA-GEN SUBJECTS, V1840, P535, DOI 10.1016/j.bbagen.2013.10.010; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; Liu JB, 2006, BIOCHEMISTRY-US, V45, P763, DOI 10.1021/bi051836n; Liu JB, 2005, BIOCHEMISTRY-US, V44, P5159, DOI 10.1021/bi0476275; Mealman TD, 2012, BIOCHEMISTRY-US, V51, P6767, DOI 10.1021/bi300596a; Mealman TD, 2011, BIOCHEMISTRY-US, V50, P2559, DOI 10.1021/bi102012j; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Noll M, 1998, J BIOL CHEM, V273, P21393, DOI 10.1074/jbc.273.33.21393; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrarca P, 2010, J BACTERIOL, V192, P1553, DOI 10.1128/JB.01310-09; Ranieri-Raggi M, 2014, BIOMOLECULES, V4, P474, DOI 10.3390/biom4020474; Shin JH, 2007, J BACTERIOL, V189, P4070, DOI 10.1128/JB.01851-06; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Sullivan MJ, 2013, P NATL ACAD SCI USA, V110, P19926, DOI 10.1073/pnas.1314529110; Sydor AM, 2013, BIOCHEMISTRY-US, V52, P1788, DOI 10.1021/bi301600z; Wang D, 2012, J INORG BIOCHEM, V111, P173, DOI 10.1016/j.jinorgbio.2012.02.008; Wang YT, 2003, BIOCHEMISTRY-US, V42, P7318, DOI 10.1021/bi034243q; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702	44	13	13	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29984	29992		10.1074/jbc.M115.684506	http://dx.doi.org/10.1074/jbc.M115.684506			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26468286	Green Published, hybrid			2022-12-28	WOS:000366614700030
J	Alswied, A; Parekh, AB				Alswied, Abdullah; Parekh, Anant B.			Ca2+ Influx through Store-operated Calcium Channels Replenishes the Functional Phosphatidylinositol 4,5-Bisphosphate Pool Used by Cysteinyl Leukotriene Type I Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATE KINASES; INOSITOL 1,4,5-TRISPHOSPHATE; OSCILLATIONS; GENE; LITHIUM; ACTIVATION; EXPRESSION; AGONIST; IMPA2; STIM	Oscillations in cytoplasmic Ca2+ concentration are a universal mode of signaling following physiological levels of stimulation with agonists that engage the phospholipase C pathway. Sustained cytoplasmic Ca2+ oscillations require replenishment of the membrane phospholipid phosphatidylinositol 4,5-bis-phosphate (PIP2), the source of the Ca2+-releasing second messenger inositol trisphosphate. Here we show that cytoplasmic Ca2+ oscillations induced by cysteinyl leukotriene type I receptor activation run down when cells are pretreated with Li+, an inhibitor of inositol monophosphatases that prevents PIP2 resynthesis. In Li+-treated cells, cytoplasmic Ca2+ signals evoked by an agonist were rescued by addition of exogenous inositol or phosphatidylinositol 4-phosphate (PI4P). Knockdown of the phosphatidylinositol 4-phosphate 5 (PIP5) kinases alpha and gamma resulted in rapid loss of the intracellular Ca2+ oscillations and also prevented rescue by PI4P. Knockdown of talin1, a protein that helps regulate PIP5 kinases, accelerated rundown of cytoplasmic Ca2+ oscillations, and these could not be rescued by inositol or PI4P. In Li+-treated cells, recovery of the cytoplasmic Ca2+ oscillations in the presence of inositol or PI4P was suppressed when Ca2+ influx through store-operated Ca2+ channels was inhibited. After rundown of the Ca2+ signals following leukotriene receptor activation, stimulation of P2Y receptors evoked prominent inositol trisphosphate-dependent Ca2+ release. Therefore, leukotriene and P2Y receptors utilize distinct membrane PIP2 pools. Our findings show that store-operated Ca2+ entry is needed to sustain cytoplasmic Ca2+ signaling following leukotriene receptor activation both by refilling the Ca2+ stores and by helping to replenish the PIP2 pool accessible to leukotriene receptors, ostensibly through control of PIP5 kinase activity.	[Alswied, Abdullah; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Pk Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk			MRC [L01047X]; Saudi Arabian government; Medical Research Council [MR/L01047X/1] Funding Source: researchfish; MRC [MR/L01047X/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Saudi Arabian government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by MRC Program Grant L01047X (to A. B. P.). The authors declare that they have no conflict of interest with the contents of this article.; Recipient of a Saudi Arabian government studentship.	ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Amcheslavsky A, 2015, BIOPHYS J, V108, P237, DOI 10.1016/j.bpj.2014.11.3473; Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; ATACK JR, 1993, BRIT J PHARMACOL, V110, P809, DOI 10.1111/j.1476-5381.1993.tb13884.x; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bate N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034461; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Di Capite J, 2009, CURR BIOL, V19, P853, DOI 10.1016/j.cub.2009.03.063; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; FAIN JN, 1979, BIOCHEM J, V180, P655, DOI 10.1042/bj1800655; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; JENKINSON S, 1994, MOL PHARMACOL, V46, P1138; Kunz J, 2000, MOL CELL, V5, P1, DOI 10.1016/S1097-2765(00)80398-6; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Maleth J., 2014, NAT COMMUN, V2014, P5; Ng SW, 2012, NATURE, V482, P111, DOI 10.1038/nature10731; Ohnishi T, 2007, J BIOL CHEM, V282, P637, DOI 10.1074/jbc.M604474200; Parekh AB, 2011, TRENDS BIOCHEM SCI, V36, P78, DOI 10.1016/j.tibs.2010.07.013; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Straube S, 2001, PFLUG ARCH EUR J PHY, V442, P391, DOI 10.1007/s004240100546; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; THORN P, 1995, J PHYSIOL-LONDON, V482, P275, DOI 10.1113/jphysiol.1995.sp020516; TSE A, 1993, SCIENCE, V260, P82, DOI 10.1126/science.8385366; Walsh CM, 2010, BIOCHEM J, V425, P159, DOI 10.1042/BJ20090884; WANG SSH, 1995, J GEN PHYSIOL, V105, P149, DOI 10.1085/jgp.105.1.149; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Xie LH, 1999, P NATL ACAD SCI USA, V96, P15292, DOI 10.1073/pnas.96.26.15292; Yeh YC, 2014, J BIOL CHEM, V289, P17843, DOI 10.1074/jbc.M114.553453; Yoshikawa T, 2001, MOL PSYCHIATR, V6, P202, DOI 10.1038/sj.mp.4000835	41	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29555	29566		10.1074/jbc.M115.678292	http://dx.doi.org/10.1074/jbc.M115.678292			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468289	Green Published, hybrid			2022-12-28	WOS:000366613400037
J	Kronert, WA; Melkani, GC; Melkani, A; Bernstein, SI				Kronert, William A.; Melkani, Girish C.; Melkani, Anju; Bernstein, Sanford I.			A Failure to Communicate MYOSIN RESIDUES INVOLVED IN HYPERTROPHIC CARDIOMYOPATHY AFFECT INTER-DOMAIN INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN; MUSCLE FUNCTION; DROSOPHILA-MELANOGASTER; ALTERNATIVE RELAY; CONVERTER DOMAINS; POWER STROKE; MUTATIONS; MOTOR; GENE; ISOFORM	Our molecular modeling studies suggest a charge-dependent interaction between residues Glu-497 in the relay domain and Arg-712 in the converter domain of human beta-cardiac myosin. To test the significance of this putative interaction, we generated transgenic Drosophila expressing indirect flight muscle myosin with charge reversal mutations in the relay (E496R) or converter (R713E). Each mutation yielded dramatic reductions in myosin Ca-ATPase activity (similar to 80%) as well as in basal (similar to 67%) and actin-activated (similar to 84%) Mg-ATPase activity. E496R myosin-induced in vitro actin-sliding velocity was reduced by 71% and R713E myosin permitted no actin motility. Indirect flight muscles of late pupae from each mutant displayed disrupted myofibril assembly, with adults having severely abnormal myofibrils and no flight ability. To understand the molecular basis of these defects, we constructed a putative compensatory mutant that expresses myosin with both E496R and R713E. Intriguingly, ATPase values were restored to similar to 73% of wild-type and actin-sliding velocity increased to 40%. The double mutation suppresses myofibril assembly defects in pupal indirect flight muscles and dramatically reduces myofibril disruption in young adults. Although sarcomere organization is not sustained in older flies and flight ability is not restored in homozygotes, young heterozygotes fly well. Our results indicate that this charge-dependent interaction between the myosin relay and converter domains is essential to the mechanochemical cycle and sarcomere assembly. Furthermore, the same inter-domain interaction is disrupted when modeling human beta-cardiac myosin heavy chain cardiomyopathy mutations E497D or R712L, implying that abolishing this salt bridge is one cause of the human disease.	[Bernstein, Sanford I.] San Diego State Univ, Inst Mol Biol, Dept Biol, San Diego, CA 92182 USA; San Diego State Univ, Inst Heart, San Diego, CA 92182 USA	California State University System; San Diego State University; California State University System; San Diego State University	Bernstein, SI (corresponding author), San Diego State Univ, Inst Mol Biol, Dept Biol, San Diego, CA 92182 USA.	sbernstein@mail.sdsu.edu	Regan, Clinton/E-6250-2012	Melkani, Girish/0000-0003-0353-4633; Bernstein, Sanford/0000-0001-7094-5390	National Institutes of Health [R01 GM32443]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM32443 (to S. I. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; BECKER KD, 1992, J CELL BIOL, V116, P669, DOI 10.1083/jcb.116.3.669; BEJSOVEC A, 1990, CELL, V60, P133, DOI 10.1016/0092-8674(90)90723-R; BERNSTEIN SI, 1983, NATURE, V302, P393, DOI 10.1038/302393a0; Bloemink MJ, 2009, J MOL BIOL, V389, P707, DOI 10.1016/j.jmb.2009.04.036; Colegrave M, 2014, ANAT REC, V297, P1670, DOI 10.1002/ar.22973; COLLIER VL, 1990, GENE DEV, V4, P885, DOI 10.1101/gad.4.6.885; DRUMMOND DR, 1991, MOL GEN GENET, V226, P70, DOI 10.1007/BF00273589; Fischer S, 2005, P NATL ACAD SCI USA, V102, P6873, DOI 10.1073/pnas.0408784102; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Gourinath S, 2003, STRUCTURE, V11, P1621, DOI 10.1016/j.str.2003.10.013; Himmel DM, 2002, P NATL ACAD SCI USA, V99, P12645, DOI 10.1073/pnas.202476799; Holmes KC, 2004, PHILOS T ROY SOC B, V359, P1819, DOI 10.1098/rstb.2004.1566; Kronert WA, 2008, J MOL BIOL, V379, P443, DOI 10.1016/j.jmb.2008.04.010; Kronert WA, 2014, J BIOL CHEM, V289, P12779, DOI 10.1074/jbc.M114.550673; Kronert WA, 2012, J MOL BIOL, V416, P543, DOI 10.1016/j.jmb.2011.12.044; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Liu X, 2005, J BIOL CHEM, V280, P26974, DOI 10.1074/jbc.M504453200; Lowey S, 2008, J BIOL CHEM, V283, P20579, DOI 10.1074/jbc.M800554200; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; ODONNELL PT, 1988, J CELL BIOL, V107, P2601, DOI 10.1083/jcb.107.6.2601; ODONNELL PT, 1989, GENE DEV, V3, P1233, DOI 10.1101/gad.3.8.1233; ROZEK CE, 1983, CELL, V32, P23, DOI 10.1016/0092-8674(83)90493-2; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sakthivel S, 2000, Hum Mutat, V15, P298, DOI 10.1002/(SICI)1098-1004(200003)15:3<298::AID-HUMU22>3.0.CO;2-7; Shih WM, 2001, J BIOL CHEM, V276, P19491, DOI 10.1074/jbc.M010887200; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; Spudich JA, 2014, BIOPHYS J, V106, P1236, DOI 10.1016/j.bpj.2014.02.011; Swank DM, 2000, MICROSC RES TECHNIQ, V50, P430, DOI 10.1002/1097-0029(20000915)50:6<430::AID-JEMT2>3.0.CO;2-E; Swank DM, 2001, J BIOL CHEM, V276, P15117, DOI 10.1074/jbc.M008379200; Tang S, 2007, J MOL BIOL, V373, P1361, DOI 10.1016/j.jmb.2007.08.059; TOHTONG R, 1995, NATURE, V374, P650, DOI 10.1038/374650a0; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; Winkelmann DA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8974; Yamashita H, 2000, J BIOL CHEM, V275, P28045; Yu H, 2007, PLOS COMPUT BIOL, V3, P214, DOI 10.1371/journal.pcbi.0030023	37	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29270	29280		10.1074/jbc.M115.681874	http://dx.doi.org/10.1074/jbc.M115.681874			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26446785	Green Published, hybrid			2022-12-28	WOS:000366613400015
J	Briggs, DC; Birchenough, HL; Ali, T; Rugg, MS; Waltho, JP; Ievoli, E; Jowitt, TA; Enghild, JJ; Richter, RP; Salustri, A; Milner, CM; Day, AJ				Briggs, David C.; Birchenough, Holly L.; Ali, Tariq; Rugg, Marilyn S.; Waltho, Jon P.; Ievoli, Elena; Jowitt, Thomas A.; Enghild, Jan J.; Richter, Ralf P.; Salustri, Antonietta; Milner, Caroline M.; Day, Anthony J.			Metal Ion-dependent Heavy Chain Transfer Activity of TSG-6 Mediates Assembly of the Cumulus-Oocyte Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hyaluronan; protein structure; protein-protein interaction; reproduction; site-directed mutagenesis; CUB module structure; TSG-6; cumulus-oocyte complex expansion; heavy chain-hyaluronan complex formation; inter--inhibitor	INTER-ALPHA-INHIBITOR; FACTOR-STIMULATED GENE-6; SHAP-HYALURONAN COMPLEX; COVALENTLY CROSS-LINKS; EXTRACELLULAR-MATRIX; TRYPSIN-INHIBITOR; PROTEIN TSG-6; CHROMOSOMAL LOCALIZATION; BINDING DOMAIN; MODULE	The matrix polysaccharide hyaluronan (HA) has a critical role in the expansion of the cumulus cell-oocyte complex (COC), a process that is necessary for ovulation and fertilization in most mammals. Hyaluronan is organized into a cross-linked network by the cooperative action of three proteins, inter--inhibitor (II), pentraxin-3, and TNF-stimulated gene-6 (TSG-6), driving the expansion of the COC and providing the cumulus matrix with its required viscoelastic properties. Although it is known that matrix stabilization involves the TSG-6-mediated transfer of II heavy chains (HCs) onto hyaluronan (to form covalent HCHA complexes that are cross-linked by pentraxin-3) and that this occurs via the formation of covalent HCTSG-6 intermediates, the underlying molecular mechanisms are not well understood. Here, we have determined the tertiary structure of the CUB module from human TSG-6, identifying a calcium ion-binding site and chelating glutamic acid residue that mediate the formation of HCTSG-6. This occurs via an initial metal ion-dependent, non-covalent, interaction between TSG-6 and HCs that also requires the presence of an HC-associated magnesium ion. In addition, we have found that the well characterized hyaluronan-binding site in the TSG-6 Link module is not used for recognition during transfer of HCs onto HA. Analysis of TSG-6 mutants (with impaired transferase and/or hyaluronan-binding functions) revealed that although the TSG-6-mediated formation of HCHA complexes is essential for the expansion of mouse COCs in vitro, the hyaluronan-binding function of TSG-6 does not play a major role in the stabilization of the murine cumulus matrix.	[Briggs, David C.; Birchenough, Holly L.; Ali, Tariq; Jowitt, Thomas A.; Day, Anthony J.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Briggs, David C.; Birchenough, Holly L.; Ali, Tariq; Waltho, Jon P.; Jowitt, Thomas A.; Milner, Caroline M.; Day, Anthony J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Rugg, Marilyn S.] Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England; [Ievoli, Elena; Salustri, Antonietta] Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy; [Enghild, Jan J.] Univ Aarhus, Dept Mol Chem, DK-8000 Aarhus C, Denmark; [Richter, Ralf P.] CIC BiomaGUNE, Donostia San Sebastian 20009, Spain; [Richter, Ralf P.] Univ Grenoble Alpes, Dept Mol Chem, F-38000 Grenoble, France; [Richter, Ralf P.] CNRS, F-38000 Grenoble, France; [Richter, Ralf P.] Max Planck Inst Intelligent Syst, D-70569 Stuttgart, Germany	University of Manchester; University of Manchester; University of Oxford; University of Rome Tor Vergata; Aarhus University; CIC biomaGUNE; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Max Planck Society	Day, AJ (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Oxford Rd, Manchester M13 9PT, Lancs, England.	anthony.day@manchester.ac.uk	Milner, Caroline M/P-5526-2015; Richter, Ralf Peter/B-3343-2013; Day, Anthony/O-1658-2015; Ievoli, Elena/ABG-8920-2021; biomaGUNE, CIC/J-9136-2014	Milner, Caroline M/0000-0001-7355-9655; Richter, Ralf Peter/0000-0003-3071-2837; Day, Anthony/0000-0002-1415-3134; Jowitt, Thomas/0000-0002-4045-0933; Briggs, David/0000-0002-9793-7339; Waltho, Jonathan/0000-0002-7402-5492; SALUSTRI, ANTONIETTA/0000-0002-8731-1041; Enghild, Jan Johannes/0000-0001-9292-9172; biomaGUNE, CIC/0000-0001-7690-0660	Arthritis Research Campaign [14871, 18472, 19489]; Medical Research Council [G0701180]; Biotechnology and Biological Sciences Research Council CASE award; Biotechnology and Biological Sciences Research Council [BB/H000844/1, 957322] Funding Source: researchfish; Medical Research Council [MC_U138274352] Funding Source: researchfish; Versus Arthritis [19489, 18472] Funding Source: researchfish; BBSRC [BB/H000844/1] Funding Source: UKRI; MRC [G0701180, MC_U138274352] Funding Source: UKRI	Arthritis Research Campaign(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council CASE award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Arthritis Research Campaign Grants 14871, 18472, and 19489 and Medical Research Council Grant G0701180. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Biotechnology and Biological Sciences Research Council CASE award.	Baranova NS, 2014, J BIOL CHEM, V289, P30481, DOI 10.1074/jbc.M114.568154; Baranova NS, 2013, J BIOL CHEM, V288, P29642, DOI 10.1074/jbc.M113.477422; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; BLOM A, 1995, J BIOL CHEM, V270, P9698, DOI 10.1074/jbc.270.17.9698; Blundell CD, 2005, J BIOL CHEM, V280, P18189, DOI 10.1074/jbc.M414343200; Blundell CD, 2003, J BIOL CHEM, V278, P49261, DOI 10.1074/jbc.M309623200; Briggs DC, 2008, TRENDS MICROBIOL, V16, P407, DOI 10.1016/j.tim.2008.06.002; Camaioni A, 1996, ARCH BIOCHEM BIOPHYS, V325, P190, DOI 10.1006/abbi.1996.0024; CAMPBELL ID, 2011, CSH PERSPECT BIOL, V3, DOI DOI 10.1101/cshperspect.a004994; Carrette O, 2001, BIOL REPROD, V65, P301, DOI 10.1095/biolreprod65.1.301; CHEN L, 1993, MOL REPROD DEV, V34, P87, DOI 10.1002/mrd.1080340114; CHEN L, 1992, J BIOL CHEM, V267, P12380; Chen L, 1996, J BIOL CHEM, V271, P19409, DOI 10.1074/jbc.271.32.19409; Coulson-Thomas VJ, 2014, J BIOL CHEM, V289, P23465, DOI 10.1074/jbc.M114.557447; Day AJ, 1996, PROTEIN EXPRES PURIF, V8, P1, DOI 10.1006/prep.1996.0068; Dyer DP, 2014, J IMMUNOL, V192, P2177, DOI 10.4049/jimmunol.1300194; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; ENGHILD JJ, 1993, J BIOL CHEM, V268, P8711; ENGHILD JJ, 1989, J BIOL CHEM, V264, P15975; Enghild JJ, 1999, BIOCHEMISTRY-US, V38, P11804, DOI 10.1021/bi9908540; EPPIG JJ, 1979, NATURE, V281, P483, DOI 10.1038/281483a0; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Fulop C, 1997, GENE, V202, P95, DOI 10.1016/S0378-1119(97)00459-9; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gregory LA, 2003, J BIOL CHEM, V278, P32157, DOI 10.1074/jbc.M305175200; He H, 2014, INVEST OPHTH VIS SCI, V55, P1647, DOI 10.1167/iovs.13-13094; He H, 2013, J BIOL CHEM, V288, P25792, DOI 10.1074/jbc.M113.479584; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Hess KA, 1999, BIOL REPROD, V61, P436, DOI 10.1095/biolreprod61.2.436; Higman VA, 2007, J MOL BIOL, V371, P669, DOI 10.1016/j.jmb.2007.05.073; Higman VA, 2014, J BIOL CHEM, V289, P5619, DOI 10.1074/jbc.M113.542357; HUANG L, 1993, J BIOL CHEM, V268, P26725; Ievoli E, 2011, MATRIX BIOL, V30, P330, DOI 10.1016/j.matbio.2011.05.002; Inforzato A, 2008, J BIOL CHEM, V283, P10147, DOI 10.1074/jbc.M708535200; Inforzato A, 2010, J BIOL CHEM, V285, P17681, DOI 10.1074/jbc.M109.085639; JESSEN TE, 1994, BIOL CHEM H-S, V375, P521, DOI 10.1515/bchm3.1994.375.8.521; Jessen TE, 2004, OSTEOARTHR CARTILAGE, V12, P142, DOI 10.1016/j.joca.2003.10.004; Jessen TE, 2003, REPRODUCTION, V125, P27, DOI 10.1530/rep.0.1250027; Kahmann JD, 1997, PROTEIN EXPRES PURIF, V9, P315, DOI 10.1006/prep.1996.0694; Kaslik G, 1999, ARCH BIOCHEM BIOPHYS, V362, P254, DOI 10.1006/abbi.1998.1035; Kohda D, 1996, CELL, V86, P767, DOI 10.1016/S0092-8674(00)80151-8; Kuznetsova SA, 2008, MATRIX BIOL, V27, P201, DOI 10.1016/j.matbio.2007.10.003; Lam X, 2000, BIOL REPROD, V62, P579, DOI 10.1095/biolreprod62.3.579; Lamkin E, 2015, J BIOL CHEM, V290, P5156, DOI 10.1074/jbc.M114.636258; Lauer ME, 2014, J BIOL CHEM, V289, P29171, DOI 10.1074/jbc.M114.600809; Lauer ME, 2014, J BIOL CHEM, V289, P6791, DOI 10.1074/jbc.M113.512491; Lauer ME, 2013, J BIOL CHEM, V288, P205, DOI 10.1074/jbc.M112.403998; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lord MS, 2013, J BIOL CHEM, V288, P22930, DOI 10.1074/jbc.M112.404186; Ly M, 2011, NAT CHEM BIOL, V7, P827, DOI 10.1038/nchembio.673; Mahoney DJ, 2005, J BIOL CHEM, V280, P27044, DOI 10.1074/jbc.M502068200; Mahoney DJ, 2001, GLYCOBIOLOGY, V11, P1025, DOI 10.1093/glycob/11.12.1025; Mahoney DJ, 2001, J BIOL CHEM, V276, P22764, DOI 10.1074/jbc.M100666200; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; MORELLE W, 1994, EUR J BIOCHEM, V221, P881, DOI 10.1111/j.1432-1033.1994.tb18803.x; Mukhopadhyay D, 2004, J BIOL CHEM, V279, P11119, DOI 10.1074/jbc.M313471200; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagyova E, 2015, Endocr Regul, V49, P37; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Neal S, 2003, J BIOMOL NMR, V26, P215, DOI 10.1023/A:1023812930288; Nentwich HA, 2002, J BIOL CHEM, V277, P15354, DOI 10.1074/jbc.M110765200; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P4376, DOI 10.1210/en.2003-0487; Ochsner SA, 2003, ENDOCRINOLOGY, V144, P1008, DOI 10.1210/en.2002-220435; Parkar AA, 1997, FEBS LETT, V410, P413, DOI 10.1016/S0014-5793(97)00621-2; Rugg MS, 2005, J BIOL CHEM, V280, P25674, DOI 10.1074/jbc.M501332200; Russell DL, 2006, SEMIN REPROD MED, V24, P217, DOI 10.1055/s-2006-948551; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; Sanggaard KW, 2006, BIOCHEMISTRY-US, V45, P7661, DOI 10.1021/bi060106s; Sanggaard KW, 2010, BBA-PROTEINS PROTEOM, V1804, P1011, DOI 10.1016/j.bbapap.2010.01.013; Sanggaard KW, 2008, J BIOL CHEM, V283, P33919, DOI 10.1074/jbc.M804240200; Sanggaard KW, 2005, J BIOL CHEM, V280, P11936, DOI 10.1074/jbc.M409016200; Sato H, 2001, BIOCHEM BIOPH RES CO, V281, P1154, DOI 10.1006/bbrc.2001.4475; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; Shay E, 2011, INVEST OPHTH VIS SCI, V52, P2669, DOI 10.1167/iovs.10-5888; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200; Thakar D, 2014, CHEM COMMUN, V50, P15148, DOI 10.1039/c4cc06905f; Tirone E, 1997, J BIOL CHEM, V272, P4787, DOI 10.1074/jbc.272.8.4787; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Yingsung W, 2003, J BIOL CHEM, V278, P32710, DOI 10.1074/jbc.M303658200; ZHAO M, 1995, J BIOL CHEM, V270, P26657, DOI 10.1074/jbc.270.44.26657; Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200; Zhuo LS, 2004, J BIOL CHEM, V279, P38079, DOI 10.1074/jbc.R300039200; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	96	35	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28708	28723		10.1074/jbc.M115.669838	http://dx.doi.org/10.1074/jbc.M115.669838			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26468290	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000365762300012
J	Endow, JK; Singhal, R; Fernandez, DE; Inoue, K				Endow, Joshua K.; Singhal, Rajneesh; Fernandez, Donna E.; Inoue, Kentaro			Chaperone-assisted Post-translational Transport of Plastidic Type I Signal Peptidase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; chloroplast; protein export; signal peptidase; transmembrane domain; Sec channel; thylakoid	SEC-INDEPENDENT INSERTION; INNER ENVELOPE MEMBRANE; IRON-SULFUR PROTEIN; THYLAKOID MEMBRANE; LEADER PEPTIDASE; TRANSMEMBRANE DOMAIN; FLUORESCENT PROTEIN; COMPLEX-FORMATION; LUMENAL PROTEINS; QUALITY-CONTROL	Type I signal peptidase (SPase I) is an integral membrane Ser/Lys protease with one or two transmembrane domains (TMDs), cleaving transport signals off translocated precursor proteins. The catalytic domain of SPase I folds to form a hydrophobic surface and inserts into the lipid bilayers at the trans-side of the membrane. In bacteria, SPase I is targeted co-translationally, and the catalytic domain remains unfolded until it reaches the periplasm. By contrast, SPases I in eukaryotes are targeted post-translationally, requiring an alternative strategy to prevent premature folding. Here we demonstrate that two distinct stromal components are involved in post-translational transport of plastidic SPase I 1 (Plsp1) from Arabidopsis thaliana, which contains a single TMD. During import into isolated chloroplasts, Plsp1 was targeted to the membrane via a soluble intermediate in an ATP hydrolysis-dependent manner. Insertion of Plsp1 into isolated chloroplast membranes, by contrast, was found to occur by two distinct mechanisms. The first mechanism requires ATP hydrolysis and the protein conducting channel cpSecY1 and was strongly enhanced by exogenously added cpSecA1. The second mechanism was independent of nucleoside triphosphates and proteinaceous components but with a high frequency of mis-orientation. This unassisted insertion was inhibited by urea and stroma extract. During import-chase assays using intact chloroplasts, Plsp1 was incorporated into a soluble 700-kDa complex that co-migrated with the Cpn60 complex before inserting into the membrane. The TMD within Plsp1 was required for the cpSecA1-dependent insertion but was dispensable for association with the 700-kDa complex and also for unassisted membrane insertion. These results indicate cooperation of Cpn60 and cpSecA1 for proper membrane insertion of Plsp1 by cpSecY1.	[Endow, Joshua K.; Inoue, Kentaro] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Singhal, Rajneesh; Fernandez, Donna E.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA	University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison	Inoue, K (corresponding author), Univ Calif Davis, Dept Plant Sci, 221 Asmundson Hall,One Shields Ave, Davis, CA 95616 USA.	kinoue@ucdavis.edu	singhal, rajneesh/AAZ-4198-2020	singhal, rajneesh/0000-0002-0412-3011; Endow-Monteiro, Joshua/0000-0002-5845-0077	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Dept. of Energy [DE-FG02-08ER15963]; National Science Foundation [MCB-1158173]; University of California Davis Plant Sciences Departmental Graduate Student Researcher Assistantship; Direct For Biological Sciences [1158173] Funding Source: National Science Foundation	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Dept. of Energy; National Science Foundation(National Science Foundation (NSF)); University of California Davis Plant Sciences Departmental Graduate Student Researcher Assistantship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Dept. of Energy through Grant DE-FG02-08ER15963 (to K. I.). Establishment of recombinant cpSecA1 preparation was supported by National Science Foundation Grant MCB-1158173 (to D. E. F.). Purchase of reagents for in vitro transcription and translation was supported by a Henry A. Jastro Research Scholarship (to J. K. E.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by a University of California Davis Plant Sciences Departmental Graduate Student Researcher Assistantship.	Albiniak AM, 2012, J EXP BOT, V63, P1689, DOI 10.1093/jxb/err444; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BLOOM MV, 1983, P NATL ACAD SCI-BIOL, V80, P1013, DOI 10.1073/pnas.80.4.1013; Bonk M, 1997, EUR J BIOCHEM, V247, P942, DOI 10.1111/j.1432-1033.1997.00942.x; Castanie-Cornet MP, 2014, BBA-MOL CELL RES, V1843, P1442, DOI 10.1016/j.bbamcr.2013.11.007; CHEN GG, 1994, P NATL ACAD SCI USA, V91, P11497, DOI 10.1073/pnas.91.24.11497; Chiang CF, 2001, ARCH BIOCHEM BIOPHYS, V394, P229, DOI 10.1006/abbi.2001.2537; Chou ML, 2003, EMBO J, V22, P2970, DOI 10.1093/emboj/cdg281; CLINE K, 1992, J BIOL CHEM, V267, P2688; CLINE K, 1989, J BIOL CHEM, V264, P14225; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dabney-Smith C, 2014, ADVAN PL BIO, V5, P271, DOI 10.1007/978-1-4939-1136-3_10; Dalbey RE, 2012, MICROBIOL MOL BIOL R, V76, P311, DOI 10.1128/MMBR.05019-11; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; Di Cola A, 2005, BIOCHEM SOC T, V33, P1024, DOI 10.1042/BST20051024; Dunschede B, 2015, J BIOL CHEM, V290, P13104, DOI 10.1074/jbc.M114.597922; ELLIS RJ, 1988, PHOTOSYNTH RES, V16, P101, DOI 10.1007/BF00039488; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Endow JK, 2013, FEBS LETT, V587, P2226, DOI 10.1016/j.febslet.2013.05.050; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Fincher V, 2003, EUR J BIOCHEM, V270, P4930, DOI 10.1046/j.1432-1033.2003.03894.x; Froehlich JE, 2011, PLANT J, V68, P844, DOI 10.1111/j.1365-313X.2011.04735.x; GATENBY AA, 1988, EMBO J, V7, P1307, DOI 10.1002/j.1460-2075.1988.tb02945.x; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; Houben E, 1999, PLANT CELL, V11, P1553; Hsu SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027258; Inoue K, 2005, J CELL BIOL, V171, P425, DOI 10.1083/jcb.200506171; Inoue K, 2003, PLANT J, V34, P661, DOI 10.1046/j.1365-313X.2003.01755.x; Inoue K, 2014, ADVAN PL BIO, V5, P305, DOI 10.1007/978-1-4939-1136-3_12; Jackson DT, 1998, J BIOL CHEM, V273, P16583, DOI 10.1074/jbc.273.26.16583; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KIM YT, 1995, EUR J BIOCHEM, V234, P358, DOI 10.1111/j.1432-1033.1995.358_c.x; Kouranov A, 1999, J BIOL CHEM, V274, P25181, DOI 10.1074/jbc.274.35.25181; Kudva R, 2013, RES MICROBIOL, V164, P505, DOI 10.1016/j.resmic.2013.03.016; LEE JI, 1992, J BIOL CHEM, V267, P938; Li HM, 2013, TRENDS PLANT SCI, V18, P360, DOI 10.1016/j.tplants.2013.04.003; LUBBEN TH, 1989, PLANT CELL, V1, P1223, DOI 10.1105/tpc.1.12.1223; MADUENO F, 1993, PLANT CELL, V5, P1865, DOI 10.1105/tpc.5.12.1865; MADUENO F, 1994, J BIOL CHEM, V269, P17458; Mao J, 2015, P NATL ACAD SCI USA, V112, P4152, DOI 10.1073/pnas.1413392111; Midorikawa T, 2014, PLANT J, V80, P592, DOI 10.1111/tpj.12655; Molik S, 2001, J BIOL CHEM, V276, P42761, DOI 10.1074/jbc.M106690200; NAKAI M, 1994, J BIOL CHEM, V269, P31338; Pace C N, 1986, Methods Enzymol, V131, P266; Paetzel M, 1998, NATURE, V396, P186, DOI 10.1038/24196; Paetzel M, 2014, BBA-MOL CELL RES, V1843, P1497, DOI 10.1016/j.bbamcr.2013.12.003; Paila YD, 2015, J MOL BIOL, V427, P1038, DOI 10.1016/j.jmb.2014.08.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rocco AG, 2008, BIOPHYS J, V94, P2241, DOI 10.1529/biophysj.107.115535; Rodrigues RAO, 2011, PLANT J, V65, P600, DOI 10.1111/j.1365-313X.2010.04448.x; ROY H, 1988, PLANT PHYSIOL, V86, P50, DOI 10.1104/pp.86.1.50; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; SANMILLAN JL, 1989, J BACTERIOL, V171, P5536, DOI 10.1128/jb.171.10.5536-5541.1989; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Shipman RL, 2009, FEBS LETT, V583, P938, DOI 10.1016/j.febslet.2009.02.016; Shipman-Roston RL, 2010, PLANT PHYSIOL, V152, P1297, DOI 10.1104/pp.109.151977; Teng YS, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001416; Thompson SJ, 1998, J BIOL CHEM, V273, P18979, DOI 10.1074/jbc.273.30.18979; Thompson SJ, 1999, J BIOL CHEM, V274, P4059, DOI 10.1074/jbc.274.7.4059; Tripp J, 2007, PLANT J, V52, P824, DOI 10.1111/j.1365-313X.2007.03279.x; Trosch R, 2015, BBA-BIOENERGETICS, V1847, P872, DOI 10.1016/j.bbabio.2015.01.002; TSUGEKI R, 1993, FEBS LETT, V320, P198, DOI 10.1016/0014-5793(93)80585-I; van Klompenburg W, 1998, FEBS LETT, V431, P75, DOI 10.1016/S0014-5793(98)00733-9; WOLFE PB, 1985, J BIOL CHEM, V260, P1836; Woolhead CA, 2001, J BIOL CHEM, V276, P14607, DOI 10.1074/jbc.M009600200; Woolhead CA, 2001, J BIOL CHEM, V276, P40841, DOI 10.1074/jbc.M106523200; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595; YUAN JG, 1994, SCIENCE, V266, P796, DOI 10.1126/science.7973633; YUAN JG, 1994, J BIOL CHEM, V269, P18463	73	16	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28778	28791		10.1074/jbc.M115.684829	http://dx.doi.org/10.1074/jbc.M115.684829			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26446787	hybrid, Green Published			2022-12-28	WOS:000365762300020
J	Wood, SJ; Goldufsky, JW; Bello, D; Masood, S; Shafikhani, SH				Wood, Stephen J.; Goldufsky, Josef W.; Bello, Daniella; Masood, Sara; Shafikhani, Sasha H.			Pseudomonas aeruginosa ExoT Induces Mitochondrial Apoptosis in Target Host Cells in a Manner That Depends on Its GTPase-activating Protein (GAP) Domain Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; bacterial toxin; Bax; c-Jun N-terminal kinase (JNK); c-Jun transcription factor; Pseudomonas aeruginosa (P; aeruginosa); BCL-2; Bim; cytochrome c; ExoT; JNK; c-Jun; Bax; Bid	SECRETED TOXIN EXOT; EPITHELIAL-CELLS; PREVENTS APOPTOSIS; DEATH PATHWAYS; BAX ACTIVATION; CANCER-CELLS; KINASE; JNK; CYTOKINESIS; NECROSIS	Pseudomonas aeruginosa is the most common cause of hospital-acquired pneumonia and a killer of immunocompromised patients. We and others have demonstrated that the type III secretion system (T3SS) effector protein ExoT plays a pivotal role in facilitating P. aeruginosa pathogenesis. ExoT possesses an N-terminal GTPase-activating protein (GAP) domain and a C-terminal ADP-ribosyltransferase (ADPRT) domain. Because it targets multiple non-overlapping cellular targets, ExoT performs several distinct virulence functions for P. aeruginosa, including induction of apoptosis in a variety of target host cells. Both the ADPRT and the GAP domain activities contribute to ExoT-induced apoptosis. The ADPRT domain of ExoT induces atypical anoikis by transforming an innocuous cellular protein, Crk, into a cytotoxin, which interferes with integrin survival signaling. However, the mechanism underlying the GAP-induced apoptosis remains unknown. In this study, we demonstrate that the GAP domain activity is both necessary and sufficient to induce mitochondrial (intrinsic) apoptosis. We show that intoxication with GAP domain results in: (i) JNK1/2 activation; (ii) substantial increases in the mitochondrial levels of activated pro-apoptotic proteins Bax and Bid, and to a lesser extent Bim; (iii) loss of mitochondrial membrane potential and cytochrome c release; and (iv) activation of initiator caspase-9 and executioner caspase-3. Further, GAP-induced apoptosis is partially mediated by JNK1/2, but it is completely dependent on caspase-9 activity. Together, the ADPRT and the GAP domains make ExoT into a highly versatile and potent cytotoxin, capable of inducing multiple forms of apoptosis in target host cells.	[Wood, Stephen J.; Goldufsky, Josef W.; Bello, Daniella; Masood, Sara; Shafikhani, Sasha H.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Shafikhani, Sasha H.] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Shafikhani, Sasha H.] Rush Univ, Med Ctr, Ctr Canc, Chicago, IL 60612 USA	Rush University; Rush University; Rush University	Shafikhani, SH (corresponding author), Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA.	Sasha_Shafikhani@rush.edu	Regan, Clinton/E-6250-2012; Shafikhani, Sasha/AAM-3460-2021	Shafikhani, Sasha/0000-0003-1755-9997	National Institutes of Health [R21 AI110685-01]; Bears Care [56613]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI110685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bears Care; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R21 AI110685-01 (to S. H. S.) and Grant 56613 from The Bears Care (to S. H. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Balachandran P, 2007, J CLIN INVEST, V117, P419, DOI 10.1172/JCI28792; Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; Bijian K, 2005, AM J PHYSIOL-RENAL, V289, pF1313, DOI 10.1152/ajprenal.00106.2005; Chen D, 2004, P NATL ACAD SCI USA, V101, P1235, DOI 10.1073/pnas.0308050100; deBentzmann S, 1996, AM J RESP CRIT CARE, V154, pS155, DOI 10.1164/ajrccm/154.4_Pt_2.S155; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Engel JN, 2003, P C C I D, V7, P201; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Feltman H., 2001, ASM ABSTR, pD22; Garrity-Ryan L, 2004, INFECT IMMUN, V72, P546, DOI 10.1128/IAI.72.1.546-558.2004; Garrity-Ryan L, 2000, INFECT IMMUN, V68, P7100, DOI 10.1128/IAI.68.12.7100-7113.2000; Goldufsky J, 2015, J MED MICROBIOL, V64, P164, DOI 10.1099/jmm.0.000003-0; Goldufsky J, 2015, WOUND REPAIR REGEN, V23, P557, DOI 10.1111/wrr.12310; Gomez J, 1997, EUR J IMMUNOL, V27, P2793, DOI 10.1002/eji.1830271108; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Jia J, 2003, INFECT IMMUN, V71, P3361, DOI 10.1128/IAI.71.6.3361-3370.2003; Kaufman MR, 2000, MICROBIOL-UK, V146, P2531, DOI 10.1099/00221287-146-10-2531; Kazmierczak BI, 2002, INFECT IMMUN, V70, P2198, DOI 10.1128/IAI.70.4.2198-2205.2002; Koch C, 2002, PEDIATR PULM, V34, P232, DOI 10.1002/ppul.10135; Krall R, 2000, INFECT IMMUN, V68, P6066, DOI 10.1128/IAI.68.10.6066-6068.2000; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; MacDonald G, 1999, J EXP MED, V189, P131, DOI 10.1084/jem.189.1.131; Okuno S, 2004, J NEUROSCI, V24, P7879, DOI 10.1523/JNEUROSCI.1745-04.2004; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Ozoren N, 2000, CANCER RES, V60, P6259; Papadakis ES, 2006, FEBS LETT, V580, P1320, DOI 10.1016/j.febslet.2006.01.053; Philchenkov A, 2004, J CELL MOL MED, V8, P432, DOI 10.1111/j.1582-4934.2004.tb00468.x; Pradelli LA, 2010, CELL MOL LIFE SCI, V67, P1589, DOI 10.1007/s00018-010-0285-y; Shafikhani S, 1997, BIOTECHNIQUES, V23, P304, DOI 10.2144/97232rr01; Shafikhani S, 2002, ENVIRON MICROBIOL, V4, P482, DOI 10.1046/j.1462-2920.2002.00326.x; Shafikhani SH, 2008, CELL CYCLE, V7, P2868, DOI 10.4161/cc.7.18.6674; Shafikhani SH, 2008, CELL MICROBIOL, V10, P994, DOI 10.1111/j.1462-5822.2007.01102.x; Shafikhani SH, 2006, P NATL ACAD SCI USA, V103, P15605, DOI 10.1073/pnas.0605949103; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200; Thapa RJ, 2013, P NATL ACAD SCI USA, V110, pE3109, DOI 10.1073/pnas.1301218110; TSANG KWT, 1994, EUR RESPIR J, V7, P1746, DOI 10.1183/09031936.94.07101746; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Wang XW, 2009, FEBS LETT, V583, P1873, DOI 10.1016/j.febslet.2009.04.045; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wood S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004934; Wood S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054646; Wood S, 2011, CELL CYCLE, V10, P648, DOI 10.4161/cc.10.4.14813; YAMAGUCHI T, 1991, AM REV RESPIR DIS, V144, P1147, DOI 10.1164/ajrccm/144.5.1147; ZAHM JM, 1991, AM J RESP CELL MOL, V5, P242, DOI 10.1165/ajrcmb/5.3.242; Zeng CW, 2012, MOL PHARMACOL, V81, P578, DOI 10.1124/mol.111.076794; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7; Zhu S, 2008, ONCOGENE, V27, P1580, DOI 10.1038/sj.onc.1210790; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	53	30	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29063	29073		10.1074/jbc.M115.689950	http://dx.doi.org/10.1074/jbc.M115.689950			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26451042	Green Published, hybrid			2022-12-28	WOS:000365762300044
J	Kuster, A; Nola, S; Dingli, F; Vacca, B; Gauchy, C; Beaujouan, JC; Nunez, M; Moncion, T; Loew, D; Formstecher, E; Galli, T; Proux-Gillardeaux, V				Kuster, Aurelia; Nola, Sebastien; Dingli, Florent; Vacca, Barbara; Gauchy, Christian; Beaujouan, Jean-Claude; Nunez, Marcela; Moncion, Thomas; Loew, Damarys; Formstecher, Etienne; Galli, Thierry; Proux-Gillardeaux, Veronique			The Q-soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor (Q-SNARE) SNAP-47 Regulates Trafficking of Selected Vesicle-associated Membrane Proteins (VAMPs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; ENDOPLASMIC-RETICULUM; TI-VAMP; SUBCELLULAR-LOCALIZATION; RECYCLING ENDOSOMES; VESICULAR TRANSPORT; PLASMA-MEMBRANE; ALPHA-SYNUCLEIN; CELL-MIGRATION; SYNTAXIN 5	SNAREs constitute the core machinery of intracellular membrane fusion, but vesicular SNAREs localize to specific compartments via largely unknown mechanisms. Here, we identified an interaction between VAMP7 and SNAP-47 using a proteomics approach. We found that SNAP-47 mainly localized to cytoplasm, the endoplasmic reticulum (ER), and ERGIC and could also shuttle between the cytoplasm and the nucleus. SNAP-47 preferentially interacted with the trans-Golgi network VAMP4 and post-Golgi VAMP7 and -8. SNAP-47 also interacted with ER and Golgi syntaxin 5 and with syntaxin 1 in the absence of Munc18a, when syntaxin 1 is retained in the ER. A C-terminally truncated SNAP-47 was impaired in interaction with VAMPs and affected their subcellular distribution. SNAP-47 silencing further shifted the subcellular localization of VAMP4 from the Golgi apparatus to the ER. WT and mutant SNAP-47 overexpression impaired VAMP7 exocytic activity. We conclude that SNAP-47 plays a role in the proper localization and function of a subset of VAMPs likely via regulation of their transport through the early secretory pathway.	[Kuster, Aurelia; Nola, Sebastien; Vacca, Barbara; Gauchy, Christian; Beaujouan, Jean-Claude; Galli, Thierry; Proux-Gillardeaux, Veronique] Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS,UMR 7592,INSERM U950,Membrane Traff Hlth & D, F-75013 Paris, France; [Dingli, Florent; Loew, Damarys] Inst Curie, Prot Mass Spectrometry Lab, F-75005 Paris, France; [Nunez, Marcela; Moncion, Thomas; Formstecher, Etienne] Hybrigenics, F-75014 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Galli, T (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS,UMR 7592,INSERM U950,Membrane Traff Hlth & D, F-75013 Paris, France.	thierry.galli@inserm.fr; veronique.proux@ijm.fr	Galli, Thierry/Q-2249-2019; Galli, Thierry/G-8842-2011; Nola, Sebastien/D-6518-2017	Galli, Thierry/0000-0001-8514-7455; Galli, Thierry/0000-0001-8514-7455; Nola, Sebastien/0000-0002-6485-9856; Vacca, Barbara/0000-0001-9064-0228; FORMSTECHER, Etienne/0000-0002-6410-4365; Damarys, Loew/0000-0002-9111-8842	French National Research Agency [ANR-10-INSB-04]	French National Research Agency(French National Research Agency (ANR))	We are grateful to N. Sakamoto for help with experiments; T. Binz for SNAP-29 and H. Ben-Tekaya for GFP-ER-GIC53 plasmids; and C. Jackson, S. Robby, L. Pintard for discussions. We acknowledge the ImagoSeine Facility, member of the France Bio-Imaging infrastructure supported by the French National Research Agency Grant ANR-10-INSB-04, "Investments of the Future."	Advani RJ, 1999, J CELL BIOL, V146, P765, DOI 10.1083/jcb.146.4.765; Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397; Antonin W, 2000, MOL BIOL CELL, V11, P3289, DOI 10.1091/mbc.11.10.3289; Arendt KL, 2015, NEURON, V86, P442, DOI 10.1016/j.neuron.2015.03.009; Bartel P. L., 1993, CELLULAR INTERACTION, P153; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; Burgo A, 2012, DEV CELL, V23, P166, DOI 10.1016/j.devcel.2012.04.019; Burgo A, 2009, EMBO REP, V10, P1117, DOI 10.1038/embor.2009.186; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chaineau M, 2008, J BIOL CHEM, V283, P34365, DOI 10.1074/jbc.M804587200; Chia J, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.59; Coco S, 1999, J NEUROSCI, V19, P9803; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; DASCHER C, 1994, J BIOL CHEM, V269, P29363; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; Guo B, 2014, NAT CELL BIOL, V16, P1215, DOI 10.1038/ncb3066; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; Ishizaki R, 2008, MOL BIOL CELL, V19, P2650, DOI 10.1091/mbc.E07-10-1067; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jurado S, 2013, NEURON, V77, P542, DOI 10.1016/j.neuron.2012.11.029; Kakinuma T, 2004, EXP CELL RES, V298, P388, DOI 10.1016/j.yexcr.2004.04.047; Kent HM, 2012, DEV CELL, V22, P979, DOI 10.1016/j.devcel.2012.01.018; Kondo A, 2000, MOL BIOL CELL, V11, P1315, DOI 10.1091/mbc.11.4.1315; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Martinez-Arca S, 2003, J CELL SCI, V116, P2805, DOI 10.1242/jcs.00467; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Miyazaki K, 2012, J CELL SCI, V125, P5658, DOI 10.1242/jcs.105304; Morelli E, 2014, AUTOPHAGY, V10, P2251, DOI 10.4161/15548627.2014.981913; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Peden AA, 2001, J BIOL CHEM, V276, P49183, DOI 10.1074/jbc.M106646200; Poullet P, 2007, PROTEOMICS, V7, P2553, DOI 10.1002/pmic.200600784; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Proux-Gillardeaux V, 2007, BIOL CELL, V99, P261, DOI 10.1042/BC20060097; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Rossi V, 2004, BIOL CELL, V96, P251, DOI 10.1016/j.biolcel.2003.12.009; Shimojo M, 2015, CELL REP, V11, P1054, DOI 10.1016/j.celrep.2015.04.032; Siddiqi SA, 2006, J BIOL CHEM, V281, P20974, DOI 10.1074/jbc.M601401200; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Stauber T, 2006, CURR BIOL, V16, P2245, DOI 10.1016/j.cub.2006.09.060; Stynen B, 2012, MICROBIOL MOL BIOL R, V76, P331, DOI 10.1128/MMBR.05021-11; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Suga K, 2005, FEBS LETT, V579, P4226, DOI 10.1016/j.febslet.2005.06.053; Takats S, 2013, AUTOPHAGY, V9, P1251, DOI 10.4161/auto.25470; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Tran THT, 2007, J CELL SCI, V120, P1028, DOI 10.1242/jcs.03387; Toonen RFG, 2005, J NEUROCHEM, V93, P1393, DOI 10.1111/j.1471-4159.2005.03128.x; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Xu DL, 2000, J BIOL CHEM, V275, P39631, DOI 10.1074/jbc.M007684200	60	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28056	+		10.1074/jbc.M115.666362	http://dx.doi.org/10.1074/jbc.M115.666362			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26359495	hybrid, Green Published			2022-12-28	WOS:000365761900003
J	Emmott, E; Sweeney, TR; Goodfellow, I				Emmott, Edward; Sweeney, Trevor R.; Goodfellow, Ian			A Cell-based Fluorescence Resonance Energy Transfer (FRET) Sensor Reveals Inter-and Intragenogroup Variations in Norovirus Protease Activity and Polyprotein Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORWALK VIRUS PROTEASE; NONSTRUCTURAL POLYPROTEIN; MURINE NOROVIRUS; PROTEINASE-POLYMERASE; EXPRESSION; SITES; INTERGENOGROUP; RECOMBINATION; TRANSLATION; PRECURSORS	The viral protease represents a key drug target for the development of antiviral therapeutics. Because many protease inhibitors mimic protease substrates, differences in substrate recognition between proteases may affect their sensitivity to a given inhibitor. Here we use a cell-based FRET sensor to investigate the activity of different norovirus proteases upon cleavage of various norovirus cleavage sites inserted into a linker region separating cyan fluorescent protein and yellow fluorescent protein. Using this system, we demonstrate that differences in substrate processing exist between proteases from human noroviruses (genogroups I (GI) and II) and the commonly used murine norovirus (MNV, genogroup V) model. These altered the cleavage efficiency of specific cleavage sites both within and between genogroups. The differences observed between these proteases may affect sensitivity to protease inhibitors and the suitability of MNV as a model system for testing such molecules against the human norovirus protease. Finally, we demonstrate that replacement of MNV polyprotein cleavage sites with the GI or GII equivalents, with the exception of the NS6-7 junction, leads to the production of infectious virus when the MNV NS6 protease, but not the GI or GII proteases, are present.	[Emmott, Edward; Sweeney, Trevor R.; Goodfellow, Ian] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Emmott, E (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Virol, Lab Block Level 5,Box 237,Hills Rd, Cambridge CB2 2QQ, England.	ee273@cam.ac.uk; ig299@cam.ac.uk		Goodfellow, Ian/0000-0002-9483-510X; Sweeney, Trevor/0000-0003-4016-7326; Emmott, Edward/0000-0002-3239-8178	Wellcome Trust Senior Fellowship [WT097997MA]; Wellcome Trust Marie Curie Fellowship [628373]	Wellcome Trust Senior Fellowship(Wellcome Trust); Wellcome Trust Marie Curie Fellowship	This work was funded by Wellcome Trust Senior Fellowship WT097997MA (to I. G.) and Marie Curie Fellowship 628373 (to T. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Belliot G, 2005, J VIROL, V79, P2393, DOI 10.1128/JVI.79.4.2393-2403.2005; Belliot G, 2003, J VIROL, V77, P10957, DOI 10.1128/JVI.77.20.10957-10974.2003; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bull RA, 2005, EMERG INFECT DIS, V11, P1079; Bull RA, 2007, J GEN VIROL, V88, P3347, DOI 10.1099/vir.0.83321-0; Cameron CE, 2010, FUTURE MICROBIOL, V5, P867, DOI 10.2217/FMB.10.40; Chaudhry Y, 2007, J GEN VIROL, V88, P2091, DOI 10.1099/vir.0.82940-0; Felber LM, 2004, BIOTECHNIQUES, V36, P878, DOI 10.2144/04365PT04; Fernandes H, 2015, PEERJ, V3, DOI 10.7717/peerj.798; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Gamlen T, 2010, J GEN VIROL, V91, P133, DOI 10.1099/vir.0.016170-0; Herod MR, 2014, BIOCHEM J, V464, P461, DOI 10.1042/BJ20140959; Hussey RJ, 2011, BIOCHEMISTRY-US, V50, P240, DOI 10.1021/bi1008497; Hwang Seungmin, 2014, Curr Protoc Microbiol, V33, DOI 10.1002/9780471729259.mc15k02s33; Hwang YC, 2006, APPL ENVIRON MICROB, V72, P3710, DOI 10.1128/AEM.72.5.3710-3715.2006; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kankanamalage ACG, 2015, J MED CHEM, V58, P3144, DOI 10.1021/jm5019934; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Karst SM, 2015, J PATHOL, V235, P206, DOI 10.1002/path.4463; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Kuyumcu-Martinez M, 2004, J VIROL, V78, P8172, DOI 10.1128/JVI.78.15.8172-8182.2004; Leen EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038723; Mandadapu SR, 2013, BIOORG MED CHEM LETT, V23, P62, DOI 10.1016/j.bmcl.2012.11.026; May J, 2014, J VIROL, V88, P10738, DOI 10.1128/JVI.01357-14; May J, 2013, VIROLOGY, V444, P218, DOI 10.1016/j.virol.2013.06.013; Muhaxhiri Z, 2013, J VIROL, V87, P4281, DOI 10.1128/JVI.02869-12; Nakamura K, 2005, J VIROL, V79, P13685, DOI 10.1128/JVI.79.21.13685-13693.2005; Nayak MK, 2008, VIROLOGY, V377, P117, DOI 10.1016/j.virol.2008.04.027; Oka T, 2005, ARCH VIROL, V150, P2539, DOI 10.1007/s00705-005-0591-0; Oka T, 2006, J GEN VIROL, V87, P3329, DOI 10.1099/vir.0.81799-0; Pathak Harsh B, 2008, J Biol Chem, V283, P30677, DOI 10.1074/jbc.M806101200; Qu L, 2014, J VIROL, V88, P10312, DOI 10.1128/JVI.01111-14; Rocha-Pereira J, 2014, ANTIMICROB AGENTS CH, V58, P4675, DOI 10.1128/AAC.02546-13; Ruether IGA, 2014, MOL CELL PROBE, V28, P204, DOI 10.1016/j.mcp.2014.04.001; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Scheffler U, 2007, J GEN VIROL, V88, P2013, DOI 10.1099/vir.0.82797-0; Sosnovtsev SV, 2006, J VIROL, V80, P7816, DOI 10.1128/JVI.00532-06; Sosnovtsev SV, 2002, J VIROL, V76, P7060, DOI 10.1128/JVI.76.14.7060-7072.2002; Subba-Reddy CV, 2012, J VIROL, V86, P10138, DOI 10.1128/JVI.01208-12; Takahashi D, 2013, VIRUS RES, V178, P437, DOI 10.1016/j.virusres.2013.09.008; Taube S, 2013, MBIO, V4, DOI 10.1128/mBio.00450-13; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Thorne LG, 2014, J GEN VIROL, V95, P278, DOI 10.1099/vir.0.059634-0; Ward VK, 2007, P NATL ACAD SCI USA, V104, P11050, DOI 10.1073/pnas.0700336104; Waters A, 2007, VIROLOGY, V363, P11, DOI 10.1016/j.virol.2007.03.012; Wei L, 2001, J VIROL, V75, P1211, DOI 10.1128/JVI.75.3.1211-1219.2001; Zeitler CE, 2006, J VIROL, V80, P5050, DOI 10.1128/JVI.80.10.5050-5058.2006; Zhang HD, 2015, J VIROL, V89, P7722, DOI 10.1128/JVI.01137-15	48	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27841	27853		10.1074/jbc.M115.688234	http://dx.doi.org/10.1074/jbc.M115.688234			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26363064	Green Published, hybrid			2022-12-28	WOS:000365757500034
J	Lagousi, T; Routsias, J; Piperi, C; Tsakris, A; Chrousos, G; Theodoridou, M; Spoulou, V				Lagousi, Theano; Routsias, John; Piperi, Christina; Tsakris, Athanassios; Chrousos, George; Theodoridou, Maria; Spoulou, Vana			Discovery of Immunodominant B Cell Epitopes within Surface Pneumococcal Virulence Proteins in Pediatric Patients with Invasive Pneumococcal Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; CHILDREN YOUNGER; EPITHELIAL-CELLS; TRIAD PROTEINS; OTITIS-MEDIA; PHT PROTEINS; ANTIBODIES; ANTIGENS; CARRIAGE	The identification of immunodominant B cell epitopes within surface pneumococcal virulence proteins in pediatric patients with invasive pneumococcal disease (IPD) is a valuable approach to define novel vaccine candidates. To this aim, we evaluated sera from children with IPD and age-matched controls against 141 20-mer synthetic peptides covering the entire sequence of major antigenic fragments within pneumococcal virulence proteins; namely, choline-binding protein D (CbpD), pneumococcal histidine triad proteins (PhtD and PhtE), pneumococcal surface protein A (PspA), plasminogen and fibronectin binding protein B (PfbB), and zinc metalloproteinase B (ZmpB). Ten immunodominant B cell epitopes were identified: CbpD-pep4 (amino acids (aa) 291-310), PhtD-pep11 (aa 88-107), PhtD-pep17 (aa 172-191), PhtD-pep19 (aa 200-219), PhtE-pep32 (aa 300-319), PhtE-pep40 (aa 79-98), PfbB-pep76 (aa 180-199), PfbB-pep79 (aa 222-241), PfbB-pep90 (aa 484-503), and ZmpB-pep125 (aa 431-450). All epitopes were highly conserved among different pneumococcal serotypes, and four of them were located within the functional zinc-binding domain of the histidine triad proteins PhtD and PhtE. Peptides CbpD-pep4, PhtD-pep19, and PhtE-pep40 were broadly recognized by IPD patient sera with prevalences of 96.4%, 92.9%, and 71.4%, respectively, whereas control sera exhibited only minor reactivities (< 10.7%). Their specificities for IPD were 93.3%, 95%, and 96.7%; their sensitivities were 96.4%, 92.9%, and 71.4% and their positivity likelihood ratios for IPD were 14.5, 18.6, and 21.4, respectively. Furthermore, purified antibodies against CbpD-pep4, PhtD-pep19, and PhtE-pep40 readily bound on the surfaces of different pneumococcal serotypes, as assessed by FACS and immunofluorescence analysis. The identified immunodominant B cell epitopes provide a better understanding of immune response in IPD and are worth evaluation in additional studies as potential vaccine candidates.	[Lagousi, Theano; Chrousos, George; Theodoridou, Maria; Spoulou, Vana] Aghia Sophia Childrens Hosp, Immunobiol Res Lab, Dept Pediat 1, Athens 11527, Greece; [Lagousi, Theano; Chrousos, George; Theodoridou, Maria; Spoulou, Vana] Sch Med, Infect Dis Dept MAKKA, Athens 11527, Greece; [Lagousi, Theano; Routsias, John; Tsakris, Athanassios] Sch Med, Dept Microbiol, Athens 11527, Greece; [Piperi, Christina] Sch Med, Dept Biol Chem, Athens 11527, Greece	The Aghia Sophia Children's Hospital; Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens	Lagousi, T (corresponding author), Aghia Sophia Childrens Hosp, Immunobiol Res Lab, Dept Pediat 1, Thivon & Papadiamantopoulou Str, Athens 11527, Greece.	theanolagousi@hotmail.com	Piperi, Christina/AAF-2009-2020	Piperi, Christina/0000-0002-2701-0618; Routsias, John/0000-0002-5819-021X	Special Account for Research Funds (ELKE) [70/3/9687, 70/3/9473]	Special Account for Research Funds (ELKE)	This work was supported by Special Account for Research Funds (ELKE) Grants 70/3/9687 and 70/3/9473. The authors declare that they have no conflicts of interest with the contents of this article.	Adamou JE, 2001, INFECT IMMUN, V69, P949, DOI 10.1128/IAI.69.2.949-958.2001; Adrian PV, 2004, VACCINE, V22, P2737, DOI 10.1016/j.vaccine.2004.01.042; Beghetto E, 2006, FEMS MICROBIOL LETT, V262, P14, DOI 10.1111/j.1574-6968.2006.00360.x; Browall S, 2014, J INFECT DIS, V209, P377, DOI 10.1093/infdis/jit481; Cao J, 2007, VACCINE, V25, P4996, DOI 10.1016/j.vaccine.2007.04.069; Chibuk TK, 2010, EUR J PEDIATR, V169, P1123, DOI 10.1007/s00431-010-1195-6; Ciapponi A, 2014, PEDIATR INFECT DIS J, V33, P971, DOI 10.1097/INF.0000000000000363; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Daniels CC, 2010, INFECT IMMUN, V78, P2163, DOI 10.1128/IAI.01199-09; Fried AJ, 2013, J CLIN IMMUNOL, V33, P847, DOI 10.1007/s10875-013-9870-9; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Godfroid F, 2011, INFECT IMMUN, V79, P238, DOI 10.1128/IAI.00378-10; Gong Y, 2011, INFECT IMMUN, V79, P867, DOI 10.1128/IAI.00717-10; Gor DO, 2005, INFECT IMMUN, V73, P1304, DOI 10.1128/IAI.73.3.1304-1312.2005; Hamel J, 2004, INFECT IMMUN, V72, P2659, DOI 10.1128/IAI.72.5.2659-2670.2004; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; IVANOV VS, 1992, J IMMUNOL METHODS, V153, P229, DOI 10.1016/0022-1759(92)90326-O; Kallio A, 2014, INFECT IMMUN, V82, P1683, DOI 10.1128/IAI.00699-13; Kausmally L, 2005, J BACTERIOL, V187, P4338, DOI 10.1128/JB.187.13.4338-4345.2005; Khan MN, 2012, VACCINE, V30, P2900, DOI 10.1016/j.vaccine.2012.02.023; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Meinke A, 2005, VACCINE, V23, P2035, DOI 10.1016/j.vaccine.2005.01.005; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Papastamatiou T., 2015, 33 ANN M EUR SOC PAE, P80; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Plumptre CD, 2012, TRENDS MICROBIOL, V20, P485, DOI 10.1016/j.tim.2012.06.004; Posfay-Barbe KM, 2011, CLIN MICROBIOL INFEC, V17, P1232, DOI 10.1111/j.1469-0691.2010.03389.x; Riboldi-Tunnicliffe A, 2005, FEBS LETT, V579, P5353, DOI 10.1016/j.febslet.2005.08.066; Rioux S, 2011, MICROBIOL-SGM, V157, P336, DOI 10.1099/mic.0.042184-0; Routsias JG, 2004, J MED CHEM, V47, P4327, DOI 10.1021/jm049844+; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; Simell B, 2009, VACCINE, V27, P4615, DOI 10.1016/j.vaccine.2009.05.071; Tai SS, 2006, CRIT REV MICROBIOL, V32, P139, DOI 10.1080/10408410600822942; Verhoeven D, 2014, VACCINE, V32, P3205, DOI 10.1016/j.vaccine.2014.04.004; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; Zhou JH, 2004, INFECT IMMUN, V72, P3505, DOI 10.1128/IAI.72.6.3505-3514.2004	40	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27500	27510		10.1074/jbc.M115.666818	http://dx.doi.org/10.1074/jbc.M115.666818			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26396191	hybrid, Green Published			2022-12-28	WOS:000365757500006
J	Lacroix, M; Rousseau, F; Guilhot, F; Malinge, P; Magistrelli, G; Herren, S; Jones, SA; Jones, GW; Scheller, J; Lissilaa, R; Kosco-Vilbois, M; Johnson, Z; Buatois, V; Ferlin, W				Lacroix, Marine; Rousseau, Francois; Guilhot, Florence; Malinge, Pauline; Magistrelli, Giovanni; Herren, Suzanne; Jones, Simon A.; Jones, Gareth W.; Scheller, Juergen; Lissilaa, Rami; Kosco-Vilbois, Marie; Johnson, Zoe; Buatois, Vanessa; Ferlin, Walter			Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRO-INFLAMMATORY ACTIVITIES; LIGAND-INDUCED ENDOCYTOSIS; DOWN-REGULATION; RECEPTOR; GP130; CYTOKINE; ACTIVATION; BLOCKADE; TRANSDUCTION; STIMULATION	Background: The IL-6 signaling complex consists of a hexameric structure essential for IL-6 cis- and trans-signaling. Results: mAb 25F10 targets site IIb of IL-6R and disrupts hexamer assembly to selectively block trans-signaling. Conclusion: Cis- and trans-signaling in mice utilize distinct mechanisms to mediate assembly of the IL-6R complex. Significance: Therapeutic targeting of site IIb of IL-6R provides a unique mode of action for IL-6 inhibition. The IL-6 signaling complex is described as a hexamer, formed by the association of two IL-6.IL-6 receptor (IL-6R).gp130 trimers, with gp130 being the signal transducer inducing cis- and trans-mediated signaling via a membrane-bound or soluble form of the IL-6R, respectively. 25F10 is an anti-mouse IL-6R mAb that binds to both membrane-bound IL-6R and soluble IL-6R with the unique property of specifically inhibiting trans-mediated signaling events. In this study, epitope mapping revealed that 25F10 interacts at site IIb of IL-6R but allows the binding of IL-6 to the IL-6R and the recruitment of gp130, forming a trimer complex. Binding of 25F10 to IL-6R prevented the formation of the hexameric complex obligate for trans-mediated signaling, suggesting that the cis- and trans-modes of IL-6 signaling adopt different mechanisms for receptor complex assembly. To study this phenomenon also in the human system, we developed NI-1201, a mAb that targets, in the human IL-6R sequence, the epitope recognized by 25F10 for mice. Interestingly, NI-1201, however, did not selectively inhibit human IL-6 trans-signaling, although both mAbs produced beneficial outcomes in conditions of exacerbated IL-6 as compared with a site I-directed mAb. These findings shed light on the complexity of IL-6 signaling. First, triggering cis-versus trans-mediated IL-6 signaling occurs via distinctive mechanisms for receptor complex assembly in mice. Second, the formation of the receptor complex leading to cis- and trans-signaling biology in mice and humans is different, and this should be taken into account when developing strategies to inhibit IL-6 clinically.	[Lacroix, Marine; Rousseau, Francois; Guilhot, Florence; Malinge, Pauline; Magistrelli, Giovanni; Herren, Suzanne; Kosco-Vilbois, Marie; Johnson, Zoe; Buatois, Vanessa; Ferlin, Walter] Novimmune SA, CH-1228 Plan Les Ouates, Switzerland; [Jones, Simon A.; Jones, Gareth W.] Cardiff Univ, Cardiff Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Scheller, Juergen] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany; [Lissilaa, Rami] Glenmark Pharmaceut SA, CH-2300 La Chaux De Fonds, Switzerland	NovImmune SA; Cardiff University; Heinrich Heine University Dusseldorf	Ferlin, W (corresponding author), Novimmune SA, 14 Chemin Aulx, CH-1228 Plan Les Ouates, Switzerland.	wferlin@novimmune.com	Scheller, Jürgen/K-5290-2015; Jones, Simon Arnett/Q-7017-2018	Johnson, Zoe/0000-0002-4120-2579; Jones, Simon Arnett/0000-0001-7297-9711; Jones, Gareth/0000-0002-0125-4841; Guilhot, Francois/0000-0001-7222-487X	Arthritis Research UK [20770, 20305] Funding Source: Medline; Versus Arthritis [20305, 20770] Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)		Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Buell G, 1998, BLOOD, V92, P3521, DOI 10.1182/blood.V92.10.3521.422k50_3521_3528; Coles B, 2007, AM J PATHOL, V171, P315, DOI 10.2353/ajpath.2007.061078; DITTRICH E, 1994, J BIOL CHEM, V269, P19014; Dittrich E, 1996, J BIOL CHEM, V271, P5487, DOI 10.1074/jbc.271.10.5487; Ferlin W., 2011, United States Patent, Patent No. [8,034,344, 8034344]; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Garbers C, 2015, CURR OPIN IMMUNOL, V34, P75, DOI 10.1016/j.coi.2015.02.008; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; Graeve L, 1996, FEBS LETT, V399, P131, DOI 10.1016/S0014-5793(96)01305-1; Grotzinger J, 1997, PROTEINS, V27, P96; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hoge J, 2013, J IMMUNOL, V190, P703, DOI 10.4049/jimmunol.1201044; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Lissilaa R, 2010, J IMMUNOL, V185, P5512, DOI 10.4049/jimmunol.1002015; Mihara M, 2005, INT IMMUNOPHARMACOL, V5, P1731, DOI 10.1016/j.intimp.2005.05.010; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Peters M, 1998, BLOOD, V92, P3495, DOI 10.1182/blood.V92.10.3495.422k47_3495_3504; Pflanz S, 2000, J IMMUNOL, V165, P7042, DOI 10.4049/jimmunol.165.12.7042; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Scheller J, 2014, SEMIN IMMUNOL, V26, P2, DOI 10.1016/j.smim.2013.11.002; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Shaw S, 2014, MABS-AUSTIN, V6, P773, DOI 10.4161/mabs.28612; Stuhlmann-Laeisz C, 2006, MOL BIOL CELL, V17, P2986, DOI 10.1091/mbc.E05-12-1129; Tabrizi MA, 2006, DRUG DISCOV TODAY, V11, P81, DOI 10.1016/S1359-6446(05)03638-X; Veverka V, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405597; YAWATA H, 1993, EMBO J, V12, P1705, DOI 10.1002/j.1460-2075.1993.tb05815.x; ZOHLNHOFER D, 1992, FEBS LETT, V306, P219, DOI 10.1016/0014-5793(92)81004-6	31	43	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26943	26953		10.1074/jbc.M115.682138	http://dx.doi.org/10.1074/jbc.M115.682138			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26363066	hybrid, Green Published			2022-12-28	WOS:000364794000006
J	Stransky, LA; Forgac, M				Stransky, Laura A.; Forgac, Michael			Amino Acid Availability Modulates Vacuolar H+-ATPase Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							V-ATPASE; IN-VIVO; ACIDIFICATION; MECHANISM; ACTIVATION; DISSOCIATION; RAGULATOR; PATHWAY; GLUCOSE; MTORC1	Background: Reversible assembly is a major mode of V-ATPase regulation. Results: Amino acid starvation reversibly increases V-ATPase assembly. Conclusion: Amino acids are a novel regulator of V-ATPase assembly. Significance: Learning how amino acids are sensed and influence cellular physiology is important to understanding the basic processes of cellular homeostasis. The vacuolar H+-ATPase (V-ATPase) is an ATP-dependent proton pump composed of a peripheral ATPase domain (V-1) and a membrane-integral proton-translocating domain (V-0) and is involved in many normal and disease processes. An important mechanism of regulating V-ATPase activity is reversible assembly of the V-1 and V-0 domains. Increased assembly in mammalian cells occurs under various conditions and has been shown to involve PI3K. The V-ATPase is necessary for amino acid-induced activation of mechanistic target of rapamycin complex 1 (mTORC1), which is important in controlling cell growth in response to nutrient availability and growth signals. The V-ATPase undergoes amino acid-dependent interactions with the Ragulator complex, which is involved in recruitment of mTORC1 to the lysosomal membrane during amino acid sensing. We hypothesized that changes in the V-ATPase/Ragulator interaction might involve amino acid-dependent changes in V-ATPase assembly. To test this, we measured V-ATPase assembly by cell fractionation in HEK293T cells treated with and without amino acids. V-ATPase assembly increases upon amino acid starvation, and this effect is reversed upon readdition of amino acids. Lysosomes from amino acid-starved cells possess greater V-ATPase-dependent proton transport, indicating that assembled pumps are catalytically active. Amino acid-dependent changes in both V-ATPase assembly and activity are independent of PI3K and mTORC1 activity, indicating the involvement of signaling pathways distinct from those implicated previously in controlling assembly. By contrast, lysosomal neutralization blocks the amino acid-dependent change in assembly and reactivation of mTORC1 after amino acid starvation. These results identify an important new stimulus for controlling V-ATPase assembly.	[Forgac, Michael] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cellular & Mol Physiol, Boston, MA 02111 USA	Tufts University; Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu	Regan, Clinton/E-6250-2012	Stransky, Laura/0000-0001-8834-936X	National Institutes of Health [GM34478, CA189321]; Sackler Families Collaborative Cancer Biology Award from Tufts University; NATIONAL CANCER INSTITUTE [F31CA189321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sackler Families Collaborative Cancer Biology Award from Tufts University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM34478 (to M. F.) and CA189321 (to L. S.) and a Sackler Families Collaborative Cancer Biology Award from Tufts University (to L. S. and M. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; BLOMMAART PJE, 1993, J BIOL CHEM, V268, P1610; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; GALLOWAY CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3334, DOI 10.1073/pnas.80.11.3334; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kohio HP, 2013, VIROLOGY, V444, P301, DOI 10.1016/j.virol.2013.06.026; Liberman R, 2014, J BIOL CHEM, V289, P1355, DOI 10.1074/jbc.M113.524561; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marjuki H, 2011, CELL MICROBIOL, V13, P587, DOI 10.1111/j.1462-5822.2010.01556.x; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; PUOPOLO K, 1990, J BIOL CHEM, V265, P14836; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; ZHANG JM, 1992, J BIOL CHEM, V267, P9773; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	24	84	89	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27360	27369		10.1074/jbc.M115.659128	http://dx.doi.org/10.1074/jbc.M115.659128			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26378229	Green Published, hybrid			2022-12-28	WOS:000364794000042
J	Hoffman, EA; Frey, BL; Smith, LM; Auble, DT				Hoffman, Elizabeth A.; Frey, Brian L.; Smith, Lloyd M.; Auble, David T.			Formaldehyde Crosslinking: A Tool for the Study of Chromatin Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ENDOCYCLIC IMINO GROUPS; RNA-POLYMERASE-II; IN-VIVO; DNA-STRUCTURE; QUANTITATIVE-ANALYSIS; PROTEIN INTERACTIONS; HISTONE ACETYLATION; MASS-SPECTROMETRY; NUCLEIC-ACID; AMINO-ACIDS	Formaldehyde has been used for decades to probe macromolecular structure and function and to trap complexes, cells, and tissues for further analysis. Formaldehyde crosslinking is routinely employed for detection and quantification of protein-DNA interactions, interactions between chromatin proteins, and interactions between distal segments of the chromatin fiber. Despite widespread use and a rich biochemical literature, important aspects of formaldehyde behavior in cells have not been well described. Here, we highlight features of formaldehyde chemistry relevant to its use in analyses of chromatin complexes, focusing on how its properties may influence studies of chromatin structure and function.	[Hoffman, Elizabeth A.; Auble, David T.] Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Frey, Brian L.; Smith, Lloyd M.] Univ Wisconsin, Dept Chem & Genome Ctr Wisconsin, Madison, WI 53706 USA	University of Virginia; University of Wisconsin System; University of Wisconsin Madison	Auble, DT (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	auble@virginia.edu	Frey, Brian L/M-5035-2015	Frey, Brian L/0000-0002-0397-7269	National Institutes of Health [R01 GM55763, P50 HG004952]; NCI Cancer Training Grant [T32 CA009109-38]; NATIONAL CANCER INSTITUTE [T32CA009109] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM55763 (to D. T. A.) and P50 HG004952 (to L. M. S. and B. L. F.) and by NCI Cancer Training Grant T32 CA009109-38 (to E. A. H.). This is the second article in the Thematic Minireview series "Protein Interactions, Structures, and Networks." The authors declare that they have no conflicts of interest with the contents of this article.	Antao JM, 2012, MOL CELL BIOL, V32, P2170, DOI 10.1128/MCB.00010-12; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; BRUTLAG D, 1969, BIOCHEMISTRY-US, V8, P3214, DOI 10.1021/bi00836a013; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Byrum SD, 2015, METHODS MOL BIOL, V1228, P83, DOI 10.1007/978-1-4939-1680-1_8; Byrum SD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt822; Byrum SD, 2012, CELL REP, V2, P198, DOI 10.1016/j.celrep.2012.06.019; CHANG YT, 1994, J AM CHEM SOC, V116, P3548, DOI 10.1021/ja00087a048; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Collas P, 2010, MOL BIOTECHNOL, V45, P87, DOI 10.1007/s12033-009-9239-8; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; DEDON PC, 1991, MOL CELL BIOL, V11, P1729, DOI 10.1128/MCB.11.3.1729; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Eckels Kenneth H, 2003, Adv Virus Res, V61, P395, DOI 10.1016/S0065-3527(03)61010-9; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Fan XC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005029; Fan XC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn535; Feldman M Y, 1973, Prog Nucleic Acid Res Mol Biol, V13, P1, DOI 10.1016/S0079-6603(08)60099-9; FRAENKELCONRAT H, 1948, J AM CHEM SOC, V70, P2673, DOI 10.1021/ja01188a018; FRAENKELCONRAT H, 1948, J BIOL CHEM, V174, P827; FRAENKELCONRAT H, 1945, J AM CHEM SOC, V67, P950, DOI 10.1021/ja01222a023; FRAENKELCONTRAT H, 1954, BIOCHIM BIOPHYS ACTA, V15, P307, DOI 10.1016/0006-3002(54)90083-9; FRENCH D, 1945, ADV PROTEIN CHEM, V2, P277, DOI 10.1016/S0065-3233(08)60627-0; Gavrilov A, 2015, BRIEF FUNCT GENOMICS, V14, P163, DOI 10.1093/bfgp/elu037; Gavrilov A, 2009, ANAL BIOCHEM, V390, P94, DOI 10.1016/j.ab.2009.04.018; GILMOUR DS, 1985, MOL CELL BIOL, V5, P2009, DOI 10.1128/MCB.5.8.2009; Guerrero C, 2006, MOL CELL PROTEOMICS, V5, P366, DOI 10.1074/mcp.M500303-MCP200; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; HAHNENSTEIN I, 1995, IND ENG CHEM RES, V34, P440, DOI 10.1021/ie00041a003; Hall DB, 2002, J BIOL CHEM, V277, P46043, DOI 10.1074/jbc.M208911200; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HASELKORN R, 1961, J BIOL CHEM, V236, P2738; Jencks WP, 1997, ANNU REV BIOCHEM, V66, P1, DOI 10.1146/annurev.biochem.66.1.1; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kasinathan S, 2014, NAT METHODS, V11, P203, DOI [10.1038/NMETH.2766, 10.1038/nmeth.2766]; Katan-Khaykovich Y, 2002, GENE DEV, V16, P743, DOI 10.1101/gad.967302; Kawashima Y, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-4; Kennedy-Darling J, 2014, J PROTEOME RES, V13, P3810, DOI 10.1021/pr5004938; Kennedy-Darling J, 2014, ANAL CHEM, V86, P5678, DOI 10.1021/ac501354y; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Klockenbusch C, 2012, ANAL BIOANAL CHEM, V404, P1057, DOI 10.1007/s00216-012-6065-9; Klockenbusch C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/927585; Komashko VM, 2008, GENOME RES, V18, P521, DOI 10.1101/gr.074609.107; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Leonid TB, 2013, P NATL ACAD SCI USA, V110, P18602, DOI 10.1073/pnas.1316064110; Lu K, 2010, J AM CHEM SOC, V132, P3388, DOI 10.1021/ja908282f; Mazza D, 2013, NAT METHODS, V10, P691, DOI 10.1038/nmeth.2573; MCGHEE JD, 1975, BIOCHEMISTRY-US, V14, P1281, DOI 10.1021/bi00677a029; MCGHEE JD, 1975, BIOCHEMISTRY-US, V14, P1297, DOI 10.1021/bi00677a030; MCGHEE JD, 1977, BIOCHEMISTRY-US, V16, P3276, DOI 10.1021/bi00634a002; MCGHEE JD, 1977, BIOCHEMISTRY-US, V16, P3267, DOI 10.1021/bi00634a001; MEANS GE, 1995, ANAL BIOCHEM, V224, P1, DOI 10.1006/abio.1995.1001; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Miele Adriana, 2008, V464, P105; Mirny L, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434013; NACHEVA GA, 1989, CELL, V58, P27, DOI 10.1016/0092-8674(89)90399-1; NENCIONI L, 1991, INFECT IMMUN, V59, P625, DOI 10.1128/IAI.59.2.625-630.1991; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; ONeill LP, 1996, METHOD ENZYMOL, V274, P189; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Poorey K, 2013, SCIENCE, V342, P369, DOI 10.1126/science.1242369; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rhee Ho Sung, 2012, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2124s100; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Shi SR, 2013, PROTEOM CLIN APPL, V7, P264, DOI 10.1002/prca.201200031; SHIKAMA K, 1976, EUR J BIOCHEM, V63, P39, DOI 10.1111/j.1432-1033.1976.tb10204.x; SIOMIN YA, 1973, BIOCHIM BIOPHYS ACTA, V331, P27, DOI 10.1016/0005-2787(73)90415-2; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Stasevich TJ, 2014, NATURE, V516, P272, DOI 10.1038/nature13714; Struhl K., 2007, EVALUATING TECHNIQUE, P29; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Toews J, 2008, ANAL CHIM ACTA, V618, P168, DOI 10.1016/j.aca.2008.04.049; Toews J, 2010, ANAL CHIM ACTA, V676, P60, DOI 10.1016/j.aca.2010.07.040; Toth J, 2000, Nucleic Acids Res, V28, pe4, DOI 10.1093/nar/28.2.e4; UTIYAMA H, 1971, BIOCHEMISTRY-US, V10, P1254; Vani K, 2006, J IMMUNOL METHODS, V317, P80, DOI 10.1016/j.jim.2006.09.009; Vasilescu J, 2004, PROTEOMICS, V4, P3845, DOI 10.1002/pmic.200400856; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Viswanathan R, 2014, METHODS, V70, P97, DOI 10.1016/j.ymeth.2014.10.029; Voit EO, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004012; Von Hippel P H, 1971, J Mol Biol, V61, P587, DOI 10.1016/0022-2836(71)90066-0; Voss TC, 2008, BBA-MOL CELL RES, V1783, P2044, DOI 10.1016/j.bbamcr.2008.06.022; Werner M, 2000, AM J SURG PATHOL, V24, P1016, DOI 10.1097/00000478-200007000-00014; Wisniewski JR, 2013, PROTEOM CLIN APPL, V7, P225, DOI 10.1002/prca.201200046; Wu CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026217; Yin YD, 2014, P NATL ACAD SCI USA, V111, P8043, DOI 10.1073/pnas.1400667111; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297	96	182	183	7	65	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26404	26411		10.1074/jbc.R115.651679	http://dx.doi.org/10.1074/jbc.R115.651679			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354429	Green Published, hybrid			2022-12-28	WOS:000364793600007
J	Heier, C; Radner, FPW; Moustafa, T; Schreiber, R; Grond, S; Eichmann, TO; Schweiger, M; Schmidt, A; Cerk, IK; Oberer, M; Theussl, HC; Wojciechowski, J; Penninger, JM; Zimmermann, R; Zechner, R				Heier, Christoph; Radner, Franz P. W.; Moustafa, Tarek; Schreiber, Renate; Grond, Susanne; Eichmann, Thomas O.; Schweiger, Martina; Schmidt, Albrecht; Cerk, Ines K.; Oberer, Monika; Theussl, H. -Christian; Wojciechowski, Jacek; Penninger, Josef M.; Zimmermann, Robert; Zechner, Rudolf			G(0)/G(1) Switch Gene 2 Regulates Cardiac Lipolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID STORAGE DISEASE; ADIPOSE LIPOLYSIS; ENERGY-METABOLISM; TRIGLYCERIDE; MICE; HEART; OVEREXPRESSION; PROLIFERATION; CATABOLISM; STEATOSIS	The anabolism and catabolism of myocardial triacylglycerol (TAG) stores are important processes for normal cardiac function. TAG synthesis detoxifies and stockpiles fatty acids to prevent lipotoxicity, whereas TAG hydrolysis (lipolysis) remobilizes fatty acids from endogenous storage pools as energy substrates, signaling molecules, or precursors for complex lipids. This study focused on the role of G(0)/G(1) switch 2 (G0S2) protein, which was previously shown to inhibit the principal TAG hydrolase adipose triglyceride lipase (ATGL), in the regulation of cardiac lipolysis. Using wild-type and mutant mice, we show the following: (i) G0S2 is expressed in the heart and regulated by the nutritional status with highest expression levels after re-feeding. (ii) Cardiac-specific overexpression of G0S2 inhibits cardiac lipolysis by direct protein-protein interaction with ATGL. This leads to severe cardiac steatosis. The steatotic hearts caused by G0S2 overexpression are less prone to fibrotic remodeling or cardiac dysfunction than hearts with a lipolytic defect due to ATGL deficiency. (iii) Conversely to the phenotype of transgenic mice, G0S2 deficiency results in a de-repression of cardiac lipolysis and decreased cardiac TAG content. We conclude that G0S2 acts as a potent ATGL inhibitor in the heart modulating cardiac substrate utilization by regulating cardiac lipolysis.	[Eichmann, Thomas O.; Schweiger, Martina; Cerk, Ines K.; Oberer, Monika] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Moustafa, Tarek] Med Univ Graz, Lab Expt & Mol Hepatol, Div Gastroenterol & Hepatol, Dept Internal Med, A-8036 Graz, Austria; [Schmidt, Albrecht] Med Univ Graz, Div Cardiol, Dept Internal Med, A-8036 Graz, Austria; [Theussl, H. -Christian; Wojciechowski, Jacek; Penninger, Josef M.] Res Inst Mol Pathol IMP, Transgen Serv, A-1030 Vienna, Austria; [Theussl, H. -Christian; Wojciechowski, Jacek; Penninger, Josef M.] Austrian Acad Sci, IMBA Inst Mol Biotechnol, A-1030 Vienna, Austria	University of Graz; Medical University of Graz; Medical University of Graz; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31-2, A-8010 Graz, Austria.	rudolf.zechner@uni-graz.at	Moustafa, Tarek/P-9509-2016; Penninger, Josef M/I-6860-2013	Moustafa, Tarek/0000-0002-6755-4687; Penninger, Josef M/0000-0002-8194-3777; Schweiger, Martina/0000-0002-3419-1007; Schreiber, Renate/0000-0002-3475-157X; Zechner, Rudolf/0000-0001-5483-1182; Zimmermann, Robert/0000-0002-7354-870X; Heier, Christoph/0000-0001-6858-408X; Grond, Susanne/0000-0002-7121-9013; Eichmann, Thomas O./0000-0002-8521-2795; Radner, Franz/0000-0003-3466-0181; Oberer, Monika/0000-0003-2525-9513; Schmidt, Albrecht/0000-0003-4783-4603	SFB LIPOTOX [F3002]; Wittgenstein Award [Z136]; DK Molecular Enzymology - Austrian Science Fund (FWF) [W901]; Fondation Leducq [12CVD04]; European Research Council (ERC) [340896]; European Research Council under the European Union;  [P22170]; Austrian Science Fund (FWF) [F 3002, W 901] Funding Source: researchfish	SFB LIPOTOX(German Research Foundation (DFG)); Wittgenstein Award(Austrian Science Fund (FWF)); DK Molecular Enzymology - Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Fondation Leducq(Leducq Foundation); European Research Council (ERC)(European Research Council (ERC)); European Research Council under the European Union(European Research Council (ERC)); ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the SFB LIPOTOX F3002, Wittgenstein Award Z136, Grant P22170, and DK Molecular Enzymology W901, which are funded by the Austrian Science Fund (FWF), Grant 12CVD04 from the Fondation Leducq and European Research Council (ERC) Grant Agreement 340896 (LipoCheX) - European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013). The authors declare that they have no conflicts of interest with the contents of this article.	Banke NH, 2010, CIRC RES, V107, P233, DOI 10.1161/CIRCRESAHA.110.221713; Borradaile NA, 2005, CURR HYPERTENS REP, V7, P412, DOI 10.1007/s11906-005-0035-y; Bosma M, 2014, BBA-MOL CELL BIOL L, V1841, P1648, DOI 10.1016/j.bbalip.2014.09.012; Ellis JM, 2011, MOL CELL BIOL, V31, P1252, DOI 10.1128/MCB.01085-10; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; FOLCH J, 1957, J BIOL CHEM, V226, P497; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Heckmann BL, 2014, J BIOL CHEM, V289, P1905, DOI 10.1074/jbc.M113.522011; Hirano K, 2008, NEW ENGL J MED, V359, P2396, DOI 10.1056/NEJMc0805305; Kaneko K, 2014, NEUROMUSCULAR DISORD, V24, P634, DOI 10.1016/j.nmd.2014.04.001; Kienesberger PC, 2013, CARDIOVASC RES, V99, P442, DOI 10.1093/cvr/cvt124; Kienesberger PC, 2013, J MOL CELL CARDIOL, V55, P101, DOI 10.1016/j.yjmcc.2012.06.018; Kienesberger PC, 2012, MOL CELL BIOL, V32, P740, DOI 10.1128/MCB.06470-11; Kioka H, 2014, P NATL ACAD SCI USA, V111, P273, DOI 10.1073/pnas.1318547111; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lewin TM, 2003, BBA-MOL CELL BIOL L, V1634, P63, DOI 10.1016/j.bbalip.2003.09.006; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/NCHEMBIO.1359, 10.1038/nchembio.1359]; McGavock JM, 2006, ANN INTERN MED, V144, P517, DOI 10.7326/0003-4819-144-7-200604040-00011; McGavock JM, 2007, CIRCULATION, V116, P1170, DOI 10.1161/CIRCULATIONAHA.106.645614; Moustafa T, 2012, GASTROENTEROLOGY, V142, P140, DOI 10.1053/j.gastro.2011.09.051; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; RUSSELL L, 1991, DNA CELL BIOL, V10, P581, DOI 10.1089/dna.1991.10.581; SADDIK M, 1991, J BIOL CHEM, V266, P8162; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Welch C, 2009, CANCER RES, V69, P6782, DOI 10.1158/0008-5472.CAN-09-0128; Yamada T, 2014, LEUKEMIA RES, V38, P210, DOI 10.1016/j.leukres.2013.10.006; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422; Zierler KA, 2013, J BIOL CHEM, V288, P9892, DOI 10.1074/jbc.M112.420620; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	38	25	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26141	26150		10.1074/jbc.M115.671842	http://dx.doi.org/10.1074/jbc.M115.671842			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26350455	hybrid, Green Published			2022-12-28	WOS:000363527300033
J	Higa-Nakamine, S; Maeda, N; Toku, S; Yamamoto, H				Higa-Nakamine, Sayomi; Maeda, Noriko; Toku, Seikichi; Yamamoto, Hideyuki			Involvement of Protein Kinase D1 in Signal Transduction from the Protein Kinase C Pathway to the Tyrosine Kinase Pathway in Response to Gonadotropin-releasing Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CULTURED HYPOTHALAMIC NEURONS; COUPLED RECEPTOR; AUTOCRINE REGULATION; MAP KINASE; ACTIVATION; PHOSPHORYLATION; SCHIZOPHRENIA; MECHANISMS; TRANSACTIVATION	The receptor for gonadotropin-releasing hormone (GnRH) belongs to the G protein-coupled receptors (GPCRs), and its stimulation activates extracellular signal-regulated protein kinase (ERK). We found that the transactivation of ErbB4 was involved in GnRH-induced ERK activation in immortalized GnRH neurons (GT1-7 cells). We found also that GnRH induced the cleavage of ErbB4. In the present study, we examined signal transduction for the activation of ERK and the cleavage of ErbB4 after GnRH treatment. Both ERK activation and ErbB4 cleavage were completely inhibited by YM-254890, an inhibitor ofGq/11 proteins. Down-regulation of protein kinase C (PKC) markedly decreased both ERK activation and ErbB4 cleavage. Experiments with two types of PKC inhibitors, Go 6976 and bisindolylmaleimide I, indicated that novel PKC isoforms but not conventional PKC isoforms were involved in ERK activation and ErbB4 cleavage. Our experiments indicated that the novel PKC isoforms activated protein kinase D (PKD) after GnRH treatment. Knockdown and inhibitor experiments suggested that PKD1 stimulated the phosphorylation of Pyk2 by constitutively activated Src and Fyn for ERK activation. Taken together, it is highly possible that PKD1 plays a critical role in signal transduction from the PKC pathway to the tyrosine kinase pathway. Activation of the tyrosine kinase pathway may be involved in the progression of cancer.	[Higa-Nakamine, Sayomi; Maeda, Noriko; Toku, Seikichi; Yamamoto, Hideyuki] Univ Ryukyus, Grad Sch Med, Dept Biochem, Nishihara, Okinawa 9030215, Japan	University of the Ryukyus	Higa-Nakamine, S (corresponding author), Univ Ryukyus, Grad Sch Med, 207 Uehara, Nishihara, Okinawa 9030215, Japan.	higasa@med.u-ryukyu.ac.jp			Japan Society for the Promotion of Science KAKENHI Grants [23500451, 24700381]	Japan Society for the Promotion of Science KAKENHI Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 23500451 and 24700381. The authors declare that they have no conflicts of interest with the contents of this article.	Andreev J, 2001, J BIOL CHEM, V276, P20130, DOI 10.1074/jbc.M102307200; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Caunt CJ, 2006, J BIOL CHEM, V281, P2701, DOI 10.1074/jbc.M507242200; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; Dobkin-Bekman M, 2010, ENDOCRINOLOGY, V151, P4894, DOI 10.1210/en.2010-0114; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Higa-Nakamine S, 2012, J CELL PHYSIOL, V227, P2492, DOI 10.1002/jcp.22988; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kennett SB, 2004, J BIOL CHEM, V279, P3300, DOI 10.1074/jbc.M305734200; Koyama H., 2012, J CLIN TOXICOL S, VS3, P002; Krsmanovic LZ, 1999, ENDOCRINOLOGY, V140, P1423, DOI 10.1210/en.140.3.1423; KRSMANOVIC LZ, 1993, P NATL ACAD SCI USA, V90, P3908, DOI 10.1073/pnas.90.9.3908; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; LI WQ, 1994, J BIOL CHEM, V269, P2349; Linggi B, 2006, TRENDS CELL BIOL, V16, P649, DOI 10.1016/j.tcb.2006.10.008; Maeda N, 2009, J NEUROCHEM, V109, P393, DOI 10.1111/j.1471-4159.2009.05971.x; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Norton N, 2006, AM J MED GENET B, V141B, P96, DOI 10.1002/ajmg.b.30236; Reiss N, 1997, ENDOCRINOLOGY, V138, P1673, DOI 10.1210/en.138.4.1673; Rey O, 2004, J BIOL CHEM, V279, P34361, DOI 10.1074/jbc.M403265200; Roelle S, 2003, J BIOL CHEM, V278, P47307, DOI 10.1074/jbc.M304377200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Ryvkin V, 2015, J BIOL CHEM, V290, P11199, DOI 10.1074/jbc.M115.643742; Shah BH, 2004, TRENDS NEUROSCI, V27, P48, DOI 10.1016/j.tins.2003.11.003; Shah BH, 2003, J BIOL CHEM, V278, P2866, DOI 10.1074/jbc.m208783200; Srivastava J, 2002, BIOCHEM J, V368, P349, DOI 10.1042/BJ20020737; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Yamanaka A, 2007, ARCH BIOCHEM BIOPHYS, V466, P234, DOI 10.1016/j.abb.2007.06.009	37	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25974	25985		10.1074/jbc.M115.681700	http://dx.doi.org/10.1074/jbc.M115.681700			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26338704	hybrid, Green Published			2022-12-28	WOS:000363527300019
J	Desai, SS; Kharade, SS; Parekh, VI; Iyer, S; Agarwal, SK				Desai, Shruti S.; Kharade, Sampada S.; Parekh, Vaishali I.; Iyer, Sucharitha; Agarwal, Sunita K.			Pro-oncogenic Roles of HLXB9 Protein in Insulinoma Cells through Interaction with Nono Protein and Down-regulation of the c-Met Inhibitor Cblb (Casitas B-lineage Lymphoma b)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; PANCREATIC NEUROENDOCRINE TUMORS; MEN1 GENE; MICE DEVELOP; TYPE-1 MEN1; MOUSE MODEL; YANG 1; EXPRESSION; MUTATIONS; P54(NRB)	Pancreatic islet beta-cells that lack the MEN1-encoded protein menin develop into tumors. Such tumors express the phosphorylated isoform of the beta-cell differentiation transcription factor HLXB9. It is not known how phospho-HLXB9 acts as an oncogenic factor in insulin-secreting beta-cell tumors (insulinomas). In this study we investigated the binding partners and target genes of phospho-HLXB9 in mouse insulinoma MIN6 beta-cells. Co-immunoprecipitation coupled with mass spectrometry showed a significant association of phospho-HLXB9 with the survival factor p54nrb/Nono (54-kDa nuclear RNA-binding protein, non-POU-domain-containing octamer). Endogenous phospho-HLXB9 co-localized with endogenous Nono in the nucleus. Overexpression of HLXB9 decreased the level of overexpressed Nono but not endogenousNono. Anti-phospho-HLXB9 chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) identified the c-Met inhibitor, Cblb, as a direct phospho-HLXB9 target gene. Phospho-HLXB9 occupied the promoter of Cblb and reduced the expression of Cblb mRNA. Cblb overexpression or HLXB9 knockdown decreased c-Met protein and reduced cell migration. Also, increased phospho-HLXB9 coincided with reduced Cblb and increased c-Met in insulinomas of two mouse models of menin loss. These data provide mechanistic insights into the role of phospho-HLXB9 as a pro-oncogenic factor by interacting with a survival factor and by promoting the oncogenic c-Met pathway. These mechanisms have therapeutic implications for reducing beta-cell proliferation in insulinomas by inhibiting phospho-HLXB9 or its interaction with Nono and modulating the expression of its direct (Cblb) or indirect(c-Met) targets. Our data also implicate the use of pro-oncogenic activities of phospho-HLXB9 in beta-cell expansion strategies to alleviate beta-cell loss in diabetes.	[Desai, Shruti S.; Kharade, Sampada S.; Parekh, Vaishali I.; Iyer, Sucharitha; Agarwal, Sunita K.] NIDDK, Metab Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Agarwal, SK (corresponding author), NIH, Bldg 10,Rm 8C-101, Bethesda, MD 20814 USA.	sunitaa@mail.nih.gov	Agarwal, Sunita K/D-1428-2016; Regan, Clinton/E-6250-2012	Agarwal, Sunita K/0000-0002-7557-3191; Desai, Shruti/0000-0002-5234-5890	National Institutes of Health [1ZIADK075035-03]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075085, ZIADK075035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 1ZIADK075035-03 (NIDDK; Intramural Research Program; to S. K. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal SK, 2014, INT J ENDOCR ONCOL, V1, P153, DOI 10.2217/IJE.14.16; Alvarez-Perez JC, 2014, DIABETES, V63, P216, DOI 10.2337/db13-0333; Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Bertolino P, 2003, CANCER RES, V63, P4836; Biondi CA, 2004, MOL CELL BIOL, V24, P3125, DOI 10.1128/MCB.24.8.3125-3131.2004; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Cao YN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3810; Conrad E, 2014, TRENDS ENDOCRIN MET, V25, P407, DOI 10.1016/j.tem.2014.03.013; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Cromer MK, 2015, P NATL ACAD SCI USA, V112, P4062, DOI 10.1073/pnas.1503696112; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Desai SS, 2014, J BIOL CHEM, V289, P5386, DOI 10.1074/jbc.M113.533612; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; GIORDANO S, 1989, ONCOGENE, V4, P1383; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Hansel DE, 2004, CLIN CANCER RES, V10, P6152, DOI 10.1158/1078-0432.CCR-04-0285; Harding B, 2009, ENDOCR-RELAT CANCER, V16, P1313, DOI 10.1677/ERC-09-0082; Harrison KA, 1999, NAT GENET, V23, P71, DOI 10.1038/12674; Hendy GN, 2009, ADV EXP MED BIOL, V668, P37; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Li H, 1999, NAT GENET, V23, P67; Li SY, 2009, NUCLEIC ACIDS RES, V37, P6746, DOI 10.1093/nar/gkp741; Lichtenauer UD, 2015, J CLIN ENDOCR METAB, V100, pE776, DOI 10.1210/jc.2015-1100; Loffler KA, 2007, INT J CANCER, V120, P259, DOI 10.1002/ijc.22288; Mellado-Gil J, 2011, DIABETES, V60, P525, DOI 10.2337/db09-1305; Miguel-Aliaga I, 2008, PLOS BIOL, V6, P538, DOI 10.1371/journal.pbio.0060058; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Modali SD, 2015, MOL ENDOCRINOL, V29, P224, DOI 10.1210/me.2014-1304; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Peschard P, 2004, J BIOL CHEM, V279, P29565, DOI 10.1074/jbc.M403954200; Roccisana J, 2005, DIABETES, V54, P2090, DOI 10.2337/diabetes.54.7.2090; Schiffnery S, 2011, CARCINOGENESIS, V32, P1176, DOI 10.1093/carcin/bgr103; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Shen HCJ, 2009, CANCER RES, V69, P1858, DOI 10.1158/0008-5472.CAN-08-3662; Shi K, 2013, ENDOCR-RELAT CANCER, V20, P111, DOI 10.1530/ERC-12-0077; Shin JJ, 2010, FUTURE ONCOL, V6, P229, DOI [10.2217/fon.09.165, 10.2217/FON.09.165]; Sukhodolets KE, 2003, MOL CELL BIOL, V23, P493, DOI 10.1128/MCB.23.2.493-509.2003; Thakker RV, 2010, BEST PRACT RES CL EN, V24, P355, DOI 10.1016/j.beem.2010.07.003; Yadav SP, 2014, HUM MOL GENET, V23, P2132, DOI 10.1093/hmg/ddt609; Zanfardino M, 2013, INT J ONCOL, V43, P1763, DOI 10.3892/ijo.2013.2126	44	8	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25595	25608		10.1074/jbc.M115.661413	http://dx.doi.org/10.1074/jbc.M115.661413			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26342078	hybrid, Green Published			2022-12-28	WOS:000362962800033
J	Santarriaga, S; Petersen, A; Ndukwe, K; Brandt, A; Gerges, N; Scaglione, JB; Scaglione, KM				Santarriaga, Stephanie; Petersen, Amber; Ndukwe, Kelechi; Brandt, Anthony; Gerges, Nashaat; Scaglione, Jamie Bruns; Scaglione, Kenneth Matthew			The Social Amoeba Dictyostelium discoideum Is Highly Resistant to Polyglutamine Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRANUCLEAR INCLUSIONS; CHAPERONE ACTIVITY; LEA PROTEINS; HUNTINGTIN; EXPRESSION; PROTEOME; DISEASES; NEURODEGENERATION; PROTEOSTASIS; EXPANSION	The expression, misfolding, and aggregation of long repetitive amino acid tracts are a major contributing factor in a number of neurodegenerative diseases, including C9ORF72 amyotrophic lateral sclerosis/frontotemporal dementia, fragile X tremor ataxia syndrome, myotonic dystrophy type 1, spinocerebellar ataxia type 8, and the nine polyglutamine diseases. Protein aggregation is a hallmark of each of these diseases. In model organisms, including yeast, worms, flies, mice, rats, and human cells, expression of proteins with the long repetitive amino acid tracts associated with these diseases recapitulates the protein aggregation that occurs in human disease. Here we show that the model organism Dictyostelium discoideum has evolved to normally encode long polyglutamine tracts and express these proteins in a soluble form. We also show that Dictyostelium has the capacity to suppress aggregation of a polyglutamine-expanded Huntingtin construct that aggregates to suppress aggregation of proteins with long polyglutamine tracts.	[Santarriaga, Stephanie; Ndukwe, Kelechi; Brandt, Anthony; Scaglione, Jamie Bruns; Scaglione, Kenneth Matthew] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Petersen, Amber; Gerges, Nashaat] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Santarriaga, Stephanie; Petersen, Amber; Ndukwe, Kelechi; Brandt, Anthony; Gerges, Nashaat; Scaglione, Jamie Bruns; Scaglione, Kenneth Matthew] Med Coll Wisconsin, Neuroscience Res Ctr, Neurosci Res Ctr, Milwaukee, WI 53226 USA; [Scaglione, Jamie Bruns] Carroll Univ, Dept Computat & Phys Sci, Waukesha, WI 53186 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Scaglione, KM (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	mscaglione@mcw.edu		Ndukwe, Kelechi/0000-0003-2940-2081; Scaglione, Kenneth/0000-0002-3858-9418	National Institutes of Health from the NINDS [R00 NS073936]; Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS073936] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R00 NS073936 from the NINDS (to K. M. S.). This work was also supported by a grant from the Research and Education Program, a component of the Advancing a Healthier Wisconsin endowment at the Medical College of Wisconsin (to K. M. S. and N. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Carra S, 2005, HUM MOL GENET, V14, P1659, DOI 10.1093/hmg/ddi174; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald Martin L, 2013, Methods Mol Biol, V1017, P153, DOI 10.1007/978-1-62703-438-8_11; DURE L, 1989, PLANT MOL BIOL, V12, P475, DOI 10.1007/BF00036962; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fey P, 2007, NAT PROTOC, V2, P1307, DOI 10.1038/nprot.2007.178; Fuchs M, 2010, BIOCHEM J, V425, P245, DOI 10.1042/BJ20090907; Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hoekstra FA, 2001, CRYOBIOLOGY, V43, P140, DOI 10.1006/cryo.2001.2358; Kappe G, 2010, CELL STRESS CHAPERON, V15, P457, DOI 10.1007/s12192-009-0155-4; Kayatekin C, 2014, P NATL ACAD SCI USA, V111, P12085, DOI 10.1073/pnas.1412504111; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Koirala S, 2010, J CELL BIOL, V191, P1127, DOI 10.1083/jcb.201005046; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Li SH, 1998, HUM MOL GENET, V7, P777, DOI 10.1093/hmg/7.5.777; Liu GB, 2015, J BIOTECHNOL, V207, P39, DOI 10.1016/j.jbiotec.2015.05.003; Liu Y, 2011, FEBS LETT, V585, P630, DOI 10.1016/j.febslet.2011.01.020; Malinovska L, 2015, P NATL ACAD SCI USA, V112, pE2620, DOI 10.1073/pnas.1504459112; Marsh JL, 2009, J BIOL CHEM, V284, P7431, DOI 10.1074/jbc.R800065200; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Morimoto RI, 2014, J GERONTOL A-BIOL, V69, pS33, DOI 10.1093/gerona/glu049; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Petersen A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11135; Rines DR, 2011, COLD SPRING HARB PRO, V2011; Ripaud L, 2014, P NATL ACAD SCI USA, V111, P18219, DOI 10.1073/pnas.1421313111; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Scala C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046150; Switonski PM, 2012, MOL NEUROBIOL, V46, P430, DOI 10.1007/s12035-012-8316-3; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Yang S, 2014, NEURON, V81, P349, DOI 10.1016/j.neuron.2013.12.002; Yu ZM, 2011, INT REV NEUROBIOL, V99, P191, DOI 10.1016/B978-0-12-387003-2.00008-2; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	42	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25571	25578		10.1074/jbc.M115.676247	http://dx.doi.org/10.1074/jbc.M115.676247			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26330554	hybrid, Green Published			2022-12-28	WOS:000362962800031
J	Miller, TW; Soto-Pantoja, DR; Schwartz, AL; Sipes, JM; DeGraff, WG; Ridnour, LA; Wink, DA; Roberts, DD				Miller, Thomas W.; Soto-Pantoja, David R.; Schwartz, Anthony L.; Sipes, John M.; DeGraff, William G.; Ridnour, Lisa A.; Wink, David A.; Roberts, David D.			CD47 Receptor Globally Regulates Metabolic Pathways That Control Resistance to Ionizing Radiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC; MASS-SPECTROMETRY; TUMOR-CELLS; URINARY-EXCRETION; GENE-EXPRESSION; IN-VITRO; IDENTIFICATION; CREATINE; EXPOSURE; DAMAGE	Modulating tissue responses to stress is an important therapeutic objective. Oxidative and genotoxic stresses caused by ionizing radiation are detrimental to healthy tissues but beneficial for treatment of cancer. CD47 is a signaling receptor for thrombospondin-1 and an attractive therapeutic target because blocking CD47 signaling protects normal tissues while sensitizing tumors to ionizing radiation. Here we utilized a metabolomic approach to define molecular mechanisms underlying this radioprotective activity. CD47-deficient cells and cd47-null mice exhibited global advantages in preserving metabolite levels after irradiation. Metabolic pathways required for controlling oxidative stress and mediating DNA repair were enhanced. Some cellular energetics pathways differed basally in CD47-deficient cells, and the global declines in the glycolytic and tricarboxylic acid cycle metabolites characteristic of normal cell and tissue responses to irradiation were prevented in the absence of CD47. Thus, CD47 mediates signaling from the extracellular matrix that coordinately regulates basal metabolism and cytoprotective responses to radiation injury.	[Miller, Thomas W.; Soto-Pantoja, David R.; Schwartz, Anthony L.; Sipes, John M.; Roberts, David D.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [DeGraff, William G.; Ridnour, Lisa A.; Wink, David A.] NCI, Radiat Biol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Miller, Thomas W.] Paradigm Shift Therapeut, Rockville, MD 20852 USA; [Soto-Pantoja, David R.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Soto-Pantoja, David R.] Wake Forest Sch Med, Dept Hypertens, Winston Salem, NC 27157 USA; [Soto-Pantoja, David R.] Wake Forest Sch Med, Vasc Res Ctr, Winston Salem, NC 27157 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Wake Forest University; Wake Forest University; Wake Forest University	Soto-Pantoja, DR (corresponding author), Wake Forest Sch Med, Dept Canc Biol & Hypertens, Winston Salem, NC 27157 USA.	dsotopan@wakehealth.edu; droberts@helix.nih.gov	Pantoja, David Soto/ABB-3764-2020; Roberts, David D./A-9699-2008; Miller, Thomas W/G-1215-2011; Regan, Clinton/E-6250-2012	Roberts, David D./0000-0002-2481-2981; Miller, Thomas W/0000-0001-8645-2785; Azad, Mahan/0000-0002-8633-3513; Wink, David/0000-0002-5652-7480; Ridnour, Lisa A./0000-0001-9446-8349	National Institutes of Health [ZIASC009172, ZIA BC 010898, ZIASC009174]; NCI Directors Career Development Innovation Award; NCI Office of Biotechnology Partnerships; Avon Foundation; NATIONAL CANCER INSTITUTE [ZIABC010898, K22CA181274, ZIASC009172, ZIASC009174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Directors Career Development Innovation Award; NCI Office of Biotechnology Partnerships; Avon Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Projects ZIASC009172, ZIA BC 010898, and ZIASC009174 (Intramural Research Program of the NCI; to D. D. R. and D. A. W), an NCI Directors Career Development Innovation Award (to T. W. M.), and by the NCI Office of Biotechnology Partnerships (to D. S.-P.). This work was also supported by the Avon Foundation (to T. W. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; BASU SK, 1985, J RADIAT RES, V26, P189, DOI 10.1269/jrr.26.189; Bourhis J, 2011, J CLIN ONCOL, V29, P2590, DOI 10.1200/JCO.2010.33.1454; Collard F, 2011, J BIOL CHEM, V286, P38220, DOI 10.1074/jbc.M111.287318; Endoh K, 2006, INT J RADIAT BIOL, V82, P223, DOI 10.1080/09553000600721817; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fan YJ, 2010, J BIOL CHEM, V285, P7324, DOI 10.1074/jbc.M109.035584; Frazier EP, 2011, MATRIX BIOL, V30, P154, DOI 10.1016/j.matbio.2010.12.004; Fujibayashi Y, 1997, RADIAT RES, V147, P729, DOI 10.2307/3579487; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; GERBER GB, 1964, RADIAT RES, V23, P648, DOI 10.2307/3571758; Ghosh SP, 2013, MOL BIOSYST, V9, P723, DOI 10.1039/c3mb25454b; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; GUPTA GS, 1977, RADIAT RES, V71, P83, DOI 10.2307/3574714; Hara T, 2008, INT J RADIAT ONCOL, V71, P1485, DOI 10.1016/j.ijrobp.2008.03.039; HOOSEIN MA, 1984, MOL CELL BIOL, V4, P247, DOI 10.1128/MCB.4.2.247; Johnson CH, 2012, RADIAT RES, V178, P328, DOI 10.1667/RR2950.1; Johnson CH, 2011, RADIAT RES, V175, P473, DOI 10.1667/RR2437.1; Kaur S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01673; Khan AR, 2011, INT J RADIAT BIOL, V87, P91, DOI 10.3109/09553002.2010.518211; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lee EJ, 2003, BRIT J CANCER, V88, P754, DOI 10.1038/sj.bjc.6600779; Lee R, 2010, ELECTROPHORESIS, V31, P2328, DOI 10.1002/elps.200900451; Lenz H, 2005, J INVEST DERMATOL, V124, P443, DOI 10.1111/j.0022-202X.2004.23522.x; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Lin X, 2003, CANCER RES, V63, P3413; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Lora J, 2004, EUR J BIOCHEM, V271, P4298, DOI 10.1111/j.1432-1033.2004.04370.x; Maxhimer JB, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000139; Mazzio E, 2003, BIOCHEM PHARMACOL, V66, P297, DOI 10.1016/S0006-2952(03)00261-2; Miccheli A, 2006, BIOCHIMIE, V88, P437, DOI 10.1016/j.biochi.2005.10.004; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Mudd SH, 2007, AM J CLIN NUTR, V85, P19, DOI 10.1093/ajcn/85.1.19; Muller TD, 2013, J CLIN INVEST, V123, P469, DOI 10.1172/JCI64209; Patterson AD, 2008, ANAL CHEM, V80, P665, DOI 10.1021/ac701807v; PRIGNITZ R, 1975, STRAHLENTHER ONKOL, V149, P621; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rambold AS, 2011, CELL CYCLE, V10, P4032, DOI 10.4161/cc.10.23.18384; Reinhold MI, 1999, INT IMMUNOL, V11, P707, DOI 10.1093/intimm/11.5.707; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Roberts DD, 2012, MATRIX BIOL, V31, P162, DOI 10.1016/j.matbio.2012.01.005; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SHARMA R, 1993, INT J RADIAT BIOL, V63, P233, DOI 10.1080/09553009314550301; Soto-Pantoja DR, 2015, CRIT REV BIOCHEM MOL, V50, P212, DOI 10.3109/10409238.2015.1014024; Soto-Pantoja DR, 2014, CANCER RES, V74, P6771, DOI 10.1158/0008-5472.CAN-14-0037-T; Soto-Pantoja DR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01038; Soto-Pantoja DR, 2012, AUTOPHAGY, V8, P1628, DOI 10.4161/auto.21562; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Truman JP, 2009, CANCER BIOL THER, V8, P54, DOI 10.4161/cbt.8.1.7119; Tsunemi T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003799; Tyburski JB, 2009, RADIAT RES, V172, P42, DOI 10.1667/RR1703.1; Varghese RS, 2010, J PROTEOME RES, V9, P2786, DOI 10.1021/pr100185b; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; von Bueren AO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-74; Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3; Wang C, 2009, BIOMED CHROMATOGR, V23, P1079, DOI 10.1002/bmc.1226; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yao X, 2012, RADIOL MED, V117, P780, DOI 10.1007/s11547-011-0757-7; Zempleni J, 2012, MUTAT RES-FUND MOL M, V733, P58, DOI 10.1016/j.mrfmmm.2011.08.001	60	44	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24858	24874		10.1074/jbc.M115.665752	http://dx.doi.org/10.1074/jbc.M115.665752			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26311851	hybrid, Green Published			2022-12-28	WOS:000362598300020
J	Wang, YC; Yamada, E; Zong, HH; Pessin, JE				Wang, Yichen; Yamada, Eijiro; Zong, Haihong; Pessin, Jeffrey E.			Fyn Activation of mTORC1 Stimulates the IRE1 alpha-JNK Pathway, Leading to Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SKELETAL-MUSCLE; ER STRESS; SELECTIVE ACTIVATION; MECHANISMS; APOPTOSIS; KINASE; JNK; PHOSPHORYLATION; MACROAUTOPHAGY	We previously reported that the skeletal muscle-specific over-expression of Fyn in mice resulted in a severe muscle wasting phenotype despite the activation of mTORC1 signaling. To investigate the bases for the loss of muscle fiber mass, we examined the relationship between Fyn activation of mTORC1, JNK, and endoplasmic reticulum stress. Overexpression of Fyn in skeletal muscle in vivo and in HEK293T cells in culture resulted in the activation of IRE1 alpha and JNK, leading to increased cell death. Fyn synergized with the general endoplasmic reticulum stress inducer thapsigargin, resulting in the activation of IRE1 alpha and further accelerated cell death. Moreover, inhibition of mTORC1with rapamycin suppressed IRE1 alpha activation and JNK phosphorylation, resulting in protecting cells against Fyn- and thapsigargin-induced cell death. Moreover, rapamycin treatment in vivo reduced the skeletal muscle IRE1 alpha activation in the Fyn-overexpressing transgenic mice. Together, these data demonstrate the presence of a Fyn-induced endoplasmic reticulum stress that occurred, at least in part, through the activation of mTORC1, as well as subsequent activation of the IRE1 alpha-JNK pathway driving cell death.	[Wang, Yichen; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Zong, Haihong; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Yamada, Eijiro] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 3718511, Japan	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Gunma University	Pessin, JE (corresponding author), Albert Einstein Coll Med, Dept Med & Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	Jeffrey.pessin@einstein.yu.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [DK033823, DK098439, DK020541]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, R01DK098439, P60DK020541, R37DK033823, R01DK033823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK033823, DK098439, and DK020541 (to J. E. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Bastie CC, 2007, CELL METAB, V5, P371, DOI 10.1016/j.cmet.2007.04.005; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Cao YY, 2014, BIOCHEM J, V461, P315, DOI 10.1042/BJ20140515; Deldicque L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00236; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Fadden P, 1997, J BIOL CHEM, V272, P10240; Fung TS, 2014, J VIROL, V88, P12752, DOI 10.1128/JVI.02138-14; Hayashi A, 2007, J BIOL CHEM, V282, P34525, DOI 10.1074/jbc.M704300200; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Jiang YP, 2001, J BIOL CHEM, V276, P10943, DOI 10.1074/jbc.M007758200; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Maiuolo J, 2011, P NATL ACAD SCI USA, V108, P7832, DOI 10.1073/pnas.1101379108; Martino MB, 2013, MUCOSAL IMMUNOL, V6, P639, DOI 10.1038/mi.2012.105; McCormick MA, 2011, PHILOS T R SOC B, V366, P17, DOI 10.1098/rstb.2010.0198; Neisch AL, 2010, J CELL BIOL, V189, P311, DOI 10.1083/jcb.200912010; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Posadas EM, 2009, BJU INT, V103, P171, DOI 10.1111/j.1464-410X.2008.08009.x; Rayavarapu S, 2012, CURR RHEUMATOL REP, V14, P238, DOI 10.1007/s11926-012-0247-5; Resh MD, 1998, INT J BIOCHEM CELL B, V30, P1159, DOI 10.1016/S1357-2725(98)00089-2; Rodriguez-Alba JC, 2008, BLOOD, V111, P3644, DOI 10.1182/blood-2007-08-107714; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Russ DW, 2014, EXP GERONTOL, V50, P40, DOI 10.1016/j.exger.2013.11.018; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Salminen A, 2010, AGEING RES REV, V9, P211, DOI 10.1016/j.arr.2010.04.003; Samali Afshin, 2010, Int J Cell Biol, V2010, P830307, DOI 10.1155/2010/830307; Sanchez AMJ, 2012, AM J PHYSIOL-CELL PH, V303, pC475, DOI 10.1152/ajpcell.00125.2012; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shin J, 2013, INT J BIOCHEM CELL B, V45, P2266, DOI 10.1016/j.biocel.2013.05.001; Sovolyova N, 2014, BIOL CHEM, V395, P1, DOI 10.1515/hsz-2013-0174; Thomas DR, 2007, CLIN NUTR, V26, P389, DOI 10.1016/j.clnu.2007.03.008; Vallerie SN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001007; Verma G, 2012, J CELL PHYSIOL, V227, P1791, DOI 10.1002/jcp.22903; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Yamada E, 2012, CELL REP, V1, P557, DOI 10.1016/j.celrep.2012.03.014; Yamada E, 2010, CELL METAB, V11, P113, DOI 10.1016/j.cmet.2009.12.010; Yasue T, 1997, P NATL ACAD SCI USA, V94, P10307, DOI 10.1073/pnas.94.19.10307	49	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24772	24783		10.1074/jbc.M115.687020	http://dx.doi.org/10.1074/jbc.M115.687020			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26306048	Green Published, hybrid			2022-12-28	WOS:000362598300013
J	Peltier, J; Shaw, HA; Couchman, EC; Dawson, LF; Yu, L; Choudhary, JS; Kaever, V; Wren, BW; Fairweather, NF				Peltier, Johann; Shaw, Helen A.; Couchman, Edward C.; Dawson, Lisa F.; Yu, Lu; Choudhary, Jyoti S.; Kaever, Volkhard; Wren, Brendan W.; Fairweather, Neil F.			Cyclic diGMP Regulates Production of Sortase Substrates of Clostridium difficile and Their Surface Exposure through Zmpl Protease-mediated Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; DI-GMP; CELL-WALL; MOLECULAR CHARACTERIZATION; LISTERIA-MONOCYTOGENES; EHRLICHIA-CHAFFEENSIS; BACILLUS-SUBTILIS; TOXIN PRODUCTION; CROSS-LINKS; PROTEINS	In Gram-positive pathogens, surface proteins may be covalently anchored to the bacterial peptidoglycan by sortase, a cysteine transpeptidase enzyme. In contrast to other Grain-positive bacteria, only one single sortase enzyme, SrtB, is conserved between strains of Clostridium difficile. Sortase-mediated peptidase activity has been reported in vitro, and seven potential substrates have been identified. Here, we demonstrate the functionality of sortase in C. difficile. We identify two sortase-anchored proteins, the putative adhesins CD2831 and CD3246, and determine the cell wall anchor structure of CD2831. The C-terminal PPKTG sorting motif of CD2831 is cleaved between the threonine and glycine residues, and the carboxyl group of threonine is amide-linked to the side chain amino group of diaminopimelic acid within the peptidoglycan peptide stem. We show that CD28:31 protein levels are elevated in the presence of high intracellular cyclic diGMP (c-diGMP) concentrations, in agreement with the control of CD2831 expression by a c-diGMP-dependent type II riboswitch. Low c-diGMP levels induce the release of CD2831 and presumably CD3246 from the surface of cells. This regulation is mediated by proteolytic cleavage of CD2831 and CD3246 by the zinc metalloprotease ZmpI, whose expression is controlled by a type I c-diGMP riboswitch. These data reveal a novel regulatory mechanism for expression of two sortase substrates by the secondary messenger c-diGMP, on which surface anchoring is dependent.	[Peltier, Johann; Shaw, Helen A.; Couchman, Edward C.; Fairweather, Neil F.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Dawson, Lisa F.; Wren, Brendan W.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1 7HT, England; [Yu, Lu; Choudhary, Jyoti S.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Metabol, D-30625 Hannover, Germany	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Wellcome Trust Sanger Institute; Hannover Medical School	Fairweather, NF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England.	n.fairweather@imperial.ac.uk	Kaever, Volkhard/G-3280-2013; Choudhary, Jyoti/S-1232-2017; Peltier, Johann/Q-2001-2017	Choudhary, Jyoti/0000-0003-0881-5477; Peltier, Johann/0000-0003-3207-9465; Fairweather, Neil/0000-0002-3224-0207	European Community [PIEF-GA-2011-302561-DIFFISORT]; Medical Research Council; Biotechnology and Biological Sciences Research Council CASE studentship; Wellcome Trust [079643/Z/06/Z]; Biotechnology and Biological Sciences Research Council [1100199] Funding Source: researchfish; Medical Research Council [G0800170, G1000214] Funding Source: researchfish; MRC [G1000214, G0800170] Funding Source: UKRI	European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by a Marie Curie Intra-European Fellowship within the 7th European Community Framework Program Grant PIEF-GA-2011-302561-DIFFISORT (to J. P.) and Medical Research Council funding (to B. W.). The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a Biotechnology and Biological Sciences Research Council CASE studentship (to N. F. F.).r Supported by Wellcome Trust Grant 079643/Z/06/Z.	Barbut F, 2007, INFECT CONT HOSP EP, V28, P131, DOI 10.1086/511794; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Bierne H, 2012, CURR OPIN MICROBIOL, V15, P715, DOI 10.1016/j.mib.2012.10.010; Bordeleau E, 2015, J BACTERIOL, V197, P819, DOI 10.1128/JB.02340-14; Bordeleau E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002039; Bruck S, 2011, J BACTERIOL, V193, P4425, DOI 10.1128/JB.01154-10; Burhenne Heike, 2013, Methods Mol Biol, V1016, P27, DOI 10.1007/978-1-62703-441-8_3; Cafardi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081306; Cartman ST, 2012, APPL ENVIRON MICROB, V78, P4683, DOI 10.1128/AEM.00249-12; Cartman ST, 2010, APPL ENVIRON MICROB, V76, P1103, DOI 10.1128/AEM.02525-09; Chambers CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09449; Chen AGY, 2011, RNA, V17, P1967, DOI 10.1261/rna.2757311; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Deneve C, 2009, INT J ANTIMICROB AG, V33, pS24, DOI 10.1016/S0924-8579(09)70012-3; Deshpande A, 2013, J ANTIMICROB CHEMOTH, V68, P1951, DOI 10.1093/jac/dkt129; Donahue EH, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0219-1; Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889; Gao XH, 2014, APPL ENVIRON MICROB, V80, P6167, DOI 10.1128/AEM.01638-14; Gupta A, 2014, INFECT DRUG RESIST, V7, P63, DOI 10.2147/IDR.S46780; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hensbergen PJ, 2014, MOL CELL PROTEOMICS, V13, P1231, DOI 10.1074/mcp.M113.034728; Kang HJ, 2011, TRENDS BIOCHEM SCI, V36, P227, DOI 10.1016/j.tibs.2010.09.007; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Kumagai Y, 2011, INFECT IMMUN, V79, P3905, DOI 10.1128/IAI.05320-11; Kumagai Y, 2010, J BACTERIOL, V192, P4122, DOI 10.1128/JB.00132-10; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Marraffini LA, 2005, J BIOL CHEM, V280, P16263, DOI 10.1074/jbc.M500071200; Mayer MJ, 2008, J BACTERIOL, V190, P6734, DOI 10.1128/JB.00686-08; Mayer MJ, 2011, J BACTERIOL, V193, P5477, DOI 10.1128/JB.00439-11; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; McKee RW, 2013, J BACTERIOL, V195, P5174, DOI 10.1128/JB.00501-13; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Peltier J, 2011, J BIOL CHEM, V286, P29053, DOI 10.1074/jbc.M111.259150; Peniche AG, 2013, CURR OPIN INFECT DIS, V26, P447, DOI 10.1097/01.qco.0000433318.82618.c6; Purcell EB, 2012, J BACTERIOL, V194, P3307, DOI 10.1128/JB.00100-12; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Valiente E, 2014, CLIN MICROBIOL INFEC, V20, P396, DOI 10.1111/1469-0691.12619; van Leeuwen HC, 2014, FEBS LETT, V588, P4325, DOI 10.1016/j.febslet.2014.09.041; Yan WJ, 2010, MICROBIOL RES, V165, P87, DOI 10.1016/j.micres.2008.10.001	51	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24453	24469		10.1074/jbc.M115.665091	http://dx.doi.org/10.1074/jbc.M115.665091			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26283789	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000362218900032
J	Singh, J; Wen, XH; Scales, SJ				Singh, Jaskirat; Wen, Xiaohui; Scales, Suzie J.			The Orphan G Protein-coupled Receptor Gpr175 (Tpra40) Enhances Hedgehog Signaling by Modulating cAMP Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY CILIUM; KINASE-A; ZEBRAFISH DEVELOPMENT; TUMOR-SUPPRESSOR; NEURAL-TUBE; CELL-LINES; BETA-TRCP; GLI3; PATHWAY; ACTIVATION	The Hedgehog (Hh) signaling pathway plays an essential role in vertebrate embryonic tissue patterning of many developing organs. Signaling occurs predominantly in primary cilia and is initiated by the entry of theGprotein-coupled receptor (GPCR)like protein Smoothened into cilia and culminates in gene transcription via the Gli family of transcription factors upon their nuclear entry. Here we identify an orphan GPCR, Gpr175 (also known as Tpra1 or Tpra40: transmembrane protein, adipocyte associated 1 or of 40 kDa), which also localizes to primary cilia upon Hh stimulation and positively regulates Hh signaling. Interaction experiments place Gpr175 at the level of PKA and upstream of the G alpha(i) component of heterotrimeric G proteins, which itself localizes to cilia and can modulate Hh signaling. Gpr175 or G alpha(i1) depletion leads to increases in cellular cAMP levels and in Gli3 processing into its repressor form. Thus we propose that Gpr175 coupled to G alpha(i1) normally functions to inhibit the production of cAMP by adenylyl cyclase upon Hh stimulation, thus maximizing signaling by turning off PKA activity and hence Gli3 repressor formation. Taken together our data suggest that Gpr175 is a novel positive regulator of the Hh signaling pathway.	[Singh, Jaskirat; Wen, Xiaohui; Scales, Suzie J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Scales, SJ (corresponding author), Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA.	sscales@gene.com	Scales, Suzie J./H-4507-2019	Scales, Suzie J./0000-0003-2544-0283				Aki T, 2008, J CELL PHYSIOL, V217, P194, DOI 10.1002/jcp.21492; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Ayers KL, 2010, TRENDS CELL BIOL, V20, P287, DOI 10.1016/j.tcb.2010.02.002; Bale AE, 2001, HUM MOL GENET, V10, P757, DOI 10.1093/hmg/10.7.757; Barzi M, 2011, J BIOL CHEM, V286, P8067, DOI 10.1074/jbc.M110.178772; Berlin J, 2013, CLIN CANCER RES, V19, P258, DOI 10.1158/1078-0432.CCR-12-1800; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chen Y, 2011, J BIOL CHEM, V286, P13502, DOI 10.1074/jbc.M110.217604; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Cohen MM, 2003, AM J MED GENET A, V123A, P5, DOI 10.1002/ajmg.a.20495; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Davenport JR, 2005, AM J PHYSIOL-RENAL, V289, pF1159, DOI 10.1152/ajprenal.00118.2005; DeCamp DL, 2000, J BIOL CHEM, V275, P26322, DOI 10.1074/jbc.M004055200; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Goldman J, 2015, CLIN CANCER RES, V21, P1002, DOI 10.1158/1078-0432.CCR-14-1234; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Hammerschmidt M, 1998, DEV BIOL, V194, P166, DOI 10.1006/dbio.1997.8796; He XL, 2014, NAT MED, V20, P1035, DOI 10.1038/nm.3666; Hsu SHC, 2011, DEVELOPMENT, V138, P3791, DOI 10.1242/dev.069492; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Lai CK, 2011, MOL BIOL CELL, V22, P1104, DOI 10.1091/mbc.E10-07-0596; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Meloni AR, 2006, MOL CELL BIOL, V26, P7550, DOI 10.1128/MCB.00546-06; Mo R, 1997, DEVELOPMENT, V124, P113; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Niewiadomski P, 2014, CELL REP, V6, P168, DOI 10.1016/j.celrep.2013.12.003; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Robarge KD, 2009, BIOORG MED CHEM LETT, V19, P5576, DOI 10.1016/j.bmcl.2009.08.049; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yang H, 1999, ENDOCRINOLOGY, V140, P2859, DOI 10.1210/en.140.6.2859; Yue S, 2009, ONCOGENE, V28, P492, DOI 10.1038/onc.2008.403; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	62	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29663	29675		10.1074/jbc.M115.665810	http://dx.doi.org/10.1074/jbc.M115.665810			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26451044	hybrid, Green Published			2022-12-28	WOS:000366613400046
J	Vajjhala, PR; Lu, A; Brown, DL; Pang, SW; Sagulenko, V; Sester, DP; Cridland, SO; Hill, JM; Schroder, K; Stow, JL; Wu, H; Stacey, KJ				Vajjhala, Parimala R.; Lu, Alvin; Brown, Darren L.; Pang, Siew Wai; Sagulenko, Vitaliya; Sester, David P.; Cridland, Simon O.; Hill, Justine M.; Schroder, Kate; Stow, Jennifer L.; Wu, Hao; Stacey, Katryn J.			The Inflammasome Adaptor ASC Induces Procaspase-8 Death Effector Domain Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOTIC CELL-DEATH; CRYSTAL-STRUCTURE; SIGNALING COMPLEX; CD95-INDUCED APOPTOSIS; NLRP3 INFLAMMASOMES; PYRIN INFLAMMASOME; SELF-ASSOCIATION; CYTOPLASMIC DNA; MELANOMA 2; C-FLIP	Inflammasomes mediate inflammatory and cell death responses to pathogens and cellular stress signals via activation of procaspases-1 and -8. During inflammasome assembly, activated receptors of the NLR or PYHIN family recruit the adaptor protein ASC and initiate polymerization of its pyrin domain (PYD) into filaments. We show that ASC filaments in turn nucleate procaspase-8 death effector domain (DED) filaments in vitro and in vivo. Interaction between ASC PYD and procaspase-8 tandem DEDs optimally required both DEDs and represents an unusual heterotypic interaction between domains of the death fold superfamily. Analysis of ASC PYD mutants showed that interaction surfaces that mediate procaspase-8 interaction overlap with those required for ASC self-association and interaction with the PYDs of inflammasome initiators. Our data indicate that multiple types of death fold domain filaments form at inflammasomes and that PYD/DED and homotypic PYD interaction modes are similar. Interestingly, we observed condensation of procaspase-8 filaments containing the catalytic domain, suggesting that procaspase-8 interactions within and/or between filaments may be involved in caspase-8 activation. Procaspase-8 filaments may also be relevant to apoptosis induced by death receptors.	[Vajjhala, Parimala R.; Pang, Siew Wai; Sagulenko, Vitaliya; Sester, David P.; Cridland, Simon O.; Hill, Justine M.; Stacey, Katryn J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Brown, Darren L.; Schroder, Kate; Stow, Jennifer L.; Stacey, Katryn J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Lu, Alvin; Wu, Hao] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lu, Alvin; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA	University of Queensland; University of Queensland; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Wu, H (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Biol Chem & Mol Pharmacol,Program Cellular &, 3 Blackfan Circle,Rm 3099, Boston, MA 02115 USA.	hao.wu@childrens.harvard.edu; katryn.stacey@uq.edu.au	Schroder, Kate/C-6132-2008; Regan, Clinton/E-6250-2012; Pang, Siew Wai/U-5651-2019; Hill, Justine M/C-5781-2009; Sester, David/GLR-2942-2022; Stow, Jennifer/I-4723-2013	Schroder, Kate/0000-0001-9261-3805; Stow, Jennifer/0000-0002-5409-9101; Brown, Darren/0000-0003-2174-7691; Lu, Alvin/0000-0003-2353-848X; Stacey, Katryn/0000-0002-3992-7802	National Health and Medical Research Council (NHMRC) [1050651]; ACRF [FT130100361]; NHMRC [606788, 1003021, 1059729]; National Institutes of Health [AI050872]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050872] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); ACRF; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Health and Medical Research Council (NHMRC) Grant 1050651 (to K. J. S. and K. S.). The Australian Cancer Research Foundation (ACRF)/Institute for Molecular Bioscience Cancer Biology Imaging Facility was established with the support of the ACRF. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Australian Research Council Fellowship FT130100361.; Supported by NHMRC Grant 606788 and Fellowship 1003021.; Supported by National Institutes of Health RO1 Grant AI050872. To whom correspondence may be addressed: Dept. of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Program in Cellular and Molecular Medicine, Boston Children's Hospital, 3 Blackfan Circle, Rm. 3099, Boston, MA 02115. Tel.: 617-713-8160; Fax: 617-713-8161; E-mail: hao.wu@childrens.harvard.edu.; Supported by NHMRC Fellowship 1059729. To whom correspondence may be addressed: School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland 4072, Australia. Tel.: 61-7-33654640; Fax: 61-7-33654273; E-mail: katryn.stacey@uq.edu.au.	Aachoui Y, 2013, CURR OPIN MICROBIOL, V16, P319, DOI 10.1016/j.mib.2013.04.004; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Antonopoulos C, 2015, J BIOL CHEM, V290, P20167, DOI 10.1074/jbc.M115.652321; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Cresswell KS, 2005, BIOCHEM BIOPH RES CO, V326, P417, DOI 10.1016/j.bbrc.2004.11.048; Dickens LS, 2012, MOL CELL, V47, P291, DOI 10.1016/j.molcel.2012.05.004; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Fernandes-Alnemri T., 2007, CELL DEATH DIFFER, V14, P1590; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gavrilin MA, 2012, J IMMUNOL, V188, P3469, DOI 10.4049/jimmunol.1102272; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; Hauenstein AV, 2015, CURR OPIN STRUC BIOL, V31, P75, DOI 10.1016/j.sbi.2015.03.014; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jin TC, 2013, J BIOL CHEM, V288, P13225, DOI 10.1074/jbc.M113.468033; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kallenberger SM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004738; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Li FY, 2006, J BIOL CHEM, V281, P2960, DOI 10.1074/jbc.M511074200; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lu A, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.13; Lu A, 2015, FEBS J, V282, P435, DOI 10.1111/febs.13133; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Lu A, 2014, J MOL BIOL, V426, P1420, DOI 10.1016/j.jmb.2013.12.029; Majkut J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4350; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Masumoto J, 2001, BIOCHEM BIOPH RES CO, V280, P652, DOI 10.1006/bbrc.2000.4190; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Monie TP, 2015, IMMUNOL REV, V265, P181, DOI 10.1111/imr.12284; Morrone SR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8827; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Pierini R, 2012, CELL DEATH DIFFER, V19, P1709, DOI 10.1038/cdd.2012.51; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Sahillioglu AC, 2014, STRUCTURE, V22, P1722, DOI 10.1016/j.str.2014.09.011; Salvesen GS, 2014, SEMIN IMMUNOL, V26, P246, DOI 10.1016/j.smim.2014.03.005; Sandu C, 2006, CELL DEATH DIFFER, V13, P2052, DOI 10.1038/sj.cdd.4401966; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Sester DP, 2015, J IMMUNOL, V194, P455, DOI 10.4049/jimmunol.1401110; Shen C, 2015, BIOCHEM BIOPH RES CO, V463, P297, DOI 10.1016/j.bbrc.2015.05.054; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Theile CS, 2013, NAT PROTOC, V8, P1800, DOI 10.1038/nprot.2013.102; Tsao KL, 1996, GENE, V169, P59, DOI 10.1016/0378-1119(95)00762-8; Vajjhala PR, 2014, J BIOL CHEM, V289, P23504, DOI 10.1074/jbc.M114.553305; Vajjhala PR, 2012, J BIOL CHEM, V287, P41732, DOI 10.1074/jbc.M112.381228; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Wu YH, 2014, CELL DEATH DIFFER, V21, P451, DOI 10.1038/cdd.2013.165; Yang JK, 2005, MOL CELL, V20, P939, DOI 10.1016/j.molcel.2005.10.023; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	67	58	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29217	29230		10.1074/jbc.M115.687731	http://dx.doi.org/10.1074/jbc.M115.687731			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468282	hybrid, Green Published			2022-12-28	WOS:000366613400009
J	Yamamoto, H; Shima, T; Yamaguchi, M; Mochizuki, Y; Hoshida, H; Kakuta, S; Kondo-Kakuta, C; Noda, NN; Inagaki, F; Itoh, T; Akada, R; Ohsumi, Y				Yamamoto, Hayashi; Shima, Takayuki; Yamaguchi, Masaya; Mochizuki, Yuh; Hoshida, Hisashi; Kakuta, Soichiro; Kondo-Kakuta, Chika; Noda, Nobuo N.; Inagaki, Fuyuhiko; Itoh, Takehiko; Akada, Rinji; Ohsumi, Yoshinori			The Thermotolerant Yeast Kluyveromyces marxianus Is a Useful Organism for Structural and Biochemical Studies of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLE TARGETING PATHWAY; SACCHAROMYCES-CEREVISIAE; ATG12-ATG5 CONJUGATE; PROTEIN LIPIDATION; ATG PROTEINS; COMPLEX; SYSTEM; CYTOPLASM; MUTANTS; GENES	Autophagy is a conserved degradation process in which autophagosomes are generated by cooperative actions of multiple autophagy-related (Atg) proteins. Previous studies using the model yeast Saccharomyces cerevisiae have provided various insights into the molecular basis of autophagy; however, because of the modest stability of several Atg proteins, structural and biochemical studies have been limited to a subset of Atg proteins, preventing us from understanding how multiple Atg proteins function cooperatively in autophagosome formation. With the goal of expanding the scope of autophagy research, we sought to identify a novel organism with stable Atg proteins that would be advantageous for in vitro analyses. Thus, we focused on a newly isolated thermotolerant yeast strain, Kluyveromyces marxianus DMKU3-1042, to utilize as a novel system elucidating autophagy. We developed experimental methods to monitor autophagy in K. marxianus cells, identified the complete set of K. marxianus Atg homologs, and confirmed that each Atg homolog is engaged in autophagosome formation. Biochemical and bioinformatic analyses revealed that recombinant K. marxianus Atg proteins have superior thermostability and solubility as compared with S. cerevisiae Atg proteins, probably due to the shorter primary sequences of KmAtg proteins. Furthermore, bioinformatic analyses showed that more than half of K. marxianus open reading frames are relatively short in length. These features make K. marxianus proteins broadly applicable as tools for structural and biochemical studies, not only in the autophagy field but also in other fields.	[Yamamoto, Hayashi; Shima, Takayuki; Kakuta, Soichiro; Kondo-Kakuta, Chika; Ohsumi, Yoshinori] Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan; [Yamaguchi, Masaya; Inagaki, Fuyuhiko] Hokkaido Univ, Fac Adv Life Sci, Dept Biol Struct, Sapporo, Hokkaido 0600812, Japan; [Mochizuki, Yuh; Itoh, Takehiko] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Lab Silico Funct Genom, Yokohama, Kanagawa 2268501, Japan; [Hoshida, Hisashi; Akada, Rinji] Yamaguchi Univ, Grad Sch Med, Dept Appl Mol Biosci, Ube, Yamaguchi 7558611, Japan; [Noda, Nobuo N.] Inst Microbial Chem, Tokyo 1410021, Japan	Tokyo Institute of Technology; Hokkaido University; Tokyo Institute of Technology; Yamaguchi University	Yamamoto, H (corresponding author), Tokyo Inst Technol, Frontier Res Ctr, Yokohama, Kanagawa 2268503, Japan.	yamamoto-hayashi@iri.titech.ac.jp; yohsumi@iri.titech.ac.jp	Ohsumi, Yoshinori/C-6449-2009; Itoh, Takehiko/E-8873-2014; Noda, Nobuo/P-1397-2015	Ohsumi, Yoshinori/0000-0003-2384-2166; Itoh, Takehiko/0000-0002-6113-557X; Noda, Nobuo/0000-0002-6940-8069; Yamaguchi, Masaya/0000-0001-6886-8058	Ministry of Education, Culture, Sports, Science and Technology of Japan [26111508, 23000015]; Grants-in-Aid for Scientific Research [25111004, 26111508] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research on Innovative Areas 26111508 (to H. Y.) and Grant-in-aid for Specially Promoted Research 23000015 (to Y. O.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Banat BMA, 2010, YEAST, V27, P29, DOI 10.1002/yea.1729; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; CHIEN A, 1976, J BACTERIOL, V127, P1550, DOI 10.1128/JB.127.3.1550-1557.1976; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fonseca GG, 2008, APPL MICROBIOL BIOT, V79, P339, DOI 10.1007/s00253-008-1458-6; Fujioka Y, 2014, NAT STRUCT MOL BIOL, V21, P513, DOI 10.1038/nsmb.2822; Fujioka Y, 2010, J BIOL CHEM, V285, P1508, DOI 10.1074/jbc.M109.053520; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2009, AUTOPHAGY, V5, P85, DOI 10.4161/auto.5.1.7180; Hong SB, 2011, NAT STRUCT MOL BIOL, V18, P1323, DOI 10.1038/nsmb.2165; Hoshida H, 2014, YEAST, V31, P29, DOI 10.1002/yea.2993; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2009, BIOCHEM BIOPH RES CO, V389, P612, DOI 10.1016/j.bbrc.2009.09.034; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Kneller D. G., 1997, SPARKY VERSION 3 105; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Lertwattanasakul N, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0227-x; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Limtong S, 2007, BIORESOURCE TECHNOL, V98, P3367, DOI 10.1016/j.biortech.2006.10.044; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Noda N. N., 1994, METHODS YEAST GENETI; Noda NN, 2011, MOL CELL, V44, P462, DOI 10.1016/j.molcel.2011.08.035; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Ragusa MJ, 2012, CELL, V151, P1501, DOI 10.1016/j.cell.2012.11.028; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; SIKORSKI RS, 1989, GENETICS, V122, P19; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Taherbhoy AM, 2011, MOL CELL, V44, P451, DOI 10.1016/j.molcel.2011.08.034; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tamura N, 2010, J CELL SCI, V123, P4107, DOI 10.1242/jcs.070045; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Watanabe Y, 2012, J BIOL CHEM, V287, P31681, DOI 10.1074/jbc.M112.397570; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Yamaguchi M, 2012, NAT STRUCT MOL BIOL, V19, P1250, DOI 10.1038/nsmb.2451; Yamaguchi M, 2012, STRUCTURE, V20, P1244, DOI 10.1016/j.str.2012.04.018; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670; Yamaguti M, 2007, ACTA CRYSTALLOGR F, V63, P443, DOI [10.1107/S1744309107017472, 10.1107/S174430910701]; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061; Yarimizu T, 2013, YEAST, V30, P485, DOI 10.1002/yea.2985	59	10	30	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29506	U476		10.1074/jbc.M115.684233	http://dx.doi.org/10.1074/jbc.M115.684233			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26442587	Green Published, hybrid			2022-12-28	WOS:000366613400033
J	Wang, JY; Kuryatov, A; Jin, Z; Norleans, J; Kamenecka, TM; Kenny, PJ; Lindstrom, J				Wang, Jingyi; Kuryatov, Alexander; Jin, Zhuang; Norleans, Jack; Kamenecka, Theodore M.; Kenny, Paul J.; Lindstrom, Jon			A Novel alpha 2/alpha 4 Subtype-selective Positive Allosteric Modulator of Nicotinic Acetylcholine Receptors Acting from the C-tail of an alpha Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug development; electrophysiology; nicotinic acetylcholine receptors (nAChR); receptor desensitization; receptor structure-function; nicotine addition; positive allosteric modulator	CYS-LOOP RECEPTORS; ACH BINDING-SITE; AGONIST BINDING; ALPHA-4-BETA-2 RECEPTOR; BETA 2; DESENSITIZATION; SENSITIVITY; ACTIVATION; EXPRESSION; DESFORMYLFLUSTRABROMINE	Positive allosteric modulators (PAMs) of nicotinic acetylcholine receptors (nAChR) are important therapeutic candidates as well as valuable research tools. We identified a novel type II PAM, (R)-7-bromo-N-(piperidin-3-yl)benzo[b]thiophene-2-carboxamide (Br-PBTC), which both increases activation and reactivates desensitized nAChRs. This compound increases acetylcholine-evoked responses of 2* and 4* nAChRs but is without effect on 3* or 6* nAChRs (* indicates the presence of other nAChR subunits). Br-BPTC acts from the C-terminal extracellular sequences of 4 subunits, which is also a PAM site for steroid hormone estrogens such as 17-estradiol. Br-PBTC is much more potent than estrogens. Like 17-estradiol, the non-steroid Br-PBTC only requires one 4 subunit to potentiate nAChR function, and its potentiation is stronger with more 4 subunits. This feature enables Br-BPTC to potentiate activation of (42)(62)3 but not (62)(2)3 nAChRs. Therefore, this compound is potentially useful in vivo for determining functions of different 6* nAChR subtypes. Besides activation, Br-BPTC affects desensitization of nAChRs induced by sustained exposure to agonists. After minutes of exposure to agonists, Br-PBTC reactivated short term desensitized nAChRs that have at least two 4 subunits but not those with only one. Three 4 subunits were required for Br-BPTC to reactivate long term desensitized nAChRs. These data suggest that higher PAM occupancy promotes channel opening more efficiently and overcomes short and long term desensitization. This C-terminal extracellular domain could be a target for developing subtype or state-selective drugs for nAChRs.	[Wang, Jingyi; Kuryatov, Alexander; Norleans, Jack; Lindstrom, Jon] Univ Penn, Perelman Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Jin, Zhuang; Kamenecka, Theodore M.] Scripps Res Inst, Dept Mol Therapeut, Scripps, FL 33458 USA; [Kenny, Paul J.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	University of Pennsylvania; Pennsylvania Medicine; Icahn School of Medicine at Mount Sinai	Lindstrom, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Neurosci, 130A John Morgan, Philadelphia, PA 19104 USA.	JSLKK@mail.med.upenn.edu	wang, jing/GRS-7509-2022; WANG, JINGYI/GSJ-1241-2022		National Institute on Drug Abuse [DA030929]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030929] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute on Drug Abuse Grant DA030929. The authors declare that they have no conflicts of interest with the contents of this article.	Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Benallegue N, 2013, BRIT J PHARMACOL, V170, P304, DOI 10.1111/bph.12268; BOYD ND, 1987, J PHYSIOL-LONDON, V389, P45, DOI 10.1113/jphysiol.1987.sp016646; Changeux JP, 2013, NAT REV MOL CELL BIO, V14, P819, DOI 10.1038/nrm3695; Curtis L, 2002, MOL PHARMACOL, V61, P127, DOI 10.1124/mol.61.1.127; De Biasi M, 2011, ANNU REV NEUROSCI, V34, P105, DOI 10.1146/annurev-neuro-061010-113734; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Fletcher GH, 1996, MOL PHARMACOL, V49, P938; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Gaimarri A, 2007, BRAIN RES REV, V55, P134, DOI 10.1016/j.brainresrev.2007.02.005; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; Gill-Thind JK, 2015, J BIOL CHEM, V290, P3552, DOI 10.1074/jbc.M114.619221; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Grupe M, 2015, BASIC CLIN PHARMACOL, V116, P187, DOI 10.1111/bcpt.12361; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Jin XC, 2014, MOL PHARMACOL, V85, P11, DOI 10.1124/mol.113.089979; Jin XC, 2011, J NEUROSCI, V31, P5045, DOI 10.1523/JNEUROSCI.4802-10.2011; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Kuryatov A, 2000, EUR J PHARMACOL, V393, P11, DOI 10.1016/S0014-2999(00)00027-3; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Kuryatov A, 2011, MOL PHARMACOL, V79, P126, DOI 10.1124/mol.110.066159; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lewis AS, 2013, PSYCHOPHARMACOLOGY, V229, P477, DOI 10.1007/s00213-013-3126-5; Ley CKK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103244; Liu X, 2013, PSYCHOPHARMACOLOGY, V230, P203, DOI 10.1007/s00213-013-3145-2; Mazzaferro S, 2011, J BIOL CHEM, V286, P31043, DOI 10.1074/jbc.M111.262014; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Paradiso K, 2001, J NEUROSCI, V21, P6561, DOI 10.1523/JNEUROSCI.21-17-06561.2001; Picciotto MR, 2008, PROG NEUROBIOL, V84, P329, DOI 10.1016/j.pneurobio.2007.12.005; Picciotto MR, 2015, NEUROPHARMACOLOGY, V96, P235, DOI 10.1016/j.neuropharm.2014.12.028; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Rayes D, 2009, J NEUROSCI, V29, P6022, DOI 10.1523/JNEUROSCI.0627-09.2009; Seo S, 2009, J NEUROSCI, V29, P8734, DOI 10.1523/JNEUROSCI.1859-09.2009; Srinivasan R, 2014, PHARMACOL RES, V83, P20, DOI 10.1016/j.phrs.2014.02.005; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Wang F, 1996, J BIOL CHEM, V271, P17656, DOI 10.1074/jbc.271.30.17656; Wang F, 1998, J BIOL CHEM, V273, P28721, DOI 10.1074/jbc.273.44.28721; Wang J, 2015, NEUROPHARMACOLOGY, V96, P194, DOI 10.1016/j.neuropharm.2014.10.009; Wang JY, 2015, J BIOL CHEM, V290, P13907, DOI 10.1074/jbc.M115.646786; Weltzin MM, 2015, J PHARMACOL EXP THER, V354, P184, DOI 10.1124/jpet.115.223933; Weltzin MM, 2010, J PHARMACOL EXP THER, V334, P917, DOI 10.1124/jpet.110.167684; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Yu KD, 2009, ACTA PHARMACOL SIN, V30, P805, DOI 10.1038/aps.2009.48; Zhou Y, 2003, J NEUROSCI, V23, P9004; Zoli M, 2015, NEUROPHARMACOLOGY, V96, P302, DOI 10.1016/j.neuropharm.2014.11.003	50	13	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28834	28846		10.1074/jbc.M115.676551	http://dx.doi.org/10.1074/jbc.M115.676551			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26432642	Green Published, hybrid			2022-12-28	WOS:000365762300025
J	Booth, EA; Vane, EW; Dovala, D; Thorner, J				Booth, Elizabeth A.; Vane, Eleanor W.; Dovala, Dustin; Thorner, Jeremy			A Forster Resonance Energy Transfer (FRET)-based System Provides Insight into the Ordered Assembly of Yeast Septin Hetero-octamers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREVISIAE CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; FILAMENT FORMATION; PROTEIN INTERACTIONS; GENE-PRODUCT; MAMMALIAN SEPTINS; DIVISION CYCLE; MYOSIN-II; BUD NECK	Prior studies in both budding yeast (Saccharomyces cerevisiae) and in human cells have established that septin protomers assemble into linear hetero-octameric rods with 2-fold rotational symmetry. In mitotically growing yeast cells, five septin subunits are expressed (Cdc3, Cdc10, Cdcl 1, Cdc12, and Shsl) and assemble into two types of rods that differ only in their terminal subunit: Cdc11-Cdc12-Cdc3-Cdc10-Cdc10-Cdc3-Cdc12-Cdc11 and Shs1-Cdc12-Cdc3-Cdc10-Cdc10-Cdc3-Cdc12-Shs1. EM analysis has shown that, under low salt conditions, the Cdc11-capped rods polymerize end to end to form long paired filaments, whereas Shsl-capped rods form arcs, spirals, and rings. To develop a facile method to study septin polymerization in vitro, we exploited our previous work in which we generated septin complexes in which all endogenous cysteine (Cys) residues were eliminated by site-directed mutagenesis, except an introduced E294C mutation in Cdc11 in these experiments. Mixing samples of a preparation of such single-Cys containing Cdc11-capped rods that have been separately derivatized with organic dyes that serve as donor and acceptor, respectively, for FRET provided a spectroscopic method to monitor filament assembly mediated by Cdc11-Cdc11 interaction and to measure its affinity under specified conditions. Modifications of this same FRET scheme also allow us to assess whether Shsi-capped rods are capable of end to end association either with themselves or with Cdcll-capped rods. This FRET approach also was used to follow the binding to septin filaments of a septin-interacting protein, the type II myosin-binding protein Bni5.	[Booth, Elizabeth A.; Vane, Eleanor W.; Thorner, Jeremy] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Biochem Biophys & Struct Biol, Berkeley, CA 94720 USA; [Dovala, Dustin] Univ Calif San Francisco, Sch Med, Dept Microbiol & Immunol, Program Microbial Pathogenesis & Host Def, San Francisco, CA 94158 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	Thorner, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Rm 526,Barker Hall, Berkeley, CA 94720 USA.	jthorner@berkeley.edu	Regan, Clinton/E-6250-2012; THORNER, Jeremy/O-6132-2019	THORNER, Jeremy/0000-0002-2583-500X	Amgen Scholars Summer Research Fellowship at University of California Berkeley; National Institutes of Health [GM21841, GM101314]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101314, R01GM021841] Funding Source: NIH RePORTER	Amgen Scholars Summer Research Fellowship at University of California Berkeley; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an Amgen Scholars Summer Research Fellowship at University of California Berkeley (to E. W. V.) and by National Institutes of Health R01 Grants GM21841 (to J. T) and GM101314 (to J. T. and Berkeley colleague, Prof. Eva Nogales, jointly). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Soufi W., 2009, REV FLUORESCENCE, P23; Barth P, 2008, J AM CHEM SOC, V130, P12038, DOI 10.1021/ja802447e; Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Bertin A, 2012, MOL BIOL CELL, V23, P423, DOI 10.1091/mbc.E11-10-0850; Bertin A, 2010, J MOL BIOL, V404, P711, DOI 10.1016/j.jmb.2010.10.002; Bolanos-Garcia VM, 2006, BBA-GEN SUBJECTS, V1760, P1304, DOI 10.1016/j.bbagen.2006.03.027; BONNE D, 1985, J BIOL CHEM, V260, P2819; Bridges AA, 2015, J BIOL CHEM, V290, P17173, DOI 10.1074/jbc.R114.634444; Bridges AA, 2014, P NATL ACAD SCI USA, V111, P2146, DOI 10.1073/pnas.1314138111; Buttery SM, 2012, MOL BIOL CELL, V23, P4041, DOI 10.1091/mbc.E12-05-0395; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; Carroll CW, 1998, J CELL BIOL, V143, P709, DOI 10.1083/jcb.143.3.709; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Cid VJ, 1998, MICROBIOL-SGM, V144, P3463, DOI 10.1099/00221287-144-12-3463; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; de Val N, 2013, PROTEINS, V81, P1964, DOI 10.1002/prot.24345; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Egelhofer TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002022; Fang XD, 2010, J CELL BIOL, V191, P1333, DOI 10.1083/jcb.201005134; Farkasovsky M, 2005, BIOL CHEM, V386, P643, DOI 10.1515/BC.2005.075; Finnigan GC, 2015, GENETICS, V200, P821, DOI 10.1534/genetics.115.176503; Finnigan GC, 2015, GENETICS, V200, P841, DOI 10.1534/genetics.115.176495; FORD SK, 1991, DEV GENET, V12, P281, DOI 10.1002/dvg.1020120405; Frazier JA, 1998, J CELL BIOL, V143, P737, DOI 10.1083/jcb.143.3.737; Fung KYY, 2014, INT REV CEL MOL BIO, V310, P289, DOI 10.1016/B978-0-12-800180-6.00007-4; Garcia G, 2011, J CELL BIOL, V195, P993, DOI 10.1083/jcb.201107123; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; Hall PA, 2012, J PATHOL, V226, P287, DOI 10.1002/path.3024; Hansen SD, 2013, METHODS MOL BIOL, V1046, P145, DOI 10.1007/978-1-62703-538-5_9; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Hieb AR, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1045; Iwase M, 2007, GENETICS, V177, P215, DOI 10.1534/genetics.107.073007; Kaplan C, 2015, NANO LETT, V15, P3859, DOI 10.1021/acs.nanolett.5b00693; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Kim MS, 2011, J CELL BIOL, V195, P815, DOI 10.1083/jcb.201106131; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lee PR, 2002, MOL CELL BIOL, V22, P6906, DOI 10.1128/MCB.22.19.6906-6920.2002; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Macedo JNA, 2013, BIOCHEM J, V450, P95, DOI 10.1042/BJ20120851; Marques ID, 2012, CELL BIOCHEM BIOPHYS, V62, P317, DOI 10.1007/s12013-011-9307-0; Mavrakis M, 2014, NAT CELL BIOL, V16, P322, DOI 10.1038/ncb2921; MCMURRAY MA, 2008, SEPTINS, P49; McMurray MA, 2008, CURR BIOL, V18, P1203, DOI 10.1016/j.cub.2008.07.020; McMurray MA, 2011, DEV CELL, V20, P540, DOI 10.1016/j.devcel.2011.02.004; McMurray MA, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-18; Miller DJ, 2004, J PHYSIOL-LONDON, V555, P585, DOI 10.1113/jphysiol.2004.060731; Mino A, 1998, BIOCHEM BIOPH RES CO, V251, P732, DOI 10.1006/bbrc.1998.9541; Nishihama R, 2011, BIOL CHEM, V392, P681, DOI 10.1515/BC.2011.086; Oh Y, 2011, TRENDS CELL BIOL, V21, P141, DOI 10.1016/j.tcb.2010.11.006; Ong K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6698; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pringle JR, 2008, SEPTINS, P7; Renz C, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-60; Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.e04-08-0734; SACKETT DL, 1990, J BIOL CHEM, V265, P14899; Schneider C, 2013, J CELL SCI, V126, P3390, DOI 10.1242/jcs.125302; Sellin ME, 2011, MOL BIOL CELL, V22, P3152, DOI 10.1091/mbc.E11-03-0253; Shulewitz MJ, 1999, MOL CELL BIOL, V19, P7123; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sirajuddin M, 2009, P NATL ACAD SCI USA, V106, P16592, DOI 10.1073/pnas.0902858106; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song Y, 2011, ANN BIOMED ENG, V39, P1224, DOI 10.1007/s10439-010-0225-x; Spiliotis ET, 2006, J CELL SCI, V119, P4, DOI 10.1242/jcs.02746; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tanaka-Takiguchi Y, 2009, CURR BIOL, V19, P140, DOI 10.1016/j.cub.2008.12.030; Versele M, 2004, MOL BIOL CELL, V15, P4568, DOI 10.1091/mbc.E04-04-0330; Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Zent E, 2014, BIOL CHEM, V395, P169, DOI 10.1515/hsz-2013-0268; Zent E, 2011, BIOL CHEM, V392, P791, DOI 10.1515/BC.2011.082; Zeraik AE, 2014, J BIOL CHEM, V289, P7799, DOI 10.1074/jbc.M113.525352; Zeug A, 2012, BIOPHYS J, V103, P1821, DOI 10.1016/j.bpj.2012.09.031; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	79	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28388	+		10.1074/jbc.M115.683128	http://dx.doi.org/10.1074/jbc.M115.683128			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26416886	Green Published, hybrid			2022-12-28	WOS:000365761900033
J	Joshi, AD; Mustafa, MG; Lichti, CF; Elferink, CJ				Joshi, Aditya D.; Mustafa, Mehnaz G.; Lichti, Cheryl F.; Elferink, Cornelis J.			Homocitrullination Is a Novel Histone H1 Epigenetic Mark Dependent on Aryl Hydrocarbon Receptor Recruitment of Carbamoyl Phosphate Synthase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN IN-VIVO; MOUSE DEVELOPMENT; TARGET GENE; AH RECEPTOR; DNA-BINDING; SYNTHETASE; ACTIVATION; EXPRESSION; MECHANISM; CELLS	The aryl hydrocarbon receptor (AhR), a regulator of xenobiotic toxicity, is a member of the eukaryotic Per-Arnt-Sim domain protein family of transcription factors. Recent evidence identified a novel AhR DNA recognition sequence called the nonconsensus xenobiotic response element (NC-XRE). AhR binding to the NC-XRE in response to activation by the canonical ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin resulted in concomitant recruitment of carbamoyl phosphate synthase 1 (CPS1) to the NC-XRE. Studies presented here demonstrate that CPS1 is a bona fide nuclear protein involved in homocitrullination (hcit), including a key lysine residue on histone H1 (H1K34hcit). H1K34hcit represents a hitherto unknown epigenetic mark implicated in enhanced gene expression of the peptidylarginine deiminase 2 gene, itself a chromatin-modifying protein. Collectively, our data suggest that AhR activation promotes CPS1 recruitment to DNA enhancer sites in the genome, resulting in a specific enzyme-independent post-translational modification of the linker histone H1 protein (H1K34hcit), pivotal in altering local chromatin structure and transcriptional activation.	[Joshi, Aditya D.; Lichti, Cheryl F.; Elferink, Cornelis J.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Mustafa, Mehnaz G.] Protea, Morgantown, WV 26505 USA	University of Texas System; University of Texas Medical Branch Galveston	Elferink, CJ (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.	coelferi@utmb.edu		Lichti, Cheryl/0000-0003-4099-4954	NIEHS, National Institutes of Health [R01ES007800, R21ES024607, P30ES006676]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026874, R01ES007800, R21ES024607, P30ES006676] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the NIEHS, National Institutes of Health Grants R01ES007800, R21ES024607 and P30ES006676 (to C. J. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Beedanagari SR, 2010, MOL PHARMACOL, V78, P608, DOI 10.1124/mol.110.064899; Biterge B, 2014, SCI REP-UK, V4, DOI 10.1038/srep06674; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Christophorou MA, 2014, NATURE, V507, P104, DOI 10.1038/nature12942; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; EMMANUEL B, 1980, COMP BIOCHEM PHYS B, V65, P693, DOI 10.1016/0305-0491(80)90181-9; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Fukunaga BN, 1996, J BIOL CHEM, V271, P3743; Ghidelli S, 1997, CHROMOSOMA, V105, P369, DOI 10.1007/BF02529752; Harper TA, 2013, J PHARMACOL EXP THER, V344, P579, DOI 10.1124/jpet.112.201111; Huang GM, 2012, MOL PHARMACOL, V81, P338, DOI 10.1124/mol.111.075952; Martinez AI, 2010, MOL GENET METAB, V101, P311, DOI 10.1016/j.ymgme.2010.08.002; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Jackson DP, 2014, MOL PHARMACOL, V85, P533, DOI 10.1124/mol.113.089730; Kamieniarz K, 2012, GENE DEV, V26, P797, DOI 10.1101/gad.182014.111; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Lever MA, 2000, NATURE, V408, P873, DOI 10.1038/35048603; Liu HY, 2011, AM J PATHOL, V178, P652, DOI 10.1016/j.ajpath.2010.10.023; MARSHALL M, 1958, J BIOL CHEM, V233, P102; METZENBERG RL, 1958, J BIOL CHEM, V233, P1560; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Moellering RE, 2013, SCIENCE, V341, P549, DOI 10.1126/science.1238327; Mydel P, 2010, J IMMUNOL, V184, P6882, DOI 10.4049/jimmunol.1000075; NEBERT DW, 1993, ANN NY ACAD SCI, V685, P624, DOI 10.1111/j.1749-6632.1993.tb35928.x; NICOLETTI M, 1977, EUR J BIOCHEM, V75, P583, DOI 10.1111/j.1432-1033.1977.tb11558.x; Over RS, 2014, MOL PLANT, V7, P481, DOI 10.1093/mp/sst164; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Pekkala S, 2010, HUM MUTAT, V31, P801, DOI 10.1002/humu.21272; Phair RD, 2004, METHOD ENZYMOL, V375, P393; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; RAMPONI G, 1971, FEBS LETT, V16, P311, DOI 10.1016/0014-5793(71)80378-2; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Shen ES, 1991, METHOD ENZYMOL, V206, P403; SIMMER JP, 1990, J BIOL CHEM, V265, P10395; Sirpal S, 2009, CLIN SCI, V116, P681, DOI 10.1042/CS20080322; Sugihara K, 2008, ARCH TOXICOL, V82, P5, DOI 10.1007/s00204-007-0232-3; Taylor RT, 2009, TOXICOL SCI, V107, P1, DOI 10.1093/toxsci/kfn217; VARGAS JL, 1987, FEBS LETT, V224, P182, DOI 10.1016/0014-5793(87)80444-1; Wilson SR, 2013, J PHARMACOL EXP THER, V345, P419, DOI 10.1124/jpet.113.203786; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; Zhang XS, 2012, P NATL ACAD SCI USA, V109, P13331, DOI 10.1073/pnas.1203280109	45	14	15	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27767	+		10.1074/jbc.M115.678144	http://dx.doi.org/10.1074/jbc.M115.678144			44	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26424795	Green Published, hybrid			2022-12-28	WOS:000365757500028
J	Son, YO; Pratheeshkumar, P; Roy, RV; Hitron, JA; Wang, L; Divya, SP; Xu, M; Luo, J; Chen, G; Zhang, Z; Shi, XL				Son, Young-Ok; Pratheeshkumar, Poyil; Roy, Ram Vinod; Hitron, John Andrew; Wang, Lei; Divya, Sasidharan Padmaja; Xu, Mei; Luo, Jia; Chen, Gang; Zhang, Zhuo; Shi, Xianglin			RETRACTED: Antioncogenic and Oncogenic Properties of Nrf2 in Arsenic-induced Carcinogenesis (Retracted article. See vol. 293, pg. 15456, 2018)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							TRANSCRIPTION FACTOR NRF2; ROS-DEPENDENT ACTIVATION; AUTOPHAGY; CANCER; MECHANISMS; P62; CELLS; KEAP1	Background: Arsenic induced cell transformation and carcinogenesis. Results: Arsenic-transformed cells have the property of apoptosis/autophagy resistance. Conclusion: The constitutive activation of Nrf2 in arsenic-transformed cells up-regulates antioxidants, decreases ROS generation, and causes apoptosis resistance and tumorigenesis. Significance: Antioncogenic role of inducible Nrf2 in normal cells and oncogenic role of constitutive activation of Nfr2 in cancer cells may increase our understanding of the mechanism of arsenic carcinogenesis and its prevention. Arsenic (As3+) is a carcinogen with considerable environmental and occupational relevancy. The present study shows that As3+-transformed human lung bronchial epithelial BEAS-2B cells (AsT cells) exhibit the property of apoptosis resistance. The level of basal reactive oxygen species (ROS) is very low in AsT cells in correlation with elevated expressions of both antioxidant enzymes and antiapoptotic proteins. Nuclear factor erythroid 2-related factor (Nrf2) and p62 are constitutively expressed. These two proteins up-regulate antioxidant enzymes and antiapoptotic proteins. The knockdown of Nrf2 or p62 by small interfering RNA (siRNA) enhanced both ROS levels and As3+-induced apoptosis in transformed cells. AsT cells have autophagy deficiency as evidenced by reduced formation of microtubule-associated protein 1 light chain 3 (LC3)-II, GFP-LC3 puncta, and autophagy flux. Results obtained using a soft agar assay and shRNA Nrf2-transfected cells show that Nrf2 plays an antioncogenic role before transformation, whereas this transcription factor plays an oncogenic role after transformation. In addition, depletion of Nrf2 by shRNA dramatically inhibited growth and proliferation of transformed cells. Furthermore, the Nrf2 protein levels and antiapoptotic and antioxidant enzyme levels are higher in lung adenocarcinoma than in normal tissues. Collectively, this study demonstrates that a constitutively high level of Nrf2 in AsT cells up-regulates the antioxidant proteins catalase and superoxide dismutase as well as the antiapoptotic proteins Bcl-2 and Bcl-xL. The final consequences are decreased ROS generation and increased apoptotic resistance, cell survival and proliferation, and tumorigenesis.	[Son, Young-Ok; Pratheeshkumar, Poyil; Roy, Ram Vinod; Wang, Lei; Shi, Xianglin] Univ Kentucky, Coll Med, Ctr Res Environm Dis, Lexington, KY 40536 USA; [Son, Young-Ok; Pratheeshkumar, Poyil; Roy, Ram Vinod; Hitron, John Andrew; Wang, Lei; Divya, Sasidharan Padmaja; Zhang, Zhuo; Shi, Xianglin] Univ Kentucky, Dept Toxicol & Canc Biol, Coll Med, Lexington, KY 40536 USA; [Xu, Mei; Luo, Jia; Chen, Gang] Univ Kentucky, Dept Pharmacol & Nutr Sci, Coll Med, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky	Shi, XL (corresponding author), Univ Kentucky, Coll Med, Ctr Res Environm Dis, Lexington, KY 40536 USA.	xshi5@email.uky.edu	Regan, Clinton/E-6250-2012; Shi, Xianglin/B-8588-2012; Son, Youngok/AAB-1380-2021; Son, Young-Ok/P-3675-2015	Son, Youngok/0000-0003-0154-4061	National Institutes of Health [R01 ES025515, R01 ES021771, R01 ES020870]; University of Kentucky Markey Cancer Center (National Institutes of Health) [P30CA177558]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021771, R01ES025515, T32ES007266, R01ES020870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kentucky Markey Cancer Center (National Institutes of Health); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants R01 ES025515, R01 ES021771, and R01 ES020870 and the Biospecimen and Tissue Procurement Shared Resource Facility and the Cytometry and Cell Sorting core facility of the University of Kentucky Markey Cancer Center (National Institutes of Health Grant P30CA177558). The authors declare that they have no conflicts of interest with the contents of this article.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Agency for Toxic Substances and Disease Registry, 2013, PRIOR LIST HAZ SUBST; Bode AM, 2002, CRIT REV ONCOL HEMAT, V42, P5, DOI 10.1016/S1040-8428(01)00215-3; Chang QS, 2010, CANCER RES, V70, P5127, DOI 10.1158/0008-5472.CAN-10-0007; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Edwards MR, 2014, CELL REP, V6, P1017, DOI 10.1016/j.celrep.2014.01.043; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Hu R, 2010, ANTIOXID REDOX SIGN, V13, P1679, DOI 10.1089/ars.2010.3276; Hughes MF, 2002, TOXICOL LETT, V133, P1, DOI 10.1016/S0378-4274(02)00084-X; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lau A, 2013, MOL CELL BIOL, V33, P2436, DOI 10.1128/MCB.01748-12; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Nezis IP, 2012, ANTIOXID REDOX SIGN, V17, P786, DOI 10.1089/ars.2011.4394; Son YO, 2012, TOXICOL APPL PHARM, V264, P153, DOI 10.1016/j.taap.2012.07.028; Son YO, 2011, TOXICOL APPL PHARM, V255, P287, DOI 10.1016/j.taap.2011.06.024; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wickre JB, 2004, ARCH ENVIRON HEALTH, V59, P400, DOI 10.3200/AEOH.59.8.400-409	26	28	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27090	27100		10.1074/jbc.M115.675371	http://dx.doi.org/10.1074/jbc.M115.675371			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26385919	Green Published, hybrid			2022-12-28	WOS:000364794000019
J	Schuler, MH; Di Bartolomeo, F; Bottinger, L; Horvath, SE; Wenz, LS; Daum, G; Becker, T				Schuler, Max-Hinderk; Di Bartolomeo, Francesca; Boettinger, Lena; Horvath, Susanne E.; Wenz, Lena-Sophie; Daum, Guenther; Becker, Thomas			Phosphatidylcholine Affects the Role of the Sorting and Assembly Machinery in the Biogenesis of Mitochondrial beta-Barrel Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLETHANOLAMINE METHYLATION PATHWAY; RESPIRATORY-CHAIN SUPERCOMPLEXES; SYNTHETIC LETHAL INTERACTION; OUTER-MEMBRANE BIOGENESIS; GENERAL IMPORT PORE; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLSERINE DECARBOXYLASE; INTERMEMBRANE SPACE; EVOLUTIONARY CONSERVATION; PREPROTEIN TRANSLOCASE	Two protein translocases drive the import of beta-barrel precursor proteins into the mitochondrial outer membrane: The translocase of the outer membrane (TOM complex) promotes transport of the precursor to the intermembrane space, whereas the sorting and assembly machinery (SAM complex) mediates subsequent folding of the beta-barrel and its integration into the target membrane. The non-bilayer-forming phospholipids phosphatidylethanolamine (PE) and cardiolipin (CL) are required for the biogenesis of beta-barrel proteins. Whether bilayer-forming phospholipids such as phosphatidylcholine (PC), the most abundant phospholipid of the mitochondrial outer membrane, play a role in the import of beta-barrel precursors is unclear. In this study, we show that PC is required for stability and function of the SAM complex during the biogenesis of beta-barrel proteins. PC further promotes the SAM-dependent assembly of the TOM complex, indicating a general role of PC for the function of the SAM complex. In contrast to PE-deficient mitochondria precursor accumulation at the TOM complex is not affected by depletion of PC. We conclude that PC and PE affect the function of distinct protein translocases in mitochondrial beta-barrel biogenesis.	[Schuler, Max-Hinderk; Boettinger, Lena; Horvath, Susanne E.; Wenz, Lena-Sophie; Becker, Thomas] Univ Freiburg, Fac Med, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Di Bartolomeo, Francesca; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Becker, Thomas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; Graz University of Technology; University of Freiburg	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at; thomas.becker@biochemie.uni-freiburg.de	Schuler, Max-Hinderk/AAZ-8376-2021; Schuler, Max-Hinderk/AAZ-8388-2021; Becker, Thomas/AAS-9404-2020	Schuler, Max-Hinderk/0000-0002-6734-8250; Di Bartolomeo, Francesca/0000-0002-4302-0701	Deutsche Forschungsgemeinschaft [BE4679/2-1, Sonderforschungsbereich 746]; Excellence Initiative of the German Federal & State Governments [EXC 294 BIOSS]; German Academy of Sciences Leopoldina [LPDS 2013-08]; Austrian Science Fund [P-26133]; Austrian Science Fund (FWF) [P 26133] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal & State Governments; German Academy of Sciences Leopoldina; Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Deutsche Forschungsgemeinschaft (BE4679/2-1), the Sonderforschungsbereich 746, the Excellence Initiative of the German Federal & State Governments (EXC 294 BIOSS), the German Academy of Sciences Leopoldina (LPDS 2013-08, to S. E. H.) and by the Austrian Science Fund (to F. W. F.), Project P-26133 (to G. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Becker T, 2013, J BIOL CHEM, V288, P16451, DOI 10.1074/jbc.M112.442392; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Becker T, 2011, J MOL BIOL, V405, P113, DOI 10.1016/j.jmb.2010.11.002; Becker T, 2010, MOL BIOL CELL, V21, P3106, DOI 10.1091/mbc.E10-06-0518; Birner R, 2003, MOL BIOL CELL, V14, P370, DOI 10.1091/mbc.E02-05-0263; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Dukanovic J, 2011, BBA-BIOMEMBRANES, V1808, P971, DOI 10.1016/j.bbamem.2010.06.021; Dukanovic J, 2009, MOL CELL BIOL, V29, P5975, DOI 10.1128/MCB.00069-09; Endo T, 2010, BBA-MOL CELL RES, V1803, P706, DOI 10.1016/j.bbamcr.2009.11.007; Frazier AE, 2003, MOL CELL BIOL, V23, P7818, DOI 10.1128/MCB.23.21.7818-7828.2003; Gallas MR, 2006, MOL BIOL CELL, V17, P4051, DOI 10.1091/mbc.E06-04-0366; GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; GREENBERG ML, 1983, J BACTERIOL, V153, P791, DOI 10.1128/JB.153.2.791-799.1983; Habib SJ, 2005, J BIOL CHEM, V280, P6434, DOI 10.1074/jbc.M411510200; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Hohr AIC, 2015, BBA-MOL CELL RES, V1853, P74, DOI 10.1016/j.bbamcr.2014.10.006; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Horvath SE, 2012, J BIOL CHEM, V287, P36744, DOI 10.1074/jbc.M112.398107; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Klein A, 2012, J CELL BIOL, V199, P599, DOI 10.1083/jcb.201207161; KODAKI T, 1987, J BIOL CHEM, V262, P15428; KODAKI T, 1989, EUR J BIOCHEM, V185, P243, DOI 10.1111/j.1432-1033.1989.tb15109.x; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Kuroda T, 2011, MOL MICROBIOL, V80, P248, DOI 10.1111/j.1365-2958.2011.07569.x; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Lackey SWK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025650; Lang A, 2015, CURR OPIN CELL BIOL, V35, P7, DOI 10.1016/j.ceb.2015.03.002; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Milenkovic D, 2004, J BIOL CHEM, V279, P22781, DOI 10.1074/jbc.C400120200; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; PREITSCHOPF W, 1993, CURR GENET, V23, P95, DOI 10.1007/BF00352006; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; Sauerwald J, 2015, MOL CELL BIOL, V35, P3200, DOI 10.1128/MCB.00107-15; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Song JY, 2014, EMBO REP, V15, P670, DOI 10.1002/embr.201338142; SPERKAGOTTLIEB CDM, 1988, BIOCHIM BIOPHYS ACTA, V946, P227, DOI 10.1016/0005-2736(88)90397-5; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; SUMMERS EF, 1988, GENETICS, V120, P909; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; Waizenegger T, 2004, EMBO REP, V5, P704, DOI 10.1038/sj.embor.7400183; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Webb CT, 2012, TRENDS MICROBIOL, V20, P612, DOI 10.1016/j.tim.2012.08.006; Wenz LS, 2014, EMBO REP, V15, P678, DOI 10.1002/embr.201338144; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Wideman JG, 2010, MOL BIOL CELL, V21, P1725, DOI 10.1091/mbc.E09-10-0844; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200; Yamano K, 2010, EMBO REP, V11, P187, DOI 10.1038/embor.2009.283; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	86	18	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26523	26532		10.1074/jbc.M115.687921	http://dx.doi.org/10.1074/jbc.M115.687921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26385920	hybrid, Green Published			2022-12-28	WOS:000364793600020
J	Yang, L; Ma, YM; Han, WX; Li, WW; Cui, L; Zhao, XH; Tian, YT; Zhou, ZX; Wang, WG; Wang, HY				Yang, Lan; Ma, Yiming; Han, Wenxiao; Li, Weiwei; Cui, Liang; Zhao, Xinhua; Tian, Yantao; Zhou, Zhixiang; Wang, Wengong; Wang, Hongying			Proteinase-activated Receptor 2 Promotes Cancer Cell Migration through RNA Methylation-mediated Repression of miR-125b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER; BREAST-CANCER; MESSENGER-RNA; EXPRESSION; PROLIFERATION; METASTASIS; INVASION; TRYPSIN; TUMOR; PROTEASE-ACTIVATED-RECEPTOR-1	Proteinase activated-receptor 2 (PAR(2)) participates in cancer metastasis promoted by serine proteinases. The current study aimed to test the molecular mechanism by which PAR(2) promotes cancer cell migration. In different cancer cells, activation of PAR(2) by activating peptide (PAR(2)-AP) dramatically increased cell migration, whereas knock down of PAR(2) inhibited cellular motility. The PAR(2) activation also repressed miR-125b expression while miR-125b mimic successfully blocked PAR(2)-induced cell migration. Moreover, Grb associated-binding protein 2 (Gab2) was identified as a novel target gene of miR-125b and it mediated PAR(2)-induced cell migration. The correlation of PAR(2) with miR-125b and Gab2 was further supported by the findings obtained from human colorectal carcinoma specimens. Remarkably, knock down of NOP2/Sun domain family, member 2 (NSun2), a RNA methyltransferase, blocked the reduction in miR-125b induced by PAR(2). Furthermore, PAR(2) activation increased the level of N-6-methyladenosine (m(6)A)-containing pre-miR-125b in NSun2-dependent manner. Taken together, our results demonstrated that miR-125b mediates PAR(2)-induced cancer cell migration by targeting Gab2 and that NSun2-dependent RNA methylation contributes to the down-regulation of miR-125b by PAR(2) signaling. These findings suggest a novel epigenetic mechanism by which microenvironment regulates cancer cell migration by altering miRNA expression.	[Yang, Lan; Ma, Yiming; Han, Wenxiao; Li, Weiwei; Zhao, Xinhua; Wang, Hongying] Chinese Acad Med Sci, State Key Lab Mol Oncol, Inst Canc, Canc Hosp,Peking Union Med Coll, Beijing 100021, Peoples R China; [Cui, Liang; Tian, Yantao] Chinese Acad Med Sci, Dept Abdominal Surg Oncol, Inst Canc, Canc Hosp,Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhou, Zhixiang] Chinese Acad Med Sci, Dept Gastrointestinal Surg Oncol, Inst Canc, Canc Hosp,Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Wengong] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Peking University	Wang, HY (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Inst Canc, Canc Hosp,Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China.	hongyingwang@cicams.ac.cn		Li, Weiwei/0000-0002-8298-2719; Wang, Hongying/0000-0001-8443-3839	973 National Key Fundamental Research Program of China [2012CB967003]; National Nature Science Foundation of China [81172034, 91129717]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funding from the 973 National Key Fundamental Research Program of China (2012CB967003) and the National Nature Science Foundation of China (81172034 and 91129717). The authors declare that they have no conflicts of interest with the contents of this article.	Amir S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061064; Bera A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106343; Black PC, 2007, PROSTATE, V67, P743, DOI 10.1002/pros.20503; Blanco S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002403; Caruso R, 2006, AM J PATHOL, V169, P268, DOI 10.2353/ajpath.2006.050841; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Dorn J, 2011, ANN ONCOL, V22, P877, DOI 10.1093/annonc/mdq462; Frye M, 2006, CURR BIOL, V16, P971, DOI 10.1016/j.cub.2006.04.027; Gieseler F, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-86; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Guan Y, 2011, INT J CANCER, V128, P2274, DOI 10.1002/ijc.25575; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hu LC, 2013, TUMOR BIOL, V34, P2573, DOI 10.1007/s13277-013-0803-2; Huang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033762; Ji LJ, 2012, CELL RES, V22, P624, DOI 10.1038/cr.2012.36; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Li YY, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-33; Liang LH, 2010, HEPATOLOGY, V52, P1731, DOI 10.1002/hep.23904; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072383; Massi D, 2005, HUM PATHOL, V36, P676, DOI 10.1016/j.humpath.2005.04.008; Matsumura T, 2014, ANN SURG ONCOL, V21, pS743, DOI 10.1245/s10434-014-3889-x; Melillo RM, 2010, ONCOGENE, V29, P6203, DOI 10.1038/onc.2010.348; Nishibori M, 2005, J PHARMACOL SCI, V97, P25, DOI 10.1254/jphs.FMJ04005X5; Nishida N, 2011, INT J ONCOL, V38, P1437, DOI 10.3892/ijo.2011.969; Ohta T, 2003, INT J ONCOL, V23, P61; Saetrom P, 2009, CANCER RES, V69, P7459, DOI 10.1158/0008-5472.CAN-09-1201; Sanchez-Hernandez PE, 2008, GYNECOL ONCOL, V108, P19, DOI 10.1016/j.ygyno.2007.08.083; Schaffner F, 2012, THROMB RES, V129, pS127, DOI 10.1016/S0049-3848(12)70032-4; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Soreide K, 2006, J PATHOL, V209, P147, DOI 10.1002/path.1999; Su S, 2009, ONCOGENE, V28, P3047, DOI 10.1038/onc.2009.163; Tsai KW, 2009, EPIGENETICS-US, V4, P587, DOI 10.4161/epi.4.8.10230; Uusitalo-Jarvinen H, 2007, ARTERIOSCL THROM VAS, V27, P1456, DOI 10.1161/ATVBAHA.107.142539; Versteeg HH, 2008, CANCER RES, V68, P7219, DOI 10.1158/0008-5472.CAN-08-0419; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Wang H, 2008, J BIOL CHEM, V283, P809, DOI 10.1074/jbc.M703021200; Wilson SR, 2004, PROSTATE, V60, P168, DOI 10.1002/pros.20047; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Yada K, 2005, J SURG ONCOL, V89, P79, DOI 10.1002/jso.20197; Yang RX, 2011, BREAST CANCER RES TR, V127, P549, DOI 10.1007/s10549-010-1244-x; Yang S, 2013, ONCOGENE, V32, P4294, DOI 10.1038/onc.2012.432; Yuan S, 2014, MOL CELL BIOL, V34, P3630, DOI 10.1128/MCB.00243-14; Zhang XT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1692; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007	46	44	47	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26627	26637		10.1074/jbc.M115.667717	http://dx.doi.org/10.1074/jbc.M115.667717			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354435	hybrid, Green Published			2022-12-28	WOS:000364793600028
J	Yang, ZF; Wilkie-Grantham, RP; Yanagi, T; Shu, CW; Matsuzawa, S; Reed, JC				Yang, Zhifen; Wilkie-Grantham, Rachel P.; Yanagi, Teruki; Shu, Chih-Wen; Matsuzawa, Shu-ichi; Reed, John C.			ATG4B (Autophagin-1) Phosphorylation Modulates Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATG8-PE DECONJUGATION; PROTEIN LIPIDATION; LC3; BIOGENESIS; SITE; MEMBRANES; GABARAP; PATHWAY; HAMPERS; CLOSURE	Autophagy is a catabolic cellular mechanism for entrapping cellular macromolecules and organelles in intracellular vesicles and degrading their contents by fusion with lysosomes. Important roles for autophagy have been elucidated for cell survival during nutrient insufficiency, eradication of intracellular pathogens, and counteracting aging through clearance of senescent proteins and mitochondria. Autophagic vesicles become decorated with LC3, a protein that mediates their fusion with lysosomes. LC3 is a substrate of the cysteine protease ATG4B (Autophagin-1), where cleavage generates a C-terminal glycine required for LC3 conjugation to lipids in autophagosomes. ATG4B both cleaves pro-LC3 and also hydrolyzes lipids from cleaved LC3. We show here that phosphorylation of ATG4B at Ser-383 and Ser-392 increases its hydrolyase activity as measured using LC3 as a substrate. Reconstituting atg4b(-/-) cells with phosphorylation-deficient ATG4B showed a role of ATG4B phosphorylation in LC3 delipidation and autophagic flux, thus demonstrating that the cellular activity of ATG4B is modulated by phosphorylation. Proteolytic conversion of pro-LC3 to LC3-I was not significantly impacted by ATG4B phosphorylation in cells. Phosphorylation-deficient ATG4B also showed reduced interactions with the lipid-conjugated LC3 but not unconjugated LC3. Taken together, these findings demonstrate a role for Ser-383 and Ser-392 phosphorylation of ATG4B in control of autophagy.	[Yang, Zhifen; Wilkie-Grantham, Rachel P.; Yanagi, Teruki; Shu, Chih-Wen; Matsuzawa, Shu-ichi; Reed, John C.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Yang, Zhifen] Stanford Univ, Dept Radiat Oncol, Palo Alto, CA 94305 USA; [Shu, Chih-Wen] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 813, Taiwan; [Reed, John C.] Roche Innovat Ctr Basel, Pharmaceut Res & Early Dev, Roche, CH-4014 Basel, Switzerland	Sanford Burnham Prebys Medical Discovery Institute; Stanford University; Kaohsiung Veterans General Hospital; Roche Holding	Matsuzawa, S (corresponding author), Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.	smatsuzawa@sbpdiscovery.org; John_C.Reed@roche.com	Yanagi, Teruki/D-4222-2017; Shu, Chih-Wen/AAE-9652-2019; Regan, Clinton/E-6250-2012	Yanagi, Teruki/0000-0003-2196-7600; Shu, Chih-Wen/0000-0002-7774-0002	National Institutes of Health [AI-091967]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI-091967. The authors declare that they have no conflicts of interest with the contents of this article.	Choi KM, 2011, AUTOPHAGY, V7, P1052, DOI 10.4161/auto.7.9.16451; Dai J, 2007, J PROTEOME RES, V6, P250, DOI 10.1021/pr0604155; Fan WL, 2010, AUTOPHAGY, V6, P614, DOI 10.4161/auto.6.5.12189; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Fujita N, 2009, AUTOPHAGY, V5, P88, DOI 10.4161/auto.5.1.7183; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Guo L, 2013, MOL CELL BIOL, V33, P3180, DOI 10.1128/MCB.00193-13; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Ketteler R, 2008, AUTOPHAGY, V4, P801, DOI 10.4161/auto.6401; Ketteler R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r64; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuang E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003007; Kumanomidou T, 2006, J MOL BIOL, V355, P612, DOI 10.1016/j.jmb.2005.11.018; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li M, 2011, J BIOL CHEM, V286, P7327, DOI 10.1074/jbc.M110.199059; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Marino G, 2010, J CLIN INVEST, V120, P2331, DOI 10.1172/JCI42601; Martinez-Lopez N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3799; Nair U, 2012, AUTOPHAGY, V8, P780, DOI 10.4161/auto.19385; Nakatogawa H, 2012, AUTOPHAGY, V8, P177, DOI 10.4161/auto.8.2.18373; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shu CW, 2010, AUTOPHAGY, V6, P936, DOI 10.4161/auto.6.7.13075; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yu ZQ, 2012, AUTOPHAGY, V8, P883, DOI 10.4161/auto.19652	38	67	67	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26549	26561		10.1074/jbc.M115.658088	http://dx.doi.org/10.1074/jbc.M115.658088			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26378241	Green Published, hybrid			2022-12-28	WOS:000364793600022
J	Brown, AC; Dysart, MM; Clarke, KC; Stabenfeldt, SE; Barker, TH				Brown, Ashley C.; Dysart, Marilyn M.; Clarke, Kimberly C.; Stabenfeldt, Sarah E.; Barker, Thomas H.			Integrin alpha 3 beta 1 Binding to Fibronectin Is Dependent on the Ninth Type III Repeat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; SYNERGY SITE; MESENCHYMAL TRANSITION; BIOLOGICAL-ACTIVITY; BETA-CATENIN; RECEPTOR; DOMAINS; BETA-1-INTEGRIN; SPECIFICITY; ADSORPTION	Fibronectin(Fn) is a promiscuous ligand for numerous cell adhesion receptors or integrins. The vast majority of Fn-integrin interactions are mediated through the Fn Arg-Gly-Asp (RGD) motif located within the tenth type III repeat. In the case of integrins alpha IIb beta 3 and alpha 5 beta 1, the integrin binds RGD and the synergy site (PHSRN) located within the adjacent ninth type III repeat. Prior work has shown that these synergy-dependent integrins are exquisitely sensitive to perturbations in the Fn integrin binding domain conformation. Our own prior studies of epithelial cell responses to recombinant fragments of the Fn integrin binding domain led us to hypothesize that integrin alpha 3 beta 1 binding may also be modulated by the synergy site. To explore this hypothesis, we created a variety of recombinant variants of the Fn integrin binding domain: (i) a previously reported (Leu -> Pro) stabilizing mutant (FnIII9'10), (ii) an Arg to Ala synergy site mutation (FnIII9(R)->(A)10), (iii) a two-Gly (FnIII9(2G)10) insertion, and (iv) a four-Gly (FNIII9(4G)10) insertion in the interdomain linker region and used surface plasmon resonance to determine binding kinetics of integrin alpha 3 beta 1 to the Fn fragments. Integrin alpha 3 beta 1 had the highest affinity for FnIII9'10 and FnIII9(2G)10. Mutation within the synergy site decreased integrin alpha 3 beta 1 binding 17-fold, and the four-Gly insertion decreased binding 39-fold compared with FnIII9'10. Cell attachment studies demonstrate that alpha 3 beta 1-mediated epithelial cell binding is greater on FnIII9'10 compared with the other fragments. These studies suggest that the presence and spacing of the RGD and synergy sites modulate integrin alpha 3 beta 1 binding to Fn.	[Brown, Ashley C.] N Carolina State Univ, Dept Biomed Engn, Raleigh, NC 27606 USA; [Brown, Ashley C.] Univ N Carolina, Raleigh, NC 27606 USA; [Dysart, Marilyn M.; Barker, Thomas H.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Dysart, Marilyn M.; Barker, Thomas H.] Emory Univ, Atlanta, GA 30332 USA; [Clarke, Kimberly C.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Stabenfeldt, Sarah E.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA; [Barker, Thomas H.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University of North Carolina; North Carolina State University; University of North Carolina; University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology; Arizona State University; Arizona State University-Tempe; University System of Georgia; Georgia Institute of Technology	Barker, TH (corresponding author), Georgia Tech, Wallace H Coulter Dept Biomed Engn, 950 Atlantic Dr,Ste 4015, Atlanta, GA 30332 USA.	thomas.barker@bme.gatech.edu			National Institutes of Health Grants [R01EB011566, R01HL127283]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011566] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EB011566 and R01HL127283. The authors declare that they have no conflicts of interest with the contents of this article.	Altroff H, 2001, J BIOL CHEM, V276, P38885, DOI 10.1074/jbc.M105868200; Altroff H, 2004, J BIOL CHEM, V279, P55995, DOI 10.1074/jbc.M406976200; AOTA S, 1994, J BIOL CHEM, V269, P24756; Bachan P., 2009, C68 ALVEOLAR EPITHEL, pA4996; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Brown AC, 2013, J PATHOL, V229, P25, DOI 10.1002/path.4114; Brown AC, 2011, TISSUE ENG PT A, V17, P139, DOI 10.1089/ten.TEA.2010.0199; Cao LZ, 2012, P NATL ACAD SCI USA, V109, P7251, DOI 10.1073/pnas.1118088109; Carson AE, 2009, REGEN MED, V4, P593, DOI 10.2217/RME.09.30; Chada D, 2006, ANN BIOMED ENG, V34, P1542, DOI 10.1007/s10439-006-9161-1; Clause KC, 2013, CURR OPIN BIOTECH, V24, P830, DOI 10.1016/j.copbio.2013.04.011; DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612; Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+; ELICES MJ, 1991, J CELL BIOL, V112, P169, DOI 10.1083/jcb.112.1.169; ELICES MJ, 1989, P NATL ACAD SCI USA, V86, P9906, DOI 10.1073/pnas.86.24.9906; ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114; Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159; Herard AL, 1996, AM J PHYSIOL-LUNG C, V271, pL726, DOI 10.1152/ajplung.1996.271.5.L726; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; HUMPHRIES MJ, 1990, J CELL SCI, V97, P585; Joss L, 1998, ANAL BIOCHEM, V261, P203, DOI 10.1006/abio.1998.2744; KAUFMANN R, 1989, J CELL BIOL, V109, P1807, DOI 10.1083/jcb.109.4.1807; Khew ST, 2007, TISSUE ENG, V13, P2451, DOI 10.1089/ten.2007.0063; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim Y, 2009, J CELL BIOL, V184, P309, DOI 10.1083/jcb.200806067; KOTELIANSKY VE, 1981, EUR J BIOCHEM, V119, P619, DOI 10.1111/j.1432-1033.1981.tb05652.x; Krammer A, 2002, MATRIX BIOL, V21, P139, DOI 10.1016/S0945-053X(01)00197-4; Kreidberg JA, 1996, DEVELOPMENT, V122, P3537; Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863; Lubman RL, 2000, AM J PHYSIOL-LUNG C, V279, pL183, DOI 10.1152/ajplung.2000.279.1.L183; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MARDON HJ, 1994, FEBS LETT, V340, P197, DOI 10.1016/0014-5793(94)80137-1; Markowski MC, 2012, J BIOMED MATER RES A, V100A, P2119, DOI 10.1002/jbm.a.34068; Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047; Morton TA, 1998, METHOD ENZYMOL, V295, P268; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; NARASIMHAN C, 1989, BIOCHEMISTRY-US, V28, P5041, DOI 10.1021/bi00438a021; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pereira P, 2008, COLLOID SURFACE B, V64, P1, DOI 10.1016/j.colsurfb.2007.12.015; Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027; PITT WG, 1993, J BIOMAT SCI-POLYM E, V4, P337, DOI 10.1163/156856293X00609; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; RAO SP, 1992, INFECT IMMUN, V60, P3652, DOI 10.1128/IAI.60.9.3652-3657.1992; Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sheppard D, 2003, PHYSIOL REV, V83, P673, DOI 10.1152/physrev.00033.2002; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; SRIRAMARAO P, 1993, J BIOL CHEM, V268, P22036; Stabenfeldt SE, 2010, BLOOD, V116, P1352, DOI 10.1182/blood-2009-11-251801; UNDERWOOD PA, 1993, J CELL SCI, V104, P793; WOLFF C, 1989, ARCH BIOCHEM BIOPHYS, V268, P536, DOI 10.1016/0003-9861(89)90320-2	56	23	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25534	25547		10.1074/jbc.M115.656702	http://dx.doi.org/10.1074/jbc.M115.656702			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26318455	Green Published, hybrid			2022-12-28	WOS:000362962800028
J	Babino, D; Palczewski, G; Widjaja-Adhi, MAK; Kiser, PD; Golczak, M; von Lintig, J				Babino, Darwin; Palczewski, Grzegorz; Widjaja-Adhi, M. Airanthi K.; Kiser, Philip D.; Golczak, Marcin; von Lintig, Johannes			Characterization of the Role of beta-Carotene 9,10-Dioxygenase in Macular Pigment Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-A; ESCHERICHIA-COLI; ZEAXANTHIN SUPPLEMENTATION; OXIDATION-PRODUCTS; ADIPOSE-TISSUE; HUMAN RETINA; DONOR EYES; LUTEIN; PROTEIN; IDENTIFICATION	A family of enzymes collectively referred to as carotenoid cleavage oxygenases is responsible for oxidative conversion of carotenoids into apocarotenoids, including retinoids (vitaminA and its derivatives). A member of this family, the beta-carotene 9,10-dioxygenase (BCO2), converts xanthophylls to rosafluene and ionones. Animals deficient in BCO2 highlight the critical role of the enzyme in carotenoid clearance as accumulation of these compounds occur in tissues. Inactivation of the enzyme by a four-amino acid-long insertion has recently been proposed to underlie xanthophyll concentration in the macula of the primate retina. Here, we focused on comparing the properties of primate and murine BCO2s. We demonstrate that the enzymes display a conserved structural fold and subcellular localization. Low temperature expression and detergent choice significantly affected binding and turnover rates of the recombinant enzymes with various xanthophyll substrates, including the unique macula pigment meso-zeaxanthin. Mice with genetically disrupted carotenoid cleavage oxygenases displayed adipose tissue rather than eye-specific accumulation of supplemented carotenoids. Studies in a human hepatic cell line revealed that BCO2 is expressed as an oxidative stress-induced gene. Our studies provide evidence that the enzymatic function of BCO2 is conserved in primates and link regulation of BCO2 gene expression with oxidative stress that can be caused by excessive carotenoid supplementation.	[Babino, Darwin; Palczewski, Grzegorz; Widjaja-Adhi, M. Airanthi K.; Kiser, Philip D.; Golczak, Marcin; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Kiser, Philip D.] Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	von Lintig, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 2109 Adelbert Rd W341, Cleveland, OH 44106 USA.	johannes.vonlintig@case.edu		Widjaja-Adhi, Made Airanthi K./0000-0002-0589-2605	National Institutes of Health from the NEI [EY020551, EY023948, EY11373, EY007157]; Department of Veterans Affairs Career Development Award [IK2BX002683]; NATIONAL EYE INSTITUTE [R01EY020551, R01EY023948, T32EY007157, P30EY011373] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002683] Funding Source: NIH RePORTER	National Institutes of Health from the NEI; Department of Veterans Affairs Career Development Award(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants EY020551, EY023948, EY11373, and EY007157 from the NEI. This work was also supported by Department of Veterans Affairs Career Development Award IK2BX002683 (to P. D. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Amengual J, 2013, J BIOL CHEM, V288, P34081, DOI 10.1074/jbc.M113.501049; Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Berry SD, 2009, GENETICS, V182, P923, DOI 10.1534/genetics.109.101741; Bhosale P, 2007, INVEST OPHTH VIS SCI, V48, P543, DOI 10.1167/iovs.06-0558; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bone RA, 1997, EXP EYE RES, V64, P211, DOI 10.1006/exer.1996.0210; Bone RA, 2001, INVEST OPHTH VIS SCI, V42, P235; BONE RA, 1988, INVEST OPHTH VIS SCI, V29, P843; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; Hurst JS, 2005, EXP EYE RES, V81, P239, DOI 10.1016/j.exer.2005.04.002; Johnson EJ, 2005, INVEST OPHTH VIS SCI, V46, P692, DOI 10.1167/iovs.02-1192; Kalariya NM, 2008, EXP EYE RES, V86, P70, DOI 10.1016/j.exer.2007.09.010; Khachik F, 1997, ANAL CHEM, V69, P1873, DOI 10.1021/ac961085i; Khachik F, 1997, INVEST OPHTH VIS SCI, V38, P1802; Khachik F, 2006, INVEST OPHTH VIS SCI, V47, P5234, DOI 10.1167/iovs.06-0504; Kiefer C, 2001, J BIOL CHEM, V276, P14110, DOI 10.1074/jbc.M011510200; Kiser PD, 2012, P NATL ACAD SCI USA, V109, pE2747, DOI 10.1073/pnas.1212025109; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Kowatz T, 2013, ARCH BIOCHEM BIOPHYS, V539, P214, DOI 10.1016/j.abb.2013.05.007; Krinsky Norman I., 2005, Molecular Aspects of Medicine, V26, P459; Landrum JT, 1997, EXP EYE RES, V65, P57, DOI 10.1006/exer.1997.0309; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li BX, 2014, P NATL ACAD SCI USA, V111, P10173, DOI 10.1073/pnas.1402526111; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Lindqvist A, 2005, J HISTOCHEM CYTOCHEM, V53, P1403, DOI 10.1369/jhc.5A6705.2005; Lindqvist A, 2007, J NUTR, V137, P2346, DOI 10.1093/jn/137.11.2346; Lobo GP, 2013, J BIOL CHEM, V288, P9017, DOI 10.1074/jbc.M112.444240; Lobo GP, 2012, DEVELOPMENT, V139, P2966, DOI 10.1242/dev.079632; Lobo GP, 2012, BBA-MOL CELL BIOL L, V1821, P78, DOI 10.1016/j.bbalip.2011.04.010; Maeda T, 2011, MOL PHARMACOL, V80, P943, DOI 10.1124/mol.111.074732; Moise AR, 2014, CHEM REV, V114, P164, DOI 10.1021/cr400106y; Mustafi D, 2013, HUM MOL GENET, V22, P2992, DOI 10.1093/hmg/ddt156; Palczewski G, 2014, FASEB J, V28, P4457, DOI 10.1096/fj.14-252411; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Palozza P, 2003, MOL ASPECTS MED, V24, P353, DOI 10.1016/S0098-2997(03)00031-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prasain JK, 2005, J MASS SPECTROM, V40, P916, DOI 10.1002/jms.868; Schalch W, 1992, EXS, V62, P280; Schalch W, 2007, ARCH BIOCHEM BIOPHYS, V458, P128, DOI 10.1016/j.abb.2006.09.032; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Sommer A, 2012, AM J CLIN NUTR, V96, p1204S, DOI 10.3945/ajcn.112.034868; Sui XW, 2014, J BIOL CHEM, V289, P12286, DOI 10.1074/jbc.M114.552836; Vage DI, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-10; Vasina JA, 1997, PROTEIN EXPRES PURIF, V9, P211, DOI 10.1006/prep.1996.0678; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; Voolstra O, 2006, BIOCHEMISTRY-US, V45, P13429, DOI 10.1021/bi060701u; Widjaja-Adhi MAK, 2015, HUM MOL GENET, V24, P3206, DOI 10.1093/hmg/ddv072	53	51	51	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24844	24857		10.1074/jbc.M115.668822	http://dx.doi.org/10.1074/jbc.M115.668822			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26307071	Green Published, hybrid			2022-12-28	WOS:000362598300019
J	Balzano, D; Fawal, MA; Velazquez, JV; Santiveri, CM; Yang, J; Pastor, J; Campos-Olivas, R; Djouder, N; Lietha, D				Balzano, Deborah; Fawal, Mohannad-Ali; Velazquez, Jose V.; Santiveri, Clara M.; Yang, Joshua; Pastor, Joaquin; Campos-Olivas, Ramon; Djouder, Nabil; Lietha, Daniel			Alternative Activation Mechanisms of Protein Kinase B Trigger Distinct Downstream Signaling Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; HYDROPHOBIC MOTIF PHOSPHORYLATION; FOCAL ADHESION KINASE; RICTOR-MTOR COMPLEX; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; BINDING POCKET; DNA-PK; AKT; PDK1; INHIBITOR	Protein kinase B (PKB/Akt) is an important mediator of signals that control various cellular processes including cell survival, growth, proliferation, and metabolism. PKB promotes these processes by phosphorylating many cellular targets, which trigger distinct downstream signaling events. However, how PKB is able to selectively target its substrates to induce specific cellular functions remains elusive. Here we perform a systematic study to dissect mechanisms that regulate intrinsic kinase activity versus mechanisms that specifically regulate activity toward specific substrates. We demonstrate that activation loop phosphorylation and the C-terminal hydrophobic motif are essential for high PKB activity in general. On the other hand, we identify membrane targeting, which for decades has been regarded as an essential step in PKB activation, as a mechanism mainly affecting substrate selectivity. Further, we show that PKB activity in cells can be triggered independently of PI3K by initial hydrophobic motif phosphorylation, presumably through a mechanism analogous to other AGC kinases. Importantly, different modes of PKB activation result in phosphorylation of distinct downstream targets. Our data indicate that specific mechanisms have evolved for signaling nodes, like PKB, to select between various downstream events. Targeting such mechanisms selectively could facilitate the development of therapeutics that might limit toxic side effects.	[Balzano, Deborah; Velazquez, Jose V.; Yang, Joshua; Lietha, Daniel] Spanish Natl Canc Res Ctr, Struct Biol & Biocomp Programme, Cell Signalling & Adhes Grp, E-28029 Madrid, Spain; [Fawal, Mohannad-Ali; Djouder, Nabil] Spanish Natl Canc Res Ctr, Canc Cell Biol Programme, Growth Factors Nutrients & Cancer Grp, E-28029 Madrid, Spain; [Santiveri, Clara M.; Campos-Olivas, Ramon] Spanish Natl Canc Res Ctr, Struct Biol & Biocomp Programme, Spect & Nucl Magnet Resonance Unit, E-28029 Madrid, Spain; [Pastor, Joaquin] Spanish Natl Canc Res Ctr, Expt Therapeut Programme, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Lietha, D (corresponding author), Spanish Natl Canc Res Ctr, Struct Biol & Biocomp Programme, Cell Signalling & Adhes Grp, Calle Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	dlietha@cnio.es	Djouder, Nabil/E-4135-2015; Lietha, Daniel/L-8041-2014; Yang, Joshua Young Cynming/P-6447-2018; Lietha, Daniel/AAD-1952-2022; Campos-Olivas, Ramón/L-9173-2014; Fernandez, Joaquin Pastor/I-4567-2015	Djouder, Nabil/0000-0001-8423-1030; Lietha, Daniel/0000-0002-6133-6486; Yang, Joshua Young Cynming/0000-0003-2410-7817; Lietha, Daniel/0000-0002-6133-6486; Campos-Olivas, Ramón/0000-0002-5743-2221; Fernandez, Joaquin Pastor/0000-0003-0553-8021; Santiveri, Clara M./0000-0001-6095-7224; FAWAL, Mohamad-Ali/0000-0002-2460-0882	Spanish Ministry of Economy and Competitiveness [BFU2010-15923, SAF2010-18518]; Comunidad Autonoma de Madrid [S2010/BMD-2457]; National Cancer Research Centre; La Caixa Foundation; Caja Navara postdoctoral fellowship; Sever Ochoa funds; Spanish Ramon y Cajal fellowship; Ramon y Cajal Program [RYC-2010-06948]; Volkswagen Foundation [Az: 86 416-1]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); National Cancer Research Centre; La Caixa Foundation(La Caixa Foundation); Caja Navara postdoctoral fellowship; Sever Ochoa funds; Spanish Ramon y Cajal fellowship(Spanish Government); Ramon y Cajal Program(Spanish Government); Volkswagen Foundation(Volkswagen)	This work was supported by Spanish Ministry of Economy and Competitiveness Grants BFU2010-15923 (to D. L) and SAF2010-18518 (to N. D.), Comunidad Autonoma de Madrid Grant S2010/BMD-2457 (to D. L and R. C.-O.), and by the National Cancer Research Centre. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an international Ph.D. fellowship from the La Caixa Foundation.; Supported by a Caja Navara postdoctoral fellowship and by Sever Ochoa funds.; Recipient of the Spanish Ramon y Cajal fellowship.; Recipient of Ramon y Cajal Program Award RYC-2010-06948 and Volkswagen Foundation Award Az: 86 416-1. To whom correspondence should be addressed: Cell Signalling and Adhesion Group, Structural Biology and Rio computing Programme, Spanish National Cancer Research Centre, Calle Melchor Fernandez Almagro, 3, E-28029, Madrid, Spain. Tel.: 34-917-328-000, Ext. 3090; Fax: 34-912-246-976; E-mail: dlietha@cnio.es.	Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Ananthanarayanan B, 2007, J BIOL CHEM, V282, P36634, DOI 10.1074/jbc.M706227200; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Bayascas JR, 2006, J BIOL CHEM, V281, P28772, DOI 10.1074/jbc.M606789200; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Cheung M, 2013, CURR CANCER DRUG TAR, V13, P234, DOI 10.2174/1568009611313030002; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Granda TG, 2013, INVEST NEW DRUG, V31, P66, DOI 10.1007/s10637-012-9835-5; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; KOHN AD, 1995, EMBO J, V14, P4288, DOI 10.1002/j.1460-2075.1995.tb00103.x; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Gonzalez SM, 2012, BIOORG MED CHEM LETT, V22, P3460, DOI 10.1016/j.bmcl.2012.03.090; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Najafov A, 2012, BIOCHEM J, V448, P285, DOI 10.1042/BJ20121287; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Waugh C, 2009, MOL CELL BIOL, V29, P5952, DOI 10.1128/MCB.00585-09; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350; Zhou XY, 2014, CELL CYCLE, V13, P3164, DOI 10.4161/15384101.2014.962954; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zurashvili T, 2013, MOL CELL BIOL, V33, P1027, DOI 10.1128/MCB.01052-12	42	12	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24975	24985		10.1074/jbc.M115.651570	http://dx.doi.org/10.1074/jbc.M115.651570			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26286748	Green Published, hybrid			2022-12-28	WOS:000362598300028
J	Karassek, S; Starost, L; Solbach, J; Greune, L; Sano, Y; Kanda, T; Kim, K; Schmidt, MA				Karassek, Sascha; Starost, Laura; Solbach, Johanna; Greune, Lilo; Sano, Yasuteru; Kanda, Takashi; Kim, KwangSik; Schmidt, M. Alexander			Pertussis Toxin Exploits Specific Host Cell Signaling Pathways for Promoting Invasion and Translocation of Escherichia coli K1 RS218 in Human Brain-derived Microvascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PROTEIN-A; CENTRAL-NERVOUS-SYSTEM; ISLET-ACTIVATING PROTEIN; IN-VIVO; NEUROTRANSMITTER RECEPTORS; VASCULAR-PERMEABILITY; BACTERIAL-MENINGITIS; SYMPATHETIC NEURONS; NEONATAL MENINGITIS; ADP-RIBOSYLATION	Pertussis toxin (PTx), an AB5 toxin and major virulence factor of the whooping cough-causing pathogen Bordetella pertussis, has been shown to affect the blood-brain barrier. Dysfunction of the blood-brain barrier may facilitate penetration of bacterial pathogens into the brain, such as Escherichia coli K1 (RS218). In this study, we investigated the influence of PTx on blood-brain barrier permissiveness to E. coli infection using human brain-derived endothelial HBMEC and TY10 cells as in vitro models. Our results indicate that PTx acts at several key points of host cell intracellular signaling pathways, which are also affected by E. coli K1 RS218 infection. Application of PTx increased the expression of the pathogen binding receptor gp96. Further, we found an activation of STAT3 and of the small GTPase Rac1, which have been described as being essential for bacterial invasion involving host cell actin cytoskeleton rearrangements at the bacterial entry site. In addition, we showed that PTx induces a remarkable relocation of VE-cadherin and beta-catenin from intercellular junctions. The observed changes in host cell signaling molecules were accompanied by differences in intracellular calcium levels, which might act as a second messenger system for PTx. In summary, PTx not only facilitates invasion of E. coli K1 RS218 by activating essential signaling cascades; it also affects intercellular barriers to increase paracellular translocation.	[Karassek, Sascha; Starost, Laura; Solbach, Johanna; Greune, Lilo; Schmidt, M. Alexander] Univ Munster, Ctr Mol Biol Inflammat, Inst Infectiol, D-48149 Munster, Germany; [Sano, Yasuteru; Kanda, Takashi] Yamaguchi Univ, Grad Sch Med, Dept Neurol & Clin Neurosci, Yamaguchi, Japan; [Kim, KwangSik] Johns Hopkins Univ, Sch Med, Pediat Infect Dis Div, Baltimore, MD 21287 USA	University of Munster; Yamaguchi University; Johns Hopkins University	Schmidt, MA (corresponding author), Univ Munster, Zentrum Mol Biol Entzundung, Inst Infektiol, Von Esmarch Str 56, D-48149 Munster, Germany.	infekt@uni-muenster.de			Deutsche Forschungsgemeinschaft [DFG SFB629 B03, GRK1409]; Cells-in-Motion Cluster of Excellence [EXC 1003-CiM]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cells-in-Motion Cluster of Excellence	This work was supported by Deutsche Forschungsgemeinschaft Grants DFG SFB629 B03 and GRK1409 and by the Cells-in-Motion Cluster of Excellence (EXC 1003-CiM). The authors declare that they have no conflicts of interest with the contents of this article.	AMIEL SA, 1976, BRIT J EXP PATHOL, V57, P653; Arimoto H, 2000, J NEUROIMMUNOL, V104, P15, DOI 10.1016/S0165-5728(99)00242-8; Armstrong G. D., 1994, INFECT IMMUN, V62, P2236; BRENNAN MJ, 1988, J BIOL CHEM, V263, P4895; Bruckener KE, 2003, J CELL SCI, V116, P1837, DOI 10.1242/jcs.00378; Chen HM, 1997, J NEUROPHYSIOL, V78, P3484, DOI 10.1152/jn.1997.78.6.3484; Croxen MA, 2010, NAT REV MICROBIOL, V8, P26, DOI 10.1038/nrmicro2265; ELBAYA A, 1995, MICROB PATHOGENESIS, V18, P173; Fan HK, 2004, SHOCK, V22, P57, DOI 10.1097/01.shk.0000129759.58490.d6; Geier DA, 2004, BRAIN DEV-JPN, V26, P296, DOI 10.1016/S0387-7604(03)00169-4; Grant CC, 1998, PEDIATRICS, V102, P986, DOI 10.1542/peds.102.4.986; Heininger U, 2004, PEDIATRICS, V114, pE9, DOI 10.1542/peds.114.1.e9; Houdouin V, 2008, ARCH PEDIATRIE, V15, pS138, DOI 10.1016/S0929-693X(08)75497-6; Houdouin V, 2008, CLIN MICROBIOL INFEC, V14, P685, DOI 10.1111/j.1469-0691.2008.02019.x; Jeong SW, 2000, P NATL ACAD SCI USA, V97, P907, DOI 10.1073/pnas.97.2.907; Jeong SW, 1998, NEURON, V21, P1201, DOI 10.1016/S0896-6273(00)80636-4; KATADA T, 1982, J BIOL CHEM, V257, P7210; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; Khan NA, 2002, J BIOL CHEM, V277, P15607, DOI 10.1074/jbc.M112224200; Khan NA, 2007, CELL MICROBIOL, V9, P169, DOI 10.1111/j.1462-5822.2006.00779.x; Kim KJ, 2005, J BIOL CHEM, V280, P1360, DOI 10.1074/jbc.M410176200; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Kim KS, 2001, INFECT IMMUN, V69, P5217, DOI 10.1128/IAI.69.9.5217-5222.2001; Kim KS, 2002, J INFECT DIS, V186, pS220, DOI 10.1086/344284; Kim KS, 2008, NAT REV MICROBIOL, V6, P625, DOI 10.1038/nrmicro1952; Kim YV, 2008, CELL TISSUE RES, V332, P427, DOI 10.1007/s00441-008-0598-4; Krishnan S, 2014, MICROBES INFECT, V16, P540, DOI 10.1016/j.micinf.2014.06.002; Krishnan S, 2014, J INFECT DIS, V209, P409, DOI 10.1093/infdis/jit499; Krishnan S, 2013, CELL MICROBIOL, V15, P63, DOI 10.1111/cmi.12026; Krishnan S, 2012, CELL MICROBIOL, V14, P1415, DOI 10.1111/j.1462-5822.2012.01805.x; Kugler S, 2007, CELL MICROBIOL, V9, P619, DOI 10.1111/j.1462-5822.2006.00813.x; Maeda T., 2013, CLIN EXP NEUROIMMUNO, V4, P326, DOI [10.1111/cen3.12045, DOI 10.1111/CEN3.12045]; Maruvada R, 2008, CELL MICROBIOL, V10, P2326, DOI 10.1111/j.1462-5822.2008.01214.x; Maruvada R, 2012, INFECT IMMUN, V80, P2035, DOI 10.1128/IAI.06320-11; Mittal R, 2010, AM J PATHOL, V176, P1292, DOI 10.2353/ajpath.2010.090851; Mittal R, 2010, CELL MICROBIOL, V12, P67, DOI 10.1111/j.1462-5822.2009.01379.x; Nishida M., 2010, J BIOL CHEM, P285; PRASADARAO NV, 1993, J BIOL CHEM, V268, P10356; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; QUAGLIARELLO V, 1992, NEW ENGL J MED, V327, P864, DOI 10.1056/NEJM199209173271208; Racke MK, 2005, TRENDS IMMUNOL, V26, P289, DOI 10.1016/j.it.2005.03.012; Richard JF, 2011, BRAIN PATHOL, V21, P661, DOI 10.1111/j.1750-3639.2011.00490.x; Sano Y., 2012, CLIN EXP NEUROIMMUNO, V3, P1; Schellenberg AE, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-10; Seidel G, 2011, INT J MED MICROBIOL, V301, P204, DOI 10.1016/j.ijmm.2010.08.018; Shin S, 2005, BIOCHEM BIOPH RES CO, V330, P1199, DOI 10.1016/j.bbrc.2005.03.097; Sukumaran SK, 2003, J INFECT DIS, V188, P1295, DOI 10.1086/379042; Sunakawa Keisuke, 2010, Kansenshogaku Zasshi, V84, P33; Teng CH, 2005, INFECT IMMUN, V73, P2923, DOI 10.1128/IAI.73.5.2923-2931.2005; Toft-Hansen H, 2006, J IMMUNOL, V177, P7242, DOI 10.4049/jimmunol.177.10.7242; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; Wang Y, 2004, MICROB PATHOGENESIS, V37, P287, DOI 10.1016/j.micpath.2004.09.002; Wang Y, 2002, PEDIATR RES, V51, P559, DOI 10.1203/00006450-200205000-00003; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Xie Y, 2004, FEMS IMMUNOL MED MIC, V42, P271, DOI 10.1016/j.femsim.2004.09.001; Zaidi AKM, 2009, CLIN INFECT DIS, V48, pS129, DOI 10.1086/596491	56	6	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24835	24843		10.1074/jbc.M115.650101	http://dx.doi.org/10.1074/jbc.M115.650101			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26324705	Green Published, hybrid			2022-12-28	WOS:000362598300018
J	Florio, P; Folli, C; Cianci, M; Del Rio, D; Zanotti, G; Berni, R				Florio, Paola; Folli, Claudia; Cianci, Michele; Del Rio, Daniele; Zanotti, Giuseppe; Berni, Rodolfo			Transthyretin Binding Heterogeneity and Anti-amyloidogenic Activity of Natural Polyphenols and Their Metabolites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATIVE-STATE STABILIZATION; STRUCTURAL EVIDENCE; THYROXINE; OLIGOMERS; VARIANTS; CURCUMIN; FEATURES; FIBRILS; PLASMA; SYSTEM	Transthyretin (TTR) is an amyloidogenic protein, the amyloidogenic potential of which is enhanced by a number of specific point mutations. The ability to inhibit TTR fibrillogenesis is known for several classes of compounds, including natural polyphenols, which protect the native state of TTR by specifically interacting with its thyroxine binding sites. Comparative analyses of the interaction and of the ability to protect the TTR native state for polyphenols, both stilbenoids and flavonoids, and some of their main metabolites have been carried out. A main finding of this investigation was the highly preferential binding of resveratrol and thyroxine, both characterized by negative binding cooperativity, to distinct sites in TTR, consistent with the data of x-ray analysis of TTR in complex with both ligands. Although revealing the ability of the two thyroxine binding sites of TTR to discriminate between different ligands, this feature has allowed us to evaluate the interactions of polyphenols with both resveratrol and thyroxine preferential binding sites, by using resveratrol and radiolabeled T4 as probes. Among flavonoids, genistein and apigenin were able to effectively displace resveratrol from its preferential binding site, whereas genistein also showed the ability to interact, albeit weakly, with the preferential thyroxine binding site. Several glucuronidated polyphenol metabolites did not exhibit significant competition for resveratrol and thyroxine preferential binding sites and lacked the ability to stabilize TTR. However, resveratrol-3-O-sulfate was able to significantly protect the protein native state. A rationale for the in vitro properties found for polyphenol metabolites was provided by x-ray analysis of their complexes with TTR.	[Florio, Paola; Berni, Rodolfo] Univ Parma, Dept Life Sci, I-43124 Parma, Italy; [Folli, Claudia; Del Rio, Daniele] Univ Parma, Dept Food Sci, I-43124 Parma, Italy; [Cianci, Michele] European Mol Biol Lab, D-22607 Hamburg, Germany; [Zanotti, Giuseppe] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy	University of Parma; University of Parma; European Molecular Biology Laboratory (EMBL); University of Padua	Berni, R (corresponding author), Univ Parma, Dept Life Sci, Parco Area Sci 23-A, I-43124 Parma, Italy.	rodolfo.berni@unipr.it	Cianci, Michele/AAD-7581-2019; Cianci, Michele/I-5577-2012; Del Rio, Daniele/E-8696-2010	Cianci, Michele/0000-0001-5607-6061; Cianci, Michele/0000-0001-5607-6061; Del Rio, Daniele/0000-0001-5394-1259; Berni, Rodolfo/0000-0002-1839-0479	European Community [283570]; MIUR (Ministero Istruzione Universita Ricerca) [2009KN2FBM, 2012A7LMS3_002]; Progetto Agroalimentare E Ricerca Grant [2011-0283]	European Community(European Commission); MIUR (Ministero Istruzione Universita Ricerca)(Ministry of Education, Universities and Research (MIUR)); Progetto Agroalimentare E Ricerca Grant	This work was supported in part by European Community Seventh Framework Program FP7/2007-2013 under Grant 283570 (to BioStruct-X), by MIUR (Ministero Istruzione Universita Ricerca) PRIN (Progetti di Rilevante Interesse Nazionale) Projects 2009KN2FBM and 2012A7LMS3_002, and by Progetto Agroalimentare E Ricerca Grant 2011-0283. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Benson MD, 2007, MUSCLE NERVE, V36, P411, DOI 10.1002/mus.20821; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Bieschke J, 2013, NEUROTHERAPEUTICS, V10, P429, DOI 10.1007/s13311-013-0192-7; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Cendron L, 2009, J BIOL CHEM, V284, P25832, DOI 10.1074/jbc.M109.017657; Cianci M, 2015, ACTA CRYSTALLOGR D, V71, P1582, DOI 10.1107/S1399004715010585; Coelho T, 2013, J NEUROL, V260, P2802, DOI 10.1007/s00415-013-7051-7; Daval M, 2010, AMYLOID, V17, P118, DOI 10.3109/13506129.2010.530008; Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FERGUSON RN, 1975, BIOCHEMISTRY-US, V14, P282, DOI 10.1021/bi00673a014; Ferrao-Gonzales AD, 2003, J MOL BIOL, V328, P963, DOI 10.1016/S0022-2836(03)00368-1; Ge JF, 2012, NEUROCHEM INT, V61, P1192, DOI 10.1016/j.neuint.2012.08.012; Green NS, 2005, P NATL ACAD SCI USA, V102, P14545, DOI 10.1073/pnas.0501609102; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; Hirohata M, 2012, BBA-MOL BASIS DIS, V1822, P1316, DOI 10.1016/j.bbadis.2012.05.006; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Johnson SM, 2005, ACCOUNTS CHEM RES, V38, P911, DOI 10.1021/ar020073i; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Kolstoe SE, 2010, P NATL ACAD SCI USA, V107, P20483, DOI 10.1073/pnas.1008255107; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; MCCUTCHEN SL, 1993, BIOCHEMISTRY-US, V32, P12119, DOI 10.1021/bi00096a024; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Obici L, 2014, EXPERT OPIN INV DRUG, V23, P1239, DOI 10.1517/13543784.2014.922541; Pasquato N, 2007, J MOL BIOL, V366, P711, DOI 10.1016/j.jmb.2006.11.076; Pullakhandam R, 2009, ARCH BIOCHEM BIOPHYS, V485, P115, DOI 10.1016/j.abb.2009.02.013; Rigacci S, 2011, CURR ALZHEIMER RES, V8, P841, DOI 10.2174/156720511798192682; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Trivella DBB, 2012, J STRUCT BIOL, V180, P143, DOI 10.1016/j.jsb.2012.07.008; Trivella DBB, 2010, J STRUCT BIOL, V170, P522, DOI 10.1016/j.jsb.2010.03.002; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wojtczak A, 1996, ACTA CRYSTALLOGR D, V52, P758, DOI 10.1107/S0907444996003046; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Zanotti G, 2013, FEBS LETT, V587, P2325, DOI 10.1016/j.febslet.2013.06.016	38	29	29	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29769	29780		10.1074/jbc.M115.690172	http://dx.doi.org/10.1074/jbc.M115.690172			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26468275	hybrid, Green Published			2022-12-28	WOS:000366614700012
J	Lenzi, GM; Domaoal, RA; Kim, DH; Schinazi, RF; Kim, B				Lenzi, Gina M.; Domaoal, Robert A.; Kim, Dong-Hyun; Schinazi, Raymond F.; Kim, Baek			Mechanistic and Kinetic Differences between Reverse Transcriptases of Vpx Coding and Non-coding Lentiviruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RESTRICTS HIV-1 INFECTION; RNA SECONDARY STRUCTURE; STEADY-STATE; VIRAL REPLICATION; SAMHD1 RESTRICTS; LEUKEMIA-VIRUS; DNA-SYNTHESIS; NUCLEOTIDE INCORPORATION; HUMAN MACROPHAGES	Among lentiviruses, HIV Type 2 (HIV-2) and many simian immunodeficiency virus (SIV) strains replicate rapidly in nondividing macrophages, whereas HIV Type 1 (HIV-1) replication in this cell type is kinetically delayed. The efficient replication capability of HIV-2/SIV in non-dividing cells is induced by a unique, virally encoded accessory protein, Vpx, which proteasomally degrades the host antiviral restriction factor, SAM domain-and HD domain-containing protein 1 (SAMHD1). SAMHD1 is a dNTPase and kinetically suppresses the reverse transcription step of HIV-1 in macrophages by hydrolyzing and depleting cellular dNTPs. In contrast, Vpx, which is encoded by HIV-2/SIV, kinetically accelerates reverse transcription by counteracting SAMHD1 and then elevating cellular dNTP concentration in non-dividing cells. Here, we conducted the presteady-state kinetic analysis of reverse transcriptases (RTs) from two Vpx non-coding and two Vpx coding lentiviruses. At all three sites of the template tested, the two RTs of the Vpx noncoding viruses (HIV-1) displayed higher k(pol) values than the RTs of the Vpx coding HIV-2/SIV, whereas there was no significant difference in the K-d values of these two groups of RTs. When we employed viral RNA templates that induce RT pausing by their secondary structures, the HIV-1 RTs showed more efficient DNA synthesis through pause sites than the HIV-2/SIV RTs, particularly at low dNTP concentrations found in macrophages. This kinetic study suggests that RTs of the Vpx non-coding HIV-1 may have evolved to execute a faster k(pol) step, which includes the conformational changes and incorporation chemistry, to counteract the limited dNTP concentration found in non-dividing cells and still promote efficient viral reverse transcription.	[Lenzi, Gina M.; Domaoal, Robert A.; Schinazi, Raymond F.; Kim, Baek] Emory Univ, Sch Med, Dept Pediat, Ctr Drug Discovery, Atlanta, GA 30322 USA; [Kim, Dong-Hyun; Kim, Baek] Kyung Hee Univ, Coll Pharm, Seoul 02447, South Korea; [Schinazi, Raymond F.] Vet Affairs Med Ctr, Decatur, GA 30033 USA	Emory University; Kyung Hee University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kim, B (corresponding author), Emory Univ, Sch Med, Dept Pediat, Ctr Drug Discovery, Atlanta, GA 30322 USA.	baek.kim@emory.edu	Schinazi, Raymond F/B-6777-2017; Regan, Clinton/E-6250-2012		National Institutes of Health [AI049781, GM104198, MH100999]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI049781, R01AI049781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104198, T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by National Institutes of Health Grants AI049781 (to B. K.), GM104198 (to B. K.), and MH100999 (to R. F. S.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Bjursell G, 1980, Antibiot Chemother (1971), V28, P78; COHEN A, 1983, J BIOL CHEM, V258, P2334; COLLIN M, 1994, VIROLOGY, V200, P114, DOI 10.1006/viro.1994.1169; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Diamond TL, 2003, J BIOL CHEM, V278, P29913, DOI 10.1074/jbc.M211754200; Einolf HJ, 2000, J BIOL CHEM, V275, P16316, DOI 10.1074/jbc.M001291200; Gao F, 1998, J VIROL, V72, P5680, DOI 10.1128/JVI.72.7.5680-5698.1998; Gao F, 2001, AIDS RES HUM RETROV, V17, P675, DOI 10.1089/088922201750236951; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; GUYADER M, 1987, NATURE, V326, P662, DOI 10.1038/326662a0; Hanson MN, 2005, J MOL BIOL, V353, P772, DOI 10.1016/j.jmb.2005.08.065; HIRSCH VM, 1995, J VIROL, V69, P955, DOI 10.1128/JVI.69.2.955-967.1995; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JACKSON RC, 1980, CANCER RES, V40, P1286; Jamburuthugoda VK, 2008, J BIOL CHEM, V283, P9206, DOI 10.1074/jbc.M710149200; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kerr SG, 1997, BIOCHEMISTRY-US, V36, P14064, DOI 10.1021/bi9713862; Kim JK, 1997, J BIOL CHEM, V272, P16769, DOI 10.1074/jbc.272.27.16769; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lenzi GM, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0111-y; MARCON L, 1991, J VIROL, V65, P3938, DOI 10.1128/JVI.65.7.3938-3942.1991; Marko RA, 2013, J PHYS CHEM B, V117, P4560, DOI 10.1021/jp308674g; MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743; MIZRAHI V, 1985, BIOCHEMISTRY-US, V24, P4010, DOI 10.1021/bi00336a031; Moumen A, 2003, J BIOL CHEM, V278, P15973, DOI 10.1074/jbc.M212306200; OBRIEN WA, 1994, J LEUKOCYTE BIOL, V56, P273, DOI 10.1002/jlb.56.3.273; Operario DJ, 2005, VIROLOGY, V335, P106, DOI 10.1016/j.virol.2005.02.010; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Purohit V, 2007, J BIOL CHEM, V282, P12598, DOI 10.1074/jbc.M700043200; REARDON JE, 1992, BIOCHEMISTRY-US, V31, P4473, DOI 10.1021/bi00133a013; ROSEN CA, 1985, P NATL ACAD SCI USA, V82, P6502, DOI 10.1073/pnas.82.19.6502; Skasko M, 2005, J BIOL CHEM, V280, P12190, DOI 10.1074/jbc.M412859200; Skasko M, 2009, BIOCHEMISTRY-US, V48, P5389, DOI 10.1021/bi900346m; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Van Cor-Hosmer SK, 2012, VIROLOGY, V422, P393, DOI 10.1016/j.virol.2011.11.004; Wang Q, 2008, RNA, V14, P2478, DOI 10.1261/rna.1252608; Weiss KK, 2002, J BIOL CHEM, V277, P22662, DOI 10.1074/jbc.M200202200; YU XF, 1991, J VIROL, V65, P5088, DOI 10.1128/JVI.65.9.5088-5091.1991; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30078	30086		10.1074/jbc.M115.691576	http://dx.doi.org/10.1074/jbc.M115.691576			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26483545	Green Published, hybrid			2022-12-28	WOS:000366614700038
J	Mueller, WF; Larsen, LSZ; Garibaldi, A; Hatfield, GW; Hertel, KJ				Mueller, William F.; Larsen, Liza S. Z.; Garibaldi, Angela; Hatfield, G. Wesley; Hertel, Klemens J.			The Silent Sway of Splicing by Synonymous Substitutions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; PRE-MESSENGER-RNA; SINGLE NUCLEOTIDE; DETERMINING GENE; CRITICAL EXON; HUMAN-DISEASE; CODON BIAS; SMN2; MUTATIONS; SELECTION	Alternative splicing diversifies mRNA transcripts in human cells. This sequence-driven process can be influenced greatly by mutations, even those that do not change the protein coding potential of the transcript. Synonymous mutations have been shown to alter gene expression through modulation of splicing, mRNA stability, and translation. Using a synonymous position mutation library in SMN1 exon 7, we show that 23% of synonymous mutations across the exon decrease exon inclusion, suggesting that nucleotide identity across the entire exon has been evolutionarily optimized to support a particular exon inclusion level. Although phylogenetic conservation scores are insufficient to identify synonymous positions important for exon inclusion, an alignment of organisms filtered based on similar exon/intron architecture is highly successful. Although many of the splicing neutral mutations are observed to occur, none of the exon inclusion reducing mutants was found in the filtered alignment. Using the modified phylogenetic comparison as an approach to evaluate the impact on pre-mRNA splicing suggests that up to 45% of synonymous SNPs are likely to alter pre-mRNA splicing. These results demonstrate that coding and pre-mRNA splicing pressures co-evolve and that a modified phylogenetic comparison based on the exon/intron architecture is a useful tool in identifying splice altering SNPs.	Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92619 USA; [Larsen, Liza S. Z.; Hatfield, G. Wesley; Hertel, Klemens J.] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92619 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Hertel, KJ (corresponding author), Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92619 USA.	khertel@uci.edu	Regan, Clinton/E-6250-2012	Hertel, Klemens/0000-0002-7560-9529; Mueller, William/0000-0001-9134-7648	National Institutes of Health [R01 GM62287, F31 Ca171791]; NATIONAL CANCER INSTITUTE [F31CA171791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM62287 (to K. J. H.) and F31 Ca171791 (to A. G.). We declare no competing interests or conflicts of interest in the writing or publishing of this paper.	Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Fox-Walsh KL, 2009, P NATL ACAD SCI USA, V106, P1766, DOI 10.1073/pnas.0813128106; Geib T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008204; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Graveley B. R., 2005, ENCY LIFE SCI; Hertel KJ, 2008, J BIOL CHEM, V283, P1211, DOI 10.1074/jbc.R700035200; HOFFMAN BE, 1992, GENE DEV, V6, P2554, DOI 10.1101/gad.6.12b.2554; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Ke SD, 2008, GENOME RES, V18, P533, DOI 10.1101/gr.070268.107; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lim SR, 2001, J BIOL CHEM, V276, P45476, DOI 10.1074/jbc.M107632200; Lorson CL, 2010, HUM MOL GENET, V19, pR111, DOI 10.1093/hmg/ddq147; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Madocsai C, 2005, MOL THER, V12, P1013, DOI 10.1016/j.ymthe.2005.08.022; Mailman MD, 2002, GENET MED, V4, P20, DOI 10.1097/00125817-200201000-00004; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Miyaso H, 2003, J BIOL CHEM, V278, P15825, DOI 10.1074/jbc.M209271200; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pagani F, 2005, P NATL ACAD SCI USA, V102, P6368, DOI 10.1073/pnas.0502288102; Parmley JL, 2006, MOL BIOL EVOL, V23, P301, DOI 10.1093/molbev/msj035; Pedrotti S, 2010, EMBO J, V29, P1235, DOI 10.1038/emboj.2010.19; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Sauna ZE, 2007, PHARMACOGENOMICS, V8, P527, DOI 10.2217/14622416.8.6.527; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Singh NN, 2004, RNA, V10, P1291, DOI 10.1261/rna.7580704; Singh RN, 2007, RNA BIOL, V4, P7, DOI 10.4161/rna.4.1.4535; Sterne-Weiler T, 2011, GENOME RES, V21, P1563, DOI 10.1101/gr.118638.110; Teng Mingxiang, 2011, BMC Proc, V5 Suppl 9, pS40, DOI 10.1186/1753-6561-5-S9-S40; Willie E, 2004, TRENDS GENET, V20, P534, DOI 10.1016/j.tig.2004.08.014	43	31	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27700	27711		10.1074/jbc.M115.684035	http://dx.doi.org/10.1074/jbc.M115.684035			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26424794	hybrid, Green Published			2022-12-28	WOS:000365757500023
J	Carpenter, BL; Chen, M; Knifley, T; Davis, KA; Harrison, SMW; Stewart, RL; O'Connor, KL				Carpenter, Brittany L.; Chen, Min; Knifley, Teresa; Davis, Kelley A.; Harrison, Susan M. W.; Stewart, Rachel L.; O'Connor, Kathleen L.			Integrin alpha 6 beta 4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PANCREATIC-CANCER; BREAST-CARCINOMA CELLS; EPITHELIAL-CELLS; CHEMOTACTIC MIGRATION; LAMELLAE FORMATION; UP-REGULATION; AMPHIREGULIN; EXPRESSION; ADENOCARCINOMA; ACTIVATION	Background: Integrin alpha 6 beta 4 is overexpressed in pancreatic cancer and enhances invasion. Results: Integrin alpha 6 beta 4 coordinately up-regulates AREG, EREG, and MMP1 through DNA demethylation and NFAT5 that in turn enhances HGF-mediated invasion. Conclusion: Integrin alpha 6 beta 4 stimulates HGF-dependent invasion through autocrine EGFR signaling. Significance: HGF-stimulated invasion is dependent on autocrine EGFR signaling, thus implicating why EGFR inhibitors are effective in a complex tumor microenvironment. Integrin alpha 6 beta 4 is up-regulated in pancreatic adenocarcinomas where it contributes to carcinoma cell invasion by altering the transcriptome. In this study, we found that integrin alpha 6 beta 4 up-regulates several genes in the epidermal growth factor receptor ( EGFR) pathway, including amphiregulin (AREG), epiregulin (EREG), and ectodomain cleavage protease MMP1, which is mediated by promoter demethylation and NFAT5. The correlation of these genes with integrin alpha 6 beta 4 was confirmed in The Cancer Genome Atlas Pancreatic Cancer Database. Based on previous observations that integrin alpha 6 beta 4 cooperates with c-Met in pancreatic cancers, we examined the impact of EGFR signaling on hepatocyte growth factor (HGF)-stimulated migration and invasion. We found that AREG and EREG were required for autocrine EGFR signaling, as knocking down either ligand inhibited HGF-mediated migration and invasion. We further determined that HGF induced secretion of AREG, which is dependent on integrin-growth factor signaling pathways, including MAPK, PI3K, and PKC. Moreover, matrix metalloproteinase activity and integrin alpha 6 beta 4 signaling were required for AREG secretion. Blocking EGFR signaling with EGFR-specific antibodies or an EGFR tyrosine kinase inhibitor hindered HGF-stimulated pancreatic carcinoma cell chemotaxis and invasive growth in three-dimensional culture. Finally, we found that EGFR was phosphorylated in response to HGF stimulation that isdependenton EGF Rkinase activity; however, c-Metphosphorylation in response to HGF was unaffected by EGFR signaling. Taken together, these data illustrate that integrin alpha 6 beta 4 stimulates invasion by promoting autocrine EGFR signaling through transcriptional up-regulation of key EGFR family members and by facilitating HGF-stimulated EGFR ligand secretion. These signaling events, in turn, promote pancreatic carcinoma migration and invasion.	[Carpenter, Brittany L.; Chen, Min; Knifley, Teresa; Davis, Kelley A.; Harrison, Susan M. W.; Stewart, Rachel L.; O'Connor, Kathleen L.] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA; [Carpenter, Brittany L.; O'Connor, Kathleen L.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; [Chen, Min] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40506 USA; [Stewart, Rachel L.] Univ Kentucky, Dept Pathol & Lab Med, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	O'Connor, KL (corresponding author), Univ Kentucky, Markey Canc Ctr, 741 S Limestone St, Lexington, KY 40506 USA.	kloconnor@uky.edu	Regan, Clinton/E-6250-2012; O'Connor, Kathleen L/H-2569-2013	O'Connor, Kathleen L/0000-0002-1088-9734; Stewart, Rachel/0000-0001-8031-5720; Carpenter, Brittany/0000-0002-0372-5811	National Institutes of Health [T32 CA165990, T32 CA160003, IRG-85-001-25, R01 CA109136]; NATIONAL CANCER INSTITUTE [R01CA109136, T32CA160003, T32CA165990] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants T32 CA165990 (to B.L.C.), T32 CA160003 (to R.L.S.), IRG-85-001-25 (to M.C.), and R01 CA109136 (to K.L.O. and M.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Baldys A, 2009, BIOCHEMISTRY-US, V48, P1462, DOI 10.1021/bi801771g; Berquin IM, 2001, ONCOGENE, V20, P4019, DOI 10.1038/sj.onc.1204537; Busser B, 2011, BBA-REV CANCER, V1816, P119, DOI 10.1016/j.bbcan.2011.05.003; Castillo J, 2006, CANCER RES, V66, P6129, DOI 10.1158/0008-5472.CAN-06-0404; Chen M, 2005, ONCOGENE, V24, P5125, DOI 10.1038/sj.onc.1208729; Chen M, 2009, J BIOL CHEM, V284, P1484, DOI 10.1074/jbc.M803997200; CHEN WH, 1982, IN VITRO CELL DEV B, V18, P24; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cline MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02652; Cruz-Monserrate Z, 2008, NEOPLASIA, V10, P408, DOI 10.1593/neo.07868; Cruz-Monserrate Z, 2007, MODERN PATHOL, V20, P656, DOI 10.1038/modpathol.3800782; de Melker AA, 2001, J CELL SCI, V114, P2167; DIRENZO MF, 1995, CANCER RES, V55, P1129; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; EBERT M, 1994, CANCER RES, V54, P3959; Eccles SA, 2011, INT J DEV BIOL, V55, P685, DOI 10.1387/ijdb.113396se; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Gilcrease MZ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-67; Gleason B, 2005, J HISTOCHEM CYTOCHEM, V53, P799, DOI 10.1369/jhc.4B6522.2005; Gschwind A, 2002, CANCER RES, V62, P6329; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; IWAMURA T, 1987, JPN J CANCER RES, V78, P54; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jimeno A, 2008, CANCER RES, V68, P2841, DOI 10.1158/0008-5472.CAN-07-5200; JOHNSON GR, 1992, J CELL BIOL, V118, P741, DOI 10.1083/jcb.118.3.741; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Lipscomb EA, 2005, CANCER RES, V65, P10970, DOI 10.1158/0008-5472.CAN-05-2327; Lipscomb EA, 2005, CANCER METAST REV, V24, P413, DOI 10.1007/s10555-005-5133-4; Liu W, 2007, CLIN CANCER RES, V13, P6788, DOI 10.1158/1078-0432.CCR-07-0547; Logsdon CD, 2003, CANCER RES, V63, P2649; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Mainiero F, 1996, J CELL BIOL, V134, P241, DOI 10.1083/jcb.134.1.241; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Nanjo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084700; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; O'Connor KL, 2012, AM J PHYSIOL-CELL PH, V302, pC605, DOI 10.1152/ajpcell.00095.2011; O'Connor KL, 2001, J BIOL CHEM, V276, P47895, DOI 10.1074/jbc.M107235200; O'Connor KL, 1998, J CELL BIOL, V143, P1749, DOI 10.1083/jcb.143.6.1749; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Park S, 2011, BIOCHEM BIOPH RES CO, V407, P680, DOI 10.1016/j.bbrc.2011.03.075; Plopper George E., 2000, Molecular Cell Biology Research Communications, V4, P129, DOI 10.1006/mcbr.2001.0267; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rathinam R, 2010, CANCER METAST REV, V29, P223, DOI 10.1007/s10555-010-9211-x; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6; SATO KI, 1995, BIOCHEM BIOPH RES CO, V215, P1078, DOI 10.1006/bbrc.1995.2574; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shelly M, 1998, J BIOL CHEM, V273, P10496, DOI 10.1074/jbc.273.17.10496; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; So WK, 2014, FEBS LETT, V588, P3998, DOI 10.1016/j.febslet.2014.09.017; Stabile L. P., 2010, CANCERS BASEL, V1, P2153; Stern KA, 2008, BIOCHEM J, V410, P585, DOI 10.1042/BJ20071505; Sun CH, 2010, J CELL PHYSIOL, V225, P673, DOI 10.1002/jcp.22262; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Tun MT, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-15; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; YOKOYAMA M, 1995, INT J ONCOL, V6, P625; Zahir N, 2003, J CELL BIOL, V163, P1397, DOI 10.1083/jcb.200302023; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200; Zhu ZW, 2000, BIOCHEM BIOPH RES CO, V273, P1019, DOI 10.1006/bbrc.2000.3033	62	22	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27228	27238		10.1074/jbc.M115.686873	http://dx.doi.org/10.1074/jbc.M115.686873			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26381405	Green Published, hybrid			2022-12-28	WOS:000364794000031
J	Fehr, N; Dietz, C; Polyhach, Y; von Hagens, T; Jeschke, G; Paulsen, H				Fehr, Niklas; Dietz, Carsten; Polyhach, Yevhen; von Hagens, Tona; Jeschke, Gunnar; Paulsen, Harald			Modeling of the N-terminal Section and the Lumenal Loop of Trimeric Light Harvesting Complex II (LHCII) by Using EPR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPHYLL-A/B-COMPLEX; AMINO-ACID-RESIDUES; CRYSTAL-STRUCTURE; PROTEIN; STATE; DEER; PHOTOPROTECTION; DOMAIN; CORE	The major light harvesting complex II (LHCII) of green plants plays a key role in the absorption of sunlight, the regulation of photosynthesis, and in preventing photodamage by excess light. The latter two functions are thought to involve the lumenal loop and the N-terminal domain. Their structure and mobility in an aqueous environment are only partially known. Electron paramagnetic resonance (EPR) has been used to measure the structure of these hydrophilic protein domains in detergent-solubilized LHCII. A new technique is introduced to prepare LHCII trimers in which only one monomer is spin-labeled. These heterogeneous trimers allow to measure intra-molecular distances within one LHCII monomer in the context of a trimer by using double electron-electron resonance (DEER). These data together with data from electron spin echo envelope modulation (ESEEM) allowed to model the N-terminal protein section, which has not been resolved in current crystal structures, and the lumenal loop domain. The N-terminal domain covers only a restricted area above the superhelix in LHCII, which is consistent with the "Velcro" hypothesis to explain thylakoid grana stacking (Standfuss, J., van Terwisscha Scheltinga, A. C., Lamborghini, M., and Kuhlbrandt, W. (2005) EMBOJ. 24, 919-928). The conformation of the lumenal loop domain is surprisingly different between LHCII monomers and trimers but not between complexes with and without neoxanthin bound.	[Fehr, Niklas; Dietz, Carsten; Paulsen, Harald] Johannes Gutenberg Univ Mainz, Dept Gen Bot, D-55128 Mainz, Germany; [Polyhach, Yevhen; von Hagens, Tona; Jeschke, Gunnar] ETH, Dept Phys Chem, CH-8093 Zurich, Switzerland	Johannes Gutenberg University of Mainz; Swiss Federal Institutes of Technology Domain; ETH Zurich	Paulsen, H (corresponding author), Johannes Gutenberg Univ Mainz, Dept Gen Bot, D-55128 Mainz, Germany.	paulsen@uni-mainz.de	Paulsen, Harald/D-3742-2011	Jeschke, Gunnar/0000-0001-6853-8585	Schweizer Nationalfonds Grant [200020_14441]; Deutsche Forschungsgemeinschaft Grant [PA 324/9-1]	Schweizer Nationalfonds Grant; Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG))	This work was supported by Schweizer Nationalfonds Grant 200020_14441 (to G. J.) and Deutsche Forschungsgemeinschaft Grant PA 324/9-1 (to H. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Adamian L, 2005, PROTEINS, V59, P496, DOI 10.1002/prot.20456; Alonso-Garcia N, 2015, ACTA CRYSTALLOGR D, V71, P969, DOI 10.1107/S1399004715002485; Belgio E, 2013, PHYS CHEM CHEM PHYS, V15, P12253, DOI 10.1039/c3cp51925b; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Bleicken S, 2014, MOL CELL, V56, P496, DOI 10.1016/j.molcel.2014.09.022; CASHMORE AR, 1984, P NATL ACAD SCI-BIOL, V81, P2960, DOI 10.1073/pnas.81.10.2960; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Dockter C, 2012, J BIOL CHEM, V287, P2915, DOI 10.1074/jbc.M111.307728; Dockter C, 2009, P NATL ACAD SCI USA, V106, P18485, DOI 10.1073/pnas.0906462106; Hagelueken G, 2012, APPL MAGN RESON, V42, P377, DOI 10.1007/s00723-012-0314-0; Hobe S, 2000, EUR J BIOCHEM, V267, P616, DOI 10.1046/j.1432-1327.2000.01060.x; HOBE S, 1994, EMBO J, V13, P3423, DOI 10.1002/j.1460-2075.1994.tb06647.x; Hobe S, 2006, J BIOL CHEM, V281, P25156, DOI 10.1074/jbc.M604828200; Hovmoller S, 2002, ACTA CRYSTALLOGR D, V58, P768, DOI 10.1107/S0907444902003359; Ilioaia C, 2011, J BIOL CHEM, V286, P27247, DOI 10.1074/jbc.M111.234617; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2005, J BIOL CHEM, V280, P18623, DOI 10.1074/jbc.M501171200; Jeschke G, 2004, APPL MAGN RESON, V26, P223, DOI 10.1007/BF03166574; Jeschke G, 2013, PROG NUCL MAG RES SP, V72, P42, DOI 10.1016/j.pnmrs.2013.03.001; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Kucerka N, 2008, BIOPHYS J, V95, P2356, DOI 10.1529/biophysj.108.132662; Lillington JED, 2011, J MOL BIOL, V405, P427, DOI 10.1016/j.jmb.2010.10.053; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Minagawa J, 2011, BBA-BIOENERGETICS, V1807, P897, DOI 10.1016/j.bbabio.2010.11.005; Pan XW, 2013, CURR OPIN STRUC BIOL, V23, P515, DOI 10.1016/j.sbi.2013.04.004; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Polyhach Y, 2012, PHYS CHEM CHEM PHYS, V14, P10762, DOI 10.1039/c2cp41520h; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Raba M, 2014, STRUCTURE, V22, P769, DOI 10.1016/j.str.2014.03.011; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruhle W, 2004, METH MOL B, V274, P93; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Shabestari MH, 2014, BIOPHYS J, V106, P1349, DOI 10.1016/j.bpj.2013.11.4506; SHIMANOUCHI T, 1955, J CHEM PHYS, V23, P707, DOI 10.1063/1.1742083; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; SUGETA H, 1967, BIOPOLYMERS, V5, P673, DOI 10.1002/bip.1967.360050708; Sunku K, 2013, J BIOL CHEM, V288, P19796, DOI 10.1074/jbc.M113.456111; Volkov A, 2009, BIOPHYS J, V96, P1124, DOI 10.1016/j.bpj.2008.09.047; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Zubik M, 2011, BBA-BIOENERGETICS, V1807, P1237, DOI 10.1016/j.bbabio.2011.06.011	41	18	18	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26007	26020		10.1074/jbc.M115.669804	http://dx.doi.org/10.1074/jbc.M115.669804			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26316535	Green Published, hybrid			2022-12-28	WOS:000363527300022
J	Mori, Y; Akita, K; Yashiro, M; Sawada, T; Hirakawa, K; Murata, T; Nakada, H				Mori, Yugo; Akita, Kaoru; Yashiro, Masakazu; Sawada, Tetsuji; Hirakawa, Kosei; Murata, Takeomi; Nakada, Hiroshi			Binding of Galectin-3, a beta-Galactoside-binding Lectin, to MUC1 Protein Enhances Phosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) and Akt, Promoting Tumor Cell Malignancy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; INTERCELLULAR-ADHESION MOLECULE-1; LUNG-CANCER CELLS; KAPPA-B P65; CIRCULATING GALECTIN-3; BREAST-CANCER; ANTIGEN; METASTASIS; EXPRESSION; PATHWAYS	Both mucin 1 (MUC1) and galectin-3 are known to be over-expressed in various malignant tumors and associated with a poor prognosis. It has been extensively reported that MUC1 is involved in potentiation of growth factor-dependent signal transduction. Because some carbohydrate moieties carried on MUC1 change to preferable ones for binding of galectin-3 in cancer cells, we speculated that MUC1-mediated signaling may occur through direct binding of galectin-3. Immunochemical studies showed that the distribution of galectin-3 coincided with that of MUC1 in various human tumor tissues but not in human nonmalignant tissues, and the level of galectin-3 retained on the surface of various cancer cells paralleled that of MUC1. Treatment of MUC1-expressing cells with galectin-3 induced phosphorylation of ERK1/2 and Akt following enhanced phosphorylation of MUC1 C-terminal domain, consistently promoting tumor cell malignancy. It is also noted that this enhanced phosphorylation occurred independently of EGF receptor-mediated signaling in both EGF receptor-and MUC1-expressing cells, and multivalency of galectin-3 was important for initiation of MUC1-mediated signaling. Expectedly, both silencing of endogenous galectin-3 and treatment with galectin-3 antagonists down-regulated cell proliferation of MUC1-expressing cells. These results suggest that the binding of galectin-3 to MUC1 plays a key role in MUC1-mediated signaling. Thus, constitutive activation of MUC1-mediated signaling in an autocrine/paracrine manner caused by ligation of galectin-3 promotes uncontrolled tumor cell malignancy. This signaling may be another MUC1-mediated pathway and function in parallel with a growth factor-dependent MUC1-mediated signaling pathway.	[Mori, Yugo; Akita, Kaoru; Nakada, Hiroshi] Kyoto Sangyo Univ, Dept Mol Biosci, Fac Life Sci, Kyoto 6038555, Japan; [Akita, Kaoru; Yashiro, Masakazu; Sawada, Tetsuji] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 5458585, Japan; [Yashiro, Masakazu] Osaka City Univ, Grad Sch Med, Oncol Inst Geriatr & Med Sci, Osaka 5458585, Japan; [Murata, Takeomi] Shizuoka Univ, Fac Agr, Dept Appl Biol Chem, Shizuoka 4228529, Japan	Kyoto Sangyo University; Osaka Metropolitan University; Osaka Metropolitan University; Shizuoka University	Nakada, H (corresponding author), Kyoto Sangyo Univ, Dept Mol Biosci, Fac Life Sci, Kita Ku, Kyoto 6038555, Japan.	hnakada@cc.kyoto-su.ac.jp			Fugaku Trust for Medical Research; Private University Strategic Research Foundation Support Program	Fugaku Trust for Medical Research; Private University Strategic Research Foundation Support Program	This work was supported by a grants-in-aid of the Fugaku Trust for Medical Research and the Private University Strategic Research Foundation Support Program. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; BECKER JW, 1989, P NATL ACAD SCI USA, V86, P1088, DOI 10.1073/pnas.86.3.1088; Bian CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025007; BRAMWELL ME, 1986, J CELL SCI, V86, P249; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Cascio S, 2011, J BIOL CHEM, V286, P42248, DOI 10.1074/jbc.M111.297630; Chauhan D, 2005, CANCER RES, V65, P8350, DOI 10.1158/0008-5472.CAN-05-0163; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; Dam TK, 2005, BIOCHEMISTRY-US, V44, P12564, DOI 10.1021/bi051144z; Davidson PJ, 2002, GLYCOBIOLOGY, V12, P329, DOI 10.1093/glycob/12.5.329; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Gao XG, 2014, ONCOTARGET, V5, P2077, DOI 10.18632/oncotarget.1786; GENDLER S, 1988, J BIOL CHEM, V263, P12820; Glinskii OV, 2012, NEOPLASIA, V14, P65, DOI 10.1593/neo.111544; HERRMANN J, 1993, J BIOL CHEM, V268, P26704; Hidari KIPJ, 2008, GLYCOBIOLOGY, V18, P779, DOI 10.1093/glycob/cwn067; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Honjo Y, 2001, CLIN CANCER RES, V7, P661; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; John CM, 2003, CLIN CANCER RES, V9, P2374; Kato K, 2007, AM J PHYSIOL-LUNG C, V293, pL686, DOI 10.1152/ajplung.00423.2006; Kharbanda A, 2014, CLIN CANCER RES, V20, P5423, DOI 10.1158/1078-0432.CCR-13-3168; Kinlough CL, 2004, J BIOL CHEM, V279, P53071, DOI 10.1074/jbc.M409360200; KUFE D, 1984, HYBRIDOMA, V3, P223, DOI 10.1089/hyb.1984.3.223; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; LIGTENBERG MJL, 1992, J BIOL CHEM, V267, P6171; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lloyd KO, 1996, J BIOL CHEM, V271, P33325, DOI 10.1074/jbc.271.52.33325; Mahanta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002054; Merlin J, 2011, ONCOGENE, V30, P2514, DOI 10.1038/onc.2010.631; Mori Y, 2014, J BIOL CHEM, V289, P35193, DOI 10.1074/jbc.M114.586461; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Ochieng J, 1998, BIOCHEM BIOPH RES CO, V246, P788, DOI 10.1006/bbrc.1998.8708; PANDEY P, 1995, CANCER RES, V55, P4000; Parry S, 2001, BIOCHEM BIOPH RES CO, V283, P715, DOI 10.1006/bbrc.2001.4775; Rahn JJ, 2004, J BIOL CHEM, V279, P29386, DOI 10.1074/jbc.C400010200; Raina D, 2012, INT J ONCOL, V40, P1644, DOI 10.3892/ijo.2011.1308; Raina D, 2011, MOL CANCER THER, V10, P806, DOI 10.1158/1535-7163.MCT-10-1050; Ramasamy S, 2007, MOL CELL, V27, P992, DOI 10.1016/j.molcel.2007.07.031; Ren J, 2006, MOL CANCER RES, V4, P873, DOI 10.1158/1541-7786.MCR-06-0204; SATO S, 1994, J BIOL CHEM, V269, P4424; Saussez S, 2008, ORAL ONCOL, V44, P86, DOI 10.1016/j.oraloncology.2006.12.014; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Senapati S, 2010, TRENDS BIOCHEM SCI, V35, P236, DOI 10.1016/j.tibs.2009.10.003; Shen Q, 2008, MOL CANCER RES, V6, P555, DOI 10.1158/1541-7786.MCR-07-2033; SIDDIQUI J, 1988, P NATL ACAD SCI USA, V85, P2320, DOI 10.1073/pnas.85.7.2320; SPARROW CP, 1987, J BIOL CHEM, V262, P7383; Streetly MJ, 2010, BLOOD, V115, P3939, DOI 10.1182/blood-2009-10-251660; Tanida S, 2014, BBA-GEN SUBJECTS, V1840, P1790, DOI 10.1016/j.bbagen.2014.02.008; Tanida S, 2013, J BIOL CHEM, V288, P31842, DOI 10.1074/jbc.M113.471318; van den Brule F, 2002, GLYCOCONJUGATE J, V19, P537, DOI 10.1023/B:GLYC.0000014083.48508.6a; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yang RY, 1998, BIOCHEMISTRY-US, V37, P4086, DOI 10.1021/bi971409c; Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096	62	34	36	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26125	26140		10.1074/jbc.M115.651489	http://dx.doi.org/10.1074/jbc.M115.651489			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26342075	Green Published, hybrid			2022-12-28	WOS:000363527300032
J	Kiyotake, R; Oh-hora, M; Ishikawa, E; Miyamoto, T; Ishibashi, T; Yamasaki, S				Kiyotake, Ryoko; Oh-hora, Masatsugu; Ishikawa, Eri; Miyamoto, Tomofumi; Ishibashi, Tatsuro; Yamasaki, Sho			Human Mincle Binds to Cholesterol Crystals and Triggers Innate Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTINS; NLRP3 INFLAMMASOME; STERILE INFLAMMATION; ACTIVATING RECEPTOR; HOST-DEFENSE; CORD FACTOR; CELL-DEATH; ATHEROSCLEROSIS; RECOGNITION; IDENTIFICATION	C-type lectin receptors (CLRs) are an emerging family of pattern recognition receptors that recognizes pathogens or damaged tissue to trigger innate immune responses. However, endogenous ligands for CLRs are not fully understood. In this study, we sought to identify an endogenous ligand(s) for human macrophage-inducible C-type lectin (hMincle). A particular fraction of lipid extracts from liver selectively activated reporter cells expressing hMincle. MS analysis determined the chemical structure of the active component as cholesterol. Purified cholesterol in plate-coated and crystalized forms activates reporter cells expressing hMincle but not murine Mincle (mMincle). Cholesterol crystals are known to activate immune cells and induce inflammatory responses through lysosomal damage. However, direct innate immune receptors for cholesterol crystals have not been identified. Murine macrophages transfected with hMincle responded to cholesterol crystals by producing pro-inflammatory cytokines. Human dendritic cells expressed a set of inflammatory genes in response to cholesterol crystals, and this was inhibited by anti-human Mincle. Importantly, other related CLRs did not bind cholesterol crystals, whereas other steroids were not recognized by hMincle. These results suggest that cholesterol crystals are an endogenous ligand for hMincle and that they activate innate immune responses.	[Kiyotake, Ryoko; Oh-hora, Masatsugu; Ishikawa, Eri; Yamasaki, Sho] Kyushu Univ, Med Inst Bioregulat, Res Ctr Infect Dis, Div Mol Immunol, Fukuoka 8128582, Japan; [Kiyotake, Ryoko; Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka 8128582, Japan; [Miyamoto, Tomofumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Nat Prod Chem, Fukuoka 8128582, Japan; [Yamasaki, Sho] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba 2608673, Japan	Kyushu University; Kyushu University; Kyushu University; Chiba University	Yamasaki, S (corresponding author), Kyushu Univ, Med Inst Bioregulat, Res Ctr Infect Dis, Div Mol Immunol,Higashi Ku, Rm 309,Stn 2 Collaborat Res,3-1-1 Maidashi, Fukuoka 8128582, Japan.	yamasaki@bioreg.kyushu-u.ac.jp			Ono Medical Research Foundation;  [40312946]	Ono Medical Research Foundation; 	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (40312946) and Ono Medical Research Foundation (to S. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Bae YS, 2009, CIRC RES, V104, P210, DOI 10.1161/CIRCRESAHA.108.181040; Desel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053531; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Feinberg H, 2013, J BIOL CHEM, V288, P28457, DOI 10.1074/jbc.M113.497149; Freigang S, 2013, NAT IMMUNOL, V14, P1045, DOI 10.1038/ni.2704; Freigang S, 2011, EUR J IMMUNOL, V41, P2040, DOI 10.1002/eji.201041316; Furukawa A, 2013, P NATL ACAD SCI USA, V110, P17438, DOI 10.1073/pnas.1312649110; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Gimpl G, 2010, SUBCELL BIOCHEM, V51, P1, DOI 10.1007/978-90-481-8622-8_1; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Hasegawa M, 2009, J IMMUNOL, V182, P7655, DOI 10.4049/jimmunol.0800448; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Jegouzo SAF, 2014, GLYCOBIOLOGY, V24, P1291, DOI 10.1093/glycob/cwu072; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Lim RS, 2011, J LIPID RES, V52, P2177, DOI 10.1194/jlr.M018077; Masumoto M, 1999, J IMMUNOL, V163, P5039; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Neumann K, 2014, IMMUNITY, V40, P389, DOI 10.1016/j.immuni.2013.12.015; Ory DS, 2004, CIRC RES, V95, P660, DOI 10.1161/01.RES.0000143422.83209.be; Osorio F, 2011, IMMUNITY, V34, P651, DOI 10.1016/j.immuni.2011.05.001; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Sancho D, 2013, CURR OPIN IMMUNOL, V25, P46, DOI 10.1016/j.coi.2012.12.007; Saric M, 2011, CURR OPIN CARDIOL, V26, P472, DOI 10.1097/HCO.0b013e32834b7fdd; Schweneker K, 2013, IMMUNOBIOLOGY, V218, P664, DOI 10.1016/j.imbio.2012.07.029; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Shenderov K, 2013, J IMMUNOL, V190, P5722, DOI 10.4049/jimmunol.1203343; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yasukawa S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4755	37	86	89	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25322	25332		10.1074/jbc.M115.645234	http://dx.doi.org/10.1074/jbc.M115.645234			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26296894	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000362962800011
J	Lin, YH; Doms, AG; Cheng, E; Kim, B; Evans, TR; Machner, MP				Lin, Yi-Han; Doms, Alexandra G.; Cheng, Eric; Kim, Byoungkwan; Evans, Timothy R.; Machner, Matthias P.			Host Cell-catalyzed S-Palmitoylation Mediates Golgi Targeting of the Legionella Ubiquitin Ligase GobX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PALMITOYLATION; PNEUMOPHILA GENOME; EFFECTOR PROTEINS; FATTY-ACYLATION; GTPASE RAB1; LOCALIZATION; SYSTEM; FAMILY; 2-BROMOPALMITATE; TRAFFICKING	The facultative intracellular pathogen Legionella pneumophila, the causative agent of Legionnaires disease, infects and replicates within human alveolar macrophages. L. pneumophila delivers almost 300 effector proteins into the besieged host cell that alter signaling cascades and create conditions that favor intracellular bacterial survival. In order for the effectors to accomplish their intracellular mission, their activity needs to be specifically directed toward the correct host cell protein or target organelle. Here, we show that the L. pneumophila effector GobX possesses E3 ubiquitin ligase activity that is mediated by a central region homologous to mammalian U-box domains. Furthermore, we demonstrate that GobX exploits host cell S-palmitoylation to specifically localize to Golgi membranes. The hydrophobic palmitate moiety is covalently attached to a cysteine residue at position 175, which is part of an amphipathic alpha-helix within the C-terminal region of GobX. Site-directed mutagenesis of cysteine 175 or residues on the hydrophobic face of the amphipathic helix strongly attenuated palmitoylation and Golgi localization of GobX. Together, our study provides evidence that the L. pneumophila effector GobX exploits two post-translational modification pathways of host cells, ubiquitination and S-palmitoylation.	[Lin, Yi-Han; Doms, Alexandra G.; Cheng, Eric; Kim, Byoungkwan; Evans, Timothy R.; Machner, Matthias P.] Eunice Kennedy Shriver NICHD, Microbial Pathogenesis Unit, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Machner, MP (corresponding author), Eunice Kennedy Shriver NICHD, Cell Biol & Metab Program, Bldg 18,Rm 101,18 Lib Dr, Bethesda, MD 20892 USA.	machnerm@mail.nih.gov	Lin, Yi-Han/Q-6352-2018	Machner, Matthias/0000-0002-6971-7451; Lin, Yi-Han/0000-0002-0469-8069	National Institutes of Health from the Intramural Research Program [1ZIAHD008893-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008893] Funding Source: NIH RePORTER	National Institutes of Health from the Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant 1ZIAHD008893-04 from the Intramural Research Program. The authors declare that they have no conflicts of interest with the contents of this article.	BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Charron G, 2009, CURR OPIN CHEM BIOL, V13, P382, DOI 10.1016/j.cbpa.2009.07.010; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Conibear E, 2010, J CELL SCI, V123, P4007, DOI 10.1242/jcs.059287; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; Davda D, 2013, ACS CHEM BIOL, V8, P1912, DOI 10.1021/cb400380s; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Derre I, 2004, INFECT IMMUN, V72, P3048, DOI 10.1128/IAI.72.5.3048-3053.2004; Dowen RH, 2009, J BIOL CHEM, V284, P15867, DOI 10.1074/jbc.M900519200; Ensminger AW, 2010, INFECT IMMUN, V78, P3905, DOI 10.1128/IAI.00344-10; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gaspar AH, 2014, P NATL ACAD SCI USA, V111, P4560, DOI 10.1073/pnas.1316376111; Ge JN, 2011, CELL MICROBIOL, V13, P1870, DOI 10.1111/j.1462-5822.2011.01710.x; Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0303s04, 10.1002/0471143030.cb0305s06, 10.1002/0471143030.cb0304s04]; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Henry SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095021; Hernandez JL, 2013, CURR OPIN CHEM BIOL, V17, P20, DOI 10.1016/j.cbpa.2012.11.023; Hicks SW, 2011, CELL HOST MICROBE, V10, P9, DOI 10.1016/j.chom.2011.06.003; Hsu FS, 2014, P NATL ACAD SCI USA, V111, P10538, DOI 10.1073/pnas.1402605111; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Ivanov SS, 2010, J BIOL CHEM, V285, P34686, DOI 10.1074/jbc.M110.170746; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Ku B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003082; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; Kubori T, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00145; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lucas M, 2014, P NATL ACAD SCI USA, V111, pE3514, DOI 10.1073/pnas.1405391111; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Neunuebel MR, 2012, J BACTERIOL, V194, P1389, DOI 10.1128/JB.06306-11; Neunuebel MR, 2011, SCIENCE, V333, P453, DOI 10.1126/science.1207193; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Ohno Y, 2012, MOL BIOL CELL, V23, P4543, DOI 10.1091/mbc.E12-05-0336; Price CTD, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00131; Ragaz C, 2008, CELL MICROBIOL, V10, P2416, DOI 10.1111/j.1462-5822.2008.01219.x; Reinicke AT, 2005, J BIOL CHEM, V280, P14620, DOI 10.1074/jbc.M500076200; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Schroeder G. N., 2015, INFECT IMMUN, DOI [10.1128/IAI.00785-1, DOI 10.1128/IAI.00785-1]; Shevchuk O, 2009, INT J MED MICROBIOL, V299, P489, DOI 10.1016/j.ijmm.2009.03.006; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Urwyler S, 2009, TRAFFIC, V10, P76, DOI 10.1111/j.1600-0854.2008.00851.x; Voth DE, 2012, FUTURE MICROBIOL, V7, P241, DOI [10.2217/fmb.11.150, 10.2217/FMB.11.150]; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046; Yount JS, 2013, CURR OPIN CHEM BIOL, V17, P27, DOI 10.1016/j.cbpa.2012.11.008; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou QJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4552	62	42	44	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25766	25781		10.1074/jbc.M115.637397	http://dx.doi.org/10.1074/jbc.M115.637397			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26316537	hybrid, Green Published			2022-12-28	WOS:000362962800047
J	Chen, JX; Ray, EC; Yates, ME; Buck, TM; Brodsky, JL; Kinlough, CL; Winarski, KL; Hughey, RP; Kleyman, TR; Sheng, SH				Chen, Jingxin; Ray, Evan C.; Yates, Megan E.; Buck, Teresa M.; Brodsky, Jeffrey L.; Kinlough, Carol L.; Winarski, Katie L.; Hughey, Rebecca P.; Kleyman, Thomas R.; Sheng, Shaohu			Functional Roles of Clusters of Hydrophobic and Polar Residues in the Epithelial Na+ Channel Knuckle Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNEL; ALPHA-SUBUNIT; EXTRACELLULAR DOMAIN; SURFACE EXPRESSION; SELF-INHIBITION; PEPTIDE; BINDING; FURIN; ENAC; DEGRADATION	The extracellular regions of epithelial Na+ channel subunits are highly ordered structures composed of domains formed by alpha helices and beta strands. Deletion of the peripheral knuckle domain of the alpha subunit in the alpha beta gamma trimer results in channel activation, reflecting an increase in channel open probability due to a loss of the inhibitory effect of external Na+ (Na+ self-inhibition). In contrast, deletion of either the beta or gamma subunit knuckle domain within the alpha beta gamma trimer dramatically reduces epithelial Na+ channel function and surface expression, and impairs subunit maturation. We systematically mutated individual alpha subunit knuckle domain residues and assessed functional properties of these mutants. Cysteine substitutions at 14 of 28 residues significantly suppressed Na+ self-inhibition. The side chains of a cluster of these residues are non-polar and are predicted to be directed toward the palm domain, whereas a group of polar residues are predicted to orient their side chains toward the space between the knuckle and finger domains. Among the mutants causing the greatest suppression of Na+ self-inhibition were alpha P521C, alpha I529C, and alpha S534C. The introduction of Cys residues at homologous sites within either the beta or gamma subunit knuckle domain resulted in little or no change in Na+ self-inhibition. Our results suggest that multiple residues in the gamma subunit knuckle domain contribute to the mechanism of Na+ self-inhibition by interacting with palm and finger domain residues via two separate and chemically distinct motifs.	[Chen, Jingxin; Ray, Evan C.; Kinlough, Carol L.; Winarski, Katie L.; Hughey, Rebecca P.; Kleyman, Thomas R.; Sheng, Shaohu] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Yates, Megan E.; Buck, Teresa M.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Hughey, Rebecca P.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kleyman, TR (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, 3550 Terrace St, Pittsburgh, PA 15261 USA.	kleyman@pitt.edu	Sheng, Shaohu/G-7052-2016; Regan, Clinton/E-6250-2012; Ray, Evan/H-8143-2019	Sheng, Shaohu/0000-0002-7198-1702; Ray, Evan/0000-0003-1491-4869; Yates, Megan/0000-0002-5932-1592; Buck, Teresa/0000-0002-9013-9756	National Institutes of Health [R01 ES014701, R37 DK051391, R01 DK098204, R01 GM075061, T32 DK061296, P30 DK079307, K01 DK90195]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK061296, K01DK090195, R37DK051391, R01DK098204, P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES014701, R37 DK051391, R01 DK098204, R01 GM075061, T32 DK061296, P30 DK079307, and K01 DK90195. The authors declare that they have no conflicts of interest with the contents of this article.	Adams A, 1997, METHODS YEAST GENETI; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Buck TM, 2013, J BIOL CHEM, V288, P18366, DOI 10.1074/jbc.M113.469882; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Chen JX, 2014, AM J PHYSIOL-RENAL, V306, pF561, DOI 10.1152/ajprenal.00587.2013; Chen JX, 2013, AM J PHYSIOL-RENAL, V304, pF207, DOI 10.1152/ajprenal.00563.2012; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Edelheit O, 2011, AM J PHYSIOL-RENAL, V300, pF887, DOI 10.1152/ajprenal.00648.2010; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Hallows KR., 2012, SELDIN GIEBISCHS KID, P983; Heidrich E, 2015, J BIOL CHEM, V290, P11569, DOI 10.1074/jbc.M115.640763; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2012, EXP CELL RES, V318, P1011, DOI 10.1016/j.yexcr.2012.02.024; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Shi Shujie, 2013, Curr Mol Pharmacol, V6, P28; Shi S, 2012, J BIOL CHEM, V287, P44027, DOI 10.1074/jbc.M112.421743; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; Soundararajan R, 2010, J BIOL CHEM, V285, P30363, DOI 10.1074/jbc.R110.155341; VANDRIESSCHE W, 1985, PHYSIOL REV, V65, P833, DOI 10.1152/physrev.1985.65.4.833; Wang ZJ, 2013, AM J PHYSIOL-CELL PH, V305, pC846, DOI 10.1152/ajpcell.00133.2013; Warnock DG, 2014, NAT REV NEPHROL, V10, P146, DOI 10.1038/nrneph.2013.275; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	44	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25140	25150		10.1074/jbc.M115.665398	http://dx.doi.org/10.1074/jbc.M115.665398			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26306034	Green Published, hybrid			2022-12-28	WOS:000362598300041
J	McDermott, SM; Guo, XM; Carnes, J; Stuart, K				McDermott, Suzanne M.; Guo, Xuemin; Carnes, Jason; Stuart, Kenneth			Differential Editosome Protein Function between Life Cycle Stages of Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA EDITING COMPLEX; PUMILIO-HOMOLOGY DOMAIN; NADH DEHYDROGENASE; MITOCHONDRIAL BIOGENESIS; DEVELOPMENTAL REGULATION; DISTINCT EDITOSOMES; TRANSCRIPTS; BINDING; ENDONUCLEASE; SUBUNIT	Uridine insertion and deletion RNA editing generates functional mitochondrial mRNAs in Trypanosoma brucei. The mRNAs are differentially edited in bloodstream form (BF) and procyclic form (PF) life cycle stages, and this correlates with the differential utilization of glycolysis and oxidative phosphorylation between the stages. The mechanism that controls this differential editing is unknown. Editing is catalyzed by multiprotein similar to 20S editosomes that contain endonuclease, 3'-terminal uridylyltransferase, exonuclease, and ligase activities. These editosomes also contain KREPB5 and KREPA3 proteins, which have no functional catalytic motifs, but they are essential for parasite viability, editing, and editosome integrity in BF cells. We show here that repression of KREPB5 or KREPA3 is also lethal in PF, but the effects on editosome structure differ from those in BF. In addition, we found that point mutations in KREPB5 or KREPA3 differentially affect cell growth, editosome integrity, and RNA editing between BF and PF stages. These results indicate that the functions of KREPB5 and KREPA3 editosome proteins are adjusted between the life cycle stages. This implies that these proteins are involved in the processes that control differential editing and that the 20S editosomes differ between the life cycle stages.	[McDermott, Suzanne M.; Guo, Xuemin; Carnes, Jason; Stuart, Kenneth] Ctr Infect Dis Res, Seattle Biomed Res Inst, Seattle, WA 98109 USA	Center for Infectious Disease Research; Walter Reed Army Institute of Research (WRAIR)	Stuart, K (corresponding author), Ctr Infect Dis Res, Seattle Biomed Res Inst, Seattle, WA 98109 USA.	ken.stuart@cidresearch.org	Regan, Clinton/E-6250-2012; McDermott, Suzanne/P-6392-2019	McDermott, Suzanne/0000-0003-2158-1695; Carnes, Jason/0000-0001-7302-1935	National Institutes of Health [R01 AI014102]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI014102 (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ammerman ML, 2012, NUCLEIC ACIDS RES, V40, P5637, DOI 10.1093/nar/gks211; Ammerman ML, 2011, RNA, V17, P865, DOI 10.1261/rna.2446311; Aphasizhev R, 2011, WIRES RNA, V2, P669, DOI 10.1002/wrna.82; Aphasizheva I, 2014, MOL CELL BIOL, V34, P4329, DOI 10.1128/MCB.01075-14; Archer SK, 2009, MOL BIOCHEM PARASIT, V164, P100, DOI 10.1016/j.molbiopara.2008.11.003; Barrett B, 2004, EXP PARASITOL, V106, P37, DOI 10.1016/j.exppara.2004.01.004; BHAT GJ, 1990, CELL, V61, P885, DOI 10.1016/0092-8674(90)90199-O; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brecht M, 2005, MOL CELL, V17, P621, DOI 10.1016/j.molcel.2005.01.018; Brenndorfer M, 2010, MOL BIOCHEM PARASIT, V172, P52, DOI 10.1016/j.molbiopara.2010.03.007; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Carnes J, 2012, RNA, V18, P1897, DOI 10.1261/rna.035048.112; Carnes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033405; Carnes J, 2011, J BIOL CHEM, V286, P19320, DOI 10.1074/jbc.M111.228965; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Cysewski P, 2008, PHYS CHEM CHEM PHYS, V10, P2636, DOI 10.1039/b718394a; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Ernst NL, 2003, MOL CELL, V11, P1525, DOI 10.1016/S1097-2765(03)00185-0; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; Goringer HU, 2012, ANNU REV MICROBIOL, V66, P65, DOI 10.1146/annurev-micro-092611-150150; Gull K, 2001, INT J PARASITOL, V31, P443, DOI 10.1016/S0020-7519(01)00154-0; Guo XM, 2008, MOL CELL BIOL, V28, P6939, DOI 10.1128/MCB.01115-08; Guo XM, 2012, RNA, V18, P308, DOI 10.1261/rna.029314.111; Guo XM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008913; Hendriks E, 2000, BIOCHEM SOC T, V28, P531, DOI 10.1042/bst0280531; KOSLOWSKY DJ, 1992, MOL CELL BIOL, V12, P2043, DOI 10.1128/MCB.12.5.2043; KOSLOWSKY DJ, 1990, CELL, V62, P901, DOI 10.1016/0092-8674(90)90265-G; KUMAR NV, 1984, BIOPOLYMERS, V23, P2009, DOI 10.1002/bip.360231015; Law JA, 2008, RNA, V14, P1187, DOI 10.1261/rna.899508; Lerch M, 2012, EUKARYOT CELL, V11, P832, DOI 10.1128/EC.00046-12; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; Madina BR, 2014, RNA, V20, P1142, DOI 10.1261/rna.044495.114; Merritt C, 2013, MOL BIOCHEM PARASIT, V190, P44, DOI 10.1016/j.molbiopara.2013.05.002; Niemann M, 2008, NUCLEIC ACIDS RES, V36, P4465, DOI 10.1093/nar/gkn410; Niemann M, 2009, NUCLEIC ACIDS RES, V37, P1897, DOI 10.1093/nar/gkp049; Panigrahi AK, 2003, J AM SOC MASS SPECTR, V14, P728, DOI 10.1016/S1044-0305(03)00126-0; Panigrahi AK, 2003, RNA, V9, P484, DOI 10.1261/rna.2194603; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Panigrahi AK, 2001, MOL CELL BIOL, V21, P380, DOI 10.1128/MCB.21.2.380-389.2001; Panigrahi AK, 2006, RNA, V12, P1038, DOI 10.1261/rna.45506; Park YJ, 2012, J STRUCT BIOL, V180, P362, DOI 10.1016/j.jsb.2012.07.012; Park YJ, 2012, NUCLEIC ACIDS RES, V40, P6966, DOI 10.1093/nar/gks369; PRIEST JW, 1994, J BIOENERG BIOMEMBR, V26, P179, DOI 10.1007/BF00763067; Qiu C, 2014, P NATL ACAD SCI USA, V111, P18554, DOI 10.1073/pnas.1407634112; Reifur L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012235; RILEY GR, 1995, NUCLEIC ACIDS RES, V23, P708, DOI 10.1093/nar/23.4.708; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scahill MD, 2008, MOL BIOCHEM PARASIT, V157, P73, DOI 10.1016/j.molbiopara.2007.10.003; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Schnaufer A, 2010, J BIOL CHEM, V285, P5282, DOI 10.1074/jbc.M109.059378; Schneider A, 2001, INT J PARASITOL, V31, P1403, DOI 10.1016/S0020-7519(01)00296-X; SHAPIRO TA, 1995, ANNU REV MICROBIOL, V49, P117, DOI 10.1146/annurev.mi.49.100195.001001; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; SOUZA AE, 1993, MOL CELL BIOL, V13, P6832, DOI 10.1128/MCB.13.11.6832; SOUZA AE, 1992, MOL CELL BIOL, V12, P2100, DOI 10.1128/MCB.12.5.2100; STUART K, 1992, INT REV CYTOL, V141, P65, DOI 10.1016/S0074-7696(08)62063-X; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; Stuart Kenneth, 2004, Methods Mol Biol, V265, P273; Trotter JR, 2005, MOL CELL, V20, P403, DOI 10.1016/j.molcel.2005.09.016; Valley CT, 2012, P NATL ACAD SCI USA, V109, P6054, DOI 10.1073/pnas.1200521109; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Wang BB, 2003, EUKARYOT CELL, V2, P578, DOI 10.1128/EC.2.3.578-587.2003; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang XQ, 2001, MOL CELL, V7, P855, DOI 10.1016/S1097-2765(01)00229-5; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P6392, DOI 10.1093/nar/gkg870; Zamore PD, 1997, RNA, V3, P1421	71	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24914	24931		10.1074/jbc.M115.669432	http://dx.doi.org/10.1074/jbc.M115.669432			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26304125	Green Published, hybrid			2022-12-28	WOS:000362598300024
J	Robb, M; Robb, CS; Higgins, MA; Hobbs, JK; Paton, JC; Boraston, AB				Robb, Melissa; Robb, Craig S.; Higgins, Melanie A.; Hobbs, Joanne K.; Paton, James C.; Boraston, Alisdair B.			A Second beta-Hexosaminidase Encoded in the Streptococcus pneumoniae Genome Provides an Expanded Biochemical Ability to Degrade Host Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; N-ACETYLHEXOSAMINIDASE; GLYCOSIDE HYDROLASE; D-GLUCOSAMINIDASE; PROTEIN; GENE; SPECIFICITY; CHITOBIASE; STRH; ACETYLGLUCOSAMINIDASE	An important facet of the interaction between the pathogen Streptococcus pneumoniae (pneumococcus) and its human host is the ability of this bacterium to process host glycans. To achieve cleavage of the glycosidic bonds in host glycans, S. pneumoniae deploys a wide array of glycoside hydrolases. Here, we identify and characterize a new family 20 glycoside hydrolase, GH20C, from S. pneumoniae. Recombinant GH20C possessed the ability to hydrolyze the beta-linkages joining either N-acetylglucosamine or N-acetylgalactosamine to a wide variety of aglycon residues, thus revealing this enzyme to be a generalist N-acetylhexosaminidase in vitro. X-ray crystal structures were determined for GH20C in a ligand-free form, in complex with the N-acetylglucosamine and N-acetylgalactosamine products of catalysis and in complex with both gluco-and galacto-configured inhibitors O-(2-acetamido-2-deoxy-D-glucopyranosylidene) amino N-phenyl carbamate (PUGNAc), O-(2-acetamido2-deoxy-D-galactopyranosylidene) amino N-phenyl carbamate (GalPUGNAc), N-acetyl-D-glucosamine-thiazoline (NGT), and N-acetyl-D-galactosamine-thiazoline (GalNGT) at resolutions from 1.84 to 2.7 angstrom. These structures showed N-acetylglucosamine and N-acetylgalactosamine to be recognized via identical sets of molecular interactions. Although the same sets of interaction were maintained with the gluco-and galacto-configured inhibitors, the inhibition constants suggested preferred recognition of the axial O4 when an aglycon moiety was present (K-i for PUGNAc > GalPUGNAc) but preferred recognition of an equatorial O4 when the aglycon was absent (Ki for GalNGT > NGT). Overall, this study reveals GH20C to be another tool that is unique in the arsenal of S. pneumoniae and that it may implement the effort of the bacterium to utilize and/or destroy the wide array of host glycans that it may encounter.	[Robb, Melissa; Robb, Craig S.; Hobbs, Joanne K.; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Higgins, Melanie A.; Paton, James C.] Univ Adelaide, Sch Biol Sci, Res Ctr Infect Dis, Adelaide, SA 5005, Australia	University of Victoria; University of Adelaide	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca		Robb, Craig/0000-0002-4563-3827; Hobbs, Joanne/0000-0001-5239-8039; Boraston, Alisdair/0000-0001-6417-0592	Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; Department of Energy Office of Biological and Environmental Research; National Institutes of Health, NCRR, Biomedical Technology Program [P41RR001209]; NIGMS; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NCRR, Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the staff at the Canadian Light Source and the Stanford Synchrotron Radiation Lightsource (SSRL) beam-lines where diffraction data were collected. The Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. SSRL is a Directorate of SLAG National Accelerator Laboratory and an Office of Science User Facility operated for the United States Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, NCRR, Biomedical Technology Program Grant P41RR001209, and the NIGMS. We thank Dr. David Vocadlo for helpful discussion.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barik S, 1996, Methods Mol Biol, V57, P203; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bohle LA, 2011, FEMS MICROBIOL LETT, V325, P123, DOI 10.1111/j.1574-6968.2011.02419.x; Bricker AL, 1999, FEMS MICROBIOL LETT, V172, P131, DOI 10.1016/S0378-1097(99)00027-0; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Burnaugh AM, 2008, J BACTERIOL, V190, P221, DOI 10.1128/JB.01251-07; Chan PF, 2003, J BACTERIOL, V185, P2051, DOI 10.1128/JB.185.6.2051-2058.2003; CLARKE VA, 1995, J BIOL CHEM, V270, P8805, DOI 10.1074/jbc.270.15.8805; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Drouillard S, 1997, BIOCHEM J, V328, P945, DOI 10.1042/bj3280945; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandes MJG, 1997, J BIOL CHEM, V272, P814, DOI 10.1074/jbc.272.2.814; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Harty DWS, 2004, BIOCHEM BIOPH RES CO, V319, P439, DOI 10.1016/j.bbrc.2004.05.015; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Hepbildikler ST, 2002, J BIOL CHEM, V277, P2562, DOI 10.1074/jbc.M105457200; HORSCH M, 1991, EUR J BIOCHEM, V197, P815, DOI 10.1111/j.1432-1033.1991.tb15976.x; HUGHES RC, 1964, BIOCHEMISTRY-US, V3, P1535, DOI 10.1021/bi00898a025; Jeong JK, 2009, J BACTERIOL, V191, P3011, DOI 10.1128/JB.01601-08; Jiang YL, 2011, J BIOL CHEM, V286, P43004, DOI 10.1074/jbc.M111.256578; Keilani S, 2012, J NEUROSCI, V32, P5223, DOI 10.1523/JNEUROSCI.4860-11.2012; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x; KRESSE H, 1981, J BIOL CHEM, V256, P2926; LACKS S, 1966, GENETICS, V53, P207; Langley DB, 2008, J MOL BIOL, V377, P104, DOI 10.1016/j.jmb.2007.09.028; Limoli DH, 2011, MICROBIOL-SGM, V157, P2369, DOI 10.1099/mic.0.045609-0; Liu TA, 2011, J BIOL CHEM, V286, P4049, DOI 10.1074/jbc.M110.184796; Mahuran DJ, 1999, BBA-MOL BASIS DIS, V1455, P105, DOI 10.1016/S0925-4439(99)00074-5; Manco S, 2006, INFECT IMMUN, V74, P4014, DOI 10.1128/IAI.01237-05; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; McCullers JA, 2001, FRONT BIOSCI-LANDMRK, V6, pD877, DOI 10.2741/McCullers; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Perez-Dorado I, 2012, MOL ORAL MICROBIOL, V27, P221, DOI 10.1111/j.2041-1014.2012.00655.x; Pluvinage B, 2011, STRUCTURE, V19, P1603, DOI 10.1016/j.str.2011.08.011; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Prag G, 2000, J MOL BIOL, V300, P611, DOI 10.1006/jmbi.2000.3906; Ramasubbu N, 2005, J MOL BIOL, V349, P475, DOI 10.1016/j.jmb.2005.03.082; Sakurama H, 2013, J BIOL CHEM, V288, P25194, DOI 10.1074/jbc.M113.484733; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Singh AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004364; Sumida T, 2012, ORG BIOMOL CHEM, V10, P2607, DOI 10.1039/c2ob06636j; Tews I, 1996, NAT STRUCT BIOL, V3, P638, DOI 10.1038/nsb0796-638; Uchiyama S, 2009, J EXP MED, V206, P1845, DOI 10.1084/jem.20090386; Val-Cid C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128075; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; YAMASHITA K, 1981, BIOCHEM BIOPH RES CO, V100, P226, DOI 10.1016/S0006-291X(81)80086-1	52	12	14	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30888	30900		10.1074/jbc.M115.688630	http://dx.doi.org/10.1074/jbc.M115.688630			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26491009	Green Published, hybrid			2022-12-28	WOS:000367199000021
J	Park, JW; Reed, JR; Backes, WL				Park, Ji Won; Reed, James R.; Backes, Wayne L.			The Localization of Cytochrome P450s CYP1A1 and CYP1A2 into Different Lipid Microdomains Is Governed by Their N-terminal and Internal Protein Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE MICRODOMAINS; NADPH; REDUCTION; INSERTION; 1A2; ADAPTATIONS; ACTIVATION; EXPRESSION; VESICLES; DOMAIN	In cellular membranes, different lipid species are heterogeneously distributed forming domains with different characteristics. Ordered domains are tightly packed with cholesterol, sphingomyelin, and saturated fatty acids, whereas disordered domains contain high levels of unsaturated fatty acids. Our laboratory has shown that membrane heterogeneity affects the organization of cytochrome P450s and their cognate redox partner, the cytochrome P450 reductase (CPR). Despite the high degree of sequence similarity, CYP1A1 was found to localize to disordered regions, whereas CYP1A2 resided in ordered domains. We hypothesized that regions of amino acid sequence variability may contain signal motifs that direct CYP1A proteins into ordered or disordered domains. Thus, chimeric constructs of CYP1A1 and CYP1A2 were created, and their localization was tested in HEK293T cells. CYP1A2, containing the N-terminal regions from CYP1A1, no longer localized in ordered domains, whereas the N terminus of CYP1A2 partially directed CYP1A1 into ordered regions. In addition, intact CYP1A2 containing a 206-302-residue peptide segment of CYP1A1 had less affinity to bind to ordered microdomains. After expression, the catalytic activity of CYP1A2 was higher than that of the CYP1A1-CYP1A2 chimera containing the N-terminal end of CYP1A1 with subsaturating CPR concentrations, but it was approximately equal with excess CPR suggesting that the localization of the CYP1A enzyme in ordered domains favored its interaction with CPR. These data demonstrate that both the N-terminal end and an internal region of CYP1A2 play roles in targeting CYP1A2 to ordered domains, and domain localization may influence P450 function under conditions that resemble those found in vivo.	[Backes, Wayne L.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Backes, WL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, 533 Bolivar St, New Orleans, LA 70112 USA.	wbacke@lsuhsc.edu		Park, Ji Won/0000-0002-7308-1986	National Institutes of Health from NIEHS, USPHS [ES004344, ES013648]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R29ES004344, P42ES013648, R01ES004344] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS, USPHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants ES004344 and ES013648 from NIEHS, USPHS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguiar M, 2005, DRUG METAB REV, V37, P379, DOI 10.1081/DMR-200046136; Ahn T, 1998, BIOCHEMISTRY-US, V37, P12860, DOI 10.1021/bi980804f; Ahn T, 2005, BIOCHEMISTRY-US, V44, P9188, DOI 10.1021/bi050051e; BALVERS WG, 1993, EUR J BIOCHEM, V218, P1021, DOI 10.1111/j.1432-1033.1993.tb18461.x; Baylon JL, 2013, J AM CHEM SOC, V135, P8542, DOI 10.1021/ja4003525; BLANCK J, 1984, EUR J BIOCHEM, V144, P509, DOI 10.1111/j.1432-1033.1984.tb08495.x; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Brignac-Huber L, 2011, MOL PHARMACOL, V79, P549, DOI 10.1124/mol.110.068817; Brignac-Huber LM, 2013, DRUG METAB DISPOS, V41, P1896, DOI 10.1124/dmd.113.053611; Cermak L, 2002, J BIOL CHEM, V277, P7955, DOI 10.1074/jbc.M108048200; Cho EY, 2008, FEBS LETT, V582, P1771, DOI 10.1016/j.febslet.2008.04.048; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; EBERHART DC, 1991, ARCH BIOCHEM BIOPHYS, V291, P231, DOI 10.1016/0003-9861(91)90128-6; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Ghosh MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057919; Graham SE, 1999, ARCH BIOCHEM BIOPHYS, V369, P24, DOI 10.1006/abbi.1999.1350; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INGELMANSUNDBERG M, 1983, EUR J BIOCHEM, V134, P157, DOI 10.1111/j.1432-1033.1983.tb07546.x; IngelmanSundberg M, 1996, BIOCHEM BIOPH RES CO, V221, P318, DOI 10.1006/bbrc.1996.0593; Jang HH, 2010, ARCH BIOCHEM BIOPHYS, V493, P143, DOI 10.1016/j.abb.2009.10.012; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Liu JG, 2004, ARCH BIOCHEM BIOPHYS, V424, P33, DOI 10.1016/j.abb.2003.12.040; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; MURAKAMI K, 1994, J BIOCHEM, V116, P164, DOI 10.1093/oxfordjournals.jbchem.a124489; Oesch-Bartlomowicz B, 2001, INT J CANCER, V94, P733, DOI 10.1002/ijc.1517; Park JW, 2014, BIOCHEM J, V464, P241, DOI 10.1042/BJ20140787; PERSCHL A, 1995, J CELL SCI, V108, P1033; PETERSON JA, 1976, J BIOL CHEM, V251, P4010; Popik W, 2004, J BIOL CHEM, V279, P704, DOI 10.1074/jbc.M306380200; Reed James R, 2011, Drug Metab Lett, V5, P6; REMMER H, 1966, MOL PHARMACOL, V2, P187; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; SAKAGUCHI M, 1987, EMBO J, V6, P2425, DOI 10.1002/j.1460-2075.1987.tb02521.x; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; SEQUEIRA DJ, 1994, BBA-PROTEIN STRUCT M, V1207, P179, DOI 10.1016/0167-4838(94)00070-0; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Sirim D, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-34; Wang YQ, 2009, J BIOL CHEM, V284, P5671, DOI 10.1074/jbc.M806104200; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Yamabhai M, 2002, J BIOL CHEM, V277, P24843, DOI 10.1074/jbc.C200277200	44	14	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29449	U399		10.1074/jbc.M115.687103	http://dx.doi.org/10.1074/jbc.M115.687103			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468279	Green Published, hybrid			2022-12-28	WOS:000366613400029
J	Peche, LY; Ladelfa, MF; Toledo, MF; Mano, M; Laiseca, JE; Schneider, C; Monte, M				Peche, Leticia Y.; Ladelfa, Maria F.; Toledo, Maria F.; Mano, Miguel; Laiseca, Julieta E.; Schneider, Claudio; Monte, Martin			Human MageB2 Protein Expression Enhances E2F Transcriptional Activity, Cell Proliferation, and Resistance to Ribotoxic Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; ANDROGEN RECEPTOR; E2F1-INDUCED APOPTOSIS; NEUROTROPHIN RECEPTOR; BINDING-PROTEIN; P53 FUNCTION; MELANOMA; CANCER; ANTIGENS; MAGE-11	MageB2 belongs to the melanoma antigen gene (MAGE-I) family of tumor-specific antigens. Expression of this gene has been detected in human tumors of different origins. However, little is known about the protein function and how its expression affects tumor cell phenotypes. In this work, we found that human MageB2 protein promotes tumor cell proliferation in a p53-independent fashion, as observed both in cultured cells and growing tumors in mice. Gene expression analysis showed that MageB2 enhances the activity of E2F transcription factors. Mechanistically, the activation of E2Fs is related to the ability of MageB2 to interact with the E2F inhibitor HDAC1. Cellular distribution of MageB2 protein includes the nucleoli. Nevertheless, ribotoxic drugs rapidly promote its nucleolar exit. Weshow that MageB2 counteracts E2 Finhibition by ribosomal proteins independently of Mdm2 expression. Importantly, MageB2 plays a critical role in impairing cell cycle arrest in response to Actinomycin D. The data presented here support a relevant function for human MageB2 in cancer cells both under cycling and stressed conditions, presenting a distinct functional feature with respect to other characterized MAGE-I proteins.	Lab Nazl Consorzio Interuniv Biotecnol, I-34149 Trieste, Italy; [Ladelfa, Maria F.; Toledo, Maria F.; Laiseca, Julieta E.; Monte, Martin] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Invest Cient & Tecn, Dept Quim Biol, RA-1428 Buenos Aires, DF, Argentina; [Ladelfa, Maria F.; Toledo, Maria F.; Laiseca, Julieta E.; Monte, Martin] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Invest Cient & Tecn, Inst Quim Biol Ciencias Exactas & Nat, RA-1428 Buenos Aires, DF, Argentina; [Mano, Miguel] Int Ctr Genet Engn & Biotechnol, I-34149 Trieste, Italy; [Schneider, Claudio] Univ Udine, Dipartimento Sci & Tecnol Biomed, I-33100 Udine, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; International Center for Genetic Engineering & Biotechnology (ICGEB); Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Udine	Schneider, C (corresponding author), Lab Nazl Consorzio Interuniv Biotecnol, Area Sci Pk,Padriciano 99, I-34149 Trieste, Italy.	claudio.schneider@lncib.it; mmonte@qb.fcen.uba.ar	Mano, Miguel/A-4462-2013	Mano, Miguel/0000-0003-1922-4824; Monte, Martin/0000-0002-5068-563X; Peche, Leticia Yamila/0000-0002-1666-9433	Ministry of Science and Technology-ANPCyT [PICT12/866]; University of Buenos Aires [UBACyT13/0013BA]; CONICET [PIP13/0411]; FIRB "Oncodiet" Grant [RBAP11LP2W_002]; Associazione Italiana per la Ricerca sul Cancro [AIRC/IG10433]; Instituto Nacional del Cancer fellowship; Consejo de Investigaciones Cientificas y Tecnicas fellowship	Ministry of Science and Technology-ANPCyT; University of Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FIRB "Oncodiet" Grant; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Instituto Nacional del Cancer fellowship; Consejo de Investigaciones Cientificas y Tecnicas fellowship	This work was supported by Ministry of Science and Technology-ANPCyT Grant PICT12/866, University of Buenos Aires Grant UBACyT13/0013BA, and CONICET Grant PIP13/0411 (to M. Monte) and FIRB "Oncodiet" Grant RBAP11LP2W_002 and Associazione Italiana per la Ricerca sul Cancro Grant AIRC/IG10433 (to C. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an Instituto Nacional del Cancer fellowship.; Recipient of a Consejo de Investigaciones Cientificas y Tecnicas fellowship.	Andorfer P, 2011, ONCOGENE, V30, P2679, DOI 10.1038/onc.2010.639; Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Bai S, 2008, MOL HUM REPROD, V14, P107, DOI 10.1093/molehr/gam080; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Berkovich E, 2001, J BIOL CHEM, V276, P42851, DOI 10.1074/jbc.M103596200; Cheng S, 2009, ENDOCR-RELAT CANCER, V16, P455, DOI 10.1677/ERC-09-0002; De Smet C, 1999, MOL CELL BIOL, V19, P7327; Demetrius L, 2005, EMBO REP, V6, pS39, DOI 10.1038/sj.embor.7400422; Donati G, 2011, J CELL SCI, V124, P3017, DOI 10.1242/jcs.086074; Engelmann D, 2010, DRUG RESIST UPDATE, V13, P119, DOI 10.1016/j.drup.2010.06.001; Ladelfa MF, 2012, CANCER LETT, V325, P11, DOI 10.1016/j.canlet.2012.05.031; Fedele M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-17; Galigniana MD, 2004, J BIOL CHEM, V279, P22483, DOI 10.1074/jbc.M402223200; Grandinetti KB, 2008, CELL CYCLE, V7, P1550, DOI 10.4161/cc.7.11.6052; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Hallstrom TC, 2006, GENE DEV, V20, P613, DOI 10.1101/gad.1345006; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; Hans CP, 2003, BLOOD, V101, P2363, DOI 10.1182/blood-2002-07-2298; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Imai T, 2004, HUM PATHOL, V35, P1469, DOI 10.1016/j.humpath.2004.09.014; Jang SJ, 2001, CANCER RES, V61, P7959; Kramer BF, 2005, CANCER BIOL THER, V4, P943; Kuwako K, 2004, J BIOL CHEM, V279, P1703, DOI 10.1074/jbc.M308454200; Laduron S, 2004, NUCLEIC ACIDS RES, V32, P4340, DOI 10.1093/nar/gkh735; Lee TJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000488; Lian YS, 2012, J CANCER RES CLIN, V138, P519, DOI 10.1007/s00432-011-1122-x; Lin YQ, 2012, BIOCHEM J, V443, P779, DOI 10.1042/BJ20112054; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lu HR, 2011, CELL CYCLE, V10, P3317, DOI 10.4161/cc.10.19.17618; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Marcar L, 2010, CANCER RES, V70, P10362, DOI 10.1158/0008-5472.CAN-10-1341; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Monte M, 2006, P NATL ACAD SCI USA, V103, P11160, DOI 10.1073/pnas.0510834103; Muller H, 1997, MOL CELL BIOL, V17, P5508; Novy M, 2005, MOL BIOL CELL, V16, P2181, DOI 10.1091/mbc.E04-11-0975; Ogata K, 2011, ANN SURG ONCOL, V18, P1195, DOI 10.1245/s10434-010-1399-z; Olarte I, 2011, HEMATOLOGY, V16, P368, DOI 10.1179/102453311X13085644680384; Pattani KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045534; Peche LY, 2012, CELL DEATH DIFFER, V19, P926, DOI 10.1038/cdd.2011.173; Sang MX, 2011, VACCINE, V29, P8496, DOI 10.1016/j.vaccine.2011.09.014; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Stanelle J, 2006, TRENDS MOL MED, V12, P177, DOI 10.1016/j.molmed.2006.02.002; Su SF, 2013, J BIOL CHEM, V288, P24809, DOI 10.1074/jbc.M113.468579; Sypniewska RK, 2005, BREAST CANCER RES TR, V91, P19, DOI 10.1007/s10549-004-6454-7; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; van Duin M, 2011, HAEMATOL-HEMATOL J, V96, P1662, DOI 10.3324/haematol.2010.037978; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Wen CJ, 2004, FEBS LETT, V564, P171, DOI 10.1016/S0014-5793(04)00353-9; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Yang B, 2007, J INVEST DERMATOL, V127, P267, DOI 10.1038/sj.jid.5700548; Zhang W, 2014, MOL CELL BIOL, V34, P765, DOI 10.1128/MCB.00878-13; Zhang YX, 2003, NUCLEIC ACIDS RES, V31, P2168, DOI 10.1093/nar/gkg318; Zhou FF, 2008, BIOCHEM BIOPH RES CO, V365, P149, DOI 10.1016/j.bbrc.2007.10.138; Zhou X, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.445122	56	17	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29652	29662		10.1074/jbc.M115.671982	http://dx.doi.org/10.1074/jbc.M115.671982			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468294	hybrid, Green Published			2022-12-28	WOS:000366613400045
J	Bachmann, AL; Mootz, HD				Bachmann, Anne-Lena; Mootz, Henning D.			An Unprecedented Combination of Serine and Cysteine Nucleophiles in a Split Intein with an Atypical Split Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biotechnology; intein; metagenomics; post-translational modification (PTM); protein splicing; site-directed mutagenesis; structural model	SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; HIGHLY EFFICIENT; ADENOSINE-TRIPHOSPHATASE; CHEMICAL-MODIFICATION; DIRECTED EVOLUTION; DNAB INTEIN; PROTEIN; MECHANISM; IDENTIFICATION	Protein splicing mediated by inteins is a self-processive reaction leading to the excision of the internal intein domain from a precursor protein and the concomitant ligation of the flanking sequences, the extein-N and extein-C parts, thereby reconstituting the host protein. Most inteins employ a splicing pathway in which the upstream scissile peptide bond is consecutively rearranged into two thioester or oxoester intermediates before intein excision and rearrangement into the new peptide bond occurs. The catalytically critical amino acids involved at the two splice junctions are cysteine, serine, or threonine. Notably, the only potential combination not observed so far in any of the known or engineered inteins corresponds to the transesterification from an oxoester to a thioester, which suggested that this formal uphill reaction with regard to the thermodynamic stability might be incompatible with intein-mediated catalysis. We show that corresponding mutations also led to inactive gp41-1 and AceL-TerL inteins. We report the novel GOS-TerL split intein identified from metagenomic databases as the first intein harboring the combination of Ser1 and Cys+1 residues. Mutational analysis showed that its efficient splicing reaction indeed follows the shift from oxoester to thioester and thus represents a rare diversion from the canonical pathway. Furthermore, the GOS-TerL intein has an atypical split site close to the N terminus. The Int(N) fragment could be shortened from 37 to 28 amino acids and exchanged with the 25-amino acid Int(N) fragment from the AceL-TerL intein, indicating a high degree of promiscuity of the Int(C) fragment of the GOS-TerL intein.	[Bachmann, Anne-Lena; Mootz, Henning D.] Univ Munster, Inst Biochem, Dept Chem & Pharm, D-48149 Munster, Germany	University of Munster	Mootz, HD (corresponding author), Univ Munster, Inst Biochem, Dept Chem & Pharm, D-48149 Munster, Germany.	Henning.Mootz@uni-muenster.de			Deutsche Forschungsgemeinschaft [MO 1073-3, MO 1073-2, SPP1623]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants MO 1073-3,2 and SPP1623. The authors declare that they have no conflicts of interest with the contents of this article.	Anraku Y, 2005, IUBMB LIFE, V57, P563, DOI 10.1080/15216540500215499; Appleby-Tagoe JH, 2011, J BIOL CHEM, V286, P34440, DOI 10.1074/jbc.M111.277350; Binschik J, 2013, ANGEW CHEM INT EDIT, V52, P4260, DOI 10.1002/anie.201208863; Brenzel S, 2009, CHEMBIOCHEM, V10, P983, DOI 10.1002/cbic.200900039; Carvajal-Vallejos P, 2012, J BIOL CHEM, V287, P28686, DOI 10.1074/jbc.M112.372680; Chong SR, 1998, J BIOL CHEM, V273, P10567, DOI 10.1074/jbc.273.17.10567; Chong SR, 1996, J BIOL CHEM, V271, P22159, DOI 10.1074/jbc.271.36.22159; Dassa B, 2009, NUCLEIC ACIDS RES, V37, P2560, DOI 10.1093/nar/gkp095; DAVIS EO, 1992, CELL, V71, P201, DOI 10.1016/0092-8674(92)90349-H; Dearden AK, 2013, PROTEIN SCI, V22, P557, DOI 10.1002/pro.2236; Dhar T, 2011, CHEM COMMUN, V47, P3063, DOI 10.1039/c0cc04172f; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Du ZM, 2011, J BIOL CHEM, V286, P38638, DOI 10.1074/jbc.M111.290569; Du ZM, 2011, J AM CHEM SOC, V133, P10275, DOI 10.1021/ja203209f; Ghosh I, 2001, J BIOL CHEM, V276, P24051, DOI 10.1074/jbc.M011049200; Hall TMT, 1997, CELL, V91, P85, DOI 10.1016/S0092-8674(01)80011-8; HIRATA R, 1990, J BIOL CHEM, V265, P6726; KANE PM, 1990, SCIENCE, V250, P651, DOI 10.1126/science.2146742; Kawasaki M, 1997, J BIOL CHEM, V272, P15668, DOI 10.1074/jbc.272.25.15668; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kurpiers T, 2008, CHEMBIOCHEM, V9, P2317, DOI 10.1002/cbic.200800319; Kurpiers T, 2007, ANGEW CHEM INT EDIT, V46, P5234, DOI 10.1002/anie.200700719; Lockless SW, 2009, P NATL ACAD SCI USA, V106, P10999, DOI 10.1073/pnas.0902964106; Ludwig C, 2006, ANGEW CHEM INT EDIT, V45, P5218, DOI 10.1002/anie.200600570; Mills KV, 2014, J BIOL CHEM, V289, P14498, DOI 10.1074/jbc.R113.540310; Mizutani R, 2002, J MOL BIOL, V316, P919, DOI 10.1006/jmbi.2001.5357; Mootz HD, 2009, CHEMBIOCHEM, V10, P2579, DOI 10.1002/cbic.200900370; Novikova O, 2014, J BIOL CHEM, V289, P14490, DOI 10.1074/jbc.R114.548255; Oeemig JS, 2012, J MOL BIOL, V421, P85, DOI 10.1016/j.jmb.2012.04.029; Pereira B, 2011, J MOL BIOL, V406, P430, DOI 10.1016/j.jmb.2010.12.024; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Perler FB, 1997, NUCLEIC ACIDS RES, V25, P1087, DOI 10.1093/nar/25.6.1087; Pietrokovski S, 1998, PROTEIN SCI, V7, P64, DOI 10.1002/pro.5560070106; PIETROKOVSKI S, 1994, PROTEIN SCI, V3, P2340, DOI 10.1002/pro.5560031218; Qi XM, 2011, PROTEIN PEPTIDE LETT, V18, P1226, DOI 10.2174/092986611797642760; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Shah NH, 2014, CHEM SCI, V5, P446, DOI 10.1039/c3sc52951g; Shao Y, 1996, BIOCHEMISTRY-US, V35, P3810, DOI 10.1021/bi952592h; Southworth MW, 2000, EMBO J, V19, P5019, DOI 10.1093/emboj/19.18.5019; Thiel IV, 2014, ANGEW CHEM INT EDIT, V53, P1306, DOI 10.1002/anie.201307969; Tori K, 2012, BIOCHEMISTRY-US, V51, P2496, DOI 10.1021/bi201840k; Tori K, 2010, J BIOL CHEM, V285, P2515, DOI 10.1074/jbc.M109.069567; Volkmann G, 2013, CELL MOL LIFE SCI, V70, P1185, DOI 10.1007/s00018-012-1120-4; Wasmuth A, 2013, BIOORGAN MED CHEM, V21, P3495, DOI 10.1016/j.bmc.2013.03.065; Wu H, 1998, BBA-PROTEIN STRUCT M, V1387, P422, DOI 10.1016/S0167-4838(98)00157-5; Wu H, 1998, P NATL ACAD SCI USA, V95, P9226, DOI 10.1073/pnas.95.16.9226; XU MQ, 1993, CELL, V75, P1371, DOI 10.1016/0092-8674(93)90623-X; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x; Yang W, 2001, J AM CHEM SOC, V123, P11004, DOI 10.1021/ja010726a; Zettler J, 2009, FEBS LETT, V583, P909, DOI 10.1016/j.febslet.2009.02.003	52	19	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28792	28804		10.1074/jbc.M115.677237	http://dx.doi.org/10.1074/jbc.M115.677237			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26453311	hybrid, Green Published			2022-12-28	WOS:000365762300021
J	Scott, MC; Sarver, AL; Tomiyasu, H; Cornax, I; Van Etten, J; Varshney, J; O'Sullivan, MG; Subramanian, S; Modiano, JF				Scott, Milcah C.; Sarver, Aaron L.; Tomiyasu, Hirotaka; Cornax, Ingrid; Van Etten, Jamie; Varshney, Jyotika; O'Sullivan, M. Gerard; Subramanian, Subbaya; Modiano, Jaime F.			Aberrant Retinoblastoma (RB)-E2F Transcriptional Regulation Defines Molecular Phenotypes of Osteosarcoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY PROTEINS; YOUNG-ADULT; GENE; RB; EXPRESSION; GROWTH; HETEROZYGOSITY; INHIBITION; ADOLESCENT; P21/WAF-1	We previously identified two distinct molecular subtypes of osteosarcoma through gene expression profiling. These subtypes are associated with distinct tumor behavior and clinical outcomes. Here, we describe mechanisms that give rise to these molecular subtypes. Using bioinformatic analyses, we identified a significant association between deregulation of the retinoblastoma (RB)-E2F pathway and the molecular subtype with worse clinical outcomes. Xenotransplantation models recapitulated the corresponding behavior for each osteosarcoma subtype; thus, we used cell lines to validate the role of the RB-E2F pathway in regulating the prognostic gene signature. Ectopic RB resets the patterns of E2F regulated gene expression in cells derived from tumors with worse clinical outcomes (molecular phenotype 2) to those comparable with those observed in cells derived from tumors with less aggressive outcomes (molecular phenotype 1), providing a functional association between RB-E2F dysfunction and altered gene expression in osteosarcoma. DNA methyltransferase and histone deacetylase inhibitors similarly reset the transcriptional state of the molecular phenotype 2 cells from a state associated with RB deficiency to one seen with RB sufficiency. Our data indicate that deregulation of RB-E2F pathway alters the epigenetic landscape and biological behavior of osteosarcoma.	[Scott, Milcah C.; Sarver, Aaron L.; Tomiyasu, Hirotaka; Cornax, Ingrid; Varshney, Jyotika; O'Sullivan, M. Gerard; Subramanian, Subbaya; Modiano, Jaime F.] Univ Minnesota, Anim Canc Care & Res Program, Minneapolis, MN 55455 USA; [Scott, Milcah C.; Sarver, Aaron L.; Tomiyasu, Hirotaka; Modiano, Jaime F.] Univ Minnesota, Dept Vet Clin Sci, Minneapolis, MN 55455 USA; [Cornax, Ingrid; O'Sullivan, M. Gerard] Univ Minnesota, Dept Vet Populat Med, Minneapolis, MN 55455 USA; [Varshney, Jyotika] Univ Minnesota, Coll Vet Med, Vet Med Grad Program, Minneapolis, MN 55455 USA; [Scott, Milcah C.; Tomiyasu, Hirotaka; Cornax, Ingrid; Van Etten, Jamie; O'Sullivan, M. Gerard; Subramanian, Subbaya; Modiano, Jaime F.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Van Etten, Jamie; Varshney, Jyotika; Subramanian, Subbaya] Univ Minnesota, Sch Med, Dept Surg, Minneapolis, MN 55455 USA; [Modiano, Jaime F.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Modiano, Jaime F.] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Modiano, JF (corresponding author), Univ Minnesota, Masonic Canc Ctr, 420 Delaware St,SE,MMC 806, Minneapolis, MN 55455 USA.	modiano@umn.edu	MODIANO, JAIME/K-3583-2019	MODIANO, JAIME/0000-0001-6398-7648; Tomiyasu, Hirotaka/0000-0001-7708-6218; Subramanian, Subbaya/0000-0002-2544-480X; Varshney, Jyotika/0000-0003-0275-1521	Morris Animal Foundation [D13CA-032]; American Cancer Society [RSG-13-381-01]; Karen Wyckoff Rein in Sarcoma Foundation [2011-1]; Zach Sobiech Fund for Osteosarcoma Research of the Children's Cancer Research Fund; Comparative Medicine Signature Program of the College of Veterinary Medicine, University of Minnesota; National Institutes of Health Comprehensive Cancer Center [P30 CA077598]; University of Minnesota; Cancer Biology Training Grant from the National Institutes of Health [T32 CA09138]; Alvin and June Perlman Chair in Animal Oncology; NATIONAL CANCER INSTITUTE [P30CA077598, T32CA009138] Funding Source: NIH RePORTER	Morris Animal Foundation; American Cancer Society(American Cancer Society); Karen Wyckoff Rein in Sarcoma Foundation; Zach Sobiech Fund for Osteosarcoma Research of the Children's Cancer Research Fund; Comparative Medicine Signature Program of the College of Veterinary Medicine, University of Minnesota; National Institutes of Health Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); Cancer Biology Training Grant from the National Institutes of Health; Alvin and June Perlman Chair in Animal Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Morris Animal Foundation Grant D13CA-032, American Cancer Society Grant RSG-13-381-01, Karen Wyckoff Rein in Sarcoma Foundation Grant 2011-1, the Zach Sobiech Fund for Osteosarcoma Research of the Children's Cancer Research Fund, and the Comparative Medicine Signature Program of the College of Veterinary Medicine, University of Minnesota. National Institutes of Health Comprehensive Cancer Center Support Grant P30 CA077598 to the Masonic Cancer Center provided support for bioinformatics, genomics, flow cytometry, bioimaging, cytogenetics, and comparative pathology services. This work was also supported by donors to the Animal Cancer Care and Research Program of the University of Minnesota, which helped support of the project The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Cancer Biology Training Grant T32 CA09138 from the National Institutes of Health.; Supported by the Alvin and June Perlman Chair in Animal Oncology. To whom correspondence should be addressed: Masonic Cancer Center, Univ. of Minnesota, 420 Delaware St., SE, MMC 806, Minneapolis, MN 55455. Tel,: 612-625-7436; Fax: 612-626-4915; E-mail: modiano@umn.edu.	Ashizawa S, 2001, J BIOL CHEM, V276, P11362, DOI 10.1074/jbc.M007992200; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; ChitkoMcKown CG, 1997, J LEUKOCYTE BIOL, V62, P430, DOI 10.1002/jlb.62.4.430; Dobson J. M., 2013, ISRN VET SCI, V2013, DOI DOI 10.1155/2013/941275); Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Feugeas O, 1996, J CLIN ONCOL, V14, P467, DOI 10.1200/JCO.1996.14.2.467; Fiorentino FP, 2013, J CELL PHYSIOL, V228, P276, DOI 10.1002/jcp.24141; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gorlick R, 2013, PEDIATR BLOOD CANCER, V60, P1009, DOI 10.1002/pbc.24429; Harbour JW, 2000, CURR OPIN CELL BIOL, V12, P685, DOI 10.1016/S0955-0674(00)00152-6; Heinsohn S, 2007, INT J ONCOL, V30, P1205; Janeway KA, 2012, CLIN CANCER RES, V18, P5837, DOI 10.1158/1078-0432.CCR-12-0875; Janeway KA, 2012, CANCER-AM CANCER SOC, V118, P4597, DOI 10.1002/cncr.27414; Jubala CM, 2005, VET PATHOL, V42, P468, DOI 10.1354/vp.42-4-468; Karlsson EK, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r132; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim JH, 2014, EXP CELL RES, V323, P155, DOI 10.1016/j.yexcr.2014.02.020; Kimura M, 2004, BIOCHEM BIOPH RES CO, V316, P930, DOI 10.1016/j.bbrc.2004.01.178; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Lukas J, 1997, GENE DEV, V11, P1479, DOI 10.1101/gad.11.11.1479; Maitra A, 2001, INT J CANCER, V95, P34, DOI 10.1002/1097-0215(20010120)95:1<34::AID-IJC1006>3.0.CO;2-V; Mann DJ, 1996, CURR BIOL, V6, P474, DOI 10.1016/S0960-9822(02)00515-8; Martin Jeff W., 2012, Sarcoma, V2012, P627254, DOI 10.1155/2012/627254; Modiano JF, 2006, GENE THER MOL BIOL, V10A, P31; Modiano JF, 2012, MOL THER, V20, P2234, DOI 10.1038/mt.2012.149; Modiano JF, 2000, J IMMUNOL, V165, P6693, DOI 10.4049/jimmunol.165.12.6693; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Park YB, 2002, CANCER GENET CYTOGEN, V133, P105, DOI 10.1016/S0165-4608(01)00575-1; Rainusso N, 2013, CURR ONCOL REP, V15, P296, DOI 10.1007/s11912-013-0321-9; Ranieri G, 2013, CRIT REV ONCOL HEMAT, V88, P187, DOI 10.1016/j.critrevonc.2013.03.005; Ritt MG, 1998, VET PATHOL, V35, P94, DOI 10.1177/030098589803500202; Ritt MG, 2000, CANCER LETT, V158, P73, DOI 10.1016/S0304-3835(00)00507-3; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; Sadasivam S, 2013, NAT REV CANCER, V13, P585, DOI 10.1038/nrc3556; Sarver AL, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-7; Scott MC, 2011, BONE, V49, P356, DOI 10.1016/j.bone.2011.05.008; Tan ML, 2009, CANCER BIOL THER, V8, P106, DOI 10.4161/cbt.8.2.7385; Thayanithy V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043720; Thayanithy V, 2012, BONE, V50, P171, DOI 10.1016/j.bone.2011.10.012; Thomas R, 2009, CHROMOSOME RES, V17, P365, DOI 10.1007/s10577-009-9028-z; Wansleben S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.365; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Withrow SJ, 2010, ILAR J, V51, P208, DOI 10.1093/ilar.51.3.208	44	23	26	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28070	28083		10.1074/jbc.M115.679696	http://dx.doi.org/10.1074/jbc.M115.679696			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26378234	hybrid, Green Published			2022-12-28	WOS:000365761900004
J	Yamasaki, K; Daiho, T; Danko, S; Suzuki, H				Yamasaki, Kazuo; Daiho, Takashi; Danko, Stefania; Suzuki, Hiroshi			Assembly of a Tyr(122) Hydrophobic Cluster in Sarcoplasmic Reticulum Ca2+-ATPase Synchronizes Ca2+ Affinity Reduction and Release with Phosphoenzyme Isomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-INSENSITIVE PHOSPHOENZYME; CALCIUM ADENOSINE-TRIPHOSPHATASE; STABLE STRUCTURAL ANALOG; REACTION-MECHANISM; SENSITIVE PHOSPHOENZYME; CRYSTAL-STRUCTURES; TRANSPORT SITES; ATP HYDROLYSIS; OCCLUDED CA2+; PHOSPHORYLATION	The mechanism whereby events in and around the catalytic site/head of Ca2+-ATPase effect Ca2+ release to the lumen from the transmembrane helices remains elusive. We developed a method to determine deoccluded bound Ca2+ by taking advantage of its rapid occlusion upon formation of E1PCa(2) and of stabilization afforded by a high concentration of Ca2+. The assay is applicable to minute amounts of Ca2+-ATPase expressed in COS-1 cells. It was validated by measuring the Ca2+ binding properties of unphosphorylated Ca2+-ATPase. The method was then applied to the isomerization of the phosphorylated intermediate associated with the Ca2+ release process E1PCa(2) -> E2PCa(2) -> E2P + 2Ca(2+). In the wild type, Ca2+ release occurs concomitantly with EP isomerization fitting with rate-limiting isomerization (E1PCa(2) -> E2PCa(2)) followed by very rapid Ca2+ release. In contrast, with alanine mutants of Leu(119) and Tyr(122) on the cytoplasmic part of the second transmembrane helix (M2) and Ile(179) on the A domain, Ca2+ release in 10 mu M Ca2+ lags EP isomerization, indicating the presence of a transient E2P state with bound Ca2+. The results suggest that these residues function in Ca2+ affinity reduction in E2P, likely via a structural rearrangement at the cytoplasmic part of M2 and a resulting association with the A and P domains, therefore leading to Ca2+ release.	[Yamasaki, Kazuo; Daiho, Takashi; Danko, Stefania; Suzuki, Hiroshi] Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Yamasaki, K (corresponding author), Asahikawa Med Univ, Dept Biochem, Midorigaoka Higashi, Asahikawa, Hokkaido 0788510, Japan.	kyamasak@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [15H04346] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (C) (to K. Y.) and (B) (to H. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	BARRABIN H, 1984, BIOCHEMISTRY-US, V23, P1542, DOI 10.1021/bi00302a031; Daiho T, 1999, FEBS LETT, V444, P54, DOI 10.1016/S0014-5793(99)00027-7; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Daiho T, 2010, J BIOL CHEM, V285, P24538, DOI 10.1074/jbc.M110.144535; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2009, J BIOL CHEM, V284, P22722, DOI 10.1074/jbc.M109.029702; DEMEIS L, 1982, J BIOL CHEM, V257, P1289; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INESI G, 1987, J BIOL CHEM, V262, P16338; INESI G, 1980, J BIOL CHEM, V255, P3025; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; LACAPERE JJ, 1990, J BIOL CHEM, V265, P8583; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; ORLOWSKI S, 1991, BIOCHEMISTRY-US, V30, P352, DOI 10.1021/bi00216a007; PETITHORY JR, 1988, BIOCHEMISTRY-US, V27, P8626, DOI 10.1021/bi00423a018; PETITHORY JR, 1986, BIOCHEMISTRY-US, V25, P4493, DOI 10.1021/bi00364a006; Picard M, 2007, J MOL BIOL, V368, P1, DOI 10.1016/j.jmb.2007.01.082; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P8698; SHIGEKAWA M, 1983, J BIOL CHEM, V258, P4157; SHIGEKAWA M, 1978, J BIOL CHEM, V253, P1451; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; WAKABAYASHI S, 1984, J BIOL CHEM, V259, P4427; WAKABAYASHI S, 1987, J BIOL CHEM, V262, P11524; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; Webb RJ, 2000, J BIOL CHEM, V275, P977, DOI 10.1074/jbc.275.2.977; WEBER K, 1969, J BIOL CHEM, V244, P4406; YAMADA S, 1980, J BIOL CHEM, V255, P3108; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2008, J BIOL CHEM, V283, P29144, DOI 10.1074/jbc.M804596200; Yamasaki K, 2010, J BIOL CHEM, V285, P38674, DOI 10.1074/jbc.M110.183343	45	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27868	27879		10.1074/jbc.M115.693770	http://dx.doi.org/10.1074/jbc.M115.693770			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26442589	Green Published, hybrid			2022-12-28	WOS:000365757500036
J	McCauliff, LA; Xu, Z; Li, R; Kodukula, S; Ko, DC; Scott, MP; Kahn, PC; Storch, J				McCauliff, Leslie A.; Xu, Zhi; Li, Ran; Kodukula, Sarala; Ko, Dennis C.; Scott, Matthew P.; Kahn, Peter C.; Storch, Judith			Multiple Surface Regions on the Niemann-Pick C2 Protein Facilitate Intracellular Cholesterol Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROL TRANSFER; FATTY-ACIDS; BINDING; NPC2; MEMBRANES; DOMAIN; IDENTIFICATION; DEFICIENT; MECHANISM; RESIDUES	Background: Niemann-Pick C2 9NPC2) protein is essential for intracellular cholesterol trafficking. Results: Several regions on the surface of NPC2 are integral to its cholesterol transfer properties, which include the promotion of membrane-membrane interactions. Conclusion: Rapid cholesterol transfer occurs via NPC2-mediated membrane interactions. Significance: NPC2 may promote rapid efflux of late endosomal/lysosomal cholesterol by functioning at intra-lysosomal membrane contact sites. The cholesterol storage disorder Niemann-Pick type C (NPC) disease is caused by defects in either of two late endosomal/lysosomal proteins, NPC1 and NPC2. NPC2 is a 16-kDa soluble protein that binds cholesterol in a 1:1 stoichiometry and can transfer cholesterol between membranes by a mechanism that involves protein-membrane interactions. To examine the structural basis of NPC2 function in cholesterol trafficking, a series of point mutations were generated across the surface of the protein. Several NPC2 mutants exhibited deficient sterol transport properties in a set of fluorescence-based assays. Notably, these mutants were also unable to promote egress of accumulated intracellular cholesterol from npc2(-/-) fibroblasts. The mutations mapped to several regions on the protein surface, suggesting that NPC2 can bind to more than one membrane simultaneously. Indeed, we have previously demonstrated that WT NPC2 promotes vesicle-vesicle interactions. These interactions were abrogated, however, by mutations causing defective sterol transfer properties. Molecular modeling shows that NPC2 is highly plastic, with several intense positively charged regions across the surface that could interact favorably with negatively charged membrane phospholipids. The point mutations generated in this study caused changes in NPC2 surface charge distribution with minimal conformational changes. The plasticity, coupled with membrane flexibility, probably allows for multiple cholesterol transfer routes. Thus, we hypothesize that, in part, NPC2 rapidly traffics cholesterol between closely appositioned membranes within the multilamellar interior of late endosomal/lysosomal proteins, ultimately effecting cholesterol egress from this compartment.	[McCauliff, Leslie A.; Xu, Zhi; Li, Ran; Kodukula, Sarala; Storch, Judith] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [McCauliff, Leslie A.; Xu, Zhi; Li, Ran; Kodukula, Sarala; Storch, Judith] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Kahn, Peter C.] Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08901 USA; [Ko, Dennis C.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Scott, Matthew P.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Duke University; Stanford University; Howard Hughes Medical Institute; Stanford University	Storch, J (corresponding author), Dept Nutr Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	storch@aesop.rutgers.edu		McCauliff, Leslie/0000-0002-5744-2737	Ara Parseghian Medical Research Foundation; American Heart Association [11PRE7330012, 0625994T, 14GRNT19990014]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115866] Funding Source: NIH RePORTER	Ara Parseghian Medical Research Foundation; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the Ara Parseghian Medical Research Foundation (to J.S.), the American Heart Association (predoctoral fellowship 11PRE7330012 (to L.A.M.), postdoctoral fellowship 0625994T (to Z.X.), and Grant-in-Aid 14GRNT19990014 (to J.S.)), and an anonymous private source (to P.C.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdul-Hammed M, 2010, J LIPID RES, V51, P1747, DOI 10.1194/jlr.M003822; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Chu BB, 2015, CELL, V161, P291, DOI 10.1016/j.cell.2015.02.019; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Goldman SDB, 2010, J BIOL CHEM, V285, P4983, DOI 10.1074/jbc.M109.037622; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; HOLST MJ, 1995, J COMPUT CHEM, V16, P337, DOI 10.1002/jcc.540160308; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Kajander T, 2000, STRUCTURE, V8, P1203, DOI 10.1016/S0969-2126(00)00520-7; Kennedy BE, 2012, J LIPID RES, V53, P2632, DOI 10.1194/jlr.M029942; Kleinfeld AM, 1997, BIOCHEMISTRY-US, V36, P5702, DOI 10.1021/bi962007s; Ko DC, 2003, P NATL ACAD SCI USA, V100, P2518, DOI 10.1073/pnas.0530027100; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2006, PROCHECK VALIDATION, DOI DOI 10.1107/97809553602060000882; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; McCauliff LA, 2011, BIOCHEMISTRY-US, V50, P7341, DOI 10.1021/bi200574f; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Mobius W, 2003, TRAFFIC, V4, P222; Ohgami N, 2004, P NATL ACAD SCI USA, V101, P12473, DOI 10.1073/pnas.0405255101; Ohgane K, 2013, CHEM BIOL, V20, P391, DOI 10.1016/j.chembiol.2013.02.009; Park WD, 2003, HUM MUTAT, V22, P313, DOI 10.1002/humu.10255; PENTCHEV PG, 1994, BBA-MOL BASIS DIS, V1225, P235, DOI 10.1016/0925-4439(94)90001-9; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Runz H, 2008, HUM MUTAT, V29, P345, DOI 10.1002/humu.20636; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; STORCH J, 1986, BIOCHEMISTRY-US, V25, P1717, DOI 10.1021/bi00355a041; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Vanier MT, 2004, BBA-MOL CELL BIOL L, V1685, P14, DOI 10.1016/j.bbalip.2004.08.007; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Wassif CA, 2016, GENET MED, V18, P41, DOI 10.1038/gim.2015.25; Wilke S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-62; Xu S, 2007, J BIOL CHEM, V282, P23525, DOI 10.1074/jbc.M703848200; Xu Z, 2008, BIOCHEMISTRY-US, V47, P11134, DOI 10.1021/bi801328u	42	24	25	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27321	27331		10.1074/jbc.M115.667469	http://dx.doi.org/10.1074/jbc.M115.667469			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26296895	Green Published, hybrid			2022-12-28	WOS:000364794000039
J	Yang, HB; Palmbos, PL; Wang, LD; Kim, EH; Ney, GM; Liu, C; Prasad, J; Misek, DE; Yu, XC; Ljungman, M; Simeone, DM				Yang, Huibin; Palmbos, Phillip L.; Wang, Lidong; Kim, Evelyn H.; Ney, Gina M.; Liu, Chao; Prasad, Jayendra; Misek, David E.; Yu, Xiaochun; Ljungman, Mats; Simeone, Diane M.			ATDC (Ataxia Telangiectasia Group D Complementing) Promotes Radioresistance through an Interaction with the RNF8 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER-CELL-PROLIFERATION; C-KINASE SUBSTRATE; PANCREATIC-CANCER; UP-REGULATION; GENE; TRIM29; REPAIR; PHOSPHORYLATION; INHIBITION; ACTIVATION	Background: ATDC/TRIM29 promotes resistance to ionizing radiation, but the factor(s) that mediate this effect are incompletely understood. Results: ATDC/TRIM29 binds to RNF8, promoting DNA repair and resistance to IR. Conclusion: Following DNA damage, ATDC/TRIM29 is phosphorylated and interacts with RNF8, promoting DNA repair and cell survival. Significance: The interaction between ATDC/TRIM29 and RNF8 is novel and is important for the DNA damage response. Induction of DNA damage by ionizing radiation (IR) and/or cytotoxic chemotherapy is an essential component of cancer therapy. The ataxia telangiectasia group D complementing gene (ATDC, also called TRIM29) is highly expressed in many malignancies. It participates in the DNA damage response downstream of ataxia telangiectasia-mutated (ATM) and p38/MK2 and promotes cell survival after IR. To elucidate the downstream mechanisms of ATDC-induced IR protection, we performed a mass spectrometry screen to identify ATDC binding partners. We identified a direct physical interaction between ATDC and the E3 ubiquitin ligase and DNA damage response protein, RNF8, which is required for ATDC-induced radioresistance. This interaction was refined to the C-terminal portion (amino acids 348-588) of ATDC and the RING domain of RNF8 and was disrupted by mutation of ATDC Ser-550 to alanine. Mutations disrupting this interaction abrogated ATDC-induced radioresistance. The interaction between RNF8 and ATDC, which was increased by IR, also promoted downstream DNA damage responses such as IR-induced gamma-H2AX ubiquitination, 53BP1 phosphorylation, and subsequent resolution of the DNA damage foci. These studies define a novel function for ATDC in the RNF8-mediated DNA damage response and implicate RNF8 binding as a key determinant of the radioprotective function of ATDC.	[Yang, Huibin; Wang, Lidong; Kim, Evelyn H.; Misek, David E.; Simeone, Diane M.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Palmbos, Phillip L.; Liu, Chao; Yu, Xiaochun] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ney, Gina M.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Prasad, Jayendra; Ljungman, Mats] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Simeone, Diane M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Yang, Huibin; Palmbos, Phillip L.; Wang, Lidong; Ney, Gina M.; Prasad, Jayendra; Ljungman, Mats; Simeone, Diane M.] Univ Michigan, Translat Oncol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Simeone, DM (corresponding author), Univ Michigan, Sch Med, Translat Oncol Program, Dept Surg, TC 2922D,Box 0331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	simeone@med.umich.edu	Regan, Clinton/E-6250-2012		Pardee Foundation; National Institutes of Health [T32 CA009357, R01 CA13104505A1, CA17483601A1]; American Society of Clinical Oncology (ASCO) Young Investigator Award; Bladder Cancer Advocacy Network (BCAN) Miriam Gleberman Young Investigator Award; NATIONAL CANCER INSTITUTE [R01CA130899, T32CA009357, R01CA132755, R01CA174836, R01CA187209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108647] Funding Source: NIH RePORTER	Pardee Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Clinical Oncology (ASCO) Young Investigator Award; Bladder Cancer Advocacy Network (BCAN) Miriam Gleberman Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the Pardee Foundation (to D. M. S.), National Institutes of Health Grants R01 CA13104505A1 and CA17483601A1 (to D. M. S.), National Institutes of Health Grant T32 CA009357 (to P. L. P.), American Society of Clinical Oncology (ASCO) Young Investigator Award (to P. L. P.), and the Bladder Cancer Advocacy Network (BCAN) Miriam Gleberman Young Investigator Award (to P. L. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Bartocci Cristina, 2013, Frontiers in Genetics, V4, P128, DOI 10.3389/fgene.2013.00128; Bertrand-Vallery V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010462; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; BRZOSKA PM, 1995, P NATL ACAD SCI USA, V92, P7824, DOI 10.1073/pnas.92.17.7824; Chen CH, 2014, AM J RESP CRIT CARE, V189, P1002, DOI 10.1164/rccm.201401-0053LE; Chiong E, 2009, J UROLOGY, V181, P2737, DOI 10.1016/j.juro.2009.01.108; Fu P, 2013, J BIOL CHEM, V288, P29890, DOI 10.1074/jbc.M113.510826; Hanada S, 2013, CANCER BIOMARK, V13, P289, DOI 10.3233/CBM-130354; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jiang T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0715-4; Kosaka Y, 2007, ANN SURG ONCOL, V14, P2543, DOI 10.1245/s10434-007-9461-1; Laderoute KR, 1996, INT J CANCER, V66, P772, DOI 10.1002/(SICI)1097-0215(19960611)66:6<772::AID-IJC11>3.0.CO;2-5; Lai W, 2013, DIS ESOPHAGUS, V26, P817, DOI 10.1111/j.1442-2050.2012.01400.x; LEONHARDT EA, 1994, GENOMICS, V19, P130, DOI 10.1006/geno.1994.1022; Lu LY, 2010, DEV CELL, V18, P371, DOI 10.1016/j.devcel.2010.01.010; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Masuda Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8299; Meroni G, 2012, ADV EXP MED BIOL, V770, P1; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Pinder Jordan B., 2013, Frontiers in Genetics, V4, P45, DOI 10.3389/fgene.2013.00045; Scully R, 2013, MUTAT RES-FUND MOL M, V750, P5, DOI 10.1016/j.mrfmmm.2013.07.007; Sho T, 2011, BBA-MOL CELL RES, V1813, P1245, DOI 10.1016/j.bbamcr.2011.03.018; Tang ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063676; Wang LD, 2014, CANCER RES, V74, P1778, DOI 10.1158/0008-5472.CAN-13-2289; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Xu Y, 2010, J CELL BIOL, V191, P31, DOI 10.1083/jcb.201001160; Yang HB, 2006, MOL BIOL CELL, V17, P2177, DOI 10.1091/mbc.E05-10-0913; Yuan ZG, 2010, J BIOL CHEM, V285, P39329, DOI 10.1074/jbc.M110.179333; Yuan ZG, 2010, MOL CELL BIOL, V30, P3004, DOI 10.1128/MCB.01023-09	31	16	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27146	27157		10.1074/jbc.M115.665489	http://dx.doi.org/10.1074/jbc.M115.665489			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26381412	Green Published, hybrid			2022-12-28	WOS:000364794000024
J	Fu, X; Zhu, MJ; Dodson, MV; Du, M				Fu, Xing; Zhu, Mei-Jun; Dodson, Mike V.; Du, Min			AMP-activated Protein Kinase Stimulates Warburg-like Glycolysis and Activation of Satellite Cells during Muscle Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; AEROBIC GLYCOLYSIS; SONIC HEDGEHOG; SELF-RENEWAL; METABOLISM; DIFFERENTIATION; PROLIFERATION; PURIFICATION; PROGENITORS; EXPRESSION	Satellite cells are the major myogenic stem cells residing inside skeletal muscle and are indispensable for muscle regeneration. Satellite cells remain largely quiescent but are rapidly activated in response to muscle injury, and the derived myogenic cells then fuse to repair damaged muscle fibers or form new muscle fibers. However, mechanisms eliciting metabolic activation, an inseparable step for satellite cell activation following muscle injury, have not been defined. We found that a non-canonical Sonic Hedgehog (Shh) pathway is rapidly activated in response to muscle injury, which activates AMPK and induces a Warburg-like glycolysis in satellite cells. AMPK alpha 1 is the dominant AMPK alpha isoform expressed in satellite cells, and AMPK alpha 1 deficiency in satellite cells impairs their activation and myogenic differentiation during muscle regeneration. Drugs activating noncanonical Shh promote proliferation of satellite cells, which is abolished because of satellite cell-specific AMPK alpha 1 knock-out. Taken together, AMPK alpha 1 is a critical mediator linking noncanonical Shh pathway to Warburg-like glycolysis in satellite cells, which is required for satellite activation and muscle regeneration.	[Fu, Xing; Dodson, Mike V.; Du, Min] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Fu, Xing; Dodson, Mike V.; Du, Min] Washington State Univ, Dept Pharmaceut Sci, Washington Ctr Muscle Biol, Pullman, WA 99164 USA; [Zhu, Mei-Jun] Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University	Du, M (corresponding author), Washington State Univ, Dept Anim Sci, Washington Ctr Muscle Biol, Pullman, WA 99164 USA.	min.du@wsu.edu	Du, Min/H-4311-2011; Regan, Clinton/E-6250-2012	Du, Min/0000-0002-7232-072X; 	National Institutes of Health [1R01HD067449]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD067449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01HD067449. The authors declare that they have no conflicts of interest with the contents of this article.	Armstrong L, 2010, STEM CELLS, V28, P661, DOI 10.1002/stem.307; BERNASCONI P, 1995, J CLIN INVEST, V96, P1137, DOI 10.1172/JCI118101; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; Bracha AL, 2010, NAT CHEM BIOL, V6, P202, DOI 10.1038/NCHEMBIO.301; Brand KA, 1997, FASEB J, V11, P388, DOI 10.1096/fasebj.11.5.9141507; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Clarke L, 2009, STEM CELLS, V27, P1879, DOI 10.1002/stem.96; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Duprez D, 1998, DEVELOPMENT, V125, P495; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Fu X, 2013, MOL CELL BIOL, V33, P4517, DOI 10.1128/MCB.01078-13; IRINTCHEV A, 1987, CELL TISSUE RES, V249, P509; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; KATZ B, 1961, PHILOS T ROY SOC B, V243, P221, DOI 10.1098/rstb.1961.0001; Kennedy JW, 1999, DIABETES, V48, P1192, DOI 10.2337/diabetes.48.5.1192; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Kruger M, 2001, DEVELOPMENT, V128, P743; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Marcelle C, 1999, DEV BIOL, V214, P277, DOI 10.1006/dbio.1999.9389; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Montarras D, 2013, FEBS J, V280, P4036, DOI 10.1111/febs.12372; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Nybakken K, 2002, CURR OPIN GENET DEV, V12, P503, DOI 10.1016/S0959-437X(02)00333-7; Ochocki JD, 2013, J CELL BIOL, V203, P23, DOI 10.1083/jcb.201303110; Pasut A, 2013, JOVE-J VIS EXP, DOI 10.3791/50074; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Repele A, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-24; Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004; Ryall JG, 2013, FEBS J, V280, P4004, DOI 10.1111/febs.12189; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Teperino R, 2012, CELL, V151, P414, DOI 10.1016/j.cell.2012.09.021; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vazquez-Martin A, 2013, CELL CYCLE, V12, P207, DOI 10.4161/cc.23352; Wagatsuma A, 2013, SCI WORLD J, DOI 10.1155/2013/593267; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Youn JY, 2015, CHEM BIOL, V22, P311, DOI 10.1016/j.chembiol.2015.03.004; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhao JX, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199372	55	49	50	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26445	26456		10.1074/jbc.M115.665232	http://dx.doi.org/10.1074/jbc.M115.665232			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370082	hybrid, Green Published			2022-12-28	WOS:000364793600012
J	Franzolin, E; Salata, C; Bianchi, V; Rampazzo, C				Franzolin, Elisa; Salata, Cristiano; Bianchi, Vera; Rampazzo, Chiara			The Deoxynucleoside Triphosphate Triphosphohydrolase Activity of SAMHD1 Protein Contributes to the Mitochondrial DNA Depletion Associated with Genetic Deficiency of Deoxyguanosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES SYNDROME; RESTRICTION FACTOR SAMHD1; HIV-1 RESTRICTION; THYMIDINE KINASE; ALLOSTERIC ACTIVATION; DEOXYCYTIDINE KINASE; REPLICATION FIDELITY; STRUCTURAL BASIS; HUMAN-CELLS; POOLS	The dNTP triphosphohydrolase SAMHD1 is a nuclear antiviral host restriction factor limiting HIV-1 infection in macrophages and a major regulator of dNTP concentrations in human cells. In normal human fibroblasts its expression increases during quiescence, contributing to the small dNTP pool sizes of these cells. Down-regulation of SAMHD1 by siRNA expands all four dNTP pools, with dGTP undergoing the largest relative increase. The deoxyguanosine released by SAMHD1 from dGTP can be phosphorylated inside mitochondria by deoxyguanosine kinase (dGK) or degraded in the cytosol by purine nucleoside phosphorylase. Genetic mutations of dGK cause mitochondrial (mt) DNA depletion in noncycling cells and hepato-cerebral mtDNA depletion syndrome in humans. We studied if SAMHD1 and dGK interact in the regulation of the dGTP pool during quiescence employing dGK-mutated skin fibroblasts derived from three unrelated patients. In the presence of SAMHD1 quiescent mutant fibroblasts manifested mt dNTP pool imbalance and mtDNA depletion. When SAMHD1 was silenced by siRNA transfection the composition of the mt dNTP pool approached that of the controls, and mtDNA copy number increased, compensating the depletion to various degrees in the different mutant fibroblasts. Chemical inhibition of purine nucleoside phosphorylase did not improve deoxyguanosine recycling by dGK in WT cells. We conclude that the activity of SAMHD1 contributes to the pathological phenotype of dGK deficiency. Our results prove the importance of SAMHD1 in the regulation of all dNTP pools and suggest that dGK inside mitochondria has the function of recycling the deoxyguanosine derived from endogenous dGTP degraded by SAMHD1 in the nucleus.	[Franzolin, Elisa; Bianchi, Vera; Rampazzo, Chiara] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Salata, Cristiano] Univ Padua, Dept Mol Med, I-35121 Padua, Italy	University of Padua; University of Padua	Bianchi, V (corresponding author), Dipartimento Biol, Via Ugo Bassi 58B, I-35131 Padua, Italy.	vbianchi@bio.unipd.it; chiara.rampazzo.1@unipd.it	Salata, Cristiano/T-6601-2019	Salata, Cristiano/0000-0002-5136-7406	Fondazione Telethon Grant [GGP14005]; Associazione Italiana per la Ricerca sul Cancro Grant [IG 2014 15818]	Fondazione Telethon Grant(Fondazione Telethon); Associazione Italiana per la Ricerca sul Cancro Grant(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Fondazione Telethon Grant GGP14005 (to V. B.) and Associazione Italiana per la Ricerca sul Cancro Grant IG 2014 15818 (to V. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; ARNER ESJ, 1992, BIOCHEM BIOPH RES CO, V188, P712, DOI 10.1016/0006-291X(92)91114-6; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Bianchi V, 2003, J BIOL CHEM, V278, P46195, DOI 10.1074/jbc.R300032200; Camara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; DARE E, 1995, J MOL BIOL, V252, P514, DOI 10.1006/jmbi.1995.0516; Del Toro M, 2005, J INHERIT METAB DIS, V28, P135; DeLucia M, 2013, J BIOL CHEM, V288, P19116, DOI 10.1074/jbc.M113.469007; Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Frangini M, 2013, J BIOL CHEM, V288, P5624, DOI 10.1074/jbc.M112.441147; Frangini M, 2009, FEBS J, V276, P1104, DOI 10.1111/j.1742-4658.2008.06853.x; Franzolin E, 2006, BIOCHEM BIOPH RES CO, V344, P30, DOI 10.1016/j.bbrc.2006.03.147; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Franzolin E, 2012, EXP CELL RES, V318, P2226, DOI 10.1016/j.yexcr.2012.05.028; Gazziola C, 2001, J BIOL CHEM, V276, P6185, DOI 10.1074/jbc.M007623200; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Govindarajan R, 2009, AM J PHYSIOL-GASTR L, V296, pG910, DOI 10.1152/ajpgi.90672.2008; Ji XY, 2014, P NATL ACAD SCI USA, V111, pE4305, DOI 10.1073/pnas.1412289111; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kicska GA, 2001, P NATL ACAD SCI USA, V98, P4593, DOI 10.1073/pnas.071050798; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Koharudin LMI, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.591958; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lai YR, 2004, J BIOL CHEM, V279, P4490, DOI 10.1074/jbc.M307938200; Leanza L, 2008, J BIOL CHEM, V283, P16437, DOI 10.1074/jbc.M801572200; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; MARKERT M L, 1991, Immunodeficiency Reviews, V3, P45; Miazzi C, 2014, J BIOL CHEM, V289, P18339, DOI 10.1074/jbc.M114.571091; Nakabeppu Y, 2010, MUTAT RES-GEN TOX EN, V703, P51, DOI 10.1016/j.mrgentox.2010.06.006; Pauls E, 2014, J IMMUNOL, V193, P1988, DOI 10.4049/jimmunol.1400873; Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062; Rampazzo C, 2004, J BIOL CHEM, V279, P17019, DOI 10.1074/jbc.M313957200; Rampazzo C, 2010, MUTAT RES-GEN TOX EN, V703, P2, DOI 10.1016/j.mrgentox.2010.06.002; Rehwinkel J, 2013, EMBO J, V32, P2454, DOI 10.1038/emboj.2013.163; Resta R, 1997, IMMUNOL TODAY, V18, P371, DOI 10.1016/S0167-5699(97)01047-5; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Saada A, 2003, BIOCHEM BIOPH RES CO, V310, P963, DOI 10.1016/j.bbrc.2003.09.104; Saada A, 2003, MOL GENET METAB, V79, P1, DOI 10.1016/S1096-7192(03)00063-5; Saada A, 2008, MOL GENET METAB, V95, P169, DOI 10.1016/j.ymgme.2008.07.007; Schmidt S, 2015, J LEUKOCYTE BIOL, V98, P5, DOI 10.1189/jlb.4HI0714-338RR; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Song SW, 2005, P NATL ACAD SCI USA, V102, P4990, DOI 10.1073/pnas.0500253102; SPASOKOUKOTSKAJA T, 1995, EUR J CANCER, V31A, P202, DOI 10.1016/0959-8049(94)00435-8; Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z; Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192; Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Yan JP, 2015, J BIOL CHEM, V290, P13279, DOI 10.1074/jbc.M115.646588; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	61	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25986	25996		10.1074/jbc.M115.675082	http://dx.doi.org/10.1074/jbc.M115.675082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26342080	Green Published, hybrid			2022-12-28	WOS:000363527300020
J	Kajabadi, NS; Ghoochani, A; Peymani, M; Ghaedi, K; Kiani-Esfahani, A; Hashemi, MS; Nasr-Esfahani, MH; Baharvand, H				Kajabadi, Nasim-Sadat; Ghoochani, Ali; Peymani, Maryam; Ghaedi, Kamran; Kiani-Esfahani, Abbas; Hashemi, Motahareh-Sadat; Nasr-Esfahani, Mohammad Hossein; Baharvand, Hossein			The Synergistic Enhancement of Cloning Efficiency in Individualized Human Pluripotent Stem Cells by Peroxisome Proliferative-activated Receptor-gamma (PPAR gamma) Activation and Rho-associated Kinase (ROCK) Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; BETA-CATENIN; MOUSE PPAR-GAMMA-1; E-CADHERIN; LOCALIZATION; SURVIVAL; PATHWAY; PHOSPHORYLATION; DIFFERENTIATION; APOPTOSIS	Although human pluripotent stem cells (hPSCs) provide valuable sources for regenerative medicine, their applicability is dependent on obtaining both suitable up-scaled and cost effective cultures. The Rho-associated kinase (ROCK) inhibitor Y-27632 permits hPSC survival upon dissociation; however, cloning efficiency is often still low. Here we have shown that pioglitazone, a selective peroxisome proliferative-activated receptor-gamma agonist, along with Y-27632 synergistically diminished dissociation-induced apoptosis and increased cloning efficiency (2-3-fold versus Y-27632) without affecting pluripotency of hPSCs. Pioglitazone exerted its positive effect by inhibition of glycogen synthase kinase (GSK3) activity and enhancement of membranous beta-catenin and E-cadherin proteins. These effects were reversed by GW-9662, an irreversible peroxisome proliferative-activated receptor-gamma antagonist. This novel setting provided a step toward hPSC manipulation and its biomedical applications.	[Kajabadi, Nasim-Sadat; Ghaedi, Kamran] Univ Isfahan, Fac Sci, Dept Biol, Esfahan 8174673441, Iran; [Ghoochani, Ali; Peymani, Maryam; Ghaedi, Kamran; Kiani-Esfahani, Abbas; Hashemi, Motahareh-Sadat; Nasr-Esfahani, Mohammad Hossein] ACECR, Royan Inst Biotechnol, Dept Cellular Biotechnol, Cell Sci Res Ctr, Esfahan 8165131378, Iran; [Baharvand, Hossein] ACECR, Royan Inst Stem Cell Biol & Technol, Dept Stem Cells & Dev Biol, Cell Sci Res Ctr, Tehran 1665659911, Iran; Univ Sci & Culture, ACECR, Dept Dev Biol, Tehran, Iran	University of Isfahan; Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR)	Ghaedi, K (corresponding author), ACECR, Royan Inst Biotechnol, Dept Cellular Biotechnol, Cell Sci Res Ctr, POB 816513-1378, Esfahan 8165131378, Iran.	kamranghaedi@royaninstitute.org; mh_nasr@royaninstitute.org; Baharvand@royaninstitute.org	Nasr-Esfahani, Mohammad Hossein/AAN-2577-2020; Ghaedi, Kamran/X-9824-2018; , Nasr-Esfahani/AAR-2434-2021; Peymani, Maryam/AAN-2134-2021	Nasr-Esfahani, Mohammad Hossein/0000-0003-1983-3435; Ghaedi, Kamran/0000-0002-9790-5644; Peymani, Maryam/0000-0001-5075-5661	Royan Institute	Royan Institute	This work was supported by a grant from the Royan Institute. The authors declare that they have no conflicts of interest with the contents of this article.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Atkins KB, 2009, AM J PHYSIOL-CELL PH, V296, pC1151, DOI 10.1152/ajpcell.00343.2008; Baharvand H, 2006, DEV GROWTH DIFFER, V48, P117, DOI 10.1111/j.1440-169x.2006.00851.x; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Dietrich C, 2002, BIOCHEM BIOPH RES CO, V292, P195, DOI 10.1006/bbrc.2002.6625; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Faunes F, 2013, DEVELOPMENT, V140, P1171, DOI 10.1242/dev.085654; Fujisawa T, 2008, J PHARMACOL SCI, V106, P627, DOI 10.1254/jphs.FP0071766; Ghasemi S, 2010, YAKHTEH, V12, P97; Gien J, 2014, AM J PHYSIOL-LUNG C, V306, pL299, DOI 10.1152/ajplung.00271.2013; Hiroki Oda, 2012, Subcell Biochem, V60, P9, DOI 10.1007/978-94-007-4186-7_2; Kilter H, 2009, DIABETES OBES METAB, V11, P1060, DOI 10.1111/j.1463-1326.2009.01097.x; Lachinani Liana, 2012, Avicenna Journal of Medical Biotechnology, V4, P160; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li L, 2012, CELL ADHES MIGR, V6, P59, DOI 10.4161/cam.19583; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Mao YS, 2007, PFLUG ARCH EUR J PHY, V455, P5, DOI 10.1007/s00424-007-0286-3; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Orsulic S, 1999, J CELL SCI, V112, P1237; Pakzad M, 2010, STEM CELL REV REP, V6, P96, DOI 10.1007/s12015-009-9103-z; Peymani M, 2013, EUR J CELL BIOL, V92, P160, DOI 10.1016/j.ejcb.2013.03.003; Prunier C, 2004, GROWTH FACTORS, V22, P141, DOI 10.1080/08977190410001720860; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shin SJ, 2006, STEM CELLS, V24, P125, DOI 10.1634/stemcells.2004-0150; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Totonchi M, 2010, INT J DEV BIOL, V54, P877, DOI 10.1387/ijdb.092903mt; Wakino S, 2004, CIRC RES, V95, pE45, DOI 10.1161/01.RES.0000142313.68389.92; Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Webster MT, 2000, GENE CHROMOSOME CANC, V28, P443	33	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26303	26313		10.1074/jbc.M114.624841	http://dx.doi.org/10.1074/jbc.M114.624841			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26336103	hybrid, Green Published			2022-12-28	WOS:000363527300046
J	Gregg, KJ; Suits, MDL; Deng, LH; Vocadlo, DJ; Boraston, AB				Gregg, Katie J.; Suits, Michael D. L.; Deng, Lehua; Vocadlo, David J.; Boraston, Alisdair B.			Structural Analysis of a Family 101 Glycoside Hydrolase in Complex with Carbohydrates Reveals Insights into Its Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-N-ACETYLGALACTOSAMINIDASES; BIFIDOBACTERIUM-LONGUM; STREPTOCOCCUS-PNEUMONIAE; STRUCTURE VALIDATION; D-GALACTOSAMINIDASE; ACTIVE-SITE; IDENTIFICATION; HYDROLYSIS; MOLPROBITY; CLONING	O-Linked glycosylation is one of the most abundant post-translational modifications of proteins. Within the secretory pathway of higher eukaryotes, the core of these glycans is frequently an N-acetylgalactosamine residue that is alpha-linked to serine or threonine residues. Glycoside hydrolases in family 101 are presently the only known enzymes to be able to hydrolyze this glycosidic linkage. Here we determine the high-resolution structures of the catalytic domain comprising a fragment of GH101 from Streptococcus pneumoniae TIGR4, SpGH101, in the absence of carbohydrate, and in complex with reaction products, inhibitor, and substrate analogues. Upon substrate binding, a tryptophan lid (residues 724-WNW-726) closes on the substrate. The closing of this lid fully engages the substrate in the active site with Asp-764 positioned directly beneath C1 of the sugar residue bound within the -1 subsite, consistent with its proposed role as the catalytic nucleophile. In all of the bound forms of the enzyme, however, the proposed catalytic acid/base residue was found to be too distant from the glycosidic oxygen (> 4.3 angstrom) to serve directly as a general catalytic acid/base residue and thereby facilitate cleavage of the glycosidic bond. These same complexes, however, revealed a structurally conserved water molecule positioned between the catalytic acid/base and the glycosidic oxygen. On the basis of these structural observations we propose a new variation of the retaining glycoside hydrolase mechanism wherein the intervening water molecule enables a Grotthuss proton shuttle between Glu-796 and the glycosidic oxygen, permitting this residue to serve as the general acid/base catalytic residue.	[Gregg, Katie J.; Suits, Michael D. L.; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Deng, Lehua; Vocadlo, David J.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of Victoria; Simon Fraser University	Boraston, AB (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055, Victoria, BC V8W 3P6, Canada.	boraston@uvic.ca	Vocadlo, David J/E-5508-2014	Vocadlo, David J/0000-0001-6897-5558; Boraston, Alisdair/0000-0001-6417-0592	Natural Sciences and Engineering Research Council of Canada (NSERC); National Research Council Canada; CIHR; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council Canada; CIHR(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan	We thank the beamline staff at the Stanford Synchrotron Research Laboratory BL9-2 and the Canadian Light Source 08ID-1 where diffraction data were collected. The Canadian Light Source is supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), the National Research Council Canada, CIHR, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. We thank Professor Lai-Xi Wang for providing us with the glycopeptide bearing the T-antigen.	Abe A, 2005, FEBS J, V272, P6145, DOI 10.1111/j.1742-4658.2005.05013.x; Ashida H, 2008, GLYCOBIOLOGY, V18, P727, DOI 10.1093/glycob/cwn053; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; BHAVANANDAN VP, 1983, CARBOHYD RES, V118, P81, DOI 10.1016/0008-6215(83)88037-9; Bras JLA, 2011, P NATL ACAD SCI USA, V108, P5237, DOI 10.1073/pnas.1015006108; Brockhausen I., 2009, ESSENTIALS GLYCOBIOL; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Caines MEC, 2008, J BIOL CHEM, V283, P31279, DOI 10.1074/jbc.C800150200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FLOWERS HM, 1965, J ORG CHEM, V30, P2041, DOI 10.1021/jo01017a078; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Gloster TM, 2012, NAT CHEM BIOL, V8, P683, DOI [10.1038/nchembio.1029, 10.1038/NCHEMBIO.1029]; Goda HM, 2008, BIOCHEM BIOPH RES CO, V375, P541, DOI 10.1016/j.bbrc.2008.08.065; Gregg KJ, 2009, ACTA CRYSTALLOGR F, V65, P133, DOI 10.1107/S1744309108042474; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Koutsioulis D, 2008, GLYCOBIOLOGY, V18, P799, DOI 10.1093/glycob/cwn069; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LUBINEAU A, 1989, J CHEM SOC CHEM COMM, P1918, DOI 10.1039/c39890001918; Marion C, 2009, INFECT IMMUN, V77, P1389, DOI 10.1128/IAI.01215-08; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Rogowski A, 2014, J BIOL CHEM, V289, P53, DOI 10.1074/jbc.M113.525295; SCHROEDER LR, 1974, CARBOHYD RES, V37, P368, DOI 10.1016/S0008-6215(00)82927-4; Stubbs KA, 2009, ANGEW CHEM INT EDIT, V48, P1300, DOI 10.1002/anie.200804583; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Suzuki R, 2009, J BIOCHEM, V146, P389, DOI 10.1093/jb/mvp086; UMEMOTO J, 1977, J BIOL CHEM, V252, P8609; van Bueren AL, 2011, STRUCTURE, V19, P640, DOI 10.1016/j.str.2011.03.001; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Willis LM, 2009, BIOCHEMISTRY-US, V48, P10334, DOI 10.1021/bi9013825; Xia J, 2000, CARBOHYD RES, V328, P147, DOI 10.1016/S0008-6215(00)00080-X	36	17	17	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25657	25669		10.1074/jbc.M115.680470	http://dx.doi.org/10.1074/jbc.M115.680470			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26304114	Green Published, hybrid			2022-12-28	WOS:000362962800038
J	Griese, JJ; Kositzki, R; Schrapers, P; Branca, RMM; Nordstrom, A; Lehtio, J; Haumann, M; Hogbom, M				Griese, Julia J.; Kositzki, Ramona; Schrapers, Peer; Branca, Rui M. M.; Nordstrom, Anders; Lehtio, Janne; Haumann, Michael; Hogbom, Martin			Structural Basis for Oxygen Activation at a Heterodinuclear Manganese/Iron Cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IB RIBONUCLEOTIDE REDUCTASE; METHANE MONOOXYGENASE HYDROXYLASE; ABSORPTION FINE-STRUCTURE; TYROSYL RADICAL COFACTOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; ACTIVE-SITE; PROTEIN R2; MANGANESE(IV)/IRON(III) COFACTOR; CORYNEBACTERIUM-AMMONIAGENES	Two recently discovered groups of prokaryotic di-metal carboxylate proteins harbor a heterodinuclear Mn/Fe cofactor. These are the class Ic ribonucleotide reductase R2 proteins and a group of oxidases that are found predominantly in pathogens and extremophiles, called R2-like ligand-binding oxidases (R2lox). We have recently shown that the Mn/Fe cofactor of R2lox self-assembles from Mn-II and Fe-II in vitro and catalyzes formation of a tyrosine-valine ether cross-link in the protein scaffold (Griese, J. J., Roos, K., Cox, N., Shafaat, H. S., Branca, R.M., Lehtio , J., Graslund, A., Lubitz, W., Siegbahn, P. E., and Hogbom, M. (2013) Proc. Natl. Acad. Sci. U.S.A. 110, 1718917194). Here, we present a detailed structural analysis of R2lox in the nonactivated, reduced, and oxidized resting Mn/Fe- and Fe/Fe-bound states, as well as the nonactivated Mn/Mn-bound state. X-ray crystallography and x-ray absorption spectroscopy demonstrate that the active site ligand configuration of R2lox is essentially the same regardless of cofactor composition. Both the Mn/Fe and the diiron cofactor activate oxygen and catalyze formation of the ether cross-link, whereas the dimanganese cluster does not. The structures delineate likely routes for gated oxygen and substrate access to the active site that are controlled by the redox state of the cofactor. These results suggest that oxygen activation proceeds via similar mechanisms at the Mn/Fe and Fe/Fe center and that R2lox proteins might utilize either cofactor in vivo based on metal availability.	[Griese, Julia J.; Hogbom, Martin] Stockholm Univ, Dept Biochem & Biophys, Stockholm Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Kositzki, Ramona; Schrapers, Peer; Haumann, Michael] Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany; [Branca, Rui M. M.; Lehtio, Janne] Karolinska Inst, Sci Life Lab, Dept Oncol Pathol, Canc Prote Mass Spectrometry, SE-17121 Solna, Sweden; [Nordstrom, Anders] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden	Stockholm University; Free University of Berlin; Karolinska Institutet; Umea University	Hogbom, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Stockholm Ctr Biomembrane Res, SE-10691 Stockholm, Sweden.	hogbom@dbb.su.se	MIchael, Haumann/A-7087-2013; Griese, Julia Johanna/GQB-0023-2022	Griese, Julia Johanna/0000-0003-3686-3062; Branca, Rui/0000-0003-3890-6476; Hogbom, Martin/0000-0001-5574-9383; Nordstrom, Anders/0000-0003-3676-817X; Lehtio, Janne/0000-0002-8100-9562	Swedish Research Council and European Union FP7 Project GlycoHit; Swedish Foundation for Strategic Research; Jane and Dan Olsson Foundations; Deutsche Forschungsgemeinschaft Grant [Ha3265/6-1]; Heisenberg Fellowship; Deutsches Bundesministerium fur Bildung und Forschung within Rontgen-Angstrom Cluster [05K14KE1]; Swedish Research Council; Knut and Alice Wallenberg Foundation; European Community's Seventh Framework Programme [283570]	Swedish Research Council and European Union FP7 Project GlycoHit; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Jane and Dan Olsson Foundations; Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Heisenberg Fellowship(German Research Foundation (DFG)); Deutsches Bundesministerium fur Bildung und Forschung within Rontgen-Angstrom Cluster; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Community's Seventh Framework Programme(European Commission)	Supported by the Swedish Research Council and European Union FP7 Project GlycoHit.; Supported by the Swedish Foundation for Strategic Research and the Jane and Dan Olsson Foundations.; Supported by Deutsche Forschungsgemeinschaft Grant Ha3265/6-1, by a Heisenberg Fellowship, and Deutsches Bundesministerium fur Bildung und Forschung Grant 05K14KE1 within the Rontgen-Angstrom Cluster.; Supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, the Knut and Alice Wallenberg Foundation, and European Community's Seventh Framework Programme FP7/2007-2013 under Grant Agreement 283570 ( for BioStruct-X). To whom correspondence should be addressed: Stockholm Center for Biomembrane Research, Dept. of Biochemistry and Biophysics, Stockholm University, SE-106 91 Stockholm, Sweden. E-mail: hogbom@dbb.su.se.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andersson CS, 2012, CHEM BIODIVERS, V9, P1981, DOI 10.1002/cbdv.201100428; Andersson CS, 2012, J AM CHEM SOC, V134, P123, DOI 10.1021/ja209678x; Andersson CS, 2009, P NATL ACAD SCI USA, V106, P5633, DOI 10.1073/pnas.0812971106; Andersson ME, 1999, J AM CHEM SOC, V121, P2346, DOI 10.1021/ja982280c; Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; Bailey LJ, 2008, P NATL ACAD SCI USA, V105, P19194, DOI 10.1073/pnas.0807948105; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Boal AK, 2012, BIOCHEMISTRY-US, V51, P3861, DOI 10.1021/bi201925t; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Bollinger JM, 1997, J AM CHEM SOC, V119, P5976, DOI 10.1021/ja970319s; Bradley JM, 2014, J BIOL INORG CHEM, V19, P775, DOI 10.1007/s00775-014-1136-3; BUNKER G, 1987, BIOCHEMISTRY-US, V26, P4708, DOI 10.1021/bi00389a017; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cotruvo JA, 2013, J AM CHEM SOC, V135, P4027, DOI 10.1021/ja312457t; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; Crona M, 2011, J BIOL CHEM, V286, P33053, DOI 10.1074/jbc.M111.278119; Dassama LMK, 2013, J AM CHEM SOC, V135, P16758, DOI 10.1021/ja407438p; Dassama LMK, 2013, BIOCHEMISTRY-US, V52, P6424, DOI 10.1021/bi400819x; Dassama LMK, 2012, J AM CHEM SOC, V134, P2520, DOI 10.1021/ja211314p; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; DEWITT JG, 1995, INORG CHEM, V34, P2505, DOI 10.1021/ic00114a007; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Elango N, 1997, PROTEIN SCI, V6, P556; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eriksson M, 1998, BIOCHEMISTRY-US, V37, P13359, DOI 10.1021/bi981380s; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Grabolle M, 2006, J BIOL CHEM, V281, P4580, DOI 10.1074/jbc.M509724200; Griese JJ, 2013, P NATL ACAD SCI USA, V110, P17189, DOI 10.1073/pnas.1304368110; Hammerstad M, 2014, ACS CHEM BIOL, V9, P526, DOI 10.1021/cb400757h; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hogbom M, 2004, SCIENCE, V305, P245, DOI 10.1126/science.1098419; Hogbom M, 2003, P NATL ACAD SCI USA, V100, P3209, DOI 10.1073/pnas.0536684100; Hogbom M, 2002, BIOCHEMISTRY-US, V41, P1381, DOI 10.1021/bi011429l; Hogbom M, 2010, J BIOL INORG CHEM, V15, P339, DOI 10.1007/s00775-009-0606-5; Huque Y, 2000, J BIOL CHEM, V275, P25365, DOI 10.1074/jbc.M002751200; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KLOCKENKAMPER R, 1997, CHEM ANAL, V140; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee SJ, 2013, NATURE, V494, P380, DOI 10.1038/nature11880; LEE SK, 1993, J AM CHEM SOC, V115, P6450, DOI 10.1021/ja00067a086; Leidel N, 2012, BBA-BIOENERGETICS, V1817, P430, DOI 10.1016/j.bbabio.2011.12.008; Li N, 2012, BIOCHEMISTRY-US, V51, P7908, DOI 10.1021/bi300912n; Li N, 2011, J AM CHEM SOC, V133, P6158, DOI 10.1021/ja2013517; Liang AD, 2014, BIOCHEMISTRY-US, V53, P7368, DOI 10.1021/bi500892n; LIU WT, 1993, INORG CHEM, V32, P4102, DOI 10.1021/ic00071a023; Logan DT, 1996, STRUCTURE, V4, P1053, DOI 10.1016/S0969-2126(96)00112-8; Lundin D, 2012, J BIOL CHEM, V287, P20565, DOI 10.1074/jbc.M112.367458; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Monje-Casas F, 2001, J BIOL CHEM, V276, P18031, DOI 10.1074/jbc.M011728200; NORDLUND P, 1993, J MOL BIOL, V232, P123, DOI 10.1006/jmbi.1993.1374; Nordlund P, 1995, CURR OPIN STRUC BIOL, V5, P758, DOI 10.1016/0959-440X(95)80008-5; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Notomista E, 2003, J MOL EVOL, V56, P435, DOI 10.1007/s00239-002-2414-1; Pandelia ME, 2013, J AM CHEM SOC, V135, P15801, DOI 10.1021/ja405047b; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reschke S, 2013, BIOCHEMISTRY-US, V52, P8295, DOI 10.1021/bi4008512; Reschke S, 2013, J BIOL CHEM, V288, P29736, DOI 10.1074/jbc.M113.497453; Roos K, 2011, J BIOL INORG CHEM, V16, P553, DOI 10.1007/s00775-011-0755-1; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; ROSENZWEIG AC, 1995, CHEM BIOL, V2, P409, DOI 10.1016/1074-5521(95)90222-8; Rosenzweig AC, 1997, PROTEINS, V29, P141, DOI 10.1002/(SICI)1097-0134(199710)29:2<141::AID-PROT2>3.3.CO;2-W; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Sazinsky MH, 2006, BIOCHEMISTRY-US, V45, P15392, DOI 10.1021/bi0618969; Sazinsky MH, 2004, J BIOL CHEM, V279, P30600, DOI 10.1074/jbc.M400710200; SCARROW RC, 1987, J AM CHEM SOC, V109, P7857, DOI 10.1021/ja00259a039; SCARROW RC, 1986, J AM CHEM SOC, V108, P6832, DOI 10.1021/ja00281a077; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Shafaat HS, 2014, J AM CHEM SOC, V136, P13399, DOI 10.1021/ja507435t; Shu LJ, 1996, J BIOL INORG CHEM, V1, P297, DOI 10.1007/s007750050057; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Sigfridsson KGV, 2013, J BIOL CHEM, V288, P9648, DOI 10.1074/jbc.M112.438796; SJOBERG BM, 1977, J BIOL CHEM, V252, P536; Stolle P, 2010, FEBS J, V277, P4849, DOI 10.1111/j.1742-4658.2010.07885.x; Stubble J, 2003, CURR OPIN CHEM BIOL, V7, P183, DOI 10.1016/S1367-5931(03)00025-5; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Theil EC, 2006, J BIOL INORG CHEM, V11, P803, DOI 10.1007/s00775-006-0125-6; THELANDER L, 1973, J BIOL CHEM, V248, P4591; Vassinova N, 2000, MICROBIOL-SGM, V146, P3171, DOI 10.1099/00221287-146-12-3171; Voegtli WC, 2003, J AM CHEM SOC, V125, P15822, DOI 10.1021/ja0370387; Voevodskaya N, 2007, FEBS LETT, V581, P3351, DOI 10.1016/j.febslet.2007.06.023; Voevodskaya N, 2009, J BIOL CHEM, V284, P4555, DOI 10.1074/jbc.M807190200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang WX, 2014, J AM CHEM SOC, V136, P9754, DOI 10.1021/ja504688z; Wang WX, 2014, J AM CHEM SOC, V136, P2244, DOI 10.1021/ja412351b; Warui DM, 2011, J AM CHEM SOC, V133, P3316, DOI 10.1021/ja111607x; Whittington DA, 2001, J AM CHEM SOC, V123, P827, DOI 10.1021/ja003240n; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wriggers W, 2001, J APPL CRYSTALLOGR, V34, P773, DOI 10.1107/S0021889801012869; Younker JM, 2008, J AM CHEM SOC, V130, P15022, DOI 10.1021/ja804365e; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Zhang Y, 2011, BIOCHEMISTRY-US, V50, P5615, DOI 10.1021/bi200348q	108	23	23	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25254	25272		10.1074/jbc.M115.675223	http://dx.doi.org/10.1074/jbc.M115.675223			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26324712	Green Published, hybrid			2022-12-28	WOS:000362962800005
J	Salvarelli, E; Krupka, M; Rivas, G; Mingorance, J; Gomez-Puertas, P; Alfonso, C; Rico, AI				Salvarelli, Estefania; Krupka, Marcin; Rivas, German; Mingorance, Jesus; Gomez-Puertas, Paulino; Alfonso, Carlos; Isabel Rico, Ana			The Cell Division Protein FtsZ from Streptococcus pneumoniae Exhibits a GTPase Activity Delay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSEMBLY DYNAMICS; STRUCTURAL INSIGHTS; SIZE-DISTRIBUTION; LIGHT-SCATTERING; POLYMERIZATION; POLYMERS; RING; ULTRACENTRIFUGATION; LOCALIZATION; ENERGETICS	The cell division protein FtsZ assembles in vitro by a mechanism of cooperative association dependent on GTP, monovalent cations, and Mg2+. We have analyzed the GTPase activity and assembly dynamics of Streptococcus pneumoniae FtsZ (SpnFtsZ). SpnFtsZ assembled in an apparently cooperative process, with a higher critical concentration than values reported for other FtsZ proteins. It sedimented in the presence of GTP as a high molecular mass polymer with a well defined size and tended to form double-stranded filaments in electron microscope preparations. GTPase activity depended on K+ and Mg2+ and was inhibited by Na+. GTP hydrolysis exhibited a delay that included a lag phase followed by a GTP hydrolysis activation step, until reaction reached the GTPase rate. The lag phase was not found in polymer assembly, suggesting a transition from an initial non-GTP-hydrolyzing polymer that switches to a GTP-hydrolyzing polymer, supporting models that explain FtsZ polymer cooperativity.	[Salvarelli, Estefania; Mingorance, Jesus] Hosp Univ La Paz, IdiPAZ, Microbiol Serv, Madrid 28046, Spain; [Salvarelli, Estefania; Gomez-Puertas, Paulino] Univ Autonoma Madrid, Biomol Informat SL, E-28049 Madrid, Spain; [Krupka, Marcin; Isabel Rico, Ana] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Gomez-Puertas, Paulino] CSIC, Ctr Biol Mol Sever Ochoa, Mol Modelling Grp, E-28049 Madrid, Spain; [Rivas, German; Alfonso, Carlos] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain	Hospital Universitario La Paz; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Salvarelli, E (corresponding author), Hosp Univ La Paz, IdiPAZ, Microbiol Serv, Paseo La Castellana 261, Madrid 28046, Spain.	esalvarelli@gmail.com	Rico, Ana Isabel/A-5242-2010; Rivas, German/AFL-7528-2022; Mingorance, Jesus/B-7562-2009; Gomez-Puertas, Paulino/G-8821-2014; Rivas, German/AAG-7458-2022; Alfonso, Carlos/K-1316-2014	Rico, Ana Isabel/0000-0001-6021-3970; Rivas, German/0000-0003-3450-7478; Mingorance, Jesus/0000-0001-6173-5711; Gomez-Puertas, Paulino/0000-0003-3131-729X; Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800	Spanish Government [BIO2011-28941-C03, BIO2011-28941-C01]; Torres Quevedo Program [PTQ-11-05049]; La Caixa Foundation	Spanish Government(Spanish GovernmentEuropean Commission); Torres Quevedo Program; La Caixa Foundation(La Caixa Foundation)	This work was supported in part by Spanish Government GrantsBIO2011-28941-C03 (to G. R. and C. A.) and BIO2011-28941-C01. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Torres Quevedo Program Grant PTQ-11-05049 to Biomol Informatics S.L. To whom correspondence should be addressed: Servicio de Microbiologia, Hospital Universitario La Paz, IdiPAZ, Paseo de La Castellana, 261, 28046 Madrid, Spain. E-mail: esalvarelli@gmail.corn.; Ph.D. fellow of the La Caixa Foundation International Fellowship Programme (La Caixa/CNB).	Ahijado-Guzman R, 2013, J BIOL CHEM, V288, P27358, DOI 10.1074/jbc.M113.482943; Ariza A, 2012, J PROTEOMICS, V77, P504, DOI 10.1016/j.jprot.2012.09.030; Biteen JS, 2012, CHEMPHYSCHEM, V13, P1007, DOI 10.1002/cphc.201100686; Caplan MR, 2003, J BIOL CHEM, V278, P13784, DOI 10.1074/jbc.M300860200; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; Cole JL, 2004, METHOD ENZYMOL, V384, P212; CORTON JC, 1987, J BACTERIOL, V169, P1; Elsen NL, 2012, J AM CHEM SOC, V134, P12342, DOI 10.1021/ja303564a; Fadda D, 2007, J BACTERIOL, V189, P1288, DOI 10.1128/JB.01168-06; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gonzalez JM, 2003, J BIOL CHEM, V278, P37664, DOI 10.1074/jbc.M305230200; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Hernandez-Rocamora VM, 2013, J BIOL CHEM, V288, P24625, DOI 10.1074/jbc.M113.483222; Huecas S, 2003, J BIOL CHEM, V278, P46146, DOI 10.1074/jbc.M307128200; Huecas S, 2008, BIOPHYS J, V94, P1796, DOI 10.1529/biophysj.107.115493; Jamous C, 2014, J BIOMOL STRUCT DYN, V32, P916, DOI 10.1080/07391102.2013.799436; Jimenez M, 2011, J BIOL CHEM, V286, P11236, DOI 10.1074/jbc.M110.194365; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Martin-Garcia F, 2012, FEBS LETT, V586, P1236, DOI 10.1016/j.febslet.2012.03.042; Massidda O, 2013, ENVIRON MICROBIOL, V15, P3133, DOI 10.1111/1462-2920.12189; Mendieta J, 2009, J MOL BIOL, V390, P17, DOI 10.1016/j.jmb.2009.05.018; Mingorance J, 2001, MOL MICROBIOL, V41, P83, DOI 10.1046/j.1365-2958.2001.02498.x; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Miraldi ER, 2008, BIOPHYS J, V95, P2470, DOI 10.1529/biophysj.107.126219; Montecinos-Franjola F, 2014, BBA-PROTEINS PROTEOM, V1844, P1193, DOI 10.1016/j.bbapap.2014.03.012; Monterroso B, 2013, METHODS, V59, P349, DOI 10.1016/j.ymeth.2012.12.014; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P6108, DOI 10.1021/bi300891q; Monterroso B, 2012, BIOCHEMISTRY-US, V51, P4541, DOI 10.1021/bi300401b; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Natale P, 2013, ENVIRON MICROBIOL, V15, P3169, DOI 10.1111/1462-2920.12227; Natarajan K, 2013, BIOCHEMISTRY-US, V52, P3543, DOI 10.1021/bi400170f; Nogales E, 1998, NAT STRUCT BIOL, V5, P451, DOI 10.1038/nsb0698-451; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Oliva MA, 2003, J BIOL CHEM, V278, P33562, DOI 10.1074/jbc.M303798200; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; OZOLS J, 1990, METHOD ENZYMOL, V182, P587; Rico AI, 2013, J BIOL CHEM, V288, P20830, DOI 10.1074/jbc.R113.479519; Rivas G, 2000, J BIOL CHEM, V275, P11740, DOI 10.1074/jbc.275.16.11740; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Salvarelli E, 2011, FEBS LETT, V585, P3880, DOI 10.1016/j.febslet.2011.10.046; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Si FW, 2013, BIOPHYS J, V105, P1976, DOI 10.1016/j.bpj.2013.09.030; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099	51	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25081	25089		10.1074/jbc.M115.650077	http://dx.doi.org/10.1074/jbc.M115.650077			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26330552	hybrid, Green Published			2022-12-28	WOS:000362598300036
J	Fujimura, K; Choi, S; Wyse, M; Strnadel, J; Wright, T; Klemke, R				Fujimura, Ken; Choi, Sunkyu; Wyse, Meghan; Strnadel, Jan; Wright, Tracy; Klemke, Richard			Eukaryotic Translation Initiation Factor 5A (EIF5A) Regulates Pancreatic Cancer Metastasis by Modulating RhoA and Rho-associated Kinase (ROCK) Protein Expression Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; PROGNOSTIC-SIGNIFICANCE; PROMOTES TRANSLATION; MAMMALIAN TARGET; EF-P; INVASION; MIGRATION; CELLS; KRAS; MTOR	Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers with an overall survival rate of less than 5%. The poor patient outcome in PDAC is largely due to the high prevalence of systemic metastasis at the time of diagnosis and lack of effective therapeutics that target disseminated cells. The fact that the underlying mechanisms driving PDAC cell migration and dissemination are poorly understood have hindered drug development and compounded the lack of clinical success in this disease. Recent evidence indicates that mutational activation of K-Ras up-regulates eIF5A, a component of the cellular translational machinery that is critical for PDAC progression. However, the role of eIF5A in PDAC cell migration and metastasis has not been investigated. We report here that pharmacological inhibition or genetic knockdown of eIF5A reduces PDAC cell migration, invasion, and metastasis in vitro and in vivo. Proteomic profiling and bioinformatic analyses revealed that eIF5A controls an integrated network of cytoskeleton-regulatory proteins involved in cell migration. Functional interrogation of this network uncovered a critical RhoA/ROCK signaling node that operates downstream of eIF5A in invasive PDAC cells. Importantly, eIF5A mediates PDAC cell migration and invasion by modulating RhoA/ROCK protein expression levels. Together our findings implicate eIF5A as a cytoskeletal rheostat controlling RhoA/ROCK protein expression during PDAC cell migration and metastasis. Our findings also implicate the eIF5A/RhoA/ROCK module as a potential new therapeutic target to treat metastatic PDAC cells.	[Fujimura, Ken; Choi, Sunkyu; Wyse, Meghan; Strnadel, Jan; Wright, Tracy; Klemke, Richard] Univ Calif San Diego, Dept Pathol, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Klemke, R (corresponding author), 9500 Gilman Dr, 0612, La Jolla, CA 92093 USA.	rklemke@ucsd.edu	Regan, Clinton/E-6250-2012; Strnadel, Jan/Y-5172-2018	Strnadel, Jan/0000-0002-7233-6537	National Institutes of Health [CA180374, CA097022, CA182495]; NATIONAL CANCER INSTITUTE [F32CA180374, R01CA182495, R01CA097022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA180374 (to K. F.), CA097022 and CA182495 (to R. K.). No author has an actual or perceived conflict of interest with the contents of this article.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Chen EI, 2007, CANCER RES, V67, P1472, DOI 10.1158/0008-5472.CAN-06-3137; Collins MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049707; Carpeno JD, 2013, TRANSL LUNG CANCER R, V2, P142, DOI 10.3978/j.issn.2218-6751.2013.02.07; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Duner S, 2010, PANCREATOLOGY, V10, P673, DOI 10.1159/000320711; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Faried A, 2007, ANN SURG ONCOL, V14, P3593, DOI 10.1245/s10434-007-9562-x; Fujimura K, 2014, CANCER RES, V74, P6671, DOI 10.1158/0008-5472.CAN-14-1031; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Irelan JT, 2011, J BIOMOL SCREEN, V16, P313, DOI 10.1177/1087057110397359; Javle MM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-368; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Kern SE, 2011, J PATHOL, V223, P295, DOI 10.1002/path.2813; Konstantinidou G, 2013, CANCER DISCOV, V3, P444, DOI 10.1158/2159-8290.CD-12-0388; Kulke Matthew H, 2002, Curr Treat Options Oncol, V3, P449, DOI 10.1007/s11864-002-0065-5; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lee NP, 2010, INT J CANCER, V127, P968, DOI 10.1002/ijc.25100; Li CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009942; Li ZK, 2009, CANCER RES, V69, P7851, DOI 10.1158/0008-5472.CAN-08-4002; Liu XJ, 2014, BIOSCI BIOTECH BIOCH, V78, P1895, DOI 10.1080/09168451.2014.943650; Maier B, 2010, DISCOV MED, V10, P18; Mandal A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111800; Mathews MB, 2015, BBA-GENE REGUL MECH, V1849, P836, DOI 10.1016/j.bbagrm.2015.05.002; Memin E, 2014, CANCER RES, V74, P552, DOI 10.1158/0008-5472.CAN-13-0474; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Morgan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053785; Nakamori S, 1996, RECENT ADVANCES IN GASTROENTEROLOGICAL CARCINOGENESIS I, P901; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Park MH, 2006, J BIOCHEM, V139, P161, DOI 10.1093/jb/mvj034; Patel RA, 2012, CANCER RES, V72, P5025, DOI 10.1158/0008-5472.CAN-12-0954; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Reichert M, 2013, GENE DEV, V27, P288, DOI 10.1101/gad.204453.112; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Roy UKB, 2013, INT J CANCER, V133, P43, DOI 10.1002/ijc.28001; Saxena M, 2013, MOL ONCOL, V7, P283, DOI 10.1016/j.molonc.2013.02.009; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Stoletov K, 2013, J CELL SCI, V126, P904, DOI 10.1242/jcs.112748; Tunca B, 2013, J CANCER RES CLIN, V139, P691, DOI 10.1007/s00432-013-1372-x; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Vigil D, 2012, CANCER RES, V72, P5338, DOI 10.1158/0008-5472.CAN-11-2373; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907; Wang YC, 2010, P NATL ACAD SCI USA, V107, P10920, DOI 10.1073/pnas.0914776107; Wolpin BM, 2009, J CLIN ONCOL, V27, P193, DOI 10.1200/JCO.2008.18.9514; Xia MX, 2007, NAT STRUCT MOL BIOL, V14, P215, DOI 10.1038/nsmb1208; Xing L, 2012, MOL BIOL CELL, V23, P1500, DOI 10.1091/mbc.E11-10-0867; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yoshioka K, 1999, CANCER RES, V59, P2004; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219	57	50	55	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29907	29919		10.1074/jbc.M115.687418	http://dx.doi.org/10.1074/jbc.M115.687418			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26483550	Green Published, hybrid			2022-12-28	WOS:000366614700023
J	Qin, XK; Jiang, YJ; Tse, YC; Wang, YL; Wong, TP; Paudel, HK				Qin, Xike; Jiang, Yongjun; Tse, Yiu Chung; Wang, Yunling; Wong, Tak Pan; Paudel, Hemant K.			Early Growth Response 1 (Egr-1) Regulates N-Methyl-D-aspartate Receptor (NMDAR)-dependent Transcription of PSD-95 and alpha-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid Receptor (AMPAR) Trafficking in Hippocampal Primary Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; POSTSYNAPTIC DENSITY 95; LONG-TERM POTENTIATION; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES; GENE-EXPRESSION; MAMMALIAN BRAIN; PLASTICITY; PHOSPHORYLATION; MECHANISMS	The N-methyl-D-aspartate receptor (NMDAR) controls synaptic plasticity and memory function and is one of the major inducers of transcription factor Egr-1 in the hippocampus. However, how Egr-1 mediates the NMDAR signal in neurons has remained unclear. Here, we show that the hippocampus of mice lacking Egr-1 displays electrophysiology properties and ultrastructure that are similar to mice overexpressing PSD-95, a major scaffolding protein of postsynaptic density involved in synapse formation, synaptic plasticity, and synaptic targeting of AMPA receptors (AMPARs), which mediate the vast majority of excitatory transmission in the CNS. We demonstrate that Egr-1 is a transcription repressor of the PSD-95 gene and is recruited to the PSD-95 promoter in response to NMDAR activation. Knockdown of Egr-1 in rat hippocampal primary neurons blocks NMDAR-induced PSD-95 down-regulation and AMPAR endocytosis. Likewise, overexpression of Egr-1 in rat hippocampal primary neurons causes reduction in PSD-95 protein level and promotes AMPAR endocytosis. Our data indicate that Egr-1 is involved in NMDAR-mediated PSD-95 down-regulation and AMPAR endocytosis, a process important in the expression of long term depression.	[Qin, Xike; Jiang, Yongjun; Wang, Yunling; Paudel, Hemant K.] Jewish Gen Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; [Jiang, Yongjun; Paudel, Hemant K.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H4H 1R3, Canada; [Tse, Yiu Chung; Wong, Tak Pan] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ H4H 1R3, Canada; [Tse, Yiu Chung; Wong, Tak Pan] McGill Univ, Dept Psychiat, Montreal, PQ H4H 1R3, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Paudel, HK (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, 3755 Cote Ste, Montreal, PQ H3T 1E2, Canada.	hemant.paudel@mcgill.ca		Wong, Tak Pan/0000-0001-8611-4911	Canadian Institute for Health Research; Alzheimer's Society of Canada	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer's Society of Canada	This work was supported by grants from Canadian Institute for Health Research and Alzheimer's Society of Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Akama KT, 2003, J NEUROSCI, V23, P2333; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; Bao JX, 2004, NAT NEUROSCI, V7, P1250, DOI 10.1038/nn1342; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Beck H, 2008, AM J PATHOL, V173, P77, DOI 10.2353/ajpath.2008.070648; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Bianchetta MJ, 2011, J NEUROSCI, V31, P12029, DOI 10.1523/JNEUROSCI.2388-11.2011; Bingol B, 2004, NEUROPHARMACOLOGY, V47, P755, DOI 10.1016/j.neuropharm.2004.07.028; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen XB, 2005, P NATL ACAD SCI USA, V102, P11551, DOI 10.1073/pnas.0505359102; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dyrvig M, 2014, GENE, V539, P8, DOI 10.1016/j.gene.2014.01.072; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Han K, 2008, PROG NEUROBIOL, V84, P263, DOI 10.1016/j.pneurobio.2007.10.011; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; Henley Jeremy M, 2013, Dialogues Clin Neurosci, V15, P11; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kerchner GA, 2008, NAT REV NEUROSCI, V9, P813, DOI 10.1038/nrn2501; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Kubosaki A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r41; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Li T, 2007, J BIOL CHEM, V282, P6619, DOI 10.1074/jbc.M606347200; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lu YF, 2011, J BIOL CHEM, V286, P20569, DOI 10.1074/jbc.M111.220962; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Mammen AL, 1997, J NEUROSCI, V17, P7351; Marra V, 2012, NEURON, V76, P579, DOI 10.1016/j.neuron.2012.08.042; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Nikonenko I, 2008, J CELL BIOL, V183, P1115, DOI 10.1083/jcb.200805132; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; de Arce KP, 2010, J NEUROSCI, V30, P3728, DOI 10.1523/JNEUROSCI.2024-09.2010; Pinheiro PS, 2008, NAT REV NEUROSCI, V9, P423, DOI 10.1038/nrn2379; Qureshi HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084615; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Stathakis DG, 1999, J NEUROCHEM, V73, P2250, DOI 10.1046/j.1471-4159.1999.0732250.x; Stein V, 2003, J NEUROSCI, V23, P5503; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Thiel G, 2010, CELL CALCIUM, V47, P397, DOI 10.1016/j.ceca.2010.02.005; Tsai NP, 2012, CELL, V151, P1581, DOI 10.1016/j.cell.2012.11.040; Tse YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027215; Yudowski GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053965	57	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29603	29616		10.1074/jbc.M115.668889	http://dx.doi.org/10.1074/jbc.M115.668889			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26475861	Green Published, hybrid			2022-12-28	WOS:000366613400041
J	Wang, XW; Yang, J; Han, L; Zhao, KX; Wu, QS; Bao, LM; Li, ZY; Lv, L; Li, B				Wang, Xiuwen; Yang, Jing; Han, Lei; Zhao, Kaixia; Wu, Qingsi; Bao, Liming; Li, Zhiyuan; Lv, Ling; Li, Bin			TRAF5-mediated Lys-63-linked Polyubiquitination Plays an Essential Role in Positive Regulation of RORt in Promoting IL-17A Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoimmune disease; T helper cells; TNF receptor-associated factor (TRAF); transcription factor; ubiquitylation (ubiquitination); RORt	NF-KAPPA-B; GAMMA-T; RECEPTOR; CELLS; ACTIVATION; DIFFERENTIATION; TRAF5; INFLAMMATION; ASSOCIATION; DEGRADATION	Background: RORt is required for Th17 cell function and differentiation. Results: TRAF5 stabilizes RORt by ubiquitination and augments RORt-mediated transcriptional expression of IL-17A. Conclusion: TRAF5 is a positive regulator for RORt. Significance: TRAF5 could be a novel target for modulating RORt-mediated inflammation and autoimmune diseases, including systemic lupus erythematosus. Retinoid-related orphan nuclear receptor t (RORt) is a key transcription factor for the development and function of Th17 cells. In this study, we show that tumor necrosis factor receptor-associated factor 5 (TRAF5), known as an E3 ubiquitin protein ligase and signal transducer, interacts with and ubiquitinates RORt via Lys-63-linked polyubiquitination. TRAF5 stabilizes the RORt protein level depending on its RING finger domain. Depletion of TRAF5 in Th17 cells destabilizes RORt protein and down-regulates Th17-related genes, including IL-17A, an inflammatory cytokine involved in pathogenic mechanisms of several autoimmune diseases such as systemic lupus erythematosus. Moreover, up-regulation of the TRAF5 mRNA level was found in systemic lupus erythematosus patient CD4(+) T cells. Our findings reveal a direct link between TRAF5-mediated ubiquitination and RORt protein regulation, which may aggravate inflammatory progress and provide new therapeutic drug targets for autoimmune diseases.	[Wang, Xiuwen; Han, Lei; Zhao, Kaixia; Lv, Ling] Fudan Univ, Huashan Hosp, Div Rheumatol, Shanghai 200040, Peoples R China; [Yang, Jing; Li, Zhiyuan; Li, Bin] Chinese Acad Sci, Key Lab Mol Virol & Immunol, Shanghai Inst Biol Sci, Unit Mol Immunol,Inst Pasteur Shanghai, Shanghai 200032, Peoples R China; [Wu, Qingsi] Anhui Med Univ, Dept Immunol, Hefei 230032, Peoples R China; [Bao, Liming] Dartmouth Coll, Dept Pathol & Lab Med, Geisel Sch Med, Lebanon, NH 03756 USA	Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Anhui Medical University; Dartmouth College	Lv, L (corresponding author), Fudan Univ, Huashan Hosp, Div Rheumatol, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.	huashanlvling@sina.com; binli@sibs.ac.cn	lI, Bin/AAR-4966-2021	lI, Bin/0000-0002-7640-8884; Yang, Jing/0000-0001-6441-709X	Chinese National Program on Key Basic Research Project [2014CB541800, 2014CB541900]; NSFC [81330072, 31300711, 31370863, 31170825, 31200646, 31200647, 81271835, 81302532]; Shanghai Key Grant [14JC1406100]; Shanghai Three-year Plan on Promoting TCM Development Grant [ZY3-LCPT-2-1003]	Chinese National Program on Key Basic Research Project; NSFC(National Natural Science Foundation of China (NSFC)); Shanghai Key Grant; Shanghai Three-year Plan on Promoting TCM Development Grant	Our research is supported by Chinese National Program on Key Basic Research Project Grants 2014CB541800, 2014CB541900, NSFC 81330072, 31300711, 31370863, 31170825, 31200646, 31200647, 81271835, and 81302532; Shanghai Key Grant 14JC1406100; and Shanghai Three-year Plan on Promoting TCM Development Grant ZY3-LCPT-2-1003. The authors declare that they have no conflicts of interest with the contents of this article.	Bian ZY, 2014, J CELL BIOCHEM, V115, P349, DOI 10.1002/jcb.24669; Buchta CM, 2014, J IMMUNOL, V192, P145, DOI 10.4049/jimmunol.1301901; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Esparza EM, 2006, J BIOL CHEM, V281, P8559, DOI 10.1074/jbc.M512915200; Han L, 2015, FRONT MED-PRC, V9, P10, DOI 10.1007/s11684-015-0388-9; Han L, 2014, J BIOL CHEM, V289, P25546, DOI 10.1074/jbc.M114.565291; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kawamata S, 1998, J BIOL CHEM, V273, P5808, DOI 10.1074/jbc.273.10.5808; Kraus ZJ, 2008, J IMMUNOL, V181, P7800, DOI 10.4049/jimmunol.181.11.7800; Liu XK, 2013, J EXP MED, V210, P1575, DOI 10.1084/jem.20122327; Manku H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003554; McKeon JE, 2015, CELL MOL LIFE SCI, V72, P1811, DOI 10.1007/s00018-014-1781-2; Nagashima H, 2014, NAT IMMUNOL, V15, P449, DOI 10.1038/ni.2863; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Potter C, 2007, ANN RHEUM DIS, V66, P1322, DOI 10.1136/ard.2006.065706; Qu FF, 2012, MOL CELL BIOL, V32, P3925, DOI 10.1128/MCB.00268-12; Rajabi P, 2012, INFLAMM RES, V61, P1347, DOI 10.1007/s00011-012-0535-6; Rutz S, 2015, NATURE, V518, P417, DOI 10.1038/nature13979; Shen J, 2013, INT J MED SCI, V10, P156, DOI 10.7150/ijms.5457; Xiang Q, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4293; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Yang J, 2015, J IMMUNOL, V194, P4094, DOI 10.4049/jimmunol.1401451; Zhong B, 2012, NAT IMMUNOL, V13, P1110, DOI 10.1038/ni.2427; Zhou XJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/597921; Zhu S, 2010, J EXP MED, V207, P2647, DOI 10.1084/jem.20100703	25	32	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					29086	29094		10.1074/jbc.M115.664573	http://dx.doi.org/10.1074/jbc.M115.664573			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26453305	hybrid, Green Published			2022-12-28	WOS:000365762300046
J	Delmar, JA; Chou, TH; Wright, CC; Licon, MH; Doh, JK; Radhakrishnan, A; Kumar, N; Lei, HT; Bolla, JR; Rajashankar, KR; Su, CC; Purdy, GE; Yu, EW				Delmar, Jared A.; Chou, Tsung-Han; Wright, Catherine C.; Licon, Meredith H.; Doh, Julia K.; Radhakrishnan, Abhijith; Kumar, Nitin; Lei, Hsiang-Ting; Bolla, Jani Reddy; Rajashankar, Kanagalaghatta R.; Su, Chih-Chia; Purdy, Georgiana E.; Yu, Edward W.			Structural Basis for the Regulation of the MmpL Transporters of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-RESISTANT TUBERCULOSIS; CRYSTAL-STRUCTURE; CELL-WALL; DNA-BINDING; REPRESSOR; BIOSYNTHESIS; FAMILY; INHIBITION; EVOLUTION; SOFTWARE	The mycobacterial cell wall is critical to the virulence of these pathogens. Recent work shows that the MmpL (mycobacterial membrane protein large) family of transporters contributes to cell wall biosynthesis by exporting fatty acids and lipidic elements of the cell wall. The expression of the Mycobacterium tuberculosis MmpL proteins is controlled by a complex regulatory network, including the TetR family transcriptional regulators Rv3249c and Rv1816. Here we report the crystal structures of these two regulators, revealing dimeric, two-domain molecules with architecture consistent with the TetR family of regulators. Buried extensively within the C-terminal regulatory domains of Rv3249c and Rv1816, we found fortuitous bound ligands, which were identified as palmitic acid (a fatty acid) and isopropyl laurate (a fatty acid ester), respectively. Our results suggest that fatty acids may be the natural ligands of these regulatory proteins. Using fluorescence polarization and electrophoretic mobility shift assays, we demonstrate the recognition of promoter and intragenic regions of multiple mmpL genes by these proteins. Binding of palmitic acid renders these regulators incapable of interacting with their respective operator DNAs, which will result in derepression of the corresponding mmpL genes. Taken together, these experiments provide new perspectives on the regulation of the MmpL family of transporters.	[Delmar, Jared A.; Chou, Tsung-Han; Su, Chih-Chia; Yu, Edward W.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Radhakrishnan, Abhijith; Kumar, Nitin; Lei, Hsiang-Ting; Bolla, Jani Reddy; Yu, Edward W.] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Wright, Catherine C.; Licon, Meredith H.; Doh, Julia K.; Purdy, Georgiana E.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Northeastern Collaborat Access Team, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA	Iowa State University; Iowa State University; Oregon Health & Science University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Yu, EW (corresponding author), Iowa State Univ, Dept Chem, Dept Phys & Astron, Ames, IA 50011 USA.	ewyu@iastate.edu	Radhakrishnan, Abhijith/V-6182-2019; Regan, Clinton/E-6250-2012; , Nitin/J-8078-2019; Bolla, Jani Reddy/AAT-1370-2020	Radhakrishnan, Abhijith/0000-0001-8107-3487; Bolla, Jani Reddy/0000-0003-4346-182X	National Institutes of Health [R56AI114664]; NIGMS, National Institutes of Health [P41 GM103403]; NIH-ORIP HEI [S10 RR029205]; U.S. Department of Energy Office of Science User Facility [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI114664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-ORIP HEI; U.S. Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R56AI114664 (to G. E. P. and E. W. Y.); by NIGMS, National Institutes of Health Grant P41 GM103403 (to the Northeastern Collaborative Access Team beamlines); by NIH-ORIP HEI Grant S10 RR029205 (to the Pilatus 6M detector on 24-ID-C Beamline); and by U.S. Department of Energy Office of Science User Facility Contract DE-AC02-06CH11357 (to Advanced Photon Source, Argonne National Laboratory). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belardinelli JM, 2014, J BIOL CHEM, V289, P27952, DOI 10.1074/jbc.M114.581199; Bolla JR, 2012, NUCLEIC ACIDS RES, V40, P9340, DOI 10.1093/nar/gks677; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Chou TH, 2015, PROTEIN SCI, V24, P1942, DOI 10.1002/pro.2802; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Dover LG, 2004, J MOL BIOL, V340, P1095, DOI 10.1016/j.jmb.2004.06.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frenois F, 2004, MOL CELL, V16, P301, DOI 10.1016/j.molcel.2004.09.020; FRIEDEN TR, 1993, NEW ENGL J MED, V328, P521, DOI 10.1056/NEJM199302253280801; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Galagan JE, 2010, TUBERCULOSIS, V90, P225, DOI 10.1016/j.tube.2010.03.010; Goldman Robert C., 2007, Infectious Disorders - Drug Targets, V7, P73; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Gu RY, 2007, J MOL BIOL, V372, P583, DOI 10.1016/j.jmb.2007.06.072; Hernandez A, 2009, J BIOL CHEM, V284, P14428, DOI 10.1074/jbc.M809221200; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; ISEMAN MD, 1993, NEW ENGL J MED, V329, P784, DOI 10.1056/NEJM199309093291108; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Kumar N, 2014, PROTEIN SCI, V23, P423, DOI 10.1002/pro.2424; Lei HT, 2011, PROTEIN SCI, V20, P712, DOI 10.1002/pro.602; Luckner SR, 2009, STRUCTURE, V17, P1004, DOI 10.1016/j.str.2009.04.012; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Marrakchi H, 2000, MICROBIOL-UK, V146, P289, DOI 10.1099/00221287-146-2-289; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; Minch KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6829; Natsume R., 2004, J MOL BIOL, V336, P409; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ML PHARE CCP4 P 80, P80; Pacheco SA, 2013, J BIOL CHEM, V288, P24213, DOI 10.1074/jbc.M113.473371; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Radhakrishnan A, 2014, J BIOL CHEM, V289, P16526, DOI 10.1074/jbc.M113.538959; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Rustad TR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0502-3; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; Wells R. M., 2013, PLOS PATHOG, V9, P1; WINDER F G, 1970, Journal of General Microbiology, V63, P41	56	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28559	28574		10.1074/jbc.M115.683797	http://dx.doi.org/10.1074/jbc.M115.683797			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26396194	Green Published, hybrid			2022-12-28	WOS:000365761900047
J	Shibata, N; Ohoka, N; Sugaki, Y; Onodera, C; Inoue, M; Sakuraba, Y; Takakura, D; Hashii, N; Kawasaki, N; Gondo, Y; Naito, M				Shibata, Norihito; Ohoka, Nobunnichi; Sugaki, Yusuke; Onodera, Chiaki; Inoue, Mizuho; Sakuraba, Yoshiyuki; Takakura, Daisuke; Hashii, Noritaka; Kawasaki, Nana; Gondo, Yoichi; Naito, Mikihiko			Degradation of Stop Codon Read-through Mutant Proteins via the Ubiquitin-Proteasorne System Causes Hereditary Disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; MESSENGER-RNA; TRANSLATION; MUTAGENESIS; DEFICIENCY; RIBOSOME; SIGNALS; OXIDASE; TRIM21; PLAYS	During translation, stop codon read-through occasionally happens when the stop codon is misread, skipped, or mutated, resulting in the production of aberrant proteins with C-terminal extension. These extended proteins are potentially deleterious, but their regulation is poorly understood. Here we show in vitro and in vivo evidence that mouse cFLIP-I, with a 46-amino acid extension encoded by a read-through mutant gene is rapidly degraded by the ubiquitin-proteasome system, causing hepatocyte apoptosis during embryogenesis. The extended peptide interacts with an E3 ubiquitin ligase, TRIM21, to induce ubiquitylation of the mutant protein. In humans, 20 read-through mutations are related to hereditary disorders, and extended peptides found in human PNPO and HSD3B2 similarly destabilize these proteins, involving TRIM21 for PNPO degradation. Our findings indicate that degradation of aberrant proteins with C-terminal extension encoded by read-through mutant genes is a mechanism for loss of function resulting in hereditary disorders.	[Shibata, Norihito; Ohoka, Nobunnichi; Naito, Mikihiko] Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, Setagaya Ku, Tokyo 1588501, Japan; [Takakura, Daisuke; Hashii, Noritaka; Kawasaki, Nana] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan; [Sugaki, Yusuke; Onodera, Chiaki] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Inoue, Mizuho] Univ Tokyo, Fac Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Sakuraba, Yoshiyuki; Gondo, Yoichi] RIKEN BioResource Ctr, Mutagenesis & Genom Team, Tsukuba, Ibaraki 3050074, Japan	National Institute of Health Sciences - Japan; National Institute of Health Sciences - Japan; University of Tokyo; University of Tokyo; RIKEN	Naito, M (corresponding author), Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	miki-naito@nihs.go.jp	Gondo, Yoichi/A-5375-2016; Sakuraba, Yoshiyuki/D-5614-2009	Gondo, Yoichi/0000-0003-2184-6489; Sakuraba, Yoshiyuki/0000-0003-4698-5530; SHIBATA, NORIHITO/0000-0001-5792-8510	Japan Society for the Promotion of Science KAKENHI [25112521, 26860050, 25241016]; Health and Labor Sciences Research [26401201]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health and Labor Sciences Research(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 25112521 (to M. N.), 26860050 (to N. S.), and 25241016 (to Y. G.) and by Health and Labor Sciences Research Grant 26401201 (to N. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe S, 2003, AM J HUM GENET, V72, P73, DOI 10.1086/345398; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Cassan M, 2001, BMC Mol Biol, V2, P3, DOI 10.1186/1471-2199-2-3; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Eswarappa SM, 2014, CELL, V157, P1605, DOI 10.1016/j.cell.2014.04.033; Inoue M, 2004, HUM MOL GENET, V13, P1147, DOI 10.1093/hmg/ddh133; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; MCCAUGHAN KK, 1995, P NATL ACAD SCI USA, V92, P5431, DOI 10.1073/pnas.92.12.5431; McEwan WA, 2013, NAT IMMUNOL, V14, P327, DOI 10.1038/ni.2548; Mills PB, 2005, HUM MOL GENET, V14, P1077, DOI 10.1093/hmg/ddi120; Ngo EO, 1998, BIOCHEMISTRY-US, V37, P7741, DOI 10.1021/bi972983r; Ohoka N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.471; Oke V, 2012, J AUTOIMMUN, V39, P77, DOI 10.1016/j.jaut.2012.01.014; Pang S., 2001, ENDOCRIN METAB CLIN, V30, pvi; Pang SY, 2002, J CLIN ENDOCR METAB, V87, P2556, DOI 10.1210/jc.87.6.2556; Pang SY, 2001, ENDOCRIN METAB CLIN, V30, P81, DOI 10.1016/S0889-8529(08)70020-3; Plevin MJ, 2005, TRENDS BIOCHEM SCI, V30, P66, DOI 10.1016/j.tibs.2004.12.001; Sakamaki K, 2002, CELL DEATH DIFFER, V9, P1196, DOI 10.1038/sj.cdd.4401090; Sakuraba Y, 2005, BIOCHEM BIOPH RES CO, V336, P609, DOI 10.1016/j.bbrc.2005.08.134; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhang ZQ, 2013, NAT IMMUNOL, V14, P172, DOI 10.1038/ni.2492	23	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28428	28437		10.1074/jbc.M115.670901	http://dx.doi.org/10.1074/jbc.M115.670901			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26442586	hybrid, Green Published			2022-12-28	WOS:000365761900036
J	Kassa, T; Jana, S; Strader, MB; Meng, FT; Jia, YP; Wilson, MT; Alayash, AI				Kassa, Tigist; Jana, Sirsendu; Strader, Michael Brad; Meng, Fantao; Jia, Yiping; Wilson, Michael T.; Alayash, Abdu I.			Sickle Cell Hemoglobin in the Ferryl State Promotes beta Cys-93 Oxidation and Mitochondrial Dysfunction in Epithelial Lung Cells (E10)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE CHEST SYNDROME; HEME OXYGENASE-1; HYDROGEN-PEROXIDE; MASS-SPECTROMETRY; CROSS-LINKING; STRESS; MYOGLOBIN; MECHANISM; RADICALS; COMPLEX	Polymerization of intraerythrocytic deoxyhemoglobin S (HbS) is the primary molecular event that leads to hemolytic anemia in sickle cell disease (SCD). We reasoned that HbS may contribute to the complex pathophysiology of SCD in part due to its pseudoperoxidase activity. We compared oxidation reactions and the turnover of oxidation intermediates of purified human HbS and HbA. Hydrogen peroxide (H2O2) drives a catalytic cycle that includes the following three distinct steps: 1) initial oxidation of ferrous (oxy) to ferryl Hb; 2) autoreduction of the ferryl intermediate to ferric (metHb); and 3) reaction of metHb with an additional H2O2 molecule to regenerate the ferryl intermediate. Ferrous and ferric forms of both proteins underwent initial oxidation to the ferryl heme in the presence of H2O2 at equal rates. However, the rate of autoreduction of ferryl to the ferric form was slower in the HbS solutions. Using quantitative mass spectrometry and the spin trap, 5,5-dimethyl-1pyrroline-N-oxide, we found more irreversibly oxidized beta Cys-93 in HbS than in HbA. Incubation of the ferric or ferryl HbS with cultured lung epithelial cells (E10) induced a drop in mitochondrial oxygen consumption rate and impairment of cellular bioenergetics that was related to the redox state of the iron. Ferryl HbS induced a substantial drop in the mitochondrial transmembrane potential and increases in cytosolic heme oxygenase (HO-1) expression and mitochondrial colocalization in E10 cells. Thus, highly oxidizing ferryl Hb and heme, the product of oxidation, may be central to the evolution of vasculopathy in SCD and may suggest therapeutic modalities that interrupt heme-mediated inflammation.	[Kassa, Tigist; Jana, Sirsendu; Strader, Michael Brad; Meng, Fantao; Jia, Yiping; Alayash, Abdu I.] Food & Drug Adm, Lab Biochem & Vasc Biol, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Wilson, Michael T.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	US Food & Drug Administration (FDA); University of Essex	Alayash, AI (corresponding author), Food & Drug Adm, Lab Biochem & Vasc Biol, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	abdu.alayash@fda.hhs.gov			National Institutes of Health NHLBI [P01-HL110900]; United States Food and Drug Administration (MODSCI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110900] Funding Source: NIH RePORTER	National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States Food and Drug Administration (MODSCI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health NHLBI Grant P01-HL110900 (to A. I. A.) and grants from the United States Food and Drug Administration (MODSCI) (to A. I. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham B, 2011, BIOCHEMISTRY-US, V50, P9752, DOI 10.1021/bi200876e; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alayash AI, 2014, TRENDS BIOTECHNOL, V32, P177, DOI 10.1016/j.tibtech.2014.02.006; Alayash AI, 2004, NAT REV DRUG DISCOV, V3, P152, DOI 10.1038/nrd1307; Alayash AI, 1999, J BIOL CHEM, V274, P2029, DOI 10.1074/jbc.274.4.2029; ASAKURA T, 1974, P NATL ACAD SCI USA, V71, P1594, DOI 10.1073/pnas.71.5.1594; BANERJEE R, 1969, BIOCHEMISTRY-US, V8, P2862, DOI 10.1021/bi00835a025; Bansal S, 2014, REDOX BIOL, V2, P273, DOI 10.1016/j.redox.2013.07.004; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; BERZOFSKY JA, 1971, J BIOL CHEM, V246, P3367; Bindu S, 2011, J BIOL CHEM, V286, P39387, DOI 10.1074/jbc.M111.279893; Boretti FS, 2009, J CLIN INVEST, V119, P2271, DOI 10.1172/JCI39115; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Cardenes N, 2014, BLOOD, V123, P2864, DOI 10.1182/blood-2013-09-529420; CASHON RE, 1995, ARCH BIOCHEM BIOPHYS, V316, P461, DOI 10.1006/abbi.1995.1061; CATALANO CE, 1989, J BIOL CHEM, V264, P10534; Chintagari NR, 2015, BLOOD CELL MOL DIS, V54, P302, DOI 10.1016/j.bcmd.2014.12.001; Cooper CE, 2013, ANTIOXID REDOX SIGN, V18, P2264, DOI 10.1089/ars.2012.4547; Cyrklaff M, 2011, SCIENCE, V334, P1283, DOI 10.1126/science.1213775; Deterding LJ, 2004, J BIOL CHEM, V279, P11600, DOI 10.1074/jbc.M310704200; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Frohnert BI, 2013, ADV NUTR, V4, P157, DOI 10.3945/an.112.003319; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; GAREL MC, 1990, BIOCHIM BIOPHYS ACTA, V1041, P133, DOI 10.1016/0167-4838(90)90056-L; George A, 2013, BLOOD, V121, P2099, DOI 10.1182/blood-2012-07-441188; Ghosh S, 2013, J CLIN INVEST, V123, P4809, DOI 10.1172/JCI64578; GIULIVI C, 1994, METHOD ENZYMOL, V231, P490; Gladwin MT, 2014, BLOOD, V123, P3689, DOI 10.1182/blood-2014-03-563874; Goldman DW, 1998, AM J PHYSIOL-HEART C, V275, pH1046, DOI 10.1152/ajpheart.1998.275.3.H1046; Gunther MR, 1998, BIOCHEM J, V330, P1293; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hebbel RP, 2014, HEMATOL ONCOL CLIN N, V28, P181, DOI 10.1016/j.hoc.2013.11.005; Hebbel RP, 2011, AM J HEMATOL, V86, P123, DOI 10.1002/ajh.21952; HEBBEL RP, 1988, P NATL ACAD SCI USA, V85, P237, DOI 10.1073/pnas.85.1.237; HEBBEL RP, 1989, AM J PHYSIOL, V256, pC579, DOI 10.1152/ajpcell.1989.256.3.C579; Herold S, 2003, FREE RADICAL BIO MED, V34, P531, DOI 10.1016/S0891-5849(02)01355-2; Higdon AN, 2012, AM J PHYSIOL-HEART C, V302, pH1394, DOI 10.1152/ajpheart.00584.2011; Hill BG, 2009, BIOCHEM J, V424, P99, DOI 10.1042/BJ20090934; Jana S, 2011, BBA-MOL BASIS DIS, V1812, P663, DOI 10.1016/j.bbadis.2011.02.013; Jia YP, 2007, J BIOL CHEM, V282, P4894, DOI 10.1074/jbc.M609955200; Kathuria H, 2004, J BIOL CHEM, V279, P30028, DOI 10.1074/jbc.M402236200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khan I, 2001, BIOCHEMISTRY-US, V40, P7581, DOI 10.1021/bi010051o; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; MAPLES KR, 1990, ARCH BIOCHEM BIOPHYS, V277, P402, DOI 10.1016/0003-9861(90)90596-Q; MARVA E, 1994, BLOOD, V83, P242; MCARTHUR KM, 1993, BIOCHIM BIOPHYS ACTA, V1202, P173, DOI 10.1016/0167-4838(93)90002-9; Mollan TL, 2014, FREE RADICAL BIO MED, V69, P265, DOI 10.1016/j.freeradbiomed.2014.01.030; Mollan TL, 2013, J BIOL CHEM, V288, P4288, DOI 10.1074/jbc.M112.412064; Nagababu E, 2002, BIOCHEMISTRY-US, V41, P7407, DOI 10.1021/bi0121048; OSAWA Y, 1993, BIOCHEM PHARMACOL, V46, P2299, DOI 10.1016/0006-2952(93)90621-3; PAULING L, 1964, Bull N Y Acad Med, V40, P334; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Pimenova T, 2010, J PROTEOME RES, V9, P4061, DOI 10.1021/pr100252e; Potoka KP, 2015, AM J PHYSIOL-LUNG C, V308, pL314, DOI 10.1152/ajplung.00252.2014; Reeder BJ, 2001, FREE RADICAL BIO MED, V30, P1311, DOI 10.1016/S0891-5849(01)00534-2; Reeder BJ, 2005, CURR MED CHEM, V12, P2741, DOI 10.2174/092986705774463021; Reeder BJ, 2010, ANTIOXID REDOX SIGN, V13, P1087, DOI 10.1089/ars.2009.2974; Reeder BJ, 2008, J BIOL CHEM, V283, P30780, DOI 10.1074/jbc.M804709200; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Safo MK, 2013, ACTA CRYSTALLOGR D, V69, P2061, DOI 10.1107/S0907444913019197; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; Silva G, 2009, J BIOL CHEM, V284, P29582, DOI 10.1074/jbc.M109.045344; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Song W, 2006, J CELL PHYSIOL, V206, P655, DOI 10.1002/jcp.20509; Strader MB, 2014, J BIOL CHEM, V289, P22342, DOI 10.1074/jbc.M114.568980; Tam MF, 2015, J BIOL CHEM, V290, P21762, DOI 10.1074/jbc.M115.658054; TEW D, 1988, J BIOL CHEM, V263, P17880; WIEDERMANN BL, 1975, J BIOL CHEM, V250, P5273; Wright PJ, 2003, J AM CHEM SOC, V125, P8655, DOI 10.1021/ja0291888	70	36	36	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27939	27958		10.1074/jbc.M115.651257	http://dx.doi.org/10.1074/jbc.M115.651257			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26396189	hybrid, Green Published			2022-12-28	WOS:000365757500042
J	Feng, YQ; Love, RP; Ara, A; Baig, TT; Adolph, MB; Chelico, L				Feng, Yuqing; Love, Robin P.; Ara, Anjuman; Baig, Tayyba T.; Adolph, Madison B.; Chelico, Linda			Natural Polymorphisms and Oligomerization of Human APOBEC3H Contribute to Single-stranded DNA Scanning Ability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTIDINE DEAMINASE APOBEC3H; AMINO-ACID DIFFERENCE; HIV-1 VIF-BINDING; CRYSTAL-STRUCTURE; RESTRICTION FACTORS; STRUCTURAL DETERMINANTS; ANTIVIRAL ACTIVITY; IN-VIVO; FUNCTIONAL IMPLICATIONS	APOBEC3H is a deoxycytidine deaminase that can restrict the replication of HIV-1 in the absence of the viral protein Vif that induces APOBEC3H degradation in cells. APOBEC3H exists in humans as seven haplotypes (I-VII) with different cellular stabilities. Of the three stable APOBEC3H haplotypes (II, V, and VII), haplotypes II and V occur most frequently in the population. Despite APOBEC3H being a bona fide restriction factor, there has been no comparative biochemical characterization of APOBEC3H haplotypes. We characterized the ssDNA scanning mechanisms that haplotypes II and V use to search their ssDNA substrate for cytosine-containing deamination motifs. APOBEC3H haplotype II was able to processively deaminate multiple cytosines in a single enzyme-substrate encounter by using sliding, jumping, and intersegmental transfer movements. In contrast, APOBEC3H haplotype V exhibited diminished sliding and intersegmental transfer abilities but was able to jump along ssDNA. Due to an Asp or Glu at amino acid 178 differentiating these APOBEC3H haplotypes, the data indicated that this amino acid on helix 6 contributes to processivity. The diminished processivity of APOBEC3H haplotype V did not result in a reduced efficiency to restrict HIV-1 replication in single-cycle infectivity assays, suggesting a redundancy in the contributions of jumping and intersegmental transfer to mutagenic efficiency. Optimal processivity on ssDNA also required dimerization of APOBEC3H through the 2 strands. The findings support a model in which jumping can compensate for deficiencies in intersegmental transfer and suggest that APOBEC3H haplotypes II and V induce HIV-1 mutagenesis efficiently but by different mechanisms.	[Feng, Yuqing; Love, Robin P.; Ara, Anjuman; Baig, Tayyba T.; Adolph, Madison B.; Chelico, Linda] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Chelico, L (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	linda.chelico@usask.ca		Ara, Anjuman/0000-0002-6302-4849; Feng, Yuqing/0000-0002-7156-1628; Chelico, Linda/0000-0003-4673-8978; Love, Robin/0000-0002-2509-706X	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes for Health Research [MOP-37090]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant and Canadian Institutes for Health Research Grant MOP-37090. The authors declare that they have no conflicts of interest with the contents of this article.	Albin JS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001343; Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Apolonia L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004609; Ara A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004024; Aydin H, 2014, STRUCTURE, V22, P668, DOI 10.1016/j.str.2014.02.011; Bach D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-54; Baig TT, 2014, J VIROL, V88, P14380, DOI 10.1128/JVI.02484-14; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Binka M, 2012, J VIROL, V86, P49, DOI 10.1128/JVI.06082-11; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Bohn MF, 2015, STRUCTURE, V23, P903, DOI 10.1016/j.str.2015.03.016; Bohn MF, 2013, STRUCTURE, V21, P1042, DOI 10.1016/j.str.2013.04.010; Carpenter MA, 2010, DNA REPAIR, V9, P579, DOI 10.1016/j.dnarep.2010.02.010; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Dang Y, 2008, J BIOL CHEM, V283, P11606, DOI 10.1074/jbc.M707586200; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Desimmie BA, 2014, J MOL BIOL, V426, P1220, DOI 10.1016/j.jmb.2013.10.033; Feng YQ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00450; Feng YQ, 2013, J BIOL CHEM, V288, P6083, DOI 10.1074/jbc.M112.421875; Feng YQ, 2011, J BIOL CHEM, V286, P11415, DOI 10.1074/jbc.M110.199604; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343; Harari A, 2009, J VIROL, V83, P295, DOI 10.1128/JVI.01665-08; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; King JJ, 2015, STRUCTURE, V23, P615, DOI 10.1016/j.str.2015.01.016; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Krzysiak TC, 2012, BIOCHEMISTRY-US, V51, P2008, DOI 10.1021/bi300021s; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Le Grice SFJ, 2012, J BIOL CHEM, V287, P40850, DOI 10.1074/jbc.R112.389056; Li JH, 2014, J MOL BIOL, V426, P1296, DOI 10.1016/j.jmb.2013.12.014; Li MMH, 2011, J VIROL, V85, P8197, DOI 10.1128/JVI.00624-11; Li MMH, 2010, J VIROL, V84, P88, DOI 10.1128/JVI.01344-09; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Lieberman BA, 1997, J BIOL CHEM, V272, P1061, DOI 10.1074/jbc.272.2.1061; Love RP, 2012, J BIOL CHEM, V287, P30812, DOI 10.1074/jbc.M112.393181; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mitra M, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-014-0130-8; Mu YX, 2012, J BIOL CHEM, V287, P28007, DOI 10.1074/jbc.M112.370189; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; OhAinle M, 2008, CELL HOST MICROBE, V4, P249, DOI 10.1016/j.chom.2008.07.005; Ooms M, 2013, CELL HOST MICROBE, V14, P411, DOI 10.1016/j.chom.2013.09.006; Ooms M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057744; Ooms M, 2010, J VIROL, V84, P7961, DOI 10.1128/JVI.00754-10; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Rathore A, 2013, J MOL BIOL, V425, P4442, DOI 10.1016/j.jmb.2013.07.040; Refsland EW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004761; Refsland EW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002800; Sakurai D, 2015, IMMUNOGENETICS, V67, P253, DOI 10.1007/s00251-015-0829-2; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Senavirathne G, 2012, J BIOL CHEM, V287, P15826, DOI 10.1074/jbc.M112.342790; Shandilya SMD, 2014, VIROLOGY, V471, P105, DOI 10.1016/j.virol.2014.09.023; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shlyakhtenko LS, 2013, J STRUCT BIOL, V184, P217, DOI 10.1016/j.jsb.2013.09.008; Siu KK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3593; Song CS, 2012, J BIOL CHEM, V287, P16965, DOI 10.1074/jbc.M111.310839; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Strebel K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-55; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Tan LD, 2009, FASEB J, V23, P279, DOI 10.1096/fj.07-088781; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wang XJ, 2011, J VIROL, V85, P3142, DOI 10.1128/JVI.02049-10; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004; Zhen AJ, 2010, J VIROL, V84, P1902, DOI 10.1128/JVI.01509-09; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	88	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27188	27203		10.1074/jbc.M115.666065	http://dx.doi.org/10.1074/jbc.M115.666065			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26396192	Green Published, hybrid			2022-12-28	WOS:000364794000028
J	Sahu, B; Sun, WY; Perusek, L; Parmar, V; Le, YZ; Griswold, MD; Palczewski, K; Maeda, A				Sahu, Bhubanananda; Sun, Wenyu; Perusek, Lindsay; Parmar, Vipulkumar; Le, Yun-Zheng; Griswold, Michael D.; Palczewski, Krzysztof; Maeda, Akiko			Conditional Ablation of Retinol Dehydrogenase 10 in the Retinal Pigmented Epithelium Causes Delayed Dark Adaption in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHORT-CHAIN DEHYDROGENASE; ALL-TRANS-RETINOL; VISUAL CYCLE; ALCOHOL-DEHYDROGENASE; RETINITIS-PIGMENTOSA; VERTEBRATE RETINA; BINDING PROTEIN; IN-VIVO; FUNDUS-ALBIPUNCTATUS; MOLECULAR-MECHANISMS	Background: RDH10 is a candidate 11-cis-retinol dehydrogenase in the retinal pigmented epithelium (RPE) capable of regenerating the visual chromophore, 11-cis-retinal. Results: Loss of Rdh10 in RPE cells caused delayed regeneration of 11-cis-retinal. Conclusion: Rdh10 is an NAD(+)-dependent 11-cis-retinol dehydrogenase localized to RPE cells. Significance: This study provides evidence that RDH10 plays a complimentary role in producing 11-cis-retinal in the RPE. Regeneration of the visual chromophore, 11-cis-retinal, is a crucial step in the visual cycle required to sustain vision. This cycle consists of sequential biochemical reactions that occur in photoreceptor cells and the retinal pigmented epithelium (RPE). Oxidation of 11-cis-retinol to 11-cis-retinal is accomplished by a family of enzymes termed 11-cis-retinol dehydrogenases, including RDH5 and RDH11. Double deletion of Rdh5 and Rdh11 does not limit the production of 11-cis-retinal in mice. Here we describe a third retinol dehydrogenase in the RPE, RDH10, which can produce 11-cis-retinal. Mice with a conditional knock-out of Rdh10 in RPE cells (Rdh10 cKO) displayed delayed 11-cis-retinal regeneration and dark adaption after bright light illumination. Retinal function measured by electroretinogram after light exposure was also delayed in Rdh10 cKO mice as compared with controls. Double deletion of Rdh5 and Rdh10 (cDKO) in mice caused elevated 11/13-cis-retinyl ester content also seen in Rdh5(-/-)Rdh11(-/-) mice as compared with Rdh5(-/-) mice. Normal retinal morphology was observed in 6-month-old Rdh10 cKO and cDKO mice, suggesting that loss of Rdh10 in the RPE does not negatively affect the health of the retina. Compensatory expression of other retinol dehydrogenases was observed in both Rdh5(-/-) and Rdh10 cKO mice. These results indicate that RDH10 acts in cooperation with other RDH isoforms to produce the 11-cis-retinal chromophore needed for vision.	[Sahu, Bhubanananda; Perusek, Lindsay; Parmar, Vipulkumar; Maeda, Akiko] Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Palczewski, Krzysztof; Maeda, Akiko] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Sun, Wenyu] Polgenix Inc, Cleveland, OH 44106 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Med Endocrinol, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Le, Yun-Zheng] Univ Oklahoma, Hlth Sci Ctr, Harold Hamm Diabet Ctr, Oklahoma City, OK 73104 USA; [Griswold, Michael D.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Washington State University	Maeda, A (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.	aam19@case.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01EY022658, R24EY021126, P30EY011373]; Research to Prevent Blindness Foundation; Foundation Fighting Blindness; Midwest Eye Banks; Ohio Lions Eye Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD042454] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY011373, R01EY022658, R24EY021126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); Midwest Eye Banks; Ohio Lions Eye Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants R01EY022658 (to A.M.), R24EY021126 (to K.P.), and P30EY011373, Research to Prevent Blindness Foundation, Foundation Fighting Blindness, Midwest Eye Banks, and Ohio Lions Eye Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Belyaeva OV, 2008, J BIOL CHEM, V283, P20299, DOI 10.1074/jbc.M800019200; BLISS AF, 1951, ARCH BIOCHEM BIOPHYS, V31, P197, DOI 10.1016/0003-9861(51)90206-8; Buczylko J, 1996, J BIOL CHEM, V271, P20621, DOI 10.1074/jbc.271.34.20621; Chai XY, 1997, J BIOL CHEM, V272, P33125, DOI 10.1074/jbc.272.52.33125; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Cideciyan AV, 2000, VISUAL NEUROSCI, V17, P667, DOI 10.1017/S0952523800175029; Driessen C, 2003, VISION RES, V43, P3075, DOI 10.1016/S0042-6989(03)00483-8; Duester G, 2001, CHEM-BIOL INTERACT, V130, P469, DOI 10.1016/S0009-2797(00)00292-1; Farjo KM, 2009, INVEST OPHTH VIS SCI, V50, P5089, DOI 10.1167/iovs.09-3797; Golczak M, 2012, J BIOL CHEM, V287, P23790, DOI 10.1074/jbc.M112.361550; Haeseleer F, 2002, J BIOL CHEM, V277, P45537, DOI 10.1074/jbc.M208882200; Jang GF, 2001, J BIOL CHEM, V276, P32456, DOI 10.1074/jbc.M104949200; JIANG M, 1993, INVEST OPHTH VIS SCI, V34, P3669; Kim TS, 2005, J BIOL CHEM, V280, P8694, DOI 10.1074/jbc.M413172200; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; Kiser PD, 2012, P NATL ACAD SCI USA, V109, pE2747, DOI 10.1073/pnas.1212025109; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Le YZ, 2008, INVEST OPHTH VIS SCI, V49, P1248, DOI 10.1167/iovs.07-1105; Maeda A, 2006, BIOCHEMISTRY-US, V45, P4210, DOI 10.1021/bi052382x; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda T, 2003, J NEUROCHEM, V85, P944, DOI 10.1046/j.1471-4159.2003.01741.x; Martras S, 2004, EUR J BIOCHEM, V271, P1660, DOI 10.1111/j.1432-1033.2004.04058.x; Mata NL, 1998, BBA-LIPID LIPID MET, V1394, P16, DOI 10.1016/S0005-2760(98)00078-2; MATSCHINSKY FM, 1968, J NEUROCHEM, V15, P643, DOI 10.1111/j.1471-4159.1968.tb08963.x; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; Morimura H, 1999, NAT GENET, V23, P393, DOI 10.1038/70496; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; PANDEY S, 1994, EXP EYE RES, V58, P605, DOI 10.1006/exer.1994.1055; Pares X, 2008, CELL MOL LIFE SCI, V65, P3936, DOI 10.1007/s00018-008-8591-3; Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; RANDO RR, 1992, PHOTOCHEM PHOTOBIOL, V56, P1145, DOI 10.1111/j.1751-1097.1992.tb09739.x; RANDO RR, 1991, BIOCHEMISTRY-US, V30, P595, DOI 10.1021/bi00217a001; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; Su J, 1998, J BIOL CHEM, V273, P17910, DOI 10.1074/jbc.273.28.17910; Sun WY, 2007, VISION RES, V47, P2055, DOI 10.1016/j.visres.2007.04.005; Svensson S, 1999, J BIOL CHEM, V274, P29712, DOI 10.1074/jbc.274.42.29712; Takahashi Y, 2009, BIOCHEM J, V419, P113, DOI 10.1042/BJ20080812; Tong MH, 2013, P NATL ACAD SCI USA, V110, P543, DOI 10.1073/pnas.1214883110; Wang J, 1999, BIOCHEM J, V338, P23, DOI 10.1042/0264-6021:3380023; Wu BX, 2004, INVEST OPHTH VIS SCI, V45, P3857, DOI 10.1167/iovs.03-1302; Wu BX, 2002, INVEST OPHTH VIS SCI, V43, P3365; Xie YJ, 2014, HUM MOL GENET, V23, P5774, DOI 10.1093/hmg/ddu291; Yamamoto H, 1999, NAT GENET, V22, P188, DOI 10.1038/9707; Yesim F, 2004, AM J OPHTHALMOL, V138, P171, DOI 10.1016/j.ajo.2004.02.060; ZGOMBICKNIGHT M, 1995, J BIOL CHEM, V270, P10868, DOI 10.1074/jbc.270.18.10868; Zhang M, 2001, J BIOL CHEM, V276, P44083, DOI 10.1074/jbc.M105748200; Zhuang R, 2002, BIOCHEMISTRY-US, V41, P3477, DOI 10.1021/bi0119316	53	16	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27239	27247		10.1074/jbc.M115.682096	http://dx.doi.org/10.1074/jbc.M115.682096			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26391396	hybrid, Green Published			2022-12-28	WOS:000364794000032
J	Staniec, D; Ksiazek, M; Thogersen, IB; Enghild, JJ; Sroka, A; Bryzek, D; Bogyo, M; Abrahamson, M; Potempa, J				Staniec, Dominika; Ksiazek, Miroslaw; Thogersen, Ida B.; Enghild, Jan J.; Sroka, Aneta; Bryzek, Danuta; Bogyo, Matthew; Abrahamson, Magnus; Potempa, Jan			Calcium Regulates the Activity and Structural Stability of Tpr, a Bacterial Calpain-like Peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORPHYROMONAS-GINGIVALIS W83; VIRULENCE FACTORS; PROTEASE GENE; PERIODONTITIS; EXPRESSION; GINGIPAINS; PROTEINASES; MECHANISM; DISEASE	Background: Calcium-activated, family C2 cysteine peptidases (calpains) are rare among prokaryotes, and none have been characterized. Results: Tpr peptidase from Porphyromonas gingivalis requires calcium for stability, autoprocessing, and activity. Conclusion: Tpr is the calcium-regulated peptidase well adapted to function on the P. gingivalis cell surface. Significance: Tpr is the first characterized bacteria-derived calpain-like peptidase. Porphyromonas gingivalis is a peptide-fermenting asaccharolytic periodontal pathogen. Its genome contains several genes encoding cysteine peptidases other than gingipains. One of these genes (PG1055) encodes a protein called Tpr (thiol protease) that has sequence similarity to cysteine peptidases of the papain and calpain families. In this study we biochemically characterize Tpr. We found that the 55-kDa Tpr inactive zymogen proteolytically processes itself into active forms of 48, 37, and 33 kDa via sequential truncations at the N terminus. These processed molecular forms of Tpr are associated with the bacterial outer membrane where they are likely responsible for the generation of metabolic peptides required for survival of the pathogen. Both autoprocessing and activity were dependent on calcium concentrations >1 mM, consistent with the protein's activity within the intestinal and inflammatory milieus. Calcium also stabilized the Tpr structure and rendered the protein fully resistant to proteolytic degradation by gingipains. Together, our findings suggest that Tpr is an example of a bacterial calpain, a calcium-responsive peptidase that may generate substrates required for the peptide-fermenting metabolism of P. gingivalis. Aside from nutrient generation, Tpr may also be involved in evasion of host immune response through degradation of the antimicrobial peptide LL-37 and complement proteins C3, C4, and C5. Taken together, these results indicate that Tpr likely represents an important pathogenesis factor for P. gingivalis.	[Staniec, Dominika; Ksiazek, Miroslaw; Sroka, Aneta; Bryzek, Danuta; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland; [Thogersen, Ida B.; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol, Ctr Insoluble Prot Struct inSPIN, DK-8000 Aarhus, Denmark; [Thogersen, Ida B.; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Bogyo, Matthew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Staniec, Dominika; Abrahamson, Magnus] Lund Univ, Dept Lab Med, Div Clin Chem & Pharmacol, S-22100 Lund, Sweden; [Potempa, Jan] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40202 USA; [Ksiazek, Miroslaw; Potempa, Jan] Jagiellonian Univ, Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland	Jagiellonian University; Aarhus University; Aarhus University; Stanford University; Lund University; University of Louisville; Jagiellonian University	Staniec, D (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Gronostajowa 7, PL-30387 Krakow, Poland.	dominika.staniec@uj.edu.pl	Potempa, Jan/AAA-6850-2021; Abrahamson, Magnus/CAG-9507-2022	Sroka, Aneta/0000-0002-3386-5364; Potempa, Jan/0000-0002-3600-7461; Enghild, Jan Johannes/0000-0001-9292-9172; Bogyo, Matthew/0000-0003-3753-4412	Ministry of Science and Higher Education; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022597] Funding Source: NIH RePORTER	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We are grateful to Anna-Cathrine Carlberg-Lofstrom for technical assistance. The Faculty of Biochemistry, Biophysics, and Biotechnology of Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education.	[Anonymous], 2005, J PERIODONTOL, V76, P1406, DOI 10.1902/jop.2005.76.8.1406; BOURGEAU G, 1992, INFECT IMMUN, V60, P3186, DOI 10.1128/IAI.60.8.3186-3192.1992; Chee B, 2013, INT J EVID-BASED HEA, V11, P317, DOI 10.1111/1744-1609.12038; Cobb CM, 2009, PERIODONTOL 2000, V50, P13, DOI 10.1111/j.1600-0757.2008.00284.x; Darby I, 2001, PERIODONTOL 2000, V26, P33, DOI 10.1034/j.1600-0757.2001.2260103.x; Dashper SG, 2011, J DENT RES, V90, P691, DOI 10.1177/0022034510385242; de Pablo P, 2009, NAT REV RHEUMATOL, V5, P218, DOI 10.1038/nrrheum.2009.28; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Fitzpatrick RE, 2009, J INNATE IMMUN, V1, P109, DOI 10.1159/000181145; Friedewald VE, 2009, J PERIODONTOL, V80, P1021, DOI [10.1902/jop.2009.097001, 10.1016/j.amjcard.2009.05.002]; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Guentsch A, 2011, J PERIODONTOL, V82, P1051, DOI 10.1902/jop.2011.100565; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Imamura T, 2003, J PERIODONTOL, V74, P111, DOI 10.1902/jop.2003.74.1.111; Jones HE, 2002, CELL CALCIUM, V32, P183, DOI 10.1016/S0143416002001537; Lu BQ, 1998, INFECT IMMUN, V66, P5147, DOI 10.1128/IAI.66.11.5147-5156.1998; Nguyen KA, 2007, J BACTERIOL, V189, P833, DOI 10.1128/JB.01530-06; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Park Y, 1997, INFECT IMMUN, V65, P1101, DOI 10.1128/IAI.65.3.1101-1104.1997; PARK Y, 1993, INFECT IMMUN, V61, P4139, DOI 10.1128/IAI.61.10.4139-4146.1993; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; POTEMPA J, 1995, TRENDS MICROBIOL, V3, P430, DOI 10.1016/S0966-842X(00)88996-9; Potempa M, 2012, BIOL CHEM, V393, P873, DOI 10.1515/hsz-2012-0174; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Tokuda M, 1998, INFECT IMMUN, V66, P5232, DOI 10.1128/IAI.66.11.5232-5237.1998; Travis J, 1997, J PERIODONTAL RES, V32, P120, DOI 10.1111/j.1600-0765.1997.tb01392.x; Veillard F, 2012, BIOL CHEM, V393, P1471, DOI 10.1515/hsz-2012-0222; Walker CB, 1997, CLIN INFECT DIS, V25, pS281, DOI 10.1086/516222; Wegner N, 2009, INT J BIOCHEM CELL B, V41, P390, DOI 10.1016/j.biocel.2008.09.012; WYSS C, 1992, J CLIN MICROBIOL, V30, P2225, DOI 10.1128/JCM.30.9.2225-2229.1992	32	11	11	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27248	27260		10.1074/jbc.M115.648782	http://dx.doi.org/10.1074/jbc.M115.648782			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26385924	Green Published, hybrid			2022-12-28	WOS:000364794000033
J	Bardwell, AJ; Bardwell, L				Bardwell, A. Jane; Bardwell, Lee			Two Hydrophobic Residues Can Determine the Specificity of Mitogen-activated Protein Kinase Docking Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; HIGH-AFFINITY BINDING; MAP KINASES; SITES; SUBSTRATE; JNK; MECHANISMS; INHIBITOR; PATHWAYS; MOTIFS	MAPKs bind to many of their upstream regulators and downstream substrates via a short docking motif (the D-site) on their binding partner. MAPKs that are in different families (e.g. ERK, JNK, and p38) can bind selectively to D-sites in their authentic substrates and regulators while discriminating against D-sites in other pathways. Here we demonstrate that the short hydrophobic region at the distal end of the D-site plays a critical role in determining the high selectivity of JNK MAPKs for docking sites in their cognate MAPK kinases. Changing just 1 or 2 key hydrophobic residues in this submotif is sufficient to turn a weak JNK-binding D-site into a strong one, or vice versa. These specificity-determining differences are also found in the D-sites of the ETS family transcription factors Elk-1 and Net. Moreover, swapping two hydrophobic residues between these D-sites switches the relative efficiency of Elk-1 and Net as substrates for ERK versus JNK, as predicted. These results provide new insights into docking specificity and suggest that this specificity can evolve rapidly by changes to just 1 or 2 amino acids.	[Bardwell, A. Jane; Bardwell, Lee] Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Complex Biol Syst, Irvine, CA 92697 USA	University of California System; University of California Irvine	Bardwell, L (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA.	bardwell@uci.edu	Bardwell, Lee/I-8284-2019	Bardwell, Lee/0000-0002-2393-8363	National Institutes of Health, NIGMS [R01 GM60366, R01 GM84332, P50 GM76516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060366, P50GM076516, R01GM084332] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grants R01 GM60366, R01 GM84332, and P50 GM76516. The authors declare that they have no conflicts of interest with the contents of this article.	Akella R, 2008, BBA-PROTEINS PROTEOM, V1784, P48, DOI 10.1016/j.bbapap.2007.09.016; Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Bardwell AJ, 2003, BIOCHEM J, V370, P1077, DOI 10.1042/BJ20021806; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Barsyte-Lovejoy D, 2002, J BIOL CHEM, V277, P9896, DOI 10.1074/jbc.M108145200; Bhaduri S, 2011, CURR BIOL, V21, P1615, DOI 10.1016/j.cub.2011.08.033; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; BRANDT RB, 1987, BIOCHEM MED METAB B, V37, P344, DOI 10.1016/0885-4505(87)90046-6; Bubici C, 2014, BRIT J PHARMACOL, V171, P24, DOI 10.1111/bph.12432; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Callaway K, 2007, BIOCHEMISTRY-US, V46, P9187, DOI 10.1021/bi700206u; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Cer RZ, 2009, NUCLEIC ACIDS RES, V37, pW441, DOI 10.1093/nar/gkp253; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Deschenes-Simard X, 2013, GENE DEV, V27, P900, DOI 10.1101/gad.203984.112; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Ducret C, 2000, ONCOGENE, V19, P5063, DOI 10.1038/sj.onc.1203892; Ember B, 2008, BIOCHEMISTRY-US, V47, P3076, DOI 10.1021/bi701852z; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Francis DM, 2011, NAT CHEM BIOL, V7, P916, DOI [10.1038/NCHEMBIO.707, 10.1038/nchembio.707]; Futran AS, 2013, CURR BIOL, V23, pR972, DOI 10.1016/j.cub.2013.09.033; Gaestel M, 2009, CURR PHARM DESIGN, V15, P2471, DOI 10.2174/138161209788682299; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; Garai A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003004; Gogl G, 2013, ACTA CRYSTALLOGR D, V69, P486, DOI 10.1107/S0907444912051062; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Grewal S, 2006, CELL SIGNAL, V18, P123, DOI 10.1016/j.cellsig.2005.04.001; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hancock CN, 2006, MED CHEM, V2, P213, DOI 10.2174/157340606776056151; Ho DT, 2006, J BIOL CHEM, V281, P13169, DOI 10.1074/jbc.M601010200; Ho DT, 2003, J BIOL CHEM, V278, P32662, DOI 10.1074/jbc.M304229200; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Koivomagi M, 2011, MOL CELL, V42, P610, DOI 10.1016/j.molcel.2011.05.016; Kusari AB, 2004, J CELL BIOL, V164, P267, DOI 10.1083/jcb.200310021; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Laudet V, 1999, ONCOGENE, V18, P1351, DOI 10.1038/sj.onc.1202444; Laughlin JD, 2012, STRUCTURE, V20, P2174, DOI 10.1016/j.str.2012.09.021; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Morrison Deborah K, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a011254; Niu LH, 2007, BIOCHEMISTRY-US, V46, P4775, DOI 10.1021/bi602423e; Papin JA, 2005, NAT REV MOL CELL BIO, V6, P99, DOI 10.1038/nrm1570; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Peti W, 2013, PROTEIN SCI, V22, P1698, DOI 10.1002/pro.2374; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Sabio G, 2010, TRENDS BIOCHEM SCI, V35, P490, DOI 10.1016/j.tibs.2010.04.004; Sakaguchi A, 2004, J BIOCHEM, V136, P7, DOI 10.1093/jb/mvh097; Stebbins JL, 2008, P NATL ACAD SCI USA, V105, P16809, DOI 10.1073/pnas.0805677105; Tanoue T, 2002, J BIOL CHEM, V277, P22942, DOI 10.1074/jbc.M202096200; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Whisenant TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000908; Wozniak MA, 2012, CURR BIOL, V22, P2017, DOI 10.1016/j.cub.2012.08.050; Wu ZG, 1997, MOL CELL BIOL, V17, P7407, DOI 10.1128/MCB.17.12.7407; Yang SH, 1998, EMBO J, V17, P1740, DOI 10.1093/emboj/17.6.1740; Yang SH, 1998, MOL CELL BIOL, V18, P710, DOI 10.1128/MCB.18.2.710; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	73	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26661	26674		10.1074/jbc.M115.691436	http://dx.doi.org/10.1074/jbc.M115.691436			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370088	hybrid, Green Published			2022-12-28	WOS:000364793600030
J	Blasic, JR; Worcester, DL; Gawrisch, K; Gurnev, P; Mihailescu, M				Blasic, Joseph R.; Worcester, David L.; Gawrisch, Klaus; Gurnev, Philip; Mihailescu, Mihaela			Pore Hydration States of KcsA Potassium Channels in Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILAYER STRUCTURE DETERMINATION; NEUTRON-DIFFRACTION DATA; X-RAY; CRYSTAL-STRUCTURE; JOINT REFINEMENT; VOLUME CHANGES; WATER; CONDUCTION; MECHANISM; SITE	Water-filled hydrophobic cavities in channel proteins serve as gateways for transfer of ions across membranes, but their properties are largely unknown. We determined water distributions along the conduction pores in two tetrameric channels embedded in lipid bilayers using neutron diffraction: potassium channel KcsA and the transmembrane domain of M2 protein of influenza A virus. For the KcsA channel in the closed state, the distribution of water is peaked in the middle of the membrane, showing water in the central cavity adjacent to the selectivity filter. This water is displaced by the channel blocker tetrabutylammonium. The amount of water associated with the channel was quantified, using neutron diffraction and solid state NMR. In contrast, the M2 proton channel shows a V-shaped water profile across the membrane, with a narrow constriction at the center, like the hourglass shape of its internal surface. These two types of water distribution are therefore very different in their connectivity to the bulk water. The water and protein profiles determined here provide important evidence concerning conformation and hydration of channels in membranes and the potential role of pore hydration in channel gating.	[Blasic, Joseph R.; Mihailescu, Mihaela] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Worcester, David L.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Worcester, David L.] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Gawrisch, Klaus] NIAAA, Lab Membrane Biochem & Biophys, NIH, Bethesda, MD 20892 USA; [Gurnev, Philip] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Gurnev, Philip] NICHHD, NIH, Bethesda, MD 20892 USA	University of California System; University of California Irvine; National Institute of Standards & Technology (NIST) - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Massachusetts System; University of Massachusetts Amherst; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Mihailescu, M (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	emihailescu@ibbr.umd.edu			National Research Council; NIST Biomanufacturing Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM086685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000003] Funding Source: NIH RePORTER	National Research Council(Consiglio Nazionale delle Ricerche (CNR)); NIST Biomanufacturing Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Crina Nimigean for providing the KcsA plasmid and Jun Wang and William F. DeGrado for the M2 peptide. We also thank Kenton Swartz, Dmitriy Krepkiy (NINDS, National Institutes of Health), and Stephen H. White (University of California, Irvine) for helpful discussions. We acknowledge the National Research Council for the postdoctoral fellowship awarded to J. B. We acknowledge the National Institute of Standards and Technology, U.S. Department of Commerce, in providing the neutron research facilities and the support provided by NIST Biomanufacturing Initiative. The identification of any commercial product or trade name does not imply endorsement or recommendation by the National Institute of Standards and Technology.	Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Aryal P, 2015, J MOL BIOL, V427, P121, DOI 10.1016/j.jmb.2014.07.030; Balannik V, 2010, BIOCHEMISTRY-US, V49, P696, DOI 10.1021/bi901799k; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; BULDT G, 1978, NATURE, V271, P182, DOI 10.1038/271182a0; Cao Y, 2011, NATURE, V473, P50, DOI 10.1038/nature09939; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; ERNST JA, 1995, SCIENCE, V267, P1813, DOI 10.1126/science.7892604; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hilser VJ, 2011, NATURE, V469, P166, DOI 10.1038/469166a; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Myles DAA, 2006, CURR OPIN STRUC BIOL, V16, P630, DOI 10.1016/j.sbi.2006.08.010; Nucci NV, 2011, NAT STRUCT MOL BIOL, V18, P245, DOI 10.1038/nsmb.1955; OTTING G, 1995, ACCOUNTS CHEM RES, V28, P171, DOI 10.1021/ar00052a002; Santos JS, 2012, J BIOL CHEM, V287, P43063, DOI 10.1074/jbc.M112.415091; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Taraphder S, 2003, J AM CHEM SOC, V125, P3931, DOI 10.1021/ja016860c; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Vaitheeswaran S, 2004, P NATL ACAD SCI USA, V101, P17002, DOI 10.1073/pnas.0407968101; WALSBY AE, 1994, MICROBIOL REV, V58, P94, DOI 10.1128/MMBR.58.1.94-144.1994; Wang J, 2011, CURR OPIN STRUC BIOL, V21, P68, DOI 10.1016/j.sbi.2010.12.002; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; WIENER MC, 1991, BIOPHYS J, V60, P568, DOI 10.1016/S0006-3495(91)82086-0; WIENER MC, 1991, BIOPHYS J, V59, P174, DOI 10.1016/S0006-3495(91)82209-3; WIENER MC, 1991, BIOPHYS J, V59, P162, DOI 10.1016/S0006-3495(91)82208-1; Wikstrom M, 1998, CURR OPIN STRUC BIOL, V8, P480, DOI 10.1016/S0959-440X(98)80127-9; WORCESTER DL, 1976, J MOL BIOL, V100, P359, DOI 10.1016/S0022-2836(76)80068-X; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; ZIMMERBERG J, 1986, NATURE, V323, P36, DOI 10.1038/323036a0; ZIMMERBERG J, 1990, BIOPHYS J, V57, P1049, DOI 10.1016/S0006-3495(90)82623-0	43	5	5	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26765	U472		10.1074/jbc.M115.661819	http://dx.doi.org/10.1074/jbc.M115.661819			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370089	hybrid, Green Published			2022-12-28	WOS:000364793600038
J	Nikel, PI; Chavarria, M; Fuhrer, T; Sauer, U; de Lorenzo, V				Nikel, Pablo I.; Chavarria, Max; Fuhrer, Tobias; Sauer, Uwe; de Lorenzo, Victor			Pseudomonas putida KT2440 Strain Metabolizes Glucose through a Cycle Formed by Enzymes of the Entner-Doudoroff, Embden-Meyerhof-Parnas, and Pentose Phosphate Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL CARBON METABOLISM; ESCHERICHIA-COLI; FLUX ANALYSIS; MICROBIAL-METABOLISM; GLYCOLYTIC STRATEGY; OXIDATIVE STRESS; CATABOLISM; MUTANTS; AERUGINOSA; BACTERIA	The soil bacterium Pseudomonas putida KT2440 lacks a functional Embden-Meyerhof-Parnas (EMP) pathway, and glycolysis is known to proceed almost exclusively through the Entner-Doudoroff (ED) route. To investigate the raison d'etre of this metabolic arrangement, the distribution of periplasmic and cytoplasmic carbon fluxes was studied in glucose cultures of this bacterium by using C-13-labeled substrates, combined with quantitative physiology experiments, metabolite quantification, and in vitro enzymatic assays under both saturating and non-saturating, quasi in vivo conditions. Metabolic flux analysis demonstrated that 90% of the consumed sugar was converted into gluconate, entering central carbon metabolism as 6-phosphogluconate and further channeled into the ED pathway. Remarkably, about 10% of the triose phosphates were found to be recycled back to form hexose phosphates. This set of reactions merges activities belonging to the ED, the EMP (operating in a gluconeogenic fashion), and the pentose phosphate pathways to form an unforeseen metabolic architecture (EDEMP cycle). Determination of the NADPH balance revealed that the default metabolic state of P. putida KT2440 is characterized by a slight catabolic overproduction of reducing power. Cells growing on glucose thus run a biochemical cycle that favors NADPH formation. Because NADPH is required not only for anabolic functions but also for counteracting different types of environmental stress, such a cyclic operation may contribute to the physiological heftiness of this bacterium in its natural habitats.	[Nikel, Pablo I.; de Lorenzo, Victor] CSIC, Ctr Nacl Biotecnol, Syst & Synthet Biol Program, E-28049 Madrid, Spain; [Chavarria, Max] Univ Costa Rica, Escuela Quim, San Jose, Costa Rica; [Fuhrer, Tobias; Sauer, Uwe] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universidad Costa Rica; Swiss Federal Institutes of Technology Domain; ETH Zurich	de Lorenzo, V (corresponding author), CSIC, Ctr Nacl Biotecnol, Syst & Synthet Biol Program, Plaza Murillo 2, E-28049 Madrid, Spain.	vdlorenzo@cnb.csic.es	Fuhrer, Tobias/B-5667-2013; Nikel, Pablo Ivan/L-4146-2014; Chavarria, Max/J-3940-2019; Sauer, Uwe/Y-3556-2019	Fuhrer, Tobias/0000-0001-5006-6874; Nikel, Pablo Ivan/0000-0002-9313-7481; Chavarria, Max/0000-0001-5901-3576; de Lorenzo, Victor/0000-0002-6041-2731	CAMBIOS Project of the Spanish Ministry of Economy and Competitiveness; ST-FLOW Contract of the European Union; EVOPROG Contract of the European Union; ARI-SYS Contract of the European Union; EmpowerPutida Contract of the European Union; PROMT Project of the Autonomous Community of Madrid; Marie Sklodowska-Curie Actions Program Grant from the European Union ALLE-GRO [UE-FP7-PEOPLE-2011-IIF-300508]; University of Costa Rica	CAMBIOS Project of the Spanish Ministry of Economy and Competitiveness(Spanish Government); ST-FLOW Contract of the European Union; EVOPROG Contract of the European Union; ARI-SYS Contract of the European Union; EmpowerPutida Contract of the European Union; PROMT Project of the Autonomous Community of Madrid; Marie Sklodowska-Curie Actions Program Grant from the European Union ALLE-GRO; University of Costa Rica	This work was supported in part by the CAMBIOS Project of the Spanish Ministry of Economy and Competitiveness, the ST-FLOW, EVOPROG, ARI-SYS, and EmpowerPutida Contracts of the European Union, the PROMT Project of the Autonomous Community of Madrid (to V.D.L.), and Marie Sklodowska-Curie Actions Program Grant from the European Union ALLE-GRO, UE-FP7-PEOPLE-2011-IIF-300508 (to P. I. N.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a fellowship from the University of Costa Rica.	Ahmed H, 2004, BIOCHEM SOC T, V32, P303, DOI 10.1042/BST0320303; ANDERSON A, 1969, FEBS LETT, V4, P19, DOI 10.1016/0014-5793(69)80184-5; Molina-Henares MA, 2010, ENVIRON MICROBIOL, V12, P1468, DOI 10.1111/j.1462-2920.2010.02166.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; BANERJEE PC, 1987, J GEN MICROBIOL, V133, P1099; BANERJEE PC, 1989, FOLIA MICROBIOL, V34, P81, DOI 10.1007/BF02823683; Bar-Even A, 2012, NAT CHEM BIOL, V8, P509, DOI [10.1038/NCHEMBIO.971, 10.1038/nchembio.971]; BAUMANN P, 1975, ARCH MICROBIOL, V105, P225, DOI 10.1007/BF00447141; Behrends V, 2013, J BIOL CHEM, V288, P15098, DOI 10.1074/jbc.M112.442814; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088368; Bidart GN, 2012, APPL ENVIRON MICROB, V78, P8784, DOI 10.1128/AEM.02558-12; Blank LM, 2008, FEBS J, V275, P5173, DOI 10.1111/j.1742-4658.2008.06648.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014; Chavarria M, 2013, ENVIRON MICROBIOL, V15, P1772, DOI 10.1111/1462-2920.12069; Chavarria M, 2012, MBIO, V3, DOI 10.1128/mBio.00028-12; Chen RR, 2013, APPL BIOCHEM BIOTECH, V170, P805, DOI 10.1007/s12010-013-0239-6; Chubukov V, 2014, NAT REV MICROBIOL, V12, P327, DOI 10.1038/nrmicro3238; CONWAY T, 1992, FEMS MICROBIOL LETT, V103, P1; del Castillo T, 2008, J BACTERIOL, V190, P2331, DOI 10.1128/JB.01726-07; del Castillo T, 2007, J BACTERIOL, V189, P5142, DOI 10.1128/JB.00203-07; dos Santos VAPM, 2004, ENVIRON MICROBIOL, V6, P1264, DOI 10.1111/j.1462-2920.2004.00734.x; Duque E., 2007, PSEUDOMONAS MODEL SY, P227, DOI DOI 10.1007/978-1-4020-6097-7_8; Ebert BE, 2011, APPL ENVIRON MICROB, V77, P6597, DOI 10.1128/AEM.05588-11; ENTNER N, 1952, J BIOL CHEM, V196, P853; Felux AK, 2015, P NATL ACAD SCI USA, V112, pE4298, DOI 10.1073/pnas.1507049112; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Green MR, 2012, MOL CLONING LAB MANU, V1; Hanke T, 2013, APPL ENVIRON MICROB, V79, P2336, DOI 10.1128/AEM.03414-12; HEATH HE, 1978, J BACTERIOL, V136, P638, DOI 10.1128/JB.136.2.638-646.1978; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kim J, 2014, APPL MICROBIOL BIOT, V98, P6933, DOI 10.1007/s00253-014-5883-4; Klingner A, 2015, APPL ENVIRON MICROB, V81, P2408, DOI 10.1128/AEM.03157-14; Klinke S, 2000, APPL ENVIRON MICROB, V66, P909, DOI 10.1128/AEM.66.3.909-913.2000; LESSIE TG, 1984, ANNU REV MICROBIOL, V38, P359, DOI 10.1146/annurev.mi.38.100184.002043; Maleki S, 2015, APPL ENVIRON MICROB, V81, P3349, DOI 10.1128/AEM.03653-14; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nikel P. I., 2015, HYDROCARBON LIPID MI; Nikel PI, 2015, MBIO, V6, DOI 10.1128/mBio.00340-15; Nikel PI, 2014, NAT REV MICROBIOL, V12, P368, DOI 10.1038/nrmicro3253; Nikel PI, 2014, ENVIRON MICROBIOL, V16, P239, DOI 10.1111/1462-2920.12224; Nikel PI, 2013, MICROB CELL FACT, V12, DOI [10.1186/s12934-014-0159-3, 10.1186/1475-2859-12-50]; Nikel PI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0377; Nikel PI, 2013, METAB ENG, V15, P98, DOI 10.1016/j.ymben.2012.09.006; Nikel PI, 2010, APPL ENVIRON MICROB, V76, P7400, DOI 10.1128/AEM.02067-10; Nikel PI, 2009, J BACTERIOL, V191, P5538, DOI 10.1128/JB.00174-09; Nikel PI, 2014, ENVIRON MICROBIOL, V16, P628, DOI 10.1111/1462-2920.12360; Nogales J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-79; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; Patra T, 2012, J BACTERIOL, V194, P3377, DOI 10.1128/JB.06379-11; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Puchalka J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000210; Reher M, 2010, J BACTERIOL, V192, P964, DOI 10.1128/JB.01281-09; Romano AH, 1996, RES MICROBIOL, V147, P448, DOI 10.1016/0923-2508(96)83998-2; Ruhl M, 2012, BIOTECHNOL BIOENG, V109, P763, DOI 10.1002/bit.24344; Schatschneider S, 2014, MOL BIOSYST, V10, P2663, DOI 10.1039/c4mb00198b; Schleissner C, 1997, MICROBIOL-SGM, V143, P1595, DOI 10.1099/00221287-143-5-1595; Sohn SB, 2010, BIOTECHNOL J, V5, P739, DOI 10.1002/biot.201000124; STEINBUCHEL A, 1986, J BACTERIOL, V166, P319, DOI 10.1128/jb.166.1.319-327.1986; Stettner AI, 2013, P NATL ACAD SCI USA, V110, P9629, DOI 10.1073/pnas.1307485110; Sudarsan S, 2014, APPL ENVIRON MICROB, V80, P5292, DOI 10.1128/AEM.01643-14; Tlemcani LL, 2008, ARCH MICROBIOL, V190, P141, DOI 10.1007/s00203-008-0380-8; van der Werf MJ, 2008, MOL BIOSYST, V4, P315, DOI 10.1039/b717340g; VICENTE M, 1973, ARCH MIKROBIOL, V93, P53, DOI 10.1007/BF00666080; VICENTE M, 1973, J BACTERIOL, V116, P908, DOI 10.1128/JB.116.2.908-914.1973; Waligora EA, 2014, INFECT IMMUN, V82, P2746, DOI 10.1128/IAI.01575-13; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Zamboni N, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-209	77	184	186	6	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25920	25932		10.1074/jbc.M115.687749	http://dx.doi.org/10.1074/jbc.M115.687749			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26350459	hybrid, Green Published			2022-12-28	WOS:000363527300015
J	Goh, VJ; Tan, JSY; Tan, BC; Seow, C; Ong, WY; Lim, YC; Sun, L; Ghosh, S; Silver, DL				Goh, Vera J.; Tan, Jolene S. Y.; Tan, Bryan C.; Seow, Colin; Ong, Wei-Yi; Lim, Yen Ching; Sun, Lei; Ghosh, Sujoy; Silver, David L.			Postnatal Deletion of Fat Storage-inducing Transmembrane Protein 2 (FIT2/FITM2) Causes Lethal Enteropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-OST-BETA; ORGANIC SOLUTE TRANSPORTER; BILE-ACID ABSORPTION; INTESTINAL STEM-CELL; ACTIVATES PPAR-ALPHA; TRIACYLGLYCEROL SYNTHESIS; LIPID DROPLETS; NOTCH; BINDING; HOMEOSTASIS	Lipid droplets (LDs) are phylogenetically conserved cytoplasmic organelles that store neutral lipids within a phospholipid monolayer. LDs compartmentalize lipids and may help to prevent cellular damage caused by their excess or bioactive forms. FIT2 is a ubiquitously expressed transmembrane endoplasmic reticulum (ER) membrane protein that has previously been implicated in LD formation in mammalian cells and tissue. Recent data indicate that FIT2 plays an essential role in fat storage in an in vivo constitutive adipose FIT2 knock-out mouse model, but the physiological effects of postnatal whole body FIT2 depletion have never been studied. Here, we show that tamoxifen-induced FIT2 deletion using a whole body ROSA26CreER(T2)-driven FIT2 knock-out (iF2KO) mouse model leads to lethal intestinal pathology, including villus blunting and death of intestinal crypts, and loss of lipid absorption. iF2KO mice lose weight and die within 2 weeks after the first tamoxifen dose. At the cellular level, LDs failed to form in iF2KO enterocytes after acute oil challenge and instead accumulated within the ER. Intestinal bile acid transporters were transcriptionally dysregulated in iF2KO mice, leading to the buildup of bile acids within enterocytes. These data support the conclusion that FIT2 plays an essential role in regulating intestinal health and survival postnatally.	[Goh, Vera J.; Tan, Jolene S. Y.; Tan, Bryan C.; Seow, Colin; Lim, Yen Ching; Sun, Lei; Ghosh, Sujoy; Silver, David L.] Duke Natl Univ Singapore, Grad Sch Med, Signature Res Program Cardiovasc & Metab Disorder, Singapore 169857, Singapore; [Ong, Wei-Yi] Natl Univ Singapore, Dept Anat, Singapore 119260, Singapore; [Ong, Wei-Yi] Natl Univ Singapore, Neurobiol & Aging Res Programme, Singapore 119260, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Silver, DL (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Signature Res Program Cardiovasc & Metab Disorder, 8 Coll Rd, Singapore 169857, Singapore.	david.silver@duke-nus.edu.sg	Ghosh, Sujoy/I-3729-2017	Ghosh, Sujoy/0000-0002-7601-165X; TAN, BRYAN CASSIDY/0000-0001-6399-8814; Goh, Vera/0000-0001-5260-6280; Silver, David/0000-0002-7289-9890	Singapore Ministry of Health National Medical Research Council [CBRG/0012/2012]; National Science Scholarship award	Singapore Ministry of Health National Medical Research Council(Ministry of Health-SingaporeNational Medical Research Council, Singapore); National Science Scholarship award	This work was supported in part by Singapore Ministry of Health National Medical Research Council Grant CBRG/0012/2012 (to D. L. S.) and a National Science Scholarship award (to V. J. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Ballatori N, 2005, HEPATOLOGY, V42, P1270, DOI 10.1002/hep.20961; Ballatori N, 2008, AM J PHYSIOL-GASTR L, V295, pG179, DOI 10.1152/ajpgi.90319.2008; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Dawson PA, 2005, J BIOL CHEM, V280, P6960, DOI 10.1074/jbc.M412752200; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gadaleta RM, 2010, BBA-MOL CELL BIOL L, V1801, P683, DOI 10.1016/j.bbalip.2010.04.006; Gracz A D, 2012, Methods Mol Biol, V879, P89, DOI 10.1007/978-1-61779-815-3_6; Gross DA, 2011, P NATL ACAD SCI USA, V108, P19581, DOI 10.1073/pnas.1110817108; Gross DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010796; Haas JT, 2012, J CLIN INVEST, V122, P4680, DOI 10.1172/JCI64873; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Ishifune C, 2014, P NATL ACAD SCI USA, V111, P5986, DOI 10.1073/pnas.1401671111; Jackson KG, 2002, AM J CLIN NUTR, V76, P942, DOI 10.1093/ajcn/76.5.942; Jung D, 2007, J LIPID RES, V48, P2693, DOI 10.1194/jlr.M700351-JLR200; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Kliewer SA, 2015, DIGEST DIS, V33, P327, DOI 10.1159/000371670; KRAG E, 1974, J CLIN INVEST, V53, P1686, DOI 10.1172/JCI107720; Kramer W, 1997, EUR J BIOCHEM, V249, P456, DOI 10.1111/j.1432-1033.1997.00456.x; KRAMER W, 1993, J BIOL CHEM, V268, P18035; Lee B, 2009, BBA-MOL CELL BIOL L, V1791, P1173, DOI 10.1016/j.bbalip.2009.08.002; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Li H, 2004, METABOLISM, V53, P927, DOI 10.1016/j.metabol.2004.01.017; Li HJ, 2012, DEV BIOL, V371, P156, DOI 10.1016/j.ydbio.2012.08.023; LIN MC, 1990, J BIOL CHEM, V265, P14986; Lodhi IJ, 2012, CELL METAB, V16, P189, DOI 10.1016/j.cmet.2012.06.013; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Miranda DA, 2014, J BIOL CHEM, V289, P9560, DOI 10.1074/jbc.M114.547687; Miranda DA, 2011, J BIOL CHEM, V286, P42188, DOI 10.1074/jbc.M111.297127; Moir RD, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002890; OELKERS P, 1995, BBA-LIPID LIPID MET, V1257, P199, DOI 10.1016/0005-2760(95)00098-W; Ohsaki Y, 2006, BIOCHEM BIOPH RES CO, V347, P279, DOI 10.1016/j.bbrc.2006.06.074; Perdigoto CN, 2011, DEVELOPMENT, V138, P4585, DOI 10.1242/dev.065292; Praslickova D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050810; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Rao A, 2008, P NATL ACAD SCI USA, V105, P3891, DOI 10.1073/pnas.0712328105; Razani B, 2011, J BIOL CHEM, V286, P30949, DOI 10.1074/jbc.M111.230508; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038965; Sancho R, 2015, EMBO REP, V16, P571, DOI 10.15252/embr.201540188; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; SCHIFF ER, 1972, J CLIN INVEST, V51, P1351, DOI 10.1172/JCI106931; Schneider JG, 2010, J BIOL CHEM, V285, P23396, DOI 10.1074/jbc.M110.100321; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; Wei XC, 2012, CELL HOST MICROBE, V11, P140, DOI 10.1016/j.chom.2011.12.006; Wei XC, 2011, J BIOL CHEM, V286, P2933, DOI 10.1074/jbc.M110.193037; Wilfling F, 2014, CURR OPIN CELL BIOL, V29, P39, DOI 10.1016/j.ceb.2014.03.008; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wolkoff AW, 2003, AM J PHYSIOL-GASTR L, V284, pG175, DOI 10.1152/ajpgi.00409.2002; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200; Zollner G, 2006, AM J PHYSIOL-GASTR L, V290, pG923, DOI 10.1152/ajpgi.00490.2005	66	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25686	25699		10.1074/jbc.M115.676700	http://dx.doi.org/10.1074/jbc.M115.676700			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26304121	hybrid, Green Published			2022-12-28	WOS:000362962800040
J	Aleidi, SM; Howe, V; Sharpe, LJ; Yang, A; Rao, G; Brown, AJ; Gelissen, IC				Aleidi, Shereen M.; Howe, Vicky; Sharpe, Laura J.; Yang, Alryel; Rao, Geetha; Brown, Andrew J.; Gelissen, Ingrid C.			The E3 Ubiquitin Ligases, HUWE1 and NEDD4-1, Are Involved in the Post-translational Regulation of the ABCG1 and ABCG4 Lipid Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTERS; CHOLESTEROL HOMEOSTASIS; MEDIATE CHOLESTEROL; HECT FAMILY; MACROPHAGES; EFFLUX; ABCA1; DEGRADATION; PROTEINS; G1	The ATP-binding cassette transporter ABCG1 has an essential role in cellular cholesterol homeostasis, and dysregulation has been associated with a number of high burden diseases. Previous studies reported that ABCG1 is ubiquitinated and degraded via the ubiquitin proteasome system. However, so far the molecular mechanism, including the identity of any of the rate-limiting ubiquitination enzymes, or E3 ligases, is unknown. Using liquid chromatography mass spectrometry, we identified two HECT domain E3 ligases associated with ABCG1, named HUWE1 (HECT, UBA, and WWE domain containing 1, E3 ubiquitin protein ligase) and NEDD4-1 (Neural precursor cell-expressed developmentally down regulated gene 4), of which the latter is the founding member of the NEDD4 family of ubiquitin ligases. Silencing both HUWE1 and NEDD4-1 in cells overexpressing human ABCG1 significantly increased levels of the ABCG1 monomeric and dimeric protein forms, however ABCA1 protein expression was unaffected. In addition, ligase silencing increased ABCG1-mediated cholesterol export to HDL in cells overexpressing the transporter as well as in THP-1 macrophages. Reciprocally, overexpression of both ligases resulted in a significant reduction in protein levels of both the ABCG1 monomeric and dimeric forms. Like ABCG1, ABCG4 protein levels and cholesterol export activity were significantly increased after silencing both HUWE1 and NEDD4-1 in cells overexpressing this closely related ABC half-transporter. In summary, we have identified for the first time two E3 ligases that are fundamental enzymes in the post-translational regulation of ABCG1 and ABCG4 protein levels and cellular cholesterol export activity.	[Aleidi, Shereen M.; Sharpe, Laura J.; Yang, Alryel; Rao, Geetha; Gelissen, Ingrid C.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Howe, Vicky; Sharpe, Laura J.; Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of Sydney; University of New South Wales Sydney	Brown, AJ (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au; ingrid.gelissen@sydney.edu.au	Aleidi, Shereen M./C-5926-2018	Aleidi, Shereen M./0000-0001-9222-464X; Howe, Vicky/0000-0002-7319-0664; Sharpe, Laura/0000-0002-9896-294X	National Health and Medical Research Council (NHMRC) of Australia [APP1004392]; University of Jordan	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Jordan	This project was funded by the National Health and Medical Research Council (NHMRC) of Australia (APP1004392). The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a scholarship from the University of Jordan.	Akkaya BG, 2015, MOL MEMBR BIOL, V32, P39, DOI 10.3109/09687688.2015.1023378; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Boase NA, 2015, GENE, V557, P113, DOI 10.1016/j.gene.2014.12.020; Burns V, 2013, ATHEROSCLEROSIS, V226, P408, DOI 10.1016/j.atherosclerosis.2012.12.009; Camera D, 2014, BEHAV BRAIN RES, V260, P15, DOI 10.1016/j.bbr.2013.11.024; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Donovan P, 2013, INT J BIOCHEM CELL B, V45, P706, DOI 10.1016/j.biocel.2012.12.006; Engel T, 2001, BIOCHEM BIOPH RES CO, V288, P483, DOI 10.1006/bbrc.2001.5756; Frisdal E, 2015, DIABETES, V64, P840, DOI 10.2337/db14-0245; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Gelissen IC, 2012, J LIPID RES, V53, P2133, DOI 10.1194/jlr.M028795; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Hao ZY, 2012, J EXP MED, V209, P173, DOI 10.1084/jem.20111363; Hsieh V, 2014, J BIOL CHEM, V289, P7524, DOI 10.1074/jbc.M113.515890; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Kaliszewski P, 2008, BBA-MOL CELL BIOL L, V1781, P627, DOI 10.1016/j.bbalip.2008.07.011; Kerr ID, 2011, BRIT J PHARMACOL, V164, P1767, DOI 10.1111/j.1476-5381.2010.01177.x; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Kruit JK, 2012, DIABETES, V61, P659, DOI 10.2337/db11-1341; Li JJ, 2015, ENDOCRINOLOGY, V156, P1283, DOI 10.1210/en.2014-1909; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Mund T, 2014, P NATL ACAD SCI USA, V111, P16736, DOI 10.1073/pnas.1412152111; Ogura M, 2011, ARTERIOSCL THROM VAS, V31, P1980, DOI 10.1161/ATVBAHA.111.228478; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sag D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7354; Sano O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109886; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Sharpe LJ, 2015, BBA-MOL CELL BIOL L, V1851, P956, DOI 10.1016/j.bbalip.2015.02.016; Sharpe LJ, 2014, TRENDS BIOCHEM SCI, V39, P527, DOI 10.1016/j.tibs.2014.08.008; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; Tarr PT, 2008, J LIPID RES, V49, P169, DOI 10.1194/jlr.M700364-JLR200; Tarr PT, 2009, BBA-MOL CELL BIOL L, V1791, P584, DOI 10.1016/j.bbalip.2009.01.007; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2008, FASEB J, V22, P1073, DOI 10.1096/fj.07-9944com; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738	44	32	33	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24604	24613		10.1074/jbc.M115.675579	http://dx.doi.org/10.1074/jbc.M115.675579			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26296893	Green Published, hybrid			2022-12-28	WOS:000362218900043
J	Okamura, T; Antoun, G; Keir, ST; Friedman, H; Bigner, DD; Ali-Osman, F				Okamura, Tatsunori; Antoun, Gamil; Keir, Stephen T.; Friedman, Henry; Bigner, Darell D.; Ali-Osman, Francis			Phosphorylation of Glutathione S-Transferase P1 (GSTP1) by Epidermal Growth Factor Receptor (EGFR) Promotes Formation of the GSTP1-c-Jun N-terminal kinase (JNK) Complex and Suppresses JNK Downstream Signaling and Apoptosis in Brain Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; CONSTITUTIVE ACTIVATION; PROTEIN-KINASE; LUNG-CANCER; JUN KINASE; PI; DRUG; EXPRESSION; TRANSFORMATION; PROLIFERATION	Under normal physiologic conditions, the glutathione S-transferase P1 (GSTP1) protein exists intracellularly as a dimer in reversible equilibrium with its monomeric subunits. In the latter form, GSTP1 binds to the mitogen-activated protein kinase, JNK, and inhibits JNK downstream signaling. In tumor cells, which frequently are characterized by constitutively high GSTP1 expression, GSTP1 undergoes phosphorylation by epidermal growth factor receptor (EGFR) at tyrosine residues 3, 7, and 198. Here we report on the effect of this EGFR-dependent GSTP1 tyrosine phosphorylation on the interaction of GSTP1 with JNK, on the regulation of JNK downstream signaling by GSTP1, and on tumor cell survival. Using in vitro and in vivo growing human brain tumors, we show that tyrosine phosphorylation shifts the GSTP1 dimer-monomer equilibrium to the monomeric state and facilitates the formation of the GSTP1-JNK complex, in which JNK is functionally inhibited. Targeted mutagenesis and functional analysis demonstrated that the increased GSTP1 binding to JNK results from phosphorylation of the GSTP1 C-terminal Tyr-198 by EGFR and is associated with a >2.5-fold decrease in JNK downstream signaling and a significant suppression of both spontaneous and drug-induced apoptosis in the tumor cells. The findings define a novel mechanism of regulatory control of JNK signaling that is mediated by the EGFR/GSTP1 cross-talk and provides a survival advantage for tumors with activated EGFR and high GSTP1 expression. The results lay the foundation for a novel strategy of dual EGFR/GSTP1 for treating EGFR + ve, GSTP1 expressing GBMs.	[Okamura, Tatsunori; Antoun, Gamil; Keir, Stephen T.; Friedman, Henry; Bigner, Darell D.; Ali-Osman, Francis] Dept Neurosurg, Durham, NC 27710 USA; [Bigner, Darell D.; Ali-Osman, Francis] Dept Pathol, Durham, NC 27710 USA; [Keir, Stephen T.; Friedman, Henry; Bigner, Darell D.; Ali-Osman, Francis] Preston Robert Tisch Brain Tumor Ctr, Durham, NC 27710 USA; [Friedman, Henry; Bigner, Darell D.; Ali-Osman, Francis] Duke Canc Inst, Durham, NC 27710 USA; [Friedman, Henry; Bigner, Darell D.; Ali-Osman, Francis] Duke Univ, Sch Med, Durham, NC 27710 USA	Duke University; Duke University	Ali-Osman, F (corresponding author), Duke Univ, Sch Med, Dept Neurosurg, 421 Med Sci Res Bldg, Durham, NC 27710 USA.	francis.aliosman@duke.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [RO1 CA153050, RO1 CA127872, RO1 CA112519, 5P30 CA114236-31, P50 CA108786]; NATIONAL CANCER INSTITUTE [R01CA127872, P50CA108786, R01CA114236, R01CA153050, R01CA112519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants RO1 CA153050, RO1 CA127872, RO1 CA112519, 5P30 CA114236-31, and P50 CA108786. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Ali-Osman F, 1996, Methods Mol Med, V2, P63, DOI 10.1385/0-89603-335-X:63; Ali-Osman F, 2004, CONT CANC RES, P359; Ali-Osman F, 1997, CLIN CANCER RES, V3, P2253; ALIOSMAN F, 1990, CANCER RES, V50, P6976; AliOsman F, 1997, J BIOL CHEM, V272, P10004; Antonyak MA, 2002, ONCOGENE, V21, P5038, DOI 10.1038/sj.onc.1205593; Antonyak MA, 1998, J BIOL CHEM, V273, P2817, DOI 10.1074/jbc.273.5.2817; BAMMLER TK, 1994, BIOCHEM J, V298, P385, DOI 10.1042/bj2980385; Barker FG, 2001, INT J RADIAT ONCOL, V51, P410, DOI 10.1016/S0360-3016(01)01609-1; Behrens A, 2000, ONCOGENE, V19, P2657, DOI 10.1038/sj.onc.1203603; Ben-Dov N, 2015, BBA-BIOMEMBRANES, V1848, P869, DOI 10.1016/j.bbamem.2014.12.015; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Caccuri AM, 1999, J BIOL CHEM, V274, P19276, DOI 10.1074/jbc.274.27.19276; Cripe LD, 2002, LEUKEMIA, V16, P799, DOI 10.1038/sj.leu.2402457; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dupont E, 2015, METHODS MOL BIOL, V1324, P29, DOI 10.1007/978-1-4939-2806-4_2; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; Feligioni M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028185; Fruehauf JP, 2006, CLIN CANCER RES, V12, P4523, DOI 10.1158/1078-0432.CCR-05-1830; GARCIASAEZ I, 1994, J MOL BIOL, V237, P298, DOI 10.1006/jmbi.1994.1232; Gildenhuys S, 2010, BIOCHEMISTRY-US, V49, P5074, DOI 10.1021/bi100552d; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; Hegazy UM, 2004, J BIOL CHEM, V279, P9586, DOI 10.1074/jbc.M312320200; Holley SL, 2007, CARCINOGENESIS, V28, P2268, DOI 10.1093/carcin/bgm135; Hsu CH, 2010, NEURODEGENER DIS, V7, P68, DOI 10.1159/000285509; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Johnson R, 1996, MOL CELL BIOL, V16, P4504; Keir ST, 2013, J NEURO-ONCOL, V111, P97, DOI 10.1007/s11060-012-0995-0; Khatlani TS, 2007, ONCOGENE, V26, P2658, DOI 10.1038/sj.onc.1210050; Kura T, 1996, BBA-PROTEIN STRUCT M, V1292, P317, DOI 10.1016/0167-4838(95)00216-2; Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80; Levresse V, 2002, MOL PHARMACOL, V62, P689, DOI 10.1124/mol.62.3.689; Li JY, 2008, J NEURO-ONCOL, V88, P11, DOI 10.1007/s11060-008-9529-1; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Lo HW, 2007, CURR OPIN PHARMACOL, V7, P367, DOI 10.1016/j.coph.2007.06.009; Lo HW, 2004, CANCER RES, V64, P9131, DOI 10.1158/0008-5472.CAN-04-0283; Monaco R, 1999, J PROTEIN CHEM, V18, P859, DOI 10.1023/A:1020679229110; Muscarella DE, 2008, TOXICOL APPL PHARM, V228, P93, DOI 10.1016/j.taap.2007.11.032; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nishiyama M, 1997, INT J CANCER, V72, P649; Oakley AJ, 1997, J MOL BIOL, V274, P84, DOI 10.1006/jmbi.1997.1364; Okamura T, 2000, INT J ONCOL, V16, P295; Okamura T, 2009, J BIOL CHEM, V284, P16979, DOI 10.1074/jbc.M808153200; Peklak-Scott C, 2008, MOL CANCER THER, V7, P3247, DOI 10.1158/1535-7163.MCT-08-0250; Potapova O, 1997, J BIOL CHEM, V272, P14041, DOI 10.1074/jbc.272.22.14041; Raizer RJ, 2005, J NEURO-ONCOL, V74, P77, DOI 10.1007/s11060-005-0603-7; Sanchez-Perez I, 1999, FEBS LETT, V453, P151, DOI 10.1016/S0014-5793(99)00690-0; Sanchez-Perez I, 1998, ONCOGENE, V16, P533, DOI 10.1038/sj.onc.1201578; Sarkaria JN, 2006, CLIN CANCER RES, V12, P2264, DOI 10.1158/1078-0432.CCR-05-2510; Sekine I, 2006, J THORAC ONCOL, V1, P31, DOI 10.1097/01243894-200601000-00008; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SHEN H, 1993, ARCH BIOCHEM BIOPHYS, V300, P137, DOI 10.1006/abbi.1993.1019; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tew KD, 1999, DRUG RESIST UPDATE, V2, P143, DOI 10.1054/drup.1999.0086; TEW KD, 1994, CANCER RES, V54, P4313; Tew KD, 2011, DRUG METAB REV, V43, P179, DOI 10.3109/03602532.2011.552912; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Tsuiki H, 2003, CANCER RES, V63, P250; Wang M, 2009, J PATHOL, V218, P95, DOI 10.1002/path.2521; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200	63	25	26	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30866	30878		10.1074/jbc.M115.656140	http://dx.doi.org/10.1074/jbc.M115.656140			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26429914	hybrid, Green Published			2022-12-28	WOS:000367199000019
J	Chandrakesan, M; Bhowmik, D; Sarkar, B; Abhyankar, R; Singh, H; Kallianpur, M; Dandekar, SP; Madhu, PK; Maiti, S; Mithu, VS				Chandrakesan, Muralidharan; Bhowmik, Debanjan; Sarkar, Bidyut; Abhyankar, Rajiv; Singh, Harwinder; Kallianpur, Mamata; Dandekar, Sucheta P.; Madhu, Perunthiruthy K.; Maiti, Sudipta; Mithu, Venus Singh			Steric Crowding of the Turn Region Alters the Tertiary Fold of Amyloid-beta(18-35) and Makes It Soluble	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-AMYLOID FIBRILS; FLUORESCENCE CORRELATION SPECTROSCOPY; SOLID-STATE NMR; SECONDARY STRUCTURE; ALZHEIMERS-DISEASE; PROTEIN OLIGOMERS; SALT BRIDGE; POLYMORPHISM; AGGREGATION; DITYROSINE	A beta self-assembles into parallel cross-beta fibrillar aggregates, which is associated with Alzheimer's disease pathology. A central hairpin turn around residues 23-29 is a defining characteristic of A beta in its aggregated state. Major biophysical properties of A beta, including this turn, remain unaltered in the central fragment A beta(18-35). Here, we synthesize a single deletion mutant, Delta G25, with the aim of sterically hindering the hairpin turn in A beta(18-35). We find that the solubility of the peptide goes up by more than 20-fold. Although some oligomeric structures do form, solution state NMR spectroscopy shows that they have mostly random coil conformations. Fibrils ultimately form at a much higher concentration but have widths approximately twice that of A beta(18-35), suggesting an opening of the hairpin bend. Surprisingly, two-dimensional solid state NMR shows that the contact between Phe(19) and Leu(34) residues, observed in full-length A beta and A beta(18-35), is still intact in these fibrils. This is possible if the monomers in the fibril are arranged in an antiparallel beta-sheet conformation. Indeed, IR measurements, supported by tyrosine cross-linking experiments, provide a characteristic signature of the antiparallel beta-sheet. We conclude that the self-assembly of A beta is critically dependent on the hairpin turn and on the contact between the Phe19 and Leu34 regions, making them potentially sensitive targets for Alzheimer's therapeutics. Our results show the importance of specific conformations in an aggregation process thought to be primarily driven by nonspecific hydrophobic interactions.	[Chandrakesan, Muralidharan; Dandekar, Sucheta P.] Seth GS Med Coll & King Edward Mem Hosp, Dept Biochem, Mumbai 400012, Maharashtra, India; [Bhowmik, Debanjan; Sarkar, Bidyut; Abhyankar, Rajiv; Kallianpur, Mamata; Madhu, Perunthiruthy K.; Maiti, Sudipta] Tata Inst Fundamental Res, Dept Chem Sci, Mumbai 400005, Maharashtra, India; [Singh, Harwinder; Mithu, Venus Singh] Guru Nanak Dev Univ, Dept Chem, Amritsar 143005, Punjab, India; [Madhu, Perunthiruthy K.] Tata Inst Fundamental Res, Ctr Interdisciplinary Sci, Hyderabad 500075, Andhra Pradesh, India	Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital; Tata Institute of Fundamental Research (TIFR); Guru Nanak Dev University; Tata Institute of Fundamental Research (TIFR); TIFR Centre for Interdisciplinary Sciences (TCIS), Hyderabad	Madhu, PK (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, 1 Homi Bhabha Rd, Mumbai 400005, Maharashtra, India.	madhu@tifr.res.in; maiti@tifr.res.in; venus.chem@gndu.ac.in	Singh, Harwinder/AFL-9754-2022	Singh, Harwinder/0000-0002-1470-6341; Sarkar, Bidyut/0000-0001-5023-7581; Maiti, Sudipta/0000-0002-6540-7472; bhowmik, debanjan/0000-0002-3480-7940; Mithu, Venus Singh/0000-0003-2869-9776				Adler J, 2014, PHYS CHEM CHEM PHYS, V16, P7461, DOI 10.1039/c3cp54501f; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Al-Hilaly YK, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-83; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Bitan G, 2006, METHOD ENZYMOL, V413, P217, DOI 10.1016/S0076-6879(06)13012-8; Chandrakesan M, 2013, CHEM PHYS, V422, P80, DOI 10.1016/j.chemphys.2013.01.010; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Das AK, 2015, ACS CHEM NEUROSCI, V6, P1290, DOI 10.1021/acschemneuro.5b00074; Fandrich M, 2009, PRION, V3, P89; Garai K, 2007, BIOPHYS J, V92, pL55, DOI 10.1529/biophysj.106.101485; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; MALENCIK DA, 1991, BIOCHEM BIOPH RES CO, V178, P60, DOI 10.1016/0006-291X(91)91779-C; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; Mithu VS, 2014, J BIOL CHEM, V289, P11122, DOI 10.1074/jbc.M113.519447; Mithu VS, 2011, BIOPHYS J, V101, P2825, DOI 10.1016/j.bpj.2011.10.023; Nag S, 2013, PHYS CHEM CHEM PHYS, V15, P19129, DOI 10.1039/c3cp52732h; Nasica-Labouze J, 2015, CHEM REV, V115, P3518, DOI 10.1021/cr500638n; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Rahimi F., 2009, J VIS EXP; Rauk A, 2009, CHEM SOC REV, V38, P2698, DOI 10.1039/b807980n; Reed J, 1997, ANAL BIOCHEM, V254, P36, DOI 10.1006/abio.1997.2355; Rezaei-Ghaleh N, 2014, J AM CHEM SOC, V136, P4913, DOI 10.1021/ja411707y; Sahoo B, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2969110; Sarkar B, 2014, ANGEW CHEM INT EDIT, V53, P6888, DOI 10.1002/anie.201402636; Scheidt HA, 2012, J BIOL CHEM, V287, P22822, DOI 10.1074/jbc.M112.367474; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; Sengupta P, 2003, BIOPHYS J, V84, P1977, DOI 10.1016/S0006-3495(03)75006-1; Sengupta P, 2002, METHODS, V27, P374, DOI 10.1016/S1046-2023(02)00096-8; Spencer RK, 2014, J AM CHEM SOC, V136, P5595, DOI 10.1021/ja5017409; Tay WM, 2013, J MOL BIOL, V425, P2494, DOI 10.1016/j.jmb.2013.04.003; Teplow DB, 2006, METHOD ENZYMOL, V413, P20, DOI 10.1016/S0076-6879(06)13002-5; Thakur RS, 2006, CHEM PHYS LETT, V426, P459, DOI 10.1016/j.cplett.2006.06.007; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walling C., 1975, ACCOUNTS CHEM RES, V8, P7; Weingarth M, 2009, CHEM PHYS LETT, V469, P342, DOI 10.1016/j.cplett.2008.12.084; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n	46	11	11	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30099	30107		10.1074/jbc.M115.674135	http://dx.doi.org/10.1074/jbc.M115.674135			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26487720	Green Published, hybrid			2022-12-28	WOS:000366614700040
J	Kwong, PN; Chambers, M; Vashisht, AA; Turki-Judeh, W; Yau, TY; Wohlschlegel, JA; Courey, AJ				Kwong, Pak N.; Chambers, Michael; Vashisht, Ajay A.; Turki-Judeh, Wiam; Yau, Tak Yu; Wohlschlegel, James A.; Courey, Albert J.			The Central Region of the Drosophila Co-repressor Groucho as a Regulatory Hub	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE CK2; P68 RNA HELICASE; INTRINSIC DISORDER; TRANSCRIPTION FACTORS; GENE-EXPRESSION; SPLICING FACTOR; ROLES; COREPRESSOR; DOMAIN; RECRUITMENT	Groucho (Gro) is a Drosophila co-repressor that regulates the expression of a large number of genes, many of which are involved in developmental control. Previous studies have shown that its central region is essential for function even though its three domains are poorly conserved and intrinsically disordered. Using these disordered domains as affinity reagents, we have now identified multiple embryonic Gro-interacting proteins. The interactors include protein complexes involved in chromosome organization, mRNA processing, and signaling. Further investigation of the interacting proteins using a reporter assay showed that many of them modulate Gro-mediated repression either positively or negatively. The positive regulators include components of the spliceosomal subcomplex U1 small nuclear ribonucleoprotein (U1 snRNP). A co-immunoprecipitation experiment confirms this finding and suggests that a sizable fraction of nuclear U1 snRNP is associated with Gro. The use of RNA-seq to analyze the gene expression profile of cells subjected to knockdown of Gro or snRNP-U1-C (a component of U1 snRNP) showed a significant overlap between genes regulated by these two factors. Furthermore, comparison of our RNA-seq data with Gro and RNA polymerase II ChIP data led to a number of insights, including the finding that Gro-repressed genes are enriched for promoter-proximal RNA polymerase II. We conclude that the Gro central domains mediate multiple interactions required for repression, thus functioning as a regulatory hub. Furthermore, interactions with the spliceosome may contribute to repression by Gro.	[Kwong, Pak N.; Chambers, Michael; Turki-Judeh, Wiam; Yau, Tak Yu; Courey, Albert J.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Turki-Judeh, Wiam; Wohlschlegel, James A.; Courey, Albert J.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Courey, AJ (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA.	courey@chem.ucla.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [GM44522, GM089778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089778, R01GM044522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM44522 (to A. J. C.) and GM089778 (to J. A. W.). The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Allen T, 2006, CANCER RES, V66, P1294, DOI 10.1158/0008-5472.CAN-05-1634; Armknecht S, 2005, METHOD ENZYMOL, V392, P55, DOI 10.1016/S0076-6879(04)92004-6; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Bentley D, 2002, CURR OPIN CELL BIOL, V14, P336, DOI 10.1016/S0955-0674(02)00333-2; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Bondos SE, 2012, ADV EXP MED BIOL, V725, P86, DOI 10.1007/978-1-4614-0659-4_6; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Brantjes H, 2001, NUCLEIC ACIDS RES, V29, P1410, DOI 10.1093/nar/29.7.1410; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Buszczak M, 2006, GENE DEV, V20, P977, DOI 10.1101/gad.1396306; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen GQ, 1998, MOL CELL BIOL, V18, P7259, DOI 10.1128/MCB.18.12.7259; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Chodaparambil JV, 2014, EMBO J, V33, P719, DOI 10.1002/embj.201387188; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Courey AJ, 2001, GENE DEV, V15, P2786; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Damgaard CK, 2008, MOL CELL, V29, P271, DOI 10.1016/j.molcel.2007.11.035; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Edmondson DG, 1996, GENE DEV, V10, P1247, DOI 10.1101/gad.10.10.1247; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Flores-Saaib RD, 2000, NUCLEIC ACIDS RES, V28, P4189, DOI 10.1093/nar/28.21.4189; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Gasperowicz M, 2005, J CELL BIOCHEM, V95, P670, DOI 10.1002/jcb.20476; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Han JH, 2011, TRENDS CELL BIOL, V21, P336, DOI 10.1016/j.tcb.2011.03.003; Hasson P, 2006, BRIT J CANCER, V94, P771, DOI 10.1038/sj.bjc.6603019; Hasson P, 2005, NAT GENET, V37, P101, DOI 10.1038/ng1486; Hasson P, 2001, EMBO J, V20, P5725, DOI 10.1093/emboj/20.20.5725; Herrmann C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks543; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Kaul A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004595; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Knoop LL, 2000, J BIOL CHEM, V275, P24865, DOI 10.1074/jbc.M001661200; Kwek KY, 2002, NAT STRUCT BIOL, V9, P800, DOI 10.1038/nsb862; Lee JS, 2007, MUTAT RES-FUND MOL M, V618, P130, DOI 10.1016/j.mrfmmm.2006.08.014; Li LM, 2011, CURR BIOL, V21, P406, DOI 10.1016/j.cub.2011.01.054; Liu ZR, 2002, MOL CELL BIOL, V22, P5443, DOI 10.1128/MCB.22.15.5443-5450.2002; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Martinez CA, 2008, MOL CELL BIOL, V28, P2792, DOI 10.1128/MCB.01203-07; MEIER UT, 1992, CELL, V70, P127; Merkhofer EC, 2014, METHODS MOL BIOL, V1126, P83, DOI 10.1007/978-1-62703-980-2_6; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nagel AC, 2005, MOL CELL BIOL, V25, P10433, DOI 10.1128/MCB.25.23.10433-10441.2005; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Niefind K, 2009, CELL MOL LIFE SCI, V66, P1800, DOI 10.1007/s00018-009-9149-8; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Patel SB, 2008, NUCLEIC ACIDS RES, V36, P6482, DOI 10.1093/nar/gkn658; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Reed R, 2003, CURR OPIN CELL BIOL, V15, P326, DOI 10.1016/S0955-0674(03)00048-6; Rossow KL, 2003, ONCOGENE, V22, P151, DOI 10.1038/sj.onc.1206067; Sekiya T, 2007, MOL CELL, V28, P291, DOI 10.1016/j.molcel.2007.10.002; SOELLER WC, 1988, GENE DEV, V2, P68, DOI 10.1101/gad.2.1.68; Song HY, 2004, MOL CELL BIOL, V24, P4341, DOI 10.1128/MCB.24.10.4341-4350.2004; Tantos A, 2012, MOL CELL ENDOCRINOL, V348, P457, DOI 10.1016/j.mce.2011.07.015; Thorne N, 2010, CHEM BIOL, V17, P646, DOI 10.1016/j.chembiol.2010.05.012; Turki-Judeh W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030610; Turki-Judeh W, 2012, CURR TOP DEV BIOL, V98, P65, DOI 10.1016/B978-0-12-386499-4.00003-3; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Walhout AJM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-109; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wilson BJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-11; Winkler CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010166; Wohlschlegel James A., 2009, V497, P33, DOI 10.1007/978-1-59745-566-4_3; Zhou Rui, 2013, Cold Spring Harb Protoc, V2013, P461, DOI 10.1101/pdb.prot074351	78	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30119	30130		10.1074/jbc.M115.681171	http://dx.doi.org/10.1074/jbc.M115.681171			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26483546	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000366614700042
J	Zhang, C; Muench, DG				Zhang, Chi; Muench, Douglas G.			A Nucleolar PUF RNA-binding Protein with Specificity for a Unique RNA Sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULAR RECOGNITION; MESSENGER-RNAS; ARABIDOPSIS; FAMILY; CODE; TRANSCRIPTOME; LOCALIZATION; APUM23; STRESS; DOMAIN	PUF proteins are a conserved group of sequence specific RNA-binding proteins that bind to RNA in a modular fashion. The RNA-binding domain of PUF proteins typically consists of eight clustered Puf repeats. Plant genomes code for large families of PUF proteins that show significant variability in their predicted Puf repeat number, organization, and amino acid sequence. Here we sought to determine whether the observed variability in the RNA-binding domains of four plant PUFs results in a preference for nonclassical PUF RNA target sequences. We report the identification of a novel RNA binding sequence for a nucleolar Arabidopsis PUF protein that contains an atypical RNA-binding domain. The Arabidopsis PUM23 (APUM23) binding sequence was 10 nucleotides in length, contained a centrally located UUGA core element, and had a preferred cytosine at nucleotide position 8. These RNA sequence characteristics differ from those of other PUF proteins, because all natural PUFs studied to date bind to RNAs that contain a conserved UGU sequence at their 5' end and lack specificity for cytosine. Gel mobility shift assays validated the identity of the APUM23 binding sequence and supported the location of 3 of the 10 predicted Puf repeats in APUM23, including the cytosine-binding repeat. The preferred 10-nucleotide sequence bound by APUM23 is present within the 18S rRNA sequence, supporting the known role of APUM23 in 18S rRNA maturation. This work also reveals that APUM23, an ortholog of yeast Nop9, could provide an advanced structural backbone for Puf repeat engineering and target-specific regulation of cellular RNAs.	[Zhang, Chi; Muench, Douglas G.] Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada	University of Calgary	Muench, DG (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	dmuench@ucalgary.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant (to D. G. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbasi N, 2010, PLANT J, V64, P960, DOI 10.1111/j.1365-313X.2010.04393.x; Abil Z, 2015, MOL BIOSYST, V11, P2658, DOI 10.1039/c5mb00289c; Bailey T. L., 1994, P 2 INT C INTEL SYST; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Campbell ZT, 2014, NAT STRUCT MOL BIOL, V21, P732, DOI 10.1038/nsmb.2847; Chang HY, 2011, CANCER RES, V71, P1126, DOI 10.1158/0008-5472.CAN-10-1831; Cheong CG, 2006, P NATL ACAD SCI USA, V103, P13635, DOI 10.1073/pnas.0606294103; Dong SY, 2011, J BIOL CHEM, V286, P26732, DOI 10.1074/jbc.M111.244889; Filipovska A, 2012, MOL BIOSYST, V8, P699, DOI 10.1039/c2mb05392f; Filipovska A, 2011, RNA BIOL, V8, P978, DOI 10.4161/rna.8.6.17907; Filipovska A, 2011, NAT CHEM BIOL, V7, P425, DOI [10.1038/NCHEMBIO.577, 10.1038/nchembio.577]; Francischini CW, 2009, FEBS J, V276, P5456, DOI 10.1111/j.1742-4658.2009.07230.x; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Gupta YK, 2009, RNA, V15, P1029, DOI 10.1261/rna.1327609; Huang TB, 2014, J EXP BOT, V65, P1181, DOI 10.1093/jxb/ert478; Huh SU, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-75; Huh SU, 2013, P NATL ACAD SCI USA, V110, P779, DOI 10.1073/pnas.1214287110; Lu G, 2009, CURR OPIN STRUC BIOL, V19, P110, DOI 10.1016/j.sbi.2008.12.009; Miller MT, 2008, NAT STRUCT MOL BIOL, V15, P397, DOI 10.1038/nsmb.1390; Qiu C, 2014, P NATL ACAD SCI USA, V111, P18554, DOI 10.1073/pnas.1407634112; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Tam PPC, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-44; Thomson E, 2007, RNA, V13, P2165, DOI 10.1261/rna.747607; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wang Y, 2013, FEBS J, V280, P3755, DOI 10.1111/febs.12367; Wang YM, 2009, P NATL ACAD SCI USA, V106, P20186, DOI 10.1073/pnas.0812076106; White EK, 2001, RNA, V7, P1855; Xiang Y, 2014, PLANT CELL, V26, P4362, DOI 10.1105/tpc.114.132811; Zhu DY, 2009, P NATL ACAD SCI USA, V106, P20192, DOI 10.1073/pnas.0812079106	29	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30108	30118		10.1074/jbc.M115.691675	http://dx.doi.org/10.1074/jbc.M115.691675			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26487722	Green Published, hybrid			2022-12-28	WOS:000366614700041
J	Chien, MW; Lin, MH; Huang, SH; Fu, SH; Hsu, CY; Yen, BLJ; Chen, JT; Chang, DM; Sytwu, HK				Chien, Ming-Wei; Lin, Ming-Hong; Huang, Shing-Hwa; Fu, Shin-Huei; Hsu, Chao-Yuan; Yen, B. Lin-Ju; Chen, Jiann-Torng; Chang, Deh-Ming; Sytwu, Huey-Kang			Glucosamine Modulates T Cell Differentiation through Down-regulating N-Linked Glycosylation of CD25	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE RECEPTORS; IL-2 RECEPTOR; ACTIVATION; EXPRESSION; INTERLEUKIN-2; STAT5; INHIBITION; COMPLEX; GLUT1; ACETYLGLUCOSAMINYLTRANSFERASE	Glucosamine has immunomodulatory effects on autoimmune diseases. However, the mechanism(s) through which glucosamine modulates different T cell subsets and diseases remain unclear. We demonstrate that glucosamine impedes Th1, Th2, and iTreg but promotes Th17 differentiation through down-regulating N-linked glycosylation of CD25 and subsequently inhibiting its downstream Stat5 signaling in a dose-dependent manner. The effect of glucosamine on T helper cell differentiation was similar to that induced by anti-IL-2 treatment, further supporting an IL-2 signaling-dependent modulation. Interestingly, excess glucose rescued this glucosamine-mediated regulation, suggesting a functional competition between glucose and glucosamine. High-dose glucosamine significantly decreased Glut1 N-glycosylation in Th1-polarized cells. This finding suggests that both down-regulated IL-2 signaling and Glut1-dependent glycolytic metabolism contribute to the inhibition of Th1 differentiation by glucosamine. Finally, glucosamine treatment inhibited Th1 cells in vivo, prolonged the survival of islet grafts in diabetic recipients, and exacerbated the severity of EAE. Taken together, our results indicate that glucosamine interferes with N-glycosylation of CD25, and thereby attenuates IL-2 downstream signaling. These effects suggest that glucosamine may be an important modulator of T cell differentiation and immune homeostasis.	[Chien, Ming-Wei; Hsu, Chao-Yuan; Sytwu, Huey-Kang] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 11490, Taiwan; [Chien, Ming-Wei; Lin, Ming-Hong; Fu, Shin-Huei; Hsu, Chao-Yuan; Sytwu, Huey-Kang] Natl Def Med Ctr, Dept & Grad Inst Microbiol & Immunol, Taipei, Taiwan; [Huang, Shing-Hwa] Natl Def Med Ctr, Dept Biol & Anat & Surg, Taipei 11490, Taiwan; [Chen, Jiann-Torng] Natl Def Med Ctr, Triserv Gen Hosp, Dept Ophthalmol, Taipei 11490, Taiwan; [Chang, Deh-Ming] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Taipei 11490, Taiwan; [Yen, B. Lin-Ju] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 35053, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Health Research Institutes - Taiwan	Sytwu, HK (corresponding author), Natl Def Med Ctr, Dept & Grad Inst Microbiol & Immunol, 161 Sect 6,Min Chuan East Rd, Taipei, Taiwan.	sytwu@ndmctsgh.edu.tw	Fu, Shinhuei/AAM-2877-2021	Fu, Shinhuei/0000-0001-9697-6814	Ministry of Science and Technology, ROC [MOST 103-2321-B-016-001, MOST 103-2320-B-016-017-MY3, MOST 104-2320-B-016-014-MY3]; Tri-Service General Hospital [TSGH-C103-005-007-009-S01, TSGH-C104-008-S02]; C. Y. Foundation for Advancement of Education, Sciences, and Medicine	Ministry of Science and Technology, ROC; Tri-Service General Hospital; C. Y. Foundation for Advancement of Education, Sciences, and Medicine	This work was supported by the Ministry of Science and Technology, ROC (MOST 103-2321-B-016-001, MOST 103-2320-B-016-017-MY3, MOST 104-2320-B-016-014-MY3), Tri-Service General Hospital (TSGH-C103-005-007-009-S01, TSGH-C104-008-S02), and in part by the C. Y. Foundation for Advancement of Education, Sciences, and Medicine. The authors declare that they have no conflicts of interest with the contents of this article.	ASANO T, 1991, J BIOL CHEM, V266, P24632; ASANO T, 1993, FEBS LETT, V324, P258, DOI 10.1016/0014-5793(93)80129-I; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen CL, 2012, INVEST OPHTH VIS SCI, V53, P2281, DOI 10.1167/iovs.11-9291; Chen Q, 2011, J IMMUNOL, V186, P6329, DOI 10.4049/jimmunol.1100061; Chesnokov V, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-45; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Forchhammer L, 2003, SCAND J IMMUNOL, V58, P404, DOI 10.1046/j.1365-3083.2003.01313.x; Gagnerault MC, 2002, J EXP MED, V196, P369, DOI 10.1084/jem.20011353; Golks A, 2007, EMBO J, V26, P4368, DOI 10.1038/sj.emboj.7601845; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Hong CW, 2014, IMMUNITY, V40, P910, DOI 10.1016/j.immuni.2014.04.020; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jang BC, 2007, J BIOL CHEM, V282, P27622, DOI 10.1074/jbc.M610778200; Jeon JH, 2014, STEM CELLS DEV, V23, P2067, DOI 10.1089/scd.2013.0583; Kang ES, 2008, EXP CELL RES, V314, P2238, DOI 10.1016/j.yexcr.2008.04.014; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Kelly E, 2002, J IMMUNOL, V168, P597, DOI 10.4049/jimmunol.168.2.597; Kim CH, 2011, SCAND J IMMUNOL, V73, P536, DOI 10.1111/j.1365-3083.2011.02526.x; KLENK HD, 1972, VIROLOGY, V49, P723, DOI 10.1016/0042-6822(72)90529-6; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Lockyer HM, 2007, J IMMUNOL, V179, P5301, DOI 10.4049/jimmunol.179.8.5301; Ma LL, 2002, J BIOL CHEM, V277, P39343, DOI 10.1074/jbc.M204924200; Macauley MS, 2010, BBA-GEN SUBJECTS, V1800, P107, DOI 10.1016/j.bbagen.2009.07.028; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MALEK TR, 1986, IMMUNOL REV, V92, P81, DOI 10.1111/j.1600-065X.1986.tb01495.x; Miller AT, 2002, J IMMUNOL, V168, P2163, DOI 10.4049/jimmunol.168.5.2163; MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Moon JJ, 2004, J BIOL CHEM, V279, P5520, DOI 10.1074/jbc.M308998200; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Nicoletti F, 1996, ENDOCRINOLOGY, V137, P5567, DOI 10.1210/en.137.12.5567; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; PLAGEMANN PG, 1973, CANCER RES, V33, P482; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; RABINOVITCH A, 1995, J IMMUNOL, V154, P4874; Ramakrishnan P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004097; SEMMES OJ, 1992, INT J IMMUNOPHARMACO, V14, P583, DOI 10.1016/0192-0561(92)90119-6; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Suh HN, 2014, J CELL PHYSIOL, V229, P1557, DOI 10.1002/jcp.24599; Takahashi T., 1998, INT IMMUNOL, V10, P1969; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; YANG XD, 1994, P NATL ACAD SCI USA, V91, P12604, DOI 10.1073/pnas.91.26.12604; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zhang GX, 2005, J IMMUNOL, V175, P7202, DOI 10.4049/jimmunol.175.11.7202	60	26	26	8	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29329	29344		10.1074/jbc.M115.674671	http://dx.doi.org/10.1074/jbc.M115.674671			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26468284	Green Published, hybrid			2022-12-28	WOS:000366613400020
J	Hang, QL; Isaji, T; Hou, SC; Im, S; Fukuda, T; Gu, JG				Hang, Qinglei; Isaji, Tomoya; Hou, Sicong; Im, Sanghun; Fukuda, Tomohiko; Gu, Jianguo			Integrin alpha 5 Suppresses the Phosphorylation of Epidermal Growth Factor Receptor and Its Cellular Signaling of Cell Proliferation via N-Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; EGF RECEPTOR; FIBRONECTIN RECEPTOR; BIOLOGICAL FUNCTION; CYTOPLASMIC DOMAIN; LUNG-CANCER; IN-VITRO; EXPRESSION; ACTIVATION; CARCINOMA	Integrin alpha 5 beta 1-mediated cell adhesion regulates a multitude of cellular responses, including cell proliferation, survival, and cross-talk between different cellular signaling pathways. Integrin alpha 5 beta 1 is known to convey permissive signals enabling anchorage-dependent receptor tyrosine kinase signaling. However, the effects of integrin alpha 5 beta 1 on cell proliferation are controversial, and the molecular mechanisms involved in the regulation between integrin alpha 5 beta 1 and receptor tyrosine kinase remain largely unclear. Here we show that integrin alpha 5 functions as a negative regulator of epidermal growth factor receptor (EGFR) signaling through its N-glycosylation. Expression of WT integrin alpha 5 suppresses the EGFR phosphorylation and internalization upon EGF stimulation. However, expression of the N-glycosylation mutant integrin alpha 5, S3-5, which contains fewer N-glycans, reversed the suppression of the EGFR-mediated signaling and cell proliferation. In a mechanistic manner, WT but not S3-5 integrin alpha 5 forms a complex with EGFR and glycolipids in the low density lipid rafts, and the complex formation is disrupted upon EGF stimulation, suggesting that the N-glycosylation of integrin alpha 5 suppresses the EGFR activation through promotion of the integrin alpha 5-glycolipids-EGFR complex formation. Furthermore, consistent restoration of those N-glycans on the Calf-1,2 domain of integrin alpha 5 reinstated the inhibitory effects as well as the complex formation with EGFR. Taken together, these data are the first to demonstrate that EGFR activation can be regulated by the N-glycosylation of integrin alpha 5, which is a novel molecular paradigm for the cross-talk between integrins and growth factor receptors.	[Hang, Qinglei; Isaji, Tomoya; Hou, Sicong; Im, Sanghun; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan	Tohoku Medical & Pharmaceutical University	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Hang, Qinglei/GOP-0218-2022; Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021	Hang, Qinglei/0000-0003-0419-6621; 	Japan Society for the Promotion of Science [15H04354, 24570169, 15K14408]; Strategic Research Foundation from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [15K14408] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research Foundation from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research 15H04354 (to J. G.) and 24570169 (to T. I.) and for Challenging Exploratory Research 15K14408 (to J. G.) from the Japan Society for the Promotion of Science and by a Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi M, 2000, CLIN CANCER RES, V6, P96; Alam N, 2007, J CELL PHYSIOL, V213, P649, DOI 10.1002/jcp.21278; Bogdan S, 2001, CURR BIOL, V11, pR292, DOI 10.1016/S0960-9822(01)00167-1; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Camidge DR, 2014, NAT REV CLIN ONCOL, V11, P473, DOI 10.1038/nrclinonc.2014.104; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clark K, 2005, J CELL SCI, V118, P291, DOI 10.1242/jcs.01623; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Gao ML, 2012, EMBO MOL MED, V4, P776, DOI 10.1002/emmm.201100944; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; Grandis JR, 2004, PHARMACOL THERAPEUT, V102, P37, DOI 10.1016/j.pharmthera.2004.01.002; Gueguinou M, 2015, BBA-BIOMEMBRANES, V1848, P2603, DOI 10.1016/j.bbamem.2014.10.036; Hampton Kaia K, 2014, Oncoscience, V1, P504; Handa K, 2012, GLYCOCONJUGATE J, V29, P627, DOI 10.1007/s10719-012-9380-7; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Izumi Y, 2002, NATURE, V416, P279, DOI 10.1038/416279b; Kariya Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027084; Kawahara E, 2005, CELL BIOL INT, V29, P521, DOI 10.1016/j.cellbi.2005.02.006; Kazui A, 2000, BIOCHEM BIOPH RES CO, V273, P159, DOI 10.1006/bbrc.2000.2903; Kuwada SK, 2000, MOL BIOL CELL, V11, P2485, DOI 10.1091/mbc.11.7.2485; Kuwada SK, 2005, J BIOL CHEM, V280, P19027, DOI 10.1074/jbc.M410540200; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lambert S, 2008, J CELL PHYSIOL, V217, P834, DOI 10.1002/jcp.21563; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Liu SC, 2000, J CELL SCI, V113, P3563; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Miljan EA, 2002, J BIOL CHEM, V277, P10108, DOI 10.1074/jbc.M111669200; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Mlcochova J, 2013, J CANCER RES CLIN, V139, P1615, DOI 10.1007/s00432-013-1470-9; Morozevich GE, 2012, AGING-US, V4, P368, DOI 10.18632/aging.100457; Mould AP, 2004, CURR OPIN CELL BIOL, V16, P544, DOI 10.1016/j.ceb.2004.07.003; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; Nicolaou N, 2012, J CLIN INVEST, V122, P4375, DOI 10.1172/JCI64100; Ono M, 2000, BIOCHEM BIOPH RES CO, V279, P744, DOI 10.1006/bbrc.2000.4030; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Qian F, 2005, BIOCHEM BIOPH RES CO, V333, P1269, DOI 10.1016/j.bbrc.2005.06.039; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Samandari E, 2006, BIOCHEM BIOPH RES CO, V342, P1329, DOI 10.1016/j.bbrc.2006.02.110; Schirner M, 1998, CLIN EXP METASTAS, V16, P427; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Tomas A, 2014, TRENDS CELL BIOL, V24, P26, DOI 10.1016/j.tcb.2013.11.002; VARNER JA, 1995, MOL BIOL CELL, V6, P725, DOI 10.1091/mbc.6.6.725; Wang J, 2013, P NATL ACAD SCI USA, V110, P19137, DOI 10.1073/pnas.1307224110; Wang XQ, 2005, J INVEST DERMATOL, V124, P839, DOI 10.1111/j.0022-202X.2005.23669.x; Wang XQ, 2003, J BIOL CHEM, V278, P48770, DOI 10.1074/jbc.M308818200; Wang Y, 2011, INT CONF ACOUST SPEE, P1, DOI 10.1109/PLASMA.2011.5993071; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Yoo NJ, 2007, TUMORI, V93, P281; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Zhou GF, 2000, MOL CELL BIOCHEM, V207, P49, DOI 10.1023/A:1007034012642	68	27	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29345	29360		10.1074/jbc.M115.682229	http://dx.doi.org/10.1074/jbc.M115.682229			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26483551	Green Published, hybrid			2022-12-28	WOS:000366613400021
J	Fang, YQ; Yan, J; Li, CH; Zhou, X; Yao, LM; Pang, T; Yan, M; Zhang, LY; Mao, L; Liao, H				Fang, Yinquan; Yan, Jun; Li, Chenhui; Zhou, Xiao; Yao, Lemeng; Pang, Tao; Yan, Ming; Zhang, Luyong; Mao, Lei; Liao, Hong			The Nogo/Nogo Receptor (NgR) Signal Is Involved in Neuroinflammation through the Regulation of Microglial Inflammatory Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microglia; neurodegenerative disease; neuroinflammation; NF-kappaB; STAT3; NgR; Nogo peptide	NF-KAPPA-B; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; NOGO-A; AXONAL REGENERATION; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; CELLS; PATHWAY	Microglia have been proposed to play a pivotal role in the inflammation response of the CNS by expressing a range of proinflammatory enzymes and cytokines under pathological stimulus. Our previous study has confirmed that Nogo receptor (NgR), an axon outgrowth inhibition receptor, is also expressed on microglia and regulates cell adhesion and migration behavior in vitro. In the present study, we further investigated the proinflammatory effects and possible mechanisms of Nogo on microglia in vitro. In this study, Nogo peptide, Nogo-P4, a 25-amino acid core inhibitory peptide sequence of Nogo-66, was used. We found that Nogo-P4 was able to induce the expression of inducible nitric-oxide synthase and cyclooxygenase-2 and the release of proinflammatory cytokines, including IL-1, TNF-, NO, and prostaglandin E-2 in microglia, which could be reversed by NEP1-40 (Nogo-66(1-40) antagonist peptide), phosphatidylinositol-specificphospholipase C, or NgR siRNA treatment. After Nogo-P4 stimulated microglia, the phosphorylation levels of NF-B and STAT3 were increased obviously, which further mediated microglia expressing proinflammatory factors induced by Nogo-P4. Taken together, we concluded that Nogo peptide could directly take part in CNS inflammatory process by influencing the expression of proinflammatory factors in microglia, which were related to the NF-B and STAT3 signal pathways. Besides neurite outgrowth restriction, the Nogo/NgR signal might be involved in multiple processes in various inflammation-associated CNS diseases.	[Fang, Yinquan; Yan, Jun; Li, Chenhui; Yao, Lemeng; Pang, Tao; Yan, Ming; Zhang, Luyong; Liao, Hong] China Pharmaceut Univ, Jiangsu Key Lab Drug Screening, Nanjing 210009, Jiangsu, Peoples R China; [Zhou, Xiao] Univ Saarland, Dept Biophys, D-66421 Homburg, Germany; [Mao, Lei] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China	China Pharmaceutical University; Saarland University; Nanjing University	Mao, L (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China.	leiching@163.com; hliao@cpu.edu.cn			National Natural Science Foundation of China [81070967, 81271338]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20130096110011]; China Pharmaceutical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Pharmaceutical University	This work was supported by National Natural Science Foundation of China Grants 81070967 and 81271338, Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 20130096110011, and the Initial Fund of China Pharmaceutical University (to H. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Acarin L, 2000, J NEUROPATH EXP NEUR, V59, P151, DOI 10.1093/jnen/59.2.151; Bethea JR, 1998, J NEUROSCI, V18, P3251; Cao Q, 2010, J NEUROSCI RES, V88, P2701, DOI 10.1002/jnr.22429; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Choi Y, 2009, BRIT J PHARMACOL, V156, P933, DOI 10.1111/j.1476-5381.2009.00022.x; Doi Y, 2009, AM J PATHOL, V175, P2121, DOI 10.2353/ajpath.2009.090418; Fontoura P, 2004, J IMMUNOL, V173, P6981, DOI 10.4049/jimmunol.173.11.6981; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fry EJ, 2007, NEURON, V53, P649, DOI 10.1016/j.neuron.2007.02.009; Gil V, 2006, J NEUROPATH EXP NEUR, V65, P433, DOI 10.1097/01.jnen.0000222894.59293.98; GIULIAN D, 1993, STROKE, V24, pI84; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Gveric D, 1998, J NEUROPATH EXP NEUR, V57, P168, DOI 10.1097/00005072-199802000-00008; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hasegawa Y, 2004, J NEUROSCI, V24, P6826, DOI 10.1523/JNEUROSCI.1856-04.2004; He GL, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-49; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; Heese K, 1998, GLIA, V22, P401, DOI 10.1002/(SICI)1098-1136(199804)22:4<401::AID-GLIA9>3.0.CO;2-5; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; KALTSCHMIDT C, 1994, J NEUROIMMUNOL, V55, P99, DOI 10.1016/0165-5728(94)90151-1; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Liu Y, 2014, J NEUROSCI, V34, P12982, DOI 10.1523/JNEUROSCI.1348-14.2014; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; McDonald CL, 2011, CURR MED CHEM, V18, P234; McDonald CL, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-113; Nam KN, 2008, EUR J PHARMACOL, V589, P53, DOI 10.1016/j.ejphar.2008.03.034; Oertle T, 2003, J NEUROSCI, V23, P5393; Pool M, 2009, EXP NEUROL, V217, P371, DOI 10.1016/j.expneurol.2009.03.014; Ren S, 2013, INT J BIOCHEM CELL B, V45, P335, DOI 10.1016/j.biocel.2012.11.012; Rolando C, 2012, J NEUROSCI, V32, P17788, DOI 10.1523/JNEUROSCI.3142-12.2012; Ryu JK, 2006, NEUROSCIENCE, V141, P1835, DOI 10.1016/j.neuroscience.2006.05.043; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129, DOI 10.1093/jnen/64.2.129; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Su ZD, 2007, J CELL SCI, V120, P1877, DOI 10.1242/jcs.03448; Vila M, 2001, CURR OPIN NEUROL, V14, P483, DOI 10.1097/00019052-200108000-00009; Wang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001856; Weydt Patrick, 2002, Curr Opin Investig Drugs, V3, P1720; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yan J, 2012, J NEUROCHEM, V120, P721, DOI 10.1111/j.1471-4159.2011.07619.x; Zhang ZH, 2014, BRAIN RES, V1563, P72, DOI 10.1016/j.brainres.2014.03.036; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	44	26	28	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28901	28914		10.1074/jbc.M115.678326	http://dx.doi.org/10.1074/jbc.M115.678326			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26472924	hybrid, Green Published			2022-12-28	WOS:000365762300030
J	Hacker, C; Christ, NA; Duchardt-Ferner, E; Korn, S; Gobl, C; Berninger, L; Dusterhus, S; Hellmich, UA; Madl, T; Kotter, P; Entian, KD; Wohnert, J				Hacker, Carolin; Christ, Nina A.; Duchardt-Ferner, Elke; Korn, Sophie; Goebl, Christoph; Berninger, Lucija; Duesterhus, Stefanie; Hellmich, Ute A.; Madl, Tobias; Koetter, Peter; Entian, Karl-Dieter; Woehnert, Jens			The Solution Structure of the Lantibiotic Immunity Protein NisI and Its Interactions with Nisin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; antibiotics; lipoprotein; nuclear magnetic resonance (NMR); protein structure; lantibiotic; nisin binding; small angle x-ray scattering	LACTOCOCCUS-LACTIS 6F3; BACILLUS-SUBTILIS; NMR-SPECTROSCOPY; GENE-CLUSTER; LIPID-II; BIOSYNTHESIS; DYNAMICS; RECOMMENDATIONS; BACTERIOCINS; ELECTROSTATICS	Many Gram-positive bacteria produce lantibiotics, genetically encoded and posttranslationally modified peptide antibiotics, which inhibit the growth of other Gram-positive bacteria. To protect themselves against their own lantibiotics these bacteria express a variety of immunity proteins including the LanI lipoproteins. The structural and mechanistic basis for LanI-mediated lantibiotic immunity is not yet understood. Lactococcus lactis produces the lantibiotic nisin, which is widely used as a food preservative. Its LanI protein NisI provides immunity against nisin but not against structurally very similar lantibiotics from other species such as subtilin from Bacillus subtilis. To understand the structural basis for LanI-mediated immunity and their specificity we investigated the structure of NisI. We found that NisI is a two-domain protein. Surprisingly, each of the two NisI domains has the same structure as the LanI protein from B. subtilis, SpaI, despite the lack of significant sequence homology. The two NisI domains and SpaI differ strongly in their surface properties and function. Additionally, SpaI-mediated lantibiotic immunity depends on the presence of a basic unstructured N-terminal region that tethers SpaI to the membrane. Such a region is absent from NisI. Instead, the N-terminal domain of NisI interacts with membranes but not with nisin. In contrast, the C-terminal domain specifically binds nisin and modulates the membrane affinity of the N-terminal domain. Thus, our results reveal an unexpected structural relationship between NisI and SpaI and shed light on the structural basis for LanI mediated lantibiotic immunity.	[Hacker, Carolin; Christ, Nina A.; Duchardt-Ferner, Elke; Korn, Sophie; Berninger, Lucija; Duesterhus, Stefanie; Koetter, Peter; Entian, Karl-Dieter; Woehnert, Jens] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Duchardt-Ferner, Elke; Hellmich, Ute A.; Woehnert, Jens] Goethe Univ Frankfurt, Ctr Biomol Magnet Resonance BMRZ, D-60438 Frankfurt, Germany; [Goebl, Christoph; Madl, Tobias] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, D-85748 Garching, Germany; [Madl, Tobias] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany; [Hellmich, Ute A.] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55128 Mainz, Germany; [Madl, Tobias] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Madl, Tobias] BioTechMed Graz, Om Ctr Graz, A-8010 Graz, Austria	Goethe University Frankfurt; Goethe University Frankfurt; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Johannes Gutenberg University of Mainz; Medical University of Graz	Wohnert, J (corresponding author), Goethe Univ Frankfurt, Inst Mol Biowissensch, Max Von Laue Str 9, D-60438 Frankfurt, Germany.	woehnert@bio.uni-frankfurt.de	Madl, Tobias/B-1682-2012; Goebl, Christoph/G-7578-2016	Madl, Tobias/0000-0002-9725-5231; Hellmich, Ute/0000-0001-7162-285X; Hacker, Carolin/0000-0001-9951-0614; Gobl, Christoph/0000-0001-8614-1434	Deutsche Forschungsgemeinschaft (DFG) [Wo 901/4-1, En 134/11-1, MA 5703/1-1]; Bavarian Ministry of Sciences, Research and the Arts (Bavarian Molecular Biosystems Research Network); Emmy-Noether program of the Deutsche Forschungsgemeinschaft; Center for Integrated Protein Science Munich (CIPSM)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bavarian Ministry of Sciences, Research and the Arts (Bavarian Molecular Biosystems Research Network); Emmy-Noether program of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for Integrated Protein Science Munich (CIPSM)	This work was supported in part by Grants Wo 901/4-1, En 134/11-1, and MA 5703/1-1 (Emmy-Noether program) from the Deutsche Forschungsgemeinschaft (DFG) (to J. W., K. D. E., and T. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Bavarian Ministry of Sciences, Research and the Arts (Bavarian Molecular Biosystems Research Network), the Emmy-Noether program of the Deutsche Forschungsgemeinschaft, and the Center for Integrated Protein Science Munich (CIPSM).	AlKhatib Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102246; Alkhatib Z, 2012, J BIOTECHNOL, V159, P145, DOI 10.1016/j.jbiotec.2012.01.032; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bergmann A, 2000, J APPL CRYSTALLOGR, V33, P1212, DOI 10.1107/S0021889800008372; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Christ NA, 2012, J BIOL CHEM, V287, P35286, DOI 10.1074/jbc.M112.401620; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dischinger J, 2014, INT J MED MICROBIOL, V304, P51, DOI 10.1016/j.ijmm.2013.09.003; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; ENGELKE G, 1994, APPL ENVIRON MICROB, V60, P814, DOI 10.1128/AEM.60.3.814-825.1994; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fuchs SW, 2011, APPL ENVIRON MICROB, V77, P1698, DOI 10.1128/AEM.01962-10; Gobl C, 2014, PROG NUCL MAG RES SP, V80, P26, DOI 10.1016/j.pnmrs.2014.05.003; Gottstein D, 2012, J BIOMOL NMR, V52, P351, DOI 10.1007/s10858-012-9615-8; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Hacker C, 2015, BIOMOL NMR ASSIGN, V9, P293, DOI 10.1007/s12104-015-9595-1; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; Huang JR, 2014, J AM CHEM SOC, V136, P7068, DOI 10.1021/ja502030n; Keller R., 2004, COMPUTER AIDED RESON, V1; KLAENHAMMER TR, 1988, BIOCHIMIE, V70, P337, DOI 10.1016/0300-9084(88)90206-4; KLEIN C, 1992, APPL ENVIRON MICROB, V58, P132, DOI 10.1128/AEM.58.1.132-142.1992; Knerr PJ, 2012, ANNU REV BIOCHEM, V81, P479, DOI 10.1146/annurev-biochem-060110-113521; Koradi R, 2000, COMPUT PHYS COMMUN, V124, P139, DOI 10.1016/S0010-4655(99)00436-1; KOSEN PA, 1986, BIOCHEMISTRY-US, V25, P2356, DOI 10.1021/bi00357a009; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; KUIPERS OP, 1995, J BIOL CHEM, V270, P27299, DOI 10.1074/jbc.270.45.27299; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Mackereth CD, 2011, NATURE, V475, P408, DOI 10.1038/nature10171; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; Montelione GT, 2013, STRUCTURE, V21, P1563, DOI 10.1016/j.str.2013.07.021; Morgan SM, 2005, ANTIMICROB AGENTS CH, V49, P2606, DOI 10.1128/AAC.49.7.2606-2611.2005; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; OLEARY WM, 1988, MICROBIAL LIPIDS; Ortega MA, 2015, NATURE, V517, P509, DOI 10.1038/nature13888; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Pozzi R, 2016, ENVIRON MICROBIOL, V18, P118, DOI 10.1111/1462-2920.12892; Ra R, 1999, MICROBIOL-SGM, V145, P1227, DOI 10.1099/13500872-145-5-1227; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; SCHMIDT PG, 1984, BIOCHEMISTRY-US, V23, P4261, DOI 10.1021/bi00313a038; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; SIEGERS K, 1995, APPL ENVIRON MICROB, V61, P1082, DOI 10.1128/AEM.61.3.1082-1089.1995; Stein T, 2003, J BIOL CHEM, V278, P89, DOI 10.1074/jbc.M207237200; Stein T, 2002, MOL MICROBIOL, V44, P403, DOI 10.1046/j.1365-2958.2002.02869.x; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Takala TM, 2006, MICROBIOL-SGM, V152, P3543, DOI 10.1099/mic.0.29083-0; Takala TM, 2004, FEMS MICROBIOL LETT, V237, P171, DOI 10.1111/j.1574-6968.2004.tb09693.x; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449	60	25	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28869	28886		10.1074/jbc.M115.679969	http://dx.doi.org/10.1074/jbc.M115.679969			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26459561	Green Published, hybrid			2022-12-28	WOS:000365762300028
J	Lu, SY; Banerjee, A; Jang, H; Zhang, J; Gaponenko, V; Nussinov, R				Lu, Shaoyong; Banerjee, Avik; Jang, Hyunbum; Zhang, Jian; Gaponenko, Vadim; Nussinov, Ruth			GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; computational biology; nuclear magnetic resonance (NMR); protein conformation; protein dynamic; Ras protein	ACTIVATED PROTEIN-KINASE; H-RAS PROTEIN; STRUCTURAL BASIS; K-RAS; MEMBRANE-BINDING; CAAX MOTIF; INHIBITORS; DYNAMICS; CANCER; PATHWAY	K-Ras4B, a frequently mutated oncogene in cancer, plays an essential role in cell growth, differentiation, and survival. Its C-terminal membrane-associated hypervariable region (HVR) is required for full biological activity. In the active GTP-bound state, the HVR interacts with acidic plasma membrane (PM) headgroups, whereas the farnesyl anchors in the membrane; in the inactive GDP-bound state, the HVR may interact with both the PM and the catalytic domain at the effector binding region, obstructing signaling and nucleotide exchange. Here, using molecular dynamics simulations and NMR, we aim to figure out the effects of nucleotides (GTP and GDP) and frequent (G12C, G12D, G12V, G13D, and Q61H) and infrequent (E37K and R164Q) oncogenic mutations on full-length K-Ras4B. The mutations are away from or directly at the HVR switch I/effector binding site. Our results suggest that full-length wild-type GDP-bound K-Ras4B (K-Ras4B(WT)-GDP) is in an intrinsically autoinhibited state via tight HVR-catalytic domain interactions. The looser association in K-Ras4B(WT)-GTP may release the HVR. Some of the oncogenic mutations weaken the HVR-catalytic domain association in the K-Ras4B-GDP/-GTP bound states, which may facilitate the HVR disassociation in a nucleotide-independent manner, thereby up-regulating oncogenic Ras signaling. Thus, our results suggest that mutations can exert their effects in more than one way, abolishing GTP hydrolysis and facilitating effector binding.	[Lu, Shaoyong; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200025, Peoples R China; [Lu, Shaoyong; Jang, Hyunbum; Nussinov, Ruth] NCI, Canc & Inflammat Program, Leidos Biomed Res Inc, Frederick, MD 21702 USA; [Banerjee, Avik] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Gaponenko, Vadim] Univ Illinois, Dept Mol Genet & Biochem, Chicago, IL 60607 USA; [Nussinov, Ruth] Tel Aviv Univ, Sackler Sch Med, Sackler Inst Mol Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	Shanghai Jiao Tong University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tel Aviv University; Sackler Faculty of Medicine	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol, Key Lab Cell Differentiat & Apoptosis,Chinese Min, Shanghai 200025, Peoples R China.	jian.zhang@sjtu.edu.cn; vadimg@uic.edu; NussinoR@helix.nih.gov	Gaponenko, Vadim/K-9729-2019; Regan, Clinton/E-6250-2012; Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X; Nussinov, Ruth/0000-0002-8115-6415; Banerjee, Avik/0000-0002-0668-5480; Gaponenko, Vadim/0000-0002-7891-9223; Jang, Hyunbum/0000-0001-9402-4051	National Basic Research Program of China (973 Program) [2015CB910403]; National Natural Science Foundation of China [81322046, 81302689, 81473137]; Shanghai Rising-Star Program Grant [13QA1402300]; Program for New Century Excellent Talents in University [NCET-12-0355]; National Institutes of Health [R01 CA135341]; American Cancer Society [RGS-09-057-01-GMC]; NCI-Frederick, National Institutes of Health [HHSN261200800001E]; NCI-Frederick, National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA188427, ZIABC010441, ZIABC010440, R01CA135341] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program Grant; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NCI-Frederick, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI-Frederick, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Basic Research Program of China (973 Program) Grant 2015CB910403 (to J. Z.), National Natural Science Foundation of China Grants 81322046, 81302689, and 81473137 (to J. Z.), Shanghai Rising-Star Program Grant 13QA1402300) (to J. Z.), Program for New Century Excellent Talents in University (NCET-12-0355) (to J. Z.), National Institutes of Health Grant R01 CA135341 (to V. G.), American Cancer Society Grant RGS-09-057-01-GMC (to V. G.). This work was also supported in whole or in part with Federal funds from the NCI-Frederick, National Institutes of Health under Contract HHSN261200800001E (to R. N.). This work was supported in part by the Intramural Research Program of NCI-Frederick, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham SJ, 2010, PROTEIN EXPRES PURIF, V73, P125, DOI 10.1016/j.pep.2010.05.015; Abraham SJ, 2009, BIOCHEMISTRY-US, V48, P7575, DOI 10.1021/bi900769j; Araki M, 2011, J BIOL CHEM, V286, P39644, DOI 10.1074/jbc.M111.227074; Arozarena Imanol, 2011, Genes Cancer, V2, P182, DOI 10.1177/1947601911409213; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Bernard V, 2014, INT J CLIN EXP PATHO, V7, P1667; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brunsveld L, 2009, BBA-BIOMEMBRANES, V1788, P273, DOI 10.1016/j.bbamem.2008.08.006; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Chavan T. S., 2015, BIOPHYS J, DOI [10.1158/1538-7445.AM2014-3224, DOI 10.1158/1538-7445.AM2014-3224]; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Evelyn CR, 2015, J BIOL CHEM, V290, P12879, DOI 10.1074/jbc.M114.634493; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; Gentry LR, 2015, J BIOL CHEM, V290, P22851, DOI 10.1074/jbc.M115.656710; Gorfe AA, 2007, ANGEW CHEM INT EDIT, V46, P8234, DOI 10.1002/anie.200702379; Gorfe AA, 2007, J AM CHEM SOC, V129, P12280, DOI 10.1021/ja073949v; Guzman C, 2014, J BIOL CHEM, V289, P9519, DOI 10.1074/jbc.M113.537001; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hernandez-Alcoceba R, 2000, CELL MOL LIFE SCI, V57, P65, DOI 10.1007/s000180050499; Jang H, 2015, J BIOL CHEM, V290, P9465, DOI 10.1074/jbc.M114.620724; Janosi L, 2012, P NATL ACAD SCI USA, V109, P8097, DOI 10.1073/pnas.1200773109; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Long SB, 2000, STRUCTURE, V8, P209, DOI 10.1016/S0969-2126(00)00096-4; Lu SY, 2015, STRUCTURE, V23, P1725, DOI 10.1016/j.str.2015.06.027; Lu SY, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003831; Lu SY, 2014, MED RES REV, V34, P1242, DOI 10.1002/med.21317; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Milroy LG, 2014, ACS CHEM BIOL, V9, P2447, DOI 10.1021/cb500555h; Muratcioglu S, 2015, STRUCTURE, V23, P1325, DOI 10.1016/j.str.2015.04.019; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Nussinov R, 2013, TRENDS MOL MED, V19, P695, DOI 10.1016/j.molmed.2013.07.009; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Partridge JR, 2009, J MOL BIOL, V391, P375, DOI 10.1016/j.jmb.2009.06.011; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rosnizeck IC, 2012, ANGEW CHEM INT EDIT, V51, P10647, DOI 10.1002/anie.201204148; Rowinsky EK, 1999, J CLIN ONCOL, V17, P3631, DOI 10.1200/JCO.1999.17.11.3631; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Schuld NJ, 2014, J BIOL CHEM, V289, P6862, DOI 10.1074/jbc.M113.527192; Shima F, 2010, J BIOL CHEM, V285, P22696, DOI 10.1074/jbc.M110.125161; Smith G, 2010, BRIT J CANCER, V102, P693, DOI 10.1038/sj.bjc.6605534; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; Tsai CJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003394; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013	59	58	60	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28887	28900		10.1074/jbc.M115.664755	http://dx.doi.org/10.1074/jbc.M115.664755			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26453300	Green Published, hybrid			2022-12-28	WOS:000365762300029
J	Baker, P; Whitfield, GB; Hill, PJ; Little, DJ; Pestrak, MJ; Robinson, H; Wozniak, DJ; Howell, PL				Baker, Perrin; Whitfield, Gregory B.; Hill, Preston J.; Little, Dustin J.; Pestrak, Matthew J.; Robinson, Howard; Wozniak, Daniel J.; Howell, P. Lynne			Characterization of the Pseudomonas aeruginosa Glycoside Hydrolase PsIG Reveals That Its Levels Are Critical for Psi Polysaccharide Biosynthesis and Biofilm Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR POLYSACCHARIDES; STRUCTURAL-CHARACTERIZATION; CAPSULAR POLYSACCHARIDES; PEPTIDOGLYCAN HYDROLASES; SURFACE-TOPOGRAPHY; PROTEIN-STRUCTURE; BETA-XYLOSIDASE; COMPUTED ATLAS; EXOPOLYSACCHARIDE; IDENTIFICATION	A key component of colonization, biofilm formation, and protection of the opportunistic human pathogen Pseudomonas aeruginosa is the biosynthesis of the exopolysaccharide Psi. Composed of a pentameric repeating unit of mannose, glucose, and rhamnose, the biosynthesis of Psi is proposed to occur via a Wzx/Wzy-dependent mechanism. Previous genetic studies have shown that the putative glycoside hydrolase PslG is essential for Psl biosynthesis. To understand the function of this protein, the apo-structure of the periplasmic domain of Pski (PslG(31-442)) and its complex with mannose were determined to 2,0 and 1.9 angstrom resolution, respectively. Despite a domain architecture and positioning of catalytic residues similar to those of other family 39 glycoside hydrolases, PslG(31 442) exhibits a unique 32-A-long active site groove that is distinct from other structurally characterized family members. PslG formed a complex with two mannose monosaccharides in this groove, consistent with binding data obtained from intrinsic tryptophan fluorescence. PslG was able to catalyze the hydrolysis of surfaceassociated Psl, and this activity was abolished in a E165Q/E276Q double catalytic variant. Surprisingly, P. aeruginosa variants with these chromosomal mutations as well as a pslG deletion mutant were still capable of forming Psl biofilms. HOWever, overexpression of PslG in a pslG deletion background impaired biofilm formation and resulted in less surface-associated Psl, suggesting that regulation of this enzyme is important during polysaccharide biosynthesis.	[Baker, Perrin; Whitfield, Gregory B.; Little, Dustin J.; Howell, P. Lynne] Hosp Sick Children, Res Inst, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Whitfield, Gregory B.; Little, Dustin J.; Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Hill, Preston J.; Pestrak, Matthew J.; Wozniak, Daniel J.] Ohio State Univ, Ctr Microbial Interface Biol, Div Infect Dis, Columbus, OH 43210 USA; [Robinson, Howard] Brookhaven Natl Lab, Photon Sci Div, Upton, NY 11973 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University System of Ohio; Ohio State University; United States Department of Energy (DOE); Brookhaven National Laboratory	Wozniak, DJ (corresponding author), Ohio State Univ, Ctr Microbial Interface Biol, Div Infect Dis, Columbus, OH 43210 USA.	daniel.wozniak@osumc.edu; howell@sickkids.ca	Regan, Clinton/E-6250-2012		Canadian Institutes of Health Research (CIHR) [43998, 13337]; National Institutes of Health (NIH) [R01A1097511]; United States Department of Energy Office of Biological and Environmental Research; NIH National Center for Research Resources; NSERC; National Research Council of Canada; CIHR; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; Cystic Fibrosis Canada postdoctoral fellowship from CIHR; Banting Fellowship from CIHR; Natural Sciences and Engineering Research Council of Canada (NSERC); University of Toronto; Ontario Graduate Scholarship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097511, R21AI119116] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Research Council of Canada; CIHR(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; Cystic Fibrosis Canada postdoctoral fellowship from CIHR; Banting Fellowship from CIHR(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Toronto(University of Toronto); Ontario Graduate Scholarship Program(Ontario Graduate Scholarship); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Canadian Institutes of Health Research (CIHR) Grants 43998 and 13337 (to P. L. H.) and National Institutes of Health (NIH) Grant R01A1097511 (to D. J. W.). The National Synchrotron Light Source beamline X29A is supported by the United States Department of Energy Office of Biological and Environmental Research and the NIH National Center for Research Resources, Beamline 08ID-1 at the Canadian Light Source is supported by NSERC, the National Research Council of Canada, CIHR, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan. The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by a Cystic Fibrosis Canada postdoctoral fellowship and a Banting Fellowship from CIHR.; Supported by a scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC).; Supported in part by graduate scholarships from the University of Toronto, the Ontario Graduate Scholarship Program, and CIHR.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Anthon GE, 2002, ANAL BIOCHEM, V305, P287, DOI 10.1006/abio.2002.5644; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Ayers M, 2009, J MOL BIOL, V394, P128, DOI 10.1016/j.jmb.2009.09.034; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bakkevig K, 2005, J BACTERIOL, V187, P8375, DOI 10.1128/JB.187.24.8375-8384.2005; Bie HY, 2013, NAT CHEM BIOL, V9, P739, DOI [10.1038/NCHEMBIO.1357, 10.1038/nchembio.1357]; Billings N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003526; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Charaoui-Boukerzaza S, 2013, MICROBIOL-SGM, V159, P2395, DOI 10.1099/mic.0.071407-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Colvin KM, 2013, J BACTERIOL, V195, P2329, DOI 10.1128/JB.02150-12; Colvin KM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001264; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Czjzek M, 2005, J MOL BIOL, V353, P838, DOI 10.1016/j.jmb.2005.09.003; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; DiGiandomenico A, 2012, J EXP MED, V209, P1273, DOI 10.1084/jem.20120033; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira AS, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00016; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Irie Y, 2012, P NATL ACAD SCI USA, V109, P20632, DOI 10.1073/pnas.1217993109; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Jackson KD, 2004, J BACTERIOL, V186, P4466, DOI 10.1128/JB.186.14.4466-4475.2004; Jennings LK, 2015, P NATL ACAD SCI USA, V112, P11353, DOI 10.1073/pnas.1503058112; Kocincova D, 2011, BIOCHEMISTRY-MOSCOW+, V76, P755, DOI 10.1134/S0006297911070054; Koseoglu VK, 2015, MOL MICROBIOL, V96, P728, DOI 10.1111/mmi.12966; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Little DJ, 2014, P NATL ACAD SCI USA, V111, P11013, DOI 10.1073/pnas.1406388111; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06; Ma LY, 2012, FEMS IMMUNOL MED MIC, V65, P377, DOI 10.1111/j.1574-695X.2012.00934.x; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Mazur O, 2011, J BIOL CHEM, V286, P17601, DOI 10.1074/jbc.M111.227660; Mendis HC, 2013, MOL PLANT MICROBE IN, V26, P1089, DOI 10.1094/MPMI-03-13-0087-R; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Mishra M, 2012, CELL MICROBIOL, V14, P95, DOI 10.1111/j.1462-5822.2011.01704.x; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nieman CE, 2003, BIOCHEMISTRY-US, V42, P8054, DOI 10.1021/bi034293v; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Omadjela O, 2013, P NATL ACAD SCI USA, V110, P17856, DOI 10.1073/pnas.1314063110; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Payne CM, 2012, J BIOL CHEM, V287, P36322, DOI 10.1074/jbc.M112.402149; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pier GB, 2007, INT J MED MICROBIOL, V297, P277, DOI 10.1016/j.ijmm.2007.03.012; Purushotham P, 2012, J BACTERIOL, V194, P4260, DOI 10.1128/JB.06473-11; REINHOLD BB, 1994, J BACTERIOL, V176, P1997, DOI 10.1128/jb.176.7.1997-2002.1994; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; Rolain T, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-137; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; SALAMITOU S, 1994, J BACTERIOL, V176, P2828, DOI 10.1128/JB.176.10.2828-2834.1994; Santos CR, 2012, ACTA CRYSTALLOGR D, V68, P1339, DOI 10.1107/S0907444912028491; SCHILLER NL, 1993, J BACTERIOL, V175, P4780, DOI 10.1128/JB.175.15.4780-4789.1993; Spiers AJ, 2002, GENETICS, V161, P33; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; van Heijenoort J, 2011, MICROBIOL MOL BIOL R, V75, P636, DOI 10.1128/MMBR.00022-11; Vocadlo DJ, 2002, BIOCHEMISTRY-US, V41, P9736, DOI 10.1021/bi020078n; Vocadlo DJ, 1998, BIOCHEM J, V335, P449, DOI 10.1042/bj3350449; Wang LX, 1999, J BACTERIOL, V181, P6788, DOI 10.1128/JB.181.21.6788-6796.1999; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001; Yang L, 2012, FEMS IMMUNOL MED MIC, V65, P366, DOI 10.1111/j.1574-695X.2012.00936.x; York GM, 1998, P NATL ACAD SCI USA, V95, P4912, DOI 10.1073/pnas.95.9.4912	82	46	50	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28374	28387		10.1074/jbc.M115.674929	http://dx.doi.org/10.1074/jbc.M115.674929			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26424791	Green Published, hybrid			2022-12-28	WOS:000365761900032
J	Selzer, L; Kant, R; Wang, JCY; Bothner, B; Zlotnick, A				Selzer, Lisa; Kant, Ravi; Wang, Joseph C. -Y.; Bothner, Brian; Zlotnick, Adam			Hepatitis B Virus Core Protein Phosphorylation Sites Affect Capsid Stability and Transient Exposure of the C-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE-RICH DOMAIN; ENCAPSIDATION; RNA	Hepatitis B virus core protein has 183 amino acids divided into an assembly domain and an arginine-rich C-terminal domain (CTD) that regulates essential functions including genome packaging, reverse transcription, and intracellular trafficking. Here, we investigated the CTD in empty hepatitis B virus (HBV) T = 4 capsids. We examined wild-type core protein (Cp183-WT) and a mutant core protein (Cp183-EEE), in which three CTD serines are replaced with glutamate to mimic phosphorylated protein. Wefound that Cp183-WT capsids were less stable than Cp183-EEE capsids. When we tested CTD sensitivity to trypsin, we detected two different populations of CTDs differentiated by their rate of trypsin cleavage. Interestingly, CTDs from Cp183-EEE capsids exhibited a much slower rate of proteolytic cleavage when compared with CTDs of Cp183-WT capsids. Cryo-electron microscopy studies of trypsin-digested capsids show that CTDs at five-fold symmetry vertices are most protected. We hypothesize that electrostatic interactions between glutamates and arginines in Cp183-EEE, particularly at five-fold, increase capsid stability and reduce CTD exposure. Our studies show that quasi-equivalent CTDs exhibit different rates of exposure and thus might perform distinct functions during the hepatitis B virus lifecycle. Our results demonstrate a structural role for CTD phosphorylation and indicate crosstalk between CTDs within a capsid particle.	[Selzer, Lisa; Wang, Joseph C. -Y.; Zlotnick, Adam] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Kant, Ravi; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Indiana University System; Indiana University Bloomington; Montana State University System; Montana State University Bozeman	Zlotnick, A (corresponding author), Dept Mol & Cellular Biochem, 212 S Hawthorne Dr, Bloomington, IN 47405 USA.	azlotnic@indiana.edu		Zlotnick, Adam/0000-0001-9945-6267; Wang, Joseph Che-Yen/0000-0001-6580-3531	Murdock Charitable Trust; National Institutes of Health of the CoBRE program [5P20RR02437]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI077688] Funding Source: NIH RePORTER	Murdock Charitable Trust; National Institutes of Health of the CoBRE program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Michael Boersma and Dr. Malcom Winkler for their experimental contributions and Jonathan Hilmer for assistance with mass spectrometry instrumentation. The mass spectrometry facility at Montana State University receives funding from the Murdock Charitable Trust and National Institutes of Health 5P20RR02437 of the CoBRE program.	BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Ceres P, 2002, BIOCHEMISTRY-US, V41, P11525, DOI 10.1021/bi0261645; Chen C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002388; Chu TH, 2014, J VIROL, V88, P2530, DOI 10.1128/JVI.03235-13; Cum X., 2013, J VIROL, V87, P11494; Dhason MS, 2012, VIROLOGY, V430, P20, DOI 10.1016/j.virol.2012.04.012; Gazina EV, 2000, J VIROL, V74, P4721, DOI 10.1128/JVI.74.10.4721-4728.2000; Guo HT, 2010, J VIROL, V84, P387, DOI 10.1128/JVI.01921-09; Hilmer JK, 2008, J MOL BIOL, V375, P581, DOI 10.1016/j.jmb.2007.10.044; HUBBARD SJ, 1994, PROTEIN SCI, V3, P757; Kann M, 1999, J CELL BIOL, V145, P45, DOI 10.1083/jcb.145.1.45; Kock J, 2004, J VIROL, V78, P13812, DOI 10.1128/JVI.78.24.13812-13818.2004; Lan YT, 1999, VIROLOGY, V259, P342, DOI 10.1006/viro.1999.9798; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Lewellyn EB, 2011, J VIROL, V85, P1298, DOI 10.1128/JVI.01957-10; Li HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001162; LIAO W, 1995, J VIROL, V69, P1025, DOI 10.1128/JVI.69.2.1025-1029.1995; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Porterfield JZ, 2010, J VIROL, V84, P7174, DOI 10.1128/JVI.00586-10; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; Rabe B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000563; Rayaprolu V., 2014, BIOPROTOC, V4, P1199; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmitz A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000741; Shepherd CM, 2006, NUCLEIC ACIDS RES, V34, pD386, DOI 10.1093/nar/gkj032; STANNARD LM, 1979, J GEN VIROL, V45, P509, DOI 10.1099/0022-1317-45-2-509; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wang JCY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002919; Wittkop L, 2010, CELL MICROBIOL, V12, P962, DOI 10.1111/j.1462-5822.2010.01444.x; Yan XD, 2007, J STRUCT BIOL, V157, P211, DOI 10.1016/j.jsb.2006.07.013; Yan X, 2007, J STRUCT BIOL, V157, P73, DOI 10.1016/j.jsb.2006.08.007; Yu XK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069729; Zlotnick A, 1996, BIOCHEMISTRY-US, V35, P7412, DOI 10.1021/bi9604800	37	50	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28584	+		10.1074/jbc.M115.678441	http://dx.doi.org/10.1074/jbc.M115.678441			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26405031	hybrid, Green Published			2022-12-28	WOS:000365761900049
J	Remesh, SG; Santosh, V; Escalante, CR				Remesh, Soumya G.; Santosh, Vishaka; Escalante, Carlos R.			Structural Studies of IRF4 Reveal a Flexible Autoinhibitory Region and a Compact Linker Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY FACTOR FAMILY; SECONDARY STRUCTURE PREDICTION; PLASMA-CELL DIFFERENTIATION; ANGLE SCATTERING DATA; X-RAY-SCATTERING; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; BIOLOGICAL MACROMOLECULES; FUNCTIONAL IMPLICATIONS; PROTEIN-PROTEIN	IRF4 is a unique member of the interferon regulatory factor (IRF) family playing critical regulatory roles in immune cell development, regulation of obesity-induced inflammation, and control of thermogenic gene expression. The ability of IRF4 to control diverse transcriptional programs arises from its proficiency to interact with numerous transcriptional partners. In this study, we present the structural characterization of full-length IRF4. Using a combination of x-ray and small angle x-ray scattering studies, we reveal unique features of the interferon activation domain, including a set of beta-sheets and loops that serve as the binding site for PU.1, and also show that unlike other IRF members, IRF4 has a flexible autoinhibitory region. In addition, we have determined the small angle x-ray scattering solution structure of full-length IRF4, which, together with circular dichroism studies, suggests that the linker region is not extended but folds into a domain structure.	[Remesh, Soumya G.; Santosh, Vishaka; Escalante, Carlos R.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA	Virginia Commonwealth University	Escalante, CR (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, 1220 E Broad St, Richmond, VA 23298 USA.	cescalante@vcu.edu	Regan, Clinton/E-6250-2012; Remesh, Soumya G/I-3558-2019		National Institutes of Health [R01-GM092854, R21-CA179008]; Virginia Commonwealth University PRQF award; NATIONAL CANCER INSTITUTE [R21CA179008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University PRQF award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health Grants R01-GM092854 and R21-CA179008 and a Virginia Commonwealth University PRQF award. The authors declare that they have no conflicts of interest with the contents of this article.	Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; BAZAN JF, 1988, P NATL ACAD SCI USA, V85, P7872, DOI 10.1073/pnas.85.21.7872; Brass AL, 1999, EMBO J, V18, P977, DOI 10.1093/emboj/18.4.977; Brass AL, 1996, GENE DEV, V10, P2335, DOI 10.1101/gad.10.18.2335; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; FUJITA T, 1987, CELL, V49, P357, DOI 10.1016/0092-8674(87)90288-1; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; GOODBOURN S, 1988, P NATL ACAD SCI USA, V85, P1447, DOI 10.1073/pnas.85.5.1447; Guo S, 2014, CELL DEATH DIFFER, V21, P888, DOI 10.1038/cdd.2014.9; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; Hayes D, 1995, PROGRAM SEDNTERP SED; Jiang DS, 2013, HYPERTENSION, V61, P1193, DOI 10.1161/HYPERTENSIONAHA.111.00614; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Kong XX, 2014, CELL, V158, P69, DOI 10.1016/j.cell.2014.04.049; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Levi BZ, 2002, J INTERF CYTOK RES, V22, P153, DOI 10.1089/107999002753452764; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Mamane Y, 2000, IMMUNITY, V12, P129, DOI 10.1016/S1074-7613(00)80166-1; Marecki S, 2002, J INTERF CYTOK RES, V22, P121, DOI 10.1089/107999002753452737; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; MATSUYAMA T, 1995, NUCLEIC ACIDS RES, V23, P2127, DOI 10.1093/nar/23.12.2127; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meraro D, 1999, J IMMUNOL, V163, P6468; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Perkel JM, 1998, J IMMUNOL, V160, P241; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Sciammas R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.25; Servant MJ, 2001, J BIOL CHEM, V276, P355, DOI 10.1074/jbc.M007790200; Shukla H, 2012, BIOCHEMISTRY-US, V51, P6320, DOI 10.1021/bi300260s; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Wang JT, 2014, INNATE IMMUN-LONDON, V20, P78, DOI 10.1177/1753425913485307; Yamagata T, 1996, MOL CELL BIOL, V16, P1283; Yee AA, 1998, J MOL BIOL, V279, P1075, DOI 10.1006/jmbi.1998.1838; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087	65	16	18	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27779	27790		10.1074/jbc.M115.678789	http://dx.doi.org/10.1074/jbc.M115.678789			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26405037	Green Published, hybrid			2022-12-28	WOS:000365757500029
J	del Prado, A; Lazaro, JM; Longas, E; Villar, L; de Vega, M; Salas, M				del Prado, Alicia; Lazaro, Jose M.; Longas, Elisa; Villar, Laurentino; de Vega, Miguel; Salas, Margarita			Insights into the Determination of the Templating Nucleotide at the Initiation of phi 29 DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PRIMED INITIATION; SLIDING-BACK MECHANISM; STRAND-DISPLACEMENT CAPACITY; BACTERIOPHAGE PRD1 DNA; IN-VITRO REPLICATION; VACCINIA VIRUS-DNA; TERMINAL PROTEIN; PHAGE PHI-29; FUNCTIONAL-CHARACTERIZATION; LINEAR TEMPLATE	Bacteriophage phi 29 from Bacillus subtilis starts replication of its terminal protein (TP)-DNA by a protein-priming mechanism. To start replication, the DNA polymerase forms a heterodimer with a free TP that recognizes the replication origins, placed at both 5 ends of the linear chromosome, and initiates replication using as primer the OH-group of Ser-232 of the TP. The initiation of phi 29 TP-DNA replication mainly occurs opposite the second nucleotide at the 3 end of the template. Earlier analyses of the template position that directs the initiation reaction were performed using single-stranded and double-stranded oligonucleotides containing the replication origin sequence without the parental TP. Here, we show that the parental TP has no influence in the determination of the nucleotide used as template in the initiation reaction. Previous studies showed that the priming domain of the primer TP determines the template position used for initiation. The results obtained here using mutant TPs at the priming loop where Ser-232 is located indicate that the aromatic residue Phe-230 is one of the determinants that allows the positioning of the penultimate nucleotide at the polymerization active site to direct insertion of the initiator dAMP during the initiation reaction. The role of Phe-230 in limiting the internalization of the template strand in the polymerization active site is discussed.	[del Prado, Alicia; Lazaro, Jose M.; Longas, Elisa; Villar, Laurentino; de Vega, Miguel; Salas, Margarita] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Inst Biol Mol Eladio Vinuela, E-28049 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	de Vega, M (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Inst Biol Mol Eladio Vinuela, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	mdevega@cbm.csic.es; msalas@cbm.csic.es	de Vega, Miguel/K-2878-2014; Salas, Margarita/J-9873-2014; del Prado, Alicia/K-4473-2017	de Vega, Miguel/0000-0003-1285-7549; Salas, Margarita/0000-0001-5939-3441; 	Spanish Ministry of Economy and Competitiveness [BFU2014-52656-P, BFU 2014-53791P]; Consolider-Ingenio from the Spanish Ministry of Science and Innovation [CSD2007-00015]; Fundacion Ramon Areces to the Centro de Biologia Molecular "Severo Ochoa"; Spanish Ministry of Education	Spanish Ministry of Economy and Competitiveness(Spanish Government); Consolider-Ingenio from the Spanish Ministry of Science and Innovation; Fundacion Ramon Areces to the Centro de Biologia Molecular "Severo Ochoa"; Spanish Ministry of Education(Spanish Government)	This work was supported in part by the Spanish Ministry of Economy and Competitiveness Grants BFU2014-52656-P (to M. S.) and BFU 2014-53791P (to M. V.), Consolider-Ingenio from the Spanish Ministry of Science and Innovation Grant CSD2007-00015 (to M. S.), and a Institutional grant from the Fundacion Ramon Areces to the Centro de Biologia Molecular "Severo Ochoa." The authors declare that they have no conflicts of interest with the content of this article.; Supported by a predoctoral fellowship from the Spanish Ministry of Education.	BARBOUR AG, 1987, SCIENCE, V237, P409, DOI 10.1126/science.3603026; BAROUDY BM, 1982, CELL, V28, P315, DOI 10.1016/0092-8674(82)90349-X; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BLANCO L, 1989, J BIOL CHEM, V264, P8935; BLANCO L, 1987, J VIROL, V61, P3983, DOI 10.1128/JVI.61.12.3983-3991.1987; BLASCO MA, 1990, NUCLEIC ACIDS RES, V18, P4763; CALDENTEY J, 1992, NUCLEIC ACIDS RES, V20, P3971, DOI 10.1093/nar/20.15.3971; CALDENTEY J, 1993, NUCLEIC ACIDS RES, V21, P3725, DOI 10.1093/nar/21.16.3725; de Vega M, 1998, J BIOL CHEM, V273, P28966, DOI 10.1074/jbc.273.44.28966; Dufour E, 2000, J MOL BIOL, V304, P289, DOI 10.1006/jmbi.2000.4216; ESTEBAN JA, 1993, J BIOL CHEM, V268, P2719; GARON CF, 1978, P NATL ACAD SCI USA, V75, P4863, DOI 10.1073/pnas.75.10.4863; GESHELIN P, 1974, J MOL BIOL, V88, P785, DOI 10.1016/0022-2836(74)90399-4; Gonzalez-Huici V, 2000, J BIOL CHEM, V275, P14678, DOI 10.1074/jbc.M910058199; Gonzalez-Huici V, 2000, J BIOL CHEM, V275, P40547, DOI 10.1074/jbc.M007170200; GUTIERREZ J, 1986, VIROLOGY, V155, P474, DOI 10.1016/0042-6822(86)90209-6; GUTIERREZ J, 1986, GENE, V43, P1, DOI 10.1016/0378-1119(86)90002-8; Illana B, 1996, J MOL BIOL, V264, P453, DOI 10.1006/jmbi.1996.0653; Kamtekar S, 2006, EMBO J, V25, P1335, DOI 10.1038/sj.emboj.7601027; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; KING AJ, 1994, EMBO J, V13, P5786, DOI 10.1002/j.1460-2075.1994.tb06917.x; Kornberg A., 1992, DNA REPLICATION; Lazaro JM, 1995, METHOD ENZYMOL, V262, P42; Longas E, 2006, NUCLEIC ACIDS RES, V34, P6051, DOI 10.1093/nar/gkl769; Longas E, 2008, P NATL ACAD SCI USA, V105, P18290, DOI 10.1073/pnas.0809882105; Martin AC, 1996, J MOL BIOL, V260, P369, DOI 10.1006/jmbi.1996.0407; MCDONELL MW, 1977, J MOL BIOL, V110, P119, DOI 10.1016/S0022-2836(77)80102-2; Mencia M, 2011, P NATL ACAD SCI USA, V108, P18655, DOI 10.1073/pnas.1114397108; Mendez J, 1997, EMBO J, V16, P2519, DOI 10.1093/emboj/16.9.2519; MENDEZ J, 1992, P NATL ACAD SCI USA, V89, P9579, DOI 10.1073/pnas.89.20.9579; Munoz-Espin D, 2010, P NATL ACAD SCI USA, V107, P16548, DOI 10.1073/pnas.1010530107; Perez-Arnaiz P, 2007, NUCLEIC ACIDS RES, V35, P7061, DOI 10.1093/nar/gkm749; Rodriguez I, 2005, P NATL ACAD SCI USA, V102, P6407, DOI 10.1073/pnas.0500597102; SALAS M, 1991, ANNU REV BIOCHEM, V60, P39, DOI 10.1146/annurev.bi.60.070191.000351; SCHLEGEL RA, 1972, J MOL BIOL, V68, P319, DOI 10.1016/0022-2836(72)90216-1; TAYLOR K, 1995, FEMS MICROBIOL REV, V17, P109	36	5	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27138	27145		10.1074/jbc.M115.682278	http://dx.doi.org/10.1074/jbc.M115.682278			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26400085	Green Published, hybrid			2022-12-28	WOS:000364794000023
J	Lee, JG; Heur, M				Lee, Jeong Goo; Heur, Martin			WNT10B Enhances Proliferation through beta-Catenin and RAC1 GTPase in Human Corneal Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MAMMARY EPITHELIAL-CELLS; MESENCHYMAL TRANSFORMATION; RHO-GTPASES; SIGNALING PATHWAY; CYCLIN D1; PHOSPHATIDYLINOSITOL 3-KINASE; VERTEBRATE GASTRULATION; CANCER CELLS; CROSS-TALK	The cornea is the anterior, transparent tissue of the human eye that serves as its main refractive element. Corneal endothelial cells are arranged as a monolayer on the posterior surface of the cornea and function as a pump to counteract the leakiness of its basement membrane. Maintaining the cornea in a slightly dehydrated state is critical for the maintenance of corneal transparency. Adult human corneal endothelial cells are G(1)-arrested, even in response to injury, leading to an age-dependent decline in endothelial cell density. Corneal edema and subsequent vision loss ensues when endothelial cell density decreases below a critical threshold. Vision loss secondary to corneal endothelial dysfunction is a common indication for transplantation in developed nations. An impending increase in demand for and a current global shortage of donor corneas will necessitate the development of treatments for vision loss because of endothelial dysfunction that do not rely on donor corneas. Wnt ligands regulate many critical cellular functions, such as proliferation, making them attractive candidates for modulation in corneal endothelial dysfunction. We show that WNT10B causes nuclear transport and binding of RAC1 and beta-catenin in human corneal endothelial cells, leading to the activation of Cyclin D1 expression and proliferation. Our findings indicate that WNT10B promotes proliferation in human corneal endothelial cells by simultaneously utilizing both beta-catenin-dependent and -independent pathways and suggest that its modulation could be used to treat vision loss secondary to corneal endothelial dysfunction.	[Lee, Jeong Goo; Heur, Martin] Univ So Calif, Keck Sch Med, Inst Eye, Los Angeles, CA 90033 USA	University of Southern California	Heur, M (corresponding author), USCEye Inst, 1450 San Pablo St,Rm 4802, Los Angeles, CA 90033 USA.	heur@usc.edu			Kehle family; NATIONAL EYE INSTITUTE [K08EY021485] Funding Source: NIH RePORTER	Kehle family; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank the Kehle family for their generous support.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cajanek L, 2013, MOL CELL BIOL, V33, P59, DOI 10.1128/MCB.00745-12; Chahdi A, 2013, J BIOL CHEM, V288, P34019, DOI 10.1074/jbc.M113.480103; Chen Y, 2006, SEMIN CELL DEV BIOL, V17, P712, DOI 10.1016/j.semcdb.2006.11.005; Chim CS, 2007, LEUKEMIA, V21, P2527, DOI 10.1038/sj.leu.2404939; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Djalilian AR, 2006, CORNEA, V25, P709, DOI 10.1097/01.ico.0000208815.02120.90; Esufali S, 2004, ONCOGENE, V23, P8260, DOI 10.1038/sj.onc.1208007; Fanto M, 2000, CURR BIOL, V10, P979, DOI 10.1016/S0960-9822(00)00645-X; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; GEROSKI DH, 1984, INVEST OPHTH VIS SCI, V25, P1056; Goel S, 2012, J BIOL CHEM, V287, P16454, DOI 10.1074/jbc.M112.362137; Grandy D, 2009, J BIOL CHEM, V284, P16256, DOI 10.1074/jbc.M109.009647; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hamilton G, 2014, MAR DRUGS, V12, P1377, DOI 10.3390/md12031377; Hatou S, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0286; Hirata-Tominaga K, 2013, STEM CELLS, V31, P1396, DOI 10.1002/stem.1390; Honda N, 2009, ARCH OPHTHALMOL-CHIC, V127, P1321, DOI 10.1001/archophthalmol.2009.253; Hsiue GH, 2006, TRANSPLANTATION, V81, P473, DOI 10.1097/01.tp.0000194864.13539.2c; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P645; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P1566; Katoh M, 2007, INT J MOL MED, V19, P699; Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003; Ko MK, 2005, INVEST OPHTH VIS SCI, V46, P4495, DOI 10.1167/iovs.05-0818; KREUTZIGER GO, 1976, EXP EYE RES, V23, P285, DOI 10.1016/0014-4835(76)90129-9; Lee HT, 2004, J BIOL CHEM, V279, P32325, DOI 10.1074/jbc.M405208200; Lee JG, 2007, J BIOL CHEM, V282, P6444, DOI 10.1074/jbc.M607808200; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P2358, DOI 10.1167/iovs.05-1490; Lee JG, 2014, MOL CELL BIOL, V34, P3535, DOI 10.1128/MCB.01572-13; Lee JG, 2013, BIOL CELL, V105, P175, DOI 10.1111/boc.201200077; Lee JG, 2012, INVEST OPHTH VIS SCI, V53, P1530, DOI 10.1167/iovs.11-9102; Lee JG, 2011, INVEST OPHTH VIS SCI, V52, P8216, DOI 10.1167/iovs.11-8213; Lee JG, 2011, INVEST OPHTH VIS SCI, V52, P417, DOI 10.1167/iovs.10-6140; Lee JG, 2009, INVEST OPHTH VIS SCI, V50, P2067, DOI 10.1167/iovs.08-3135; Lee JG, 2006, INVEST OPHTH VIS SCI, V47, P1376, DOI 10.1167/iovs.05-1223; Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moore JE, 2002, INVEST OPHTH VIS SCI, V43, P2905; Nakano Y, 2008, INVEST OPHTH VIS SCI, V49, P93, DOI 10.1167/iovs.07-0255; Numata R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088169; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Okumura N, 2014, CORNEA, V33, pS37, DOI 10.1097/ICO.0000000000000229; Okumura N, 2014, INVEST OPHTH VIS SCI, V55, P318, DOI 10.1167/iovs.13-12225; Okumura N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058000, 10.1371/journal.pone.0075961]; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Polakis P, 2000, GENE DEV, V14, P1837; Randall RM, 2012, J ORTHOP RES, V30, P1906, DOI 10.1002/jor.22152; Roose J, 1999, BBA-REV CANCER, V1424, pM23, DOI 10.1016/S0304-419X(99)00026-8; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Rossol-Allisone J, 2009, CELL SIGNAL, V21, P1559, DOI 10.1016/j.cellsig.2009.05.010; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Seidensticker MJ, 2000, BBA-MOL CELL RES, V1495, P168, DOI 10.1016/S0167-4889(99)00158-5; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Senoo T, 2000, INVEST OPHTH VIS SCI, V41, P660; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Song JS, 2010, INVEST OPHTH VIS SCI, V51, P822, DOI 10.1167/iovs.09-4240; Stump RJW, 2003, DEV BIOL, V259, P48, DOI 10.1016/S0012-1606(03)00179-9; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang JD, 2012, HUM PATHOL, V43, P1044, DOI 10.1016/j.humpath.2011.08.013; Zhu YT, 2014, J CELL BIOL, V206, P799, DOI 10.1083/jcb.201404032	72	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26752	26764		10.1074/jbc.M115.677245	http://dx.doi.org/10.1074/jbc.M115.677245			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26370090	Green Published, hybrid			2022-12-28	WOS:000364793600037
J	Shi, ZB; Zhang, Z; Zhang, ZZ; Wang, YY; Li, CC; Wang, X; He, F; Sun, LN; Jiao, S; Shi, WY; Zhou, ZC				Shi, Zhubing; Zhang, Zhen; Zhang, Zhenzhen; Wang, Yanyan; Li, Chuanchuan; Wang, Xin; He, Feng; Sun, Lina; Jiao, Shi; Shi, Weiyang; Zhou, Zhaocai			Structural Insights into Mitochondrial Antiviral Signaling Protein (MAVS)-Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIG-I; ADAPTER PROTEIN; CD40 RECOGNITION; RNA RECOGNITION; IMMUNE; ACTIVATION; LGP2; REGULATOR; MECHANISM; SEQUENCE	In response to viral infection, cytosolic retinoic acid-inducible gene I-like receptors sense viral RNA and promote oligomerization of mitochondrial antiviral signaling protein (MAVS), which then recruits tumor necrosis factor receptor-associated factor (TRAF) family proteins, including TRAF6, to activate an antiviral response. Currently, the interaction between MAVS and TRAF6 is only partially understood, and atomic details are lacking. Here, we demonstrated that MAVS directly interacts with TRAF6 through its potential TRAF6-binding motif 2 (T6BM2; amino acids 455-460). Further, we solved the crystal structure of MAVS T6BM2 in complex with the TRAF6 TRAF_C domain at 2.95 angstrom resolution. T6BM2 of MAVS binds to the canonical adaptor-binding groove of the TRAF_C domain. Structure-directed mutational analyses in vitro and in cells revealed that MAVS binding to TRAF6 via T6BM2 instead of T6BM1 is essential but not sufficient for an optimal antiviral response. Particularly, a MAVS mutant Y460E retained its TRAF6-binding ability as predicted but showed significantly impaired signaling activity, highlighting the functional importance of this tyrosine. Moreover, these observations were further confirmed in MAVS(-/-) mouse embryonic fibroblast cells. Collectively, our work provides a structural basis for understanding the MAVS-TRAF6 antiviral response.	[Shi, Zhubing; Shi, Weiyang] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Shi, Zhubing; Zhang, Zhen; Zhang, Zhenzhen; Wang, Yanyan; Li, Chuanchuan; Wang, Xin; He, Feng; Jiao, Shi; Zhou, Zhaocai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Sun, Lina] Qingdao Binhai Univ, Qingdao 266555, Shandong, Peoples R China	Tongji University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Shi, WY (corresponding author), Tongji Univ, Sch Life Sci & Technol, 1239 Siping Rd, Shanghai 200092, Peoples R China.	wshi@tongji.edu.cn; zczhou@sibcb.ac.cn	wang, yan/GSE-6489-2022; Shi, Zhubing/F-9490-2010; Wang, Yanbo/HFZ-8018-2022	Shi, Zhubing/0000-0002-9624-4960; He, Feng/0000-0002-6286-8134	973 program of the Ministry of Science and Technology of China [2012CB910204]; National Natural Science Foundation of China [31270808, 31300734, 31470736, 31470868, 41476120, 91442125, 91542125]; Science and Technology Commission of Shanghai Municipality [11JC14140000, 13ZR1446400]; "Cross and Cooperation in Science and Technology Innovation Team" Project of the Chinese Academy of Sciences; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2014KIP202]	973 program of the Ministry of Science and Technology of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); "Cross and Cooperation in Science and Technology Innovation Team" Project of the Chinese Academy of Sciences; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences)	This work was supported by the 973 program of the Ministry of Science and Technology of China (Grant 2012CB910204); National Natural Science Foundation of China Grants 31270808, 31300734, 31470736, 31470868, 41476120, 91442125, and 91542125; Science and Technology Commission of Shanghai Municipality Grants 11JC14140000 and 13ZR1446400; the "Cross and Cooperation in Science and Technology Innovation Team" Project of the Chinese Academy of Sciences; and the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Grant 2014KIP202. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li CL, 2002, STRUCTURE, V10, P403, DOI 10.1016/S0969-2126(02)00733-5; Liu SQ, 2013, ELIFE, V2, DOI 10.7554/eLife.00785; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Ni CZ, 2000, P NATL ACAD SCI USA, V97, P10395, DOI 10.1073/pnas.97.19.10395; Ni CZ, 2004, J IMMUNOL, V173, P7394, DOI 10.4049/jimmunol.173.12.7394; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YC, 1999, NATURE, V398, P533, DOI 10.1038/19110; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Peisley A, 2013, MOL CELL, V51, P573, DOI 10.1016/j.molcel.2013.07.024; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shi ZB, 2013, STRUCTURE, V21, P449, DOI 10.1016/j.str.2013.01.007; Vitour D, 2009, J BIOL CHEM, V284, P21797, DOI 10.1074/jbc.M109.018275; Wang YY, 2010, SCI CHINA LIFE SCI, V53, P159, DOI 10.1007/s11427-010-0050-3; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Wu SD, 2005, J BIOL CHEM, V280, P33620, DOI 10.1074/jbc.M502511200; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Xu H, 2014, ELIFE, V3, DOI 10.7554/eLife.01489; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Ye H, 1999, MOL CELL, V4, P321, DOI 10.1016/S1097-2765(00)80334-2; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yoshida R, 2008, J BIOL CHEM, V283, P36211, DOI 10.1074/jbc.M806576200; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang P, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003152	48	26	26	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26811	26820		10.1074/jbc.M115.666578	http://dx.doi.org/10.1074/jbc.M115.666578			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26385923	hybrid, Green Published			2022-12-28	WOS:000364793600043
J	Guzman, RE; Miranda-Laferte, E; Franzen, A; Fahlke, C				Guzman, Raul E.; Miranda-Laferte, Erick; Franzen, Arne; Fahlke, Christoph			Neuronal ClC-3 Splice Variants Differ in Subcellular Localizations, but Mediate Identical Transport Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNEL; PLASMA-MEMBRANE; TRANSMEMBRANE PROTEINS; CHARGE MOVEMENT; EXPRESSION; EXCHANGER; VOLUME; LEADS; OSTEOPETROSIS; TRANSMISSION	ClC-3 is a member of the CLC family of anion channels and transporters, for which multiple functional properties and subcellular localizations have been reported. Since alternative splicing often results in proteins with diverse properties, we investigated to what extent alternative splicing might influence subcellular targeting and function of ClC-3. Weidentified three alternatively spliced ClC-3 isoforms, ClC-3a, ClC-3b, and ClC-3c, in mouse brain, with ClC-3c being the predominant splice variant. Whereas ClC-3a and ClC-3b are present in late endosomes/lysosomes, ClC-3c is targeted to recycling endosomes via a novel N-terminal isoleucine-proline (IP) motif. Surface membrane insertion of a fraction of ClC-3c transporters permitted electrophysiological characterization of this splice variant through whole-cell patch clamping on transfected mammalian cells. In contrast, neutralization of the N-terminal dileucine-like motifs was required for functional analysis of ClC-3a and ClC-3b. Heterologous expression of ClC-3a or ClC-3b carrying mutations in N-terminal dileucine motifs as well as WTClC-3c in HEK293T cells resulted in outwardly rectifying Cl- currents with significant capacitive current components. We conclude that alternative splicing of Clcn3 results in proteins with different subcellular localizations, but leaves the transport function of the proteins unaffected.	[Guzman, Raul E.; Miranda-Laferte, Erick; Franzen, Arne; Fahlke, Christoph] Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophys ICS 4, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Guzman, RE (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophys ICS 4, D-52425 Julich, Germany.	r.guzman@fz-juelich.de; c.fahlke@fz-juelich.de	Fahlke, Christoph/G-3635-2013	Fahlke, Christoph/0000-0001-8602-9952; Franzen, Arne/0000-0002-8731-674X				Alekov AK, 2009, J GEN PHYSIOL, V133, P485, DOI 10.1085/jgp.200810155; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Cheng CL, 2002, J NEUROSCI, V22, P10643; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Dickerson LW, 2002, BRAIN RES, V958, P227, DOI 10.1016/S0006-8993(02)03519-9; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fahlke C, 2001, J BIOL CHEM, V276, P1759, DOI 10.1074/jbc.M007649200; Farmer LM, 2013, J PHYSIOL-LONDON, V591, P1001, DOI 10.1113/jphysiol.2012.243485; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Gentzsch M, 2003, J BIOL CHEM, V278, P6440, DOI 10.1074/jbc.M211050200; Gough NR, 1999, J CELL SCI, V112, P4257; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Grieschat M, 2014, BIOPHYS J, V107, pL13, DOI 10.1016/j.bpj.2014.07.063; Grieschat M, 2012, J BIOL CHEM, V287, P8101, DOI 10.1074/jbc.M111.298265; Guzman RE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00143; Guzman RE, 2013, ACS CHEM NEUROSCI, V4, P994, DOI 10.1021/cn400032z; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; KAWASAKI M, 1995, NEURON, V14, P1285, DOI 10.1016/0896-6273(95)90275-9; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; Kobayashi Hotaka, 2013, Commun Integr Biol, V6, pe25036, DOI 10.4161/cib.25036; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Mao JW, 2009, BIOCHEM PHARMACOL, V77, P159, DOI 10.1016/j.bcp.2008.10.009; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Miranda-Laferte E, 2014, J BIOL CHEM, V289, P10387, DOI 10.1074/jbc.M113.507244; Neagoe I, 2010, J BIOL CHEM, V285, P21689, DOI 10.1074/jbc.M110.125971; Ogura T, 2002, FASEB J, V16, P863, DOI 10.1096/fj.01-0845fje; Okada T, 2014, CELL PHYSIOL BIOCHEM, V33, P539, DOI 10.1159/000358633; Orhan G, 2011, BIOPHYS J, V100, P1233, DOI 10.1016/j.bpj.2011.01.045; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Riazanski V, 2011, NAT NEUROSCI, V14, P487, DOI 10.1038/nn.2775; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Smith AJ, 2010, FASEB J, V24, P3696, DOI 10.1096/fj.09-150649; Stauber T, 2010, J BIOL CHEM, V285, P34537, DOI 10.1074/jbc.M110.162545; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; STOCKER M, 1990, P NATL ACAD SCI USA, V87, P8903, DOI 10.1073/pnas.87.22.8903; Suzuki T, 2006, J CELL PHYSIOL, V206, P792, DOI 10.1002/jcp.20516; Suzuki T, 2014, J BIOL CHEM, V289, P7438, DOI 10.1074/jbc.M113.542324; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wang XQ, 2006, NEURON, V52, P321, DOI 10.1016/j.neuron.2006.08.035; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; Yamazaki J, 1998, J PHYSIOL-LONDON, V507, P729, DOI 10.1111/j.1469-7793.1998.729bs.x; Yoshikawa M, 2002, GENES CELLS, V7, P597, DOI 10.1046/j.1365-2443.2002.00539.x; Zhang HF, 2014, INT J BIOCHEM CELL B, V57, P96, DOI 10.1016/j.biocel.2014.10.014; Zhao ZF, 2007, J BIOL CHEM, V282, P29022, DOI 10.1074/jbc.M703506200; Zifarelli G, 2012, BIOPHYS J, V102, P2060, DOI 10.1016/j.bpj.2012.03.067	60	33	33	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25851	25862		10.1074/jbc.M115.668186	http://dx.doi.org/10.1074/jbc.M115.668186			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26342074	Green Published, hybrid			2022-12-28	WOS:000363527300010
J	Narayana, SK; Helbig, KJ; McCartney, EM; Eyre, NS; Bull, RA; Eltahla, A; Lloyd, AR; Beard, MR				Narayana, Sumudu K.; Helbig, Karla J.; McCartney, Erin M.; Eyre, Nicholas S.; Bull, Rowena A.; Eltahla, Auda; Lloyd, Andrew R.; Beard, Michael R.			The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEST NILE VIRUS; S-PALMITOYLATION; DENGUE VIRUS; ANTIVIRAL EFFECTOR; MEMBRANE-PROTEINS; FAMILY PROTEINS; REPLICATION; INFECTION; EXPRESSION; RESISTANCE	The interferon-induced transmembrane (IFITM) family of proteins have recently been identified as important host effector molecules of the type I interferon response against viruses. IFITM1 has been identified as a potent antiviral effector against hepatitis C virus (HCV), whereas the related family members IFITM2 and IFITM3 have been described to have antiviral effects against a broad range of RNA viruses. Here, we demonstrate that IFITM2 and IFITM3 play an integral role in the interferon response against HCV and act at the level of late entry stages of HCV infection. We have established that in hepatocytes, IFITM2 and IFITM3 localize to the late and early endosomes, respectively, as well as the lysosome. Furthermore, we have demonstrated that S-palmitoylation of all three IFITM proteins is essential for anti-HCV activity, whereas the conserved tyrosine residue in the N-terminal domain of IFITM2 and IFITM3 plays a significant role in protein localization. However, this tyrosine was found to be dispensable for anti-HCV activity, with mutation of the tyrosine resulting in an IFITM1-like phenotype with the retention of anti-HCV activity and colocalization of IFITM2 and IFITM3 with CD81. In conclusion, we propose that the IFITM proteins act in a coordinated manner to restrict HCV infection by targeting the endocytosed HCV virion for lysosomal degradation and demonstrate that the actions of the IFITM proteins are indeed virus and cell-type specific.	[Narayana, Sumudu K.; Helbig, Karla J.; McCartney, Erin M.; Eyre, Nicholas S.; Beard, Michael R.] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia; [Narayana, Sumudu K.; Helbig, Karla J.; McCartney, Erin M.; Eyre, Nicholas S.; Beard, Michael R.] Univ Adelaide, Res Ctr Infect Dis, Adelaide, SA 5005, Australia; [Narayana, Sumudu K.; Helbig, Karla J.; McCartney, Erin M.; Eyre, Nicholas S.; Beard, Michael R.] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Bull, Rowena A.; Eltahla, Auda; Lloyd, Andrew R.] Univ New S Wales, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW 2052, Australia	University of Adelaide; University of Adelaide; Centre for Cancer Biology; SA Pathology; University of New South Wales Sydney	Beard, MR (corresponding author), Univ Adelaide, Sch Biol Sci, Dept Mol & Cellular Biol, Adelaide, SA 5005, Australia.	michael.beard@adelaide.edu.au	Helbig, Karla/AAC-5515-2019; Lloyd, Andrew/AFJ-8960-2022; Lloyd, Andrew/AAF-6071-2022; Lloyd, Andrew/E-7334-2017; Beard, Michael/AAS-3477-2020	Helbig, Karla/0000-0001-6306-2821; Lloyd, Andrew/0000-0001-6277-8887; Lloyd, Andrew/0000-0001-6277-8887; Beard, Michael/0000-0002-4106-1016; Eyre, Nicholas/0000-0002-5424-7573; Bull, Rowena/0000-0002-9844-3744; Eltahla, Auda/0000-0002-2995-8832	National Health & Medical Research Council of Australia [1053206]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health & Medical Research Council of Australia Grant 1053206. The authors declare that they have no conflicts of interest with the contents of this article.	Aloia AL, 2012, ANTIVIR THER, V17, P1147, DOI 10.3851/IMP2426; Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006; Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chan YK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034508; Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694; Chowdhury JB, 2012, J VIROL, V86, P10221, DOI 10.1128/JVI.00882-12; Chutiwitoonchai N, 2013, MICROBES INFECT, V15, P280, DOI 10.1016/j.micinf.2012.12.003; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Dubuisson J, 2014, J HEPATOL, V61, pS3, DOI 10.1016/j.jhep.2014.06.031; Eyre NS, 2014, J VIROL, V88, P3636, DOI 10.1128/JVI.02490-13; Eyre NS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001130; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Helbig KJ, 2004, HEPATOLOGY, V39, P1220, DOI 10.1002/hep.20167; Hickford D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-155; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Ikeda M, 2002, J VIROL, V76, P2997, DOI 10.1128/JVI.76.6.2997-3006.2002; Jia R, 2014, CELL MICROBIOL, V16, P1080, DOI 10.1111/cmi.12262; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Li QS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004163; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Manna D, 2010, VIROLOGY, V398, P21, DOI 10.1016/j.virol.2009.11.034; McCartney EM, 2013, HEPATOLOGY, V58, P1558, DOI 10.1002/hep.26496; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Raychoudhuri A, 2011, J VIROL, V85, P12881, DOI 10.1128/JVI.05633-11; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Siegrist F., 2011, J INTERFERON CYTOKIN, V1, P183; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Wilkins C, 2013, HEPATOLOGY, V57, P461, DOI 10.1002/hep.26066; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhao H, 2012, J HEPATOL, V56, P326, DOI 10.1016/j.jhep.2011.07.026; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	46	89	93	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25946	25959		10.1074/jbc.M115.657346	http://dx.doi.org/10.1074/jbc.M115.657346			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26354436	Green Published, hybrid			2022-12-28	WOS:000363527300017
J	Ebert, SM; Dyle, MC; Bullard, SA; Dierdorff, JM; Murry, DJ; Fox, DK; Bongers, KS; Lira, VA; Meyerholz, DK; Talley, JJ; Adams, CM				Ebert, Scott M.; Dyle, Michael C.; Bullard, Steven A.; Dierdorff, Jason M.; Murry, Daryl J.; Fox, Daniel K.; Bongers, Kale S.; Lira, Vitor A.; Meyerholz, David K.; Talley, John J.; Adams, Christopher M.			Identification and Small Molecule Inhibition of an Activating Transcription Factor 4 (ATF4)-dependent Pathway to Age-related Skeletal Muscle Weakness and Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA EXPRESSION SIGNATURES; PROTEIN-SYNTHESIS; URSOLIC ACID; MASS; REVEALS; DISRUPTION; SARCOPENIA; AUTOPHAGY; PROFILES; MYOPATHY	Aging reduces skeletal muscle mass and strength, but the underlying molecular mechanisms remain elusive. Here, we used mouse models to investigate molecular mechanisms of age-related skeletal muscle weakness and atrophy as well as new potential interventions for these conditions. We identified two small molecules that significantly reduce age-related deficits in skeletal muscle strength, quality, and mass: ursolic acid (a pentacyclic triterpenoid found in apples) and tomatidine (a steroidal alkaloid derived from green tomatoes). Because small molecule inhibitors can sometimes provide mechanistic insight into disease processes, we used ursolic acid and tomatidine to investigate the pathogenesis of age-related muscle weakness and atrophy. We found that ursolic acid and tomatidine generate hundreds of small positive and negative changes in mRNA levels in aged skeletal muscle, and the mRNA expression signatures of the two compounds are remarkably similar. Interestingly, a subset of the mRNAs repressed by ursolic acid and tomatidine in aged muscle are positively regulated by activating transcription factor 4 (ATF4). Based on this finding, we investigated ATF4 as a potential mediator of age-related muscle weakness and atrophy. We found that a targeted reduction in skeletal muscle ATF4 expression reduces age-related deficits in skeletal muscle strength, quality, and mass, similar to ursolic acid and tomatidine. These results elucidate ATF4 as a critical mediator of age-related muscle weakness and atrophy. In addition, these results identify ursolic acid and tomatidine as potential agents and/or lead compounds for reducing ATF4 activity, weakness, and atrophy in aged skeletal muscle.	[Ebert, Scott M.; Dyle, Michael C.; Bullard, Steven A.; Dierdorff, Jason M.; Murry, Daryl J.; Fox, Daniel K.; Bongers, Kale S.; Adams, Christopher M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Dyle, Michael C.; Fox, Daniel K.; Bongers, Kale S.; Adams, Christopher M.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Lira, Vitor A.] Univ Iowa, Dept Hlth & Human Physiol, Iowa City, IA 52242 USA; [Meyerholz, David K.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Ebert, Scott M.; Dyle, Michael C.; Bullard, Steven A.; Dierdorff, Jason M.; Fox, Daniel K.; Bongers, Kale S.; Lira, Vitor A.; Adams, Christopher M.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; [Murry, Daryl J.] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA; [Ebert, Scott M.; Dyle, Michael C.; Bullard, Steven A.; Dierdorff, Jason M.; Fox, Daniel K.; Bongers, Kale S.; Adams, Christopher M.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52246 USA; [Ebert, Scott M.; Talley, John J.; Adams, Christopher M.] Emmyon Inc, Coralville, IA 52241 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Adams, CM (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	christopher-adams@uiowa.edu	Lira, Vitor/AAN-3403-2021; Meyerholz, David/J-8131-2019	Lira, Vitor/0000-0002-3162-3804; Meyerholz, David/0000-0003-1552-3253; Bongers, Kale/0000-0002-9297-9185; Adams, Christopher/0000-0002-5795-7212	National Institutes of Health Grants [1R43AG044898, 1R01AR059115, 1F31AG04603801]; Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant [IBX000976A]; Department of Veterans Affairs Rehabilitation and Research Development Service Grant [1I01RX001477]; Fraternal Order of Eagles Diabetes Research Center at University of Iowa; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R43AG044898, F30AG044964] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000976, I01RX001477] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant(US Department of Veterans Affairs); Department of Veterans Affairs Rehabilitation and Research Development Service Grant(US Department of Veterans Affairs); Fraternal Order of Eagles Diabetes Research Center at University of Iowa; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants 1R43AG044898, 1R01AR059115, and 1F31AG04603801. This work was also supported by Department of Veterans Affairs Biomedical Laboratory Research and Development Service Grant IBX000976A, Department of Veterans Affairs Rehabilitation and Research Development Service Grant 1I01RX001477, and the Fraternal Order of Eagles Diabetes Research Center at the University of Iowa. C. M. A., S. M. E., and M. C. D. are inventors on patent applications related to ursolic acid and tomatidine that have been filed by the University of Iowa Research Foundation and licensed to Emmyon, Inc. C. M. A. is a co-founder and officer of Emmyon, Inc. S. M. E. is an employee of Emmyon, Inc. C. M. A., J. J. T., and S. M. E. hold equity in Emmyon, Inc.	Adams CM, 2015, CURR OPIN CLIN NUTR, V18, P263, DOI 10.1097/MCO.0000000000000159; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013; Bujak AL, 2015, CELL METAB, V21, P883, DOI 10.1016/j.cmet.2015.05.016; Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Demontis F, 2013, DIS MODEL MECH, V6, P1339, DOI 10.1242/dmm.012559; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; Dyle MC, 2014, J BIOL CHEM, V289, P14913, DOI 10.1074/jbc.M114.556241; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Federal Interagency Forum on Aging-Related Statistics, 2013, OLD AM KEY IND WELL; Figueiredo VC, 2012, CELL BIOCHEM FUNCT, V30, P432, DOI 10.1002/cbf.2821; Fox DK, 2014, AM J PHYSIOL-ENDOC M, V307, pE245, DOI 10.1152/ajpendo.00010.2014; Frighetto RTS, 2008, FOOD CHEM, V106, P767, DOI 10.1016/j.foodchem.2007.06.003; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Gordon BS, 2013, INT J BIOCHEM CELL B, V45, P2147, DOI 10.1016/j.biocel.2013.05.039; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hwee DT, 2014, AGING CELL, V13, P92, DOI 10.1111/acel.12150; Ibebunjo C, 2013, MOL CELL BIOL, V33, P194, DOI 10.1128/MCB.01036-12; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Maden-Wilkinson TM, 2014, AGE, V36, P383, DOI 10.1007/s11357-013-9571-6; Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674; Sandri M, 2013, BIOGERONTOLOGY, V14, P303, DOI 10.1007/s10522-013-9432-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106	34	68	72	2	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25497	25511		10.1074/jbc.M115.681445	http://dx.doi.org/10.1074/jbc.M115.681445			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26338703	hybrid, Green Published			2022-12-28	WOS:000362962800025
J	Lim, NTY; Harder, MJ; Kennedy, AT; Lin, CS; Weir, C; Cowman, AF; Call, MJ; Schmidt, CQ; Tham, WH				Lim, Nicholas T. Y.; Harder, Markus J.; Kennedy, Alexander T.; Lin, Clara S.; Weir, Christopher; Cowman, Alan F.; Call, Melissa J.; Schmidt, Christoph Q.; Tham, Wai-Hong			Characterization of Inhibitors and Monoclonal Antibodies That Modulate the Interaction between Plasmodium falciparum Adhesin PfRh4 with Its Erythrocyte Receptor Complement Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIAL PARASITES; BINDING-PROTEINS; INVASION LIGAND; GLYCOPHORIN-C; MEROZOITES; VACCINE; IDENTIFICATION; SPECIFICITY; IMMUNITY; JUNCTION	Plasmodium falciparum parasites must invade red blood cells to survive within humans. Entry into red blood cells is governed by interactions between parasite adhesins and red blood cell receptors. Previously we identified that P. falciparum reticulocyte binding protein-like homologue 4 (PfRh4) binds to complement receptor 1 (CR1) to mediate entry of malaria parasites into human red blood cells. In this report we characterize a collection of anti-PfRh4 monoclonal antibodies and CR1 protein fragments that modulate the interaction between PfRh4 and CR1. We identify an anti-PfRh4 monoclonal that blocks PfRh4-CR1 interaction in vitro, inhibits PfRh4 binding to red blood cells, and as a result abolishes the PfRh4-CR1 invasion pathway in P. falciparum. Epitope mapping of anti-PfRh4 monoclonal antibodies identified distinct functional regions within PfRh4 involved in modulating its interaction with CR1. Furthermore, we designed a set of protein fragments based on extensive mutagenesis analyses of the PfRh4 binding site on CR1 and determined their interaction affinities using surface plasmon resonance. These CR1 protein fragments bind tightly to PfRh4 and also function as soluble inhibitors to block PfRh4 binding to red blood cells and to inhibit the PfRh4-CR1 invasion pathway. Our findings can aid future efforts in designing specific single epitope antibodies to block P. falciparum invasion via complement receptor 1.	[Lim, Nicholas T. Y.; Kennedy, Alexander T.; Lin, Clara S.; Weir, Christopher; Cowman, Alan F.; Call, Melissa J.; Tham, Wai-Hong] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Harder, Markus J.; Schmidt, Christoph Q.] Univ Ulm, Inst Pharmacol Nat Prod & Clin Pharmacol, D-89081 Ulm, Germany; [Kennedy, Alexander T.; Lin, Clara S.; Weir, Christopher; Cowman, Alan F.; Call, Melissa J.; Tham, Wai-Hong] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Weir, Christopher] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	Walter & Eliza Hall Institute; Ulm University; University of Melbourne; University of Edinburgh	Tham, WH (corresponding author), Walter & Eliza Hall Inst Med Res, Div Infect & Immun, 1G Royal Parade, Parkville, Vic 3052, Australia.	tham@wehi.edu.au	Call, Melissa/HHZ-6671-2022; Tham, Wai-Hong/P-6474-2019; Tham, Wai-Hong/L-3173-2018	Call, Melissa/0000-0001-7684-5841; Tham, Wai-Hong/0000-0001-7950-8699; Tham, Wai-Hong/0000-0001-7950-8699	National Health and Medical Research Council Grant [APP1026581]; Australian Research Council Future Fellowship	National Health and Medical Research Council Grant(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council)	This work was supported by National Health and Medical Research Council Grant APP1026581 and an Australian Research Council Future Fellowship (to W. H.-T.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Awandare GA, 2011, MOL BIOCHEM PARASIT, V177, P57, DOI 10.1016/j.molbiopara.2011.01.005; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Chen L, 2014, ELIFE, V3, DOI 10.7554/eLife.04187; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Douglas AD, 2015, CELL HOST MICROBE, V17, P130, DOI 10.1016/j.chom.2014.11.017; Douglas AD, 2014, J IMMUNOL, V192, P245, DOI 10.4049/jimmunol.1302045; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; Gao XH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3862; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; HAYNES JD, 1988, J EXP MED, V167, P1873, DOI 10.1084/jem.167.6.1873; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Mayer DCG, 2002, J EXP MED, V196, P1523, DOI 10.1084/jem.20020750; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; Park HJ, 2014, J BIOL CHEM, V289, P450, DOI 10.1074/jbc.M113.520346; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Reiling L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045253; Reiling L, 2010, J IMMUNOL, V185, P6157, DOI 10.4049/jimmunol.1001555; Richards JS, 2013, J IMMUNOL, V191, P795, DOI 10.4049/jimmunol.1300778; Schmidt CQ, 2015, MOL IMMUNOL, V67, P71, DOI 10.1016/j.molimm.2015.03.006; Schmidt CQ, 2011, PROTEIN EXPRES PURIF, V76, P254, DOI 10.1016/j.pep.2010.12.002; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Spadafora C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000968; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Tham WH, 2011, BLOOD, V118, P1923, DOI 10.1182/blood-2011-03-341305; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Tham WH, 2009, INFECT IMMUN, V77, P2427, DOI 10.1128/IAI.00048-09; Triglia T, 2001, INFECT IMMUN, V69, P1084, DOI 10.1128/IAI.69.2.1084-1092.2001; Triglia T, 2009, CELL MICROBIOL, V11, P1671, DOI 10.1111/j.1462-5822.2009.01358.x; Weiss GE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004670; Wilson DW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-152; Wright KE, 2014, NATURE, V515, P427, DOI 10.1038/nature13715	37	6	7	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25307	25321		10.1074/jbc.M115.657171	http://dx.doi.org/10.1074/jbc.M115.657171			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26324715	hybrid, Green Published			2022-12-28	WOS:000362962800010
J	Tsai, CJ; Aslam, K; Drendel, HM; Asiago, JM; Goode, KM; Paul, LN; Rochet, JC; Hazbun, TR				Tsai, Chai-jui; Aslam, Kiran; Drendel, Holli M.; Asiago, Josephat M.; Goode, Kourtney M.; Paul, Lake N.; Rochet, Jean-Christophe; Hazbun, Tony R.			Hsp31 Is a Stress Response Chaperone That Intervenes in the Protein Misfolding Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN TOXICITY; ESCHERICHIA-COLI HSP31; SACCHAROMYCES-CEREVISIAE; PARKINSONS-DISEASE; OXIDATIVE STRESS; HEAT-SHOCK; CRYSTAL-STRUCTURE; GENETIC-ANALYSIS; CELLULAR-MODEL; DIAUXIC-SHIFT	The Saccharomyces cerevisiae heat shock protein Hsp31 is a stress-inducible homodimeric protein that is involved in diauxic shift reprogramming and has glyoxalase activity. We show that substoichiometric concentrations of Hsp31 can abrogate aggregation of a broad array of substrates in vitro. Hsp31 also modulates the aggregation of alpha-synuclein (alpha Syn), a target of the chaperone activity of human DJ-1, an Hsp31 homolog. We demonstrate that Hsp31 is able to suppress the in vitro fibrillization or aggregation of alpha Syn, citrate synthase and insulin. Chaperone activity was also observed in vivo because constitutive overexpression of Hsp31 reduced the incidence of alpha Syn cytoplasmic foci, and yeast cells were rescued from alpha Syn-generated proteotoxicity upon Hsp31 overexpression. Moreover, we showed that Hsp31 protein levels are increased by H2O2, in the diauxic phase of normal growth conditions, and in cells under alpha Syn-mediated proteotoxic stress. We show that Hsp31 chaperone activity and not the methylglyoxalase activity or the autophagy pathway drives the protective effects. We also demonstrate reduced aggregation of the Sup35 prion domain, PrD-Sup35, as visualized by fluorescent protein fusions. In addition, Hsp31 acts on its substrates prior to the formation of large aggregates because Hsp31 does not mutually localize with prion aggregates, and it prevents the formation of detectable in vitro alpha Syn fibrils. These studies establish that the protective role of Hsp31 against cellular stress is achieved by chaperone activity that intervenes early in the protein misfolding process and is effective on a wide spectrum of substrate proteins, including alpha Syn and prion proteins.	[Tsai, Chai-jui; Aslam, Kiran; Drendel, Holli M.; Asiago, Josephat M.; Goode, Kourtney M.; Rochet, Jean-Christophe; Hazbun, Tony R.] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Tsai, Chai-jui; Aslam, Kiran; Drendel, Holli M.; Asiago, Josephat M.; Goode, Kourtney M.; Rochet, Jean-Christophe; Hazbun, Tony R.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA; [Paul, Lake N.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hazbun, TR (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, 575 Stadium Mall Dr, W Lafayette, IN 47906 USA.	thazbun@purdue.edu	Regan, Clinton/E-6250-2012; Hazbun, Tony/K-2597-2019	Hazbun, Tony/0000-0003-0675-8093; Rochet, Jean-Christophe/0000-0002-6484-1541	National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award [UL1TR001108]; National Institutes of Health [R01 GM087461]; Showalter Foundation; Purdue Research Foundation; Fulbright Foundation; United States Education Foundation - Pakistan; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087461] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Foundation; Purdue Research Foundation; Fulbright Foundation; United States Education Foundation - Pakistan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award UL1TR001108 and National Institutes of Health Grant R01 GM087461 (to the Indiana Clinical and Translational Sciences Institute). This publication also supported by a Showalter Foundation grant (to J-C. R. and T. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by a Purdue Research Foundation fellowship.; Supported by a Fulbright Foundation fellowship, United States Education Foundation - Pakistan.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Amberg DC., 2005, METHODS YEAST GENETI; Angeloni Cristina, 2014, Biomed Res Int, V2014, P238485, DOI 10.1155/2014/238485; Au AK, 2010, BBA-MOL BASIS DIS, V1802, P918, DOI 10.1016/j.bbadis.2009.10.010; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Batelli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001884; Bito A, 1997, J BIOL CHEM, V272, P21509, DOI 10.1074/jbc.272.34.21509; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Choi D, 2013, BBA-PROTEINS PROTEOM, V1834, P621, DOI 10.1016/j.bbapap.2012.11.006; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; de Melo HF, 2010, J APPL MICROBIOL, V109, P116, DOI 10.1111/j.1365-2672.2009.04633.x; Duennwald Martin L, 2012, PLoS Biol, V10, pe1001346, DOI 10.1371/journal.pbio.1001346; Esteves AR, 2009, ANTIOXID REDOX SIGN, V11, P439, DOI [10.1089/ars.2008.2247, 10.1089/ARS.2008.2247]; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Galdieri L, 2010, OMICS, V14, P629, DOI 10.1089/omi.2010.0069; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Graille M, 2004, STRUCTURE, V12, P839, DOI 10.1016/S0969-2126(04)00113-3; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Hasim S, 2014, J BIOL CHEM, V289, P1662, DOI 10.1074/jbc.M113.505784; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Inoue Y, 1996, J BIOL CHEM, V271, P25958, DOI 10.1074/jbc.271.42.25958; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jellinger KA, 2010, J CELL MOL MED, V14, P457, DOI 10.1111/j.1582-4934.2010.01010.x; Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Ko LW, 2008, J NEUROPATH EXP NEUR, V67, P1084, DOI 10.1097/NEN.0b013e31818c3618; Krasnoslobodtsev AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038099; Kvam E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005727; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Lee SJ, 2003, J BIOL CHEM, V278, P44552, DOI 10.1074/jbc.M304517200; Lev N, 2006, J MOL NEUROSCI, V29, P215, DOI 10.1385/JMN:29:3:215; Liu F, 2008, J NEUROCHEM, V105, P2435, DOI 10.1111/j.1471-4159.2008.05333.x; Lucas JI, 2007, MOL BIOL EVOL, V24, P551, DOI 10.1093/molbev/msl186; Luo GR, 2007, INT J BIOL SCI, V3, P20; Malki A, 2003, BIOCHEM BIOPH RES CO, V301, P430, DOI 10.1016/S0006-291X(02)03053-X; Marini I, 2005, CELL MOL LIFE SCI, V62, P3092, DOI 10.1007/s00018-005-5397-4; Miller-Fleming Leonor, 2008, Biotechnol J, V3, P325, DOI 10.1002/biot.200700217; Miller-Fleming L, 2014, P NATL ACAD SCI USA, V111, P7012, DOI 10.1073/pnas.1319221111; Miura T, 2006, EXTREMOPHILES, V10, P279, DOI 10.1007/s00792-005-0496-6; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Petroi D, 2012, J BIOL CHEM, V287, P27567, DOI 10.1074/jbc.M112.361865; Qi L, 2014, ACTA BIOCH BIOPH SIN, V46, P83, DOI 10.1093/abbs/gmt133; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; Saibil HR, 2012, P NATL ACAD SCI USA, V109, P14906, DOI 10.1073/pnas.1211976109; Sastry MSR, 2009, PROTEIN SCI, V18, P1439, DOI 10.1002/pro.158; Sastry MSR, 2002, J BIOL CHEM, V277, P46026, DOI 10.1074/jbc.M205800200; Shaikh S, 2008, J NEUROSCI RES, V86, P2071, DOI 10.1002/jnr.21644; Sharma N, 2006, J MOL NEUROSCI, V28, P161, DOI 10.1385/JMN:28:2:161; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Skoneczna A, 2007, FREE RADICAL BIO MED, V42, P1409, DOI 10.1016/j.freeradbiomed.2007.01.042; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takanishi CL, 2011, J PROTEOME RES, V10, P2715, DOI 10.1021/pr1009542; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Tenreiro S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004302; Trott A, 2003, TOP CURR GENET, V1, P71; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Vistoli G, 2013, FREE RADICAL RES, V47, P3, DOI 10.3109/10715762.2013.815348; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; Wenig P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-405; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Wilson MA, 2004, P NATL ACAD SCI USA, V101, P1531, DOI 10.1073/pnas.0308089100; Wilson MA, 2014, P NATL ACAD SCI USA, V111, P6858, DOI 10.1073/pnas.1405511111; Zhao QQ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-86; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030; Zhou WB, 2005, J BIOL CHEM, V280, P43150, DOI 10.1074/jbc.M507124200; Zondler L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.307	78	23	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24816	24834		10.1074/jbc.M115.678367	http://dx.doi.org/10.1074/jbc.M115.678367			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26306045	hybrid, Green Published			2022-12-28	WOS:000362598300017
J	Jakobson, CM; Kim, EY; Slininger, MF; Chien, A; Tullman-Ercek, D				Jakobson, Christopher M.; Kim, Edward Y.; Slininger, Marilyn F.; Chien, Alex; Tullman-Ercek, Danielle			Localization of Proteins to the 1,2-Propanediol Utilization Microcompartment by Non-native Signal Sequences Is Mediated by a Common Hydrophobic Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; IMPROVED CATALYTIC EFFICIENCY; BACTERIAL MICROCOMPARTMENT; SALMONELLA-TYPHIMURIUM; TRANSCRIPTIONAL ACTIVATOR; ETHANOLAMINE UTILIZATION; SHELL PROTEINS; EUT OPERON; DEGRADATION; ENZYMES	Various bacteria localize metabolic pathways to proteinaceous organelles known as bacterial microcompartments (MCPs), enabling the metabolism of carbon sources to enhance survival and pathogenicity in the gut. There is considerable interest in exploiting bacterial MC:Ps for metabolic engineering applications, but little is known about the interactions between MCP signal sequences and the protein shells of different MCP systems. We found that the N-terminal sequences from the ethanolamine utilization (Eut) and glycyl radical-generating protein NICPs are able to target reporter proteins to the 1,2-propanediol utilization (Pdu) MCP, and that this localization is mediated by a conserved hydrophobic residue motif. Recapitulation of this motif by the addition of a single amino acid conferred targeting function on an N-terminal sequence from the ethanol utilization MCP system that previously did not act as a Pdu signal sequence. Moreover, the Pdu-localized signal sequences competed with native Pdu targeting sequences for encapsulation in the Pdu MCP. Salmonella enterica natively possesses both the Pdu and Eut operons, and our results suggest that Eut proteins might be localized to the Pdu MCP in vivo. We further demonstrate that S. enterica I,T2 retained the ability to grow on 1,2propanediol as the sole carbon source when a Pdu enzyme was replaced with its Eut homolog. Although the relevance of this finding to the native system remains to be explored, we show that the Pdu-localized signal sequences described herein allow control over the ratio of heterologous proteins encapsulated within Pdu MCPs.	[Jakobson, Christopher M.; Kim, Edward Y.; Slininger, Marilyn F.; Tullman-Ercek, Danielle] Univ Calif Berkeley, Dept Chem & Biomol Engn, 116 Gilman Hall, Berkeley, CA 94720 USA; [Chien, Alex] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Tullman-Ercek, D (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, 116 Gilman Hall, Berkeley, CA 94720 USA.	dtercek@berkeley.edu	Tullman-Ercek, Danielle/L-2792-2016		National Science Foundation [1150567]; Army Research Office [W911NF-15-1-0144]; University of California Berkeley; Direct For Biological Sciences [1150567] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Army Research Office; University of California Berkeley(University of California System); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant 1150567 (to C. M. J., E. Y. K., M. F. S., and D. T.-E.), Army Research Office Grant W911NF-15-1-0144 (to D. T.-E.), and a University of California Berkeley fellowship (to C. M. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Aussignargues Clement, 2015, Commun Integr Biol, V8, pe1039755, DOI 10.1080/19420889.2015.1039755; Axen SD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003898; Bertin Y, 2011, ENVIRON MICROBIOL, V13, P365, DOI 10.1111/j.1462-2920.2010.02334.x; BOBIK TA, 1992, J BACTERIOL, V174, P2253, DOI 10.1128/JB.174.7.2253-2266.1992; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; CHEN P, 1995, J BACTERIOL, V177, P5401, DOI 10.1128/jb.177.19.5401-5410.1995; Cheng SQ, 2011, J BACTERIOL, V193, P1385, DOI 10.1128/JB.01473-10; Choudhary S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033342; Chowdhury C, 2015, P NATL ACAD SCI USA, V112, P2990, DOI 10.1073/pnas.1423672112; Conrado RJ, 2007, METAB ENG, V9, P355, DOI 10.1016/j.ymben.2007.05.002; Conrado RJ, 2012, NUCLEIC ACIDS RES, V40, P1879, DOI 10.1093/nar/gkr888; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Erbilgin O, 2014, APPL ENVIRON MICROB, V80, P2193, DOI 10.1128/AEM.03887-13; Fan CG, 2012, P NATL ACAD SCI USA, V109, P14995, DOI 10.1073/pnas.1207516109; Fan CG, 2011, J BACTERIOL, V193, P5623, DOI 10.1128/JB.05661-11; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Heldt D, 2009, BIOCHEM J, V423, P199, DOI 10.1042/BJ20090780; Huseby DL, 2013, J BACTERIOL, V195, P2864, DOI 10.1128/JB.02179-12; Jorda J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004067; Jorda J, 2013, PROTEIN SCI, V22, P179, DOI 10.1002/pro.2196; Kerfeld CA, 2015, TRENDS MICROBIOL, V23, P22, DOI 10.1016/j.tim.2014.10.003; Kim EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113814; Kim EY, 2014, BIOTECHNOL J, V9, P348, DOI 10.1002/biot.201300391; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lassila JK, 2014, J MOL BIOL, V426, P2217, DOI 10.1016/j.jmb.2014.02.025; Lawrence AD, 2014, ACS SYNTH BIOL, V3, P454, DOI 10.1021/sb4001118; Leal NA, 2003, ARCH MICROBIOL, V180, P353, DOI 10.1007/s00203-003-0601-0; Lee H, 2012, METAB ENG, V14, P242, DOI 10.1016/j.ymben.2011.09.003; Pang A, 2014, J BIOL CHEM, V289, P22377, DOI 10.1074/jbc.M114.569285; Pang A, 2012, ACTA CRYSTALLOGR D, V68, P1642, DOI 10.1107/S0907444912039315; Rondon MR, 1996, J BACTERIOL, V178, P2196, DOI 10.1128/jb.178.8.2196-2203.1996; ROOF DM, 1992, J BACTERIOL, V174, P6634, DOI 10.1128/JB.174.20.6634-6643.1992; Sachdeva G, 2014, NUCLEIC ACIDS RES, V42, P9493, DOI 10.1093/nar/gku617; Sampson EM, 2008, J BACTERIOL, V190, P2966, DOI 10.1128/JB.01925-07; SHEPPARD DE, 1994, J BACTERIOL, V176, P1287, DOI 10.1128/jb.176.5.1287-1296.1994; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sinha S, 2012, J BACTERIOL, V194, P1912, DOI 10.1128/JB.06529-11; Srikumar S, 2011, APPL ENVIRON MICROB, V77, P281, DOI 10.1128/AEM.01403-10; Temme K, 2008, J MOL BIOL, V377, P47, DOI 10.1016/j.jmb.2007.12.044; Thompson MC, 2014, ACTA CRYSTALLOGR F, V70, P1584, DOI 10.1107/S2053230X1402158X	45	35	37	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24519	24533		10.1074/jbc.M115.651919	http://dx.doi.org/10.1074/jbc.M115.651919			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26283792	Green Published, hybrid			2022-12-28	WOS:000362218900037
J	Multhaup, G; Huber, O; Buee, L; Galas, MC				Multhaup, Gerhard; Huber, Otmar; Buee, Luc; Galas, Marie-Christine			Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), A beta 42, and Tau in Nuclear Roles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							C-TERMINAL FRAGMENT; HUMAN NEUROBLASTOMA-CELLS; SINGLE-STRANDED-DNA; ALZHEIMERS-DISEASE; GENE-EXPRESSION; BETA-PROTEIN; IN-VIVO; EPSILON-CLEAVAGE; TRANSGENIC MICE; DOMAIN AICD	Amyloid precursor protein (APP) metabolites (amyloid-beta (A beta) peptides) and Tau are the main components of senile plaques and neurofibrillary tangles, the two histopathological hallmarks of Alzheimer disease. Consequently, intense research has focused upon deciphering their physiological roles to understand their altered state in Alzheimer disease pathophysiology. Recently, the impact of APP metabolites (APP intracellular fragment (AICD) and A beta) and Tau on the nucleus has emerged as an important, new topic. Here we discuss (i) how AICD, A beta, and Tau reach the nucleus and how AICD and A beta control protein expression at the transcriptional level, (ii) post-translational modifications of AICD, A beta, and Tau, and (iii) what these three molecules have in common.	[Multhaup, Gerhard] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Huber, Otmar] Univ Jena, Jena Univ Hosp, Inst Biochem 2, D-07743 Jena, Germany; [Buee, Luc; Galas, Marie-Christine] Univ Lille, CHU Lille, Jean Pierre Aubert Res Ctr, Alzheimer & Tauopathies,INSERM,UMR S 1172, F-59000 Lille, France	McGill University; Friedrich Schiller University of Jena; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm)	Multhaup, G (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada.	gerhard.multhaup@mcgill.ca	Huber, Otmar/AAA-4548-2021; BUEE, Luc/B-3126-2010; Galas, Marie-Christine/AAL-9812-2020	Huber, Otmar/0000-0003-4359-1747; BUEE, Luc/0000-0002-6261-4230; Galas, Marie-Christine/0000-0002-3766-7103	Canadian Institute of Health Research [MOP-133411]; French government from Agence Nationale de la Recherche MALZ EPITAUDNA grant; LabEx (Excellence Laboratory); DISTALZ (Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease); INSERM (Institut National de la sante et de la recherche medicale); LMCU (Lille Metropole Communaute urbaine); Region Nord/Pas-de-Calais; FEDER (Fonds Europeen de Developpement Economique et Regional)	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); French government from Agence Nationale de la Recherche MALZ EPITAUDNA grant(French National Research Agency (ANR)); LabEx (Excellence Laboratory); DISTALZ (Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease); INSERM (Institut National de la sante et de la recherche medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); LMCU (Lille Metropole Communaute urbaine); Region Nord/Pas-de-Calais(Region Hauts-de-France); FEDER (Fonds Europeen de Developpement Economique et Regional)	This work was supported by grants from the Canadian Institute of Health Research (MOP-133411) (to G. M.), by French government funding from the Agence Nationale de la Recherche MALZ EPITAUDNA grant, and by LabEx (Excellence Laboratory), DISTALZ (Development of Innovative Strategies for a Transdisciplinary Approach to Alzheimer's Disease), INSERM (Institut National de la sante et de la recherche medicale), LMCU (Lille Metropole Communaute urbaine), Region Nord/Pas-de-Calais, and FEDER (Fonds Europeen de Developpement Economique et Regional). The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez G, 2012, J NEUROSCI RES, V90, P1020, DOI 10.1002/jnr.23003; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Barrantes A, 2007, J ALZHEIMERS DIS, V12, P345; Barucker C, 2015, J ALZHEIMERS DIS, V44, P613, DOI 10.3233/JAD-141902; Barucker C, 2014, J BIOL CHEM, V289, P20182, DOI 10.1074/jbc.M114.564690; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; BRADY RM, 1995, NEUROBIOL AGING, V16, P479; Camero S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104690; Cao X, 2001, SCIENCE, V293, P1436; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cooper-Knock J, 2012, NAT REV NEUROL, V8, P518, DOI 10.1038/nrneurol.2012.156; CORCES VG, 1978, EUR J BIOCHEM, V86, P473, DOI 10.1111/j.1432-1033.1978.tb12330.x; Cross DC, 2000, J CELL BIOCHEM, V78, P305, DOI 10.1002/(SICI)1097-4644(20000801)78:2<305::AID-JCB12>3.3.CO;2-N; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Dimitrov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3246; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Gersbacher MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069363; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; de Barreda EG, 2011, BIOCHEM BIOPH RES CO, V408, P500, DOI 10.1016/j.bbrc.2011.04.082; de Barreda EG, 2010, FEBS LETT, V584, P2265, DOI 10.1016/j.febslet.2010.03.032; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; GREENWOOD JA, 1995, EXP CELL RES, V220, P332, DOI 10.1006/excr.1995.1323; Grimm MOW, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00077; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hamdane M, 2003, BIOCHEM PHARMACOL, V66, P1619, DOI 10.1016/S0006-2952(03)00533-1; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hegde ML, 2004, J MOL NEUROSCI, V22, P19, DOI 10.1385/JMN:22:1-2:19; Hua Q, 2003, CELL MOL LIFE SCI, V60, P413, DOI 10.1007/s000180300034; Hua Q, 2003, BBA-PROTEINS PROTEOM, V1645, P205, DOI 10.1016/S1570-9639(02)00538-1; Hua Q, 2002, PROTEIN PEPTIDE LETT, V9, P349, DOI 10.2174/0929866023408652; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Krylova SM, 2005, FEBS LETT, V579, P1371, DOI 10.1016/j.febslet.2005.01.032; Kume H, 2004, INT J MOL MED, V13, P121; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LAMBERT MP, 1995, NEUROBIOL AGING, V16, P583, DOI 10.1016/0197-4580(95)00042-D; Lefebvre T, 2003, BBA-GEN SUBJECTS, V1619, P167, DOI 10.1016/S0304-4165(02)00477-4; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Liu C., 2013, ABSTR APPL ANAL, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0084849; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; LOOMIS PA, 1990, P NATL ACAD SCI USA, V87, P8422, DOI 10.1073/pnas.87.21.8422; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Lu J, 2013, BBA-GEN SUBJECTS, V1830, P4102, DOI 10.1016/j.bbagen.2013.04.028; Lu Y, 2013, J ALZHEIMERS DIS, V37, P551, DOI 10.3233/JAD-130602; McLoughlin DM, 1996, FEBS LETT, V397, P197; Muller T, 2007, MOL BIOL CELL, V18, P201, DOI 10.1091/mbc.E06-04-0283; Munter LM, 2010, J BIOL CHEM, V285, P21636, DOI 10.1074/jbc.M109.088005; Nakaya T, 2008, J BIOL CHEM, V283, P19119, DOI 10.1074/jbc.M801827200; Oestereich F, 2015, BIOCHEMISTRY-US, V54, P2777, DOI 10.1021/acs.biochem.5b00217; Olsson F, 2014, J BIOL CHEM, V289, P1540, DOI 10.1074/jbc.M113.498246; Padmaraju V, 2010, NEUROCHEM INT, V57, P51, DOI 10.1016/j.neuint.2010.04.013; PAPASOZOMENOS SC, 1995, CLIN NEUROPATHOL, V14, P100; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Qi HL, 2015, BIOCHEMISTRY-US, V54, P1525, DOI 10.1021/bi5014613; Rossi G, 2008, CELL CYCLE, V7, P1788, DOI 10.4161/cc.7.12.6012; Rowe A, 2008, NEOPLASIA, V10, P1421, DOI 10.1593/neo.08850; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Sjoberg MK, 2006, J CELL SCI, V119, P2025, DOI 10.1242/jcs.02907; Slomnicki LP, 2008, ACTA NEUROBIOL EXP, V68, P219; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Takahashi K, 2009, J NEUROCHEM, V109, P1324, DOI 10.1111/j.1471-4159.2009.06067.x; Takahashi RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051965; Telese F, 2005, EMBO REP, V6, P77, DOI 10.1038/sj.embor.7400309; Thurston VC, 1996, CHROMOSOMA, V105, P20, DOI 10.1007/BF02510035; Trazzi S, 2011, HUM MOL GENET, V20, P1560, DOI 10.1093/hmg/ddr033; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Venugopal C, 2007, NEUROCHEM RES, V32, P2225, DOI 10.1007/s11064-007-9449-z; VILLASANTE A, 1981, NUCLEIC ACIDS RES, V9, P895, DOI 10.1093/nar/9.4.895; Violet M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00084; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Waldron E, 2008, EXP CELL RES, V314, P2419, DOI 10.1016/j.yexcr.2008.05.003; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; WANG Y, 1993, J CELL BIOL, V121, P257, DOI 10.1083/jcb.121.2.257; Wei Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002600; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; WICHE G, 1978, NATURE, V273, P403, DOI 10.1038/273403a0; Wirths O, 2002, BRAIN PATHOL, V12, P275, DOI 10.1111/j.1750-3639.2002.tb00442.x; Xu XA, 2011, EMBO REP, V12, P216, DOI 10.1038/embor.2010.210; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200; Zekanowski C, 2009, ACTA NEUROBIOL EXP, V69, P232; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104	99	59	60	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23515	23522		10.1074/jbc.R115.677211	http://dx.doi.org/10.1074/jbc.R115.677211			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26296890	Green Published, hybrid			2022-12-28	WOS:000361816500004
J	LoPiccolo, J; Kim, SJ; Shi, Y; Wu, B; Wu, HY; Chait, BT; Singer, RH; Sali, A; Brenowitz, M; Bresnick, AR; Backer, JM				LoPiccolo, Jaclyn; Kim, Seung Joong; Shi, Yi; Wu, Bin; Wu, Haiyan; Chait, Brian T.; Singer, Robert H.; Sali, Andrej; Brenowitz, Michael; Bresnick, Anne R.; Backer, Jonathan M.			Assembly and Molecular Architecture of the Phosphoinositide 3-Kinase p85 alpha Homodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; NUCLEAR-PORE COMPLEX; FLUORESCENCE FLUCTUATION SPECTROSCOPY; PROTEIN HOMOLOGY DETECTION; SMALL-ANGLE SCATTERING; TERMINAL SH2 DOMAIN; PHOSPHATIDYLINOSITOL 3-KINASE; REGULATORY SUBUNIT; CRYSTAL-STRUCTURE; MACROMOLECULAR ASSEMBLIES	Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases that are activated by growth factor and G-protein-coupled receptors and propagate intracellular signals for growth, survival, proliferation, and metabolism. p85 alpha, a modular protein consisting of five domains, binds and inhibits the enzymatic activity of class IA PI3K catalytic subunits. Here, we describe the structural states of the p85 alpha dimer, based on data from in vivo and in vitro solution characterization. Our in vitro assembly and structural analyses have been enabled by the creation of cysteine-free p85 alpha that is functionally equivalent to native p85 alpha. Analytical ultracentrifugation studies showed that p85 alpha undergoes rapidly reversible monomer-dimer assembly that is highly exothermic in nature. In addition to the documented SH3-PR1 dimerization interaction, we identified a second intermolecular interaction mediated by cSH2 domains at the C-terminal end of the polypeptide. We have demonstrated in vivo concentration-dependent dimerization of p85 alpha using fluorescence fluctuation spectroscopy. Finally, we have defined solution conditions under which the protein is predominantly monomeric or dimeric, providing the basis for small angle x-ray scattering and chemical cross-linking structural analysis of the discrete dimer. These experimental data have been used for the integrative structure determination of the p85 alpha dimer. Our study provides new insight into the structure and assembly of the p85 alpha homodimer and suggests that this protein is a highly dynamic molecule whose conformational flexibility allows it to transiently associate with multiple binding proteins.	[LoPiccolo, Jaclyn; Wu, Haiyan] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Brenowitz, Michael; Bresnick, Anne R.; Backer, Jonathan M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Wu, Bin; Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Kim, Seung Joong; Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Kim, Seung Joong; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Shi, Yi; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Rockefeller University	Brenowitz, M (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	michael.brenowitz@einstein.yu.edu; anne.bresnick@einstein.yu.edu; jonathan.backer@einstein.yu.edu	Shi, Yi/P-7972-2018; Kim, Seung Joong/S-6970-2018; Regan, Clinton/E-6250-2012	Shi, Yi/0000-0002-2761-8324; 	National Institutes of Health [R01 GM112524, R01 NS83085, T32 GM007288]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health, NCRR, Biomedical Technology Program [P41RR001209]; NIGMS, National Institutes of Health [P41GM103393]; NATIONAL CANCER INSTITUTE [P30CA013330, P01CA100324] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103314, P41GM103393, R01GM112524, T32GM007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NCRR, Biomedical Technology Program; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 GM112524 (to J. M. B. and A. R. B.), R01 NS83085 (to R. H. S.), and T32 GM007288 (to J. L.). Portions of this research were carried out at the SSRL, SLAC National Accelerator Laboratory operated for the United States Department of Energy by Stanford University. The SSRL SMBP is supported by the Department of Energy Office of Biological and Environmental Research; by National Institutes of Health, NCRR, Biomedical Technology Program Grant P41RR001209; and by NIGMS, National Institutes of Health, Grant P41GM103393. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; Backer JM, 2010, CURR TOP MICROBIOL, V346, P87, DOI 10.1007/82_2010_52; Batra-Safferling R, 2010, BIOL CHEM, V391, P33, DOI 10.1515/BC.2010.003; Bernauer J, 2008, BIOINFORMATICS, V24, P652, DOI 10.1093/bioinformatics/btn022; BOOKER GW, 1992, NATURE, V358, P684, DOI 10.1038/358684a0; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burke JE, 2015, TRENDS BIOCHEM SCI, V40, P88, DOI 10.1016/j.tibs.2014.12.003; Carter L, 2015, BIOPHYS J, V109, P793, DOI 10.1016/j.bpj.2015.06.065; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Cheung LWT, 2015, ELIFE, V4, DOI 10.7554/eLife.06866; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Erzberger JP, 2014, CELL, V158, P1123, DOI 10.1016/j.cell.2014.07.044; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Fernandez-Martinez J, 2012, J CELL BIOL, V196, P419, DOI 10.1083/jcb.201109008; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fritsch R, 2013, CELL, V153, P1050, DOI 10.1016/j.cell.2013.04.031; Fu Z, 2003, P NATL ACAD SCI USA, V100, P3275, DOI 10.1073/pnas.0535975100; Hale BG, 2008, J BIOL CHEM, V283, P1372, DOI 10.1074/jbc.M708862200; Harpur AG, 1999, J BIOL CHEM, V274, P12323, DOI 10.1074/jbc.274.18.12323; Hersleth HP, 2008, BIOCHEM J, V412, P257, DOI 10.1042/BJ20070921; Hoedemaeker FJ, 1999, J MOL BIOL, V292, P763, DOI 10.1006/jmbi.1999.3111; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KAPELLER R, 1994, J BIOL CHEM, V269, P1927; Kim SJ, 2014, MOL CELL PROTEOMICS, V13, P2911, DOI 10.1074/mcp.M114.040915; KOYAMA S, 1993, CELL, V72, P945, DOI 10.1016/0092-8674(93)90582-B; Kuwamoto S, 2004, J SYNCHROTRON RADIAT, V11, P462, DOI 10.1107/S0909049504019272; LAWLER EL, 1966, OPER RES, V14, P699, DOI 10.1287/opre.14.4.699; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Marino SM, 2012, J BIOL CHEM, V287, P4419, DOI 10.1074/jbc.R111.275578; Marino SM, 2010, J MOL BIOL, V404, P902, DOI 10.1016/j.jmb.2010.09.027; Marsden RL, 2002, PROTEIN SCI, V11, P2814, DOI 10.1110/ps.0209902; Martel A, 2012, J SYNCHROTRON RADIAT, V19, P431, DOI 10.1107/S0909049512008072; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Molnar KS, 2014, STRUCTURE, V22, P1239, DOI 10.1016/j.str.2014.04.019; Musacchio A, 1996, P NATL ACAD SCI USA, V93, P14373, DOI 10.1073/pnas.93.25.14373; Nolte RT, 1996, NAT STRUCT BIOL, V3, P364, DOI 10.1038/nsb0496-364; Park SW, 2014, CELL METAB, V20, P73, DOI 10.1016/j.cmet.2014.04.006; Pauptit RA, 2001, ACTA CRYSTALLOGR D, V57, P1397, DOI 10.1107/S0907444901012434; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Perez-Garcia V, 2014, MOL CELL BIOL, V34, P3359, DOI 10.1128/MCB.00167-14; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Pieper U, 2014, NUCLEIC ACIDS RES, V42, pD336, DOI 10.1093/nar/gkt1144; PLEIMAN CM, 1994, SCIENCE, V263, P1609, DOI 10.1126/science.8128248; Rabinovsky R, 2009, MOL CELL BIOL, V29, P5377, DOI 10.1128/MCB.01649-08; Rieping W, 2005, SCIENCE, V309, P303, DOI 10.1126/science.1110428; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sali A, 2015, STRUCTURE, V23, P1156, DOI 10.1016/j.str.2015.05.013; Sanchez-Andres A, 2005, BIOPHYS J, V89, P3531, DOI 10.1529/biophysj.105.067082; Schneidman-Duhovny D, 2014, CURR OPIN STRUC BIOL, V28, P96, DOI 10.1016/j.sbi.2014.08.001; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-17; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi Y, 2015, NAT METHODS, V12, P1135, DOI 10.1038/nmeth.3617; Shi Y, 2014, MOL CELL PROTEOMICS, V13, P2927, DOI 10.1074/mcp.M114.041673; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sprules T, 1998, BIOTECHNIQUES, V25, P20, DOI 10.2144/98251bm02; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Vincent TL, 2013, BIOINFORMATICS, V29, P69, DOI 10.1093/bioinformatics/bts648; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Ward AB, 2013, SCIENCE, V339, P913, DOI 10.1126/science.1228565; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Webb B, 2011, METHODS MOL BIOL, V781, P377, DOI 10.1007/978-1-61779-276-2_19; Wu B, 2012, BIOPHYS J, V102, P2936, DOI 10.1016/j.bpj.2012.05.017; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379; Zhang XX, 2011, MOL CELL, V41, P567, DOI 10.1016/j.molcel.2011.01.026; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; ZHENG Y, 1994, J BIOL CHEM, V269, P18727	85	16	16	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30390	30405		10.1074/jbc.M115.689604	http://dx.doi.org/10.1074/jbc.M115.689604			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26475863	Green Published, hybrid			2022-12-28	WOS:000366738200017
J	Wang, C; Liu, WY; Liu, ZJ; Chen, L; Liu, XQ; Kuang, SH				Wang, Chao; Liu, Weiyi; Liu, Zuojun; Chen, Long; Liu, Xiaoqi; Kuang, Shihuan			Hypoxia Inhibits Myogenic Differentiation through p53 Protein-dependent Induction of Bhlhe40 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; SATELLITE CELL; GENE-EXPRESSION; DEC1 STRA13; MUSCLE; MYOD; BETA; OXYGENATION; CARCINOMA; PERFUSION	Satellite cells are muscle-resident stem cells capable of self-renewal and differentiation to repair injured muscles. However, muscle injury often leads to an ischemic hypoxia environment that impedes satellite cell differentiation and reduces the efficiency of muscle regeneration. Here we performed microarray analyses and identified the basic helix-loop-helix family transcription factor Bhlhe40 as a candidate mediator of the myogenic inhibitory effect of hypoxia. Bhlhe40 is strongly induced by hypoxia in satellite cell-derived primary myoblasts. Overexpression of Bhlhe40 inhibits Myog expression and mimics the effect of hypoxia on myogenesis. Inhibition of Bhlhe40, conversely, up-regulates Myog expression and promotes myogenic differentiation. Importantly, Bhlhe40 knockdown rescues myogenic differentiation under hypoxia. Mechanistically, Bhlhe40 binds to the proximal E-boxes of the Myog promoter and reduces the binding affinity and transcriptional activity of MyoD on Myog. Interestingly, hypoxia induces Bhlhe40 expression independent of HIF1 alpha but through a novel p53-dependent signaling pathway. Our study establishes a crucial role of Bhlhe40 in mediating the repressive effect of hypoxia on myogenic differentiation and suggests that inhibition of Bhlhe40 or p53 may facilitate muscle regeneration after ischemic injuries.	[Wang, Chao; Liu, Weiyi; Liu, Zuojun; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47906 USA; [Chen, Long; Liu, Xiaoqi] Purdue Univ, Dept Biochem, W Lafayette, IN 47906 USA; [Liu, Xiaoqi; Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47906 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Kuang, SH (corresponding author), 174B Smith Hall,901 W State St, W Lafayette, IN 47907 USA.	skuang@purdue.edu	Wang, Chao/V-8994-2019; Regan, Clinton/E-6250-2012	Wang, Chao/0000-0002-4051-364X; Kuang, Shihuan/0000-0001-9180-3180	Muscular Dystrophy Association; National Institutes of Health [R01 AR060652]; NATIONAL CANCER INSTITUTE [R01CA192894, P30CA023168, K01CA114401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060652] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was partially sponsored by the Muscular Dystrophy Association and the National Institutes of Health Grant R01 AR060652 (to S. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BRAUN T, 1990, EMBO J, V9, P821, DOI 10.1002/j.1460-2075.1990.tb08179.x; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Di Carlo A, 2004, J BIOL CHEM, V279, P16332, DOI 10.1074/jbc.M313931200; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Giatromanolaki A, 2003, J PATHOL, V200, P222, DOI 10.1002/path.1330; Greenbaum AR, 1997, J MUSCLE RES CELL M, V18, P149, DOI 10.1023/A:1018653521686; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Hoppeler H, 2001, J EXP BIOL, V204, P3133; Hsiao SP, 2009, BIOCHEM J, V422, P343, DOI 10.1042/BJ20090072; Hu GN, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3830; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu Y, 2013, TUMOR BIOL, V34, P1641, DOI 10.1007/s13277-013-0697-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Ma JF, 2012, AGEING RES REV, V11, P432, DOI 10.1016/j.arr.2012.05.004; Majmundar AJ, 2012, MOL CELL BIOL, V32, P36, DOI 10.1128/MCB.05857-11; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Sair M, 2001, CRIT CARE MED, V29, P1343, DOI 10.1097/00003246-200107000-00008; Sun H, 2007, J CELL BIOL, V177, P647, DOI 10.1083/jcb.200609007; Tong JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE917, DOI 10.1152/ajpendo.90924.2008; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772; Yun Z, 2005, MOL CELL BIOL, V25, P3040, DOI 10.1128/MCB.25.8.3040-3055.2005; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zawel L, 2002, P NATL ACAD SCI USA, V99, P2848, DOI 10.1073/pnas.261714999	38	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29707	29716		10.1074/jbc.M115.688671	http://dx.doi.org/10.1074/jbc.M115.688671			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26468276	Green Published, hybrid			2022-12-28	WOS:000366614700004
J	Butler, B; Saha, K; Rana, T; Becker, JP; Sambo, D; Davari, P; Goodwin, JS; Khoshbouei, H				Butler, Brittany; Saha, Kaustuv; Rana, Tanu; Becker, Jonas P.; Sambo, Danielle; Davari, Paran; Goodwin, J. Shawn; Khoshbouei, Habibeh			Dopamine Transporter Activity Is Modulated by alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; MEMBRANE DEPOLARIZATION; FLUORESCENCE RECOVERY; AMPHETAMINE; TRAFFICKING; MOBILITY; MUTATION; BINDING; EFFLUX; NA+	The duration and strength of the dopaminergic signal are regulated by the dopamine transporter (DAT). Drug addiction and neurodegenerative and neuropsychiatric diseases have all been associated with altered DAT activity. The membrane localization and the activity of DAT are regulated by a number of intracellular proteins. alpha-Synuclein, a protein partner of DAT, is implicated in neurodegenerative disease and drug addiction. Little is known about the regulatory mechanisms of the interaction between DAT and alpha-synuclein, the cellular location of this interaction, and the functional consequences of this interaction on the basal, amphetamine-induced DAT-mediated dopamine efflux, and membrane microdomain distribution of the transporter. Here, we found that the majority of DAT.alpha-synuclein protein complexes are found at the plasma membrane of dopaminergic neurons or mammalian cells and that the amphetamine-mediated increase in DAT activity enhances the association of these proteins at the plasma membrane. Further examination of the interaction of DAT and alpha-synuclein revealed a transient interaction between these two proteins at the plasma membrane. Additionally, we found DAT-induced membrane depolarization enhances plasma membrane localization of alpha-synuclein, which in turn increases dopamine efflux and enhances DAT localization in cholesterol-rich membrane microdomains.	[Khoshbouei, Habibeh] Univ Florida, Dept Neurosci, Gainesville, FL 32611 USA; [Khoshbouei, Habibeh] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Goodwin, J. Shawn] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Meharry Medical College	Goodwin, JS (corresponding author), Meharry Med Coll, Dept Biochem & Canc Biol, 1005 Dr DB Todd Jr,Blvd, Nashville, TN 37208 USA.	jgoodwin@mmc.edu; Habibeh@ufl.edu	Becker, Jonas Philipp/AAQ-4959-2021; Becker, Jonas/GZG-4234-2022; Regan, Clinton/E-6250-2012; Becker, Jonas/AAH-3484-2019; Becker, Jonas/ABB-1688-2021	Becker, Jonas Philipp/0000-0002-1594-9652; Khoshbouei, Habibeh/0000-0002-1533-8771; SAHA, KAUSTUV/0000-0002-2931-1422	National Institutes of Health [MD007593, MD007586, CA163069, RR0254970]; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026947, R24DA036420] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586, U54MD007593] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Benjamin Richardson for the insightful suggestions and critical review of the manuscript. We also thank Dr. Etienne Cartier for technical assistance. Some of the confocal microscopy experiments were conducted at the Meharry Morphology Core, which is supported by National Institutes of Health Grants MD007593, MD007586, CA163069, and RR0254970.	Adkins EM, 2007, BIOCHEMISTRY-US, V46, P10484, DOI 10.1021/bi700429z; Alfonta L, 2001, ANAL CHEM, V73, P5287, DOI 10.1021/ac010542e; Amara S G, 1998, Adv Pharmacol, V42, P164; ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Baba M, 1998, AM J PATHOL, V152, P879; Bowton E, 2010, J NEUROSCI, V30, P6048, DOI 10.1523/JNEUROSCI.5094-09.2010; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chen NH, 1999, J PHARMACOL EXP THER, V290, P940; Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Feng LR, 2010, EUR J NEUROSCI, V32, P10, DOI 10.1111/j.1460-9568.2010.07266.x; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Fraser R, 2014, MOL PHARMACOL, V86, P76, DOI 10.1124/mol.114.091926; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; GIRGUS JS, 1975, CAN J PSYCHOL, V29, P59, DOI 10.1037/h0082021; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; Gualandris A, 1996, J NEUROSCI, V16, P2220; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Kahlig KM, 2004, J BIOL CHEM, V279, P8966, DOI 10.1074/jbc.M303976200; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Kahlig KM, 2006, MOL PHARMACOL, V70, P542, DOI 10.1124/mol.106.023952; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; KILBOURNE EJ, 1991, J NEUROSCI METH, V40, P193, DOI 10.1016/0165-0270(91)90068-B; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Kolanos R, 2013, ACS CHEM NEUROSCI, V4, P1524, DOI 10.1021/cn4001236; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lam HA, 2011, J NEUROSCI RES, V89, P1091, DOI 10.1002/jnr.22611; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; Li LB, 2000, J NEUROCHEM, V74, P1538, DOI 10.1046/j.1471-4159.2000.0741538.x; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Mash DC, 2003, J NEUROSCI, V23, P2564; Melikian HE, 1999, J NEUROSCI, V19, P7699; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Qin YJ, 2005, NEUROREPORT, V16, P1489, DOI 10.1097/01.wnr.0000175617.39054.ba; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Rocha BA, 1998, NAT NEUROSCI, V1, P132, DOI 10.1038/381; Roitman MF, 1999, AM J PHYSIOL-REG I, V276, pR1339, DOI 10.1152/ajpregu.1999.276.5.R1339; Sager JJ, 2011, BIOCHEMISTRY-US, V50, P7295, DOI 10.1021/bi200405c; Saha K, 2014, J BIOL CHEM, V289, P22246, DOI 10.1074/jbc.M114.563056; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snapp Erik L, 2006, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1709s32; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sorkina T, 2013, TRAFFIC, V14, P709, DOI 10.1111/tra.12059; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stockl M, 2012, MOL BIOSYST, V8, P338, DOI 10.1039/c1mb05293d; Swant J, 2011, J BIOL CHEM, V286, P43933, DOI 10.1074/jbc.M111.241232; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Varrone A, 2001, MOVEMENT DISORD, V16, P1023, DOI 10.1002/mds.1256; VAZ WLC, 1982, BIOCHEMISTRY-US, V21, P5608, DOI 10.1021/bi00265a034; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wersinger C, 2006, EUR J NEUROSCI, V24, P3141, DOI 10.1111/j.1460-9568.2006.05181.x; Wersinger C, 2006, EUR J NEUROSCI, V24, P55, DOI 10.1111/j.1460-9568.2006.04900.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhen J, 2005, NEUROPHARMACOLOGY, V49, P769, DOI 10.1016/j.neuropharm.2005.07.002	67	61	63	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29542	29554		10.1074/jbc.M115.691592	http://dx.doi.org/10.1074/jbc.M115.691592			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26442590	hybrid, Green Published			2022-12-28	WOS:000366613400036
J	Honsho, M; Abe, Y; Fujiki, Y				Honsho, Masanori; Abe, Yuichi; Fujiki, Yukio			Dysregulation of Plasmalogen Homeostasis Impairs Cholesterol Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell metabolism; cholesterol; endoplasmic reticulum (ER); peroxisome; plasmalogen; squalen; squalene monooxygenase	COENZYME-A REDUCTASE; E3 UBIQUITIN LIGASE; HMG-COA REDUCTASE; LIVER-X-RECEPTOR; SQUALENE EPOXIDASE; ZELLWEGER-SYNDROME; PEROXISOME DEFICIENCY; BINDING PROTEINS; LIPID-METABOLISM; MOUSE MODEL	Plasmalogen biosynthesis is regulated by modulating fatty acyl-CoA reductase 1 stability in a manner dependent on cellular plasmalogen level. However, physiological significance of the regulation of plasmalogen biosynthesis remains unknown. Here we show that elevation of the cellular plasmalogen level reduces cholesterol biosynthesis without affecting the isoprenylation of proteins such as Rab and Pex19p. Analysis of intermediate metabolites in cholesterol biosynthesis suggests that the first oxidative step in cholesterol biosynthesis catalyzed by squalene monooxygenase (SQLE), an important regulator downstream HMG-CoA reductase in cholesterol synthesis, is reduced by degradation of SQLE upon elevation of cellular plasmalogen level. By contrast, the defect of plasmalogen synthesis causes elevation of SQLE expression, resulting in the reduction of 2,3-epoxysqualene required for cholesterol synthesis, hence implying a novel physiological consequence of the regulation of plasmalogen biosynthesis.	[Honsho, Masanori; Abe, Yuichi; Fujiki, Yukio] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan	Kyushu University	Fujiki, Y (corresponding author), Kyushu Univ, Med Inst Bioregulat, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yfujiki@kyudai.jp		Honsho, Masanori/0000-0001-6165-4516	CREST from the Science and Technology Agency of Japan; Global COE Program from The Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants for Excellent Graduate Schools from The Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; Takeda Science Foundation; Japan Foundation for Applied Enzymology;  [23570236];  [26440102];  [24247038];  [25112518];  [25116717];  [26116007];  [15K14511]; Grants-in-Aid for Scientific Research [15K14511] Funding Source: KAKEN	CREST from the Science and Technology Agency of Japan; Global COE Program from The Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants for Excellent Graduate Schools from The Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Foundation for Applied Enzymology; ; ; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a CREST grant (to Y. F.) from the Science and Technology Agency of Japan, grants from the Global COE Program and Grants for Excellent Graduate Schools from The Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grants-in-Aid for Scientific Research 23570236 and 26440102 (to M. H.) and 24247038, 25112518, 25116717, 26116007, and 15K14511 (to Y. F.), Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (to M. H. and Y. F.), the Takeda Science Foundation (to M. H. and Y. F.), and the Japan Foundation for Applied Enzymology (to Y. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2014, BBA-MOL CELL BIOL L, V1841, P610, DOI 10.1016/j.bbalip.2014.01.001; ASTRUC M, 1977, BIOCHIM BIOPHYS ACTA, V487, P204, DOI 10.1016/0005-2760(77)90056-X; BALAKRISHNAN S, 1961, J NEUROCHEM, V8, P276, DOI 10.1111/j.1471-4159.1961.tb13553.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brown AJ, 2009, INT J BIOCHEM CELL B, V41, P744, DOI 10.1016/j.biocel.2008.05.029; BROWN MS, 1973, P NATL ACAD SCI USA, V70, P2162, DOI 10.1073/pnas.70.7.2162; Buchert R, 2014, AM J HUM GENET, V95, P602, DOI 10.1016/j.ajhg.2014.10.003; Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002; Chan P, 1996, J CLIN PHARMACOL, V36, P422, DOI 10.1002/j.1552-4604.1996.tb05029.x; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Dang HX, 2009, J BIOL CHEM, V284, P6218, DOI 10.1074/jbc.M803702200; Doblas VG, 2013, PLANT CELL, V25, P728, DOI 10.1105/tpc.112.108696; Du XM, 2006, MOL BIOL CELL, V17, P2735, DOI 10.1091/mbc.E05-11-1094; Faust PL, 2014, BIOCHIMIE, V98, P75, DOI 10.1016/j.biochi.2013.10.019; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Ghaedi K, 2000, AM J HUM GENET, V67, P976, DOI 10.1086/303086; Gill S, 2008, PROG LIPID RES, V47, P391, DOI 10.1016/j.plipres.2008.04.002; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GONZALEZ R, 1979, ARCH BIOCHEM BIOPHYS, V196, P574, DOI 10.1016/0003-9861(79)90310-2; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hayashi H, 2011, BIOL PHARM BULL, V34, P453, DOI 10.1248/bpb.34.453; HIDAKA Y, 1991, J BIOL CHEM, V266, P13171; HIDAKA Y, 1990, J LIPID RES, V31, P2087; HODGE VJ, 1991, BIOCHEM BIOPH RES CO, V181, P537, DOI 10.1016/0006-291X(91)91222-X; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Honsho M, 1998, AM J HUM GENET, V63, P1622, DOI 10.1086/302161; Honsho M, 2008, BBA-MOL CELL RES, V1783, P1857, DOI 10.1016/j.bbamcr.2008.05.018; Honsho M, 2013, J BIOL CHEM, V288, P34588, DOI 10.1074/jbc.M113.498345; Honsho M, 2010, J BIOL CHEM, V285, P8537, DOI 10.1074/jbc.M109.083311; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; JAMES GL, 1994, J BIOL CHEM, V269, P14182; JOLLOW D, 1968, J CELL BIOL, V37, P221, DOI 10.1083/jcb.37.2.221; KINSELLA BT, 1992, J BIOL CHEM, V267, P3940; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Kovacs WJ, 2009, J BIOL CHEM, V284, P7232, DOI 10.1074/jbc.M809064200; Kovacs WJ, 2004, MOL CELL BIOL, V24, P1, DOI 10.1128/MCB.24.1.1-13.2004; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Mandel H, 1998, BIOCHEM BIOPH RES CO, V250, P369, DOI 10.1006/bbrc.1998.9321; MANGOLD HK, 1987, LIPIDS, V22, P789, DOI 10.1007/BF02535533; Mankidy R, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-62; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; Miyata N, 2005, MOL CELL BIOL, V25, P10822, DOI 10.1128/MCB.25.24.10822-10832.2005; Morand OH, 1997, J LIPID RES, V38, P373; Munn NJ, 2003, J LIPID RES, V44, P182, DOI 10.1194/jlr.M200363-JLR200; Nagase T, 1998, DNA Res, V5, P31, DOI 10.1093/dnares/5.1.31; NAGUMO A, 1995, J LIPID RES, V36, P1489; Nieweg K, 2009, J NEUROCHEM, V109, P125, DOI 10.1111/j.1471-4159.2009.05917.x; Okumoto K, 1997, EXP CELL RES, V233, P11, DOI 10.1006/excr.1997.3552; Okumoto K, 1998, HUM MOL GENET, V7, P1399, DOI 10.1093/hmg/7.9.1399; Ostrowski SM, 2007, J BIOL CHEM, V282, P26832, DOI 10.1074/jbc.M702640200; RIZZO WB, 1993, BIOCHEM MED METAB B, V50, P93, DOI 10.1006/bmmb.1993.1050; SAKAKIBARA J, 1995, J BIOL CHEM, V270, P17, DOI 10.1074/jbc.270.1.17; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Sawada M, 2001, EUR J PHARMACOL, V431, P11, DOI 10.1016/S0014-2999(01)01411-X; Sharpe LJ, 2014, TRENDS BIOCHEM SCI, V39, P527, DOI 10.1016/j.tibs.2014.08.008; Sharpe LJ, 2013, J BIOL CHEM, V288, P18707, DOI 10.1074/jbc.R113.479808; Steinberg SJ, 2006, BBA-MOL CELL RES, V1763, P1733, DOI 10.1016/j.bbamcr.2006.09.010; Teigler A, 2009, HUM MOL GENET, V18, P1897, DOI 10.1093/hmg/ddp110; Thai TP, 2001, HUM MOL GENET, V10, P127, DOI 10.1093/hmg/10.2.127; Vanhorebeek I, 2001, BBA-MOL CELL BIOL L, V1532, P28, DOI 10.1016/S1388-1981(01)00108-1; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang BT, 2011, P NATL ACAD SCI USA, V108, P15201, DOI 10.1073/pnas.1103746108; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; Wong J, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-10; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Wu LC, 2011, J BIOL CHEM, V286, P24916, DOI 10.1074/jbc.M111.247163; Zavacki AM, 2009, MOL CELL BIOL, V29, P5339, DOI 10.1128/MCB.01498-08; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1350, DOI 10.1016/j.bbalip.2012.07.006; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1269, DOI 10.1016/j.bbalip.2011.11.009	75	36	36	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28822	28833		10.1074/jbc.M115.656983	http://dx.doi.org/10.1074/jbc.M115.656983			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26463208	Green Published, hybrid			2022-12-28	WOS:000365762300024
J	Nozoye, T; Nagasaka, S; Kobayashi, T; Sato, Y; Uozumi, N; Nakanishi, H; Nishizawa, NK				Nozoye, Tomoko; Nagasaka, Seiji; Kobayashi, Takanori; Sato, Yuki; Uozumi, Nobuyuki; Nakanishi, Hiromi; Nishizawa, Naoko K.			The Phytosiderophore Efflux Transporter TOM2 Is Involved in Metal Transport in Rice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTIANAMINE SYNTHASE GENES; MAJOR FACILITATOR SUPERFAMILY; LONG-DISTANCE TRANSPORT; FE-DEFICIENT CONDITIONS; GRAMINEOUS PLANTS; IRON-DEFICIENT; APOPLASMIC IRON; MUGINEIC ACID; CLONING; PHLOEM	Iron is an essential metal element for all living organisms. Graminaceous plants produce and secrete mugineic acid family phytosiderophores from their roots to acquire iron in the soil. Phytosiderophores chelate and solubilize insoluble iron hydroxide in the soil. Subsequently, plants take up iron-phytosiderophore complexes through specific transporters on the root cell membrane. Phytosiderophores are also thought to be important for the internal transport of various transition metals, including iron. In this study, we analyzed TOM2 and TOM3, rice homologs of transporter of mugineic acid family phytosiderophores 1 (TOM1), a crucial efflux transporter directly involved in phytosiderophore secretion into the soil. Transgenic rice analysis using promoter-beta-glucuronidase revealed that TOM2 was expressed in tissues involved in metal translocation, whereas TOM3 was expressed only in restricted parts of the plant. Strong TOM2 expression was observed in developing tissues during seed maturation and germination, whereas TOM3 expression was weak during seed maturation. Transgenic rice in which TOM2 expression was repressed by RNA interference showed growth defects compared with non-transformants and TOM3-repressed rice. Xenopus laevis oocytes expressing TOM2 released C-14-labeled deoxymugineic acid, the initial phytosiderophore compound in the biosynthetic pathway in rice. In onion epidermal and rice root cells, the TOM2-GFP fusion protein localized to the cell membrane, indicating that the TOM2 protein is a transporter for phytosiderophore efflux to the cell exterior. Our results indicate that TOM2 is involved in the internal transport of deoxymugineic acid, which is required for normal plant growth.	[Nozoye, Tomoko; Nagasaka, Seiji; Nakanishi, Hiromi; Nishizawa, Naoko K.] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Kobayashi, Takanori; Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Sato, Yuki; Uozumi, Nobuyuki] Tohoku Univ, Grad Sch Engn, Dept Biomol Engn, Sendai, Miyagi 9808579, Japan	University of Tokyo; Ishikawa Prefecture University; Tohoku University	Nishizawa, NK (corresponding author), 1-1-1 Yayoi,Bunkyo Ku, Tokyo 1138657, Japan.	annaoko@mail.ecc.u-tokyo.ac.jp	Uozumi, Nobuyuki/AAG-3252-2019	Uozumi, Nobuyuki/0000-0003-4268-1126	Ministry of Education, Culture, Sports, Science, and Technology, Japan; JSPS KAKENHI	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to N. K. N. and N. U.) and by a grant-in-aid for Young Scientists (B) grant number from JSPS KAKENHI (to T. N.). The authors declare that they have no conflicts of interest with the contents of this article.	Aoyama T, 2009, PLANT MOL BIOL, V70, P681, DOI 10.1007/s11103-009-9500-3; Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; Bashir K, 2011, SOIL SCI PLANT NUTR, V57, P803, DOI 10.1080/00380768.2011.637305; Bughio N, 2002, J EXP BOT, V53, P1677, DOI 10.1093/jxb/erf004; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Haydon MJ, 2007, PLANT PHYSIOL, V143, P1705, DOI 10.1104/pp.106.092015; Haydon MJ, 2012, PLANT CELL, V24, P724, DOI 10.1105/tpc.111.095042; Herbik A, 1999, EUR J BIOCHEM, V265, P231, DOI 10.1046/j.1432-1327.1999.00717.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Higuchi K, 1996, PLANT SOIL, V178, P171, DOI 10.1007/BF00011580; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Higuchi K, 2001, PLANT J, V25, P159, DOI 10.1046/j.1365-313x.2001.00951.x; HOSHIKAWA K, 1984, JPN J CROP SCI, V53, P153, DOI 10.1626/jcs.53.153; Hoshikawa K., 1975, ANATOMICAL ILLUSTRAT; Inoue H, 2003, PLANT J, V36, P366, DOI 10.1046/j.1365-313X.2003.01878.x; Inoue H, 2009, J BIOL CHEM, V284, P3470, DOI 10.1074/jbc.M806042200; Inoue H, 2008, PLANT MOL BIOL, V66, P193, DOI 10.1007/s11103-007-9262-8; Ishimaru Y, 2006, PLANT J, V45, P335, DOI 10.1111/j.1365-313X.2005.02624.x; Ishimaru Y, 2011, J BIOL CHEM, V286, P24649, DOI 10.1074/jbc.M111.221168; Ishimaru Y, 2010, PLANT J, V62, P379, DOI 10.1111/j.1365-313X.2010.04158.x; Kakei Y, 2012, PLANT MOL BIOL, V79, P583, DOI 10.1007/s11103-012-9930-1; Kakei Y, 2009, PLANT CELL PHYSIOL, V50, P1988, DOI 10.1093/pcp/pcp141; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kato Y, 2001, P NATL ACAD SCI USA, V98, P6488, DOI 10.1073/pnas.101556598; Kawai S, 2001, SOIL SCI PLANT NUTR, V47, P265, DOI 10.1080/00380768.2001.10408390; Kobayashi T, 2009, PLANT J, V60, P948, DOI 10.1111/j.1365-313X.2009.04015.x; Koike S, 2004, PLANT J, V39, P415, DOI 10.1111/j.1365-313X.2004.02146.x; Lee S, 2012, MOL CELLS, V33, P117, DOI 10.1007/s10059-012-2165-9; Ling HQ, 1999, P NATL ACAD SCI USA, V96, P7098, DOI 10.1073/pnas.96.12.7098; Mizuno D, 2003, PLANT PHYSIOL, V132, P1989, DOI 10.1104/pp.102.019869; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; MORI S, 1991, PLANT SOIL, V130, P143, DOI 10.1007/BF00011869; Murata Y, 2006, PLANT J, V46, P563, DOI 10.1111/j.1365-313X.2006.02714.x; Nishiyama R, 2012, PLANT CELL PHYSIOL, V53, P381, DOI 10.1093/pcp/pcr188; Nozoye T, 2007, PLANT MOL BIOL, V64, P35, DOI 10.1007/s11103-007-9132-4; Nozoye T, 2014, PLANT J, V77, P246, DOI 10.1111/tpj.12383; Nozoye T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062567; Nozoye T, 2011, J BIOL CHEM, V286, P5446, DOI 10.1074/jbc.M110.180026; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; Ogo Y, 2006, J EXP BOT, V57, P2867, DOI 10.1093/jxb/erl054; Ogo Y, 2014, NEW PHYTOL, V201, P781, DOI 10.1111/nph.12577; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; Schaaf G, 2004, J BIOL CHEM, V279, P9091, DOI 10.1074/jbc.M311799200; Schroeder JI, 2013, NATURE, V497, P60, DOI 10.1038/nature11909; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; Stein RJ, 2009, PLANT SCI, V177, P563, DOI 10.1016/j.plantsci.2009.08.001; STEPHAN UW, 1993, PHYSIOL PLANTARUM, V88, P522, DOI 10.1111/j.1399-3054.1993.tb01367.x; TAKAGI S, 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; Takagi S., 1976, SOIL SCI PLANT NUTR, V45, P993; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Takahashi M, 2009, PLANT SOIL, V325, P39, DOI 10.1007/s11104-009-0045-7; TAKEMOTO T, 1978, P JPN ACAD B-PHYS, V54, P469, DOI 10.2183/pjab.54.469; Tsukamoto T, 2009, PLANT CELL PHYSIOL, V50, P48, DOI 10.1093/pcp/pcn192; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; Zheng LQ, 2012, PLANT CELL, V24, P3767, DOI 10.1105/tpc.112.103820	61	46	49	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27688	27699		10.1074/jbc.M114.635193	http://dx.doi.org/10.1074/jbc.M114.635193			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26432636	Green Published, hybrid			2022-12-28	WOS:000365757500022
J	Gunasekara, SM; Hicks, MN; Park, J; Brooks, CL; Serate, J; Saunders, CV; Grover, SK; Goto, JJ; Lee, JW; Youn, H				Gunasekara, Sanjiva M.; Hicks, Matt N.; Park, Jin; Brooks, Cory L.; Serate, Jose; Saunders, Cameron V.; Grover, Simranjeet K.; Goto, Joy J.; Lee, Jin-Won; Youn, Hwan			Directed Evolution of the Escherichia coli cAMP Receptor Protein at the cAMP Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATABOLITE ACTIVATOR PROTEIN; VIRULENCE FACTOR REGULATOR; CYCLIC-AMP; TRANSCRIPTION ACTIVATION; PSEUDOMONAS-AERUGINOSA; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; DNA-BINDING; SUGGESTS; CAP	The Escherichia coli cAMP receptor protein (CRP) requires cAMP binding to undergo a conformational change for DNA binding and transcriptional regulation. Two CRP residues, Thr(127) and Ser(128), are known to play important roles in cAMP binding through hydrogen bonding and in the cAMP-induced conformational change, but the connection between the two is not completely clear. Here, we simultaneously randomized the codons for these two residues and selected CRP mutants displaying high CRP activity in a cAMP-producing E. coli. Many different CRP mutants satisfied the screening condition for high CRP activity, including those that cannot form any hydrogen bonds with the incoming cAMP at the two positions. In vitro DNA-binding analysis confirmed that these selected CRP mutants indeed display high CRP activity in response to cAMP. These results indicate that the hydrogen bonding ability of the Thr(127) and Ser(128) residues is not critical for the cAMP-induced CRP activation. However, the hydrogen bonding ability of Thr(127) and Ser(128) was found to be important in attaining high cAMP affinity. Computational analysis revealed that most natural cAMP-sensing CRP homologs have Thr/Ser, Thr/Thr, or Thr/Asn at positions 127 and 128. All of these pairs are excellent hydrogen bonding partners and they do not elevate CRP activity in the absence of cAMP. Taken together, our analyses suggest that CRP evolved to have hydrogen bonding residues at the cAMP pocket residues 127 and 128 for performing dual functions: preserving high cAMP affinity and keeping CRP inactive in the absence of cAMP.	[Gunasekara, Sanjiva M.; Hicks, Matt N.; Saunders, Cameron V.; Grover, Simranjeet K.; Youn, Hwan] Calif State Univ Fresno, Dept Biol, Fresno, CA 93740 USA; [Park, Jin] Calif State Univ Fresno, Dept Comp Sci, Fresno, CA 93740 USA; [Brooks, Cory L.; Goto, Joy J.] Calif State Univ Fresno, Dept Chem, Fresno, CA 93740 USA; [Serate, Jose] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Lee, Jin-Won] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Lee, Jin-Won] Hanyang Univ, Inst Nat Sci, Seoul 133791, South Korea	California State University System; California State University Fresno; California State University System; California State University Fresno; California State University System; California State University Fresno; University of Wisconsin System; University of Wisconsin Madison; Hanyang University; Hanyang University	Youn, H (corresponding author), 2555 East San Ramon Ave M-S SB73, Fresno, CA 93740 USA.	hyoun@csufresno.edu	LEE, JIN-WON/L-1116-2016	LEE, JIN-WON/0000-0002-1201-8254	National Institutes of Health from the NIAID [R15AI101919]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI101919] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R15AI101919 from the NIAID (to H. Y.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arce-Rodriguez A, 2012, ENVIRON MICROBIOL, V14, P702, DOI 10.1111/j.1462-2920.2011.02622.x; Baichoo N, 1999, J MOL BIOL, V290, P37, DOI 10.1006/jmbi.1999.2858; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Bettenbrock K, 2007, J BACTERIOL, V189, P6891, DOI 10.1128/JB.00819-07; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; CHENG XD, 1995, BIOCHEMISTRY-US, V34, P10816, DOI 10.1021/bi00034a014; Cordes TJ, 2011, J BACTERIOL, V193, P4069, DOI 10.1128/JB.00666-10; Derouaux A, 2004, BIOCHEM BIOPH RES CO, V325, P983, DOI 10.1016/j.bbrc.2004.10.143; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; EBRIGHT RH, 1985, J MOL BIOL, V182, P91, DOI 10.1016/0022-2836(85)90030-0; Forcada-Nadal A, 2014, FEBS LETT, V588, P2270, DOI 10.1016/j.febslet.2014.05.010; Green J, 2014, CURR OPIN MICROBIOL, V18, P1, DOI 10.1016/j.mib.2014.01.003; GRONENBORN AM, 1988, BIOCHEM J, V253, P801, DOI 10.1042/bj2530801; Harman JG, 2001, BBA-PROTEIN STRUCT M, V1547, P1, DOI 10.1016/S0167-4838(01)00187-X; Hogema BM, 1998, MOL MICROBIOL, V28, P755, DOI 10.1046/j.1365-2958.1998.00833.x; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; Kumar S, 2000, PROTEIN SCI, V9, P10; Lee Eun Ju, 1994, Nucleic Acids Research, V22, P2894, DOI 10.1093/nar/22.15.2894; Leu SF, 1999, BIOCHEMISTRY-US, V38, P6222, DOI 10.1021/bi982938z; Lyell NL, 2013, J BACTERIOL, V195, P5051, DOI 10.1128/JB.00751-13; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NotleyMcRobb L, 1997, MICROBIOL-SGM, V143, P1909, DOI 10.1099/00221287-143-6-1909; Nussinov R, 2014, TRENDS PHARMACOL SCI, V35, P256, DOI 10.1016/j.tips.2014.03.006; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Phillips R., 2009, PHYS BIOL CELL; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Reddy MCM, 2009, J BIOL CHEM, V284, P36581, DOI 10.1074/jbc.M109.041343; Ryu MH, 2015, PROTEINS, V83, P799, DOI 10.1002/prot.24769; Serate J, 2011, J BACTERIOL, V193, P4859, DOI 10.1128/JB.00352-11; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; Shinkai A, 2007, J BACTERIOL, V189, P3891, DOI 10.1128/JB.01739-06; Stapleton M, 2010, J BIOL CHEM, V285, P7016, DOI 10.1074/jbc.M109.047720; Townsend PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113265; Villarreal JM, 2011, MICROBIOL-SGM, V157, P636, DOI 10.1099/mic.0.046045-0; Youn H, 2006, J BIOL CHEM, V281, P1119, DOI 10.1074/jbc.M509421200; Youn H, 2008, J BACTERIOL, V190, P4532, DOI 10.1128/JB.00074-08; Youn H, 2007, J BIOL CHEM, V282, P3632, DOI 10.1074/jbc.M606602200	40	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26587	26596		10.1074/jbc.M115.678474	http://dx.doi.org/10.1074/jbc.M115.678474			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26378231	hybrid, Green Published			2022-12-28	WOS:000364793600025
J	Nakadai, T; Fukuda, A; Shimada, M; Nishimura, K; Hisatake, K				Nakadai, Tomoyoshi; Fukuda, Aya; Shimada, Miho; Nishimura, Ken; Hisatake, Koji			The RNA Binding Complexes NF45-NF90 and NF45-NF110 Associate Dynamically with the c-fos Gene and Function as Transcriptional Coactivators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; DEPENDENT PROTEIN-KINASE; PRE-MESSENGER-RNA; ACTIVATED T-CELLS; PROMOTER IN-VITRO; NUCLEAR FACTOR-90; RESPONSE ELEMENT; HISTONE H3; INTRACELLULAR-DISTRIBUTION; POLYMERASE-II	The c-fos gene is rapidly induced to high levels by various extracellular stimuli. We used a defined in vitro transcription system that utilizes the c-fos promoter to purify a coactivator activity in an unbiased manner. We report here that NF45-NF90 and NF45-NF110, which possess archetypical double-stranded RNA binding motifs, have a direct function as transcriptional coactivators. The transcriptional activities of the nuclear factor (NF) complexes (NF45-NF90 and NF45-NF110) are mediated by both the upstream enhancer and core promoter regions of the c-fos gene and do not require their double-stranded RNA binding activities. The NF complexes cooperate with general coactivators, PC4 and Mediator, to elicit a high level of transcription and display multiple interactions with activators and the components of the general transcriptional machinery. Knockdown of the endogenous NF90/NF110 in mouse cells shows an important role for the NF complexes in inducing c-fos transcription. Chromatin immunoprecipitation assays demonstrate that the NF complexes occupy the c-fos enhancer/promoter region before and after serum induction and that their occupancies within the coding region of the c-fos gene increase in parallel to that of RNAPII upon serum induction. In light of their dynamic occupancy on the c-fos gene as well as direct functions in both transcription and posttranscriptional processes, the NF complexes appear to serve as multifunctional coactivators that coordinate different steps of gene expression to facilitate rapid response of inducible genes.	[Nakadai, Tomoyoshi; Shimada, Miho] Saitama Med Univ, Fac Med, Dept Mol Biol, Moroyama, Saitama 3500495, Japan; [Fukuda, Aya; Nishimura, Ken; Hisatake, Koji] Univ Tsukuba, Dept Biochem, Fac Med, Tsukuba, Ibaraki 3058575, Japan	Saitama Medical University; University of Tsukuba	Hisatake, K (corresponding author), Univ Tsukuba, Dept Biochem, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	kojihisa@md.tsukuba.ac.jp	Nishimura, KEN/HGC-6147-2022	Nishimura, Ken/0000-0002-0716-4142; Hisatake, Koji/0000-0002-5795-3115	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [25460354] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for Scientific Research (to T. N., A. F., M. S., K. N., and K. H.) and Special Coordination Funds for Promoting Science and Technology (to A. F. and K. N.) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Auboeuf D, 2004, MOL CELL BIOL, V24, P442, DOI 10.1128/MCB.24.1.442-453.2004; Auboeuf D, 2007, TRENDS ENDOCRIN MET, V18, P122, DOI 10.1016/j.tem.2007.02.003; Barber GN, 2009, RNA BIOL, V6, P35, DOI 10.4161/rna.6.1.7565; BASS BL, 1994, CURR BIOL, V4, P301, DOI 10.1016/S0960-9822(00)00069-5; BENNETT M, 1992, MOL CELL BIOL, V12, P3165, DOI 10.1128/MCB.12.7.3165; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Brownawell AM, 2002, J CELL BIOL, V156, P53, DOI 10.1083/jcb.200110082; Brzostowski J, 2000, EMBO J, V19, P3683, DOI 10.1093/emboj/19.14.3683; Buaas FW, 1999, MAMM GENOME, V10, P451, DOI 10.1007/s003359901022; Bunimov N, 2010, CELL MOL BIOL LETT, V15, P196, DOI 10.2478/s11658-010-0005-5; Chan HM, 2001, J CELL SCI, V114, P2363; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Coolidge CJ, 2000, NUCLEIC ACIDS RES, V28, P1407, DOI 10.1093/nar/28.6.1407; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Fukuda A, 2004, MOL CELL BIOL, V24, P6525, DOI 10.1128/MCB.24.14.6525-6535.2004; Fukuda A, 2001, GENES CELLS, V6, P707, DOI 10.1046/j.1365-2443.2001.00456.x; Fukuda A, 2009, J BIOL CHEM, V284, P23472, DOI 10.1074/jbc.M109.013656; Isken O, 2003, EMBO J, V22, P5655, DOI 10.1093/emboj/cdg562; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Iwasaki T, 2001, J BIOL CHEM, V276, P33375, DOI 10.1074/jbc.M101517200; KAO PN, 1994, J BIOL CHEM, V269, P20691; Krasnoselskaya-Riz I, 2002, AIDS RES HUM RETROV, V18, P591, DOI 10.1089/088922202753747941; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Langland JO, 1999, BIOCHEMISTRY-US, V38, P6361, DOI 10.1021/bi982410u; Larcher JC, 2004, FASEB J, V18, P1761, DOI 10.1096/fj.04-1763fje; Liao HJ, 1998, P NATL ACAD SCI USA, V95, P8514, DOI 10.1073/pnas.95.15.8514; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; MICHAUD S, 1991, GENE DEV, V5, P2534, DOI 10.1101/gad.5.12b.2534; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Nakajima T, 1997, CELL, V90, P1107, DOI 10.1016/S0092-8674(00)80376-1; Nie YZ, 2005, MOL CELL BIOL, V25, P6956, DOI 10.1128/MCB.25.16.6956-6963.2005; Orford RL, 1998, MOL CELL BIOL, V18, P5557, DOI 10.1128/MCB.18.9.5557; Parker LM, 2001, J BIOL CHEM, V276, P32522, DOI 10.1074/jbc.M104408200; Parrott AM, 2005, J MOL BIOL, V348, P281, DOI 10.1016/j.jmb.2005.02.047; Parrott AM, 2007, NUCLEIC ACIDS RES, V35, P6249, DOI 10.1093/nar/gkm668; Patel RC, 1999, J BIOL CHEM, V274, P20432, DOI 10.1074/jbc.274.29.20432; Pfeifer I, 2008, P NATL ACAD SCI USA, V105, P4173, DOI 10.1073/pnas.0711222105; Price MA, 1996, PHILOS T ROY SOC B, V351, P551, DOI 10.1098/rstb.1996.0054; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Reichman TW, 2003, J MOL BIOL, V332, P85, DOI 10.1016/S0022-2836(03)00885-4; Reichman TW, 2003, RNA, V9, P543, DOI 10.1261/rna.2181103; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Sakamoto S, 1999, BIOCHEMISTRY-US, V38, P3355, DOI 10.1021/bi982099g; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Saunders LR, 2001, J BIOL CHEM, V276, P32300, DOI 10.1074/jbc.M104207200; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shi LF, 2007, J EXP MED, V204, P971, DOI 10.1084/jem.20052078; Shi LF, 2007, NUCLEIC ACIDS RES, V35, P2302, DOI 10.1093/nar/gkm117; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Shimada M, 2010, J BIOL CHEM, V285, P9390, DOI 10.1074/jbc.M109.057745; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Stevens JL, 2002, SCIENCE, V296, P755, DOI 10.1126/science.1068943; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Ting NSY, 1998, J BIOL CHEM, V273, P2136, DOI 10.1074/jbc.273.4.2136; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Vumbaca F, 2008, MOL CELL BIOL, V28, P772, DOI 10.1128/MCB.02078-06; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Xu YH, 1999, MOL GENET METAB, V68, P441, DOI 10.1006/mgme.1999.2934; Xu YH, 2003, MOL GENET METAB, V80, P426, DOI 10.1016/j.ymgme.2003.09.006; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	68	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26832	26845		10.1074/jbc.M115.688317	http://dx.doi.org/10.1074/jbc.M115.688317			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26381409	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000364793600045
J	Schumacher, N; Meyer, D; Mauermann, A; von der Heyde, J; Wolf, J; Schwarz, J; Knittler, K; Murphy, G; Michalek, M; Garbers, C; Bartsch, JW; Guo, SB; Schacher, B; Eickholz, P; Chalaris, A; Rose-John, S; Rabe, B				Schumacher, Neele; Meyer, Doerte; Mauermann, Andre; von der Heyde, Jan; Wolf, Janina; Schwarz, Jeanette; Knittler, Katharina; Murphy, Gillian; Michalek, Matthias; Garbers, Christoph; Bartsch, Joerg W.; Guo, Songbo; Schacher, Beate; Eickholz, Peter; Chalaris, Athena; Rose-John, Stefan; Rabe, Bjoern			Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOSOME-LIKE VESICLES; T-CELL; DISINTEGRIN/METALLOPROTEINASE ADAM10; BIOLOGICAL FUNCTION; SERINE PROTEASES; MESSENGER-RNA; HUMAN PLASMA; INFLAMMATION; GENERATION; ECTODOMAIN	Generation of the soluble interleukin-6 receptor (sIL-6R) is a prerequisite for pathogenic IL-6 trans-signaling, which constitutes a distinct signaling pathway of the pleiotropic cytokine interleukin-6 (IL-6). Although in vitro experiments using ectopically overexpressed IL-6R and candidate proteases revealed major roles for the metalloproteinases ADAM10 and ADAM17 in IL-6R shedding, the identity of the protease(s) cleaving IL-6R in more physiological settings, or even in vivo, remains unknown. By taking advantage of specific pharmacological inhibitors and primary cells from ADAM-deficient mice we established that endogenous IL-6R of both human and murine origin is shed by ADAM17 in an induced manner, whereas constitutive release of endogenous IL-6R is largely mediated by ADAM10. Although circulating IL-6R levels are altered in various diseases, the origin of blood-borne IL-6R is still poorly understood. It has been shown previously that ADAM17 hypomorphic mice exhibit unaltered levels of serum sIL-6R. Here, by quantification of serum sIL-6R in protease-deficient mice as well as human patients we also excluded ADAM10, ADAM8, neutrophil elastase, cathepsin G, and proteinase 3 from contributing to circulating sIL-6R. Furthermore, we ruled out alternative splicing of the IL-6R mRNA as a potential source of circulating sIL-6R in the mouse. Instead, we found full-length IL-6R on circulating microvesicles, establishing microvesicle release as a novel mechanism for sIL-6R generation.	[Schumacher, Neele; Meyer, Doerte; Mauermann, Andre; von der Heyde, Jan; Wolf, Janina; Schwarz, Jeanette; Knittler, Katharina; Michalek, Matthias; Garbers, Christoph; Chalaris, Athena; Rose-John, Stefan; Rabe, Bjoern] Univ Kiel, Fac Med, Inst Biochem, D-24118 Kiel, Germany; [Murphy, Gillian] Univ Cambridge, Canc Res UK Cambridge Inst, Dept Oncol, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Bartsch, Joerg W.; Guo, Songbo] Univ Marburg, Dept Neurosurg Lab, D-35033 Marburg, Germany; [Schacher, Beate; Eickholz, Peter] Goethe Univ Frankfurt, Ctr Dent & Oral Med Carolinum, Dept Periodontol, D-60596 Frankfurt, Germany	University of Kiel; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Philipps University Marburg; Goethe University Frankfurt	Rabe, B (corresponding author), Univ Kiel, Fac Med, Inst Biochem, Rudolf Hober Str 1, D-24118 Kiel, Germany.	brabe@biochem.uni-kiel.de	Garbers, Christoph/D-9932-2015; Bartsch, Joerg Walter/AAB-2951-2020; Rose-John, Stefan/A-7998-2010	Garbers, Christoph/0000-0003-4939-6950; Rose-John, Stefan/0000-0002-7519-3279; Bartsch, Prof. Joerg Walter/0000-0002-2773-3357	Deutsche Forschungsgemeinschaft, Bonn, Germany [RA 2404/1-1, SFB 877]; Cluster of Excellence "Inflammation at Interfaces"; Cancer Research UK	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); Cluster of Excellence "Inflammation at Interfaces"; Cancer Research UK(Cancer Research UK)	This work was supported in part by Deutsche Forschungsgemeinschaft, Bonn, Germany, Project Grant RA 2404/1-1 (to B. R.), SFB 877, project A1 (to A. C. and S. R.-J.), and project A10 (to C. G.), the Cluster of Excellence "Inflammation at Interfaces" (to S. R.-J., B. R., and A. C.), and Cancer Research UK (to G. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Bank U, 1999, J INTERF CYTOK RES, V19, P1277, DOI 10.1089/107999099312957; Calabrese LH, 2014, NAT REV RHEUMATOL, V10, P720, DOI 10.1038/nrrheum.2014.127; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Chalaris A, 2011, EUR J CELL BIOL, V90, P484, DOI 10.1016/j.ejcb.2010.10.007; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Dimitrov S, 2006, FASEB J, V20, P2174, DOI 10.1096/fj.06-5754fje; Dusterhoft S, 2014, J BIOL CHEM, V289, P16336, DOI 10.1074/jbc.M114.557322; Effenberger T, 2014, FASEB J, V28, P4847, DOI 10.1096/fj.14-254565; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Ferreira RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003444; Garbers C, 2014, BBA-MOL BASIS DIS, V1842, P1485, DOI 10.1016/j.bbadis.2014.05.018; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hawari FI, 2004, P NATL ACAD SCI USA, V101, P1297, DOI 10.1073/pnas.0307981100; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Higginbotham JN, 2011, CURR BIOL, V21, P779, DOI 10.1016/j.cub.2011.03.043; HONDA M, 1992, J IMMUNOL, V148, P2175; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; HORIUCHI S, 1994, EUR J IMMUNOL, V24, P1945, DOI 10.1002/eji.1830240837; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kelly K, 2005, DEV DYNAM, V232, P221, DOI 10.1002/dvdy.20221; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Levine SJ, 2008, J BIOL CHEM, V283, P14177, DOI 10.1074/jbc.R700052200; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; LUST JA, 1992, CYTOKINE, V4, P96, DOI 10.1016/1043-4666(92)90043-Q; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; Moller-Hackbarth K, 2013, J BIOL CHEM, V288, P34529, DOI 10.1074/jbc.M113.488478; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; MULLBERG J, 1993, EUR J IMMUNOL, V23, P473, DOI 10.1002/eji.1830230226; MullerNewen G, 1996, EUR J BIOCHEM, V236, P837, DOI 10.1111/j.1432-1033.1996.00837.x; Oberg HH, 2006, INT IMMUNOL, V18, P555, DOI 10.1093/intimm/dxh396; Oh JW, 1996, CYTOKINE, V8, P401, DOI 10.1006/cyto.1996.0055; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Rabe B, 2008, BLOOD, V111, P1021, DOI 10.1182/blood-2007-07-102137; Reich D, 2007, AM J HUM GENET, V80, P716, DOI 10.1086/513206; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Sanderson MP, 2008, J CELL BIOCHEM, V103, P1783, DOI 10.1002/jcb.21569; Scheller J, 2014, SEMIN IMMUNOL, V26, P2, DOI 10.1016/j.smim.2013.11.002; Scheller J, 2012, LANCET, V380, P338, DOI 10.1016/S0140-6736(12)61246-X; Schlomann U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7175; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; Toomes C, 1999, NAT GENET, V23, P421, DOI 10.1038/70525; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; WOGNUM AW, 1993, BLOOD, V81, P2036; Zhang J, 2008, BIOCHEM BIOPH RES CO, V366, P579, DOI 10.1016/j.bbrc.2007.12.011	54	91	92	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26059	26071		10.1074/jbc.M115.649509	http://dx.doi.org/10.1074/jbc.M115.649509			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26359498	Green Published, hybrid			2022-12-28	WOS:000363527300027
J	Choo, J; Lee, Y; Yan, XJ; Noh, TH; Kim, SJ; Son, S; Pothoulakis, C; Moon, HR; Jung, JH; Im, E				Choo, Jieun; Lee, Yunna; Yan, Xin-jia; Noh, Tae Hwan; Kim, Seong Jin; Son, Sujin; Pothoulakis, Charalabos; Moon, Hyung Ryong; Jung, Jee H.; Im, Eunok			A Novel Peroxisome Proliferator-activated Receptor (PPAR) gamma Agonist 2-Hydroxyethyl 5-chloro-4,5-didehydrojasmonate Exerts Anti-Inflammatory Effects in Colitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; EPITHELIAL-CELLS; MOLECULAR-MECHANISMS; PROTEIN-KINASE; PATHWAYS; CYTOKINES; MUCOSA; IL-6; MACROPHAGES	Inflammatory bowel disease (IBD) is a chronic inflammatory disease with increasing incidence and prevalence worldwide. Here we investigated the newly synthesized jasmonate analogue 2-hydroxyethyl 5-chloro-4,5-didehydrojasmonate (J11-Cl) for its anti-inflammatory effects on intestinal inflammation. First, to test whether J11-Cl can activate peroxisome proliferator-activated receptors (PPARs), we performed docking simulations because J11-Cl has a structural similarity with anti-inflammatory 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)), one of the endogenous ligands of PPAR gamma. J11-Cl bound to the ligand binding domain of PPAR gamma in the same manner as 15d-PGJ(2) and rosiglitazone, and significantly increased transcriptional activity of PPAR gamma. In animal experiments, colitis was significantly reduced in mice with J11-Cl treatment, determined by analyses of survival rate, body weight changes, clinical symptoms, and histological evaluation. Moreover, J11-Cl decreased production of pro-inflammatory cytokines including IL-6, IL-8, and G-CSF as well as chemokines including chemokine (C-C motif) ligand (CCL) 20, chemokine (C-X-C motif) ligand (CXCL) 2, CXCL3, and chemokine (C-X3-C motif) ligand 1 (CX3CL1) in colon tissues, and LPS or TNF-alpha-stimulated macrophages and epithelial cells. In contrast, production of anti-inflammatory cytokines including IL-2 and IL-4 as well as the proliferative factor, GM-CSF, was increased by J11-Cl. Furthermore, inhibition of MAPKs and NF-kappa B activation by J11-Cl was also observed. J11-Cl reduced intestinal inflammation by increasing the transcriptional activity of PPAR gamma and modulating inflammatory signaling pathways. Therefore, our study suggests that J11-Cl may serve as a novel therapeutic agent against IBD.	[Choo, Jieun; Lee, Yunna; Noh, Tae Hwan; Kim, Seong Jin; Son, Sujin; Moon, Hyung Ryong; Jung, Jee H.; Im, Eunok] Pusan Natl Univ, Coll Pharm, Busan 609735, South Korea; [Yan, Xin-jia] Harbin Univ Commerce, Coll Pharm, Harbin 150076, Heilongjiang, Peoples R China; [Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Sect Inflammatory Bowel Dis, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90095 USA; [Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90095 USA	Pusan National University; Harbin University of Commerce; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Im, E (corresponding author), Pusan Natl Univ, Coll Pharm, Busan 609735, South Korea.	eoim@pusan.ac.kr			National Research Foundation of Korea (NRF) [2009-0083538, 2014R1A1A2057432]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Research Foundation of Korea (NRF) Grant 2009-0083538 and 2014R1A1A2057432. The authors declare that they have no conflicts of interest with the contents of this article.	Ananthakrishnan AN, 2013, GASTROENTEROL HEPATO, V9, P367; Assi K, 2006, IMMUNOLOGY, V118, P112, DOI 10.1111/j.1365-2567.2006.02349.x; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Baker MS, 2003, J SURG RES, V110, P295, DOI 10.1016/S0022-4804(03)00027-1; Banchereau J, 2012, NAT IMMUNOL, V13, P925, DOI 10.1038/ni.2406; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Broom OJ, 2009, CLIN EXP IMMUNOL, V158, P272, DOI 10.1111/j.1365-2249.2009.04033.x; Carothers AM, 2010, CANCER RES, V70, P4433, DOI 10.1158/0008-5472.CAN-09-4289; Caruso R, 2007, GASTROENTEROLOGY, V132, P166, DOI 10.1053/j.gastro.2006.09.053; Cesari Italo Mario, 2014, Int J Cell Biol, V2014, P572097, DOI 10.1155/2014/572097; Daig R, 1996, GUT, V38, P216, DOI 10.1136/gut.38.2.216; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Dang HT, 2008, BIOORGAN MED CHEM, V16, P10228, DOI 10.1016/j.bmc.2008.10.050; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Egea L, 2013, J IMMUNOL, V190, P1702, DOI 10.4049/jimmunol.1202368; Fujiie S, 2001, INT IMMUNOL, V13, P1255, DOI 10.1093/intimm/13.10.1255; Garat C, 2003, CYTOKINE, V23, P31, DOI 10.1016/S1043-4666(03)00182-0; Hollenbach E, 2004, FASEB J, V18, P1550, DOI 10.1096/fj.04-1642fje; Dang HT, 2012, BIOORGAN MED CHEM, V20, P4109, DOI 10.1016/j.bmc.2012.04.052; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kim JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004561; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kolonics A, 2001, CELL SIGNAL, V13, P743, DOI 10.1016/S0898-6568(01)00201-7; Kota BP, 2005, PHARMACOL RES, V51, P85, DOI 10.1016/j.phrs.2004.07.012; Kwon KH, 2007, LIFE SCI, V81, P362, DOI 10.1016/j.lfs.2007.05.022; Leonard M, 1999, KIDNEY INT, V56, P1366, DOI 10.1046/j.1523-1755.1999.00664.x; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Mitsuyama K, 2006, INT J MOL MED, V17, P449; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Muzes G, 2012, WORLD J GASTROENTERO, V18, P5848, DOI 10.3748/wjg.v18.i41.5848; Puleston J, 2005, ALIMENT PHARM THER, V21, P109, DOI 10.1111/j.1365-2036.2004.02262.x; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Rotondo D, 2002, IMMUNOLOGY, V105, P20, DOI 10.1046/j.0019-2805.2001.01361.x; Sainathan SK, 2008, INFLAMM BOWEL DIS, V14, P88, DOI 10.1002/ibd.20279; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shih David Q, 2009, Curr Gastroenterol Rep, V11, P473; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Suttles J, 1999, J BIOL CHEM, V274, P5835, DOI 10.1074/jbc.274.9.5835; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	43	41	42	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25609	25619		10.1074/jbc.M115.673046	http://dx.doi.org/10.1074/jbc.M115.673046			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26342083	Green Published, hybrid			2022-12-28	WOS:000362962800034
J	Rouka, E; Simister, PC; Janning, M; Kumbrink, J; Konstantinou, T; Muniz, JRC; Joshi, D; O'Reilly, N; Volkmer, R; Ritter, B; Knapp, S; von Delft, F; Kirsch, KH; Feller, SM				Rouka, Evgenia; Simister, Philip C.; Janning, Melanie; Kumbrink, Joerg; Konstantinou, Tassos; Muniz, Joao R. C.; Joshi, Dhira; O'Reilly, Nicola; Volkmer, Rudolf; Ritter, Brigitte; Knapp, Stefan; von Delft, Frank; Kirsch, Kathrin H.; Feller, Stephan M.			Differential Recognition Preferences of the Three Src Homology 3 (SH3) Domains from the Adaptor CD2-associated Protein (CD2AP) and Direct Association with Ras and Rab Interactor 3 (RIN3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; NUCLEOTIDE EXCHANGE FACTOR; GROWTH-FACTOR RECEPTOR; SUSCEPTIBILITY LOCI; NEPHROTIC SYNDROME; COMMON VARIANTS; CAPPING PROTEIN; PAGETS-DISEASE; BINDING; CBL	CD2AP is an adaptor protein involved in membrane trafficking, with essential roles in maintaining podocyte function within the kidney glomerulus. CD2AP contains three Src homology 3 (SH3) domains that mediate multiple protein-protein interactions. However, a detailed comparison of the molecular binding preferences of each SH3 remained unexplored, as well as the discovery of novel interactors. Thus, we studied the binding properties of each SH3 domain to the known interactor Casitas B-lineage lymphoma protein (c-CBL), conducted a peptide array screen based on the recognition motif PxPxPR and identified 40 known or novel candidate binding proteins, such as RIN3, a RAB5-activating guanine nucleotide exchange factor. CD2APSH3 domains 1 and 2 generally bound with similar characteristics and specificities, whereas the SH3-3 domain bound more weakly to most peptide ligands tested yet recognized an unusually extended sequence in ALG-2-interacting protein X (ALIX). RIN3 peptide scanning arrays revealed two CD2AP binding sites, recognized by all three SH3 domains, but SH3-3 appeared non-functional in precipitation experiments. RIN3 recruited CD2AP to RAB5a-positive early endosomes via these interaction sites. Permutation arrays and isothermal titration calorimetry data showed that the preferred binding motif is Px(P/A)xPR. Two high-resolution crystal structures (1.65 and 1.11 angstrom) of CD2AP SH3-1 and SH3-2 solved in complex with RIN3 epitopes 1 and 2, respectively, indicated that another extended motif is relevant in epitope 2. In conclusion, we have discovered novel interaction candidates for CD2AP and characterized subtle yet significant differences in the recognition preferences of its three SH3 domains for c-CBL, ALIX, and RIN3.	[Rouka, Evgenia; Simister, Philip C.; Janning, Melanie; Konstantinou, Tassos; Feller, Stephan M.] Univ Oxford, Dept Oncol, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Feller, Stephan M.] Univ Halle Wittenberg, Inst Mol Med, D-06120 Halle, Germany; [Ritter, Brigitte; Kirsch, Kathrin H.] Boston Univ, Dept Biochem, Sch Med, Boston, MA 02118 USA; [Muniz, Joao R. C.; Knapp, Stefan; von Delft, Frank] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7DQ, England; [Joshi, Dhira; O'Reilly, Nicola] London Res Inst Canc Res UK, Peptide Chem Lab, London WC2A 3LY, England; [Volkmer, Rudolf] Charite, Inst Med Immunol, D-10115 Berlin, Germany; [von Delft, Frank] Diamond Light Source Ltd, Didcot OX11 0QX, Oxon, England; [Kumbrink, Joerg; von Delft, Frank] Univ Johannesburg, Dept Biochem, ZA-2006 Auckland Pk, South Africa; [Muniz, Joao R. C.] Univ Sao Paulo, Sao Carlos Inst Phys, BR-13566590 Sao Carlos, Brazil	University of Oxford; Martin Luther University Halle Wittenberg; Boston University; University of Oxford; University of London; Institute of Cancer Research - UK; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Diamond Light Source; University of Johannesburg; Universidade de Sao Paulo	Simister, PC (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	philip.simister@imm.ox.ac.uk; stephan.feller@uk-halle.de	Muniz, Joao R/B-7782-2016; Janning, Melanie/AAC-9357-2019; Regan, Clinton/E-6250-2012; Knapp, Stefan/AAG-2347-2019	Muniz, Joao R/0000-0003-2731-3966; Janning, Melanie/0000-0002-6632-8506; Knapp, Stefan/0000-0001-5995-6494; Volkmer, Rudolf/0000-0003-4710-1143; O'Reilly, Nicola/0000-0002-4204-6491; Kirsch, Kathrin/0000-0003-1532-1715; von Delft, Frank/0000-0003-0378-0017	National Institutes of Health [CA143108]; Medical Research Council, Funds for Women Graduates, University of Oxford; Breast Cancer Now, University of Oxford; Rosetrees Trust; DAAD (Deutscher Akademischer Austauschdienst) fellowship; Susan G. Komen for Cure Breast Cancer Foundation [KG101208]; Breast Cancer Now; EU FP7 Grant Targetbinder; Rosetrees Trust [M215] Funding Source: researchfish; The Francis Crick Institute [10013] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA143108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council, Funds for Women Graduates, University of Oxford; Breast Cancer Now, University of Oxford; Rosetrees Trust(Rosetrees Trust); DAAD (Deutscher Akademischer Austauschdienst) fellowship(Deutscher Akademischer Austausch Dienst (DAAD)); Susan G. Komen for Cure Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Breast Cancer Now; EU FP7 Grant Targetbinder; Rosetrees Trust(Rosetrees Trust); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA143108 (to K. H. K). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the Medical Research Council, Funds for Women Graduates, and University of Oxford.r Supported by Breast Cancer Now, University of Oxford, and the Rosetrees Trust. To whom correspondence should be addressed: Sir William Dunn School of Pathology, University of Oxford, South Parks Rd., Oxford OX13RE, UK. E-mail: philip.simister@imm.ox.ac.uk.r Supported by a DAAD (Deutscher Akademischer Austauschdienst) fellowship. Present address: Dept. of Hematology and Oncology, BMT with Section of Pneumology, and Dept. of Tumor Biology, Hamburg-Eppendorf University Hospital, 20246 Hamburg, Germany.r Supported by Susan G. Komen for the Cure Breast Cancer Foundation Post-doctoral Fellowship KG101208.r Supported by Breast Cancer Now and EU FP7 Grant Targetbinder. To whom correspondence should be addressed. E-mail: stephan.feller@uk-halle.de.	Ababou A, 2009, J MOL BIOL, V387, P1120, DOI 10.1016/j.jmb.2009.02.061; Adair BD, 2014, J AM SOC NEPHROL, V25, P1465, DOI 10.1681/ASN.2013090949; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albagha OME, 2011, NAT GENET, V43, P685, DOI 10.1038/ng.845; Bao MS, 2012, J IMMUNOL, V189, P786, DOI 10.4049/jimmunol.1200887; Buday L, 1996, J BIOL CHEM, V271, P6159, DOI 10.1074/jbc.271.11.6159; Calco GN, 2014, J BIOL CHEM, V289, P7307, DOI 10.1074/jbc.M113.537878; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Emaduddin M, 2008, P NATL ACAD SCI USA, V105, P2358, DOI 10.1073/pnas.0712176105; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Gaidos G, 2007, J CELL SCI, V120, P2366, DOI 10.1242/jcs.004333; Gigante M, 2009, NEPHROL DIAL TRANSPL, V24, P1858, DOI 10.1093/ndt/gfn712; Haglund K, 2002, P NATL ACAD SCI USA, V99, P12191, DOI 10.1073/pnas.192462299; Harkiolaki M, 2009, STRUCTURE, V17, P809, DOI 10.1016/j.str.2009.03.017; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Huang FT, 2005, MOL BIOL CELL, V16, P1268, DOI 10.1091/mbc.E04-09-0832; Janson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049615; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Jozic D, 2005, NAT STRUCT MOL BIOL, V12, P972, DOI 10.1038/nsmb1000; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kajiho H, 2011, J BIOL CHEM, V286, P24364, DOI 10.1074/jbc.M110.172445; Kemp JP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004423; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Kirsch KH, 1999, P NATL ACAD SCI USA, V96, P6211, DOI 10.1073/pnas.96.11.6211; Kirsch KH, 1998, J BIOL CHEM, V273, P25673, DOI 10.1074/jbc.273.40.25673; Kobayashi S, 2004, FASEB J, V18, P929, DOI 10.1096/fj.03-0767fje; Kowanetz K, 2004, MOL BIOL CELL, V15, P3155, DOI 10.1091/mbc.E03-09-0683; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; Krieger JM, 2014, BIOPHYS J, V106, P1771, DOI 10.1016/j.bpj.2014.03.004; Kumbrink J, 2012, NEOPLASIA, V14, P108, DOI 10.1593/neo.111760; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Landgraf C, 2004, PLOS BIOL, V2, P94, DOI 10.1371/journal.pbio.0020014; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lehtonen S, 2002, AM J PHYSIOL-RENAL, V283, pF734, DOI 10.1152/ajprenal.00312.2001; Lowik MM, 2007, KIDNEY INT, V72, P1198, DOI 10.1038/sj.ki.5002469; Ortega-Roldan JL, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp211; Lynch DK, 2003, J BIOL CHEM, V278, P21805, DOI 10.1074/jbc.M211407200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minegishi Y, 2013, CANCER SCI, V104, P345, DOI 10.1111/cas.12086; Moncalian G, 2006, J BIOL CHEM, V281, P38845, DOI 10.1074/jbc.M606411200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Neuvonen M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002383; Ni L, 2012, NEPHROLOGY, V17, P525, DOI 10.1111/j.1440-1797.2012.01619.x; Oellerich T, 2011, EMBO J, V30, P3620, DOI 10.1038/emboj.2011.251; Roldan JLO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073018; Roldan JLO, 2011, J BIOMOL NMR, V50, P103, DOI 10.1007/s10858-011-9505-5; Philippe D, 2011, BIOCHEMISTRY-US, V50, P3649, DOI 10.1021/bi1019644; Roldan JLO, 2007, J BIOMOL NMR, V39, P331, DOI 10.1007/s10858-007-9201-7; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Simister PC, 2013, BIOORGAN MED CHEM, V21, P4027, DOI 10.1016/j.bmc.2012.10.023; Simister PC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000591; Stollar EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051282; Tan MS, 2013, TRENDS MOL MED, V19, P594, DOI 10.1016/j.molmed.2013.06.004; Tang VW, 2013, J CELL BIOL, V203, P815, DOI 10.1083/jcb.201304143; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Tsui CC, 2008, J NEUROSCI, V28, P8789, DOI 10.1523/JNEUROSCI.2738-08.2008; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; Vallet M, 2015, HUM MOL GENET, V24, P3286, DOI 10.1093/hmg/ddv068; Watanabe S, 2000, BIOCHEM BIOPH RES CO, V278, P167, DOI 10.1006/bbrc.2000.3760; Yang ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092298; Yao B, 2007, BBA-PROTEINS PROTEOM, V1774, P35, DOI 10.1016/j.bbapap.2006.09.018; Zhao JP, 2013, MOL CELL BIOL, V33, P38, DOI 10.1128/MCB.00734-12	70	24	25	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25275	25292		10.1074/jbc.M115.637207	http://dx.doi.org/10.1074/jbc.M115.637207			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26296892	Green Published, hybrid			2022-12-28	WOS:000362962800008
J	Capel, RA; Bolton, EL; Lin, WK; Aston, D; Wang, YW; Liu, W; Wang, X; Burton, RAB; Bloor-Young, D; Shade, KT; Ruas, M; Parrington, J; Churchill, GC; Lei, M; Galione, A; Terrar, DA				Capel, Rebecca A.; Bolton, Emma L.; Lin, Wee K.; Aston, Daniel; Wang, Yanwen; Liu, Wei; Wang, Xin; Burton, Rebecca-Ann B.; Bloor-Young, Duncan; Shade, Kai-Ting; Ruas, Margarida; Parrington, John; Churchill, Grant C.; Lei, Ming; Galione, Antony; Terrar, Derek A.			Two-pore Channels (TPC2s) and Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) at Lysosomal-Sarcoplasmic Reticular Junctions Contribute to Acute and Chronic beta-Adrenoceptor Signaling in the Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; SENSITIVE CA2+; ION CHANNELS; CALCIUM; PROTEINS; CAMKII; MICE; IDENTIFICATION; DYSFUNCTION; MORPHOLOGY	Ca2+-permeable type 2 two-pore channels (TPC2) are lysosomal proteins required for nicotinic acid adenine dinucleotide phosphate (NAADP)-evoked Ca2+ release in many diverse cell types. Here, we investigate the importance of TPC2 proteins for the physiology and pathophysiology of the heart. NAADP-AM failed to enhance Ca2+ responses in cardiac myocytes from Tpcn2(-/-) mice, unlike myocytes from wild-type (WT) mice. Ca2+ /calmodulin-dependent protein kinase II inhibitors suppressed actions of NAADP in myocytes. Ca2+ transients and contractions accompanying action potentials were increased by isoproterenol in myocytes from WT mice, but these effects of beta-adrenoreceptor stimulation were reduced in myocytes from Tpcn2(-/-) mice. Increases in amplitude of L-type Ca2+ currents evoked by isoproterenol remained unchanged in myocytes from Tpcn2(-/-) mice showing no loss of beta-adrenoceptors or coupling mechanisms. Whole hearts from Tpcn2(-/-) mice also showed reduced inotropic effects of isoproterenol and a reduced tendency for arrhythmias following acute beta-adrenoreceptor stimulation. Hearts from Tpcn2(-/-) mice chronically exposed to isoproterenol showed less cardiac hypertrophy and increased threshold for arrhythmogenesis compared with WT controls. Electron microscopy showed that lysosomes form close contacts with the sarcoplasmic reticulum (separation similar to 25 nm). We propose that Ca2+-signaling nanodomains between lysosomes and sarcoplasmic reticulum dependent on NAADP and TPC2 comprise an important element in beta-adrenoreceptor signal transduction in cardiac myocytes. In summary, our observations define a role for NAADP and TPC2 at lysosomal/sarcoplasmic reticulum junctions as unexpected but major contributors in the acute actions of beta-adrenergic signaling in the heart and also in stress pathways linking chronic stimulation of beta-adrenoceptors to hypertrophy and associated arrhythmias.	[Capel, Rebecca A.; Bolton, Emma L.; Lin, Wee K.; Aston, Daniel; Wang, Yanwen; Bloor-Young, Duncan; Shade, Kai-Ting; Ruas, Margarida; Parrington, John; Churchill, Grant C.; Lei, Ming; Galione, Antony; Terrar, Derek A.] Univ Oxford, Dept Pharmacol, BHF Ctr Res Excellence, Oxford OX1 3QT, England; [Liu, Wei; Wang, Xin] Univ Manchester, Fac Life Sci, Manchester M13 9NT, Lancs, England; [Burton, Rebecca-Ann B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford; University of Manchester; University of Oxford	Terrar, DA (corresponding author), Univ Oxford, Dept Pharmacol, BHF Ctr Res Excellence, Mansfield Rd, Oxford OX1 3QT, England.	derek.terrar@pharm.ox.ac.uk	Lei, Ming/S-7209-2016; Burton, Rebecca-Ann Beatrice/AAT-2417-2020	Lei, Ming/0000-0002-0928-341X; Burton, Rebecca-Ann Beatrice/0000-0002-0904-3862; Capel, Rebecca/0000-0002-7422-589X; Terrar, Derek/0000-0001-9408-6594; Ruas, Margarida/0000-0002-4872-7618; Liu, Wei/0000-0003-1592-6693; Galione, Antony/0000-0002-4132-7646	British Heart Foundation; British Heart Foundation Oxford Centre of Research Excellence, Oxford, United Kingdom; British Heart Foundation Centre of Research Excellence, Oxford, United Kingdom [RE/08/004]; Medical Research Council; National Institute for Health Research Oxford Biomedical Research Center; Goodger Award; Wellcome Trust; BBSRC [BB/G008523/1] Funding Source: UKRI; MRC [G1002647] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; British Heart Foundation [PG/14/71/31063, PG/12/21/29473, PG/11/59/29006, PG/12/76/29852, PG/14/80/31106, PG/14/70/31039] Funding Source: researchfish; Medical Research Council [973929, G1002647] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation Oxford Centre of Research Excellence, Oxford, United Kingdom; British Heart Foundation Centre of Research Excellence, Oxford, United Kingdom; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Oxford Biomedical Research Center(National Institute for Health Research (NIHR)); Goodger Award; Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the British Heart Foundation (to the D. A. T. laboratory). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the British Heart Foundation; 4-year Ph.D. scholarships, and British Heart Foundation research grants.; Supported by the British Heart Foundation Oxford Centre of Research Excellence, Oxford, United Kingdom.; Supported by Grant RE/08/004 from the British Heart Foundation Centre of Research Excellence, Oxford, United Kingdom.; Supported by the Medical Research Council, National Institute for Health Research Oxford Biomedical Research Center, and the Goodger Award.; Supported by the Medical Research Council and British Heart Foundation.; Supported by a Wellcome Trust Programme Grant and Senior Investigator Award.	Aley PK, 2010, P NATL ACAD SCI USA, V107, P19927, DOI 10.1073/pnas.1007381107; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Anderson ME, 1998, J PHARMACOL EXP THER, V287, P996; Arndt L, 2014, MOL BIOL CELL, V25, P948, DOI 10.1091/mbc.E13-09-0523; Arredouani A, 2015, J BIOL CHEM, V290, P21376, DOI 10.1074/jbc.M115.671248; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Churamani D, 2012, BIOCHEM J, V441, P317, DOI 10.1042/BJ20111617; Churchill GC, 2001, EMBO J, V20, P2666, DOI 10.1093/emboj/20.11.2666; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Collins TP, 2011, CELL CALCIUM, V50, P449, DOI 10.1016/j.ceca.2011.07.007; Davis LC, 2012, CURR BIOL, V22, P2331, DOI 10.1016/j.cub.2012.10.035; De Vos KJ, 2012, HUM MOL GENET, V21, P1299, DOI 10.1093/hmg/ddr559; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Fameli Nicola, 2014, F1000Res, V3, P93, DOI 10.12688/f1000research.3720.1; Favia A, 2014, P NATL ACAD SCI USA, V111, pE4706, DOI 10.1073/pnas.1406029111; Galione A, 2015, CELL CALCIUM, V58, P27, DOI 10.1016/j.ceca.2014.09.010; Gerasimenko JV, 2015, CELL CALCIUM, V58, P237, DOI 10.1016/j.ceca.2015.05.005; Grimm C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5699; Grimm M, 2010, J MOL CELL CARDIOL, V48, P322, DOI 10.1016/j.yjmcc.2009.10.016; Higashida H, 1999, J BIOL CHEM, V274, P33348, DOI 10.1074/jbc.274.47.33348; Hockey LN, 2015, J CELL SCI, V128, P232, DOI 10.1242/jcs.164152; Huke S, 2011, J MOL CELL CARDIOL, V50, P230, DOI 10.1016/j.yjmcc.2010.10.014; Jentsch TJ, 2015, EMBO J, V34, P1737, DOI 10.15252/embj.201591884; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Kannt A, 2012, N-S ARCH PHARMACOL, V385, P717, DOI 10.1007/s00210-012-0750-2; Khoo MSC, 2006, CIRCULATION, V114, P1352, DOI 10.1161/CIRCULATIONAHA.106.644583; Kinnear NP, 2004, J BIOL CHEM, V279, P54319, DOI 10.1074/jbc.M406132200; Lear PV, 2015, ENDOCRINOLOGY, V156, P975, DOI 10.1210/en.2014-1766; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Lewis AM, 2012, BIOCHEM BIOPH RES CO, V427, P326, DOI 10.1016/j.bbrc.2012.09.054; Lin PH, 2015, J BIOL CHEM, V290, P3377, DOI 10.1074/jbc.M114.608471; Lin-Moshier Y, 2014, P NATL ACAD SCI USA, V111, P13087, DOI 10.1073/pnas.1407004111; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Liu W, 2011, CIRCULATION, V124, P2702, DOI 10.1161/CIRCULATIONAHA.111.048785; Lu YY, 2013, J BIOL CHEM, V288, P24247, DOI 10.1074/jbc.M113.484253; Luo WS, 1996, CIRC RES, V78, P839, DOI 10.1161/01.RES.78.5.839; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Mattiazzi A, 2011, HEART RHYTHM, V8, P784, DOI 10.1016/j.hrthm.2010.11.035; Mishra S, 2011, CIRC RES, V109, P1354, DOI 10.1161/CIRCRESAHA.111.248401; Morgan AJ, 2007, BIOCHEM J, V402, P301, DOI 10.1042/BJ20060759; Morgan AJ, 2014, BIOESSAYS, V36, P173, DOI 10.1002/bies.201300118; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Morris J. K., 1965, J CELL BIOL, V27, p1A; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Parkesh R, 2007, ORG BIOMOL CHEM, V5, P441, DOI 10.1039/b617344f; Patel S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3314; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Rakovic S., 2002, CYCLIC ADP RIBOSE NA, P319; Rietdorf K, 2011, J BIOL CHEM, V286, P37058, DOI 10.1074/jbc.C111.289835; Ruas M, 2015, EMBO J, V34, P1743, DOI 10.15252/embj.201490009; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Tsaih SW, 2014, GENETICS, V198, P17, DOI 10.1534/genetics.114.162982; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Zhang F, 2006, AM J PHYSIOL-HEART C, V291, pH274, DOI 10.1152/ajpheart.01064.2005; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	61	45	45	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30087	30098		10.1074/jbc.M115.684076	http://dx.doi.org/10.1074/jbc.M115.684076			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26438825	Green Published, hybrid			2022-12-28	WOS:000366614700039
J	Hsu, MF; Fu, HY; Cai, CJ; Yi, HP; Yang, CS; Wang, AHJ				Hsu, Min-Feng; Fu, Hsu-Yuan; Cai, Chun-Jie; Yi, Hsiu-Pin; Yang, Chii-Shen; Wang, Andrew H. -J.			Structural and Functional Studies of a Newly Grouped Haloquadratum walsbyi Bacteriorhodopsin Reveal the Acid-resistant Light-driven Proton Pumping Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ION PUMPS; RHODOPSIN; PROTEORHODOPSIN; SYSTEM; XANTHORHODOPSIN; PHOTOCYCLE; REFINEMENT; MEMBRANE; PROTEINS	Retinal bound light-driven proton pumps are widespread in eukaryotic and prokaryotic organisms. Among these pumps, bacteriorhodopsin (BR) proteins cooperate with ATP synthase to convert captured solar energy into a biologically consumable form, ATP. In an acidic environment or when pumped-out protons accumulate in the extracellular region, the maximum absorbance of BR proteins shifts markedly to the longer wavelengths. These conditions affect the light-driven proton pumping functional exertion as well. In this study, wild-type crystal structure of a BR with optical stability under wide pH range from a square halophilic archaeon, Haloquadratum walsbyi (HwBR), was solved in two crystal forms. One crystal form, refined to 1.85 angstrom resolution, contains a trimer in the asymmetric unit, whereas another contains an antiparallel dimer was refined at 2.58 angstrom. HwBR could not be classified into any existing subgroup of archaeal BR proteins based on the protein sequence phylogenetic tree, and it showed unique absorption spectral stability when exposed to low pH values. All structures showed a unique hydrogen-bonding network between Arg(82) and Thr(201), linking the BC and FG loops to shield the retinal-binding pocket in the interior from the extracellular environment. This result was supported by R82E mutation that attenuated the optical stability. The negatively charged cytoplasmic side and the Arg(82)-Thr(201) hydrogen bond may play an important role in the proton translocation trend in HwBR under acidic conditions. Our findings have unveiled a strategy adopted by BR proteins to solidify their defenses against unfavorable environments and maintain their optical properties associated with proton pumping.	[Hsu, Min-Feng; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Hsu, Min-Feng; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Struct Anal, Taipei 11529, Taiwan; [Fu, Hsu-Yuan; Cai, Chun-Jie; Yi, Hsiu-Pin; Yang, Chii-Shen] Natl Taiwan Univ, Coll Life Sci, Dept Biochem Sci & Technol, Taipei 10617, Taiwan; [Fu, Hsu-Yuan] Natl Taiwan Univ, Coll Bioresources & Agr, Yen Tjing Ling Ind Res Inst, Taipei 10617, Taiwan; [Yang, Chii-Shen] Natl Taiwan Univ, Coll Bioresources & Agr, Inst Biotechnol, Taipei 10617, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University	Yang, CS (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, 1 Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	chiishen@ntu.edu.tw; ahjwang@gate.sinica.edu.tw	Hsiao, Wei-Hung/B-9931-2013	Fu, Hsu-Yuan/0000-0002-5327-2208	National Science Council [NSC101-2319-B-001-003, NSC102-2319-B-001-003, NSC 103-2311-B-002-022]; Yen Tjing Ling Industrial Research Institute, National Taiwan University [100-S-A71]; Giant Lion Know-How, Taipei, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Yen Tjing Ling Industrial Research Institute, National Taiwan University; Giant Lion Know-How, Taipei, Taiwan	This work was supported by the National Science Council (Grants NSC101-2319-B-001-003, NSC102-2319-B-001-003, and NSC 103-2311-B-002-022), the Yen Tjing Ling Industrial Research Institute, National Taiwan University (Grant 100-S-A71), and Giant Lion Know-How, Taipei, Taiwan. The authors declare that they have no conflicts of interest with the contents of this article.	Adamian L, 2006, PHOTOCHEM PHOTOBIOL, V82, P1426, DOI 10.1562/2006-02-14-RA-802; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balashov SP, 2012, BIOCHEMISTRY-US, V51, P5748, DOI 10.1021/bi300409m; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Brown LS, 2014, BBA-BIOENERGETICS, V1837, P553, DOI 10.1016/j.bbabio.2013.05.006; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chan SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108362; Chu LK, 2010, BIOSENS BIOELECTRON, V26, P620, DOI 10.1016/j.bios.2010.07.013; DANON A, 1974, P NATL ACAD SCI USA, V71, P1234, DOI 10.1073/pnas.71.4.1234; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enamil N, 2006, J MOL BIOL, V358, P675, DOI 10.1016/j.jmb.2006.02.032; Ernst OP, 2008, J BIOL CHEM, V283, P1637, DOI 10.1074/jbc.M708039200; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Fu HY, 2013, MOL MICROBIOL, V88, P551, DOI 10.1111/mmi.12208; Fu HY, 2010, J BACTERIOL, V192, P5866, DOI 10.1128/JB.00642-10; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Gushchin I, 2013, P NATL ACAD SCI USA, V110, P12631, DOI 10.1073/pnas.1221629110; HENDERSON R, 1977, ANNU REV BIOPHYS BIO, V6, P87, DOI 10.1146/annurev.bb.06.060177.000511; Hendler RW, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1311, DOI 10.1023/A:1013143621346; Hirai T, 2009, CURR OPIN STRUC BIOL, V19, P433, DOI 10.1016/j.sbi.2009.07.009; Hsu MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056363; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; KUAN G, 1994, RES MICROBIOL, V145, P273, DOI 10.1016/0923-2508(94)90183-X; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Luecke H, 2000, BBA-BIOENERGETICS, V1460, P133, DOI 10.1016/S0005-2728(00)00135-3; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Man DL, 2003, EMBO J, V22, P1725, DOI 10.1093/emboj/cdg183; MUKOHATA Y, 1994, BIOPHYS CHEM, V50, P191, DOI 10.1016/0301-4622(94)85031-3; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Okumura H, 2005, J MOL BIOL, V351, P481, DOI 10.1016/j.jmb.2005.06.026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pastrana E, 2011, NAT METHODS, V8, P24, DOI 10.1038/NMETH.F.323; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Ran TT, 2013, ACTA CRYSTALLOGR D, V69, P1965, DOI 10.1107/S0907444913017575; Reckel S, 2011, ANGEW CHEM INT EDIT, V50, P11942, DOI 10.1002/anie.201105648; Rodrigues DF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-547; Schopf JW, 2006, PHILOS T R SOC B, V361, P869, DOI 10.1098/rstb.2006.1834; Sharma AK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-79; Sharma AK, 2009, ISME J, V3, P726, DOI 10.1038/ismej.2009.13; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Tsukamoto T, 2013, J BIOL CHEM, V288, P21581, DOI 10.1074/jbc.M113.479394; VARO G, 1989, BIOPHYS J, V56, P1143, DOI 10.1016/S0006-3495(89)82761-4; Wada T, 2011, J MOL BIOL, V411, P986, DOI 10.1016/j.jmb.2011.06.028; WALSBY AE, 1980, NATURE, V283, P69, DOI 10.1038/283069a0; Wang JP, 2002, BIOPHYS J, V83, P1557, DOI 10.1016/S0006-3495(02)73925-8; Worth CL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-161; Yoshimura K, 2008, J MOL BIOL, V375, P1267, DOI 10.1016/j.jmb.2007.11.039; Zhai YF, 2001, BBA-BIOMEMBRANES, V1511, P206, DOI 10.1016/S0005-2736(00)00389-8; Zhang J, 2013, PROTEINS, V81, P1585, DOI 10.1002/prot.24316; ZIMANYI L, 1992, BIOCHEMISTRY-US, V31, P8535, DOI 10.1021/bi00151a022	54	12	12	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29567	29577		10.1074/jbc.M115.685065	http://dx.doi.org/10.1074/jbc.M115.685065			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26483542	Green Published, hybrid			2022-12-28	WOS:000366613400038
J	Trusch, F; Matena, A; Vuk, M; Koerver, L; Knaevelsrud, H; Freemont, PS; Meyer, H; Bayer, P				Trusch, Franziska; Matena, Anja; Vuk, Maja; Koerver, Lisa; Knaevelsrud, Helene; Freemont, Paul S.; Meyer, Hemmo; Bayer, Peter			The N-terminal Region of the Ubiquitin Regulatory X (UBX) Domain-containing Protein 1 (UBXD1) Modulates Interdomain Communication within the Valosin-containing Protein p97	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; ATPASE ACTIVITY; AAA-ATPASE; SUBSTOICHIOMETRIC INHIBITION; SECONDARY STRUCTURE; CRYSTAL-STRUCTURES; MOLECULAR-BASIS; VCP/P97; DISEASE; CAVEOLIN-1	Valosin-containing protein/p97 is an ATP-driven protein segregase that cooperates with distinct protein cofactors to control various aspects of cellular homeostasis. Mutations at the interface between the regulatory N-domain and the first of two ATPase domains (D1 and D2) deregulate the ATPase activity and cause a multisystem degenerative disorder, inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia/amyotrophic lateral sclerosis. Intriguingly, the mutations affect only a subset of p97-mediated pathways correlating with unbalanced cofactor interactions and most prominently compromised binding of the ubiquitin regulatory X domain-containing protein 1 (UBXD1) cofactor during endolysosomal sorting of caveolin-1. However, how the mutations impinge on the p97-cofactor interplay is unclear so far. In cell-based endosomal localization studies, we identified a critical role of the N-terminal region of UBXD1 (UBXD1-N). Biophysical studies using NMR and CD spectroscopy revealed that UBXD1-N can be classified as intrinsically disordered. NMR titration experiments confirmed a valosin-containing protein/p97 interaction motif and identified a second binding site at helices 1 and 2 of UBXD1-N as binding interfaces for p97. In reverse titration experiments, we identified two distant epitopes on the p97 N-domain that include disease-associated residues and an additional interaction between UBXD1-N and the D1D2 barrel of p97 that was confirmed by fluorescence anisotropy. Functionally, binding of UBXD1-N to p97 led to a reduction of ATPase activity and partial protection from proteolysis. These findings indicate that UBXD1-N intercalates into the p97-ND1 interface, thereby modulating interdomain communication of p97 domains and its activity with relevance for disease pathogenesis. We propose that the polyvalent binding mode characterized for UBXD1-N is a more general principle that defines a subset of p97 cofactors.	[Trusch, Franziska; Matena, Anja; Bayer, Peter] Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Struct & Med Biochem, D-45117 Essen, Germany; [Vuk, Maja; Koerver, Lisa; Knaevelsrud, Helene; Meyer, Hemmo] Univ Duisburg Essen, Ctr Med Biotechnol ZMB, Mol Biol 1, D-45117 Essen, Germany; [Freemont, Paul S.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Struct Biol, London SW7 2AZ, England	University of Duisburg Essen; University of Duisburg Essen; Imperial College London	Bayer, P (corresponding author), Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol ZMB, Struct & Med Biochem, Rm S03 S01 A35,Univ Str 1-5, D-45141 Essen, Germany.	peter.bayer@uni-due.de	Bayer, Peter/B-8803-2009; Meyer, Hemmo/GNH-5784-2022; Knævelsrud, Helene/G-9302-2016	Bayer, Peter/0000-0003-0435-7202; Meyer, Hemmo/0000-0003-1883-1796; Knævelsrud, Helene/0000-0001-8848-8829	Deutsche Forschungsgemeinschaft Collaborative Research Centre [1093]	Deutsche Forschungsgemeinschaft Collaborative Research Centre(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Collaborative Research Centre 1093 (to P. B. and H. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Benirschke RC, 2010, STRUCTURE, V18, P955, DOI 10.1016/j.str.2010.04.017; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Christensen LC, 2012, J BIOL CHEM, V287, P26388, DOI 10.1074/jbc.M112.346775; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fernandez-Saiz V, 2010, EMBO REP, V11, P479, DOI 10.1038/embor.2010.49; Frye JJ, 2013, NAT STRUCT MOL BIOL, V20, P827, DOI 10.1038/nsmb.2593; Gersch M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7320; Grum D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065346; Hanzelmann P, 2011, J BIOL CHEM, V286, P38679, DOI 10.1074/jbc.M111.274506; Haines DS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016444; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Isaacson RL, 2007, J BIOL CHEM, V282, P21361, DOI 10.1074/jbc.M610069200; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Ju JS, 2010, AUTOPHAGY, V6, P283, DOI 10.4161/auto.6.2.11063; Kern M, 2009, BIOCHEM BIOPH RES CO, V380, P303, DOI 10.1016/j.bbrc.2009.01.076; Kirchner P, 2013, J BIOL CHEM, V288, P7363, DOI 10.1074/jbc.M112.429076; Kloppsteck P, 2012, BBA-MOL CELL RES, V1823, P125, DOI 10.1016/j.bbamcr.2011.09.006; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035628; Liu J, 2013, BIOCHEMISTRY-US, V52, P3051, DOI 10.1021/bi4001358; Liu S, 2013, BBA-PROTEINS PROTEOM, V1834, P2672, DOI 10.1016/j.bbapap.2013.09.021; Madsen L, 2008, INT J BIOCHEM CELL B, V40, P2927, DOI 10.1016/j.biocel.2008.06.008; Meyer H, 2014, J CELL SCI, V127, P3877, DOI 10.1242/jcs.093831; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer HH, 1998, FEBS LETT, V437, P255, DOI 10.1016/S0014-5793(98)01232-0; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Mustafi SM, 2010, BIOCHEM BIOPH RES CO, V397, P509, DOI 10.1016/j.bbrc.2010.05.144; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Orosz F, 1999, BIOCHEMISTRY-US, V38, P1857, DOI 10.1021/bi981350p; PlengeTellechea F, 1997, J BIOL CHEM, V272, P2794, DOI 10.1074/jbc.272.5.2794; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Ritz D, 2011, NAT CELL BIOL, V13, P1116, DOI 10.1038/ncb2301; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; SMITH SL, 1992, BIOCHEM PHARMACOL, V44, P65, DOI 10.1016/0006-2952(92)90039-L; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stapf C, 2011, J BIOL CHEM, V286, P38670, DOI 10.1074/jbc.M111.274472; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Tanaka N, 2006, J MOL BIOL, V356, P312, DOI 10.1016/j.jmb.2005.11.076; Tang WK, 2013, J BIOL CHEM, V288, P36624, DOI 10.1074/jbc.M113.488924; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Uchiyama K, 2005, J BIOCHEM, V137, P115, DOI 10.1093/jb/mvi028; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009; Williams R M, 2001, Pac Symp Biocomput, P89; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Wu JW, 2013, BIOCHEM BIOPH RES CO, V440, P173, DOI 10.1016/j.bbrc.2013.09.056; Xu Y, 2013, J BIOL CHEM, V288, P18068, DOI 10.1074/jbc.M112.449199; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	58	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29414	29427		10.1074/jbc.M115.680686	http://dx.doi.org/10.1074/jbc.M115.680686			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26475856	hybrid, Green Published			2022-12-28	WOS:000366613400026
J	Zhang, HT; Unal, H; Desnoyer, R; Han, GW; Patel, N; Katritch, V; Karnik, SS; Cherezov, V; Stevens, RC				Zhang, Haitao; Unal, Hamiyet; Desnoyer, Russell; Han, Gye Won; Patel, Nilkanth; Katritch, Vsevolod; Karnik, Sadashiva S.; Cherezov, Vadim; Stevens, Raymond C.			Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPIDIC CUBIC PHASE; AT(1) RECEPTOR; BINDING; AGONIST; ACTIVATION; MUTATIONS; MECHANISM; SODIUM; ENERGY	Angiotensin II type 1 receptor (AT(1)R) is the primary blood pressure regulator. AT(1)R blockers (ARBs) have been widely used in clinical settings as anti-hypertensive drugs and share a similar chemical scaffold, although even minor variations can lead to distinct therapeutic efficacies toward cardiovascular etiologies. The structural basis for AT(1)R modulation by different peptide and non-peptide ligands has remained elusive. Here, we report the crystal structure of the human AT(1)R in complex with an inverse agonist olmesartan (Benicar (TM)), a highly potent anti-hypertensive drug. Olmesartan is anchored to the receptor primarily by the residues Tyr-35(1.39), Trp-84(2.60), and Arg-167(ECL2), similar to the antagonist ZD7155, corroborating a common binding mode of different ARBs. Using docking simulations and site-directed mutagenesis, we identified specific interactions between AT(1)R and different ARBs, including olmesartan derivatives with inverse agonist, neutral antagonist, or agonist activities. We further observed that the mutation N111(3.35)A in the putative sodium-binding site affects binding of the endogenous peptide agonist angiotensin II but not the beta-arrestin-biased peptide TRV120027.	[Zhang, Haitao; Patel, Nilkanth; Katritch, Vsevolod; Stevens, Raymond C.] Univ So Calif, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90089 USA; [Zhang, Haitao; Han, Gye Won; Cherezov, Vadim; Stevens, Raymond C.] Univ So Calif, Bridge Inst, Dept Chem, Los Angeles, CA 90089 USA; [Unal, Hamiyet; Desnoyer, Russell; Karnik, Sadashiva S.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	University of Southern California; University of Southern California; Cleveland Clinic Foundation	Karnik, SS (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA.	karniks@ccf.org; stevens@usc.edu	Stevens, Raymond/K-7272-2015; Cherezov, Vadim/L-9812-2013; Katritch, Vsevolod/Y-2721-2019; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8724-2022; Katritch, Vsevolod/Q-8357-2016; Patel, Nilkanth/S-2659-2019; Zhang, Haitao/L-7612-2015; Han, Gye Won/GLQ-8673-2022; Karnik, Sadashiva/Y-2477-2019	Stevens, Raymond/0000-0002-4522-8725; Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Katritch, Vsevolod/0000-0003-3883-4505; Patel, Nilkanth/0000-0002-9856-3041; Zhang, Haitao/0000-0003-4879-2951; Karnik, Sadashiva/0000-0003-0746-2753	Department of Energy Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NCI [ACB-12002]; NIGMS [AGM-12006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057470, T32HL007914, R01HL115964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618] Funding Source: NIH RePORTER	Department of Energy Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Velasquez for help with molecular biology, M. Chu for help with baculovirus expression, and A. Walker for assistance with manuscript preparation. We thank Dr. Shin-ichiro (Fukuoka University School of Medicine, Fukuoka, Japan) for help and Daiichi Sankyo Co., Ltd., Tokyo, Japan for generous supply of olmesartan and its derivatives. This research used resources of the Advanced Photon Source, a United States Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Parts of this research were carried out at the General Medical Sciences and NCI Structural Biology Facility at the Advanced Photon Source (GM/CA@APS), Argonne National Laboratory. GM/CA@APS has been funded in whole or in part by Grant ACB-12002 from NCI and Grant AGM-12006 from NIGMS.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balakumar P, 2014, J MOL ENDOCRINOL, V53, pR71, DOI 10.1530/JME-14-0125; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BIHOREAU C, 1993, P NATL ACAD SCI USA, V90, P5133, DOI 10.1073/pnas.90.11.5133; Burnier M, 2000, LANCET, V355, P637, DOI 10.1016/S0140-6736(99)10365-9; Bursulaya BD, 2003, J COMPUT AID MOL DES, V17, P755, DOI 10.1023/B:JCAM.0000017496.76572.6f; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chun E, 2012, STRUCTURE, V20, P967, DOI 10.1016/j.str.2012.04.010; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Feng YH, 2005, MOL PHARMACOL, V68, P347, DOI 10.1124/mol.105.011601; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Imaizumi S, 2013, CURR PHARM DESIGN, V19, P3002; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Liu W, 2014, NAT PROTOC, V9, P2123, DOI 10.1038/nprot.2014.141; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miura S, 2004, HYPERTENS RES, V27, P765, DOI 10.1291/hypres.27.765; Miura S, 2006, J BIOL CHEM, V281, P19288, DOI 10.1074/jbc.M602144200; Miura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079914; Miura S, 2013, HYPERTENS RES, V36, P134, DOI 10.1038/hr.2012.147; Miura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037974; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; Parnot C, 2000, P NATL ACAD SCI USA, V97, P7615, DOI 10.1073/pnas.110142297; PERLMAN S, 1995, J BIOL CHEM, V270, P1493, DOI 10.1074/jbc.270.4.1493; Schapira M, 1999, J MOL RECOGNIT, V12, P177, DOI 10.1002/(SICI)1099-1352(199905/06)12:3<177::AID-JMR451>3.0.CO;2-Z; Totrov M, 1997, PROTEINS, P215; Unal Hamiyet, 2014, Adv Pharmacol, V70, P155, DOI 10.1016/B978-0-12-417197-8.00006-7; Unal H, 2013, J BIOL CHEM, V288, P540, DOI 10.1074/jbc.M112.392514; Unal H, 2010, J BIOL CHEM, V285, P16341, DOI 10.1074/jbc.M109.094870; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873; Zhang HT, 2015, CELL, V161, P833, DOI 10.1016/j.cell.2015.04.011	43	108	109	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29127	29139		10.1074/jbc.M115.689000	http://dx.doi.org/10.1074/jbc.M115.689000			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26420482	hybrid, Green Published			2022-12-28	WOS:000366613400002
J	Molina, R; Redondo, P; Lopez-Mendez, B; Villate, M; Merino, N; Blanco, FJ; Valton, J; Grizot, S; Duchateau, P; Prieto, J; Montoya, G				Molina, Rafael; Redondo, Pilar; Lopez-Mendez, Blanca; Villate, Maider; Merino, Nekane; Blanco, Francisco J.; Valton, Julien; Grizot, Silvestre; Duchateau, Phillipe; Prieto, Jesus; Montoya, Guillermo			Crystal Structure of the Homing Endonuclease I-CvuI Provides a New Template for Genome Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA endonuclease; enzyme; genetics; protein-DNA interaction; X-ray crystallography; gene targeting; homing endonucleases	PROTEIN-DNA INTERACTIONS; HOMOLOGOUS RECOMBINATION; MOLECULAR-BASIS; SYSTEM; SITE; FEATURES; COMPLEX; BINDING	Homing endonucleases recognize and generate a DNA double-strand break, which has been used to promote gene targeting. These enzymes recognize long DNA stretches; they are highly sequence-specific enzymes and display a very low frequency of cleavage even in complete genomes. Although a large number of homing endonucleases have been identified, the landscape of possible target sequences is still very limited to cover the complexity of the whole eukaryotic genome. Therefore, the finding and molecular analysis of homing endonucleases identified but not yet characterized may widen the landscape of possible target sequences. The previous characterization of protein-DNA interaction before the engineering of new homing endonucleases is essential for further enzyme modification. Here we report the crystal structure of I-CvuI in complex with its target DNA and with the target DNA of I-CreI, a homologue enzyme widely used in genome engineering. To characterize the enzyme cleavage mechanism, we have solved the I-CvuI DNA structures in the presence of non-catalytic (Ca2+) and catalytic ions (Mg2+). We have also analyzed the metal dependence of DNA cleavage using Mg2+ ions at different concentrations ranging from non-cleavable to cleavable concentrations obtained from in vitro cleavage experiments. The structure of I-CvuI homing endonuclease expands the current repertoire for engineering custom specificities, both by itself as a new scaffold alone and in hybrid constructs with other related homing endonucleases or other DNA-binding protein templates.	[Molina, Rafael; Redondo, Pilar; Prieto, Jesus; Montoya, Guillermo] Spanish Natl Canc Res Ctr CNIO, Macromol Crystallog Grp, Struct Biol & Biocomp Programme, Madrid 28029, Spain; [Lopez-Mendez, Blanca] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, Prot Struct & Funct Programme, DK-2200 Copenhagen, Denmark; [Villate, Maider; Merino, Nekane; Blanco, Francisco J.] CIC BioGUNE, Struct Biol Unit, Derio 48160, Spain; [Blanco, Francisco J.] Basque Fdn Sci, Ikerbasque, Bilbao 48013, Spain; [Valton, Julien; Grizot, Silvestre; Duchateau, Phillipe] CELLECTIS SA, F-75013 Paris, France	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Copenhagen; CIC bioGUNE; Basque Foundation for Science	Prieto, J (corresponding author), Spanish Natl Canc Res Ctr CNIO, Macromol Crystallog Grp, Struct Biol & Biocomp Programme, C Melchor Fernandez Almagro 3, Madrid 28029, Spain.	jprieto@cnio.es; guillermo.montoya@cpr.ku.dk	Blanco, Francisco J/D-4401-2009; Molina, Rafael/AAG-6552-2019; Molina, Rafael/L-6203-2016; Redondo, Pilar/L-7612-2014	Blanco, Francisco J/0000-0003-2545-4319; Molina, Rafael/0000-0002-6443-4989; Molina, Rafael/0000-0002-6443-4989; Redondo, Pilar/0000-0002-6723-0818; Valton, Julien/0000-0003-0826-5401; GRIZOT, Sylvestre/0000-0002-0670-0687	Novo Nordisk Foundation [NNF14CC0001]; Novo Nordisk Foundation Center for Protein Research [PI Guillermo Montoya] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Foundation Center for Protein Research	We thank the Swiss Light Source and XALOC beamline staff from the Spanish Synchrotron Radiation Facility for their support. The Novo Nordisk Foundation Center for Protein Research is supported financially by the Novo Nordisk Foundation (Grant NNF14CC0001).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065; Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Chevalier B, 2004, BIOCHEMISTRY-US, V43, P14015, DOI 10.1021/bi048970c; Chevalier BS, 2001, NAT STRUCT BIOL, V8, P312, DOI 10.1038/86181; CHOULIKA A, 1994, CR ACAD SCI III-VIE, V317, P1013; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Jurica NS, 1998, MOL CELL, V2, P469, DOI 10.1016/S1097-2765(00)80146-X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Lucas P, 2001, NUCLEIC ACIDS RES, V29, P960, DOI 10.1093/nar/29.4.960; Marcaida MJ, 2010, CELL MOL LIFE SCI, V67, P727, DOI 10.1007/s00018-009-0188-y; Marciada MJ, 2008, P NATL ACAD SCI USA, V105, P16888, DOI 10.1073/pnas.0804795105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molina R, 2015, NAT STRUCT MOL BIOL, V22, P65, DOI 10.1038/nsmb.2932; Molina R, 2012, NUCLEIC ACIDS RES, V40, P6936, DOI 10.1093/nar/gks320; Munoz IG, 2011, NUCLEIC ACIDS RES, V39, P729, DOI 10.1093/nar/gkq801; Prieto J, 2008, J BIOL CHEM, V283, P4364, DOI 10.1074/jbc.M706323200; Prieto J, 2012, CRIT REV BIOCHEM MOL, V47, P207, DOI 10.3109/10409238.2011.652358; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Redondo P, 2014, ACTA CRYSTALLOGR F, V70, P256, DOI 10.1107/S2053230X1400065X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Seligman LM, 1997, GENETICS, V147, P1653; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Wang JS, 1997, NUCLEIC ACIDS RES, V25, P3767, DOI 10.1093/nar/25.19.3767	28	2	2	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28727	28736		10.1074/jbc.M115.678342	http://dx.doi.org/10.1074/jbc.M115.678342			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26363068	Green Published, hybrid			2022-12-28	WOS:000365762300016
J	Suarez, S; McCollunn, GW; Jayagopal, A; Penn, JS				Suarez, Sandra; McCollunn, Gary W.; Jayagopal, Ashwath; Penn, John S.			High Glucose-induced Retinal Pericyte Apoptosis Depends on Association of GAPDH and Siah1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; DIABETIC-RETINOPATHY; NUCLEAR TRANSLOCATION; S-NITROSYLATION; CELL-DEATH; ENDOTHELIAL-CELLS; GROWTH-FACTOR; MULLER CELLS; NITRIC-OXIDE; FUNCTIONAL DIVERSITY	Diabetic retinopathy (DR) is a leading cause of blindness worldwide, and its prevalence is growing. Current therapies for DR address only the later stages of the disease, are invasive, and have limited effectiveness. Retinal pericyte death is an early pathologic feature of DR. Although it has been observed in diabetic patients and in animal models of DR, the cause of pericyte death remains unknown. A novel pro-apoptotic pathway initiated by the interaction between glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the E3 ubiquitin ligase, seven in absentia homolog 1 (Siah1), was recently identified in ocular tissues. In this article we examined the involvement of the GAPDH/Siah1 interaction in human retinal pericyte (hRP) apoptosis. HRP were cultured in 5 mm normal glucose, 25 mM L- or D-glucose for 48 h (osmotic control and high glucose treatments, respectively). Siah1 siRNA was used to down-regulate Siah1 expression. TAT-FLAG GAPDH and/or Siah1-directed peptides were used to block GAPDH and Siah1 interaction. Co-immunoprecipitation assays were conducted to analyze the effect of high glucose on the association of GAPDH and Siah1. Apoptosis was measured by Annexin V staining and caspase-3 enzymatic activity assay. High glucose increased Siah1 total protein levels, induced the association between GAPDH and Siah1, and led to GAPDH nuclear translocation. Our findings demonstrate that dissociation of the GAPDH/Siah1 pro-apoptotic complex can block high glucose-induced pericyte apoptosis, widely considered a hallmark feature of DR. Thus, the work presented in this article can provide a foundation to identify novel targets for early treatment of DR.	[Suarez, Sandra; Penn, John S.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [McCollunn, Gary W.; Penn, John S.] Vanderbilt Univ, Sch Med, Dept Ophthalmol & Visual Sci, Nashville, TN 37232 USA; [Jayagopal, Ashwath] F Hoffmann La Roche Ltd, pRED, CH-4070 Basel, Switzerland	Vanderbilt University; Vanderbilt University; Roche Holding	Suarez, S (corresponding author), Vanderbilt Eye Inst, 1215 21st Ave South,8000 Med Ctr East,North Tower, Nashville, TN 37232 USA.	Sandra.suarez@vanderbilt.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 EY07533, R01 EY07533-S25-27, R01 EY023639, P30 EY008126]; Research to Prevent Blindness, Inc.; OneSight Foundation; Vanderbilt CTSA [UL1TR000445, KL2TR000446, TL1TR000447]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000447, KL2TR000446, UL1TR000445] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126, R01EY023639, R01EY007533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); OneSight Foundation; Vanderbilt CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 EY07533 (to J. S. P.), R01 EY07533-S25-27 (to J. S. P.), R01 EY023639 (to J. S. P.), and P30 EY008126 (Core Grant in Vision Research), an Unrestricted Grant from Research to Prevent Blindness, Inc., a grant from the OneSight Foundation, and Vanderbilt CTSA Grants UL1TR000445, KL2TR000446, and/or TL1TR000447. The authors declare that they have no conflicts of interest with the contents of this article.	Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Beltramo E, 2013, CURR MED CHEM, V20, P3218, DOI 10.2174/09298673113209990022; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Cai CX, 2006, J BIOL CHEM, V281, P16649, DOI 10.1074/jbc.M512026200; CALNE DB, 1995, HOSP PRACT, V30, P83, DOI 10.1080/21548331.1995.11443136; Carlile GW, 2000, MOL PHARMACOL, V57, P2; Dastoor Z, 2001, J CELL SCI, V114, P1643; Du XL, 2003, J CLIN INVEST, V112, P1049, DOI 10.1172/JCI200318127; Eberth C., 1871, HDB LEHR GEWEBEN MEN; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Ejaz S, 2008, DIABETES OBES METAB, V10, P53, DOI 10.1111/j.1463-1326.2007.00795.x; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Gandica Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113165; Geevarghese A, 2014, TRANSL RES, V163, P296, DOI 10.1016/j.trsl.2014.01.011; Haddock LJ, 2014, SEMIN OPHTHALMOL, V29, P257, DOI 10.3109/08820538.2014.959616; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Heng LZ, 2013, DIABETIC MED, V30, P640, DOI 10.1111/dme.12089; Hoshiyama M, 2003, NEPHRON EXP NEPHROL, V95, pE62, DOI 10.1159/000073673; HOTTA N, 1995, EXP PHYSIOL, V80, P981, DOI 10.1113/expphysiol.1995.sp003909; Ishitani R, 1998, MOL PHARMACOL, V53, P701, DOI 10.1124/mol.53.4.701; Iwasaki Y, 1996, NEUROL RES, V18, P168; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kamba T, 2007, BRIT J CANCER, V96, P1788, DOI 10.1038/sj.bjc.6603813; Koutsilieri E, 1996, EUR J PHARMACOL, V306, P181, DOI 10.1016/0014-2999(96)00184-7; Kowluru RA, 2005, ANTIOXID REDOX SIGN, V7, P1581, DOI 10.1089/ars.2005.7.1581; Kragten E, 1998, J BIOL CHEM, V273, P5821, DOI 10.1074/jbc.273.10.5821; Kusner LL, 2004, INVEST OPHTH VIS SCI, V45, P1553, DOI 10.1167/iovs.03-1294; Li C, 2012, BIOCHEMISTRY-MOSCOW+, V77, P671, DOI 10.1134/S0006297912060156; Li WY, 1997, CHINESE MED J-PEKING, V110, P659; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Mizutani M, 1996, J CLIN INVEST, V97, P2883, DOI 10.1172/JCI118746; Mohr S, 1996, J BIOL CHEM, V271, P4209; Moliejunaite R., 2008, EXP EYE RES, V86, P171; MYTILINEOU C, 1985, J NEUROCHEM, V45, P1951, DOI 10.1111/j.1471-4159.1985.tb10556.x; Naruse K, 2000, EXP EYE RES, V71, P309, DOI 10.1006/exer.2000.0882; Nentwich MM, 2015, WORLD J DIABETES, V6, P489, DOI 10.4239/wjd.v6.i3.489; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; OAKES D, 1993, ANN NEUROL, V34, P634, DOI 10.1002/ana.410340423; Reed JC, 2002, NAT STRUCT BIOL, V9, P8, DOI 10.1038/nsb0102-8; Rodrigues M, 2013, DIABETES, V62, P3863, DOI 10.2337/db13-0014; Romeo G, 2002, DIABETES, V51, P2241, DOI 10.2337/diabetes.51.7.2241; Roperch JP, 1999, P NATL ACAD SCI USA, V96, P8070, DOI 10.1073/pnas.96.14.8070; ROY E, 1993, NEUROREPORT, V4, P1183; Saaddine JB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1740, DOI 10.1001/archopht.126.12.1740; SALO PT, 1992, J NEUROSCI RES, V31, P394, DOI 10.1002/jnr.490310223; Saunders PA, 1997, J NEUROCHEM, V69, P1820; Saunders PA, 1999, J NEUROCHEM, V72, P925, DOI 10.1046/j.1471-4159.1999.0720925.x; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Shin Eui Seok, 2014, J Ophthalmic Vis Res, V9, P362, DOI 10.4103/2008-322X.143378; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; TATTON WG, 1991, J NEUROSCI RES, V30, P666, DOI 10.1002/jnr.490300410; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Weerasekera LY, 2015, INVEST OPHTH VIS SCI, V56, P3721, DOI 10.1167/iovs.14-16289; Yego ECK, 2010, J BIOL CHEM, V285, P3181, DOI 10.1074/jbc.M109.083907	59	22	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28311	28320		10.1074/jbc.M115.682385	http://dx.doi.org/10.1074/jbc.M115.682385			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26438826	Green Published, hybrid			2022-12-28	WOS:000365761900023
J	Tatavosian, R; Zhen, CY; Duc, HN; Balas, MM; Johnson, AM; Ren, XJ				Tatavosian, Roubina; Zhen, Chao Yu; Huy Nguyen Duc; Balas, Maggie M.; Johnson, Aaron M.; Ren, Xiaojun			Distinct Cellular Assembly Stoichiometry of Polycomb Complexes on Chromatin Revealed by Single-molecule Chromatin Immunoprecipitation Imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; HISTONE H3; NUCLEOSOME DYNAMICS; GENE-EXPRESSION; CBX PROTEINS; SAM DOMAIN; PRC1; METHYLATION; BINDING; HETEROCHROMATIN	Epigenetic complexes play an essential role in regulating chromatin structure, but information about their assembly stoichiometry on chromatin within cells is poorly understood. The cellular assembly stoichiometry is critical for appreciating the initiation, propagation, and maintenance of epigenetic inheritance during normal development and in cancer. By combining genetic engineering, chromatin biochemistry, and single-molecule fluorescence imaging, we developed a novel and sensitive approach termed single-molecule chromatin immunoprecipitation imaging (Sm-ChIPi) to enable investigation of the cellular assembly stoichiometry of epigenetic complexes on chromatin. Sm-ChIPi was validated by using chromatin complexes with known stoichiometry. The stoichiometry of subunits within a polycomb complex and the assembly stoichiometry of polycomb complexes on chromatin have been extensively studied but reached divergent views. Moreover, the cellular assembly stoichiometry of polycomb complexes on chromatin remains unexplored. Using Sm-ChIPi, we demonstrated that within mouse embryonic stem cells, one polycomb repressive complex (PRC) 1 associates with multiple nucleosomes, whereas two PRC2s can bind to a single nucleosome. Furthermore, we obtained direct physical evidence that the nucleoplasmic PRC1 is monomeric, whereas PRC2 can dimerize in the nucleoplasm. We showed that ES cell differentiation induces selective alteration of the assembly stoichiometry of Cbx2 on chromatin but not other PRC1 components. We additionally showed that the PRC2-mediated trimethylation of H3K27 is not required for the assembly stoichiometry of PRC1 on chromatin. Thus, these findings uncover that PRC1 and PRC2 employ distinct mechanisms to assemble on chromatin, and the novel Sm-ChIPi technique could provide single-molecule insight into other epigenetic complexes.	[Tatavosian, Roubina; Zhen, Chao Yu; Huy Nguyen Duc; Ren, Xiaojun] Univ Colorado, Dept Chem, Denver, CO 80217 USA; [Balas, Maggie M.; Johnson, Aaron M.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus	Ren, XJ (corresponding author), Univ Colorado, Dept Chem, Denver, CO 80217 USA.	xiaojun.ren@ucdenver.edu		Ren, Xiaojun/0000-0002-3931-7625; Balas, Maggie/0000-0002-0701-1787	National Institutes of Health Pathway to Independence Award [K99/R00 GM094291]; University of Colorado Denver; CU-Denver Office Research Service; American Cancer Society [IRG 57-001-53]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM094291, K99GM094291] Funding Source: NIH RePORTER	National Institutes of Health Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado Denver; CU-Denver Office Research Service; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Pathway to Independence Award K99/R00 GM094291 (to A.J.). This work was also supported by grants from the University of Colorado Denver (to X. R.), the CU-Denver Office Research Service (to X. R.), and American Cancer Society Grant IRG 57-001-53 subaward (to X. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Alves D, 2008, NAT CHEM BIOL, V4, P287, DOI 10.1038/nchembio.82; An WJ, 2004, METHOD ENZYMOL, V377, P460; Baeza J, 2014, J BIOL CHEM, V289, P21326, DOI 10.1074/jbc.M114.581843; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Bowman GD, 2015, CHEM REV, V115, P2274, DOI 10.1021/cr500350x; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Cheng B, 2014, MOL CELL BIOL, V34, P2075, DOI 10.1128/MCB.01729-13; CHUNG SH, 1991, J NEUROSCI METH, V40, P71, DOI 10.1016/0165-0270(91)90118-J; Ciferri C, 2012, ELIFE, V1, DOI 10.7554/eLife.00005; Coffman VC, 2012, TRENDS BIOCHEM SCI, V37, P499, DOI 10.1016/j.tibs.2012.08.002; Cowell IG, 1997, BBA-PROTEIN STRUCT M, V1337, P198, DOI 10.1016/S0167-4838(96)00165-3; Czypionka A, 2007, BIOCHEMISTRY-US, V46, P12764, DOI 10.1021/bi701343q; Davidovich C, 2015, MOL CELL, V57, P552, DOI 10.1016/j.molcel.2014.12.017; Davidovich C, 2014, NUCLEIC ACIDS RES, V42, P9236, DOI 10.1093/nar/gku540; Deindl S, 2013, CELL, V152, P442, DOI 10.1016/j.cell.2012.12.040; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Frey A, 2014, CURR BIOL, V24, P2195, DOI 10.1016/j.cub.2014.07.077; Fujisaki S, 2003, BIOCHEM BIOPH RES CO, V300, P135, DOI 10.1016/S0006-291X(02)02791-2; Gambetta MC, 2014, DEV CELL, V31, P629, DOI 10.1016/j.devcel.2014.10.020; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Grau DJ, 2011, GENE DEV, V25, P2210, DOI 10.1101/gad.17288211; Isono K, 2013, DEV CELL, V26, P565, DOI 10.1016/j.devcel.2013.08.016; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Johnson A, 2013, J BIOL CHEM, V288, P28771, DOI 10.1074/jbc.M113.460071; Johnson A, 2009, MOL CELL, V35, P769, DOI 10.1016/j.molcel.2009.07.030; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee JY, 2015, J BIOL CHEM, V290, P4291, DOI 10.1074/jbc.M114.619213; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li M, 2015, ELIFE, V4, DOI 10.7554/eLife.06249; Lo SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047162; Lo SM, 2010, BIOCHEMISTRY-US, V49, P9438, DOI 10.1021/bi100532a; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382; Luo Y, 2014, NUCLEIC ACIDS RES, V42, P3017, DOI 10.1093/nar/gkt1319; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Murphy PJ, 2013, P NATL ACAD SCI USA, V110, P7772, DOI 10.1073/pnas.1218495110; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Ngo TTM, 2015, CELL, V160, P1135, DOI 10.1016/j.cell.2015.02.001; Oliver SS, 2011, CHEMBIOCHEM, V12, P299, DOI 10.1002/cbic.201000474; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Ren XJ, 2011, MOL CELL BIOL, V31, P2100, DOI 10.1128/MCB.05088-11; Ren XJ, 2006, J AM CHEM SOC, V128, P4992, DOI 10.1021/ja056613z; Ren XJ, 2003, NUCLEIC ACIDS RES, V31, P6509, DOI 10.1093/nar/gkg871; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Swygert SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5751; Tardat M, 2015, MOL CELL, V58, P157, DOI 10.1016/j.molcel.2015.02.013; Tie F, 2003, MOL CELL BIOL, V23, P3352, DOI 10.1128/MCB.23.9.3352-3362.2003; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Vary JC, 2004, METHOD ENZYMOL, V375, P88; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wu L, 2013, BIOCHEMISTRY-US, V52, P9519, DOI 10.1021/bi401085h; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zhen CY, 2014, MOL BIOL CELL, V25, P3726, DOI 10.1091/mbc.E14-06-1109; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	77	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28038	28054		10.1074/jbc.M115.671115	http://dx.doi.org/10.1074/jbc.M115.671115			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26381410	Green Published, hybrid			2022-12-28	WOS:000365761900002
J	Payne, KAP; Fisher, K; Sjuts, H; Dunstan, MS; Bellina, B; Johannissen, L; Barran, P; Hay, S; Rigby, SEJ; Leys, D				Payne, Karl A. P.; Fisher, Karl; Sjuts, Hanno; Dunstan, Mark S.; Bellina, Bruno; Johannissen, Linus; Barran, Perdita; Hay, Sam; Rigby, Stephen E. J.; Leys, David			Epoxyqueuosine Reductase Structure Suggests a Mechanism for Cobalamin-dependent tRNA Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RES; IRON-SULFUR CLUSTER; ESCHERICHIA-COLI; REPEAT PROTEINS; NUCLEOSIDE Q; QUEUOSINE; BIOSYNTHESIS; VITAMIN-B-12; PURIFICATION; DISCOVERY	Queuosine (Q) is a hypermodified RNA base that replaces guanine in the wobble positions of 5'-GUN-3' tRNA molecules. Q is exclusively made by bacteria, and the corresponding queuine base is a micronutrient salvaged by eukaryotic species. The final step in Q biosynthesis is the reduction of the epoxide precursor, epoxyqueuosine, to yield the Q cyclopentene ring. The epoxyqueuosine reductase responsible, QueG, shares distant homology with the cobalamin-dependent reductive dehalogenase (RdhA), however the role played by cobalamin in QueG catalysis has remained elusive. Wereport the solution and structural characterization of Streptococcus thermophilus QueG, revealing the enzyme harbors a redox chain consisting of two [4Fe-4S] clusters and a cob(II) alamin in the base-off form, similar to RdhAs. In contrast to the shared redox chain architecture, the QueG active site shares little homology with RdhA, with the notable exception of a conserved Tyr that is proposed to function as a proton donor during reductive dehalogenation. Docking of an epoxyqueuosine substrate suggests the QueG active site places the substrate cyclopentane moiety in close proximity of the cobalt. Both the Tyr and a conserved Asp are implicated as proton donors to the epoxide leaving group. This suggests that, in contrast to the unusual carbon-halogen bond chemistry catalyzed by RdhAs, QueG acts via Co-C bond formation. Our study establishes the common features of Class III cobalamin-dependent enzymes, and reveals an unexpected diversity in the reductive chemistry catalyzed by these enzymes.	[Payne, Karl A. P.; Fisher, Karl; Sjuts, Hanno; Dunstan, Mark S.; Bellina, Bruno; Johannissen, Linus; Barran, Perdita; Hay, Sam; Rigby, Stephen E. J.; Leys, David] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England	University of Manchester	Payne, KAP (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Princess St 131, Manchester M1 7DN, Lancs, England.	karl.payne@manchester.ac.uk; david.leys@manchester.ac.uk	Barran, Perdita/AAY-6303-2021; Hay, Sam/D-5974-2012	Hay, Sam/0000-0003-3274-0938; payne, karl/0000-0002-6331-6374; bellina, bruno/0000-0001-5763-7676; Dunstan, Mark/0000-0002-9416-5505; Barran, Perdita/0000-0002-7720-586X	European Research Council [DEHALORES206080]; BBSRC [BB/M007316/1]; BBSRC [BB/H021523/1, BB/L015048/1, BB/L002655/1, BB/E013007/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L002655/1, BB/E013007/1, BB/C00521X/1, BB/H021523/1, BB/L015048/1, BB/M007316/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Research Council Grant DEHALORES206080 and by BBSRC Grant BB/M007316/1 (both to D. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; BAYSTON JH, 1970, BIOCHEMISTRY-US, V9, P2164, DOI 10.1021/bi00812a020; Beveridge R, 2014, ANAL CHEM, V86, P10979, DOI 10.1021/ac5027435; Biedendieck R, 2007, BIOTECHNOL BIOENG, V96, P525, DOI 10.1002/bit.21145; Bommer M, 2014, SCIENCE, V346, P455, DOI 10.1126/science.1258118; CONOVER RC, 1990, J BIOL CHEM, V265, P8533; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Fergus C, 2015, NUTRIENTS, V7, P2897, DOI 10.3390/nu7042897; Foadi J, 2013, ACTA CRYSTALLOGR D, V69, P1617, DOI 10.1107/S0907444913012274; FREY B, 1988, J BACTERIOL, V170, P2078, DOI 10.1128/jb.170.5.2078-2082.1988; Futagami T, 2008, CHEM REC, V8, P1, DOI 10.1002/tcr.20134; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; HAGEN WR, 1985, J MAGN RESON, V61, P220, DOI 10.1016/0022-2364(85)90077-0; HARADA F, 1972, BIOCHEMISTRY-US, V11, P301, DOI 10.1021/bi00752a024; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KASAI H, 1975, NUCLEIC ACIDS RES, V2, P1931, DOI 10.1093/nar/2.10.1931; Koutmos M, 2011, J BIOL CHEM, V286, P29780, DOI 10.1074/jbc.M111.261370; LINDAHL PA, 1987, J BIOL CHEM, V262, P14945; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P3847, DOI 10.1021/bi900400e; Miles ZD, 2015, BIOCHEMISTRY-US, V54, P4927, DOI 10.1021/acs.biochem.5b00335; Miles ZD, 2011, P NATL ACAD SCI USA, V108, P7368, DOI 10.1073/pnas.1018636108; Moore SJ, 2013, P NATL ACAD SCI USA, V110, P14906, DOI 10.1073/pnas.1308098110; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OKADA N, 1979, J BIOL CHEM, V254, P3061; Payne KAP, 2015, NATURE, V517, P513, DOI 10.1038/nature13901; Reader JS, 2004, J BIOL CHEM, V279, P6280, DOI 10.1074/jbc.M310858200; Rubinson EH, 2012, CURR OPIN STRUC BIOL, V22, P101, DOI 10.1016/j.sbi.2011.11.005; Sjuts H, 2012, PROTEIN EXPRES PURIF, V85, P224, DOI 10.1016/j.pep.2012.08.007; SLANY RK, 1993, BIOCHEMISTRY-US, V32, P7811, DOI 10.1021/bi00081a028; SWEENEY WV, 1980, ANNU REV BIOCHEM, V49, P139, DOI 10.1146/annurev.bi.49.070180.001035; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Urvoas A, 2010, J MOL BIOL, V404, P307, DOI 10.1016/j.jmb.2010.09.048; Van Lanen SG, 2005, P NATL ACAD SCI USA, V102, P4264, DOI 10.1073/pnas.0408056102; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	34	26	26	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27572	27581		10.1074/jbc.M115.685693	http://dx.doi.org/10.1074/jbc.M115.685693			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26378237	Green Published, hybrid			2022-12-28	WOS:000365757500013
J	Borges-Pereira, L; Budu, A; McKnight, CA; Moore, CA; Vella, SA; Triana, MAH; Liu, J; Garcia, CRS; Pace, DA; Moreno, SNJ				Borges-Pereira, Lucas; Budu, Alexandre; McKnight, Ciara A.; Moore, Christina A.; Vella, Stephen A.; Triana, Miryam A. Hortua; Liu, Jing; Garcia, Celia R. S.; Pace, Douglas A.; Moreno, Silvia N. J.			Calcium Signaling throughout the Toxoplasma gondii Lytic Cycle A STUDY USING GENETICALLY ENCODED CALCIUM INDICATORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CA2+; PARASITOPHOROUS VACUOLE; MICRONEME SECRETION; PROTEIN SECRETION; CONOID EXTRUSION; PHOSPHOLIPASE-C; HOST-CELLS; TACHYZOITES; STORES; THAPSIGARGIN	Background: Ca2+ signaling is important for the lytic cycle of T. gondii. Results: Genetically encoded Ca2+ indicators revealed cytosolic Ca2+ changes in real time. Conclusion: New approach highlights important features of the lytic cycle. Significance: Ca2+ influx leads to signaling that results in enhancement of important lytic cycle features. Toxoplasma gondii is an obligate intracellular parasite that invades host cells, creating a parasitophorous vacuole where it communicates with the host cell cytosol through the parasitophorous vacuole membrane. The lytic cycle of the parasite starts with its exit from the host cell followed by gliding motility, conoid extrusion, attachment, and invasion of another host cell. Here, we report that Ca2(+) oscillations occur in the cytosol of the parasite during egress, gliding, and invasion, which are critical steps of the lytic cycle. Extracellular Ca2(+) enhances each one of these processes. We used tachyzoite clonal lines expressing genetically encoded calcium indicators combined with host cells expressing transiently expressed calcium indicators of different colors, and we measured Ca2(+) changes in both parasites and host simultaneously during egress. We demonstrated a link between cytosolic Ca2(+) oscillations in the host and in the parasite. Our approach also allowed us to measure two new features of motile parasites, which were enhanced by Ca2(+) influx. This is the first study showing, inreal time, Ca2(+) signals preceding egress and their direct link with motility, an essential virulence trait.	[Triana, Miryam A. Hortua; Liu, Jing; Garcia, Celia R. S.; Pace, Douglas A.; Moreno, Silvia N. J.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Moore, Christina A.; Moreno, Silvia N. J.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Moreno, SNJ (corresponding author), Univ Georgia, Dept Cellular Biol, 350A Paul Coverdell Ctr, Athens, GA 30602 USA.	smoreno@uga.edu	Regan, Clinton/E-6250-2012; Garcia, Celia R. S./A-4093-2011; Budu, Alexandre/F-6498-2013; Borges Pereira, Lucas/F-3503-2016	Garcia, Celia R. S./0000-0003-2825-1701; Budu, Alexandre/0000-0002-7110-9754; Hortua Triana, Miryam Andrea/0000-0001-5964-8512	National Institutes of Health [AI-110027, AI-096836, AI060546]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil; CNPq (Ciencia sem Fronteiras) [243462/2012-3]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060546, R01AI096836, R21AI110027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Ciencia sem Fronteiras); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-110027 and AI-096836 (to S. N. J. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil, during his stay at University of Georgia.; Supported by a research fellowship from CNPq (Ciencia sem Fronteiras) Project 243462/2012-3.; Supported in part by National Institutes of Health Training Grant AI060546 to the Center for Tropical and Emerging Global Diseases, University of Georgia.	Alves E, 2011, J BIOL CHEM, V286, P5905, DOI 10.1074/jbc.M110.188474; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Billups B, 2002, J NEUROSCI, V22, P5840; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Case RM, 2007, CELL CALCIUM, V42, P345, DOI 10.1016/j.ceca.2007.05.001; Chini EN, 2005, BIOCHEM J, V389, P269, DOI 10.1042/BJ20041971; Choi S, 2001, BRIT J PHARMACOL, V132, P641, DOI 10.1038/sj.bjp.0703856; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; ENDO T, 1982, EXP PARASITOL, V53, P179, DOI 10.1016/0014-4894(82)90059-5; Fang JM, 2006, BIOCHEM J, V394, P417, DOI 10.1042/BJ20051393; Garrison E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003049; Del Carmen MG, 2009, CELL MICROBIOL, V11, P967, DOI 10.1111/j.1462-5822.2009.01304.x; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Leybaert L, 2012, PHYSIOL REV, V92, P1359, DOI 10.1152/physrev.00029.2011; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Lukyanenko V, 1999, J PHYSIOL-LONDON, V521, P575, DOI 10.1111/j.1469-7793.1999.00575.x; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; MONDRAGON R, 1994, J EUKARYOT MICROBIOL, V41, P330, DOI 10.1111/j.1550-7408.1994.tb06086.x; Mondragon R, 1996, J EUKARYOT MICROBIOL, V43, P120, DOI 10.1111/j.1550-7408.1996.tb04491.x; Moreno SNJ, 1998, BIOCHEM J, V330, P853; Moreno SNJ, 1996, BIOCHEM J, V313, P655, DOI 10.1042/bj3130655; Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200; Nagamune K, 2007, EUKARYOT CELL, V6, P2147, DOI 10.1128/EC.00262-07; Pace DA, 2014, J BIOL CHEM, V289, P19637, DOI 10.1074/jbc.M114.565390; Passos APD, 1998, BIOCHEM BIOPH RES CO, V245, P155, DOI 10.1006/bbrc.1998.8338; Pernas L, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001845; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; Silverman JA, 1998, J BIOL CHEM, V273, P12352, DOI 10.1074/jbc.273.20.12352; Stommel EW, 1997, EXP PARASITOL, V87, P88, DOI 10.1006/expr.1997.4187; Striepen B, 1998, MOL BIOCHEM PARASIT, V92, P325, DOI 10.1016/S0166-6851(98)00011-5; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Tian Lin, 2012, Cold Spring Harb Protoc, V2012, P647, DOI 10.1101/pdb.top069609; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999; TSUKAMOTO A, 1993, CELL BIOL INT, V17, P969, DOI 10.1006/cbir.1993.1021; VERCESI AE, 1993, J BIOL CHEM, V268, P8564; Vieira MCF, 2000, MOL BIOCHEM PARASIT, V106, P157, DOI 10.1016/S0166-6851(99)00182-6; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	48	42	43	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26914	26926		10.1074/jbc.M115.652511	http://dx.doi.org/10.1074/jbc.M115.652511			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26374900	hybrid, Green Published			2022-12-28	WOS:000364794000004
J	Dusaban, SS; Kunkel, MT; Smrcka, AV; Brown, JH				Dusaban, Stephanie S.; Kunkel, Maya T.; Smrcka, Alan V.; Brown, Joan Heller			Thrombin Promotes Sustained Signaling and Inflammatory Gene Expression through the CDC25 and Ras-associating Domains of Phospholipase C epsilon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLC-EPSILON; DEPENDENT ACTIVATION; RECEPTOR ACTIVATION; CRUCIAL ROLE; RHO; ENHANCEMENT; REPORTER; DISTINCT; PATHWAY; G(12)	Phospholipase C-epsilon (PLC epsilon) plays a critical role in G-protein-coupled receptor-mediated inflammation. In addition to its ability to generate the second messengers inositol 1,4,5-trisphosphate and diacylglycerol, PLC epsilon, unlike the other phospholipase C family members, is activated in a sustained manner. We hypothesized that the ability of PLC epsilon to function as a guanine nucleotide exchange factor (GEF) for Rap1 supports sustained downstream signaling via feedback of Rap1 to the enzyme Ras-associating (RA2) domain. Using gene deletion and adenoviral rescue, we demonstrate that both the GEF (CDC25 homology domain) and RA2 domains of PLC epsilon are required for long term protein kinase D (PKD) activation and subsequent induction of inflammatory genes. PLC epsilon localization is largely intracellular and its compartmentalization could contribute to its sustained activation. Here we show that localization of PLC epsilon to the Golgi is required for activation of PKD in this compartment as well as for subsequent induction of inflammatory genes. These data provide a molecular mechanism by which PLC epsilon mediates sustained signaling and by which astrocytes mediate pathophysiological inflammatory responses.	[Dusaban, Stephanie S.; Kunkel, Maya T.; Brown, Joan Heller] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Dusaban, Stephanie S.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Smrcka, Alan V.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Rochester	Brown, JH (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, 9500 Gilman Dr,Biomed Sci Bldg,Rm 3024, La Jolla, CA 92093 USA.	jhbrown@ucsd.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01GM36927, R01GM53536, R03CA178524]; NIH [T32GM007752]; NATIONAL CANCER INSTITUTE [R03CA178524] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL028143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536, T32GM007752, R01GM036927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01GM36927 (to J. H. B.), R01GM53536 (to A. V. S.), R03CA178524 (to M. T. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by NIH Grant T32GM007752.	ARAGAY AM, 1995, J BIOL CHEM, V270, P20073, DOI 10.1074/jbc.270.34.20073; Bai YF, 2004, CANCER RES, V64, P8808, DOI 10.1158/0008-5472.CAN-04-3143; Bunney TD, 2006, TRENDS CELL BIOL, V16, P640, DOI 10.1016/j.tcb.2006.10.007; Citro S, 2007, P NATL ACAD SCI USA, V104, P15543, DOI 10.1073/pnas.0702943104; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Del Re DP, 2007, J BIOL CHEM, V282, P8069, DOI 10.1074/jbc.M604298200; Dusaban Stephanie S, 2015, Adv Biol Regul, V57, P17, DOI 10.1016/j.jbior.2014.09.014; Dusaban SS, 2013, P NATL ACAD SCI USA, V110, P3609, DOI 10.1073/pnas.1217355110; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; Harada Y, 2011, BIOCHEM BIOPH RES CO, V414, P106, DOI 10.1016/j.bbrc.2011.09.032; Ikuta S, 2008, CANCER RES, V68, P64, DOI 10.1158/0008-5472.CAN-07-3245; Jin TG, 2001, J BIOL CHEM, V276, P30301, DOI 10.1074/jbc.M103530200; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; Kelley GG, 2004, BIOCHEM J, V378, P129, DOI 10.1042/BJ20031370; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kunkel MT, 2007, J BIOL CHEM, V282, P6733, DOI 10.1074/jbc.M608086200; Kunkel MT, 2010, J BIOL CHEM, V285, P22746, DOI 10.1074/jbc.C110.123133; Li MZ, 2009, CARCINOGENESIS, V30, P1424, DOI 10.1093/carcin/bgp125; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Martins M, 2014, P NATL ACAD SCI USA, V111, P4239, DOI 10.1073/pnas.1311500111; Nicole O, 2005, J NEUROSCI, V25, P4319, DOI 10.1523/JNEUROSCI.5200-04.2005; Oestreich EA, 2007, J BIOL CHEM, V282, P5488, DOI 10.1074/jbc.M608495200; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Oka M, 2010, CARCINOGENESIS, V31, P1897, DOI 10.1093/carcin/bgq164; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Satoh T, 2006, METHOD ENZYMOL, V407, P281, DOI 10.1016/S0076-6879(05)07024-2; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seifert JP, 2008, J BIOL CHEM, V283, P29690, DOI 10.1074/jbc.M805038200; Seifert JP, 2004, J BIOL CHEM, V279, P47992, DOI 10.1074/jbc.M407111200; Shibatohge M, 1998, J BIOL CHEM, V273, P6218, DOI 10.1074/jbc.273.11.6218; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Smrcka AV, 2012, CELL SIGNAL, V24, P1333, DOI 10.1016/j.cellsig.2012.01.009; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Song CH, 2002, ONCOGENE, V21, P8105, DOI 10.1038/sj.onc.1206003; Sorensen SD, 2003, MOL PHARMACOL, V64, P1199, DOI 10.1124/mol.64.5.1199; Sternweis PC, 2007, ADV PROTEIN CHEM, V74, P189, DOI 10.1016/S0065-3233(07)74006-8; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Wing MR, 2003, J BIOL CHEM, V278, P41253, DOI 10.1074/jbc.M306904200; Xiang SY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004405; Xiang SY, 2013, BBA-MOL CELL BIOL L, V1831, P213, DOI 10.1016/j.bbalip.2012.09.004; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047; Zhang LH, 2011, J BIOL CHEM, V286, P23012, DOI 10.1074/jbc.M111.231993	44	11	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26776	26783		10.1074/jbc.M115.676098	http://dx.doi.org/10.1074/jbc.M115.676098			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26350460	Green Published, hybrid			2022-12-28	WOS:000364793600039
J	Hagen, S; Drepper, F; Fischer, S; Fodor, K; Passon, D; Platta, HW; Zenn, M; Schliebs, W; Girzalsky, W; Wilmanns, M; Warscheid, B; Erdmann, R				Hagen, Stefanie; Drepper, Friedel; Fischer, Sven; Fodor, Krisztian; Passon, Daniel; Platta, Harald W.; Zenn, Michael; Schliebs, Wolfgang; Girzalsky, Wolfgang; Wilmanns, Matthias; Warscheid, Bettina; Erdmann, Ralf			Structural Insights into Cargo Recognition by the Yeast PTS1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXISOMAL TARGETING SIGNAL-1; STEROL CARRIER PROTEIN-2; PHOTO-CROSS-LINKING; N-TERMINAL HALF; CYCLING RECEPTOR; POLYACRYLAMIDE GELS; GENETIC-CODE; AMINO-ACID; IMPORT; BINDING	The peroxisomal matrix protein import is facilitated by cycling import receptors that shuttle between the cytosol and the peroxisomal membrane. The import receptor Pex5p mediates the import of proteins harboring a peroxisomal targeting signal of type I (PTS1). Purified recombinant Pex5p forms a dimeric complex with the PTS1-protein Pcs60p in vitro with a K-D of 0.19 mu M. To analyze the structural basis for receptor-cargo recognition, the PTS1 and adjacent amino acids of Pcs60p were systematically scanned for Pex5p binding by an in vitro site-directed photo-cross-linking approach. The cross-linked binding regions of the receptor were subsequently identified by high resolution mass spectrometry. Most cross-links were found with TPR6, TPR7, as well as the 7C-loop of Pex5p. Surface plasmon resonance analysis revealed a bivalent interaction mode for Pex5p and Pcs60p. Interestingly, Pcs60p lacking its C-terminal tripeptide sequence was efficiently cross-linked to the same regions of Pex5p. The KD value of the interaction of truncated Pcs60p and Pex5p was in the range of 7.7 mu M. Isothermal titration calorimetry and surface plasmon resonance measurements revealed a monovalent binding mode for the interaction of Pex5p and Pcs60p lacking the PTS1. Our data indicate that Pcs60p contains a second contact site for its receptor Pex5p, beyond the C-terminal tripeptide. The physiological relevance of the ancillary binding region was supported by in vivo import studies. The bivalent binding mode might be explained by a two-step concept as follows: first, cargo recognition and initial tethering by the PTS1-receptor Pex5p; second, lock-in of receptor and cargo.	[Hagen, Stefanie; Schliebs, Wolfgang; Girzalsky, Wolfgang; Erdmann, Ralf] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Fac Med, Syst Biochem, D-44780 Bochum, Germany; [Drepper, Friedel; Fischer, Sven; Warscheid, Bettina] Univ Freiburg, Dept Biochem & Funct Prote, Fac Biol, D-79104 Freiburg, Germany; [Drepper, Friedel; Fischer, Sven; Warscheid, Bettina] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Passon, Daniel; Wilmanns, Matthias] European Mol Biol Lab Hamburg, D-22607 Hamburg, Germany; [Fodor, Krisztian] Eotvos Lorand Univ, Dept Biochem, H-1117 Budapest, Hungary; [Platta, Harald W.] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Fac Med, Biochem Intracellular Transport Mech, D-44781 Bochum, Germany; [Zenn, Michael] Biaffin GmbH & Co KG, D-34132 Kassel, Germany	Ruhr University Bochum; University of Freiburg; University of Freiburg; European Molecular Biology Laboratory (EMBL); Eotvos Lorand University; Ruhr University Bochum	Erdmann, R (corresponding author), Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Univ Str 150, D-44780 Bochum, Germany.	ralf.erdmann@rub.de	Platta, Harald Wolfgang/G-7423-2014	Platta, Harald Wolfgang/0000-0001-8968-7280; Passon, Daniel M/0000-0001-7306-250X; Warscheid, Bettina/0000-0001-5096-1975; Drepper, Friedel/0000-0002-2043-5795; Wilmanns, Matthias/0000-0002-4643-5435; Schliebs, Wolfgang/0000-0003-2762-3403	Deutsche Forschungsgemeinschaft [FOR1905]; Excellence Initiative of the German Federal Government [EXC 294 BIOSS]; Excellence Initiative of the German State Government [EXC 294 BIOSS]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	This work was supported by Deutsche Forschungsgemeinschaft Grant FOR1905 (to B. W., H. P., M. W., and R. E.) and Excellence Initiative of the German Federal and State Governments Grant EXC 294 BIOSS (to B. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; Blobel F, 1996, EUR J BIOCHEM, V240, P468, DOI 10.1111/j.1432-1033.1996.0468h.x; Boteva R, 2003, EUR J BIOCHEM, V270, P4332, DOI 10.1046/j.1432-1033.2003.03827.x; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Carvalho AF, 2006, J MOL BIOL, V356, P864, DOI 10.1016/j.jmb.2005.12.002; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; Costa-Rodrigues J, 2005, J BIOL CHEM, V280, P24404, DOI 10.1074/jbc.M501985200; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cramer Jana, 2015, Cold Spring Harb Protoc, V2015, DOI 10.1101/pdb.top074500; Cristodero M, 2013, MOL MICROBIOL, V90, P744, DOI 10.1111/mmi.12397; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; ELGERSMA Y, 1995, EMBO J, V14, P3472, DOI 10.1002/j.1460-2075.1995.tb07353.x; Elgersma Y, 1996, J BIOL CHEM, V271, P26375, DOI 10.1074/jbc.271.42.26375; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENTIAN KD, 1988, FEBS LETT, V236, P195, DOI 10.1016/0014-5793(88)80313-2; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Erdmann R, 2005, NAT REV MOL CELL BIO, V6, P738, DOI 10.1038/nrm1710; Fodor K, 2015, TRAFFIC, V16, P85, DOI 10.1111/tra.12238; Fodor K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001309; Foster J, 2014, FEBS LETT, V588, P160, DOI 10.1016/j.febslet.2013.11.026; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Ghosh D, 2010, J AM CHEM SOC, V132, P3973, DOI 10.1021/ja9109049; Gietz R.D., 1994, MOL GENETICS YEAST P, P121; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Gouveia AM, 2003, ADV EXP MED BIOL, V544, P219; Harper CC, 2003, J BIOL CHEM, V278, P7897, DOI 10.1074/jbc.M206651200; Hasan S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00261; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kerssen D, 2006, J BIOL CHEM, V281, P27003, DOI 10.1074/jbc.M509257200; KIONKA C, 1985, J BACTERIOL, V161, P153, DOI 10.1128/JB.161.1.153-157.1985; Kionka C., 1986, THESIS; Klein ATJ, 2001, J BIOL CHEM, V276, P15034, DOI 10.1074/jbc.M010776200; Kragler F, 1998, P NATL ACAD SCI USA, V95, P13336, DOI 10.1073/pnas.95.22.13336; Kumar A, 2001, J MOL BIOL, V307, P271, DOI 10.1006/jmbi.2000.4465; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lametschwandtner G, 1998, J BIOL CHEM, V273, P33635, DOI 10.1074/jbc.273.50.33635; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Ma CL, 2013, J BIOL CHEM, V288, P27220, DOI 10.1074/jbc.M113.492694; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Madrid KP, 2004, MOL CELL BIOL, V24, P7331, DOI 10.1128/MCB.24.17.7331-7344.2004; Maynard EL, 2007, J MOL BIOL, V368, P1259, DOI 10.1016/j.jmb.2007.03.005; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Neuberger G, 2003, J MOL BIOL, V328, P567, DOI 10.1016/S0022-2836(03)00318-8; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Sampathkumar P, 2008, J MOL BIOL, V381, P867, DOI 10.1016/j.jmb.2008.05.089; Schafer A, 2004, MOL CELL BIOL, V24, P8895, DOI 10.1128/MCB.24.20.8895-8906.2004; Schliebs W, 1999, J BIOL CHEM, V274, P5666, DOI 10.1074/jbc.274.9.5666; Shimozawa N, 1999, J MED GENET, V36, P779, DOI 10.1136/jmg.36.10.779; SIKORSKI RS, 1989, GENETICS, V122, P19; Song JG, 2015, STRUCTURE, V23, P558, DOI 10.1016/j.str.2015.01.011; Stanley WA, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-24; Stanley WA, 2007, FEBS LETT, V581, P4795, DOI 10.1016/j.febslet.2007.09.001; Stanley WA, 2007, ARCH BIOCHEM BIOPHYS, V461, P50, DOI 10.1016/j.abb.2007.02.026; Stanley WA, 2006, MOL CELL, V24, P653, DOI 10.1016/j.molcel.2006.10.024; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Theodoulou FL, 2013, BIOCHEM J, V451, P345, DOI 10.1042/BJ20130078; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; Wang DY, 2003, J BIOL CHEM, V278, P43340, DOI 10.1074/jbc.M307789200; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Willard FS, 2006, ANAL BIOCHEM, V353, P147, DOI 10.1016/j.ab.2006.02.004; Williams CP, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-12; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050	66	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26610	26626		10.1074/jbc.M115.657973	http://dx.doi.org/10.1074/jbc.M115.657973			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26359497	Green Published, hybrid			2022-12-28	WOS:000364793600027
J	Kowalsky, CA; Faber, MS; Nath, A; Dann, HE; Kelly, VW; Liu, L; Shanker, P; Wagner, EK; Maynard, JA; Chan, C; Whitehead, TA				Kowalsky, Caitlin A.; Faber, Matthew S.; Nath, Aritro; Dann, Hailey E.; Kelly, Vince W.; Liu, Li; Shanker, Purva; Wagner, Ellen K.; Maynard, Jennifer A.; Chan, Christina; Whitehead, Timothy A.			Rapid Fine Conformational Epitope Mapping Using Comprehensive Mutagenesis and Deep Sequencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBODY REPERTOIRE; CRYSTAL-STRUCTURE; PERTUSSIS TOXIN; TROP2; VACCINE; DESIGN; EXPRESSION; DISEASE; DISPLAY; CANCER	Knowledge of the fine location of neutralizing and non-neutralizing epitopes on human pathogens affords a better understanding of the structural basis of antibody efficacy, which will expedite rational design of vaccines, prophylactics, and therapeutics. However, full utilization of the wealth of information from single cell techniques and antibody repertoire sequencing awaits the development of a high throughput, inexpensive method to map the conformational epitopes for antibody-antigen interactions. Here we show such an approach that combines comprehensive mutagenesis, cell surface display, and DNA deep sequencing. We develop analytical equations to identify epitope positions and show the method effectiveness by mapping the fine epitope for different antibodies targeting TNF, pertussis toxin, and the cancer target TROP2. In all three cases, the experimentally determined conformational epitope was consistent with previous experimental datasets, confirming the reliability of the experimental pipeline. Once the comprehensive library is generated, fine conformational epitope maps can be prepared at a rate of four per day.	[Kowalsky, Caitlin A.; Dann, Hailey E.; Kelly, Vince W.; Shanker, Purva; Chan, Christina; Whitehead, Timothy A.] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; [Faber, Matthew S.; Chan, Christina] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Nath, Aritro; Chan, Christina] Michigan State Univ, Grad Program Genet, E Lansing, MI 48824 USA; [Liu, Li] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Whitehead, Timothy A.] Michigan State Univ, Dept Biosyst & Agr Engn, E Lansing, MI 48824 USA; [Wagner, Ellen K.; Maynard, Jennifer A.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University; University of Texas System; University of Texas Austin	Whitehead, TA (corresponding author), Michigan State Univ, Dept Chem Engn & Mat Sci, 428 S Shaw Lane, E Lansing, MI 48824 USA.	taw@egr.msu.edu	Regan, Clinton/E-6250-2012; Nath, Aritro/AAV-8720-2020	Nath, Aritro/0000-0002-3225-4203; Whitehead, Timothy/0000-0003-3177-1361; Faber, Matthew/0000-0002-5583-5115	National Institutes of Health [5R21CA176854-02]; National Science Foundation CAREER Award [CBET-1254238]; Synthetic Biologics; NATIONAL CANCER INSTITUTE [R21CA176854] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1254238] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation CAREER Award(National Science Foundation (NSF)); Synthetic Biologics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R21CA176854-02 (to T. A. W. and C. C.). This work was also supported by National Science Foundation CAREER Award CBET-1254238 (to T. A. W.) and a grant from Synthetic Biologics (to J. A. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aizner Y, 2014, STRUCTURE, V22, P636, DOI 10.1016/j.str.2014.01.012; Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Bilgin B, 2013, ANAL BIOANAL CHEM, V405, P2461, DOI 10.1007/s00216-013-6712-9; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Casina VC, 2015, P NATL ACAD SCI USA, V112, P9620, DOI 10.1073/pnas.1512561112; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen LH, 2006, PROTEIN EXPRES PURIF, V46, P495, DOI 10.1016/j.pep.2005.09.002; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Doolan KM, 2015, J MOL BIOL, V427, P328, DOI 10.1016/j.jmb.2014.10.024; Firnberg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052031; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fong D, 2008, BRIT J CANCER, V99, P1290, DOI 10.1038/sj.bjc.6604677; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; KIM KJ, 1989, INFECT IMMUN, V57, P944, DOI 10.1128/IAI.57.3.944-950.1989; Kowalsky CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118193; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Laserson U, 2014, P NATL ACAD SCI USA, V111, P4928, DOI 10.1073/pnas.1323862111; Le J, 1997, Methods of treating TNF-a-mediated Crohn's disease using chimeric anti-TNF antibodies, Patent No. [5,656,272, 5656272, US5656272]; Liang SY, 2013, J BIOL CHEM, V288, P13799, DOI 10.1074/jbc.M112.433961; Liu L, 2014, NEUROBIOL AGING, V35, P309, DOI 10.1016/j.neurobiolaging.2013.08.016; Liu L, 2013, NEUROBIOL AGING, V34, P540, DOI 10.1016/j.neurobiolaging.2012.05.017; Liu S.-h., 2014, U. S. Patent, Patent No. [20,140,357,844, 20140357844]; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Mata-Fink J, 2013, J MOL BIOL, V425, P444, DOI 10.1016/j.jmb.2012.11.010; McDougall ARA, 2015, DEV DYNAM, V244, P99, DOI 10.1002/dvdy.24242; McLellan JS, 2013, SCIENCE, V342, P592, DOI 10.1126/science.1243283; McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914; Ohmachi T, 2006, CLIN CANCER RES, V12, P3057, DOI 10.1158/1078-0432.CCR-05-1961; Ong YT, 2012, CELL MOL BIOL, V58, P71, DOI 10.1170/T923; Pandit D, 2012, J MOL RECOGNIT, V25, P114, DOI 10.1002/jmr.1169; Patil SP, 2013, NEUROSCI LETT, V554, P121, DOI 10.1016/j.neulet.2013.09.008; Pavsic M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5764; Sela-Culang I, 2015, CURR OPIN VIROL, V11, P98, DOI 10.1016/j.coviro.2015.03.012; Spatola BN, 2013, ANAL CHEM, V85, P1215, DOI 10.1021/ac303201d; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; Stoyanova T, 2012, GENE DEV, V26, P2271, DOI 10.1101/gad.196451.112; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sutherland JN, 2009, BIOCHEMISTRY-US, V48, P11982, DOI 10.1021/bi901532z; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Van Blarcom T, 2015, J MOL BIOL, V427, P1513, DOI 10.1016/j.jmb.2014.09.020; Vidmar T, 2013, PROTEIN EXPRES PURIF, V91, P69, DOI 10.1016/j.pep.2013.07.006; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; Wu M, 2013, BIOINFORMATICS, V29, P1541, DOI 10.1093/bioinformatics/btt186; Wu M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-547; Zhang LX, 2011, CELL MOL LIFE SCI, V68, P863, DOI 10.1007/s00018-010-0497-1	49	42	43	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26457	U150		10.1074/jbc.M115.676635	http://dx.doi.org/10.1074/jbc.M115.676635			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26296891	hybrid, Green Published			2022-12-28	WOS:000364793600013
J	Oyola-Cintron, J; Caballero-Rivera, D; Ballester, L; Baez-Pagan, CA; Martinez, HL; Velez-Arroyo, KP; Quesada, O; Lasalde-Dominicci, JA				Oyola-Cintron, Jessica; Caballero-Rivera, Daniel; Ballester, Leomar; Baez-Pagan, Carlos A.; Martinez, Hernan L.; Velez-Arroyo, Karla P.; Quesada, Orestes; Lasalde-Dominicci, Jose A.			Lateral Diffusion, Function, and Expression of the Slow Channel Congenital Myasthenia Syndrome alpha C418W Nicotinic Receptor Mutation with Changes in Lipid Raft Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYL-BETA-CYCLODEXTRIN; ACETYLCHOLINE-RECEPTOR; PLASMA-MEMBRANE; NEUROMUSCULAR-JUNCTION; CELLULAR CHOLESTEROL; POTASSIUM CHANNELS; STRUCTURAL BASIS; MAMMALIAN-CELLS; MUSCLE-FIBERS; GAMMA-SUBUNIT	Lipid rafts, specialized membrane microdomains in the plasma membrane rich in cholesterol and sphingolipids, are hot spots for a number of important cellular processes. The novel nicotinic acetylcholine receptor (nAChR) mutation alpha C418W, the first lipid-exposed mutation identified in a patient that causes slow channel congenital myasthenia syndrome was shown to be cholesterol-sensitive and to accumulate in microdomains rich in the membrane raft marker protein caveolin-1. The objective of this study is to gain insight into the mechanism by which lateral segregation into specialized raft membrane microdomains regulates the activable pool of nAChRs. We performed fluorescent recovery after photobleaching (FRAP), quantitative RT-PCR, and whole cell patch clamp recordings of GFP-encoding Mus musculus nAChRs transfected into HEK 293 cells to assess the role of cholesterol and caveolin-1 (CAV-1) in the diffusion, expression, and functionality of the nAChR (WT and alpha C418W). Our findings support the hypothesis that a cholesterol-sensitive nAChR might reside in specialized membrane microdomains that upon cholesterol depletion become disrupted and release the cholesterol-sensitive nAChRs to the pool of activable receptors. In addition, our results in HEK 293 cells show an interdependence between CAV-1 and alpha C418W that could confer end plates rich in alpha C418W nAChRs to a susceptibility to changes in cholesterol levels that could cause adverse drug reactions to cholesterol-lowering drugs such as statins. The current work suggests that the interplay between cholesterol and CAV-1 provides the molecular basis for modulating the function and dynamics of the cholesterol-sensitive alpha C418W nAChR.	[Oyola-Cintron, Jessica; Caballero-Rivera, Daniel; Velez-Arroyo, Karla P.; Lasalde-Dominicci, Jose A.] Univ Puerto Rico, Dept Chem, Rio Piedras, PR 00931 USA; [Caballero-Rivera, Daniel; Ballester, Leomar; Baez-Pagan, Carlos A.; Lasalde-Dominicci, Jose A.] Univ Puerto Rico, Dept Biol, Rio Piedras, PR 00931 USA; [Quesada, Orestes] Univ Puerto Rico, Dept Phys Sci, Rio Piedras, PR 00931 USA; [Martinez, Hernan L.] Calif State Univ Dominguez Hills, Carson, CA 90747 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Rio Piedras; California State University System; California State University Dominguez Hills	Lasalde-Dominicci, JA (corresponding author), Univ Puerto Rico, Dept Biol, Rio Piedras Campus,POB 23360, Rio Piedras, PR 00931 USA.	jlasalde@gmail.com	Regan, Clinton/E-6250-2012		National Institutes of Health [1R01GM098343, 1P20GM103642, 2 R25 GM061151]; Research Initiative for Scientific Enhancement (RISE) Program; Puerto Rico Industrial Development Company (PRIDCO); UPR Golf Tournament Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098343, R25GM061151, P20GM103642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Initiative for Scientific Enhancement (RISE) Program; Puerto Rico Industrial Development Company (PRIDCO); UPR Golf Tournament Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01GM098343 (to J. A. L. D.) and 1P20GM103642 (to J. R. and J. A. L. D.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Research Initiative for Scientific Enhancement (RISE) Program, National Institutes of Health Grant 2 R25 GM061151, and the Puerto Rico Industrial Development Company (PRIDCO).; Supported by the Research Initiative for Scientific Enhancement (RISE) Program, National Institutes of Health Grant 2 R25 GM061151, the Puerto Rico Industrial Development Company (PRIDCO), and the UPR Golf Tournament Fellowship.	Anderson TG, 2004, BIOCHEMISTRY-US, V43, P2251, DOI 10.1021/bi0358869; Antollini SS, 1998, BIOCHEMISTRY-US, V37, P16653, DOI 10.1021/bi9808215; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; AXELROD D, 1976, P NATL ACAD SCI USA, V73, P4594, DOI 10.1073/pnas.73.12.4594; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; Baez-Pagan CA, 2008, CHANNELS, V2, P180, DOI 10.4161/chan.2.3.6155; Baier CJ, 2010, EUR BIOPHYS J BIOPHY, V39, P213, DOI 10.1007/s00249-009-0521-2; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Barrantes Francisco J, 2014, Front Synaptic Neurosci, V6, P25, DOI 10.3389/fnsyn.2014.00025; Bian JS, 2004, AM J PHYSIOL-HEART C, V287, pH2154, DOI 10.1152/ajpheart.00120.2004; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borroni V, 2007, MOL MEMBR BIOL, V24, P1, DOI 10.1080/09687860600903387; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; Campagna JA, 2006, NEUROSCIENCE, V138, P123, DOI 10.1016/j.neuroscience.2005.11.019; Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; Christian AE, 1997, J LIPID RES, V38, P2264; Corbin J, 1998, BBA-BIOMEMBRANES, V1414, P65, DOI 10.1016/S0005-2736(98)00153-9; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Engel AG, 2002, MOL NEUROBIOL, V26, P347, DOI 10.1385/MN:26:2-3:347; Fernandes CC, 2010, J NEUROSCI, V30, P8841, DOI 10.1523/JNEUROSCI.6236-09.2010; FERNANDEZBALLESTER G, 1994, BIOCHEM SOC T, V22, P776, DOI 10.1042/bst0220776; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Gensler S, 2001, EUR J BIOCHEM, V268, P2209, DOI 10.1046/j.1432-1327.2001.02093.x; Grajales-Reyes GE, 2013, PHARMACOGENOMICS J, V13, P362, DOI 10.1038/tpj.2012.21; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; He F, 2004, J BIOL CHEM, V279, P8986, DOI 10.1074/jbc.M311488200; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Huang CL, 2007, AM J PHYSIOL-RENAL, V293, pF1761, DOI 10.1152/ajprenal.00400.2007; Hucho F, 1996, EUR J BIOCHEM, V239, P539, DOI 10.1111/j.1432-1033.1996.0539u.x; JONES OT, 1988, BIOCHEMISTRY-US, V27, P2364, DOI 10.1021/bi00407a018; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Klonis N, 2002, EUR BIOPHYS J BIOPHY, V31, P36, DOI 10.1007/s00249-001-0202-2; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Ma HP, 2002, J BIOL CHEM, V277, P7641, DOI 10.1074/jbc.C100737200; Marty S, 2009, LANGMUIR, V25, P8780, DOI 10.1021/la900255u; NARAYANASWAMI V, 1993, BIOCHEMISTRY-US, V32, P12420, DOI 10.1021/bi00097a021; Nishimura SY, 2006, BIOPHYS J, V90, P927, DOI 10.1529/biophysj.105.070524; Niu SL, 2002, J BIOL CHEM, V277, P20139, DOI 10.1074/jbc.M200594200; O'Connell KMS, 2005, J CELL SCI, V118, P2155, DOI 10.1242/jcs.02348; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pochynyuk O, 2005, J BIOL CHEM, V280, P37565, DOI 10.1074/jbc.M509071200; Rohacs T, 2007, PFLUG ARCH EUR J PHY, V453, P753, DOI 10.1007/s00424-006-0153-7; Shen XM, 2006, ANN NEUROL, V60, P128, DOI 10.1002/ana.20861; Shvartsman DE, 2006, TRAFFIC, V7, P917, DOI 10.1111/j.1600-0854.2006.00437.x; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; St John PA, 2009, ACTA PHARMACOL SIN, V30, P656, DOI 10.1038/aps.2009.76; Stetzkowski-Marden F, 2006, J MOL NEUROSCI, V30, P37, DOI 10.1385/JMN:30:1:37; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; STYA M, 1984, J NEUROSCI, V4, P70; STYA M, 1983, J CELL BIOL, V97, P48, DOI 10.1083/jcb.97.1.48; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Sun M, 2007, J CELL SCI, V120, P2223, DOI 10.1242/jcs.001370; SUNSHINE C, 1994, BBA-BIOMEMBRANES, V1191, P59, DOI 10.1016/0005-2736(94)90233-X; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Vrljic M, 2005, BIOPHYS J, V88, P334, DOI 10.1529/biophsj.104.045989; Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288; Womack KB, 2000, J NEUROSCI, V20, P2792; YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	68	6	6	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26790	26800		10.1074/jbc.M115.678573	http://dx.doi.org/10.1074/jbc.M115.678573			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354438	hybrid, Green Published			2022-12-28	WOS:000364793600041
J	Cilli, P; Minoprio, A; Bossa, C; Bignami, M; Mazzei, F				Cilli, Piera; Minoprio, Anna; Bossa, Cecilia; Bignami, Margherita; Mazzei, Filomena			Formation and Repair of Mismatches Containing Ribonucleotides and Oxidized Bases at Repeated DNA Sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-BETA; EXCISION-REPAIR; OXIDATIVE DAMAGE; INSERTION; REMOVAL; MUTYH; 8-OXO-DEOXYGUANOSINE; ACCUMULATION; 8-OXOGUANINE; COMPLEX	The cellular pool of ribonucleotide triphosphates (rNTPs) is higher than that of deoxyribonucleotide triphosphates. To ensure genome stability, DNA polymerases must discriminate against rNTPs and incorporated ribonucleotides must be removed by ribo-nucleotide excision repair (RER). We investigated DNA polymerase beta (POL beta) capacity to incorporate ribonucleotides into trinucleotide repeated DNA sequences and the efficiency of base excision repair (BER) and RER enzymes (OGG1, MUTYH, and RNase H2) when presented with an incorrect sugar and an oxidized base. POL beta incorporated rAMP and rCMP opposite 7,8-dihydro-8- oxoguanine (8-oxodG) and extended both mispairs. In addition, POL beta was able to insert and elongate an oxidized rGMP when paired with dA. We show that RNase H2 always preserves the capacity to remove a single ribonucleotide when paired to an oxidized base or to incise an oxidized ribonucleotide in a DNA duplex. In contrast, BER activity is affected by the presence of a ribonucleotide opposite an 8-oxodG. In particular, MUTYH activity on 8-oxodG:rA mispairs is fully inhibited, although its binding capacity is retained. This results in the reduction of RNase H2 incision capability of this substrate. Thus complex mispairs formed by an oxidized base and a ribonucleotide can compromise BER and RER in repeated sequences.	[Cilli, Piera; Minoprio, Anna; Bossa, Cecilia; Bignami, Margherita; Mazzei, Filomena] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy; [Cilli, Piera] Univ Roma Tre, Dept Sci, I-00154 Rome, Italy	Istituto Superiore di Sanita (ISS); Italfarmaco; Roma Tre University	Bignami, M (corresponding author), Ist Super Sanita, Viale Regina Elena 299, I-00161 Rome, Italy.	margherita.bignami@gmail.com	Bossa, Cecilia/K-4454-2016	Bossa, Cecilia/0000-0003-2084-2902	Associazione Italiana Ricerca sul Cancro Investigator Grant [11755]; Ministry of Health Project "Malattie Rare"	Associazione Italiana Ricerca sul Cancro Investigator Grant(Fondazione AIRC per la ricerca sul cancro); Ministry of Health Project "Malattie Rare"	This work was supported in part by Associazione Italiana Ricerca sul Cancro Investigator Grant 11755 (to M. B. and F. M.) and Ministry of Health Project "Malattie Rare" (to M. B. and F. M.). The authors declare that there are no competing financial interests in relationship to the work described.	Batra VK, 2012, P NATL ACAD SCI USA, V109, P113, DOI 10.1073/pnas.1112235108; Batra VK, 2010, NAT STRUCT MOL BIOL, V17, P889, DOI 10.1038/nsmb.1852; Beard WA, 2010, MUTAT RES-GEN TOX EN, V703, P18, DOI 10.1016/j.mrgentox.2010.07.013; Bebenek K, 2005, J BIOL CHEM, V280, P20051, DOI 10.1074/jbc.M501981200; Bergoglio V, 2003, J MOL BIOL, V331, P1017, DOI 10.1016/S0022-2836(03)00837-4; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; Clausen AR, 2013, DNA REPAIR, V12, P121, DOI 10.1016/j.dnarep.2012.11.006; D'Agostino VG, 2010, DNA REPAIR, V9, P700, DOI 10.1016/j.dnarep.2010.03.008; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; FURUICHI M, 1994, GENOMICS, V24, P485, DOI 10.1006/geno.1994.1657; Gosavi RA, 2012, NUCLEIC ACIDS RES, V40, P7518, DOI 10.1093/nar/gks413; Goula AV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000749; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286; Mazzei F, 2013, MUTAT RES-FUND MOL M, V743, P33, DOI 10.1016/j.mrfmmm.2013.03.003; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Miller H, 2000, BIOCHEMISTRY-US, V39, P1029, DOI 10.1021/bi991789x; Nick McElhinny S.A., 2003, MOL CELL BIOL, V23, P2309, DOI [DOI 10.1128/MCB.23.7.2309-2315.2003, 10.1128/MCB.23.7.2309-2315.2003]; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Ruggieri V, 2013, ONCOGENE, V32, P4500, DOI 10.1038/onc.2012.479; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; Sastre-Moreno G, 2014, NUCLEIC ACIDS RES, V42, P9821, DOI 10.1093/nar/gku711; SCHARER OD, 1995, J AM CHEM SOC, V117, P10781, DOI 10.1021/ja00148a036; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Turco E, 2013, NUCLEIC ACIDS RES, V41, P4093, DOI 10.1093/nar/gkt130; Vaisman A, 2015, DNA REPAIR, V29, P74, DOI 10.1016/j.dnarep.2015.02.008; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004	39	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26259	26269		10.1074/jbc.M115.679209	http://dx.doi.org/10.1074/jbc.M115.679209			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26338705	hybrid, Green Published			2022-12-28	WOS:000363527300042
J	Kuszak, AJ; Jacobs, D; Gurnev, PA; Shiota, T; Louis, JM; Lithgow, T; Bezrukov, SM; Rostovtseva, TK; Buchanan, SK				Kuszak, Adam J.; Jacobs, Daniel; Gurnev, Philip A.; Shiota, Takuya; Louis, John M.; Lithgow, Trevor; Bezrukov, Sergey M.; Rostovtseva, Tatiana K.; Buchanan, Susan K.			Evidence of Distinct Channel Conformations and Substrate Binding Affinities for the Mitochondrial Outer Membrane Protein Translocase Pore Tom40	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; GENERAL IMPORT PORE; PREPROTEIN TRANSLOCASE; SACCHAROMYCES-CEREVISIAE; PRECURSOR PROTEINS; RECEPTOR COMPLEX; CONDUCTING PORE; PRESEQUENCE; BIOGENESIS; MACHINERY	Nearly all mitochondrial proteins are coded by the nuclear genome and must be transported into mitochondria by the translocase of the outer membrane complex. Tom40 is the central subunit of the translocase complex and forms a pore in the mitochondrial outer membrane. To date, the mechanism it utilizes for protein transport remains unclear. Tom40 is predicted to comprise a membrane-spanning beta-barrel domain with conserved beta-helical domains at both the N and C termini. To investigate Tom40 function, including the role of the N- and C-terminal domains, recombinant forms of the Tom40 protein from the yeast Candida glabrata, and truncated constructs lacking the N- and/or C-terminal domains, were functionally characterized in planar lipid membranes. Our results demonstrate that each of these Tom40 constructs exhibits at least four distinct conductive levels and that full-length and truncated Tom40 constructs specifically interact with a presequence peptide in a concentration- and voltage-dependent manner. Therefore, neither the first 51 amino acids of the N terminus nor the last 13 amino acids of the C terminus are required for Tom40 channel formation or for the interaction with a presequence peptide. Unexpectedly, substrate binding affinity was dependent upon the Tom40 state corresponding to a particular conductive level. A model where two Tom40 pores act in concert as a dimeric protein complex best accounts for the observed biochemical and electrophysiological data. These results provide the first evidence for structurally distinct Tom40 conformations playing a role in substrate recognition and therefore in transport function.	[Kuszak, Adam J.; Jacobs, Daniel; Buchanan, Susan K.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Louis, John M.] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Jacobs, Daniel; Gurnev, Philip A.; Bezrukov, Sergey M.; Rostovtseva, Tatiana K.] NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Gurnev, Philip A.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Shiota, Takuya; Lithgow, Trevor] Monash Univ, Dept Microbiol, Melbourne, Vic 3800, Australia	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Massachusetts System; University of Massachusetts Amherst; Monash University	Rostovtseva, TK (corresponding author), Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bldg 9,Rm 1E-106,9 Mem Dr, Bethesda, MD 20892 USA.	rostovtt@mail.nih.gov; skbuchan@helix.nih.gov	Lithgow, Trevor J/H-5925-2017	Lithgow, Trevor J/0000-0002-0102-7884; Kuszak, Adam/0000-0001-8719-145X; Louis, John M/0000-0002-0052-1899; Jacobs, Daniel/0000-0001-5280-1254	National Institutes of Health grants from Intramural Research Program of NIDDK; Intramural Research Program of Eunice Kennedy Shriver NICHD; National Science Foundation EAGER Award [1249199]; Gluckstern fund of the University of Massachusetts; Australian Research Council Discovery Project Grant; Australian Research Council Linkage International Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036139] Funding Source: NIH RePORTER	National Institutes of Health grants from Intramural Research Program of NIDDK; Intramural Research Program of Eunice Kennedy Shriver NICHD; National Science Foundation EAGER Award; Gluckstern fund of the University of Massachusetts; Australian Research Council Discovery Project Grant(Australian Research Council); Australian Research Council Linkage International Grant(Australian Research Council); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health grants from Intramural Research Program of NIDDK (to A. J. K., D. J., and S. K. B.) and Intramural Research Program of Eunice Kennedy Shriver NICHD (to T. K. R. and S. M. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Science Foundation EAGER Award 1249199 and the Gluckstern fund of the University of Massachusetts.; Australian Research Council Laureate Fellow and acknowledges support from an Australian Research Council Discovery Project Grant and Australian Research Council Linkage International Grant.	Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; Ahting U, 2001, J CELL BIOL, V153, P1151, DOI 10.1083/jcb.153.6.1151; Aiyar A, 2000, Methods Mol Biol, V132, P221; Alcock F, 2010, SCIENCE, V327, P649, DOI 10.1126/science.1182129; Alconada A, 1995, METHOD ENZYMOL, V260, P263, DOI 10.1016/0076-6879(95)60144-9; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Becker L, 2005, J MOL BIOL, V353, P1011, DOI 10.1016/j.jmb.2005.09.019; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Buchanan SK, 1999, BIOCHEM SOC T, V27, P903, DOI 10.1042/bst0270903; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; DAUM G, 1982, J BIOL CHEM, V257, P3075; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Dietmeier K, 1997, NATURE, V388, P195, DOI 10.1038/40663; Dimmer KS, 2012, BBA-BIOMEMBRANES, V1818, P1085, DOI 10.1016/j.bbamem.2011.08.027; Dukanovic J, 2011, BBA-BIOMEMBRANES, V1808, P971, DOI 10.1016/j.bbamem.2010.06.021; Endo T, 2011, BBA-BIOMEMBRANES, V1808, P955, DOI 10.1016/j.bbamem.2010.07.018; Gessmann D, 2011, BBA-BIOENERGETICS, V1807, P1647, DOI 10.1016/j.bbabio.2011.08.006; Gessmann D, 2011, J MOL BIOL, V413, P150, DOI 10.1016/j.jmb.2011.07.054; Gordon DM, 2001, BIOCHEM J, V356, P207, DOI 10.1042/0264-6021:3560207; Grigoriev SM, 2004, INT REV CYTOL, V238, P227, DOI 10.1016/S0074-7696(04)38005-8; HACHIYA N, 1995, NATURE, V376, P705, DOI 10.1038/376705a0; Harbauer AB, 2014, SCIENCE, V346, P1109, DOI 10.1126/science.1261253; Hewitt VL, 2012, P NATL ACAD SCI USA, V109, pE3358, DOI 10.1073/pnas.1206345109; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; KIEBLER M, 1990, NATURE, V348, P610, DOI 10.1038/348610a0; Kunkele KP, 1998, J BIOL CHEM, V273, P31032, DOI 10.1074/jbc.273.47.31032; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; Lueder F, 2009, FEBS LETT, V583, P1475, DOI 10.1016/j.febslet.2009.03.064; Mager F, 2011, J MEMBRANE BIOL, V242, P11, DOI 10.1007/s00232-011-9372-8; Mahendran KR, 2012, BIOPHYS J, V102, P39, DOI 10.1016/j.bpj.2011.11.4003; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Melin J, 2014, MOL CELL BIOL, V34, P3473, DOI 10.1128/MCB.00433-14; Model K, 2002, J MOL BIOL, V316, P657, DOI 10.1006/jmbi.2001.5365; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Model K, 2008, J MOL BIOL, V383, P1049, DOI 10.1016/j.jmb.2008.07.087; O'Malley MA, 2010, STUD HIST PHI PART C, V41, P212, DOI 10.1016/j.shpsc.2010.07.010; Omura T, 1998, J BIOCHEM-TOKYO, V123, P1010; Perry AJ, 2008, PLANT PHYSIOL BIOCH, V46, P265, DOI 10.1016/j.plaphy.2007.12.012; Poynor M, 2008, BIOPHYS J, V95, P1511, DOI 10.1529/biophysj.108.131003; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; Rao S, 2011, CELL CYCLE, V10, P2083, DOI 10.4161/cc.10.13.16054; Rapaport D, 1998, MOL CELL BIOL, V18, P5256, DOI 10.1128/MCB.18.9.5256; Rapaport D, 1998, J BIOL CHEM, V273, P8806, DOI 10.1074/jbc.273.15.8806; Rapaport D, 1997, J BIOL CHEM, V272, P18725, DOI 10.1074/jbc.272.30.18725; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Roetzer A, 2011, FEMS MICROBIOL LETT, V314, P1, DOI 10.1111/j.1574-6968.2010.02102.x; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Shiota T, 2011, P NATL ACAD SCI USA, V108, P15179, DOI 10.1073/pnas.1105921108; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; SOLLNER T, 1992, NATURE, V355, P84, DOI 10.1038/355084a0; Suzuki H, 2004, J BIOL CHEM, V279, P50619, DOI 10.1074/jbc.M408604200; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Zeth K, 2010, BBA-BIOENERGETICS, V1797, P1292, DOI 10.1016/j.bbabio.2010.04.019	60	22	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26204	26217		10.1074/jbc.M115.642173	http://dx.doi.org/10.1074/jbc.M115.642173			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26336107	Green Published, hybrid			2022-12-28	WOS:000363527300038
J	Xiao, L; Xian, HX; Lee, KY; Xiao, B; Wang, HY; Yu, FW; Shen, HM; Liou, YC				Xiao, Lin; Xian, Hongxu; Lee, Kit Yee; Xiao, Bin; Wang, Hongyan; Yu, Fengwei; Shen, Han-Ming; Liou, Yih-Cherng			Death-associated Protein 3 Regulates Mitochondrial-encoded Protein Synthesis and Mitochondrial Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CELL-DEATH; DRP1 PHOSPHORYLATION; SIGNALING PATHWAYS; MAMMALIAN-CELLS; FISSION; AUTOPHAGY; FUSION; APOPTOSIS; DAP3; MORPHOLOGY	Mitochondrial morphologies change over time and are tightly regulated by dynamic machinery proteins such as dynamin-related protein 1 (Drp1), mitofusion 1/2, and optic atrophy 1 (OPA1). However, the detailed mechanisms of how these molecules cooperate to mediate fission and fusion remain elusive. DAP3 is a mitochondrial ribosomal protein that involves in apoptosis, but its biological function has not been well characterized. Here, we demonstrate that DAP3 specifically localizes in the mitochondrial matrix. Knockdown of DAP3 in mitochondria leads to defects in mitochondrial-encoded protein synthesis and abnormal mitochondrial dynamics. Moreover, depletion of DAP3 dramatically decreases the phosphorylation of Drp1 at Ser-637 on mitochondria, enhancing the retention time of Drp1 puncta on mitochondria during the fission process. Furthermore, autophagy is inhibited in the DAP3-depleted cells, which sensitizes cells to different types of death stimuli. Together, our results suggest that DAP3 plays important roles in mitochondrial function and dynamics, providing new insights into the mechanism of a mitochondrial ribosomal protein function in cell death.	[Xiao, Lin; Xian, Hongxu; Lee, Kit Yee; Xiao, Bin; Liou, Yih-Cherng] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Singapore 117543, Singapore; [Wang, Hongyan] Duke NUS Grad Med Sch, Neurosci & Behav Disorders Program, Singapore 169857, Singapore; [Wang, Hongyan; Yu, Fengwei; Liou, Yih-Cherng] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117573, Singapore; [Yu, Fengwei] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Yu, Fengwei] Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore; [Shen, Han-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Liou, YC (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbslyc@nus.edu.sg	SHEN, Han-Ming/B-5942-2011; LEE, KIT/GZM-4116-2022	SHEN, Han-Ming/0000-0001-7369-5227; Yu, Fengwei/0000-0003-0268-199X; Xiao, Bin/0000-0003-2986-4980; Wang, Hongyan/0000-0003-4623-1878; Xian, Hongxu/0000-0002-8610-2029	Ministry of Education, Singapore [MOE-T2-1-153, NMRC-CBRG13nov097]	Ministry of Education, Singapore(Ministry of Education, Singapore)	This work was supported in part by Grants MOE-T2-1-153 and Tier 1 from the Ministry of Education, and NMRC-CBRG13nov097, Singapore (to Y.-C. L.) The authors declare that they have no conflicts of interest with the contents of this article.	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Berger T, 2002, NAT IMMUNOL, V3, P3, DOI 10.1038/ni0102-3b; CAVDAR KE, 2001, FEBS LETT, V492, P166; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chang CR, 2007, EMBO REP, V8, P1088, DOI 10.1038/sj.embor.7401118; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Dickey AS, 2011, J NEUROSCI, V31, P15716, DOI 10.1523/JNEUROSCI.3159-11.2011; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Graef M, 2011, EMBO J, V30, P2101, DOI 10.1038/emboj.2011.104; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Kashatus DF, 2011, NAT CELL BIOL, V13, P1108, DOI 10.1038/ncb2310; Kim HR, 2007, FASEB J, V21, P188, DOI 10.1096/fj.06-6283com; KISSIL JL, 1995, J BIOL CHEM, V270, P27932, DOI 10.1074/jbc.270.46.27932; Kissil JL, 1999, EMBO J, V18, P353, DOI 10.1093/emboj/18.2.353; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Miyazaki T, 2001, NAT IMMUNOL, V2, P493, DOI 10.1038/88684; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Mukamel Z, 2004, J BIOL CHEM, V279, P36732, DOI 10.1074/jbc.M400041200; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Richter U, 2013, CURR BIOL, V23, P535, DOI 10.1016/j.cub.2013.02.019; Santel A, 2001, J CELL SCI, V114, P867; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Tang TD, 2009, J BIOL CHEM, V284, P5414, DOI 10.1074/jbc.M807797200; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wang HX, 2011, J BIOL CHEM, V286, P11649, DOI 10.1074/jbc.M110.144238; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Xia Y, 2009, J BIOL CHEM, V284, P17428, DOI 10.1074/jbc.M109.007823; Ye F, 2011, CURR BIOL, V21, P1584, DOI 10.1016/j.cub.2011.08.024; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yue W, 2014, CELL RES, V24, P482, DOI 10.1038/cr.2014.20; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198	56	20	21	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24961	24974		10.1074/jbc.M115.673343	http://dx.doi.org/10.1074/jbc.M115.673343			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26306039	Green Published, hybrid			2022-12-28	WOS:000362598300027
J	Lovas, S; Het, DZZ; Liu, HZ; Tang, J; Pecka, JL; Hatfield, MPD; Beiser, KW				Lovas, Sandor; Het, David Z. Z.; Liu, Huizhan; Tang, Jie; Pecka, Jason L.; Hatfield, Marcus P. D.; Beiser, Kirk W.			Glutamate Transporter Homolog-based Model Predicts That Anion-pi Interaction Is the Mechanism for the Voltage-dependent Response of Prestin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR CELL; PROTEIN SECONDARY STRUCTURE; LATERAL MEMBRANE; MOTOR PROTEIN; ELECTROMOTILITY; SUPERFAMILY; RECOGNITION; SIMULATION; DOMAINS; PATTERN	Prestin is the motor protein of cochlear outer hair cells. Its unique capability to perform direct, rapid, and reciprocal electromechanical conversion depends on membrane potential and interaction with intracellular anions. How prestin senses the voltage change and interacts with anions are still unknown. Our three-dimensional model of prestin using molecular dynamics simulations predicts that prestin contains eight transmembrane-spanning segments and two helical re-entry loops and that tyrosyl residues are the structural specialization of the molecule for the unique function of prestin. Using site-directed mutagenesis and electrophysiological techniques, we confirmed that residues Tyr(367), Tyr(486), Tyran, and Tyr(501) contribute to anion binding, interacting with intracellular anions through novel anion-Tr interactions. Such weak interactions, sensitive to voltage and mechanical stimulation, confer prestin with a unique capability to perform electromechanical and mechano-electric conversions with exquisite sensitivity. This novel mechanism is completely different from all known mechanisms seen in ion channels, transporters, and motor proteins.	[Lovas, Sandor; Het, David Z. Z.; Liu, Huizhan; Tang, Jie; Pecka, Jason L.; Hatfield, Marcus P. D.; Beiser, Kirk W.] Creighton Univ, Sch Med, Dept Biomed Sci, 2500 Calif Plaza, Omaha, NE 68178 USA	Creighton University	Lovas, S (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, 2500 Calif Plaza, Omaha, NE 68178 USA.	slovas@creighton.edu; davidhe@creighton.edu; kirkbeisel@creighton.edu	Tang, Jie/GNW-2318-2022	He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634; Tang, Jie/0000-0001-7882-4462	National Institutes of Health from the NIDCD [R01 DC 004696]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696] Funding Source: NIH RePORTER	National Institutes of Health from the NIDCD; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DC 004696 from the NIDCD (to D. Z. Z. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Ashmore J. F., 1989, COCHLEAR MECH, P107; Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Chourasia M, 2011, INT J BIOL MACROMOL, V48, P540, DOI 10.1016/j.ijbiomac.2011.01.008; Csontos J, 2008, J COMPUT CHEM, V29, P1344, DOI 10.1002/jcc.20898; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Dong XX, 2000, BIOPHYS J, V79, P1876, DOI 10.1016/S0006-3495(00)76437-X; Fisher JAN, 2012, NEURON, V76, P989, DOI 10.1016/j.neuron.2012.09.031; Frontera A, 2011, ANGEW CHEM INT EDIT, V50, P9564, DOI 10.1002/anie.201100208; GALE JE, 1994, P ROY SOC B-BIOL SCI, V255, P243, DOI 10.1098/rspb.1994.0035; Gorbunov D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4622; Hallworth R, 2012, J NEUROPHYSIOL, V107, P5, DOI 10.1152/jn.00728.2011; He DZZ, 2014, HEARING RES, V311, P25, DOI 10.1016/j.heares.2013.12.002; He DZZ, 2010, CYTOSKELETON, V67, P43, DOI 10.1002/cm.20423; Homma K, 2013, J BIOL CHEM, V288, P2452, DOI 10.1074/jbc.M112.411579; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; Jones GJ, 2013, J PHYS CHEM B, V117, P3315, DOI 10.1021/jp400345s; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Lippert RA, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2431176; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lovas S., 2011, P 22 AM PEPT S AM PE, P120; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Naider Fred, 2007, V386, P95, DOI 10.1007/978-1-59745-430-8_4; Nishio M, 2014, PHYS CHEM CHEM PHYS, V16, P12648, DOI 10.1039/c4cp00099d; Ohana E, 2011, J GEN PHYSIOL, V137, P239, DOI 10.1085/jgp.201010531; Ohana E, 2009, J PHYSIOL-LONDON, V587, P2179, DOI 10.1113/jphysiol.2008.164863; Okoruwa OE, 2008, EVOL DEV, V10, P300, DOI 10.1111/j.1525-142X.2008.00239.x; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Palermo NY, 2012, J PEPT SCI, V18, P252, DOI 10.1002/psc.2393; Philip V, 2011, BIOCHEMISTRY-US, V50, P2939, DOI 10.1021/bi200066k; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Robertazzi A, 2011, CRYSTENGCOMM, V13, P3293, DOI 10.1039/c0ce00819b; Rybalchenko V, 2003, BIOPHYSICS OF THE COCHLEA: FROM MOLECULES TO MODELS, P116, DOI 10.1142/9789812704931_0015; SANTOS-SACCHI J, 1989, J NEUROSCI, V9, P2954; Santos-Sacchi J, 2001, J PHYSIOL-LONDON, V531, P661, DOI 10.1111/j.1469-7793.2001.0661h.x; Schaechinger TJ, 2011, EMBO J, V30, P2793, DOI 10.1038/emboj.2011.202; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Song L, 2010, BIOPHYS J, V98, P371, DOI 10.1016/j.bpj.2009.10.027; Sousounis K, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-10; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SZENDREI GI, 1994, EUR J BIOCHEM, V226, P917, DOI 10.1111/j.1432-1033.1994.t01-1-00917.x; Tan XD, 2012, J CELL SCI, V125, P1039, DOI 10.1242/jcs.097337; Tan XD, 2011, J NEUROPHYSIOL, V105, P36, DOI 10.1152/jn.00234.2010; Tang J, 2011, J BIOL CHEM, V286, P31014, DOI 10.1074/jbc.M111.259564; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vastermark A, 2014, PROTEINS, V82, P336, DOI 10.1002/prot.24401; Vastermark A, 2014, PROTEINS, V82, P2797, DOI 10.1002/prot.24643; Wang X, 2010, BRAIN RES, V1333, P28, DOI 10.1016/j.brainres.2010.03.070; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Yamaguchi T, 2010, J MOL BIOL, V397, P179, DOI 10.1016/j.jmb.2010.01.027; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2001, NEUROREPORT, V12, P1929, DOI 10.1097/00001756-200107030-00032	61	8	8	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24326	24339		10.1074/jbc.M115.649962	http://dx.doi.org/10.1074/jbc.M115.649962			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26283790	Green Published, hybrid			2022-12-28	WOS:000362218900022
J	Das, N; Xie, LW; Ramakrishnan, SK; Campbell, A; Rivella, S; Shah, YM				Das, Nupur; Xie, Liwei; Ramakrishnan, Sadeesh K.; Campbell, Andrew; Rivella, Stefano; Shah, Yatrik M.			Intestine-specific Disruption of Hypoxia-inducible Factor (HIF)-2 alpha Improves Anemia in Sickle Cell Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON OVERLOAD; EXPRESSION; HEPCIDIN-1; ADULTS	Sickle cell disease (SCD) is caused by genetic defects in the beta-globin chain. SCD is a frequently inherited blood disorder, and sickle cell anemia is a common type of hemoglobinopathy. During anemia, the hypoxic response via the transcription factor hypoxia-inducible factor (HIF)-2 alpha is highly activated in the intestine and is essential in iron absorption. Intestinal disruption of HIF-2 alpha protects against tissue iron accumulation in iron overload anemias. However, the role of intestinal HIF-2 alpha in regulating anemia in SCD is currently not known. Here we show that in mouse models of SCD, disruption of intestinal HIF-2 alpha significantly decreased tissue iron accumulation. This was attributed to a decrease in intestinal iron absorptive genes, which were highly induced in a mouse model of SCD. Interestingly, disruption of intestinal HIF-2 alpha led to a robust improvement in anemia with an increase in RBC, hemoglobin, and hematocrit. This was attributed to improvement in RBC survival, hemolysis, and insufficient erythropoiesis, which is evident from a significant decrease in serum bilirubin, reticulocyte counts, and serum erythropoietin following intestinal HIF-2 alpha disruption. These data suggest that targeting intestinal HIF-2 alpha has a significant therapeutic potential in SCD pathophysiology.	[Das, Nupur; Xie, Liwei; Ramakrishnan, Sadeesh K.; Shah, Yatrik M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Campbell, Andrew] Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI 48109 USA; [Shah, Yatrik M.] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Rivella, Stefano] Childrens Hosp Philadelphia, Abramson Res Ctr, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Shah, YM (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	shahy@umich.edu	Das, Nupur/AAK-7877-2020; Regan, Clinton/E-6250-2012; Campbell, Andrew/AAX-8590-2020	Das, Nupur/0000-0002-5652-1134; Campbell, Andrew/0000-0002-8829-0043; Rivella, Stefano/0000-0002-0938-6558	National Institutes of Health [P30 DK034933]; NATIONAL CANCER INSTITUTE [R01CA148828] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL080954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095112, P30DK034933, R01DK095201, R01DK090554] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the staff of the University of Michigan Gastrointestinal Peptide Research Center (supported by National Institutes of Health Grant P30 DK034933).	Anderson ER, 2013, P NATL ACAD SCI USA, V110, pE4922, DOI 10.1073/pnas.1314197110; Anderson ER, 2011, J BIOL CHEM, V286, P19533, DOI 10.1074/jbc.M111.238667; Campbell AD, 2011, P NATL ACAD SCI USA, V108, P18808, DOI 10.1073/pnas.1104964108; Chakravorty S, 2015, ARCH DIS CHILD, V100, P48, DOI 10.1136/archdischild-2013-303773; Drasar E, 2012, BRIT J HAEMATOL, V157, P645, DOI 10.1111/j.1365-2141.2012.09060.x; Felfly Hady, 2014, J Stem Cells, V9, P163, DOI jsc.2014.9.3.163; Gardenghi S, 2010, J CLIN INVEST, V120, P4466, DOI 10.1172/JCI41717; Gutschow P, 2015, HAEMATOLOGICA, V100, P167, DOI 10.3324/haematol.2014.116723; Ilyin G, 2003, FEBS LETT, V542, P22, DOI 10.1016/S0014-5793(03)00329-6; Inati A, 2009, BLOOD REV, V23, pS9, DOI 10.1016/S0268-960X(09)70004-9; Kato Gregory J, 2009, Am J Hematol, V84, P618, DOI 10.1002/ajh.21475; Manwani D, 2013, BLOOD, V122, P3892, DOI 10.1182/blood-2013-05-498311; Mastrogiannaki M, 2013, BLOOD, V122, P885, DOI 10.1182/blood-2012-11-427765; Raghupathy Radha, 2010, Adv Hematol, V2010, P272940, DOI 10.1155/2010/272940; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; Scheuermann TH, 2013, NAT CHEM BIOL, V9, P271, DOI [10.1038/NCHEMBIO.1185, 10.1038/nchembio.1185]; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; van Beers EJ, 2015, CIRC RES, V116, P298, DOI 10.1161/CIRCRESAHA.116.304577; Weatherall DJ, 2008, CURR MOL MED, V8, P592, DOI 10.2174/156652408786241375; Williams TN, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011692; Xue X, 2013, GASTROENTEROLOGY, V145, P831, DOI 10.1053/j.gastro.2013.07.010; Xue X, 2012, CANCER RES, V72, P2285, DOI 10.1158/0008-5472.CAN-11-3836	24	20	20	0	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23523	23527		10.1074/jbc.C115.681643	http://dx.doi.org/10.1074/jbc.C115.681643			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26296885	hybrid, Green Published			2022-12-28	WOS:000361816500005
J	Pribasnig, MA; Mrak, I; Grabner, GF; Taschler, U; Knittelfelder, O; Scherz, B; Eichmann, TO; Heier, C; Grumet, L; Kowaliuk, J; Romauch, M; Holler, S; Anderl, F; Wolinski, H; Lass, A; Breinbauer, R; Marsche, G; Brown, JM; Zimmermann, R				Pribasnig, Maria A.; Mrak, Irina; Grabner, Gernot F.; Taschler, Ulrike; Knittelfelder, Oskar; Scherz, Barbara; Eichmann, Thomas O.; Heier, Christoph; Grumet, Lukas; Kowaliuk, Jakob; Romauch, Matthias; Holler, Stefan; Anderl, Felix; Wolinski, Heimo; Lass, Achim; Breinbauer, Rolf; Marsche, Gunther; Brown, J. Mark; Zimmermann, Robert			alpha/beta Hydrolase Domain-containing 6 (ABHD6) Degrades the Late Endosomal/Lysosomal Lipid Bis(monoacylglycero)phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOLIPID ACTIVATOR PROTEINS; LIPASE-RELATED PROTEIN-2; LYSOBISPHOSPHATIDIC ACID; ENDOCANNABINOID SYSTEM; CHOLESTEROL TRANSPORT; LYSOSOMAL LIPIDS; MONOACYLGLYCEROL; PHOSPHATE; MODEL; STIMULATION	alpha/beta Hydrolase domain-containing 6 (ABHD6) can act as monoacylglycerol hydrolase and is believed to play a role in endocannabinoid signaling as well as in the pathogenesis of obesity and liver steatosis. However, the mechanistic link between gene function and disease is incompletely understood. Here we aimed to further characterize the role of ABHD6 in lipid metabolism. We show that mouse and human ABHD6 degrade bis(monoacylglycero)phosphate (BMP) with high specific activity. BMP, also known as lysobisphosphatidic acid, is enriched in late endosomes/lysosomes, where it plays a key role in the formation of intraluminal vesicles and in lipid sorting. Up to now, little has been known about the catabolism of this lipid. Our data demonstrate that ABHD6 is responsible for similar to 90% of the BMP hydrolase activity detected in the liver and that knockdown of ABHD6 increases hepatic BMP levels. Tissue fractionation and live-cell imaging experiments revealed that ABHD6 co-localizes with late endosomes/lysosomes. The enzyme is active at cytosolic pH and lacks acid hydrolase activity, implying that it degrades BMP exported from acidic organelles or de novo-formed BMP. In conclusion, our data suggest that ABHD6 controls BMP catabolism and is therefore part of the late endosomal/lysosomal lipid-sorting machinery.	[Pribasnig, Maria A.; Mrak, Irina; Grabner, Gernot F.; Taschler, Ulrike; Knittelfelder, Oskar; Scherz, Barbara; Eichmann, Thomas O.; Heier, Christoph; Grumet, Lukas; Kowaliuk, Jakob; Romauch, Matthias; Wolinski, Heimo; Lass, Achim; Zimmermann, Robert] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Holler, Stefan; Anderl, Felix; Breinbauer, Rolf] Graz Univ Technol, A-8010 Graz, Austria; [Marsche, Gunther] Med Univ Graz, Inst Organ Chem, A-8010 Graz, Austria; [Brown, J. Mark] Cleveland Clin Lerner Res Inst, Inst Expt & Clin Pharmacol, Dept Cellular & Mol Med, Cleveland, OH 44195 USA	University of Graz; Graz University of Technology; Medical University of Graz; Cleveland Clinic Foundation	Zimmermann, R (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31A, A-8010 Graz, Austria.	robert.zimmermann@uni-graz.at	Lass, Achim/C-3332-2008; Breinbauer, Rolf/AAK-1750-2020	Lass, Achim/0000-0002-8190-7151; Breinbauer, Rolf/0000-0001-6009-7359; Eichmann, Thomas O./0000-0002-8521-2795; Knittelfelder, Oskar/0000-0002-1565-7238; Grabner, Gernot/0000-0002-7110-9957; Wolinski, Heimo/0000-0002-1583-6092; Zimmermann, Robert/0000-0002-7354-870X; Marsche, Gunther/0000-0002-2422-5381; Taschler, Ulrike/0000-0001-9000-1602; Heier, Christoph/0000-0001-6858-408X	Austrian Science Fund [P 26166, P 24294]; doctoral program Molecular Enzymology Grant [W 09]; NAWI Graz; Austrian Science Fund (FWF) [P 26166, W 901] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); doctoral program Molecular Enzymology Grant; NAWI Graz; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund Grants P 26166 and P 24294, doctoral program Molecular Enzymology Grant W 09, and NAWI Graz. The authors declare that they have no conflicts of interest with the contents of this article.	Bissig C, 2014, TRENDS CELL BIOL, V24, P19, DOI 10.1016/j.tcb.2013.10.009; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Blankman JL, 2013, P NATL ACAD SCI USA, V110, P1500, DOI 10.1073/pnas.1217121110; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chanda PK, 2010, MOL PHARMACOL, V78, P996, DOI 10.1124/mol.110.068304; Chapuy-Regaud S, 2013, BIOCHIMIE, V95, P1677, DOI 10.1016/j.biochi.2013.05.019; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Christie W.W., 1993, ADV LIPID METHODOLOG, P69, DOI DOI 10.1016/0009-3084(94)02308-5; Crooke Stanley T., 1997, V40, P1; Delton-Vandenbroucke I, 2007, J LIPID RES, V48, P543, DOI 10.1194/jlr.M600266-JLR200; Di Marzo V, 2011, HANDB EXP PHARMACOL, V203, P75, DOI 10.1007/978-3-642-17214-4_4; Fiskerstrand T, 2010, AM J HUM GENET, V87, P410, DOI 10.1016/j.ajhg.2010.08.002; Gallala HD, 2011, NEUROCHEM RES, V36, P1594, DOI 10.1007/s11064-010-0337-6; Hartler J, 2013, BRIEF BIOINFORM, V14, P375, DOI 10.1093/bib/bbs030; Hsu KL, 2013, J MED CHEM, V56, P8270, DOI 10.1021/jm400899c; Hullin-Matsuda F, 2009, PROSTAG LEUKOTR ESS, V81, P313, DOI 10.1016/j.plefa.2009.09.006; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Ito M, 2002, J BIOL CHEM, V277, P43674, DOI 10.1074/jbc.M202817200; Jiang GW, 2006, J ORG CHEM, V71, P934, DOI 10.1021/jo051894e; JOUTTI A, 1981, CHEM PHYS LIPIDS, V29, P235, DOI 10.1016/0009-3084(81)90054-2; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Knittelfelder OL, 2014, J CHROMATOGR B, V951, P119, DOI 10.1016/j.jchromb.2014.01.011; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Li F, 2009, MOL BIOL REP, V36, P691, DOI 10.1007/s11033-008-9230-7; Linke T, 2001, BIOL CHEM, V382, P283, DOI 10.1515/BC.2001.035; Linke T, 2001, J BIOL CHEM, V276, P5760, DOI 10.1074/jbc.M006846200; Liu NJ, 2014, TOXICOL APPL PHARM, V279, P467, DOI 10.1016/j.taap.2014.06.014; Lord CC, 2013, BBA-MOL CELL BIOL L, V1831, P792, DOI 10.1016/j.bbalip.2013.01.002; Lowe ME, 2000, BIOCHIMIE, V82, P997, DOI 10.1016/S0300-9084(00)01184-6; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Max D, 2009, CANCER SCI, V100, P2383, DOI 10.1111/j.1349-7006.2009.01347.x; Navia-Paldanius D, 2012, J LIPID RES, V53, P2413, DOI 10.1194/jlr.M030411; Naydenov AV, 2014, NEURON, V83, P361, DOI 10.1016/j.neuron.2014.06.030; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Piccoli E, 2011, BIOCHEM PHARMACOL, V82, P1234, DOI 10.1016/j.bcp.2011.07.090; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Record M, 2011, BBA-MOL CELL BIOL L, V1811, P419, DOI 10.1016/j.bbalip.2011.04.008; Savinainen JR, 2012, ACTA PHYSIOL, V204, P267, DOI 10.1111/j.1748-1716.2011.02280.x; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Schneider JL, 2014, NAT REV GASTRO HEPAT, V11, P187, DOI 10.1038/nrgastro.2013.211; Taschler U, 2011, J BIOL CHEM, V286, P17467, DOI 10.1074/jbc.M110.215434; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Thomas G, 2013, CELL REP, V5, P508, DOI 10.1016/j.celrep.2013.08.047; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Vanier MT, 2015, J INHERIT METAB DIS, V38, P187, DOI 10.1007/s10545-014-9794-4; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Zhao SG, 2014, CELL METAB, V19, P993, DOI 10.1016/j.cmet.2014.04.003; Zorzano A, 2003, BBA-PROTEINS PROTEOM, V1647, P3, DOI 10.1016/S1570-9639(03)00039-6	51	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29869	29881		10.1074/jbc.M115.669168	http://dx.doi.org/10.1074/jbc.M115.669168			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26491015	hybrid, Green Published			2022-12-28	WOS:000366614700020
J	Zita, MM; Soncin, F; Natale, D; Pizzo, D; Parast, M				Zita, Matteo Moretto; Soncin, Francesca; Natale, David; Pizzo, Donald; Parast, Mana			Gene Expression Profiling Reveals a Novel Regulatory Role for Sox21 Protein in Mouse Trophoblast Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; VERTEBRATE NEUROGENESIS; PROLIFERATION; TROPHECTODERM; PROMOTES; CDX2; PROGRESSION; ECTODERM; PLACENTA; LISTS	Appropriate self-renewal and differentiation of trophoblast stem cells (TSCs) are key factors for proper placental development and function and, in turn, for appropriate in utero fetal growth. To identify novel TSC-specific genes, we performed genome-wide expression profiling of TSCs, embryonic stem cells, epiblast stem cells, and mouse embryo fibroblasts, derived from mice of the same genetic background. Our analysis revealed a high expression of Sox21 in TSCs compared with other cell types. Sox21 levels were high in undifferentiated TSCs and were dramatically reduced upon differentiation. In addition, modulation of Sox21 expression in TSCs affected lineage-specific differentiation, based on both marker analysis and functional assessment. Our results implicate Sox21 specifically in the promotion of spongiotrophoblast and giant cell differentiation and establish a new mechanism through which trophoblast sublineages are specified.	[Zita, Matteo Moretto; Soncin, Francesca; Pizzo, Donald; Parast, Mana] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Natale, David] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Parast, M (corresponding author), Sanford Consortium Regenerat Med, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.	mparast@ucsd.edu	Soncin, Francesca/AAB-6143-2021; Regan, Clinton/E-6250-2012		National Institutes of Health [R01-HD071100]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Grant R01-HD071100 (NICHD award; to M. P.). The authors declare no competing potential conflict of interests. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi K, 2013, MOL CELL, V52, P380, DOI 10.1016/j.molcel.2013.09.002; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Archer TC, 2011, DEV BIOL, V350, P429, DOI 10.1016/j.ydbio.2010.12.013; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; Erlebacher A, 2004, DEV BIOL, V275, P158, DOI 10.1016/j.ydbio.2004.07.032; Ferletta M, 2011, INT J CANCER, V129, P45, DOI 10.1002/ijc.25647; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes M, 2013, PLACENTA, V34, P831, DOI 10.1016/j.placenta.2013.05.011; Keramari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013952; Kiso M, 2009, P NATL ACAD SCI USA, V106, P9292, DOI 10.1073/pnas.0808324106; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kuckenberg P, 2010, MOL CELL BIOL, V30, P3310, DOI 10.1128/MCB.01215-09; Kuzmichev AN, 2012, CURR BIOL, V22, P1705, DOI 10.1016/j.cub.2012.07.013; Li YC, 2014, AM J PATHOL, V184, P3332, DOI 10.1016/j.ajpath.2014.08.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Matsuda S, 2012, J NEUROSCI, V32, P12543, DOI 10.1523/JNEUROSCI.5803-11.2012; Parast MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008055; Parast MM, 2001, DEV BIOL, V230, P43, DOI 10.1006/dbio.2000.0102; Pettersson K, 1996, MECH DEVELOP, V54, P211, DOI 10.1016/0925-4773(95)00479-3; Popovic J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091852; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Sandberg M, 2005, NAT NEUROSCI, V8, P995, DOI 10.1038/nn1493; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Tada H., 2007, INFLAMM REGEN, V27, P37; Takao T, 2012, J BIOL CHEM, V287, P42685, DOI 10.1074/jbc.M112.388777; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tanaka Satoshi, 2006, V329, P35; Uchikawa M, 1999, MECH DEVELOP, V84, P103, DOI 10.1016/S0925-4773(99)00083-0; Ueno M, 2013, DEV CELL, V27, P373, DOI 10.1016/j.devcel.2013.10.019; Uy GD, 2002, DEVELOPMENT, V129, P3913; Whittington N, 2015, DEV BIOL, V397, P237, DOI 10.1016/j.ydbio.2014.11.012; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Zhang KJ, 2010, DEVELOPMENT, V137, P2095, DOI 10.1242/dev.049494	41	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					30152	30162		10.1074/jbc.M115.659094	http://dx.doi.org/10.1074/jbc.M115.659094			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26491013	Green Published, hybrid			2022-12-28	WOS:000366614700045
J	Meng, T; Huang, YY; Wang, SZ; Zhang, H; Dechow, PC; Wang, XF; Qin, CL; Shi, B; D'Souza, RN; Lu, YB				Meng, Tian; Huang, Yanyu; Wang, Suzhen; Zhang, Hua; Dechow, Paul C.; Wang, Xiaofang; Qin, Chunlin; Shi, Bing; D'Souza, Rena N.; Lu, Yongbo			Twist1 Is Essential for Tooth Morphogenesis and Odontoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SAETHRE-CHOTZEN-SYNDROME; NEURAL CREST; SONIC-HEDGEHOG; BETA-CATENIN; MOUSE; MODULATION; MUTATIONS; EXPRESSION; MESENCHYME; EVOLUTION	Twist1 is a basic helix-loop-helix-containing transcription factor that is expressed in the dental mesenchyme during the early stages of tooth development. To better delineate its roles in tooth development, we generated Twist1 conditional knockout embryos (Twist2(Cre/+);Twist1(fl/fl)) by breeding Twist1 floxed mice (Twist1(fl/fl)) with Twist2-Cre recombinase knockin mice (Twist2(Cre/+)). The Twist2(Cre/+);Twist1(fl/fl) embryos formed smaller tooth germs and abnormal cusps during early tooth morphogenesis. Molecular and histological analyses showed that the developing molars of the Twist2(Cre/+);Twist1(fl/fl) embryos had reduced cell proliferation and expression of fibroblast growth factors 3, 4, 9, and 10 and FGF receptors 1 and 2 in the dental epithelium and mesenchyme. In addition, 3-week-old renal capsular transplants of embryonic day 18.5 Twist2(Cre/+); Twist1(fl/fl) molars showed malformed crowns and cusps with defective crown dentin and enamel. Immunohistochemical analyses revealed that the implanted mutant molars had defects in odontoblast differentiation and delayed ameloblast differentiation. Furthermore, in vitro ChIP assays demonstrated that Twist1 was able to bind to a specific region of the Fgf10 promoter. In conclusion, our findings suggest that Twist1 plays crucial roles in regulating tooth development and that it may exert its functions through the FGF signaling pathway.	[Meng, Tian; Huang, Yanyu; Wang, Suzhen; Zhang, Hua; Dechow, Paul C.; Wang, Xiaofang; Qin, Chunlin; Lu, Yongbo] Texas A&M Univ, Baylor Coll Dent, Dept Biomed Sci, Dallas, TX 75246 USA; [Meng, Tian; Huang, Yanyu; Wang, Suzhen; Zhang, Hua; Dechow, Paul C.; Wang, Xiaofang; Qin, Chunlin; Lu, Yongbo] Texas A&M Univ, Baylor Coll Dent, Ctr Craniofacial Res & Diag, Dallas, TX 75246 USA; [Meng, Tian; Shi, Bing] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China; [Meng, Tian; Shi, Bing] Sichuan Univ, West China Hosp Stomatol, Dept Cleft Lip & Palate Surg, Chengdu 610041, Peoples R China; [Huang, Yanyu] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Guangzhou 510055, Guangdong, Peoples R China; [D'Souza, Rena N.] Univ Utah Hlth Sci, Salt Lake City, UT 84112 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Sichuan University; Sichuan University; Sun Yat Sen University; Utah System of Higher Education; University of Utah; University of Utah Hospital	D'Souza, RN (corresponding author), Univ Utah, Biomed Polymers Res Bldg,20 S 2030 E, Salt Lake City, UT 84112 USA.	rena.dsouza@hsc.utah.edu; ylu@bcd.tamhsc.edu		Wang, Xiaofang/0000-0002-7370-7192; Lu, Yongbo/0000-0003-3692-1736; Zhang, Hua/0000-0002-6789-9343	NIDCR/National Institutes of Health [DE13368, DE021773]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE021773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013368] Funding Source: NIH RePORTER	NIDCR/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIDCR/National Institutes of Health Grants DE13368 (to R. D. S.) and DE021773 (to Y. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bildsoe H, 2009, DEV BIOL, V331, P176, DOI 10.1016/j.ydbio.2009.04.034; Bourgeois P, 1998, HUM MOL GENET, V7, P945, DOI 10.1093/hmg/7.6.945; Chai Y, 2000, DEVELOPMENT, V127, P1671; Charles C, 2009, P NATL ACAD SCI USA, V106, P22364, DOI 10.1073/pnas.0910086106; Chen YT, 2007, GENESIS, V45, P588, DOI 10.1002/dvg.20332; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Chuong CM, 2000, CELL MOL LIFE SCI, V57, P1672, DOI 10.1007/PL00000650; Connerney J, 2008, DEV BIOL, V318, P323, DOI 10.1016/j.ydbio.2008.03.037; Franco HL, 2011, NUCLEIC ACIDS RES, V39, P1177, DOI 10.1093/nar/gkq890; Goodnough LH, 2012, DEVELOPMENT, V139, P4428, DOI 10.1242/dev.081679; Guenou H, 2005, HUM MOL GENET, V14, P1429, DOI 10.1093/hmg/ddi152; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Huang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099331; Kettunen P, 2000, DEV DYNAM, V219, P322, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1062>3.0.CO;2-J; Li CY, 2014, ODONTOLOGY, V102, P1, DOI 10.1007/s10266-013-0142-1; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Li Y, 2011, Adv Dent Res, V23, P280, DOI 10.1177/0022034511405387; Liu C, 2013, DEVELOPMENT, V140, P4375, DOI 10.1242/dev.097733; Lu YB, 2012, DEV DYNAM, V241, P1708, DOI 10.1002/dvdy.23858; Milunsky JM, 2006, CLIN GENET, V69, P349, DOI 10.1111/j.1399-0004.2006.00597.x; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Otsu Keishi, 2012, Methods Mol Biol, V887, P59, DOI 10.1007/978-1-61779-860-3_7; Rice R, 2005, DEV DYNAM, V234, P28, DOI 10.1002/dvdy.20501; Simmer JP, 2010, J DENT RES, V89, P1024, DOI 10.1177/0022034510375829; Song ZC, 2013, J BIOL CHEM, V288, P10440, DOI 10.1074/jbc.M112.432286; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Tekin M, 2007, AM J HUM GENET, V80, P338, DOI 10.1086/510920; THESLEFF I, 1981, DIFFERENTIATION, V18, P75, DOI 10.1111/j.1432-0436.1981.tb01107.x; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Thesleff I, 2001, Adv Dent Res, V15, P14; Thesleff I, 2002, INT REV CYTOL, V217, P93; Thesleff I, 1996, CURR OPIN CELL BIOL, V8, P844, DOI 10.1016/S0955-0674(96)80086-X; Thesleff I, 1997, COLD SPRING HARB SYM, V62, P257; Tukel T, 2010, AM J HUM GENET, V87, P289, DOI 10.1016/j.ajhg.2010.07.009; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Xu Y, 2013, AM J PATHOL, V183, P1281, DOI 10.1016/j.ajpath.2013.06.021; Zhang YP, 2012, DEV DYNAM, V241, P924, DOI 10.1002/dvdy.23776; Zhang YD, 1999, DEV DYNAM, V215, P45, DOI 10.1002/(SICI)1097-0177(199905)215:1<45::AID-DVDY5>3.3.CO;2-X	41	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29593	29602		10.1074/jbc.M115.680546	http://dx.doi.org/10.1074/jbc.M115.680546			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26487719	hybrid, Green Published			2022-12-28	WOS:000366613400040
J	Mishra, J; Verma, RK; Alpini, G; Meng, FY; Kumar, N				Mishra, Jayshree; Verma, Raj K.; Alpini, Gianfranco; Meng, Fanyin; Kumar, Narendra			Role of Janus Kinase 3 in Predisposition to Obesity-associated Metabolic Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-GRADE INFLAMMATION; TOLL-LIKE RECEPTORS; INSULIN-RESISTANCE; GUT MICROBIOTA; INTESTINAL MICROBIOTA; JAK3 EXPRESSION; CELLS; ACTIVATION; MATURATION; INHIBITOR	Obesity, a worldwide epidemic, is a major risk factor for the development of metabolic syndrome (MetS) including diabetes and associated health complications. Recent studies indicate that chronic low-grade inflammation (CLGI) plays a key role in metabolic deterioration in the obese population. Previously, we reported that Jak3 was essential for mucosal differentiation and enhanced colonic barrier functions and its loss in mice resulted in basal CLGI and predisposition to DSS induced colitis. Since CLGI is associated with diabetes, obesity, and metabolic syndrome, present studies determined the role of Jak3 in development of such conditions. Our data show that loss of Jak3 resulted in increased body weight, basal systemic CLGI, compromised glycemic homeostasis, hyperinsulinemia, and early symptoms of liver steatosis. Lack of Jak3 also resulted in exaggerated symptoms of metabolic syndrome by western high-fat diet. Mechanistically, Jak3 was essential for reduced expression and activation of Toll-like receptors (TLRs) in murine intestinal mucosa and human intestinal epithelial cells where Jak3 interacted with and activated p85, the regulatory subunit of the PI3K, through tyrosine phosphorylation of adapter protein insulin receptor substrate (IRS1). These interactions resulted in activation of PI3K-Akt axis, which was essential for reduced TLR expression and TLR associated NF kappa B activation. Collectively, these results demonstrate the essential role of Jak3 in promoting mucosal tolerance through suppressed expression and limiting activation of TLRs thereby preventing intestinal and systemic CLGI and associated obesity and MetS.	[Mishra, Jayshree; Verma, Raj K.; Kumar, Narendra] Texas A&M Univ Syst Hlth Sci Ctr, ILR Coll Pharm, Dept Pharmaceut Sci, Kingsville, TX 78363 USA; [Alpini, Gianfranco; Meng, Fanyin] Scott & White Digest Dis Res Ctr, Cent Texas Vet Hlth Care Syst, Temple, TX 76504 USA; [Alpini, Gianfranco; Meng, Fanyin] Texas A&M HSC Coll Med, Temple, TX 76504 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Mishra, J (corresponding author), Texas A&M Univ HSC, Coll Pharm, 1010 West Ave B MSC 131, Kingsville, TX 78363 USA.	mishra@pharmacy.tamhsc.edu; nkumar@tamhsc.edu	MISHRA, JAYSHREE/O-3468-2018; Regan, Clinton/E-6250-2012	MISHRA, JAYSHREE/0000-0003-0619-0629; Kumar, Narendra/0000-0002-1193-0954	Crohn's & Colitis Foundation of America (CCFA) [2188]; NIH [DK081661, 1R43GM109528-01]; Baylor Scott & White and VA Merit award [5I01BX000574]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054811, R01DK076898, K01DK081661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM109528] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001724, I01BX000574] Funding Source: NIH RePORTER	Crohn's & Colitis Foundation of America (CCFA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor Scott & White and VA Merit award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported by grants from Crohn's & Colitis Foundation of America (CCFA Ref. 2188) and NIH (Grant DK081661) (to N. K.), NIH (sub-awarded) Grant 1R43GM109528-01 (to N. K. and J. M.), and the Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology endowment from Baylor Scott & White and VA Merit award (5I01BX000574) (to G. A.). The authors declare that they have no conflicts of interest with the content of this article.	Arslan N, 2014, WORLD J GASTROENTERO, V20, P16452, DOI 10.3748/wjg.v20.i44.16452; Bertrand RL, 2011, ENDOCRINOLOGY, V152, P36, DOI 10.1210/en.2010-0377; Bleau C, 2015, DIABETES-METAB RES, V31, P545, DOI 10.1002/dmrr.2617; Cetkovic-Cyrlje M, 2004, CURR PHARM DESIGN, V10, P1767, DOI 10.2174/1381612043384529; Chassaing B, 2014, GASTROENTEROLOGY, V147, P1363, DOI 10.1053/j.gastro.2014.08.033; Chassaing B, 2014, TOXICOL PATHOL, V42, P49, DOI 10.1177/0192623313508481; Crunkhorn S, 2013, NAT REV DRUG DISCOV, V12, DOI 10.1038/nrd3929; Cuda C, 2011, METABOLISM, V60, P1131, DOI 10.1016/j.metabol.2010.12.006; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; DESPRES JP, 1992, MOL CELL BIOCHEM, V113, P151, DOI 10.1007/BF00231535; Ding SL, 2011, CURR OPIN CLIN NUTR, V14, P328, DOI 10.1097/MCO.0b013e3283478727; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Esteve E, 2011, CURR OPIN CLIN NUTR, V14, P483, DOI 10.1097/MCO.0b013e328348c06d; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Fresno Manuel, 2011, Archives of Physiology and Biochemistry, V117, P151, DOI 10.3109/13813455.2011.562514; Grima P, 2012, SCAND J INFECT DIS, V44, P133, DOI 10.3109/00365548.2011.623312; Guarner V, 2015, INTERD T GERONT GERI, V40, P99, DOI 10.1159/000364934; HALL BM, 1991, TRANSPLANTATION, V51, P1141, DOI 10.1097/00007890-199106000-00001; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Jialal I, 2012, CURR DIABETES REP, V12, P172, DOI 10.1007/s11892-012-0258-7; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim F, 2008, ARTERIOSCL THROM VAS, V28, P1982, DOI 10.1161/ATVBAHA.108.169722; Kim JJ, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/212563; Konner AC, 2011, TRENDS ENDOCRIN MET, V22, P16, DOI 10.1016/j.tem.2010.08.007; Kumar N.M., 2012, J IMMUNODEFIC DISOR, V1, p1000.; Kumar N, 2007, J BIOL CHEM, V282, P30341, DOI 10.1074/jbc.C600319200; LAI KS, 1995, J BIOL CHEM, V270, P25028, DOI 10.1074/jbc.270.42.25028; Lucas K, 2013, MOL NEUROBIOL, V48, P190, DOI 10.1007/s12035-013-8425-7; Malaviya R, 1999, J BIOL CHEM, V274, P27028, DOI 10.1074/jbc.274.38.27028; Maziak Wasim, 2005, BMC Pulm Med, V5, P5, DOI 10.1186/1471-2466-5-5; Mishra J, 2014, J BIOL CHEM, V289, P15951, DOI 10.1074/jbc.C113.527523; Mishra J, 2013, J BIOL CHEM, V288, P31795, DOI 10.1074/jbc.M113.504126; Mishra J, 2013, CRIT REV ONCOL HEMAT, V86, P232, DOI 10.1016/j.critrevonc.2012.09.014; Mishra J, 2012, J BIOL CHEM, V287, P41386, DOI 10.1074/jbc.C112.363507; Mishra J, 2012, AM J PHYSIOL-CELL PH, V302, pC735, DOI 10.1152/ajpcell.00316.2011; Murata Y, 2002, INT IMMUNOL, V14, P627, DOI 10.1093/intimm/dxf031; Nunemaker CS, 2008, AM J PHYSIOL-ENDOC M, V295, pE1065, DOI 10.1152/ajpendo.90371.2008; Onat A, 2007, INT J OBESITY, V31, P1119, DOI 10.1038/sj.ijo.0803552; Park JS, 2013, PEDIATR GASTROENTERO, V16, P22, DOI 10.5223/pghn.2013.16.1.22; Phillips CM, 2013, J CLIN ENDOCR METAB, V98, pE1610, DOI 10.1210/jc.2013-2038; Phillips CM, 2012, J NUTR BIOCHEM, V23, P239, DOI 10.1016/j.jnutbio.2010.11.020; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Saemann MD, 2003, AM J TRANSPLANT, V3, P1341, DOI 10.1046/j.1600-6143.2003.00225.x; Safford MG, 1997, EXP HEMATOL, V25, P374; Stadnyk AW, 2002, CAN J GASTROENTEROL, V16, P241, DOI 10.1155/2002/941087; Stempel DA, 2005, J ALLERGY CLIN IMMUN, V115, P230, DOI 10.1016/j.jaci.2004.10.035; Stepkowski SM, 2002, BLOOD, V99, P680, DOI 10.1182/blood.V99.2.680; Takahashi K, 2009, J IMMUNOL, V183, P6522, DOI 10.4049/jimmunol.0901271; TAKAHASHI T, 1994, FEBS LETT, V342, P124, DOI 10.1016/0014-5793(94)80485-0; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; TILLY BC, 1991, J BIOL CHEM, V266, P2036; TORTOLANI PJ, 1995, J IMMUNOL, V155, P5220; Tulk HMF, 2009, METABOLISM, V58, P1709, DOI 10.1016/j.metabol.2009.05.031; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Wang HZ, 2013, J IMMUNOL, V191, P1164, DOI 10.4049/jimmunol.1203084; Ward AC, 2000, BLOOD, V95, P19; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Yan ZQ, 2006, ARTERIOSCL THROM VAS, V26, P2582, DOI 10.1161/01.ATV.0000250933.92917.dd	61	19	19	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2015	290	49					29301	29312		10.1074/jbc.M115.670331	http://dx.doi.org/10.1074/jbc.M115.670331			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7TY	26451047	hybrid, Green Published			2022-12-28	WOS:000366613400018
J	Nagashinna, H; Nakajima, Y; Shen, JR; Mino, H				Nagashinna, Hiroki; Nakajima, Yoshiki; Shen, Jian-Ren; Mino, Hiroyuki			Proton Matrix ENDOR Studies on Ca2+-depleted and Sr2+-substituted Manganese Cluster in Photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; ELECTRON-PARAMAGNETIC-RESONANCE; PHOTOSYNTHETIC WATER OXIDATION; EPR MULTILINE SIGNAL; LOW PH TREATMENT; S-2 STATE; ANGSTROM RESOLUTION; OXIDIZING COMPLEX; S2 STATE; PS-II	Proton matrix ENDOR spectra were measured for Ca2+-depleted and Sr2+-substituted photosystem II (PSII) membrane samples from spinach and core complexes from Theymosynechococcus vulcanus in the S-2 state. The ENDOR spectra obtained were similar for untreated PSII from T. vulcanus and spinach, as well as for Ca2+-containing and Sr2+-substituted PSII, indicating that the proton arrangements around the manganese cluster in cyanobacterial and higher plant PSII and Ca2+-containing and Sr2+-substituted are similar in the S-2 state, in agreement with the similarity of the crystal structure of both Ca2+-containing and Sr2+-substituted PSII in the Si state. Nevertheless, slightly different hyperfine separations were found between Ca2+-containing and Sr2+-substituted PSII because of modifications of the water protons ligating to the Sr2+ ion. Importantly, Ca2+ depletion caused the loss of ENDOR signals with a 1.36-MHz separation because of the loss of the water proton W4 connecting Ca2+ and Y, directly. With respect to the crystal structure and the functions of Ca2+ in oxygen evolution, it was concluded that the roles of Ca2+ and Sr2+ involve the maintenance of the hydrogen bond network near the Ca2+ site and electron transfer pathway to the manganese cluster.	[Nagashinna, Hiroki; Mino, Hiroyuki] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Nakajima, Yoshiki; Shen, Jian-Ren] Okayama Univ, Fac Sci, Grad Sch Nat Sci & Technol, Photosynth Res Ctr, Okayama 7008530, Japan	Nagoya University; Okayama University	Mino, H (corresponding author), Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	mino@bio.phys.nagoya-u.ac.jp	Shen, Jian-Ren/B-2558-2011; mino, hiroyuki/GYD-5422-2022; Nagashima, Hiroki/Z-6128-2019	Nagashima, Hiroki/0000-0003-1162-6669; Nakajima, Yoshiki/0000-0002-0529-8075; Mino, Hiroyuki/0000-0003-4040-8732	Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences," MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan; JSPS [24000018]; MEXT/JSPS [26620003];  [26011113]	Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences," MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT/JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported by a Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences," MEXT (Ministry of Education, Culture, Sports, Science and Technology), Japan; Grant-in-Aid for JSPS (Japan Society for the Promotion of Science) Fellows 26011113 (to H. N.); JSPS Grant-in-Aid for Specially Promoted Research 24000018 (to J.-R. S.); and MEXT/JSPS Grant-in-Aid for Exploratory Research 26620003 (to H. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ames W, 2011, J AM CHEM SOC, V133, P19743, DOI 10.1021/ja2041805; Asada M, 2013, BBA-BIOENERGETICS, V1827, P438, DOI 10.1016/j.bbabio.2012.12.011; BERATAN DN, 1992, SCIENCE, V258, P1740, DOI 10.1126/science.1334572; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Boussac A, 2004, J BIOL CHEM, V279, P22809, DOI 10.1074/jbc.M401677200; BOUSSAC A, 1989, BIOCHEMISTRY-US, V28, P8984, DOI 10.1021/bi00449a005; BOUSSAC A, 1988, BIOCHEMISTRY-US, V27, P3476, DOI 10.1021/bi00409a052; Boussac A, 2009, J AM CHEM SOC, V131, P5050, DOI 10.1021/ja900680t; Chatterjee R, 2014, PHYS CHEM CHEM PHYS, V16, P20834, DOI 10.1039/c4cp03082f; Cox N, 2011, J AM CHEM SOC, V133, P3635, DOI 10.1021/ja110145v; DISMUKES GC, 1981, P NATL ACAD SCI-BIOL, V78, P274, DOI 10.1073/pnas.78.1.274; GHANOTAKIS DF, 1984, FEBS LETT, V167, P127, DOI 10.1016/0014-5793(84)80846-7; GHANOTAKIS DF, 1984, FEBS LETT, V170, P169, DOI 10.1016/0014-5793(84)81393-9; Haddy A, 2010, BIOCHEMISTRY-US, V49, P3805, DOI 10.1021/bi901700n; Jin L, 2014, PHYS CHEM CHEM PHYS, V16, P7799, DOI 10.1039/c3cp55189j; Kawakami K, 2011, J PHOTOCH PHOTOBIO B, V104, P9, DOI 10.1016/j.jphotobiol.2011.03.017; KAWAMORI A, 1989, FEBS LETT, V254, P219, DOI 10.1016/0014-5793(89)81043-9; Kimura Y, 2001, BIOCHEMISTRY-US, V40, P14061, DOI 10.1021/bi011216w; KODERA Y, 1995, BBA-BIOENERGETICS, V1232, P43, DOI 10.1016/0005-2728(95)00108-3; Kolling DRJ, 2012, BIOPHYS J, V103, P313, DOI 10.1016/j.bpj.2012.05.031; Koua FHM, 2013, P NATL ACAD SCI USA, V110, P3889, DOI 10.1073/pnas.1219922110; Latimer MJ, 1998, J PHYS CHEM B, V102, P8257, DOI 10.1021/jp981668r; Lohmiller T, 2012, J BIOL CHEM, V287, P24721, DOI 10.1074/jbc.M112.365288; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Messinger J, 1997, J AM CHEM SOC, V119, P11349, DOI 10.1021/ja972696a; Milikisiyants S, 2012, ENERG ENVIRON SCI, V5, P7747, DOI 10.1039/c2ee21210b; Mino H, 2005, BBA-BIOENERGETICS, V1708, P42, DOI 10.1016/j.bbabio.2005.01.001; Mino H, 2003, BBA-BIOENERGETICS, V1606, P127, DOI 10.1016/S0005-2728(03)00107-5; Mino H, 2001, BBA-BIOENERGETICS, V1503, P112, DOI 10.1016/S0005-2728(00)00229-2; Mino H, 1998, BIOCHEMISTRY-US, V37, P2794, DOI 10.1021/bi972471c; Miqyass M, 2007, PHOTOSYNTH RES, V92, P275, DOI 10.1007/s11120-006-9124-2; Nagashima H, 2013, BBA-BIOENERGETICS, V1827, P1165, DOI 10.1016/j.bbabio.2013.06.001; Nakamura S, 2014, BIOCHEMISTRY-US, V53, P3131, DOI 10.1021/bi500237y; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; ONO T, 1988, FEBS LETT, V227, P147, DOI 10.1016/0014-5793(88)80886-X; ONO T, 1990, BIOCHIM BIOPHYS ACTA, V1020, P269, DOI 10.1016/0005-2728(90)90157-Y; ONO T, 1986, BIOCHIM BIOPHYS ACTA, V850, P380, DOI 10.1016/0005-2728(86)90194-5; ONO TA, 1990, BIOCHIM BIOPHYS ACTA, V1015, P373, DOI 10.1016/0005-2728(90)90043-4; Pantazis DA, 2012, ANGEW CHEM INT EDIT, V51, P9935, DOI 10.1002/anie.201204705; Rapatskiy L, 2012, J AM CHEM SOC, V134, P16619, DOI 10.1021/ja3053267; Saito K, 2014, BBA-BIOENERGETICS, V1837, P159, DOI 10.1016/j.bbabio.2013.09.013; Shen JR, 2015, ANNU REV PLANT BIOL, V66, P23, DOI 10.1146/annurev-arplant-050312-120129; SHEN JR, 1993, BIOCHEMISTRY-US, V32, P1825, DOI 10.1021/bi00058a017; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Shoji M, 2013, CATAL SCI TECHNOL, V3, P1831, DOI 10.1039/c3cy00051f; Siegbahn PEM, 2014, PHYS CHEM CHEM PHYS, V16, P11893, DOI 10.1039/c3cp55329a; Siegbahn PEM, 2012, PHYS CHEM CHEM PHYS, V14, P4849, DOI 10.1039/c2cp00034b; SIVARAJA M, 1989, BIOCHEMISTRY-US, V28, P9459, DOI 10.1021/bi00450a032; Stich TA, 2011, BIOCHEMISTRY-US, V50, P7390, DOI 10.1021/bi2010703; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Terrett R, 2014, CHEM COMMUN, V50, P3187, DOI 10.1039/c3cc49324e; TSO J, 1991, BIOCHEMISTRY-US, V30, P4740, DOI 10.1021/bi00233a015; TYRYSHKIN AM, 1993, J MAGN RESON SER A, V105, P271, DOI 10.1006/jmra.1993.1281; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VANVLIET P, 1994, BIOCHEMISTRY-US, V33, P12998, DOI 10.1021/bi00248a008; Vinyard DJ, 2013, ANNU REV BIOCHEM, V82, P577, DOI 10.1146/annurev-biochem-070511-100425; Yachandra VK, 2011, J PHOTOCH PHOTOBIO B, V104, P51, DOI 10.1016/j.jphotobiol.2011.02.019; Yamada H, 2007, BBA-BIOENERGETICS, V1767, P197, DOI 10.1016/j.bbabio.2007.02.001; Yang JX, 2014, J PHYS CHEM B, V118, P14215, DOI 10.1021/jp505889p; Yeagle GJ, 2008, INORG CHEM, V47, P1803, DOI 10.1021/ic701680c; Yocum CF, 2008, COORDIN CHEM REV, V252, P296, DOI 10.1016/j.ccr.2007.08.010; ZIMMERMANN JL, 1993, BIOCHEMISTRY-US, V32, P4831, DOI 10.1021/bi00069a019	62	4	4	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28166	28174		10.1074/jbc.M115.675496	http://dx.doi.org/10.1074/jbc.M115.675496			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26438823	Green Published, hybrid			2022-12-28	WOS:000365761900012
J	Agarwal, S; Bell, CM; Rothbart, SB; Moran, RG				Agarwal, Stuti; Bell, Catherine M.; Rothbart, Scott B.; Moran, Richard G.			AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53-and TSC2-independent in Pemetrexed-treated Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; MAMMALIAN TARGET; METABOLIC CHECKPOINT; RAPAMYCIN INHIBITION; TUBEROUS-SCLEROSIS; PURINE SYNTHESIS; TOS MOTIF; PATHWAY; P53; PHOSPHORYLATION	The key sensor of energy status in mammalian cells, AMP-activated protein kinase (AMPK), can also be activated by the AMP analog aminoimidazolecarboxamide nucleoside monophosphate (ZMP) generated directly from aminoimidazolecarboxamide ribonucleoside (AICAR) or from inhibition of purine synthesis by the antifolate pemetrexed (PTX), a drug used extensively in the treatment of lung cancers. Despite this common mechanism, signaling downstream of AMPK activated by PTX or AICAR differed. AICAR-activated AMPK inhibited mTORC1 both directly by phosphorylation of the mTORC1 subunit Raptor and indirectly by phosphorylation of the regulator TSC2. In contrast, PTX-activated AMPK inhibited mTORC1 solely through Raptor phosphorylation. This dichotomy was due to p53 function. Transcription of p53 target genes, including TSC2, was activated by AICAR but not by PTX. Although both PTX and AICAR stabilized p53, only AICAR activated Chk2 phosphorylation, stimulating p53-dependent transcription. However, Raptor phosphorylation by AMPK was independent of p53 and was sufficient, after PTX treatment, to inhibit mTORC1. We concluded that PTX effects on mTORC1 were independent of TSC2 and p53 and that the activation of a p53 transcriptional response by AICAR was due to an activation of Chk2 that was not elicited by PTX.	[Agarwal, Stuti; Bell, Catherine M.; Moran, Richard G.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [Agarwal, Stuti; Bell, Catherine M.; Moran, Richard G.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Rothbart, Scott B.] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA	Virginia Commonwealth University; Virginia Commonwealth University; Van Andel Institute	Moran, RG (corresponding author), Massey Canc Ctr, 401 Coll St, Richmond, VA 23298 USA.	rmoran@vcu.edu			National Institutes of Health Cancer Center from NCI [P30-CA016059]; NATIONAL CANCER INSTITUTE [P30CA016059, R01CA140416] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center from NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. Andrei Budanov and Bert Vogelstein for essential cell lines and Dr. Reuben Shaw for generous deposition of Raptor vectors in Addgene. We also are grateful to Drs. Shirley Taylor and Andrei Budanov for helpful discussions. The Macromolecular Core Laboratory of the Massey Cancer Center helped support these experiments through National Institutes of Health Cancer Center Support Grant P30-CA016059 from NCI.	Agarwal S., 2015, MOL CANC RES; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Beckerman R, 2009, GENE DEV, V23, P1364, DOI 10.1101/gad.1795709; Bronder JL, 2003, J BIOL CHEM, V278, P48861, DOI 10.1074/jbc.M304844200; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jobson AG, 2009, J PHARMACOL EXP THER, V331, P816, DOI 10.1124/jpet.109.154997; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mondesire WH, 2004, CLIN CANCER RES, V10, P7031, DOI 10.1158/1078-0432.CCR-04-0361; MORAN RG, 1989, J BIOL CHEM, V264, P21047; Noh WC, 2004, CLIN CANCER RES, V10, P1013, DOI 10.1158/1078-0432.CCR-03-0043; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Racanelli AC, 2009, CANCER RES, V69, P5467, DOI 10.1158/0008-5472.CAN-08-4979; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rothbart S. B., 2010, THESIS; Rothbart SB, 2010, CANCER RES, V70, P10299, DOI 10.1158/0008-5472.CAN-10-1873; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Sengupta TK, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-46; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shieh SY, 2000, GENE DEV, V14, P289; Shih C, 1997, CANCER RES, V57, P1116; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; TAYLOR EC, 1992, J MED CHEM, V35, P4450, DOI 10.1021/jm00101a023; Tonkinson JL, 1997, CANCER CHEMOTH PHARM, V39, P521, DOI 10.1007/s002800050608; Vecchio D, 2014, INT J CANCER, V135, P479, DOI 10.1002/ijc.28680; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Weeks LD, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.477; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Workman P, 2010, CANCER RES, V70, P2146, DOI 10.1158/0008-5472.CAN-09-4355	65	43	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27473	27486		10.1074/jbc.M115.665133	http://dx.doi.org/10.1074/jbc.M115.665133			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26391395	hybrid, Green Published			2022-12-28	WOS:000365757500004
J	Jevtic, P; Edens, LJ; Li, XY; Nguyen, T; Chen, P; Levy, DL				Jevtic, Predrag; Edens, Lisa J.; Li, Xiaoyang; Thang Nguyen; Chen, Pan; Levy, Daniel L.			Concentration-dependent Effects of Nuclear Lamins on Nuclear Size in Xenopus and Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GILFORD-PROGERIA-SYNDROME; IN-VITRO; DIFFERENTIAL EXPRESSION; ENDOPLASMIC-RETICULUM; INHIBITING FARNESYLATION; CAENORHABDITIS-ELEGANS; ENVELOPE FORMATION; PROTEOME ANALYSIS; IMPORTIN-ALPHA; OVARIAN-CANCER	A fundamental question in cell biology concerns the regulation of organelle size. While nuclear size is exquisitely controlled in different cell types, inappropriate nuclear enlargement is used to diagnose and stage cancer. Clarifying the functional significance of nuclear size necessitates an understanding of the mechanisms and proteins that control nuclear size. One structural component implicated in the regulation of nuclear morphology is the nuclear lamina, a meshwork of intermediate lamin filaments that lines the inner nuclear membrane. However, there has not been a systematic investigation of how the level and type of lamin expression influences nuclear size, in part due to difficulties in precisely controlling lamin expression levels in vivo. In this study, we circumvent this limitation by studying nuclei in Xenopus laevis egg and embryo extracts, open biochemical systems that allow for precise manipulation of lamin levels by the addition of recombinant proteins. We find that nuclear growth and size are sensitive to the levels of nuclear lamins, with low and high concentrations increasing and decreasing nuclear size, respectively. Interestingly, each type of lamin that we tested (lamins B1, B2, B3, and A) similarly affected nuclear size whether added alone or in combination, suggesting that total lamin concentration, and not lamin type, is more critical to determining nuclear size. Furthermore, we show that altering lamin levels in vivo, both in Xenopus embryos and mammalian tissue culture cells, also impacts nuclear size. These results have implications for normal development and carcinogenesis where both nuclear size and lamin expression levels change.	[Jevtic, Predrag; Edens, Lisa J.; Li, Xiaoyang; Thang Nguyen; Chen, Pan; Levy, Daniel L.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	University of Wyoming	Levy, DL (corresponding author), Univ Wyoming, Dept Mol Biol, 1000 E Univ Ave, Laramie, WY 82071 USA.	dlevy1@uwyo.edu	Levy, Daniel/AAA-7205-2019; Jevtic, Predrag/AHC-8991-2022; Regan, Clinton/E-6250-2012	Levy, Daniel/0000-0002-7853-3275; Jevtic, Predrag/0000-0003-3978-5311; 	National Institutes of Health [R15GM106318]; American Cancer Society [RSG-15-035-01-DDC]; University of Wyoming Agricultural Experiment Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM106318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); University of Wyoming Agricultural Experiment Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R15GM106318 and American Cancer Society Grant RSG-15-035-01-DDC (to D. L. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a graduate assistantship from the University of Wyoming Agricultural Experiment Station.	Abdalla F, 2009, ANTICANCER RES, V29, P1771; Adam SA, 2008, J BIOL CHEM, V283, P8462, DOI 10.1074/jbc.M709572200; Agrelo R, 2005, J CLIN ONCOL, V23, P3940, DOI 10.1200/JCO.2005.11.650; Alfonso P, 2008, J PROTEOME RES, V7, P4247, DOI 10.1021/pr800152u; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; BENAVENTE R, 1985, CELL, V41, P177, DOI 10.1016/0092-8674(85)90072-8; Bengtsson S, 2007, J PROTEOME RES, V6, P1440, DOI 10.1021/pr060593y; BROERS JLV, 1993, AM J PATHOL, V143, P211; Capell BC, 2005, P NATL ACAD SCI USA, V102, P12879, DOI 10.1073/pnas.0506001102; Chan Rene C., 2006, V322, P289; Chan YHM, 2010, ORGANOGENESIS, V6, P88, DOI 10.4161/org.6.2.11464; Chow KH, 2012, NAT REV CANCER, V12, P196, DOI 10.1038/nrc3219; Conklin EG, 1912, J EXP ZOOL, V12, P1, DOI 10.1002/jez.1400120102; Coradeghini R, 2006, ONCOL REP, V15, P609; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Davidson PM, 2014, TRENDS CELL BIOL, V24, P247, DOI 10.1016/j.tcb.2013.11.004; Dittmer T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-222; Edens LJ, 2014, XENOPUS DEVELOPMENT, P325; Edens LJ, 2014, J CELL BIOL, V206, P473, DOI 10.1083/jcb.201406004; Ellis DJ, 1997, J CELL SCI, V110, P2507; Foeger N, 2006, J STRUCT BIOL, V155, P340, DOI 10.1016/j.jsb.2006.03.026; Foster CR, 2010, BIOCHEM SOC T, V38, P297, DOI 10.1042/BST0380297; GIEFFERS C, 1991, EUR J CELL BIOL, V55, P191; Gu L, 2004, EXP CELL RES, V298, P249, DOI 10.1016/j.yexcr.2004.04.020; Guo YX, 2014, MOL BIOL CELL, V25, P1287, DOI 10.1091/mbc.E13-11-0644; Hatch E, 2014, J CELL BIOL, V205, P133, DOI 10.1083/jcb.201402003; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485; HEITLINGER E, 1992, J STRUCT BIOL, V108, P74, DOI 10.1016/1047-8477(92)90009-Y; Hudson ME, 2007, P NATL ACAD SCI USA, V104, P17494, DOI 10.1073/pnas.0708572104; Isobe K, 2007, BIOSCI BIOTECH BIOCH, V71, P1252, DOI 10.1271/bbb.60674; Izumi M, 2000, MOL BIOL CELL, V11, P4323, DOI 10.1091/mbc.11.12.4323; JENKINS H, 1993, J CELL SCI, V106, P275; Jevtic P, 2015, CURR BIOL, V25, P45, DOI 10.1016/j.cub.2014.10.051; Jevtic P, 2014, ADV EXP MED BIOL, V773, P537, DOI 10.1007/978-1-4899-8032-8_25; Jung HJ, 2014, MOL CELL BIOL, V34, P4534, DOI 10.1128/MCB.00997-14; Karabinos A, 2003, J MOL BIOL, V325, P241, DOI 10.1016/S0022-2836(02)01240-8; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; KAUFMANN SH, 1991, CANCER RES, V51, P581; KITTEN GT, 1991, J CELL BIOL, V113, P13, DOI 10.1083/jcb.113.1.13; Kochin V, 2014, J CELL SCI, V127, P2683, DOI 10.1242/jcs.141820; Kuramitsu Y, 2010, ANTICANCER RES, V30, P2093; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Levy DL, 2012, ANNU REV CELL DEV BI, V28, P113, DOI 10.1146/annurev-cellbio-092910-154158; Levy DL, 2010, CELL, V143, P288, DOI 10.1016/j.cell.2010.09.012; Lim SO, 2002, BIOCHEM BIOPH RES CO, V291, P1031, DOI 10.1006/bbrc.2002.6547; Mall M, 2012, J CELL BIOL, V198, P981, DOI 10.1083/jcb.201205103; Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102; Moss SF, 1999, GUT, V45, P723, DOI 10.1136/gut.45.5.723; Mossbacher U, 1996, J INVEST DERMATOL, V106, P437, DOI 10.1111/1523-1747.ep12343580; NEWPORT JW, 1990, J CELL BIOL, V111, P2247, DOI 10.1083/jcb.111.6.2247; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Oguchi M, 2002, BRIT J DERMATOL, V147, P853, DOI 10.1046/j.1365-2133.2002.04948.x; Paradisi M, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-27; Prufert K, 2005, EUR J CELL BIOL, V84, P637, DOI 10.1016/j.ejcb.2004.12.027; Prufert K, 2004, J CELL SCI, V117, P6105, DOI 10.1242/jcs.01532; Ralle T, 2004, J CELL SCI, V117, P6095, DOI 10.1242/jcs.01528; Roth U, 2010, PROTEOMICS, V10, P194, DOI 10.1002/pmic.200900614; Schirmer EC, 2004, J BIOL CHEM, V279, P42811, DOI 10.1074/jbc.M407705200; Schirmer EC, 2001, J CELL BIOL, V153, P479, DOI 10.1083/jcb.153.3.479; Shimi T, 2014, ADV EXP MED BIOL, V773, P415, DOI 10.1007/978-1-4899-8032-8_19; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Shumaker DK, 2005, P NATL ACAD SCI USA, V102, P15494, DOI 10.1073/pnas.0507612102; Skvortsov S, 2011, J PROTEOME RES, V10, P259, DOI 10.1021/pr100921j; STICK R, 1985, CELL, V41, P191, DOI 10.1016/0092-8674(85)90073-X; Sun LL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04365; Sun S, 2010, J PROTEOME RES, V9, P70, DOI 10.1021/pr9002118; Venables RS, 2001, BRIT J CANCER, V84, P512, DOI 10.1054/bjoc.2000.1632; WANG NN, 1992, ANAL QUANT CYTOL, V14, P210; Wang YF, 2009, J PROTEOME RES, V8, P1452, DOI 10.1021/pr800820z; Wilson E. B., 1925, CELL DEV HEREDITY, P727; Wilson KL, 2010, J CELL SCI, V123, P1973, DOI 10.1242/jcs.019042; Wu ZR, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-8; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	78	44	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27557	27571		10.1074/jbc.M115.673798	http://dx.doi.org/10.1074/jbc.M115.673798			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26429910	Green Published, hybrid			2022-12-28	WOS:000365757500012
J	Jost, M; Born, DA; Cracan, V; Banerjee, R; Drennan, CL				Jost, Marco; Born, David A.; Cracan, Valentin; Banerjee, Ruma; Drennan, Catherine L.			Structural Basis for Substrate Specificity in Adenosylcobalamin-dependent Isobutyryl-CoA Mutase and Related Acyl-CoA Mutases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON BOND HOMOLYSIS; X-RAY-STRUCTURE; COENZYME B-12; ACTIVE-SITE; STREPTOMYCES-CINNAMONENSIS; METHYLMALONYL-COENZYME; ANAEROBIC DEGRADATION; CRYSTAL-STRUCTURE; PROTEIN; INTERMEDIATE	Background: Acyl-CoA mutases catalyze radical-based carbon skeleton rearrangements. Results: Crystal structures of isobutyryl-CoA mutase in complex with four different substrates reveal active site architecture and determinants of substrate specificity. Conclusion: Identification of specificity-determining residues allows for prediction of new acyl-CoA mutase activities. Significance: Improved understanding of acyl-CoA mutase substrate specificity is critical for biotechnological and engineering applications.	[Jost, Marco; Born, David A.; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Born, David A.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Cracan, Valentin; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; University of Michigan System; University of Michigan	Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cdrennan@mit.edu	Regan, Clinton/E-6250-2012	Cracan, Valentin/0000-0002-3280-0593	National Institutes of Health [GM069857, DK45776, T32 GM008313]; MIT Poitras pre-doctoral fellowship; National Institutes of Health from NIGMS [P41 GM103403]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069857, T32GM008313, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT Poitras pre-doctoral fellowship; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM069857 (to C. L. D.) and DK45776 (to R. B.), Training Grant T32 GM008313 (to D. A. B.). This work was also supported by an MIT Poitras pre-doctoral fellowship (to M. J.). This work is based in part on research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, supported by the National Institutes of Health and Grant P41 GM103403 from NIGMS. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bothe H, 1998, BIOCHEMISTRY-US, V37, P4105, DOI 10.1021/bi971393q; BRENDELBERGER G, 1988, ANGEW CHEM INT EDIT, V27, P1089, DOI 10.1002/anie.198810891; Brown KL, 2005, CHEM REV, V105, P2075, DOI 10.1021/cr030720z; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bucher D, 2012, J AM CHEM SOC, V134, P1591, DOI 10.1021/ja207809b; Callaghan AV, 2012, ENVIRON MICROBIOL, V14, P101, DOI 10.1111/j.1462-2920.2011.02516.x; Callaghan AV, 2006, APPL ENVIRON MICROB, V72, P4274, DOI 10.1128/AEM.02896-05; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Cracan V, 2013, METAL IONS LIFE SCI, V12, P333, DOI 10.1007/978-94-007-5561-1_10; Cracan V, 2012, BIOCHEMISTRY-US, V51, P6039, DOI 10.1021/bi300827v; Cracan V, 2012, J BIOL CHEM, V287, P3723, DOI 10.1074/jbc.M111.320051; Cracan V, 2010, J BIOL CHEM, V285, P655, DOI 10.1074/jbc.M109.062182; Dayem LC, 2002, BIOCHEMISTRY-US, V41, P5193, DOI 10.1021/bi015593k; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dowling DP, 2012, ANNU REV BIOPHYS, V41, P403, DOI 10.1146/annurev-biophys-050511-102225; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Ebenau-Jehle C, 2012, J BACTERIOL, V194, P2894, DOI 10.1128/JB.00250-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Frey PA, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P501; Froese DS, 2010, J BIOL CHEM, V285, P38204, DOI 10.1074/jbc.M110.177717; Gruber K, 2001, ANGEW CHEM INT EDIT, V40, P3377, DOI 10.1002/1521-3773(20010917)40:18<3377::AID-ANIE3377>3.0.CO;2-8; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALPERN J, 1985, SCIENCE, V227, P869, DOI 10.1126/science.2857503; Jarling R, 2012, ANGEW CHEM INT EDIT, V51, P1334, DOI 10.1002/anie.201106055; Jensen KP, 2005, J AM CHEM SOC, V127, P9117, DOI 10.1021/ja050744i; Jost M, 2015, P NATL ACAD SCI USA, V112, P2419, DOI 10.1073/pnas.1419582112; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kitanishi K, 2015, J BIOL CHEM, V290, P20466, DOI 10.1074/jbc.M115.646299; Kniemeyer O, 2003, APPL ENVIRON MICROB, V69, P760, DOI 10.1128/AEM.69.2.760-768.2003; Kurteva-Yaneva N, 2015, J BIOL CHEM, V290, P9727, DOI 10.1074/jbc.M115.645689; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LoBrutto R, 2001, BIOCHEMISTRY-US, V40, P9, DOI 10.1021/bi001865s; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Mancia F, 1999, BIOCHEMISTRY-US, V38, P7999, DOI 10.1021/bi9903852; Mansoorabadi SO, 2005, BIOCHEMISTRY-US, V44, P3153, DOI 10.1021/bi0482102; Masuda J, 2000, STRUCTURE, V8, P775, DOI 10.1016/S0969-2126(00)00164-7; MOORE BS, 1995, J AM CHEM SOC, V117, P11285, DOI 10.1021/ja00150a028; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Ratnatilleke A, 1999, J BIOL CHEM, V274, P31679, DOI 10.1074/jbc.274.44.31679; REYNOLDS KA, 1988, J CHEM SOC PERK T 1, P3195, DOI 10.1039/p19880003195; Rodriguez GM, 2014, NAT CHEM BIOL, V10, P259, DOI 10.1038/nchembio.1476; ROHWERDER T, 2007, VITAMIN B NEW RES, P81; Roman-Melendez GD, 2014, BIOCHEMISTRY-US, V53, P169, DOI 10.1021/bi4012644; Schrodinger L. L. C., 2014, PYMOL MOL GRAPHICS S; Sharma PK, 2007, P NATL ACAD SCI USA, V104, P9661, DOI 10.1073/pnas.0702238104; Smart O.S., 2011, GRADE; So CM, 1999, APPL ENVIRON MICROB, V65, P2969; Thoma NH, 2000, BIOCHEMISTRY-US, V39, P9213, DOI 10.1021/bi0004302; Toraya T, 2014, ARCH BIOCHEM BIOPHYS, V544, P40, DOI 10.1016/j.abb.2013.11.002; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Vlasie MD, 2004, BIOCHEMISTRY-US, V43, P8410, DOI 10.1021/bi036299q; Vlasie MD, 2003, J AM CHEM SOC, V125, P5431, DOI 10.1021/ja029420+; Vrijbloed JW, 1999, J BACTERIOL, V181, P5600, DOI 10.1128/JB.181.18.5600-5605.1999; Weichler MT, 2015, APPL ENVIRON MICROB, V81, P4564, DOI 10.1128/AEM.00716-15; Wilkes H, 2002, ARCH MICROBIOL, V177, P235, DOI 10.1007/s00203-001-0381-3; Yabuta Y, 2015, BIOSCI BIOTECH BIOCH, V79, P710, DOI 10.1080/09168451.2014.993353; Yaneva N, 2012, J BIOL CHEM, V287, P15502, DOI 10.1074/jbc.M111.314690	71	13	13	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26882	26898		10.1074/jbc.M115.676890	http://dx.doi.org/10.1074/jbc.M115.676890			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26318610	hybrid, Green Published			2022-12-28	WOS:000364794000002
J	Liu, X; Dai, FY; Guo, E; Li, K; Ma, L; Tian, L; Cao, Y; Zhang, GZ; Palli, SR; Li, S				Liu, Xi; Dai, Fangyin; Guo, Enen; Li, Kang; Ma, Li; Tian, Ling; Cao, Yang; Zhang, Guozheng; Palli, Subba R.; Li, Sheng			20-Hydroxyecdysone (20E) Primary Response Gene E93 Modulates 20E Signaling to Promote Bombyx Larval-Pupal Metamorphosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; TISSUE-SPECIFIC REGULATION; CUTICLE PROTEIN GENE; FAT-BODY; JUVENILE-HORMONE; WING DISCS; DROSOPHILA DEVELOPMENT; STEROID REGULATION; PIPSQUEAK PROTEIN; NUCLEAR RECEPTOR	Background: 20-Hydroxyecdysone (20E) and juvenile hormone (JH) coordinately control insect molting and metamorphosis. Results: Induced by 20E and suppressed by JH, E93 acts through GAGA-containing motifs and up-regulates a subset of 20E response genes. Conclusion: E93 transcriptionally modulates 20E signaling to promote Bombyx metamorphosis. Significance: Our study helps in understanding the complicated molecular mechanisms of insect metamorphosis. As revealed in a previous microarray study to identify genes regulated by 20-hydroxyecdysone (20E) and juvenile hormone (JH) in the silkworm, Bombyx mori, E93 expression in the fat body was markedly low prior to the wandering stage but abundant during larval-pupal metamorphosis. Induced by 20E and suppressed by JH, E93 expression follows this developmental profile in multiple silkworm alleles. The reduction of E93 expression by RNAi disrupted 20E signaling and the 20E-induced autophagy, caspase activity, and cell dissociation in the fat body. Reducing E93 expression also decreased the expression of the 20E-induced pupal-specific cuticle protein genes and prevented growth and differentiation of the wing discs. Importantly, the two HTH domains in E93 are critical for inducing the expression of a subset of 20E response genes, including EcR, USP, E74, Br-C, and Atg1. By contrast, the LLQHLL and PLDLSAK motifs in E93 inhibit its transcriptional activity. E93 binds to the EcR-USP complex via a physical association with USP through its LLQHLL motif; and this association is enhanced by 20E-induced EcR-USP interaction, which attenuates the transcriptional activity of E93. E93 acts through the two HTH domains to bind to GAGA-containing motifs present in the Atg1 promoter region for inducing gene expression. In conclusion, E93 transcriptionally modulates 20E signaling to promote Bombyx larval- pupal metamorphosis.	[Liu, Xi; Guo, Enen; Li, Kang; Ma, Li; Tian, Ling; Li, Sheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China; [Liu, Xi; Dai, Fangyin] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China; [Liu, Xi; Dai, Fangyin] Southwest Univ, Coll Biotechnol, Chongqing 400715, Peoples R China; [Guo, Enen; Li, Kang; Cao, Yang] South China Agr Univ, Lab Insect Mol Biol & Biotechnol, Guangdong Prov Key Lab Agroanim Genom & Mol Breed, Coll Anim Sci, Guangzhou 510642, Guangdong, Peoples R China; [Zhang, Guozheng] Chinese Acad Agr Sci, Sericultural Res Inst, Zhenjiang 212018, Peoples R China; [Palli, Subba R.] Univ Kentucky, Coll Agr, Dept Entomol, Lexington, KY 40546 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Southwest University - China; Southwest University - China; South China Agricultural University; Chinese Academy of Agricultural Sciences; University of Kentucky	Li, S (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai 200032, Peoples R China.	lisheng01@sibs.ac.cn	PALLI, SUBBA REDDY/AAU-8289-2020	PALLI, SUBBA REDDY/0000-0002-0873-3247	National Science Foundation of China [31330072, 31472042, 31201747]; 973 program Grant [2012CB114605]; National Program for the Development of New Transgenic Species of China [2014ZX08010-016B]; 863 Program Grant [2013AA102507]; State Key Laboratory of Silkworm Genome Biology [20120003]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program Grant(National Basic Research Program of China); National Program for the Development of New Transgenic Species of China; 863 Program Grant; State Key Laboratory of Silkworm Genome Biology	This study was supported by National Science Foundation of China Grant 31330072, 973 program Grant 2012CB114605, and National Program for the Development of New Transgenic Species of China Grant 2014ZX08010-016B (to S. L.), National Science Foundation of China Grants 31472042 (to L. T.) and 31201747 (to L. M.), 863 Program Grant 2013AA102507 (to F. D.), and State Key Laboratory of Silkworm Genome Biology Grant 20120003 (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Ali MS, 2013, GENE, V512, P337, DOI 10.1016/j.gene.2012.09.126; BAEHRECKE EH, 1995, DEV BIOL, V171, P85, DOI 10.1006/dbio.1995.1262; Belles X, 2014, INSECT BIOCHEM MOLEC, V52, P60, DOI 10.1016/j.ibmb.2014.06.009; Benyajati C, 1997, NUCLEIC ACIDS RES, V25, P3345, DOI 10.1093/nar/25.16.3345; Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; Cheng D, 2008, INSECT BIOCHEM MOLEC, V38, P1130, DOI 10.1016/j.ibmb.2008.09.013; Deng H, 2011, INSECT MOL BIOL, V20, P45, DOI 10.1111/j.1365-2583.2010.01041.x; Deng HM, 2012, P NATL ACAD SCI USA, V109, P12598, DOI 10.1073/pnas.1203149109; Guo EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053256; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; He QY, 2014, J BIOL CHEM, V289, P27874, DOI 10.1074/jbc.M114.582825; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hossain MS, 2013, INSECT BIOCHEM MOLEC, V43, P829, DOI 10.1016/j.ibmb.2013.06.007; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Khurad AM, 2009, IN VITRO CELL DEV-AN, V45, P414, DOI 10.1007/s11626-009-9197-2; Lee CY, 2000, MOL CELL, V6, P433, DOI 10.1016/S1097-2765(00)00042-3; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Lee CY, 2002, DEV BIOL, V252, P138, DOI 10.1006/dbio.2002.0838; Lee CY, 2002, DEV BIOL, V250, P101, DOI 10.1006/dbio.2002.0784; Lee CY, 2001, DEVELOPMENT, V128, P1443; Lehmann M, 1998, J BIOL CHEM, V273, P28504, DOI 10.1074/jbc.273.43.28504; Li K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12114; Liu HH, 2014, INSECT BIOCHEM MOLEC, V45, P30, DOI 10.1016/j.ibmb.2013.11.005; Liu HH, 2013, INSECT BIOCHEM MOLEC, V43, P1068, DOI 10.1016/j.ibmb.2013.09.001; Moeller ME, 2013, DEVELOPMENT, V140, P4730, DOI 10.1242/dev.099739; Mou XC, 2012, P NATL ACAD SCI USA, V109, P2949, DOI 10.1073/pnas.1117559109; Noji T, 2003, INSECT BIOCHEM MOLEC, V33, P671, DOI 10.1016/S0965-1748(03)00048-1; Parvy JP, 2005, DEV BIOL, V282, P84, DOI 10.1016/j.ydbio.2005.02.028; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Ryoo HD, 2010, CURR OPIN CELL BIOL, V22, P889, DOI 10.1016/j.ceb.2010.08.022; Schwendemann A, 2002, P NATL ACAD SCI USA, V99, P12883, DOI 10.1073/pnas.202341499; Siegmund T, 2002, DEV GENES EVOL, V212, P152, DOI 10.1007/s00427-002-0219-2; Tian L, 2013, AUTOPHAGY, V9, P1172, DOI 10.4161/auto.24731; Tian L, 2012, ARCH INSECT BIOCHEM, V79, P207, DOI 10.1002/arch.20457; Tian L, 2010, J MOL CELL BIOL, V2, P255, DOI 10.1093/jmcb/mjq020; Tian L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-549; Urena E, 2014, P NATL ACAD SCI USA, V111, P7024, DOI 10.1073/pnas.1401478111; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; Wang HB, 2009, INSECT BIOCHEM MOLEC, V39, P624, DOI 10.1016/j.ibmb.2009.06.007; Wang HB, 2009, INSECT BIOCHEM MOLEC, V39, P615, DOI 10.1016/j.ibmb.2009.06.008; Xia QY, 2014, ANNU REV ENTOMOL, V59, P513, DOI 10.1146/annurev-ento-011613-161940; Xiang YH, 2010, DEV BIOL, V344, P800, DOI 10.1016/j.ydbio.2010.05.510; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007; Zitnan D, 2007, GEN COMP ENDOCR, V153, P88, DOI 10.1016/j.ygcen.2007.04.002	46	64	71	10	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27370	27383		10.1074/jbc.M115.687293	http://dx.doi.org/10.1074/jbc.M115.687293			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26378227	hybrid, Green Published			2022-12-28	WOS:000364794000043
J	Min, XS; Ungureanu, D; Maxwell, S; Hammaren, H; Thibault, S; Hillert, EK; Ayres, M; Greenfield, B; Eksterowicz, J; Gabel, C; Walker, N; Silvennoinen, O; Wang, ZL				Min, Xiaoshan; Ungureanu, Daniela; Maxwell, Sarah; Hammaren, Henrik; Thibault, Steve; Hillert, Ellin-Kristina; Ayres, Merrill; Greenfield, Brad; Eksterowicz, John; Gabel, Chris; Walker, Nigel; Silvennoinen, Olli; Wang, Zhulun			Structural and Functional Characterization of the JH2 Pseudokinase Domain of JAK Family Tyrosine Kinase 2 (TYK2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON-ALPHA/BETA; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; JANUS KINASES; RECEPTOR; MUTATION; ACTIVATION; BINDING; AUTOINHIBITION; SPECIFICITY	Background: JAK JH2s (pseudokinase domains) mediate important regulatory functions; it is unclear whether TYK2 JH2 binds ATP and possesses enzymatic activity. Results: TYK2 JH2 binds ATP, but is catalytically inactive; ATP stabilizes JH2 and modulates TYK2 activity. Conclusion: ATP binding to JH2 is functionally important; the rigid activation loop probably hinders substrate phosphorylation. Significance: The TYK2 JH2 domain can be targeted with ATP-competitive compounds for therapeutics. JAK (Janus family of cytoplasmic tyrosine kinases) family tyrosine kinase 2 (TYK2) participates in signaling through cytokine receptors involved in immune responses and inflammation. JAKs are characterized by dual kinase domain: a tyrosine kinase domain (JH1) that is preceded by a pseudokinase domain (JH2). The majority of disease-associated mutations in JAKs map to JH2, demonstrating its central regulatory function. JH2s were considered catalytically inactive, but JAK2 JH2 was found to have low autoregulatory catalytic activity. Whether the other JAK JH2s share ATP binding and enzymatic activity has been unclear. Here we report the crystal structure of TYK2 JH2 in complex with adenosine 5'-O-(thiotriphosphate) (ATP-gamma S) and characterize its nucleotide binding by biochemical and biophysical methods. TYK2 JH2 did not show phosphotransfer activity, but it binds ATP and the nucleotide binding stabilizes the protein without inducing major conformational changes. Mutation of the JH2 ATP-binding pocket increased basal TYK2 phosphorylation and downstream signaling. The overall structural characteristics of TYK2 JH2 resemble JAK2 JH2, but distinct stabilizing molecular interactions around helix alpha AL in the activation loop provide a structural basis for differences in substrate access and catalytic activities among JAK family JH2s. The structural and biochemical data suggest that ATP binding is functionally important for both TYK2 and JAK2 JH2s, whereas the regulatory phosphorylation appears to be a unique property of JAK2. Finally, the co-crystal structure of TYK2 JH2 complexed with a small molecule inhibitor demonstrates that JH2 is accessible to ATP-competitive compounds, which offers novel approaches for targeting cytokine signaling as well as potential therapeutic applications.	[Min, Xiaoshan; Thibault, Steve; Ayres, Merrill; Eksterowicz, John; Walker, Nigel; Wang, Zhulun] Amgen Inc, Dept Therapeut Discovery, San Francisco, CA 94080 USA; [Maxwell, Sarah; Greenfield, Brad; Gabel, Chris] Amgen Inc, Dept Inflammat, San Francisco, CA 94080 USA; [Ungureanu, Daniela; Hillert, Ellin-Kristina] Univ Tampere, Inst Biomed Technol, Tampere 33014, Finland; [Hammaren, Henrik; Silvennoinen, Olli] Univ Tampere, Sch Med, Tampere 33014, Finland; [Silvennoinen, Olli] Tampere Univ Hosp, Dept Clin Hematol, Tampere 33520, Finland	Amgen; Amgen; Tampere University; Tampere University; Tampere University; Tampere University Hospital	Silvennoinen, O (corresponding author), Univ Tampere, Sch Med, Tampere 33014, Finland.	olli.silvennoinen@uta.fi; zwang@amgen.com	Hammarén, Henrik/AAB-5120-2022	Hammarén, Henrik/0000-0002-8534-2530; Ungureanu, Daniela/0000-0002-9314-4972; Hillert Triola, Ellin-Kristina/0000-0001-5619-6450	U. S. Department of Energy at the Lawrence Berkeley National Laboratory [DE-AC03-76SF00098]; Novo Nordisk Fonden [NNF13SA0008469] Funding Source: researchfish; Cancer Foundation Finland sr [140164, 100141] Funding Source: researchfish	U. S. Department of Energy at the Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Novo Nordisk Fonden(Novo Nordisk Foundation); Cancer Foundation Finland sr	We thank Tuija Pekkala, Juha Saarikettu, Yashavanthi Niranjan, Clifford Young, and Ole N. Jensen for experimental contribution and Paula Kosonen, Merja Lehtinen, and Elina Koskenalho for technical assistance. We also thank Michal Hammel and Gregory Hura at the SIBYLS beamline at ALS for data collection and analysis of the SAXS experiments. The ALS is supported by the U. S. Department of Energy under Contract DE-AC03-76SF00098 at the Lawrence Berkeley National Laboratory.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bandaranayake RM, 2012, NAT STRUCT MOL BIOL, V19, P754, DOI 10.1038/nsmb.2348; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bream JH, 2004, J BIOL CHEM, V279, P41249, DOI 10.1074/jbc.M401168200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forster S, 2010, J APPL CRYSTALLOGR, V43, P639, DOI 10.1107/S0021889810008289; Gakovic M, 2008, J BIOL CHEM, V283, P18522, DOI 10.1074/jbc.M801427200; Gauzzi MC, 1996, J BIOL CHEM, V271, P20494, DOI 10.1074/jbc.271.34.20494; Goldsmith MA, 1998, P NATL ACAD SCI USA, V95, P7006, DOI 10.1073/pnas.95.12.7006; Guinier A., 1955, SMALL ANGLE SCATTERI; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lai SY, 1996, P NATL ACAD SCI USA, V93, P231, DOI 10.1073/pnas.93.1.231; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Li Z, 2013, J IMMUNOL, V190, P2335, DOI 10.4049/jimmunol.1203118; Liu KD, 1997, CURR BIOL, V7, P817, DOI 10.1016/S0960-9822(06)00369-1; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murphy JM, 2014, BIOCHEM J, V457, P323, DOI 10.1042/BJ20131174; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; Ragimbeau J, 2001, J BIOL CHEM, V276, P30812, DOI 10.1074/jbc.M103559200; Richter MF, 1998, J BIOL CHEM, V273, P24723, DOI 10.1074/jbc.273.38.24723; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Sanda T, 2013, CANCER DISCOV, V3, P564, DOI 10.1158/2159-8290.CD-12-0504; Shan YB, 2014, NAT STRUCT MOL BIOL, V21, P579, DOI 10.1038/nsmb.2849; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Shimoda K, 2000, IMMUNITY, V13, P561, DOI 10.1016/S1074-7613(00)00055-8; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Strobl B, 2011, FRONT BIOSCI-LANDMRK, V16, P3224, DOI 10.2741/3908; Ten Eyck LF, 2008, BBA-PROTEINS PROTEOM, V1784, P238, DOI 10.1016/j.bbapap.2007.11.002; Tokarski JS, 2015, J BIOL CHEM, V290, P11061, DOI 10.1074/jbc.M114.619502; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; VELAZQUEZ L, 1995, J BIOL CHEM, V270, P3327, DOI 10.1074/jbc.270.7.3327; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Yeh TC, 2000, P NATL ACAD SCI USA, V97, P8991, DOI 10.1073/pnas.160130297; Zeqiraj E, 2010, CURR OPIN STRUC BIOL, V20, P772, DOI 10.1016/j.sbi.2010.10.001; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126	44	45	49	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27261	27270		10.1074/jbc.M115.672048	http://dx.doi.org/10.1074/jbc.M115.672048			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26359499	hybrid, Green Published			2022-12-28	WOS:000364794000034
J	Miyazawa, T; Takahashi, S; Kawata, A; Panthee, S; Hayashi, T; Shimizu, T; Nogawa, T; Osada, H				Miyazawa, Takeshi; Takahashi, Shunji; Kawata, Akihiro; Panthee, Suresh; Hayashi, Teruo; Shimizu, Takeshi; Nogawa, Toshihiko; Osada, Hiroyuki			Identification of Middle Chain Fatty Acyl-CoA Ligase Responsible for the Biosynthesis of 2-Alkylmalonyl-CoAs for Polyketide Extender Unit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A SYNTHETASE; ESCHERICHIA-COLI K-12; LUNG-CANCER CELLS; MYCOBACTERIUM-TUBERCULOSIS; REVEROMYCIN-A; MYCOLIC ACIDS; STREPTOMYCES; PATHWAY; SYNTHASE; BONE	Background: Fatty acyl-CoA ligases involved in polyketide biosynthesis remain uncharacterized. Results: RevS classified in fatty acyl-AMP ligase clade was the middle chain fatty acyl-CoA ligase. Conclusion: RevS was responsible for 2-alkylmalonyl-CoA biosynthesis through enzyme coupling with RevT carboxylase/reductase. Significance: 2-Alkylmalonyl-CoA biosynthesis was strongly supported by the function of RevR and RevS, which utilized fatty acids derived from de novo biosynthesis and degradation products, respectively. Understanding the biosynthetic mechanism of the atypical polyketide extender unit is important for the development of bioactive natural products. Reveromycin (RM) derivatives produced by Streptomyces sp. SN-593 possess several aliphatic extender units. Here, we studied the molecular basis of 2-alkyl-malonyl- CoA formation by analyzing the revR and revS genes, which form a transcriptional unit with the revT gene, a crotonyl-CoA carboxylase/reductase homolog. We mainly focused on the uncharacterized adenylate-forming enzyme (RevS). revS gene disruption resulted in the reduction of all RM derivatives, whereas reintroduction of the gene restored the yield of RMs. Although RevS was classified in the fatty acyl-AMP ligase clade based on phylogenetic analysis, biochemical characterization revealed that the enzyme catalyzed the middle chain fatty acyl-CoA ligase (FACL) but not the fatty acyl-AMP ligase activity, suggesting the molecular evolution for acyl-CoA biosynthesis. Moreover, we examined the in vitro conversion of fatty acid into 2-alkylmalonyl-CoA using purified RevS and RevT. The coupling reaction showed efficient conversion of hexenoic acid into butylmalonyl-CoA. RevS efficiently catalyzed C8-C10 middle chain FACL activity; therefore, we speculated that the acyl-CoA precursor was truncated via beta-oxidation and converted into (E)-2-enoyl-CoA, a RevT substrate. To determine whether the beta-oxidation process is involved between the RevS and RevT reaction, we performed the feeding experiment using [1,2,3,4-C-13] octanoic acid. C-13 NMR analysis clearly demonstrated incorporation of the [3,4-C-13] octanoic acid moiety into the structure of RM-A. Our results provide insight into the role of uncharacterized RevS homologs that may catalyze middle chain FACL to produce a unique polyketide extender unit.	[Miyazawa, Takeshi; Takahashi, Shunji; Panthee, Suresh; Hayashi, Teruo; Shimizu, Takeshi; Nogawa, Toshihiko; Osada, Hiroyuki] RIKEN, Ctr Sustainable Resource Sci, Chem Biol Res Grp, Saitama 3510198, Japan; [Miyazawa, Takeshi; Kawata, Akihiro; Osada, Hiroyuki] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan	RIKEN; Saitama University	Takahashi, S (corresponding author), RIKEN, Ctr Sustainable Resource Sci, Chem Biol Res Grp, Saitama 3510198, Japan.	shunjitaka@riken.jp	Takahashi, Shunji/N-6921-2015; Nogawa, Toshihiko/ABG-2652-2020; Osada, Hiroyuki/N-4305-2014; Panthee, Suresh/H-2754-2013; Osada, Hiroyuki/AAY-6254-2020; Takahashi, Shunji/GLT-3245-2022; Nogawa, Toshihiko/C-4095-2017	Takahashi, Shunji/0000-0003-1684-9298; Panthee, Suresh/0000-0003-4021-7936; Takahashi, Shunji/0000-0003-1684-9298; Nogawa, Toshihiko/0000-0003-1270-5270	Japan Society for the Promotion of Science KAKENHI [24380052]; Ministry of Economy, Trade and Industry, Japan; "Science and technology research promotion program for agriculture, forestry, fisheries and food industry"	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Economy, Trade and Industry, Japan; "Science and technology research promotion program for agriculture, forestry, fisheries and food industry"	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 24380052, by a grant for "Project Focused on Developing Key Technology of Discovering and Manufacturing Drug for Next-generation Treatment and Diagnosis" from the Ministry of Economy, Trade and Industry, Japan, and by "Science and technology research promotion program for agriculture, forestry, fisheries and food industry." The authors declare that they have no conflicts of interest with the contents of this article.	Arabolaza A, 2008, APPL ENVIRON MICROB, V74, P2573, DOI 10.1128/AEM.02638-07; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Black PN, 2003, MICROBIOL MOL BIOL R, V67, P454, DOI 10.1128/MMBR.67.3.454-472.2003; Cacho RA, 2012, J AM CHEM SOC, V134, P16781, DOI 10.1021/ja307220z; Chang CC, 2015, J AM CHEM SOC, V137, P4183, DOI 10.1021/jacs.5b00728; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dehesh K, 1996, PLANT PHYSIOL, V110, P203, DOI 10.1104/pp.110.1.203; Dias DA, 2012, METABOLITES, V2, DOI 10.3390/metabo2020303; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Eustaquio AS, 2009, P NATL ACAD SCI USA, V106, P12295, DOI 10.1073/pnas.0901237106; Gago G, 2011, FEMS MICROBIOL REV, V35, P475, DOI 10.1111/j.1574-6976.2010.00259.x; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hansen DB, 2007, J AM CHEM SOC, V129, P6366, DOI 10.1021/ja070890j; Harvey AL, 2015, NAT REV DRUG DISCOV, V14, P111, DOI 10.1038/nrd4510; Hayashi T, 2011, CHEMBIOCHEM, V12, P2166, DOI 10.1002/cbic.201100344; He X, 2006, J MED CHEM, V49, P6308, DOI 10.1021/jm060715y; Hiraoka K, 2008, CANCER SCI, V99, P1595, DOI 10.1111/j.1349-7006.2008.00880.x; HOSAKA K, 1979, EUR J BIOCHEM, V93, P197, DOI 10.1111/j.1432-1033.1979.tb12811.x; Khare G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008387; Kieser T., 2000, PRACTICAL STREPTOMYC, P232; Komatsua M, 2010, P NATL ACAD SCI USA, V107, P2646, DOI 10.1073/pnas.0914833107; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Lechner A, 2013, ACS SYNTH BIOL, V2, P379, DOI 10.1021/sb3001062; Leger M, 2009, CHEM BIOL, V16, P510, DOI 10.1016/j.chembiol.2009.03.012; Liu Z, 2013, J BIOL CHEM, V288, P18473, DOI 10.1074/jbc.M113.466912; Mares J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111904; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Mo S, 2011, J AM CHEM SOC, V133, P976, DOI 10.1021/ja108399b; Morsczeck C, 2001, BBA-GENE STRUCT EXPR, V1521, P59, DOI 10.1016/S0167-4781(01)00287-1; Muguruma H, 2005, CLIN CANCER RES, V11, P8822, DOI 10.1158/1078-0432.CCR-05-1335; Nakamura H, 2012, J AM CHEM SOC, V134, P18518, DOI 10.1021/ja308318p; OLUKOSHI ER, 1994, MICROBIOL-SGM, V140, P931, DOI 10.1099/00221287-140-4-931; Onaka H, 2003, J ANTIBIOT, V56, P950, DOI 10.7164/antibiotics.56.950; OSADA H, 1991, J ANTIBIOT, V44, P259, DOI 10.7164/antibiotics.44.259; PADMAKUMAR R, 1993, ANAL BIOCHEM, V214, P318, DOI 10.1006/abio.1993.1494; Parikh S, 1999, BIOCHEMISTRY-US, V38, P13623, DOI 10.1021/bi990529c; Quade N, 2012, NAT CHEM BIOL, V8, P117, DOI 10.1038/nchembio.734; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Ross C, 2014, ANGEW CHEM INT EDIT, V53, P7794, DOI 10.1002/anie.201403344; Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004; Steenbergen JN, 2005, J ANTIMICROB CHEMOTH, V55, P283, DOI 10.1093/jac/dkh546; Takahashi S, 2011, NAT CHEM BIOL, V7, P461, DOI [10.1038/NCHEMBIO.583, 10.1038/nchembio.583]; Takahashi S, 2010, J BACTERIOL, V192, P2839, DOI 10.1128/JB.01557-09; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; TSAY JT, 1992, J BIOL CHEM, V267, P6807; VARA J, 1989, J BACTERIOL, V171, P5872, DOI 10.1128/jb.171.11.5872-5881.1989; Vats A, 2012, J BIOL CHEM, V287, P30677, DOI 10.1074/jbc.M112.384966; Wilkinson B, 2007, NAT CHEM BIOL, V3, P379, DOI 10.1038/nchembio.2007.7; Wilson MC, 2012, NAT PROD REP, V29, P72, DOI 10.1039/c1np00082a; Winter JM, 2012, CURR OPIN BIOTECH, V23, P736, DOI 10.1016/j.copbio.2011.12.016; Wittmann M, 2008, FEBS J, V275, P5343, DOI 10.1111/j.1742-4658.2008.06664.x; Wong FT, 2012, CURR OPIN CHEM BIOL, V16, P117, DOI 10.1016/j.cbpa.2012.01.018; Woo JT, 2006, P NATL ACAD SCI USA, V103, P4729, DOI 10.1073/pnas.0505663103; Xu Z, 2007, J AM CHEM SOC, V129, P6022, DOI 10.1021/ja069045b; Xu ZL, 2011, ANGEW CHEM INT EDIT, V50, P4667, DOI 10.1002/anie.201008265; Xu ZL, 2009, J BIOTECHNOL, V140, P107, DOI 10.1016/j.jbiotec.2008.10.013; Yano A, 2008, P NATL ACAD SCI USA, V105, P15541, DOI 10.1073/pnas.0805354105; Zhang ZN, 2011, J MOL BIOL, V406, P313, DOI 10.1016/j.jmb.2010.12.011	67	12	13	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					26994	27011		10.1074/jbc.M115.677195	http://dx.doi.org/10.1074/jbc.M115.677195			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26378232	Green Published, hybrid			2022-12-28	WOS:000364794000010
J	Zhu, LJ; Wang, ZK; Wang, WW; Wang, CL; Hua, SS; Su, ZQ; Brako, L; Garcia-Barrio, M; Ye, ML; Wei, X; Zou, HF; Ding, X; Liu, LF; Liu, X; Yao, XB				Zhu, Lijuan; Wang, Zhikai; Wang, Wenwen; Wang, Chunli; Hua, Shasha; Su, Zeqi; Brako, Larry; Garcia-Barrio, Minerva; Ye, Mingliang; Wei, Xuan; Zou, Hanfa; Ding, Xia; Liu, Lifang; Liu, Xing; Yao, Xuebiao			Mitotic Protein CSPP1 Interacts with CENP-H Protein to Coordinate Accurate Chromosome Oscillation in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINETOCHORE-MICROTUBULE DYNAMICS; AURORA-B KINASE; SPINDLE MICROTUBULES; JOUBERT SYNDROME; PROGRESSION; SEGREGATION; CENTROMERE; MUTATIONS; COMPLEX; CILIA	Mitotic chromosome segregation is orchestrated by the dynamic interaction of spindle microtubules with the kinetochores. During chromosome alignment, kinetochore-bound microtubules undergo dynamic cycles between growth and shrinkage, leading to an oscillatory movement of chromosomes along the spindle axis. Although kinetochore protein CENP-H serves as a molecular control of kinetochore-microtubule dynamics, the mechanistic link between CENP-H and kinetochore microtubules (kMT) has remained less characterized. Here, we show that CSPP1 is a kinetochore protein essential for accurate chromosome movements in mitosis. CSPP1 binds to CENP-H in vitro and in vivo. Suppression of CSPP1 perturbs proper mitotic progression and compromises the satisfaction of spindle assembly checkpoint. In addition, chromosome oscillation is greatly attenuated in CSPP1-depleted cells, similar to what was observed in the CENP-H-depleted cells. Importantly, CSPP1 depletion enhances velocity of kinetochore movement, and overexpression of CSPP1 decreases the speed, suggesting that CSPP1 promotes kMT stability during cell division. Specific perturbation of CENP-H/CSPP1 interaction using a membrane-permeable competing peptide resulted in a transient mitotic arrest and chromosome segregation defect. Based on these findings, we propose that CSPP1 cooperates with CENP-H on kinetochores to serve as a novel regulator of kMT dynamics for accurate chromosome segregation.	[Zhu, Lijuan; Wang, Zhikai; Wang, Wenwen; Hua, Shasha; Liu, Xing; Yao, Xuebiao] Univ Sci & Technol China, Lab Cellular Dynam, Hefei 230027, Peoples R China; [Wang, Zhikai; Wang, Wenwen; Brako, Larry; Garcia-Barrio, Minerva; Liu, Xing] Morehouse Sch Med, Atlanta, GA 30310 USA; [Wang, Zhikai; Wang, Wenwen; Brako, Larry; Garcia-Barrio, Minerva; Liu, Xing] Atlanta Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Wang, Chunli; Ye, Mingliang; Zou, Hanfa] Chinese Acad Sci, Natl Chromatog Res & Anal Ctr, Dalian 116023, Peoples R China; [Su, Zeqi; Ding, Xia] Beijing Univ Chinese Med, Beijing 100029, Peoples R China; [Wang, Wenwen; Hua, Shasha; Wei, Xuan; Liu, Lifang] Airforce Gen Hosp, Beijing 100036, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Chinese Academy of Sciences; Beijing University of Chinese Medicine	Liu, LF (corresponding author), Airforce Gen Hosp, Beijing 100036, Peoples R China.	lfliubj@hotmail.com; xing1017@ustc.edu.cn; yaoxb@ustc.edu.cn	liu, li/HGC-0900-2022; WANG, WENWEN/AAF-1080-2020; Yao, Xuebiao/P-5771-2014; Liu, Xing/H-2989-2018; Regan, Clinton/E-6250-2012	WANG, WENWEN/0000-0002-1545-4369; Liu, Xing/0000-0002-7480-5085; 	Chinese 973 Project [2012CB917204, 2012CB945002, 2002CB713700]; Anhui Province Key Project [08040102005]; International Collaboration Grant [2009DFA31010]; Chinese Natural Science Foundation [90508002, 31301120, 91129714, 31301121, 31071184, 81270466, 90913016, 31501095, MOE20113402130010]; Fundamental Research Funds for Central Universities [WK2060190018]; Anhui Provincial Natural Science Foundation [1508085SMC213]; China Postdoctoral Science Foundation [2014M560517]; National Institutes of Health [DK56292, CA164133, G12RR03034]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	Chinese 973 Project(National Basic Research Program of China); Anhui Province Key Project; International Collaboration Grant; Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by Chinese 973 Project Grants 2012CB917204, 2012CB945002, and 2002CB713700, Anhui Province Key Project Grant 08040102005, International Collaboration Grant 2009DFA31010, Chinese Natural Science Foundation Grants 90508002, 31301120, 91129714, 31301121, 31071184, 81270466, 90913016, 31501095, and MOE20113402130010, Fundamental Research Funds for Central Universities Grant WK2060190018, Anhui Provincial Natural Science Foundation Grant 1508085SMC213, China Postdoctoral Science Foundation Grant 2014M560517, and National Institutes of Health Grants DK56292, CA164133, and G12RR03034. The authors declare that they have no conflicts of interest with the contents of this article.	Akizu N, 2014, AM J HUM GENET, V94, P80, DOI 10.1016/j.ajhg.2013.11.015; Amaro AC, 2010, NAT CELL BIOL, V12, P319, DOI 10.1038/ncb2033; Asiedu M, 2009, MOL BIOL CELL, V20, P1428, DOI 10.1091/mbc.E08-01-0001; Bakhoum SF, 2012, CURR OPIN CELL BIOL, V24, P64, DOI 10.1016/j.ceb.2011.11.012; Cao D, 2015, J BIOL CHEM, V290, P23766, DOI 10.1074/jbc.M115.673517; Cheeseman IM, 2008, MOL BIOL CELL, V19, P587, DOI 10.1091/mbc.E07-10-1051; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Dumont S, 2012, SCIENCE, V337, P355, DOI 10.1126/science.1221886; Ems-McClung SC, 2013, CURR BIOL, V23, P2491, DOI 10.1016/j.cub.2013.10.054; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Jaqaman K, 2010, J CELL BIOL, V188, P665, DOI 10.1083/jcb.200909005; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; Mikami Y, 2005, MOL CELL BIOL, V25, P1958, DOI 10.1128/MCB.25.5.1958-1970.2005; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Patzke S, 2005, ONCOGENE, V24, P1159, DOI 10.1038/sj.onc.1208267; Patzke S, 2006, J CELL PHYSIOL, V209, P199, DOI 10.1002/jcp.20725; Patzke S, 2010, MOL BIOL CELL, V21, P2555, DOI 10.1091/mbc.E09-06-0503; Shaheen R, 2014, AM J HUM GENET, V94, P73, DOI 10.1016/j.ajhg.2013.11.010; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Sternemalm J, 2014, BRIT J CANCER, V111, P326, DOI 10.1038/bjc.2014.297; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Tuz K, 2014, AM J HUM GENET, V94, P62, DOI 10.1016/j.ajhg.2013.11.019; Walczak CE, 2010, NAT REV MOL CELL BIO, V11, P91, DOI 10.1038/nrm2832; Wang XW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406652; Ward T, 2013, J BIOL CHEM, V288, P15771, DOI 10.1074/jbc.M112.448886; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Wordeman L, 2007, J CELL BIOL, V179, P869, DOI 10.1083/jcb.200707120; Xia P, 2014, J MOL CELL BIOL, V6, P240, DOI 10.1093/jmcb/mju016; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yao XB, 2009, CELL RES, V19, P152, DOI 10.1038/cr.2009.7; Yuan K, 2009, J BIOL CHEM, V284, P23072, DOI 10.1074/jbc.M109.001990; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	42	11	11	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27053	27066		10.1074/jbc.M115.658534	http://dx.doi.org/10.1074/jbc.M115.658534			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26378239	Green Published, hybrid			2022-12-28	WOS:000364794000017
J	Quijada, P; Hariharan, N; Cubillo, JD; Bala, KM; Emathinger, JM; Wang, BJY; Ormachea, L; Bers, DM; Sussman, MA; Poizat, C				Quijada, Pearl; Hariharan, Nirmala; Cubillo, Jonathan D.; Bala, Kristin M.; Emathinger, Jacqueline M.; Wang, Bingyan J.; Ormachea, Lucia; Bers, Donald M.; Sussman, Mark A.; Poizat, Coralie			Nuclear Calcium/Calmodulin-dependent Protein Kinase II Signaling Enhances Cardiac Progenitor Cell Survival and Cardiac Lineage Commitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; HISTONE DEACETYLASE-4; CAM KINASE; DELTA-B; DIFFERENTIATION; EXPRESSION; HEART; ACTIVATION; INHIBITORS; DEATH	Ca2+/Calmodulin-dependent protein kinase II (CaMKII) signaling in the heart regulates cardiomyocyte contractility and growth in response to elevated intracellular Ca2+. The delta B isoform of CaMKII is the predominant nuclear splice variant in the adult heart and regulates cardiomyocyte hypertrophic gene expression by signaling to the histone deacetylase HDAC4. However, the role of CaMKII delta in cardiac progenitor cells (CPCs) has not been previously explored. During post-natal growth endogenous CPCs display primarily cytosolic CaMKII delta, which localizes to the nuclear compartment of CPCs after myocardial infarction injury. CPCs undergoing early differentiation in vitro increase levels of CaMKII delta B in the nuclear compartment where the kinase may contribute to the regulation of CPC commitment. CPCs modified with lentiviral-based constructs to overexpress CaMKII delta B (CPCe delta B) have reduced proliferative rate compared with CPCs expressing eGFP alone (CPCe). Additionally, stable expression of CaMKII delta B promotes distinct morphological changes such as increased cell surface area and length of cells compared with CPCe. CPCe delta B are resistant to oxidative stress induced by hydrogen peroxide (H2O2) relative to CPCe, whereas knockdown of CaMKII delta B resulted in an up-regulation of cell death and cellular senescence markers compared with scrambled treated controls. Dexamethasone (Dex) treatment increased mRNA and protein expression of cardiomyogenic markers cardiac troponin T and alpha-smooth muscle actin in CPCe delta B compared with CPCe, suggesting increased differentiation. Therefore, CaMKII delta B may serve as a novel modulatory protein to enhance CPC survival and commitment into the cardiac and smooth muscle lineages.	[Quijada, Pearl; Cubillo, Jonathan D.; Bala, Kristin M.; Emathinger, Jacqueline M.; Wang, Bingyan J.; Ormachea, Lucia; Sussman, Mark A.; Poizat, Coralie] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Hariharan, Nirmala; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Poizat, Coralie] King Faisal Specialist Hosp & Res Ctr, Cardiovasc Res Program, Riyadh 11211, Saudi Arabia	California State University System; San Diego State University; University of California System; University of California Davis; King Faisal Specialist Hospital & Research Center	Poizat, C (corresponding author), Cardiovasc Res Program, POB 3354,MBC 03, Riyadh, Saudi Arabia.	cpoizat99@kfshrc.edu.sa	Wang, Bingyan/AAB-3883-2019; Regan, Clinton/E-6250-2012; Sussman, Mark/H-2284-2014	Wang, Bingyan/0000-0002-3522-2848; Sussman, Mark/0000-0002-0104-4799; Bers, Donald/0000-0002-2237-9483	National Institutes of Health [F31HL117623, R01HL067245, R37HL091102, R01HL105759, R01HL113647, R01HL117163, P01HL085577, R01HL122525]; Rees Stealy Research Foundation; SDSU Heart Institute Fellowship; Achievement Rewards for College Scientists Scholarship; American Heart Association [15BGIA23010047]; Fondation Leducq Transatlantic Network; King Abdulaziz City for Science and Technology [KACST 10-BIO 1350-20, 13-MED456-20]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030077, R01HL113647, F31HL117623, R01HL067245, R37HL091102, R01HL122525, P01HL080101, P01HL085577, R01HL117163, R01HL105759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rees Stealy Research Foundation; SDSU Heart Institute Fellowship; Achievement Rewards for College Scientists Scholarship; American Heart Association(American Heart Association); Fondation Leducq Transatlantic Network(Leducq Foundation); King Abdulaziz City for Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant F31HL117623 (to P. Q.), Rees Stealy Research Foundation, and SDSU Heart Institute Fellowship and Achievement Rewards for College Scientists Scholarship. This work was also supported by American Heart Association Grant 15BGIA23010047 (to N. H.), by National Institutes of Health Grants R01HL067245, R37HL091102, R01HL105759, R01HL113647, R01HL117163, P01HL085577, and R01HL122525 as well as an award from the Fondation Leducq Transatlantic Network (to M. A. S.), and by King Abdulaziz City for Science and Technology (Grant No. KACST 10-BIO 1350-20 and 13-MED456-20, to C. P.). Mark A. Sussman is a founder and co-owner of CardioCreate Inc. All other authors declare that they have no conflicts of interest with the contents of this article.	Awad S, 2015, J PATHOL, V235, P606, DOI 10.1002/path.4489; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Bailey B, 2009, REGEN MED, V4, P823, DOI [10.2217/rme.09.51, 10.2217/RME.09.51]; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Clocchiatti A, 2011, J CELL MOL MED, V15, P1833, DOI 10.1111/j.1582-4934.2011.01321.x; EDMAN CF, 1994, BBA-MOL CELL RES, V1221, P89, DOI 10.1016/0167-4889(94)90221-6; Ellison GM, 2007, J BIOL CHEM, V282, P11397, DOI 10.1074/jbc.M607391200; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Ferreira-Martins J, 2012, CIRC RES, V110, P701, DOI 10.1161/CIRCRESAHA.111.259507; Ferreira-Martins J, 2009, CIRC RES, V105, P764, DOI 10.1161/CIRCRESAHA.109.206698; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Fischer TH, 2014, EUR J HEART FAIL, V16, P1292, DOI 10.1002/ejhf.163; Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751; Galvin KE, 2008, STEM CELLS, V26, P1027, DOI 10.1634/stemcells.2007-0879; Gomez AM, 2013, CURR VASC PHARMACOL, V11, P497, DOI 10.2174/1570161111311040013; Hariharan N, 2015, J AM COLL CARDIOL, V65, P133, DOI 10.1016/j.jacc.2014.09.086; Harrison BC, 2010, FEBS LETT, V584, P1103, DOI 10.1016/j.febslet.2010.02.057; Hoch B, 2000, J CELL BIOCHEM, V79, P293, DOI 10.1002/1097-4644(20001101)79:2<293::AID-JCB120>3.3.CO;2-H; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Inagawa K, 2012, CIRC RES, V111, P1147, DOI 10.1161/CIRCRESAHA.112.271148; Khan M, 2013, CIRC RES, V112, P476, DOI 10.1161/CIRCRESAHA.112.280735; Konstandin MH, 2013, CIRC RES, V113, P115, DOI 10.1161/CIRCRESAHA.113.301152; Lee S, 2009, CELL PROLIFERAT, V42, P711, DOI 10.1111/j.1365-2184.2009.00633.x; Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154; Li H, 2010, AM J PHYSIOL-HEART C, V298, pH688, DOI 10.1152/ajpheart.01014.2009; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Ling HY, 2013, CIRC RES, V112, P935, DOI 10.1161/CIRCRESAHA.112.276915; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Little GH, 2009, J BIOL CHEM, V284, P24857, DOI 10.1074/jbc.M109.003186; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Mohsin S, 2013, CIRC RES, V113, P1169, DOI 10.1161/CIRCRESAHA.113.302302; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Peng W, 2010, CIRC RES, V106, P102, DOI 10.1161/CIRCRESAHA.109.210914; Porrello ER, 2014, STEM CELL RES, V13, P556, DOI 10.1016/j.scr.2014.06.003; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Savatier P, 1996, ONCOGENE, V12, P309; Scott JA, 2012, AM J PHYSIOL-HEART C, V302, pH1953, DOI 10.1152/ajpheart.00978.2011; Sossalla S, 2010, CIRC RES, V107, P1150, DOI 10.1161/CIRCRESAHA.110.220418; SRINIVASAN M, 1994, J CELL BIOL, V126, P839, DOI 10.1083/jcb.126.4.839; Sun GQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/835968; Tallini YN, 2009, P NATL ACAD SCI USA, V106, P1808, DOI 10.1073/pnas.0808920106; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; Zaruba MM, 2010, CIRCULATION, V121, P1992, DOI 10.1161/CIRCULATIONAHA.109.909093; Zhang LX, 2014, AM J PHYSIOL-CELL PH, V307, pC358, DOI 10.1152/ajpcell.00187.2013; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200	46	15	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25411	25426		10.1074/jbc.M115.657775	http://dx.doi.org/10.1074/jbc.M115.657775			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26324717	Green Published, hybrid			2022-12-28	WOS:000362962800018
J	Yao, W; Beckwith, SL; Zheng, TN; Young, T; Dinh, VT; Ranjan, A; Morrison, AJ				Yao, Wei; Beckwith, Sean L.; Zheng, Tina; Young, Thomas; Dinh, Van T.; Ranjan, Anand; Morrison, Ashby J.			Assembly of the Arp5 (Actin-related Protein) Subunit Involved in Distinct INO80 Chromatin Remodeling Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; SACCHAROMYCES-CEREVISIAE; COMPLEX PROMOTES; NUCLEOSOME; GENOME; REVEALS; BINDING; YEAST; SWR1; TRANSLOCATION	ATP-dependent chromatin remodeling, which repositions and restructures nucleosomes, is essential to all DNA-templated processes. The INO80 chromatin remodeling complex is an evolutionarily conserved complex involved in diverse cellular processes, including transcription, DNA repair, and replication. The functional diversity of the INO80 complex can, in part, be attributed to specialized activities of distinct subunits that compose the complex. Furthermore, structural analyses have identified biochemically discrete subunit modules that assemble along the Ino80 ATPase scaffold. Of particular interest is the Saccharomyces cerevisiae Arp5-Ies6 module located proximal to the Ino80 ATPase and the Rvb1-Rvb2 helicase module needed for INO80-mediated in vitro activity. In this study we demonstrate that the previously uncharacterized Ies2 subunit is required for Arp5-Ies6 association with the catalytic components of the INO80 complex. In addition, Arp5-Ies6 module assembly with the INO80 complex is dependent on distinct conserved domains within Arp5, Ies6, and Ino80, including the spacer region within the Ino80 ATPase domain. Arp5-Ies6 interacts with chromatin via assembly with the INO80 complex, as IES2 and INO80 deletion results in loss of Arp5-Ies6 chromatin association. Interestingly, ectopic addition of the wild-type Arp5-Ies6 module stimulates INO80-mediated ATP hydrolysis and nucleosome sliding in vitro. However, the addition of mutant Arp5 lacking unique insertion domains facilitates ATP hydrolysis in the absence of nucleosome sliding. Collectively, these results define the requirements of Arp5-Ies6 assembly, which are needed to couple ATP hydrolysis to productive nucleosome movement.	[Yao, Wei; Beckwith, Sean L.; Zheng, Tina; Young, Thomas; Dinh, Van T.; Morrison, Ashby J.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Ranjan, Anand] NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA	Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Morrison, AJ (corresponding author), Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA.	ashbym@stanford.edu	Regan, Clinton/E-6250-2012; Morrison, Ashby/AHE-2820-2022	Beckwith, Sean/0000-0001-6559-1030; Morrison, Ashby/0000-0003-1228-5093	National Institutes of Health [R00 GM085212]; Frederick Terman Award; Stanford Graduate Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM085212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick Terman Award; Stanford Graduate Fellowship(Stanford University); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R00 GM085212 (to A. J. M.). This work was also supported by a Frederick Terman Award (to A. J. M.) and a Stanford Graduate Fellowship (to S. L. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Chambers AL, 2012, GENE DEV, V26, P2590, DOI 10.1101/gad.199976.112; Chen L, 2013, P NATL ACAD SCI USA, V110, P20497, DOI 10.1073/pnas.1317092110; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dion V, 2010, CURR OPIN CELL BIOL, V22, P383, DOI 10.1016/j.ceb.2010.02.006; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; Fenn S, 2011, EMBO J, V30, P2153, DOI 10.1038/emboj.2011.118; Gerhold CB, 2014, TRENDS CELL BIOL, V24, P619, DOI 10.1016/j.tcb.2014.06.004; Gerhold CB, 2012, NUCLEIC ACIDS RES, V40, P11036, DOI 10.1093/nar/gks842; Hogan CJ, 2010, MOL CELL BIOL, V30, P657, DOI 10.1128/MCB.01117-09; Horigome C, 2014, MOL CELL, V55, P626, DOI 10.1016/j.molcel.2014.06.027; HORIKAWA I, 1995, BIOCHEM BIOPH RES CO, V208, P999, DOI 10.1006/bbrc.1995.1433; Jiang YJ, 2010, P NATL ACAD SCI USA, V107, P17274, DOI 10.1073/pnas.1008388107; Jonsson ZO, 2004, MOL CELL, V16, P465, DOI 10.1016/j.molcel.2004.09.033; Kim JH, 2007, P NATL ACAD SCI USA, V104, P20793, DOI 10.1073/pnas.0710343105; Kim JH, 2006, NAT CELL BIOL, V8, P631, DOI 10.1038/ncb1415; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morita T, 2014, J CELL BIOL, V204, P683, DOI 10.1083/jcb.201307158; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Morrison AJ, 2007, CELL, V130, P499, DOI 10.1016/j.cell.2007.06.010; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Patel A, 2011, J BIOL CHEM, V286, P43984, DOI 10.1074/jbc.M111.282970; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Seeber A, 2013, GENE DEV, V27, P1999, DOI 10.1101/gad.222992.113; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2004, METHOD ENZYMOL, V377, P401; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Shimada K, 2008, CURR BIOL, V18, P566, DOI 10.1016/j.cub.2008.03.049; Snoek ISI, 2006, FEMS YEAST RES, V6, P393, DOI 10.1111/j.1567-1364.2005.00007.x; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Tosi A, 2013, CELL, V154, P1207, DOI 10.1016/j.cell.2013.08.016; Udugama M, 2011, MOL CELL BIOL, V31, P662, DOI 10.1128/MCB.01035-10; Wang L, 2014, CELL STEM CELL, V14, P575, DOI 10.1016/j.stem.2014.02.013; Watanabe S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8108; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023; Xiao H, 2011, MOL CELL, V43, P369, DOI 10.1016/j.molcel.2011.07.009; Xue Y, 2015, GENE DEV, V29, P350, DOI 10.1101/gad.256255.114; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Yoshida T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000910; Yu EY, 2007, MOL CELL BIOL, V27, P5639, DOI 10.1128/MCB.00418-07; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	46	20	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25700	25709		10.1074/jbc.M115.674887	http://dx.doi.org/10.1074/jbc.M115.674887			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26306040	Green Published, hybrid			2022-12-28	WOS:000362962800041
J	Barman, B; Bhattacharyya, SN				Barman, Bahnisikha; Bhattacharyya, Suvendra N.			mRNA Targeting to Endoplasmic Reticulum Precedes Ago Protein Interaction and MicroRNA (miRNA)-mediated Translation Repression in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIRNA-MEDIATED REPRESSION; MEMBRANE-BOUND RIBOSOMES; LOCALIZATION; INHIBITION; INITIATION; BODIES	MicroRNA (miRNA) binds to the 3'-UTR of its target mRNAs to repress protein synthesis. Extensive research was done to understand the mechanism of miRNA-mediated repression in animal cells. Considering the progress in understanding the mechanism, information about the subcellular sites of miRNA-mediated repression is surprisingly limited. In this study, using an inducible expression system for an miRNA target message, we have delineated how a target mRNA passes through polysome association and Ago2 interaction steps on rough endoplasmic reticulum (ER) before the miRNA-mediated repression sets in. From this study, de novo formed target mRNA localization to the ER-bound polysomes manifested as the earliest event, which is followed by Ago2 micro-ribonucleoprotein binding, and translation repression of target message. Compartmentalization of this process to rough ER membrane ensures enrichment of miRNA-targeted messages and micro-ribonucleoprotein components on ER upon reaching a steady state.	[Barman, Bahnisikha; Bhattacharyya, Suvendra N.] CSIR, Indian Inst Chem Biol, Div Mol Genet, RNA Biol Res Lab, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Bhattacharyya, SN (corresponding author), CSIR, Indian Inst Chem Biol, Div Mol Genet, RNA Biol Res Lab, 4 Raja SC Mullick Rd, Kolkata 700032, India.	suvendra@iicb.res.in	Barman, Ph.D., Bahnisikha/AAG-8527-2020	Barman, Ph.D., Bahnisikha/0000-0002-7677-1595	Wellcome Trust [084324]; Council of Scientific and Industrial Research (CSIR),Government of India [BSC 0206]; Council of Scientific and Industrial Research, Government of India	Wellcome Trust(Wellcome TrustEuropean Commission); Council of Scientific and Industrial Research (CSIR),Government of India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Wellcome Trust International Senior Research Fellowship Fund (084324) and partly by Council of Scientific and Industrial Research (CSIR),Government of India, Grant BSC 0206 (to S. N. B) The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a predoctoral fellowship from the Council of Scientific and Industrial Research, Government of India.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bethune J, 2012, EMBO REP, V13, P716, DOI 10.1038/embor.2012.82; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Ghosh S, 2015, MOL BIOL CELL, V26, P1072, DOI 10.1091/mbc.E14-11-1521; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Hamilton RL, 1999, J LIPID RES, V40, P1140; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jagannathan S, 2014, RNA, V20, P1489, DOI 10.1261/rna.045526.114; Kundu P, 2012, NUCLEIC ACIDS RES, V40, P5088, DOI 10.1093/nar/gks148; Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403; Li SB, 2013, CELL, V153, P562, DOI 10.1016/j.cell.2013.04.005; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mazumder A, 2013, EMBO REP, V14, P1008, DOI 10.1038/embor.2013.149; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pyhtila B, 2008, RNA, V14, P445, DOI 10.1261/rna.721108; Schenkman J B, 1978, Methods Enzymol, V52, P83; Stalder L, 2013, EMBO J, V32, P1115, DOI 10.1038/emboj.2013.52; WONG WL, 1993, BIOCHEM J, V289, P71, DOI 10.1042/bj2890071	23	40	40	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24650	24656		10.1074/jbc.C115.661868	http://dx.doi.org/10.1074/jbc.C115.661868			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26304123	hybrid, Green Published			2022-12-28	WOS:000362598300002
J	Burzynski, LC; Humphry, M; Bennett, MR; Clarke, MCH				Burzynski, Laura C.; Humphry, Melanie; Bennett, Martin R.; Clarke, Murray C. H.			Interleukin-1 a Activity in Necrotic Endothelial Cells Is Controlled by Caspase-1 Cleavage of Interleukin-1 Receptor-2 IMPLICATIONS FOR ALLOGRAFT REJECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; ARTERIOSCLEROSIS; TRANSPLANTATION; INFLAMMASOME; ACTIVATION; EXPRESSION; IL-1-ALPHA; PROMOTES; DISEASE; FAMILY	Inflammation is a key instigator of the immune responses that drive atherosclerosis and allograft rejection. IL-1 alpha, a powerful cytokine that activates both innate and adaptive immunity, induces vessel inflammation after release from necrotic vascular smooth muscle cells (VSMCs). Similarly, IL-1 alpha released from endothelial cells (ECs) damaged during transplant drives allograft rejection. However, IL-1 alpha requires cleavage for full cytokine activity, and what controls cleavage in necrotic ECs is currently unknown. We find that ECs have very low levels of IL-1 alpha activity upon necrosis. However, TNF alpha or IL-1 induces significant levels of active IL-1 alpha in EC necrotic lysates without alteration in protein levels. Increased activity requires cleavage of IL-1 alpha by calpain to the more active mature form. Immunofluorescence and proximity ligation assays show that IL-1 alpha associates with interleukin-1 receptor-2, and this association is decreased by TNf alpha or IL-1 and requires caspase activity. Thus, TNFa or IL-1 treatment of ECs leads to caspase proteolytic activity that cleaves interleukin-1 receptor-2, allowing IL-1 alpha dissociation and subsequent processing by calpain. Importantly, ECs could be primed by IL-1 alpha from adjacent damaged VSMCs, and necrotic ECs could activate neighboring normal ECs and VSMCs, causing them to release inflammatory cytokines and up-regulate adhesion molecules, thus amplifying inflammation. These data unravel the molecular mechanisms and interplay between damaged ECs and VSMCs that lead to activation of IL-1 alpha and, thus, initiation of adaptive responses that cause graft rejection.	[Burzynski, Laura C.; Humphry, Melanie; Bennett, Martin R.; Clarke, Murray C. H.] Univ Cambridge, Div Cardiovasc Med, Addenbrookes Hosp, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Clarke, MCH (corresponding author), Univ Cambridge, Div Cardiovasc Med, Addenbrookes Hosp, Level 6,Box 110, Cambridge CB2 0QQ, England.	mchc2@cam.ac.uk		Clarke, Murray/0000-0002-8215-8885; Bennett, Martin/0000-0002-2565-1825	British Heart Foundation (BHF) [FS/09/005/26845, FS/13/3/30038, FS/11/77/29327, RG/13/14/30314]; BHF Cambridge Centre for Cardiovascular Research Excellence; National Institute for Health Research Cambridge Biomedical Research Centre; British Heart Foundation [RG/13/14/30314, FS/09/005/26845, FS/13/3/30038] Funding Source: researchfish	British Heart Foundation (BHF)(British Heart Foundation); BHF Cambridge Centre for Cardiovascular Research Excellence; National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation (BHF) Grants FS/09/005/26845, FS/13/3/30038 and FS/11/77/29327 (to M. C. H. C.) & RG/13/14/30314 (to M. R. B.); the BHF Cambridge Centre for Cardiovascular Research Excellence; and the National Institute for Health Research Cambridge Biomedical Research Centre. The authors declare that they have no conflicts of interest with the contents of this article.	Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Antonysamy MA, 1999, J IMMUNOL, V162, P577; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; FANSLOW WC, 1990, SCIENCE, V248, P739, DOI 10.1126/science.2139736; Halloran PF, 1997, TRANSPL P, V29, P79, DOI 10.1016/S0041-1345(96)00015-2; Imaizumi T, 2000, ARTERIOSCL THROM VAS, V20, P410, DOI 10.1161/01.ATV.20.2.410; Kim B, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00391; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Libby P, 2001, IMMUNITY, V14, P387, DOI 10.1016/S1074-7613(01)00119-4; LOETSCHER P, 1994, FASEB J, V8, P1055, DOI 10.1096/fasebj.8.13.7926371; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McCall M, 2012, AM J TRANSPLANT, V12, P322, DOI 10.1111/j.1600-6143.2011.03796.x; MCCARTHY PL, 1991, BLOOD, V78, P1915; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; POBER JS, 1986, J IMMUNOL, V136, P1680; Rao DA, 2007, J IMMUNOL, V179, P6536, DOI 10.4049/jimmunol.179.10.6536; Rao DA, 2008, J EXP MED, V205, P3145, DOI 10.1084/jem.20081661; Seto T, 2010, J HEART LUNG TRANSPL, V29, P352, DOI 10.1016/j.healun.2009.09.008; Simeoni E, 2007, EUR J CARDIO-THORAC, V31, P222, DOI 10.1016/j.ejcts.2006.10.042; Tellides G, 2000, NATURE, V403, P207, DOI 10.1038/35003221; Tellides G, 2006, CIRCULATION, V114, P1561, DOI 10.1161/CIRCULATIONAHA.106.651521; Yamada J, 1998, ARCH OPHTHALMOL-CHIC, V116, P1351, DOI 10.1001/archopht.116.10.1351; Zheng Y, 2011, ARTERIOSCL THROM VAS, V31, P2781, DOI 10.1161/ATVBAHA.111.224907	24	18	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25188	25196		10.1074/jbc.M115.667915	http://dx.doi.org/10.1074/jbc.M115.667915			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26324711	hybrid, Green Published			2022-12-28	WOS:000362598300045
J	James, AD; Patel, W; Butt, Z; Adiamah, M; Dakhel, R; Latif, A; Uggenti, C; Swanton, E; Imamura, H; Siriwardena, AK; Bruce, JIE				James, Andrew D.; Patel, Waseema; Butt, Zohra; Adiamah, Magretta; Dakhel, Raga; Latif, Ayse; Uggenti, Carolina; Swanton, Eileithyia; Imamura, Hiromi; Siriwardena, Ajith K.; Bruce, Jason I. E.			The Plasma Membrane Calcium Pump in Pancreatic Cancer Cells Exhibiting the Warburg Effect Relies on Glycolytic ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH AEROBIC GLYCOLYSIS; HEPATOMA-CELLS; OXIDATIVE-PHOSPHORYLATION; ENERGY-METABOLISM; TUMOR-CELLS; MITOCHONDRIA; 3-BROMOPYRUVATE; GLUTAMINE; PHOSPHATIDYLSERINE; CA2+-ATPASE	Evidence suggests that the plasma membrane Ca2+-ATPase (PMCA), which is critical for maintaining a low intracellular Ca2+ concentration ([Ca2+](i)), utilizes glycolytically derived ATP in pancreatic ductal adenocarcinoma (PDAC) and that inhibition of glycolysis in PDAC cell lines results in ATP depletion, PMCAinhibition, and an irreversible [Ca2+](i) overload. We explored whether this is a specific weakness of highly glycolytic PDAC by shifting PDAC cell (MIA PaCa-2 and PANC-1) metabolism from a highly glycolytic phenotype toward mitochondrial metabolism and assessing the effects of mitochondrial versus glycolytic inhibitors on ATP depletion, PMCA inhibition, and [Ca2+](i) overload. The highly glycolytic phenotype of these cells was first reversed by depriving MIA PaCa-2 and PANC-1 cells of glucose and supplementing with alpha-ketoisocaproate or galactose. These culture conditions resulted in a significant decrease in both glycolytic flux and proliferation rate, and conferred resistance to ATP depletion by glycolytic inhibition while sensitizing cells to mitochondrial inhibition. Moreover, in direct contrast to cells exhibiting a high glycolytic rate, glycolytic inhibition had no effect on PMCA activity and resting [Ca2+](i) in alpha-ketoisocaproateand galactose-cultured cells, suggesting that the glycolytic dependence of the PMCA is a specific vulnerability of PDAC cells exhibiting the Warburg phenotype.	[James, Andrew D.; Patel, Waseema; Butt, Zohra; Adiamah, Magretta; Dakhel, Raga; Swanton, Eileithyia; Bruce, Jason I. E.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Latif, Ayse] Univ Manchester, Manchester Pharm Sch, Manchester M13 9PT, Lancs, England; [Uggenti, Carolina] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England; [Imamura, Hiromi] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068501, Japan; [Imamura, Hiromi] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Siriwardena, Ajith K.] Manchester Royal Infirm, Hepatobiliary Surg Unit, Manchester M13 9NT, Lancs, England	University of Manchester; University of Manchester; University of Manchester; Kyoto University; Kyoto University; University of Manchester	Bruce, JIE (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9NT, Lancs, England.	jason.bruce@manchester.ac.uk	Uggenti, Carolina/G-9145-2017; Imamura, Hiromi/AAD-5109-2019; Latif, A/U-4241-2019	Uggenti, Carolina/0000-0003-2673-5120; Imamura, Hiromi/0000-0002-1896-0443; Latif, A/0000-0002-7245-8729; Swanton, Eileithyia/0000-0002-3299-4228; James, Andrew/0000-0002-2432-5948	Pancreatic Cancer Research Fund; Central Manchester Foundation Trust/National Institutes of Health Research Manchester Biological Research Centre pump priming fund; Biotechnology and Biological Sciences Research Council; AstraZeneca plc; Central Manchester Healthcare Trust Strategic Investment Fund project; RP Fighting Blindness Ph.D studentship; Grants-in-Aid for Scientific Research [26291027] Funding Source: KAKEN	Pancreatic Cancer Research Fund; Central Manchester Foundation Trust/National Institutes of Health Research Manchester Biological Research Centre pump priming fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca plc(AstraZeneca); Central Manchester Healthcare Trust Strategic Investment Fund project; RP Fighting Blindness Ph.D studentship; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Pancreatic Cancer Research Fund research grant (to J. I. E. B.) and a Central Manchester Foundation Trust/National Institutes of Health Research Manchester Biological Research Centre pump priming fund (to A. K. S. and J. I. E. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Biotechnology and Biological Sciences Research Council and AstraZeneca plc CASE Ph.D. studentship.; Supported by a Central Manchester Healthcare Trust Strategic Investment Fund project grant to Prof. Ian Stratford and Dr. Emma Crosbie.; Supported by RP Fighting Blindness Ph.D studentship.	Amin Z, 2006, CLIN RADIOL, V61, P996, DOI 10.1016/j.crad.2006.07.005; Baggaley EM, 2008, AM J PHYSIOL-CELL PH, V295, pC1247, DOI 10.1152/ajpcell.00083.2008; Bellance N, 2009, INT J BIOCHEM CELL B, V41, P2566, DOI 10.1016/j.biocel.2009.08.012; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Busk M, 2008, INT J CANCER, V122, P2726, DOI 10.1002/ijc.23449; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chaika NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032996; Chen Z, 2009, BBA-BIOENERGETICS, V1787, P553, DOI 10.1016/j.bbabio.2009.03.003; Echarte MM, 2007, BIOCHEMISTRY-US, V46, P1034, DOI 10.1021/bi061857x; Frezza C, 2009, SEMIN CANCER BIOL, V19, P4, DOI 10.1016/j.semcancer.2008.11.008; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; Guppy M, 2002, BIOCHEM BIOPH RES CO, V299, P676, DOI 10.1016/S0006-291X(02)02710-9; HARDIN CD, 1992, J GEN PHYSIOL, V99, P21, DOI 10.1085/jgp.99.1.21; HUTTON JC, 1979, BIOCHEM J, V184, P291, DOI 10.1042/bj1840291; Ihrlund LS, 2008, MOL ONCOL, V2, P94, DOI 10.1016/j.molonc.2008.01.003; Kim JS, 2008, J BIOENERG BIOMEMBR, V40, P607, DOI 10.1007/s10863-008-9188-0; Le A, 2012, CLIN CANCER RES, V18, P4285, DOI 10.1158/1078-0432.CCR-12-0041; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MALAISSE WJ, 1981, BIOCHIM BIOPHYS ACTA, V677, P39, DOI 10.1016/0304-4165(81)90143-4; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Martin M, 1998, J BIOENERG BIOMEMBR, V30, P565, DOI 10.1023/A:1020584517588; Nakano M, 2011, ACS CHEM BIOL, V6, P709, DOI 10.1021/cb100313n; NAKASHIMA RA, 1984, CANCER RES, V44, P5702; NODA C, 1974, J BIOCHEM-TOKYO, V76, P1123; PAUL RJ, 1989, FASEB J, V3, P2298, DOI 10.1096/fasebj.3.11.2528493; Puchulu-Campanella E, 2013, J BIOL CHEM, V288, P848, DOI 10.1074/jbc.M112.428573; Rodriguez-Enriquez S, 2008, J CELL PHYSIOL, V216, P189, DOI 10.1002/jcp.21392; Rodriguez-Enriquez S, 2006, TOXICOL APPL PHARM, V215, P208, DOI 10.1016/j.taap.2006.02.005; ROSSI JPFC, 1989, BIOCHIM BIOPHYS ACTA, V996, P153, DOI 10.1016/0167-4838(89)90241-0; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Shukla SK, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-18; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu RH, 2005, LEUKEMIA, V19, P2153, DOI 10.1038/sj.leu.2403968; Zhang J, 2009, CELL CALCIUM, V45, P177, DOI [10.1016/j.ceca.2008.09.002, 10.3778/j.issn.1002-8331.2009.04.050]; Zhou WD, 2012, J PROTEOME RES, V11, P554, DOI 10.1021/pr2009274; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	42	26	27	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24760	24771		10.1074/jbc.M115.668707	http://dx.doi.org/10.1074/jbc.M115.668707			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26294767	Green Published, hybrid			2022-12-28	WOS:000362598300012
J	Srinivasan, S; Schiemer, J; Zhang, XW; Chishti, AH; Le Breton, GC				Srinivasan, Subhashini; Schiemer, James; Zhang, Xiaowei; Chishti, Athar H.; Le Breton, Guy C.			G alpha(13) Switch Region 2 Binds to the Talin Head Domain and Activates alpha IIb beta 3 Integrin in Human Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEINS; MONOCLONAL-ANTIBODIES; CYTOPLASMIC TAILS; BLOOD-PLATELETS; SHAPE CHANGE; SUBUNIT; IDENTIFICATION; ADHESION; PROTEASE; CALCIUM	Even though GPCR signaling in human platelets is directly involved in hemostasis and thrombus formation, the sequence of events by which G protein activation leads to alpha IIb beta 3 integrin activation (inside-out signaling) is not clearly defined. We previously demonstrated that a conformationally sensitive domain of one G protein, i.e. G alpha(13) switch region 1 (G alpha(13)SR1), can directly participate in the platelet inside-out signaling process. Interestingly however, the dependence on G alpha(13)SR1 signaling was limited to PAR1 receptors, and did not involve signaling through other important platelet GPCRs. Based on the limited scope of this involvement, and the known importance of G(13) in hemostasis and thrombosis, the present study examined whether signaling through another switch region of G(13), i.e. G alpha(13) switch region 2 (G alpha(13)SR2) may represent a more global mechanism of platelet activation. Using multiple experimental approaches, our results demonstrate that G alpha(13)SR2 forms a bimolecular complex with the head domain of talin and thereby promotes beta 3 integrin activation. Moreover, additional studies provided evidence that G alpha(13)SR2 is not constitutively associated with talin in unactivated platelets, but becomes bound to talin in response to elevated intraplatelet calcium levels. Collectively, these findings provide evidence for a novel paradigm of inside-out signaling in platelets, whereby beta 3 integrin activation involves the direct binding of the talin head domain to the switch region 2 sequence of the G alpha(13) subunit.	[Srinivasan, Subhashini; Zhang, Xiaowei; Le Breton, Guy C.] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; [Schiemer, James; Chishti, Athar H.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dept Dev Mol & Chem Biol,Program Cellular & Mol P, Boston, MA 02111 USA; [Schiemer, James; Chishti, Athar H.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dept Dev Mol & Chem Biol,Program Pharmacol & Micr, Boston, MA 02111 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tufts University; Tufts University	Le Breton, GC (corresponding author), Univ Illinois, Dept Mol Pharmacol, Coll Med, 835 South Wolcott Ave,MC 868, Chicago, IL 60612 USA.	gcl@uic.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [HL24530-29, HL089517]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089517, R01HL024530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL24530-29 (to G. C. L.), HL089517 (to A. H. C.), and grant-in-aid from the American Heart Association (to A. H. C.). The authors declare that they have no conflicts of interest with the contents of this article.	BAI Y, 1984, BLOOD, V64, P139; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; BRACE LD, 1985, AM J PHYSIOL, V249, pH1, DOI 10.1152/ajpheart.1985.249.1.H1; Brass LF, 1997, THROMB HAEMOSTASIS, V78, P581; BURRIDGE K, 1983, J CELL BIOL, V97, P359, DOI 10.1083/jcb.97.2.359; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Djellas Y, 1999, J BIOL CHEM, V274, P14325, DOI 10.1074/jbc.274.20.14325; FOX JEB, 1983, CELL MOTIL CYTOSKEL, V3, P579, DOI 10.1002/cm.970030524; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Galvagni F, 2010, CIRC RES, V106, P1839, DOI 10.1161/CIRCRESAHA.109.206326; GERRARD JM, 1974, AM J PATHOL, V77, P151; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Huang JS, 2007, J BIOL CHEM, V282, P10210, DOI 10.1074/jbc.M605678200; Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; KIM SO, 1992, BIOCHEM PHARMACOL, V43, P313; Kuchay SM, 2007, CURR OPIN HEMATOL, V14, P249, DOI 10.1097/MOH.0b013e3280ef68f8; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; MICHAL F, 1971, NATURE-NEW BIOL, V231, P220, DOI 10.1038/newbio231220a0; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Patil S, 1999, J BIOL CHEM, V274, P28575, DOI 10.1074/jbc.274.40.28575; PHILLIPS DR, 1987, ANN NY ACAD SCI, V509, P177, DOI 10.1111/j.1749-6632.1987.tb30994.x; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; SHATTIL SJ, 1987, BLOOD, V70, P307; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Sonde J., 1994, NATURE, V217, P503; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200	34	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25129	25139		10.1074/jbc.M115.650978	http://dx.doi.org/10.1074/jbc.M115.650978			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26292217	Green Published, hybrid			2022-12-28	WOS:000362598300040
J	Cao, GS; Wang, J; Zheng, XD; Wei, HM; Tian, ZG; Sun, R				Cao, Guoshuai; Wang, Jian; Zheng, Xiaodong; Wei, Haiming; Tian, Zhigang; Sun, Rui			Tumor Therapeutics Work as Stress Inducers to Enhance Tumor Sensitivity to Natural Killer (NK) Cell Cytolysis by Up-regulating NKp30 Ligand B7-H6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING RECEPTOR NKP30; IMMUNE-SYSTEM; TRIGGERING RECEPTOR; TNF-ALPHA; T-CELLS; CHAIN-A; CHEMOTHERAPY; RADIATION; CANCER; NKG2D	Immune cells are believed to participate in initiating anti-tumor effects during regular tumor therapy such as chemotherapy, radiation, hyperthermia, and cytokine injection. One of the mechanisms underlying this process is the expression of so-called stress-inducible immunostimulating ligands. Although the activating receptor NKG2D has been proven to play roles in tumor therapy through targeting its ligands, the role of NKp30, another key activating receptor, is seldom addressed. In this study, we found that the NKp30 ligand B7-H6 was widely expressed in tumor cells and closely correlated to their susceptibility to NK cell lysis. Further studies showed that treatment of tumor cells with almost all standard tumor therapeutics, including chemotherapy (cisplatin, 5-fluorouracil), radiation therapy, non-lethal heat shock, and cytokine therapy (TNF-alpha), could upregulate the expression of B7-H6 in tumor cells and enhance tumor sensitivity to NK cell cytolysis. B7-H6 shRNA treatment effectively dampened sensitization of tumor cells to NK-mediated lysis. Our study not only reveals the possibility that tumor therapeutics work as stress inducers to enhance tumor sensitivity to NK cell cytolysis but also suggests that B7-H6 could be a potential target for tumor therapy in the future.	[Cao, Guoshuai; Wang, Jian; Zheng, Xiaodong; Wei, Haiming; Tian, Zhigang; Sun, Rui] Univ Sci & Technol China, Chinese Acad Sci, Sch Life Sci, Inst Immunol,Key Lab Innate Immun & Chron Dis, Hefei 230027, Anhui, Peoples R China; [Cao, Guoshuai; Wang, Jian; Zheng, Xiaodong; Wei, Haiming; Tian, Zhigang; Sun, Rui] Univ Sci & Technol China, Med Ctr, Hefei 230027, Anhui, Peoples R China; [Wei, Haiming; Tian, Zhigang; Sun, Rui] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Signaling Network, State Key Lab Cellular Stress Biol, Xiamen 361005, Fujian, Peoples R China; [Sun, Rui] Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Xiamen University	Wang, J (corresponding author), Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei 230027, Anhui, Peoples R China.	ustcwj@mail.ustc.edu.cn; sunr@ustc.edu.cn	Tian, Zhigang/J-3512-2013; Wei, Haiming/G-7703-2018; Zheng, Xiaodong/N-2830-2013	Wei, Haiming/0000-0002-1675-6502; 	Ministry of Science & Technology of China [2013CB530506, 2012ZX10002014, 2012AA020901]; Natural Science Foundation of China [91029303]	Ministry of Science & Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science & Technology of China (2013CB530506, 2012ZX10002014, and 2012AA020901) and Natural Science Foundation of China (#91029303). The authors declare that they have no conflicts of interest with the contents of this article.	Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Cheng M, 2013, CELL MOL IMMUNOL, V10, P230, DOI 10.1038/cmi.2013.10; Cheng M, 2011, CELL TRANSPLANT, V20, P1731, DOI 10.3727/096368911X580536; Fiegler N, 2013, BLOOD, V122, P684, DOI 10.1182/blood-2013-02-482513; Frey B, 2014, CANCER IMMUNOL IMMUN, V63, P29, DOI 10.1007/s00262-013-1474-y; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Ghiringhelli F, 2014, EXPERT REV CLIN IMMU, V10, P19, DOI 10.1586/1744666X.2014.865520; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Jinushi M, 2003, J IMMUNOL, V170, P1249, DOI 10.4049/jimmunol.170.3.1249; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Lin D, 2012, J BIOL CHEM, V287, P4299, DOI 10.1074/jbc.M111.282152; Luevano M, 2012, CELL MOL IMMUNOL, V9, P310, DOI 10.1038/cmi.2012.17; Manusama ER, 1996, EUR J SURG ONCOL, V22, P152, DOI 10.1016/S0748-7983(96)90671-X; Matsui S, 1999, J IMMUNOL, V163, P184; Matta J, 2013, BLOOD, V122, P394, DOI 10.1182/blood-2013-01-481705; Morandi B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039170; Moretta L, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00087; Nice TJ, 2009, J EXP MED, V206, P287, DOI 10.1084/jem.20081335; Park B, 2014, INT J MOL SCI, V15, P927, DOI 10.3390/ijms15010927; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Schlecker E, 2014, CANCER RES, V74, P3429, DOI 10.1158/0008-5472.CAN-13-3017; Smyth MJ, 2005, J EXP MED, V202, P583, DOI 10.1084/jem.20050994; Sonn CH, 2012, J RADIAT RES, V53, P823, DOI 10.1093/jrr/rrs037; Takeshima T, 2010, CANCER RES, V70, P2697, DOI 10.1158/0008-5472.CAN-09-2982; TARNOWSKI GS, 1978, CANCER RES, V38, P4540; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Toraya-Brown S, 2014, NANOMED-NANOTECHNOL, V10, P1273, DOI 10.1016/j.nano.2014.01.011; Venkataraman GM, 2007, J IMMUNOL, V178, P961, DOI 10.4049/jimmunol.178.2.961; Vitale M, 2005, BLOOD, V106, P566, DOI 10.1182/blood-2004-10-4035; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Zitvogel L, 2008, J CLIN INVEST, V118, P1991, DOI 10.1172/JCI35180; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	38	52	59	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29964	29973		10.1074/jbc.M115.674010	http://dx.doi.org/10.1074/jbc.M115.674010			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26472927	Green Published, hybrid			2022-12-28	WOS:000366614700028
J	Chakka, D; Gudla, R; Madikonda, AK; Pandeeti, EVP; Parthasarathy, S; Nandavaram, A; Siddavattam, D				Chakka, Deviprasanna; Gudla, Ramurthy; Madikonda, Ashok Kumar; Pandeeti, Emmanuel Vijay Paul; Parthasarathy, Sunil; Nandavaram, Aparna; Siddavattam, Dayananda			The Organophosphate Degradation (opd) Island-borne Esterase-induced Metabolic Diversion in Escherichia coli and Its Influence on p-Nitrophenol Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECENTLY DIVERGED PHOSPHOTRIESTERASE; FLAVOBACTERIUM SP; METHYL PARATHION; SPHINGOBIUM-FULIGINIS; AROMATIC-COMPOUNDS; ATCC 27551; GENE; BIODEGRADATION; HYDROLASE; LACTONASES	In previous studies of the organophosphate degradation gene cluster, we showed that expression of an open reading frame (orf306) present within the cluster in Escherichia coli allowed growth on p-nitrophenol (PNP) as sole carbon source. We have now shown that expression of orf306 in E. coli causes a dramatic up-regulation in genes coding for alternative carbon catabolism. The propionate, glyoxylate, and methylcitrate cycle pathway-specific enzymes are up-regulated along with hca (phenylpropionate) and mhp (hydroxyphenylpropionate) degradation operons. These hca and mhp operons play a key role in degradation of PNP, enabling E. coli to grow using it as sole carbon source. Supporting growth experiments, PNP degradation products entered central metabolic pathways and were incorporated into the carbon backbone. The protein and RNA samples isolated from E. coli (pSDP10) cells grown in C-14-labeled PNP indicated incorporation of C-14 carbon, suggesting Orf306-dependent assimilation of PNP in E. coli cells.	[Chakka, Deviprasanna; Gudla, Ramurthy; Madikonda, Ashok Kumar; Pandeeti, Emmanuel Vijay Paul; Parthasarathy, Sunil; Nandavaram, Aparna; Siddavattam, Dayananda] Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Hyderabad 500046, Andhra Pradesh, India	University of Hyderabad	Siddavattam, D (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Prof CR Rao Rd, Hyderabad 500046, Andhra Pradesh, India.	sdsl@uohyd.ernet.in	Chakka, Deviprasanna/J-4980-2015	Chakka, Deviprasanna/0000-0002-9703-3823; Pandeeti, Emmanuel/0000-0001-8244-7401	Department of Animal Biology is a Department of Science and Technology-Fund for Improvement of Science and Technology Infrastructure in Higher Educational Institutions; Department of Biotechnology-Centre for Education and Research in Biology and Biotechnology; University Grants Commission-Center of Advanced Study; CSIR; DST; DBT	Department of Animal Biology is a Department of Science and Technology-Fund for Improvement of Science and Technology Infrastructure in Higher Educational Institutions; Department of Biotechnology-Centre for Education and Research in Biology and Biotechnology; University Grants Commission-Center of Advanced Study; CSIR(Council of Scientific & Industrial Research (CSIR) - India); DST(Department of Science & Technology (India)); DBT(Department of Biotechnology (DBT) India)	The Department of Animal Biology is a Department of Science and Technology-Fund for Improvement of Science and Technology Infrastructure in Higher Educational Institutions supported Department. The School of Life Sciences, University of Hyderabad is supported by the Department of Biotechnology-Centre for Education and Research in Biology and Biotechnology and University Grants Commission-Center of Advanced Study. Funding provided by CSIR, DST, and DBT to the D. S. laboratory is respectfully acknowledged. We thank Dr. M. J. Merrick for critical reading of the manuscript and Dr. Manjula Reddy for useful suggestions and providing E. coli mutants. Genotypic Technology Pvt. Ltd. is acknowledged for help in transcriptome data analysis.	Afriat L, 2006, BIOCHEMISTRY-US, V45, P13677, DOI 10.1021/bi061268r; Afriat-Jurnou L, 2012, BIOCHEMISTRY-US, V51, P6047, DOI 10.1021/bi300694t; Bar-Rogovsky H, 2013, J BIOL CHEM, V288, P23914, DOI 10.1074/jbc.M112.427922; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Copley SD, 2009, NAT CHEM BIOL, V5, P560, DOI 10.1038/nchembio.197; Diaz E, 2001, MICROBIOL MOL BIOL R, V65, P523, DOI 10.1128/MMBR.65.4.523-569.2001; Garau G, 2005, ANTIMICROB AGENTS CH, V49, P2778, DOI 10.1128/AAC.49.7.2778-2784.2005; HUGGINS C, 1947, J BIOL CHEM, V170, P467; Kadiyala V, 1998, APPL ENVIRON MICROB, V64, P2479; Kawahara K, 2010, J GEN APPL MICROBIOL, V56, P249, DOI 10.2323/jgam.56.249; Khajamohiddin S, 2008, CRIT REV MICROBIOL, V34, P13, DOI [10.1080/10408410701683656, 10.1080/10408410701683656 ]; Longkumer T, 2014, MICROBIOL-SGM, V160, P102, DOI 10.1099/mic.0.070664-0; Manso I, 2009, J BIOL CHEM, V284, P21218, DOI 10.1074/jbc.M109.008243; Merone L, 2005, EXTREMOPHILES, V9, P297, DOI 10.1007/s00792-005-0445-4; Miller J. H, 1972, EXPT MOL GENETICS; MORALES VM, 1991, GENE, V97, P39, DOI 10.1016/0378-1119(91)90007-X; MULBRY WW, 1987, PLASMID, V18, P173, DOI 10.1016/0147-619X(87)90046-1; Pakala SB, 2007, APPL MICROBIOL BIOT, V73, P1452, DOI 10.1007/s00253-006-0595-z; Pandeeti EVP, 2009, LETT APPL MICROBIOL, V48, P566, DOI 10.1111/j.1472-765X.2009.02564.x; Pandeeti EVP, 2012, G3-GENES GENOM GENET, V2, P1541, DOI 10.1534/g3.112.004051; Pandeeti EVP, 2011, PLASMID, V65, P226, DOI 10.1016/j.plasmid.2011.02.003; Pech-Canul A, 2011, J BACTERIOL, V193, P6295, DOI 10.1128/JB.05450-11; Roodveldt C, 2005, BIOCHEMISTRY-US, V44, P12728, DOI 10.1021/bi051021e; Sambrook J, 1989, MOL CLONING LAB MANU, V3; Siddavattam D, 2003, APPL ENVIRON MICROB, V69, P2533, DOI 10.1128/AEM.69.5.2533-2539.2003; Singh BK, 2006, FEMS MICROBIOL REV, V30, P428, DOI 10.1111/j.1574-6976.2006.00018.x; Singh BK, 2009, NAT REV MICROBIOL, V7, P156, DOI 10.1038/nrmicro2050; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Stepankova A, 2013, ACTA CRYSTALLOGR F, V69, P346, DOI 10.1107/S1744309113002674; Turlin E, 2001, J MOL MICROB BIOTECH, V3, P127; WALSH K, 1984, J BIOL CHEM, V259, P9646; Wei M, 2009, FEMS MICROBIOL LETT, V292, P85, DOI 10.1111/j.1574-6968.2008.01468.x; Zhang RF, 2006, BIODEGRADATION, V17, P465, DOI 10.1007/s10532-005-9018-6	33	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29920	29930		10.1074/jbc.M115.661249	http://dx.doi.org/10.1074/jbc.M115.661249			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26453310	Green Published, hybrid			2022-12-28	WOS:000366614700024
J	Lin, KY; Kao, SH; Lai, CM; Chen, CT; Wu, CY; Hsu, HJ; Wang, WD				Lin, Kun-Yang; Kao, Shih-Han; Lai, Chun-Ming; Chen, Ciao-Ting; Wu, Chang-Yi; Hsu, Hwei-Jan; Wang, Wen-Der			Tumor Suppressor Lzap Suppresses Wnt/beta-Catenin Signaling to Promote Zebrafish Embryonic Ventral Cell Fates via the Suppression of Inhibitory Phosphorylation of Glycogen Synthase Kinase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORSOVENTRAL PATTERN-FORMATION; BMP ACTIVITY GRADIENT; BINDING PROTEIN; BETA-CATENIN; GENE-EXPRESSION; AXIS FORMATION; CHORDIN; WNT; PATHWAY; XENOPUS	Wnt/beta-catenin signaling controls various cell fates in metazoan development, and its dysregulation is often associated with cancer formation. However, regulations of this signaling pathway are not completely understood. Here, we report that Lzap, a tumor suppressor, controls nuclear translocation of beta-catenin. In zebrafish embryos disruption of lzap increases the expression of chordin (chd), which encodes a bone morphogenetic protein (BMP) antagonist that is localized in prospective dorsal cells and promotes dorsal fates. Consistently, lzap-deficient embryos with attenuated BMP signaling are dorsalized, which can be rescued by overexpression of zebrafish lzap or bmp2b or human LZAP. The expansion of chd expression in embryos lacking lzap is due to the accumulation of nuclear beta-catenin in ventral cells, in which beta-catenin is usually degraded. Furthermore, the activity of GSK3, a master regulator of beta-catenin degradation, is suppressed in lzap-deficient embryos via inhibitory phosphorylation. Finally, we also report that a similar regulatory axis is also likely to be present in a human tongue carcinoma cell line, SAS. Our results reveal that Lzap is a novel regulator of GSK3 for the maintenance of ventral cell properties and may prevent carcinogenesis via the regulation of beta-catenin degradation.	[Lin, Kun-Yang; Kao, Shih-Han; Hsu, Hwei-Jan] Acad Sinica, Inst Cellular & Organism Biol, Taipei 11529, Taiwan; [Lai, Chun-Ming] Natl Chung Hsing Univ, Taiwan Int Grad Program, Mol & Biol Agr Sci Program, Taipei 11529, Taiwan; [Lai, Chun-Ming] Acad Sinica, Taipei 11529, Taiwan; [Lin, Kun-Yang; Chen, Ciao-Ting; Wang, Wen-Der] Natl Chiayi Univ, Dept BioAgr Sci, Chiayi 60004, Taiwan; [Wu, Chang-Yi] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan	Academia Sinica - Taiwan; National Chung Hsing University; Academia Sinica - Taiwan; National Chiayi University; National Sun Yat Sen University	Hsu, HJ (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	cohsu@gate.sinica.edu.tw; wangw4@mail.ncyu.edu.tw	Wang, Wen-Der/AGO-2974-2022; Hsu, Hwei-Jan/AAD-1518-2022	Hsu, Hwei-Jan/0000-0001-7892-2310; Lin, Kun-Yang/0000-0002-6197-3995	Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan	Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by intramural funding from the Institute of Cellular and Organismic Biology, Academia Sinica, Taiwan. The authors declare that they have no conflicts of interest with the contents of this article.	An HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016427; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Branam AM, 2010, DEV BIOL, V341, P444, DOI 10.1016/j.ydbio.2010.03.001; Cao Y, 2004, DEV BIOL, V271, P130, DOI 10.1016/j.ydbio.2004.03.032; Cha SW, 2008, DEVELOPMENT, V135, P3719, DOI 10.1242/dev.029025; Chen CY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-100; Chen YF, 2015, AM J PHYSIOL-CELL PH, V309, pC148, DOI 10.1152/ajpcell.00031.2015; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davuluri G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000240; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Detrich HW, 1999, METHODS CELL BIOL, V59, P3, DOI 10.1016/S0091-679X(08)61816-6; Dick A, 2000, DEVELOPMENT, V127, P343; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dougan ST, 2003, DEVELOPMENT, V130, P1837, DOI 10.1242/dev.00400; Furthauer M, 2004, DEVELOPMENT, V131, P2853, DOI 10.1242/dev.01156; Furthauer M, 1999, DEV BIOL, V214, P181, DOI 10.1006/dbio.1999.9401; GRIFFIN K, 1995, DEVELOPMENT, V121, P2983; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jurynec MJ, 2010, DIS MODEL MECH, V3, P733, DOI 10.1242/dmm.000703; Kane D, 2002, RES PRO CEL, V40, P117; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kwon J, 2010, J BIOL CHEM, V285, P12232, DOI 10.1074/jbc.M109.065920; Langdon YG, 2011, ANNU REV GENET, V45, P357, DOI 10.1146/annurev-genet-110410-132517; Larrain J, 2000, DEVELOPMENT, V127, P821; Lee HC, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-93; Lepage SE, 2010, INT J DEV BIOL, V54, P1213, DOI 10.1387/ijdb.093028sl; Liang J, 2011, J ZHEJIANG UNIV-SC B, V12, P951, DOI 10.1631/jzus.B1100121; Lin CW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386235; Liu D, 2011, DEV DYNAM, V240, P1613, DOI 10.1002/dvdy.22644; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu FI, 2011, P NATL ACAD SCI USA, V108, P15876, DOI 10.1073/pnas.1106801108; Maegawa S, 2006, DEVELOPMENT, V133, P3265, DOI 10.1242/dev.02483; MartinezBarbera JP, 1997, GENE, V198, P53, DOI 10.1016/S0378-1119(97)00292-8; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Miller-Bertoglio VE, 1997, DEV BIOL, V192, P537, DOI 10.1006/dbio.1997.8788; Muller II, 2006, DEV DYNAM, V235, P2881, DOI 10.1002/dvdy.20925; Mullins MC, 1996, DEVELOPMENT, V123, P81; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Ramel MC, 2013, DEV BIOL, V378, P170, DOI 10.1016/j.ydbio.2013.03.003; Sandoval J, 2009, J PHARMACOL EXP THER, V331, P609, DOI 10.1124/jpet.109.157537; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Schmid B, 2000, DEVELOPMENT, V127, P957; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Shao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036655; Sherwood V, 2015, MOL CELL BIOL, V35, P2, DOI 10.1128/MCB.00992-14; Shimizu T, 2005, DEV BIOL, V279, P125, DOI 10.1016/j.ydbio.2004.12.007; Shimizu T, 2000, MECH DEVELOP, V91, P293, DOI 10.1016/S0925-4773(99)00319-6; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sun ZH, 2006, DEV DYNAM, V235, P2999, DOI 10.1002/dvdy.20945; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wang JL, 2006, BIOCHEM J, V393, P489, DOI 10.1042/BJ20050960; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Westfall TA, 2003, DEV BIOL, V259, P380, DOI 10.1016/S0012-1606(03)00209-4; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Wu JC, 2010, J BIOL CHEM, V285, P15126, DOI 10.1074/jbc.M110.110619	64	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29808	29819		10.1074/jbc.M115.669309	http://dx.doi.org/10.1074/jbc.M115.669309			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26475862	hybrid, Green Published			2022-12-28	WOS:000366614700016
J	Yadav, DB; Sharma, VK; Boswell, CA; Hotzel, I; Tesar, D; Shang, YL; Ying, Y; Fischer, SK; Grogan, JL; Chiang, EY; Urban, K; Ulufatu, S; Khawli, LA; Prabhu, S; Joseph, S; Kelley, RF				Yadav, Daniela Bumbaca; Sharma, Vikas K.; Boswell, Charles Andrew; Hotzel, Isidro; Tesar, Devin; Shang, Yonglei; Ying, Yong; Fischer, Saloumeh K.; Grogan, Jane L.; Chiang, Eugene Y.; Urban, Konnie; Ulufatu, Sheila; Khawli, Leslie A.; Prabhu, Saileta; Joseph, Sean; Kelley, Robert F.			Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; THERAPEUTIC ANTIBODIES; SCANNING MUTAGENESIS; RECEPTOR; BIODISTRIBUTION; CATIONIZATION; CHEMOTAXIS; ACTIVATION; CLEARANCE; SELECTION	The pharmacokinetic (PK) behavior of monoclonal antibodies in cynomolgus monkeys (cynos) is generally translatable to that in humans. Unfortunately, about 39% of the antibodies evaluated for PKs in cynos have fast nonspecific (or non-target-mediated) clearance (in-house data). An empirical model relating variable region (Fv) charge and hydrophobicity to cyno nonspecific clearance was developed to gauge the risk an antibody would have for fast nonspecific clearance in the monkey. The purpose of this study was to evaluate the predictability of this empirical model on cyno nonspecific clearance with antibodies specifically engineered to have either high or low Fv charge. These amino acid changes were made in the Fv region of two test antibodies, humAb4D5-8 and anti-lymphotoxin alpha. The humAb4D5-8 has a typical nonspecific clearance in cynos, and by making it more positively charged, the antibody acquires fast nonspecific clearance, and making it less positively charged did not impact its clearance. Anti-lymphotoxin alpha has fast nonspecific clearance in cynos, and making it more positively charged caused it to clear even faster, whereas making it less positively charged caused it to clear slower and within the typical range. These trends in clearance were also observed in two other preclinical species, mice and rats. The effect of modifying Fv charge on subcutaneous bioavailability was also examined, and in general bioavailability was inversely related to the direction of the Fv charge change. Thus, modifying Fv charge appears to impact antibody PKs, and the changes tended to correlate with those predicted by the empirical model.	[Yadav, Daniela Bumbaca; Boswell, Charles Andrew; Khawli, Leslie A.; Prabhu, Saileta; Joseph, Sean] Genentech Inc, Dept Preclin & Translat Pharmacokinet, San Francisco, CA 94080 USA; [Sharma, Vikas K.] Genentech Inc, Dept Late Stage Pharmaceut Dev, San Francisco, CA 94080 USA; [Hotzel, Isidro; Shang, Yonglei] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Ying, Yong; Fischer, Saloumeh K.] Genentech Inc, Dept BioAnalyt Sci, San Francisco, CA 94080 USA; [Grogan, Jane L.; Chiang, Eugene Y.] Genentech Inc, Dept Res, San Francisco, CA 94080 USA; [Urban, Konnie; Ulufatu, Sheila] Genentech Inc, Dept Nonclin Operat, San Francisco, CA 94080 USA; [Tesar, Devin; Kelley, Robert F.] Genentech Inc, Dept Drug Delivery, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Kelley, RF (corresponding author), 1 DNA Way MS 561A, San Francisco, CA 94080 USA.	kelley.bob@gene.com	Sharma, Vikas/AAE-5762-2020	Sharma, Vikas/0000-0002-7378-557X; Hotzel, Isidro/0000-0001-6910-7840; Boswell, Charles/0000-0002-0426-9846; Joseph, Sean/0000-0002-2602-8517				Bass RB, 2007, METHOD ENZYMOL, V423, P3, DOI 10.1016/S0076-6879(07)23001-0; Boswell CA, 2010, BIOCONJUGATE CHEM, V21, P2153, DOI 10.1021/bc100261d; BOXENBAUM H, 1982, J PHARMACOKINET BIOP, V10, P201, DOI 10.1007/BF01062336; Bumbaca D, 2012, AAPS J, V14, P554, DOI 10.1208/s12248-012-9369-y; Bumbaca D, 2011, MABS-AUSTIN, V3, P376, DOI 10.4161/mabs.3.4.15786; Cao YG, 2014, J PHARMACOKINET PHAR, V41, P375, DOI 10.1007/s10928-014-9372-2; Chiang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033106; Chirmule N, 2012, AAPS J, V14, P296, DOI 10.1208/s12248-012-9340-y; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Davda JP, 2010, MABS-AUSTIN, V2, P576, DOI 10.4161/mabs.2.5.12833; Davies CD, 2002, BRIT J CANCER, V86, P1639, DOI 10.1038/sj/bjc/6600270; Deng R, 2011, MABS-AUSTIN, V3, P61, DOI 10.4161/mabs.3.1.13799; Dong JQ, 2011, CLIN PHARMACOKINET, V50, P131, DOI 10.2165/11537430-000000000-00000; Everds N, 2013, TOXICOL PATHOL, V41, P951, DOI 10.1177/0192623312474727; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Herve F, 2008, AAPS J, V10, P455, DOI 10.1208/s12248-008-9055-2; Hotzel I, 2012, MABS-AUSTIN, V4, P753, DOI 10.4161/mabs.22189; Kelley Robert F, 2012, Methods Mol Biol, V901, P277, DOI 10.1007/978-1-61779-931-0_18; Khawli LA, 1996, CANCER BIOTHER RADIO, V11, P203, DOI 10.1089/cbr.1996.11.203; Lee HJ, 2003, BIOCONJUGATE CHEM, V14, P546, DOI 10.1021/bc0256648; Li B, 2014, MABS-AUSTIN, V6, P1255, DOI 10.4161/mabs.29809; LIN JH, 1995, DRUG METAB DISPOS, V23, P1008; Mach H, 2011, THER DELIV, V2, P727, DOI 10.4155/TDE.11.31; Mehan RS, 2003, BIOCHEMISTRY-US, V42, P2952, DOI 10.1021/bi027127g; Miller AS, 2006, BIOCHEMISTRY-US, V45, P8699, DOI 10.1021/bi060580y; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Pantua H, 2013, J MOL BIOL, V425, P1899, DOI 10.1016/j.jmb.2013.02.025; PARDRIDGE WM, 1995, J PHARM SCI-US, V84, P943, DOI 10.1002/jps.2600840808; Pippig S. D., 2014, BIOSIMILAR MONOCLONA; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Richter WF, 2012, AAPS J, V14, P559, DOI 10.1208/s12248-012-9367-0; Sampei Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057479; Santostefano MJ, 2012, TOXICOL PATHOL, V40, P899, DOI 10.1177/0192623312444029; Schoch A, 2015, P NATL ACAD SCI USA, V112, P5997, DOI 10.1073/pnas.1408766112; SHALABY MR, 1992, J EXP MED, V175, P217, DOI 10.1084/jem.175.1.217; Sharma VK, 2014, P NATL ACAD SCI USA, V111, P18601, DOI 10.1073/pnas.1421779112; SHARP LL, 1995, P NATL ACAD SCI USA, V92, P7946, DOI 10.1073/pnas.92.17.7946; Sudhamsu J, 2013, P NATL ACAD SCI USA, V110, P19896, DOI 10.1073/pnas.1310838110; Tabrizi M, 2010, AAPS J, V12, P33, DOI 10.1208/s12248-009-9157-5; Vugmeyster Y, 2011, PHARM RES-DORDR, V28, P1696, DOI 10.1007/s11095-011-0405-x; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; Xin Y, 2012, CLIN CANCER RES, V18, P6040, DOI 10.1158/1078-0432.CCR-12-1652	43	45	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2015	290	50					29732	29741		10.1074/jbc.M115.692434	http://dx.doi.org/10.1074/jbc.M115.692434			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY7UL	26491012	hybrid, Green Published			2022-12-28	WOS:000366614700006
J	Ciesielski, GL; Bermek, O; Rosado-Ruiz, FA; Hovde, SL; Neitzke, OJ; Griffith, JD; Kaguni, LS				Ciesielski, Grzegorz L.; Bermek, Oya; Rosado-Ruiz, Fernando A.; Hovde, Stacy L.; Neitzke, Orrin J.; Griffith, Jack D.; Kaguni, Laurie S.			Mitochondrial Single-stranded DNA-binding Proteins Stimulate the Activity of DNA Polymerase by Organization of the Template DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA polymerase; DNA replication; electron microscopy (EM); enzyme mechanism; mitochondrial DNA (mtDNA)	ESCHERICHIA-COLI; FUNCTIONAL INTERACTIONS; FACILITATE REPLICATION; DROSOPHILA EMBRYOS; III HOLOENZYME; IN-VITRO; GAMMA; MUTATIONS; HELICASE; DEFECTS	The activity of the mitochondrial replicase, DNA polymerase (Pol ) is stimulated by another key component of the mitochondrial replisome, the mitochondrial single-stranded DNA-binding protein (mtSSB). We have performed a comparative analysis of the human and Drosophila Pols with their cognate mtSSBs, evaluating their functional relationships using a combined approach of biochemical assays and electron microscopy. We found that increasing concentrations of both mtSSBs led to the elimination of template secondary structure and gradual opening of the template DNA, through a series of visually similar template species. The stimulatory effect of mtSSB on Pol on these ssDNA templates is not species-specific. We observed that human mtSSB can be substituted by its Drosophila homologue, and vice versa, finding that a lower concentration of insect mtSSB promotes efficient stimulation of either Pol. Notably, distinct phases of the stimulation by both mtSSBs are distinguishable, and they are characterized by a similar organization of the template DNA for both Pols . We conclude that organization of the template DNA is the major factor contributing to the stimulation of Pol activity. Additionally, we observed that human Pol preferentially utilizes compacted templates, whereas the insect enzyme achieves its maximal activity on open templates, emphasizing the relative importance of template DNA organization in modulating Pol activity and the variation among systems.	[Ciesielski, Grzegorz L.; Kaguni, Laurie S.] Univ Tampere, Inst Biosci & Med Technol, Tampere 33520, Finland; [Ciesielski, Grzegorz L.; Rosado-Ruiz, Fernando A.; Hovde, Stacy L.; Neitzke, Orrin J.; Kaguni, Laurie S.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48823 USA; [Ciesielski, Grzegorz L.; Rosado-Ruiz, Fernando A.; Hovde, Stacy L.; Neitzke, Orrin J.; Kaguni, Laurie S.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48823 USA; [Bermek, Oya; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27514 USA	Tampere University; Michigan State University; Michigan State University; University of North Carolina; University of North Carolina Chapel Hill	Kaguni, LS (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd, E Lansing, MI 48823 USA.	lskaguni@msu.edu	Regan, Clinton/E-6250-2012; Ciesielski, Grzegorz/AAK-2235-2020	Ciesielski, Grzegorz/0000-0001-6528-6781	National Institutes of Health [GM45295, GM31819, ES13773]; University of Tampere; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045295, R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Tampere; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM45295 (to L. S. K.) and GM31819 and ES13773 (to J. D. G.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the University of Tampere.	ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; CHRYSOGELOS S, 1982, P NATL ACAD SCI-BIOL, V79, P5803, DOI 10.1073/pnas.79.19.5803; Copeland WC, 2003, ACTA BIOCHIM POL, V50, P155; Copeland WC, 2014, J CHILD NEUROL, V29, P1216, DOI 10.1177/0883073814537380; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618; Fan L, 2006, J MOL BIOL, V358, P1229, DOI 10.1016/j.jmb.2006.02.073; Farr CL, 1999, J BIOL CHEM, V274, P14779, DOI 10.1074/jbc.274.21.14779; Farr CL, 2004, J BIOL CHEM, V279, P17047, DOI 10.1074/jbc.M400283200; Ghosh S, 2010, J BIOL CHEM, V285, P18103, DOI 10.1074/jbc.M110.107656; Glover BP, 1998, J BIOL CHEM, V273, P23476, DOI 10.1074/jbc.273.36.23476; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; GUTIERREZ C, 1991, J BIOL CHEM, V266, P2104; HOKE GD, 1990, ARCH BIOCHEM BIOPHYS, V282, P116, DOI 10.1016/0003-9861(90)90094-F; Jemt E, 2011, NUCLEIC ACIDS RES, V39, P9238, DOI 10.1093/nar/gkr653; Johnson AA, 2001, J BIOL CHEM, V276, P38090; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Korhonen JA, 2003, J BIOL CHEM, V278, P48627, DOI 10.1074/jbc.M306981200; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P3555, DOI 10.1021/bi100069s; Lee YS, 2010, J BIOL CHEM, V285, P1490, DOI 10.1074/jbc.M109.062752; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Luo NG, 2005, J BIOL CHEM, V280, P2491, DOI 10.1074/jbc.M411447200; Maier D, 2001, MOL BIOL CELL, V12, P821, DOI 10.1091/mbc.12.4.821; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Mikhailov VS, 1996, J BIOL CHEM, V271, P18939, DOI 10.1074/jbc.271.31.18939; Oliveira MT, 2015, GENOME BIOL EVOL, V7, P943, DOI 10.1093/gbe/evv042; Oliveira MT, 2011, J BIOL CHEM, V286, P40649, DOI 10.1074/jbc.M111.289983; Oliveira MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015379; Oliveira MT, 2009, METHODS MOL BIOL, V554, P37, DOI 10.1007/978-1-59745-521-3_3; Rajala N, 2014, NUCLEIC ACIDS RES, V42, P952, DOI 10.1093/nar/gkt988; Ruhanen H, 2010, BBA-MOL CELL RES, V1803, P931, DOI 10.1016/j.bbamcr.2010.04.008; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Takamatsu C, 2002, EMBO REP, V3, P451, DOI 10.1093/embo-reports/kvf099; THOMMES P, 1995, J BIOL CHEM, V270, P21137, DOI 10.1074/jbc.270.36.21137; WILLIAMS AJ, 1993, J BIOL CHEM, V268, P24855; WILLIAMS AJ, 1995, J BIOL CHEM, V270, P860, DOI 10.1074/jbc.270.2.860; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P568, DOI 10.1093/nar/gkn974; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	43	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28697	28707		10.1074/jbc.M115.673707	http://dx.doi.org/10.1074/jbc.M115.673707			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26446790	Green Published, hybrid			2022-12-28	WOS:000365762300011
J	Colbran, RJ				Colbran, Roger J.			Thematic Minireview Series: Molecular Mechanisms of Synaptic Plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material						brain; glutamate receptor; neuron; signaling; synaptic plasticity	CAMKII	The human brain contains approximate to 86 billion neurons, which are precisely organized in specific brain regions and nuclei. High fidelity synaptic communication between subsets of neurons in specific circuits is required for most human behaviors, and is often disrupted in neuropsychiatric disorders. The presynaptic axon terminals of one neuron release neurotransmitters that activate receptors on multiple postsynaptic neuron targets to induce electrical and chemical responses. Typically, postsynaptic neurons integrate signals from multiple presynaptic neurons at thousands of synaptic inputs to control downstream communication to the next neuron in the circuit. Importantly, the strength (or efficiency) of signal transmission at each synapse can be modulated on time scales ranging up to the lifetime of the organism. This synaptic plasticity leads to changes in overall neuronal circuit activity, resulting in behavioral modifications. This series of minireviews will focus on recent advances in our understanding of the molecular and cellular mechanisms that control synaptic plasticity.	[Colbran, Roger J.] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Colbran, Roger J.] Vanderbilt Univ, Sch Med, Vanderbilt Kennedy Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Colbran, RJ (corresponding author), Vanderbilt Univ, Sch Med, Rm 702,Light Hall, Nashville, TN 37232 USA.	roger.colbran@vanderbilt.edu	Colbran, Roger/AAU-7708-2021	Colbran, Roger/0000-0001-7401-8244	National Institutes of Health Grants [R01-MH063232, R01-NS078291]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078291] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01-MH063232 and R01-NS078291 (to R.J.C.). The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Alvarez-Castelao B, 2015, J BIOL CHEM, V290, P28623, DOI 10.1074/jbc.R115.657130; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Hell JW, 2014, NEURON, V81, P249, DOI 10.1016/j.neuron.2013.12.024; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lussier MP, 2015, J BIOL CHEM, V290, P28596, DOI 10.1074/jbc.R115.652750; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Shonesy BC, 2014, PROG MOL BIOL TRANSL, V122, P61, DOI 10.1016/B978-0-12-420170-5.00003-9; Spence EF, 2015, J BIOL CHEM, V290, P28613, DOI 10.1074/jbc.R115.655118; Woolfrey KM, 2015, J BIOL CHEM, V290, P28604, DOI 10.1074/jbc.R115.657262	12	15	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28594	28595		10.1074/jbc.R115.696468	http://dx.doi.org/10.1074/jbc.R115.696468			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26453312	Green Published, hybrid			2022-12-28	WOS:000365762300001
J	Thai, TL; Yu, L; Galarza-Paez, L; Wu, MM; Lam, HYC; Bao, HF; Duke, BJ; Al-Khalili, O; Ma, HP; Liu, BC; Eaton, DC				Thai, Tiffany L.; Yu, Ling; Galarza-Paez, Laura; Wu, Ming Ming; Lam, Ho Yin Colin; Bao, Hui Fang; Duke, Billie Jeanne; Al-Khalili, Otor; Ma, He-Ping; Liu, Bingchen; Eaton, Douglas C.			The Polarized Effect of Intracellular Calcium on the Renal Epithelial Sodium Channel Occurs as a Result of Subcellular Calcium Signaling Domains Maintained by Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium intracellular release; calcium transport; cell polarity; epithelial sodium channel (ENaC); kidney; cortical collecting duct; mitochondrial barrier; polarization	PROTEIN-KINASE-C; NA+ CHANNEL; BLOOD-PRESSURE; ENAC ACTIVITY; A6 CELLS; INHIBITION; MEMBRANE; HYPERTENSION; KIDNEY; ALPHA	The renal epithelial sodium channel (ENaC) provides regulated sodium transport in the distal nephron. The effects of intracellular calcium ([Ca2+](i)) on this channel are only beginning to be elucidated. It appears from previous studies that the [Ca2+](i) increases downstream of ATP administration may have a polarized effect on ENaC, where apical application of ATP and the subsequent [Ca2+](i) increase have an inhibitory effect on the channel, whereas basolateral ATP and [Ca2+](i) have a stimulatory effect. We asked whether this polarized effect of ATP is, in fact, reflective of a polarized effect of increased [Ca2+](i) on ENaC and what underlying mechanism is responsible. We began by performing patch clamp experiments in which ENaC activity was measured during apical or basolateral application of ionomycin to increase [Ca2+](i) near the apical or basolateral membrane, respectively. We found that ENaC does indeed respond to increased [Ca2+](i) in a polarized fashion, with apical increases being inhibitory and basolateral increases stimulating channel activity. In other epithelial cell types, mitochondria sequester [Ca2+](i), creating [Ca2+](i) signaling microdomains within the cell that are dependent on mitochondrial localization. We found that mitochondria localize in bands just beneath the apical and basolateral membranes in two different cortical collecting duct principal cell lines and in cortical collecting duct principal cells in mouse kidney tissue. We found that inhibiting mitochondrial [Ca2+](i) uptake destroyed the polarized response of ENaC to [Ca2+](i). Overall, our data suggest that ENaC is regulated by [Ca2+](i) in a polarized fashion and that this polarization is maintained by mitochondrial [Ca2+](i) sequestration.	[Thai, Tiffany L.; Yu, Ling; Galarza-Paez, Laura; Wu, Ming Ming; Lam, Ho Yin Colin; Bao, Hui Fang; Duke, Billie Jeanne; Al-Khalili, Otor; Ma, He-Ping; Liu, Bingchen; Eaton, Douglas C.] Emory Univ, Dept Physiol, Atlanta, GA 30322 USA	Emory University	Thai, TL (corresponding author), Emory Univ, Dept Physiol, 615 Michael St,Suite 600, Atlanta, GA 30322 USA.	tiffany.thai@emory.edu	Wu, Ming-Ming/AAP-6543-2021; wu, mingming/GXN-1864-2022; LIU, BING-CHEN/AAG-9141-2020	Wu, Ming-Ming/0000-0002-6861-6376; 	NIDDK/National Institutes of Health [R37-DK037963, R01-DK100582]; American Heart Association [13POST16820072]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100582, R25DK101390, R37DK037963] Funding Source: NIH RePORTER	NIDDK/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK/National Institutes of Health Grants R37-DK037963 (to D. C. E.) and R01-DK100582 (to H. M.) and American Heart Association Grant 13POST16820072 (to T. L. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Alli AA, 2012, AM J PHYSIOL-RENAL, V303, pF800, DOI 10.1152/ajprenal.00703.2011; Bao HF, 2007, AM J PHYSIOL-RENAL, V293, pF1178, DOI 10.1152/ajprenal.00153.2007; Bao HF, 2014, AM J PHYSIOL-RENAL, V306, pF309, DOI 10.1152/ajprenal.00519.2013; Bao HF, 2012, AM J PHYSIOL-CELL PH, V303, pC1129, DOI 10.1152/ajpcell.00139.2012; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Busst CJ, 2013, CLIN EXP PHARMACOL P, V40, P495, DOI 10.1111/1440-1681.12124; Farah CA, 2012, ADV EXP MED BIOL, V740, P663, DOI 10.1007/978-94-007-2888-2_29; Finkel T, 2015, CIRC RES, V116, P1810, DOI 10.1161/CIRCRESAHA.116.305484; Gilmore ES, 2001, J BIOL CHEM, V276, P42610, DOI 10.1074/jbc.M106919200; Gincel D, 2002, INVEST OPHTH VIS SCI, V43, P2097; Henry PC, 2003, J BIOL CHEM, V278, P20019, DOI 10.1074/jbc.M211153200; Hill WG, 2007, J BIOL CHEM, V282, P37402, DOI 10.1074/jbc.M704084200; Kashlan OB, 2012, EXP CELL RES, V318, P1011, DOI 10.1016/j.yexcr.2012.02.024; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Laffer CL, 2014, J AM SOC HYPERTENS, V8, P475, DOI 10.1016/j.jash.2014.04.011; Liu YQ, 2011, BIOCHEM BIOPH RES CO, V404, P364, DOI 10.1016/j.bbrc.2010.11.124; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Ribeiro CMP, 2003, J GEN PHYSIOL, V122, P377, DOI 10.1085/jgp.200308893; Rossier BC, 2014, CURR OPIN PHARMACOL, V15, P33, DOI 10.1016/j.coph.2013.11.010; Schaeffer C, 2014, NEPHROL DIAL TRANSPL, V29, P33, DOI 10.1093/ndt/gfu231; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Su YR, 2001, DRUG METAB DISPOS, V29, P553; Thai TL, 2014, AM J PHYSIOL-RENAL, V307, pF806, DOI 10.1152/ajprenal.00350.2013; Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999; Toney GM, 2012, CURR OPIN NEPHROL HY, V21, P52, DOI 10.1097/MNH.0b013e32834db4a0; Trollinger DR, 1997, BIOCHEM BIOPH RES CO, V236, P738, DOI 10.1006/bbrc.1997.7042; Vallon V, 2011, AM J PHYSIOL-RENAL, V301, pF463, DOI 10.1152/ajprenal.00236.2011; Wang J, 2010, J BIOL CHEM, V285, P12279, DOI 10.1074/jbc.M109.086405; Wildman SSP, 2009, PURINERG SIGNAL, V5, P481, DOI 10.1007/s11302-009-9150-6; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zhang YJ, 2007, AM J PHYSIOL-RENAL, V292, pF1734, DOI 10.1152/ajprenal.00382.2006	33	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28805	28811		10.1074/jbc.M115.668293	http://dx.doi.org/10.1074/jbc.M115.668293			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26451045	Green Published, hybrid			2022-12-28	WOS:000365762300022
J	Wichelecki, DJ; Vetting, MW; Chou, LYS; Al-Obaidi, N; Bouvier, JT; Almo, SC; Gerlt, JA				Wichelecki, Daniel J.; Vetting, Matthew W.; Chou, Liyushang; Al-Obaidi, Nawar; Bouvier, Jason T.; Almo, Steven C.; Gerlt, John A.			ATP-binding Cassette (ABC) Transport System Solute-binding Protein-guided Identification of Novel D-Altritol and Galactitol Catabolic Pathways in Agrobacterium tumefaciens C58	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; bioinformatics; carbohydrate metabolism; enzyme; transcriptomics; Agrobacterium tumefaciens C58; D-altritol catabolism; genome neighborhood networks; sequence similarity networks	D-TAGATOSE; D-TALITOL; PLANT-CELLS; D-PSICOSE; METABOLISM; DATABASE; ENZYME; GENES; DEHYDROGENASE; EVOLUTION	Innovations in the discovery of the functions of uncharacterized proteins/enzymes have become increasingly important as advances in sequencing technology flood protein databases with an exponentially growing number of open reading frames. This study documents one such innovation developed by the Enzyme Function Initiative (EFI; U54GM093342), the use of solute-binding proteins for transport systems to identify novel metabolic pathways. In a previous study, this strategy was applied to the tripartite ATP-independent periplasmic transporters. Here, we apply this strategy to the ATP-binding cassette transporters and report the discovery of novel catabolic pathways for d-altritol and galactitol in Agrobacterium tumefaciens C58. These efforts resulted in the description of three novel enzymatic reactions as follows: 1) oxidation of d-altritol to d-tagatose via a dehydrogenase in Pfam family PF00107, a previously unknown reaction; 2) phosphorylation of d-tagatose to d-tagatose 6-phosphate via a kinase in Pfam family PF00294, a previously orphan EC number; and 3) epimerization of d-tagatose 6-phosphate C-4 to d-fructose 6-phosphate via a member of Pfam family PF08013, another previously unknown reaction. The epimerization reaction catalyzed by a member of PF08013 is especially noteworthy, because the functions of members of PF08013 have been unknown. These discoveries were assisted by the following two synergistic bioinformatics web tools made available by the Enzyme Function Initiative: the EFI-Enzyme Similarity Tool and the EFI-Genome Neighborhood Tool.	[Wichelecki, Daniel J.; Chou, Liyushang; Bouvier, Jason T.; Gerlt, John A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Wichelecki, Daniel J.; Chou, Liyushang; Bouvier, Jason T.; Gerlt, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Wichelecki, Daniel J.; Chou, Liyushang; Bouvier, Jason T.; Gerlt, John A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Vetting, Matthew W.; Al-Obaidi, Nawar; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Yeshiva University; Albert Einstein College of Medicine	Gerlt, JA (corresponding author), Univ Illinois, Inst Genom Biol, 1206 W Gregory Dr, Urbana, IL 61801 USA.	j-gerlt@illinois.edu	Regan, Clinton/E-6250-2012	Al Obaidi, Nawar/0000-0002-3659-9233	National Institutes of Health [U54GM093342]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM093342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant U54GM093342. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alajarin R., 1995, BEILSTEIN J ORG CHEM, V9, P2434; ARTHUR LO, 1973, J BACTERIOL, V116, P304, DOI 10.1128/JB.116.1.304-313.1973; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Beerens K, 2012, J IND MICROBIOL BIOT, V39, P823, DOI 10.1007/s10295-012-1089-x; Bouvier JT, 2014, BIOCHEMISTRY-US, V53, P614, DOI 10.1021/bi5000492; Brenner D. J., 2005, BERGEYS MANUAL SYSTE, V2, P326; Brinkkotter A, 2000, MOL MICROBIOL, V37, P125, DOI 10.1046/j.1365-2958.2000.01969.x; Brinkkotter A, 2002, ARCH MICROBIOL, V177, P410, DOI 10.1007/s00203-002-0406-6; CANGELOSI GA, 1990, P NATL ACAD SCI USA, V87, P6708, DOI 10.1073/pnas.87.17.6708; CHILTON MD, 1977, CELL, V11, P263, DOI 10.1016/0092-8674(77)90043-5; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; Erb TJ, 2012, NAT CHEM BIOL, V8, P926, DOI [10.1038/NCHEMBIO.1087, 10.1038/nchembio.1087]; Fisher M, 2007, NUCLEIC ACIDS RES, V35, P1064, DOI 10.1093/nar/gkl1126; FOX TC, 1986, PLANT PHYSIOL, V82, P307, DOI 10.1104/pp.82.1.307; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; Gilks WR, 2002, BIOINFORMATICS, V18, P1641, DOI 10.1093/bioinformatics/18.12.1641; Groninger-Poe FP, 2014, BIOCHEMISTRY-US, V53, P4192, DOI 10.1021/bi5005377; Hean Justin, 2010, Artif DNA PNA XNA, V1, P17; Jagtap SS, 2014, ENZYME MICROB TECH, V58-59, P44, DOI 10.1016/j.enzmictec.2014.02.012; Jones CE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-170; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Li ZJ, 2013, BEILSTEIN J ORG CHEM, V9, P2434, DOI 10.3762/bjoc.9.281; Luo Y, 2001, BIOCHEMISTRY-US, V40, P14763, DOI 10.1021/bi0112513; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Mojzita D, 2012, FUNGAL GENET BIOL, V49, P152, DOI 10.1016/j.fgb.2011.11.005; Moore LW, 1997, APPL ENVIRON MICROB, V63, P201, DOI 10.1128/AEM.63.1.201-207.1997; MUNIRUZZAMAN S, 1994, J FERMENT BIOENG, V78, P346, DOI 10.1016/0922-338X(94)90278-X; Nobelmann B, 1996, J BACTERIOL, V178, P6790, DOI 10.1128/jb.178.23.6790-6795.1996; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poonperm W, 2008, BIOSCI BIOTECH BIOCH, V72, P231, DOI 10.1271/bbb.70475; Raven JA, 2001, PHYTOCHEMISTRY, V58, P389, DOI 10.1016/S0031-9422(01)00286-2; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Reizer J, 1996, MICROBIOL-SGM, V142, P231, DOI 10.1099/13500872-142-2-231; Sasahara H, 1998, J FERMENT BIOENG, V85, P84, DOI 10.1016/S0922-338X(97)80359-5; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; SHAW DRD, 1956, BIOCHEM J, V64, P394, DOI 10.1042/bj0640394; SZUMILO T, 1981, BIOCHIM BIOPHYS ACTA, V660, P366, DOI 10.1016/0005-2744(81)90182-0; Toporowski MC, 2004, J BACTERIOL, V186, P8000, DOI 10.1128/JB.186.23.8000-8009.2004; VANKEER C, 1976, A VAN LEEUW J MICROB, V42, P13, DOI 10.1007/BF00399445; Vetting MW, 2015, BIOCHEMISTRY-US, V54, P909, DOI 10.1021/bi501388y; Wichelecki DJ, 2014, BIOCHEMISTRY-US, V53, P2722, DOI 10.1021/bi500264p; Yoshihara K, 2006, J BIOSCI BIOENG, V101, P219, DOI 10.1263/jbb.101.219; ZAMBRYSKI P, 1983, EMBO J, V2, P2143, DOI 10.1002/j.1460-2075.1983.tb01715.x; Zhao JL, 2014, J BACTERIOL, V196, P3150, DOI 10.1128/JB.01648-14; Zhao SW, 2014, ELIFE, V3, DOI 10.7554/eLife.03275; Zhao SW, 2013, NATURE, V502, P698, DOI 10.1038/nature12576	52	20	31	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28963	28976		10.1074/jbc.M115.686857	http://dx.doi.org/10.1074/jbc.M115.686857			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26472925	Green Published, hybrid			2022-12-28	WOS:000365762300035
J	Dubuke, ML; Maniatis, S; Shaffer, SA; Munson, M				Dubuke, Michelle L.; Maniatis, Stephanie; Shaffer, Scott A.; Munson, Mary			The Exocyst Subunit Sec6 Interacts with Assembled Exocytic SNARE Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-FUSION SPECIFICITY; N-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE; TETHERING COMPLEX; VACUOLE FUSION; COG COMPLEX; SECRETORY VESICLES; CRYSTAL-STRUCTURE; SM PROTEIN; YEAST	In eukaryotic cells, membrane-bound vesicles carry cargo between intracellular compartments, to and from the cell surface, and into the extracellular environment. Many conserved families of proteins are required for properly localized vesicle fusion, including the multisubunit tethering complexes and the SNARE complexes. These protein complexes work together to promote proper vesicle fusion in intracellular trafficking pathways. However, the mechanism by which the exocyst, the exocytosis-specific multisubunit tethering complex, interacts with the exocytic SNAREs to mediate vesicle targeting and fusion is currently unknown. We have demonstrated previously that the Saccharomyces cerevisiae exocyst subunit Sec6 directly bound the plasma membrane SNARE protein Sec9 in vitro and that Sec6 inhibited the assembly of the binary Sso1-Sec9 SNARE complex. Therefore, we hypothesized that the interaction between Sec6 and Sec9 prevented the assembly of premature SNARE complexes at sites of exocytosis. To map the determinants of this interaction, we used cross-linking and mass spectrometry analyses to identify residues required for binding. Mutation of residues identified by this approach resulted in a growth defect when introduced into yeast. Contrary to our previous hypothesis, we discovered that Sec6 does not change the rate of SNARE assembly but, rather, binds both the binary Sec9-Sso1 and ternary Sec9-Sso1-Snc2 SNARE complexes. Together, these results suggest a new model in which Sec6 promotes SNARE complex assembly, similar to the role proposed for other tether subunit-SNARE interactions.	[Dubuke, Michelle L.; Maniatis, Stephanie; Shaffer, Scott A.; Munson, Mary] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Maniatis, Stephanie; Shaffer, Scott A.] Univ Massachusetts, Sch Med, Prote & Mass Spectrometry Facil, Shrewsbury, MA 01545 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System	Munson, M (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 364 Plantat St, Worcester, MA 01605 USA.	mary.munson@umassmed.edu	Munson, Mary/A-9777-2009; Regan, Clinton/E-6250-2012	Munson, Mary/0000-0003-2297-8053; 	National Institutes of Health [GM068803]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM068803 (to M. M.). The authors declare they have no conflicts of interest with the contents of this article.	AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; Arasaki K, 2013, MOL BIOL CELL, V24, P2907, DOI 10.1091/mbc.E13-01-0014; Baek K, 2010, J BIOL CHEM, V285, P10424, DOI 10.1074/jbc.M109.096966; Balderhaar HJK, 2013, P NATL ACAD SCI USA, V110, P3823, DOI 10.1073/pnas.1221785110; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Brachmann CB, 1998, YEAST, V14, P115; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; Brunet S, 2014, TRAFFIC, V15, P1282, DOI 10.1111/tra.12200; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Collins KM, 2005, EMBO J, V24, P1775, DOI 10.1038/sj.emboj.7600658; Conibear E, 2003, MOL BIOL CELL, V14, P1610, DOI 10.1091/mbc.E02-10-0654; Croteau NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004443; Diefenbacher M, 2011, J BIOL CHEM, V286, P25027, DOI 10.1074/jbc.M110.215657; Dietrich LEP, 2003, BBA-MOL CELL RES, V1641, P111, DOI 10.1016/S0167-4889(03)00094-6; Dong G, 2005, NAT STRUCT MOL BIOL, V12, P1094, DOI 10.1038/nsmb1017; Farre JC, 2011, CELL, V144, P172, DOI 10.1016/j.cell.2011.01.005; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; GERST JE, 1992, P NATL ACAD SCI USA, V89, P4338, DOI 10.1073/pnas.89.10.4338; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Grote E, 2000, J CELL BIOL, V151, P439, DOI 10.1083/jcb.151.2.439; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x; Hohenstein AC, 2001, BIOCHEM BIOPH RES CO, V285, P167, DOI 10.1006/bbrc.2001.5141; Izawa R, 2012, J BIOL CHEM, V287, P3445, DOI 10.1074/jbc.M111.307439; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Laufman O, 2013, J CELL SCI, V126, P1506, DOI 10.1242/jcs.122101; Laufman O, 2009, EMBO J, V28, P2006, DOI 10.1038/emboj.2009.168; Lobingier BT, 2012, MOL BIOL CELL, V23, P4611, DOI 10.1091/mbc.E12-05-0343; Lurick A, 2015, J BIOL CHEM, V290, P5405, DOI 10.1074/jbc.M114.631465; MCLELLAN T, 1982, ANAL BIOCHEM, V126, P94, DOI 10.1016/0003-2697(82)90113-0; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Moore BA, 2007, J MOL BIOL, V371, P410, DOI 10.1016/j.jmb.2007.05.018; Morgera F, 2012, MOL BIOL CELL, V23, P337, DOI 10.1091/mbc.E11-08-0670; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Nichols CD, 2010, CURR BIOL, V20, P1316, DOI 10.1016/j.cub.2010.05.065; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Panchaud A, 2010, J PROTEOME RES, V9, P2508, DOI 10.1021/pr9011816; Perez-Victoria FJ, 2009, MOL CELL BIOL, V29, P5251, DOI 10.1128/MCB.00495-09; Radulovic D, 2004, MOL CELL PROTEOMICS, V3, P984, DOI 10.1074/mcp.M400061-MCP200; Rice LM, 1997, FEBS LETT, V415, P49, DOI 10.1016/S0014-5793(97)01091-0; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; ROSSETTO O, 1994, NATURE, V372, P415, DOI 10.1038/372415a0; Rost B., 2004, PROTEINS, DOI [10.1110/ps.03503304/full, DOI 10.1110/PS.03503304/FULL]; Shen D, 2013, J CELL BIOL, V202, P509, DOI 10.1083/jcb.201211148; Shestakova A, 2007, J CELL BIOL, V179, P1179, DOI 10.1083/jcb.200705145; SIKORSKI RS, 1989, GENETICS, V122, P19; Sivaram MVS, 2005, BIOCHEMISTRY-US, V44, P6302, DOI 10.1021/bi048008z; Sivaram MVS, 2006, NAT STRUCT MOL BIOL, V13, P555, DOI 10.1038/nsmb1096; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Starai VJ, 2008, MOL BIOL CELL, V19, P2500, DOI 10.1091/mbc.E08-01-0077; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wiederkehr A, 2004, J CELL BIOL, V167, P875, DOI 10.1083/jcb.200408001; Wong C, 2000, BIOTECHNIQUES, V28, P426, DOI 10.2144/00283bm07; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu H, 2010, MOL BIOL CELL, V21, P430, DOI 10.1091/mbc.E09-06-0501; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97; Yamashita M, 2010, NAT STRUCT MOL BIOL, V17, P180, DOI 10.1038/nsmb.1722; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Zhang XY, 2008, J CELL BIOL, V180, P145, DOI 10.1083/jcb.200704128; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200	75	26	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28245	28256		10.1074/jbc.M115.673806	http://dx.doi.org/10.1074/jbc.M115.673806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26446795	Green Published, hybrid			2022-12-28	WOS:000365761900018
J	Mizuno, S; Yoda, M; Shimoda, M; Tohmonda, T; Okada, Y; Toyama, Y; Takeda, S; Nakamura, M; Matsumoto, M; Horiuchi, K				Mizuno, Sakiko; Yoda, Masaki; Shimoda, Masayuki; Tohmonda, Takahide; Okada, Yasunori; Toyama, Yoshiaki; Takeda, Shin'ichi; Nakamura, Masaya; Matsumoto, Mono; Horiuchi, Keisuke			A Disintegrin and Metalloprotease 10 (ADAM10) Is Indispensable for Maintenance of the Muscle Satellite Cell Pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; STEM-CELLS; DISINTEGRIN/METALLOPROTEINASE ADAM10; EPIDERMAL ADAM17; NOTCH ACTIVATION; REGENERATION; MYOGENESIS; REQUIREMENT; QUIESCENCE; ESTABLISHMENT	Satellite cells (SCs) are muscle-specific stem cells that are essential for the regeneration of damaged muscles. Although SCs have a robust capacity to regenerate myofibers, the number of SCs decreases with aging, leading to insufficient recovery after muscle injury. We herein show that ADAM10 (a disintegrin and metalloprotease 10), a membrane-bound proteolytic enzyme with a critical role in Notch processing (S2 cleavage), is essential for the maintenance of SC quiescence. We generated mutant mice in which ADAM10 in SCs can be conditionally abrogated by tamoxifen injection. Tamoxifen-treated mutant mice did not show any apparent defects and grew normally under unchallenged conditions. However, these mice showed a nearly complete loss of muscle regeneration after chemically induced muscle injury, in situ hybridization and flow cytometric analyses revealed that the mutant mice had significantly less SCs compared with wild type controls. Of note, we found that inactivation of ADAM10 in SCs severely compromised Notch signaling and led to dysregulated myogenic differentiation, ultimately resulting in deprivation of the SC pool in vivo. Taken together, the present findings underscore the role of ADAM 10 as an indispensable component of Notch signaling in SCs and for maintaining the SC pool.	[Mizuno, Sakiko; Toyama, Yoshiaki; Nakamura, Masaya; Matsumoto, Mono; Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo 1608582, Japan; [Yoda, Masaki; Tohmonda, Takahide; Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Antiaging Orthoped Res, Tokyo 1608582, Japan; [Shimoda, Masayuki; Okada, Yasunori] Keio Univ, Sch Med, Dept Pathol, Tokyo 1608582, Japan; [Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Tokyo 1878502, Japan	Keio University; Keio University; Keio University; National Center for Neurology & Psychiatry - Japan	Horiuchi, K (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	horiuchi@z3.keio.jp	Okada, Yasunori/B-5550-2014; Horiuchi, Keisuke/L-2277-2013; Nakamura, Masaya/K-4111-2013	Okada, Yasunori/0000-0001-9208-4755; Horiuchi, Keisuke/0000-0001-7063-9609; Mizuno, Sakiko/0000-0003-4081-3973	MEXT (Ministry of Education, Culture, Sports, Science, and Technology) KAKENHI [24390358]	MEXT (Ministry of Education, Culture, Sports, Science, and Technology) KAKENHI	This work was supported in part MEXT (Ministry of Education, Culture, Sports, Science, and Technology) KAKENHI (24390358; to K. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buas MF, 2010, EXP CELL RES, V316, P3028, DOI 10.1016/j.yexcr.2010.05.002; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Franzke CW, 2012, J EXP MED, V209, P1105, DOI 10.1084/jem.20112258; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Fukada S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00317; Fukada S, 2011, DEVELOPMENT, V138, P4609, DOI 10.1242/dev.067165; Groot AJ, 2013, J INVEST DERMATOL, V133, P2286, DOI 10.1038/jid.2013.162; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Jorissen E, 2010, J NEUROSCI, V30, P4833, DOI 10.1523/JNEUROSCI.5221-09.2010; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Koch U, 2013, DEVELOPMENT, V140, P689, DOI 10.1242/dev.080614; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Lin SB, 2013, STEM CELLS, V31, P823, DOI 10.1002/stem.1319; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Mourikis P, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-2; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; Nagao K, 2012, STEM CELLS, V30, P1781, DOI 10.1002/stem.1153; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Pruessmeyer J, 2009, SEMIN CELL DEV BIOL, V20, P164, DOI 10.1016/j.semcdb.2008.09.005; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Saito K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054853; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Yoda M, 2011, BLOOD, V118, P6939, DOI 10.1182/blood-2011-06-357210	47	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28456	28464		10.1074/jbc.M115.653477	http://dx.doi.org/10.1074/jbc.M115.653477			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26453297	Green Published, hybrid			2022-12-28	WOS:000365761900039
J	Agamasu, C; Ghanam, RH; Saad, JS				Agamasu, Constance; Ghanam, Ruba H.; Saad, Jamil S.			Structural and Biophysical Characterization of the Interactions between Calmodulin and the Pleckstrin Homology Domain of Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; TARGET RECOGNITION; ANALYTICAL ULTRACENTRIFUGATION; NMR-SPECTROSCOPY; BINDING DOMAIN; KINASE; CANCER; ACTIVATION; DIVERSITY; PROTEINS	The translocation of Akt, a serine/threonine kinase, to the plasma membrane is a critical step in the Akt activation pathway. It is established that membrane binding of Akt is mediated by direct interactions between its pleckstrin homology domain (PHD) and phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P-3). There is now evidence that Akt activation in many breast cancer cells is also modulated by the calcium-binding protein, calmodulin (CaM). Upon EGF stimulation of breast cancer cells, CaM co-localizes with Akt at the plasma membrane to enhance activation. However, the molecular details of Akt(PHD) interaction with CaM are not known. In this study, we employed NMR, biochemical, and biophysical techniques to characterize CaM binding to Akt(PHD). Our data show that CaM forms a tight complex with the PHD of Akt (dissociation constant = 100 nm). The interaction between CaM and Akt(PHD) is enthalpically driven, and the affinity is greatly dependent on salt concentration, indicating that electrostatic interactions are important for binding. The CaM-binding interface in Akt(PHD) was mapped to two loops adjacent to the PI(3,4,5)P-3 binding site, which represents a rare CaM-binding motif and suggests a synergistic relationship between CaM and PI(3,4,5)P-3 upon Akt activation. Elucidation of the mechanism by which Akt interacts with CaM will help in understanding the activation mechanism, which may provide insights for new potential targets to control the pathophysiological processes of cell survival.	[Agamasu, Constance; Ghanam, Ruba H.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Saad, JS (corresponding author), 845 19th St S, Birmingham, AL 35294 USA.	saad@uab.edu		Saad, Jamil/0000-0001-9503-6484	comprehensive cancer center at the University of Alabama at Birmingham (National Institutes of Health (NIH), NCI) [P30 CA013148]; comprehensive cancer center at the University of Alabama at Birmingham [1S10RR026478]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026478] Funding Source: NIH RePORTER	comprehensive cancer center at the University of Alabama at Birmingham (National Institutes of Health (NIH), NCI); comprehensive cancer center at the University of Alabama at Birmingham; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a pilot grant (to J. S. S.) from the comprehensive cancer center at the University of Alabama at Birmingham (supported by National Institutes of Health (NIH), NCI, Grant P30 CA013148). The highfield NMR facility and the x-ray core facility that houses the Auto-ITC<INF>200</INF> (acquired through NIH Grant 1S10RR026478) are supported by the comprehensive cancer center at the University of Alabama at Birmingham. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Auguin D, 2004, J BIOMOL NMR, V28, P137, DOI 10.1023/B:JNMR.0000013836.62154.c2; Boyken SE, 2012, PROTEIN SCI, V21, P1288, DOI 10.1002/pro.2114; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Coticchia CM, 2009, BREAST CANCER RES TR, V115, P545, DOI 10.1007/s10549-008-0097-z; Cristiano BE, 2006, CANCER RES, V66, P11718, DOI 10.1158/0008-5472.CAN-06-1968; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Dong B, 2007, J BIOL CHEM, V282, P25131, DOI 10.1074/jbc.M702123200; Fernandez TF, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.471821; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Fushman D, 1997, J MOL BIOL, V266, P173, DOI 10.1006/jmbi.1996.0771; Ghanam RH, 2010, J BIOL CHEM, V285, P41911, DOI 10.1074/jbc.M110.179093; Hayashi N, 2002, PROTEIN SCI, V11, P529, DOI 10.1110/ps.23702; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaliman P, 1996, J BIOL CHEM, V271, P19146, DOI 10.1074/jbc.271.32.19146; KRISHNARAJU K, 1991, BRIT J CANCER, V63, P346, DOI 10.1038/bjc.1991.82; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Majava V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005402; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Meuillet EJ, 2011, CURR MED CHEM, V18, P2727; Miao BC, 2011, AUTOPHAGY, V7, P650, DOI 10.4161/auto.7.6.15248; Mruk K, 2014, J GEN PHYSIOL, V144, P103, DOI 10.1085/jgp.201311140; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Osawa M, 1998, J MOL BIOL, V276, P165, DOI 10.1006/jmbi.1997.1524; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Samal AB, 2011, J BIOL CHEM, V286, P33533, DOI 10.1074/jbc.M111.273623; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SIIVARI K, 1995, FEBS LETT, V366, P104, DOI 10.1016/0014-5793(95)00504-3; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Villarroel A, 2014, J MOL BIOL, V426, P2717, DOI 10.1016/j.jmb.2014.05.016; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang XX, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005147; Xu Q, 2010, J MOL BIOL, V396, P31, DOI 10.1016/j.jmb.2009.11.006; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; Yun SJ, 2009, FEBS LETT, V583, P685, DOI 10.1016/j.febslet.2009.01.005	62	19	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27403	27413		10.1074/jbc.M115.673939	http://dx.doi.org/10.1074/jbc.M115.673939			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26391397	hybrid, Green Published			2022-12-28	WOS:000364794000046
J	Billesbolle, CB; Kruger, MB; Shi, L; Quick, M; Li, Z; Stolzenberg, S; Kniazeff, J; Gotfryd, K; Mortensen, JS; Javitch, JA; Weinstein, H; Loland, CJ; Gether, U				Billesbolle, Christian B.; Kruger, Mie B.; Shi, Lei; Quick, Matthias; Li, Zheng; Stolzenberg, Sebastian; Kniazeff, Julie; Gotfryd, Kamil; Mortensen, Jonas S.; Javitch, Jonathan A.; Weinstein, Harel; Loland, Claus J.; Gether, Ulrik			Substrate-induced Unlocking of the Inner Gate Determines the Catalytic Efficiency of a Neurotransmitter:Sodium Symporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATION; BETA(2) ADRENERGIC-RECEPTOR; CONFORMATIONAL-CHANGES; SEROTONIN TRANSPORTER; DOPAMINE TRANSPORTER; BACTERIAL HOMOLOG; BINDING-SITE; MONOAMINE TRANSPORTERS; ALTERNATING ACCESS; SODIUM SYMPORTERS	Neurotransmitter: sodium symporters (NSSs) mediate reuptake of neurotransmitters from the synaptic cleft and are targets for several therapeutics and psychostimulants. The prokaryotic NSS homologue, LeuT, represents a principal structural model for Na+ coupled transport catalyzed by these proteins. Here, we used site-directed fluorescence quenching spectroscopy to identify in LeuTa substrate-induced conformational rearrangement at the inner gate conceivably leading to formation of a structural intermediate preceding transition to the in ward-open conformation. The substrate induced, Na+-dependent change required an intact primary substrate-binding site and involved increased water exposure of the cytoplasmic end of transmembrane segment 5. The findings were supported by simulations predicting disruption of an intracellular interaction network leading to a discrete rotation of transmembrane segment 5 and the adjacent intracellular loop 2. The magnitude of the spectroscopic response correlated inversely with the transport rate for different substrates, suggesting that stability of the intermediate represents an unrecognized rate-limiting barrier in the NSS transport mechanism.	[Billesbolle, Christian B.; Kruger, Mie B.; Kniazeff, Julie; Gotfryd, Kamil; Mortensen, Jonas S.; Loland, Claus J.; Gether, Ulrik] Univ Copenhagen, Panum Inst, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Shi, Lei; Li, Zheng; Stolzenberg, Sebastian; Weinstein, Harel] Cornell Univ, Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Shi, Lei; Weinstein, Harel] Cornell Univ, Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA	University of Copenhagen; Cornell University; Cornell University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute	Gether, U (corresponding author), Univ Copenhagen, Mol Neuropharmacol & Genet Lab, Dept Neurosci & Pharmacol, Fac Hlth & Med Sci,Panum Inst 18 6, DK-2200 Copenhagen N, Denmark.	gether@sund.ku.dk	Shi, Lei/AAV-1321-2020; Mortensen, Jonas Sigurd/AAP-6768-2020; Regan, Clinton/E-6250-2012; WEINSTEIN, HAREL/O-8245-2019; Mortensen, Jonas S/R-1655-2017; Gourdon, Pontus/E-1076-2014; Loland, Claus/E-5975-2014	Shi, Lei/0000-0002-4137-096X; Mortensen, Jonas Sigurd/0000-0002-6743-276X; WEINSTEIN, HAREL/0000-0003-3473-9818; Gourdon, Pontus/0000-0002-8631-3539; Javitch, Jonathan/0000-0001-7395-2967; Loland, Claus/0000-0002-1773-1446; Gotfryd, Kamil/0000-0002-0299-0779; Gether, Ulrik/0000-0002-0020-3807; Kniazeff, Julie/0000-0002-0426-0999	National Institutes of Health [P01 DA 12408, DA022413, DA17293]; Danish Council for Independent Research-Sapere Aude Program; Lundbeck Foundation Center for Biomembranes in Nanomedicine; UNIK Center for Synthetic Biology; European Community [HEALTH-F4-2007-201924]; Carlsberg Foundation; Bikuben Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000606] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Council for Independent Research-Sapere Aude Program; Lundbeck Foundation Center for Biomembranes in Nanomedicine; UNIK Center for Synthetic Biology; European Community(European Commission); Carlsberg Foundation(Carlsberg Foundation); Bikuben Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants P01 DA 12408 (to U. G. and H. W.), DA022413 (to J. A. J.), and DA17293 (to J. A. J.). This work was also supported by the Danish Council for Independent Research-Sapere Aude Program (to C. J. L.), the Lundbeck Foundation Center for Biomembranes in Nanomedicine (to U. G.), the UNIK Center for Synthetic Biology (to U. G. and C. J. L.), the European Community's Seventh Framework Programme FP7/2007-2013 HEALTH-F4-2007-201924 (to U. G.), The Carlsberg Foundation (to C. J. L.), and the Bikuben Foundation (to C. B. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Dayan O, 2014, J BIOL CHEM, V289, P28172, DOI 10.1074/jbc.M114.589721; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; GETHER U, 1995, J BIOL CHEM, V270, P28268; Gether U, 2006, TRENDS PHARMACOL SCI, V27, P375, DOI 10.1016/j.tips.2006.05.003; Hahn MK, 2007, ANNU REV PHARMACOL, V47, P401, DOI 10.1146/annurev.pharmtox.47.120505.105242; Iversen L, 2006, BRIT J PHARMACOL, V147, pS82, DOI 10.1038/sj.bjp.0706428; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Larsen MB, 2011, J NEUROSCI, V31, P6605, DOI 10.1523/JNEUROSCI.0576-11.2011; LeVine MV, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003603; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; Malinauskaite L, 2014, NAT STRUCT MOL BIOL, V21, P1006, DOI 10.1038/nsmb.2894; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piscitelli CL, 2012, EMBO J, V31, P228, DOI 10.1038/emboj.2011.353; Piscitelli CL, 2010, NATURE, V468, P1129, DOI 10.1038/nature09581; Quick M, 2007, P NATL ACAD SCI USA, V104, P3603, DOI 10.1073/pnas.0609573104; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Rasmussen SGF, 2001, J BIOL CHEM, V276, P4717, DOI 10.1074/jbc.M008067200; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Shi L, 2010, BIOPHYS J, V99, pL103, DOI 10.1016/j.bpj.2010.10.003; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Vastermark A, 2014, PROTEINS, V82, P336, DOI 10.1002/prot.24401; Venkatesan P, 1998, P NATL ACAD SCI USA, V95, P9802, DOI 10.1073/pnas.95.17.9802; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Wang QD, 1997, BIOCHEMISTRY-US, V36, P14120, DOI 10.1021/bi9716433; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yesselman JD, 2012, J COMPUT CHEM, V33, P189, DOI 10.1002/jcc.21963; Zhang Y, 2010, J MOL RECOGNIT, V23, P360, DOI 10.1002/jmr.1002; Zhang YW, 2005, J BIOL CHEM, V280, P30807, DOI 10.1074/jbc.M504087200; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	57	27	27	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26725	26738		10.1074/jbc.M115.677658	http://dx.doi.org/10.1074/jbc.M115.677658			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26363074	hybrid, Green Published			2022-12-28	WOS:000364793600035
J	Prakhar, P; Holla, S; Ghorpade, DS; Gilleron, M; Puzo, G; Udupa, V; Balaji, KN				Prakhar, Praveen; Holla, Sahana; Ghorpade, Devram Sampat; Gilleron, Martine; Puzo, Germain; Udupa, Vibha; Balaji, Kithiganahalli Narayanaswamy			Ac2PIM-responsive miR-150 and miR-143 Target Receptor-interacting Protein Kinase 2 and Transforming Growth Factor Beta-activated Kinase 1 to Suppress NOD2-induced Immunomodulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-CALMETTE-GUERIN; MYCOBACTERIUM-BOVIS BCG; SIGNALING PATHWAYS; PHOSPHATIDYLINOSITOL MANNOSIDES; ACYLATION STATE; INNATE IMMUNITY; IN-VIVO; MURAMYL DIPEPTIDE; SOCS3 EXPRESSION; DENDRITIC CELLS	Specific and coordinated regulation of innate immune receptor-driven signaling networks often determines the net outcome of the immune responses. Here, we investigated the cross-regulation of toll-like receptor (TLR)2 and nucleotide-binding oligomerization domain (NOD)2 pathways mediated by Ac2PIM, a tetra-acylated form of mycobacterial cell wall component and muramyl dipeptide (MDP), a peptidoglycan derivative respectively. While Ac2PIM treatment of macrophages compromised their ability to induce NOD2-dependent immunomodulators like cyclooxygenase (COX)-2, suppressor of cytokine signaling (SOCS)-3, and matrix metalloproteinase (MMP)-9, no change in the NOD2-responsive NO, TNF-alpha, VEGF-A, and IL-12 levels was observed. Further, genome-wide microRNA expression profiling identified Ac2PIM-responsive miR-150 and miR-143 to target NOD2 signaling adaptors, RIP2 and TAK1, respectively. Interestingly, Ac2PIM was found to activate the SRC-FAK-PYK2-CREB cascade via TLR2 to recruit CBP/P300 at the promoters of miR-150 and miR-143 and epigenetically induce their expression. Loss-of-function studies utilizing specific miRNA inhibitors establish that Ac2PIM, via the miRNAs, abrogate NOD2-induced PI3K-PKC delta-MAPK pathway to suppress beta-catenin-mediated expression of COX-2, SOCS-3, and MMP-9. Our investigation has thus underscored the negative regulatory role of Ac2PIM-TLR2 signaling on NOD2 pathway which could broaden our understanding on vaccine potential or adjuvant utilities of Ac2PIM and/or MDP.	[Prakhar, Praveen; Holla, Sahana; Ghorpade, Devram Sampat; Udupa, Vibha; Balaji, Kithiganahalli Narayanaswamy] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Gilleron, Martine; Puzo, Germain] CNRS, IPBS, F-31077 Toulouse, France; [Gilleron, Martine; Puzo, Germain] Univ Toulouse, F-31077 Toulouse, France	Indian Institute of Science (IISC) - Bangalore; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse	Balaji, KN (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	balaji@mcbl.iisc.ernet.in		Holla, Sahana/0000-0001-5186-0180; Prakhar, Praveen/0000-0001-8726-7397	Dept. of Biotechnology (DBT); Dept. of Science and Technology (DST); Council for Scientific and Industrial Research (CSIR); Indian Council of Medical Research (ICMR); Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA); IISc; CSIR	Dept. of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Dept. of Science and Technology (DST)(Department of Science & Technology (India)); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA); IISc; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This study is supported by funds from the Dept. of Biotechnology (DBT), Dept. of Science and Technology (DST), Council for Scientific and Industrial Research (CSIR), Indian Council of Medical Research (ICMR), and Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA). Infrastructure support from ICMR (Center for Advanced Study in Molecular Medicine), DST (FIST) and UGC (special assistance) (to K. N. B.) and fellowship from IISc (to P. P. and S. H.) and CSIR (to D. S. G.) are acknowledged. The authors declare that they have no conflicts of interest with the contents of this article.	Abdullah Z, 2014, EMBO J, V33, P2283, DOI 10.15252/embj.201489055; Juarez-Verdayes MA, 2013, GRAEF ARCH CLIN EXP, V251, P53, DOI 10.1007/s00417-012-2130-5; Bansal K, 2011, J BIOL CHEM, V286, P37032, DOI 10.1074/jbc.M111.260414; Bansal K, 2011, J BIOL CHEM, V286, P5823, DOI 10.1074/jbc.M110.192393; Bansal K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004911; Bansal K, 2009, J LEUKOCYTE BIOL, V85, P804, DOI 10.1189/jlb.0908561; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Beynon V, 2008, INFLAMM BOWEL DIS, V14, P1033, DOI 10.1002/ibd.20441; Brain O, 2013, IMMUNITY, V39, P521, DOI 10.1016/j.immuni.2013.08.035; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Chen KQ, 2008, J LEUKOCYTE BIOL, V83, P1467, DOI 10.1189/jlb.0907607; Cho MK, 2004, BIOCHEM PHARMACOL, V67, P2239, DOI 10.1016/j.bcp.2004.02.024; Court N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024631; Doz E, 2009, J BIOL CHEM, V284, P23187, DOI 10.1074/jbc.M109.037846; Faisal SM, 2011, VACCINE, V29, P2381, DOI 10.1016/j.vaccine.2011.01.110; Gandotra S, 2007, INFECT IMMUN, V75, P5127, DOI 10.1128/IAI.00458-07; Ghorpade DS, 2013, J BIOL CHEM, V288, P33037, DOI 10.1074/jbc.M113.492496; Ghorpade DS, 2013, J BIOL CHEM, V288, P20592, DOI 10.1074/jbc.M113.472183; Ghorpade DS, 2013, MOL CELL BIOL, V33, P543, DOI 10.1128/MCB.01108-12; Ghorpade DS, 2012, MOL CELL BIOL, V32, P2239, DOI 10.1128/MCB.06597-11; Ghorpade DS, 2011, J BIOL CHEM, V286, P31347, DOI 10.1074/jbc.M111.232413; Gilleron M, 2003, J BIOL CHEM, V278, P29880, DOI 10.1074/jbc.M303446200; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Gilleron M, 2001, J BIOL CHEM, V276, P34896, DOI 10.1074/jbc.M103908200; Goodman RH, 2000, GENE DEV, V14, P1553; He ZY, 2013, BIOTECHNOL LETT, V35, P499, DOI 10.1007/s10529-012-1112-3; Holla S, 2014, AUTOPHAGY, V10, P311, DOI 10.4161/auto.27225; Kapoor N, 2010, J IMMUNOL, V184, P3117, DOI 10.4049/jimmunol.0903174; Katsume A, 2011, ARTERIOSCL THROM VAS, V31, P1084, DOI 10.1161/ATVBAHA.110.221804; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kornbluth RS, 2006, J LEUKOCYTE BIOL, V80, P1084, DOI 10.1189/jlb.0306147; Koslowski MJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002523; Landes M. B., 2015, J LEUKOC BIOL; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Nag K, 2009, CURR SIGNAL TRANSD T, V4, P76, DOI 10.2174/157436209788167501; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Narayana Y, 2009, MOL IMMUNOL, V46, P2947, DOI 10.1016/j.molimm.2009.06.019; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Pavot V, 2014, J IMMUNOL, V193, P5781, DOI 10.4049/jimmunol.1402184; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Raisch J, 2013, WORLD J GASTROENTERO, V19, P2985, DOI 10.3748/wjg.v19.i20.2985; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Singh V, 2015, J IMMUNOL, V194, P3351, DOI 10.4049/jimmunol.1402498; Sprott GD, 2004, INFECT IMMUN, V72, P5235, DOI 10.1128/IAI.72.9.5235-5246.2004; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Tan RST, 2014, INT REV IMMUNOL, V33, P443, DOI 10.3109/08830185.2014.921164; Toubiana J, 2015, INNATE IMMUN-LONDON, V21, P685, DOI 10.1177/1753425915586075; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Trinath J, 2014, MOL CELL BIOL, V34, P4301, DOI 10.1128/MCB.00641-14; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; Vergne I, 2015, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00187; Vissers M, 2014, INFECT IMMUN, V82, P4952, DOI 10.1128/IAI.02150-14; Watanabe T, 2005, GUT, V54, P1515, DOI 10.1136/gut.2005.071795; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wedlock DN, 2008, CLIN VACCINE IMMUNOL, V15, P765, DOI 10.1128/CVI.00034-08; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Wu JY, 2015, MOL IMMUNOL, V64, P235, DOI 10.1016/j.molimm.2014.11.021; Yang YC, 2003, J NEUROSCI, V23, P4072; Zhang XY, 2009, HEPATOLOGY, V50, P490, DOI 10.1002/hep.23008; Zhao XY, 2014, STEM CELLS, V32, P521, DOI 10.1002/stem.1543; Zheng SS, 2015, J IMMUNOL, V194, P1928, DOI 10.4049/jimmunol.1401933; Zhou R, 2011, CELL MOL IMMUNOL, V8, P371, DOI 10.1038/cmi.2011.19	70	10	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26576	26586		10.1074/jbc.M115.662817	http://dx.doi.org/10.1074/jbc.M115.662817			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26391398	Green Published, hybrid			2022-12-28	WOS:000364793600024
J	Liu, X; Chen, Z; Ouyang, G; Song, TS; Liang, HG; Liu, W; Xiao, WH				Liu, Xing; Chen, Zhu; Ouyang, Gang; Song, Tieshan; Liang, Huageng; Liu, Wei; Xiao, Wuhan			ELL Protein-associated Factor 2 (EAF2) Inhibits Transforming Growth Factor beta Signaling through a Direct Interaction with Smad3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; NUCLEAR EXPORT; TRANSCRIPTIONAL ACTIVITY; II RECEPTORS; COACTIVATORS; EXPRESSION; CBP/P300; TRANSLOCATION; TRANSDUCTION; CONVERGENCE	A series of in vitro and in vivo studies has shown that EAF2 can affect multiple signaling pathways involved in cellular processes. However, the molecular mechanisms underlying its effects have remained elusive. Here we report the discovery of a new functional link between EAF2 and TGF-beta signaling. Promoter reporter assays indicated that EAF2 suppresses Smad3 transcriptional activity, resulting in inhibition of TGF-beta signaling. Coimmunoprecipitation assays showed that EAF2 specifically interacts with Smad3 in vitro and in vivo but not with other Smad proteins. In addition, we observed that EAF2 binding does not alter Smad3 phosphorylation but causes Smad3 cytoplasmic retention, competes with Smad4 for binding to Smad3, and prevents p300-Smad3 complex formation. Furthermore, we demonstrated that EAF2 suppresses both TGF-beta -induced G(1) cell cycle arrest and TGF-beta -induced cell migration. This study identifies and characterizes a novel repressor of TGF-beta signaling.	[Liu, Xing; Chen, Zhu; Ouyang, Gang; Liu, Wei; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China; [Chen, Zhu] Maternal & Child Hlth Hosp Hubei Prov, Dept Reprod, Wuhan 430070, Peoples R China; [Song, Tieshan] Hubei Univ Sci & Technol, Xianning 437100, Peoples R China; [Liang, Huageng] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Urol, Wuhan 430030, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Hubei University of Science & Technology; Huazhong University of Science & Technology	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China.	w-xiao@ihb.ac.cn	Xiao, Wuhan/GLU-7352-2022		CAS Major Scientific and Technological Project [XDA08010208]; NSFC (National Natural Science Foundation of China) [31461163003, 31071212, 91019008, 31401072, 81160266/H1603]	CAS Major Scientific and Technological Project; NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC))	This work is supported by CAS Major Scientific and Technological Project XDA08010208 and NSFC (National Natural Science Foundation of China) Grants 31461163003, 31071212, and 91019008 (to W. X.), 31401072 (to X. L.), and 81160266/H1603 (to T. S.). The authors declared that they have no conflict of interest to this work.	Bai RY, 2002, NAT CELL BIOL, V4, P181, DOI 10.1038/ncb753; Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; Chen Q, 2012, CLIN CANCER RES, V18, P5520, DOI 10.1158/1078-0432.CCR-11-2904; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen Z, 2014, MOL CELL BIOL, V34, P1085, DOI 10.1128/MCB.00718-13; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; Dai FY, 2007, MOL CELL BIOL, V27, P6183, DOI 10.1128/MCB.00132-07; Dai FY, 2011, EMBO REP, V12, P1175, DOI 10.1038/embor.2011.174; Dai FY, 2009, DEV CELL, V16, P345, DOI 10.1016/j.devcel.2009.01.022; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; FENG XH, 1995, J BIOL CHEM, V270, P24237, DOI 10.1074/jbc.270.41.24237; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; Imoto S, 2008, BIOCHEM BIOPH RES CO, V370, P359, DOI 10.1016/j.bbrc.2008.03.116; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Kim RH, 2000, GENE DEV, V14, P1605; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Li XM, 2006, J BIOL CHEM, V281, P23748, DOI 10.1074/jbc.M508365200; Liu JX, 2013, DEVELOPMENT, V140, P1067, DOI 10.1242/dev.086157; Liu JX, 2009, J BIOL CHEM, V284, P16679, DOI 10.1074/jbc.M109.009654; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Mori N, 2001, BLOOD, V97, P2137, DOI 10.1182/blood.V97.7.2137; OKADOME T, 1994, J BIOL CHEM, V269, P30753; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Simone F, 2003, BLOOD, V101, P2355, DOI 10.1182/blood-2002-06-1664; Simone F, 2001, BLOOD, V98, P201, DOI 10.1182/blood.V98.1.201; Suh JH, 2006, J BIOL CHEM, V281, P39169, DOI 10.1074/jbc.M605947200; Sun HQ, 2010, J BIOL CHEM, V285, P4243, DOI 10.1074/jbc.M109.079533; THIRMAN MJ, 1994, P NATL ACAD SCI USA, V91, P12110, DOI 10.1073/pnas.91.25.12110; Topper JN, 1998, P NATL ACAD SCI USA, V95, P9506, DOI 10.1073/pnas.95.16.9506; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; VIVIEN D, 1995, J BIOL CHEM, V270, P7134, DOI 10.1074/jbc.270.13.7134; Wesolowska A, 2008, ONCOGENE, V27, P918, DOI 10.1038/sj.onc.1210683; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Xiao WH, 2003, CANCER RES, V63, P4698; Xiao WH, 2009, CANCER RES, V69, P2599, DOI 10.1158/0008-5472.CAN-08-2595; Xiao Z, 2000, P NATL ACAD SCI USA, V97, P7853, DOI 10.1073/pnas.97.14.7853; Xiao Z, 2000, J BIOL CHEM, V275, P23425, DOI 10.1074/jbc.C000345200; Xu L, 2003, J BIOL CHEM, V278, P42569, DOI 10.1074/jbc.M307601200; Yanagi Y, 1999, J BIOL CHEM, V274, P12971, DOI 10.1074/jbc.274.19.12971; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; Zhang L, 2012, NAT CELL BIOL, V14, P717, DOI 10.1038/ncb2522; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814; Zhao X, 2008, J BIOL CHEM, V283, P3272, DOI 10.1074/jbc.M708033200	53	7	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25933	25945		10.1074/jbc.M115.663542	http://dx.doi.org/10.1074/jbc.M115.663542			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26370086	Green Published, hybrid			2022-12-28	WOS:000363527300016
J	Singhal, A; Arora, G; Virmani, R; Kundu, P; Khanna, T; Sajid, A; Misra, R; Joshi, J; Yadav, V; Samanta, S; Saini, N; Pandey, AK; Visweswariah, SS; Hentschker, C; Becher, D; Gerth, U; Singh, Y				Singhal, Anshika; Arora, Gunjan; Virmani, Richa; Kundu, Parijat; Khanna, Tanya; Sajid, Andaleeb; Misra, Richa; Joshi, Jayadev; Yadav, Vikas; Samanta, Sintu; Saini, Neeru; Pandey, Amit K.; Visweswariah, Sandhya S.; Hentschker, Christian; Becher, Doerte; Gerth, Ulf; Singh, Yogendra			Systematic Analysis of Mycobacterial Acylation Reveals First Example of Acylation-mediated Regulation of Enzyme Activity of a Bacterial Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; L-HOMOCYSTEINE HYDROLASE; ACETYL-COA SYNTHETASE; X-RAY-STRUCTURE; LYSINE ACETYLATION; PROPIONATE METABOLISM; POSTTRANSLATIONAL MODIFICATIONS; FUNCTIONAL-CHARACTERIZATION; REVERSIBLE ACETYLATION; METHYLCITRATE CYCLE	Protein lysine acetylation is known to regulate multiple aspects of bacterial metabolism. However, its presence in mycobacterial signal transduction and virulence-associated proteins has not been studied. In this study, analysis of mycobacterial proteins from different cellular fractions indicated dynamic and widespread occurrence of lysine acetylation. Mycobacterium tuberculosis proteins regulating diverse physiological processes were then selected and expressed in the surrogate host Mycobacterium smegmatis. The purified proteins were analyzed for the presence of lysine acetylation, leading to the identification of 24 acetylated proteins. In addition, novel lysine succinylation and propionylation events were found to co-occur with acetylation on several proteins. Protein-tyrosine phosphatase B (PtpB), a secretory phosphatase that regulates phosphorylation of host proteins and plays a critical role in Mycobacterium infection, is modified by acetylation and succinylation at Lys-224. This residue is situated in a lid region that covers the enzyme's active site. Consequently, acetylation and succinylation negatively regulate the activity of PtpB.	[Singhal, Anshika; Arora, Gunjan; Virmani, Richa; Kundu, Parijat; Khanna, Tanya; Sajid, Andaleeb; Misra, Richa; Joshi, Jayadev; Yadav, Vikas; Saini, Neeru; Singh, Yogendra] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India; [Arora, Gunjan; Pandey, Amit K.] Translat Hlth Sci & Technol Inst, Faridabad 121001, India; [Samanta, Sintu; Visweswariah, Sandhya S.] Indian Inst Sci, Bangalore 560012, Karnataka, India; [Hentschker, Christian; Becher, Doerte; Gerth, Ulf] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, D-17487 Greifswald, Germany	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Indian Institute of Science (IISC) - Bangalore; Ernst Moritz Arndt Universitat Greifswald	Pandey, AK (corresponding author), Translat Hlth Sci & Technol Inst, Faridabad 121001, India.	amitpandey@thsti.res.in	Arora, Gunjan/AAL-3448-2020; Visweswariah, Sandhya/Q-7500-2019; yadav, vikas/AAZ-7364-2021; Misra, Richa/AAE-6257-2019; Sajid, Andaleeb/AAI-2960-2020; Joshi, Jayadev/AHD-1520-2022; Misra, Richa/B-3860-2018; Becher, Dorte/B-4454-2015	Arora, Gunjan/0000-0003-0575-6205; Visweswariah, Sandhya/0000-0003-2786-7344; yadav, vikas/0000-0003-4353-3731; Sajid, Andaleeb/0000-0001-6248-4985; Misra, Richa/0000-0003-3630-827X; Singhal, Anshika/0000-0001-7932-5809; Kundu, Parijat/0000-0003-1944-4579; Becher, Dorte/0000-0002-9630-5735	Department of Biotechnology, Government of India [BT/PR6556/GBD/27/459/2012, BT/RLF/Re-entry/45/2011]; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research [BSC-0123]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Department of Biotechnology, Government of India, Grants BT/PR6556/GBD/27/459/2012 and BT/RLF/Re-entry/45/2011 (to A. K. P.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Department of Biotechnology, Government of India.; Recipient of support from Council of Scientific and Industrial Research-funded Project BSC-0123.	Arora G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003315; Arora G, 2013, BIOMETALS, V26, P715, DOI 10.1007/s10534-013-9646-y; Arora G, 2012, J BIOL CHEM, V287, P26749, DOI 10.1074/jbc.M112.351304; Arora G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010772; Bach H, 2009, BIOCHEM J, V420, P155, DOI 10.1042/BJ20090478; Bernal V, 2014, NEW BIOTECHNOL, V31, P586, DOI 10.1016/j.nbt.2014.03.002; Beste DJV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002091; Bhaduri A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088090; Bonn F, 2014, ANAL CHEM, V86, P7421, DOI 10.1021/ac501189j; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Canova MJ, 2014, J BIOL CHEM, V289, P9473, DOI 10.1074/jbc.R113.529917; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Connor SE, 2011, ACTA CRYSTALLOGR D, V67, P1017, DOI 10.1107/S0907444911042971; COOPER JB, 1995, J MOL BIOL, V246, P531, DOI 10.1006/jmbi.1994.0105; Corrales RM, 2013, BIOCHEM BIOPH RES CO, V430, P858, DOI 10.1016/j.bbrc.2012.11.038; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Crosby HA, 2012, J BIOL CHEM, V287, P15590, DOI 10.1074/jbc.M112.352104; Ecco G, 2010, CHEM COMMUN, V46, P7501, DOI 10.1039/c0cc01704c; Ferraris DM, 2015, PROTEINS, V83, P389, DOI 10.1002/prot.24743; Festa RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008589; Gould TA, 2006, MOL MICROBIOL, V61, P940, DOI 10.1111/j.1365-2958.2006.05297.x; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Grundner C, 2005, STRUCTURE, V13, P1625, DOI 10.1016/j.str.2005.07.017; Gu J, 2009, BIOCHEMISTRY-MOSCOW+, V74, P743, DOI 10.1134/S0006297909070062; Gupta M, 2014, J BACTERIOL, V196, P2646, DOI 10.1128/JB.01625-14; Hayden JD, 2013, MICROBIOL-SGM, V159, P1986, DOI 10.1099/mic.0.068585-0; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Henriksson LM, 2004, EUR J BIOCHEM, V271, P4107, DOI 10.1111/j.1432-1033.2004.04348.x; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jayachandran R, 2012, EXPERT REV ANTI-INFE, V10, P1007, DOI [10.1586/ERI.12.95, 10.1586/eri.12.95]; Jeffers V, 2012, EUKARYOT CELL, V11, P735, DOI 10.1128/EC.00088-12; Kim D, 2013, PROTEOMICS, V13, P1726, DOI 10.1002/pmic.201200001; Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307; Koul A, 2000, J BACTERIOL, V182, P5425, DOI 10.1128/JB.182.19.5425-5432.2000; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee DW, 2013, PROTEOMICS, V13, P2278, DOI 10.1002/pmic.201200072; Lee S, 2013, TOX RESEARCH, V29, P81, DOI 10.5487/TR.2013.29.2.081; Lee W, 2013, J BIOL CHEM, V288, P6788, DOI 10.1074/jbc.M112.445056; Liu FY, 2014, MOL CELL PROTEOMICS, V13, P3352, DOI 10.1074/mcp.M114.041962; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Miao J, 2013, MOL MICROBIOL, V89, P660, DOI 10.1111/mmi.12303; Minguez P, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.31; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Nambi S, 2013, J BIOL CHEM, V288, P14114, DOI 10.1074/jbc.M113.463992; Nambi S, 2010, J BIOL CHEM, V285, P24313, DOI 10.1074/jbc.M110.118398; Noens EE, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-27; Norris KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe76; Noy T, 2014, ARCH BIOCHEM BIOPHYS, V550, P42, DOI 10.1016/j.abb.2014.04.004; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Okanishi H, 2013, J PROTEOME RES, V12, P3952, DOI 10.1021/pr400245k; Parandhaman DK, 2014, LIFE SCI, V109, P116, DOI 10.1016/j.lfs.2014.06.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podobnik M, 2014, J BIOL CHEM, V289, P16588, DOI 10.1074/jbc.M114.560086; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Reddy MCM, 2008, PROTEIN SCI, V17, P2134, DOI 10.1110/ps.038125.108; Rhee KY, 2005, P NATL ACAD SCI USA, V102, P467, DOI 10.1073/pnas.0406133102; Sajid A, 2011, J BACTERIOL, V193, P5347, DOI 10.1128/JB.05469-11; Sajid A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017871; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104; Sharma V, 2000, NAT STRUCT BIOL, V7, P663, DOI 10.1038/77964; Singh DK, 2014, APPL MICROBIOL BIOT, V98, P10065, DOI 10.1007/s00253-014-5859-4; Singh R, 2003, MOL MICROBIOL, V50, P751, DOI 10.1046/j.1365-2958.2003.03712.x; Singhal A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02264; Sol EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050545; Still AJ, 2013, J BIOL CHEM, V288, P26209, DOI 10.1074/jbc.M113.483396; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; van Noort V, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.4; Vetting MW, 2008, ACTA CRYSTALLOGR F, V64, P978, DOI 10.1107/S1744309108031679; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Wu X, 2013, J PROTEOMICS, V79, P60, DOI 10.1016/j.jprot.2012.12.001; Xie LX, 2015, INT J BIOCHEM CELL B, V59, P193, DOI 10.1016/j.biocel.2014.11.010; Xie LX, 2015, J PROTEOME RES, V14, P107, DOI 10.1021/pr500859a; Xu H, 2011, BIOCHEMISTRY-US, V50, P5883, DOI 10.1021/bi200156t; Xue B, 2013, MOL BIOSYST, V9, P645, DOI 10.1039/c3mb25517d; Yadav V, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1560-y; Yang MK, 2015, MOL CELL PROTEOMICS, V14, P796, DOI 10.1074/mcp.M114.045922; Yu BJ, 2008, J MICROBIOL BIOTECHN, V18, P1529; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang K, 2009, J PROTEOME RES, V8, P900, DOI 10.1021/pr8005155; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI 10.1038/NCHEMBIO.495; Zhou B, 2010, P NATL ACAD SCI USA, V107, P4573, DOI 10.1073/pnas.0909133107; Zhou PF, 2015, FEBS LETT, V589, P326, DOI 10.1016/j.febslet.2014.12.015	98	31	31	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26218	+		10.1074/jbc.M115.687269	http://dx.doi.org/10.1074/jbc.M115.687269			26	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26350458	hybrid, Green Published			2022-12-28	WOS:000363527300039
J	Yesildag, B; Bock, T; Herrmanns, K; Wollscheid, B; Stoffel, M				Yesildag, Burcak; Bock, Thomas; Herrmanns, Karolin; Wollscheid, Bernd; Stoffel, Markus			Kin of IRRE-like Protein 2 Is a Phosphorylated Glycoprotein That Regulates Basal Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; KIDNEY SLIT DIAPHRAGM; SRC-FAMILY KINASE; MOLECULE N-CAM; E-CADHERIN; ISLET CELLS; NEPHRIN; ADHESION; RELEASE; PODOCYTES	Direct interactions among pancreatic beta-cells via cell surface proteins inhibit basal and enhance stimulated insulin secretion. Here, we functionally and biochemically characterized Kirrel2, an immunoglobulin superfamily protein with beta-cell-specific expression in the pancreas. Our results show that Kirrel2 is a phosphorylated glycoprotein that co-localizes and interacts with the adherens junction proteins E-cadherin and beta-catenin in MIN6 cells. We further demonstrate that the phosphosites Tyr(595-596) are functionally relevant for the regulation of Kirrel2 stability and localization. Analysis of the extracellular and intracellular domains of Kirrel2 revealed that it is cleaved and shed from MIN6 cells and that the remaining membrane spanning cytoplasmic domain is processed by gamma-secretase complex. Kirrel2 knockdown with RNA interference in MIN6 cells and ablation of Kirrel2 from mice with genetic deletion resulted in increased basal insulin secretion from beta-cells, with no immediate influence on stimulated insulin secretion, total insulin content, or whole body glucose metabolism. Our results show that in pancreatic beta-cells Kirrel2 localizes to adherens junctions, is regulated by multiple post-translational events, including glycosylation, extracellular cleavage, and phosphorylation, and engages in the regulation of basal insulin secretion.	[Yesildag, Burcak; Herrmanns, Karolin; Stoffel, Markus] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, CH-8093 Zurich, Switzerland; [Bock, Thomas; Wollscheid, Bernd; Stoffel, Markus] Swiss Fed Inst Technol Zurich, Inst Mol Syst Biol, Dept Hlth Sci & Technol, CH-8093 Zurich, Switzerland; [Stoffel, Markus] Univ Zurich, Fac Med, CH-8091 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva; University of Zurich	Stoffel, M (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, Otto Stern Weg 7,HPL H36, CH-8093 Zurich, Switzerland.	stoffel@biol.ethz.ch	Wollscheid, Bernd/E-8909-2010	Wollscheid, Bernd/0000-0002-3923-1610; Bock, Thomas Klaus Christian/0000-0002-9314-5318; Stoffel, Markus/0000-0003-1304-5817				Aaltonen P, 2007, NEPHROL DIAL TRANSPL, V22, P3408, DOI 10.1093/ndt/gfm403; Akerblom B, 2007, MOL CELL ENDOCRINOL, V270, P73, DOI 10.1016/j.mce.2007.02.009; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Bock T, 2012, J PROTEOME RES, V11, P4885, DOI 10.1021/pr300360a; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Calabrese A, 2004, EXP CELL RES, V294, P379, DOI 10.1016/j.yexcr.2003.12.007; Charollais A, 2000, J CLIN INVEST, V106, P235, DOI 10.1172/JCI9398; Cheng HY, 2007, AM J PHYSIOL-ENDOC M, V292, pE845, DOI 10.1152/ajpendo.00103.2006; CIRULLI V, 1994, J CELL SCI, V107, P1429; Collino F, 2008, AM J PHYSIOL-RENAL, V294, pF1185, DOI 10.1152/ajprenal.00442.2007; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dahl U, 1996, DEVELOPMENT, V122, P2895; Dhanvantari S, 2002, BIOCHEMISTRY-US, V41, P52, DOI 10.1021/bi015698n; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; Esterhazy D, 2012, BIOL CHEM, V393, P473, DOI 10.1515/hsz-2012-0104; Fornoni A, 2010, DIABETES, V59, P190, DOI 10.2337/db09-0655; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Gerke P, 2005, J AM SOC NEPHROL, V16, P1693, DOI 10.1681/ASN.2004060439; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; HALBAN PA, 1982, ENDOCRINOLOGY, V111, P86, DOI 10.1210/endo-111-1-86; Harita Y, 2008, J BIOL CHEM, V283, P9177, DOI 10.1074/jbc.M707247200; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Heikkila E, 2011, BIOCHEM J, V435, P619, DOI 10.1042/BJ20101599; Hodson DJ, 2013, J CLIN INVEST, V123, P4182, DOI 10.1172/JCI68459; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Jaques F, 2008, ENDOCRINOLOGY, V149, P2494, DOI 10.1210/en.2007-0974; Jeon J, 2009, J HISTOCHEM CYTOCHEM, V57, P811, DOI 10.1369/jhc.2009.953307; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kapodistria K, 2015, MOL CELL ENDOCRINOL, V400, P112, DOI 10.1016/j.mce.2014.11.003; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Lal M, 2011, PHYSIOLOGY, V26, P34, DOI 10.1152/physiol.00028.2010; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Meda P, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/621249; Olofsson CS, 2009, ENDOCRINOLOGY, V150, P3067, DOI 10.1210/en.2008-0475; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; PIPELEERS DG, 1992, DIABETES, V41, P777, DOI 10.2337/diabetes.41.7.777; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Qin XS, 2009, J AM SOC NEPHROL, V20, P2534, DOI 10.1681/ASN.2009010011; Rantanen M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016142.29721.22; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Rinta-Valkama J, 2007, MOL CELL BIOCHEM, V294, P117, DOI 10.1007/s11010-006-9251-2; Rinta-Valkama J, 2007, DIABETES-METAB RES, V23, P119, DOI 10.1002/dmrr.655; Ristola M, 2014, CLIN SCI, V126, P315, DOI 10.1042/CS20130258; Rogers GJ, 2007, CELL PHYSIOL BIOCHEM, V20, P987, DOI 10.1159/000110459; ROUILLER DG, 1991, DEV BIOL, V148, P233, DOI 10.1016/0012-1606(91)90332-W; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; SALOMON D, 1986, EXP CELL RES, V162, P507, DOI 10.1016/0014-4827(86)90354-X; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Serre-Beinier V, 2000, DIABETES, V49, P727, DOI 10.2337/diabetes.49.5.727; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Speier S, 2007, DIABETES, V56, P1078, DOI 10.2337/db06-0232; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Stutzer I, 2012, DIABETOLOGIA, V55, P1877, DOI 10.1007/s00125-012-2531-3; Sun C, 2003, GENOMICS, V82, P130, DOI 10.1016/S0888-7543(03)00110-1; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; VOZZI C, 1995, J CELL BIOL, V131, P1561, DOI 10.1083/jcb.131.6.1561; Wellershaus K, 2008, EXP CELL RES, V314, P997, DOI 10.1016/j.yexcr.2007.12.024; Yoder SM, 2014, J BIOL CHEM, V289, P11476, DOI 10.1074/jbc.M114.559328	71	8	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25891	25906		10.1074/jbc.M115.684704	http://dx.doi.org/10.1074/jbc.M115.684704			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26324709	hybrid, Green Published			2022-12-28	WOS:000363527300013
J	Johnson, RM; Vu, NT; Griffin, BP; Gentry, AE; Archer, KJ; Chalfant, CE; Park, MA				Johnson, Ryan M.; Vu, Ngoc T.; Griffin, Brian P.; Gentry, Amanda E.; Archer, Kellie J.; Chalfant, Charles E.; Park, Margaret A.			The Alternative Splicing of Cytoplasmic Polyadenylation Element Binding Protein 2 Drives Anoikis Resistance and the Metastasis of Triple Negative Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; C-BETA-II; TRANSLATIONAL CONTROL; CELL-LINES; EXPRESSION; PATHWAY; PHOSPHORYLATION; OSTEOPONTIN; AUTOPHAGY; SURVIVAL	Triple negative breast cancer (TNBC) represents an anomalous subset of breast cancer with a greatly reduced (30%) 5-year survival rate. The enhanced mortality and morbidity of TNBC arises from the high metastatic rate, which requires the acquisition of AnR, a process whereby anchorage-dependent cells become resistant to cell death induced by detachment. In this study TNBC cell lines were selected for AnR, and these cell lines demonstrated dramatic enhancement in the formation of lung metastases as compared with parental cells. Genetic analysis of the AnR subclones versus parental cells via next generation sequencing and analysis of global alternative RNA splicing identified that the mRNA splicing of cytoplasmic polyadenylation element binding 2 (CPEB2), a translational regulator, was altered in AnR TNBC cells. Specifically, increased inclusion of exon 4 into the mature mRNA to produce the CPEB2B isoform was observed in AnR cell lines. Molecular manipulations of CPEB2 splice variants demonstrated a key role for this RNA splicing event in the resistance of cells to anoikis. Specifically, down-regulation of the CPEB2B isoform using siRNA re-sensitized the AnR cell lines to detachment-induced cell death. The ectopic expression of CPEB2B in parental TNBC cell lines induced AnR and dramatically increased metastatic potential. Importantly, alterations in the alternative splicing of CPEB2 were also observed in human TNBC and additional subtypes of human breast cancer tumors linked to a high metastatic rate. Our findings demonstrate that the regulation of CPEB2 mRNA splicing is a key mechanism in AnR and a driving force in TNBC metastasis.	[Johnson, Ryan M.; Vu, Ngoc T.; Griffin, Brian P.; Chalfant, Charles E.; Park, Margaret A.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Vu, Ngoc T.] Vietnam Educ Fdn, Arlington, VA 22201 USA; [Gentry, Amanda E.; Archer, Kellie J.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Archer, Kellie J.] Virginia Commonwealth Univ, Massey Canc Ctr Biostat Shared Resource, Richmond, VA 23298 USA; [Archer, Kellie J.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23298 USA; [Chalfant, Charles E.; Park, Margaret A.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Chalfant, Charles E.] Hunter Holmes McGuire Vet Affairs Med Ctr, Res & Dev, Richmond, VA 23224 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Inst Mol Med, Richmond, VA 23298 USA; [Chalfant, Charles E.] Virginia Commonwealth Univ, Johnson Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; Virginia Commonwealth University	Chalfant, CE (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sanger Hall,Rm 2-016, Richmond, VA 23298 USA.	cechalfant@vcu.edu; mpark4@vcu.edu		Archer, Kellie/0000-0003-1555-5781	NCI, National Institutes of Health Cancer Center [P30 CA016059]; NATIONAL CANCER INSTITUTE [R01CA154314, P30CA016059] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000057, UL1TR000058] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA026119] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011169] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001792] Funding Source: NIH RePORTER	NCI, National Institutes of Health Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Veterans Affairs(US Department of Veterans Affairs)	Services (Biostatistics Shared Resource Core, Flow Cytometry Shared Resource Core, TDAAC) and products in support of the research project were generated by the VCU Massey Cancer Center supported, in part, with funding from NCI, National Institutes of Health Cancer Center Support Grant P30 CA016059. We acknowledge Dr. Jenn Mietla and Dr. L. Alexis Hoeferlin for tireless efforts in editing this manuscript. In addition, we acknowledge Dr. Kazuake Takabe for great help with interpreting lung metastasis data.	Afroz T, 2014, GENE DEV, V28, P1498, DOI 10.1101/gad.241133.114; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Bava FA, 2013, NATURE, V495, P121, DOI 10.1038/nature11901; Belloc E, 2008, NATURE, V452, P1017, DOI 10.1038/nature06809; Belloc E, 2008, BIOCHEM SOC T, V36, P665, DOI 10.1042/BST0360665; Buchheit CL, 2012, SEMIN CELL DEV BIOL, V23, P402, DOI 10.1016/j.semcdb.2012.04.007; Chang G, 2014, BRIT J CANCER, V110, P916, DOI 10.1038/bjc.2013.809; Chen PJ, 2012, EMBO J, V31, P959, DOI 10.1038/emboj.2011.448; Cooper DR, 1999, ARCH BIOCHEM BIOPHYS, V372, P69, DOI 10.1006/abbi.1999.1472; Cuenca-Lopez MD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-302; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; Drury LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012895; Fernandez-Miranda G, 2012, AGEING RES REV, V11, P460, DOI 10.1016/j.arr.2012.03.004; Gautrey HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051497; Goehe RW, 2010, J CLIN INVEST, V120, P3923, DOI 10.1172/JCI43552; Hagele S, 2009, BIOCHEM J, V417, P235, DOI 10.1042/BJ20081353; Howe EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049987; Hu YY, 2012, ADV EXP MED BIOL, V727, P186, DOI 10.1007/978-1-4614-0899-4_14; Jiang ZF, 2013, ANN ONCOL, V24, P2766, DOI 10.1093/annonc/mdt246; Kandouz M, 2012, CANCER METAST REV, V31, P353, DOI 10.1007/s10555-012-9352-1; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kotiyal S, 2014, BIOCHEM BIOPH RES CO, V453, P112, DOI 10.1016/j.bbrc.2014.09.069; Krawczyk N, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/415721; Kurihara Y, 2003, BIOL REPROD, V69, P261, DOI 10.1095/biolreprod.103.015677; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Marzese DM, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12307; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; Nairismagi ML, 2012, ONCOGENE, V31, P4960, DOI 10.1038/onc.2011.650; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Patel NA, 2001, J BIOL CHEM, V276, P22648, DOI 10.1074/jbc.M101260200; Qin LX, 2014, FRONT MED-PRC, V8, P24, DOI 10.1007/s11684-014-0312-8; Rashid OM, 2014, BREAST CANCER RES TR, V147, P501, DOI 10.1007/s10549-014-3118-0; Rashid OM, 2013, SURGERY, V153, P771, DOI 10.1016/j.surg.2013.02.002; Schmadeka R, 2014, AM J CLIN PATHOL, V141, P462, DOI 10.1309/AJCPQN8GZ8SILKGN; Shen H, 2014, MOL CARCINOGEN, V53, P480, DOI 10.1002/mc.21997; Shultz JC, 2010, CANCER RES, V70, P9185, DOI 10.1158/0008-5472.CAN-10-1545; Sun L, 2014, FUTURE ONCOL, V10, P1387, DOI [10.2217/FON.14.70, 10.2217/fon.14.70]; Turimella SL, 2015, HIPPOCAMPUS, V25, P630, DOI 10.1002/hipo.22399; Vu NT, 2013, J BIOL CHEM, V288, P8575, DOI 10.1074/jbc.M112.443333; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; West NW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-256; Xu YL, 2014, GENE DEV, V28, P1191, DOI 10.1101/gad.241968.114; Yang J, 2013, ANAT REC, V296, P1501, DOI 10.1002/ar.22769	43	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25717	25727		10.1074/jbc.M115.671206	http://dx.doi.org/10.1074/jbc.M115.671206			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26304115	hybrid, Green Published			2022-12-28	WOS:000362962800043
J	Kim, HS; Im, HN; An, DR; Yoon, JY; Jang, JY; Mobashery, S; Hesek, D; Lee, M; Yoo, J; Cui, MH; Choi, S; Kim, C; Lee, NK; Kim, SJ; Kim, JY; Bang, G; Han, BW; Lee, BI; Yoon, HJ; Suh, SW				Kim, Hyoun Sook; Im, Ha Na; An, Doo Ri; Yoon, Ji Young; Jang, Jun Young; Mobashery, Shahriar; Hesek, Dusan; Lee, Mijoon; Yoo, Jakyung; Cui, Minghua; Choi, Sun; Kim, Cheolhee; Lee, Nam Ki; Kim, Soon-Jong; Kim, Jin Young; Bang, Geul; Han, Byung Woo; Lee, Byung Il; Yoon, Hye Jin; Suh, Se Won			The Cell Shape-determining Csd6 Protein from Helicobacter pylori Constitutes a New Family of L,D-Carboxypeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; LD-CARBOXYPEPTIDASE; BACTERIAL PEPTIDOGLYCAN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CROSS-LINKING; MOTILITY; CAMPYLOBACTER; COLONIZATION; RECOGNITION	Helicobacter pylori causes gastrointestinal diseases, including gastric cancer. Its high motility in the viscous gastric mucosa facilitates colonization of the human stomach and depends on the helical cell shape and the flagella. In H. pylori, Csd6 is one of the cell shape-determining proteins that play key roles in alteration of cross-linking or by trimming of peptidoglycan muropeptides. Csd6 is also involved in deglycosylation of the flagellar protein FlaA. To better understand its function, biochemical, biophysical, and structural characterizations were carried out. We show that Csd6 has a three-domain architecture and exists as a dimer in solution. The N-terminal domain plays a key role in dimerization. The middle catalytic domain resembles those of L,D-transpeptidases, but its pocket-shaped active site is uniquely defined by the four loops I to IV, among which loops I and III show the most distinct variations from the known L,D-transpeptidases. Mass analyses confirm that Csd6 functions only as an L,D-carboxypeptidase and not as an L,D-transpeptidase. The D-Ala-complexed structure suggests possible binding modes of both the substrate and product to the catalytic domain. The C-terminal nuclear transport factor 2-like domain possesses a deep pocket for possible binding of pseudaminic acid, and in silico docking supports its role in deglycosylation of flagellin. On the basis of these findings, it is proposed that H. pylori Csd6 and its homologs constitute a new family of L,D-carboxypeptidase. This work provides insights into the function of Csd6 in regulating the helical cell shape and motility of H. pylori.	[Kim, Hyoun Sook; Jang, Jun Young; Yoon, Hye Jin; Suh, Se Won] Seoul Natl Univ, Coll Pharm, Dept Chem, Seoul 151742, South Korea; [Im, Ha Na; An, Doo Ri; Yoon, Ji Young; Suh, Se Won] Seoul Natl Univ, Coll Nat Sci, Dept Biophys & Chem Biol, Seoul 151742, South Korea; [Kim, Hyoun Sook; Han, Byung Woo] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Seoul 151742, South Korea; [Mobashery, Shahriar; Hesek, Dusan; Lee, Mijoon] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Yoo, Jakyung; Cui, Minghua; Choi, Sun] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Coll Pharm, Natl Leading Res Lab Mol Modeling & Drug Design, Seoul 120750, South Korea; [Yoo, Jakyung; Cui, Minghua; Choi, Sun] Ewha Womans Univ, Global Top Res Program 5, Seoul 120750, South Korea; [Kim, Cheolhee; Lee, Nam Ki] POSTECH, Dept Phys, Pohang 790784, South Korea; [Kim, Soon-Jong] Mokpo Natl Univ, Dept Chem, Chungnam 534729, South Korea; [Kim, Jin Young; Bang, Geul] Korea Basic Sci Inst, Div Mass Spectrometry, Chungbuk 363883, South Korea; [Lee, Byung Il] Natl Canc Ctr, Res Inst, Div Convergence Technol, Biomol Funct Res Branch, Gyeonggi 410769, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Notre Dame; Ewha Womans University; Ewha Womans University; Pohang University of Science & Technology (POSTECH); Mokpo National University; Korea Basic Science Institute (KBSI); National Cancer Center - Korea (NCC)	Suh, SW (corresponding author), Seoul Natl Univ, Coll Pharm, Dept Chem, Seoul 151742, South Korea.	yoonhj@snu.ac.kr; sewonsuh@snu.ac.kr	Lee, Mijoon/AFK-1543-2022; Choi, Sun/AAQ-9407-2020; Regan, Clinton/E-6250-2012; Lee, Nam/C-9477-2013	Lee, Mijoon/0000-0001-7432-0427; Choi, Sun/0000-0002-7669-7954	Korea Ministry of Science, ICT and Future Planning, National Research Foundation of Korea [2013R1A2A1A05067303]; Innovative Drug Research Center for Metabolic and Inflammatory Disease [2007-0056817]; Korea Ministry of Health, Welfare and Family Affairs, Korea Healthcare Technology RD Project [A092006]; Ministry of Science, ICT and Future Planning, the National Research Foundation of Korea, National Leading Research Lab Program [2011-0028885]; National Institutes of Health [AI090348]; Korea Ministry of Education [NRF-2012R1A1A2039930]; National Research Foundation of Korea [2014R1A1A3A04050250]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090348] Funding Source: NIH RePORTER	Korea Ministry of Science, ICT and Future Planning, National Research Foundation of Korea(National Research Foundation of Korea); Innovative Drug Research Center for Metabolic and Inflammatory Disease; Korea Ministry of Health, Welfare and Family Affairs, Korea Healthcare Technology RD Project; Ministry of Science, ICT and Future Planning, the National Research Foundation of Korea, National Leading Research Lab Program(National Research Foundation of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Ministry of Education(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Korea Ministry of Science, ICT and Future Planning, National Research Foundation of Korea Grant 2013R1A2A1A05067303, Innovative Drug Research Center for Metabolic and Inflammatory Disease (2007-0056817), the Korea Ministry of Health, Welfare and Family Affairs, Korea Healthcare Technology R&D Project A092006 (to S. W. S.), and by the Ministry of Science, ICT and Future Planning, the National Research Foundation of Korea, National Leading Research Lab Program, Grant 2011-0028885 (to the S. C. laboratory). This work was supported in part by National Institutes of Health Grant AI090348 (to S. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Korea Ministry of Education Grant NRF-2012R1A1A2039930.; Supported by National Research Foundation of Korea Grant 2014R1A1A3A04050250. To whom correspondence may be addressed. Tel.: 82-2-882-3515; E-mail: yoonhj@snu.ac.kr.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; An DR, 2015, ACTA CRYSTALLOGR D, V71, P675, DOI 10.1107/S1399004715000152; Baudron CR, 2013, HELICOBACTER, V18, P44, DOI 10.1111/hel.12077; BERG HC, 1979, NATURE, V278, P349, DOI 10.1038/278349a0; Biarrotte-Sorin S, 2006, J MOL BIOL, V359, P533, DOI 10.1016/j.jmb.2006.03.014; Bielnicki J, 2006, PROTEINS, V62, P144, DOI 10.1002/prot.20702; Bonis M, 2010, MOL MICROBIOL, V78, P809, DOI 10.1111/j.1365-2958.2010.07383.x; Cadby IT, 2014, STRUCTURE, V22, P932, DOI 10.1016/j.str.2014.06.001; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chaput C, 2007, J BACTERIOL, V189, P422, DOI 10.1128/JB.01270-06; Chaput C, 2006, PLOS PATHOG, V2, P844, DOI 10.1371/journal.ppat.0020097; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cordillot M, 2013, ANTIMICROB AGENTS CH, V57, P5940, DOI 10.1128/AAC.01663-13; Costa K, 1999, J BACTERIOL, V181, P3710, DOI 10.1128/JB.181.12.3710-3715.1999; Covaleda G, 2012, J BIOL CHEM, V287, P9250, DOI 10.1074/jbc.M111.330100; Das D, 2013, J BACTERIOL, V195, P5555, DOI 10.1128/JB.00900-13; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Doerks T, 2000, TRENDS BIOCHEM SCI, V25, P317, DOI 10.1016/S0968-0004(00)01599-1; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frirdich E, 2014, J BIOL CHEM, V289, P8007, DOI 10.1074/jbc.M113.491829; Gakhar L, 2005, J BACTERIOL, V187, P7222, DOI 10.1128/JB.187.21.7222-7231.2005; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Guruge JL, 1998, P NATL ACAD SCI USA, V95, P3925, DOI 10.1073/pnas.95.7.3925; Harris BZ, 2002, J BIOL CHEM, V277, P34902, DOI 10.1074/jbc.M205856200; HAZELL SL, 1986, J INFECT DIS, V153, P658, DOI 10.1093/infdis/153.4.658; Hohlbein J, 2014, CHEM SOC REV, V43, P1156, DOI 10.1039/c3cs60233h; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hoyland CN, 2014, STRUCTURE, V22, P949, DOI 10.1016/j.str.2014.04.015; Josenhans C, 2002, FEMS MICROBIOL LETT, V210, P165, DOI 10.1016/S0378-1097(02)00638-9; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim HS, 2014, ACTA CRYSTALLOGR D, V70, P2800, DOI 10.1107/S1399004714018732; Kim HS, 2013, ACTA CRYSTALLOGR D, V69, P420, DOI 10.1107/S0907444912048998; Kim S, 2011, APPL MICROBIOL BIOT, V91, P1, DOI 10.1007/s00253-011-3307-2; Kim SW, 1997, BIOCHEMISTRY-US, V36, P14030, DOI 10.1021/bi971546+; Korza HJ, 2005, J BIOL CHEM, V280, P40802, DOI 10.1074/jbc.M506328200; KOSTRZYNSKA M, 1991, J BACTERIOL, V173, P937, DOI 10.1128/jb.173.3.937-946.1991; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Lee MJ, 2009, J AM CHEM SOC, V131, P8742, DOI 10.1021/ja9025566; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Logan SM, 2006, MICROBIOL-SGM, V152, P1249, DOI 10.1099/mic.0.28735-0; Mainardi JL, 2000, J BIOL CHEM, V275, P16490, DOI 10.1074/jbc.M909877199; Malfertheiner P, 2012, CURR OPIN GASTROEN, V28, P608, DOI 10.1097/MOG.0b013e32835918a7; MCCARTER L, 1990, MOL MICROBIOL, V4, P1057, DOI 10.1111/j.1365-2958.1990.tb00678.x; Medina-Franco JL, 2014, INT J MOL SCI, V15, P3253, DOI 10.3390/ijms15023253; Meroueh SO, 2006, P NATL ACAD SCI USA, V103, P4404, DOI 10.1073/pnas.0510182103; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Motoyama T, 2002, ACTA CRYSTALLOGR D, V58, P148, DOI 10.1107/S0907444901017371; Ottemann KM, 2002, INFECT IMMUN, V70, P1984, DOI 10.1128/IAI.70.4.1984-1990.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Roesler BM, 2014, CLIN MED INSIGHTS-GA, V7, P9, DOI 10.4137/CGast.S13760; Schirm M, 2003, MOL MICROBIOL, V48, P1579, DOI 10.1046/j.1365-2958.2003.03527.x; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Silva JRA, 2014, J CHEM INF MODEL, V54, P2402, DOI 10.1021/ci5003069; Sycuro LK, 2013, MOL MICROBIOL, V90, P869, DOI 10.1111/mmi.12405; Sycuro LK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002603; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Worku ML, 1999, MICROBIOL-SGM, V145, P2803, DOI 10.1099/00221287-145-10-2803; Wyckoff TJ, 2012, TRENDS MICROBIOL, V20, P540, DOI 10.1016/j.tim.2012.08.003; Xu GG, 2009, J MOL BIOL, V386, P828, DOI 10.1016/j.jmb.2008.12.084; Yoo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062152; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	72	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25103	25117		10.1074/jbc.M115.658781	http://dx.doi.org/10.1074/jbc.M115.658781			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26306031	hybrid, Green Published			2022-12-28	WOS:000362598300038
J	Simpson, PD; Eipper, BA; Katz, MJ; Gandara, L; Wappner, P; Fischer, R; Hodson, EJ; Ratcliffe, PJ; Masson, N				Simpson, Peter D.; Eipper, Betty A.; Katz, Maximiliano J.; Gandara, Lautaro; Wappner, Pablo; Fischer, Roman; Hodson, Emma J.; Ratcliffe, Peter J.; Masson, Norma			Striking Oxygen Sensitivity of the Peptidylglycine alpha-Amidating Monooxygenase (PAM) in Neuroendocrine Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; PROLYL HYDROXYLATION; SECRETORY GRANULES; PEPTIDE AMIDATION; JOINING PEPTIDE; ATT-20 CELLS; BIOSYNTHESIS; EXPRESSION; ANIMALS; HIF	Interactions between biological pathways and molecular oxygen require robust mechanisms for detecting and responding to changes in cellular oxygen availability, to support oxygen homeostasis. Peptidylglycine alpha-amidating monooxygenase (PAM) catalyzes a two-step reaction resulting in the C-terminal amidation of peptides, a process important for their stability and biological activity. Here we show that in human, mouse, and insect cells, peptide amidation is exquisitely sensitive to hypoxia. Different amidation events on chromogranin A, and on peptides processed from proopiomelanocortin, manifest similar striking sensitivity to hypoxia in a range of neuroendocrine cells, being progressively inhibited from mild (7% O-2) to severe (1% O-2) hypoxia. In developing Drosophila melanogaster larvae, FMRF amidation in thoracic ventral (Tv) neurons is strikingly suppressed by hypoxia. Our findings have thus defined a novel monooxygenase-based oxygen sensing mechanism that has the capacity to signal changes in oxygen availability to peptidergic pathways.	[Simpson, Peter D.; Hodson, Emma J.; Ratcliffe, Peter J.; Masson, Norma] Univ Oxford, Ctr Cellular & Mol Physiol, Oxford OX3 7BN, England; [Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; [Katz, Maximiliano J.; Gandara, Lautaro; Wappner, Pablo] Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Fischer, Roman] Univ Oxford, Target Discovery Inst, Oxford OX3 7FZ, England	University of Oxford; University of Connecticut; Leloir Institute; University of Oxford	Ratcliffe, PJ (corresponding author), Univ Oxford, Ctr Cellular & Mol Physiol, Oxford OX3 7BN, England.	pjr@well.ox.ac.uk; nmasson@well.ox.ac.uk	Regan, Clinton/E-6250-2012; Fischer, Roman/N-4408-2017	Fischer, Roman/0000-0002-9715-5951; Ratcliffe, Peter/0000-0002-2853-806X; Wappner, Pablo/0000-0003-1517-0742	National Institutes of Health [DK032949]; Ludwig Institute for Cancer Research; Wellcome Trust; British Heart Foundation [RG/11/1/28684] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK032949, R37DK032949, R01DK032949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK032949, Ludwig Institute for Cancer Research, and the Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article.	An ZM, 2012, PROTEOMICS, V12, P173, DOI 10.1002/pmic.201100327; Attenborough RMF, 2012, MOL BIOL EVOL, V29, P3095, DOI 10.1093/molbev/mss114; Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Crippa L, 2013, BLOOD, V121, P392, DOI 10.1182/blood-2012-05-430314; CULLEN EI, 1987, MOL ENDOCRINOL, V1, P583, DOI 10.1210/mend-1-9-583; Czyzyk TA, 2005, DEV BIOL, V287, P301, DOI 10.1016/j.ydbio.2005.09.001; De M, 2007, J BIOL CHEM, V282, P23362, DOI 10.1074/jbc.M702891200; EIPPER BA, 1986, J BIOL CHEM, V261, P8686; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ge W, 2012, NAT CHEM BIOL, V8, P960, DOI [10.1038/NCHEMBIO.1093, 10.1038/nchembio.1093]; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Jiang N, 2000, DEV BIOL, V226, P118, DOI 10.1006/dbio.2000.9832; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Katz MJ, 2014, P NATL ACAD SCI USA, V111, P4025, DOI 10.1073/pnas.1314485111; Knowles HJ, 2003, CANCER RES, V63, P1764; Koshimizu H, 2011, MOL ENDOCRINOL, V25, P732, DOI 10.1210/me.2010-0124; MALTESE JY, 1992, MOL ENDOCRINOL, V6, P1998, DOI 10.1210/me.6.12.1998; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; MERKLER DJ, 1994, ENZYME MICROB TECH, V16, P450, DOI 10.1016/0141-0229(94)90014-0; Merkler DJ, 1999, J AM CHEM SOC, V121, P4904, DOI 10.1021/ja990517e; Michiels C, 2004, AM J PATHOL, V164, P1875, DOI 10.1016/S0002-9440(10)63747-9; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; NOEL G, 1991, MOL ENDOCRINOL, V5, P404, DOI 10.1210/mend-5-3-404; O'Donnell PJ, 2003, J MOL CELL CARDIOL, V35, P915, DOI 10.1016/S0022-2828(03)00171-8; OLDHAM CD, 1992, BIOCHEM BIOPH RES CO, V184, P323, DOI 10.1016/0006-291X(92)91196-W; Orr DF, 2002, PROTEOMICS, V2, P1586, DOI 10.1002/1615-9861(200211)2:11<1586::AID-PROT1586>3.0.CO;2-K; Ortega-Saenz P, 2007, RESP PHYSIOL NEUROBI, V157, P140, DOI 10.1016/j.resp.2007.02.009; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; Ratcliffe PJ, 2013, J PHYSIOL-LONDON, V591, P2027, DOI 10.1113/jphysiol.2013.251470; Ritenour-Rodgers KJ, 2000, BIOCHEM BIOPH RES CO, V267, P521, DOI 10.1006/bbrc.1999.1977; Sharma SD, 2009, J APPL PHYSIOL, V106, P12, DOI 10.1152/japplphysiol.90702.2008; Singleton RS, 2014, P NATL ACAD SCI USA, V111, P4031, DOI 10.1073/pnas.1314482111; Tanaka S, 1997, J HISTOCHEM CYTOCHEM, V45, P425, DOI 10.1177/002215549704500310; Tarhonskaya H, 2014, BIOCHEM J, V463, P363, DOI 10.1042/BJ20140779; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	40	18	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24891	24901		10.1074/jbc.M115.667246	http://dx.doi.org/10.1074/jbc.M115.667246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26296884	Green Published, hybrid			2022-12-28	WOS:000362598300022
J	Lu, SZ; Mott, JL; Harrison-Findik, DD				Lu, Sizhao; Mott, Justin L.; Harrison-Findik, Duygu Dee			Saturated Fatty Acids Induce Post-transcriptional Regulation of HAMP mRNA via AU-rich Element-binding Protein, Human Antigen R (HuR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPCIDIN EXPRESSION; PALMITIC ACID; IRON; LIVER; METABOLISM; ACCUMULATION; TARGET; DELTA; IDENTIFICATION; STABILIZATION	Iron is implicated in fatty liver disease pathogenesis. The human hepcidin gene, HAMP, is the master switch of iron metabolism. The aim of this study is to investigate the regulation of HAMP expression by fatty acids in HepG2 cells. For these studies, both saturated fatty acids (palmitic acid (PA) and stearic acid (SA)) and unsaturated fatty acid (oleic acid (OA)) were used. PA and, to a lesser extent, SA, but not OA, up-regulated HAMP mRNA levels, as determined by real-time PCR. To understand whether PA regulates HAMP mRNA at the transcriptional or post-transcriptional level, the transcription inhibitor actinomycin D was employed. PA-mediated induction of HAMP mRNA expression was not blocked by actinomycin D. Furthermore, PA activated HAMP 3'-UTR, but not promoter, activity, as shown by reporter assays. HAMP 3'-UTR harbors a single AU-rich element (ARE). Mutation of this ARE abolished the effect of PA, suggesting the involvement of ARE-binding proteins. The ARE-binding protein human antigen R (HuR) stabilizes mRNA through direct interaction with AREs on 3'-UTR. HuR is regulated by phosphorylation-mediated nucleo-cytoplasmic shuttling. PA activated this process. The binding of HuR to HAMP mRNA was also induced by PA in HepG2 cells. Silencing of HuR by siRNA abolished PA-mediated up-regulation of HAMP mRNA levels. PKC is known to phosphorylate HuR. Staurosporine, a broad-spectrum PKC inhibitor, inhibited both PA-mediated translocation of HuR and induction of HAMP expression. Similarly, rottlerin, a novel class PKC inhibitor, abrogated PA mediated up-regulation of HAMP expression. In conclusion, lipids mediate post-transcriptional regulation of HAMP through PKC- and HuR-dependent mechanisms.	[Lu, Sizhao; Mott, Justin L.] Univ Nebraska, Dept Biochem & Mol Biol, Med Ctr, Omaha, NE 68198 USA; [Harrison-Findik, Duygu Dee] Univ Nebraska, Div Gastroenterol & Hepatol, Dept Internal Med, Med Ctr, 95820 UNMC, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Harrison-Findik, DD (corresponding author), Univ Nebraska, Div Gastroenterol & Hepatol, Dept Internal Med, Med Ctr, 95820 UNMC, Omaha, NE 68198 USA.	dharrisonfindik@unmc.edu	Regan, Clinton/E-6250-2012	Mott, Justin/0000-0002-2927-6962; Lu, Sizhao/0000-0002-9892-8784	National Institutes of Health [R01AA017738, P20GM104320]; University of Nebraska Medical Center Graduate Assistantship/Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017738] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nebraska Medical Center Graduate Assistantship/Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AA017738 (to D. H.-F.) and P20GM104320 (to J. L. M.). This work was also supported by a University of Nebraska Medical Center Graduate Assistantship/Fellowship (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Aigner E, 2008, AM J CLIN NUTR, V87, P1374, DOI 10.1093/ajcn/87.5.1374; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Castoldi M, 2011, J CLIN INVEST, V121, P1386, DOI 10.1172/JCI44883; Chen CYA, 2008, METHOD ENZYMOL, V448, P335, DOI 10.1016/S0076-6879(08)02617-7; Costantino CL, 2009, CANCER RES, V69, P4567, DOI 10.1158/0008-5472.CAN-09-0371; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; Dasgupta S, 2011, BBA-MOL BASIS DIS, V1812, P495, DOI 10.1016/j.bbadis.2011.01.001; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Doller A, 2008, CELL SIGNAL, V20, P2165, DOI 10.1016/j.cellsig.2008.05.007; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Garcia-Dominguez DJ, 2011, MOL BIOL CELL, V22, P1227, DOI 10.1091/mbc.E10-10-0808; Greene MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085848; Greene MW, 2010, J BIOL CHEM, V285, P42115, DOI 10.1074/jbc.M110.168575; Harrison-Findik DD, 2006, J BIOL CHEM, V281, P22974, DOI 10.1074/jbc.M602098200; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kubitz R, 2004, J BIOL CHEM, V279, P10323, DOI 10.1074/jbc.M306242200; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lal S, 2014, CANCER RES, V74, P1128, DOI 10.1158/0008-5472.CAN-13-1915; Lee JY, 2010, METABOLISM, V59, P927, DOI 10.1016/j.metabol.2009.10.012; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Nelson JE, 2012, HEPATOLOGY, V56, P1730, DOI 10.1002/hep.25856; Nelson James E, 2012, Curr Gastroenterol Rep, V14, P8, DOI 10.1007/s11894-011-0234-4; Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Rizk A, 2014, NAT PROTOC, V9, P586, DOI 10.1038/nprot.2014.037; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Valenti L, 2010, GASTROENTEROLOGY, V138, P905, DOI 10.1053/j.gastro.2009.11.013; Vecchi C, 2010, HEPATOLOGY, V51, P654, DOI 10.1002/hep.23410; Vock C, 2007, BBA-GEN SUBJECTS, V1770, P1283, DOI 10.1016/j.bbagen.2007.07.001; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Yang ZZ, 2009, IUBMB LIFE, V61, P1075, DOI 10.1002/iub.252; Zumbrennen-Bullough KB, 2014, J BIOL CHEM, V289, P23796, DOI 10.1074/jbc.M114.577387	48	12	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24178	24189		10.1074/jbc.M115.648212	http://dx.doi.org/10.1074/jbc.M115.648212			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26304124	hybrid, Green Published			2022-12-28	WOS:000362218900011
J	Simonin, A; Montalbetti, N; Gyimesi, G; Pujol-Gimenez, J; Hediger, MA				Simonin, Alexandre; Montalbetti, Nicolas; Gyimesi, Gergely; Pujol-Gimenez, Jonai; Hediger, Matthias A.			The Hydroxyl Side Chain of a Highly Conserved Serine Residue Is Required for Cation Selectivity and Substrate Transport in the Glial Glutamate Transporter GLT-1/SLC1A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID TRANSPORTER; EXTRACELLULAR GATE; BINDING; HOMOLOG; MECHANISM; SODIUM; FLUXES; GLT-1; NA+; STOICHIOMETRY	Glutamate transporters maintain synaptic concentration of the excitatory neurotransmitter below neurotoxic levels. Their transport cycle consists of cotransport of glutamate with three sodium ions and one proton, followed by countertransport of potassium. Structural studies proposed that a highly conserved serine located in the binding pocket of the homologous Glt(Ph) coordinates L-aspartate as well as the sodium ion Na1. To experimentally validate these findings, we generated and characterized several mutants of the corresponding serine residue, Ser-364, of human glutamate transporter SLC1A2 (solute carrier family 1 member 2), also known as glutamate transporter GLT-1 and excitatory amino acid transporter EAAT2. S364T, S364A, S364C, S364N, and S364D were expressed in HEK cells and Xenopus laevis oocytes to measure radioactive substrate transport and transport currents, respectively. All mutants exhibited similar plasma membrane expression when compared with WT SLC1A2, but substitutions of serine by aspartate or asparagine completely abolished substrate transport. On the other hand, the threonine mutant, which is a more conservative mutation, exhibited similar substrate selectivity, substrate and sodium affinities as WT but a lower selectivity for Na+ over Li+. S364A and S364C exhibited drastically reduced affinities for each substrate and enhanced selectivity for L-aspartate over D-aspartate and L-glutamate, and lost their selectivity for Na+ over Li+. Furthermore, we extended the analysis of our experimental observations using molecular dynamics simulations. Altogether, our findings confirm a pivotal role of the serine 364, and more precisely its hydroxyl group, in coupling sodium and substrate fluxes.	[Simonin, Alexandre] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; Univ Bern, Swiss Natl Ctr Competence Res, NCCR, CH-3012 Bern, Switzerland	University of Bern; University of Bern	Simonin, A (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	asimonin@hotmail.fr; nim71@pitt.edu; matthias.hediger@ibmm.unibe.ch	Montalbetti, Nicolas/T-4212-2019; Gyimesi, Gergely/AAL-7340-2021	Montalbetti, Nicolas/0000-0003-2897-9540; Gyimesi, Gergely/0000-0002-2054-4633; Hediger, Matthias/0000-0003-1946-027X; Pujol, Jonai/0000-0002-9951-1390	Swiss National Science Foundation (SNSF) through the National Center of Competence in Research (NCCR) TransCure; Marie Curie Actions International Fellowship Program (IFP) TransCure	Swiss National Science Foundation (SNSF) through the National Center of Competence in Research (NCCR) TransCure(Swiss National Science Foundation (SNSF)); Marie Curie Actions International Fellowship Program (IFP) TransCure	This work was in part supported by the Swiss National Science Foundation (SNSF) through the National Center of Competence in Research (NCCR) TransCure and by the Marie Curie Actions International Fellowship Program (IFP) TransCure (to G. G. and J. P.-G.). The authors declare that they have no conflicts of interest with the contents of this article.	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Bastug T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033058; Bergeron MJ, 2011, J BIOL CHEM, V286, P11242, DOI 10.1074/jbc.M110.171728; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Grazioso G, 2012, J AM CHEM SOC, V134, P453, DOI 10.1021/ja208485w; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Gua Y, 2009, P NATL ACAD SCI USA, V106, P2589, DOI 10.1073/pnas.0812299106; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kanai Y, 2003, EUR J PHARMACOL, V479, P237, DOI 10.1016/j.ejphar.2003.08.073; Kanai Y, 2013, MOL ASPECTS MED, V34, P108, DOI 10.1016/j.mam.2013.01.001; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Machtens JP, 2015, CELL, V160, P542, DOI 10.1016/j.cell.2014.12.035; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; Marcus Y, 2009, CHEM REV, V109, P1346, DOI 10.1021/cr8003828; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rosental N, 2010, J BIOL CHEM, V285, P21241, DOI 10.1074/jbc.M109.087163; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Shabaneh M, 2014, J BIOL CHEM, V289, P11175, DOI 10.1074/jbc.M114.550277; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Simonin A, 2010, J BIOL CHEM, V285, P38293, DOI 10.1074/jbc.M110.115089; Tao Z, 2006, J BIOL CHEM, V281, P10263, DOI 10.1074/jbc.M510739200; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Teichman S, 2012, J BIOL CHEM, V287, P17198, DOI 10.1074/jbc.M112.355040; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; Trotti D, 2001, J BIOL CHEM, V276, P576, DOI 10.1074/jbc.M003779200; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, J GEN PHYSIOL, V117, P547, DOI 10.1085/jgp.117.6.547; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710	48	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2015	290	51					30464	30474		10.1074/jbc.M115.689836	http://dx.doi.org/10.1074/jbc.M115.689836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY9PG	26483543	Green Published, hybrid			2022-12-28	WOS:000366738200023
J	Riss, A; Scheer, E; Joint, M; Trowitzsch, S; Berger, I; Tora, L				Riss, Anne; Scheer, Elisabeth; Joint, Mathilde; Trowitzsch, Simon; Berger, Imre; Tora, Laszlo			Subunits of ADA-two-A-containing (ATAC) or Spt-Ada-Gcn5-acetyltrasferase (SAGA) Coactivator Complexes Enhance the Acetyltransferase Activity of GCN5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromatin modification; chromatin regulation; complex; histone; histone acetylase; histone acetylation; human; mass spectrometry (MS); KAT2A	GENE REGULATORY ELEMENTS; DROSOPHILA ADA2 HOMOLOGS; TATA-BINDING PROTEIN; RNA-POLYMERASE-II; MULTIPROTEIN COMPLEXES; ACETYLASE COMPLEX; SANT DOMAIN; TAF(II)-CONTAINING COMPLEX; TRANSCRIPTIONAL ADAPTERS; LYSINE ACETYLATION	Histone acetyl transferases (HATs) play a crucial role in eukaryotes by regulating chromatin architecture and locus specific transcription. GCN5 (KAT2A) is a member of the GNAT (Gcn5-related N-acetyltransferase) family of HATs. In metazoans this enzyme is found in two functionally distinct coactivator complexes, SAGA (Spt Ada Gcn5 acetyltransferase) and ATAC (Ada Two A-containing). These two multiprotein complexes comprise complex-specific and shared subunits, which are organized in functional modules. The HAT module of ATAC is composed of GCN5, ADA2a, ADA3, and SGF29, whereas in the SAGA HAT module ADA2b is present instead of ADA2a. To better understand how the activity of human (h) hGCN5 is regulated in the two related, but different, HAT complexes we carried out in vitro HAT assays. We compared the activity of hGCN5 alone with its activity when it was part of purified recombinant hATAC or hSAGA HAT modules or endogenous hATAC or hSAGA complexes using histone tail peptides and full-length histones as substrates. We demonstrated that the subunit environment of the HAT complexes into which GCN5 incorporates determines the enhancement of GCN5 activity. On histone peptides we show that all the tested GCN5-containing complexes acetylate mainly histone H3K14. Our results suggest a stronger influence of ADA2b as compared with ADA2a on the activity of GCN5. However, the lysine acetylation specificity of GCN5 on histone tails or full-length histones was not changed when incorporated in the HAT modules of ATAC or SAGA complexes. Our results thus demonstrate that the catalytic activity of GCN5 is stimulated by subunits of the ADA2a- or ADA2b-containing HAT modules and is further increased by incorporation of the distinct HAT modules in the ATAC or SAGA holo-complexes.	[Joint, Mathilde] Univ Strasbourg, CNRS UMR 7104, Inst Genet & Biol Moleculaire & Cellulaire, Prote platform, F-67404 Illkirch Graffenstaden, France; [Trowitzsch, Simon; Berger, Imre] EMBL Grenoble Outstat, F-38042 Grenoble, France; [Riss, Anne; Scheer, Elisabeth; Tora, Laszlo] Univ Strasbourg, Cellular Signaling & Nucl Dynam Program, F-67404 Illkirch Graffenstaden, CU Strasbourg, France; [Joint, Mathilde] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, CNRS UMR 7104, INSERM U964,Prote Platform, F-67404 Illkirch Graffenstaden, CU Strasbourg, France; [Trowitzsch, Simon; Berger, Imre] EMBL Grenoble Outstat, F-38042 Grenoble, France; [Trowitzsch, Simon; Berger, Imre] Univ Bristol, Sch Biochem, Clifton BS8 1TD, Avon, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; European Molecular Biology Laboratory (EMBL); University of Bristol		laszlo@igbmc.fr	Tora, Laszlo/E-9999-2018; Trowitzsch, Simon/O-4957-2016	Tora, Laszlo/0000-0001-7398-2250; Trowitzsch, Simon/0000-0001-9143-766X; Berger, Imre/0000-0001-7518-9045	Association pour la Recherche sur le Cancer grant (Orbitrap)	Association pour la Recherche sur le Cancer grant (Orbitrap)	We are grateful to Z. Nagy, J. Bonnet, M. Stierle, P. Tropberger, C. Bieniossek, E. Y. D. Chua, and C. A. Davey for materials, helpful discussions, and advice. We thank D. Devys for critically reading the manuscript and for helpful comments, the Institut de Genetique et de Biologie Moleculaire et Cellulaire cell culture facility for HeLa cells, I. Kolb-Cheynel for help in baculovirus overexpression, P. Eberling for peptide synthesis, K. J. Babu for technical help, and F. Garzoni for tissue culture work. The Institut de Genetique et de Biologie Moleculaire et Cellulaire Proteomics platform is supported by an Association pour la Recherche sur le Cancer grant (Orbitrap).	Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Bonnet J, 2014, GENE DEV, V28, P1999, DOI 10.1101/gad.250225.114; Boyer LA, 2002, MOL CELL, V10, P935, DOI 10.1016/S1097-2765(02)00634-2; Brand M, 1999, J BIOL CHEM, V274, P18285, DOI 10.1074/jbc.274.26.18285; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Candau R, 1996, MOL CELL BIOL, V16, P593; Cieniewicz AM, 2014, MOL CELL PROTEOMICS, V13, P2896, DOI 10.1074/mcp.M114.038174; Ciurciu A, 2006, MOL CELL BIOL, V26, P9413, DOI 10.1128/MCB.01401-06; Demeny MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000316; Eberharter A, 1998, METHODS, V15, P315, DOI 10.1006/meth.1998.0635; Feller C, 2015, MOL CELL, V57, P559, DOI 10.1016/j.molcel.2014.12.008; Gamper AM, 2009, MOL CELL BIOL, V29, P266, DOI 10.1128/MCB.00315-08; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1999, J BIOL CHEM, V274, P5895, DOI 10.1074/jbc.274.9.5895; Guelman S, 2006, MOL CELL BIOL, V26, P871, DOI 10.1128/MCB.26.3.871-882.2006; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; HINNEBUSCH AG, 1983, P NATL ACAD SCI-BIOL, V80, P5374, DOI 10.1073/pnas.80.17.5374; HONG L, 1993, J BIOL CHEM, V268, P305; HORIUCHI J, 1995, MOL CELL BIOL, V15, P1203; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krebs AR, 2010, EMBO REP, V11, P541, DOI 10.1038/embor.2010.75; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Kuo YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054896; Kusch T, 2003, MOL CELL BIOL, V23, P3305, DOI 10.1128/MCB.23.9.3305-3319.2003; Lang G, 2011, MOL CELL BIOL, V31, P3734, DOI 10.1128/MCB.05231-11; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; LI R, 1993, COLD SPRING HARB SYM, V58, P403, DOI 10.1101/SQB.1993.058.01.047; Lu R, 2013, TRENDS BIOCHEM SCI, V38, P546, DOI 10.1016/j.tibs.2013.08.002; MARCUS GA, 1994, EMBO J, V13, P4807, DOI 10.1002/j.1460-2075.1994.tb06806.x; Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781; Muratoglu S, 2003, MOL CELL BIOL, V23, P306, DOI 10.1128/MCB.23.1.306-321.2003; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Nagy Z, 2010, CELL MOL LIFE SCI, V67, P611, DOI 10.1007/s00018-009-0199-8; Nguyen-Huynh NT, 2015, PROTEIN SCI, V24, P1232, DOI 10.1002/pro.2676; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pankotai T, 2005, MOL CELL BIOL, V25, P8215, DOI 10.1128/MCB.25.18.8215-8227.2005; PENN MD, 1983, P NATL ACAD SCI-BIOL, V80, P2704, DOI 10.1073/pnas.80.9.2704; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Schnitzler G R, 2001, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2105s50; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Sterner DE, 2002, J BIOL CHEM, V277, P8178, DOI 10.1074/jbc.M108601200; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Trievel RC, 2000, ANAL BIOCHEM, V287, P319, DOI 10.1006/abio.2000.4855; Tropberger P, 2013, CELL, V152, P859, DOI 10.1016/j.cell.2013.01.032; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283	59	28	28	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28997	29009		10.1074/jbc.M115.668533	http://dx.doi.org/10.1074/jbc.M115.668533			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	26468280	Green Published, hybrid			2022-12-28	WOS:000365762300038
J	Li, SJ; Tan, M; Juillard, F; Ponnusamy, R; Correia, B; Simas, JP; Carrondo, MA; McVey, CE; Kaye, KM				Li, Shijun; Tan, Min; Juillard, Franceline; Ponnusamy, Rajesh; Correia, Bruno; Pedro Simas, J.; Carrondo, Maria A.; McVey, Colin E.; Kaye, Kenneth M.			The Kaposi Sarcoma Herpesvirus Latency-associated Nuclear Antigen DNA Binding Domain Dorsal Positive Electrostatic Patch Facilitates DNA Replication and Episome Persistence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTICENTRIC CASTLEMANS-DISEASE; REVERSE-TRANSCRIPTASE PROMOTER; CELL-CYCLE ARREST; TERMINAL REPEAT; MITOTIC CHROMOSOMES; GENE-EXPRESSION; LANA RECRUITS; HIV-INFECTION; VIRAL GENOME; PROTEIN	Kaposi sarcoma-associated herpesvirus (KSHV) has a causative role in several human malignancies. KSHV latency-associated nuclear antigen (LANA) mediates persistence of viral episomes in latently infected cells. LANA mediates KSHV DNA replication and segregates episomes to progeny nuclei. The structure of the LANA DNA binding domain was recently solved, revealing a positive electrostatic patch opposite the DNA binding surface, which is the site of BET protein binding. Here we investigate the functional role of the positive patch in LANA mediated episome persistence. As expected, LANA mutants with alanine or glutamate substitutions in the central, peripheral, or lateral portions of the positive patch maintained the ability to bind DNA by EMSA. However, all of the substitution mutants were deficient for LANA DNA replication and episome maintenance. Mutation of the peripheral region generated the largest deficiencies. Despite these deficiencies, all positive patch mutants concentrated to dots along mitotic chromosomes in cells containing episomes, similar to LANA. The central and peripheral mutants, but not the lateral mutants, were reduced for BET protein interaction as assessed by co-immunoprecipitation. However, defects in BET protein binding were independent of episome maintenance function. Overall, the reductions in episome maintenance closely correlated with DNA replication deficiencies, suggesting that the replication defects account for the reduced episome persistence. Therefore, the electrostatic patch exerts a key role in LANA-mediated DNA replication and episome persistence and may act through a host cell partner(s) other than a BET protein or by inducing specific structures or complexes.	[Li, Shijun; Tan, Min; Juillard, Franceline; Kaye, Kenneth M.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Li, Shijun; Tan, Min; Kaye, Kenneth M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ponnusamy, Rajesh; Correia, Bruno; Carrondo, Maria A.; McVey, Colin E.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2781901 Oeiras, Portugal; [Pedro Simas, J.] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Universidade Nova de Lisboa; Universidade de Lisboa	Kaye, KM (corresponding author), Brigham & Womens Hosp, Dept Med, 181 Longwood Ave, Boston, MA 02115 USA.	kkaye@bwh.harvard.edu	Tan, Min/K-1780-2016; Ponnusamy, Rajesh/K-3909-2012; McVey, Colin E/C-2110-2008; Simas, J Pedro/M-5157-2013; Juillard, Franceline/O-3246-2017	Ponnusamy, Rajesh/0000-0002-2828-061X; McVey, Colin E/0000-0001-7457-2130; Simas, J Pedro/0000-0001-6982-9253; Juillard, Franceline/0000-0003-1449-3603; Carrondo, Maria Armenia/0000-0002-1261-1162	National Institutes of Health (NCI) [CA082036]; National Institutes of Health (NIDCR) [DE025208]; Harvard Medical School-Portugal Program in Translational research and Information; Brigham and Women's Hospital Research Institute; NATIONAL CANCER INSTITUTE [R01CA082036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025208] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Harvard Medical School-Portugal Program in Translational research and Information; Brigham and Women's Hospital Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by National Institutes of Health Grants CA082036 (NCI) and DE025208 (NIDCR; both to K. M. K.), Harvard Medical School-Portugal Program in Translational research and Information (to J. P. S., M. A. C., C. E. M., and K. M. K.), and Brigham and Women's Hospital Research Institute (to K. M. K.). The authors declare that they have no conflicts of interest with the contents of this article.	An FQ, 2005, J BIOL CHEM, V280, P3862, DOI 10.1074/jbc.M407435200; Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Ballestas ME, 2001, J VIROL, V75, P3250, DOI 10.1128/JVI.75.7.3250-3258.2001; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Barbera AJ, 2004, J VIROL, V78, P294, DOI 10.1128/JVI.78.1.294-301.2004; Campbell M, 2012, J BIOL CHEM, V287, P5806, DOI 10.1074/jbc.M111.289496; Canham M, 2004, J GEN VIROL, V85, P1363, DOI 10.1099/vir.0.79802-0; CESARMAN E, 1995, BLOOD, V86, P2708, DOI 10.1182/blood.V86.7.2708.bloodjournal8672708; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; Correia B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003673; Cotter MA, 1999, VIROLOGY, V264, P254, DOI 10.1006/viro.1999.9999; Cotter MA, 2001, VIROLOGY, V291, P241, DOI 10.1006/viro.2001.1202; Decker LL, 1996, J EXP MED, V184, P283, DOI 10.1084/jem.184.1.283; Di Bartolo DL, 2008, BLOOD, V111, P4731, DOI 10.1182/blood-2007-09-110544; Domsic JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003672; Dupin N, 2000, BLOOD, V95, P1406, DOI 10.1182/blood.V95.4.1406.004k26_1406_1412; Dupin N, 1999, P NATL ACAD SCI USA, V96, P4546, DOI 10.1073/pnas.96.8.4546; Fejer G, 2003, J GEN VIROL, V84, P1451, DOI 10.1099/vir.0.18940-0; Garber AC, 2002, J BIOL CHEM, V277, P27401, DOI 10.1074/jbc.M203489200; Garber AC, 2001, J VIROL, V75, P7882, DOI 10.1128/JVI.75.17.7882-7892.2001; GARDELLA T, 1984, J VIROL, V50, P248, DOI 10.1128/JVI.50.1.248-254.1984; Grundhoff A, 2003, J VIROL, V77, P2779, DOI 10.1128/JVI.77.4.2779-2783.2003; Habison AC, 2012, J VIROL, V86, P11863, DOI 10.1128/JVI.01656-12; Hellert J, 2015, P NATL ACAD SCI USA, V112, P6694, DOI 10.1073/pnas.1421804112; Hellert J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003640; Hu JH, 2002, J VIROL, V76, P11677, DOI 10.1128/JVI.76.22.11677-11687.2002; Hu JH, 2009, J VIROL, V83, P11051, DOI 10.1128/JVI.00907-09; Jager W, 2012, J VIROL, V86, P6745, DOI 10.1128/JVI.06840-11; Kedes DH, 1997, J CLIN INVEST, V100, P2606, DOI 10.1172/JCI119804; Kelley-Clarke B, 2007, J VIROL, V81, P4348, DOI 10.1128/JVI.01289-06; Kelley-Clarke B, 2007, VIROLOGY, V357, P149, DOI 10.1016/j.virol.2006.07.052; Kelley-Clarke B, 2009, J VIROL, V83, P4326, DOI 10.1128/JVI.02395-08; Kim KY, 2013, J VIROL, V87, P6782, DOI 10.1128/JVI.00011-13; Knight JS, 2001, J BIOL CHEM, V276, P22971, DOI 10.1074/jbc.M101890200; Komatsu T, 2004, VIROLOGY, V319, P225, DOI 10.1016/j.virol.2003.11.002; Krithivas A, 2002, J VIROL, V76, P11596, DOI 10.1128/JVI.76.22.11596-11604.2002; Lagunoff M, 1997, VIROLOGY, V236, P147, DOI 10.1006/viro.1997.8713; Lim C, 2004, J VIROL, V78, P7248, DOI 10.1128/JVI.78.13.7248-7256.2004; Lim C, 2002, J VIROL, V76, P10320, DOI 10.1128/JVI.76.20.10320-10331.2002; Lu F, 2006, J VIROL, V80, P5273, DOI 10.1128/JVI.02541-05; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; Murakami Y, 2006, J BIOL CHEM, V281, P28113, DOI 10.1074/jbc.M602026200; Oksenhendler E, 1996, AIDS, V10, P61, DOI 10.1097/00002030-199601000-00009; Ottinger M, 2006, J VIROL, V80, P10772, DOI 10.1128/JVI.00804-06; Ottinger M, 2009, J VIROL, V83, P4423, DOI 10.1128/JVI.02274-08; Piolot T, 2001, J VIROL, V75, P3948, DOI 10.1128/JVI.75.8.3948-3959.2001; Purushothaman P, 2012, J VIROL, V86, P9983, DOI 10.1128/JVI.00839-12; Rainbow L, 1997, J VIROL, V71, P5915, DOI 10.1128/JVI.71.8.5915-5921.1997; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Shamay M, 2006, P NATL ACAD SCI USA, V103, P14554, DOI 10.1073/pnas.0604469103; Shamay M, 2012, J VIROL, V86, P5179, DOI 10.1128/JVI.00169-12; SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276; Srinivasan V, 2004, J VIROL, V78, P14033, DOI 10.1128/JVI.78.24.14033-14038.2004; Stedman W, 2004, J VIROL, V78, P12566, DOI 10.1128/JVI.78.22.12566-12575.2004; Sun QM, 2014, P NATL ACAD SCI USA, V111, P11816, DOI 10.1073/pnas.1404219111; Szekely L, 1999, J GEN VIROL, V80, P2889, DOI 10.1099/0022-1317-80-11-2889; Tang J, 2003, J VIROL, V77, P5975, DOI 10.1128/JVI.77.10.5975-5984.2003; Toptan T, 2013, J VIROL, V87, P2744, DOI 10.1128/JVI.03061-12; Vazquez Ede L., 2013, J VIROL, V87, P12270; Vazquez ED, 2014, VIROLOGY, V448, P344, DOI 10.1016/j.virol.2013.10.026; Vazquez ED, 2011, ARCH VIROL, V156, P1323, DOI 10.1007/s00705-011-0985-0; Vazquez ED, 2011, J VIROL, V85, P7622, DOI 10.1128/JVI.00304-11; Verma SC, 2006, J VIROL, V80, P2243, DOI 10.1128/JVI.80.5.2243-2256.2006; Verma SC, 2004, J VIROL, V78, P10348, DOI 10.1128/JVI.78.19.10348-10359.2004; Viejo-Borbolla A, 2005, J VIROL, V79, P13618, DOI 10.1128/JVI.79.21.13618-13629.2005; Ye FC, 2004, J VIROL, V78, P11121, DOI 10.1128/JVI.78.20.11121-11129.2004; You JX, 2006, J VIROL, V80, P8909, DOI 10.1128/JVI.00502-06	67	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28084	28096		10.1074/jbc.M115.674622	http://dx.doi.org/10.1074/jbc.M115.674622			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26420481	hybrid, Green Published			2022-12-28	WOS:000365761900005
J	Musayev, FN; Zarate-Perez, F; Bishop, C; Burgner, JW; Escalante, CR				Musayev, Faik N.; Zarate-Perez, Francisco; Bishop, Clayton; Burgner, John W., II; Escalante, Carlos R.			Structural Insights into the Assembly of the Adeno-associated Virus Type 2 Rep68 Protein on the Integration Site AAVS1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEIC-ACID STRUCTURES; NUCLEOTIDE-SEQUENCE; BINDING-PROTEIN; DNA RECOGNITION; HUMAN GENOME; ORIGIN; VISUALIZATION; REPLICATION; HELICASE; RECOMBINATION	Adeno-associated virus (AAV) is the only eukaryotic virus with the property of establishing latency by integrating site-specifically into the human genome. The integration site known as AAVS1 is located in chromosome 19 and contains multiple GCTC repeats that are recognized by the AAV non-structural Rep proteins. These proteins are multifunctional, with an N-terminal origin-binding domain (OBD) and a helicase domain joined together by a short linker. As a first step to understand the process of site-specific integration, we proceeded to characterize the recognition and assembly of Rep68 onto the AAVS1 site. We first determined the x-ray structure of AAV-2 Rep68 OBD in complex with the AAVS1 DNA site. Specificity is achieved through the interaction of a glycine-rich loop that binds the major groove and an alpha-helix that interacts with a downstream minor groove on the same face of the DNA. Although the structure shows a complex with three OBD molecules bound to the AAVS1 site, we show by using analytical centrifugation and electron microscopy that the full-length Rep68 forms a heptameric complex. Moreover, we determined that a minimum of two direct repeats is required to form a stable complex and to melt DNA. Finally, we show that although the individual domains bind DNA poorly, complex assembly requires oligomerization and cooperation between its OBD, helicase, and the linker domains.	[Musayev, Faik N.] Virginia Commonwealth Univ, Dept Med Chem, Sch Pharm, Richmond, VA 23298 USA; [Zarate-Perez, Francisco; Bishop, Clayton; Burgner, John W., II; Escalante, Carlos R.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Escalante, CR (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Sch Med, 1220 East Broad St, Richmond, VA 23298 USA.	cescalante@vcu.edu	ZARATE PEREZ, FRANCISCO/ABF-1106-2021; Regan, Clinton/E-6250-2012; Musayev, Faik/AAY-2010-2020	ZARATE PEREZ, FRANCISCO/0000-0001-7014-6804; 	National Institutes of Health [R01-GM092854]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM092854. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Berns KI, 1996, CURR TOP MICROBIOL, V218, P1; BERNS KI, 1995, BIOESSAYS, V17, P237, DOI 10.1002/bies.950170310; Chandler M, 2013, NAT REV MICROBIOL, V11, P525, DOI 10.1038/nrmicro3067; Chang YP, 2013, CELL REP, V3, P1117, DOI 10.1016/j.celrep.2013.03.002; Chiorini JA, 1999, J VIROL, V73, P4293, DOI 10.1128/JVI.73.5.4293-4298.1999; CHIORINI JA, 1994, J VIROL, V68, P7448, DOI 10.1128/JVI.68.11.7448-7457.1994; COLEMAN RA, 1995, J BIOL CHEM, V270, P13850, DOI 10.1074/jbc.270.23.13850; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Duderstadt KE, 2011, NATURE, V478, P209, DOI 10.1038/nature10455; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feng DM, 2006, J MOL BIOL, V358, P38, DOI 10.1016/j.jmb.2006.01.029; FIFE KH, 1977, VIROLOGY, V78, P475, DOI 10.1016/0042-6822(77)90124-6; GINIGER E, 1988, P NATL ACAD SCI USA, V85, P382, DOI 10.1073/pnas.85.2.382; Gonzalez-Prieto C, 2013, TRENDS BIOTECHNOL, V31, P41, DOI 10.1016/j.tibtech.2013.02.002; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Grimm D, 2006, J VIROL, V80, P426, DOI 10.1128/JVI.80.1.426-439.2006; HAUSWIRTH WW, 1977, VIROLOGY, V78, P488, DOI 10.1016/0042-6822(77)90125-8; Henckaerts E, 2009, P NATL ACAD SCI USA, V106, P7571, DOI 10.1073/pnas.0806821106; Hertel KJ, 1997, CURR OPIN CELL BIOL, V9, P350, DOI 10.1016/S0955-0674(97)80007-5; Hickman AB, 2004, MOL CELL, V13, P403, DOI 10.1016/S1097-2765(04)00023-1; Huser D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000985; IM DS, 1990, CELL, V61, P447, DOI 10.1016/0092-8674(90)90526-K; James JA, 2003, STRUCTURE, V11, P1025, DOI 10.1016/S0969-2126(03)00152-7; KIM JG, 1987, J MOL BIOL, V196, P149, DOI 10.1016/0022-2836(87)90517-1; Kim R, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-45; KOTIN RM, 1991, GENOMICS, V10, P831, DOI 10.1016/0888-7543(91)90470-Y; KOTIN RM, 1990, P NATL ACAD SCI USA, V87, P2211, DOI 10.1073/pnas.87.6.2211; Li L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r101; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Linden RM, 1996, P NATL ACAD SCI USA, V93, P7966, DOI 10.1073/pnas.93.15.7966; Linden RM, 1996, P NATL ACAD SCI USA, V93, P11288, DOI 10.1073/pnas.93.21.11288; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Maggin JE, 2012, J VIROL, V86, P3337, DOI 10.1128/JVI.06775-11; Mansilla-Soto J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000513; Musayev FN, 2015, BIOCHEMISTRY-US, V54, P5907, DOI 10.1021/acs.biochem.5b00610; Otwinowski Z, 1997, METHODS ENZYMOL, V276, P307; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ponnazhagan S, 1997, HUM GENE THER, V8, P275, DOI 10.1089/hum.1997.8.3-275; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Smith RH, 1997, J VIROL, V71, P4461, DOI 10.1128/JVI.71.6.4461-4471.1997; SNYDER RO, 1990, CELL, V60, P105, DOI 10.1016/0092-8674(90)90720-Y; SPEAR IS, 1977, J VIROL, V24, P627, DOI 10.1128/JVI.24.2.627-634.1977; SRIVASTAVA A, 1983, J VIROL, V45, P555, DOI 10.1128/JVI.45.2.555-564.1983; Surosky RT, 1997, J VIROL, V71, P7951, DOI 10.1128/JVI.71.10.7951-7959.1997; Tan I, 2001, J BIOL CHEM, V276, P21209, DOI 10.1074/jbc.M102615200; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Xu ZX, 2009, GENE THER, V16, P589, DOI 10.1038/gt.2009.9; Young SM, 2000, J VIROL, V74, P3953, DOI 10.1128/JVI.74.9.3953-3966.2000; Young SM, 2001, P NATL ACAD SCI USA, V98, P13525, DOI 10.1073/pnas.241508998; Zarate-Perez F, 2013, J VIROL, V87, P1232, DOI 10.1128/JVI.02441-12; Zarate-Perez F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002764	57	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27487	27499		10.1074/jbc.M115.669960	http://dx.doi.org/10.1074/jbc.M115.669960			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26370092	hybrid, Green Published			2022-12-28	WOS:000365757500005
J	Dai, A; Ye, F; Taylor, DW; Hu, GQ; Ginsberg, MH; Taylor, KA				Dai, Aguang; Ye, Feng; Taylor, Dianne W.; Hu, Guiqing; Ginsberg, Mark H.; Taylor, Kenneth A.			The Structure of a Full-length Membrane-embedded Integrin Bound to a Physiological Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID-BILAYER NANODISCS; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; EXTENDED CONFORMATIONS; EXTRACELLULAR SEGMENT; GLYCOPROTEIN-IIB; ACTIVATION; FIBRINOGEN; COMPLEX; ALPHA(IIB)BETA(3)	Increased ligand binding to integrin ("activation") underpins many biological processes, such as leukocyte trafficking, cell migration, host-pathogen interaction, and hemostasis. Integrins exist in several conformations, ranging from compact and bent to extended and open. However, the exact conformation of membrane-embedded, full-length integrin bound to its physiological macromolecular ligand is still unclear. Integrin alpha(IIb)beta(3), the most abundant integrin in platelets, has been a prototype for integrin activation studies. Using negative stain electron microscopy and nanodisc-embedding to provide a membrane-like environment, we visualized the conformation of full-length alpha(IIb)beta(3) in both a Mn2+-activated, ligand-free state and a Mn2+-activated, fibrin-bound state. Activated but ligand-free integrins exist mainly in the compact conformation, whereas fibrin-bound alpha(IIb)beta(3) predominantly exists in a fully extended, headpiece open conformation. Our results show that membrane-embedded, full-length integrin adopts an extended and open conformation when bound to its physiological macromolecular ligand.	[Dai, Aguang; Taylor, Dianne W.; Hu, Guiqing; Taylor, Kenneth A.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Ye, Feng; Ginsberg, Mark H.] Univ Calif San Diego, Dept Hematol & Oncol, La Jolla, CA 92093 USA	State University System of Florida; Florida State University; University of California System; University of California San Diego	Taylor, KA (corresponding author), Florida State Univ, Inst Mol Biophys, 91 Chieftan Way, Tallahassee, FL 32306 USA.	taylor@bio.fsu.edu			Florida State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078784, R01HL117807, P01HL031950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	Florida State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We utilized the instruments at the Biological Science Imaging Resource supported by Florida State University for this study.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bledzka K, 2013, CIRC RES, V112, P1189, DOI 10.1161/CIRCRESAHA.112.300570; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chigaev A, 2003, BIOPHYS J, V85, P3951, DOI 10.1016/S0006-3495(03)74809-7; Choi WS, 2013, BLOOD, V122, P4165, DOI 10.1182/blood-2013-04-499194; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Coutinho A, 2007, BIOPHYS CHEM, V130, P76, DOI 10.1016/j.bpc.2007.07.007; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Eng ET, 2011, J BIOL CHEM, V286, P35218, DOI 10.1074/jbc.M111.275107; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GAILIT J, 1988, J BIOL CHEM, V263, P12927; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kato A, 1997, CRIT REV ONCOL HEMAT, V26, P1, DOI 10.1016/S1040-8428(97)00011-5; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kim C, 2009, BLOOD, V113, P4747, DOI 10.1182/blood-2008-10-186551; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Lau TL, 2008, J BIOL CHEM, V283, P16162, DOI 10.1074/jbc.M801748200; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; MULLER B, 1993, J BIOL CHEM, V268, P6800; NACHMAN RL, 1982, J CLIN INVEST, V69, P263, DOI 10.1172/JCI110448; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; PARISE LV, 1985, J BIOL CHEM, V260, P698; Quinn MJ, 2003, ARTERIOSCL THROM VAS, V23, P945, DOI 10.1161/01.ATV.0000066686.46338.F1; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shi ML, 2007, J BIOL CHEM, V282, P30198, DOI 10.1074/jbc.M701670200; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Taylor DW, 2007, J STRUCT BIOL, V160, P305, DOI 10.1016/j.jsb.2007.04.011; Taylor KA, 1999, J STRUCT BIOL, V128, P75, DOI 10.1006/jsbi.1999.4167; Winkler H, 2009, J STRUCT BIOL, V165, P64, DOI 10.1016/j.jsb.2008.10.004; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2010, EMBO J, V29, P666, DOI 10.1038/emboj.2009.367; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200	53	18	18	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27168	27175		10.1074/jbc.M115.682377	http://dx.doi.org/10.1074/jbc.M115.682377			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26391523	Green Published, hybrid			2022-12-28	WOS:000364794000026
J	Feng, Y; Chen, HL; Cai, JY; Zou, L; Yan, D; Xu, GQ; Li, D; Chao, W				Feng, Yan; Chen, Hongliang; Cai, Jiayan; Zou, Lin; Yan, Dan; Xu, Ganqiong; Li, Dan; Chao, Wei			Cardiac RNA Induces Inflammatory Responses in Cardiomyocytes and Immune Cells via Toll-like Receptor 7 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENTIAL BIOMARKER; MESSENGER-RNA; CIRCULATING MICRORNAS; PATTERN-RECOGNITION; MYOCARDIAL INJURY; DENDRITIC CELLS; NECROTIC CELLS; NUCLEIC-ACIDS; CUTTING EDGE; STRANDED-RNA	We have recently reported that extracellular RNA (exRNA) released from necrotic cells induces cytokine production in cardiomyocytes and immune cells and contributes to myocardial ischemia/reperfusion injury. However, the signaling mechanism by which exRNA exhibits its pro-inflammatory effect is unknown. Here we hypothesize that exRNA directly induces inflammation through specific Toll-like receptors (TLRs). To test the hypothesis, we treated rat neonatal cardiomyocytes, mouse bone marrow-derived macrophages (BMDM), or mouse neutrophils with RNA (2.5-10 mu g/ml) isolated from rat cardiomyocytes or the hearts from mouse, rat, and human. We found that cellular RNA induced production of several cytokines such as macrophage inflammatory protein-2 (MIP-2), ILs, TNF alpha, and the effect was completely diminished by RNase, but not DNase. The RNA-induced cytokine production was partially inhibited in cells treated with TLR7 antagonist or genetically deficient in TLR7. Deletion of myeloid differentiation primary response protein 88 (MyD88), a downstream adapter of TLRs including TLR7, abolished the RNA-induced MIP-2 production. Surprisingly, genetic deletion of TLR3 had no impact on the RNA-induced MIP-2 response. Importantly, extracellular RNA released from damaged cardiomyocytes also induced cytokine production. Finally, mice treated with 50 mu g of RNA intraperitoneal injection exhibited acute peritonitis as evidenced by marked neutrophil and monocyte migration into the peritoneal space. Together, these data demonstrate that exRNA of cardiac origin exhibits a potent pro-inflammatory property in vitro and in vivo and that exRNA induces cytokine production through TLR7-MyD88 signaling.	[Feng, Yan; Chen, Hongliang; Cai, Jiayan; Zou, Lin; Yan, Dan; Xu, Ganqiong; Li, Dan; Chao, Wei] Harvard Univ, Sch Med, Dept Anesthesia Crit Care & Pain Med, Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Feng, Y (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia & Crit Care, 149 13th St,Rm 4-212, Charlestown, MA 02129 USA.	yfeng@mgh.harvard.edu; wchao@mgh.harvard.edu	Regan, Clinton/E-6250-2012	Chao, Wei/0000-0002-2505-1360	National Institutes of Health [R01-GM080906, R01-GM097259]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080906, R01GM097259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01-GM080906 and R01-GM097259 (to W. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Baiersdorfer M, 2010, EXP CELL RES, V316, P3489, DOI 10.1016/j.yexcr.2010.07.022; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Brencicova E, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00037; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Cabrera-Fuentes HA, 2014, THROMB HAEMOSTASIS, V112, P1110, DOI 10.1160/TH14-08-0703; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chen C, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000683; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Ding XF, 2012, MOL MED REP, V5, P1428, DOI 10.3892/mmr.2012.838; Dinger ME, 2008, J MOL ENDOCRINOL, V40, P151, DOI 10.1677/JME-07-0160; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Feng Y, 2008, AM J PHYSIOL-HEART C, V295, pH1311, DOI 10.1152/ajpheart.00119.2008; Feng Y, 2011, ANESTHESIOLOGY, V115, P555, DOI 10.1097/ALN.0b013e31822a22f7; Feng Y, 2010, AM J PHYSIOL-CELL PH, V299, pC760, DOI 10.1152/ajpcell.00155.2010; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Gorden KKB, 2006, J IMMUNOL, V177, P6584, DOI 10.4049/jimmunol.177.10.6584; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Koski GK, 2004, J IMMUNOL, V172, P3989, DOI 10.4049/jimmunol.172.7.3989; Lee H, 2006, BIOCHEM BIOPH RES CO, V350, P742, DOI 10.1016/j.bbrc.2006.09.108; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Li Y, 2011, J BIOL CHEM, V286, P31308, DOI 10.1074/jbc.M111.246124; Lim DM, 2011, AM J PHYSIOL-GASTR L, V301, pG91, DOI 10.1152/ajpgi.00471.2010; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Matsumoto M, 2011, REV MED VIROL, V21, P67, DOI 10.1002/rmv.680; Mattick JS, 2007, J EXP BIOL, V210, P1526, DOI 10.1242/jeb.005017; Miura N, 2008, CLIN MED INSIGHTS-ON, V2, P511; Pun JCS, 2014, MOL CLIN ONCOL, V2, P817, DOI 10.3892/mco.2014.321; Sueoka E, 2005, LUNG CANCER, V48, P77, DOI 10.1016/j.lungcan.2004.10.007; Wang HY, 2014, J SURG ONCOL, V109, P574, DOI 10.1002/jso.23526; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang SJ, 2011, ARCH DERMATOL RES, V303, P771, DOI 10.1007/s00403-011-1170-8; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850; Zhu C, 2014, BRIT J CANCER, V110, P2291, DOI 10.1038/bjc.2014.119; Zou L, 2010, CRIT CARE MED, V38, P1335, DOI 10.1097/CCM.0b013e3181d99e67	48	39	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26688	26698		10.1074/jbc.M115.661835	http://dx.doi.org/10.1074/jbc.M115.661835			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26363072	hybrid, Green Published			2022-12-28	WOS:000364793600032
J	Rosenfeld, L; Shirian, J; Zur, Y; Levaot, N; Shifman, JM; Papo, N				Rosenfeld, Lior; Shirian, Jason; Zur, Yuval; Levaot, Noam; Shifman, Julia M.; Papo, Niv			Combinatorial and Computational Approaches to Identify Interactions of Macrophage Colony-stimulating Factor (M-CSF) and Its Receptor c-FMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; YEAST SURFACE DISPLAY; PICHIA-PASTORIS; GROWTH-FACTOR; CYTOKINES IL-34; EXPRESSION; ANTIBODIES; AFFINITY; CANCER; DOMAIN	The molecular interactions between macrophage colony-stimulating factor (M-CSF) and the tyrosine kinase receptor c-FMS play a key role in the immune response, bone metabolism, and the development of some cancers. Because no x-ray structure is available for the human M-CSF.c-FMS complex, the binding epitope for this complex is largely unknown. Our goal was to identify the residues that are essential for binding of the human M-CSF to c-FMS. For this purpose, we used a yeast surface display (YSD) approach. We expressed a combinatorial library of monomeric M-CSF (M-CSFM) single mutants and screened this library to isolate variants with reduced affinity for c-FMS using FACS. Sequencing yielded a number of single M-CSFM variants with mutations both in the direct binding interface and distant from the binding site. In addition, we used computational modeling to map the identified mutations onto the M-CSFM structure and to classify the mutations into three groups as follows: those that significantly decrease protein stability; those that destroy favorable intermolecular interactions; and those that decrease affinity through allosteric effects. To validate the YSD and computational data, M-CSFM and three variants were produced as soluble proteins; their affinity and structure were analyzed; and very good correlations with both YSD data and computational predictions were obtained. By identifying the M-CSFM residues critical for M-CSF.c-FMS interactions, we have laid down the basis for a deeper understanding of the M-CSF.c-FMS signaling mechanism and for the development of target-specific therapeutic agents with the ability to sterically occlude the M-CSF.c-FMS binding interface.	[Rosenfeld, Lior; Zur, Yuval; Papo, Niv] Ben Gurion Univ Negev, Dept Biotechnol Engn, 1 Ben Gurion Ave, IL-8410501 Beer Sheva, Israel; [Rosenfeld, Lior; Zur, Yuval; Papo, Niv] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-8410501 Beer Sheva, Israel; [Zur, Yuval; Levaot, Noam] Ben Gurion Univ Negev, Dept Physiol & Cell Biol, IL-8410501 Beer Sheva, Israel; [Shirian, Jason; Shifman, Julia M.] Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silberman Inst Life Sci, IL-9190401 Jerusalem, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem	Papo, N (corresponding author), Ben Gurion Univ Negev, Dept Biotechnol Engn, 1 Ben Gurion Ave, IL-8410501 Beer Sheva, Israel.	papo@bgu.ac.il	Levaot, Noam/AAA-3052-2022; Papo, Niv/R-3946-2017	Levaot, Noam/0000-0001-7747-3883; 	European Research Council [336041]; Israel Science Foundation [1372/10]	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation)	This work was supported in part by the European Research Council "Ideas Program" ERC-2013-StG Contract Grant 336041 (to N. P.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by Israel Science Foundation Grant 1372/10.	Aizner Y, 2014, STRUCTURE, V22, P636, DOI 10.1016/j.str.2014.01.012; BARTELMEZ SH, 1989, EXP HEMATOL, V17, P240; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Brooks SA, 2004, MOL BIOTECHNOL, V28, P241, DOI 10.1385/MB:28:3:241; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chao G, 2004, J MOL BIOL, V342, P539, DOI 10.1016/j.jmb.2004.07.053; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen XY, 2008, P NATL ACAD SCI USA, V105, P18267, DOI 10.1073/pnas.0807762105; Chockalingam S, 2014, TUMOR BIOL, V35, P10635, DOI 10.1007/s13277-014-2627-0; Cochran JR, 2004, J IMMUNOL METHODS, V287, P147, DOI 10.1016/j.jim.2004.01.024; Colby DW, 2004, METHOD ENZYMOL, V388, P348; CORTESE R, 1994, TRENDS BIOTECHNOL, V12, P262, DOI 10.1016/0167-7799(94)90137-6; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376; Dahiyat BI, 1997, J MOL BIOL, V273, P789, DOI 10.1006/jmbi.1997.1341; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0; Doolan KM, 2015, J MOL BIOL, V427, P328, DOI 10.1016/j.jmb.2014.10.024; Douglass TG, 2008, INT IMMUNOPHARMACOL, V8, P1354, DOI 10.1016/j.intimp.2008.04.016; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Elegheert J, 2012, NAT STRUCT MOL BIOL, V19, P938, DOI 10.1038/nsmb.2367; Erijman A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110085; Escamilla J, 2015, CANCER RES, V75, P950, DOI 10.1158/0008-5472.CAN-14-0992; Fack F, 1997, J IMMUNOL METHODS, V206, P43, DOI 10.1016/S0022-1759(97)00083-5; Filchtinski D, 2010, J MOL BIOL, V399, P422, DOI 10.1016/j.jmb.2010.03.046; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Gordon DB, 2003, J COMPUT CHEM, V24, P232, DOI 10.1002/jcc.10121; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; GRONSKI P, 1988, Behring Institute Mitteilungen, P246; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Lefevre F, 1997, NUCLEIC ACIDS RES, V25, P447, DOI 10.1093/nar/25.2.447; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Lin EY, 2002, J MAMMARY GLAND BIOL, V7, P147, DOI 10.1023/A:1020399802795; Liu HL, 2012, BBA-PROTEINS PROTEOM, V1824, P938, DOI 10.1016/j.bbapap.2012.04.012; Luo YX, 2008, BIOTECHNOL PROGR, V24, P214, DOI 10.1021/bp0702727; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mata-Fink J, 2013, J MOL BIOL, V425, P444, DOI 10.1016/j.jmb.2012.11.010; Murciano-Calles J, 2014, J MOL BIOL, V426, P3500, DOI 10.1016/j.jmb.2014.05.003; Murray LJ, 2003, CLIN EXP METASTAS, V20, P757, DOI 10.1023/B:CLIN.0000006873.65590.68; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; Sharabi O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093712; Sharabi O, 2013, BIOCHEM SOC T, V41, P1166, DOI 10.1042/BST20130121; Sharabi O, 2013, METHOD ENZYMOL, V523, P41, DOI 10.1016/B978-0-12-394292-0.00003-5; Sharabi O, 2011, PROTEINS, V79, P1487, DOI 10.1002/prot.22977; Shi XZ, 2003, PROTEIN EXPRES PURIF, V28, P321, DOI 10.1016/S1046-5928(02)00706-4; Sluijter M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104230; Stanley ER, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a021857; TANNER W, 1987, BIOCHIM BIOPHYS ACTA, V906, P81, DOI 10.1016/0304-4157(87)90006-2; TAYLOR EW, 1994, J BIOL CHEM, V269, P31171; Thompson LC, 2006, BIOCHEMISTRY-US, V45, P2267, DOI 10.1021/bi0519506; TUSHINSKI RJ, 1982, CELL, V28, P71, DOI 10.1016/0092-8674(82)90376-2; Van Overmeire E, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00127; Weiss GA, 2000, P NATL ACAD SCI USA, V97, P8950, DOI 10.1073/pnas.160252097; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhao YM, 1996, P NATL ACAD SCI USA, V93, P4020, DOI 10.1073/pnas.93.9.4020	64	16	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26180	26193		10.1074/jbc.M115.671271	http://dx.doi.org/10.1074/jbc.M115.671271			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26359491	hybrid, Green Published			2022-12-28	WOS:000363527300036
J	Wang, HY; Jin, HN; Rapraeger, AC				Wang, Haiyao; Jin, Haining; Rapraeger, Alan C.			Syndecan-1 and Syndecan-4 Capture Epidermal Growth Factor Receptor Family Members and the alpha 3 beta 1 Integrin Via Binding Sites in Their Ectodomains NOVEL SYNSTATINS PREVENT KINASE CAPTURE AND INHIBIT alpha 6 beta 4-INTEGRIN-DEPENDENT EPITHELIAL CELL MOTILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE 3-OH KINASE; FACTOR-I RECEPTOR; ALPHA-6-BETA-4 INTEGRIN; CARCINOMA INVASION; ALPHA(6)BETA(4) INTEGRIN; SURFACE PROTEOGLYCAN; ERBB-3 EXPRESSION; ACTIVATION; HEMIDESMOSOMES; DOMAIN	The alpha 6 beta 4 integrin is known to associate with receptor tyrosine kinases when engaged in epithelial wound healing and in carcinoma invasion and survival. Prior work has shown that HER2 associates with alpha 6 beta 4 integrin and syndecan-1 (Sdc1), in which Sdc1 engages the cytoplasmic domain of the beta 4 integrin subunit allowing HER2-dependent motility and carcinoma cell survival. In contrast, EGFR associates with Sdc4 and the alpha 6 beta 4 integrin, and EGFR-dependent motility depends on cytoplasmic engagement of beta 4 integrin with Sdc4. However, how HER2 and EGFR assimilate into a complex with the syndecans and integrin, and why kinase capture is syndecan-specific has remained unknown. In the present study, we demonstrate that HER2 is captured via a site, comprised of amino acids 210-240, in the extracellular domain of human Sdc1, and EGFR is captured via an extracellular site comprised of amino acids 87-131 in human Sdc4. Binding assays using purified recombinant proteins demonstrate that the interaction between the EGFR family members and the syndecans is direct. The alpha 3 beta 1 integrin, which is responsible for the motility of the cells, is captured at these sites as well. Peptides based on the interaction motifs in Sdc1 and Sdc4, called synstatins (SSTN210-240 and SSTN87-131) competitively displace the receptor tyrosine kinase and alpha 3 beta 1 integrin from the syndecan with an IC50 of 100-300 nM. The syndecans remain anchored to the alpha 6 beta 4 integrin via its cytoplasmic domain, but the activation of cell motility is disrupted. These novel SSTN peptides are potential therapeutics for carcinomas that depend on these HER2-and EGFR-coupled mechanisms for their invasion and survival.	[Wang, Haiyao; Jin, Haining; Rapraeger, Alan C.] Univ Wisconsin, Wisconsin Inst Med Res, Dept Human Oncol, Madison, WI 53705 USA; [Rapraeger, Alan C.] Univ Wisconsin, Wisconsin Inst Med Res, Carbone Canc Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rapraeger, AC (corresponding author), Wisconsin Inst Med Res, 1111 Highland Ave, Madison, WI 53705 USA.	rapraeger@humonc.wisc.edu			National Cancer Institute [P30 CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520, R01CA109010, R01CA163662] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the University of Wisconsin Carbone Cancer Center for the use of its shared services, supported by the National Cancer Institute (P30 CA014520). We are especially thankful for reagents from Filippo Giancotti, Memorial Sloan-Kettering Cancer Center, that have made this work possible.	Beauvais DM, 2010, J CELL SCI, V123, P3796, DOI 10.1242/jcs.067645; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bertotti A, 2006, J CELL BIOL, V175, P993, DOI 10.1083/jcb.200605114; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; de Pereda JM, 2009, EMBO J, V28, P1180, DOI 10.1038/emboj.2009.48; Dutta U, 2008, CANCER RES, V68, P8779, DOI 10.1158/0008-5472.CAN-08-2125; Falcioni R, 1997, EXP CELL RES, V236, P76, DOI 10.1006/excr.1997.3695; Folgiero V, 2007, CANCER RES, V67, P1645, DOI 10.1158/0008-5472.CAN-06-2980; Folgiero V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001592; Frijns E, 2012, MOL BIOL CELL, V23, P1475, DOI 10.1091/mbc.E11-11-0957; Gambaletta D, 2000, J BIOL CHEM, V275, P10604, DOI 10.1074/jbc.275.14.10604; Goldfinger LE, 1999, J CELL SCI, V112, P2615; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Langford JK, 2005, J BIOL CHEM, V280, P3467, DOI 10.1074/jbc.M412451200; Mariotti A, 2001, J CELL BIOL, V155, P447, DOI 10.1083/jcb.200105017; McFall AJ, 1997, J BIOL CHEM, V272, P12901, DOI 10.1074/jbc.272.20.12901; McFall AJ, 1998, J BIOL CHEM, V273, P28270, DOI 10.1074/jbc.273.43.28270; Merdek KD, 2007, J BIOL CHEM, V282, P30322, DOI 10.1074/jbc.M703156200; Nievers MG, 1999, MATRIX BIOL, V18, P5, DOI 10.1016/S0945-053X(98)00003-1; Nikolopoulos SN, 2004, CANCER CELL, V6, P471, DOI 10.1016/j.ccr.2004.09.029; Nistico P, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0459-x; Rabinovitz I, 2004, MOL CELL BIOL, V24, P4351, DOI 10.1128/MCB.24.10.4351-4360.2004; RAPRAEGER A, 1985, J BIOL CHEM, V260, P1046; Rapraeger AC, 2013, FEBS J, V280, P2207, DOI 10.1111/febs.12160; Rapraeger AC, 2013, FEBS J, V280, P2194, DOI 10.1111/febs.12134; Russell AJ, 2003, J CELL SCI, V116, P3543, DOI 10.1242/jcs.00663; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Trusolino L, 2001, CELL, V107, P643, DOI 10.1016/S0092-8674(01)00567-0; Wang HY, 2014, J BIOL CHEM, V289, P30318, DOI 10.1074/jbc.M114.586438; Wang HY, 2010, J BIOL CHEM, V285, P13569, DOI 10.1074/jbc.M110.102137; Whiteford JR, 2006, J BIOL CHEM, V281, P32156, DOI 10.1074/jbc.M605553200; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Wilhelmsen K, 2007, MOL BIOL CELL, V18, P3512, DOI 10.1091/mbc.E07-04-0306; Yang XQ, 2010, MOL CELL BIOL, V30, P5306, DOI 10.1128/MCB.00326-10; Yoshioka T, 2013, J CLIN INVEST, V123, P682, DOI 10.1172/JCI60720	40	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					26103	26113		10.1074/jbc.M115.679084	http://dx.doi.org/10.1074/jbc.M115.679084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26350464	Green Published, hybrid			2022-12-28	WOS:000363527300030
J	Hernandez-Corbacho, MJ; Canals, D; Adada, MM; Liu, ML; Senkal, CE; Yi, JK; Mao, CG; Luberto, C; Hannun, YA; Obeid, LM				Hernandez-Corbacho, Maria Jose; Canals, Daniel; Adada, Mohamad M.; Liu, Mengling; Senkal, Can E.; Yi, Jae Kyo; Mao, Cungui; Luberto, Chiara; Hannun, Yusuf A.; Obeid, Lina M.			Tumor Necrosis Factor-alpha (TNF alpha)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONGEVITY ASSURANCE GENE-1; SMALL-MOLECULE INHIBITOR; ACID BETA-GLUCOSIDASE; HUMAN BREAST-CANCER; INDUCED APOPTOSIS; NEUTRAL SPHINGOMYELINASE; SECONDARY NECROSIS; SPHINGOLIPID METABOLISM; PANCREATIC-CANCER; MASS-SPECTROMETRY	Ceramide synthases (CerS1-CerS6), which catalyze the N-acylation of the (dihydro) sphingosine backbone to produce (dihydro) ceramide in both the de novo and the salvage or recycling pathway of ceramide generation, have been implicated in the control of programmed cell death. However, the regulation of the de novo pathway compared with the salvage pathway is not fully understood. In the current study, we have found that late accumulation of multiple ceramide and dihydroceramide species in MCF-7 cells treated with TNF alpha occurred by up-regulation of both pathways of ceramide synthesis. Nevertheless, fumonisin B1 but not myriocin was able to protect from TNF alpha induced cell death, suggesting that ceramide synthase activity is crucial for the progression of cell death and that the pool of ceramide involved derives from the salvage pathway rather than de novo biosynthesis. Furthermore, compared with control cells, TNF alpha-treated cells exhibited reduced focal adhesion kinase and subsequent plasma membrane permeabilization, which was blocked exclusively by fumonisin B1. In addition, exogenously added C6-ceramide mimicked the effects of TNF alpha that lead to cell death, which were inhibited by fumonisin B1. Knockdown of individual ceramide synthases identified CerS6 and its product C16-ceramide as the ceramide synthase isoform essential for the regulation of cell death. In summary, our data suggest a novel role for CerS6/C16-ceramide as an upstream effector of the loss of focal adhesion protein and plasma membrane permeabilization, via the activation of caspase-7, and identify the salvage pathway as the critical mechanism of ceramide generation that controls cell death.	[Hernandez-Corbacho, Maria Jose; Canals, Daniel; Adada, Mohamad M.; Liu, Mengling; Senkal, Can E.; Yi, Jae Kyo; Mao, Cungui; Luberto, Chiara; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Hlth Sci Ctr, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Hernandez-Corbacho, Maria Jose; Canals, Daniel; Adada, Mohamad M.; Liu, Mengling; Senkal, Can E.; Yi, Jae Kyo; Mao, Cungui; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Hlth Sci Ctr, Dept Med, Stony Brook, NY 11794 USA; [Luberto, Chiara] SUNY Stony Brook, Hlth Sci Ctr, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY 11768 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Obeid, LM (corresponding author), SUNY Stony Brook, Hlth Sci Ctr, Dept Med, L-4 179, Stony Brook, NY 11794 USA.	lina.obeid@stonybrookmedicine.edu	Canals, Daniel/AAW-1998-2021; Canals, Daniel/AAJ-8176-2021	Canals, Daniel/0000-0002-9293-5123; Liu, Mengling/0000-0003-1309-0087; Adada, Mohamad/0000-0002-2988-2081; Yi, Jae Kyo/0000-0001-7053-601X	National Institutes of Health Grants [GM097741, PO1CA097132]; Veterans Affairs Merit Award; NATIONAL CANCER INSTITUTE [R01CA163825, P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097741] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants GM097741 and PO1CA097132 (to L. M. O.). This work was also supported by a Veterans Affairs Merit Award. The authors declare that they have no conflicts of interest with the contents of this article.	Beierle EA, 2010, CELL CYCLE, V9, P1005, DOI 10.4161/cc.9.5.10936; Beviglia L, 2003, BIOCHEM J, V373, P201, DOI 10.1042/BJ20021846; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000; Ciccimaro E, 2006, RAPID COMMUN MASS SP, V20, P3681, DOI 10.1002/rcm.2783; Cohen-Jonathan E, 1999, CURR OPIN CHEM BIOL, V3, P77, DOI 10.1016/S1367-5931(99)80014-3; Dbaibo GS, 2001, FEBS LETT, V503, P7, DOI 10.1016/S0014-5793(01)02625-4; Dbaibo GS, 1997, J EXP MED, V185, P481, DOI 10.1084/jem.185.3.481; Di Bartolomeo S, 2002, NEUROSCI LETT, V334, P149, DOI 10.1016/S0304-3940(02)01074-1; DINUR T, 1986, P NATL ACAD SCI USA, V83, P1660, DOI 10.1073/pnas.83.6.1660; Dunn KB, 2010, ANTI-CANCER AGENT ME, V10, P722; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Enongene EN, 2002, TOXICOL SCI, V67, P173, DOI 10.1093/toxsci/67.2.173; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Gervais FG, 1998, J BIOL CHEM, V273, P17102, DOI 10.1074/jbc.273.27.17102; Golubovskaya V, 2015, ARCH TOXICOL, V89, P1095, DOI 10.1007/s00204-014-1290-y; Golubovskaya VM, 2014, FRONT BIOSCI-LANDMRK, V19, P687, DOI 10.2741/4236; Golubovskaya VM, 2013, MOL CANCER THER, V12, P162, DOI 10.1158/1535-7163.MCT-12-0701; Golubovskaya VM, 2009, INT J CANCER, V125, P1735, DOI 10.1002/ijc.24486; Golubovskaya VM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-280; Golubovskaya VM, 2003, MOL CANCER RES, V1, P755; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hao HF, 2009, ONCOL REP, V22, P973, DOI 10.3892/or_00000524; Heffler M, 2013, ANTI-CANCER AGENT ME, V13, P584, DOI 10.2174/1871520611313040008; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Hoeferlin LA, 2013, J BIOL CHEM, V288, P12880, DOI 10.1074/jbc.M113.461798; JAYADEV S, 1994, J BIOL CHEM, V269, P5757; Jin JF, 2009, J LIPID RES, V50, P2389, DOI 10.1194/jlr.M900119-JLR200; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim WJ, 2008, BLOOD, V111, P4716, DOI 10.1182/blood-2007-10-113068; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Laouar A, 1999, J BIOL CHEM, V274, P23526, DOI 10.1074/jbc.274.33.23526; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Lee H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019783; Levkau B, 1998, J EXP MED, V187, P579, DOI 10.1084/jem.187.4.579; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Marushige Y, 1998, ANTICANCER RES, V18, P301; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mullen TD, 2012, ANTI-CANCER AGENT ME, V12, P340, DOI 10.2174/187152012800228661; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Neumeyer J, 2006, EXP CELL RES, V312, P2142, DOI 10.1016/j.yexcr.2006.03.014; Novgorodov SA, 2005, J BIOL CHEM, V280, P16096, DOI 10.1074/jbc.M411707200; O'Brien S, 2014, ONCOTARGET, V5, P7945, DOI 10.18632/oncotarget.2381; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Oktay MH, 2003, HUM PATHOL, V34, P240, DOI 10.1053/hupa.2003.40; Oropesa-Avila M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.58; Oropesa-Avila M, 2014, APOPTOSIS, V19, P1364, DOI 10.1007/s10495-014-1015-y; Ozoren N., 2003, SEMIN CANC BIOL, V13, P135; Panjarian S, 2008, PROSTAG OTH LIPID M, V86, P41, DOI 10.1016/j.prostaglandins.2008.02.004; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Radin NS, 2003, BIOCHEM J, V371, P243, DOI 10.1042/BJ20021878; Rath G, 2009, INT J BIOCHEM CELL B, V41, P1165, DOI 10.1016/j.biocel.2008.10.021; Riboni L, 1998, ANN NY ACAD SCI, V845, P46, DOI 10.1111/j.1749-6632.1998.tb09661.x; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; ROBERTSON AMG, 1978, J PATHOL, V126, P181, DOI 10.1002/path.1711260307; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Segui B, 2001, J CLIN INVEST, V108, P143, DOI 10.1172/JCI200111498; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Silva MT, 2010, FEBS LETT, V584, P4491, DOI 10.1016/j.febslet.2010.10.046; Sridevi P, 2010, EXP CELL RES, V316, P78, DOI 10.1016/j.yexcr.2009.09.027; Sridevi P, 2009, BBA-MOL CELL RES, V1793, P1218, DOI 10.1016/j.bbamcr.2009.04.006; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Taha TA, 2005, J BIOL CHEM, V280, P17196, DOI 10.1074/jbc.M413744200; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Takeda S, 2006, J BIOCHEM, V139, P255, DOI 10.1093/jb/mvj026; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Wang JL, 2014, TUMOR BIOL, V35, P1551, DOI 10.1007/s13277-013-1214-0; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xu LH, 2000, J BIOL CHEM, V275, P30597, DOI 10.1074/jbc.M910027199; Xu LH, 1998, CELL GROWTH DIFFER, V9, P999; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; Zachary I, 1997, INT J BIOCHEM CELL B, V29, P929, DOI 10.1016/S1357-2725(97)00008-3; Zhao YG, 2001, J BIOL CHEM, V276, P27432, DOI 10.1074/jbc.M102465200; Zheng DH, 2010, MOL CARCINOGEN, V49, P200, DOI 10.1002/mc.20590	93	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25356	25373		10.1074/jbc.M115.658658	http://dx.doi.org/10.1074/jbc.M115.658658			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26318452	Green Published, hybrid			2022-12-28	WOS:000362962800014
J	Manzanares, D; Krick, S; Baumlin, N; Dennis, JS; Tyrrell, J; Tarran, R; Salathe, M				Manzanares, Dahis; Krick, Stefanie; Baumlin, Nathalie; Dennis, John S.; Tyrrell, Jean; Tarran, Robert; Salathe, Matthias			Airway Surface Dehydration by Transforming Growth Factor beta (TGF-beta) in Cystic Fibrosis Is Due to Decreased Function of a Voltage-dependent Potassium Channel and Can Be Rescued by the Drug Pirfenidone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-CELLS; LIQUID VOLUME; LARGE-CONDUCTANCE; CFTR POTENTIATOR; LUNG-DISEASE; K+ CHANNELS; PATHOGENESIS; LAYER; ION	Transforming growth factor beta 1 (TGF-beta 1) is not only elevated in airways of cystic fibrosis (CF) patients, whose airways are characterized by abnormal ion transport and mucociliary clearance, but TGF-beta 1 is also associated with worse clinical outcomes. Effective mucociliary clearance depends on adequate airway hydration, governed by ion transport. Apically expressed, large-conductance, Ca2+- and voltage-dependent K+ (BK) channels play an important role in this process. In this study, TGF-beta 1 decreased airway surface liquid volume, ciliary beat frequency, and BK activity in fully differentiated CF bronchial epithelial cells by reducing mRNA expression of the BK gamma subunit leucine-rich repeat-containing protein 26 (LRRC26) and its function. Although LRRC26 knockdown itself reduced BK activity, LRRC26 overexpression partially reversed TGF-beta 1-induced BK dysfunction. TGF-beta 1-induced airway surface liquid volume hyper-absorption was reversed by the BK opener mallotoxin and the clinically useful TGF-beta signaling inhibitor pirfenidone. The latter increased BK activity via rescue of LRRC26. Therefore, we propose that TGF-beta 1-induced mucociliary dysfunction in CF airways is associated with BK inactivation related to a LRRC26 decrease and is amenable to treatment with clinically useful TGF-beta 1 inhibitors.	[Manzanares, Dahis; Krick, Stefanie; Baumlin, Nathalie; Dennis, John S.; Salathe, Matthias] Univ Miami, Div Pulm Allergy Crit Care & Sleep Med, Miami, FL 33136 USA; [Tyrrell, Jean; Tarran, Robert] Univ N Carolina, Cyst Fibrosis Ctr, Chapel Hill, NC 27599 USA	University of Miami; University of North Carolina; University of North Carolina Chapel Hill	Salathe, M (corresponding author), Univ Miami, Miller Sch Med, Div Pulm Allergy Crit Care & Sleep Med, 1600 N-W 10th Ave,RMSB 7061 R-47, Miami, FL 33136 USA.	msalathe@med.miami.edu		Salathe, Matthias/0000-0001-9092-4861	Cystic Fibrosis Foundation	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by a grant from the Cystic Fibrosis Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Almassy J, 2012, MOL PHARMACOL, V81, P21, DOI 10.1124/mol.111.075234; Arkwright PD, 2000, THORAX, V55, P459, DOI 10.1136/thorax.55.6.459; Bentzen BH, 2007, MOL PHARMACOL, V72, P1033, DOI 10.1124/mol.107.038331; Boucher RC, 2003, PFLUG ARCH EUR J PHY, V445, P495, DOI 10.1007/s00424-002-0955-1; Boucher RC, 2002, ADV DRUG DELIVER REV, V54, P1359, DOI 10.1016/S0169-409X(02)00144-8; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Collaco JM, 2008, CURR OPIN PULM MED, V14, P559, DOI 10.1097/MCP.0b013e3283121cdc; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Guillot L, 2014, INT J BIOCHEM CELL B, V52, P83, DOI 10.1016/j.biocel.2014.02.011; Harris WT, 2009, PEDIATR PULM, V44, P1057, DOI 10.1002/ppul.21079; Harvey PR, 2011, AM J RESP CELL MOL, V45, P592, DOI 10.1165/rcmb.2010-0484OC; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Manzanares D, 2014, AM J PHYSIOL-LUNG C, V306, pL453, DOI 10.1152/ajplung.00247.2013; Manzanares D, 2011, J BIOL CHEM, V286, P19830, DOI 10.1074/jbc.M110.185074; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Perkett EA, 2006, PEDIATR PULM, V41, P771, DOI 10.1002/ppul.20452; Peters DM, 2014, P NATL ACAD SCI USA, V111, pE374, DOI 10.1073/pnas.1306798111; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Ratjen F, 2012, J CYST FIBROS, V11, P539, DOI 10.1016/j.jcf.2012.05.003; Roomans Godfried M, 2004, J Cyst Fibros, V3 Suppl 2, P135, DOI 10.1016/j.jcf.2004.05.029; Salathe M, 1999, J PHYSIOL-LONDON, V520, P851, DOI 10.1111/j.1469-7793.1999.00851.x; Schmid A, 2006, J CELL SCI, V119, P4176, DOI 10.1242/jcs.03181; Snodgrass SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063167; Sun HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106842; Tarran Robert, 2004, Proc Am Thorac Soc, V1, P42, DOI 10.1513/pats.2306014; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Yan JS, 2012, P NATL ACAD SCI USA, V109, P7917, DOI 10.1073/pnas.1205435109; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162	29	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25710	25716		10.1074/jbc.M115.670885	http://dx.doi.org/10.1074/jbc.M115.670885			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26338706	Green Published, hybrid			2022-12-28	WOS:000362962800042
J	Xiong, C; Liu, XF; Meng, AM				Xiong, Cong; Liu, Xingfeng; Meng, Anming			The Kinase Activity-deficient Isoform of the Protein Araf Antagonizes Ras/Mitogen-activated Protein Kinase (Ras/MAPK) Signaling in the Zebrafish Embryo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENDODERM INDUCTION; FGF; SMAD2; RAS	Raf kinases are important components of the Ras-Raf-Mek-Erk pathway and also cross-talk with other signaling pathways. Araf kinase has been demonstrated to inhibit TGF-beta/Smad2 signaling by directly phosphorylating and accelerating degradation of activated Smad2. In this study, we show that the araf gene expresses in zebrafish embryos to produce a shorter transcript variant, araf-tv2, in addition to the full-length variant araf-tv1. araf-tv2 is predicted to encode a C-terminally truncated peptide without the kinase activity domain. Araf-tv2 can physically associate with Araf-tv1 but does not antagonize the inhibitory effect of Araf-tv1 on TGF-beta/Smad2 signaling. Instead, Araf-tv2 interacts strongly with Kras and Nras, ultimately blocking MAPK activation by these Ras proteins. In zebrafish embryos, overexpression of araf-tv2 is sufficient to inhibit Fgf/Ras-promoted Erk activation, mesodermal induction, dorsal development, and neuroectodermal posteriorization. Therefore, different isoforms of Araf may participate in similar developmental processes but by regulating different signaling pathways.	[Xiong, Cong; Liu, Xingfeng; Meng, Anming] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Membrane Biol, Beijing 10084, Peoples R China	Tsinghua University	Meng, AM (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 10084, Peoples R China.	mengam@mail.tsinghua.edu.cn	Meng, Anming/A-4785-2012	Meng, Anming/0000-0001-7228-3431	Major Science Programs of China [2011CB943800]; National Natural Science Foundation of China [31330052, 31221064]	Major Science Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Major Science Programs of China (#2011CB943800) and from the National Natural Science Foundation of China (#31330052 and #31221064). The authors declare that they have no conflicts of interest with the contents of this article.	Cao Y, 2004, DEV BIOL, V271, P130, DOI 10.1016/j.ydbio.2004.03.032; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Furthauer M, 1997, DEVELOPMENT, V124, P4253; Furthauer M, 2004, DEVELOPMENT, V131, P2853, DOI 10.1242/dev.01156; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Jia SJ, 2008, J BIOL CHEM, V283, P2418, DOI 10.1074/jbc.M707578200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Langdon YG, 2011, ANNU REV GENET, V45, P357, DOI 10.1146/annurev-genet-110410-132517; Liu XF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2762; Maegawa S, 2006, DEVELOPMENT, V133, P3265, DOI 10.1242/dev.02483; Mathieu J, 2004, DEVELOPMENT, V131, P629, DOI 10.1242/dev.00964; Nekhoroshkova E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004647; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Sundaram MV, 2006, WORMBOOK, V11, P1; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Tian T, 2006, CELL MOL LIFE SCI, V63, P672, DOI 10.1007/s00018-005-5503-7; Weber CK, 2000, ONCOGENE, V19, P169, DOI 10.1038/sj.onc.1203261; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wimmer R, 2010, TRENDS BIOCHEM SCI, V35, P660, DOI 10.1016/j.tibs.2010.06.001; Xu PF, 2014, J MOL CELL BIOL, V6, P272, DOI 10.1093/jmcb/mju028; Yokoyama T, 2007, J CELL BIOL, V177, P781, DOI 10.1083/jcb.200703195	22	6	7	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25512	25521		10.1074/jbc.M115.676726	http://dx.doi.org/10.1074/jbc.M115.676726			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26306042	hybrid, Green Published			2022-12-28	WOS:000362962800026
J	Ariotti, N; Rae, J; Leneva, N; Ferguson, C; Loo, D; Okano, S; Hill, MM; Walser, P; Collins, BM; Parton, RG				Ariotti, Nicholas; Rae, James; Leneva, Natalya; Ferguson, Charles; Loo, Dorothy; Okano, Satomi; Hill, Michelle M.; Walser, Piers; Collins, Brett M.; Parton, Robert G.			Molecular Characterization of Caveolin-induced Membrane Curvature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAP KINASE CASCADE; C-TERMINAL DOMAIN; SCAFFOLDING DOMAIN; IN-VIVO; BINDING DOMAIN; PLASMA-MEMBRANE; GOLGI-COMPLEX; LIPID BODIES; CHOLESTEROL; PROTEIN	The generation of caveolae involves insertion of the cholesterol-binding integral membrane protein caveolin-1 (Cav1) into the membrane, however, the precise molecular mechanisms are as yet unknown. Wehave speculated that insertion of the caveolin scaffolding domain (CSD), a conserved amphipathic region implicated in interactions with signaling proteins, is crucial for caveola formation. We now define the core membrane-juxtaposed region of Cav1 and show that the oligomerization domain and CSD are protected by tight association with the membrane in both mature mammalian caveolae and a model prokaryotic system for caveola biogenesis. Cryoelectron tomography reveals the core membrane-juxtaposed domain to be sufficient to maintain oligomerization as defined by polyhedral distortion of the caveolar membrane. Through mutagenesis we demonstrate the importance of the membrane association of the oligomerization domain/CSD for defined caveola biogenesis and furthermore, highlight the functional significance of the intramembrane domain and the CSD for defined caveolin-induced membrane deformation. Finally, we define the core structural domain of Cav1, constituting only 66 amino acids and of great potential to nanoengineering applications, which is required for caveolin- induced vesicle formation in a bacterial system. These results have significant implications for understanding the role of Cav1 in caveola formation and in regulating cellular signaling events.	[Ariotti, Nicholas; Rae, James; Leneva, Natalya; Ferguson, Charles; Okano, Satomi; Walser, Piers; Collins, Brett M.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Loo, Dorothy; Hill, Michelle M.] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland; University of Queensland	Parton, RG (corresponding author), Univ Queensland, Inst Mol Biosci, Div Mol & Cellular Biol, 306 Carmody Rd, St Lucia, Qld 4072, Australia.	r.parton@imb.uq.edu.au	Ariotti, Nicholas/GXH-4833-2022; Hill, Michelle Mei Chih/G-4417-2010; Okano, Satomi/AAX-9546-2021; Collins, Brett/J-1563-2014; Parton, Robert/C-5673-2009	Hill, Michelle Mei Chih/0000-0003-1134-0951; Okano, Satomi/0000-0003-4913-9612; Ariotti, Nicholas/0000-0003-3901-0831; Leneva, Natalya/0000-0001-8102-9769; Collins, Brett/0000-0002-6070-3774; Parton, Robert/0000-0002-7494-5248	National Institutes of Health [P41 RR001081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We acknowledge the use of the Australian Microscopy and Microanalysis Research Facility at the Center for Microscopy and Microanalysis at The University of Queensland. We also acknowledge Professor Ulf Skoglund for generously donating his time to peruse the manuscript. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Bio-computing, Visualization, and Informatics at the University of California San Francisco, CA, supported by National Institutes of Health Grant P41 RR001081.	Ariotti N, 2014, J CELL BIOL, V204, P777, DOI 10.1083/jcb.201307055; Benferhat R, 2009, MOL IMMUNOL, V46, P705, DOI 10.1016/j.molimm.2008.10.001; Benferhat R, 2009, VACCINE, V27, P3620, DOI 10.1016/j.vaccine.2009.03.057; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Byrne DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044879; Collins BM, 2012, DEV CELL, V23, P11, DOI 10.1016/j.devcel.2012.06.012; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Couvreur P, 2006, PHARM RES-DORDR, V23, P1417, DOI 10.1007/s11095-006-0284-8; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; Fielding PE, 2004, BIOCHEMISTRY-US, V43, P2578, DOI 10.1021/bi035442c; Foti M, 2007, P NATL ACAD SCI USA, V104, P1242, DOI 10.1073/pnas.0610523104; Frangakis AS, 2001, J STRUCT BIOL, V135, P239, DOI 10.1006/jsbi.2001.4406; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Head BP, 2007, TRENDS CELL BIOL, V17, P51, DOI 10.1016/j.tcb.2006.11.008; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hoop CL, 2012, BIOCHEMISTRY-US, V51, P90, DOI 10.1021/bi201356v; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Ingelmo-Torres M, 2009, TRAFFIC, V10, P1785, DOI 10.1111/j.1600-0854.2009.00994.x; Kim JH, 2014, BIOCHEMISTRY-US, V53, P4320, DOI 10.1021/bi5005238; Kirkham M, 2008, J CELL SCI, V121, P2075, DOI 10.1242/jcs.024588; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Le Lan C, 2006, FEBS LETT, V580, P5301, DOI 10.1016/j.febslet.2006.08.075; Le Lan C, 2010, EUR BIOPHYS J BIOPHY, V39, P307, DOI 10.1007/s00249-009-0548-4; Lee H, 2002, AM J PATHOL, V161, P1357, DOI 10.1016/S0002-9440(10)64412-4; Lee JW, 2012, BBA-BIOMEMBRANES, V1818, P1158, DOI 10.1016/j.bbamem.2011.12.033; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; LISANTI MP, 1995, MOL MEMBR BIOL, V12, P121, DOI 10.3109/09687689509038506; Luetterforst R, 1999, J CELL BIOL, V145, P1443, DOI 10.1083/jcb.145.7.1443; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Nomura R, 1999, MOL BIOL CELL, V10, P975, DOI 10.1091/mbc.10.4.975; Noske AB, 2008, J STRUCT BIOL, V161, P298, DOI 10.1016/j.jsb.2007.09.015; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Richter T, 2008, TRAFFIC, V9, P893, DOI 10.1111/j.1600-0854.2008.00733.x; Rieth MD, 2012, BIOCHEMISTRY-US, V51, P3911, DOI 10.1021/bi3001853; Rui H, 2014, BIOPHYS J, V106, P1371, DOI 10.1016/j.bpj.2014.02.005; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Schlegel A, 2000, J BIOL CHEM, V275, P21605, DOI 10.1074/jbc.M002558200; Schlegel A, 1999, J BIOL CHEM, V274, P22660, DOI 10.1074/jbc.274.32.22660; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Song KS, 1997, J BIOL CHEM, V272, P4398, DOI 10.1074/jbc.272.7.4398; Spisni E, 2005, BIOCHEM BIOPH RES CO, V338, P1383, DOI 10.1016/j.bbrc.2005.10.099; Stachowiak JC, 2013, NAT CELL BIOL, V15, P1019, DOI 10.1038/ncb2832; Walser PJ, 2012, CELL, V150, P752, DOI 10.1016/j.cell.2012.06.042; Yang GH, 2015, BIOPOLYMERS, V104, P11, DOI 10.1002/bip.22597; Yang GH, 2014, BBA-BIOMEMBRANES, V1838, P2588, DOI 10.1016/j.bbamem.2014.06.018	54	60	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24875	24890		10.1074/jbc.M115.644336	http://dx.doi.org/10.1074/jbc.M115.644336			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26304117	Green Published, hybrid			2022-12-28	WOS:000362598300021
J	Heine, CL; Schmidt, R; Geckl, K; Schrammel, A; Gesslbauer, B; Schmidt, K; Mayer, B; Gorren, ACF				Heine, Christian L.; Schmidt, Renate; Geckl, Kerstin; Schrammel, Astrid; Gesslbauer, Bernd; Schmidt, Kurt; Mayer, Bernd; Gorren, Antonius C. F.			Selective Irreversible Inhibition of Neuronal and Inducible Nitric-oxide Synthase in the Combined Presence of Hydrogen Sulfide and Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-NITROSYLATION; ENZYME-ACTIVITY; H2S; TETRAHYDROBIOPTERIN; NITROSATION; CHEMISTRY; NITROGEN; BIOLOGY; NO; AUTOINHIBITION	Citrulline formation by both human neuronal nitric-oxide synthase (nNOS) and mouse macrophage inducible NOS was inhibited by the hydrogen sulfide (H2S) donor Na2S with IC50 values of similar to 2.4.10(-5) and similar to 7.9.10(-5) (M), respectively, whereas human endothelial NOS was hardly affected at all. Inhibition of nNOS was not affected by the concentrations of L-arginine (Arg), NADPH, FAD, FMN, tetrahydrobiopterin (BH4), and calmodulin, indicating that H2S does not interfere with substrate or cofactor binding. The IC50 decreased to similar to 1.5.10(-5) (M) at pH 6.0 and increased to similar to 8.3.10(-5) (M) at pH 8.0. Preincubation of concentrated nNOS with H2S under turnover conditions decreased activity after dilution by similar to 70%, suggesting irreversible inhibition. However, when calmodulin was omitted during preincubation, activity was not affected, suggesting that irreversible inhibition requires both H2S and NO. Likewise, NADPH oxidation was inhibited with an IC50 of similar to 1.9.10(-5) M in the presence of Arg and BH4 but exhibited much higher IC50 values (similar to 1.0-6.1.10(-4) (M)) when Arg and/or BH4 was omitted. Moreover, the relatively weak inhibition of nNOS by Na2S in the absence of Arg and/or BH4 was markedly potentiated by the NO donor 1-(hydroxy-NNO-azoxy)-L-proline, disodium salt (IC50 similar to 1.3-2.0.10(-5) (M)). These results suggest that nNOS and inducible NOS but not endothelial NOS are irreversibly inhibited by H2S/NOat modest concentrations of H2S in a reaction that may allow feedback inhibition of NO production under conditions of excessive NO/H2S formation.	[Heine, Christian L.; Schmidt, Renate; Geckl, Kerstin; Schrammel, Astrid; Schmidt, Kurt; Mayer, Bernd; Gorren, Antonius C. F.] Karl Franzens Univ Graz, Inst Pharmaceut Sci, Dept Pharmacol & Toxicol, A-8010 Graz, Austria; [Gesslbauer, Bernd] Karl Franzens Univ Graz, Inst Pharmaceut Sci, Dept Pharmaceut Chem, A-8010 Graz, Austria	University of Graz; University of Graz	Gorren, ACF (corresponding author), Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, Humboldtstr 46, A-8010 Graz, Austria.	antonius.gorren@uni-graz.at	Gesslbauer, Bernd/U-4033-2018	Gesslbauer, Bernd/0000-0003-4910-8322; Gorren, Antonius Cornelis Franciscus/0000-0003-3476-6162; Mayer, Bernd/0000-0002-2921-3494	Austrian Science Fund (FWF) [P23135, P24946]; Austrian Science Fund (FWF) [P 23135] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Grants P23135 (to A. C. F. G.) and P24946 (to B. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P17349, DOI 10.1074/jbc.M000050200; ABUSOUD HM, 1995, J BIOL CHEM, V270, P22997, DOI 10.1074/jbc.270.39.22997; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Altaany Z, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005478; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bucci M, 2010, ARTERIOSCL THROM VAS, V30, P1998, DOI 10.1161/ATVBAHA.110.209783; Chen CA, 2013, BIOCHEMISTRY-US, V52, P6712, DOI 10.1021/bi400404s; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Cortese-Krott MM, 2015, NITRIC OXIDE-BIOL CH, V46, P14, DOI 10.1016/j.niox.2014.12.009; Cortese-Krott MM, 2014, REDOX BIOL, V2, P234, DOI 10.1016/j.redox.2013.12.031; Crabtree MJ, 2013, J BIOL CHEM, V288, P561, DOI 10.1074/jbc.M112.415992; Eberhardt M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5381; Erwin PA, 2005, J BIOL CHEM, V280, P19888, DOI 10.1074/jbc.M413058200; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Francoleon NE, 2011, ARCH BIOCHEM BIOPHYS, V516, P146, DOI 10.1016/j.abb.2011.09.015; Fukuto JM, 2012, CHEM RES TOXICOL, V25, P769, DOI 10.1021/tx2005234; Gao YS, 2010, PFLUG ARCH EUR J PHY, V459, P829, DOI 10.1007/s00424-009-0773-9; Gorren ACF, 2000, BIOCHEM J, V347, P475, DOI 10.1042/0264-6021:3470475; Gorren ACF, 1997, BIOCHEMISTRY-US, V36, P4360, DOI 10.1021/bi962381s; Gorren ACF, 2002, CURR DRUG METAB, V3, P133, DOI 10.2174/1389200024605154; Gorren ACF, 2007, BBA-GEN SUBJECTS, V1770, P432, DOI 10.1016/j.bbagen.2006.08.019; Hemmens B, 2000, J BIOL CHEM, V275, P35786, DOI 10.1074/jbc.M005976200; HERSHEY JP, 1988, GEOCHIM COSMOCHIM AC, V52, P2047, DOI 10.1016/0016-7037(88)90183-4; Kimura H, 2014, ANTIOXID REDOX SIGN, V20, P783, DOI 10.1089/ars.2013.5309; King SB, 2013, FREE RADICAL BIO MED, V55, P1, DOI 10.1016/j.freeradbiomed.2012.11.005; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Kolesnik B, 2014, FREE RADICAL BIO MED, V76, P286, DOI 10.1016/j.freeradbiomed.2014.08.024; Kolesnik B, 2013, FREE RADICAL BIO MED, V63, P51, DOI 10.1016/j.freeradbiomed.2013.04.034; Kolluru GK, 2013, REDOX BIOL, V1, P313, DOI 10.1016/j.redox.2013.05.001; Kolluru GK, 2013, NITRIC OXIDE-BIOL CH, V35, P5, DOI 10.1016/j.niox.2013.07.002; Kotsonis P, 1999, BIOCHEM J, V340, P745, DOI 10.1042/0264-6021:3400745; Kubo A, 2007, TOXICOLOGY, V241, P92, DOI 10.1016/j.tox.2007.08.087; Kubo S, 2007, TOXICOLOGY, V232, P138, DOI 10.1016/j.tox.2006.12.023; Laggner H, 2007, J HYPERTENS, V25, P2100, DOI 10.1097/HJH.0b013e32829b8fd0; Leber A, 1999, J BIOL CHEM, V274, P37658, DOI 10.1074/jbc.274.53.37658; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Li Q, 2013, NITRIC OXIDE-BIOL CH, V35, P21, DOI 10.1016/j.niox.2013.07.001; List BM, 1997, BIOCHEM J, V323, P159, DOI 10.1042/bj3230159; Lo Faro ML, 2014, NITRIC OXIDE-BIOL CH, V41, P38, DOI 10.1016/j.niox.2014.05.014; MAYER B, 1994, NEUROPHARMACOLOGY, V33, P1253, DOI 10.1016/0028-3908(94)90024-8; Mayer B, 1996, METHOD ENZYMOL, V268, P420; MAYER B, 1991, FEBS LETT, V288, P187, DOI 10.1016/0014-5793(91)81031-3; Mitchell DA, 2005, BIOCHEMISTRY-US, V44, P4636, DOI 10.1021/bi0474463; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Olson KR, 2014, NITRIC OXIDE-BIOL CH, V41, P11, DOI 10.1016/j.niox.2014.05.012; Panda K, 2002, J BIOL CHEM, V277, P31020, DOI 10.1074/jbc.M203749200; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Qu ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052788; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; Ravi K, 2004, P NATL ACAD SCI USA, V101, P2619, DOI 10.1073/pnas.0300464101; Wedmann R, 2014, NITRIC OXIDE-BIOL CH, V41, P85, DOI 10.1016/j.niox.2014.06.003; Wei CC, 2003, CHEM REV, V103, P2365, DOI 10.1021/cr0204350; Whiteman M, 2009, J CELL MOL MED, V13, P488, DOI 10.1111/j.1582-4934.2009.00645.x; Wu CQ, 1996, BIOCHEM BIOPH RES CO, V222, P439, DOI 10.1006/bbrc.1996.0763	54	14	14	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24932	24944		10.1074/jbc.M115.660316	http://dx.doi.org/10.1074/jbc.M115.660316			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26296888	Green Published, hybrid			2022-12-28	WOS:000362598300025
J	Herrmann, J; Nathin, D; Lee, SG; Sun, T; Jez, JM				Herrmann, Jonathan; Nathin, David; Lee, Soon Goo; Sun, Tony; Jez, Joseph M.			Recapitulating the Structural Evolution of Redox Regulation in Adenosine 5 '-Phosphosulfate Kinase from Cyanobacteria to Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-CYSTEINE LIGASE; SOYBEAN ATP SULFURYLASE; CRYSTAL-STRUCTURE; APS-KINASE; ADENOSINE-5'-PHOSPHOSULFATE KINASE; PENICILLIUM-CHRYSOGENUM; SULFATE ASSIMILATION; NUCLEOTIDE-BINDING; METABOLISM; MECHANISM	In plants, adenosine 5'-phosphosulfate (APS) kinase (APSK) is required for reproductive viability and the production of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) as a sulfur donor in specialized metabolism. Previous studies of the APSK from Arabidopsis thaliana (AtAPSK) identified a regulatory disulfide bond formed between the N-terminal domain (NTD) and a cysteine on the core scaffold. This thiol switch is unique to mosses, gymnosperms, and angiosperms. To understand the structural evolution of redox control of APSK, we investigated the redox-insensitive APSK from the cyanobacterium Synechocystis sp. PCC6803 (SynAPSK). Crystallographic analysis of SynAPSK in complex with either APS and a non-hydrolyzable ATP analog or APS and sulfate revealed the overall structure of the enzyme, which lacks the NTD found in homologs from mosses and plants. A series of engineered SynAPSK variants reconstructed the structural evolution of the plant APSK. Biochemical analyses of SynAPSK, SynAPSK H23C mutant, SynAPSK fused to the AtAPSK NTD, and the fusion protein with the H23C mutation showed that the addition of the NTD and cysteines recapitulated thiol-based regulation. These results reveal the molecular basis for structural changes leading to the evolution of redox control of APSK in the green lineage from cyanobacteria to plants.	[Herrmann, Jonathan; Nathin, David; Lee, Soon Goo; Sun, Tony; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu		Lee, Soon Goo/0000-0002-1541-8587	National Science Foundation [MCB-0904215]; American Society of Plant Biologists	National Science Foundation(National Science Foundation (NSF)); American Society of Plant Biologists	This work was supported by Grant MCB-0904215 from the National Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Summer Undergraduate Research Fellowship from the American Society of Plant Biologists.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen A, 2004, BIOCHEMISTRY-US, V43, P14431, DOI 10.1021/bi048817i; ASAHI T, 1964, BIOCHIM BIOPHYS ACTA, V82, P58, DOI 10.1016/0304-4165(64)90007-8; Ballicora MA, 2005, J BIOL CHEM, V280, P10189, DOI 10.1074/jbc.M413540200; Bick JA, 2001, BIOCHEMISTRY-US, V40, P9040, DOI 10.1021/bi010518v; Carter CW, 2014, J BIOL CHEM, V289, P30213, DOI 10.1074/jbc.R114.567495; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Gay SC, 2009, ACTA CRYSTALLOGR D, V65, P1021, DOI 10.1107/S0907444909026547; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gromes R, 2008, PLANT J, V54, P1063, DOI 10.1111/j.1365-313X.2008.03477.x; Harjes S, 2005, J MOL BIOL, V347, P623, DOI 10.1016/j.jmb.2005.01.005; Harms MJ, 2013, NAT REV GENET, V14, P559, DOI 10.1038/nrg3540; Hatzios SK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002036; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Herrmann J, 2014, J BIOL CHEM, V289, P10919, DOI 10.1074/jbc.M113.540401; Hicks LM, 2007, PLANT CELL, V19, P2653, DOI 10.1105/tpc.107.052597; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hothorn M, 2006, J BIOL CHEM, V281, P27557, DOI 10.1074/jbc.M602770200; Jez JM, 2004, J BIOL CHEM, V279, P33463, DOI 10.1074/jbc.M405127200; Kopriva S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00163; Koprivova A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00589; Lansdon EB, 2002, BIOCHEMISTRY-US, V41, P13672, DOI 10.1021/bi026556b; Lillig CH, 2001, ARCH BIOCHEM BIOPHYS, V392, P303, DOI 10.1006/abbi.2001.2453; MacRae IJ, 2000, BIOCHEMISTRY-US, V39, P1613, DOI 10.1021/bi9924157; MacRae IJ, 2001, BIOCHEMISTRY-US, V40, P6795, DOI 10.1021/bi010367w; Martin MN, 2005, PHOTOSYNTH RES, V86, P309, DOI 10.1007/s11120-005-9006-z; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; Mueller JW, 2013, FEBS J, V280, P3050, DOI 10.1111/febs.12252; Mugford SG, 2010, FEBS LETT, V584, P119, DOI 10.1016/j.febslet.2009.11.014; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; OSSLUND T, 1982, PLANT PHYSIOL, V70, P39, DOI 10.1104/pp.70.1.39; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palde PB, 2015, P NATL ACAD SCI USA, V112, P7960, DOI 10.1073/pnas.1504376112; Perez-Jimenez R, 2011, NAT STRUCT MOL BIOL, V18, P592, DOI 10.1038/nsmb.2020; Phartiyal P, 2006, ARCH BIOCHEM BIOPHYS, V450, P20, DOI 10.1016/j.abb.2006.03.033; Prioretti L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00597; Ravilious GE, 2013, BIOSCIENCE REP, V33, P585, DOI 10.1042/BSR20130073; Ravilious GE, 2013, J BIOL CHEM, V288, P6107, DOI 10.1074/jbc.M112.439414; Ravilious GE, 2012, NAT PROD REP, V29, P1138, DOI 10.1039/c2np20009k; Ravilious GE, 2012, J BIOL CHEM, V287, P30385, DOI 10.1074/jbc.M112.387001; Ravilious GE, 2012, P NATL ACAD SCI USA, V109, P309, DOI 10.1073/pnas.1115772108; RENOSTO F, 1985, J BIOL CHEM, V260, P1903; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Satishchandran C, 2000, ARCH BIOCHEM BIOPHYS, V378, P210, DOI 10.1006/abbi.2000.1841; Schnell R, 2010, BIOCHEM BIOPH RES CO, V396, P33, DOI 10.1016/j.bbrc.2010.02.118; Sekulic N, 2007, J MOL BIOL, V367, P488, DOI 10.1016/j.jmb.2007.01.025; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; van der Ploeg JR, 2001, ARCH MICROBIOL, V176, P1, DOI 10.1007/s002030100298; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Yatusevich R, 2010, PLANT J, V62, P1, DOI 10.1111/j.1365-313X.2009.04118.x; Yi H, 2010, AMINO ACIDS, V39, P963, DOI 10.1007/s00726-010-0572-9; Yi H, 2010, MOL PLANT, V3, P269, DOI 10.1093/mp/ssp112; Yu ZH, 2007, J MOL BIOL, V365, P732, DOI 10.1016/j.jmb.2006.10.035; Zhang M, 2012, J AM CHEM SOC, V134, P16979, DOI 10.1021/ja3078522	57	6	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24705	24714		10.1074/jbc.M115.679514	http://dx.doi.org/10.1074/jbc.M115.679514			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26294763	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000362598300007
J	Riquelme, MA; Burra, S; Kar, R; Lampe, PD; Jiang, JX				Riquelme, Manuel A.; Burra, Sirisha; Kar, Rekha; Lampe, Paul D.; Jiang, Jean X.			Mitogen-activated Protein Kinase (MAPK) Activated by Prostaglandin E2 Phosphorylates Connexin 43 and Closes Osteocytic Hemichannels in Response to Continuous Flow Shear Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; MECHANICAL STRAIN; ERK ACTIVATION; UP-REGULATION; CELLS; RELEASE; RECEPTOR; PGE(2); RATS; E-2	Cx43 hemichannels serve as a portal for the release of prostaglandins, a critical process in mediating biological responses of mechanical loading on bone formation and remodeling. We have previously observed that fluid flow shear stress (FESS) opens hemichannels; however, sustained FESS results in hemichannel closure, as continuous opening of hemichannels is detrimental to cell viability and bone remodeling. However, the mechanism that regulates the closure of the hemichannels is unknown. Here, we show that activation of p44/42 ERK upon continuous ITSS leads to Cx43 phosphorylation at Ser(279)-Ser(282), sites known to be phosphorylated sites by p44/42 MAPK. Incubation of osteocytic MLO-Y4 cells with conditioned media (CM) collected after continuous FESS increased MAPK-dependent phosphorylation of Cx43. CM treatment inhibited hemichannel opening and this inhibition was reversed when cells were pretreated with the MAPK pathway inhibitor. We found that prostaglandin E-2 (PGE(2)) accumulates in the CM in a time-dependent manner. Treatment with PGE, increased phosphop44/42 ERK levels and also Cx43 phosphorylation at Ser(279)-Ser(282) sites. Depletion of PGE(2) from CM, and pre-treatment with a p44/42 ERK pathway-specific inhibitor, resulted in a complete inhibition of ERK-dependent Cx43 phosphorylation and attenuated the inhibition of hemichannels by CM and PGE(2). Consistently, the opening of hemichannels by FESS was blocked by PGE, and CM and this blockage was reversed by U0126 and the CM depleted of PGE(2). A similar observation was also obtained in isolated primary osteocytes. Together, results from this study suggest that extracellular PGE(2) accumulated after continuous FFSS is responsible for activation of p44/42 ERK signaling and subsequently, direct Cx43 phosphorylation by activated ERK leads to hemichannel closure.	[Riquelme, Manuel A.; Burra, Sirisha; Kar, Rekha; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Lampe, Paul D.] Fred Hutchinson Canc Res Ctr, Translat Res Program, Seattle, WA 98109 USA	University of Texas System; University of Texas Health San Antonio; Fred Hutchinson Cancer Center	Jiang, JX (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Riquelme, Manuel/B-1082-2015; Regan, Clinton/E-6250-2012	Riquelme, Manuel/0000-0002-1915-0434; Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [AR46798, GM55632]; Welch Foundation [AQ-1507]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR046798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR46798 and GM55632 and Welch Foundation Grant AQ-1507. We declare that they have no conflicts of interest with the contents of this article.	Ajubi NE, 1996, BIOCHEM BIOPH RES CO, V225, P62, DOI 10.1006/bbrc.1996.1131; Bao XY, 2007, P NATL ACAD SCI USA, V104, P4919, DOI 10.1073/pnas.0603154104; Batra N, 2014, J BIOL CHEM, V289, P10582, DOI 10.1074/jbc.M114.550608; Bonewald Lynda F, 2006, Bonekey Osteovision, V3, P7; Burra S, 2010, P NATL ACAD SCI USA, V107, P13648, DOI 10.1073/pnas.1009382107; Cheng BX, 2001, ENDOCRINOLOGY, V142, P3464, DOI 10.1210/en.142.8.3464; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Cherian PP, 2003, J BIOL CHEM, V278, P43146, DOI 10.1074/jbc.M302993200; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; Genetos DC, 2007, J CELL PHYSIOL, V212, P207, DOI 10.1002/jcp.21021; Harada S I, 1995, Connect Tissue Res, V31, P279, DOI 10.3109/03008209509010823; Johnson KE, 2013, MOL BIOL CELL, V24, P715, DOI 10.1091/mbc.E12-07-0537; Kajii T, 1999, ARCH ORAL BIOL, V44, P233, DOI 10.1016/S0003-9969(98)00120-4; KE HZ, 1992, CALCIFIED TISSUE INT, V50, P245, DOI 10.1007/BF00296289; Kitase Y, 2010, J BONE MINER RES, V25, P2381, DOI 10.1002/jbmr.168; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; OKUDA A, 1989, BONE MINER, V7, P255, DOI 10.1016/0169-6009(89)90082-2; Ono K, 2002, J BONE MINER RES, V17, P774, DOI 10.1359/jbmr.2002.17.5.774; Pahujaa M, 2007, EXP CELL RES, V313, P4083, DOI 10.1016/j.yexcr.2007.09.010; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Siller-Jackson AJ, 2008, J BIOL CHEM, V283, P26374, DOI 10.1074/jbc.M803136200; Solan JL, 2008, CELL COMMUN ADHES, V15, P75, DOI 10.1080/15419060802014016; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; TenBroek EM, 2001, J CELL BIOL, V155, P1307, DOI 10.1083/jcb.200102017; Tian XY, 2008, BONE, V42, P914, DOI 10.1016/j.bone.2007.12.228; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Warn-Cramer BJ, 1998, J BIOL CHEM, V273, P9188, DOI 10.1074/jbc.273.15.9188; Xia XC, 2010, MOL CELL BIOL, V30, P206, DOI 10.1128/MCB.01844-08; Yu L, 2009, INT J CANCER, V125, P2540, DOI 10.1002/ijc.24607	33	37	40	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28321	28328		10.1074/jbc.M115.683417	http://dx.doi.org/10.1074/jbc.M115.683417			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26442583	Green Published, hybrid			2022-12-28	WOS:000365761900024
J	Shen, L; Macnaughtan, MA; Frohlich, KM; Cong, YG; Goodwin, OY; Chou, CW; LeCour, L; Krup, K; Luo, M; Worthylake, DK				Shen, Li; Macnaughtan, Megan A.; Frohlich, Kyla M.; Cong, Yanguang; Goodwin, Octavia Y.; Chou, Chau-wen; LeCour, Louis, Jr.; Krup, Kristen; Luo, Miao; Worthylake, David K.			Multipart Chaperone-Effector Recognition in the Type III Secretion System of Chlamydia trachomatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBLIGATE INTRACELLULAR PATHOGEN; RNA-POLYMERASE; TEMPORAL EXPRESSION; PROTEIN SECRETION; GENE-EXPRESSION; COMPLEX; COPN; PROMOTER; VISUALIZATION; INSIGHTS	Secretion of effector proteins into the eukaryotic host cell is required for Chlamydia trachomatis virulence. In the infection process, Scc1 and Scc4, two chaperones of the type III secretion (T3S) system, facilitate secretion of the important effector and plug protein, CopN, but little is known about the details of this event. Here we use biochemistry, mass spectrometry, nuclear magnetic resonance spectroscopy, and genetic analyses to characterize this trimolecular event. We find that Scc4 complexes with Scc1 and CopN in situ at the late developmental cycle of C. trachomatis. We show that Scc4 and Scc1 undergo dynamic interactions as part of the unique bacterial developmental cycle. Using alanine substitutions, we identify several amino acid residues in Scc4 that are critical for the Scc4-Scc1 interaction, which is required for forming the Scc4.Scc1.CopN ternary complex. These results, combined with our previous findings that Scc4 plays a role in transcription (Rao, X., Deighan, P., Hua, Z., Hu, X., Wang, J., Luo, M., Wang, J., Liang, Y., Zhong, G., Hochschild, A., and Shen, L. (2009) Genes Dev. 23, 1818-1829), reveal that the T3S process is linked to bacterial transcriptional events, all of which are mediated by Scc4 and its interacting proteins. A model describing how the T3S process may affect gene expression is proposed.	[Shen, Li; Frohlich, Kyla M.; Cong, Yanguang; Krup, Kristen; Luo, Miao] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA; [LeCour, Louis, Jr.; Worthylake, David K.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Macnaughtan, Megan A.; Goodwin, Octavia Y.] Louisiana State Univ, Dept Chem, Baton Range, LA 70803 USA; [Chou, Chau-wen] Univ Georgia, Dept Chem, Athens, GA 30602 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; University System of Georgia; University of Georgia	Shen, L (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, 1901 Perdido St, New Orleans, LA 70112 USA.	lshen@lsuhsc.edu		Macnaughtan, Megan/0000-0003-4626-0062; Cong, Yanguang/0000-0001-6630-6078	NIAID, National Institutes of Health (NIH) [R01 AI055869, R56 AI093565]; Louisiana State University School of Medicine's Dean's Research Bridge Funding; Louisiana Center of Biomedical Research Excellence (COBRE) in Experimental Infectious Disease Research (CEIDR) NIGMS, NIH [P20GM110760]; NIGMS, NIH [R15GM109413]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093565, R01AI055869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110760, R15GM109413] Funding Source: NIH RePORTER	NIAID, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Louisiana State University School of Medicine's Dean's Research Bridge Funding; Louisiana Center of Biomedical Research Excellence (COBRE) in Experimental Infectious Disease Research (CEIDR) NIGMS, NIH; NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIAID, National Institutes of Health (NIH), Grants R01 AI055869 and R56 AI093565 and the Louisiana State University School of Medicine's Dean's Research Bridge Funding (to L. S.). This work is also supported by the Louisiana Center of Biomedical Research Excellence (COBRE) in Experimental Infectious Disease Research (CEIDR) NIGMS, NIH, Grant P20GM110760 and NIGMS, NIH, Grant R15GM109413 (to M. A. M). The authors declare that they have no conflicts of interest with the contents of this article.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Agaisse H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057090; Archuleta TL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004498; Archuleta TL, 2011, J BIOL CHEM, V286, P33992, DOI 10.1074/jbc.M111.258426; Bauler LD, 2014, J BACTERIOL, V196, P1325, DOI 10.1128/JB.01290-13; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Betts HJ, 2008, J BACTERIOL, V190, P1680, DOI 10.1128/JB.01671-07; Brinkworth AJ, 2011, MOL MICROBIOL, V82, P131, DOI 10.1111/j.1365-2958.2011.07802.x; Brutinel ED, 2008, CURR OPIN MICROBIOL, V11, P128, DOI 10.1016/j.mib.2008.02.010; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Button JE, 2011, MOL MICROBIOL, V81, P1474, DOI 10.1111/j.1365-2958.2011.07784.x; Case ED, 2010, J BACTERIOL, V192, P2569, DOI 10.1128/JB.00068-10; Choroszy-Krol I, 2014, ADV CLIN EXP MED, V23, P123, DOI 10.17219/acem/37035; Cooper CA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000751; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Day JB, 1998, MOL MICROBIOL, V30, P777, DOI 10.1046/j.1365-2958.1998.01110.x; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fadoulogiou VE, 2008, ANAL BIOCHEM, V373, P404, DOI 10.1016/j.ab.2007.10.027; Ferracci F, 2005, MOL MICROBIOL, V57, P970, DOI 10.1111/j.1365-2958.2005.04738.x; Fields KA, 2000, MOL MICROBIOL, V38, P1048, DOI 10.1046/j.1365-2958.2000.02212.x; Francis MS, 2010, CELL BIO RES PROG, P79; Golubeva YA, 2012, GENETICS, V190, P79, DOI 10.1534/genetics.111.132779; Hefty PS, 2007, J BACTERIOL, V189, P198, DOI 10.1128/JB.01034-06; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Janjusevic R, 2013, J BACTERIOL, V195, P658, DOI 10.1128/JB.01621-12; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Knodler LA, 2002, MOL MICROBIOL, V43, P1089, DOI 10.1046/j.1365-2958.2002.02820.x; Knodler LA, 2006, MOL MICROBIOL, V62, P928, DOI 10.1111/j.1365-2958.2006.05418.x; Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Montero-Diez C, 2013, J BACTERIOL, V195, P3621, DOI 10.1128/JB.00499-13; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Mueller KE, 2014, INFECT IMMUN, V82, P2, DOI 10.1128/IAI.00917-13; Nawrotek A, 2014, J BIOL CHEM, V289, P25199, DOI 10.1074/jbc.M114.568436; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Pais SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056292; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phan J, 2004, ACTA CRYSTALLOGR D, V60, P1591, DOI 10.1107/S0907444904017597; Plano GV, 2013, IMMUNOL RES, V57, P237, DOI 10.1007/s12026-013-8454-3; Rao XC, 2009, GENE DEV, V23, P1818, DOI 10.1101/gad.1784009; Rekart ML, 2013, J INFECT DIS, V207, P30, DOI 10.1093/infdis/jis644; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Severinova E, 1998, J MOL BIOL, V279, P9, DOI 10.1006/jmbi.1998.1742; Shaw EI, 2000, MOL MICROBIOL, V37, P913, DOI 10.1046/j.1365-2958.2000.02057.x; Silva-Herzog E, 2011, J BACTERIOL, V193, P3490, DOI 10.1128/JB.00203-11; Slepenkin A, 2005, J BACTERIOL, V187, P473, DOI 10.1128/JB.187.2.473-479.2005; Slepenkin A, 2003, INFECT IMMUN, V71, P2555, DOI 10.1128/IAI.71.5.2555-2562.2003; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Thibodeau SA, 2004, BIOTECHNIQUES, V36, P410, DOI 10.2144/04363BM07; Tree JJ, 2009, TRENDS MICROBIOL, V17, P361, DOI 10.1016/j.tim.2009.06.001; Vakulskas CA, 2010, J BACTERIOL, V192, P3597, DOI 10.1128/JB.00129-10; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Wang J, 2011, MICROBIOL-SGM, V157, P2759, DOI 10.1099/mic.0.044917-0; Wang YB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002258; Yuan AH, 2008, MOL MICROBIOL, V70, P1136, DOI 10.1111/j.1365-2958.2008.06462.x; Zhang L, 2007, BIOCHEM BIOPH RES CO, V361, P611, DOI 10.1016/j.bbrc.2007.07.089	61	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2015	290	47					28141	28155		10.1074/jbc.M115.670232	http://dx.doi.org/10.1074/jbc.M115.670232			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SD	26438824	hybrid, Green Published			2022-12-28	WOS:000365761900010
J	Effenberger, KA; James, RC; Urabe, VK; Dickey, BJ; Linington, RG; Jurica, MS				Effenberger, Kerstin A.; James, Robert C.; Urabe, Veronica K.; Dickey, Bailey J.; Linington, Roger G.; Jurica, Melissa S.			The Natural Product N-Palmitoyl-L-leucine Selectively Inhibits Late Assembly of Human Spliceosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITRO SPLICING ASSAY; RNA; SPLICEOSTATIN; COMPLEXES; ACID	The spliceosome is a dynamic complex of five structural RNAs and dozens of proteins, which assemble together to remove introns from nascent eukaryotic gene transcripts in a process called splicing. Small molecules that target different components of the spliceosome represent valuable research tools to investigate this complicated macromolecular machine. However, the current collection of spliceosome inhibitors is very limited. To expand the toolkit we used a high-throughput in vitro splicing assay to screen a collection of pre-fractions of natural compounds derived from marine bacteria for splicing inhibition. Further fractionation of initial hits generated individual peaks of splicing inhibitors that interfere with different stages of spliceosome assembly. With additional characterization of individual peaks, we identified N-palmitoyl-L-leucine as a new splicing inhibitor that blocks a late stage of spliceosome assembly. Structure-activity relationship analysis of the compound revealed that length of carbon chain is important for activity in splicing, as well as for effects on the cytological profile of cells in culture. Together these results demonstrate that our combination of in vitro splicing analysis with complex natural product libraries is a powerful strategy for identifying new small molecule tools with which to probe different aspects of spliceosome assembly and function.	[Effenberger, Kerstin A.; Urabe, Veronica K.; Jurica, Melissa S.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Effenberger, Kerstin A.; Urabe, Veronica K.; Jurica, Melissa S.] Univ Calif Santa Cruz, Ctr Mol Biol RNA, Santa Cruz, CA 95064 USA; [James, Robert C.; Dickey, Bailey J.; Linington, Roger G.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Linington, RG (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, 1156 High St, Santa Cruz, CA 95064 USA.	rliningt@ucsc.edu; mjurica@ucsc.edu	Linington, Roger/ABD-5582-2021; Regan, Clinton/E-6250-2012	Linington, Roger/0000-0003-1818-4971; 	NIH [1S10RR022455]; California Institute for Quantitative Biosciences [QB3]; United States Department of State; NATIONAL CANCER INSTITUTE [R01CA136762] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022455] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Quantitative Biosciences; United States Department of State; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank R. S. Lokey, W. Bray, and the UCSC Chemical Screening Center, supported by NIH 1S10RR022455 and grants from the California Institute for Quantitative Biosciences (QB3) and the United States Department of State for assistance with cytological profiling measurements.	Beller M, 1997, ANGEW CHEM INT EDIT, V36, P1494, DOI 10.1002/anie.199714941; Berg MG, 2012, MOL CELL BIOL, V32, P1271, DOI 10.1128/MCB.05788-11; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Das R, 1999, RNA, V5, P1504, DOI 10.1017/S1355838299991501; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Effenberger KA, 2014, J BIOL CHEM, V289, P1938, DOI 10.1074/jbc.M113.515536; Effenberger KA, 2013, J BIOMOL SCREEN, V18, P1110, DOI 10.1177/1087057113493117; Folco EG, 2011, GENE DEV, V25, P440, DOI 10.1101/gad.2009411; Jurica MS, 2008, NAT CHEM BIOL, V4, P3, DOI 10.1038/nchembio0108-3; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; PADGETT RA, 1983, P NATL ACAD SCI-BIOL, V80, P5230, DOI 10.1073/pnas.80.17.5230; Pawellek A, 2014, J BIOL CHEM, V289, P34683, DOI 10.1074/jbc.M114.590976; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; Roybal GA, 2010, NUCLEIC ACIDS RES, V38, P6664, DOI 10.1093/nar/gkq494; Samatov TR, 2012, CHEMBIOCHEM, V13, P640, DOI 10.1002/cbic.201100790; Schulze CJ, 2013, CHEM BIOL, V20, P285, DOI 10.1016/j.chembiol.2012.12.007; TAKEHARA M, 1972, J AM OIL CHEM SOC, V49, P157, DOI 10.1007/BF02633785; Tan B, 2010, J LIPID RES, V51, P112, DOI 10.1194/jlr.M900198-JLR200; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Woehrmann MH, 2013, MOL BIOSYST, V9, P2604, DOI 10.1039/c3mb70245f	21	18	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27524	27531		10.1074/jbc.M115.673210	http://dx.doi.org/10.1074/jbc.M115.673210			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26408199	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000365757500008
J	Huang, L; Liu, QF; Zhang, LJ; Zhang, Q; Hu, L; Li, CY; Wang, SN; Li, JN; Zhang, YF; Yu, HB; Wang, Y; Zhong, ZH; Xiong, T; Xia, XS; Wang, XJ; Yu, L; Deng, GH; Cai, XH; Cui, SJ; Weng, CJ				Huang, Li; Liu, Qinfang; Zhang, Lijie; Zhang, Quan; Hu, Liang; Li, Changyao; Wang, Shengnan; Li, Jiangnan; Zhang, Yuanfeng; Yu, Huibin; Wang, Yan; Zhong, Zhaohua; Xiong, Tao; Xia, Xueshan; Wang, Xiaojun; Yu, Li; Deng, Guohua; Cai, Xuehui; Cui, Shangjin; Weng, Changjiang			Encephalomyocarditis Virus 3C Protease Relieves TRAF Family Member-associated NF-kappa B Activator (TANK) Inhibitory Effect on TRAF6-mediated NF-kappa B Signaling through Cleavage of TANK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING PROTEIN; NEGATIVE REGULATOR; PHOSPHORYLATION; EXPRESSION; MECHANISM; APOPTOSIS; RESPONSES; PATHWAY; LIGAND; REGION	TRAF family member-associated NF-kappa B activator (TANK) is a negative regulator of canonical NF-kappa B signaling in the Toll-like receptor-and B-cell receptor-mediated signaling pathways. However, functions of TANK in viral infection-mediated NF-kappa B activation remain unclear. Here, we reported that TANK was cleaved by encephalomyocarditis virus 3C at the 197 and 291 glutamine residues, which depends on its cysteine protease activity. In addition, encephalomyocarditis virus 3C impaired the ability of TANK to inhibit TRAF6-mediated NF-kappa B signaling. Interestingly, we found that several viral proteases encoded by the foot and mouth disease virus, porcine reproductive and respiratory syndrome virus, and equine arteritis virus also cleaved TANK. Our results suggest that TANK is a novel target of some viral proteases, indicating that some positive RNA viruses have evolved to utilize their major proteases to regulate NF-kappa B activation.	[Huang, Li; Liu, Qinfang; Zhang, Lijie; Zhang, Quan; Hu, Liang; Li, Changyao; Wang, Shengnan; Li, Jiangnan; Zhang, Yuanfeng; Yu, Huibin; Wang, Yan; Wang, Xiaojun; Yu, Li; Deng, Guohua; Cai, Xuehui; Cui, Shangjin; Weng, Changjiang] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150001, Heilongjiang, Peoples R China; [Zhang, Quan; Xiong, Tao] Yangtze Univ, Coll Life Sci, Jingzhou 434100, Peoples R China; [Wang, Yan; Xia, Xueshan] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming 650093, Peoples R China; [Zhong, Zhaohua] Harbin Med Univ, Dept Microbiol, Harbin 150081, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Yangtze University; Kunming University of Science & Technology; Harbin Medical University	Cui, SJ (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150001, Heilongjiang, Peoples R China.	cuishangjin@caas.cn; wengcj@hvri.ac.cn	weng, changjiang/HHR-8479-2022; Zhong, Zhaohua/N-1659-2019; Hu, Liang/HHM-7463-2022; YU, HUIBIN/AHB-5025-2022	Zhong, Zhaohua/0000-0002-0778-5053; Hu, Liang/0000-0002-9386-6406; YU, HUIBIN/0000-0002-2430-272X; Huang, Lan/0000-0001-9594-4722; Liu, Qinfang/0000-0003-2930-3892; Wang, Xiaojun/0000-0003-4521-4099	National Natural Science Foundation of China [31172333, 31300139]; State Key Laboratory of Veterinary Biotechnological Foundation [SKLVBP201432]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Veterinary Biotechnological Foundation	This work was supported by the National Natural Science Foundation of China Grants 31172333 and 31300139 (to C. J. W. and L. H.) and State Key Laboratory of Veterinary Biotechnological Foundation Grant SKLVBP201432 (to L. H.). The authors declare that they have no conflict of interest with the contents of this article.	Bonif M, 2006, BIOCHEM J, V394, P593, DOI 10.1042/BJ20051659; Carocci M, 2012, VIRULENCE, V3, P351, DOI 10.4161/viru.20573; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Chiu YH, 2009, CHEM REV, V109, P1549, DOI 10.1021/cr800554j; Fang Y, 2010, VIRUS RES, V154, P61, DOI 10.1016/j.virusres.2010.07.030; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hall DJ, 1996, J VIROL, V70, P5954, DOI 10.1128/JVI.70.9.5954-5961.1996; Huang C, 2014, J VIROL, V88, P10934, DOI 10.1128/JVI.01396-14; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Ito M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002857; Jakus PB, 2013, J NUTR BIOCHEM, V24, P819, DOI 10.1016/j.jnutbio.2012.04.017; Jiang JY, 2010, PROTEIN CELL, V1, P1106, DOI 10.1007/s13238-010-0141-8; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kobayashi M, 2012, J VIROL, V86, P10686, DOI 10.1128/JVI.00896-12; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; Lei XB, 2013, J VIROL, V87, P1690, DOI 10.1128/JVI.01855-12; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Li D, 2013, J VIROL, V87, P2072, DOI 10.1128/JVI.02807-12; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Loiarro M, 2013, CL LYMPH MYELOM LEUK, V13, P222, DOI 10.1016/j.clml.2013.02.003; Loiarro M, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/674363; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Loughran G, 2011, P NATL ACAD SCI USA, V108, pE1111, DOI 10.1073/pnas.1102932108; Maruyama K, 2012, J BIOL CHEM, V287, P29114, DOI 10.1074/jbc.M112.347799; Matsumura T, 2003, IMMUNOLOGY, V109, P127, DOI 10.1046/j.1365-2567.2003.01627.x; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Muroi M, 2008, J LEUKOCYTE BIOL, V83, P702, DOI 10.1189/jlb.0907629; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Ng CS, 2013, J VIROL, V87, P9511, DOI 10.1128/JVI.03248-12; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Rothe M, 1996, P NATL ACAD SCI USA, V93, P8241, DOI 10.1073/pnas.93.16.8241; Schwarz EM, 1998, J VIROL, V72, P5654, DOI 10.1128/JVI.72.7.5654-5660.1998; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shi HX, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002057; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Sun JY, 2005, PROTEIN EXPRES PURIF, V42, P122, DOI 10.1016/j.pep.2005.03.009; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Tian XS, 2009, J MOL BIOL, V392, P977, DOI 10.1016/j.jmb.2009.07.062; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Wang B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003231; Wang D, 2012, J VIROL, V86, P9311, DOI 10.1128/JVI.00722-12; Wang Z, 2012, MOL BIOL REP, V39, P10013, DOI 10.1007/s11033-012-1870-y; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Wu H, 2003, BIOESSAYS, V25, P1096, DOI 10.1002/bies.10352; Xue M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-191; Zaragoza C, 2006, P NATL ACAD SCI USA, V103, P19051, DOI 10.1073/pnas.0606019103; Zhang YN, 2011, AUTOPHAGY, V7, P613, DOI 10.4161/auto.7.6.15267; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	54	41	45	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27618	27632		10.1074/jbc.M115.660761	http://dx.doi.org/10.1074/jbc.M115.660761			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26363073	Green Published, hybrid			2022-12-28	WOS:000365757500017
J	Malik, S; Dolan, TM; Maben, ZJ; Hinkle, PM				Malik, Sundeep; Dolan, Terrance M.; Maben, Zachary J.; Hinkle, Patricia M.			Adrenocorticotropic Hormone (ACTH) Responses Require Actions of the Melanocortin-2 Receptor Accessory Protein on the Extracellular Surface of the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; MC2 RECEPTOR; FUNCTIONAL EXPRESSION; ODORANT RECEPTORS; GPCR DIMERS; MRAP; TRAFFICKING; IDENTIFICATION; DOMAINS; GLYCOSYLATION	The melanocortin-2 (MC2) receptor is a G protein-coupled receptor that mediates responses to ACTH. The MC2 receptor acts in concert with the MC2 receptor accessory protein (MRAP) that is absolutely required for ACTH binding and signaling. MRAP has a single transmembrane domain and forms a highly unusual antiparallel homodimer that is stably associated with MC2 receptors at the plasma membrane. Despite the physiological importance of the interaction between the MC2 receptor and MRAP, there is little understanding of how the accessory protein works. The dual topology of MRAP has made it impossible to determine whether highly conserved and necessary regions of MRAP are required on the intracellular or extracellular face of the plasma membrane. The strategy used here was to fix the orientation of two antiparallel MRAP molecules and then introduce inactivating mutations on one side of the membrane or the other. This was achieved by engineering proteins containing tandem copies of MRAP fused to the amino terminus of the MC2 receptor. The data firmly establish that only the extracellular amino terminus (N-out) copy of MRAP, oriented with critical segments on the extracellular side of the membrane, is essential. The transmembrane domain of MRAP is also required in only the N-out orientation. Finally, activity of MRAP-MRAP-MC2-receptor fusion proteins with inactivating mutations in either MRAP or the receptor was rescued by co-expression of free wild-type MRAP or free wild-type receptor. These results show that the basic MRAP-MRAP-receptor signaling unit forms higher order complexes and that these multimers signal.	[Malik, Sundeep; Dolan, Terrance M.; Maben, Zachary J.; Hinkle, Patricia M.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Rochester	Hinkle, PM (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	patricia_hinkle@urmc.rochester.edu	Regan, Clinton/E-6250-2012	Maben, Zachary/0000-0002-3197-8437	National Institutes of Health [DK19974, DK67214]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019974, R01DK067214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK19974 and DK67214. The authors declare that they have no conflicts of interest with the contents of this article.	Asai M, 2013, SCIENCE, V341, P275, DOI 10.1126/science.1233000; Bjork S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076366; Bouvier M, 2014, J PHYSIOL-LONDON, V592, P2439, DOI 10.1113/jphysiol.2014.272252; Chan LF, 2009, P NATL ACAD SCI USA, V106, P6146, DOI 10.1073/pnas.0809918106; Chen M, 2007, BIOCHEMISTRY-US, V46, P11389, DOI 10.1021/bi700125e; Chepurny OG, 2007, J BIOMOL SCREEN, V12, P740, DOI 10.1177/1087057107301856; Chung TT, 2008, J CLIN ENDOCR METAB, V93, P4948, DOI 10.1210/jc.2008-1744; Cooray SN, 2011, ENDOCRINOLOGY, V152, P495, DOI 10.1210/en.2010-1053; Decaillot FM, 2008, P NATL ACAD SCI USA, V105, P16045, DOI 10.1073/pnas.0804106105; Dores RM, 2015, MOL CELL ENDOCRINOL, V408, P12, DOI 10.1016/j.mce.2014.12.022; Fridmanis D, 2014, J MOL ENDOCRINOL, V53, P201, DOI 10.1530/JME-14-0169; Fridmanis D, 2010, MOL CELL ENDOCRINOL, V321, P175, DOI 10.1016/j.mce.2010.02.032; Hinkle PM, 2011, EUR J PHARMACOL, V660, P94, DOI 10.1016/j.ejphar.2010.10.113; Hinkle PM, 2009, MOL CELL ENDOCRINOL, V300, P25, DOI 10.1016/j.mce.2008.10.041; Kay EI, 2013, J MOL ENDOCRINOL, V50, P217, DOI 10.1530/JME-12-0220; Kay EI, 2013, J MOL ENDOCRINOL, V50, P203, DOI 10.1530/JME-12-0221; Lambert NA, 2014, J PHYSIOL-LONDON, V592, P2443, DOI 10.1113/jphysiol.2014.272997; Liang L, 2013, GEN COMP ENDOCR, V181, P203, DOI 10.1016/j.ygcen.2012.11.011; Meimaridou E, 2013, ENDOCR DEV, V24, P57, DOI 10.1159/000342504; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; Rached M, 2005, PEPTIDES, V26, P1842, DOI 10.1016/j.peptides.2004.11.037; Reinick CL, 2012, ENDOCRINOLOGY, V153, P4757, DOI 10.1210/en.2012-1482; Roy S, 2007, MOL ENDOCRINOL, V21, P1656, DOI 10.1210/me.2007-0041; Roy S, 2012, GEN COMP ENDOCR, V176, P265, DOI 10.1016/j.ygcen.2012.02.003; Roy S, 2011, MOL ENDOCRINOL, V25, P1961, DOI 10.1210/me.2011-0018; Roy S, 2010, ENDOCRINOLOGY, V151, P660, DOI 10.1210/en.2009-0826; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Sebag JA, 2007, P NATL ACAD SCI USA, V104, P20244, DOI 10.1073/pnas.0708916105; Sebag JA, 2013, SCIENCE, V341, P278, DOI 10.1126/science.1232995; Sebag JA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000593; Sebag JA, 2009, J BIOL CHEM, V284, P22641, DOI 10.1074/jbc.M109.022400; Sebag JA, 2009, J BIOL CHEM, V284, P610, DOI 10.1074/jbc.M804413200; Sexton PM, 2012, ADV EXP MED BIOL, V744, P61, DOI 10.1007/978-1-4614-2364-5_6; ter Haar E, 2010, STRUCTURE, V18, P1083, DOI 10.1016/j.str.2010.05.014; Valsalan R, 2013, GEN COMP ENDOCR, V188, P123, DOI 10.1016/j.ygcen.2013.01.004; Webb TR, 2009, ENDOCRINOLOGY, V150, P720, DOI 10.1210/en.2008-0941; Wu LF, 2012, J BIOL CHEM, V287, P22287, DOI 10.1074/jbc.M112.345884; Yang YK, 2007, AM J PHYSIOL-REG I, V293, pR1120, DOI 10.1152/ajpregu.00240.2007; Yang YK, 2014, BIOCHEMISTRY-US, V53, P7086, DOI 10.1021/bi500856x	39	27	30	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2015	290	46					27972	27985		10.1074/jbc.M115.668491	http://dx.doi.org/10.1074/jbc.M115.668491			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5QP	26424796	Green Published, hybrid			2022-12-28	WOS:000365757500044
J	Singh, DR; Ahmed, F; King, C; Gupta, N; Salotto, M; Pasquale, EB; Hristova, K				Singh, Deo R.; Ahmed, Fozia; King, Christopher; Gupta, Nisha; Salotto, Matt; Pasquale, Elena B.; Hristova, Kalina			EphA2 Receptor Unliganded Dimers Suppress EphA2 Pro-tumorigenic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; ENERGY-TRANSFER; ACTIVATION; LIGAND; CELLS; DIMERIZATION; EPHRINA1; CONSEQUENCES; INHIBITION; COMPLEXES	Background: The EphA2 receptor tyrosine kinase can promote cell migration and cancer malignancy in the absence of ligand binding. Results: We uncover a correlation between unliganded dimerization and tumorigenic signaling. Conclusion: EphA2 pro-tumorigenic signaling is likely mediated by the EphA2 monomer. Significance: A therapeutic strategy that aims at the stabilization of EphA2 dimers may be beneficial for the treatment of cancers linked to EphA2 overexpression. The EphA2 receptor tyrosine kinase promotes cell migration and cancer malignancy through a ligand- and kinase-independent distinctive mechanism that has been linked to high Ser-897 phosphorylation and low tyrosine phosphorylation. Here, we demonstrate that EphA2 forms dimers in the plasma membrane of HEK293T cells in the absence of ephrin ligand binding, suggesting that the current seeding mechanism model of EphA2 activation is incomplete. We also characterize a dimerization-deficient EphA2 mutant that shows enhanced ability to promote cell migration, concomitant with increased Ser-897 phosphorylation and decreased tyrosine phosphorylation compared with EphA2 wild type. Our data reveal a correlation between unliganded dimerization and tumorigenic signaling and suggest that EphA2 pro-tumorigenic activity is mediated by the EphA2 monomer. Thus, a therapeutic strategy that aims at the stabilization of EphA2 dimers may be beneficial for the treatment of cancers linked to EphA2 overexpression.	[Singh, Deo R.; Ahmed, Fozia; Gupta, Nisha; Salotto, Matt; Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [King, Christopher; Hristova, Kalina] Johns Hopkins Univ, Program Mol Biophys, Baltimore, MD 21218 USA; [Pasquale, Elena B.] Sanford Burnham Prebys Med Discovery Inst, San Diego, CA 92037 USA	Johns Hopkins University; Johns Hopkins University; Sanford Burnham Prebys Medical Discovery Institute	Hristova, K (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, 3400 Charles St, Baltimore, MD 21218 USA.	kh@jhu.edu	Singh, Deo/AAI-7013-2020; Regan, Clinton/E-6250-2012; Singh, Deo/J-9773-2017	King, Christopher/0000-0002-2400-5717; Singh, Deo/0000-0001-9027-1813	National Science Foundation [MCB 1157687]; National Science Foundation Graduate Research Fellowship [DGE-1232825]; National Institutes of Health [GM068619, CA138390]; NATIONAL CANCER INSTITUTE [P01CA138390, P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068619] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB 1157687, National Science Foundation Graduate Research Fellowship DGE-1232825 (to C. K.), and National Institutes of Health Grants GM068619 (to K. H.) and CA138390 (to E. B. P.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAIR BD, 1994, BIOCHEMISTRY-US, V33, P5539, DOI 10.1021/bi00184a024; Adler J, 2010, NAT METHODS, V7, P170, DOI 10.1038/nmeth0310-170; Barquilla A, 2015, ANNU REV PHARMACOL, V55, P465, DOI 10.1146/annurev-pharmtox-011112-140226; Beauchamp A, 2012, MOL CELL BIOL, V32, P3253, DOI 10.1128/MCB.06791-11; Biener G, 2014, INT J MOL SCI, V15, P261, DOI 10.3390/ijms15010261; Binda E, 2012, CANCER CELL, V22, P765, DOI 10.1016/j.ccr.2012.11.005; Chen LR, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001195; Chen LR, 2010, J AM CHEM SOC, V132, P3628, DOI 10.1021/ja910692u; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Del Piccolo N, 2015, BIOPHYS J, V108, P272, DOI 10.1016/j.bpj.2014.11.3460; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; Fang BW, 2008, J CELL SCI, V121, P358, DOI 10.1242/jcs.017145; Funk SD, 2012, ARTERIOSCL THROM VAS, V32, P686, DOI 10.1161/ATVBAHA.111.242792; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Ireton RC, 2005, CURR CANCER DRUG TAR, V5, P149, DOI 10.2174/1568009053765780; Janes PW, 2012, SEMIN CELL DEV BIOL, V23, P43, DOI 10.1016/j.semcdb.2012.01.001; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; Lin CC, 2012, CELL, V149, P1514, DOI 10.1016/j.cell.2012.04.033; Liu Y, 2014, NUCL MED BIOL, V41, P450, DOI 10.1016/j.nucmedbio.2014.03.020; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Miao H, 2015, ONCOGENE, V34, P558, DOI 10.1038/onc.2013.590; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miao H, 2009, CANCER CELL, V16, P9, DOI 10.1016/j.ccr.2009.04.009; Miura K, 2009, MOL BIOL CELL, V20, P1949, DOI 10.1091/mbc.E08-06-0549; Nasreen N, 2007, CANCER LETT, V258, P215, DOI 10.1016/j.canlet.2007.09.005; Paraiso KHT, 2015, CANCER DISCOV, V5, P264, DOI 10.1158/2159-8290.CD-14-0293; Parmryd I, 2013, FEBS J, V280, P2775, DOI 10.1111/febs.12209; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pratt RL, 2002, ONCOGENE, V21, P7690, DOI 10.1038/sj.onc.1205758; Raicu V, 2007, J BIOL PHYS, V33, P109, DOI 10.1007/s10867-007-9046-z; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; Rong BX, 2011, CURR CANCER DRUG TAR, V11, P1082, DOI 10.2174/156800911798073050; Sarabipour S, 2015, J MOL BIOL, V427, P1705, DOI 10.1016/j.jmb.2015.02.013; Schick S, 2010, BIOPHYS J, V99, P1810, DOI 10.1016/j.bpj.2010.07.026; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Wakayama Y, 2011, J BIOL CHEM, V286, P44243, DOI 10.1074/jbc.M111.267047; Wimmer-Kleikamp SH, 2008, BLOOD, V112, P721, DOI 10.1182/blood-2007-11-121681; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Xu K, 2013, P NATL ACAD SCI USA, V110, P14634, DOI 10.1073/pnas.1311000110	42	44	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 6	2015	290	45					27271	27279		10.1074/jbc.M115.676866	http://dx.doi.org/10.1074/jbc.M115.676866			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AS	26363067	Green Published, hybrid			2022-12-28	WOS:000364794000035
J	Phillips, AH; Corn, JE				Phillips, Aaron H.; Corn, Jacob E.			Using Protein Motion to Read, Write, and Erase Ubiquitin Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DEUBIQUITINATING ENZYME; POLYUBIQUITIN CHAINS; CONJUGATING ENZYME; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CONFORMATIONAL SELECTION; ACTIVATE PARKIN; LIGASE ACTIVITY; INDUCED FIT; E3 LIGASE	Eukaryotes use a tiny protein called ubiquitin to send a variety of signals, most often by post-translationally attaching ubiquitins to substrate proteins and to each other, thereby forming polyubiquitin chains. A combination of biophysical, biochemical, and biological studies has shown that complex macromolecular dynamics are central to many aspects of ubiquitin signaling. This review focuses on how equilibrium fluctuations and coordinated motions of ubiquitin itself, the ubiquitin conjugation machinery, and deubiquitinating enzymes enable activity and regulation on many levels, with implications for how such a tiny protein can send so many signals.	[Phillips, Aaron H.; Corn, Jacob E.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94702 USA	University of California System; University of California Berkeley	Phillips, AH (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale, Memphis, TN 38105 USA.	Aaron.Phillips@stjude.org; jcorn@berkeley.edu		Corn, Jacob/0000-0002-7798-5309				Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Ban D, 2011, ANGEW CHEM INT EDIT, V50, P11437, DOI 10.1002/anie.201105086; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Boudreaux DA, 2010, P NATL ACAD SCI USA, V107, P9117, DOI 10.1073/pnas.0910870107; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Castaneda CA, 2013, STRUCTURE, V21, P1168, DOI 10.1016/j.str.2013.04.029; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085744; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; COOK WJ, 1992, J BIOL CHEM, V267, P16467; Cunningham CN, 2015, NAT CELL BIOL, V17, P160, DOI 10.1038/ncb3097; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; Dittmer J, 2004, J AM CHEM SOC, V126, P1314, DOI 10.1021/ja0386243; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Duda DM, 2013, STRUCTURE, V21, P1030, DOI 10.1016/j.str.2013.04.019; Dueber EC, 2011, SCIENCE, V334, P376, DOI 10.1126/science.1207862; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Faesen AC, 2011, MOL CELL, V44, P147, DOI 10.1016/j.molcel.2011.06.034; Feltham R, 2011, J BIOL CHEM, V286, P17015, DOI 10.1074/jbc.M111.222919; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Haririnia A, 2008, J MOL BIOL, V375, P979, DOI 10.1016/j.jmb.2007.11.016; Hospenthal MK, 2013, NAT STRUCT MOL BIOL, V20, P555, DOI 10.1038/nsmb.2547; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang OW, 2012, NAT STRUCT MOL BIOL, V19, P171, DOI 10.1038/nsmb.2206; Iwai K, 2014, NAT REV MOL CELL BIO, V15, P503, DOI 10.1038/nrm3836; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Lee SY, 2014, J MOL BIOL, V426, P1377, DOI 10.1016/j.jmb.2013.10.042; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Long D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002035; Lorenz S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-65; Majumdar A, 2004, J BIOMOL NMR, V28, P213, DOI 10.1023/B:JNMR.0000013705.98136.99; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Michielssens S, 2014, ANGEW CHEM INT EDIT, V53, P10367, DOI 10.1002/anie.201403102; Mills JL, 2002, J BIOMOL NMR, V23, P63, DOI 10.1023/A:1015397305148; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peters JH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002704; Phillips AH, 2014, NAT STRUCT MOL BIOL, V21, P1068, DOI 10.1038/nsmb.2916; Phillips AH, 2013, P NATL ACAD SCI USA, V110, P11379, DOI 10.1073/pnas.1302407110; Piana S, 2013, P NATL ACAD SCI USA, V110, P5915, DOI 10.1073/pnas.1218321110; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Ryabov Y, 2006, PROTEINS, V63, P787, DOI 10.1002/prot.20917; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sahtoe DD, 2015, MOL CELL, V57, P887, DOI 10.1016/j.molcel.2014.12.039; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; SCHNEIDER DM, 1992, BIOCHEMISTRY-US, V31, P3645, DOI 10.1021/bi00129a013; Shiba-Fukushima K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004391; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Tenno T, 2004, GENES CELLS, V9, P865, DOI 10.1111/j.1365-2443.2004.00780.x; Tjandra N, 1995, J AM CHEM SOC, V117, P12562, DOI 10.1021/ja00155a020; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; VanderLinden RT, 2015, MOL CELL, V57, P901, DOI 10.1016/j.molcel.2015.01.016; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Varshavsky AV, 2006, PROTEIN SCI, V15, P647, DOI 10.1110/ps.052012306; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wauer T, 2015, EMBO J, V34, P307, DOI 10.15252/embj.201489847; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Wist J, 2004, J BIOMOL NMR, V28, P263, DOI 10.1023/B:JNMR.0000013699.48099.38; Wlodarski T, 2009, P NATL ACAD SCI USA, V106, P19346, DOI 10.1073/pnas.0906966106; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Ye Y, 2012, NATURE, V492, P266, DOI 10.1038/nature11722; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zhang YN, 2013, NAT CHEM BIOL, V9, P51, DOI [10.1038/NCHEMBIO.1134, 10.1038/nchembio.1134]; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	94	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26437	26444		10.1074/jbc.R115.653675	http://dx.doi.org/10.1074/jbc.R115.653675			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26354440	Green Published, hybrid			2022-12-28	WOS:000364793600011
J	Iqbal, J; Walsh, MT; Hammad, SM; Cuchel, M; Tarugi, P; Hegele, RA; Davidson, NO; Rader, DJ; Klein, RL; Hussain, MM				Iqbal, Jahangir; Walsh, Meghan T.; Hammad, Samar M.; Cuchel, Marina; Tarugi, Patrizia; Hegele, Robert A.; Davidson, Nicholas O.; Rader, Daniel J.; Klein, Richard L.; Hussain, M. Mahmood			Microsomal Triglyceride Transfer Protein Transfers and Determines Plasma Concentrations of Ceramide and Sphingomyelin but Not Glycosylceramide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTER TRANSFER PROTEIN; ABETALIPOPROTEINEMIA GENE; LIPID ABSORPTION; APOLIPOPROTEIN-B; SPHINGOLIPIDS; LIVER; INHIBITION; KNOCKOUT; BINDING; ATHEROSCLEROSIS	Sphingolipids, a large family of bioactive lipids, are implicated in stress responses, differentiation, proliferation, apoptosis, and other physiological processes. Aberrant plasma levels of sphingolipids contribute to metabolic disease, atherosclerosis, and insulin resistance. They are fairly evenly distributed in high density and apoB-containing lipoproteins (B-lps). Mechanisms involved in the transport of sphingolipids to the plasma are unknown. Here, we investigated the role of microsomal triglyceride transfer protein (MTP), required for B-lp assembly and secretion, in sphingolipid transport to the plasma. Abetalipoproteinemia patients with deleterious mutations in MTP and absence of B-lps had significantly lower plasma ceramide and sphingomyelin but normal hexosylceramide, lactosylceramide, and different sphingosines compared with unaffected controls. Furthermore, similar differential effects on plasma sphingolipids were seen in liver-and intestine-specific MTP knock-out (L, I-Mttp(-/-)) mice, suggesting that MTP specifically plays a role in the regulation of plasma ceramide and sphingomyelin. We hypothesized that MTP deficiency may affect either their synthesis or secretion. MTP deficiency had no effect on ceramide and sphingomyelin synthesis but reduced secretion from primary hepatocytes and hepatoma cells. Therefore, MTP is involved in ceramide and sphingomyelin secretion but not in their synthesis. We also found that MTP transferred these lipids between vesicles in vitro. Therefore, we propose that MTP might regulate plasma ceramide and sphingomyelin levels by transferring these lipids to B-lps in the liver and intestine and facilitating their secretion.	[Iqbal, Jahangir; Walsh, Meghan T.; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Hammad, Samar M.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Cuchel, Marina; Rader, Daniel J.] Univ Penn, Cardiovasc Inst, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Tarugi, Patrizia] Univ Modena & Reggio Emilia, Dept Life Sci, I-41121 Modena, Italy; [Hegele, Robert A.] Robarts Res Inst, Blackburn Cardiovasc Genet Lab, London, ON N6A 5B7, Canada; [Davidson, Nicholas O.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Klein, Richard L.] Med Univ S Carolina, Dept Med, Div Endocrinol Metab & Med Genet, Charleston, SC 29425 USA; [Klein, Richard L.] Ralph H Johnson Dept Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA; [Hussain, M. Mahmood] New York Harbor Healthcare Syst, Dept Vet Affairs, Brooklyn, NY 11209 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Medical University of South Carolina; University of Pennsylvania; Pennsylvania Medicine; Universita di Modena e Reggio Emilia; Western University (University of Western Ontario); Washington University (WUSTL); Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Hussain, MM (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.	mahmood.hussain@downstate.edu	Iqbal, Jahangir/B-3903-2014; Hegele, Robert/G-3301-2011; Regan, Clinton/E-6250-2012; Hegele, Robert/AAF-6482-2020	Iqbal, Jahangir/0000-0002-9021-2271; Hegele, Robert/0000-0003-2861-5325; Hammad, Samar/0000-0002-1313-2542	National Institutes of Health [HL-95924, R56DK046900-17A1, HL-38180, DK-56260, DK-52574, P20 RR017677]; Veterans Affairs Merit Award [BX001728, BX000978]; American Heart Association; Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095924, R01HL038180, R37HL038180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056260, P30DK052574, R56DK046900, R01DK099177] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000978, I01BX001728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); American Heart Association(American Heart Association); Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HL-95924 and R56DK046900-17A1 (to M. M. H.) and Grants HL-38180, DK-56260, and DK-52574 (to N. O. D.). This work was also supported by Veterans Affairs Merit Award BX001728 (to M. M. H.), American Heart Association grant-in-aid (to J. I.), and Veterans Affairs Merit Award BX000978 (to R. L. K.).; Supported in part by the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina Grant P30 CA138313 and National Institutes of Health Grant P20 RR017677 (to the Lipidomics Core, Lipidomics and Pathobiology COBRE, Medical University of South Carolina for sphingolipid analysis).	ATZEL A, 1994, BIOCHEMISTRY-US, V33, P15382, DOI 10.1021/bi00255a019; Bakillah A, 2000, BIOCHEMISTRY-US, V39, P4892, DOI 10.1021/bi9924009; Bakillah A, 1997, LIPIDS, V32, P1113, DOI 10.1007/s11745-997-0143-8; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Chatterjee S, 1998, ARTERIOSCL THROM VAS, V18, P1523, DOI 10.1161/01.ATV.18.10.1523; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; DAWSON G, 1976, J LIPID RES, V17, P125; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Hammad SM, 2012, J LIPIDS, V2012, DOI 10.1155/2012/180705; Hammad SM, 2011, ADV EXP MED BIOL, V721, P57, DOI 10.1007/978-1-4614-0650-1_4; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Hussain MM, 2014, CURR OPIN LIPIDOL, V25, P200, DOI 10.1097/MOL.0000000000000084; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; HUSSAIN MM, 1995, ARTERIOSCL THROM VAS, V15, P485, DOI 10.1161/01.ATV.15.4.485; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; Iqbal J, 2014, J LIPID RES, V55, P2261, DOI 10.1194/jlr.M047951; Iqbal J, 2013, J BIOL CHEM, V288, P30432, DOI 10.1074/jbc.M113.501247; Iqbal J, 2010, J LIPID RES, V51, P1929, DOI 10.1194/jlr.M005744; Ishibashi Y, 2013, BBA-MOL CELL BIOL L, V1831, P1475, DOI 10.1016/j.bbalip.2013.06.001; Jiang XC, 2000, ARTERIOSCL THROM VAS, V20, P2614, DOI 10.1161/01.ATV.20.12.2614; Jiang XC, 2011, ADV EXP MED BIOL, V721, P19, DOI 10.1007/978-1-4614-0650-1_2; Khatun I, 2012, HEPATOLOGY, V55, P1356, DOI 10.1002/hep.25504; Konstantynowicz-Nowicka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116858; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; MERRILL AH, 1995, J BIOL CHEM, V270, P13834, DOI 10.1074/jbc.270.23.13834; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Tuuf J, 2014, CHEM PHYS LIPIDS, V178, P27, DOI 10.1016/j.chemphyslip.2013.10.013; WETTERAU JR, 1985, CHEM PHYS LIPIDS, V38, P205, DOI 10.1016/0009-3084(85)90068-4; WETTERAU JR, 1984, J BIOL CHEM, V259, P863; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200	46	45	45	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25863	25875		10.1074/jbc.M115.659110	http://dx.doi.org/10.1074/jbc.M115.659110			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26350457	Green Published, hybrid			2022-12-28	WOS:000363527300011
J	Saha, PP; Srivastava, S; Kumar, SKP; Sinha, D; D'Silva, P				Saha, Prasenjit Prasad; Srivastava, Shubhi; Kumar, Praveen S. K.; Sinha, Devanjan; D'Silva, Patrick			Mapping Key Residues of ISD11 Critical for NFS1-ISD11 Subcomplex Stability IMPLICATIONS IN THE DEVELOPMENT OF MITOCHONDRIAL DISORDER, COXPD19	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; CYSTEINE DESULFURASE NFS1; SACCHAROMYCES-CEREVISIAE; PROTEIN MATURATION; CRYSTAL-STRUCTURE; BIOGENESIS; COMPLEX; EUKARYOTES; SCAFFOLD; METABOLISM	Biogenesis of the iron-sulfur (Fe-S) cluster is an indispensable process in living cells. In mammalian mitochondria, the initial step of the Fe-S cluster assembly process is assisted by the NFS1-ISD11 complex, which delivers sulfur to scaffold protein ISCU during Fe-S cluster synthesis. Although ISD11 is an essential protein, its cellular role in Fe-S cluster biogenesis is still not defined. Our study maps the important ISD11 amino acid residues belonging to putative helix 1 (Phe-40), helix 3 (Leu-63, Arg-68, Gln-69, Ile-72, Tyr-76), and C-terminal segment (Leu-81, Glu-84) are critical for in vivo Fe-S cluster biogenesis. Importantly, mutation of these conserved ISD11 residues into alanine leads to its compromised interaction with NFS1, resulting in reduced stability and enhanced aggregation of NFS1 in the mitochondria. Due to altered interaction with ISD11 mutants, the levels of NFS1 and Isu1 were significantly depleted, which affects Fe-S cluster biosynthesis, leading to reduced electron transport chain complex (ETC) activity and mitochondrial respiration. In humans, a clinically relevant ISD11 mutation (R68L) has been associated in the development of a mitochondrial genetic disorder, COXPD19. Our findings highlight that the ISD11 R68A/R68L mutation display reduced affinity to form a stable subcomplex with NFS1, and thereby fails to prevent NFS1 aggregation resulting in impairment of the Fe-S cluster biogenesis. The prime affected machinery is the ETC complex, which showed compromised redox properties, causing diminished mitochondrial respiration. Furthermore, the R68L ISD11 mutant displayed accumulation of mitochondrial iron and reactive oxygen species, leading to mitochondrial dysfunction, which correlates with the phenotype observed in COXPD19 patients.	[Saha, Prasenjit Prasad; Srivastava, Shubhi; Sinha, Devanjan; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Kumar, Praveen S. K.] Karnatak Univ, Dept Biochem, Dharwad 580003, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Karnatak University	D'Silva, P (corresponding author), Indian Inst Sci, Dept Biochem, Biol Sci Bldg, Bangalore 560012, Karnataka, India.	patrick@biochem.iisc.ernet.in	Sinha, Devanjan/A-3953-2017; D'Silva, Patrick/L-6653-2019; Saha, Prasenjit/ABC-6481-2020; S K, Praveen Kumar/AAA-8999-2022; Srivastava, Shubhi/C-7048-2018	Sinha, Devanjan/0000-0001-5060-2075; S K, Praveen Kumar/0000-0002-9696-9734; Srivastava, Shubhi/0000-0001-9922-1943; Saha, Prasenjit/0000-0003-4679-2368	Council of Scientific and Industrial Research, India [CSIR 37(1534)/12/EMR-II]; Swarnajayanthi Fellowship from Department of Science and Technology (DST), Ministry of Science and Technology, India; DST, India INSPIRE fellowship; Department of Biotechnology for Research Associate fellowship, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Swarnajayanthi Fellowship from Department of Science and Technology (DST), Ministry of Science and Technology, India; DST, India INSPIRE fellowship; Department of Biotechnology for Research Associate fellowship, India	This work was supported in part by Council of Scientific and Industrial Research Grant CSIR 37(1534)/12/EMR-II, India (to P. D. S.), and Swarnajayanthi Fellowship from Department of Science and Technology (DST), Ministry of Science and Technology, India (to P. D. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Council of Scientific and Industrial Research, India for Senior Research fellowships.; Supported by a DST, India INSPIRE fellowship.; Supported by a Department of Biotechnology for Research Associate fellowship, India.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Batandier C, 2002, J CELL MOL MED, V6, P175, DOI 10.1111/j.1582-4934.2002.tb00185.x; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Craig EA, 1999, BIOL CHEM, V380, P1167, DOI 10.1515/BC.1999.148; Craig EA, 2002, CELL MOL LIFE SCI, V59, P1658, DOI 10.1007/PL00012493; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; GALLET PF, 1995, EUR J BIOCHEM, V228, P113, DOI 10.1111/j.1432-1033.1995.tb20238.x; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Goswami AV, 2012, HUM MOL GENET, V21, P3317, DOI 10.1093/hmg/dds162; GUTTERIDGE JMC, 1990, BIOCHEM J, V269, P169, DOI 10.1042/bj2690169; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Levi S, 2009, BBA-GEN SUBJECTS, V1790, P629, DOI 10.1016/j.bbagen.2008.09.008; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2006, BBA-MOL CELL RES, V1763, P652, DOI 10.1016/j.bbamcr.2006.05.011; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Lim SC, 2013, HUM MOL GENET, V22, P4460, DOI 10.1093/hmg/ddt295; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Majewska J, 2013, J BIOL CHEM, V288, P29134, DOI 10.1074/jbc.M113.503524; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Richards TA, 2006, MOL BIOL EVOL, V23, P1341, DOI 10.1093/molbev/msl001; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Saha PP, 2014, J BIOL CHEM, V289, P10359, DOI 10.1074/jbc.M113.526665; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; Shi YB, 2009, HUM MOL GENET, V18, P3014, DOI 10.1093/hmg/ddp239; Song JY, 2012, P NATL ACAD SCI USA, V109, P10370, DOI 10.1073/pnas.1206945109; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Srivastava S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.355; Stehling O, 2014, BIOCHIMIE, V100, P61, DOI 10.1016/j.biochi.2014.01.010; Toyokuni S, 2002, REDOX REP, V7, P189, DOI 10.1179/135100002125000596; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; ZHENG LM, 1994, J BIOL CHEM, V269, P18723; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031	48	18	20	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25876	25890		10.1074/jbc.M115.678508	http://dx.doi.org/10.1074/jbc.M115.678508			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26342079	Green Published, hybrid			2022-12-28	WOS:000363527300012
J	Bao, H; Dalal, K; Cytrynbaum, E; Duong, F				Bao, Huan; Dalal, Kush; Cytrynbaum, Eric; Duong, Franck			Sequential Action of MalE and Maltose Allows Coupling ATP Hydrolysis to Translocation in the MalFGK(2) Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING CASSETTE TRANSPORTER; ABC-TRANSPORTER; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; CONFORMATIONAL-CHANGES; FACING CONFORMATION; ALTERNATING ACCESS; CRYSTAL-STRUCTURE; PERIPLASMIC LOOP; PROTEIN	ATP-binding cassette (ABC) transporters have evolved an ATP-dependent alternating-access mechanism to transport substrates across membranes. Despite important progress, especially in their structural analysis, it is still unknown how the substrate stimulates ATP hydrolysis, the hallmark of ABC transporters. In this study, we measure the ATP turnover cycle of MalFGK(2) in steady and pre-steady state conditions. We show that (i) the basal ATPase activity of MalFGK(2) is very low because the cleavage of ATP is rate-limiting, (ii) the binding of open-state MalE to the transporter induces ATP cleavage but leaves release of P-i limiting, and (iii) the additional presence of maltose stimulates release of P-i, and therefore increases the overall ATP turnover cycle. We conclude that open-state MalE stabilizes MalFGK(2) in the outward-facing conformation until maltose triggers return to the inward-facing state for substrate and P-i release. This concerted action explains why ATPase activity of MalFGK(2) depends on maltose, and why MalE is essential for transport.	[Bao, Huan; Dalal, Kush; Duong, Franck] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Cytrynbaum, Eric] Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Duong, F (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	fduong@mail.ubc.ca		Bao, Huan/0000-0002-4301-4627; Cytrynbaum, Eric/0000-0001-8789-1667; Duong Van Hoa, Franck/0000-0001-7328-6124	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research (CIHR); Four-Year Fellowship from University of British Columbia	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Four-Year Fellowship from University of British Columbia	This work was supported by operating grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institutes of Health Research (CIHR) (to F. D. and E. C.) and a Four-Year Fellowship from the University of British Columbia (to H. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Ames GFL, 1996, J BIOL CHEM, V271, P14264, DOI 10.1074/jbc.271.24.14264; Bao H, 2014, J BIOL CHEM, V289, P9844, DOI 10.1074/jbc.M113.545525; Bao H, 2013, J BIOL CHEM, V288, P3439, DOI 10.1074/jbc.M112.431932; Bao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034836; Bohm S, 2013, P NATL ACAD SCI USA, V110, P5492, DOI 10.1073/pnas.1217745110; Bordignon E, 2010, MOL MICROBIOL, V77, P1354, DOI 10.1111/j.1365-2958.2010.07319.x; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Chen J, 2013, CURR OPIN STRUC BIOL, V23, P492, DOI 10.1016/j.sbi.2013.03.011; Chen SS, 2013, NATURE, V499, P364, DOI 10.1038/nature12232; Choudhury HG, 2014, P NATL ACAD SCI USA, V111, P9145, DOI 10.1073/pnas.1320506111; Cole SPC, 2014, J BIOL CHEM, V289, P30880, DOI 10.1074/jbc.R114.609248; COVITZ KMY, 1994, EMBO J, V13, P1752, DOI 10.1002/j.1460-2075.1994.tb06439.x; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Daus ML, 2007, J BIOL CHEM, V282, P22387, DOI 10.1074/jbc.M701979200; Daus ML, 2006, J BIOL CHEM, V281, P3856, DOI 10.1074/jbc.M511953200; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Doshi R, 2013, J BIOL CHEM, V288, P21638, DOI 10.1074/jbc.M113.485714; Doshi R, 2013, J BIOL CHEM, V288, P6801, DOI 10.1074/jbc.M112.430074; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Gould AD, 2009, BIOCHEMISTRY-US, V48, P8051, DOI 10.1021/bi9007066; Grossmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6419; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Jacso T, 2012, J BIOL CHEM, V287, P17040, DOI 10.1074/jbc.M112.340679; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Landmesser H, 2002, BBA-BIOMEMBRANES, V1565, P64, DOI 10.1016/S0005-2736(02)00506-0; Lee JY, 2014, SCIENCE, V343, P1133, DOI 10.1126/science.1246489; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Patzlaff JS, 2003, J BIOL CHEM, V278, P29546, DOI 10.1074/jbc.M304796200; Poolman B, 2005, METHOD ENZYMOL, V400, P429, DOI 10.1016/S0076-6879(05)00025-X; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Robson A, 2009, P NATL ACAD SCI USA, V106, P5111, DOI 10.1073/pnas.0809592106; Sauna ZE, 2004, J BIOL CHEM, V279, P48855, DOI 10.1074/jbc.M408849200; Seyffer F, 2015, BBA-GEN SUBJECTS, V1850, P449, DOI 10.1016/j.bbagen.2014.05.022; Shilton BH, 2008, BBA-BIOMEMBRANES, V1778, P1772, DOI 10.1016/j.bbamem.2007.09.005; Sianidis G, 2001, EMBO J, V20, P961, DOI 10.1093/emboj/20.5.961; Syberg F, 2012, J BIOL CHEM, V287, P23923, DOI 10.1074/jbc.M112.359208; Telmer PG, 2003, J BIOL CHEM, V278, P34555, DOI 10.1074/jbc.M301004200; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104	48	13	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25452	25460		10.1074/jbc.M115.671826	http://dx.doi.org/10.1074/jbc.M115.671826			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26338707	Green Published, hybrid			2022-12-28	WOS:000362962800021
J	Fado, R; Soto, D; Minano-Molina, AJ; Pozo, M; Carrasco, P; Yefimenko, N; Rodriguez-Alvarez, J; Casals, N				Fado, Rut; Soto, David; Minano-Molina, Alfredo J.; Pozo, Macarena; Carrasco, Patricia; Yefimenko, Natalia; Rodriguez-Alvarez, Jose; Casals, Nuria			Novel Regulation of the Synthesis of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Subunit GluA1 by Carnitine Palmitoyltransferase 1C (CPT1C) in the Hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; SYNAPTIC PLASTICITY; DENDRITIC SPINE; DEPENDENT REGULATION; GLUTAMATE RECEPTORS; SIGNALING PATHWAYS; BRAIN; TRANSLATION; TRAFFICKING; GHRELIN	The regulation of AMPA-type receptor (AMPAR) abundance in the postsynaptic membrane is an important mechanism involved in learning and memory formation. Recent data suggest that one of the constituents of the AMPAR complex is carnitine palmitoyltransferase 1C (CPT1C), a brain-specific isoform located in the endoplasmic reticulum of neurons. Previous results had demonstrated that CPT1C deficiency disrupted spine maturation in hippocampal neurons and impaired spatial learning, but the role of CPT1C in AMPAR physiology had remained mostly unknown. In the present study, we show that CPT1C binds GluA1 and GluA2 and that the three proteins have the same expression profile during neuronal maturation. Moreover, in hippocampal neurons of CPT1C KO mice, AMPAR-mediated miniature excitatory postsynaptic currents and synaptic levels of AMPAR subunits GluA1 and GluA2 are significantly reduced. We show that AMPAR expression is dependent on CPT1C levels because total protein levels of GluA1 and GluA2 are decreased in CPT1C KO neurons and are increased in CPT1C-overexpressing neurons, whereas other synaptic proteins remain unaltered. Notably, mRNA levels of AMPARs remained unchanged in those cultures, indicating that CPT1C is post-transcriptionally involved. We demonstrate that CPT1C is directly involved in the de novo synthesis of GluA1 and not in protein degradation. Moreover, in CPT1C KO cultured neurons, GluA1 synthesis after chemical long term depression was clearly diminished, and brain-derived neurotrophic factor treatment was unable to phosphorylate the mammalian target of rapamycin (mTOR) and stimulate GluA1 protein synthesis. These data newly identify CPT1C as a regulator of AMPAR translation efficiency and therefore also synaptic function in the hippocampus.	[Fado, Rut; Pozo, Macarena; Casals, Nuria] Univ Int Catalunya, Fac Med & Ciencies Salut, Dept Basic Sci, Sant Cugat Del Valles 08195, Spain; [Soto, David; Yefimenko, Natalia] IDIBELL, Neurobiol Lab, Lhospitalet De Llobregat 08907, Spain; [Soto, David; Yefimenko, Natalia] Univ Barcelona, Fac Med, Dept Pathol & Expt Therapeut, Lhospitalet De Llobregat 08907, Spain; [Minano-Molina, Alfredo J.; Rodriguez-Alvarez, Jose] Univ Autonoma Barcelona, Inst Neurociencies, Cerdanyola Del Valles 08193, Spain; [Minano-Molina, Alfredo J.; Rodriguez-Alvarez, Jose] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Cerdanyola Del Valles 08193, Spain; [Minano-Molina, Alfredo J.; Rodriguez-Alvarez, Jose] CIBERNED, Madrid 28031, Spain; [Carrasco, Patricia; Casals, Nuria] CIBEROBN, Santiago De Compostela 15706, Spain	Universitat Internacional de Catalunya (UIC); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; CIBERNED; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Casals, N (corresponding author), Univ Int Catalunya, Fac Med & Ciencies Salut, Dept Basic Sci, Josep Trueta S-N, Sant Cugat Del Valles 08195, Spain.	ncasals@uic.es	Soto, David/L-4403-2014; Andrés, Fadó Fadó/L-8585-2014; Miñano-Molina, Alfredo J/C-9863-2011; Rodriguez-Alvarez, Jose/F-8403-2011; Casals, Nuria/L-3378-2014	Soto, David/0000-0001-7995-3805; Andrés, Fadó Fadó/0000-0002-3293-2342; Miñano-Molina, Alfredo J/0000-0002-7761-5682; Rodriguez-Alvarez, Jose/0000-0001-8582-8082; Casals, Nuria/0000-0002-6719-4300; Pozo Ariza, Macarena/0000-0003-0723-2499	Ministerio de Ciencia e Innovacion (MICINN) Grants [SAF2011-30520-C02-02, SAF2011-30281, BFU2011-24725]; Ministerio de Economia y Competitividad (MINECO) Grants [SAF2014-52223-C2-2-R, SAF2014-59697-R]; CIBEROBN (initiatives of ISCIII); European Commission [FP7-PEOPLE-2011-CIG, 293498]; Generalitat de Catalunya [SGR2009-1231, SGR2009-152, SGR2014-0984, SGR2014-465]; Fundacio La Marato de TV3 Grant [2014-36-10]; "Ramon y Cajal" Programme [RyC-2010-05970]; Agencia de Gestio d'Ajuts Universitaris i de la Recerca (AGAUR) in Catalunya; CIBERNED (initiatives of ISCIII)	Ministerio de Ciencia e Innovacion (MICINN) Grants; Ministerio de Economia y Competitividad (MINECO) Grants; CIBEROBN (initiatives of ISCIII); European Commission(European CommissionEuropean Commission Joint Research Centre); Generalitat de Catalunya(Generalitat de Catalunya); Fundacio La Marato de TV3 Grant; "Ramon y Cajal" Programme(Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de la Recerca (AGAUR) in Catalunya; CIBERNED (initiatives of ISCIII)	This work was supported by Ministerio de Ciencia e Innovacion (MICINN) Grants SAF2011-30520-C02-02 (to N. C.), SAF2011-30281 (to J. R.), and BFU2011-24725 (to D. S.) and Ministerio de Economia y Competitividad (MINECO) Grants SAF2014-52223-C2-2-R (to N. C.) and SAF2014-59697-R (to J. R.). This work was also supported by grants from CIBEROBN and CIBERNED (initiatives of ISCIII), the European Commission (FP7-PEOPLE-2011-CIG; Grant 293498 to D. S.), the Generalitat de Catalunya (Grants SGR2009-1231, SGR2009-152, SGR2014-0984, and SGR2014-465), and Fundacio La Marato de TV3 Grant 2014-36-10 (to J. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the "Ramon y Cajal" Programme (RyC-2010-05970).; Recipient of a fellowship from the Agencia de Gestio d'Ajuts Universitaris i de la Recerca (AGAUR) in Catalunya.	Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Carlini VP, 2002, BIOCHEM BIOPH RES CO, V299, P739, DOI 10.1016/S0006-291X(02)02740-7; Carrasco P, 2013, BEHAV BRAIN RES, V256, P291, DOI 10.1016/j.bbr.2013.08.004; Carrasco P, 2012, J BIOL CHEM, V287, P21224, DOI 10.1074/jbc.M111.337493; Chen LA, 2011, EUR J NEUROSCI, V33, P266, DOI 10.1111/j.1460-9568.2010.07491.x; Chen N, 2008, FASEB J, V22, P236, DOI 10.1096/fj.07-8739com; Chen N, 2014, J PROTEOME RES, V13, P5695, DOI 10.1021/pr500697b; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Fado R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02397; Fernandez-Monreal M, 2012, J NEUROSCI, V32, P13200, DOI 10.1523/JNEUROSCI.0061-12.2012; Fortin DA, 2012, NEUROSCIENTIST, V18, P326, DOI 10.1177/1073858411407206; Fortin DA, 2012, J NEUROSCI, V32, P8127, DOI 10.1523/JNEUROSCI.6034-11.2012; Gao S, 2011, P NATL ACAD SCI USA, V108, P9691, DOI 10.1073/pnas.1103267108; Gao XF, 2009, DIABETOLOGIA, V52, P912, DOI 10.1007/s00125-009-1284-0; Gratacos-Batlle E, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00469; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Henley Jeremy M, 2013, Dialogues Clin Neurosci, V15, P11; Hu ZH, 2015, J CELL BIOL, V208, P949, DOI 10.1083/jcb.201404092; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kudoh SN, 2002, BIOSENS BIOELECTRON, V17, P773, DOI 10.1016/S0956-5663(02)00053-2; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003; Lissin DV, 1999, J NEUROSCI, V19, P1263; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Minano-Molina AJ, 2011, J BIOL CHEM, V286, P27311, DOI 10.1074/jbc.M111.227504; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Pedraza N, 2014, J NEUROSCI, V34, P13988, DOI 10.1523/JNEUROSCI.1573-14.2014; Prendergast J, 2014, J NEUROSCI, V34, P13246, DOI 10.1523/JNEUROSCI.1149-14.2014; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Ramirez S, 2013, DIABETES, V62, P2329, DOI 10.2337/db12-1451; Ran I, 2013, J NEUROSCI, V33, P1872, DOI 10.1523/JNEUROSCI.3264-12.2013; Reilly PT, 2012, CLIN CANCER RES, V18, P5850, DOI 10.1158/1078-0432.CCR-11-3281; Ribeiro LF, 2014, P NATL ACAD SCI USA, V111, pE149, DOI 10.1073/pnas.1313798111; Rinaldi C, 2015, JAMA NEUROL, V72, P561, DOI 10.1001/jamaneurol.2014.4769; Schwenk J, 2014, NEURON, V84, P41, DOI 10.1016/j.neuron.2014.08.044; Schwenk J, 2012, NEURON, V74, P621, DOI 10.1016/j.neuron.2012.03.034; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Shehata M, 2012, J NEUROSCI, V32, P10413, DOI 10.1523/JNEUROSCI.4533-11.2012; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Tokutake Y, 2010, BIOCHEM BIOPH RES CO, V402, P158, DOI 10.1016/j.bbrc.2010.10.009; Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002; Wang G, 2015, NEUROPHARMACOLOGY, V95, P144, DOI 10.1016/j.neuropharm.2015.03.003; Wolfgang MJ, 2008, J NEUROCHEM, V105, P1550, DOI 10.1111/j.1471-4159.2008.05255.x; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	47	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25548	25560		10.1074/jbc.M115.681064	http://dx.doi.org/10.1074/jbc.M115.681064			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26338711	Green Published, hybrid			2022-12-28	WOS:000362962800029
J	Reddy, V; Wu, M; Ciavattone, N; McKenty, N; Menon, M; Barrack, ER; Reddy, GPV; Kim, SH				Reddy, Vidyavathi; Wu, Min; Ciavattone, Nicholas; McKenty, Nathan; Menon, Mani; Barrack, Evelyn R.; Reddy, G. Prem-Veer; Kim, Sahn-Ho			ATM Inhibition Potentiates Death of Androgen Receptor-inactivated Prostate Cancer Cells with Telomere Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; MAMMALIAN TELOMERES; BREAST-CANCER; REPAIR; PROTEINS; LENGTH; TRF2; P53; CHROMOSOMES; MAINTENANCE	Androgen receptor (AR) plays a role in maintaining telomere stability in prostate cancer cells, as AR inactivation induces telomere dysfunction within 3 h. Since telomere dysfunction in other systems is known to activate ATM (ataxia telangiectasia mutated)-mediated DNA damage response (DDR) signaling pathways, we investigated the role of ATM-mediated DDR signaling in AR-inactivated prostate cancer cells. Indeed, the induction of telomere dysfunction in cells treated with AR-antagonists (Casodex or MDV3100) or AR-siRNA was associated with a dramatic increase in phosphorylation (activation) of ATM and its downstream effector Chk2 and the presence of phosphorylated ATM at telomeres, indicating activation of DDR signaling at telomeres. Moreover, Casodex washout led to the reversal of telomere dysfunction, indicating repair of damaged telomeres. ATM inhibitor blocked ATM phosphorylation, induced PARP cleavage, abrogated cell cycle checkpoint activation and attenuated the formation of gamma H2AX foci at telomeres in AR-inactivated cells, suggesting that ATM inhibitor induces apoptosis in AR-inactivated cells by blocking the repair of damaged DNA at telomeres. Finally, colony formation assay revealed a dramatic decrease in the survival of cells co-treated with Casodex and ATM inhibitor as compared with those treated with either Casodex or ATM inhibitor alone. These observations indicate that inhibitors of DDR signaling pathways may offer a unique opportunity to enhance the potency of AR-targeted therapies for the treatment of androgen-sensitive as well as castration-resistant prostate cancer.	[Reddy, Vidyavathi; Wu, Min; Ciavattone, Nicholas; McKenty, Nathan; Menon, Mani; Barrack, Evelyn R.; Reddy, G. Prem-Veer; Kim, Sahn-Ho] Henry Ford Hosp, Vattikuti Urol Inst, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Kim, SH (corresponding author), Henry Ford Hlth Syst, 1 Ford Pl, Detroit, MI 48202 USA.	skim3@hfhs.org		Ciavattone, Nicholas/0000-0001-9265-8202	Department of Defense Prostate Cancer Research Program Grant [W81XWH-10-1-0117]; Henry Ford Health System; NIH Center Grant [P30CA022455]	Department of Defense Prostate Cancer Research Program Grant(United States Department of Defense); Henry Ford Health System; NIH Center Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Department of Defense Prostate Cancer Research Program Grant W81XWH-10-1-0117 (to S. K.) and a grant from Henry Ford Health System (to S. K.). The Cytometry Resources Core is supported in part by NIH Center Grant P30CA022455 to the Karmanos Cancer Institute, Wayne State University, and the Perinatology Research Branch of the National Institutes of Child Health and Development, Wayne State University. The authors declare that they have no conflicts of interest with the contents of this article.	Angele S, 2004, AM J CLIN PATHOL, V121, P231, DOI 10.1309/JTKGGGKURFX3XMGT; Bai VU, 2005, J CELL PHYSIOL, V204, P381, DOI 10.1002/jcp.20422; Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bouchal J, 2005, J PHARM PHARMACOL, V57, P83, DOI 10.1211/0022357055164; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; D'Antonio JM, 2009, ENDOCR-RELAT CANCER, V16, P325, DOI 10.1677/ERC-08-0205; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Fan C, 2006, BBA-MOL CELL RES, V1763, P1090, DOI 10.1016/j.bbamcr.2006.08.026; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Gong Y, 2010, MOL CELL, V40, P377, DOI 10.1016/j.molcel.2010.10.016; Goodwin JF, 2013, CANCER DISCOV, V3, P1254, DOI 10.1158/2159-8290.CD-13-0108; Guo CH, 2003, J UROLOGY, V170, P615, DOI 10.1097/01.ju.0000074653.22766.c8; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Heaphy CM, 2013, CANCER DISCOV, V3, P1130, DOI 10.1158/2159-8290.CD-13-0135; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Joshua AM, 2011, PROSTATE, V71, P778, DOI 10.1002/pros.21294; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 2010, J BIOL CHEM, V285, P10472, DOI 10.1074/jbc.M109.098798; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Liu SA, 2010, MOL CANCER THER, V9, P2016, DOI 10.1158/1535-7163.MCT-09-0924; Martinez P, 2012, J CELL BIOL, V197, P283, DOI 10.1083/jcb.201110124; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Mayeur GL, 2005, J BIOL CHEM, V280, P10827, DOI 10.1074/jbc.M413336200; Min J, 2012, J BIOL CHEM, V287, P5091, DOI 10.1074/jbc.M111.278994; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Murnane JP, 2010, CANCER RES, V70, P4255, DOI 10.1158/0008-5472.CAN-09-4357; Murthy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056692; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Polkinghorn WR, 2013, CANCER DISCOV, V3, P1245, DOI 10.1158/2159-8290.CD-13-0172; Prevo R, 2012, CANCER BIOL THER, V13, P1072, DOI 10.4161/cbt.21093; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smith J, 2010, ADV CANCER RES, V108, P73, DOI [10.1016/B978-0-12-380888-2.00003-0, 10.1016/S0065.230X(10)08002.4]; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Yamashita S, 2012, NEOPLASIA, V14, P74, DOI 10.1593/neo.111436; Zhan P, 2002, J STEROID BIOCHEM, V83, P101, DOI 10.1016/S0960-0760(02)00275-3; Zhou JY, 2013, AGING-US, V5, P3, DOI 10.18632/aging.100524	50	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25522	25533		10.1074/jbc.M115.671404	http://dx.doi.org/10.1074/jbc.M115.671404			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26336104	hybrid, Green Published			2022-12-28	WOS:000362962800027
J	Xu, C; Liu, K; Ahmed, H; Loppnau, P; Schapira, M; Min, JR				Xu, Chao; Liu, Ke; Ahmed, Hazem; Loppnau, Peter; Schapira, Matthieu; Min, Jinrong			Structural Basis for the Discriminative Recognition of N-6-Methyladenosine RNA by the Human YT521-B Homology Domain Family of Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; YTH DOMAIN; M(6)A RNA; NUCLEAR-RNA; REVEALS; N6-METHYLADENOSINE; BINDING; CRYSTALLOGRAPHY; DEMETHYLASE; METABOLISM	N-6-Methyladenosine (m(6)A) is the most abundant internal modification in RNA and is specifically recognized by YT521-B homology (YTH) domain-containing proteins. Recently we reported that YTHDC1 prefers guanosine and disfavors adenosine at the position preceding the m(6)A nucleotide in RNA and preferentially binds to the GG(m(6)A)C sequence. Now we systematically characterized the binding affinities of the YTH domains of three other human proteins and yeast YTH domain protein Pho92 and determined the crystal structures of theYTH domains of human YTHDF1 and yeast Pho92 in complex with a 5-mer m(6)A RNA, respectively. Our binding and structural data revealed that the YTH domain used a conserved aromatic cage to recognize m(6)A. Nevertheless, none of these YTH domains, except YTHDC1, display sequence selectivity at the position preceding the m(6)A modification. Structural comparison of these different YTH domains revealed that among those, only YTHDC1 harbors a distinctly selective binding pocket for the nucleotide preceding the m(6)A nucleotide.	[Xu, Chao; Liu, Ke; Ahmed, Hazem; Loppnau, Peter; Schapira, Matthieu; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto	Xu, C (corresponding author), Univ Toronto, Struct Genom Consortium, 101 Coll St, Toronto, ON M5G 1L7, Canada.	xuchaor@gmail.com; jr.min@utoronto.ca	Min, Jinrong/G-3449-2011; Xu, Chao/G-3885-2010	Min, Jinrong/0000-0001-5210-3130; Xu, Chao/0000-0003-0444-7080; Hussein, Hazem/0000-0002-9298-7038; , KE/0000-0002-7082-262X	AbbVie; Bayer Pharma AG; Baehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; Innovative Medicines Initiative (the European Federation of Pharmaceutical Industries and Associations (European Union)) under ULTRA-DD Grant [115766]; Janssen; Merck Co.; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Takeda; Wellcome Trust	AbbVie(AbbVie); Bayer Pharma AG; Baehringer Ingelheim; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); Innovative Medicines Initiative (the European Federation of Pharmaceutical Industries and Associations (European Union)) under ULTRA-DD Grant; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co.(Merck & Company); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Takeda; Wellcome Trust(Wellcome TrustEuropean Commission)	The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Baehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (the European Federation of Pharmaceutical Industries and Associations (European Union)) under ULTRA-DD Grant 115766, Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Takeda, and the Wellcome Trust.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertonati C, 2009, PROTEINS, V75, P760, DOI 10.1002/prot.22287; Bokar JA, 1997, RNA, V3, P1233; Bokar JA, 2005, TOP CURR GENET, V12, P141, DOI 10.1007/b106365; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; DUBIN DT, 1975, NUCLEIC ACIDS RES, V2, P1653, DOI 10.1093/nar/2.10.1653; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gildea RJ, 2011, J APPL CRYSTALLOGR, V44, P1259, DOI 10.1107/S0021889811041161; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kampf G, 2002, J CHEM SOC PERK T 2, P1320, DOI 10.1039/b202023h; Kang HJ, 2014, BIOCHEM J, V457, P391, DOI 10.1042/BJ20130862; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Li FD, 2014, CELL RES, V24, P1490, DOI 10.1038/cr.2014.153; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Luo SK, 2014, P NATL ACAD SCI USA, V111, P13834, DOI 10.1073/pnas.1412742111; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pan T, 2013, TRENDS BIOCHEM SCI, V38, P204, DOI 10.1016/j.tibs.2012.12.006; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; PERRY RP, 1975, CELL, V4, P387, DOI 10.1016/0092-8674(75)90159-2; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Xu C, 2014, J BIOL CHEM, V289, P17299, DOI 10.1074/jbc.M114.550350; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhu TT, 2014, CELL RES, V24, P1493, DOI 10.1038/cr.2014.152	50	147	155	6	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24902	24913		10.1074/jbc.M115.680389	http://dx.doi.org/10.1074/jbc.M115.680389			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26318451	Green Published, hybrid			2022-12-28	WOS:000362598300023
J	Zha, L; Li, FF; Wu, R; Artinian, L; Rehder, V; Yu, LQ; Liang, HJ; Xue, BZ; Shi, H				Zha, Lin; Li, Fenfen; Wu, Rui; Artinian, Liana; Rehder, Vincent; Yu, Liqing; Liang, Houjie; Xue, Bingzhong; Shi, Hang			The Histone Demethylase UTX Promotes Brown Adipocyte Thermogenic Program Via Coordinated Regulation of H3K27 Demethylation and Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCOUPLING PROTEIN-1 GENE; ADIPOSE-TISSUE; EPIGENETIC REGULATION; WHITE FAT; ENVIRONMENTAL-FACTORS; PGC-1 COACTIVATORS; UPSTREAM ENHANCER; DISEASE ETIOLOGY; BEIGE ADIPOCYTES; DNA METHYLATION	Brown adipocytes function to dissipate energy as heat through adaptive thermogenesis. Understanding the molecular mechanisms underlying the brown fat thermogenic program may provide insights for the development of therapeutic approaches in the treatment of obesity. Most studies investigating the mechanisms underlying brown fat development focus on genetic mechanisms; little is known about the epigenetic mechanisms in this process. We have discovered that ubiquitously transcribed tetratricopeptide repeat on chromosome X (UTX), a histone demethylase for di-or tri-methylated histone 3 lysine 27 (H3K27me2/3), plays a potential role in regulating brown adipocyte thermogenic program. We found that UTX is up-regulated during brown adipocyte differentiation and by cold exposure in both brown adipose tissue (BAT) and white adipose tissue (WAT) of mice, suggesting a potential role in thermogenesis. Inactivation of UTX down-regulates brown fat specific gene expression, while overexpression of UTX does the opposite. Notably, activation of beta adrenergic signaling recruits UTX to the UCP1 and PGC1 alpha promoters, leading to decreased H3K27me3, a histone transcriptional repressive mark. UTX demethylates H3K27me3 and subsequently interacts with the histone acetyltransferase (HAT) protein CBP, resulting in increased H3K27 acetylation (H3K27ac), a histone transcriptional active mark. UTX positively regulate brown adipocyte thermogenic program through coordinated control of demethylating H3K27me3 and acetylating H3K27, switching the transcriptional repressive state to the transcriptional active state at the promoters of UCP1 and PGC1 alpha. We conclude that UTX may play a potential role in regulation of brown adipocyte gene expression and may mediate beta adrenergic activation of brown fat function.	[Zha, Lin; Liang, Houjie] Third Mil Med Univ, Dept Oncol, Southwest Hosp, Chongqing 400038, Peoples R China; [Zha, Lin; Liang, Houjie] Third Mil Med Univ, Southwest Canc Ctr, Chongqing 400038, Peoples R China; [Zha, Lin; Li, Fenfen; Wu, Rui; Artinian, Liana; Rehder, Vincent; Xue, Bingzhong; Shi, Hang] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Zha, Lin; Li, Fenfen; Wu, Rui; Artinian, Liana; Rehder, Vincent; Xue, Bingzhong; Shi, Hang] Georgia State Univ, Ctr Obes Reversal, Atlanta, GA 30303 USA; [Yu, Liqing] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	Army Medical University; Army Medical University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Maryland; University of Maryland College Park	Liang, HJ (corresponding author), Third Mil Med Univ, Dept Oncol, Southwest Hosp, Chongqing 400038, Peoples R China.	lianghoujie@sina.com; bxue@gsu.edu; hshi3@gsu.edu	Regan, Clinton/E-6250-2012	Zha, Lin/0000-0002-0527-7944	National Institutes of Health [R01HL107500, R01DK084172]; American Heart Association (AHA) [10SDG3900046]; American Diabetes Association (ADA) [7-13-BS-159]; Center for Obesity Reversal at Georgia State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); American Diabetes Association (ADA)(American Diabetes Association); Center for Obesity Reversal at Georgia State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01HL107500 (to B. X.), R01DK084172 (to H. S.), American Heart Association (AHA) Grants 10SDG3900046 (to B. X.), American Diabetes Association (ADA) Grant 7-13-BS-159 (to H. S.), and seed grants from Center for Obesity Reversal at Georgia State University (to V.R. B.X., and H.S.). The authors declare that they have no conflicts of interest with the work presented in the paper.	Brito NA, 2008, AM J PHYSIOL-REG I, V294, pR1445, DOI 10.1152/ajpregu.00068.2008; Campion J, 2009, OBES REV, V10, P383, DOI 10.1111/j.1467-789X.2009.00595.x; CANNON B, 1985, ESSAYS BIOCHEM, V20, P110; Cao Q, 2014, ENDOCRINOLOGY, V155, P4925, DOI 10.1210/en.2014-1595; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dambacher S, 2010, HEREDITY, V105, P24, DOI 10.1038/hdy.2010.49; Edwards TM, 2007, ENVIRON HEALTH PERSP, V115, P1264, DOI 10.1289/ehp.9951; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gaydos LJ, 2014, SCIENCE, V345, P1515, DOI 10.1126/science.1255023; Ge K, 2012, BBA-GENE REGUL MECH, V1819, P727, DOI 10.1016/j.bbagrm.2011.12.008; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hill JO, 2012, CIRCULATION, V126, P126, DOI 10.1161/CIRCULATIONAHA.111.087213; Holness MJ, 2006, CURR OPIN CLIN NUTR, V9, P482, DOI 10.1097/01.mco.0000232912.69236.e0; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Iida A, 2014, P NATL ACAD SCI USA, V111, P3751, DOI 10.1073/pnas.1311480111; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Maier S, 2002, J NUTR, V132, p2440S, DOI 10.1093/jn/132.8.2440S; Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Rim JS, 2002, J BIOL CHEM, V277, P34589, DOI 10.1074/jbc.M108866200; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Shi H, 1999, FASEB J, V13, P1833, DOI 10.1096/fasebj.13.13.1833; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Shore A, 2010, DIABETOLOGIA, V53, P1164, DOI 10.1007/s00125-010-1701-4; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Szic KSV, 2010, BIOCHEM PHARMACOL, V80, P1816, DOI 10.1016/j.bcp.2010.07.029; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vaughan CH, 2014, METHOD ENZYMOL, V537, P199, DOI 10.1016/B978-0-12-411619-1.00011-2; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang LF, 2013, EMBO J, V32, P45, DOI 10.1038/emboj.2012.306; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Yang XS, 2014, MOL ENDOCRINOL, V28, P565, DOI 10.1210/me.2013-1293; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	60	53	54	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25151	25163		10.1074/jbc.M115.662650	http://dx.doi.org/10.1074/jbc.M115.662650			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26306033	hybrid, Green Published			2022-12-28	WOS:000362598300042
J	Tsaktanis, T; Kremling, H; Pavslc, M; von Stackelberg, R; Mack, B; Fukumori, A; Steiner, H; Vielmuth, F; Spindler, V; Huang, Z; Jakubowski, J; Stoecklein, NH; Luxenburger, E; Lauber, K; Lenarcic, B; Gires, O				Tsaktanis, Thanos; Kremling, Heidi; Pavslc, Miha; von Stackelberg, Ricarda; Mack, Brigitte; Fukumori, Akio; Steiner, Harald; Vielmuth, Franziska; Spindler, Volker; Huang, Zhe; Jakubowski, Jasmine; Stoecklein, Nikolas H.; Luxenburger, Elke; Lauber, Kirsten; Lenarcic, Brigita; Gires, Olivier			Cleavage and Cell Adhesion Properties of Human Epithelial Cell Adhesion Molecule (HEPCAM)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; AMYLOID PRECURSOR PROTEIN; ATOMIC-FORCE MICROSCOPY; EP-CAM; ANTIGEN EPCAM; MESENCHYMAL TRANSITION; COLORECTAL-CARCINOMA; STRUCTURE PREDICTION; GAMMA-SECRETASE; TIGHT JUNCTION	Human epithelial cell adhesion molecule (HEPCAM) is a tumor-associated antigen frequently expressed in carcinomas, which promotes proliferation after regulated intramembrane proteolysis. Here, we describe extracellular shedding of HEPCAM at two alpha-sites through a disintegrin and metalloprotease (ADAM) and at one beta-site through BACE1. Transmembrane cleavage by gamma-secretase occurs at three gamma-sites to generate extracellular A beta-like fragments and at two epsilon-sites to release human EPCAM intracellular domain HEPICD, which is efficiently degraded by the proteasome. Mapping of cleavage sites onto three-dimensional structures of HEPEX cis-dimer predicted conditional availability of alpha- and beta-sites. Endocytosis of HEPCAM warrants acidification in cytoplasmic vesicles to dissociate protein cis-dimers required for cleavage by BACE1 at low pH values. Intramembrane cleavage sites are accessible and not part of the structurally important transmembrane helix dimer crossing region. Surprisingly, neither chemical inhibition of cleavage nor cellular knock-out of HEPCAM using CRISPR-Cas9 technology impacted the adhesion of carcinoma cell lines. Hence, a direct function of HEPCAM as an adhesion molecule in carcinoma cells is not supported and appears to be questionable.	[Tsaktanis, Thanos; Kremling, Heidi; Pavslc, Miha; von Stackelberg, Ricarda; Huang, Zhe; Jakubowski, Jasmine; Luxenburger, Elke; Gires, Olivier] Univ Munich, Grosshadern Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Marchioninistr 15, D-81377 Munich, Germany; [Steiner, Harald] Univ Munich, Biomed Ctr, Biochem, D-81377 Munich, Germany; [Spindler, Volker] Univ Munich, Inst Anat & Cell Biol, Dept 1, D-81377 Munich, Germany; [Lauber, Kirsten] Univ Munich, Clin Radiotherapy & Radiat Oncol, D-81377 Munich, Germany; [Lauber, Kirsten] Univ Munich, Clin Cooperat Grp Personalized Radiotherapy Head, D-81377 Munich, Germany; [Lenarcic, Brigita] Univ Ljubljana, Fac Chem & Chem Technol, Dept Chem & Biochem, SI-511000 Ljubljana, Slovenia; [Fukumori, Akio; Steiner, Harald] DZNE German Ctr Neurodegenerat Dis, D-81377 Munich, Germany; [Jakubowski, Jasmine] Univ Munich, AMGEN Scholars Programme, LMU Bioctr, Munich Ctr Neurosci, D-82152 Martinsried, Germany; [Stoecklein, Nikolas H.] Univ Dusseldorf, Univ Hosp, Dept Gen Visceral & Pediat Surg, D-40225 Dusseldorf, Germany; [Stoecklein, Nikolas H.] Univ Dusseldorf, Fac Med, D-40225 Dusseldorf, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich; University of Ljubljana; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Gires, O (corresponding author), Univ Munich, Grosshadern Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Marchioninistr 15, D-81377 Munich, Germany.	Olivier.gires@med.uni-muenchen.de	Gires, Olivier/V-2689-2017; Spindler, Volker/G-1704-2019; Vielmuth, Franziska/AGF-7873-2022; Pavšič, Miha/AAZ-4772-2020	Gires, Olivier/0000-0002-2292-7064; Spindler, Volker/0000-0002-1302-5421; Pavšič, Miha/0000-0002-2230-1758; Lenarcic, Brigita/0000-0002-2508-3776	Wilhelm-Sander-Stiftung [2009.083.1]; Deutsche Krebshilfe Grant [109080]; AMGEN Scholar Program; FoFoLe Program of the Ludwig-Maximilians-Universitat Munchen	Wilhelm-Sander-Stiftung; Deutsche Krebshilfe Grant(Deutsche Krebshilfe); AMGEN Scholar Program; FoFoLe Program of the Ludwig-Maximilians-Universitat Munchen	This work was supported by Wilhelm-Sander-Stiftung Grant 2009.083.1, Deutsche Krebshilfe Grant 109080, the AMGEN Scholar Program, and the FoFoLe Program of the Ludwig-Maximilians-Universitat Munchen. The authors declare that they have no conflicts of interest with the contents of this article.	AKESON AL, 1993, J IMMUNOL METHODS, V163, P181, DOI 10.1016/0022-1759(93)90121-M; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Dolle L, 2015, AM J PHYSIOL-GASTR L, V308, pG233, DOI 10.1152/ajpgi.00069.2014; Driemel C, 2014, ONCOGENE, V33, P4904, DOI 10.1038/onc.2013.441; Gires O, 2014, CELL MOL LIFE SCI, V71, P4393, DOI 10.1007/s00018-014-1693-1; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Guerra E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049302; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hachmeister M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071836; HERLYN D, 1979, EUR J IMMUNOL, V9, P657, DOI 10.1002/eji.1830090817; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Imrich S, 2012, CELL ADHES MIGR, V6, P30, DOI 10.4161/cam.18953; JOACHIM CL, 1992, ALZ DIS ASSOC DIS, V6, P7, DOI 10.1097/00002093-199205000-00003; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; Lei ZL, 2012, DEV BIOL, V371, P136, DOI 10.1016/j.ydbio.2012.07.005; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; LITVINOV SV, 1994, CELL ADHES COMMUN, V2, P417, DOI 10.3109/15419069409004452; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Litvinov SV, 1996, AM J PATHOL, V148, P865; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Maghzal N, 2013, DEV CELL, V27, P263, DOI 10.1016/j.devcel.2013.10.003; Maghzal N, 2010, J CELL BIOL, V191, P645, DOI 10.1083/jcb.201004074; Monteiro AC, 2014, MOL BIOL CELL, V25, P1574, DOI 10.1091/mbc.E14-01-0018; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2008, FRONT BIOSCI-LANDMRK, V13, P5195, DOI 10.2741/3075; Nagao K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008543; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Patriarca C, 2012, CANCER TREAT REV, V38, P68, DOI 10.1016/j.ctrv.2011.04.002; Pavsic M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5764; Pavsic M, 2011, ACTA CRYSTALLOGR F, V67, P1363, DOI 10.1107/S1744309111031897; Philip R, 2015, ONCOTARGET, V6, P2046, DOI 10.18632/oncotarget.2858; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Rao CG, 2005, INT J ONCOL, V27, P49; RIETHMULLER G, 1994, LANCET, V343, P1177, DOI 10.1016/S0140-6736(94)92398-1; Sankpal NV, 2009, CANCER RES, V69, P753, DOI 10.1158/0008-5472.CAN-08-2708; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; SCHON MP, 1994, J INVEST DERMATOL, V102, P987, DOI 10.1111/1523-1747.ep12384258; Simon M, 2013, EXPERT OPIN DRUG DEL, V10, P451, DOI 10.1517/17425247.2013.759938; Sivagnanam M, 2008, GASTROENTEROLOGY, V135, P429, DOI 10.1053/j.gastro.2008.05.036; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Thuma F, 2013, INT J CANCER, V133, P855, DOI 10.1002/ijc.28085; Trzpis M, 2008, J PATHOL, V216, P201, DOI 10.1002/path.2396; Vannier C, 2013, J BIOL CHEM, V288, P18643, DOI 10.1074/jbc.M113.467787; Vielmuth F, 2015, NANOMED-NANOTECHNOL, V11, P511, DOI 10.1016/j.nano.2014.10.006; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Wildling L, 2011, BIOCONJUGATE CHEM, V22, P1239, DOI 10.1021/bc200099t; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187	63	37	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24574	24591		10.1074/jbc.M115.662700	http://dx.doi.org/10.1074/jbc.M115.662700			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26292218	Green Published, hybrid			2022-12-28	WOS:000362218900041
